{"idB": "749647_12_item1_p119_s0", "idA": "749647_11_item1_p100_s0", "sentA": "On February 25, 2011, the Company s board of directors approved the recommendations and ratified the determinations of its compensation committee and granted stock options to all of the Company s executive officers and directors.", "sentB": "In February 2012, the Company s board of directors approved the recommendations and ratified the determinations of its compensation committee and granted stock options to all of the Company s executive officers and directors.", "type": 2, "words": ["<tag1>", "On", "February", "25,", "2011,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors.", "<tag2>", "In", "February", "2012,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors.", "<tag3>"], "wordsA": ["On", "February", "25,", "2011,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors."], "wordsB": ["In", "February", "2012,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0150839164853096, 0.1463274210691452, 0.99253910779953, 0.0020273285917937756, 0.006947083864361048, 0.0034623374231159687, 0.005691970698535442, 0.0034578125923871994, 0.0068311067298054695, 0.008427640423178673, 0.002573632635176182, 0.007085242308676243, 0.003142864676192403, 0.004007022362202406, 0.0020427140407264233, 0.0037860076408833265, 0.002141498029232025, 0.0020808428525924683, 0.004083124455064535, 0.003545566461980343, 0.002888571470975876, 0.0028613731265068054, 0.005079863127321005, 0.005482502747327089, 0.002364563522860408, 0.004530257545411587, 0.002611342119053006, 0.002187222009524703, 0.005916725844144821, 0.0030923369340598583, 0.005145934410393238, 0.004275824874639511, 0.0029964065179228783, 0.0049048056825995445, -1]}
{"idB": "749647_12_item1_p121_s0", "idA": "749647_11_item1_p100_s0", "sentA": "On February 25, 2011, the Company s board of directors approved the recommendations and ratified the determinations of its compensation committee and granted stock options to all of the Company s executive officers and directors.", "sentB": "Following are the biographical summaries for each of the Company's executive officers.", "type": 2, "words": ["<tag1>", "On", "February", "25,", "2011,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors.", "<tag2>", "Following", "are", "the", "biographical", "summaries", "for", "each", "of", "the", "Company's", "executive", "officers.", "<tag3>"], "wordsA": ["On", "February", "25,", "2011,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors."], "wordsB": ["Following", "are", "the", "biographical", "summaries", "for", "each", "of", "the", "Company's", "executive", "officers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.17070372402668, 0.0686582550406456, 0.09056961536407471, 0.9006097316741943, 0.7241193056106567, 0.03161138668656349, 0.10502833127975464, 0.03375326842069626, 0.016853634268045425, 0.050782859325408936, 0.05488559976220131, 0.06949217617511749, -1]}
{"idB": "749647_12_item1_p130_s0", "idA": "749647_11_item1_p100_s0", "sentA": "On February 25, 2011, the Company s board of directors approved the recommendations and ratified the determinations of its compensation committee and granted stock options to all of the Company s executive officers and directors.", "sentB": "Mr. Church was appointed by the board of directors of the Company as Senior Vice President, Corporate Strategy and Investor Relations effective July 8, 2011.", "type": 2, "words": ["<tag1>", "On", "February", "25,", "2011,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors.", "<tag2>", "Mr.", "Church", "was", "appointed", "by", "the", "board", "of", "directors", "of", "the", "Company", "as", "Senior", "Vice", "President,", "Corporate", "Strategy", "and", "Investor", "Relations", "effective", "July", "8,", "2011.", "<tag3>"], "wordsA": ["On", "February", "25,", "2011,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors."], "wordsB": ["Mr.", "Church", "was", "appointed", "by", "the", "board", "of", "directors", "of", "the", "Company", "as", "Senior", "Vice", "President,", "Corporate", "Strategy", "and", "Investor", "Relations", "effective", "July", "8,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2377748340368271, 0.2573634088039398, 0.05707346275448799, 0.18064647912979126, 0.029648182913661003, 0.01809697225689888, 0.03395364433526993, 0.01657128892838955, 0.04304685816168785, 0.00765611557289958, 0.0104911457747221, 0.04371900111436844, 0.07875148952007294, 0.2687241733074188, 0.24121041595935822, 0.2222999781370163, 0.2883053421974182, 0.26125645637512207, 0.1997162252664566, 0.3586622178554535, 0.3933882415294647, 0.06099972873926163, 0.48313605785369873, 0.31874585151672363, 0.08203426003456116, -1]}
{"idB": "749647_12_item1_p133_s2", "idA": "749647_11_item1_p100_s0", "sentA": "On February 25, 2011, the Company s board of directors approved the recommendations and ratified the determinations of its compensation committee and granted stock options to all of the Company s executive officers and directors.", "sentB": "On February 25, 2011, Dr. Reed was appointed as Vice President, CMC and Technical Operations.", "type": 2, "words": ["<tag1>", "On", "February", "25,", "2011,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors.", "<tag2>", "On", "February", "25,", "2011,", "Dr.", "Reed", "was", "appointed", "as", "Vice", "President,", "CMC", "and", "Technical", "Operations.", "<tag3>"], "wordsA": ["On", "February", "25,", "2011,", "the", "Company", "s", "board", "of", "directors", "approved", "the", "recommendations", "and", "ratified", "the", "determinations", "of", "its", "compensation", "committee", "and", "granted", "stock", "options", "to", "all", "of", "the", "Company", "s", "executive", "officers", "and", "directors."], "wordsB": ["On", "February", "25,", "2011,", "Dr.", "Reed", "was", "appointed", "as", "Vice", "President,", "CMC", "and", "Technical", "Operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008512570522725582, 0.006508307531476021, 0.007759511470794678, 0.015444507822394371, 0.6347030997276306, 0.4434571862220764, 0.0646849274635315, 0.26201340556144714, 0.21445076167583466, 0.4750406742095947, 0.4803136885166168, 0.37880241870880127, 0.0782148465514183, 0.19074513018131256, 0.237696573138237, -1]}
{"idB": "749647_12_item1_p119_s1", "idA": "749647_11_item1_p100_s2", "sentA": "Executive officers Michael H. Tardugno, Jeffrey W. Church, Dr. Nicholas Borys and Dr. Robert A. Reed were awarded options to purchase 180,000, 70,000, 70,000 and 70,000 shares of Common Stock respectively.", "sentB": "Collectively, directors and executive officers were granted options to purchase 135,000 and 77,000 options respectively to purchase our common stock, respectively.", "type": 2, "words": ["<tag1>", "Executive", "officers", "Michael", "H.", "Tardugno,", "Jeffrey", "W.", "Church,", "Dr.", "Nicholas", "Borys", "and", "Dr.", "Robert", "A.", "Reed", "were", "awarded", "options", "to", "purchase", "180,000,", "70,000,", "70,000", "and", "70,000", "shares", "of", "Common", "Stock", "respectively.", "<tag2>", "Collectively,", "directors", "and", "executive", "officers", "were", "granted", "options", "to", "purchase", "135,000", "and", "77,000", "options", "respectively", "to", "purchase", "our", "common", "stock,", "respectively.", "<tag3>"], "wordsA": ["Executive", "officers", "Michael", "H.", "Tardugno,", "Jeffrey", "W.", "Church,", "Dr.", "Nicholas", "Borys", "and", "Dr.", "Robert", "A.", "Reed", "were", "awarded", "options", "to", "purchase", "180,000,", "70,000,", "70,000", "and", "70,000", "shares", "of", "Common", "Stock", "respectively."], "wordsB": ["Collectively,", "directors", "and", "executive", "officers", "were", "granted", "options", "to", "purchase", "135,000", "and", "77,000", "options", "respectively", "to", "purchase", "our", "common", "stock,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023410599678754807, 0.07584358751773834, 0.008044910617172718, 0.020367126911878586, 0.02004363015294075, 0.0023121885024011135, 0.014874523505568504, 0.015555727295577526, 0.003494455711916089, 0.03854669630527496, 0.936945915222168, 0.12752003967761993, 0.887066125869751, 0.1418837308883667, 0.0040817707777023315, 0.0015188645338639617, 0.01256374828517437, 0.00887116976082325, 0.01846742443740368, 0.028562724590301514, 0.00690602557733655, -1]}
{"idB": "749647_12_item1_p16_s0", "idA": "749647_11_item1_p10_s0", "sentA": "Celsion has also demonstrated feasibility for a product pipeline of cancer drugs that employ its heat activated liposomal technology in combination with known chemotherapeutics including docetaxel and carboplatin.", "sentB": "We have also demonstrated the feasibility for a product pipeline of cancer drugs that employ our heat activated liposomal technology in combination with known chemotherapeutics including docetaxel and carboplatin.", "type": 2, "words": ["<tag1>", "Celsion", "has", "also", "demonstrated", "feasibility", "for", "a", "product", "pipeline", "of", "cancer", "drugs", "that", "employ", "its", "heat", "activated", "liposomal", "technology", "in", "combination", "with", "known", "chemotherapeutics", "including", "docetaxel", "and", "carboplatin.", "<tag2>", "We", "have", "also", "demonstrated", "the", "feasibility", "for", "a", "product", "pipeline", "of", "cancer", "drugs", "that", "employ", "our", "heat", "activated", "liposomal", "technology", "in", "combination", "with", "known", "chemotherapeutics", "including", "docetaxel", "and", "carboplatin.", "<tag3>"], "wordsA": ["Celsion", "has", "also", "demonstrated", "feasibility", "for", "a", "product", "pipeline", "of", "cancer", "drugs", "that", "employ", "its", "heat", "activated", "liposomal", "technology", "in", "combination", "with", "known", "chemotherapeutics", "including", "docetaxel", "and", "carboplatin."], "wordsB": ["We", "have", "also", "demonstrated", "the", "feasibility", "for", "a", "product", "pipeline", "of", "cancer", "drugs", "that", "employ", "our", "heat", "activated", "liposomal", "technology", "in", "combination", "with", "known", "chemotherapeutics", "including", "docetaxel", "and", "carboplatin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7175284624099731, 0.08867333084344864, 0.06526435911655426, 0.12494274228811264, 0.00481700012460351, 0.08946603536605835, 0.01794537343084812, 0.009121577255427837, 0.03213026002049446, 0.05061056464910507, 0.010915884748101234, 0.044180043041706085, 0.06396432965993881, 0.010690782219171524, 0.03043261170387268, 0.023964153602719307, 0.09909961372613907, 0.06858611106872559, 0.04409313201904297, 0.027357596904039383, 0.01303180679678917, 0.019936831668019295, 0.01612594909965992, 0.06654113531112671, 0.05004371330142021, 0.01712709479033947, 0.045654747635126114, 0.01264577079564333, 0.027961067855358124, -1]}
{"idB": "749647_12_item1_p118_s0", "idA": "749647_11_item1_p11_s0", "sentA": "We believe that our technology can improve efficacy and safety of anticancer agents whose mechanism of action and safety profile are well understood by the medical and regulatory communities.", "sentB": "We believe that our cash and investment resources of $30.5 million on hand at December 31, 2011 are sufficient to fund operations into the second half of 2013.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "technology", "can", "improve", "efficacy", "and", "safety", "of", "anticancer", "agents", "whose", "mechanism", "of", "action", "and", "safety", "profile", "are", "well", "understood", "by", "the", "medical", "and", "regulatory", "communities.", "<tag2>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "technology", "can", "improve", "efficacy", "and", "safety", "of", "anticancer", "agents", "whose", "mechanism", "of", "action", "and", "safety", "profile", "are", "well", "understood", "by", "the", "medical", "and", "regulatory", "communities."], "wordsB": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018771018832921982, 0.042928170412778854, 0.02045305445790291, 0.02749795839190483, 0.40330857038497925, 0.21564818918704987, 0.5295897126197815, 0.4166603982448578, 0.028866909444332123, 0.2048283964395523, 0.16484308242797852, 0.04201703518629074, 0.08334717154502869, 0.016593070700764656, 0.021630313247442245, 0.030584270134568214, 0.04390581697225571, 0.03481470048427582, 0.13416126370429993, 0.015094446949660778, 0.11969254165887833, 0.14356325566768646, 0.0304793082177639, 0.01399950496852398, 0.040785785764455795, 0.09144022315740585, 0.057900361716747284, 0.2313745766878128, -1]}
{"idB": "749647_12_item1_p17_s3", "idA": "749647_11_item1_p11_s2", "sentA": "Additionally, we have formed a joint research agreement with Phillips Healthcare to evaluate the combination of Phillips high intensity focused ultrasound (HIFU) with ThermoDox to determine the potential of this combination to treat a broad range of cancers.", "sentB": "Additionally, we had formed a joint research agreement with Philips Healthcare, a division of Royal Philips Electronics to evaluate the combination of Philips high intensity focused ultrasound (HIFU) with ThermoDox to determine the potential of this combination to treat a broad range of cancers.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "have", "formed", "a", "joint", "research", "agreement", "with", "Phillips", "Healthcare", "to", "evaluate", "the", "combination", "of", "Phillips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers.", "<tag2>", "Additionally,", "we", "had", "formed", "a", "joint", "research", "agreement", "with", "Philips", "Healthcare,", "a", "division", "of", "Royal", "Philips", "Electronics", "to", "evaluate", "the", "combination", "of", "Philips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers.", "<tag3>"], "wordsA": ["Additionally,", "we", "have", "formed", "a", "joint", "research", "agreement", "with", "Phillips", "Healthcare", "to", "evaluate", "the", "combination", "of", "Phillips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers."], "wordsB": ["Additionally,", "we", "had", "formed", "a", "joint", "research", "agreement", "with", "Philips", "Healthcare,", "a", "division", "of", "Royal", "Philips", "Electronics", "to", "evaluate", "the", "combination", "of", "Philips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0024638178292661905, 0.0025172363966703415, 0.002339570317417383, 0.003035141620784998, 0.0018490480724722147, 0.0036658516619354486, 0.0036100151482969522, 0.006142163183540106, 0.003204953158274293, 0.8923934102058411, 0.27623242139816284, 0.001943135168403387, 0.015428679995238781, 0.012095347978174686, 0.08943041414022446, 0.7049979567527771, 0.2827807366847992, 0.0020777983590960503, 0.003176563885062933, 0.0021274257451295853, 0.004768084734678268, 0.0022108424454927444, 0.8865033388137817, 0.058019306510686874, 0.028550975024700165, 0.012918430380523205, 0.007563556078821421, 0.004855311010032892, 0.002068406203761697, 0.0031854421831667423, 0.0018582739867269993, 0.0021680891513824463, 0.002016260987147689, 0.0022316703107208014, 0.002017813269048929, 0.0019124081591144204, 0.0030323034152388573, 0.0018292467575520277, 0.00212107808329165, 0.0015708564314991236, 0.0024140910245478153, 0.002490536542609334, 0.0018092032987624407, 0.003933316562324762, -1]}
{"idB": "749647_12_item1_p17_s5", "idA": "749647_11_item1_p12_s1", "sentA": "We will also evaluate licensing cancer products from third parties for cancer treatments to expand our development pipeline.", "sentB": "We will also evaluate licensing cancer products from third parties for cancer treatments to expand our product pipeline.", "type": 2, "words": ["<tag1>", "We", "will", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "development", "pipeline.", "<tag2>", "We", "will", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "product", "pipeline.", "<tag3>"], "wordsA": ["We", "will", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "development", "pipeline."], "wordsB": ["We", "will", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "product", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04921456053853035, 0.03947284445166588, 0.04398808255791664, 0.30052855610847473, 0.15919765830039978, 0.21580418944358826, 0.26326605677604675, 0.025457991287112236, 0.13787998259067535, 0.2454380840063095, 0.016701556742191315, 0.06777951866388321, 0.06747027486562729, 0.00893510039895773, 0.05094701796770096, 0.12309735268354416, 0.7505557537078857, 0.5004336833953857, -1]}
{"idB": "749647_12_item1_p19_s0", "idA": "749647_11_item1_p13_s0", "sentA": "In the fourth quarter of 2008, we entered into a Development, Product Supply and Commercialization Agreement with Yakult Honsha under which Yakult was granted the exclusive right to commercialize and market ThermoDox for the Japanese market.", "sentB": "On December 5, 2008, we entered into a development, product supply and commercialization agreement with Yakult Honsha Co. (the Yakult Agreement) under which Yakult was granted the exclusive right to commercialize and market ThermoDox for the Japanese market.", "type": 2, "words": ["<tag1>", "In", "the", "fourth", "quarter", "of", "2008,", "we", "entered", "into", "a", "Development,", "Product", "Supply", "and", "Commercialization", "Agreement", "with", "Yakult", "Honsha", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market.", "<tag2>", "On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.", "(the", "Yakult", "Agreement)", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market.", "<tag3>"], "wordsA": ["In", "the", "fourth", "quarter", "of", "2008,", "we", "entered", "into", "a", "Development,", "Product", "Supply", "and", "Commercialization", "Agreement", "with", "Yakult", "Honsha", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market."], "wordsB": ["On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.", "(the", "Yakult", "Agreement)", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05561944097280502, 0.9193740487098694, 0.7587156891822815, 0.059657350182533264, 0.006891269236803055, 0.007083369884639978, 0.005997464060783386, 0.005408525466918945, 0.006630237214267254, 0.004961101338267326, 0.00579925999045372, 0.004448498133569956, 0.005208589602261782, 0.010548096150159836, 0.005955686327069998, 0.025293894112110138, 0.06407483667135239, 0.468951016664505, 0.008683616295456886, 0.042245667427778244, 0.027904054149985313, 0.007012871094048023, 0.004881484899669886, 0.02043732814490795, 0.0058137220330536366, 0.006863293703645468, 0.005391070153564215, 0.0070962063036859035, 0.0070727672427892685, 0.004668035078793764, 0.007250981405377388, 0.0061801434494555, 0.011869015172123909, 0.01302192360162735, 0.003180371131747961, 0.003440553555265069, 0.0119356419891119, 0.015028929337859154, -1]}
{"idB": "749647_12_item1_p19_s1", "idA": "749647_11_item1_p13_s1", "sentA": "We were paid a $2.5 million up-front licensing fee and we have the potential to receive additional payments from Yakult upon receipt of marketing approval by the Japanese Ministry of Health, Labor and Welfare as well as upon the achievement of certain levels of sales and approval for new indications.", "sentB": "We were paid a $2.5 million up-front licensing fee and may receive additional payments from Yakult upon receipt of marketing approval by the Japanese Ministry of Health, Labor and Welfare as well as upon the achievement of certain levels of sales and approval for new indications.", "type": 2, "words": ["<tag1>", "We", "were", "paid", "a", "$2.5", "million", "up-front", "licensing", "fee", "and", "we", "have", "the", "potential", "to", "receive", "additional", "payments", "from", "Yakult", "upon", "receipt", "of", "marketing", "approval", "by", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare", "as", "well", "as", "upon", "the", "achievement", "of", "certain", "levels", "of", "sales", "and", "approval", "for", "new", "indications.", "<tag2>", "We", "were", "paid", "a", "$2.5", "million", "up-front", "licensing", "fee", "and", "may", "receive", "additional", "payments", "from", "Yakult", "upon", "receipt", "of", "marketing", "approval", "by", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare", "as", "well", "as", "upon", "the", "achievement", "of", "certain", "levels", "of", "sales", "and", "approval", "for", "new", "indications.", "<tag3>"], "wordsA": ["We", "were", "paid", "a", "$2.5", "million", "up-front", "licensing", "fee", "and", "we", "have", "the", "potential", "to", "receive", "additional", "payments", "from", "Yakult", "upon", "receipt", "of", "marketing", "approval", "by", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare", "as", "well", "as", "upon", "the", "achievement", "of", "certain", "levels", "of", "sales", "and", "approval", "for", "new", "indications."], "wordsB": ["We", "were", "paid", "a", "$2.5", "million", "up-front", "licensing", "fee", "and", "may", "receive", "additional", "payments", "from", "Yakult", "upon", "receipt", "of", "marketing", "approval", "by", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare", "as", "well", "as", "upon", "the", "achievement", "of", "certain", "levels", "of", "sales", "and", "approval", "for", "new", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11922945827245712, 0.04200168699026108, 0.23733142018318176, 0.050719160586595535, 0.17884385585784912, 0.2741606831550598, 0.09265472739934921, 0.07960819453001022, 0.09075269848108292, 0.0009195339516736567, 0.0269002802670002, 0.08102582395076752, 0.14498139917850494, 0.16298310458660126, 0.0520000122487545, 0.10762015730142593, 0.038986027240753174, 0.04192422702908516, 0.031016908586025238, 0.05225984752178192, 0.07400909066200256, 0.02382330223917961, 0.02778460830450058, 0.04819072037935257, 0.04860598221421242, 0.03971237689256668, 0.04047451913356781, 0.03308085724711418, 0.03131278231739998, 0.0395960807800293, 0.020824860781431198, 0.01732965186238289, 0.017170125618577003, 0.020464377477765083, 0.02098744735121727, 0.023904558271169662, 0.021752361208200455, 0.03723296523094177, 0.03923186659812927, 0.023560328409075737, 0.039125509560108185, 0.019328901544213295, 0.04589587450027466, 0.025055043399333954, 0.059582918882369995, 0.10688799619674683, -1]}
{"idB": "749647_12_item1_p19_s2", "idA": "749647_11_item1_p13_s2", "sentA": "We will receive double digit escalating royalties on the sale ThermoDox in Japan, when and if any such sales occur.", "sentB": "Under the Yakult Agreement, we will receive double digit escalating royalties on the sale of ThermoDox in Japan, when and if any such sales occur and we also will be the exclusive supplier of ThermoDox to Yakult.", "type": 2, "words": ["<tag1>", "We", "will", "receive", "double", "digit", "escalating", "royalties", "on", "the", "sale", "ThermoDox", "in", "Japan,", "when", "and", "if", "any", "such", "sales", "occur.", "<tag2>", "Under", "the", "Yakult", "Agreement,", "we", "will", "receive", "double", "digit", "escalating", "royalties", "on", "the", "sale", "of", "ThermoDox", "in", "Japan,", "when", "and", "if", "any", "such", "sales", "occur", "and", "we", "also", "will", "be", "the", "exclusive", "supplier", "of", "ThermoDox", "to", "Yakult.", "<tag3>"], "wordsA": ["We", "will", "receive", "double", "digit", "escalating", "royalties", "on", "the", "sale", "ThermoDox", "in", "Japan,", "when", "and", "if", "any", "such", "sales", "occur."], "wordsB": ["Under", "the", "Yakult", "Agreement,", "we", "will", "receive", "double", "digit", "escalating", "royalties", "on", "the", "sale", "of", "ThermoDox", "in", "Japan,", "when", "and", "if", "any", "such", "sales", "occur", "and", "we", "also", "will", "be", "the", "exclusive", "supplier", "of", "ThermoDox", "to", "Yakult."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2919454872608185, 0.10484430193901062, 0.19380253553390503, 0.4277092218399048, 0.008464784361422062, 0.010511709377169609, 0.026137040928006172, 0.014674171805381775, 0.012827849015593529, 0.007802181877195835, 0.016705816611647606, 0.004537344444543123, 0.006473894231021404, 0.008416211232542992, 0.0058764321729540825, 0.014774325303733349, 0.0039028264582157135, 0.007483757100999355, 0.005961786489933729, 0.00857847835868597, 0.006953139323741198, 0.005451706703752279, 0.007191492710262537, 0.010491165332496166, 0.008060512132942677, 0.0064636641182005405, 0.006660259794443846, 0.010687202215194702, 0.008493920788168907, 0.03422793373465538, 0.05920754000544548, 0.7097350358963013, 0.7533447742462158, 0.15860050916671753, 0.26009759306907654, 0.013712584972381592, 0.02714201994240284, -1]}
{"idB": "749647_12_item1_p19_s3", "idA": "749647_11_item1_p14_s0", "sentA": "Concurrent with a preferred equity financing in January 2011, the Company amended its Development, Product Supply and Commercialization Agreement with Yakult to provide for up to $4.0 million in an accelerated partial payment to us of a future drug approval milestone.", "sentB": "Concurrent with a convertible preferred stock equity financing in January 2011, we amended the Yakult Agreement to provide for up to $4.0 million in an accelerated partial payment to us of a future drug approval milestone.", "type": 2, "words": ["<tag1>", "Concurrent", "with", "a", "preferred", "equity", "financing", "in", "January", "2011,", "the", "Company", "amended", "its", "Development,", "Product", "Supply", "and", "Commercialization", "Agreement", "with", "Yakult", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone.", "<tag2>", "Concurrent", "with", "a", "convertible", "preferred", "stock", "equity", "financing", "in", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone.", "<tag3>"], "wordsA": ["Concurrent", "with", "a", "preferred", "equity", "financing", "in", "January", "2011,", "the", "Company", "amended", "its", "Development,", "Product", "Supply", "and", "Commercialization", "Agreement", "with", "Yakult", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone."], "wordsB": ["Concurrent", "with", "a", "convertible", "preferred", "stock", "equity", "financing", "in", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0075668287463486195, 0.0040922206826508045, 0.004624297842383385, 0.9519686698913574, 0.5035952925682068, 0.49376383423805237, 0.20147264003753662, 0.06824234873056412, 0.002741321222856641, 0.0028930618427693844, 0.0031546358950436115, 0.002975442912429571, 0.005006040912121534, 0.0023944107815623283, 0.01143000926822424, 0.02115580253303051, 0.0026407609693706036, 0.0026227463968098164, 0.0026209447532892227, 0.003005485748872161, 0.002924124011769891, 0.004864696878939867, 0.0036484943702816963, 0.0028761127032339573, 0.002730255015194416, 0.004376980476081371, 0.01987527869641781, 0.009823944419622421, 0.0030253601726144552, 0.0033410422038286924, 0.0024067526683211327, 0.0022234227508306503, 0.0024961386807262897, 0.0029796978924423456, 0.00297436211258173, 0.0032432307489216328, -1]}
{"idB": "749647_12_item1_p19_s4", "idA": "749647_11_item1_p14_s1", "sentA": "The terms of the agreement with Yakult provide for the payment to the Company of $2.0 million upon the closing of the preferred equity financing and an additional $2.0 million conditioned upon the resumption of enrollment of Japanese patients in the Japan cohort of the HEAT study.", "sentB": "The terms of the Yakult Agreement provided for the payment to us of $2.0 million upon the closing of the preferred equity financing and an additional $2.0 million conditioned upon the resumption of enrollment of Japanese patients in the Japan cohort of the HEAT Study.", "type": 2, "words": ["<tag1>", "The", "terms", "of", "the", "agreement", "with", "Yakult", "provide", "for", "the", "payment", "to", "the", "Company", "of", "$2.0", "million", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study.", "<tag2>", "The", "terms", "of", "the", "Yakult", "Agreement", "provided", "for", "the", "payment", "to", "us", "of", "$2.0", "million", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["The", "terms", "of", "the", "agreement", "with", "Yakult", "provide", "for", "the", "payment", "to", "the", "Company", "of", "$2.0", "million", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study."], "wordsB": ["The", "terms", "of", "the", "Yakult", "Agreement", "provided", "for", "the", "payment", "to", "us", "of", "$2.0", "million", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006374162621796131, 0.017602866515517235, 0.00713307736441493, 0.0059745218604803085, 0.019826751202344894, 0.01867508701980114, 0.01570146717131138, 0.014243233017623425, 0.009417152032256126, 0.04131808131933212, 0.12421581149101257, 0.8990447521209717, 0.02569444477558136, 0.03221279755234718, 0.020202243700623512, 0.0061259944923222065, 0.007166580762714148, 0.009700228460133076, 0.007215841673314571, 0.006064042914658785, 0.00975340697914362, 0.010240532457828522, 0.011765694245696068, 0.009359005838632584, 0.008243937976658344, 0.009232057258486748, 0.015452045015990734, 0.011697877198457718, 0.006435135845094919, 0.007925408892333508, 0.0073188901878893375, 0.016315190121531487, 0.007403458468616009, 0.029521550983190536, 0.01110130175948143, 0.03681646287441254, 0.05781441554427147, 0.0036611943505704403, 0.003997663035988808, 0.01447488646954298, 0.014359904453158379, 0.0043692574836313725, 0.004607463721185923, 0.013507841154932976, 0.015623791143298149, -1]}
{"idB": "749647_12_item1_p18_s3", "idA": "749647_11_item1_p15_s2", "sentA": "Since then, the Company has raised approximately $15.4 million in equity financing providing a total of $60 million to support its research and operations.", "sentB": "To support our research and development, we have raised gross proceeds of approximately $67.6 million in equity financings in the years 2009 through 2011.", "type": 2, "words": ["<tag1>", "Since", "then,", "the", "Company", "has", "raised", "approximately", "$15.4", "million", "in", "equity", "financing", "providing", "a", "total", "of", "$60", "million", "to", "support", "its", "research", "and", "operations.", "<tag2>", "To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$67.6", "million", "in", "equity", "financings", "in", "the", "years", "2009", "through", "2011.", "<tag3>"], "wordsA": ["Since", "then,", "the", "Company", "has", "raised", "approximately", "$15.4", "million", "in", "equity", "financing", "providing", "a", "total", "of", "$60", "million", "to", "support", "its", "research", "and", "operations."], "wordsB": ["To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$67.6", "million", "in", "equity", "financings", "in", "the", "years", "2009", "through", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005394011735916138, 0.008965155109763145, 0.01018743310123682, 0.012365240603685379, 0.005235828459262848, 0.01100122183561325, 0.03760259598493576, 0.013056988827884197, 0.07311408966779709, 0.24660858511924744, 0.38978785276412964, 0.038665130734443665, 0.05706511065363884, 0.8177832365036011, 0.39356353878974915, 0.007292069494724274, 0.029935229569673538, 0.07455979287624359, 0.00883401371538639, 0.008469555526971817, 0.0379708893597126, 0.12250767648220062, 0.13963501155376434, 0.20012266933918, -1]}
{"idB": "749647_12_item1_p28_s0", "idA": "749647_11_item1_p16_s0", "sentA": "Liposomes are manufactured submicroscopic vesicles consisting of a discrete aqueous central compartment surrounded by a membrane bilayer composed of naturally occurring fats.", "sentB": "Liposomes are manufactured submicroscopic vesicles consisting of a discrete aqueous central compartment surrounded by a membrane bilayer composed of naturally occurring lipids.", "type": 2, "words": ["<tag1>", "Liposomes", "are", "manufactured", "submicroscopic", "vesicles", "consisting", "of", "a", "discrete", "aqueous", "central", "compartment", "surrounded", "by", "a", "membrane", "bilayer", "composed", "of", "naturally", "occurring", "fats.", "<tag2>", "Liposomes", "are", "manufactured", "submicroscopic", "vesicles", "consisting", "of", "a", "discrete", "aqueous", "central", "compartment", "surrounded", "by", "a", "membrane", "bilayer", "composed", "of", "naturally", "occurring", "lipids.", "<tag3>"], "wordsA": ["Liposomes", "are", "manufactured", "submicroscopic", "vesicles", "consisting", "of", "a", "discrete", "aqueous", "central", "compartment", "surrounded", "by", "a", "membrane", "bilayer", "composed", "of", "naturally", "occurring", "fats."], "wordsB": ["Liposomes", "are", "manufactured", "submicroscopic", "vesicles", "consisting", "of", "a", "discrete", "aqueous", "central", "compartment", "surrounded", "by", "a", "membrane", "bilayer", "composed", "of", "naturally", "occurring", "lipids."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.12417309731245041, 0.006895427592098713, 0.014981364831328392, 0.016277996823191643, 0.024992849677801132, 0.005029967520385981, 0.007490390446037054, 0.0035417797043919563, 0.011186899617314339, 0.011462252587080002, 0.008139077574014664, 0.01902417093515396, 0.006660833489149809, 0.006849344354122877, 0.005197710357606411, 0.014220614917576313, 0.012532769702374935, 0.007676008623093367, 0.009468944743275642, 0.025553029030561447, 0.037227172404527664, 0.8666381239891052, -1]}
{"idB": "749647_12_item1_p31_s0", "idA": "749647_11_item1_p20_s0", "sentA": "Celsion intends to use several available focused-heat technologies, such as radio frequency ablation ( RFA ), microwave energy and high intensity focused ultrasound, to activate the release of drugs from its novel heat-sensitive liposomes.", "sentB": "We intend to use several available focused-heat technologies, such as radio frequency ablation (RFA), microwave energy and high intensity focused ultrasound (HIFU), to activate the release of drugs from our novel heat-sensitive liposomes.", "type": 2, "words": ["<tag1>", "Celsion", "intends", "to", "use", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(", "RFA", "),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound,", "to", "activate", "the", "release", "of", "drugs", "from", "its", "novel", "heat-sensitive", "liposomes.", "<tag2>", "We", "intend", "to", "use", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(RFA),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat-sensitive", "liposomes.", "<tag3>"], "wordsA": ["Celsion", "intends", "to", "use", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(", "RFA", "),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound,", "to", "activate", "the", "release", "of", "drugs", "from", "its", "novel", "heat-sensitive", "liposomes."], "wordsB": ["We", "intend", "to", "use", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(RFA),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat-sensitive", "liposomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10834218561649323, 0.023366978392004967, 0.013142845593392849, 0.007941081188619137, 0.00654286565259099, 0.007861606776714325, 0.011843557469546795, 0.008021830581128597, 0.00529832486063242, 0.004157497081905603, 0.006497903726994991, 0.008481665514409542, 0.009044411592185497, 0.018408972769975662, 0.0084233982488513, 0.009511572308838367, 0.004901561886072159, 0.008189365267753601, 0.009391307830810547, 0.010112248361110687, 0.017825856804847717, 0.9482204914093018, 0.0039885747246444225, 0.004938911180943251, 0.0051653264090418816, 0.004848749376833439, 0.004046242218464613, 0.005092579405754805, 0.004042862914502621, 0.0056874412111938, 0.0057450393214821815, 0.007792486809194088, 0.011249969713389874, -1]}
{"idB": "749647_12_item1_p32_s2", "idA": "749647_11_item1_p23_s0", "sentA": "Celsion s proprietary heat-activated liposome technology enables delivery of significantly higher concentrations of proven chemotherapy drugs directly to the tumor, stopping the progression of cancer and minimizing systemic toxicities.", "sentB": "Our proprietary heat-activated liposome technology enables delivery of significantly higher concentrations of proven chemotherapy drugs directly to the tumor, stopping the progression of cancer and minimizing systemic toxicities.", "type": 2, "words": ["<tag1>", "Celsion", "s", "proprietary", "heat-activated", "liposome", "technology", "enables", "delivery", "of", "significantly", "higher", "concentrations", "of", "proven", "chemotherapy", "drugs", "directly", "to", "the", "tumor,", "stopping", "the", "progression", "of", "cancer", "and", "minimizing", "systemic", "toxicities.", "<tag2>", "Our", "proprietary", "heat-activated", "liposome", "technology", "enables", "delivery", "of", "significantly", "higher", "concentrations", "of", "proven", "chemotherapy", "drugs", "directly", "to", "the", "tumor,", "stopping", "the", "progression", "of", "cancer", "and", "minimizing", "systemic", "toxicities.", "<tag3>"], "wordsA": ["Celsion", "s", "proprietary", "heat-activated", "liposome", "technology", "enables", "delivery", "of", "significantly", "higher", "concentrations", "of", "proven", "chemotherapy", "drugs", "directly", "to", "the", "tumor,", "stopping", "the", "progression", "of", "cancer", "and", "minimizing", "systemic", "toxicities."], "wordsB": ["Our", "proprietary", "heat-activated", "liposome", "technology", "enables", "delivery", "of", "significantly", "higher", "concentrations", "of", "proven", "chemotherapy", "drugs", "directly", "to", "the", "tumor,", "stopping", "the", "progression", "of", "cancer", "and", "minimizing", "systemic", "toxicities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.46258965134620667, 0.1925392746925354, 0.1719007045030594, 0.14923563599586487, 0.10104688256978989, 0.020173588767647743, 0.02472717873752117, 0.0214425940066576, 0.0763678178191185, 0.33305639028549194, 0.20869342982769012, 0.028191590681672096, 0.10148867219686508, 0.0773623138666153, 0.09989792108535767, 0.035073403269052505, 0.016128377988934517, 0.012870622798800468, 0.02562473528087139, 0.026930879801511765, 0.016554784029722214, 0.035824909806251526, 0.016671590507030487, 0.04112449660897255, 0.013999084942042828, 0.025961553677916527, 0.023203659802675247, 0.026993490755558014, -1]}
{"idB": "749647_12_item1_p32_s3", "idA": "749647_11_item1_p23_s1", "sentA": "Currently in a Phase III clinical trial for primary liver cancer and a Phase I/II study for recurrent chest wall breast cancer, Celsion has completed animal studies that demonstrated intravenous administration of ThermoDox , in combination with targeted heat to the tumor, can produce doxorubicin drug concentrations in tumor tissue that are much greater than existing approved liposomal formulations of doxorubicin on the market today.", "sentB": "Currently in a Phase III clinical trial for primary liver cancer and in two Phase II studies for recurrent chest wall breast cancer and CRLM, Celsion has completed animal studies that demonstrate intravenous administration of ThermoDox , in combination with targeted heat to the tumor, can produce doxorubicin drug concentrations in tumor tissue that are much greater than approved liposomal formulations of doxorubicin on the market today.", "type": 2, "words": ["<tag1>", "Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "a", "Phase", "I/II", "study", "for", "recurrent", "chest", "wall", "breast", "cancer,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrated", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "existing", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today.", "<tag2>", "Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "in", "two", "Phase", "II", "studies", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "CRLM,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrate", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today.", "<tag3>"], "wordsA": ["Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "a", "Phase", "I/II", "study", "for", "recurrent", "chest", "wall", "breast", "cancer,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrated", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "existing", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today."], "wordsB": ["Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "in", "two", "Phase", "II", "studies", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "CRLM,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrate", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007713933475315571, 0.0076479543931782246, 0.006769305095076561, 0.014307215809822083, 0.015024751424789429, 0.010755767114460468, 0.016599901020526886, 0.00714454147964716, 0.043049156665802, 0.0365622416138649, 0.019776582717895508, 0.00705439317971468, 0.006449810694903135, 0.02395460568368435, 0.025026021525263786, 0.021705850958824158, 0.027224771678447723, 0.00773243885487318, 0.01443247590214014, 0.016222819685935974, 0.017922883853316307, 0.020159536972641945, 0.025779474526643753, 0.03434836119413376, 0.6895231008529663, 0.02702520228922367, 0.011135672219097614, 0.01136835291981697, 0.012740401551127434, 0.02488652430474758, 0.009018778800964355, 0.01104053296148777, 0.03528643399477005, 0.020341213792562485, 0.01253096479922533, 0.03799745813012123, 0.0011006685672327876, 0.01674901507794857, 0.01910792663693428, 0.013529341667890549, 0.016341261565685272, 0.022103434428572655, 0.01065080240368843, 0.011631595902144909, 0.021231040358543396, 0.008255166001617908, 0.009658163413405418, 0.02820846438407898, 0.01470088493078947, 0.015520317479968071, 0.0063302116468548775, 0.014957452192902565, 0.017266282811760902, 0.010272460989654064, 0.015010652132332325, 0.0326608307659626, 0.37041938304901123, 0.0754006877541542, 0.07215586304664612, 0.05568747967481613, 0.055702753365039825, 0.00936710461974144, 0.04306298494338989, 0.007329634856432676, 0.009820745326578617, 0.01627417840063572, 0.009857765398919582, -1]}
{"idB": "749647_12_item1_p75_s0", "idA": "749647_11_item1_p24_s0", "sentA": "Primary liver cancer (hepatocellular carcinoma or HCC ) is one of the most common and deadliest forms of cancer worldwide.", "sentB": "If the HEAT Study proves successful, it would add not only one of the most important new chemotherapeutic treatments to the oncologists arsenal, but validate a novel, highly-versatile technology with the potential to affect many cancers.", "type": 2, "words": ["<tag1>", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC", ")", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag2>", "If", "the", "HEAT", "Study", "proves", "successful,", "it", "would", "add", "not", "only", "one", "of", "the", "most", "important", "new", "chemotherapeutic", "treatments", "to", "the", "oncologists", "arsenal,", "but", "validate", "a", "novel,", "highly-versatile", "technology", "with", "the", "potential", "to", "affect", "many", "cancers.", "<tag3>"], "wordsA": ["Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC", ")", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "wordsB": ["If", "the", "HEAT", "Study", "proves", "successful,", "it", "would", "add", "not", "only", "one", "of", "the", "most", "important", "new", "chemotherapeutic", "treatments", "to", "the", "oncologists", "arsenal,", "but", "validate", "a", "novel,", "highly-versatile", "technology", "with", "the", "potential", "to", "affect", "many", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022539691999554634, 0.008338364772498608, 0.40958428382873535, 0.5908036231994629, 0.01933744177222252, 0.0214033592492342, 0.003969046752899885, 0.008609277196228504, 0.02394510805606842, 0.015153570100665092, 0.01385621726512909, 0.01456756703555584, 0.007412126287817955, 0.007580547593533993, 0.024921314790844917, 0.026290180161595345, 0.05207902565598488, 0.3404165506362915, 0.13637122511863708, 0.005495397839695215, 0.005013009067624807, 0.05670574679970741, 0.03343672677874565, 0.0001143347835750319, 0.02313218079507351, 0.006160855758935213, 0.04056651145219803, 0.1595134139060974, 0.08133653551340103, 0.00013339126599021256, 0.0062379599548876286, 0.007889319211244583, 0.006676519755274057, 0.0316561795771122, 0.03809080272912979, 0.08877655863761902, -1]}
{"idB": "749647_12_item1_p70_s0", "idA": "749647_11_item1_p25_s0", "sentA": "The incidence of primary liver cancer is approximately 20,000 cases per year in the United States, approximately 40,000 cases per year in Europe and is rapidly growing worldwide at approximately 750,000 cases per year.", "sentB": "Clinical outcomes in the treatment of primary liver cancer remain poor worldwide, with the 5-year survival rate at less than 10% and median survival from time of diagnosis at approximately 30 months.", "type": 2, "words": ["<tag1>", "The", "incidence", "of", "primary", "liver", "cancer", "is", "approximately", "20,000", "cases", "per", "year", "in", "the", "United", "States,", "approximately", "40,000", "cases", "per", "year", "in", "Europe", "and", "is", "rapidly", "growing", "worldwide", "at", "approximately", "750,000", "cases", "per", "year.", "<tag2>", "Clinical", "outcomes", "in", "the", "treatment", "of", "primary", "liver", "cancer", "remain", "poor", "worldwide,", "with", "the", "5-year", "survival", "rate", "at", "less", "than", "10%", "and", "median", "survival", "from", "time", "of", "diagnosis", "at", "approximately", "30", "months.", "<tag3>"], "wordsA": ["The", "incidence", "of", "primary", "liver", "cancer", "is", "approximately", "20,000", "cases", "per", "year", "in", "the", "United", "States,", "approximately", "40,000", "cases", "per", "year", "in", "Europe", "and", "is", "rapidly", "growing", "worldwide", "at", "approximately", "750,000", "cases", "per", "year."], "wordsB": ["Clinical", "outcomes", "in", "the", "treatment", "of", "primary", "liver", "cancer", "remain", "poor", "worldwide,", "with", "the", "5-year", "survival", "rate", "at", "less", "than", "10%", "and", "median", "survival", "from", "time", "of", "diagnosis", "at", "approximately", "30", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11276015639305115, 0.1871422976255417, 0.012413090094923973, 0.007316264323890209, 0.03582244738936424, 0.00933176837861538, 0.00921887718141079, 0.014463543891906738, 0.013809045776724815, 0.0906091257929802, 0.4583479166030884, 0.06737072765827179, 0.005490417592227459, 0.007094778586179018, 0.07899339497089386, 0.13314978778362274, 0.09934501349925995, 0.04109383001923561, 0.3134189248085022, 0.3464396595954895, 0.32030969858169556, 0.008712677285075188, 0.14552751183509827, 0.19532398879528046, 0.017238140106201172, 0.01590554043650627, 0.019924789667129517, 0.048184290528297424, 0.01766148954629898, 0.1035107895731926, 0.3318338990211487, 0.23859505355358124, -1]}
{"idB": "749647_12_item1_p72_s3", "idA": "749647_11_item1_p25_s0", "sentA": "The incidence of primary liver cancer is approximately 20,000 cases per year in the United States, approximately 40,000 cases per year in Europe and is rapidly growing worldwide at approximately 750,000 cases per year.", "sentB": "Enrollment in China is quickly approaching the minimum 200 patient requirement necessary to support local registrational filing in this important market, where over 50% of the incidences of primary liver cancer exist.", "type": 2, "words": ["<tag1>", "The", "incidence", "of", "primary", "liver", "cancer", "is", "approximately", "20,000", "cases", "per", "year", "in", "the", "United", "States,", "approximately", "40,000", "cases", "per", "year", "in", "Europe", "and", "is", "rapidly", "growing", "worldwide", "at", "approximately", "750,000", "cases", "per", "year.", "<tag2>", "Enrollment", "in", "China", "is", "quickly", "approaching", "the", "minimum", "200", "patient", "requirement", "necessary", "to", "support", "local", "registrational", "filing", "in", "this", "important", "market,", "where", "over", "50%", "of", "the", "incidences", "of", "primary", "liver", "cancer", "exist.", "<tag3>"], "wordsA": ["The", "incidence", "of", "primary", "liver", "cancer", "is", "approximately", "20,000", "cases", "per", "year", "in", "the", "United", "States,", "approximately", "40,000", "cases", "per", "year", "in", "Europe", "and", "is", "rapidly", "growing", "worldwide", "at", "approximately", "750,000", "cases", "per", "year."], "wordsB": ["Enrollment", "in", "China", "is", "quickly", "approaching", "the", "minimum", "200", "patient", "requirement", "necessary", "to", "support", "local", "registrational", "filing", "in", "this", "important", "market,", "where", "over", "50%", "of", "the", "incidences", "of", "primary", "liver", "cancer", "exist."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2552734613418579, 0.13885478675365448, 0.5236260890960693, 0.006888482719659805, 0.011458082124590874, 0.029926231130957603, 0.012932567857205868, 0.07430152595043182, 0.17185968160629272, 0.2663924992084503, 0.058602020144462585, 0.003999668173491955, 0.009635244496166706, 0.003650438040494919, 0.014499027281999588, 0.023823628202080727, 0.023030009120702744, 0.006295575760304928, 0.00378630799241364, 0.020647520199418068, 0.04062725976109505, 0.005240016616880894, 0.055880848318338394, 0.14351196587085724, 0.04149480164051056, 0.016612526029348373, 0.07917625457048416, 0.006056652404367924, 0.0075786178931593895, 0.012174774892628193, 0.014560045674443245, 0.11707565933465958, -1]}
{"idB": "749647_12_item1_p71_s0", "idA": "749647_11_item1_p25_s1", "sentA": "HCC has the fastest rate of growth of all cancers and is projected to be the most prevalent form of cancer by 2020.", "sentB": "The World Health Organization estimates that primary liver cancer may become the number one cancer worldwide, surpassing lung cancer, by 2020.", "type": 2, "words": ["<tag1>", "HCC", "has", "the", "fastest", "rate", "of", "growth", "of", "all", "cancers", "and", "is", "projected", "to", "be", "the", "most", "prevalent", "form", "of", "cancer", "by", "2020.", "<tag2>", "The", "World", "Health", "Organization", "estimates", "that", "primary", "liver", "cancer", "may", "become", "the", "number", "one", "cancer", "worldwide,", "surpassing", "lung", "cancer,", "by", "2020.", "<tag3>"], "wordsA": ["HCC", "has", "the", "fastest", "rate", "of", "growth", "of", "all", "cancers", "and", "is", "projected", "to", "be", "the", "most", "prevalent", "form", "of", "cancer", "by", "2020."], "wordsB": ["The", "World", "Health", "Organization", "estimates", "that", "primary", "liver", "cancer", "may", "become", "the", "number", "one", "cancer", "worldwide,", "surpassing", "lung", "cancer,", "by", "2020."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01318067405372858, 0.0618494413793087, 0.06318184733390808, 0.09669332206249237, 0.09095950424671173, 0.027054563164711, 0.36732402443885803, 0.4702260494232178, 0.5010454058647156, 0.03131774440407753, 0.05245327949523926, 0.02685333974659443, 0.14236891269683838, 0.18128719925880432, 0.13232912123203278, 0.033602356910705566, 0.22605565190315247, 0.2345857471227646, 0.4886991083621979, 0.008781573735177517, 0.01820126548409462, -1]}
{"idB": "749647_12_item1_p36_s0", "idA": "749647_11_item1_p27_s0", "sentA": "At an early stage, the standard first line treatment for liver cancer is surgical resection of the tumor, up to 80% of patients are ineligible for surgery at time of diagnosis as early stage liver cancer generally has few symptoms and when finally detected the tumor frequently is too large for surgery.", "sentB": "At an early stage, the standard first line treatment for liver cancer is surgical resection of the tumor, up to 80% of patients are ineligible for surgery or transplantation at time of diagnosis as early stage liver cancer generally has few symptoms and when finally detected the tumor frequently is too large for surgery.", "type": 2, "words": ["<tag1>", "At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor,", "up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery.", "<tag2>", "At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor,", "up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery.", "<tag3>"], "wordsA": ["At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor,", "up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery."], "wordsB": ["At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor,", "up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008042149245738983, 0.009016645140945911, 0.011579628102481365, 0.01067416276782751, 0.006710079964250326, 0.013027348555624485, 0.011951702646911144, 0.013692439533770084, 0.017390146851539612, 0.005913568660616875, 0.012354834005236626, 0.00955488532781601, 0.008233940228819847, 0.01197077240794897, 0.01617145724594593, 0.006037864834070206, 0.006662941537797451, 0.01290153805166483, 0.007475282996892929, 0.009226659312844276, 0.02194499969482422, 0.00878396537154913, 0.04723731055855751, 0.05526656284928322, 0.5498657822608948, 0.08219550549983978, 0.03974035009741783, 0.01950174942612648, 0.07500090450048447, 0.012342911213636398, 0.010628847405314445, 0.009885202161967754, 0.01020767167210579, 0.006250635255128145, 0.01000535860657692, 0.007855978794395924, 0.010840050876140594, 0.012187093496322632, 0.009585823863744736, 0.01056097261607647, 0.08562400937080383, 0.043391939252614975, 0.004915569443255663, 0.009513341821730137, 0.017574602738022804, 0.020062079653143883, 0.008039611391723156, 0.03798782825469971, 0.026759879663586617, 0.03289420157670975, 0.24206453561782837, 0.10133244097232819, 0.044783707708120346, 0.07330653816461563, -1]}
{"idB": "749647_12_item1_p36_s2", "idA": "749647_11_item1_p27_s2", "sentA": "For tumors generally up to 5 centimeters in diameter, radio frequency ablation (RFA) has emerged as the standard of care treatment approach which directly destroys the tumor tissue through the application of high temperatures by a probe inserted into the core of the tumor.", "sentB": "For tumors generally up to 5 centimeters in diameter, RFA has emerged as the standard of care treatment which directly destroys the tumor tissue through the application of high temperatures by a probe inserted into the core of the tumor.", "type": 2, "words": ["<tag1>", "For", "tumors", "generally", "up", "to", "5", "centimeters", "in", "diameter,", "radio", "frequency", "ablation", "(RFA)", "has", "emerged", "as", "the", "standard", "of", "care", "treatment", "approach", "which", "directly", "destroys", "the", "tumor", "tissue", "through", "the", "application", "of", "high", "temperatures", "by", "a", "probe", "inserted", "into", "the", "core", "of", "the", "tumor.", "<tag2>", "For", "tumors", "generally", "up", "to", "5", "centimeters", "in", "diameter,", "RFA", "has", "emerged", "as", "the", "standard", "of", "care", "treatment", "which", "directly", "destroys", "the", "tumor", "tissue", "through", "the", "application", "of", "high", "temperatures", "by", "a", "probe", "inserted", "into", "the", "core", "of", "the", "tumor.", "<tag3>"], "wordsA": ["For", "tumors", "generally", "up", "to", "5", "centimeters", "in", "diameter,", "radio", "frequency", "ablation", "(RFA)", "has", "emerged", "as", "the", "standard", "of", "care", "treatment", "approach", "which", "directly", "destroys", "the", "tumor", "tissue", "through", "the", "application", "of", "high", "temperatures", "by", "a", "probe", "inserted", "into", "the", "core", "of", "the", "tumor."], "wordsB": ["For", "tumors", "generally", "up", "to", "5", "centimeters", "in", "diameter,", "RFA", "has", "emerged", "as", "the", "standard", "of", "care", "treatment", "which", "directly", "destroys", "the", "tumor", "tissue", "through", "the", "application", "of", "high", "temperatures", "by", "a", "probe", "inserted", "into", "the", "core", "of", "the", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014600074850022793, 0.09417211264371872, 0.0666748657822609, 0.09510431438684464, 0.04436507076025009, 0.24819977581501007, 0.0924600213766098, 0.031775981187820435, 0.06618353724479675, 0.21315079927444458, 0.02151002176105976, 0.0396796315908432, 0.01301304716616869, 0.012139791622757912, 0.02977968379855156, 0.014667168259620667, 0.019497718662023544, 0.03927429020404816, 0.010693268850445747, 0.039617788046598434, 0.22947973012924194, 0.034961238503456116, 0.12798205018043518, 0.11625600606203079, 0.01175010297447443, 0.01306858193129301, 0.01843259297311306, 0.01292898878455162, 0.11338825523853302, 0.1528225690126419, 0.013595923781394958, 0.0157600287348032, 0.11090631783008575, 0.03145681694149971, 0.032584164291620255, 0.024194197729229927, 0.1557101309299469, 0.022703353315591812, 0.026575524359941483, 0.07019229233264923, -1]}
{"idB": "749647_12_item1_p36_s3", "idA": "749647_11_item1_p27_s3", "sentA": "Local recurrence rates after RFA are directly correlated to the size of the tumor.", "sentB": "Local recurrence rates after RFA directly correlates to the size of the tumor.", "type": 2, "words": ["<tag1>", "Local", "recurrence", "rates", "after", "RFA", "are", "directly", "correlated", "to", "the", "size", "of", "the", "tumor.", "<tag2>", "Local", "recurrence", "rates", "after", "RFA", "directly", "correlates", "to", "the", "size", "of", "the", "tumor.", "<tag3>"], "wordsA": ["Local", "recurrence", "rates", "after", "RFA", "are", "directly", "correlated", "to", "the", "size", "of", "the", "tumor."], "wordsB": ["Local", "recurrence", "rates", "after", "RFA", "directly", "correlates", "to", "the", "size", "of", "the", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018232040107250214, 0.0548834428191185, 0.07009242475032806, 0.1341254711151123, 0.13638468086719513, 0.3005389869213104, 0.9174947738647461, 0.20784752070903778, 0.11129944026470184, 0.16813039779663086, 0.0674690529704094, 0.07242823392152786, 0.14490771293640137, -1]}
{"idB": "749647_12_item1_p38_s0", "idA": "749647_11_item1_p29_s0", "sentA": "Local recurrence can be a problem especially for tumors greater than about three centimeters in diameter.", "sentB": "Local recurrence can be a problem especially for tumors greater than three centimeters in diameter.", "type": 2, "words": ["<tag1>", "Local", "recurrence", "can", "be", "a", "problem", "especially", "for", "tumors", "greater", "than", "about", "three", "centimeters", "in", "diameter.", "<tag2>", "Local", "recurrence", "can", "be", "a", "problem", "especially", "for", "tumors", "greater", "than", "three", "centimeters", "in", "diameter.", "<tag3>"], "wordsA": ["Local", "recurrence", "can", "be", "a", "problem", "especially", "for", "tumors", "greater", "than", "about", "three", "centimeters", "in", "diameter."], "wordsB": ["Local", "recurrence", "can", "be", "a", "problem", "especially", "for", "tumors", "greater", "than", "three", "centimeters", "in", "diameter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0082748644053936, 0.009677517227828503, 0.005871330387890339, 0.004107572603970766, 0.003066938603296876, 0.012098276056349277, 0.010781913064420223, 0.0077520813792943954, 0.031067032366991043, 0.9094634652137756, 0.8306005597114563, 0.571802020072937, 0.2816290259361267, 0.09960328042507172, 0.053419891744852066, -1]}
{"idB": "749647_12_item1_p39_s1", "idA": "749647_11_item1_p30_s1", "sentA": "This treatment is intended to deliver the drug directly to those cancer cells that survive RFA.", "sentB": "This novel treatment approach is intended to deliver the drug directly to those cancer cells that survive RFA.", "type": 2, "words": ["<tag1>", "This", "treatment", "is", "intended", "to", "deliver", "the", "drug", "directly", "to", "those", "cancer", "cells", "that", "survive", "RFA.", "<tag2>", "This", "novel", "treatment", "approach", "is", "intended", "to", "deliver", "the", "drug", "directly", "to", "those", "cancer", "cells", "that", "survive", "RFA.", "<tag3>"], "wordsA": ["This", "treatment", "is", "intended", "to", "deliver", "the", "drug", "directly", "to", "those", "cancer", "cells", "that", "survive", "RFA."], "wordsB": ["This", "novel", "treatment", "approach", "is", "intended", "to", "deliver", "the", "drug", "directly", "to", "those", "cancer", "cells", "that", "survive", "RFA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016122007742524147, 0.8571118712425232, 0.6100461483001709, 0.3777299225330353, 0.005639592185616493, 0.010582923889160156, 0.00223042001016438, 0.021267909556627274, 0.00559841375797987, 0.050069309771060944, 0.026941202580928802, 0.004815784282982349, 0.0056668417528271675, 0.015824763104319572, 0.02988424524664879, 0.005465541034936905, 0.022608138620853424, 0.025899415835738182, -1]}
{"idB": "749647_12_item1_p26_s0", "idA": "749647_11_item1_p31_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "In January 2012, we announced the enrollment of our first patient in the randomized Phase II study of ThermoDox in combination with radiofrequency ablation for the treatment of colorectal liver metastases (the ABLATE Study).", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "In", "January", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "Study).", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["In", "January", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02747991494834423, 0.26014676690101624, 0.7393439412117004, 0.021079231053590775, 0.08370228856801987, 0.012561210431158543, 0.17996522784233093, 0.01723877713084221, 0.016507409512996674, 0.06191257759928703, 0.08204429596662521, 0.005385801196098328, 0.005579766351729631, 0.050954073667526245, 0.030983801931142807, 0.0611499585211277, 0.059358131140470505, 0.007483636494725943, 0.021482251584529877, 0.004144739825278521, 0.015931401401758194, 0.013890883885324001, 0.5231761336326599, 0.2943956255912781, 0.004480784293264151, 0.004913458600640297, 0.05266920477151871, 0.02589382417500019, 0.48979583382606506, 0.3534126281738281, 0.48386669158935547, 0.004857500549405813, 0.22307106852531433, 0.2310803383588791, -1]}
{"idB": "749647_12_item1_p66_s0", "idA": "749647_11_item1_p31_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "In 2011, we initiated a Phase II study of ThermoDox in combination with RFA for the treatment of colorectal liver metastases.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05089924857020378, 0.8361928462982178, 0.02222982607781887, 0.04859302192926407, 0.010867724195122719, 0.03557193651795387, 0.04654683172702789, 0.0672343298792839, 0.009417828172445297, 0.014882002957165241, 0.0032382463105022907, 0.004579049069434404, 0.002973790979012847, 0.007071695756167173, 0.005198128987103701, 0.0046675121411681175, 0.06114688888192177, 0.028893154114484787, 0.6694691777229309, 0.4524605870246887, 0.570364773273468, -1]}
{"idB": "749647_12_item1_p41_s0", "idA": "749647_11_item1_p32_s0", "sentA": "In 2007, we initiated a second Phase I dose escalation study designed to investigate simplification of the current RFA/ThermoDox treatment regimen including a single vial formulation of ThermoDox and a reduction of the pre-treatment prophylactic dosing.", "sentB": "In 2007 we initiated a second Phase I dose escalation study designed to investigate simplification of the current RFA/ThermoDox treatment regimen including a single vial formulation of ThermoDox designed for commercial distribution.", "type": 2, "words": ["<tag1>", "In", "2007,", "we", "initiated", "a", "second", "Phase", "I", "dose", "escalation", "study", "designed", "to", "investigate", "simplification", "of", "the", "current", "RFA/ThermoDox", "treatment", "regimen", "including", "a", "single", "vial", "formulation", "of", "ThermoDox", "and", "a", "reduction", "of", "the", "pre-treatment", "prophylactic", "dosing.", "<tag2>", "In", "2007", "we", "initiated", "a", "second", "Phase", "I", "dose", "escalation", "study", "designed", "to", "investigate", "simplification", "of", "the", "current", "RFA/ThermoDox", "treatment", "regimen", "including", "a", "single", "vial", "formulation", "of", "ThermoDox", "designed", "for", "commercial", "distribution.", "<tag3>"], "wordsA": ["In", "2007,", "we", "initiated", "a", "second", "Phase", "I", "dose", "escalation", "study", "designed", "to", "investigate", "simplification", "of", "the", "current", "RFA/ThermoDox", "treatment", "regimen", "including", "a", "single", "vial", "formulation", "of", "ThermoDox", "and", "a", "reduction", "of", "the", "pre-treatment", "prophylactic", "dosing."], "wordsB": ["In", "2007", "we", "initiated", "a", "second", "Phase", "I", "dose", "escalation", "study", "designed", "to", "investigate", "simplification", "of", "the", "current", "RFA/ThermoDox", "treatment", "regimen", "including", "a", "single", "vial", "formulation", "of", "ThermoDox", "designed", "for", "commercial", "distribution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009390167891979218, 0.014858949929475784, 0.009375359863042831, 0.010822010226547718, 0.004641898442059755, 0.007542142644524574, 0.013776435516774654, 0.012723175808787346, 0.027803024277091026, 0.01337442547082901, 0.02380288764834404, 0.0058817933313548565, 0.004833729937672615, 0.006819570437073708, 0.010416479781270027, 0.006748727988451719, 0.00626413244754076, 0.017216164618730545, 0.0714888721704483, 0.02669653855264187, 0.014642573893070221, 0.0041578845120966434, 0.004254288040101528, 0.06466136127710342, 0.12247510254383087, 0.0316435806453228, 0.0048451912589371204, 0.040418483316898346, 0.029200220480561256, 0.06768806278705597, 0.8072136640548706, 0.8219533562660217, -1]}
{"idB": "749647_12_item1_p70_s1", "idA": "749647_11_item1_p32_s1", "sentA": "The study also permitted multiple dosing in liver cancer patients.", "sentB": "Cure, usually through surgery, is possible in fewer than 20% of patients.", "type": 2, "words": ["<tag1>", "The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients.", "<tag2>", "Cure,", "usually", "through", "surgery,", "is", "possible", "in", "fewer", "than", "20%", "of", "patients.", "<tag3>"], "wordsA": ["The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients."], "wordsB": ["Cure,", "usually", "through", "surgery,", "is", "possible", "in", "fewer", "than", "20%", "of", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6201840043067932, 0.0363321453332901, 0.15333104133605957, 0.329611599445343, 0.009389955550432205, 0.063960500061512, 0.01948770135641098, 0.510729968547821, 0.4892504811286926, 0.576809823513031, 0.07397284358739853, 0.17397810518741608, -1]}
{"idB": "749647_12_item1_p42_s0", "idA": "749647_11_item1_p33_s0", "sentA": "For primary liver cancer, ThermoDox is being evaluated in a pivotal 600 patient double-blinded, placebo-controlled, global Phase III study (the HEAT study ) at 76 clinical sites under a Special Protocol Assessment ( SPA ) agreement with the U.S. Food Drug Administration ( FDA ).", "sentB": "For primary liver cancer, our HEAT study to evaluate ThermoDox is a pivotal 600 patient double-blinded, placebo-controlled, global Phase III study conducted at 79 clinical sites under a Special Protocol Assessment (SPA) agreement with the FDA.", "type": 2, "words": ["<tag1>", "For", "primary", "liver", "cancer,", "ThermoDox", "is", "being", "evaluated", "in", "a", "pivotal", "600", "patient", "double-blinded,", "placebo-controlled,", "global", "Phase", "III", "study", "(the", "HEAT", "study", ")", "at", "76", "clinical", "sites", "under", "a", "Special", "Protocol", "Assessment", "(", "SPA", ")", "agreement", "with", "the", "U.S.", "Food", "Drug", "Administration", "(", "FDA", ").", "<tag2>", "For", "primary", "liver", "cancer,", "our", "HEAT", "study", "to", "evaluate", "ThermoDox", "is", "a", "pivotal", "600", "patient", "double-blinded,", "placebo-controlled,", "global", "Phase", "III", "study", "conducted", "at", "79", "clinical", "sites", "under", "a", "Special", "Protocol", "Assessment", "(SPA)", "agreement", "with", "the", "FDA.", "<tag3>"], "wordsA": ["For", "primary", "liver", "cancer,", "ThermoDox", "is", "being", "evaluated", "in", "a", "pivotal", "600", "patient", "double-blinded,", "placebo-controlled,", "global", "Phase", "III", "study", "(the", "HEAT", "study", ")", "at", "76", "clinical", "sites", "under", "a", "Special", "Protocol", "Assessment", "(", "SPA", ")", "agreement", "with", "the", "U.S.", "Food", "Drug", "Administration", "(", "FDA", ")."], "wordsB": ["For", "primary", "liver", "cancer,", "our", "HEAT", "study", "to", "evaluate", "ThermoDox", "is", "a", "pivotal", "600", "patient", "double-blinded,", "placebo-controlled,", "global", "Phase", "III", "study", "conducted", "at", "79", "clinical", "sites", "under", "a", "Special", "Protocol", "Assessment", "(SPA)", "agreement", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003175492165610194, 0.004190891515463591, 0.005850570742040873, 0.004094894975423813, 0.005060442257672548, 0.007830790244042873, 0.02607216127216816, 0.0027843809220939875, 0.006417777389287949, 0.005976635031402111, 0.001832181471399963, 0.0020304815843701363, 0.00432989839464426, 0.0043707056902348995, 0.00374792143702507, 0.004620862193405628, 0.004229538142681122, 0.003295605070888996, 0.0036698230542242527, 0.003388885874301195, 0.0061258841305971146, 0.007569743786007166, 0.006813595071434975, 0.9328858256340027, 0.11894290894269943, 0.05983886495232582, 0.0030953341629356146, 0.002781453775241971, 0.004502007272094488, 0.005334721878170967, 0.004236971493810415, 0.0038168937899172306, 0.00447638425976038, 0.003143240697681904, 0.003061716677621007, 0.006393749732524157, -1]}
{"idB": "749647_12_item1_p42_s2", "idA": "749647_11_item1_p33_s2", "sentA": "The study is being conducted in 76 clinical sites in the United States, Canada, Italy, China, Taiwan, Hong Kong, Korea, Japan, Thailand, Malaysia and the Philippines, with approximately 90% of the planned 600 patients now enrolled in the study.", "sentB": "The study is being conducted in 79 clinical sites in the United States, Canada, Italy, China, Taiwan, Hong Kong, Korea, Thailand, Malaysia and the Philippines, and we reached our preplanned enrollment objective of 600 patients in August 2011.", "type": 2, "words": ["<tag1>", "The", "study", "is", "being", "conducted", "in", "76", "clinical", "sites", "in", "the", "United", "States,", "Canada,", "Italy,", "China,", "Taiwan,", "Hong", "Kong,", "Korea,", "Japan,", "Thailand,", "Malaysia", "and", "the", "Philippines,", "with", "approximately", "90%", "of", "the", "planned", "600", "patients", "now", "enrolled", "in", "the", "study.", "<tag2>", "The", "study", "is", "being", "conducted", "in", "79", "clinical", "sites", "in", "the", "United", "States,", "Canada,", "Italy,", "China,", "Taiwan,", "Hong", "Kong,", "Korea,", "Thailand,", "Malaysia", "and", "the", "Philippines,", "and", "we", "reached", "our", "preplanned", "enrollment", "objective", "of", "600", "patients", "in", "August", "2011.", "<tag3>"], "wordsA": ["The", "study", "is", "being", "conducted", "in", "76", "clinical", "sites", "in", "the", "United", "States,", "Canada,", "Italy,", "China,", "Taiwan,", "Hong", "Kong,", "Korea,", "Japan,", "Thailand,", "Malaysia", "and", "the", "Philippines,", "with", "approximately", "90%", "of", "the", "planned", "600", "patients", "now", "enrolled", "in", "the", "study."], "wordsB": ["The", "study", "is", "being", "conducted", "in", "79", "clinical", "sites", "in", "the", "United", "States,", "Canada,", "Italy,", "China,", "Taiwan,", "Hong", "Kong,", "Korea,", "Thailand,", "Malaysia", "and", "the", "Philippines,", "and", "we", "reached", "our", "preplanned", "enrollment", "objective", "of", "600", "patients", "in", "August", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0016444665379822254, 0.019505741074681282, 0.00154013279825449, 0.008561055175960064, 0.014489465393126011, 0.011040346696972847, 0.9585222601890564, 0.152031809091568, 0.11076764017343521, 0.0021540718153119087, 0.0019576523918658495, 0.003407466458156705, 0.003613428445532918, 0.0035709028597921133, 0.004541815258562565, 0.00451609306037426, 0.00447183009237051, 0.0042137508280575275, 0.003709839191287756, 0.0035392900463193655, 0.0032949475571513176, 0.0029524865094572306, 0.00228567305020988, 0.001760306186042726, 0.002602214924991131, 0.003353816457092762, 0.005536296404898167, 0.013871635310351849, 0.008254162967205048, 0.16184483468532562, 0.07301589101552963, 0.03861406818032265, 0.010310017503798008, 0.04606253281235695, 0.04262203723192215, 0.0051521784625947475, 0.026510952040553093, 0.04581834375858307, -1]}
{"idB": "749647_12_item1_p48_s1", "idA": "749647_11_item1_p33_s2", "sentA": "The study is being conducted in 76 clinical sites in the United States, Canada, Italy, China, Taiwan, Hong Kong, Korea, Japan, Thailand, Malaysia and the Philippines, with approximately 90% of the planned 600 patients now enrolled in the study.", "sentB": "A total of 380 events of progression are required to reach the planned final analysis of the study.", "type": 2, "words": ["<tag1>", "The", "study", "is", "being", "conducted", "in", "76", "clinical", "sites", "in", "the", "United", "States,", "Canada,", "Italy,", "China,", "Taiwan,", "Hong", "Kong,", "Korea,", "Japan,", "Thailand,", "Malaysia", "and", "the", "Philippines,", "with", "approximately", "90%", "of", "the", "planned", "600", "patients", "now", "enrolled", "in", "the", "study.", "<tag2>", "A", "total", "of", "380", "events", "of", "progression", "are", "required", "to", "reach", "the", "planned", "final", "analysis", "of", "the", "study.", "<tag3>"], "wordsA": ["The", "study", "is", "being", "conducted", "in", "76", "clinical", "sites", "in", "the", "United", "States,", "Canada,", "Italy,", "China,", "Taiwan,", "Hong", "Kong,", "Korea,", "Japan,", "Thailand,", "Malaysia", "and", "the", "Philippines,", "with", "approximately", "90%", "of", "the", "planned", "600", "patients", "now", "enrolled", "in", "the", "study."], "wordsB": ["A", "total", "of", "380", "events", "of", "progression", "are", "required", "to", "reach", "the", "planned", "final", "analysis", "of", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01977500319480896, 0.07537595182657242, 0.07585223019123077, 0.6916758418083191, 0.549968957901001, 0.17000265419483185, 0.19383364915847778, 0.01091762538999319, 0.034097205847501755, 0.010216554626822472, 0.01410400215536356, 0.008898859843611717, 0.028966067358851433, 0.06940906494855881, 0.08183670043945312, 0.008647145703434944, 0.0089415879920125, 0.05784312263131142, -1]}
{"idB": "749647_12_item1_p26_s3", "idA": "749647_11_item1_p33_s3", "sentA": "The primary endpoint for the study is progression free survival ( PFS ) with a secondary confirmatory endpoint of overall survival.", "sentB": "The primary study endpoint is based on one year local tumor recurrence, with secondary endpoints of time to progression and overall survival.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "the", "study", "is", "progression", "free", "survival", "(", "PFS", ")", "with", "a", "secondary", "confirmatory", "endpoint", "of", "overall", "survival.", "<tag2>", "The", "primary", "study", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "recurrence,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "the", "study", "is", "progression", "free", "survival", "(", "PFS", ")", "with", "a", "secondary", "confirmatory", "endpoint", "of", "overall", "survival."], "wordsB": ["The", "primary", "study", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "recurrence,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0016854776768013835, 0.011065557599067688, 0.012877136468887329, 0.019402561709284782, 0.00244652247056365, 0.04046483710408211, 0.02675790525972843, 0.5230804085731506, 0.5023604035377502, 0.47709745168685913, 0.6679178476333618, 0.6854689717292786, 0.0028079331386834383, 0.031287312507629395, 0.022219734266400337, 0.003692113095894456, 0.11131913959980011, 0.0434703454375267, 0.06973405927419662, 0.00543364929035306, 0.03714810684323311, 0.06375571340322495, -1]}
{"idB": "749647_12_item1_p43_s0", "idA": "749647_11_item1_p33_s3", "sentA": "The primary endpoint for the study is progression free survival ( PFS ) with a secondary confirmatory endpoint of overall survival.", "sentB": "The primary endpoint for the study is PFS with a secondary confirmatory endpoint of Overall Survival (OS).", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "the", "study", "is", "progression", "free", "survival", "(", "PFS", ")", "with", "a", "secondary", "confirmatory", "endpoint", "of", "overall", "survival.", "<tag2>", "The", "primary", "endpoint", "for", "the", "study", "is", "PFS", "with", "a", "secondary", "confirmatory", "endpoint", "of", "Overall", "Survival", "(OS).", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "the", "study", "is", "progression", "free", "survival", "(", "PFS", ")", "with", "a", "secondary", "confirmatory", "endpoint", "of", "overall", "survival."], "wordsB": ["The", "primary", "endpoint", "for", "the", "study", "is", "PFS", "with", "a", "secondary", "confirmatory", "endpoint", "of", "Overall", "Survival", "(OS)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0016825324855744839, 0.013823885470628738, 0.01976870186626911, 0.0016981706721708179, 0.0014904538402333856, 0.006007877178490162, 0.004376158118247986, 0.4989071488380432, 0.002782091498374939, 0.002987735206261277, 0.014046670868992805, 0.017314579337835312, 0.020055586472153664, 0.0030786055140197277, 0.12698917090892792, 0.08140961080789566, 0.908236563205719, -1]}
{"idB": "749647_12_item1_p66_s3", "idA": "749647_11_item1_p33_s3", "sentA": "The primary endpoint for the study is progression free survival ( PFS ) with a secondary confirmatory endpoint of overall survival.", "sentB": "The primary study endpoint is based on one year local tumor recurrence, with secondary endpoints of time to progression and overall survival.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "the", "study", "is", "progression", "free", "survival", "(", "PFS", ")", "with", "a", "secondary", "confirmatory", "endpoint", "of", "overall", "survival.", "<tag2>", "The", "primary", "study", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "recurrence,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "the", "study", "is", "progression", "free", "survival", "(", "PFS", ")", "with", "a", "secondary", "confirmatory", "endpoint", "of", "overall", "survival."], "wordsB": ["The", "primary", "study", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "recurrence,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0016854776768013835, 0.011065557599067688, 0.012877136468887329, 0.019402561709284782, 0.00244652247056365, 0.04046483710408211, 0.02675790525972843, 0.5230804085731506, 0.5023604035377502, 0.47709745168685913, 0.6679178476333618, 0.6854689717292786, 0.0028079331386834383, 0.031287312507629395, 0.022219734266400337, 0.003692113095894456, 0.11131913959980011, 0.0434703454375267, 0.06973405927419662, 0.00543364929035306, 0.03714810684323311, 0.06375571340322495, -1]}
{"idB": "749647_12_item1_p22_s2", "idA": "749647_11_item1_p33_s4", "sentA": "A pre-planned, unblinded interim efficacy analysis will be performed by an independent Data Monitoring Committee when enrollment in the HEAT study is complete and 190 PFS events are realized in the study population.", "sentB": "The second trigger was the occurrence of 190 progression-free survival (PFS) events in the study population.", "type": 2, "words": ["<tag1>", "A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population.", "<tag2>", "The", "second", "trigger", "was", "the", "occurrence", "of", "190", "progression-free", "survival", "(PFS)", "events", "in", "the", "study", "population.", "<tag3>"], "wordsA": ["A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population."], "wordsB": ["The", "second", "trigger", "was", "the", "occurrence", "of", "190", "progression-free", "survival", "(PFS)", "events", "in", "the", "study", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0050841160118579865, 0.05163278430700302, 0.07836112380027771, 0.006227309349924326, 0.005346637684851885, 0.05739101395010948, 0.010303149931132793, 0.12109042704105377, 0.9082942605018616, 0.7455110549926758, 0.1584431231021881, 0.21083024144172668, 0.004316429141908884, 0.0034687567967921495, 0.018234120681881905, 0.017363261431455612, -1]}
{"idB": "749647_12_item1_p22_s3", "idA": "749647_11_item1_p33_s4", "sentA": "A pre-planned, unblinded interim efficacy analysis will be performed by an independent Data Monitoring Committee when enrollment in the HEAT study is complete and 190 PFS events are realized in the study population.", "sentB": "We met the second trigger of 190 PFS events in the third quarter of 2011 which allowed us to conduct a planned interim analysis in the fourth quarter of 2011.", "type": 2, "words": ["<tag1>", "A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population.", "<tag2>", "We", "met", "the", "second", "trigger", "of", "190", "PFS", "events", "in", "the", "third", "quarter", "of", "2011", "which", "allowed", "us", "to", "conduct", "a", "planned", "interim", "analysis", "in", "the", "fourth", "quarter", "of", "2011.", "<tag3>"], "wordsA": ["A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population."], "wordsB": ["We", "met", "the", "second", "trigger", "of", "190", "PFS", "events", "in", "the", "third", "quarter", "of", "2011", "which", "allowed", "us", "to", "conduct", "a", "planned", "interim", "analysis", "in", "the", "fourth", "quarter", "of", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07587763667106628, 0.12872010469436646, 0.05536944046616554, 0.19023287296295166, 0.17009243369102478, 0.02109522558748722, 0.03570297360420227, 0.04338853433728218, 0.07271157950162888, 0.016158685088157654, 0.018435675650835037, 0.3057412803173065, 0.1912151575088501, 0.12024260312318802, 0.25563478469848633, 0.0011759335175156593, 0.010661509819328785, 0.028982697054743767, 0.026162531226873398, 0.049818165600299835, 0.013533002696931362, 0.05565060302615166, 0.12038235366344452, 0.09364600479602814, 0.014426901005208492, 0.015891052782535553, 0.3464706540107727, 0.19312460720539093, 0.11407431215047836, 0.28676027059555054, -1]}
{"idB": "749647_12_item1_p23_s0", "idA": "749647_11_item1_p33_s4", "sentA": "A pre-planned, unblinded interim efficacy analysis will be performed by an independent Data Monitoring Committee when enrollment in the HEAT study is complete and 190 PFS events are realized in the study population.", "sentB": "The DMC evaluated data from 613 patients in its review, which was conducted following realization of 219 PFS events within the study population.", "type": 2, "words": ["<tag1>", "A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population.", "<tag2>", "The", "DMC", "evaluated", "data", "from", "613", "patients", "in", "its", "review,", "which", "was", "conducted", "following", "realization", "of", "219", "PFS", "events", "within", "the", "study", "population.", "<tag3>"], "wordsA": ["A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population."], "wordsB": ["The", "DMC", "evaluated", "data", "from", "613", "patients", "in", "its", "review,", "which", "was", "conducted", "following", "realization", "of", "219", "PFS", "events", "within", "the", "study", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008244390599429607, 0.19786357879638672, 0.14688198268413544, 0.09957985579967499, 0.03922567144036293, 0.4667697250843048, 0.2554936110973358, 0.006970683578401804, 0.010935846716165543, 0.05053137242794037, 0.00015345789142884314, 0.004212166182696819, 0.0107220858335495, 0.03064296580851078, 0.03483854979276657, 0.00983052421361208, 0.6548868417739868, 0.20330482721328735, 0.09753219038248062, 0.006815234664827585, 0.005256955511868, 0.02486235462129116, 0.025015367195010185, -1]}
{"idB": "749647_12_item1_p43_s1", "idA": "749647_11_item1_p33_s4", "sentA": "A pre-planned, unblinded interim efficacy analysis will be performed by an independent Data Monitoring Committee when enrollment in the HEAT study is complete and 190 PFS events are realized in the study population.", "sentB": "In the third quarter of 2011, we reached 190 PFS events in the study population, which allowed us to conduct the planned interim efficacy analysis.", "type": 2, "words": ["<tag1>", "A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population.", "<tag2>", "In", "the", "third", "quarter", "of", "2011,", "we", "reached", "190", "PFS", "events", "in", "the", "study", "population,", "which", "allowed", "us", "to", "conduct", "the", "planned", "interim", "efficacy", "analysis.", "<tag3>"], "wordsA": ["A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population."], "wordsB": ["In", "the", "third", "quarter", "of", "2011,", "we", "reached", "190", "PFS", "events", "in", "the", "study", "population,", "which", "allowed", "us", "to", "conduct", "the", "planned", "interim", "efficacy", "analysis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.039322566241025925, 0.03481639549136162, 0.3718216121196747, 0.2371518462896347, 0.1728939265012741, 0.36978474259376526, 0.09136313945055008, 0.211860790848732, 0.23925437033176422, 0.09587868303060532, 0.12764525413513184, 0.024109311401844025, 0.022005870938301086, 0.039748042821884155, 0.05196664482355118, 0.00670486968010664, 0.050844889134168625, 0.06198418512940407, 0.1432790458202362, 0.31374382972717285, 0.029542049393057823, 0.07638372480869293, 0.04596433788537979, 0.03381863981485367, 0.0691521167755127, -1]}
{"idB": "749647_12_item1_p48_s0", "idA": "749647_11_item1_p33_s4", "sentA": "A pre-planned, unblinded interim efficacy analysis will be performed by an independent Data Monitoring Committee when enrollment in the HEAT study is complete and 190 PFS events are realized in the study population.", "sentB": "The DMC evaluated data from 613 patients in its review, which was conducted following the realization of 219 progression-free survival (PFS) events within the study population.", "type": 2, "words": ["<tag1>", "A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population.", "<tag2>", "The", "DMC", "evaluated", "data", "from", "613", "patients", "in", "its", "review,", "which", "was", "conducted", "following", "the", "realization", "of", "219", "progression-free", "survival", "(PFS)", "events", "within", "the", "study", "population.", "<tag3>"], "wordsA": ["A", "pre-planned,", "unblinded", "interim", "efficacy", "analysis", "will", "be", "performed", "by", "an", "independent", "Data", "Monitoring", "Committee", "when", "enrollment", "in", "the", "HEAT", "study", "is", "complete", "and", "190", "PFS", "events", "are", "realized", "in", "the", "study", "population."], "wordsB": ["The", "DMC", "evaluated", "data", "from", "613", "patients", "in", "its", "review,", "which", "was", "conducted", "following", "the", "realization", "of", "219", "progression-free", "survival", "(PFS)", "events", "within", "the", "study", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008102799765765667, 0.1728355586528778, 0.14262107014656067, 0.10120938718318939, 0.03398403152823448, 0.4990287721157074, 0.23474402725696564, 0.006565250921994448, 0.011580046266317368, 0.048376280814409256, 0.00011317704775137827, 0.00437496742233634, 0.010284136049449444, 0.019435236230492592, 0.0057653202675282955, 0.03430964797735214, 0.009414270520210266, 0.3791062533855438, 0.6654601097106934, 0.4738729000091553, 0.08391302824020386, 0.11450634896755219, 0.005091729573905468, 0.0057328008115291595, 0.024618536233901978, 0.023265069350600243, -1]}
{"idB": "749647_12_item1_p22_s4", "idA": "749647_11_item1_p34_s0", "sentA": "On October 1, 2010, we were advised that after reviewing data from 401 randomized patients enrolled in the HEAT study, the Data Monitoring Committee (the DMC ) for this trial unanimously recommended that the trial continue to enroll patients with the goal of reaching the 600 patients required to complete the study.", "sentB": "On November 28, 2011, we announced that the independent DMC for the HEAT Study completed a pre-planned interim analysis for safety, efficacy and futility and unanimously recommended that the study continue to its final analysis as planned.", "type": 2, "words": ["<tag1>", "On", "October", "1,", "2010,", "we", "were", "advised", "that", "after", "reviewing", "data", "from", "401", "randomized", "patients", "enrolled", "in", "the", "HEAT", "study,", "the", "Data", "Monitoring", "Committee", "(the", "DMC", ")", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "with", "the", "goal", "of", "reaching", "the", "600", "patients", "required", "to", "complete", "the", "study.", "<tag2>", "On", "November", "28,", "2011,", "we", "announced", "that", "the", "independent", "DMC", "for", "the", "HEAT", "Study", "completed", "a", "pre-planned", "interim", "analysis", "for", "safety,", "efficacy", "and", "futility", "and", "unanimously", "recommended", "that", "the", "study", "continue", "to", "its", "final", "analysis", "as", "planned.", "<tag3>"], "wordsA": ["On", "October", "1,", "2010,", "we", "were", "advised", "that", "after", "reviewing", "data", "from", "401", "randomized", "patients", "enrolled", "in", "the", "HEAT", "study,", "the", "Data", "Monitoring", "Committee", "(the", "DMC", ")", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "with", "the", "goal", "of", "reaching", "the", "600", "patients", "required", "to", "complete", "the", "study."], "wordsB": ["On", "November", "28,", "2011,", "we", "announced", "that", "the", "independent", "DMC", "for", "the", "HEAT", "Study", "completed", "a", "pre-planned", "interim", "analysis", "for", "safety,", "efficacy", "and", "futility", "and", "unanimously", "recommended", "that", "the", "study", "continue", "to", "its", "final", "analysis", "as", "planned."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016970688477158546, 0.5702317953109741, 0.5227043032646179, 0.6132274270057678, 0.024558328092098236, 0.05157722160220146, 0.006736503913998604, 0.005767569411545992, 0.19557544589042664, 0.19482971727848053, 0.005652755498886108, 0.0037537633907049894, 0.01872820220887661, 0.02656177431344986, 0.049084827303886414, 0.00850629061460495, 0.03379472345113754, 0.156696617603302, 0.16467714309692383, 0.004490754567086697, 0.06372614204883575, 0.030809149146080017, 0.017858054488897324, 0.03947790712118149, 0.0003462443419266492, 0.007981671020388603, 0.02724049799144268, 0.0076143136247992516, 0.006009155884385109, 0.11468024551868439, 0.0754421129822731, 0.04475666955113411, 0.023889867588877678, 0.22982335090637207, 0.2996932864189148, 0.013139912858605385, 0.02314087189733982, -1]}
{"idB": "749647_12_item1_p20_s1", "idA": "749647_11_item1_p34_s2", "sentA": "In addition, the DMC has recommended, and confirmed such recommendation on November 24, 2010, a hold on enrollment of additional patients in this trial in Japan in accordance with the requirements of the DMC s charter pending review by the DMC of certain safety and efficacy data as required by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.", "sentB": "The DMC maintained its recommendation to continue withholding enrollment of additional patients in Japan pending certain guidance from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "DMC", "has", "recommended,", "and", "confirmed", "such", "recommendation", "on", "November", "24,", "2010,", "a", "hold", "on", "enrollment", "of", "additional", "patients", "in", "this", "trial", "in", "Japan", "in", "accordance", "with", "the", "requirements", "of", "the", "DMC", "s", "charter", "pending", "review", "by", "the", "DMC", "of", "certain", "safety", "and", "efficacy", "data", "as", "required", "by", "the", "Pharmaceuticals", "and", "Medical", "Devices", "Agency", "(PMDA)", "in", "Japan.", "<tag2>", "The", "DMC", "maintained", "its", "recommendation", "to", "continue", "withholding", "enrollment", "of", "additional", "patients", "in", "Japan", "pending", "certain", "guidance", "from", "the", "Pharmaceuticals", "and", "Medical", "Devices", "Agency", "(PMDA)", "in", "Japan.", "<tag3>"], "wordsA": ["In", "addition,", "the", "DMC", "has", "recommended,", "and", "confirmed", "such", "recommendation", "on", "November", "24,", "2010,", "a", "hold", "on", "enrollment", "of", "additional", "patients", "in", "this", "trial", "in", "Japan", "in", "accordance", "with", "the", "requirements", "of", "the", "DMC", "s", "charter", "pending", "review", "by", "the", "DMC", "of", "certain", "safety", "and", "efficacy", "data", "as", "required", "by", "the", "Pharmaceuticals", "and", "Medical", "Devices", "Agency", "(PMDA)", "in", "Japan."], "wordsB": ["The", "DMC", "maintained", "its", "recommendation", "to", "continue", "withholding", "enrollment", "of", "additional", "patients", "in", "Japan", "pending", "certain", "guidance", "from", "the", "Pharmaceuticals", "and", "Medical", "Devices", "Agency", "(PMDA)", "in", "Japan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0046149445697665215, 0.059662964195013046, 0.1891912817955017, 0.10906105488538742, 0.2529377341270447, 0.044159162789583206, 0.192103773355484, 0.8608267903327942, 0.4801234006881714, 0.10348185151815414, 0.07437673211097717, 0.15457572042942047, 0.010779975913465023, 0.05086193606257439, 0.007980925031006336, 0.005193835590034723, 0.030563704669475555, 0.005121233407407999, 0.004088762681931257, 0.00894876942038536, 0.002628536894917488, 0.004302487708628178, 0.004031382035464048, 0.007946868427097797, 0.009846020489931107, 0.0033379001542925835, 0.007480273023247719, -1]}
{"idB": "749647_12_item1_p22_s0", "idA": "749647_11_item1_p35_s0", "sentA": "On February 9, 2011, after reviewing data from 482 randomized patients enrolled in our pivotal Phase III HEAT study, the DMC for this trial unanimously recommended that the trial continue to enroll patients at all clinical sites except for those in Japan with the goal of reaching the 600 patients required to complete the study.", "sentB": "On August 3, 2011, we announced that we had reached our preplanned enrollment objective of 600 patients in the pivotal Phase III HEAT study.", "type": 2, "words": ["<tag1>", "On", "February", "9,", "2011,", "after", "reviewing", "data", "from", "482", "randomized", "patients", "enrolled", "in", "our", "pivotal", "Phase", "III", "HEAT", "study,", "the", "DMC", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "at", "all", "clinical", "sites", "except", "for", "those", "in", "Japan", "with", "the", "goal", "of", "reaching", "the", "600", "patients", "required", "to", "complete", "the", "study.", "<tag2>", "On", "August", "3,", "2011,", "we", "announced", "that", "we", "had", "reached", "our", "preplanned", "enrollment", "objective", "of", "600", "patients", "in", "the", "pivotal", "Phase", "III", "HEAT", "study.", "<tag3>"], "wordsA": ["On", "February", "9,", "2011,", "after", "reviewing", "data", "from", "482", "randomized", "patients", "enrolled", "in", "our", "pivotal", "Phase", "III", "HEAT", "study,", "the", "DMC", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "at", "all", "clinical", "sites", "except", "for", "those", "in", "Japan", "with", "the", "goal", "of", "reaching", "the", "600", "patients", "required", "to", "complete", "the", "study."], "wordsB": ["On", "August", "3,", "2011,", "we", "announced", "that", "we", "had", "reached", "our", "preplanned", "enrollment", "objective", "of", "600", "patients", "in", "the", "pivotal", "Phase", "III", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022689344361424446, 0.748662531375885, 0.5543466210365295, 0.0776183232665062, 0.042170505970716476, 0.08386493474245071, 0.006366667337715626, 0.023188704624772072, 0.016594592481851578, 0.022391928359866142, 0.009347112849354744, 0.29684561491012573, 0.23638181388378143, 0.09588034451007843, 0.01336700189858675, 0.4175070822238922, 0.3281473219394684, 0.003913550172001123, 0.003965741489082575, 0.007177955936640501, 0.005269788205623627, 0.005001040641218424, 0.008321032859385014, 0.015081215649843216, -1]}
{"idB": "749647_12_item1_p12_s0", "idA": "749647_11_item1_p37_s0", "sentA": "In August 2010, the FDA designated the HEAT Study of the Company s investigational drug, ThermoDox@, in combination with RFA, as a Fast Track Development Program.", "sentB": "The U.S. Food and Drug Administration (FDA) has granted our pivotal Phase III HEAT study for ThermoDox , in combination with radiofrequency ablation a Special Protocol Assessment and has designated it as a Fast Track Development Program.", "type": 2, "words": ["<tag1>", "In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program.", "<tag2>", "The", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "has", "granted", "our", "pivotal", "Phase", "III", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "a", "Special", "Protocol", "Assessment", "and", "has", "designated", "it", "as", "a", "Fast", "Track", "Development", "Program.", "<tag3>"], "wordsA": ["In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program."], "wordsB": ["The", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "has", "granted", "our", "pivotal", "Phase", "III", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "a", "Special", "Protocol", "Assessment", "and", "has", "designated", "it", "as", "a", "Fast", "Track", "Development", "Program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007460389286279678, 0.3014940917491913, 0.36331868171691895, 0.40655481815338135, 0.1997113972902298, 0.45122313499450684, 0.061238013207912445, 0.01350514218211174, 0.05278296023607254, 0.03335793688893318, 0.06009550392627716, 0.08684268593788147, 0.2181544005870819, 0.08378434181213379, 0.11655247956514359, 0.015343728475272655, 0.021291863173246384, 9.330113971373066e-05, 0.0036124757025390863, 0.010530431754887104, 0.007550988811999559, 0.3259982764720917, 0.18407398462295532, 0.005816197954118252, 0.06365442276000977, 0.06889597326517105, 0.059409432113170624, 0.0073998793959617615, 0.0057037812657654285, 0.0265071839094162, 0.006109138019382954, 0.0040538739413022995, 0.003343211952596903, 0.007785795256495476, 0.009227952919900417, 0.00805698987096548, 0.00985676422715187, -1]}
{"idB": "749647_12_item1_p14_s0", "idA": "749647_11_item1_p37_s0", "sentA": "In August 2010, the FDA designated the HEAT Study of the Company s investigational drug, ThermoDox@, in combination with RFA, as a Fast Track Development Program.", "sentB": "In December 2011, the European Medicines Agency (EMA) provided written, scientific advice confirming that the HEAT Study is acceptable as a basis for submission of a marketing authorization application (MAA).", "type": 2, "words": ["<tag1>", "In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program.", "<tag2>", "In", "December", "2011,", "the", "European", "Medicines", "Agency", "(EMA)", "provided", "written,", "scientific", "advice", "confirming", "that", "the", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application", "(MAA).", "<tag3>"], "wordsA": ["In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program."], "wordsB": ["In", "December", "2011,", "the", "European", "Medicines", "Agency", "(EMA)", "provided", "written,", "scientific", "advice", "confirming", "that", "the", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application", "(MAA)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.020596710965037346, 0.6695420742034912, 0.5649890303611755, 0.013189229182898998, 0.21523058414459229, 0.3169088661670685, 0.19998839497566223, 0.3937758505344391, 0.054143697023391724, 0.07486125826835632, 0.06017013266682625, 0.08354921638965607, 0.015570368617773056, 0.009702893905341625, 0.009488235227763653, 0.07422233372926712, 0.09688527882099152, 0.029745986685156822, 0.06222321093082428, 0.018591368570923805, 0.020887410268187523, 0.0626065731048584, 0.02636229619383812, 0.09591490775346756, 0.02720232680439949, 0.034511130303144455, 0.25654613971710205, 0.23355649411678314, 0.1879812777042389, 0.1947466880083084, -1]}
{"idB": "749647_12_item1_p25_s0", "idA": "749647_11_item1_p37_s0", "sentA": "In August 2010, the FDA designated the HEAT Study of the Company s investigational drug, ThermoDox@, in combination with RFA, as a Fast Track Development Program.", "sentB": "In December 2011, Celsion completed the consultative review process with the European Medicines Agency (EMA) for the HEAT Study and received written scientific advice from the EMA confirming that the Company s HEAT Study is acceptable as a basis for submission of a marketing authorization application.", "type": 2, "words": ["<tag1>", "In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program.", "<tag2>", "In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application.", "<tag3>"], "wordsA": ["In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program."], "wordsB": ["In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02134816162288189, 0.6517336368560791, 0.5858521461486816, 0.21410338580608368, 0.07226771116256714, 0.014552487060427666, 0.14449189603328705, 0.22080355882644653, 0.09232581406831741, 0.013383741490542889, 0.012889591045677662, 0.0516577772796154, 0.14020998775959015, 0.06411531567573547, 0.1242571547627449, 0.00623574061319232, 0.006567129399627447, 0.03875500336289406, 0.043299995362758636, 0.0002435540227452293, 0.016609104350209236, 0.050200194120407104, 0.08095373958349228, 0.05193047970533371, 0.013244185596704483, 0.010157770477235317, 0.14200939238071442, 0.018520934507250786, 0.008411792106926441, 0.007211989723145962, 0.05058950185775757, 0.020605936646461487, 0.08828752487897873, 0.11563034355640411, 0.03866703063249588, 0.08730944991111755, 0.01725701242685318, 0.022180898115038872, 0.06138740852475166, 0.01606232486665249, 0.05934540927410126, 0.014670691452920437, 0.01517085637897253, 0.07734652608633041, 0.10292822867631912, 0.12346653640270233, -1]}
{"idB": "749647_12_item1_p43_s2", "idA": "749647_11_item1_p37_s0", "sentA": "In August 2010, the FDA designated the HEAT Study of the Company s investigational drug, ThermoDox@, in combination with RFA, as a Fast Track Development Program.", "sentB": "With agreement of the FDA, enrollment of the HEAT Study was increased to 700 in 2011.", "type": 2, "words": ["<tag1>", "In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program.", "<tag2>", "With", "agreement", "of", "the", "FDA,", "enrollment", "of", "the", "HEAT", "Study", "was", "increased", "to", "700", "in", "2011.", "<tag3>"], "wordsA": ["In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program."], "wordsB": ["With", "agreement", "of", "the", "FDA,", "enrollment", "of", "the", "HEAT", "Study", "was", "increased", "to", "700", "in", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027172647416591644, 0.08789221197366714, 0.020910920575261116, 0.015312638133764267, 0.07743909955024719, 0.34682658314704895, 0.0312885120511055, 0.016345340758562088, 0.08119470626115799, 0.09384485334157944, 0.04719817638397217, 0.1992311328649521, 0.10180265456438065, 0.6357237100601196, 0.0786706879734993, 0.5167809128761292, -1]}
{"idB": "749647_12_item1_p44_s0", "idA": "749647_11_item1_p37_s0", "sentA": "In August 2010, the FDA designated the HEAT Study of the Company s investigational drug, ThermoDox@, in combination with RFA, as a Fast Track Development Program.", "sentB": "In August 2010, the FDA designated the HEAT study for ThermoDox , in combination with RFA, as a Fast Track Development Program.", "type": 2, "words": ["<tag1>", "In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program.", "<tag2>", "In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program.", "<tag3>"], "wordsA": ["In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "Study", "of", "the", "Company", "s", "investigational", "drug,", "ThermoDox@,", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program."], "wordsB": ["In", "August", "2010,", "the", "FDA", "designated", "the", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "RFA,", "as", "a", "Fast", "Track", "Development", "Program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012485918588936329, 0.04307880625128746, 0.05230419710278511, 0.005915526300668716, 0.1875370591878891, 0.12498339265584946, 0.01621883548796177, 0.11404426395893097, 0.4859062135219574, 0.11612991243600845, 0.7763974666595459, 0.00013006877270527184, 0.015076146461069584, 0.05801272764801979, 0.026311462745070457, 0.1999967396259308, 0.006884947419166565, 0.00454103946685791, 0.011474988423287868, 0.013276898302137852, 0.014745674096047878, 0.01689426228404045, -1]}
{"idB": "749647_12_item1_p44_s1", "idA": "749647_11_item1_p38_s0", "sentA": "The FDA's Fast Track Development Program provides for expedited regulatory review for new drugs that treat serious or life threatening diseases which are not satisfactorily treated by existing therapies, or for drugs that provide a significant advantage over existing therapies for serious diseases.", "sentB": "The Fast Track Development Program provides for expedited regulatory review for new drugs that treat serious or life threatening diseases which are not satisfactorily treated by existing therapies, or for drugs that provide a significant advantage over existing therapies for serious diseases.", "type": 2, "words": ["<tag1>", "The", "FDA's", "Fast", "Track", "Development", "Program", "provides", "for", "expedited", "regulatory", "review", "for", "new", "drugs", "that", "treat", "serious", "or", "life", "threatening", "diseases", "which", "are", "not", "satisfactorily", "treated", "by", "existing", "therapies,", "or", "for", "drugs", "that", "provide", "a", "significant", "advantage", "over", "existing", "therapies", "for", "serious", "diseases.", "<tag2>", "The", "Fast", "Track", "Development", "Program", "provides", "for", "expedited", "regulatory", "review", "for", "new", "drugs", "that", "treat", "serious", "or", "life", "threatening", "diseases", "which", "are", "not", "satisfactorily", "treated", "by", "existing", "therapies,", "or", "for", "drugs", "that", "provide", "a", "significant", "advantage", "over", "existing", "therapies", "for", "serious", "diseases.", "<tag3>"], "wordsA": ["The", "FDA's", "Fast", "Track", "Development", "Program", "provides", "for", "expedited", "regulatory", "review", "for", "new", "drugs", "that", "treat", "serious", "or", "life", "threatening", "diseases", "which", "are", "not", "satisfactorily", "treated", "by", "existing", "therapies,", "or", "for", "drugs", "that", "provide", "a", "significant", "advantage", "over", "existing", "therapies", "for", "serious", "diseases."], "wordsB": ["The", "Fast", "Track", "Development", "Program", "provides", "for", "expedited", "regulatory", "review", "for", "new", "drugs", "that", "treat", "serious", "or", "life", "threatening", "diseases", "which", "are", "not", "satisfactorily", "treated", "by", "existing", "therapies,", "or", "for", "drugs", "that", "provide", "a", "significant", "advantage", "over", "existing", "therapies", "for", "serious", "diseases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0060240221209824085, 0.022149790078401566, 0.028267813846468925, 0.01871315762400627, 0.027131441980600357, 0.012084828689694405, 0.008257875218987465, 0.013640819117426872, 0.012473084963858128, 0.01597301848232746, 0.0055909049697220325, 0.008079398423433304, 0.02729029767215252, 0.009159556590020657, 0.00858304277062416, 0.010773326270282269, 0.010686097666621208, 0.013408288359642029, 0.011069324798882008, 0.013214623555541039, 0.014826438389718533, 0.05015357583761215, 0.8897560834884644, 0.17179876565933228, 0.15978281199932098, 0.03680197149515152, 0.04724041745066643, 0.03763486072421074, 0.006601912900805473, 0.004673674236983061, 0.017128396779298782, 0.008292144164443016, 0.01320501510053873, 0.011259372346103191, 0.019195556640625, 0.020334897562861443, 0.009003544226288795, 0.015159404836595058, 0.016138967126607895, 0.0073697734624147415, 0.036823563277721405, 0.020543642342090607, -1]}
{"idB": "749647_12_item1_p45_s0", "idA": "749647_11_item1_p38_s1", "sentA": "Under the Fast Track Designation, we are now eligible to submit a U.S. New Drug Application (NDA) on a rolling basis.", "sentB": "Under the Fast Track designation, we are eligible to submit an NDA on a rolling basis.", "type": 2, "words": ["<tag1>", "Under", "the", "Fast", "Track", "Designation,", "we", "are", "now", "eligible", "to", "submit", "a", "U.S.", "New", "Drug", "Application", "(NDA)", "on", "a", "rolling", "basis.", "<tag2>", "Under", "the", "Fast", "Track", "designation,", "we", "are", "eligible", "to", "submit", "an", "NDA", "on", "a", "rolling", "basis.", "<tag3>"], "wordsA": ["Under", "the", "Fast", "Track", "Designation,", "we", "are", "now", "eligible", "to", "submit", "a", "U.S.", "New", "Drug", "Application", "(NDA)", "on", "a", "rolling", "basis."], "wordsB": ["Under", "the", "Fast", "Track", "designation,", "we", "are", "eligible", "to", "submit", "an", "NDA", "on", "a", "rolling", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02394932508468628, 0.006941270083189011, 0.03796292841434479, 0.0359414666891098, 0.04954178258776665, 0.04345253109931946, 0.041630979627370834, 0.38928693532943726, 0.10387874394655228, 0.15975721180438995, 0.08794663846492767, 0.8506441116333008, 0.027408041059970856, 0.012017866596579552, 0.1148674264550209, 0.04661216214299202, -1]}
{"idB": "749647_12_item1_p46_s0", "idA": "749647_11_item1_p39_s0", "sentA": "We have received written guidance from the FDA stating that, assuming the results of our ongoing studies are adequate, we may submit our New Drug Application ( NDA ) for ThermoDox pursuant to Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act.", "sentB": "We have received written guidance from the FDA stating that, assuming the results of our ongoing studies are adequate, we may submit our NDA for ThermoDox pursuant to Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act.", "type": 2, "words": ["<tag1>", "We", "have", "received", "written", "guidance", "from", "the", "FDA", "stating", "that,", "assuming", "the", "results", "of", "our", "ongoing", "studies", "are", "adequate,", "we", "may", "submit", "our", "New", "Drug", "Application", "(", "NDA", ")", "for", "ThermoDox", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act.", "<tag2>", "We", "have", "received", "written", "guidance", "from", "the", "FDA", "stating", "that,", "assuming", "the", "results", "of", "our", "ongoing", "studies", "are", "adequate,", "we", "may", "submit", "our", "NDA", "for", "ThermoDox", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act.", "<tag3>"], "wordsA": ["We", "have", "received", "written", "guidance", "from", "the", "FDA", "stating", "that,", "assuming", "the", "results", "of", "our", "ongoing", "studies", "are", "adequate,", "we", "may", "submit", "our", "New", "Drug", "Application", "(", "NDA", ")", "for", "ThermoDox", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act."], "wordsB": ["We", "have", "received", "written", "guidance", "from", "the", "FDA", "stating", "that,", "assuming", "the", "results", "of", "our", "ongoing", "studies", "are", "adequate,", "we", "may", "submit", "our", "NDA", "for", "ThermoDox", "pursuant", "to", "Section", "505(b)(2)", "of", "the", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03733043372631073, 0.03653285279870033, 0.04123317822813988, 0.0451587475836277, 0.055239636451005936, 0.030253173783421516, 0.02420000731945038, 0.09408765286207199, 0.04634885862469673, 0.03163556382060051, 0.1014680489897728, 0.032604869455099106, 0.09354119747877121, 0.029712792485952377, 0.03008957765996456, 0.09049171954393387, 0.0964120626449585, 0.060538146644830704, 0.4510447084903717, 0.03712056949734688, 0.045788250863552094, 0.10712210088968277, 0.05574279651045799, 0.31508713960647583, 0.05169114097952843, 0.0949723869562149, 0.03704245761036873, 0.029969489201903343, 0.05995359644293785, 0.14487099647521973, 0.018626617267727852, 0.02154853567481041, 0.037095390260219574, 0.05441983789205551, 0.0299585722386837, 0.03431258723139763, 0.03888683021068573, 0.03885003551840782, -1]}
{"idB": "749647_12_item1_p78_s1", "idA": "749647_11_item1_p39_s2", "sentA": "The availability of Section 505(b)(2) and the designation of ThermoDox as a Fast Track Development Program will provide us with an expedited pathway to approval.", "sentB": "We view this as a critical means of multiplying the clinical and commercial value of ThermoDox as rapidly as possible following its validation in the HEAT Study.", "type": 2, "words": ["<tag1>", "The", "availability", "of", "Section", "505(b)(2)", "and", "the", "designation", "of", "ThermoDox", "as", "a", "Fast", "Track", "Development", "Program", "will", "provide", "us", "with", "an", "expedited", "pathway", "to", "approval.", "<tag2>", "We", "view", "this", "as", "a", "critical", "means", "of", "multiplying", "the", "clinical", "and", "commercial", "value", "of", "ThermoDox", "as", "rapidly", "as", "possible", "following", "its", "validation", "in", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["The", "availability", "of", "Section", "505(b)(2)", "and", "the", "designation", "of", "ThermoDox", "as", "a", "Fast", "Track", "Development", "Program", "will", "provide", "us", "with", "an", "expedited", "pathway", "to", "approval."], "wordsB": ["We", "view", "this", "as", "a", "critical", "means", "of", "multiplying", "the", "clinical", "and", "commercial", "value", "of", "ThermoDox", "as", "rapidly", "as", "possible", "following", "its", "validation", "in", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07029353827238083, 0.11339153349399567, 0.05822285637259483, 0.031971339136362076, 0.021327344700694084, 0.17477431893348694, 0.14019657671451569, 0.026168473064899445, 0.6190939545631409, 0.05711154267191887, 0.09386429935693741, 0.04037449136376381, 0.15608154237270355, 0.10367275774478912, 0.05184035748243332, 0.06196095794439316, 0.03733668848872185, 0.05934462323784828, 0.01986059360206127, 0.021904952824115753, 0.017648134380578995, 0.014478614553809166, 0.06169871985912323, 0.01544832345098257, 0.013212784193456173, 0.09719294309616089, 0.13602007925510406, -1]}
{"idB": "749647_12_item1_p75_s1", "idA": "749647_11_item1_p39_s3", "sentA": "There can be no assurance, however, that the results of our ongoing studies will be adequate to obtain approval of ThermoDox under Section 505(b)(2).", "sentB": "While the significant majority of our capital resources are focused on the HEAT study, we recognize that the unique properties of ThermoDox support its potential well beyond this study's indication, and are taking steps to explore its utility in other areas.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance,", "however,", "that", "the", "results", "of", "our", "ongoing", "studies", "will", "be", "adequate", "to", "obtain", "approval", "of", "ThermoDox", "under", "Section", "505(b)(2).", "<tag2>", "While", "the", "significant", "majority", "of", "our", "capital", "resources", "are", "focused", "on", "the", "HEAT", "study,", "we", "recognize", "that", "the", "unique", "properties", "of", "ThermoDox", "support", "its", "potential", "well", "beyond", "this", "study's", "indication,", "and", "are", "taking", "steps", "to", "explore", "its", "utility", "in", "other", "areas.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance,", "however,", "that", "the", "results", "of", "our", "ongoing", "studies", "will", "be", "adequate", "to", "obtain", "approval", "of", "ThermoDox", "under", "Section", "505(b)(2)."], "wordsB": ["While", "the", "significant", "majority", "of", "our", "capital", "resources", "are", "focused", "on", "the", "HEAT", "study,", "we", "recognize", "that", "the", "unique", "properties", "of", "ThermoDox", "support", "its", "potential", "well", "beyond", "this", "study's", "indication,", "and", "are", "taking", "steps", "to", "explore", "its", "utility", "in", "other", "areas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0307716503739357, 0.012739106081426144, 0.09441483020782471, 0.1177494153380394, 0.034746844321489334, 0.028311712667346, 0.13373509049415588, 0.18348470330238342, 0.043430399149656296, 0.1284443587064743, 0.07205256819725037, 0.04711286351084709, 0.2106601446866989, 0.321898877620697, 0.02863372303545475, 0.09403271228075027, 0.02257595583796501, 0.018795788288116455, 0.07271559536457062, 0.06500696390867233, 0.03684616833925247, 0.060760870575904846, 0.08944515883922577, 0.03482396900653839, 0.10310498625040054, 0.05315786972641945, 0.2572387158870697, 0.04311974719166756, 0.16570889949798584, 0.15855464339256287, 0.008802368305623531, 0.01709643565118313, 0.08466321974992752, 0.11211545765399933, 0.021349303424358368, 0.09793788194656372, 0.02706327475607395, 0.04466847702860832, 0.02490321360528469, 0.03775429353117943, 0.058158595114946365, -1]}
{"idB": "749647_12_item1_p26_s2", "idA": "749647_11_item1_p40_s0", "sentA": "In 2009, the FDA granted Orphan Drug Designation for ThermoDox for the treatment of HCC.", "sentB": "Patients will be randomized to receive either RFA plus ThermoDox or RFA alone for the treatment of their liver tumors.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC.", "<tag2>", "Patients", "will", "be", "randomized", "to", "receive", "either", "RFA", "plus", "ThermoDox", "or", "RFA", "alone", "for", "the", "treatment", "of", "their", "liver", "tumors.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC."], "wordsB": ["Patients", "will", "be", "randomized", "to", "receive", "either", "RFA", "plus", "ThermoDox", "or", "RFA", "alone", "for", "the", "treatment", "of", "their", "liver", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2247234284877777, 0.03851744160056114, 0.08697263151407242, 0.6424971222877502, 0.18108896911144257, 0.26160597801208496, 0.1160479336977005, 0.3720797896385193, 0.2507323622703552, 0.20267502963542938, 0.028446609154343605, 0.20934849977493286, 0.25234898924827576, 0.004357887897640467, 0.0049373311921954155, 0.0420021116733551, 0.009109199047088623, 0.010533717460930347, 0.10266163945198059, 0.12723597884178162, -1]}
{"idB": "749647_12_item1_p66_s2", "idA": "749647_11_item1_p40_s0", "sentA": "In 2009, the FDA granted Orphan Drug Designation for ThermoDox for the treatment of HCC.", "sentB": "Patients will be randomized to receive either RFA plus ThermoDox or RFA alone for the treatment of their liver tumors.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC.", "<tag2>", "Patients", "will", "be", "randomized", "to", "receive", "either", "RFA", "plus", "ThermoDox", "or", "RFA", "alone", "for", "the", "treatment", "of", "their", "liver", "tumors.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC."], "wordsB": ["Patients", "will", "be", "randomized", "to", "receive", "either", "RFA", "plus", "ThermoDox", "or", "RFA", "alone", "for", "the", "treatment", "of", "their", "liver", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2247234284877777, 0.03851744160056114, 0.08697263151407242, 0.6424971222877502, 0.18108896911144257, 0.26160597801208496, 0.1160479336977005, 0.3720797896385193, 0.2507323622703552, 0.20267502963542938, 0.028446609154343605, 0.20934849977493286, 0.25234898924827576, 0.004357887897640467, 0.0049373311921954155, 0.0420021116733551, 0.009109199047088623, 0.010533717460930347, 0.10266163945198059, 0.12723597884178162, -1]}
{"idB": "749647_12_item1_p49_s1", "idA": "749647_11_item1_p40_s1", "sentA": "FDA s Orphan Drug Act provides economic incentives to encourage companies to develop drugs that demonstrate promise for the treatment of life-threatening or very serious conditions that are rare and affect less than 200,000 individuals in the U.S. Orphan drug designation entitles Celsion to seven years of market exclusivity following FDA approval, FDA assistance in clinical trial design, reduction in FDA user fees, U.S tax credits related to development expenses as well as the opportunity to apply funding from the U.S. government to defray costs of clinical trial expenses.", "sentB": "The Orphan Drug Act provides economic incentives to companies to develop drugs that demonstrate promise for the treatment of life-threatening or very serious conditions that are rare and affect less than 200,000 individuals in the U.S. Orphan drug designation entitles us to seven years of market exclusivity following FDA approval, if any, FDA assistance in clinical trial design, reduction in FDA user fees, U.S tax credits related to development expenses as well as the opportunity to apply for funding from the U.S. government to defray costs of clinical trial expenses.", "type": 2, "words": ["<tag1>", "FDA", "s", "Orphan", "Drug", "Act", "provides", "economic", "incentives", "to", "encourage", "companies", "to", "develop", "drugs", "that", "demonstrate", "promise", "for", "the", "treatment", "of", "life-threatening", "or", "very", "serious", "conditions", "that", "are", "rare", "and", "affect", "less", "than", "200,000", "individuals", "in", "the", "U.S.", "Orphan", "drug", "designation", "entitles", "Celsion", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "FDA", "assistance", "in", "clinical", "trial", "design,", "reduction", "in", "FDA", "user", "fees,", "U.S", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "funding", "from", "the", "U.S.", "government", "to", "defray", "costs", "of", "clinical", "trial", "expenses.", "<tag2>", "The", "Orphan", "Drug", "Act", "provides", "economic", "incentives", "to", "companies", "to", "develop", "drugs", "that", "demonstrate", "promise", "for", "the", "treatment", "of", "life-threatening", "or", "very", "serious", "conditions", "that", "are", "rare", "and", "affect", "less", "than", "200,000", "individuals", "in", "the", "U.S.", "Orphan", "drug", "designation", "entitles", "us", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "if", "any,", "FDA", "assistance", "in", "clinical", "trial", "design,", "reduction", "in", "FDA", "user", "fees,", "U.S", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "costs", "of", "clinical", "trial", "expenses.", "<tag3>"], "wordsA": ["FDA", "s", "Orphan", "Drug", "Act", "provides", "economic", "incentives", "to", "encourage", "companies", "to", "develop", "drugs", "that", "demonstrate", "promise", "for", "the", "treatment", "of", "life-threatening", "or", "very", "serious", "conditions", "that", "are", "rare", "and", "affect", "less", "than", "200,000", "individuals", "in", "the", "U.S.", "Orphan", "drug", "designation", "entitles", "Celsion", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "FDA", "assistance", "in", "clinical", "trial", "design,", "reduction", "in", "FDA", "user", "fees,", "U.S", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "funding", "from", "the", "U.S.", "government", "to", "defray", "costs", "of", "clinical", "trial", "expenses."], "wordsB": ["The", "Orphan", "Drug", "Act", "provides", "economic", "incentives", "to", "companies", "to", "develop", "drugs", "that", "demonstrate", "promise", "for", "the", "treatment", "of", "life-threatening", "or", "very", "serious", "conditions", "that", "are", "rare", "and", "affect", "less", "than", "200,000", "individuals", "in", "the", "U.S.", "Orphan", "drug", "designation", "entitles", "us", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "if", "any,", "FDA", "assistance", "in", "clinical", "trial", "design,", "reduction", "in", "FDA", "user", "fees,", "U.S", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "costs", "of", "clinical", "trial", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018334250897169113, 0.18373481929302216, 0.08058246225118637, 0.06921159476041794, 0.04796979948878288, 0.10136010497808456, 0.22904697060585022, 0.046870362013578415, 0.21814113855361938, 0.0667947456240654, 0.0939459428191185, 0.09791778773069382, 0.03047778271138668, 0.05910655856132507, 0.06521662324666977, 0.03250976651906967, 0.03113917075097561, 0.034423865377902985, 0.03132622689008713, 0.05147554725408554, 0.02623874880373478, 0.04350131005048752, 0.047104284167289734, 0.05007496103644371, 0.02892114967107773, 0.02342589944601059, 0.05480891838669777, 0.027266472578048706, 0.03223113715648651, 0.09621742367744446, 0.05483005568385124, 0.10368087887763977, 0.0683877170085907, 0.02783176302909851, 0.0274848360568285, 0.05702699348330498, 0.04983117803931236, 0.03711128979921341, 0.03673575446009636, 0.039834845811128616, 0.10084216296672821, 0.03411470726132393, 0.03944113850593567, 0.04477475583553314, 0.030828187242150307, 0.039158426225185394, 0.048377588391304016, 0.028048470616340637, 0.04973683878779411, 0.0767180398106575, 0.1066986620426178, 0.15229572355747223, 0.04262996464967728, 0.0482061468064785, 0.03003421239554882, 0.04299453645944595, 0.047478873282670975, 0.03746189922094345, 0.03183871880173683, 0.02717805653810501, 0.04606463387608528, 0.05457717925310135, 0.05554357171058655, 0.046780191361904144, 0.06640490144491196, 0.06624548137187958, 0.025834158062934875, 0.029243068769574165, 0.048027172684669495, 0.050345536321401596, 0.021401040256023407, 0.02082793414592743, 0.019590195268392563, 0.023018887266516685, 0.032302748411893845, 0.028597909957170486, 0.032407987862825394, 0.03274175897240639, 0.03878284990787506, 0.02233305014669895, 0.027858754619956017, 0.04745505005121231, 0.041152775287628174, 0.021228959783911705, 0.02335292287170887, 0.02026044763624668, 0.017557939514517784, 0.031664568930864334, 0.0504998080432415, 0.048426736146211624, -1]}
{"idB": "749647_12_item1_p15_s0", "idA": "749647_11_item1_p40_s2", "sentA": "In 2011, the European Commission granted Orphan Drug Designation for ThermoDox for the treatment of HCC in Europe.", "sentB": "In March of 2011, we announced that the European Commission granted orphan drug designation for ThermoDox in primary liver cancer, which provides assistance and incentives, including 10 years of marketing exclusivity subsequent to product approval, in support of product candidates intended for the treatment of a life-threatening or chronically debilitating condition affecting no more than five in 10,000 persons in the European Union.", "type": 2, "words": ["<tag1>", "In", "2011,", "the", "European", "Commission", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe.", "<tag2>", "In", "March", "of", "2011,", "we", "announced", "that", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "in", "primary", "liver", "cancer,", "which", "provides", "assistance", "and", "incentives,", "including", "10", "years", "of", "marketing", "exclusivity", "subsequent", "to", "product", "approval,", "in", "support", "of", "product", "candidates", "intended", "for", "the", "treatment", "of", "a", "life-threatening", "or", "chronically", "debilitating", "condition", "affecting", "no", "more", "than", "five", "in", "10,000", "persons", "in", "the", "European", "Union.", "<tag3>"], "wordsA": ["In", "2011,", "the", "European", "Commission", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe."], "wordsB": ["In", "March", "of", "2011,", "we", "announced", "that", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "in", "primary", "liver", "cancer,", "which", "provides", "assistance", "and", "incentives,", "including", "10", "years", "of", "marketing", "exclusivity", "subsequent", "to", "product", "approval,", "in", "support", "of", "product", "candidates", "intended", "for", "the", "treatment", "of", "a", "life-threatening", "or", "chronically", "debilitating", "condition", "affecting", "no", "more", "than", "five", "in", "10,000", "persons", "in", "the", "European", "Union."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011192512698471546, 0.02873881906270981, 0.012703944928944111, 0.03665781021118164, 0.03153815492987633, 0.04095710813999176, 0.007651951164007187, 0.00427173962816596, 0.01550812367349863, 0.016715053468942642, 0.017450829967856407, 0.015613441355526447, 0.01282065361738205, 0.020021801814436913, 0.005475352518260479, 0.032229792326688766, 0.04842953383922577, 0.38671836256980896, 0.6953247785568237, 0.6674932837486267, 8.147409243974835e-05, 0.0034837983548641205, 0.005058526527136564, 0.0017288619419559836, 0.007612800691276789, 0.00011185812763869762, 0.0029832615982741117, 0.004071325063705444, 0.0036702395882457495, 0.010460651479661465, 0.010781749151647091, 0.0033437141682952642, 0.0027165946085006, 0.008031899109482765, 0.019126521423459053, 0.00022315642854664475, 0.002865038113668561, 0.0026230409275740385, 0.01163975615054369, 0.016807658597826958, 0.0033781081438064575, 0.004079596605151892, 0.0041407207027077675, 0.0403842069208622, 0.00602564075961709, 0.005591870751231909, 0.1946595311164856, 0.010944722220301628, 0.19222135841846466, 0.5303195118904114, 0.21293726563453674, 0.04015550762414932, 0.046790849417448044, 0.09187577664852142, 0.13556252419948578, 0.09408668428659439, 0.10635092854499817, 0.1157028004527092, 0.13963556289672852, 0.007650343701243401, 0.005817308556288481, 0.012972314842045307, 0.015219169668853283, -1]}
{"idB": "749647_12_item1_p51_s0", "idA": "749647_11_item1_p40_s2", "sentA": "In 2011, the European Commission granted Orphan Drug Designation for ThermoDox for the treatment of HCC in Europe.", "sentB": "In March of 2011, we announced that the European Commission granted orphan drug designation for ThermoDox in primary liver cancer, which provides assistance and incentives, including 10 years of marketing exclusivity subsequent to product approval, in support of product candidates intended for the treatment of a life-threatening or chronically debilitating condition affecting no more than five in 10,000 persons in the European Union.", "type": 2, "words": ["<tag1>", "In", "2011,", "the", "European", "Commission", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe.", "<tag2>", "In", "March", "of", "2011,", "we", "announced", "that", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "in", "primary", "liver", "cancer,", "which", "provides", "assistance", "and", "incentives,", "including", "10", "years", "of", "marketing", "exclusivity", "subsequent", "to", "product", "approval,", "in", "support", "of", "product", "candidates", "intended", "for", "the", "treatment", "of", "a", "life-threatening", "or", "chronically", "debilitating", "condition", "affecting", "no", "more", "than", "five", "in", "10,000", "persons", "in", "the", "European", "Union.", "<tag3>"], "wordsA": ["In", "2011,", "the", "European", "Commission", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe."], "wordsB": ["In", "March", "of", "2011,", "we", "announced", "that", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "in", "primary", "liver", "cancer,", "which", "provides", "assistance", "and", "incentives,", "including", "10", "years", "of", "marketing", "exclusivity", "subsequent", "to", "product", "approval,", "in", "support", "of", "product", "candidates", "intended", "for", "the", "treatment", "of", "a", "life-threatening", "or", "chronically", "debilitating", "condition", "affecting", "no", "more", "than", "five", "in", "10,000", "persons", "in", "the", "European", "Union."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011192512698471546, 0.02873881906270981, 0.012703944928944111, 0.03665781021118164, 0.03153815492987633, 0.04095710813999176, 0.007651951164007187, 0.00427173962816596, 0.01550812367349863, 0.016715053468942642, 0.017450829967856407, 0.015613441355526447, 0.01282065361738205, 0.020021801814436913, 0.005475352518260479, 0.032229792326688766, 0.04842953383922577, 0.38671836256980896, 0.6953247785568237, 0.6674932837486267, 8.147409243974835e-05, 0.0034837983548641205, 0.005058526527136564, 0.0017288619419559836, 0.007612800691276789, 0.00011185812763869762, 0.0029832615982741117, 0.004071325063705444, 0.0036702395882457495, 0.010460651479661465, 0.010781749151647091, 0.0033437141682952642, 0.0027165946085006, 0.008031899109482765, 0.019126521423459053, 0.00022315642854664475, 0.002865038113668561, 0.0026230409275740385, 0.01163975615054369, 0.016807658597826958, 0.0033781081438064575, 0.004079596605151892, 0.0041407207027077675, 0.0403842069208622, 0.00602564075961709, 0.005591870751231909, 0.1946595311164856, 0.010944722220301628, 0.19222135841846466, 0.5303195118904114, 0.21293726563453674, 0.04015550762414932, 0.046790849417448044, 0.09187577664852142, 0.13556252419948578, 0.09408668428659439, 0.10635092854499817, 0.1157028004527092, 0.13963556289672852, 0.007650343701243401, 0.005817308556288481, 0.012972314842045307, 0.015219169668853283, -1]}
{"idB": "749647_12_item1_p55_s0", "idA": "749647_11_item1_p44_s0", "sentA": "Since its inception, Celsion has been actively seeking a targeted localized treatment for breast cancer.", "sentB": "Since its inception, we have been actively seeking a targeted localized treatment for breast cancer.", "type": 2, "words": ["<tag1>", "Since", "its", "inception,", "Celsion", "has", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer.", "<tag2>", "Since", "its", "inception,", "we", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer.", "<tag3>"], "wordsA": ["Since", "its", "inception,", "Celsion", "has", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer."], "wordsB": ["Since", "its", "inception,", "we", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09232554584741592, 0.04006269574165344, 0.17684601247310638, 0.8806806206703186, 0.06742455810308456, 0.03814408928155899, 0.10008601099252701, 0.08553018420934677, 0.016294389963150024, 0.03623858839273453, 0.039732255041599274, 0.04742886498570442, 0.01263540331274271, 0.022053316235542297, 0.033148426562547684, -1]}
{"idB": "749647_12_item1_p55_s1", "idA": "749647_11_item1_p44_s1", "sentA": "ThermoDox in conjunction with localized microwave hyperthermia is being developed to treat RCW breast cancer.", "sentB": "ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "type": 2, "words": ["<tag1>", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "is", "being", "developed", "to", "treat", "RCW", "breast", "cancer.", "<tag2>", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "is", "being", "developed", "to", "treat", "RCW", "breast", "cancer."], "wordsB": ["ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7401009798049927, 0.19800730049610138, 0.2757153809070587, 0.12144375592470169, 0.4110800623893738, 0.1728932112455368, 0.2400856614112854, 0.11902498453855515, 0.20699888467788696, 0.2791050970554352, 0.16383902728557587, 0.24125316739082336, -1]}
{"idB": "749647_12_item1_p56_s0", "idA": "749647_11_item1_p45_s0", "sentA": "Celsion s liposomal encapsulated doxorubicin is released by heat generated from an external microwave tissue hyperthermia device that is placed on a woman s chest.", "sentB": "Our liposomal encapsulated doxorubicin is released by heat generated from an external microwave tissue hyperthermia device that is placed on a woman s chest.", "type": 2, "words": ["<tag1>", "Celsion", "s", "liposomal", "encapsulated", "doxorubicin", "is", "released", "by", "heat", "generated", "from", "an", "external", "microwave", "tissue", "hyperthermia", "device", "that", "is", "placed", "on", "a", "woman", "s", "chest.", "<tag2>", "Our", "liposomal", "encapsulated", "doxorubicin", "is", "released", "by", "heat", "generated", "from", "an", "external", "microwave", "tissue", "hyperthermia", "device", "that", "is", "placed", "on", "a", "woman", "s", "chest.", "<tag3>"], "wordsA": ["Celsion", "s", "liposomal", "encapsulated", "doxorubicin", "is", "released", "by", "heat", "generated", "from", "an", "external", "microwave", "tissue", "hyperthermia", "device", "that", "is", "placed", "on", "a", "woman", "s", "chest."], "wordsB": ["Our", "liposomal", "encapsulated", "doxorubicin", "is", "released", "by", "heat", "generated", "from", "an", "external", "microwave", "tissue", "hyperthermia", "device", "that", "is", "placed", "on", "a", "woman", "s", "chest."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7862557172775269, 0.9058987498283386, 0.14429382979869843, 0.1668836623430252, 0.019823448732495308, 0.053434472531080246, 0.00806995015591383, 0.020657917484641075, 0.013326678425073624, 0.006802845746278763, 0.0046518524177372456, 0.022579286247491837, 0.015284858644008636, 0.010955257341265678, 0.010206452570855618, 0.008338774554431438, 0.0031224284321069717, 0.004146224353462458, 0.010454701259732246, 0.012680169194936752, 0.007498129270970821, 0.03720748797059059, 0.029635919257998466, 0.016837304458022118, -1]}
{"idB": "749647_12_item1_p56_s3", "idA": "749647_11_item1_p45_s3", "sentA": "As in our liver cancer program, the Company uses a commercially available thermotherapy device to heat the target tissue and activate ThermoDox at the desired target site.", "sentB": "As in our liver cancer program, we use a commercially available thermotherapy device to heat the target tissue and activate ThermoDox at the desired target site.", "type": 2, "words": ["<tag1>", "As", "in", "our", "liver", "cancer", "program,", "the", "Company", "uses", "a", "commercially", "available", "thermotherapy", "device", "to", "heat", "the", "target", "tissue", "and", "activate", "ThermoDox", "at", "the", "desired", "target", "site.", "<tag2>", "As", "in", "our", "liver", "cancer", "program,", "we", "use", "a", "commercially", "available", "thermotherapy", "device", "to", "heat", "the", "target", "tissue", "and", "activate", "ThermoDox", "at", "the", "desired", "target", "site.", "<tag3>"], "wordsA": ["As", "in", "our", "liver", "cancer", "program,", "the", "Company", "uses", "a", "commercially", "available", "thermotherapy", "device", "to", "heat", "the", "target", "tissue", "and", "activate", "ThermoDox", "at", "the", "desired", "target", "site."], "wordsB": ["As", "in", "our", "liver", "cancer", "program,", "we", "use", "a", "commercially", "available", "thermotherapy", "device", "to", "heat", "the", "target", "tissue", "and", "activate", "ThermoDox", "at", "the", "desired", "target", "site."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.060859113931655884, 0.0737776905298233, 0.06009836494922638, 0.296211302280426, 0.11585187166929245, 0.18009835481643677, 0.4957083761692047, 0.17187081277370453, 0.03501889854669571, 0.16105778515338898, 0.10477006435394287, 0.39060667157173157, 0.236453577876091, 0.044294774532318115, 0.13977393507957458, 0.04627138003706932, 0.11129391938447952, 0.14451472461223602, 0.022884413599967957, 0.10610220581293106, 0.11972638964653015, 0.03806954622268677, 0.028054434806108475, 0.05296850949525833, 0.08630283176898956, 0.10839094966650009, -1]}
{"idB": "749647_12_item1_p57_s0", "idA": "749647_11_item1_p46_s0", "sentA": "Microwave hyperthermia as a separate stand alone treatment has been found to have the ability to kill breast cancer cells.", "sentB": "Microwave hyperthermia as a separate standalone treatment has been found to have the ability to kill breast cancer cells.", "type": 2, "words": ["<tag1>", "Microwave", "hyperthermia", "as", "a", "separate", "stand", "alone", "treatment", "has", "been", "found", "to", "have", "the", "ability", "to", "kill", "breast", "cancer", "cells.", "<tag2>", "Microwave", "hyperthermia", "as", "a", "separate", "standalone", "treatment", "has", "been", "found", "to", "have", "the", "ability", "to", "kill", "breast", "cancer", "cells.", "<tag3>"], "wordsA": ["Microwave", "hyperthermia", "as", "a", "separate", "stand", "alone", "treatment", "has", "been", "found", "to", "have", "the", "ability", "to", "kill", "breast", "cancer", "cells."], "wordsB": ["Microwave", "hyperthermia", "as", "a", "separate", "standalone", "treatment", "has", "been", "found", "to", "have", "the", "ability", "to", "kill", "breast", "cancer", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004279790911823511, 0.006771704647690058, 0.0038324634078890085, 0.003193786833435297, 0.018201041966676712, 0.9213263988494873, 0.26590675115585327, 0.0017419884679839015, 0.0016336147673428059, 0.0018859360134229064, 0.001409666845574975, 0.0015192111022770405, 0.0015284160617738962, 0.00275243679061532, 0.001977668609470129, 0.008079207502305508, 0.004668980836868286, 0.005520917475223541, 0.007166926749050617, -1]}
{"idB": "749647_12_item1_p58_s1", "idA": "749647_11_item1_p47_s1", "sentA": "Thus, just heating cancer cells with a microwave device for sixty minutes at 43 C has been found to be tumoricidal.", "sentB": "Thus heating cancer cells with a microwave device for sixty minutes at 43 C has been found to be tumoricidal.", "type": 2, "words": ["<tag1>", "Thus,", "just", "heating", "cancer", "cells", "with", "a", "microwave", "device", "for", "sixty", "minutes", "at", "43", "C", "has", "been", "found", "to", "be", "tumoricidal.", "<tag2>", "Thus", "heating", "cancer", "cells", "with", "a", "microwave", "device", "for", "sixty", "minutes", "at", "43", "C", "has", "been", "found", "to", "be", "tumoricidal.", "<tag3>"], "wordsA": ["Thus,", "just", "heating", "cancer", "cells", "with", "a", "microwave", "device", "for", "sixty", "minutes", "at", "43", "C", "has", "been", "found", "to", "be", "tumoricidal."], "wordsB": ["Thus", "heating", "cancer", "cells", "with", "a", "microwave", "device", "for", "sixty", "minutes", "at", "43", "C", "has", "been", "found", "to", "be", "tumoricidal."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.19315259158611298, 0.5165753960609436, 0.3205304443836212, 0.26666173338890076, 0.04833093658089638, 0.026946401223540306, 0.1781383752822876, 0.13174346089363098, 0.03646725416183472, 0.22208213806152344, 0.1435985118150711, 0.041890621185302734, 0.26638907194137573, 0.4498234689235687, 0.05467845872044563, 0.04695013165473938, 0.11424534767866135, 0.1160377487540245, 0.1121814176440239, 0.36054912209510803, -1]}
{"idB": "749647_12_item1_p59_s0", "idA": "749647_11_item1_p48_s0", "sentA": "In 2009, the Company commenced a pivotal open label, dose-escalating ThermoDox Phase I/Phase II clinical trial for patients with RCW breast cancer.", "sentB": "In 2009, the Company commenced a pivotal open label, dose-escalating ThermoDox Phase I/Phase II clinical trial for patients with RCW breast cancer (the DIGNITY Study).", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "Company", "commenced", "a", "pivotal", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer.", "<tag2>", "In", "2009,", "the", "Company", "commenced", "a", "pivotal", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag3>"], "wordsA": ["In", "2009,", "the", "Company", "commenced", "a", "pivotal", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer."], "wordsB": ["In", "2009,", "the", "Company", "commenced", "a", "pivotal", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007894187234342098, 0.017793968319892883, 0.0034683181438595057, 0.030797958374023438, 0.02494480274617672, 0.0034624855034053326, 0.008880659006536007, 0.00710940919816494, 0.008334051817655563, 0.007477699778974056, 0.008968706242740154, 0.004414535127580166, 0.00585200497880578, 0.005425080191344023, 0.005466977134346962, 0.009092368185520172, 0.00402053352445364, 0.02516184188425541, 0.0053990487940609455, 0.00842412281781435, 0.010669348761439323, 0.015335042960941792, 0.16404524445533752, 0.8052421808242798, 0.8370932936668396, -1]}
{"idB": "749647_12_item1_p23_s1", "idA": "749647_11_item1_p48_s2", "sentA": "The Company has completed enrollment of the Phase I portion (9 patients) of the study in 2010.", "sentB": "A total of 380 events of progression are required to reach the planned final analysis of the study which we reconfirmed was projected to occur in late 2012.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "(9", "patients)", "of", "the", "study", "in", "2010.", "<tag2>", "A", "total", "of", "380", "events", "of", "progression", "are", "required", "to", "reach", "the", "planned", "final", "analysis", "of", "the", "study", "which", "we", "reconfirmed", "was", "projected", "to", "occur", "in", "late", "2012.", "<tag3>"], "wordsA": ["The", "Company", "has", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "(9", "patients)", "of", "the", "study", "in", "2010."], "wordsB": ["A", "total", "of", "380", "events", "of", "progression", "are", "required", "to", "reach", "the", "planned", "final", "analysis", "of", "the", "study", "which", "we", "reconfirmed", "was", "projected", "to", "occur", "in", "late", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023671932518482208, 0.15049462020397186, 0.13300015032291412, 0.6505857110023499, 0.5135122537612915, 0.10904333740472794, 0.14937148988246918, 0.008414242416620255, 0.053563687950372696, 0.006344042252749205, 0.011249576695263386, 0.009060690179467201, 0.02226935885846615, 0.05665219575166702, 0.07774471491575241, 0.00859492365270853, 0.011414775624871254, 0.07725884765386581, 0.00015326777065638453, 0.006815735250711441, 0.017963258549571037, 0.003469969844445586, 0.00676274299621582, 0.005541234277188778, 0.005768822506070137, 0.007507894653826952, 0.0525762103497982, 0.401509165763855, -1]}
{"idB": "749647_12_item1_p60_s0", "idA": "749647_11_item1_p48_s2", "sentA": "The Company has completed enrollment of the Phase I portion (9 patients) of the study in 2010.", "sentB": "The Company completed enrollment of the Phase I portion of the study in 2010 and an independent Data Safety Monitoring Board declared 50mg/m 2 to be the phase II dose.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "(9", "patients)", "of", "the", "study", "in", "2010.", "<tag2>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m", "2", "to", "be", "the", "phase", "II", "dose.", "<tag3>"], "wordsA": ["The", "Company", "has", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "(9", "patients)", "of", "the", "study", "in", "2010."], "wordsB": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m", "2", "to", "be", "the", "phase", "II", "dose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003508791094645858, 0.036355141550302505, 0.029495636001229286, 0.017411263659596443, 0.002283031353726983, 0.0022093409206718206, 0.007537839002907276, 0.009438884444534779, 0.01378545630723238, 0.001657268963754177, 0.00238395226188004, 0.018642133101820946, 0.0028348714113235474, 0.010526166297495365, 0.007281859405338764, 0.013540724292397499, 0.14740949869155884, 0.2245786190032959, 0.16272301971912384, 0.1408117562532425, 0.18913233280181885, 0.14407795667648315, 0.3535346984863281, 0.4051152467727661, 0.047708090394735336, 0.039507556706666946, 0.022430380806326866, 0.041588082909584045, 0.03957671299576759, 0.11852985620498657, -1]}
{"idB": "749647_12_item1_p62_s0", "idA": "749647_11_item1_p48_s2", "sentA": "The Company has completed enrollment of the Phase I portion (9 patients) of the study in 2010.", "sentB": "The American Cancer Society estimates that there were over 141,000 new cases of colorectal cancer and about 51,000 colorectal cancer deaths in 2010.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "(9", "patients)", "of", "the", "study", "in", "2010.", "<tag2>", "The", "American", "Cancer", "Society", "estimates", "that", "there", "were", "over", "141,000", "new", "cases", "of", "colorectal", "cancer", "and", "about", "51,000", "colorectal", "cancer", "deaths", "in", "2010.", "<tag3>"], "wordsA": ["The", "Company", "has", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "(9", "patients)", "of", "the", "study", "in", "2010."], "wordsB": ["The", "American", "Cancer", "Society", "estimates", "that", "there", "were", "over", "141,000", "new", "cases", "of", "colorectal", "cancer", "and", "about", "51,000", "colorectal", "cancer", "deaths", "in", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03812796622514725, 0.40976089239120483, 0.4324190616607666, 0.6283819675445557, 0.177741140127182, 0.038793545216321945, 0.012877609580755234, 0.016300177201628685, 0.19406890869140625, 0.46333563327789307, 0.3370474874973297, 0.23769685626029968, 0.046186234802007675, 0.06562697142362595, 0.10217734426259995, 0.0001893666194519028, 0.09463974088430405, 0.36624643206596375, 0.0712367594242096, 0.15612120926380157, 0.35006117820739746, 0.016424424946308136, 0.03108765184879303, -1]}
{"idB": "749647_12_item1_p61_s0", "idA": "749647_11_item1_p49_s0", "sentA": "Duke University is also conducting a Phase I dose escalating ThermoDox study in patients with RCW breast cancer.", "sentB": "Duke University has completed a Phase I dose escalating ThermoDox study in patients with RCW breast cancer and has presented preliminary results from the 16 enrolled patients that characterize the safety of the drug in RCW patients and the feasibility of ThermoDox administration in these patients.", "type": 2, "words": ["<tag1>", "Duke", "University", "is", "also", "conducting", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer.", "<tag2>", "Duke", "University", "has", "completed", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients.", "<tag3>"], "wordsA": ["Duke", "University", "is", "also", "conducting", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer."], "wordsB": ["Duke", "University", "has", "completed", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022112814709544182, 0.042152658104896545, 0.04828716441988945, 0.8414326310157776, 0.03139198198914528, 0.03702060133218765, 0.02923213317990303, 0.05804450437426567, 0.02440820075571537, 0.034711576998233795, 0.14895667135715485, 0.00789815466850996, 0.03126433491706848, 0.00526123121380806, 0.013103704899549484, 0.012182547710835934, 0.009441872127354145, 0.0003073806583415717, 0.012234479188919067, 0.06569855660200119, 0.050917379558086395, 0.0531470961868763, 0.008730808272957802, 0.00977046974003315, 0.12024747580289841, 0.11601545661687851, 0.11800696700811386, 0.00878650601953268, 0.027853073552250862, 0.014546703547239304, 0.032444946467876434, 0.024018172174692154, 0.0269940048456192, 0.08387666940689087, 0.007777335122227669, 0.015111597254872322, 0.04309461638331413, 0.009679884649813175, 0.013479087501764297, 0.061107076704502106, 0.02629290521144867, 0.03051380068063736, 0.07021264731884003, 0.008212745189666748, 0.01227269135415554, 0.06092919409275055, -1]}
{"idB": "749647_12_item1_p61_s1", "idA": "749647_11_item1_p49_s1", "sentA": "Duke has presented preliminary results from the first twelve patients that demonstrate ThermoDox had a beneficial clinical effect, even at lower than optimal dosages.", "sentB": "Futhermore, data presented by Duke suggested a beneficial clinical effect of ThermoDox .", "type": 2, "words": ["<tag1>", "Duke", "has", "presented", "preliminary", "results", "from", "the", "first", "twelve", "patients", "that", "demonstrate", "ThermoDox", "had", "a", "beneficial", "clinical", "effect,", "even", "at", "lower", "than", "optimal", "dosages.", "<tag2>", "Futhermore,", "data", "presented", "by", "Duke", "suggested", "a", "beneficial", "clinical", "effect", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["Duke", "has", "presented", "preliminary", "results", "from", "the", "first", "twelve", "patients", "that", "demonstrate", "ThermoDox", "had", "a", "beneficial", "clinical", "effect,", "even", "at", "lower", "than", "optimal", "dosages."], "wordsB": ["Futhermore,", "data", "presented", "by", "Duke", "suggested", "a", "beneficial", "clinical", "effect", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8169392347335815, 0.22479359805583954, 0.056505002081394196, 0.025374896824359894, 0.029962928965687752, 0.12814082205295563, 0.03545626625418663, 0.11608679592609406, 0.06717364490032196, 0.11057446897029877, 0.03401778265833855, 0.05948846414685249, 5.460593456518836e-05, -1]}
{"idB": "749647_12_item1_p61_s2", "idA": "749647_11_item1_p49_s2", "sentA": "The first eight patients all showed evidence of clinical activity and two out of six patients that were treated at the 30mg dosage had a complete local response.", "sentB": "Duke reported that the combination of ThermoDox with HEAT in all the patients showed evidence of clinical activity and two of the six patients who were treated with the 50mg/m 2 dosage had a complete local response.", "type": 2, "words": ["<tag1>", "The", "first", "eight", "patients", "all", "showed", "evidence", "of", "clinical", "activity", "and", "two", "out", "of", "six", "patients", "that", "were", "treated", "at", "the", "30mg", "dosage", "had", "a", "complete", "local", "response.", "<tag2>", "Duke", "reported", "that", "the", "combination", "of", "ThermoDox", "with", "HEAT", "in", "all", "the", "patients", "showed", "evidence", "of", "clinical", "activity", "and", "two", "of", "the", "six", "patients", "who", "were", "treated", "with", "the", "50mg/m", "2", "dosage", "had", "a", "complete", "local", "response.", "<tag3>"], "wordsA": ["The", "first", "eight", "patients", "all", "showed", "evidence", "of", "clinical", "activity", "and", "two", "out", "of", "six", "patients", "that", "were", "treated", "at", "the", "30mg", "dosage", "had", "a", "complete", "local", "response."], "wordsB": ["Duke", "reported", "that", "the", "combination", "of", "ThermoDox", "with", "HEAT", "in", "all", "the", "patients", "showed", "evidence", "of", "clinical", "activity", "and", "two", "of", "the", "six", "patients", "who", "were", "treated", "with", "the", "50mg/m", "2", "dosage", "had", "a", "complete", "local", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.26783454418182373, 0.06528615951538086, 0.008650260046124458, 0.009141751565039158, 0.07876314967870712, 0.12464290112257004, 0.532452404499054, 0.24767975509166718, 0.27992120385169983, 0.015513760037720203, 0.08063322305679321, 0.02691703289747238, 0.0916406586766243, 0.0028391098603606224, 0.003929579630494118, 0.001575527130626142, 0.0034807275515049696, 0.005894638132303953, 0.0002062357816612348, 0.008452937938272953, 0.0019918212201446295, 0.002367128152400255, 0.026509545743465424, 0.03365800529718399, 0.0019555198960006237, 0.00155033846385777, 0.01043170876801014, 0.007734648883342743, 0.007293529808521271, 0.7825135588645935, 0.2917938828468323, 0.11873530596494675, 0.0024102837778627872, 0.001911118975840509, 0.004224845673888922, 0.0037032815162092447, 0.005630550906062126, -1]}
{"idB": "749647_12_item1_p68_s0", "idA": "749647_11_item1_p50_s1", "sentA": "The Company has also evaluated the liposomal docetaxel formulation in animal studies that demonstrated a statistically significant tumor inhibition effect when compared both to free Docetaxel and a non-heat sensitive formulation.", "sentB": "We developed a stable heat activated liposomal formulation of docetaxel which we have evaluated the liposomal docetaxel formulation in animal studies that demonstrated a statistically significant tumor inhibition effect when compared both to free docetaxel and a non-heat sensitive formulation.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "also", "evaluated", "the", "liposomal", "docetaxel", "formulation", "in", "animal", "studies", "that", "demonstrated", "a", "statistically", "significant", "tumor", "inhibition", "effect", "when", "compared", "both", "to", "free", "Docetaxel", "and", "a", "non-heat", "sensitive", "formulation.", "<tag2>", "We", "developed", "a", "stable", "heat", "activated", "liposomal", "formulation", "of", "docetaxel", "which", "we", "have", "evaluated", "the", "liposomal", "docetaxel", "formulation", "in", "animal", "studies", "that", "demonstrated", "a", "statistically", "significant", "tumor", "inhibition", "effect", "when", "compared", "both", "to", "free", "docetaxel", "and", "a", "non-heat", "sensitive", "formulation.", "<tag3>"], "wordsA": ["The", "Company", "has", "also", "evaluated", "the", "liposomal", "docetaxel", "formulation", "in", "animal", "studies", "that", "demonstrated", "a", "statistically", "significant", "tumor", "inhibition", "effect", "when", "compared", "both", "to", "free", "Docetaxel", "and", "a", "non-heat", "sensitive", "formulation."], "wordsB": ["We", "developed", "a", "stable", "heat", "activated", "liposomal", "formulation", "of", "docetaxel", "which", "we", "have", "evaluated", "the", "liposomal", "docetaxel", "formulation", "in", "animal", "studies", "that", "demonstrated", "a", "statistically", "significant", "tumor", "inhibition", "effect", "when", "compared", "both", "to", "free", "docetaxel", "and", "a", "non-heat", "sensitive", "formulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0788862407207489, 0.06328875571489334, 0.014809572137892246, 0.7985699772834778, 0.5196970701217651, 0.45353493094444275, 0.16774055361747742, 0.08940284699201584, 0.005667583551257849, 0.016796203330159187, 0.004784899298101664, 0.004784232005476952, 0.005168350879102945, 0.009535438381135464, 0.004376319702714682, 0.02063867636024952, 0.014740901067852974, 0.025220002979040146, 0.0031413098331540823, 0.011238031089305878, 0.015519324690103531, 0.0006441787700168788, 0.005304274149239063, 0.0038531902246177197, 0.006855490617454052, 0.0051000602543354034, 0.0155244842171669, 0.01255049742758274, 0.009185731410980225, 0.00481541408225894, 0.006791938096284866, 0.010498618707060814, 0.0064999014139175415, 0.02168315276503563, 0.022115010768175125, 0.003989802673459053, 0.003613832173869014, 0.03590759262442589, 0.020421436056494713, 0.03927456587553024, -1]}
{"idB": "749647_12_item1_p68_s1", "idA": "749647_11_item1_p50_s2", "sentA": "The Company is continuing to evaluate its formulation and is seeking a licensing partner to assist in the funding of this product.", "sentB": "We continue to evaluate its formulation.", "type": 2, "words": ["<tag1>", "The", "Company", "is", "continuing", "to", "evaluate", "its", "formulation", "and", "is", "seeking", "a", "licensing", "partner", "to", "assist", "in", "the", "funding", "of", "this", "product.", "<tag2>", "We", "continue", "to", "evaluate", "its", "formulation.", "<tag3>"], "wordsA": ["The", "Company", "is", "continuing", "to", "evaluate", "its", "formulation", "and", "is", "seeking", "a", "licensing", "partner", "to", "assist", "in", "the", "funding", "of", "this", "product."], "wordsB": ["We", "continue", "to", "evaluate", "its", "formulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7253372073173523, 0.1931302845478058, 0.15379583835601807, 0.6599671840667725, 0.1448015421628952, 0.30388152599334717, -1]}
{"idB": "749647_12_item1_p69_s1", "idA": "749647_11_item1_p51_s1", "sentA": "This funding will support the Company's efforts to develop its proprietary heat-activated liposomal technology in combination with carboplatin, an approved and frequently used oncology drug for treatment of a wide range of cancers.", "sentB": "This funding supports our efforts to develop a proprietary heat-activated liposomal technology in combination with carboplatin, an approved and frequently used oncology drug for treatment of a wide range of cancers.", "type": 2, "words": ["<tag1>", "This", "funding", "will", "support", "the", "Company's", "efforts", "to", "develop", "its", "proprietary", "heat-activated", "liposomal", "technology", "in", "combination", "with", "carboplatin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "treatment", "of", "a", "wide", "range", "of", "cancers.", "<tag2>", "This", "funding", "supports", "our", "efforts", "to", "develop", "a", "proprietary", "heat-activated", "liposomal", "technology", "in", "combination", "with", "carboplatin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "treatment", "of", "a", "wide", "range", "of", "cancers.", "<tag3>"], "wordsA": ["This", "funding", "will", "support", "the", "Company's", "efforts", "to", "develop", "its", "proprietary", "heat-activated", "liposomal", "technology", "in", "combination", "with", "carboplatin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "treatment", "of", "a", "wide", "range", "of", "cancers."], "wordsB": ["This", "funding", "supports", "our", "efforts", "to", "develop", "a", "proprietary", "heat-activated", "liposomal", "technology", "in", "combination", "with", "carboplatin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "treatment", "of", "a", "wide", "range", "of", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018108844757080078, 0.2676502764225006, 0.3532920777797699, 0.5197325944900513, 0.24702107906341553, 0.036328792572021484, 0.07432543486356735, 0.018362905830144882, 0.10808492451906204, 0.21854326128959656, 0.1867379993200302, 0.08643078058958054, 0.026477448642253876, 0.04843822121620178, 0.03551134094595909, 0.397603303194046, 0.016118165105581284, 0.06442219018936157, 0.00875997543334961, 0.03420400246977806, 0.02933909371495247, 0.06617820262908936, 0.08518195897340775, 0.011524737812578678, 0.021974198520183563, 0.014147158712148666, 0.011957153677940369, 0.02980721928179264, 0.027453791350126266, 0.018874134868383408, 0.0756479799747467, -1]}
{"idB": "749647_12_item1_p69_s2", "idA": "749647_11_item1_p51_s2", "sentA": "The grant is valued at approximately $200,000 and will support formulation development and preclinical efficacy studies in collaboration with Duke University.", "sentB": "We received approximately $153,000 from this grant in 2011 to support formulation development and preclinical efficacy studies in collaboration with Duke University.", "type": 2, "words": ["<tag1>", "The", "grant", "is", "valued", "at", "approximately", "$200,000", "and", "will", "support", "formulation", "development", "and", "preclinical", "efficacy", "studies", "in", "collaboration", "with", "Duke", "University.", "<tag2>", "We", "received", "approximately", "$153,000", "from", "this", "grant", "in", "2011", "to", "support", "formulation", "development", "and", "preclinical", "efficacy", "studies", "in", "collaboration", "with", "Duke", "University.", "<tag3>"], "wordsA": ["The", "grant", "is", "valued", "at", "approximately", "$200,000", "and", "will", "support", "formulation", "development", "and", "preclinical", "efficacy", "studies", "in", "collaboration", "with", "Duke", "University."], "wordsB": ["We", "received", "approximately", "$153,000", "from", "this", "grant", "in", "2011", "to", "support", "formulation", "development", "and", "preclinical", "efficacy", "studies", "in", "collaboration", "with", "Duke", "University."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.038817837834358215, 0.1373223215341568, 0.05787002295255661, 0.9746400713920593, 0.020533349364995956, 0.011749573051929474, 0.06905383616685867, 0.015168691985309124, 0.10945964604616165, 0.0039246403612196445, 0.00451394310221076, 0.0037337401881814003, 0.0033447532914578915, 0.001848515821620822, 0.00352412648499012, 0.0032069296576082706, 0.003623468801379204, 0.002160929376259446, 0.002809797879308462, 0.002179292030632496, 0.004109709057956934, 0.004300049506127834, -1]}
{"idB": "749647_12_item1_p18_s2", "idA": "749647_11_item1_p53_s0", "sentA": "Furthermore, our current business strategy includes the option of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "Since this divesture, we have dedicated our efforts and resources to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems.", "type": 2, "words": ["<tag1>", "Furthermore,", "our", "current", "business", "strategy", "includes", "the", "option", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "innovative", "cancer", "drugs", "including", "tumor-targeting", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems.", "<tag3>"], "wordsA": ["Furthermore,", "our", "current", "business", "strategy", "includes", "the", "option", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "innovative", "cancer", "drugs", "including", "tumor-targeting", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024138525128364563, 0.009490938857197762, 0.08719450980424881, 0.031321845948696136, 0.009582343511283398, 0.10146332532167435, 0.05867386609315872, 0.08516507595777512, 0.03927973657846451, 0.11806007474660873, 0.01883934810757637, 0.014089872129261494, 0.10951904207468033, 0.013715357519686222, 0.11331921070814133, 0.04005161300301552, 0.11819017678499222, 0.37176716327667236, 0.3582570552825928, 0.0008721352787688375, 0.13294340670108795, 0.21947097778320312, 0.00996584165841341, 0.024686457589268684, 0.02945130504667759, 0.04552144557237625, 0.00038877816405147314, 0.007658891845494509, 0.005545192398130894, 0.05775798112154007, 0.08539693057537079, 0.0349496565759182, 0.06276272237300873, -1]}
{"idB": "749647_12_item1_p27_s0", "idA": "749647_11_item1_p53_s0", "sentA": "Furthermore, our current business strategy includes the option of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "type": 2, "words": ["<tag1>", "Furthermore,", "our", "current", "business", "strategy", "includes", "the", "option", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Furthermore,", "our", "current", "business", "strategy", "includes", "the", "option", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007702853064984083, 0.02403230406343937, 0.034430380910634995, 0.08270211517810822, 0.08405731618404388, 0.14419397711753845, 0.9086261987686157, 0.4601387083530426, 0.26333579421043396, 0.23718459904193878, 0.18819968402385712, 0.18953610956668854, 0.08393782377243042, 0.12300430983304977, 0.1374177485704422, 0.0212077833712101, 0.013736143708229065, 0.01484899315983057, 0.012415187433362007, 0.010617075487971306, 0.009419296868145466, 0.0073495409451425076, 0.008389366790652275, 0.016112765297293663, 0.02161060832440853, -1]}
{"idB": "749647_12_item1_p27_s3", "idA": "749647_11_item1_p53_s3", "sentA": "Our programs may also benefit from subsidies, grants, or government or agency-sponsored studies that could reduce our development costs.", "sentB": "We may also apply for subsidies, grants, or government or agency-sponsored studies that could reduce our development costs.", "type": 2, "words": ["<tag1>", "Our", "programs", "may", "also", "benefit", "from", "subsidies,", "grants,", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs.", "<tag2>", "We", "may", "also", "apply", "for", "subsidies,", "grants,", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs.", "<tag3>"], "wordsA": ["Our", "programs", "may", "also", "benefit", "from", "subsidies,", "grants,", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs."], "wordsB": ["We", "may", "also", "apply", "for", "subsidies,", "grants,", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.13220146298408508, 0.05389627441763878, 0.048105016350746155, 0.8657103776931763, 0.3139491379261017, 0.1835242211818695, 0.062110535800457, 0.007468924857676029, 0.0077969785779714584, 0.004699311219155788, 0.009863492101430893, 0.03847597539424896, 0.006129205692559481, 0.006046547554433346, 0.07792199403047562, 0.017509112134575844, 0.048648953437805176, 0.03770928084850311, -1]}
{"idB": "749647_12_item1_p24_s0", "idA": "749647_11_item1_p54_s2", "sentA": "These uncertainties could force us to seek additional, external sources of financing from time to time in order to continue with our business strategy.", "sentB": "Consistent with our global regulatory strategy, we are continuing to enroll patients in the HEAT Study in order to randomize at least 200 patients in the People s Republic of China (PRC), a requirement for registrational filing in the PRC.", "type": 2, "words": ["<tag1>", "These", "uncertainties", "could", "force", "us", "to", "seek", "additional,", "external", "sources", "of", "financing", "from", "time", "to", "time", "in", "order", "to", "continue", "with", "our", "business", "strategy.", "<tag2>", "Consistent", "with", "our", "global", "regulatory", "strategy,", "we", "are", "continuing", "to", "enroll", "patients", "in", "the", "HEAT", "Study", "in", "order", "to", "randomize", "at", "least", "200", "patients", "in", "the", "People", "s", "Republic", "of", "China", "(PRC),", "a", "requirement", "for", "registrational", "filing", "in", "the", "PRC.", "<tag3>"], "wordsA": ["These", "uncertainties", "could", "force", "us", "to", "seek", "additional,", "external", "sources", "of", "financing", "from", "time", "to", "time", "in", "order", "to", "continue", "with", "our", "business", "strategy."], "wordsB": ["Consistent", "with", "our", "global", "regulatory", "strategy,", "we", "are", "continuing", "to", "enroll", "patients", "in", "the", "HEAT", "Study", "in", "order", "to", "randomize", "at", "least", "200", "patients", "in", "the", "People", "s", "Republic", "of", "China", "(PRC),", "a", "requirement", "for", "registrational", "filing", "in", "the", "PRC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024525130167603493, 0.007959848269820213, 0.007971975021064281, 0.06743369996547699, 0.146043598651886, 0.07484426349401474, 0.036911215633153915, 0.009334520436823368, 0.1784137487411499, 0.10790816694498062, 0.5004460215568542, 0.32889601588249207, 0.08187542110681534, 0.05294995754957199, 0.17154046893119812, 0.2611321806907654, 0.005014629103243351, 0.005213943775743246, 0.005704321898519993, 0.09505595266819, 0.007585748098790646, 0.014681302011013031, 0.09564525634050369, 0.098021499812603, 0.006023941561579704, 0.006529291160404682, 0.016035066917538643, 0.011509520933032036, 0.008931773714721203, 0.008668734692037106, 0.010955370962619781, 0.01342121884226799, 0.0004476571048144251, 0.022897643968462944, 0.010362678207457066, 0.06043691188097, 0.05668721720576286, 0.009766853414475918, 0.008249967359006405, 0.026226377114653587, -1]}
{"idB": "749647_12_item1_p13_s0", "idA": "749647_11_item1_p57_s1", "sentA": "The majority of the spending in research and development is for the funding of ThermoDox clinical trials.", "sentB": "Drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and the outcome of clinical results is extremely difficult to predict.", "type": 2, "words": ["<tag1>", "The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials.", "<tag2>", "Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials."], "wordsB": ["Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0612342469394207, 0.08723941445350647, 0.011885961517691612, 0.04061218723654747, 0.012593341991305351, 0.010275889188051224, 0.04947700351476669, 0.4217519164085388, 0.26675841212272644, 0.00024859816767275333, 0.005308995954692364, 0.004556433763355017, 0.005885235499590635, 0.02081575058400631, 0.04234961047768593, 0.1345130056142807, 0.4046761691570282, 0.01946955733001232, 0.06529561430215836, 0.05054789036512375, 0.02931630238890648, 0.020800750702619553, 0.06777626276016235, 0.00026426580734550953, 0.00678033335134387, 0.04293216019868851, 0.007941562682390213, 0.009633648209273815, 0.052470654249191284, 0.01749558560550213, 0.052589721977710724, 0.029757944867014885, 0.011805915273725986, 0.025734424591064453, 0.07536580413579941, 0.11699900031089783, 0.11530444771051407, -1]}
{"idB": "749647_12_item1_p80_s2", "idA": "749647_11_item1_p57_s2", "sentA": "Research and development expenses were approximately $14.7 million and $13.7 million for the years ended December 31, 2010 and 2009, respectively.", "sentB": "Research and development expenses were approximately $19.9 million and $14.7 million for the years ended December 31, 2011 and 2010, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$14.7", "million", "and", "$13.7", "million", "for", "the", "years", "ended", "December", "31,", "2010", "and", "2009,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "were", "approximately", "$19.9", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2011", "and", "2010,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$14.7", "million", "and", "$13.7", "million", "for", "the", "years", "ended", "December", "31,", "2010", "and", "2009,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "were", "approximately", "$19.9", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2011", "and", "2010,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004065686371177435, 0.002215515822172165, 0.003468199400231242, 0.006199032533913851, 0.0036427315790206194, 0.012294396758079529, 0.9826323986053467, 0.28174638748168945, 0.00460886349901557, 0.007616267539560795, 0.006387591827660799, 0.0023625586181879044, 0.002352045616135001, 0.0074828932993113995, 0.006881297565996647, 0.009480392560362816, 0.010211221873760223, 0.7414842844009399, 0.022095490247011185, 0.022048519924283028, 0.004354323260486126, -1]}
{"idB": "749647_12_item1_p81_s0", "idA": "749647_11_item1_p58_s0", "sentA": "Our research and development activities, pre-clinical tests and clinical trials and, ultimately, the manufacturing, marketing and labeling of our products, are subject to extensive regulation by the Food and Drug Administration (the FDA ).", "sentB": "Our research and development activities, pre-clinical tests and clinical trials are subject to extensive regulation by the FDA as would the manufacturing, marketing and labeling of our products, if any.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities,", "pre-clinical", "tests", "and", "clinical", "trials", "and,", "ultimately,", "the", "manufacturing,", "marketing", "and", "labeling", "of", "our", "products,", "are", "subject", "to", "extensive", "regulation", "by", "the", "Food", "and", "Drug", "Administration", "(the", "FDA", ").", "<tag2>", "Our", "research", "and", "development", "activities,", "pre-clinical", "tests", "and", "clinical", "trials", "are", "subject", "to", "extensive", "regulation", "by", "the", "FDA", "as", "would", "the", "manufacturing,", "marketing", "and", "labeling", "of", "our", "products,", "if", "any.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities,", "pre-clinical", "tests", "and", "clinical", "trials", "and,", "ultimately,", "the", "manufacturing,", "marketing", "and", "labeling", "of", "our", "products,", "are", "subject", "to", "extensive", "regulation", "by", "the", "Food", "and", "Drug", "Administration", "(the", "FDA", ")."], "wordsB": ["Our", "research", "and", "development", "activities,", "pre-clinical", "tests", "and", "clinical", "trials", "are", "subject", "to", "extensive", "regulation", "by", "the", "FDA", "as", "would", "the", "manufacturing,", "marketing", "and", "labeling", "of", "our", "products,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0251130610704422, 0.07107608765363693, 0.031769365072250366, 0.04560213163495064, 0.07850201427936554, 0.06024656817317009, 0.06805974990129471, 0.01285635121166706, 0.035742390900850296, 0.051428258419036865, 0.020387105643749237, 0.05788882449269295, 0.017759565263986588, 0.05860190466046333, 0.07379714399576187, 0.024765828624367714, 0.02565915323793888, 0.21070362627506256, 0.0851389467716217, 0.09206902980804443, 0.0264759361743927, 0.1659722775220871, 0.06929469853639603, 0.0259269829839468, 0.08593858778476715, 0.035691652446985245, 0.05197715014219284, 0.11943893879652023, 0.22323952615261078, 0.36198940873146057, -1]}
{"idB": "749647_12_item1_p82_s1", "idA": "749647_11_item1_p59_s1", "sentA": "The steps ordinarily required before such products can be marketed in the U.S. include (a) pre-clinical and clinical studies; (b) the submission to the FDA of an application for, or approval, as an Investigational New Drug ( IND ), which must become effective before human clinical trials may commence; (c) adequate and well-controlled human clinical trials to establish the safety and efficacy of the product; (d) the submission to the FDA of a New Drug Application ( NDA and (e) FDA approval of the application, including approval of all product labeling.", "sentB": "The steps ordinarily required before such products can be marketed in the U.S. include (a) pre-clinical and clinical studies; (b) the submission to the FDA of an application for, or approval, as IND, which must become effective before human clinical trials may commence; (c) adequate and well-controlled human clinical trials to establish the safety and efficacy of the product; (d) the submission to the FDA of a NDA; and (e) FDA approval of the application, including approval of all product labeling.", "type": 2, "words": ["<tag1>", "The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "an", "Investigational", "New", "Drug", "(", "IND", "),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "New", "Drug", "Application", "(", "NDA", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling.", "<tag2>", "The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "IND,", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "NDA;", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling.", "<tag3>"], "wordsA": ["The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "an", "Investigational", "New", "Drug", "(", "IND", "),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "New", "Drug", "Application", "(", "NDA", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling."], "wordsB": ["The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "IND,", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "NDA;", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015499441884458065, 0.15151117742061615, 0.19424378871917725, 0.15737363696098328, 0.11679890751838684, 0.08962661027908325, 0.11253496259450912, 0.09150809049606323, 0.09710533916950226, 0.11091294884681702, 0.05676999315619469, 0.0461224801838398, 0.09511172026395798, 0.03051880933344364, 0.06938567757606506, 0.07101523131132126, 0.03241170570254326, 0.049436893314123154, 0.048340290784835815, 0.04634169116616249, 0.021952979266643524, 0.09521209448575974, 0.05147179961204529, 0.04464925825595856, 0.18218794465065002, 0.038775667548179626, 0.03867831081151962, 0.1153237372636795, 0.05366288870573044, 0.03585412725806236, 0.049978647381067276, 0.035372450947761536, 0.0699530690908432, 0.03097873367369175, 0.03518732264637947, 0.03948478028178215, 0.05712738633155823, 0.03435445576906204, 0.053201861679553986, 0.05377401411533356, 0.0686081051826477, 0.028319571167230606, 0.038478802889585495, 0.04794251546263695, 0.06625789403915405, 0.031333085149526596, 0.05507252365350723, 0.03801615163683891, 0.04845578223466873, 0.05390343815088272, 0.026781335473060608, 0.03709105774760246, 0.03319776430726051, 0.056002046912908554, 0.04191824048757553, 0.05325087904930115, 0.027528921142220497, 0.03093000315129757, 0.051442794501781464, 0.05450771376490593, 0.022176772356033325, 0.06590543687343597, 0.033783867955207825, 0.03162655979394913, 0.06674692034721375, 0.03657225891947746, 0.03320445120334625, 0.08433443307876587, 0.019223082810640335, 0.05554740130901337, 0.05153284966945648, 0.060587335377931595, 0.0260126031935215, 0.030159462243318558, 0.06638132035732269, 0.021747125312685966, 0.024064134806394577, 0.02597065083682537, 0.04234643280506134, 0.13277213275432587, 0.053760431706905365, -1]}
{"idB": "749647_12_item1_p21_s0", "idA": "749647_11_item1_p61_s1", "sentA": "Clinical trials must be conducted in accordance with Good Clinical Practices under protocols submitted to the FDA as part of an IND.", "sentB": "As a part of its commitment to the PMDA, the DMC independently assesses patients randomized at Japanese sites.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "Good", "Clinical", "Practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND.", "<tag2>", "As", "a", "part", "of", "its", "commitment", "to", "the", "PMDA,", "the", "DMC", "independently", "assesses", "patients", "randomized", "at", "Japanese", "sites.", "<tag3>"], "wordsA": ["Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "Good", "Clinical", "Practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND."], "wordsB": ["As", "a", "part", "of", "its", "commitment", "to", "the", "PMDA,", "the", "DMC", "independently", "assesses", "patients", "randomized", "at", "Japanese", "sites."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007504836190491915, 0.007523299194872379, 0.01575499400496483, 0.008097577840089798, 0.01378965750336647, 0.055061258375644684, 0.04156818613409996, 0.031384117901325226, 0.11528775095939636, 0.010365025140345097, 0.08669909834861755, 0.19425293803215027, 0.2784360945224762, 0.3234542906284332, 0.4035628139972687, 0.03900749981403351, 0.13688120245933533, 0.17000393569469452, -1]}
{"idB": "749647_12_item1_p84_s2", "idA": "749647_11_item1_p61_s2", "sentA": "Also, each clinical trial must be approved and conducted under the auspices of an internal review board, or IRB, and with patient informed consent.", "sentB": "Also, each clinical trial must be approved and conducted under the auspices of an internal review board (IRB), and with patient informed consent.", "type": 2, "words": ["<tag1>", "Also,", "each", "clinical", "trial", "must", "be", "approved", "and", "conducted", "under", "the", "auspices", "of", "an", "internal", "review", "board,", "or", "IRB,", "and", "with", "patient", "informed", "consent.", "<tag2>", "Also,", "each", "clinical", "trial", "must", "be", "approved", "and", "conducted", "under", "the", "auspices", "of", "an", "internal", "review", "board", "(IRB),", "and", "with", "patient", "informed", "consent.", "<tag3>"], "wordsA": ["Also,", "each", "clinical", "trial", "must", "be", "approved", "and", "conducted", "under", "the", "auspices", "of", "an", "internal", "review", "board,", "or", "IRB,", "and", "with", "patient", "informed", "consent."], "wordsB": ["Also,", "each", "clinical", "trial", "must", "be", "approved", "and", "conducted", "under", "the", "auspices", "of", "an", "internal", "review", "board", "(IRB),", "and", "with", "patient", "informed", "consent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06455764919519424, 0.2688295543193817, 0.2673628330230713, 0.43884024024009705, 0.12155845016241074, 0.08864530175924301, 0.3538534343242645, 0.062061961740255356, 0.12526573240756989, 0.10328315943479538, 0.06356027722358704, 0.1710953712463379, 0.06236378848552704, 0.05973947420716286, 0.1711098700761795, 0.17498894035816193, 0.142691507935524, 0.37400612235069275, 0.029144683852791786, 0.07428135722875595, 0.17741836607456207, 0.33192408084869385, 0.218827486038208, -1]}
{"idB": "749647_12_item1_p67_s0", "idA": "749647_11_item1_p63_s1", "sentA": "Phase II trials are generally larger trials conducted in the target population.", "sentB": "On February 13, 2012, we announced that the first patient had been enrolled in the Phase II ABLATE study.", "type": 2, "words": ["<tag1>", "Phase", "II", "trials", "are", "generally", "larger", "trials", "conducted", "in", "the", "target", "population.", "<tag2>", "On", "February", "13,", "2012,", "we", "announced", "that", "the", "first", "patient", "had", "been", "enrolled", "in", "the", "Phase", "II", "ABLATE", "study.", "<tag3>"], "wordsA": ["Phase", "II", "trials", "are", "generally", "larger", "trials", "conducted", "in", "the", "target", "population."], "wordsB": ["On", "February", "13,", "2012,", "we", "announced", "that", "the", "first", "patient", "had", "been", "enrolled", "in", "the", "Phase", "II", "ABLATE", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.052020445466041565, 0.12113624066114426, 0.08371023833751678, 0.15476451814174652, 0.10608445107936859, 0.15941780805587769, 0.0459417887032032, 0.06300483644008636, 0.3184126317501068, 0.4439861476421356, 0.12501293420791626, 0.08841399848461151, 0.21405547857284546, 0.05828287824988365, 0.034219928085803986, 0.063869908452034, 0.06900609284639359, 0.13203899562358856, 0.2742207646369934, -1]}
{"idB": "749647_12_item1_p87_s0", "idA": "749647_11_item1_p64_s0", "sentA": "determine dosage tolerance and optimal dosage and to identify possible adverse effects and safety risks.", "sentB": "In the case of drugs and biological products, Phase II clinical trials generally are conducted in a target patient population to gather evidence about the pharmacokinetics, safety and biological or clinical efficacy of the drug for specific indications, to determine dosage tolerance and optimal dosage and to identify possible adverse effects and safety risks.", "type": 2, "words": ["<tag1>", "determine", "dosage", "tolerance", "and", "optimal", "dosage", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag2>", "In", "the", "case", "of", "drugs", "and", "biological", "products,", "Phase", "II", "clinical", "trials", "generally", "are", "conducted", "in", "a", "target", "patient", "population", "to", "gather", "evidence", "about", "the", "pharmacokinetics,", "safety", "and", "biological", "or", "clinical", "efficacy", "of", "the", "drug", "for", "specific", "indications,", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag3>"], "wordsA": ["determine", "dosage", "tolerance", "and", "optimal", "dosage", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks."], "wordsB": ["In", "the", "case", "of", "drugs", "and", "biological", "products,", "Phase", "II", "clinical", "trials", "generally", "are", "conducted", "in", "a", "target", "patient", "population", "to", "gather", "evidence", "about", "the", "pharmacokinetics,", "safety", "and", "biological", "or", "clinical", "efficacy", "of", "the", "drug", "for", "specific", "indications,", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011796695180237293, 0.01419905200600624, 0.03573896363377571, 0.017309289425611496, 0.1467362493276596, 0.06249489262700081, 0.2653989791870117, 0.23849591612815857, 0.04788919910788536, 0.08485181629657745, 0.10925961285829544, 0.14868536591529846, 0.021889464929699898, 0.009237943217158318, 0.028005095198750496, 0.04360305517911911, 0.027336686849594116, 0.10871016979217529, 0.19437430799007416, 0.1605537235736847, 0.01048465259373188, 0.01848914846777916, 0.02307092770934105, 0.008489050902426243, 0.00948431994765997, 0.031200282275676727, 0.010569212026894093, 0.005735405255109072, 0.011133882217109203, 0.007511956617236137, 0.008888821117579937, 0.010505654849112034, 0.015497935935854912, 0.013281120918691158, 0.049641650170087814, 0.009699197486042976, 0.014822726137936115, 0.016493255272507668, 0.010065540671348572, 0.00829344242811203, 0.0131588289514184, 0.012259237468242645, 0.006090693641453981, 0.010601804591715336, 0.00906346645206213, 0.004766752012073994, 0.006536985747516155, 0.00597476027905941, 0.006718016695231199, 0.0077721839770674706, 0.008973276242613792, 0.0067606037482619286, 0.008548213168978691, 0.010149609297513962, -1]}
{"idB": "749647_12_item1_p73_s1", "idA": "749647_11_item1_p65_s1", "sentA": "In 2007, the Company, with the support of the FDA, received a Special Protocol Assessment for its Phase III trial, having proceeded to this phase directly from Phase I assessment.", "sentB": "In addition to the Special Protocol Assessment (SPA) with the FDA, we have received Fast Track designation from the FDA, providing for a rolling NDA submission, a 6 month regulatory review and a simplified review process.", "type": 2, "words": ["<tag1>", "In", "2007,", "the", "Company,", "with", "the", "support", "of", "the", "FDA,", "received", "a", "Special", "Protocol", "Assessment", "for", "its", "Phase", "III", "trial,", "having", "proceeded", "to", "this", "phase", "directly", "from", "Phase", "I", "assessment.", "<tag2>", "In", "addition", "to", "the", "Special", "Protocol", "Assessment", "(SPA)", "with", "the", "FDA,", "we", "have", "received", "Fast", "Track", "designation", "from", "the", "FDA,", "providing", "for", "a", "rolling", "NDA", "submission,", "a", "6", "month", "regulatory", "review", "and", "a", "simplified", "review", "process.", "<tag3>"], "wordsA": ["In", "2007,", "the", "Company,", "with", "the", "support", "of", "the", "FDA,", "received", "a", "Special", "Protocol", "Assessment", "for", "its", "Phase", "III", "trial,", "having", "proceeded", "to", "this", "phase", "directly", "from", "Phase", "I", "assessment."], "wordsB": ["In", "addition", "to", "the", "Special", "Protocol", "Assessment", "(SPA)", "with", "the", "FDA,", "we", "have", "received", "Fast", "Track", "designation", "from", "the", "FDA,", "providing", "for", "a", "rolling", "NDA", "submission,", "a", "6", "month", "regulatory", "review", "and", "a", "simplified", "review", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015266324393451214, 0.030753863975405693, 0.01055050827562809, 0.008699057623744011, 0.05065783113241196, 0.06393640488386154, 0.07983314245939255, 0.151677668094635, 0.007634853944182396, 0.0082510095089674, 0.035830140113830566, 0.026179678738117218, 0.007410361431539059, 0.01915702223777771, 0.28838834166526794, 0.25912654399871826, 0.07854948937892914, 0.009556970559060574, 0.0130228316411376, 0.04453420639038086, 0.02121000923216343, 0.014712140895426273, 0.01876513473689556, 0.4059743583202362, 0.49362894892692566, 0.3921104371547699, 0.012747024185955524, 0.1978154182434082, 0.15829646587371826, 0.1164826825261116, 0.22744369506835938, 0.0006454745307564735, 0.00789780355989933, 0.3367367684841156, 0.23957419395446777, 0.12273713201284409, -1]}
{"idB": "749647_12_item1_p87_s2", "idA": "749647_11_item1_p65_s1", "sentA": "In 2007, the Company, with the support of the FDA, received a Special Protocol Assessment for its Phase III trial, having proceeded to this phase directly from Phase I assessment.", "sentB": "In 2008, we, in collaboration with the FDA, received a Special Protocol Assessment for our Phase III HEAT study, having proceeded to this phase directly from Phase I assessment.", "type": 2, "words": ["<tag1>", "In", "2007,", "the", "Company,", "with", "the", "support", "of", "the", "FDA,", "received", "a", "Special", "Protocol", "Assessment", "for", "its", "Phase", "III", "trial,", "having", "proceeded", "to", "this", "phase", "directly", "from", "Phase", "I", "assessment.", "<tag2>", "In", "2008,", "we,", "in", "collaboration", "with", "the", "FDA,", "received", "a", "Special", "Protocol", "Assessment", "for", "our", "Phase", "III", "HEAT", "study,", "having", "proceeded", "to", "this", "phase", "directly", "from", "Phase", "I", "assessment.", "<tag3>"], "wordsA": ["In", "2007,", "the", "Company,", "with", "the", "support", "of", "the", "FDA,", "received", "a", "Special", "Protocol", "Assessment", "for", "its", "Phase", "III", "trial,", "having", "proceeded", "to", "this", "phase", "directly", "from", "Phase", "I", "assessment."], "wordsB": ["In", "2008,", "we,", "in", "collaboration", "with", "the", "FDA,", "received", "a", "Special", "Protocol", "Assessment", "for", "our", "Phase", "III", "HEAT", "study,", "having", "proceeded", "to", "this", "phase", "directly", "from", "Phase", "I", "assessment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02711763046681881, 0.7446298599243164, 0.06626857817173004, 0.015486102551221848, 0.03236810117959976, 0.009753350168466568, 0.006563730537891388, 0.02644055150449276, 0.00577116385102272, 0.0022684193681925535, 0.00785852037370205, 0.01113797351717949, 0.022473985329270363, 0.008477880619466305, 0.016678789630532265, 0.03976834937930107, 0.10875675082206726, 0.692850649356842, 0.7874228954315186, 0.002797970548272133, 0.005231734365224838, 0.0024752498138695955, 0.0028416516724973917, 0.007343465927988291, 0.004149903077632189, 0.0023027947172522545, 0.007049165666103363, 0.006736766081303358, 0.018146134912967682, -1]}
{"idB": "749647_12_item1_p60_s1", "idA": "749647_11_item1_p72_s1", "sentA": "Manufacturing establishments in the U.S. and abroad are subject to inspections by the FDA and must comply with current Good Manufacturing Practices.", "sentB": "The Phase II portion of the DIGNITY Study protocol has been reviewed by the FDA and is planned to commence in 2012 at four to five investigation sites.", "type": 2, "words": ["<tag1>", "Manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "Good", "Manufacturing", "Practices.", "<tag2>", "The", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "is", "planned", "to", "commence", "in", "2012", "at", "four", "to", "five", "investigation", "sites.", "<tag3>"], "wordsA": ["Manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "Good", "Manufacturing", "Practices."], "wordsB": ["The", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "is", "planned", "to", "commence", "in", "2012", "at", "four", "to", "five", "investigation", "sites."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009197677485644817, 0.18433381617069244, 0.4288894534111023, 0.07484360784292221, 0.02614670805633068, 0.023817094042897224, 0.20465436577796936, 0.43909239768981934, 0.20726603269577026, 0.010006473399698734, 0.023184670135378838, 0.14869849383831024, 0.017153572291135788, 0.016395216807723045, 0.06591474264860153, 0.00013457250315696, 0.005077589303255081, 0.03330206498503685, 0.020825793966650963, 0.04115957021713257, 0.020834917202591896, 0.06312675029039383, 0.021807970479130745, 0.14474301040172577, 0.03924986720085144, 0.2751419246196747, 0.5160796046257019, 0.28476664423942566, -1]}
{"idB": "749647_12_item1_p110_s3", "idA": "749647_11_item1_p76_s1", "sentA": "We must also comply with record keeping requirements as well as requirements to report certain adverse events involving our products.", "sentB": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "type": 2, "words": ["<tag1>", "We", "must", "also", "comply", "with", "record", "keeping", "requirements", "as", "well", "as", "requirements", "to", "report", "certain", "adverse", "events", "involving", "our", "products.", "<tag2>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag3>"], "wordsA": ["We", "must", "also", "comply", "with", "record", "keeping", "requirements", "as", "well", "as", "requirements", "to", "report", "certain", "adverse", "events", "involving", "our", "products."], "wordsB": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023963546380400658, 0.4290255308151245, 0.34053289890289307, 0.24080400168895721, 0.29112306237220764, 0.35384508967399597, 0.5353462100028992, 0.03183908015489578, 0.022306226193904877, 0.04847125709056854, 0.03421785682439804, 0.3090853691101074, 0.05507649481296539, 0.11841169744729996, 0.10047870129346848, 0.2677113711833954, 0.1697799116373062, 0.26784640550613403, 0.07196563482284546, 0.12260893732309341, -1]}
{"idB": "749647_12_item1_p74_s2", "idA": "749647_11_item1_p76_s1", "sentA": "We must also comply with record keeping requirements as well as requirements to report certain adverse events involving our products.", "sentB": "Together, these strategies are expected to provide for a more streamlined and straightforward review process as well as a successful product launch.", "type": 2, "words": ["<tag1>", "We", "must", "also", "comply", "with", "record", "keeping", "requirements", "as", "well", "as", "requirements", "to", "report", "certain", "adverse", "events", "involving", "our", "products.", "<tag2>", "Together,", "these", "strategies", "are", "expected", "to", "provide", "for", "a", "more", "streamlined", "and", "straightforward", "review", "process", "as", "well", "as", "a", "successful", "product", "launch.", "<tag3>"], "wordsA": ["We", "must", "also", "comply", "with", "record", "keeping", "requirements", "as", "well", "as", "requirements", "to", "report", "certain", "adverse", "events", "involving", "our", "products."], "wordsB": ["Together,", "these", "strategies", "are", "expected", "to", "provide", "for", "a", "more", "streamlined", "and", "straightforward", "review", "process", "as", "well", "as", "a", "successful", "product", "launch."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0716295838356018, 0.05890330672264099, 0.22505620121955872, 0.020682822912931442, 0.09662116318941116, 0.018094060942530632, 0.03596031293272972, 0.018078064545989037, 0.013203287497162819, 0.03619959577918053, 0.14960765838623047, 0.008446833118796349, 0.2926901578903198, 0.2745118737220764, 0.0862603411078453, 0.0005738906329497695, 0.0051245312206447124, 0.00780290924012661, 0.011740854009985924, 0.08484234660863876, 0.14366377890110016, 0.05446816235780716, -1]}
{"idB": "749647_12_item1_p110_s0", "idA": "749647_11_item1_p76_s2", "sentA": "The FDA can impose other post-marketing controls on us as well as our products including, but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise.", "sentB": "Please refer to Item 1A, Risk Factors, including, but not limited to, We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "The", "FDA", "can", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise.", "<tag2>", "Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["The", "FDA", "can", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise."], "wordsB": ["Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06168770417571068, 0.13028442859649658, 0.049348171800374985, 0.19161666929721832, 0.3265977203845978, 0.03907826170325279, 0.02690315432846546, 0.004139841999858618, 0.004953870549798012, 0.004978668875992298, 0.007531944662332535, 0.004716875962913036, 0.011844451539218426, 0.054565221071243286, 0.020788177847862244, 0.16987334191799164, 0.16816291213035583, 0.17393158376216888, 0.00692483875900507, 0.006361161824315786, 0.01906982623040676, 0.1135307103395462, 0.19834189116954803, 0.007368782535195351, 0.01444899383932352, 0.04599080979824066, 0.05114471912384033, 0.00030171030084602535, 0.009928936138749123, 0.05401767045259476, 0.02889949083328247, 0.006517918314784765, 0.06534124910831451, 0.006588975433260202, 0.027136381715536118, 0.01506693847477436, 0.06378448009490967, 0.014251811429858208, 0.012987001799046993, 0.03922988474369049, 0.01487715169787407, 0.05421203374862671, 0.04854291304945946, -1]}
{"idB": "749647_12_item1_p110_s2", "idA": "749647_11_item1_p76_s2", "sentA": "The FDA can impose other post-marketing controls on us as well as our products including, but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise.", "sentB": "Please refer to Item 1A, Risk Factors, including, but not limited to, Our business depends on licensing agreements with third parties to permit us to use patented technologies.", "type": 2, "words": ["<tag1>", "The", "FDA", "can", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise.", "<tag2>", "Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "Our", "business", "depends", "on", "licensing", "agreements", "with", "third", "parties", "to", "permit", "us", "to", "use", "patented", "technologies.", "<tag3>"], "wordsA": ["The", "FDA", "can", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise."], "wordsB": ["Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "Our", "business", "depends", "on", "licensing", "agreements", "with", "third", "parties", "to", "permit", "us", "to", "use", "patented", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06809625774621964, 0.14814446866512299, 0.04758869484066963, 0.18440431356430054, 0.345012366771698, 0.04496341198682785, 0.026487132534384727, 0.0036589493975043297, 0.003979647532105446, 0.004065929912030697, 0.007455563638359308, 0.004779933486133814, 0.009108931757509708, 0.09083380550146103, 0.04238315299153328, 0.01850023679435253, 0.359500527381897, 0.3412037193775177, 0.03971722349524498, 0.10069134831428528, 0.1272357553243637, 0.008848905563354492, 0.05513528361916542, 0.03495752438902855, 0.0456896610558033, 0.07481878250837326, 0.12084858864545822, 0.08752389997243881, -1]}
{"idB": "749647_12_item1_p78_s0", "idA": "749647_11_item1_p78_s1", "sentA": "We face, and will continue to face, intense competition from pharmaceutical and biotechnology companies, as well as academic and research institutions and government agencies both in the U.S. and abroad.", "sentB": "Compendia listing in the US supports adoption from the medical community as well as reimbursement from private and public payors.", "type": 2, "words": ["<tag1>", "We", "face,", "and", "will", "continue", "to", "face,", "intense", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad.", "<tag2>", "Compendia", "listing", "in", "the", "US", "supports", "adoption", "from", "the", "medical", "community", "as", "well", "as", "reimbursement", "from", "private", "and", "public", "payors.", "<tag3>"], "wordsA": ["We", "face,", "and", "will", "continue", "to", "face,", "intense", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad."], "wordsB": ["Compendia", "listing", "in", "the", "US", "supports", "adoption", "from", "the", "medical", "community", "as", "well", "as", "reimbursement", "from", "private", "and", "public", "payors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.26504382491111755, 0.18606479465961456, 0.027807556092739105, 0.02159620262682438, 0.06893719732761383, 0.12630367279052734, 0.2838681936264038, 0.050385236740112305, 0.048276182264089584, 0.31793439388275146, 0.26062411069869995, 0.0045460122637450695, 0.005202211439609528, 0.007324490696191788, 0.17134034633636475, 0.017307700589299202, 0.16570442914962769, 0.09807471185922623, 0.24473418295383453, 0.21659715473651886, -1]}
{"idB": "749647_12_item1_p104_s1", "idA": "749647_11_item1_p82_s0", "sentA": "With regard to liposome patents licensed from Duke University, the Company has filed two additional patents related to the formulation and use of liposomes.", "sentB": "In relation to these liposome patents licensed from Duke University, we have filed two additional patents related to the formulation and use of liposomes.", "type": 2, "words": ["<tag1>", "With", "regard", "to", "liposome", "patents", "licensed", "from", "Duke", "University,", "the", "Company", "has", "filed", "two", "additional", "patents", "related", "to", "the", "formulation", "and", "use", "of", "liposomes.", "<tag2>", "In", "relation", "to", "these", "liposome", "patents", "licensed", "from", "Duke", "University,", "we", "have", "filed", "two", "additional", "patents", "related", "to", "the", "formulation", "and", "use", "of", "liposomes.", "<tag3>"], "wordsA": ["With", "regard", "to", "liposome", "patents", "licensed", "from", "Duke", "University,", "the", "Company", "has", "filed", "two", "additional", "patents", "related", "to", "the", "formulation", "and", "use", "of", "liposomes."], "wordsB": ["In", "relation", "to", "these", "liposome", "patents", "licensed", "from", "Duke", "University,", "we", "have", "filed", "two", "additional", "patents", "related", "to", "the", "formulation", "and", "use", "of", "liposomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.041647687554359436, 0.20905983448028564, 0.06584752351045609, 0.02529548853635788, 0.25514620542526245, 0.4575856029987335, 0.057204801589250565, 0.03298121690750122, 0.07642259448766708, 0.082247793674469, 0.3501335680484772, 0.1053866595029831, 0.2677205801010132, 0.061283551156520844, 0.04949929565191269, 0.23855164647102356, 0.030376991257071495, 0.018951967358589172, 0.014999874867498875, 0.031231369823217392, 0.014888993464410305, 0.02715936303138733, 0.02633586712181568, 0.09018805623054504, -1]}
{"idB": "749647_12_item1_p104_s2", "idA": "749647_11_item1_p82_s1", "sentA": "Further, in relation to the patents licensed from Duke, the Company has licensed from Valentis, CA certain global rights covering the use of pegylation for temperature sensitive liposomes.", "sentB": "We have also licensed from Valentis, CA certain global rights covering the use of pegylation for temperature sensitive liposomes.", "type": 2, "words": ["<tag1>", "Further,", "in", "relation", "to", "the", "patents", "licensed", "from", "Duke,", "the", "Company", "has", "licensed", "from", "Valentis,", "CA", "certain", "global", "rights", "covering", "the", "use", "of", "pegylation", "for", "temperature", "sensitive", "liposomes.", "<tag2>", "We", "have", "also", "licensed", "from", "Valentis,", "CA", "certain", "global", "rights", "covering", "the", "use", "of", "pegylation", "for", "temperature", "sensitive", "liposomes.", "<tag3>"], "wordsA": ["Further,", "in", "relation", "to", "the", "patents", "licensed", "from", "Duke,", "the", "Company", "has", "licensed", "from", "Valentis,", "CA", "certain", "global", "rights", "covering", "the", "use", "of", "pegylation", "for", "temperature", "sensitive", "liposomes."], "wordsB": ["We", "have", "also", "licensed", "from", "Valentis,", "CA", "certain", "global", "rights", "covering", "the", "use", "of", "pegylation", "for", "temperature", "sensitive", "liposomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.28804293274879456, 0.12058337032794952, 0.14566804468631744, 0.819406270980835, 0.15432238578796387, 0.13329291343688965, 0.019713643938302994, 0.007958636619150639, 0.008262758143246174, 0.018148750066757202, 0.007193529047071934, 0.004921155981719494, 0.009987407363951206, 0.005400257185101509, 0.017587920650839806, 0.003469567745923996, 0.004835211206227541, 0.004941925406455994, 0.007614278234541416, -1]}
{"idB": "749647_12_item1_p104_s0", "idA": "749647_11_item1_p83_s0", "sentA": "In 1999, the Company entered into a license agreement with Duke University under which the Company received exclusive rights (subject to certain exceptions) to commercialize and use Duke s thermo-liposome technology.", "sentB": "In 1999, the Company entered into a license agreement with Duke University under which the we received exclusive rights (subject to certain exceptions) to commercialize and use Duke s thermo-liposome technology.", "type": 2, "words": ["<tag1>", "In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "Company", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag2>", "In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "we", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag3>"], "wordsA": ["In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "Company", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "wordsB": ["In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "we", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04332984983921051, 0.0827263593673706, 0.013116264715790749, 0.14228284358978271, 0.06639689207077026, 0.018106969073414803, 0.02522118389606476, 0.06805974990129471, 0.09380017220973969, 0.04330432042479515, 0.16293630003929138, 0.10519887506961823, 0.043572306632995605, 0.027882808819413185, 0.018582550808787346, 0.8091295957565308, 0.2142321616411209, 0.17742718756198883, 0.11750130355358124, 0.040769919753074646, 0.02464362420141697, 0.06538242846727371, 0.06861193478107452, 0.02394251525402069, 0.05454011261463165, 0.019996514543890953, 0.03734280914068222, 0.18604512512683868, 0.08910426497459412, 0.0999898687005043, 0.08902238309383392, -1]}
{"idB": "749647_12_item1_p105_s0", "idA": "749647_11_item1_p84_s0", "sentA": "In 2003, Celsion s obligations under the license agreement with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment from Celsion in shares of its Common Stock.", "sentB": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "type": 2, "words": ["<tag1>", "In", "2003,", "Celsion", "s", "obligations", "under", "the", "license", "agreement", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "from", "Celsion", "in", "shares", "of", "its", "Common", "Stock.", "<tag2>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "2003,", "Celsion", "s", "obligations", "under", "the", "license", "agreement", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "from", "Celsion", "in", "shares", "of", "its", "Common", "Stock."], "wordsB": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004762709140777588, 0.007541275583207607, 0.013879956677556038, 0.0559062659740448, 0.0060203769244253635, 0.004932435695081949, 0.01496502012014389, 0.030946781858801842, 0.056517187505960464, 0.9681140184402466, 0.9558707475662231, 0.008466408587992191, 0.006486437749117613, 0.005261341109871864, 0.004812750034034252, 0.006934052798897028, 0.005806431174278259, 0.007756050210446119, 0.007902071811258793, 0.003779682330787182, 0.0040121544152498245, 0.007295815274119377, 0.007217871490865946, 0.0064750597812235355, 0.0071555315516889095, 0.0133229224011302, 0.028436103835701942, 0.007112378720194101, 0.0073017580434679985, 0.0041252318769693375, 0.004107964690774679, 0.008850985206663609, 0.0037565736565738916, 0.009305145591497421, 0.004262986592948437, 0.006257012486457825, 0.009474442340433598, 0.009957488626241684, -1]}
{"idB": "749647_12_item1_p106_s0", "idA": "749647_11_item1_p85_s0", "sentA": "In conjunction with the patent holder, the Company intends to file international applications for certain of the United States patents.", "sentB": "In conjunction with the patent holder, we have filed international applications for a certain number of the United States patents.", "type": 2, "words": ["<tag1>", "In", "conjunction", "with", "the", "patent", "holder,", "the", "Company", "intends", "to", "file", "international", "applications", "for", "certain", "of", "the", "United", "States", "patents.", "<tag2>", "In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "United", "States", "patents.", "<tag3>"], "wordsA": ["In", "conjunction", "with", "the", "patent", "holder,", "the", "Company", "intends", "to", "file", "international", "applications", "for", "certain", "of", "the", "United", "States", "patents."], "wordsB": ["In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "United", "States", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04024933651089668, 0.103127121925354, 0.03137822076678276, 0.022301238030195236, 0.09959693253040314, 0.22227896749973297, 0.4139194190502167, 0.2745946943759918, 0.20139247179031372, 0.0737847313284874, 0.15572044253349304, 0.042765747755765915, 0.04085875675082207, 0.0532807931303978, 0.39779600501060486, 0.04273344948887825, 0.03867775574326515, 0.11680613458156586, 0.1772553026676178, 0.37880828976631165, -1]}
{"idB": "749647_12_item1_p124_s0", "idA": "749647_11_item1_p85_s0", "sentA": "In conjunction with the patent holder, the Company intends to file international applications for certain of the United States patents.", "sentB": "Dr. Borys joined Celsion on October 1, 2007 as Vice President and Chief Medical Officer of the Company.", "type": 2, "words": ["<tag1>", "In", "conjunction", "with", "the", "patent", "holder,", "the", "Company", "intends", "to", "file", "international", "applications", "for", "certain", "of", "the", "United", "States", "patents.", "<tag2>", "Dr.", "Borys", "joined", "Celsion", "on", "October", "1,", "2007", "as", "Vice", "President", "and", "Chief", "Medical", "Officer", "of", "the", "Company.", "<tag3>"], "wordsA": ["In", "conjunction", "with", "the", "patent", "holder,", "the", "Company", "intends", "to", "file", "international", "applications", "for", "certain", "of", "the", "United", "States", "patents."], "wordsB": ["Dr.", "Borys", "joined", "Celsion", "on", "October", "1,", "2007", "as", "Vice", "President", "and", "Chief", "Medical", "Officer", "of", "the", "Company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.31865692138671875, 0.26087871193885803, 0.14940132200717926, 0.11534544825553894, 0.039763178676366806, 0.04634223133325577, 0.0459970161318779, 0.09390877932310104, 0.04551071301102638, 0.23587103188037872, 0.18503867089748383, 0.07993134111166, 0.2383132129907608, 0.4660356044769287, 0.2878291606903076, 0.026817835867404938, 0.02819063887000084, 0.08832892775535583, -1]}
{"idB": "749647_12_item1_p128_s1", "idA": "749647_11_item1_p85_s0", "sentA": "In conjunction with the patent holder, the Company intends to file international applications for certain of the United States patents.", "sentB": "Mr. Weaver had been a director of the Company since June 2005.", "type": 2, "words": ["<tag1>", "In", "conjunction", "with", "the", "patent", "holder,", "the", "Company", "intends", "to", "file", "international", "applications", "for", "certain", "of", "the", "United", "States", "patents.", "<tag2>", "Mr.", "Weaver", "had", "been", "a", "director", "of", "the", "Company", "since", "June", "2005.", "<tag3>"], "wordsA": ["In", "conjunction", "with", "the", "patent", "holder,", "the", "Company", "intends", "to", "file", "international", "applications", "for", "certain", "of", "the", "United", "States", "patents."], "wordsB": ["Mr.", "Weaver", "had", "been", "a", "director", "of", "the", "Company", "since", "June", "2005."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.3688617944717407, 0.40023282170295715, 0.07700728625059128, 0.12322987616062164, 0.171312615275383, 0.5286845564842224, 0.12364311516284943, 0.12606056034564972, 0.23502925038337708, 0.11245664954185486, 0.09332364052534103, 0.1950637698173523, -1]}
{"idB": "749647_12_item1_p107_s0", "idA": "749647_11_item1_p86_s0", "sentA": "The Company s rights under the license agreement with Duke University extend for the longer of 20 years or the end of any term for which any relevant patents are issued by the United States Patent and Trademark Office.", "sentB": "Our rights under the license agreement with Duke University extend for the longer of 20 years or the end of any term for which any relevant patents are issued by the United States Patent and Trademark Office.", "type": 2, "words": ["<tag1>", "The", "Company", "s", "rights", "under", "the", "license", "agreement", "with", "Duke", "University", "extend", "for", "the", "longer", "of", "20", "years", "or", "the", "end", "of", "any", "term", "for", "which", "any", "relevant", "patents", "are", "issued", "by", "the", "United", "States", "Patent", "and", "Trademark", "Office.", "<tag2>", "Our", "rights", "under", "the", "license", "agreement", "with", "Duke", "University", "extend", "for", "the", "longer", "of", "20", "years", "or", "the", "end", "of", "any", "term", "for", "which", "any", "relevant", "patents", "are", "issued", "by", "the", "United", "States", "Patent", "and", "Trademark", "Office.", "<tag3>"], "wordsA": ["The", "Company", "s", "rights", "under", "the", "license", "agreement", "with", "Duke", "University", "extend", "for", "the", "longer", "of", "20", "years", "or", "the", "end", "of", "any", "term", "for", "which", "any", "relevant", "patents", "are", "issued", "by", "the", "United", "States", "Patent", "and", "Trademark", "Office."], "wordsB": ["Our", "rights", "under", "the", "license", "agreement", "with", "Duke", "University", "extend", "for", "the", "longer", "of", "20", "years", "or", "the", "end", "of", "any", "term", "for", "which", "any", "relevant", "patents", "are", "issued", "by", "the", "United", "States", "Patent", "and", "Trademark", "Office."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.5158828496932983, 0.39137545228004456, 0.033788613975048065, 0.014660017564892769, 0.054203543812036514, 0.04487131908535957, 0.017369665205478668, 0.07254880666732788, 0.06744173914194107, 0.044440947473049164, 0.0008570986683480442, 0.022630754858255386, 0.08176176249980927, 0.024376465007662773, 0.04685795679688454, 0.04231034964323044, 0.013797550462186337, 0.014979866333305836, 0.039084624499082565, 0.016076287254691124, 0.022132759913802147, 0.040684930980205536, 0.01827436126768589, 0.012491492554545403, 0.017621278762817383, 0.05286789685487747, 0.15683072805404663, 0.018244914710521698, 0.03884672373533249, 0.011479727923870087, 0.01091988105326891, 0.05104679614305496, 0.038120657205581665, 0.036577675491571426, 0.022490940988063812, 0.03157617524266243, 0.025085752829909325, -1]}
{"idB": "749647_12_item1_p107_s1", "idA": "749647_11_item1_p86_s1", "sentA": "Currently, the Company has rights to Duke s patent for its thermo-liposome technology in the United States, which expires in 2018, and to future patents received by Duke in Canada, Europe, Japan and Australia, where it has patent applications pending.", "sentB": "Currently, the Company has rights to Duke s patent for its thermo-liposome technology in the United States, which expires in 2018, and to future patents received by Duke in Canada, Europe, Japan and Australia, where it has patent applications have been granted.", "type": 2, "words": ["<tag1>", "Currently,", "the", "Company", "has", "rights", "to", "Duke", "s", "patent", "for", "its", "thermo-liposome", "technology", "in", "the", "United", "States,", "which", "expires", "in", "2018,", "and", "to", "future", "patents", "received", "by", "Duke", "in", "Canada,", "Europe,", "Japan", "and", "Australia,", "where", "it", "has", "patent", "applications", "pending.", "<tag2>", "Currently,", "the", "Company", "has", "rights", "to", "Duke", "s", "patent", "for", "its", "thermo-liposome", "technology", "in", "the", "United", "States,", "which", "expires", "in", "2018,", "and", "to", "future", "patents", "received", "by", "Duke", "in", "Canada,", "Europe,", "Japan", "and", "Australia,", "where", "it", "has", "patent", "applications", "have", "been", "granted.", "<tag3>"], "wordsA": ["Currently,", "the", "Company", "has", "rights", "to", "Duke", "s", "patent", "for", "its", "thermo-liposome", "technology", "in", "the", "United", "States,", "which", "expires", "in", "2018,", "and", "to", "future", "patents", "received", "by", "Duke", "in", "Canada,", "Europe,", "Japan", "and", "Australia,", "where", "it", "has", "patent", "applications", "pending."], "wordsB": ["Currently,", "the", "Company", "has", "rights", "to", "Duke", "s", "patent", "for", "its", "thermo-liposome", "technology", "in", "the", "United", "States,", "which", "expires", "in", "2018,", "and", "to", "future", "patents", "received", "by", "Duke", "in", "Canada,", "Europe,", "Japan", "and", "Australia,", "where", "it", "has", "patent", "applications", "have", "been", "granted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03250962123274803, 0.011910454370081425, 0.09686043858528137, 0.053821831941604614, 0.1611844152212143, 0.04771355912089348, 0.3012140095233917, 0.22037659585475922, 0.4721437990665436, 0.025974396616220474, 0.020549438893795013, 0.09954828023910522, 0.04561790078878403, 0.017382489517331123, 0.02086586318910122, 0.056566812098026276, 0.06735859811306, 0.016622615978121758, 0.09249033033847809, 0.043080419301986694, 0.08979988098144531, 0.011108976788818836, 0.014876410365104675, 0.039212916046381, 0.2546223998069763, 0.028082510456442833, 0.03118249773979187, 0.19043418765068054, 0.020639972761273384, 0.048866529017686844, 0.036372534930706024, 0.03507963940501213, 0.02996637299656868, 0.03602396696805954, 0.023618299514055252, 0.024526657536625862, 0.01630748063325882, 0.45356616377830505, 0.6226837038993835, 0.441043496131897, 0.5474681854248047, 0.7569011449813843, -1]}
{"idB": "749647_12_item1_p107_s2", "idA": "749647_11_item1_p86_s2", "sentA": "The European application can result in coverage in the European Community.", "sentB": "The European grant provides coverage in the European Community.", "type": 2, "words": ["<tag1>", "The", "European", "application", "can", "result", "in", "coverage", "in", "the", "European", "Community.", "<tag2>", "The", "European", "grant", "provides", "coverage", "in", "the", "European", "Community.", "<tag3>"], "wordsA": ["The", "European", "application", "can", "result", "in", "coverage", "in", "the", "European", "Community."], "wordsB": ["The", "European", "grant", "provides", "coverage", "in", "the", "European", "Community."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010297005996108055, 0.1296963095664978, 0.9710906147956848, 0.09557190537452698, 0.054426562041044235, 0.006334550213068724, 0.0047883749939501286, 0.010923156514763832, 0.013251547701656818, -1]}
{"idB": "749647_12_item1_p107_s3", "idA": "749647_11_item1_p86_s3", "sentA": "For this technology, the Company s license rights are worldwide, including the United States, Canada, the European Community, Australia, Hong Kong, and Japan.", "sentB": "For this technology, the Company s license rights are worldwide, including the United States, Canada, certain European countries, Australia, Hong Kong, and Japan.", "type": 2, "words": ["<tag1>", "For", "this", "technology,", "the", "Company", "s", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "the", "European", "Community,", "Australia,", "Hong", "Kong,", "and", "Japan.", "<tag2>", "For", "this", "technology,", "the", "Company", "s", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "certain", "European", "countries,", "Australia,", "Hong", "Kong,", "and", "Japan.", "<tag3>"], "wordsA": ["For", "this", "technology,", "the", "Company", "s", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "the", "European", "Community,", "Australia,", "Hong", "Kong,", "and", "Japan."], "wordsB": ["For", "this", "technology,", "the", "Company", "s", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "certain", "European", "countries,", "Australia,", "Hong", "Kong,", "and", "Japan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07536330819129944, 0.05593614652752876, 0.10489381849765778, 0.016241446137428284, 0.20976099371910095, 0.13141277432441711, 0.34448349475860596, 0.3382580578327179, 0.11532429605722427, 0.2990974485874176, 0.061076268553733826, 0.042010147124528885, 0.22091619670391083, 0.13048477470874786, 0.0962592363357544, 0.12055736780166626, 0.23434200882911682, 0.3488486111164093, 0.15023772418498993, 0.10391607880592346, 0.10168980807065964, 0.02866966277360916, 0.13933904469013214, -1]}
{"idB": "749647_12_item1_p73_s0", "idA": "749647_11_item1_p86_s3", "sentA": "For this technology, the Company s license rights are worldwide, including the United States, Canada, the European Community, Australia, Hong Kong, and Japan.", "sentB": "In the United States, we have secured several designations which will support our clinical, regulatory and commercial strategies.", "type": 2, "words": ["<tag1>", "For", "this", "technology,", "the", "Company", "s", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "the", "European", "Community,", "Australia,", "Hong", "Kong,", "and", "Japan.", "<tag2>", "In", "the", "United", "States,", "we", "have", "secured", "several", "designations", "which", "will", "support", "our", "clinical,", "regulatory", "and", "commercial", "strategies.", "<tag3>"], "wordsA": ["For", "this", "technology,", "the", "Company", "s", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "the", "European", "Community,", "Australia,", "Hong", "Kong,", "and", "Japan."], "wordsB": ["In", "the", "United", "States,", "we", "have", "secured", "several", "designations", "which", "will", "support", "our", "clinical,", "regulatory", "and", "commercial", "strategies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03540575131773949, 0.02426743693649769, 0.17852482199668884, 0.27355700731277466, 0.09266737103462219, 0.052137341350317, 0.3725462555885315, 0.2115635722875595, 0.5065265893936157, 0.005988703109323978, 0.008381563238799572, 0.0093125244602561, 0.008899119682610035, 0.05090385302901268, 0.0222044438123703, 0.016038015484809875, 0.03175339847803116, 0.045789748430252075, -1]}
{"idB": "749647_12_item1_p15_s1", "idA": "749647_11_item1_p87_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox .", "sentB": "ThermoDox also holds orphan drug designation in the U.S.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", ".", "<tag2>", "ThermoDox", "also", "holds", "orphan", "drug", "designation", "in", "the", "U.S.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "."], "wordsB": ["ThermoDox", "also", "holds", "orphan", "drug", "designation", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7502230405807495, 0.1776302307844162, 0.5539523363113403, 0.43696922063827515, 0.32121986150741577, 0.35787034034729004, 0.13562174141407013, 0.11685629934072495, 0.6925467252731323, -1]}
{"idB": "749647_12_item1_p24_s1", "idA": "749647_11_item1_p87_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox .", "sentB": "The HEAT study has already enrolled a sufficient number to support registrational filings in South Korea and Taiwan, two important markets for ThermoDox .", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", ".", "<tag2>", "The", "HEAT", "study", "has", "already", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", ".", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "."], "wordsB": ["The", "HEAT", "study", "has", "already", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.019529424607753754, 0.6089190244674683, 0.7380271553993225, 0.02730231173336506, 0.026520350947976112, 0.17416223883628845, 0.04165929928421974, 0.14491680264472961, 0.23923185467720032, 0.010849302634596825, 0.04434783384203911, 0.2380719631910324, 0.19887703657150269, 0.024375928565859795, 0.1352805346250534, 0.17512911558151245, 0.09809769690036774, 0.21672360599040985, 0.01664404757320881, 0.05281361564993858, 0.06899283826351166, 0.03816826269030571, 0.026389585807919502, 5.569940185523592e-05, -1]}
{"idB": "749647_12_item1_p51_s1", "idA": "749647_11_item1_p87_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox .", "sentB": "ThermoDox also holds orphan drug designation in the U.S.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", ".", "<tag2>", "ThermoDox", "also", "holds", "orphan", "drug", "designation", "in", "the", "U.S.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "."], "wordsB": ["ThermoDox", "also", "holds", "orphan", "drug", "designation", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7502230405807495, 0.1776302307844162, 0.5539523363113403, 0.43696922063827515, 0.32121986150741577, 0.35787034034729004, 0.13562174141407013, 0.11685629934072495, 0.6925467252731323, -1]}
{"idB": "749647_12_item1_p108_s1", "idA": "749647_11_item1_p87_s1", "sentA": "Orphan drug designation entitles the Company to seven years of market exclusivity following FDA approval, FDA assistance in clinical trial design, a reduction in FDA user fees, U.S. tax credits related to development expenses as well as the opportunity to apply for funding from the U.S. government to defray the costs of clinical trial expenses.", "sentB": "Orphan drug designation entitles the Company to seven years of market exclusivity following FDA approval, if any, FDA assistance in clinical trial design, a reduction in FDA user fees, U.S. tax credits related to development expenses as well as the opportunity to apply for funding from the U.S. government to defray the costs of clinical trial expenses.", "type": 2, "words": ["<tag1>", "Orphan", "drug", "designation", "entitles", "the", "Company", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "FDA", "assistance", "in", "clinical", "trial", "design,", "a", "reduction", "in", "FDA", "user", "fees,", "U.S.", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "the", "costs", "of", "clinical", "trial", "expenses.", "<tag2>", "Orphan", "drug", "designation", "entitles", "the", "Company", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "if", "any,", "FDA", "assistance", "in", "clinical", "trial", "design,", "a", "reduction", "in", "FDA", "user", "fees,", "U.S.", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "the", "costs", "of", "clinical", "trial", "expenses.", "<tag3>"], "wordsA": ["Orphan", "drug", "designation", "entitles", "the", "Company", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "FDA", "assistance", "in", "clinical", "trial", "design,", "a", "reduction", "in", "FDA", "user", "fees,", "U.S.", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "the", "costs", "of", "clinical", "trial", "expenses."], "wordsB": ["Orphan", "drug", "designation", "entitles", "the", "Company", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "if", "any,", "FDA", "assistance", "in", "clinical", "trial", "design,", "a", "reduction", "in", "FDA", "user", "fees,", "U.S.", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "the", "costs", "of", "clinical", "trial", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1911119669675827, 0.0992954820394516, 0.1023927628993988, 0.1072755977511406, 0.039272673428058624, 0.11265137791633606, 0.04231591522693634, 0.06876987218856812, 0.08242622017860413, 0.04037121683359146, 0.05945133790373802, 0.08305338770151138, 0.04528219252824783, 0.11214182525873184, 0.21395434439182281, 0.2594088017940521, 0.726353108882904, 0.06729242950677872, 0.12506595253944397, 0.025929991155862808, 0.054540492594242096, 0.05548420548439026, 0.06215521693229675, 0.023323502391576767, 0.07437705993652344, 0.037553709000349045, 0.17342089116573334, 0.21190887689590454, 0.21065281331539154, 0.07982287555932999, 0.08363867551088333, 0.10268975794315338, 0.031100617721676826, 0.037453509867191315, 0.05609317868947983, 0.07805397361516953, 0.027627205476164818, 0.02171269617974758, 0.0222429521381855, 0.024526743218302727, 0.06306890398263931, 0.09617205709218979, 0.17114083468914032, 0.1317138969898224, 0.16534094512462616, 0.052435293793678284, 0.038482364267110825, 0.17512160539627075, 0.15891531109809875, 0.04061346873641014, 0.07553078979253769, 0.04105840623378754, 0.0904243141412735, 0.03489827737212181, 0.09512615948915482, 0.16578108072280884, 0.19816473126411438, -1]}
{"idB": "749647_12_item1_p50_s0", "idA": "749647_11_item1_p87_s2", "sentA": "In 2011, the European Commission granted Orphan Drug Designation for ThermoDox for the treatment of HCC in Europe.", "sentB": "In December 2011, the European Medicines Agency (EMA) provided written, scientific advice confirming that the HEAT Study, a multinational, double-blind, placebo controlled pivotal study of ThermoDox in combination with radio frequency ablation (RFA) for the treatment of hepatocellular carcinoma (HCC), or primary liver cancer, is acceptable as a basis for submission of a marketing authorization application (MAA).", "type": 2, "words": ["<tag1>", "In", "2011,", "the", "European", "Commission", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe.", "<tag2>", "In", "December", "2011,", "the", "European", "Medicines", "Agency", "(EMA)", "provided", "written,", "scientific", "advice", "confirming", "that", "the", "HEAT", "Study,", "a", "multinational,", "double-blind,", "placebo", "controlled", "pivotal", "study", "of", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "hepatocellular", "carcinoma", "(HCC),", "or", "primary", "liver", "cancer,", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application", "(MAA).", "<tag3>"], "wordsA": ["In", "2011,", "the", "European", "Commission", "granted", "Orphan", "Drug", "Designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe."], "wordsB": ["In", "December", "2011,", "the", "European", "Medicines", "Agency", "(EMA)", "provided", "written,", "scientific", "advice", "confirming", "that", "the", "HEAT", "Study,", "a", "multinational,", "double-blind,", "placebo", "controlled", "pivotal", "study", "of", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "hepatocellular", "carcinoma", "(HCC),", "or", "primary", "liver", "cancer,", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application", "(MAA)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005224396008998156, 0.01926320046186447, 0.03370670601725578, 0.006847645156085491, 0.06507037580013275, 0.12961800396442413, 0.19705429673194885, 0.34661737084388733, 0.07544953376054764, 0.18961557745933533, 0.0929211899638176, 0.13533297181129456, 0.015975642949342728, 0.007787570357322693, 0.006404067389667034, 0.11999744921922684, 0.26318931579589844, 0.0039958711713552475, 0.024808956310153008, 0.06082385778427124, 0.05637379735708237, 0.02114352025091648, 0.027060523629188538, 0.03794560208916664, 0.009573079645633698, 0.012088005430996418, 0.005472206044942141, 0.009151246398687363, 0.009051166474819183, 0.15269829332828522, 0.26475250720977783, 0.13952766358852386, 0.05220013111829758, 0.004612491466104984, 0.005110076628625393, 0.025103077292442322, 0.010333778336644173, 0.05349810793995857, 0.053379423916339874, 0.013461573980748653, 0.004931253846734762, 0.05035867169499397, 0.04571368545293808, 0.060500241816043854, 0.009229701943695545, 0.035651933401823044, 0.008313930593430996, 0.018351400271058083, 0.04827333241701126, 0.013924249447882175, 0.12443338334560394, 0.026195337995886803, 0.028726641088724136, 0.39902904629707336, 0.5196306705474854, 0.3815840482711792, 0.31343767046928406, -1]}
{"idB": "749647_12_item1_p49_s4", "idA": "749647_11_item1_p87_s4", "sentA": "The Orphan Drug Designation in Europe also provides 10 years of market exclusivity subsequent to product approval.", "sentB": "The orphan drug designation in Europe also provides 10 years of market exclusivity subsequent to product approval, if any.", "type": 2, "words": ["<tag1>", "The", "Orphan", "Drug", "Designation", "in", "Europe", "also", "provides", "10", "years", "of", "market", "exclusivity", "subsequent", "to", "product", "approval.", "<tag2>", "The", "orphan", "drug", "designation", "in", "Europe", "also", "provides", "10", "years", "of", "market", "exclusivity", "subsequent", "to", "product", "approval,", "if", "any.", "<tag3>"], "wordsA": ["The", "Orphan", "Drug", "Designation", "in", "Europe", "also", "provides", "10", "years", "of", "market", "exclusivity", "subsequent", "to", "product", "approval."], "wordsB": ["The", "orphan", "drug", "designation", "in", "Europe", "also", "provides", "10", "years", "of", "market", "exclusivity", "subsequent", "to", "product", "approval,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01452835462987423, 0.8555744290351868, 0.44624063372612, 0.2547655403614044, 0.02303117886185646, 0.06697140634059906, 0.04697409272193909, 0.0651158019900322, 0.22967290878295898, 0.05243785306811333, 0.01992202363908291, 0.04476453363895416, 0.060678109526634216, 0.041903700679540634, 0.02847904898226261, 0.15533633530139923, 0.27646172046661377, 0.26263272762298584, 0.4325682818889618, -1]}
{"idB": "749647_12_item1_p74_s1", "idA": "749647_11_item1_p87_s4", "sentA": "The Orphan Drug Designation in Europe also provides 10 years of market exclusivity subsequent to product approval.", "sentB": "Adding to a successful commercial strategy, we have also secured Orphan Drug Designation for ThermoDox in primary liver cancer in both Europe and the United States, providing for ten and seven years of market exclusivity, respectively, following approval.", "type": 2, "words": ["<tag1>", "The", "Orphan", "Drug", "Designation", "in", "Europe", "also", "provides", "10", "years", "of", "market", "exclusivity", "subsequent", "to", "product", "approval.", "<tag2>", "Adding", "to", "a", "successful", "commercial", "strategy,", "we", "have", "also", "secured", "Orphan", "Drug", "Designation", "for", "ThermoDox", "in", "primary", "liver", "cancer", "in", "both", "Europe", "and", "the", "United", "States,", "providing", "for", "ten", "and", "seven", "years", "of", "market", "exclusivity,", "respectively,", "following", "approval.", "<tag3>"], "wordsA": ["The", "Orphan", "Drug", "Designation", "in", "Europe", "also", "provides", "10", "years", "of", "market", "exclusivity", "subsequent", "to", "product", "approval."], "wordsB": ["Adding", "to", "a", "successful", "commercial", "strategy,", "we", "have", "also", "secured", "Orphan", "Drug", "Designation", "for", "ThermoDox", "in", "primary", "liver", "cancer", "in", "both", "Europe", "and", "the", "United", "States,", "providing", "for", "ten", "and", "seven", "years", "of", "market", "exclusivity,", "respectively,", "following", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009430363774299622, 0.0039728605188429356, 0.004180214833468199, 0.016276057809591293, 0.026232657954096794, 0.018917731940746307, 0.00737401656806469, 0.003527336288243532, 0.003039865056052804, 0.03944329544901848, 0.01905529573559761, 0.01325732097029686, 0.032033927738666534, 0.023963576182723045, 0.12052241712808609, 0.06200962886214256, 0.1248924732208252, 0.1278395652770996, 0.11302977055311203, 0.004006341099739075, 0.011392977088689804, 0.021646667271852493, 0.012507244013249874, 0.014339389279484749, 0.05276240035891533, 0.0749230906367302, 0.012303938157856464, 0.009623812511563301, 0.7101462483406067, 0.20224973559379578, 0.8341878652572632, 0.2792959213256836, 0.008409548550844193, 0.026358608156442642, 0.014524518512189388, 0.020498910918831825, 0.0889664888381958, 0.06693676114082336, -1]}
{"idB": "749647_12_item1_p109_s0", "idA": "749647_11_item1_p88_s0", "sentA": "In addition to the rights available to the Company under completed or pending license agreements, the Company relies on its own proprietary know-how and experience in the development and use of heat for medical therapies, which the Company seeks to protect, in part, through proprietary information agreements with employees, consultants and others.", "sentB": "In addition to the rights available to us under completed or pending license agreements, we rely on our proprietary know-how and experience in the development and use of heat for medical therapies, which we seek to protect, in part, through proprietary information agreements with employees, consultants and others.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "rights", "available", "to", "the", "Company", "under", "completed", "or", "pending", "license", "agreements,", "the", "Company", "relies", "on", "its", "own", "proprietary", "know-how", "and", "experience", "in", "the", "development", "and", "use", "of", "heat", "for", "medical", "therapies,", "which", "the", "Company", "seeks", "to", "protect,", "in", "part,", "through", "proprietary", "information", "agreements", "with", "employees,", "consultants", "and", "others.", "<tag2>", "In", "addition", "to", "the", "rights", "available", "to", "us", "under", "completed", "or", "pending", "license", "agreements,", "we", "rely", "on", "our", "proprietary", "know-how", "and", "experience", "in", "the", "development", "and", "use", "of", "heat", "for", "medical", "therapies,", "which", "we", "seek", "to", "protect,", "in", "part,", "through", "proprietary", "information", "agreements", "with", "employees,", "consultants", "and", "others.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "rights", "available", "to", "the", "Company", "under", "completed", "or", "pending", "license", "agreements,", "the", "Company", "relies", "on", "its", "own", "proprietary", "know-how", "and", "experience", "in", "the", "development", "and", "use", "of", "heat", "for", "medical", "therapies,", "which", "the", "Company", "seeks", "to", "protect,", "in", "part,", "through", "proprietary", "information", "agreements", "with", "employees,", "consultants", "and", "others."], "wordsB": ["In", "addition", "to", "the", "rights", "available", "to", "us", "under", "completed", "or", "pending", "license", "agreements,", "we", "rely", "on", "our", "proprietary", "know-how", "and", "experience", "in", "the", "development", "and", "use", "of", "heat", "for", "medical", "therapies,", "which", "we", "seek", "to", "protect,", "in", "part,", "through", "proprietary", "information", "agreements", "with", "employees,", "consultants", "and", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00806927029043436, 0.02116309478878975, 0.017685595899820328, 0.012625222094357014, 0.13933058083057404, 0.14520224928855896, 0.1657051146030426, 0.9129313230514526, 0.02388121373951435, 0.0208599716424942, 0.014934285543859005, 0.01389007456600666, 0.01592576503753662, 0.01826714351773262, 0.02510606311261654, 0.020803742110729218, 0.01371935848146677, 0.04854496195912361, 0.059517137706279755, 0.024866066873073578, 0.011259075254201889, 0.013109661638736725, 0.00840164814144373, 0.008578803390264511, 0.009763081558048725, 0.008506998419761658, 0.008457062765955925, 0.009494193829596043, 0.013133762404322624, 0.006810750346630812, 0.009221638552844524, 0.012232167646288872, 0.009165538474917412, 0.009898044168949127, 0.012893512845039368, 0.010579041205346584, 0.009750938042998314, 0.010330278426408768, 0.012928820215165615, 0.007556529715657234, 0.017007600516080856, 0.016332626342773438, 0.020732596516609192, 0.00685822544619441, 0.011124305427074432, 0.010433855466544628, 0.008008030243217945, 0.009265631437301636, -1]}
{"idB": "749647_12_item1_p109_s1", "idA": "749647_11_item1_p88_s1", "sentA": "The Company cannot offer assurances that these information agreements will not be breached, that the Company will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "sentB": "We cannot offer assurances that these information agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "type": 2, "words": ["<tag1>", "The", "Company", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "the", "Company", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag2>", "We", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag3>"], "wordsA": ["The", "Company", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "the", "Company", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "wordsB": ["We", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06729988008737564, 0.45280933380126953, 0.08181749284267426, 0.04137439280748367, 0.010655148886144161, 0.008739156648516655, 0.062310196459293365, 0.08693184703588486, 0.09441804140806198, 0.5798829197883606, 0.1867963820695877, 0.29778096079826355, 0.007991597056388855, 0.02363942563533783, 0.01602630503475666, 0.021547814831137657, 0.02645477093756199, 0.016207167878746986, 0.005810192320495844, 0.008720047771930695, 0.015290738083422184, 0.007206696551293135, 0.006228622980415821, 0.005664437543600798, 0.03692035749554634, 0.01234484277665615, 0.01187988556921482, 0.017556259408593178, 0.01463550329208374, 0.011876314878463745, 0.01565057598054409, 0.04019298031926155, 0.01610473170876503, 0.03156830742955208, 0.04824788495898247, 0.019478783011436462, 0.007499230094254017, 0.008019975386559963, 0.031742360442876816, 0.0103429751470685, 0.021391326561570168, 0.02044999785721302, -1]}
{"idB": "749647_12_item1_p110_s1", "idA": "749647_11_item1_p88_s2", "sentA": "Similarly, the Company cannot guarantee that technology rights licensed to it by others will not be successfully challenged or circumvented by third parties, or that the rights granted will provide the Company with adequate protection.", "sentB": "Similarly, we cannot guarantee that technology rights licensed to us by others will not be successfully challenged or circumvented by third parties, or that the rights granted will provide us with adequate protection.", "type": 2, "words": ["<tag1>", "Similarly,", "the", "Company", "cannot", "guarantee", "that", "technology", "rights", "licensed", "to", "it", "by", "others", "will", "not", "be", "successfully", "challenged", "or", "circumvented", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "the", "Company", "with", "adequate", "protection.", "<tag2>", "Similarly,", "we", "cannot", "guarantee", "that", "technology", "rights", "licensed", "to", "us", "by", "others", "will", "not", "be", "successfully", "challenged", "or", "circumvented", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "us", "with", "adequate", "protection.", "<tag3>"], "wordsA": ["Similarly,", "the", "Company", "cannot", "guarantee", "that", "technology", "rights", "licensed", "to", "it", "by", "others", "will", "not", "be", "successfully", "challenged", "or", "circumvented", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "the", "Company", "with", "adequate", "protection."], "wordsB": ["Similarly,", "we", "cannot", "guarantee", "that", "technology", "rights", "licensed", "to", "us", "by", "others", "will", "not", "be", "successfully", "challenged", "or", "circumvented", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "us", "with", "adequate", "protection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02306721918284893, 0.1699187308549881, 0.10766604542732239, 0.059801578521728516, 0.010039318352937698, 0.055835358798503876, 0.11172198504209518, 0.04050285369157791, 0.044573813676834106, 0.087558314204216, 0.02477644383907318, 0.05336499214172363, 0.024955159053206444, 0.2934138774871826, 0.024145914241671562, 0.042661961168050766, 0.044326722621917725, 0.012939631938934326, 0.028324395418167114, 0.015297137200832367, 0.049767788499593735, 0.07393012195825577, 0.009790170006453991, 0.006193659268319607, 0.008672291412949562, 0.061465755105018616, 0.020971544086933136, 0.012325153686106205, 0.021251188591122627, 0.0722639411687851, 0.019694671034812927, 0.0460304357111454, 0.054233744740486145, -1]}
{"idB": "749647_12_item1_p111_s0", "idA": "749647_11_item1_p89_s0", "sentA": "As of March 15, 2011, we employed 16 full-time employees.", "sentB": "As of March 14, 2012, we employed 19 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "15,", "2011,", "we", "employed", "16", "full-time", "employees.", "<tag2>", "As", "of", "March", "14,", "2012,", "we", "employed", "19", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "15,", "2011,", "we", "employed", "16", "full-time", "employees."], "wordsB": ["As", "of", "March", "14,", "2012,", "we", "employed", "19", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008446657098829746, 0.007962649688124657, 0.0732923224568367, 0.7618739008903503, 0.6638909578323364, 0.004413319751620293, 0.037703704088926315, 0.8005130290985107, 0.14470404386520386, 0.12027992308139801, -1]}
{"idB": "749647_12_item1_p114_s0", "idA": "749647_11_item1_p89_s0", "sentA": "As of March 15, 2011, we employed 16 full-time employees.", "sentB": "During 2011, we completed the following equity transactions:", "type": 2, "words": ["<tag1>", "As", "of", "March", "15,", "2011,", "we", "employed", "16", "full-time", "employees.", "<tag2>", "During", "2011,", "we", "completed", "the", "following", "equity", "transactions:", "<tag3>"], "wordsA": ["As", "of", "March", "15,", "2011,", "we", "employed", "16", "full-time", "employees."], "wordsB": ["During", "2011,", "we", "completed", "the", "following", "equity", "transactions:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06653768569231033, 0.05745578557252884, 0.08032676577568054, 0.2732515335083008, 0.07077984511852264, 0.17234066128730774, 0.7051002383232117, 0.5967951416969299, -1]}
{"idB": "749647_12_item1_p9_s0", "idA": "749647_11_item1_p8_s0", "sentA": "Celsion Corporation is an innovative oncology drug development company focused on the development of therapeutics for those suffering with difficult to treat forms of cancer.", "sentB": "Celsion Corporation is an innovative oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer.", "type": 2, "words": ["<tag1>", "Celsion", "Corporation", "is", "an", "innovative", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "therapeutics", "for", "those", "suffering", "with", "difficult", "to", "treat", "forms", "of", "cancer.", "<tag2>", "Celsion", "Corporation", "is", "an", "innovative", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult", "to", "treat", "forms", "of", "cancer.", "<tag3>"], "wordsA": ["Celsion", "Corporation", "is", "an", "innovative", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "therapeutics", "for", "those", "suffering", "with", "difficult", "to", "treat", "forms", "of", "cancer."], "wordsB": ["Celsion", "Corporation", "is", "an", "innovative", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult", "to", "treat", "forms", "of", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.41837623715400696, 0.3161006569862366, 0.03963508456945419, 0.027422068640589714, 0.1456555724143982, 0.654932975769043, 0.1846516728401184, 0.163730189204216, 0.2372281700372696, 0.09095031768083572, 0.04185319319367409, 0.021944435313344002, 0.10679136961698532, 0.046059414744377136, 0.39892691373825073, 0.1498355269432068, 0.13202299177646637, 0.18371161818504333, 0.1286097913980484, 0.3940982520580292, 0.16398514807224274, 0.1786741316318512, 0.12670287489891052, 0.11387387663125992, 0.19892039895057678, -1]}
{"idB": "749647_12_item1_p132_s1", "idA": "749647_11_item1_p90_s0", "sentA": "Celsion was founded in 1982 and is a Delaware corporation.", "sentB": "Mr. Church holds a B.S. degree in accounting from the University of Maryland and is a certified public accountant.", "type": 2, "words": ["<tag1>", "Celsion", "was", "founded", "in", "1982", "and", "is", "a", "Delaware", "corporation.", "<tag2>", "Mr.", "Church", "holds", "a", "B.S.", "degree", "in", "accounting", "from", "the", "University", "of", "Maryland", "and", "is", "a", "certified", "public", "accountant.", "<tag3>"], "wordsA": ["Celsion", "was", "founded", "in", "1982", "and", "is", "a", "Delaware", "corporation."], "wordsB": ["Mr.", "Church", "holds", "a", "B.S.", "degree", "in", "accounting", "from", "the", "University", "of", "Maryland", "and", "is", "a", "certified", "public", "accountant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.17974098026752472, 0.2045649141073227, 0.11117913573980331, 0.07205493003129959, 0.2196885645389557, 0.19724729657173157, 0.06500069797039032, 0.1825503557920456, 0.036384306848049164, 0.04025671258568764, 0.17336776852607727, 0.12976495921611786, 0.4302709400653839, 0.0043212114833295345, 0.01802670769393444, 0.02497677505016327, 0.4212630093097687, 0.42325007915496826, 0.5597919821739197, -1]}
{"idB": "749647_12_item1_p112_s1", "idA": "749647_11_item1_p90_s1", "sentA": "Our principal executive offices are located at 10220-L Old Columbia Road, Columbia, Maryland 21046.", "sentB": "Our principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648.", "type": 2, "words": ["<tag1>", "Our", "principal", "executive", "offices", "are", "located", "at", "10220-L", "Old", "Columbia", "Road,", "Columbia,", "Maryland", "21046.", "<tag2>", "Our", "principal", "executive", "offices", "are", "located", "at", "997", "Lenox", "Drive,", "Suite", "100,", "Lawrenceville,", "NJ", "08648.", "<tag3>"], "wordsA": ["Our", "principal", "executive", "offices", "are", "located", "at", "10220-L", "Old", "Columbia", "Road,", "Columbia,", "Maryland", "21046."], "wordsB": ["Our", "principal", "executive", "offices", "are", "located", "at", "997", "Lenox", "Drive,", "Suite", "100,", "Lawrenceville,", "NJ", "08648."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002016757382079959, 0.00904877483844757, 0.010318233631551266, 0.015306169167160988, 0.0026963800191879272, 0.028084028512239456, 0.030214503407478333, 0.8037819266319275, 0.5025002360343933, 0.44955116510391235, 0.19442453980445862, 0.1444251537322998, 0.1933537870645523, 0.29870709776878357, 0.4447362422943115, -1]}
{"idB": "749647_12_item1_p112_s2", "idA": "749647_11_item1_p90_s2", "sentA": "Our telephone numbers are (410) 290-5490 and (800) 262-0394.", "sentB": "Our telephone number is (609) 896-9100.", "type": 2, "words": ["<tag1>", "Our", "telephone", "numbers", "are", "(410)", "290-5490", "and", "(800)", "262-0394.", "<tag2>", "Our", "telephone", "number", "is", "(609)", "896-9100.", "<tag3>"], "wordsA": ["Our", "telephone", "numbers", "are", "(410)", "290-5490", "and", "(800)", "262-0394."], "wordsB": ["Our", "telephone", "number", "is", "(609)", "896-9100."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002192423213273287, 0.020403282716870308, 0.023549243807792664, 0.009652582928538322, 0.7232605218887329, 0.6991425156593323, -1]}
{"idB": "749647_12_item1_p113_s0", "idA": "749647_11_item1_p91_s0", "sentA": "The Company makes available free of charge through its website, www.celsion.com, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission (the SEC ).", "sentB": "We make available free of charge through our website, www.celsion.com, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission (the SEC ).", "type": 2, "words": ["<tag1>", "The", "Company", "makes", "available", "free", "of", "charge", "through", "its", "website,", "www.celsion.com,", "its", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K,", "and", "all", "amendments", "to", "those", "reports", "as", "soon", "as", "reasonably", "practicable", "after", "such", "material", "is", "electronically", "filed", "with", "or", "furnished", "to", "the", "Securities", "and", "Exchange", "Commission", "(the", "SEC", ").", "<tag2>", "We", "make", "available", "free", "of", "charge", "through", "our", "website,", "www.celsion.com,", "its", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K,", "and", "all", "amendments", "to", "those", "reports", "as", "soon", "as", "reasonably", "practicable", "after", "such", "material", "is", "electronically", "filed", "with", "or", "furnished", "to", "the", "Securities", "and", "Exchange", "Commission", "(the", "SEC", ").", "<tag3>"], "wordsA": ["The", "Company", "makes", "available", "free", "of", "charge", "through", "its", "website,", "www.celsion.com,", "its", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K,", "and", "all", "amendments", "to", "those", "reports", "as", "soon", "as", "reasonably", "practicable", "after", "such", "material", "is", "electronically", "filed", "with", "or", "furnished", "to", "the", "Securities", "and", "Exchange", "Commission", "(the", "SEC", ")."], "wordsB": ["We", "make", "available", "free", "of", "charge", "through", "our", "website,", "www.celsion.com,", "its", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K,", "and", "all", "amendments", "to", "those", "reports", "as", "soon", "as", "reasonably", "practicable", "after", "such", "material", "is", "electronically", "filed", "with", "or", "furnished", "to", "the", "Securities", "and", "Exchange", "Commission", "(the", "SEC", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.277874231338501, 0.05522971227765083, 0.08024224638938904, 0.07514560967683792, 0.05177291855216026, 0.07642874866724014, 0.02656594291329384, 0.021892577409744263, 0.089668408036232, 0.07695189863443375, 0.01776917651295662, 0.06449153274297714, 0.071208655834198, 0.021139686927199364, 0.08923275023698807, 0.15584640204906464, 0.05901239812374115, 0.06243138387799263, 0.02474605105817318, 0.07456845045089722, 0.10341541469097137, 0.0392267145216465, 0.060425907373428345, 0.02811276912689209, 0.06580411642789841, 0.11502090096473694, 0.015723813325166702, 0.032963674515485764, 0.3384559452533722, 0.028950903564691544, 0.02421339973807335, 0.06180162355303764, 0.0426010861992836, 0.05474285036325455, 0.036888401955366135, 0.05065611004829407, 0.06605084985494614, 0.045027174055576324, 0.11003904789686203, 0.12224048376083374, 0.07151765376329422, 0.13681840896606445, 0.08086401969194412, 0.07497481256723404, 0.04288342967629433, 0.06386535614728928, 0.03291101008653641, 0.03234907612204552, 0.08057674765586853, 0.055330339819192886, 0.07200051844120026, 0.0888475850224495, 0.025079533457756042, 0.0878201574087143, 0.0005303697544150054, -1]}
{"idB": "749647_12_item1_p113_s1", "idA": "749647_11_item1_p91_s1", "sentA": "In addition, the Company s website includes other items related to corporate governance matters, including, among other things, the Company s corporate governance principles, charters of various committees of the Board of Directors, and the Company s code of business conduct and ethics applicable to all employees, officers and directors.", "sentB": "In addition, our website includes other items related to corporate governance matters, including, among other things, our corporate governance principles, charters of various committees of the Board of Directors, and our code of business conduct and ethics applicable to all employees, officers and directors.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "s", "website", "includes", "other", "items", "related", "to", "corporate", "governance", "matters,", "including,", "among", "other", "things,", "the", "Company", "s", "corporate", "governance", "principles,", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors,", "and", "the", "Company", "s", "code", "of", "business", "conduct", "and", "ethics", "applicable", "to", "all", "employees,", "officers", "and", "directors.", "<tag2>", "In", "addition,", "our", "website", "includes", "other", "items", "related", "to", "corporate", "governance", "matters,", "including,", "among", "other", "things,", "our", "corporate", "governance", "principles,", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors,", "and", "our", "code", "of", "business", "conduct", "and", "ethics", "applicable", "to", "all", "employees,", "officers", "and", "directors.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "s", "website", "includes", "other", "items", "related", "to", "corporate", "governance", "matters,", "including,", "among", "other", "things,", "the", "Company", "s", "corporate", "governance", "principles,", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors,", "and", "the", "Company", "s", "code", "of", "business", "conduct", "and", "ethics", "applicable", "to", "all", "employees,", "officers", "and", "directors."], "wordsB": ["In", "addition,", "our", "website", "includes", "other", "items", "related", "to", "corporate", "governance", "matters,", "including,", "among", "other", "things,", "our", "corporate", "governance", "principles,", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors,", "and", "our", "code", "of", "business", "conduct", "and", "ethics", "applicable", "to", "all", "employees,", "officers", "and", "directors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017400968819856644, 0.05866523087024689, 0.5418887734413147, 0.5702868103981018, 0.11845167726278305, 0.06121021509170532, 0.11236922442913055, 0.04588281735777855, 0.02433762326836586, 0.17483606934547424, 0.18773970007896423, 0.04867226630449295, 0.01971772499382496, 0.031112249940633774, 0.03250753879547119, 0.02507905662059784, 0.019639315083622932, 0.16992677748203278, 0.19083023071289062, 0.0940057784318924, 0.04593981057405472, 0.015883978456258774, 0.028573665767908096, 0.05302686616778374, 0.01730714924633503, 0.01566535420715809, 0.04345773905515671, 0.033789295703172684, 0.07752516120672226, 0.00926284771412611, 0.014617374166846275, 0.04839380085468292, 0.023843584582209587, 0.04857196286320686, 0.05406579375267029, 0.022531704977154732, 0.0395999550819397, 0.037381190806627274, 0.027143768966197968, 0.08418895304203033, 0.257321298122406, 0.04996151104569435, 0.031246062368154526, 0.08259463310241699, -1]}
{"idB": "749647_12_item1_p113_s2", "idA": "749647_11_item1_p91_s2", "sentA": "The Company intends to disclose on its internet website any amendments to or waivers from its code of business conduct and ethics as well as any amendments to its corporate governance principles or the charters of various committees of the Board of Directors.", "sentB": "We intend to disclose on our internet website any amendments to or waivers from our code of business conduct and ethics as well as any amendments to its corporate governance principles or the charters of various committees of the Board of Directors.", "type": 2, "words": ["<tag1>", "The", "Company", "intends", "to", "disclose", "on", "its", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "its", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors.", "<tag2>", "We", "intend", "to", "disclose", "on", "our", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "our", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors.", "<tag3>"], "wordsA": ["The", "Company", "intends", "to", "disclose", "on", "its", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "its", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors."], "wordsB": ["We", "intend", "to", "disclose", "on", "our", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "our", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8980551958084106, 0.2022615224123001, 0.04373736307024956, 0.18908677995204926, 0.060169968754053116, 0.0877624973654747, 0.3014647662639618, 0.47117850184440613, 0.029453907161951065, 0.080726757645607, 0.020278025418519974, 0.030331578105688095, 0.05602484568953514, 0.022491026669740677, 0.02049482986330986, 0.03554052487015724, 0.027996432036161423, 0.03519545868039131, 0.033403899520635605, 0.020014770328998566, 0.030363084748387337, 0.018409697338938713, 0.013865545392036438, 0.007891910150647163, 0.01761307567358017, 0.040900278836488724, 0.017541363835334778, 0.018621299415826797, 0.03765145316720009, 0.045038558542728424, 0.03386674448847771, 0.013772048056125641, 0.012218043208122253, 0.04320299252867699, 0.014155813492834568, 0.023215677589178085, 0.0500233955681324, 0.01710647903382778, 0.013189024291932583, 0.027766956016421318, 0.023917950689792633, 0.039642807096242905, -1]}
{"idB": "749647_12_item1_p122_s0", "idA": "749647_11_item1_p91_s2", "sentA": "The Company intends to disclose on its internet website any amendments to or waivers from its code of business conduct and ethics as well as any amendments to its corporate governance principles or the charters of various committees of the Board of Directors.", "sentB": "Each executive officer is elected by, and serves at the pleasure of the Board of Directors.", "type": 2, "words": ["<tag1>", "The", "Company", "intends", "to", "disclose", "on", "its", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "its", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors.", "<tag2>", "Each", "executive", "officer", "is", "elected", "by,", "and", "serves", "at", "the", "pleasure", "of", "the", "Board", "of", "Directors.", "<tag3>"], "wordsA": ["The", "Company", "intends", "to", "disclose", "on", "its", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "its", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors."], "wordsB": ["Each", "executive", "officer", "is", "elected", "by,", "and", "serves", "at", "the", "pleasure", "of", "the", "Board", "of", "Directors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2386178821325302, 0.4979970157146454, 0.5378854870796204, 0.08503318578004837, 0.415866494178772, 0.15962433815002441, 0.017753278836607933, 0.2714536786079407, 0.09644219279289246, 0.07348097115755081, 0.14086724817752838, 0.06151482090353966, 0.06197469308972359, 0.09407293796539307, 0.05919179320335388, 0.09565138816833496, -1]}
{"idB": "749647_12_item1_p123_s0", "idA": "749647_11_item1_p91_s2", "sentA": "The Company intends to disclose on its internet website any amendments to or waivers from its code of business conduct and ethics as well as any amendments to its corporate governance principles or the charters of various committees of the Board of Directors.", "sentB": "Mr. Tardugno was appointed President and Chief Executive Officer of the Company on January 3, 2007 and was elected to the Board of Directors on January 22, 2007.", "type": 2, "words": ["<tag1>", "The", "Company", "intends", "to", "disclose", "on", "its", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "its", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors.", "<tag2>", "Mr.", "Tardugno", "was", "appointed", "President", "and", "Chief", "Executive", "Officer", "of", "the", "Company", "on", "January", "3,", "2007", "and", "was", "elected", "to", "the", "Board", "of", "Directors", "on", "January", "22,", "2007.", "<tag3>"], "wordsA": ["The", "Company", "intends", "to", "disclose", "on", "its", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "its", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors."], "wordsB": ["Mr.", "Tardugno", "was", "appointed", "President", "and", "Chief", "Executive", "Officer", "of", "the", "Company", "on", "January", "3,", "2007", "and", "was", "elected", "to", "the", "Board", "of", "Directors", "on", "January", "22,", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.29726430773735046, 0.37205085158348083, 0.07652095705270767, 0.21249361336231232, 0.16910746693611145, 0.1707635521888733, 0.2310272753238678, 0.3056637644767761, 0.22056785225868225, 0.0386502780020237, 0.03566065803170204, 0.10535544157028198, 0.019075555726885796, 0.04212002828717232, 0.06252925097942352, 0.09105315059423447, 0.006952095776796341, 0.0775136649608612, 0.3027494549751282, 0.14310672879219055, 0.10989491641521454, 0.12649951875209808, 0.07912880927324295, 0.13052792847156525, 0.03197679668664932, 0.06409518420696259, 0.08049609512090683, 0.06403087824583054, -1]}
{"idB": "749647_12_item1_p113_s3", "idA": "749647_11_item1_p91_s3", "sentA": "Copies of these documents may be obtained, free of charge, from the Company s website.", "sentB": "Copies of these documents may be obtained, free of charge, from our website.", "type": 2, "words": ["<tag1>", "Copies", "of", "these", "documents", "may", "be", "obtained,", "free", "of", "charge,", "from", "the", "Company", "s", "website.", "<tag2>", "Copies", "of", "these", "documents", "may", "be", "obtained,", "free", "of", "charge,", "from", "our", "website.", "<tag3>"], "wordsA": ["Copies", "of", "these", "documents", "may", "be", "obtained,", "free", "of", "charge,", "from", "the", "Company", "s", "website."], "wordsB": ["Copies", "of", "these", "documents", "may", "be", "obtained,", "free", "of", "charge,", "from", "our", "website."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11299997568130493, 0.014840548858046532, 0.01583803817629814, 0.07695534825325012, 0.019381310790777206, 0.013425103388726711, 0.041958488523960114, 0.04523921385407448, 0.01973549649119377, 0.044251494109630585, 0.027694791555404663, 0.8241177201271057, 0.7014890909194946, -1]}
{"idB": "749647_12_item1_p112_s4", "idA": "749647_11_item1_p91_s7", "sentA": "The information available on or through our website is not a part of this Annual Report on Form 10-K and should not be relied upon.", "sentB": "The information contained in, or that can be accessed through, our website is not part of, and is not incorporated in, this Annual Report.", "type": 2, "words": ["<tag1>", "The", "information", "available", "on", "or", "through", "our", "website", "is", "not", "a", "part", "of", "this", "Annual", "Report", "on", "Form", "10-K", "and", "should", "not", "be", "relied", "upon.", "<tag2>", "The", "information", "contained", "in,", "or", "that", "can", "be", "accessed", "through,", "our", "website", "is", "not", "part", "of,", "and", "is", "not", "incorporated", "in,", "this", "Annual", "Report.", "<tag3>"], "wordsA": ["The", "information", "available", "on", "or", "through", "our", "website", "is", "not", "a", "part", "of", "this", "Annual", "Report", "on", "Form", "10-K", "and", "should", "not", "be", "relied", "upon."], "wordsB": ["The", "information", "contained", "in,", "or", "that", "can", "be", "accessed", "through,", "our", "website", "is", "not", "part", "of,", "and", "is", "not", "incorporated", "in,", "this", "Annual", "Report."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009757155552506447, 0.11585627496242523, 0.04467826709151268, 0.04234255105257034, 0.01124368142336607, 0.009140732698142529, 0.05981966108083725, 0.07848644256591797, 0.15830989181995392, 0.06162753328680992, 0.007886819541454315, 0.06417015194892883, 0.08455463498830795, 0.379864901304245, 0.148528590798378, 0.04298555478453636, 0.0074280910193920135, 0.09764444082975388, 0.4914361536502838, 0.5046137571334839, 0.15807025134563446, 0.03114101104438305, 0.0827246904373169, 0.11017099022865295, -1]}
{"idB": "749647_12_item1_p20_s0", "idA": "749647_11_item1_p93_s0", "sentA": "On February 9, 2011, after reviewing data from 482 randomized patients enrolled in our pivotal Phase III HEAT study, the DMC for this trial unanimously recommended that the trial continue to enroll patients at all clinical sites except for those in Japan with the goal of reaching the 600 patients required to complete the study.", "sentB": "On July 11, 2011, after reviewing data from 535 randomized patients enrolled in our pivotal Phase III HEAT study, the Data Monitoring Committee (DMC) for this trial unanimously recommended that the trial continue to enroll patients at all clinical sites except those in Japan with the goal of reaching enrollment of 600 patients, as required by the study protocol.", "type": 2, "words": ["<tag1>", "On", "February", "9,", "2011,", "after", "reviewing", "data", "from", "482", "randomized", "patients", "enrolled", "in", "our", "pivotal", "Phase", "III", "HEAT", "study,", "the", "DMC", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "at", "all", "clinical", "sites", "except", "for", "those", "in", "Japan", "with", "the", "goal", "of", "reaching", "the", "600", "patients", "required", "to", "complete", "the", "study.", "<tag2>", "On", "July", "11,", "2011,", "after", "reviewing", "data", "from", "535", "randomized", "patients", "enrolled", "in", "our", "pivotal", "Phase", "III", "HEAT", "study,", "the", "Data", "Monitoring", "Committee", "(DMC)", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "at", "all", "clinical", "sites", "except", "those", "in", "Japan", "with", "the", "goal", "of", "reaching", "enrollment", "of", "600", "patients,", "as", "required", "by", "the", "study", "protocol.", "<tag3>"], "wordsA": ["On", "February", "9,", "2011,", "after", "reviewing", "data", "from", "482", "randomized", "patients", "enrolled", "in", "our", "pivotal", "Phase", "III", "HEAT", "study,", "the", "DMC", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "at", "all", "clinical", "sites", "except", "for", "those", "in", "Japan", "with", "the", "goal", "of", "reaching", "the", "600", "patients", "required", "to", "complete", "the", "study."], "wordsB": ["On", "July", "11,", "2011,", "after", "reviewing", "data", "from", "535", "randomized", "patients", "enrolled", "in", "our", "pivotal", "Phase", "III", "HEAT", "study,", "the", "Data", "Monitoring", "Committee", "(DMC)", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "at", "all", "clinical", "sites", "except", "those", "in", "Japan", "with", "the", "goal", "of", "reaching", "enrollment", "of", "600", "patients,", "as", "required", "by", "the", "study", "protocol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0076900264248251915, 0.8475505709648132, 0.7479928135871887, 0.02301875315606594, 0.0021424293518066406, 0.0042963349260389805, 0.006347054615616798, 0.004584053531289101, 0.8695082068443298, 0.11952029913663864, 0.14320039749145508, 0.002841770416125655, 0.0016057732282206416, 0.0016035441076382995, 0.0020720292814075947, 0.0021739478688687086, 0.0019890167750418186, 0.0021761565003544092, 0.003178742015734315, 0.001612735097296536, 0.029113270342350006, 0.033784277737140656, 0.04301351681351662, 0.006600637454539537, 0.0016051068669185042, 0.0016502465587109327, 0.0033165968488901854, 0.0020716229919344187, 0.002689971122890711, 0.0017899206141009927, 0.0014568828046321869, 0.004948725458234549, 0.0025929026305675507, 0.0019001031760126352, 0.005555799230933189, 0.005170884542167187, 0.0015321522951126099, 0.0021342725958675146, 0.0024244762025773525, 0.002594535704702139, 0.002002124674618244, 0.0018788912566378713, 0.0015821732813492417, 0.0020977696403861046, 0.0021321051754057407, 0.003540679346770048, 0.001962163019925356, 0.0018648497061803937, 0.0032476456835865974, 0.026391051709651947, 0.0030337106436491013, 0.027103444561362267, 0.016218561679124832, 0.00273667904548347, 0.0031064245849847794, 0.0018764151027426124, 0.0019117147894576192, 0.00816724169999361, 0.005088088568300009, -1]}
{"idB": "749647_12_item1_p47_s1", "idA": "749647_11_item1_p93_s0", "sentA": "On February 9, 2011, after reviewing data from 482 randomized patients enrolled in our pivotal Phase III HEAT study, the DMC for this trial unanimously recommended that the trial continue to enroll patients at all clinical sites except for those in Japan with the goal of reaching the 600 patients required to complete the study.", "sentB": "In November, 2011, the DMC completed a planned interim analysis for safety, efficacy and futility and unanimously recommended that the study continue to its final analysis as planned.", "type": 2, "words": ["<tag1>", "On", "February", "9,", "2011,", "after", "reviewing", "data", "from", "482", "randomized", "patients", "enrolled", "in", "our", "pivotal", "Phase", "III", "HEAT", "study,", "the", "DMC", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "at", "all", "clinical", "sites", "except", "for", "those", "in", "Japan", "with", "the", "goal", "of", "reaching", "the", "600", "patients", "required", "to", "complete", "the", "study.", "<tag2>", "In", "November,", "2011,", "the", "DMC", "completed", "a", "planned", "interim", "analysis", "for", "safety,", "efficacy", "and", "futility", "and", "unanimously", "recommended", "that", "the", "study", "continue", "to", "its", "final", "analysis", "as", "planned.", "<tag3>"], "wordsA": ["On", "February", "9,", "2011,", "after", "reviewing", "data", "from", "482", "randomized", "patients", "enrolled", "in", "our", "pivotal", "Phase", "III", "HEAT", "study,", "the", "DMC", "for", "this", "trial", "unanimously", "recommended", "that", "the", "trial", "continue", "to", "enroll", "patients", "at", "all", "clinical", "sites", "except", "for", "those", "in", "Japan", "with", "the", "goal", "of", "reaching", "the", "600", "patients", "required", "to", "complete", "the", "study."], "wordsB": ["In", "November,", "2011,", "the", "DMC", "completed", "a", "planned", "interim", "analysis", "for", "safety,", "efficacy", "and", "futility", "and", "unanimously", "recommended", "that", "the", "study", "continue", "to", "its", "final", "analysis", "as", "planned."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018100447952747345, 0.6416657567024231, 0.06852935999631882, 0.004416946321725845, 0.03908366337418556, 0.10130057483911514, 0.02443734183907509, 0.1283644288778305, 0.48185408115386963, 0.41401028633117676, 0.0067189657129347324, 0.048066336661577225, 0.02591722644865513, 0.0170609038323164, 0.029220612719655037, 0.0011507022427394986, 0.009467988274991512, 0.029265450313687325, 0.008656620979309082, 0.006235500797629356, 0.13198637962341309, 0.05237811431288719, 0.03492523357272148, 0.018508588895201683, 0.22495344281196594, 0.2996079921722412, 0.014993508346378803, 0.029605478048324585, -1]}
{"idB": "749647_12_item1_p21_s1", "idA": "749647_11_item1_p93_s1", "sentA": "The DMC continues to review safety and efficacy data in accordance with the PMDA in Japan and the DMC s charter, however there can be no assurance that the DMC will permit resumption of patient enrollment in Japan or at all nor can there be any assurance that the Company will receive the second $2 million payment from Yakult pursuant to the Amendment to the Yakult Agreement.", "sentB": "The DMC continues to review safety and efficacy data in accordance with the PMDA in Japan and the DMC s charter, however there can be no assurance that the DMC will permit resumption of patient enrollment in Japan or at all nor can there be any assurance that we will receive the second $2 million payment from Yakult pursuant to the amended Yakult Agreement.", "type": 2, "words": ["<tag1>", "The", "DMC", "continues", "to", "review", "safety", "and", "efficacy", "data", "in", "accordance", "with", "the", "PMDA", "in", "Japan", "and", "the", "DMC", "s", "charter,", "however", "there", "can", "be", "no", "assurance", "that", "the", "DMC", "will", "permit", "resumption", "of", "patient", "enrollment", "in", "Japan", "or", "at", "all", "nor", "can", "there", "be", "any", "assurance", "that", "the", "Company", "will", "receive", "the", "second", "$2", "million", "payment", "from", "Yakult", "pursuant", "to", "the", "Amendment", "to", "the", "Yakult", "Agreement.", "<tag2>", "The", "DMC", "continues", "to", "review", "safety", "and", "efficacy", "data", "in", "accordance", "with", "the", "PMDA", "in", "Japan", "and", "the", "DMC", "s", "charter,", "however", "there", "can", "be", "no", "assurance", "that", "the", "DMC", "will", "permit", "resumption", "of", "patient", "enrollment", "in", "Japan", "or", "at", "all", "nor", "can", "there", "be", "any", "assurance", "that", "we", "will", "receive", "the", "second", "$2", "million", "payment", "from", "Yakult", "pursuant", "to", "the", "amended", "Yakult", "Agreement.", "<tag3>"], "wordsA": ["The", "DMC", "continues", "to", "review", "safety", "and", "efficacy", "data", "in", "accordance", "with", "the", "PMDA", "in", "Japan", "and", "the", "DMC", "s", "charter,", "however", "there", "can", "be", "no", "assurance", "that", "the", "DMC", "will", "permit", "resumption", "of", "patient", "enrollment", "in", "Japan", "or", "at", "all", "nor", "can", "there", "be", "any", "assurance", "that", "the", "Company", "will", "receive", "the", "second", "$2", "million", "payment", "from", "Yakult", "pursuant", "to", "the", "Amendment", "to", "the", "Yakult", "Agreement."], "wordsB": ["The", "DMC", "continues", "to", "review", "safety", "and", "efficacy", "data", "in", "accordance", "with", "the", "PMDA", "in", "Japan", "and", "the", "DMC", "s", "charter,", "however", "there", "can", "be", "no", "assurance", "that", "the", "DMC", "will", "permit", "resumption", "of", "patient", "enrollment", "in", "Japan", "or", "at", "all", "nor", "can", "there", "be", "any", "assurance", "that", "we", "will", "receive", "the", "second", "$2", "million", "payment", "from", "Yakult", "pursuant", "to", "the", "amended", "Yakult", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015199794434010983, 0.853484570980072, 0.033585917204618454, 0.019341062754392624, 0.03204311057925224, 0.026171278208494186, 0.016212275251746178, 0.02187427692115307, 0.019581079483032227, 0.013559839688241482, 0.01938648149371147, 0.014114495366811752, 0.012133365496993065, 0.033940304070711136, 0.01093094889074564, 0.022652307525277138, 0.009214941412210464, 0.00971872266381979, 0.03336669132113457, 0.012717067264020443, 0.030664360150694847, 0.008329442702233791, 0.006203006021678448, 0.007939962670207024, 0.009610668756067753, 0.0412302240729332, 0.05649886280298233, 0.010127811692655087, 0.011312035843729973, 0.2466951459646225, 0.037074800580739975, 0.023278269916772842, 0.026472482830286026, 0.008634584955871105, 0.020950475707650185, 0.03216073662042618, 0.010113537311553955, 0.01784496195614338, 0.014025026932358742, 0.013574096374213696, 0.02580389194190502, 0.031248876824975014, 0.017119642347097397, 0.007932078093290329, 0.008184664882719517, 0.010938038118183613, 0.040529731661081314, 0.007592453621327877, 0.09961050748825073, 0.04082338139414787, 0.04137401282787323, 0.011703863739967346, 0.024721356108784676, 0.026241485029459, 0.02738245576620102, 0.0544448085129261, 0.009939647279679775, 0.037819184362888336, 0.010045708157122135, 0.0066551510244607925, 0.007349756546318531, 0.03267509490251541, 0.021447205916047096, 0.02002285234630108, -1]}
{"idB": "749647_12_item1_p20_s2", "idA": "749647_11_item1_p94_s0", "sentA": "At this time, the Company is unable to determine what, if any, effect the catastrophic events resulting from the March 11, 2011 earthquake and Tsunami in Japan will have on the conduct or timeframe of the Phase III HEAT Trial or the DMC s review of safety and efficacy data.", "sentB": "The recommendation followed a review of safety data from 18 Japanese patients enrolled in the study, when compared to patient data from the rest of the Phase III trial.", "type": 2, "words": ["<tag1>", "At", "this", "time,", "the", "Company", "is", "unable", "to", "determine", "what,", "if", "any,", "effect", "the", "catastrophic", "events", "resulting", "from", "the", "March", "11,", "2011", "earthquake", "and", "Tsunami", "in", "Japan", "will", "have", "on", "the", "conduct", "or", "timeframe", "of", "the", "Phase", "III", "HEAT", "Trial", "or", "the", "DMC", "s", "review", "of", "safety", "and", "efficacy", "data.", "<tag2>", "The", "recommendation", "followed", "a", "review", "of", "safety", "data", "from", "18", "Japanese", "patients", "enrolled", "in", "the", "study,", "when", "compared", "to", "patient", "data", "from", "the", "rest", "of", "the", "Phase", "III", "trial.", "<tag3>"], "wordsA": ["At", "this", "time,", "the", "Company", "is", "unable", "to", "determine", "what,", "if", "any,", "effect", "the", "catastrophic", "events", "resulting", "from", "the", "March", "11,", "2011", "earthquake", "and", "Tsunami", "in", "Japan", "will", "have", "on", "the", "conduct", "or", "timeframe", "of", "the", "Phase", "III", "HEAT", "Trial", "or", "the", "DMC", "s", "review", "of", "safety", "and", "efficacy", "data."], "wordsB": ["The", "recommendation", "followed", "a", "review", "of", "safety", "data", "from", "18", "Japanese", "patients", "enrolled", "in", "the", "study,", "when", "compared", "to", "patient", "data", "from", "the", "rest", "of", "the", "Phase", "III", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008685325272381306, 0.1446668803691864, 0.15588973462581635, 0.027822429314255714, 0.1704547256231308, 0.033893998712301254, 0.21942231059074402, 0.24682527780532837, 0.051083777099847794, 0.478770911693573, 0.3424578309059143, 0.4527536928653717, 0.07152733206748962, 0.049389440566301346, 0.03347252681851387, 0.2093755453824997, 0.006728576496243477, 0.06594937294721603, 0.02301439456641674, 0.12533098459243774, 0.15443561971187592, 0.009383220225572586, 0.006961754523217678, 0.04427909478545189, 0.011990844272077084, 0.00917481817305088, 0.03781865909695625, 0.06036129966378212, 0.079372338950634, -1]}
{"idB": "749647_12_item1_p116_s0", "idA": "749647_11_item1_p95_s0", "sentA": "On June 17, 2010, we entered into a financing arrangement, sometimes referred to as a committed equity line financing facility (the CEFF ), with Small Cap Biotech Value, Ltd. (the Purchaser ) that provides that, upon the terms and subject to the conditions set forth therein, the Purchaser is committed to purchase up to $15.0 million worth of our common stock over the 24-month term of the Purchase Agreement, up to a maximum of 2,404,434 shares, under certain specified conditions and limitations.", "sentB": "We raised gross proceeds of approximately $3.2 million by selling 1,340,514 shares of common stock under our committed equity financing facility with Small Cap Biotech Value Ltd. during 2011.", "type": 2, "words": ["<tag1>", "On", "June", "17,", "2010,", "we", "entered", "into", "a", "financing", "arrangement,", "sometimes", "referred", "to", "as", "a", "committed", "equity", "line", "financing", "facility", "(the", "CEFF", "),", "with", "Small", "Cap", "Biotech", "Value,", "Ltd.", "(the", "Purchaser", ")", "that", "provides", "that,", "upon", "the", "terms", "and", "subject", "to", "the", "conditions", "set", "forth", "therein,", "the", "Purchaser", "is", "committed", "to", "purchase", "up", "to", "$15.0", "million", "worth", "of", "our", "common", "stock", "over", "the", "24-month", "term", "of", "the", "Purchase", "Agreement,", "up", "to", "a", "maximum", "of", "2,404,434", "shares,", "under", "certain", "specified", "conditions", "and", "limitations.", "<tag2>", "We", "raised", "gross", "proceeds", "of", "approximately", "$3.2", "million", "by", "selling", "1,340,514", "shares", "of", "common", "stock", "under", "our", "committed", "equity", "financing", "facility", "with", "Small", "Cap", "Biotech", "Value", "Ltd.", "during", "2011.", "<tag3>"], "wordsA": ["On", "June", "17,", "2010,", "we", "entered", "into", "a", "financing", "arrangement,", "sometimes", "referred", "to", "as", "a", "committed", "equity", "line", "financing", "facility", "(the", "CEFF", "),", "with", "Small", "Cap", "Biotech", "Value,", "Ltd.", "(the", "Purchaser", ")", "that", "provides", "that,", "upon", "the", "terms", "and", "subject", "to", "the", "conditions", "set", "forth", "therein,", "the", "Purchaser", "is", "committed", "to", "purchase", "up", "to", "$15.0", "million", "worth", "of", "our", "common", "stock", "over", "the", "24-month", "term", "of", "the", "Purchase", "Agreement,", "up", "to", "a", "maximum", "of", "2,404,434", "shares,", "under", "certain", "specified", "conditions", "and", "limitations."], "wordsB": ["We", "raised", "gross", "proceeds", "of", "approximately", "$3.2", "million", "by", "selling", "1,340,514", "shares", "of", "common", "stock", "under", "our", "committed", "equity", "financing", "facility", "with", "Small", "Cap", "Biotech", "Value", "Ltd.", "during", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0417412705719471, 0.22679592669010162, 0.19016848504543304, 0.20656581223011017, 0.04637662321329117, 0.09128576517105103, 0.2990584075450897, 0.0941658616065979, 0.014368579722940922, 0.30974942445755005, 0.6358128190040588, 0.3315833806991577, 0.05017341300845146, 0.09241599589586258, 0.13226674497127533, 0.01709766313433647, 0.0064840721897780895, 0.020379023626446724, 0.016079358756542206, 0.023651283234357834, 0.025854038074612617, 0.005749014671891928, 0.007929748855531216, 0.008591599762439728, 0.012187684886157513, 0.009283534251153469, 0.00981108658015728, 0.08700364828109741, 0.5787558555603027, -1]}
{"idB": "749647_12_item1_p115_s0", "idA": "749647_11_item1_p96_s0", "sentA": "On January 12, 2011, the Company entered into a Securities Purchase Agreement (the Purchase Agreement ) with a select group of institutional investors, including certain officers and directors of the Company, to sell up to 5,000 shares of 8% redeemable convertible preferred stock (the Preferred Stock ) with a stated value of $1,000 and warrants (the Included Warrants ) to purchase up to 2,083,333 shares of common stock in a registered direct offering.", "sentB": "We raised gross proceeds of approximately $5.1 million in a registered direct offering on January 18, 2011, in which we issued 5,000 shares of 8% redeemable convertible preferred stock (which were all converted into shares of common stock in connection with the Company s registered direct offering on July 25, 2011), and warrants to purchase up to 2,083,333 shares of common stock.", "type": 2, "words": ["<tag1>", "On", "January", "12,", "2011,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "(the", "Purchase", "Agreement", ")", "with", "a", "select", "group", "of", "institutional", "investors,", "including", "certain", "officers", "and", "directors", "of", "the", "Company,", "to", "sell", "up", "to", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(the", "Preferred", "Stock", ")", "with", "a", "stated", "value", "of", "$1,000", "and", "warrants", "(the", "Included", "Warrants", ")", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock", "in", "a", "registered", "direct", "offering.", "<tag2>", "We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["On", "January", "12,", "2011,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "(the", "Purchase", "Agreement", ")", "with", "a", "select", "group", "of", "institutional", "investors,", "including", "certain", "officers", "and", "directors", "of", "the", "Company,", "to", "sell", "up", "to", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(the", "Preferred", "Stock", ")", "with", "a", "stated", "value", "of", "$1,000", "and", "warrants", "(the", "Included", "Warrants", ")", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock", "in", "a", "registered", "direct", "offering."], "wordsB": ["We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07219312340021133, 0.24566757678985596, 0.2522231340408325, 0.2581579387187958, 0.038542479276657104, 0.06414184719324112, 0.059744637459516525, 0.015617984347045422, 0.008670410141348839, 0.00716122891753912, 0.013169782236218452, 0.011775322258472443, 0.030777381733059883, 0.010486294515430927, 0.015749361366033554, 0.10008862614631653, 0.017544321715831757, 0.006211536005139351, 0.005965413060039282, 0.01731290854513645, 0.08851287513971329, 0.05577000603079796, 0.0694565549492836, 0.008242659270763397, 0.01170446164906025, 0.01020087581127882, 0.014453841373324394, 0.019140899181365967, 0.021567516028881073, 0.00972006842494011, 0.008457447402179241, 0.022492587566375732, 0.08009171485900879, 0.03797801211476326, 0.050819262862205505, 0.013790564611554146, 0.026798315346240997, 0.02889510989189148, 0.007350246887654066, 0.005130962934345007, 0.005045756231993437, 0.006406100001186132, 0.011674432083964348, 0.003849950386211276, 0.009479030966758728, 0.01311060506850481, 0.01806865818798542, 0.0054102553986012936, 0.0802132710814476, 0.2908174991607666, 0.018261272460222244, 0.007020678836852312, 0.02318277396261692, 0.007472488097846508, 0.036818403750658035, 0.0096159428358078, 0.008072041906416416, 0.008113307878375053, 0.015174554660916328, 0.006055693607777357, 0.01016846764832735, 0.014202043414115906, -1]}
{"idB": "749647_12_item1_p117_s0", "idA": "749647_11_item1_p96_s1", "sentA": "The Preferred Stock and Included Warrants were sold in units (the Units ), with each Unit consisting of one share of Preferred Stock and an Included Warrant to purchase up to 416.6666 shares of common stock at an exercise price of $3.25 per whole share of common stock.", "sentB": "As a result of these equity transactions, the Company collectively raised $58.0 million in gross proceeds by issuing approximately 19.7 million shares of our common stock and warrants to purchase approximately 10.6 million shares of our common stock.", "type": 2, "words": ["<tag1>", "The", "Preferred", "Stock", "and", "Included", "Warrants", "were", "sold", "in", "units", "(the", "Units", "),", "with", "each", "Unit", "consisting", "of", "one", "share", "of", "Preferred", "Stock", "and", "an", "Included", "Warrant", "to", "purchase", "up", "to", "416.6666", "shares", "of", "common", "stock", "at", "an", "exercise", "price", "of", "$3.25", "per", "whole", "share", "of", "common", "stock.", "<tag2>", "As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["The", "Preferred", "Stock", "and", "Included", "Warrants", "were", "sold", "in", "units", "(the", "Units", "),", "with", "each", "Unit", "consisting", "of", "one", "share", "of", "Preferred", "Stock", "and", "an", "Included", "Warrant", "to", "purchase", "up", "to", "416.6666", "shares", "of", "common", "stock", "at", "an", "exercise", "price", "of", "$3.25", "per", "whole", "share", "of", "common", "stock."], "wordsB": ["As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007757474668323994, 0.008688224479556084, 0.015275395475327969, 0.00695462804287672, 0.010848965495824814, 0.1121363416314125, 0.11693163216114044, 0.00494208512827754, 0.04608812928199768, 0.043198179453611374, 0.13475845754146576, 0.3252483010292053, 0.2592109739780426, 0.07968302816152573, 0.1231246069073677, 0.13813674449920654, 0.007777213118970394, 0.0924014151096344, 0.07404898852109909, 0.3015187382698059, 0.34500735998153687, 0.17480215430259705, 0.014856097288429737, 0.013597637414932251, 0.0604688934981823, 0.06234101578593254, 0.0037319986149668694, 0.03842298686504364, 0.004240385256707668, 0.05452226102352142, 0.07698336988687515, 0.32895103096961975, 0.3885970413684845, 0.20283262431621552, 0.011616804637014866, 0.012445637956261635, 0.04458094760775566, 0.04495931416749954, -1]}
{"idB": "749647_12_item1_p117_s1", "idA": "749647_11_item1_p96_s1", "sentA": "The Preferred Stock and Included Warrants were sold in units (the Units ), with each Unit consisting of one share of Preferred Stock and an Included Warrant to purchase up to 416.6666 shares of common stock at an exercise price of $3.25 per whole share of common stock.", "sentB": "This includes approximately $433,000 of gross proceeds received from the exercise of certain warrants issued by the Company to certain holders thereof into approximately 157,000 shares of common stock.", "type": 2, "words": ["<tag1>", "The", "Preferred", "Stock", "and", "Included", "Warrants", "were", "sold", "in", "units", "(the", "Units", "),", "with", "each", "Unit", "consisting", "of", "one", "share", "of", "Preferred", "Stock", "and", "an", "Included", "Warrant", "to", "purchase", "up", "to", "416.6666", "shares", "of", "common", "stock", "at", "an", "exercise", "price", "of", "$3.25", "per", "whole", "share", "of", "common", "stock.", "<tag2>", "This", "includes", "approximately", "$433,000", "of", "gross", "proceeds", "received", "from", "the", "exercise", "of", "certain", "warrants", "issued", "by", "the", "Company", "to", "certain", "holders", "thereof", "into", "approximately", "157,000", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["The", "Preferred", "Stock", "and", "Included", "Warrants", "were", "sold", "in", "units", "(the", "Units", "),", "with", "each", "Unit", "consisting", "of", "one", "share", "of", "Preferred", "Stock", "and", "an", "Included", "Warrant", "to", "purchase", "up", "to", "416.6666", "shares", "of", "common", "stock", "at", "an", "exercise", "price", "of", "$3.25", "per", "whole", "share", "of", "common", "stock."], "wordsB": ["This", "includes", "approximately", "$433,000", "of", "gross", "proceeds", "received", "from", "the", "exercise", "of", "certain", "warrants", "issued", "by", "the", "Company", "to", "certain", "holders", "thereof", "into", "approximately", "157,000", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00918639823794365, 0.0421287901699543, 0.09664973616600037, 0.6557541489601135, 0.13128186762332916, 0.24287502467632294, 0.23061063885688782, 0.05592210963368416, 0.014779394492506981, 0.008152978494763374, 0.04264095425605774, 0.018317565321922302, 0.06017220765352249, 0.10745906829833984, 0.038967713713645935, 0.008369104005396366, 0.007967736572027206, 0.0324656181037426, 0.006769141182303429, 0.02083764597773552, 0.051154159009456635, 0.021621571853756905, 0.016455605626106262, 0.05874735862016678, 0.45314568281173706, 0.23843812942504883, 0.03124825470149517, 0.0466286726295948, 0.06395889073610306, -1]}
{"idB": "749647_12_item1_p10_s0", "idA": "749647_11_item1_p9_s0", "sentA": "Our lead product, ThermoDox , is being evaluated in a Phase III clinical trial, which we refer to as the HEAT study, for primary liver cancer and a Phase I/II study for recurrent chest wall breast cancer.", "sentB": "Our lead product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis (CRLM) and a Phase II clinical trial for recurrent chest wall breast cancer.", "type": 2, "words": ["<tag1>", "Our", "lead", "product,", "ThermoDox", ",", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "which", "we", "refer", "to", "as", "the", "HEAT", "study,", "for", "primary", "liver", "cancer", "and", "a", "Phase", "I/II", "study", "for", "recurrent", "chest", "wall", "breast", "cancer.", "<tag2>", "Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "HEAT", "study),", "a", "Phase", "II", "clinical", "trial", "for", "colorectal", "liver", "metastasis", "(CRLM)", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer.", "<tag3>"], "wordsA": ["Our", "lead", "product,", "ThermoDox", ",", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "which", "we", "refer", "to", "as", "the", "HEAT", "study,", "for", "primary", "liver", "cancer", "and", "a", "Phase", "I/II", "study", "for", "recurrent", "chest", "wall", "breast", "cancer."], "wordsB": ["Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "HEAT", "study),", "a", "Phase", "II", "clinical", "trial", "for", "colorectal", "liver", "metastasis", "(CRLM)", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0030749430879950523, 0.016735613346099854, 0.01759105920791626, 0.015446081757545471, 0.0032834261655807495, 0.004929821938276291, 0.01265445351600647, 0.0028409785591065884, 0.0024940739385783672, 0.006174007896333933, 0.005595950409770012, 0.005957433488219976, 0.010708671063184738, 0.0028283412102609873, 0.008199620060622692, 0.011475837789475918, 0.012326361611485481, 0.023611299693584442, 0.0209236778318882, 0.03135260194540024, 0.0032372339628636837, 0.014540689066052437, 0.011029533110558987, 0.01571892946958542, 0.0360453762114048, 0.05322742462158203, 0.9052007794380188, 0.7088577151298523, 0.848236083984375, 0.5551995635032654, 0.003977247513830662, 0.0025283293798565865, 0.013585747219622135, 0.030585767701268196, 0.013471323065459728, 0.01958930306136608, 0.0027858668472617865, 0.012832033447921276, 0.008915487676858902, 0.006714664865285158, 0.009473972953855991, 0.0150171322748065, -1]}
{"idB": "749647_12_item1_p11_s1", "idA": "749647_11_item1_p9_s2", "sentA": "Localized mild hyperthermia (greater than 40 degrees Celsius) releases the encapsulated doxorubicin from the liposome enabling high concentrations of doxorubicin to be deposited preferentially in the region of the tumor target.", "sentB": "Localized heat at mild hyperthermia temperatures (greater than 40 degrees Celsius) releases the encapsulated doxorubicin from the liposome enabling high concentrations of doxorubicin to be deposited preferentially in and around the targeted tumor.", "type": 2, "words": ["<tag1>", "Localized", "mild", "hyperthermia", "(greater", "than", "40", "degrees", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "the", "region", "of", "the", "tumor", "target.", "<tag2>", "Localized", "heat", "at", "mild", "hyperthermia", "temperatures", "(greater", "than", "40", "degrees", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor.", "<tag3>"], "wordsA": ["Localized", "mild", "hyperthermia", "(greater", "than", "40", "degrees", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "the", "region", "of", "the", "tumor", "target."], "wordsB": ["Localized", "heat", "at", "mild", "hyperthermia", "temperatures", "(greater", "than", "40", "degrees", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.26938316226005554, 0.9573221206665039, 0.023349056020379066, 0.0131040308624506, 0.02173498645424843, 0.0272703655064106, 0.016620848327875137, 0.012002520263195038, 0.008718345314264297, 0.01642308570444584, 0.00852768775075674, 0.012116242200136185, 0.003135594306513667, 0.009384860284626484, 0.013074401766061783, 0.003533724695444107, 0.0034997398033738136, 0.010248543694615364, 0.003167981281876564, 0.006207010243088007, 0.006625678855925798, 0.0031166747212409973, 0.01364512462168932, 0.0022573349997401237, 0.0030034177470952272, 0.01099351979792118, 0.0062906499952077866, 0.005956222303211689, 0.02057514525949955, 0.028041811659932137, 0.008184204809367657, 0.03111797384917736, 0.05055256932973862, -1]}
{"idB": "749647_13_item1_p0_s1", "idA": "749647_12_item1_p0_s1", "sentA": "In addition, from time to time we may publish forward-looking statements relating to such matters as anticipated financial performance, business prospects, technological developments, new products, research and development activities and other aspects of our present and future business operations and similar matters that also constitute such forward-looking statements.", "sentB": "In addition, from time to time we may publish forward-looking statements relating to such matters as anticipated financial performance, business prospects, technological developments, product pipelines, clinical trials and research and development activities, the adequacy of capital reserves and anticipated operating results and cash expenditures, current and potential collaborations, strategic alternatives and other aspects of our present and future business operations and similar matters that also constitute such forward-looking statements.", "type": 2, "words": ["<tag1>", "In", "addition,", "from", "time", "to", "time", "we", "may", "publish", "forward-looking", "statements", "relating", "to", "such", "matters", "as", "anticipated", "financial", "performance,", "business", "prospects,", "technological", "developments,", "new", "products,", "research", "and", "development", "activities", "and", "other", "aspects", "of", "our", "present", "and", "future", "business", "operations", "and", "similar", "matters", "that", "also", "constitute", "such", "forward-looking", "statements.", "<tag2>", "In", "addition,", "from", "time", "to", "time", "we", "may", "publish", "forward-looking", "statements", "relating", "to", "such", "matters", "as", "anticipated", "financial", "performance,", "business", "prospects,", "technological", "developments,", "product", "pipelines,", "clinical", "trials", "and", "research", "and", "development", "activities,", "the", "adequacy", "of", "capital", "reserves", "and", "anticipated", "operating", "results", "and", "cash", "expenditures,", "current", "and", "potential", "collaborations,", "strategic", "alternatives", "and", "other", "aspects", "of", "our", "present", "and", "future", "business", "operations", "and", "similar", "matters", "that", "also", "constitute", "such", "forward-looking", "statements.", "<tag3>"], "wordsA": ["In", "addition,", "from", "time", "to", "time", "we", "may", "publish", "forward-looking", "statements", "relating", "to", "such", "matters", "as", "anticipated", "financial", "performance,", "business", "prospects,", "technological", "developments,", "new", "products,", "research", "and", "development", "activities", "and", "other", "aspects", "of", "our", "present", "and", "future", "business", "operations", "and", "similar", "matters", "that", "also", "constitute", "such", "forward-looking", "statements."], "wordsB": ["In", "addition,", "from", "time", "to", "time", "we", "may", "publish", "forward-looking", "statements", "relating", "to", "such", "matters", "as", "anticipated", "financial", "performance,", "business", "prospects,", "technological", "developments,", "product", "pipelines,", "clinical", "trials", "and", "research", "and", "development", "activities,", "the", "adequacy", "of", "capital", "reserves", "and", "anticipated", "operating", "results", "and", "cash", "expenditures,", "current", "and", "potential", "collaborations,", "strategic", "alternatives", "and", "other", "aspects", "of", "our", "present", "and", "future", "business", "operations", "and", "similar", "matters", "that", "also", "constitute", "such", "forward-looking", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006315621081739664, 0.00990487914532423, 0.008938089944422245, 0.010318517684936523, 0.010346231050789356, 0.008386288769543171, 0.00701586389914155, 0.011568974703550339, 0.00875055231153965, 0.011019675061106682, 0.0084402896463871, 0.0055003417655825615, 0.005666255950927734, 0.007451560348272324, 0.008177894167602062, 0.0061661661602556705, 0.00864727608859539, 0.007635754533112049, 0.008590081706643105, 0.0063802506774663925, 0.008085599169135094, 0.006133913062512875, 0.009383698925375938, 0.36447787284851074, 0.2575351595878601, 0.5299263596534729, 0.28102606534957886, 0.006457628216594458, 0.008430777117609978, 0.008286526426672935, 0.009149676188826561, 0.01152107771486044, 0.006648780312389135, 0.07217278331518173, 0.09985245764255524, 0.44542884826660156, 0.40482866764068604, 0.008961944840848446, 0.009037164971232414, 0.026473287492990494, 0.01643611490726471, 0.011069738306105137, 0.12015943229198456, 0.09977934509515762, 0.005301261320710182, 0.008410313166677952, 0.009088597260415554, 0.009292787872254848, 0.1301049441099167, 0.10399314761161804, 0.006519789807498455, 0.00800580345094204, 0.00926569290459156, 0.00647919625043869, 0.006936880759894848, 0.007374672219157219, 0.007750819902867079, 0.007818962447345257, 0.00992092676460743, 0.009102108888328075, 0.00804266519844532, 0.008018719032406807, 0.00826799962669611, 0.010698743164539337, 0.006986323744058609, 0.0071207378059625626, 0.006598568055778742, 0.0077180881053209305, 0.007467228453606367, -1]}
{"idB": "749647_13_item1_p0_s3", "idA": "749647_12_item1_p0_s3", "sentA": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost and timing of development and testing, capital structure, and other financial items; changes in approaches to medical treatment; introduction of new products by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities, as well as those listed under Risk Factors below and elsewhere in this Annual Report on Form 10-K.", "sentB": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost and timing of development and testing, possible changes in capital structure, financial condition, future working capital needs and other financial items; changes in approaches to medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks and uncertainties associated with possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities, as well as those listed under Risk Factors below and elsewhere in this Annual Report on Form 10-K.", "type": 2, "words": ["<tag1>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost", "and", "timing", "of", "development", "and", "testing,", "capital", "structure,", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities,", "as", "well", "as", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag2>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost", "and", "timing", "of", "development", "and", "testing,", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities,", "as", "well", "as", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag3>"], "wordsA": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost", "and", "timing", "of", "development", "and", "testing,", "capital", "structure,", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities,", "as", "well", "as", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K."], "wordsB": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost", "and", "timing", "of", "development", "and", "testing,", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities,", "as", "well", "as", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03582289069890976, 0.141451895236969, 0.03101004846394062, 0.04520828649401665, 0.044711727648973465, 0.055767498910427094, 0.0796605572104454, 0.08044490218162537, 0.029731640592217445, 0.027469659224152565, 0.03874793276190758, 0.03911646828055382, 0.048196278512477875, 0.034430790692567825, 0.04200798273086548, 0.045265186578035355, 0.018693625926971436, 0.017063798382878304, 0.028613412752747536, 0.036993492394685745, 0.019445525482296944, 0.03557147830724716, 0.02930673025548458, 0.03669782727956772, 0.026002051308751106, 0.03531670942902565, 0.02556980960071087, 0.03084062598645687, 0.026641186326742172, 0.03213393688201904, 0.017746994271874428, 0.026020435616374016, 0.028807170689105988, 0.03239647299051285, 0.039104629307985306, 0.016452904790639877, 0.02103080227971077, 0.01394264679402113, 0.0881025493144989, 0.12111850827932358, 0.04221576079726219, 0.01443476788699627, 0.01999315805733204, 0.02410523220896721, 0.030044376850128174, 0.026958752423524857, 0.0347692146897316, 0.04577290266752243, 0.034662723541259766, 0.04210963100194931, 0.04654388874769211, 0.026445038616657257, 0.027372539043426514, 0.028595581650733948, 0.0326714888215065, 0.029386332258582115, 0.030485734343528748, 0.015598319470882416, 0.03623242676258087, 0.03922051191329956, 0.020849699154496193, 0.012815168127417564, 0.017567910254001617, 0.02024160698056221, 0.026267005130648613, 0.025314174592494965, 0.02486768737435341, 0.020815586671233177, 0.015939004719257355, 0.0337987057864666, 0.01988411135971546, 0.023602809756994247, 0.025917967781424522, 0.02219306491315365, 0.024668211117386818, 0.02551012486219406, 0.03315653279423714, 0.030343979597091675, 0.027829879894852638, 0.025657452642917633, 0.027536168694496155, 0.03999943286180496, 0.021698959171772003, 0.03396173194050789, 0.04778024181723595, 0.037200212478637695, 0.03594420477747917, 0.024195363745093346, 0.02820758707821369, 0.02766999416053295, 0.023251289501786232, 0.023143092170357704, 0.02853066846728325, 0.031681813299655914, 0.023647181689739227, 0.023720890283584595, 0.019941696897149086, 0.027510222047567368, 0.03132417052984238, 0.026431670412421227, 0.027721600607037544, 0.04746011272072792, 0.0251405518501997, 0.028676239773631096, 0.029551833868026733, 0.025000212714076042, 0.024493595585227013, 0.03153266757726669, 0.030930975452065468, 0.025862591341137886, 0.0303539726883173, 0.05095405504107475, -1]}
{"idB": "749647_13_item1_p104_s1", "idA": "749647_12_item1_p104_s0", "sentA": "In 1999, the Company entered into a license agreement with Duke University under which the we received exclusive rights (subject to certain exceptions) to commercialize and use Duke s thermo-liposome technology.", "sentB": "Celsion holds an exclusive license agreement with Duke University for its temperature-sensitive liposome technology that covers the ThermoDox formulation.", "type": 2, "words": ["<tag1>", "In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "we", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag2>", "Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation.", "<tag3>"], "wordsA": ["In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "we", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "wordsB": ["Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.3729482889175415, 0.09567877650260925, 0.015564975328743458, 0.11960288137197495, 0.11518742144107819, 0.06992229074239731, 0.013927535153925419, 0.02410074509680271, 0.036299124360084534, 0.007389693520963192, 0.010565055534243584, 0.44436535239219666, 0.1507299244403839, 0.08316738158464432, 0.008695644326508045, 0.19751347601413727, 0.022564027458429337, 0.29913726449012756, 0.20496387779712677, -1]}
{"idB": "749647_13_item1_p111_s0", "idA": "749647_12_item1_p104_s0", "sentA": "In 1999, the Company entered into a license agreement with Duke University under which the we received exclusive rights (subject to certain exceptions) to commercialize and use Duke s thermo-liposome technology.", "sentB": "On June 27, 2012, the Company entered into a Loan and Security Agreement (the Credit Agreement ) with Oxford Finance LLC ( Oxford ) and Horizon Technology Finance Corporation ( Horizon ).", "type": 2, "words": ["<tag1>", "In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "we", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag2>", "On", "June", "27,", "2012,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(the", "Credit", "Agreement", ")", "with", "Oxford", "Finance", "LLC", "(", "Oxford", ")", "and", "Horizon", "Technology", "Finance", "Corporation", "(", "Horizon", ").", "<tag3>"], "wordsA": ["In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "we", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "wordsB": ["On", "June", "27,", "2012,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(the", "Credit", "Agreement", ")", "with", "Oxford", "Finance", "LLC", "(", "Oxford", ")", "and", "Horizon", "Technology", "Finance", "Corporation", "(", "Horizon", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.026879888027906418, 0.12698623538017273, 0.1041368693113327, 0.6421863436698914, 0.004556808155030012, 0.05492935702204704, 0.04771953076124191, 0.035460736602544785, 0.027752380818128586, 0.5556414127349854, 0.3083786070346832, 0.5013024806976318, 0.36787718534469604, 0.019643817096948624, 0.1973465383052826, 0.23451068997383118, 4.124908082303591e-05, 0.03307357802987099, 0.43076634407043457, 0.47315505146980286, 0.2394973635673523, 0.03972897306084633, 0.21801303327083588, 5.957566463621333e-05, 0.04797748103737831, 0.3505799174308777, 0.3188774287700653, 0.4996988773345947, 0.3976139724254608, 0.06266874819993973, 0.27275556325912476, 3.46818778780289e-05, -1]}
{"idB": "749647_13_item1_p99_s0", "idA": "749647_12_item1_p104_s0", "sentA": "In 1999, the Company entered into a license agreement with Duke University under which the we received exclusive rights (subject to certain exceptions) to commercialize and use Duke s thermo-liposome technology.", "sentB": "In 1999, the Company entered into a license agreement with Duke University under which we received exclusive rights, subject to certain exceptions, to commercialize and use Duke s thermo-liposome technology.", "type": 2, "words": ["<tag1>", "In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "we", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag2>", "In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag3>"], "wordsA": ["In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "the", "we", "received", "exclusive", "rights", "(subject", "to", "certain", "exceptions)", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "wordsB": ["In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.18300975859165192, 0.25183653831481934, 0.03921576961874962, 0.27739277482032776, 0.16395166516304016, 0.09835011512041092, 0.08776888251304626, 0.2444216012954712, 0.23779861629009247, 0.12415463477373123, 0.3980848491191864, 0.2905661463737488, 0.1245565116405487, 0.0708044096827507, 0.13009190559387207, 0.1771405041217804, 0.347932904958725, 0.25764861702919006, 0.11287016421556473, 0.08133742958307266, 0.18048128485679626, 0.24346281588077545, 0.08353327214717865, 0.18171405792236328, 0.05458501726388931, 0.12577137351036072, 0.4207032024860382, 0.23997478187084198, 0.23612520098686218, 0.19936738908290863, -1]}
{"idB": "749647_13_item1_p118_s1", "idA": "749647_12_item1_p105_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "On January 18, 2013, we also entered into an exclusive option agreement with Hisun, terminable at any time by Hisun, under which we granted Hisun an option to enter into an exclusive license agreement with us for the manufacturing and commercialization of ThermoDox with respect to all indications in the China territory under the terms and conditions set forth in the exclusive option agreement and other customary terms and conditions to be set forth in the license agreement, if any.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "On", "January", "18,", "2013,", "we", "also", "entered", "into", "an", "exclusive", "option", "agreement", "with", "Hisun,", "terminable", "at", "any", "time", "by", "Hisun,", "under", "which", "we", "granted", "Hisun", "an", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "manufacturing", "and", "commercialization", "of", "ThermoDox", "with", "respect", "to", "all", "indications", "in", "the", "China", "territory", "under", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "exclusive", "option", "agreement", "and", "other", "customary", "terms", "and", "conditions", "to", "be", "set", "forth", "in", "the", "license", "agreement,", "if", "any.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["On", "January", "18,", "2013,", "we", "also", "entered", "into", "an", "exclusive", "option", "agreement", "with", "Hisun,", "terminable", "at", "any", "time", "by", "Hisun,", "under", "which", "we", "granted", "Hisun", "an", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "manufacturing", "and", "commercialization", "of", "ThermoDox", "with", "respect", "to", "all", "indications", "in", "the", "China", "territory", "under", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "exclusive", "option", "agreement", "and", "other", "customary", "terms", "and", "conditions", "to", "be", "set", "forth", "in", "the", "license", "agreement,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05663971230387688, 0.118934765458107, 0.10152044892311096, 0.7501497864723206, 0.023982033133506775, 0.019033459946513176, 0.050408147275447845, 0.032212261110544205, 0.023230962455272675, 0.13910788297653198, 0.08840922266244888, 0.1085827648639679, 0.020673956722021103, 0.1119394302368164, 0.040713921189308167, 0.010180112905800343, 0.022839898243546486, 0.018857209011912346, 0.01385468803346157, 0.05243489518761635, 0.010774459689855576, 0.0057280948385596275, 0.014088057912886143, 0.07506018131971359, 0.08334077894687653, 0.03689727187156677, 0.05494390055537224, 0.02768954075872898, 0.03185461461544037, 0.01586439460515976, 0.013966265134513378, 0.11544542014598846, 0.06976985186338425, 0.05919988453388214, 0.010344737209379673, 0.023673320189118385, 0.006177867762744427, 0.0074264355935156345, 0.08285902440547943, 0.02924465388059616, 0.19167675077915192, 0.06695824861526489, 0.22970795631408691, 0.005265655927360058, 0.012243281118571758, 0.011000631377100945, 0.0576285645365715, 0.02350465953350067, 0.008773591369390488, 0.00795760378241539, 0.042902201414108276, 0.04838905110955238, 0.0023268081713467836, 0.009536988101899624, 0.02615918219089508, 0.012651821598410606, 0.022145183756947517, 0.0052729882299900055, 0.005588795989751816, 0.004440269432961941, 0.005253969691693783, 0.018304485827684402, 0.015469485893845558, 0.020803315564990044, 0.00616732332855463, 0.0058472235687077045, 0.04000241681933403, 0.03788062557578087, 0.019110433757305145, 0.03295125439763069, 0.006962466519325972, 0.006925438530743122, 0.007160753943026066, 0.015736393630504608, 0.0073979562148451805, 0.006085142958909273, 0.03958559036254883, 0.040592536330223083, 0.046200793236494064, 0.027972789481282234, -1]}
{"idB": "749647_13_item1_p128_s2", "idA": "749647_12_item1_p105_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "We may need to pursue dilutive equity financings, such as the issuance of shares of common stock, convertible debt or other convertible or exercisable securities, which financings could dilute the percentage ownership of our current common stockholders and could significantly lower the market value of our common stock.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities,", "which", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities,", "which", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04984533041715622, 0.03162110969424248, 0.06188584119081497, 0.025206124410033226, 0.17127929627895355, 0.3010222017765045, 0.40507596731185913, 0.48933345079421997, 0.0010073066223412752, 0.007163893897086382, 0.006090246606618166, 0.035698868334293365, 0.010261790826916695, 0.028233066201210022, 0.006994578987360001, 0.02056395448744297, 0.021104732528328896, 0.12145672738552094, 0.11997663229703903, 0.004055439028888941, 0.005208742804825306, 0.06140260025858879, 0.009760132059454918, 0.05271916463971138, 0.058891091495752335, 0.0005435346974991262, 0.062301795929670334, 0.001703251851722598, 0.05522759631276131, 0.019976651296019554, 0.0464005284011364, 0.03253859281539917, 0.005737972911447287, 0.0035405480302870274, 0.014066285453736782, 0.027047298848628998, 0.026185818016529083, 0.00041549972957000136, 0.005042339209467173, 0.02154448814690113, 0.09285303950309753, 0.012876590713858604, 0.09091216325759888, 0.08012035489082336, 0.011468055658042431, 0.006860693916678429, 0.051896121352910995, 0.035092297941446304, -1]}
{"idB": "749647_13_item1_p43_s1", "idA": "749647_12_item1_p105_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "On January 18, 2013, we also entered into an exclusive option agreement with Hisun, terminable at any time by Hisun, under which we granted Hisun an option to enter into an exclusive license agreement with us for the manufacturing and commercialization of ThermoDox with respect to all indications in the China territory under the terms and conditions set forth in the exclusive option agreement and other customary terms and conditions to be set forth in the license agreement, if any.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "On", "January", "18,", "2013,", "we", "also", "entered", "into", "an", "exclusive", "option", "agreement", "with", "Hisun,", "terminable", "at", "any", "time", "by", "Hisun,", "under", "which", "we", "granted", "Hisun", "an", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "manufacturing", "and", "commercialization", "of", "ThermoDox", "with", "respect", "to", "all", "indications", "in", "the", "China", "territory", "under", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "exclusive", "option", "agreement", "and", "other", "customary", "terms", "and", "conditions", "to", "be", "set", "forth", "in", "the", "license", "agreement,", "if", "any.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["On", "January", "18,", "2013,", "we", "also", "entered", "into", "an", "exclusive", "option", "agreement", "with", "Hisun,", "terminable", "at", "any", "time", "by", "Hisun,", "under", "which", "we", "granted", "Hisun", "an", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "manufacturing", "and", "commercialization", "of", "ThermoDox", "with", "respect", "to", "all", "indications", "in", "the", "China", "territory", "under", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "exclusive", "option", "agreement", "and", "other", "customary", "terms", "and", "conditions", "to", "be", "set", "forth", "in", "the", "license", "agreement,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05663971230387688, 0.118934765458107, 0.10152044892311096, 0.7501497864723206, 0.023982033133506775, 0.019033459946513176, 0.050408147275447845, 0.032212261110544205, 0.023230962455272675, 0.13910788297653198, 0.08840922266244888, 0.1085827648639679, 0.020673956722021103, 0.1119394302368164, 0.040713921189308167, 0.010180112905800343, 0.022839898243546486, 0.018857209011912346, 0.01385468803346157, 0.05243489518761635, 0.010774459689855576, 0.0057280948385596275, 0.014088057912886143, 0.07506018131971359, 0.08334077894687653, 0.03689727187156677, 0.05494390055537224, 0.02768954075872898, 0.03185461461544037, 0.01586439460515976, 0.013966265134513378, 0.11544542014598846, 0.06976985186338425, 0.05919988453388214, 0.010344737209379673, 0.023673320189118385, 0.006177867762744427, 0.0074264355935156345, 0.08285902440547943, 0.02924465388059616, 0.19167675077915192, 0.06695824861526489, 0.22970795631408691, 0.005265655927360058, 0.012243281118571758, 0.011000631377100945, 0.0576285645365715, 0.02350465953350067, 0.008773591369390488, 0.00795760378241539, 0.042902201414108276, 0.04838905110955238, 0.0023268081713467836, 0.009536988101899624, 0.02615918219089508, 0.012651821598410606, 0.022145183756947517, 0.0052729882299900055, 0.005588795989751816, 0.004440269432961941, 0.005253969691693783, 0.018304485827684402, 0.015469485893845558, 0.020803315564990044, 0.00616732332855463, 0.0058472235687077045, 0.04000241681933403, 0.03788062557578087, 0.019110433757305145, 0.03295125439763069, 0.006962466519325972, 0.006925438530743122, 0.007160753943026066, 0.015736393630504608, 0.0073979562148451805, 0.006085142958909273, 0.03958559036254883, 0.040592536330223083, 0.046200793236494064, 0.027972789481282234, -1]}
{"idB": "749647_13_item1_p105_s1", "idA": "749647_12_item1_p109_s1", "sentA": "We cannot offer assurances that these information agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "sentB": "There can be no assurance that these proprietary information agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "type": 2, "words": ["<tag1>", "We", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "these", "proprietary", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag3>"], "wordsA": ["We", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "these", "proprietary", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010848687961697578, 0.056396882981061935, 0.02814948372542858, 0.6616026163101196, 0.43365731835365295, 0.017956597730517387, 0.006554013583809137, 0.040355537086725235, 0.02968999184668064, 0.02881041169166565, 0.06091247498989105, 0.2524121403694153, 0.09213210642337799, 0.1532479077577591, 0.005473386961966753, 0.01038188487291336, 0.014203564263880253, 0.014525637030601501, 0.02839605137705803, 0.01567152515053749, 0.0044710407964885235, 0.006985132582485676, 0.010938230901956558, 0.005010010674595833, 0.005200028419494629, 0.003990473225712776, 0.02316945046186447, 0.007221067324280739, 0.007579045370221138, 0.011678140610456467, 0.011626038700342178, 0.013280202634632587, 0.013974739238619804, 0.03865507245063782, 0.011698444373905659, 0.0283797699958086, 0.027640607208013535, 0.01622925139963627, 0.005567711777985096, 0.005566094070672989, 0.013658120296895504, 0.006078112404793501, 0.009863706305623055, 0.011477584950625896, -1]}
{"idB": "749647_13_item1_p111_s4", "idA": "749647_12_item1_p109_s1", "sentA": "We cannot offer assurances that these information agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "sentB": "On January 31, 2013, the Company announced it did not meet the primary endpoint of the HEAT study, therefore the Term B Loan will not be drawn down.", "type": 2, "words": ["<tag1>", "We", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag2>", "On", "January", "31,", "2013,", "the", "Company", "announced", "it", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study,", "therefore", "the", "Term", "B", "Loan", "will", "not", "be", "drawn", "down.", "<tag3>"], "wordsA": ["We", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "wordsB": ["On", "January", "31,", "2013,", "the", "Company", "announced", "it", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study,", "therefore", "the", "Term", "B", "Loan", "will", "not", "be", "drawn", "down."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021381359547376633, 0.044546715915203094, 0.05035538971424103, 0.0860888659954071, 0.010086186230182648, 0.11669574677944183, 0.06819133460521698, 0.052149493247270584, 0.3858393430709839, 0.45540696382522583, 0.3505646288394928, 0.15026426315307617, 0.1743633896112442, 0.19802409410476685, 0.03699931129813194, 0.06171340122818947, 0.17808210849761963, 0.23689381778240204, 0.006433278787881136, 0.009427949786186218, 0.0713295042514801, 0.0855189859867096, 0.13339859247207642, 0.03834621235728264, 0.09681502729654312, 0.05916699394583702, 0.07117284089326859, 0.1182582750916481, -1]}
{"idB": "749647_13_item1_p112_s1", "idA": "749647_12_item1_p109_s1", "sentA": "We cannot offer assurances that these information agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "sentB": "The proceeds of the Credit Agreement will be used to fund the Company s working capital and general corporate purposes.", "type": 2, "words": ["<tag1>", "We", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag2>", "The", "proceeds", "of", "the", "Credit", "Agreement", "will", "be", "used", "to", "fund", "the", "Company", "s", "working", "capital", "and", "general", "corporate", "purposes.", "<tag3>"], "wordsA": ["We", "cannot", "offer", "assurances", "that", "these", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "wordsB": ["The", "proceeds", "of", "the", "Credit", "Agreement", "will", "be", "used", "to", "fund", "the", "Company", "s", "working", "capital", "and", "general", "corporate", "purposes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.058800116181373596, 0.2792417109012604, 0.03497013449668884, 0.03126276284456253, 0.2156326025724411, 0.2568455934524536, 0.0646224394440651, 0.07358512282371521, 0.20147526264190674, 0.11566825211048126, 0.31856369972229004, 0.0833766758441925, 0.12036692351102829, 0.11086958646774292, 0.27544182538986206, 0.24900440871715546, 0.017583487555384636, 0.1975984424352646, 0.20848621428012848, 0.2282516211271286, -1]}
{"idB": "749647_13_item1_p107_s0", "idA": "749647_12_item1_p111_s0", "sentA": "As of March 14, 2012, we employed 19 full-time employees.", "sentB": "As of March 15, 2013, we employed 19 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "14,", "2012,", "we", "employed", "19", "full-time", "employees.", "<tag2>", "As", "of", "March", "15,", "2013,", "we", "employed", "19", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "14,", "2012,", "we", "employed", "19", "full-time", "employees."], "wordsB": ["As", "of", "March", "15,", "2013,", "we", "employed", "19", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010141012258827686, 0.009575262665748596, 0.11479026079177856, 0.9333759546279907, 0.7694733142852783, 0.002762200077995658, 0.011095654219388962, 0.008027766831219196, 0.007974961772561073, 0.01630162075161934, -1]}
{"idB": "749647_13_item1_p121_s1", "idA": "749647_12_item1_p112_s3", "sentA": "The Company s website is www.celsion.com .", "sentB": "The Company is not obligated to sell any ATM Shares under the ATM Agreement.", "type": 2, "words": ["<tag1>", "The", "Company", "s", "website", "is", "www.celsion.com", ".", "<tag2>", "The", "Company", "is", "not", "obligated", "to", "sell", "any", "ATM", "Shares", "under", "the", "ATM", "Agreement.", "<tag3>"], "wordsA": ["The", "Company", "s", "website", "is", "www.celsion.com", "."], "wordsB": ["The", "Company", "is", "not", "obligated", "to", "sell", "any", "ATM", "Shares", "under", "the", "ATM", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 0.010957355611026287, 0.0936770811676979, 0.06074213981628418, 0.5242609977722168, 0.6630274653434753, 0.31540611386299133, 0.5122418999671936, 0.21008506417274475, 0.5344699025154114, 0.527511715888977, 0.04007875546813011, 0.016500838100910187, 0.05691496282815933, 0.05502383038401604, -1]}
{"idB": "749647_13_item1_p109_s0", "idA": "749647_12_item1_p113_s0", "sentA": "We make available free of charge through our website, www.celsion.com, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission (the SEC ).", "sentB": "We make available free of charge through our website, www.celsion.com, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission (the SEC ).", "type": 2, "words": ["<tag1>", "We", "make", "available", "free", "of", "charge", "through", "our", "website,", "www.celsion.com,", "its", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K,", "and", "all", "amendments", "to", "those", "reports", "as", "soon", "as", "reasonably", "practicable", "after", "such", "material", "is", "electronically", "filed", "with", "or", "furnished", "to", "the", "Securities", "and", "Exchange", "Commission", "(the", "SEC", ").", "<tag2>", "We", "make", "available", "free", "of", "charge", "through", "our", "website,", "www.celsion.com,", "our", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K,", "and", "all", "amendments", "to", "those", "reports", "as", "soon", "as", "reasonably", "practicable", "after", "such", "material", "is", "electronically", "filed", "with", "or", "furnished", "to", "the", "Securities", "and", "Exchange", "Commission", "(the", "SEC", ").", "<tag3>"], "wordsA": ["We", "make", "available", "free", "of", "charge", "through", "our", "website,", "www.celsion.com,", "its", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K,", "and", "all", "amendments", "to", "those", "reports", "as", "soon", "as", "reasonably", "practicable", "after", "such", "material", "is", "electronically", "filed", "with", "or", "furnished", "to", "the", "Securities", "and", "Exchange", "Commission", "(the", "SEC", ")."], "wordsB": ["We", "make", "available", "free", "of", "charge", "through", "our", "website,", "www.celsion.com,", "our", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K,", "and", "all", "amendments", "to", "those", "reports", "as", "soon", "as", "reasonably", "practicable", "after", "such", "material", "is", "electronically", "filed", "with", "or", "furnished", "to", "the", "Securities", "and", "Exchange", "Commission", "(the", "SEC", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.031305670738220215, 0.052327435463666916, 0.07101013511419296, 0.07032551616430283, 0.06213393434882164, 0.07240046560764313, 0.033816587179899216, 0.03342537209391594, 0.08167194575071335, 0.07507611066102982, 0.023245252668857574, 0.0679347887635231, 0.07501795887947083, 0.02234364114701748, 0.09973778575658798, 0.15452390909194946, 0.05324114114046097, 0.06613336503505707, 0.023977084085345268, 0.09268471598625183, 0.16718697547912598, 0.04181024804711342, 0.0764547660946846, 0.0330817811191082, 0.07313816994428635, 0.1344020962715149, 0.019272051751613617, 0.0356871597468853, 0.32845690846443176, 0.03562750667333603, 0.026868708431720734, 0.06301254779100418, 0.04465913772583008, 0.05296263471245766, 0.039674993604421616, 0.05212513729929924, 0.06961939483880997, 0.05114858224987984, 0.1277463138103485, 0.13286057114601135, 0.09309741854667664, 0.15175604820251465, 0.09037391096353531, 0.09038317948579788, 0.05246608331799507, 0.07490158826112747, 0.03986017405986786, 0.04039977118372917, 0.09478463232517242, 0.06647538393735886, 0.08606046438217163, 0.09733577072620392, 0.03345460817217827, 0.10721667855978012, 0.0005999025888741016, -1]}
{"idB": "749647_13_item1_p120_s1", "idA": "749647_12_item1_p113_s5", "sentA": "The SEC also maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file periodic and other reports electronically with the Securities and Exchange Commission.", "sentB": "The ATM Shares will be issued pursuant to the Company s previously filed and effective Registration Statement on Form S-3 the base prospectus dated September 14, 2012, filed as part of such Registration Statement, and the prospectus supplement dated February 1, 2013, filed by the Company with the Securities and Exchange Commission.", "type": 2, "words": ["<tag1>", "The", "SEC", "also", "maintains", "an", "internet", "site", "that", "contains", "reports,", "proxy", "and", "information", "statements", "and", "other", "information", "regarding", "issuers", "that", "file", "periodic", "and", "other", "reports", "electronically", "with", "the", "Securities", "and", "Exchange", "Commission.", "<tag2>", "The", "ATM", "Shares", "will", "be", "issued", "pursuant", "to", "the", "Company", "s", "previously", "filed", "and", "effective", "Registration", "Statement", "on", "Form", "S-3", "the", "base", "prospectus", "dated", "September", "14,", "2012,", "filed", "as", "part", "of", "such", "Registration", "Statement,", "and", "the", "prospectus", "supplement", "dated", "February", "1,", "2013,", "filed", "by", "the", "Company", "with", "the", "Securities", "and", "Exchange", "Commission.", "<tag3>"], "wordsA": ["The", "SEC", "also", "maintains", "an", "internet", "site", "that", "contains", "reports,", "proxy", "and", "information", "statements", "and", "other", "information", "regarding", "issuers", "that", "file", "periodic", "and", "other", "reports", "electronically", "with", "the", "Securities", "and", "Exchange", "Commission."], "wordsB": ["The", "ATM", "Shares", "will", "be", "issued", "pursuant", "to", "the", "Company", "s", "previously", "filed", "and", "effective", "Registration", "Statement", "on", "Form", "S-3", "the", "base", "prospectus", "dated", "September", "14,", "2012,", "filed", "as", "part", "of", "such", "Registration", "Statement,", "and", "the", "prospectus", "supplement", "dated", "February", "1,", "2013,", "filed", "by", "the", "Company", "with", "the", "Securities", "and", "Exchange", "Commission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016590796411037445, 0.5996320843696594, 0.4592910408973694, 0.01340316142886877, 0.015666499733924866, 0.11958853155374527, 0.01186386588960886, 0.005794796161353588, 0.0053274803794920444, 0.040601249784231186, 0.007846031337976456, 0.008987942710518837, 0.012666855938732624, 0.011396071873605251, 0.03450582176446915, 0.08339492231607437, 0.046256452798843384, 0.004195208195596933, 0.03196822479367256, 0.07253316789865494, 0.005090970546007156, 0.02902672439813614, 0.025454403832554817, 0.005051317624747753, 0.017461461946368217, 0.017768917605280876, 0.038587361574172974, 0.004144739825278521, 0.0028987149707973003, 0.0032764298375695944, 0.003254421055316925, 0.004469794686883688, 0.03370507434010506, 0.01820831000804901, 0.008344226516783237, 0.0036223670467734337, 0.030698029324412346, 0.026220889762043953, 0.007221090607345104, 0.039973512291908264, 0.04123404249548912, 0.13555197417736053, 0.003377994056791067, 0.002874721074476838, 0.004180568270385265, 0.018051981925964355, 0.00368472165428102, 0.003642911557108164, 0.005680253729224205, 0.004022011999040842, 0.004975109826773405, 0.008270679041743279, -1]}
{"idB": "749647_13_item1_p115_s0", "idA": "749647_12_item1_p115_s0", "sentA": "We raised gross proceeds of approximately $5.1 million in a registered direct offering on January 18, 2011, in which we issued 5,000 shares of 8% redeemable convertible preferred stock (which were all converted into shares of common stock in connection with the Company s registered direct offering on July 25, 2011), and warrants to purchase up to 2,083,333 shares of common stock.", "sentB": "As a fee in connection with the Credit Agreement, the Company issued warrants to Horizon and Oxford to purchase the number of shares of the Company s common stock equal to 3% of each loan amount divided by the exercise price equal to $2.92 per share, which is calculated as the average NASDAQ closing price of Celsion common stock for the three days prior to the funding of the loan amount.", "type": 2, "words": ["<tag1>", "We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock.", "<tag2>", "As", "a", "fee", "in", "connection", "with", "the", "Credit", "Agreement,", "the", "Company", "issued", "warrants", "to", "Horizon", "and", "Oxford", "to", "purchase", "the", "number", "of", "shares", "of", "the", "Company", "s", "common", "stock", "equal", "to", "3%", "of", "each", "loan", "amount", "divided", "by", "the", "exercise", "price", "equal", "to", "$2.92", "per", "share,", "which", "is", "calculated", "as", "the", "average", "NASDAQ", "closing", "price", "of", "Celsion", "common", "stock", "for", "the", "three", "days", "prior", "to", "the", "funding", "of", "the", "loan", "amount.", "<tag3>"], "wordsA": ["We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock."], "wordsB": ["As", "a", "fee", "in", "connection", "with", "the", "Credit", "Agreement,", "the", "Company", "issued", "warrants", "to", "Horizon", "and", "Oxford", "to", "purchase", "the", "number", "of", "shares", "of", "the", "Company", "s", "common", "stock", "equal", "to", "3%", "of", "each", "loan", "amount", "divided", "by", "the", "exercise", "price", "equal", "to", "$2.92", "per", "share,", "which", "is", "calculated", "as", "the", "average", "NASDAQ", "closing", "price", "of", "Celsion", "common", "stock", "for", "the", "three", "days", "prior", "to", "the", "funding", "of", "the", "loan", "amount."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016208861023187637, 0.02403802052140236, 0.041492413729429245, 0.010001296177506447, 0.01315801776945591, 0.009843622334301472, 0.010221723467111588, 0.14273184537887573, 0.07674455642700195, 0.004435763228684664, 0.029852604493498802, 0.10536038130521774, 0.22556327283382416, 0.031155141070485115, 0.11322225630283356, 0.09524532407522202, 0.16747072339057922, 0.012434683740139008, 0.06394062936306, 0.03850060701370239, 0.09633439779281616, 0.06976950913667679, 0.09067650139331818, 0.012551112100481987, 0.01013021171092987, 0.03329796716570854, 0.009771318174898624, 0.05001407489180565, 0.04575342684984207, 0.012254595756530762, 0.012151919305324554, 0.24848808348178864, 0.013472730293869972, 0.01780633255839348, 0.07636935263872147, 0.08511900156736374, 0.009616589173674583, 0.008749018423259258, 0.006286627147346735, 0.06647041440010071, 0.07614991813898087, 0.017970390617847443, 0.013148942962288857, 0.5847912430763245, 0.1117592304944992, 0.05130571499466896, 0.0002508258621674031, 0.006054609082639217, 0.012577307410538197, 0.008191335014998913, 0.008766661398112774, 0.04173251986503601, 0.04833380877971649, 0.0790899321436882, 0.05623225122690201, 0.006797209847718477, 0.0635753870010376, 0.12171483784914017, 0.07604184001684189, 0.004879204090684652, 0.0052634235471487045, 0.012882823124527931, 0.018530314788222313, 0.008764490485191345, 0.006174422800540924, 0.005589872132986784, 0.019852306693792343, 0.0057471697218716145, 0.005756672937422991, 0.03758528456091881, 0.030152475461363792, -1]}
{"idB": "749647_13_item1_p122_s4", "idA": "749647_12_item1_p115_s0", "sentA": "We raised gross proceeds of approximately $5.1 million in a registered direct offering on January 18, 2011, in which we issued 5,000 shares of 8% redeemable convertible preferred stock (which were all converted into shares of common stock in connection with the Company s registered direct offering on July 25, 2011), and warrants to purchase up to 2,083,333 shares of common stock.", "sentB": "In connection with the preferred stock offering discussed below, the Company agreed to not sell any ATM Shares for a period of one year from February 26, 2013.", "type": 2, "words": ["<tag1>", "We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock.", "<tag2>", "In", "connection", "with", "the", "preferred", "stock", "offering", "discussed", "below,", "the", "Company", "agreed", "to", "not", "sell", "any", "ATM", "Shares", "for", "a", "period", "of", "one", "year", "from", "February", "26,", "2013.", "<tag3>"], "wordsA": ["We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock."], "wordsB": ["In", "connection", "with", "the", "preferred", "stock", "offering", "discussed", "below,", "the", "Company", "agreed", "to", "not", "sell", "any", "ATM", "Shares", "for", "a", "period", "of", "one", "year", "from", "February", "26,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0074163684621453285, 0.015508846379816532, 0.004930682480335236, 0.005304523278027773, 0.032253194600343704, 0.01689128391444683, 0.038192495703697205, 0.009647957980632782, 0.021829431876540184, 0.006181865464895964, 0.0759362056851387, 0.19054777920246124, 0.23986968398094177, 0.7817264199256897, 0.7263011932373047, 0.2664130628108978, 0.4523463249206543, 0.536059558391571, 0.017808090895414352, 0.009051498956978321, 0.025283578783273697, 0.011103242635726929, 0.03242876008152962, 0.03751469776034355, 0.039311930537223816, 0.2075905203819275, 0.1159524992108345, 0.448693186044693, -1]}
{"idB": "749647_13_item1_p123_s0", "idA": "749647_12_item1_p115_s0", "sentA": "We raised gross proceeds of approximately $5.1 million in a registered direct offering on January 18, 2011, in which we issued 5,000 shares of 8% redeemable convertible preferred stock (which were all converted into shares of common stock in connection with the Company s registered direct offering on July 25, 2011), and warrants to purchase up to 2,083,333 shares of common stock.", "sentB": "On February 22, 2013, the Company entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company agreed to sell, in a registered offering, an aggregate of 15,000.00422 shares of its Series A 0% convertible preferred stock and the warrants to purchase shares of its common stock, for an aggregate purchase price of approximately $15.0 million (the Preferred Stock Offering).", "type": 2, "words": ["<tag1>", "We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock.", "<tag2>", "On", "February", "22,", "2013,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "agreed", "to", "sell,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "its", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "the", "warrants", "to", "purchase", "shares", "of", "its", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "(the", "Preferred", "Stock", "Offering).", "<tag3>"], "wordsA": ["We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock."], "wordsB": ["On", "February", "22,", "2013,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "agreed", "to", "sell,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "its", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "the", "warrants", "to", "purchase", "shares", "of", "its", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "(the", "Preferred", "Stock", "Offering)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014280538074672222, 0.22456234693527222, 0.1663120985031128, 0.6618869304656982, 0.0046057323925197124, 0.05362710356712341, 0.07382871210575104, 0.09333723783493042, 0.051735758781433105, 0.15758803486824036, 0.32442545890808105, 0.2009781152009964, 0.033525846898555756, 0.05720590800046921, 0.10949274897575378, 0.10160354524850845, 0.008832305669784546, 0.011276722885668278, 0.007143424358218908, 0.004423606675118208, 0.020150475203990936, 0.022758042439818382, 0.03890042006969452, 0.025752577930688858, 0.003861866658553481, 0.003832798218354583, 0.010431939736008644, 0.013969858177006245, 0.005867808125913143, 0.03974716365337372, 0.011983219534158707, 0.2733268439769745, 0.1966862827539444, 0.0038413209840655327, 0.0045011695474386215, 0.02482593059539795, 0.009164208546280861, 0.3112304210662842, 0.02245066873729229, 0.01837378554046154, 0.02270497940480709, 0.0029811235144734383, 0.003548986278474331, 0.019198989495635033, 0.004715951159596443, 0.027694592252373695, 0.025122525170445442, 0.003960463684052229, 0.005010008346289396, 0.012995182536542416, 0.016295336186885834, 0.0038681323640048504, 0.0056320722214877605, 0.07351484149694443, 0.037920769304037094, 0.0243290476500988, 0.006136533338576555, 0.011166347190737724, 0.4208816885948181, 0.05876001715660095, 0.0042282394133508205, 0.01422274112701416, 0.011885837651789188, 0.012862428091466427, -1]}
{"idB": "749647_13_item1_p124_s0", "idA": "749647_12_item1_p115_s0", "sentA": "We raised gross proceeds of approximately $5.1 million in a registered direct offering on January 18, 2011, in which we issued 5,000 shares of 8% redeemable convertible preferred stock (which were all converted into shares of common stock in connection with the Company s registered direct offering on July 25, 2011), and warrants to purchase up to 2,083,333 shares of common stock.", "sentB": "Subject to certain ownership limitations, shares of Series A 0% convertible preferred stock are convertible, at the option of the holder thereof, into an aggregate of up to 12,072,438 shares of common stock, and the warrants are exercisable to purchase an aggregate of up to 6,036,219 shares of common stock.", "type": 2, "words": ["<tag1>", "We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock.", "<tag2>", "Subject", "to", "certain", "ownership", "limitations,", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "are", "convertible,", "at", "the", "option", "of", "the", "holder", "thereof,", "into", "an", "aggregate", "of", "up", "to", "12,072,438", "shares", "of", "common", "stock,", "and", "the", "warrants", "are", "exercisable", "to", "purchase", "an", "aggregate", "of", "up", "to", "6,036,219", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["We", "raised", "gross", "proceeds", "of", "approximately", "$5.1", "million", "in", "a", "registered", "direct", "offering", "on", "January", "18,", "2011,", "in", "which", "we", "issued", "5,000", "shares", "of", "8%", "redeemable", "convertible", "preferred", "stock", "(which", "were", "all", "converted", "into", "shares", "of", "common", "stock", "in", "connection", "with", "the", "Company", "s", "registered", "direct", "offering", "on", "July", "25,", "2011),", "and", "warrants", "to", "purchase", "up", "to", "2,083,333", "shares", "of", "common", "stock."], "wordsB": ["Subject", "to", "certain", "ownership", "limitations,", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "are", "convertible,", "at", "the", "option", "of", "the", "holder", "thereof,", "into", "an", "aggregate", "of", "up", "to", "12,072,438", "shares", "of", "common", "stock,", "and", "the", "warrants", "are", "exercisable", "to", "purchase", "an", "aggregate", "of", "up", "to", "6,036,219", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024354685097932816, 0.014705353416502476, 0.03364834561944008, 0.08896675705909729, 0.16178454458713531, 0.0659572035074234, 0.010180862620472908, 0.045600034296512604, 0.026508353650569916, 0.32150769233703613, 0.025684699416160583, 0.024694541469216347, 0.023917967453598976, 0.026717351749539375, 0.058986466377973557, 0.013466095551848412, 0.00030780441011302173, 0.03836178034543991, 0.021430375054478645, 0.01903565041720867, 0.06402004510164261, 0.03555691987276077, 0.009956869296729565, 0.006131989415735006, 0.020335564389824867, 0.006809769198298454, 0.017256172373890877, 0.014053184539079666, 0.6210031509399414, 0.2023395597934723, 0.008257750421762466, 0.014314367435872555, 0.02191619575023651, 0.0037224581465125084, 0.002571266610175371, 0.05679183080792427, 0.006884354632347822, 0.055370181798934937, 0.004869977477937937, 0.02144281193614006, 0.006367422174662352, 0.032230861485004425, 0.006357654929161072, 0.017000459134578705, 0.010281584225594997, 0.7236365079879761, 0.23031163215637207, 0.008285502903163433, 0.015800459310412407, 0.04065354913473129, -1]}
{"idB": "749647_13_item1_p110_s0", "idA": "749647_12_item1_p117_s0", "sentA": "As a result of these equity transactions, the Company collectively raised $58.0 million in gross proceeds by issuing approximately 19.7 million shares of our common stock and warrants to purchase approximately 10.6 million shares of our common stock.", "sentB": "During 2012, we received approximately $10.2 million of gross proceeds from the exercise of warrants to purchase approximately 3.8 million shares of the Company s common stock and $0.7 million of gross proceeds from the exercise of options to purchase approximately 0.2 million shares of the Company s common stock.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock.", "<tag2>", "During", "2012,", "we", "received", "approximately", "$10.2", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "warrants", "to", "purchase", "approximately", "3.8", "million", "shares", "of", "the", "Company", "s", "common", "stock", "and", "$0.7", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "options", "to", "purchase", "approximately", "0.2", "million", "shares", "of", "the", "Company", "s", "common", "stock.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock."], "wordsB": ["During", "2012,", "we", "received", "approximately", "$10.2", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "warrants", "to", "purchase", "approximately", "3.8", "million", "shares", "of", "the", "Company", "s", "common", "stock", "and", "$0.7", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "options", "to", "purchase", "approximately", "0.2", "million", "shares", "of", "the", "Company", "s", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06670393794775009, 0.19129164516925812, 0.06692282855510712, 0.09702664613723755, 0.03359176591038704, 0.07820791751146317, 0.02261687070131302, 0.018067432567477226, 0.026053616777062416, 0.02980339154601097, 0.004485270939767361, 0.0056000384502112865, 0.017475178465247154, 0.010329185985028744, 0.04523414373397827, 0.004432691726833582, 0.012765363790094852, 0.01722276769578457, 0.3652379810810089, 0.15404456853866577, 0.03766997903585434, 0.003722005756571889, 0.004007743671536446, 0.024791020900011063, 0.007636404130607843, 0.013011584058403969, 0.019580073654651642, 0.0038870531134307384, 0.015036807395517826, 0.009333462454378605, 0.0034674806520342827, 0.008856810629367828, 0.009697433561086655, 0.002999860094860196, 0.0035642071161419153, 0.054299287497997284, 0.03118051216006279, 0.112654909491539, 0.0039550503715872765, 0.013506648130714893, 0.01540813036262989, 0.5643152594566345, 0.1194954365491867, 0.03872543200850487, 0.0037059145979583263, 0.00453134486451745, 0.025845447555184364, 0.0076084863394498825, 0.014266415499150753, 0.016327472403645515, -1]}
{"idB": "749647_13_item1_p119_s1", "idA": "749647_12_item1_p117_s0", "sentA": "As a result of these equity transactions, the Company collectively raised $58.0 million in gross proceeds by issuing approximately 19.7 million shares of our common stock and warrants to purchase approximately 10.6 million shares of our common stock.", "sentB": "As a result of the termination, we will not receive the additional $5 million payment or any future payment originally contemplated by the exclusive option agreement.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock.", "<tag2>", "As", "a", "result", "of", "the", "termination,", "we", "will", "not", "receive", "the", "additional", "$5", "million", "payment", "or", "any", "future", "payment", "originally", "contemplated", "by", "the", "exclusive", "option", "agreement.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock."], "wordsB": ["As", "a", "result", "of", "the", "termination,", "we", "will", "not", "receive", "the", "additional", "$5", "million", "payment", "or", "any", "future", "payment", "originally", "contemplated", "by", "the", "exclusive", "option", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009798046201467514, 0.01035263855010271, 0.01859295926988125, 0.014434111304581165, 0.03257095813751221, 0.3361677825450897, 0.0944051593542099, 0.11239451915025711, 0.6635259389877319, 0.6038021445274353, 0.1381978839635849, 0.1764206886291504, 0.339836061000824, 0.3610500693321228, 0.27075690031051636, 0.015453864820301533, 0.050426043570041656, 0.14042986929416656, 0.30278027057647705, 0.011948920786380768, 0.021192416548728943, 0.009914619848132133, 0.014554573222994804, 0.1752365380525589, 0.20768441259860992, 0.18222711980342865, -1]}
{"idB": "749647_13_item1_p120_s0", "idA": "749647_12_item1_p117_s0", "sentA": "As a result of these equity transactions, the Company collectively raised $58.0 million in gross proceeds by issuing approximately 19.7 million shares of our common stock and warrants to purchase approximately 10.6 million shares of our common stock.", "sentB": "On February 1, 2013, the Company entered into a Controlled Equity Offering SM Sales Agreement (the ATM Agreement ) with Cantor Fitzgerald Co., as sales agent ( Cantor ), pursuant to which Celsion may offer and sell, from time to time, through Cantor, shares of our common stock having an aggregate offering price of up to $25.0 million (the ATM Shares ).", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock.", "<tag2>", "On", "February", "1,", "2013,", "the", "Company", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent", "(", "Cantor", "),", "pursuant", "to", "which", "Celsion", "may", "offer", "and", "sell,", "from", "time", "to", "time,", "through", "Cantor,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million", "(the", "ATM", "Shares", ").", "<tag3>"], "wordsA": ["As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock."], "wordsB": ["On", "February", "1,", "2013,", "the", "Company", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent", "(", "Cantor", "),", "pursuant", "to", "which", "Celsion", "may", "offer", "and", "sell,", "from", "time", "to", "time,", "through", "Cantor,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million", "(the", "ATM", "Shares", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02549426443874836, 0.04655051231384277, 0.03930152580142021, 0.09804335236549377, 0.006421074271202087, 0.04493989050388336, 0.06865847855806351, 0.07315201312303543, 0.045806966722011566, 0.3254312574863434, 0.40414509177207947, 0.15498200058937073, 0.09466836601495743, 0.21728608012199402, 0.14984755218029022, 0.016329126432538033, 0.0496329739689827, 0.047875478863716125, 0.0004382312181405723, 0.02727450244128704, 0.08647391945123672, 0.07155150920152664, 0.06746405363082886, 0.01367864664644003, 0.04290848597884178, 0.03065541945397854, 0.00723354471847415, 0.026402845978736877, 0.00022843653277959675, 0.010538116097450256, 0.007779174018651247, 0.00891223456710577, 0.01028158888220787, 0.00929930154234171, 0.010380856692790985, 0.016297515481710434, 0.018477248027920723, 0.006036757025867701, 0.007523857988417149, 0.006619442254304886, 0.009698761627078056, 0.01537669450044632, 0.021051639690995216, 0.05956653133034706, 0.00841656606644392, 0.006498408503830433, 0.021451536566019058, 0.01882426254451275, 0.006955428048968315, 0.008234181441366673, 0.043794531375169754, 0.05576079338788986, 0.042653314769268036, 0.01524878665804863, 0.013251329772174358, 0.021545931696891785, 0.3471805453300476, 0.1334621012210846, 0.018535500392317772, 0.05954678729176521, 0.08490943908691406, 0.0002287028473801911, -1]}
{"idB": "749647_13_item1_p123_s1", "idA": "749647_12_item1_p117_s0", "sentA": "As a result of these equity transactions, the Company collectively raised $58.0 million in gross proceeds by issuing approximately 19.7 million shares of our common stock and warrants to purchase approximately 10.6 million shares of our common stock.", "sentB": "The closing of the Preferred Stock Offering occurred on February 26, 2013, in which the Company received approximately $15.0 million in gross proceeds.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock.", "<tag2>", "The", "closing", "of", "the", "Preferred", "Stock", "Offering", "occurred", "on", "February", "26,", "2013,", "in", "which", "the", "Company", "received", "approximately", "$15.0", "million", "in", "gross", "proceeds.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock."], "wordsB": ["The", "closing", "of", "the", "Preferred", "Stock", "Offering", "occurred", "on", "February", "26,", "2013,", "in", "which", "the", "Company", "received", "approximately", "$15.0", "million", "in", "gross", "proceeds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025008784607052803, 0.459177702665329, 0.05824526771903038, 0.045128922909498215, 0.5142183303833008, 0.5438833236694336, 0.28069841861724854, 0.010945981368422508, 0.01672494038939476, 0.0340951643884182, 0.03437349572777748, 0.07426770031452179, 0.006686206441372633, 0.004373845644295216, 0.005119965877383947, 0.056500427424907684, 0.17431427538394928, 0.06997937709093094, 0.47574296593666077, 0.17425088584423065, 0.03395944461226463, 0.041826918721199036, 0.07022983580827713, -1]}
{"idB": "749647_13_item1_p44_s1", "idA": "749647_12_item1_p117_s0", "sentA": "As a result of these equity transactions, the Company collectively raised $58.0 million in gross proceeds by issuing approximately 19.7 million shares of our common stock and warrants to purchase approximately 10.6 million shares of our common stock.", "sentB": "As a result of the termination, we will not receive the additional $5 million payment or any future payment originally contemplated by the exclusive option agreement.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock.", "<tag2>", "As", "a", "result", "of", "the", "termination,", "we", "will", "not", "receive", "the", "additional", "$5", "million", "payment", "or", "any", "future", "payment", "originally", "contemplated", "by", "the", "exclusive", "option", "agreement.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock."], "wordsB": ["As", "a", "result", "of", "the", "termination,", "we", "will", "not", "receive", "the", "additional", "$5", "million", "payment", "or", "any", "future", "payment", "originally", "contemplated", "by", "the", "exclusive", "option", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009798046201467514, 0.01035263855010271, 0.01859295926988125, 0.014434111304581165, 0.03257095813751221, 0.3361677825450897, 0.0944051593542099, 0.11239451915025711, 0.6635259389877319, 0.6038021445274353, 0.1381978839635849, 0.1764206886291504, 0.339836061000824, 0.3610500693321228, 0.27075690031051636, 0.015453864820301533, 0.050426043570041656, 0.14042986929416656, 0.30278027057647705, 0.011948920786380768, 0.021192416548728943, 0.009914619848132133, 0.014554573222994804, 0.1752365380525589, 0.20768441259860992, 0.18222711980342865, -1]}
{"idB": "749647_13_item1_p45_s1", "idA": "749647_12_item1_p117_s0", "sentA": "As a result of these equity transactions, the Company collectively raised $58.0 million in gross proceeds by issuing approximately 19.7 million shares of our common stock and warrants to purchase approximately 10.6 million shares of our common stock.", "sentB": "As a result of our progress to clinical development status, we are currently negotiating a new agreement with Philips.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock.", "<tag2>", "As", "a", "result", "of", "our", "progress", "to", "clinical", "development", "status,", "we", "are", "currently", "negotiating", "a", "new", "agreement", "with", "Philips.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock."], "wordsB": ["As", "a", "result", "of", "our", "progress", "to", "clinical", "development", "status,", "we", "are", "currently", "negotiating", "a", "new", "agreement", "with", "Philips."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006350771989673376, 0.006223336327821016, 0.010766057297587395, 0.007055782712996006, 0.022563030943274498, 0.09747820347547531, 0.09159884601831436, 0.24408096075057983, 0.2076510190963745, 0.08240314573049545, 0.038884036242961884, 0.009210988879203796, 0.02291814051568508, 0.4865846037864685, 0.1682177484035492, 0.3055244982242584, 0.3771172761917114, 0.09490055590867996, 0.4290373623371124, -1]}
{"idB": "749647_13_item1_p125_s0", "idA": "749647_12_item1_p117_s1", "sentA": "This includes approximately $433,000 of gross proceeds received from the exercise of certain warrants issued by the Company to certain holders thereof into approximately 157,000 shares of common stock.", "sentB": "As of March 15, 2013, the Company has issued an aggregate of 8,018,112 shares of common stock upon conversion of 9 ,963 shares of the Series A 0% convertible preferred stock.", "type": 2, "words": ["<tag1>", "This", "includes", "approximately", "$433,000", "of", "gross", "proceeds", "received", "from", "the", "exercise", "of", "certain", "warrants", "issued", "by", "the", "Company", "to", "certain", "holders", "thereof", "into", "approximately", "157,000", "shares", "of", "common", "stock.", "<tag2>", "As", "of", "March", "15,", "2013,", "the", "Company", "has", "issued", "an", "aggregate", "of", "8,018,112", "shares", "of", "common", "stock", "upon", "conversion", "of", "9", ",963", "shares", "of", "the", "Series", "A", "0%", "convertible", "preferred", "stock.", "<tag3>"], "wordsA": ["This", "includes", "approximately", "$433,000", "of", "gross", "proceeds", "received", "from", "the", "exercise", "of", "certain", "warrants", "issued", "by", "the", "Company", "to", "certain", "holders", "thereof", "into", "approximately", "157,000", "shares", "of", "common", "stock."], "wordsB": ["As", "of", "March", "15,", "2013,", "the", "Company", "has", "issued", "an", "aggregate", "of", "8,018,112", "shares", "of", "common", "stock", "upon", "conversion", "of", "9", ",963", "shares", "of", "the", "Series", "A", "0%", "convertible", "preferred", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.032210975885391235, 0.03714260831475258, 0.03859836608171463, 0.029797552153468132, 0.07900814712047577, 0.005213874392211437, 0.045264486223459244, 0.012030747719109058, 0.07497386634349823, 0.02203572727739811, 0.1045365184545517, 0.03990937024354935, 0.5378133058547974, 0.32961025834083557, 0.026978464797139168, 0.061195723712444305, 0.07036002725362778, 0.005672169383615255, 0.05795498937368393, 0.014269990846514702, 0.21079030632972717, 0.35131412744522095, 0.13738833367824554, 0.005722265224903822, 0.006592550780624151, 0.012806194834411144, 0.0077658300288021564, 0.05379454419016838, 0.061811577528715134, 0.060160402208566666, 0.06588031351566315, -1]}
{"idB": "749647_13_item1_p126_s0", "idA": "749647_12_item1_p117_s1", "sentA": "This includes approximately $433,000 of gross proceeds received from the exercise of certain warrants issued by the Company to certain holders thereof into approximately 157,000 shares of common stock.", "sentB": "During the first quarter of 2013 thus far, we received approximately $0.4 million of gross proceeds from the exercise of warrants and options to purchase 120,516 shares of the Company s common stock.", "type": 2, "words": ["<tag1>", "This", "includes", "approximately", "$433,000", "of", "gross", "proceeds", "received", "from", "the", "exercise", "of", "certain", "warrants", "issued", "by", "the", "Company", "to", "certain", "holders", "thereof", "into", "approximately", "157,000", "shares", "of", "common", "stock.", "<tag2>", "During", "the", "first", "quarter", "of", "2013", "thus", "far,", "we", "received", "approximately", "$0.4", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "warrants", "and", "options", "to", "purchase", "120,516", "shares", "of", "the", "Company", "s", "common", "stock.", "<tag3>"], "wordsA": ["This", "includes", "approximately", "$433,000", "of", "gross", "proceeds", "received", "from", "the", "exercise", "of", "certain", "warrants", "issued", "by", "the", "Company", "to", "certain", "holders", "thereof", "into", "approximately", "157,000", "shares", "of", "common", "stock."], "wordsB": ["During", "the", "first", "quarter", "of", "2013", "thus", "far,", "we", "received", "approximately", "$0.4", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "warrants", "and", "options", "to", "purchase", "120,516", "shares", "of", "the", "Company", "s", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011535465717315674, 0.00617503747344017, 0.03310644254088402, 0.020706405863165855, 0.016025854274630547, 0.03748394176363945, 0.013227209448814392, 0.01045900397002697, 0.019960464909672737, 0.03566800057888031, 0.039365023374557495, 0.680142879486084, 0.4464515745639801, 0.017457127571105957, 0.02336396835744381, 0.03277433663606644, 0.002715739654377103, 0.002923665102571249, 0.008518340066075325, 0.0036841423716396093, 0.02060571499168873, 0.012365520931780338, 0.04310929402709007, 0.005624632816761732, 0.09234268963336945, 0.5909785032272339, 0.23250481486320496, 0.009465000592172146, 0.008819966576993465, 0.03278142213821411, 0.011824948713183403, 0.02439980022609234, 0.026936572045087814, -1]}
{"idB": "749647_13_item1_p127_s0", "idA": "749647_12_item1_p118_s0", "sentA": "We believe that our cash and investment resources of $30.5 million on hand at December 31, 2011 are sufficient to fund operations into the second half of 2013.", "sentB": "We believe that our cash and investment resources of $23.1 million on hand at December 31, 2012, as well as the $26 million of net proceeds the Company collectively received thus far in the first quarter of 2013 from warrant exercises, the non-refundable payment from Hisun under the technology development agreement, the ATM Agreement and the Preferred Stock Offering, is sufficient to fund operations through 2015.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013.", "<tag2>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$23.1", "million", "on", "hand", "at", "December", "31,", "2012,", "as", "well", "as", "the", "$26", "million", "of", "net", "proceeds", "the", "Company", "collectively", "received", "thus", "far", "in", "the", "first", "quarter", "of", "2013", "from", "warrant", "exercises,", "the", "non-refundable", "payment", "from", "Hisun", "under", "the", "technology", "development", "agreement,", "the", "ATM", "Agreement", "and", "the", "Preferred", "Stock", "Offering,", "is", "sufficient", "to", "fund", "operations", "through", "2015.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013."], "wordsB": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$23.1", "million", "on", "hand", "at", "December", "31,", "2012,", "as", "well", "as", "the", "$26", "million", "of", "net", "proceeds", "the", "Company", "collectively", "received", "thus", "far", "in", "the", "first", "quarter", "of", "2013", "from", "warrant", "exercises,", "the", "non-refundable", "payment", "from", "Hisun", "under", "the", "technology", "development", "agreement,", "the", "ATM", "Agreement", "and", "the", "Preferred", "Stock", "Offering,", "is", "sufficient", "to", "fund", "operations", "through", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003777388483285904, 0.007324716076254845, 0.002589525654911995, 0.002276922110468149, 0.010417109355330467, 0.0016500296769663692, 0.006158292293548584, 0.010231208987534046, 0.003828770015388727, 0.9128764867782593, 0.22007983922958374, 0.003175365272909403, 0.009448197670280933, 0.0034023586194962263, 0.027864757925271988, 0.022009199485182762, 0.7671322226524353, 0.004155571106821299, 0.0026780320331454277, 0.0026033164467662573, 0.0031830815132707357, 0.2609177231788635, 0.14261668920516968, 0.003390358528122306, 0.013838520273566246, 0.01699727214872837, 0.0025316616520285606, 0.01207662932574749, 0.004913880489766598, 0.004051787778735161, 0.002571930643171072, 0.0036918180994689465, 0.0024469236377626657, 0.0026486117858439684, 0.00908107589930296, 0.010630110278725624, 0.00415439298376441, 0.03111269511282444, 0.0038839117623865604, 0.03126015141606331, 0.030666904523968697, 0.0044605848379433155, 0.11343428492546082, 0.0345311239361763, 0.0070586432702839375, 0.0222553089261055, 0.01428152434527874, 0.006245418451726437, 0.016662336885929108, 0.016571350395679474, 0.02130947634577751, 0.004847122821956873, 0.023891998454928398, 0.03800300881266594, 0.0084014181047678, 0.005565914325416088, 0.03886837139725685, 0.028720084577798843, 0.03857141360640526, 0.003107571043074131, 0.011564012616872787, 0.0025632421020418406, 0.017284682020545006, 0.02005912736058235, 0.10136640071868896, 0.46198537945747375, -1]}
{"idB": "749647_13_item1_p46_s3", "idA": "749647_12_item1_p118_s0", "sentA": "We believe that our cash and investment resources of $30.5 million on hand at December 31, 2011 are sufficient to fund operations into the second half of 2013.", "sentB": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013.", "<tag2>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013."], "wordsB": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7070504426956177, 0.2929321527481079, 0.2222607433795929, 0.4662008583545685, 0.5629512071609497, 0.03298891335725784, 0.018082214519381523, 0.12930795550346375, 0.1399228721857071, 0.006934972479939461, 0.04527733847498894, 0.009829976595938206, 0.00922382716089487, 0.021435130387544632, 0.025130795314908028, 0.01839347369968891, 0.041941672563552856, -1]}
{"idB": "749647_13_item1_p122_s0", "idA": "749647_12_item1_p124_s0", "sentA": "Dr. Borys joined Celsion on October 1, 2007 as Vice President and Chief Medical Officer of the Company.", "sentB": "The ATM Agreement will terminate upon the earlier of (i) the sale of Shares under the ATM Agreement having an aggregate offering price of $25.0 million and (ii) the termination of the ATM Agreement by Cantor or the Company.", "type": 2, "words": ["<tag1>", "Dr.", "Borys", "joined", "Celsion", "on", "October", "1,", "2007", "as", "Vice", "President", "and", "Chief", "Medical", "Officer", "of", "the", "Company.", "<tag2>", "The", "ATM", "Agreement", "will", "terminate", "upon", "the", "earlier", "of", "(i)", "the", "sale", "of", "Shares", "under", "the", "ATM", "Agreement", "having", "an", "aggregate", "offering", "price", "of", "$25.0", "million", "and", "(ii)", "the", "termination", "of", "the", "ATM", "Agreement", "by", "Cantor", "or", "the", "Company.", "<tag3>"], "wordsA": ["Dr.", "Borys", "joined", "Celsion", "on", "October", "1,", "2007", "as", "Vice", "President", "and", "Chief", "Medical", "Officer", "of", "the", "Company."], "wordsB": ["The", "ATM", "Agreement", "will", "terminate", "upon", "the", "earlier", "of", "(i)", "the", "sale", "of", "Shares", "under", "the", "ATM", "Agreement", "having", "an", "aggregate", "offering", "price", "of", "$25.0", "million", "and", "(ii)", "the", "termination", "of", "the", "ATM", "Agreement", "by", "Cantor", "or", "the", "Company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01496637612581253, 0.41512104868888855, 0.23251886665821075, 0.053581953048706055, 0.1617070436477661, 0.019052578136324883, 0.016181882470846176, 0.023548344150185585, 0.008752881549298763, 0.03447204828262329, 0.030053237453103065, 0.20772822201251984, 0.19783467054367065, 0.3411833345890045, 0.024894215166568756, 0.014504342339932919, 0.07735375314950943, 0.05478101596236229, 0.00027457455871626735, 0.009495645761489868, 0.017901727929711342, 0.020485486835241318, 0.01837323233485222, 0.009229650720953941, 0.034743569791316986, 0.03517059609293938, 0.00042740991921164095, 0.032967060804367065, 0.014017696492373943, 0.22879543900489807, 0.03375415503978729, 0.029901087284088135, 0.3186931610107422, 0.18540361523628235, 0.054365675896406174, 0.30200865864753723, 0.14400959014892578, 0.04182210564613342, 0.14009156823158264, -1]}
{"idB": "749647_13_item1_p113_s0", "idA": "749647_12_item1_p128_s1", "sentA": "Mr. Weaver had been a director of the Company since June 2005.", "sentB": "The obligations under the Credit Agreement are secured by substantially all assets of the Company other than its intellectual property and certain other agreed-upon exclusions.", "type": 2, "words": ["<tag1>", "Mr.", "Weaver", "had", "been", "a", "director", "of", "the", "Company", "since", "June", "2005.", "<tag2>", "The", "obligations", "under", "the", "Credit", "Agreement", "are", "secured", "by", "substantially", "all", "assets", "of", "the", "Company", "other", "than", "its", "intellectual", "property", "and", "certain", "other", "agreed-upon", "exclusions.", "<tag3>"], "wordsA": ["Mr.", "Weaver", "had", "been", "a", "director", "of", "the", "Company", "since", "June", "2005."], "wordsB": ["The", "obligations", "under", "the", "Credit", "Agreement", "are", "secured", "by", "substantially", "all", "assets", "of", "the", "Company", "other", "than", "its", "intellectual", "property", "and", "certain", "other", "agreed-upon", "exclusions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02037901245057583, 0.23847375810146332, 0.04276302084326744, 0.02574431151151657, 0.16918866336345673, 0.1346898376941681, 0.02756735496222973, 0.14329391717910767, 0.026135841384530067, 0.42447027564048767, 0.3624122142791748, 0.4190202057361603, 0.0409623421728611, 0.04347819834947586, 0.14559535682201385, 0.0005928153404965997, 0.020207522436976433, 0.016028214246034622, 0.11681520938873291, 0.100030317902565, 0.0001363508781651035, 0.018015025183558464, 0.014522799290716648, 0.04821748286485672, 0.1761193722486496, -1]}
{"idB": "749647_13_item1_p35_s0", "idA": "749647_12_item1_p12_s0", "sentA": "The U.S. Food and Drug Administration (FDA) has granted our pivotal Phase III HEAT study for ThermoDox , in combination with radiofrequency ablation a Special Protocol Assessment and has designated it as a Fast Track Development Program.", "sentB": "The HEAT study for ThermoDox , in combination with radiofrequency ablation (RFA), is being conducted under a Special Protocol Assessment agreed to with the U.S. Food and Drug Administration (FDA).", "type": 2, "words": ["<tag1>", "The", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "has", "granted", "our", "pivotal", "Phase", "III", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "a", "Special", "Protocol", "Assessment", "and", "has", "designated", "it", "as", "a", "Fast", "Track", "Development", "Program.", "<tag2>", "The", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "(RFA),", "is", "being", "conducted", "under", "a", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA).", "<tag3>"], "wordsA": ["The", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "has", "granted", "our", "pivotal", "Phase", "III", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "a", "Special", "Protocol", "Assessment", "and", "has", "designated", "it", "as", "a", "Fast", "Track", "Development", "Program."], "wordsB": ["The", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "(RFA),", "is", "being", "conducted", "under", "a", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006097319535911083, 0.10508298128843307, 0.10445049405097961, 0.007624590303748846, 0.01716620661318302, 0.0005935545777902007, 0.005543199367821217, 0.006325719878077507, 0.005386317148804665, 0.009844337590038776, 0.00819186121225357, 0.8086787462234497, 0.008353416807949543, 0.042561132460832596, 0.0548676922917366, 0.17425833642482758, 0.06799966096878052, 0.16481000185012817, 0.24409045279026031, 0.2144733965396881, 0.07968895137310028, 0.0643664076924324, 0.024174708873033524, 0.03303546458482742, 0.02466421388089657, 0.012132559902966022, 0.007434436120092869, 0.008691724389791489, 0.012149041518568993, 0.033188655972480774, -1]}
{"idB": "749647_13_item1_p42_s1", "idA": "749647_12_item1_p12_s0", "sentA": "The U.S. Food and Drug Administration (FDA) has granted our pivotal Phase III HEAT study for ThermoDox , in combination with radiofrequency ablation a Special Protocol Assessment and has designated it as a Fast Track Development Program.", "sentB": "In addition, Hisun will collaborate with us in relation to the regulatory approval activities for ThermoDox with the China State Food and Drug Administration (SFDA).", "type": 2, "words": ["<tag1>", "The", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "has", "granted", "our", "pivotal", "Phase", "III", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "a", "Special", "Protocol", "Assessment", "and", "has", "designated", "it", "as", "a", "Fast", "Track", "Development", "Program.", "<tag2>", "In", "addition,", "Hisun", "will", "collaborate", "with", "us", "in", "relation", "to", "the", "regulatory", "approval", "activities", "for", "ThermoDox", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(SFDA).", "<tag3>"], "wordsA": ["The", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "has", "granted", "our", "pivotal", "Phase", "III", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "a", "Special", "Protocol", "Assessment", "and", "has", "designated", "it", "as", "a", "Fast", "Track", "Development", "Program."], "wordsB": ["In", "addition,", "Hisun", "will", "collaborate", "with", "us", "in", "relation", "to", "the", "regulatory", "approval", "activities", "for", "ThermoDox", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(SFDA)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025215022265911102, 0.029431231319904327, 0.308937668800354, 0.06710200756788254, 0.22529657185077667, 0.04809274151921272, 0.06257234513759613, 0.027859050780534744, 0.06391386687755585, 0.030892424285411835, 0.033765245229005814, 0.26368483901023865, 0.511930525302887, 0.15562060475349426, 0.03889172896742821, 0.05816434323787689, 0.026558777317404747, 0.028675498440861702, 0.2991534471511841, 0.18354785442352295, 0.1395246982574463, 0.0645332857966423, 0.05049413815140724, 0.11962344497442245, 0.5666202902793884, -1]}
{"idB": "749647_13_item1_p47_s1", "idA": "749647_12_item1_p132_s1", "sentA": "Mr. Church holds a B.S. degree in accounting from the University of Maryland and is a certified public accountant.", "sentB": "The studies are being conducted at the University of Washington (UW) School of Medicine.", "type": 2, "words": ["<tag1>", "Mr.", "Church", "holds", "a", "B.S.", "degree", "in", "accounting", "from", "the", "University", "of", "Maryland", "and", "is", "a", "certified", "public", "accountant.", "<tag2>", "The", "studies", "are", "being", "conducted", "at", "the", "University", "of", "Washington", "(UW)", "School", "of", "Medicine.", "<tag3>"], "wordsA": ["Mr.", "Church", "holds", "a", "B.S.", "degree", "in", "accounting", "from", "the", "University", "of", "Maryland", "and", "is", "a", "certified", "public", "accountant."], "wordsB": ["The", "studies", "are", "being", "conducted", "at", "the", "University", "of", "Washington", "(UW)", "School", "of", "Medicine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008991112932562828, 0.27426183223724365, 0.006726020947098732, 0.035589441657066345, 0.08353358507156372, 0.08365835249423981, 0.06525896489620209, 0.4355595111846924, 0.36765387654304504, 0.6434807181358337, 0.3543219268321991, 0.5106193423271179, 0.36465564370155334, 0.8063636422157288, -1]}
{"idB": "749647_13_item1_p19_s0", "idA": "749647_12_item1_p13_s0", "sentA": "Drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "As demonstrated by the HEAT study results, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "type": 2, "words": ["<tag1>", "Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "As", "demonstrated", "by", "the", "HEAT", "study", "results,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag3>"], "wordsA": ["Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["As", "demonstrated", "by", "the", "HEAT", "study", "results,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04694643244147301, 0.11924508959054947, 0.014835599809885025, 0.011597821488976479, 0.8339706659317017, 0.8306620717048645, 0.22125938534736633, 0.005831968504935503, 0.00537700904533267, 0.0023808188270777464, 0.004772114101797342, 0.004120300058275461, 0.0033162059262394905, 0.010369820520281792, 0.035381805151700974, 0.019345136359333992, 0.0007321729208342731, 0.002401713514700532, 0.0028512366116046906, 0.0025362232699990273, 0.01087247859686613, 0.010006916709244251, 0.004694353323429823, 0.08771192282438278, 0.002638262929394841, 0.006285462528467178, 0.00736299529671669, 0.0037128329277038574, 0.0031223467085510492, 0.0076494235545396805, -1]}
{"idB": "749647_13_item1_p20_s0", "idA": "749647_12_item1_p13_s0", "sentA": "Drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "The timing and the outcome of clinical results is extremely difficult to predict.", "type": 2, "words": ["<tag1>", "Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011042471043765545, 0.39961400628089905, 0.021338919177651405, 0.01927020214498043, 0.10248780995607376, 0.01786474511027336, 0.060640495270490646, 0.07204285264015198, 0.032584480941295624, 0.10719931870698929, 0.28224247694015503, 0.437305748462677, 0.6955630779266357, -1]}
{"idB": "749647_13_item1_p37_s5", "idA": "749647_12_item1_p13_s0", "sentA": "Drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "However, as demonstrated by the HEAT study results announced on January 31, 2013, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "type": 2, "words": ["<tag1>", "Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "However,", "as", "demonstrated", "by", "the", "HEAT", "study", "results", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag3>"], "wordsA": ["Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["However,", "as", "demonstrated", "by", "the", "HEAT", "study", "results", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.042502958327531815, 0.035204071551561356, 0.07486613094806671, 0.008190442807972431, 0.008086757734417915, 0.5253599882125854, 0.7341543436050415, 0.06809826195240021, 0.006000261753797531, 0.008731220848858356, 0.07402545213699341, 0.11448762565851212, 0.17896747589111328, 0.005980075336992741, 0.006296074483543634, 0.0031633239705115557, 0.00532918144017458, 0.004602237604558468, 0.00393318198621273, 0.009944899007678032, 0.034446410834789276, 0.01325233280658722, 0.000591568008530885, 0.0030228327959775925, 0.0036368335131555796, 0.0039617824368178844, 0.07423540204763412, 0.051009997725486755, 0.028464937582612038, 0.14603972434997559, 0.003072809660807252, 0.008003286086022854, 0.009673980064690113, 0.0033895832020789385, 0.0035680586006492376, 0.008314484730362892, -1]}
{"idB": "749647_13_item1_p38_s0", "idA": "749647_12_item1_p13_s0", "sentA": "Drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "The timing and the outcome of clinical results is extremely difficult to predict.", "type": 2, "words": ["<tag1>", "Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011042471043765545, 0.39961400628089905, 0.021338919177651405, 0.01927020214498043, 0.10248780995607376, 0.01786474511027336, 0.060640495270490646, 0.07204285264015198, 0.032584480941295624, 0.10719931870698929, 0.28224247694015503, 0.437305748462677, 0.6955630779266357, -1]}
{"idB": "749647_13_item1_p69_s0", "idA": "749647_12_item1_p13_s0", "sentA": "Drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "As demonstrated by the Heat study results, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "type": 2, "words": ["<tag1>", "Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "As", "demonstrated", "by", "the", "Heat", "study", "results,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag3>"], "wordsA": ["Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["As", "demonstrated", "by", "the", "Heat", "study", "results,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04694643244147301, 0.11924508959054947, 0.014835599809885025, 0.011597821488976479, 0.8339706659317017, 0.8306620717048645, 0.22125938534736633, 0.005831968504935503, 0.00537700904533267, 0.0023808188270777464, 0.004772114101797342, 0.004120300058275461, 0.0033162059262394905, 0.010369820520281792, 0.035381805151700974, 0.019345136359333992, 0.0007321729208342731, 0.002401713514700532, 0.0028512366116046906, 0.0025362232699990273, 0.01087247859686613, 0.010006916709244251, 0.004694353323429823, 0.08771192282438278, 0.002638262929394841, 0.006285462528467178, 0.00736299529671669, 0.0037128329277038574, 0.0031223467085510492, 0.0076494235545396805, -1]}
{"idB": "749647_13_item1_p70_s0", "idA": "749647_12_item1_p13_s0", "sentA": "Drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "The timing and the outcome of clinical results is extremely difficult to predict.", "type": 2, "words": ["<tag1>", "Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["Drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011042471043765545, 0.39961400628089905, 0.021338919177651405, 0.01927020214498043, 0.10248780995607376, 0.01786474511027336, 0.060640495270490646, 0.07204285264015198, 0.032584480941295624, 0.10719931870698929, 0.28224247694015503, 0.437305748462677, 0.6955630779266357, -1]}
{"idB": "749647_13_item1_p104_s4", "idA": "749647_12_item1_p15_s1", "sentA": "ThermoDox also holds orphan drug designation in the U.S.", "sentB": "The patents in these three countries are the first in this family, which includes pending applications in the U.S., Europe and additional key commercial geographies in Asia.", "type": 2, "words": ["<tag1>", "ThermoDox", "also", "holds", "orphan", "drug", "designation", "in", "the", "U.S.", "<tag2>", "The", "patents", "in", "these", "three", "countries", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia.", "<tag3>"], "wordsA": ["ThermoDox", "also", "holds", "orphan", "drug", "designation", "in", "the", "U.S."], "wordsB": ["The", "patents", "in", "these", "three", "countries", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014657358638942242, 0.537994921207428, 0.02030239999294281, 0.011372437700629234, 0.0859597846865654, 0.062295883893966675, 0.014696002006530762, 0.01432762574404478, 0.09365556389093399, 0.022541791200637817, 0.013685416430234909, 0.06366539001464844, 0.00010892370482906699, 0.009788098745048046, 0.17638182640075684, 0.18776854872703552, 0.013125976547598839, 0.010769027285277843, 0.03413969650864601, 0.029298342764377594, 0.008432196453213692, 0.010433431714773178, 0.040541235357522964, 0.15436778962612152, 0.19672180712223053, 0.015540292486548424, 0.051207635551691055, -1]}
{"idB": "749647_13_item1_p47_s3", "idA": "749647_12_item1_p16_s0", "sentA": "We have also demonstrated the feasibility for a product pipeline of cancer drugs that employ our heat activated liposomal technology in combination with known chemotherapeutics including docetaxel and carboplatin.", "sentB": "We believe that these collaborations are just the beginning for combining important device technologies such as HIFU with our low heat activated liposomal technology.", "type": 2, "words": ["<tag1>", "We", "have", "also", "demonstrated", "the", "feasibility", "for", "a", "product", "pipeline", "of", "cancer", "drugs", "that", "employ", "our", "heat", "activated", "liposomal", "technology", "in", "combination", "with", "known", "chemotherapeutics", "including", "docetaxel", "and", "carboplatin.", "<tag2>", "We", "believe", "that", "these", "collaborations", "are", "just", "the", "beginning", "for", "combining", "important", "device", "technologies", "such", "as", "HIFU", "with", "our", "low", "heat", "activated", "liposomal", "technology.", "<tag3>"], "wordsA": ["We", "have", "also", "demonstrated", "the", "feasibility", "for", "a", "product", "pipeline", "of", "cancer", "drugs", "that", "employ", "our", "heat", "activated", "liposomal", "technology", "in", "combination", "with", "known", "chemotherapeutics", "including", "docetaxel", "and", "carboplatin."], "wordsB": ["We", "believe", "that", "these", "collaborations", "are", "just", "the", "beginning", "for", "combining", "important", "device", "technologies", "such", "as", "HIFU", "with", "our", "low", "heat", "activated", "liposomal", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.041425902396440506, 0.09998680651187897, 0.016324609518051147, 0.010110978968441486, 0.09127841889858246, 0.025951122865080833, 0.04979458078742027, 0.03074752725660801, 0.08753123134374619, 0.005595239344984293, 0.04018395021557808, 0.05114201083779335, 0.3391570448875427, 0.2495144158601761, 0.00714736245572567, 0.013563411310315132, 0.6138765215873718, 0.004961877595633268, 0.0051119825802743435, 0.07474944740533829, 0.05958209186792374, 0.02302488684654236, 0.019408799707889557, 0.028934651985764503, -1]}
{"idB": "749647_13_item1_p67_s0", "idA": "749647_12_item1_p17_s0", "sentA": "An element of our business strategy is to pursue, as resources permit, the research and development of a range of product candidates for a variety of indications.", "sentB": "An element of our business strategy has been to pursue, as resources permit, the research and development of a range of product candidates for a variety of indications.", "type": 2, "words": ["<tag1>", "An", "element", "of", "our", "business", "strategy", "is", "to", "pursue,", "as", "resources", "permit,", "the", "research", "and", "development", "of", "a", "range", "of", "product", "candidates", "for", "a", "variety", "of", "indications.", "<tag2>", "An", "element", "of", "our", "business", "strategy", "has", "been", "to", "pursue,", "as", "resources", "permit,", "the", "research", "and", "development", "of", "a", "range", "of", "product", "candidates", "for", "a", "variety", "of", "indications.", "<tag3>"], "wordsA": ["An", "element", "of", "our", "business", "strategy", "is", "to", "pursue,", "as", "resources", "permit,", "the", "research", "and", "development", "of", "a", "range", "of", "product", "candidates", "for", "a", "variety", "of", "indications."], "wordsB": ["An", "element", "of", "our", "business", "strategy", "has", "been", "to", "pursue,", "as", "resources", "permit,", "the", "research", "and", "development", "of", "a", "range", "of", "product", "candidates", "for", "a", "variety", "of", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.039979223161935806, 0.2140270471572876, 0.0526670403778553, 0.08168032020330429, 0.18631182610988617, 0.2649614214897156, 0.27218103408813477, 0.49773457646369934, 0.3074190616607666, 0.47982391715049744, 0.26197370886802673, 0.23225528001785278, 0.2703908383846283, 0.0458812490105629, 0.08090890944004059, 0.0636059045791626, 0.08389896899461746, 0.05116533488035202, 0.03960806876420975, 0.10703176259994507, 0.052962251007556915, 0.11392266303300858, 0.14134202897548676, 0.038053955882787704, 0.029977921396493912, 0.0534520149230957, 0.04129460081458092, 0.09219899773597717, -1]}
{"idB": "749647_13_item1_p37_s2", "idA": "749647_12_item1_p17_s1", "sentA": "This is intended to allow us to diversify the risks associated with our research and development expenditures.", "sentB": "In addition, we will assess our product pipeline and research and development priorities.", "type": 2, "words": ["<tag1>", "This", "is", "intended", "to", "allow", "us", "to", "diversify", "the", "risks", "associated", "with", "our", "research", "and", "development", "expenditures.", "<tag2>", "In", "addition,", "we", "will", "assess", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag3>"], "wordsA": ["This", "is", "intended", "to", "allow", "us", "to", "diversify", "the", "risks", "associated", "with", "our", "research", "and", "development", "expenditures."], "wordsB": ["In", "addition,", "we", "will", "assess", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.020218465477228165, 0.017697371542453766, 0.05056466907262802, 0.02961234375834465, 0.8586239218711853, 0.12105041742324829, 0.35757800936698914, 0.32184675335884094, 0.014307934790849686, 0.06260602176189423, 0.018170703202486038, 0.036682795733213425, 0.2222716212272644, -1]}
{"idB": "749647_13_item1_p17_s2", "idA": "749647_12_item1_p17_s2", "sentA": "To the extent we are unable to maintain a broad range of product candidates, our dependence on the success of one or a few product candidates would increase.", "sentB": "To the extent we are unable to maintain a broad range of product candidates, our dependence on the success of one or a few product candidates would increase and results such as those announced in relation to the HEAT study on January 31, 2013 will have a more significant impact on our financial prospects, financial condition and market value.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "we", "are", "unable", "to", "maintain", "a", "broad", "range", "of", "product", "candidates,", "our", "dependence", "on", "the", "success", "of", "one", "or", "a", "few", "product", "candidates", "would", "increase.", "<tag2>", "To", "the", "extent", "we", "are", "unable", "to", "maintain", "a", "broad", "range", "of", "product", "candidates,", "our", "dependence", "on", "the", "success", "of", "one", "or", "a", "few", "product", "candidates", "would", "increase", "and", "results", "such", "as", "those", "announced", "in", "relation", "to", "the", "HEAT", "study", "on", "January", "31,", "2013", "will", "have", "a", "more", "significant", "impact", "on", "our", "financial", "prospects,", "financial", "condition", "and", "market", "value.", "<tag3>"], "wordsA": ["To", "the", "extent", "we", "are", "unable", "to", "maintain", "a", "broad", "range", "of", "product", "candidates,", "our", "dependence", "on", "the", "success", "of", "one", "or", "a", "few", "product", "candidates", "would", "increase."], "wordsB": ["To", "the", "extent", "we", "are", "unable", "to", "maintain", "a", "broad", "range", "of", "product", "candidates,", "our", "dependence", "on", "the", "success", "of", "one", "or", "a", "few", "product", "candidates", "would", "increase", "and", "results", "such", "as", "those", "announced", "in", "relation", "to", "the", "HEAT", "study", "on", "January", "31,", "2013", "will", "have", "a", "more", "significant", "impact", "on", "our", "financial", "prospects,", "financial", "condition", "and", "market", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005797175690531731, 0.006940281484276056, 0.020047888159751892, 0.015499914065003395, 0.025357555598020554, 0.5505737662315369, 0.11029398441314697, 0.17976361513137817, 0.031095465645194054, 0.04853769391775131, 0.045086368918418884, 0.011145957745611668, 0.022313173860311508, 0.0353817492723465, 0.007580914068967104, 0.03912580758333206, 0.009897634387016296, 0.00998244434595108, 0.020252753049135208, 0.007511519826948643, 0.01199226826429367, 0.011704785749316216, 0.008281034417450428, 0.009979866445064545, 0.010654741898179054, 0.016989417374134064, 0.008028131909668446, 0.02778390608727932, 0.005726102273911238, 0.037485361099243164, 0.006838814355432987, 0.006929940078407526, 0.010241040028631687, 0.020744843408465385, 0.02231418341398239, 0.03959185257554054, 0.05190970376133919, 0.03972087800502777, 0.16259931027889252, 0.20016534626483917, 0.023377176374197006, 0.05538561940193176, 0.060123588889837265, 0.14594754576683044, 0.011486927047371864, 0.021974043920636177, 0.013075570575892925, 0.07739432901144028, 0.05900908261537552, 0.056421276181936264, 0.01931733451783657, 0.022488806396722794, 0.09254924207925797, 0.10474548488855362, 0.11891470104455948, 0.11335055530071259, 0.04390311613678932, 0.1363552212715149, 0.1827775537967682, -1]}
{"idB": "749647_13_item1_p67_s3", "idA": "749647_12_item1_p17_s2", "sentA": "To the extent we are unable to maintain a broad range of product candidates, our dependence on the success of one or a few product candidates would increase.", "sentB": "To the extent we are unable to maintain a broad range of product candidates, our dependence on the success of one or a few product candidates would increase and results such as those announced in relation to the HEAT study on January 31, 2013 will have a more significant impact on our financial prospects, financial condition and market value.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "we", "are", "unable", "to", "maintain", "a", "broad", "range", "of", "product", "candidates,", "our", "dependence", "on", "the", "success", "of", "one", "or", "a", "few", "product", "candidates", "would", "increase.", "<tag2>", "To", "the", "extent", "we", "are", "unable", "to", "maintain", "a", "broad", "range", "of", "product", "candidates,", "our", "dependence", "on", "the", "success", "of", "one", "or", "a", "few", "product", "candidates", "would", "increase", "and", "results", "such", "as", "those", "announced", "in", "relation", "to", "the", "HEAT", "study", "on", "January", "31,", "2013", "will", "have", "a", "more", "significant", "impact", "on", "our", "financial", "prospects,", "financial", "condition", "and", "market", "value.", "<tag3>"], "wordsA": ["To", "the", "extent", "we", "are", "unable", "to", "maintain", "a", "broad", "range", "of", "product", "candidates,", "our", "dependence", "on", "the", "success", "of", "one", "or", "a", "few", "product", "candidates", "would", "increase."], "wordsB": ["To", "the", "extent", "we", "are", "unable", "to", "maintain", "a", "broad", "range", "of", "product", "candidates,", "our", "dependence", "on", "the", "success", "of", "one", "or", "a", "few", "product", "candidates", "would", "increase", "and", "results", "such", "as", "those", "announced", "in", "relation", "to", "the", "HEAT", "study", "on", "January", "31,", "2013", "will", "have", "a", "more", "significant", "impact", "on", "our", "financial", "prospects,", "financial", "condition", "and", "market", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005797175690531731, 0.006940281484276056, 0.020047888159751892, 0.015499914065003395, 0.025357555598020554, 0.5505737662315369, 0.11029398441314697, 0.17976361513137817, 0.031095465645194054, 0.04853769391775131, 0.045086368918418884, 0.011145957745611668, 0.022313173860311508, 0.0353817492723465, 0.007580914068967104, 0.03912580758333206, 0.009897634387016296, 0.00998244434595108, 0.020252753049135208, 0.007511519826948643, 0.01199226826429367, 0.011704785749316216, 0.008281034417450428, 0.009979866445064545, 0.010654741898179054, 0.016989417374134064, 0.008028131909668446, 0.02778390608727932, 0.005726102273911238, 0.037485361099243164, 0.006838814355432987, 0.006929940078407526, 0.010241040028631687, 0.020744843408465385, 0.02231418341398239, 0.03959185257554054, 0.05190970376133919, 0.03972087800502777, 0.16259931027889252, 0.20016534626483917, 0.023377176374197006, 0.05538561940193176, 0.060123588889837265, 0.14594754576683044, 0.011486927047371864, 0.021974043920636177, 0.013075570575892925, 0.07739432901144028, 0.05900908261537552, 0.056421276181936264, 0.01931733451783657, 0.022488806396722794, 0.09254924207925797, 0.10474548488855362, 0.11891470104455948, 0.11335055530071259, 0.04390311613678932, 0.1363552212715149, 0.1827775537967682, -1]}
{"idB": "749647_13_item1_p45_s0", "idA": "749647_12_item1_p17_s3", "sentA": "Additionally, we had formed a joint research agreement with Philips Healthcare, a division of Royal Philips Electronics to evaluate the combination of Philips high intensity focused ultrasound (HIFU) with ThermoDox to determine the potential of this combination to treat a broad range of cancers.", "sentB": "In 2009, we formed a joint research agreement with Philips Healthcare, a division of Royal Philips Electronics, to evaluate the combination of Philips high intensity focused ultrasound (HIFU) with ThermoDox to determine the potential of this combination to treat a broad range of cancers.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "had", "formed", "a", "joint", "research", "agreement", "with", "Philips", "Healthcare,", "a", "division", "of", "Royal", "Philips", "Electronics", "to", "evaluate", "the", "combination", "of", "Philips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers.", "<tag2>", "In", "2009,", "we", "formed", "a", "joint", "research", "agreement", "with", "Philips", "Healthcare,", "a", "division", "of", "Royal", "Philips", "Electronics,", "to", "evaluate", "the", "combination", "of", "Philips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers.", "<tag3>"], "wordsA": ["Additionally,", "we", "had", "formed", "a", "joint", "research", "agreement", "with", "Philips", "Healthcare,", "a", "division", "of", "Royal", "Philips", "Electronics", "to", "evaluate", "the", "combination", "of", "Philips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers."], "wordsB": ["In", "2009,", "we", "formed", "a", "joint", "research", "agreement", "with", "Philips", "Healthcare,", "a", "division", "of", "Royal", "Philips", "Electronics,", "to", "evaluate", "the", "combination", "of", "Philips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07023998349905014, 0.8182432651519775, 0.013087501749396324, 0.011587734334170818, 0.006696700118482113, 0.015843071043491364, 0.017530567944049835, 0.02124110795557499, 0.00860441941767931, 0.06921927630901337, 0.08817356079816818, 0.0054749995470047, 0.021461693570017815, 0.008095440454781055, 0.0191350094974041, 0.057798389345407486, 0.041661351919174194, 0.007308452855795622, 0.0082982974126935, 0.006837094202637672, 0.013954581692814827, 0.00801856815814972, 0.03429761156439781, 0.14144501090049744, 0.206247478723526, 0.031535759568214417, 0.03118246980011463, 0.03214303031563759, 0.007659500930458307, 0.02304004319012165, 0.006857958622276783, 0.006551587022840977, 0.006966044660657644, 0.009673052467405796, 0.007169241551309824, 0.00651171850040555, 0.018351497128605843, 0.006150342524051666, 0.0062476093880832195, 0.0057572792284190655, 0.010364057496190071, 0.010065284557640553, 0.007002946920692921, 0.016625849530100822, -1]}
{"idB": "749647_13_item1_p17_s1", "idA": "749647_12_item1_p17_s5", "sentA": "We will also evaluate licensing cancer products from third parties for cancer treatments to expand our product pipeline.", "sentB": "We may evaluate licensing cancer products from third parties for cancer treatments to expand our product pipeline.", "type": 2, "words": ["<tag1>", "We", "will", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "product", "pipeline.", "<tag2>", "We", "may", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "product", "pipeline.", "<tag3>"], "wordsA": ["We", "will", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "product", "pipeline."], "wordsB": ["We", "may", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "product", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.14594541490077972, 0.3106776475906372, 0.40354859828948975, 0.2896265983581543, 0.3247552812099457, 0.29513823986053467, 0.04099143669009209, 0.1757674515247345, 0.22456620633602142, 0.017223475500941277, 0.05221311002969742, 0.06338247656822205, 0.010412494651973248, 0.021759606897830963, 0.01707383804023266, 0.04472402110695839, 0.05293155461549759, -1]}
{"idB": "749647_13_item1_p67_s1", "idA": "749647_12_item1_p17_s5", "sentA": "We will also evaluate licensing cancer products from third parties for cancer treatments to expand our product pipeline.", "sentB": "We may also evaluate licensing cancer products from third parties for cancer treatments to expand our current product pipeline.", "type": 2, "words": ["<tag1>", "We", "will", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "product", "pipeline.", "<tag2>", "We", "may", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "current", "product", "pipeline.", "<tag3>"], "wordsA": ["We", "will", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "product", "pipeline."], "wordsB": ["We", "may", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "current", "product", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03494718298316002, 0.04458894208073616, 0.014919203706085682, 0.06708774715662003, 0.016713634133338928, 0.021746626123785973, 0.03276510164141655, 0.005156276281923056, 0.011048116721212864, 0.022657424211502075, 0.003953795880079269, 0.008367457427084446, 0.009478596970438957, 0.0036356395576149225, 0.015399524010717869, 0.044030770659446716, 0.7564668655395508, 0.5205807685852051, 0.20881786942481995, -1]}
{"idB": "749647_13_item1_p14_s2", "idA": "749647_12_item1_p18_s2", "sentA": "Since this divesture, we have dedicated our efforts and resources to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems.", "sentB": "Since this divesture, we have dedicated our efforts and resources to the development and commercialization of cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems.", "type": 2, "words": ["<tag1>", "Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "innovative", "cancer", "drugs", "including", "tumor-targeting", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems.", "<tag2>", "Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems.", "<tag3>"], "wordsA": ["Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "innovative", "cancer", "drugs", "including", "tumor-targeting", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems."], "wordsB": ["Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1776585727930069, 0.05641339719295502, 0.11851152032613754, 0.07981429249048233, 0.040425341576337814, 0.20357394218444824, 0.11094138026237488, 0.10665111243724823, 0.0452822707593441, 0.08773273974657059, 0.03333476558327675, 0.024635320529341698, 0.06906875967979431, 0.0337299145758152, 0.07995866239070892, 0.040106337517499924, 0.16097259521484375, 0.19671213626861572, 0.061412304639816284, 0.23603561520576477, 0.1484072208404541, 0.055419981479644775, 0.15692904591560364, 0.12245191633701324, 0.10201229155063629, 0.055356092751026154, 0.06530381739139557, 0.04005276411771774, 0.3225134015083313, 0.12172508984804153, 0.10401711612939835, 0.08198072016239166, -1]}
{"idB": "749647_13_item1_p14_s3", "idA": "749647_12_item1_p18_s3", "sentA": "To support our research and development, we have raised gross proceeds of approximately $67.6 million in equity financings in the years 2009 through 2011.", "sentB": "To support our research and development, we have raised gross proceeds of approximately $68 million in equity financings, debt financing and warrant and option exercises in the years 2009 through 2012.", "type": 2, "words": ["<tag1>", "To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$67.6", "million", "in", "equity", "financings", "in", "the", "years", "2009", "through", "2011.", "<tag2>", "To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$68", "million", "in", "equity", "financings,", "debt", "financing", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2012.", "<tag3>"], "wordsA": ["To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$67.6", "million", "in", "equity", "financings", "in", "the", "years", "2009", "through", "2011."], "wordsB": ["To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$68", "million", "in", "equity", "financings,", "debt", "financing", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002212041988968849, 0.003069803351536393, 0.002188683720305562, 0.0038397705648094416, 0.0028216494247317314, 0.003384117968380451, 0.0026611187495291233, 0.002672425238415599, 0.005177241284400225, 0.005209667142480612, 0.0063604810275137424, 0.0029969734605401754, 0.007145657204091549, 0.6655357480049133, 0.020451216027140617, 0.0022591096349060535, 0.0090862438082695, 0.018952345475554466, 0.11362193524837494, 0.2633940875530243, 0.017106302082538605, 0.18342910706996918, 0.12149601429700851, 0.2048419564962387, 0.22473132610321045, 0.0032128081656992435, 0.0027946995105594397, 0.008652697317302227, 0.047069065272808075, 0.05947336181998253, 0.8632680773735046, -1]}
{"idB": "749647_13_item1_p16_s0", "idA": "749647_12_item1_p19_s0", "sentA": "On December 5, 2008, we entered into a development, product supply and commercialization agreement with Yakult Honsha Co. (the Yakult Agreement) under which Yakult was granted the exclusive right to commercialize and market ThermoDox for the Japanese market.", "sentB": "On May 6, 2012, we entered into a long term commercial supply agreement with Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun) for the production of ThermoDox in mainland China, Hong Kong and Macau (the China territory).", "type": 2, "words": ["<tag1>", "On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.", "(the", "Yakult", "Agreement)", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market.", "<tag2>", "On", "May", "6,", "2012,", "we", "entered", "into", "a", "long", "term", "commercial", "supply", "agreement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "for", "the", "production", "of", "ThermoDox", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau", "(the", "China", "territory).", "<tag3>"], "wordsA": ["On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.", "(the", "Yakult", "Agreement)", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market."], "wordsB": ["On", "May", "6,", "2012,", "we", "entered", "into", "a", "long", "term", "commercial", "supply", "agreement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "for", "the", "production", "of", "ThermoDox", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau", "(the", "China", "territory)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016221068799495697, 0.35828813910484314, 0.42380866408348083, 0.7062621116638184, 0.013191898353397846, 0.017455190420150757, 0.01175648346543312, 0.007938249967992306, 0.405696839094162, 0.18686047196388245, 0.16679342091083527, 0.1922985017299652, 0.10851198434829712, 0.01680641993880272, 0.4779678285121918, 0.37462905049324036, 0.3316986560821533, 0.1535477638244629, 0.1158299669623375, 0.19425147771835327, 0.005571818444877863, 0.00599316181614995, 0.03927580267190933, 0.013962949626147747, 0.024921642616391182, 0.018040357157588005, 0.5497493743896484, 0.4262554943561554, 0.42046859860420227, 0.35732337832450867, 0.16279979050159454, 0.3281897306442261, 0.012118103913962841, 0.10374774038791656, 0.1662631332874298, -1]}
{"idB": "749647_13_item1_p40_s0", "idA": "749647_12_item1_p19_s0", "sentA": "On December 5, 2008, we entered into a development, product supply and commercialization agreement with Yakult Honsha Co. (the Yakult Agreement) under which Yakult was granted the exclusive right to commercialize and market ThermoDox for the Japanese market.", "sentB": "On May 6, 2012, we entered into a long term commercial supply agreement with Hisun for the production of ThermoDox in mainland China, Hong Kong and Macau (the China territory).", "type": 2, "words": ["<tag1>", "On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.", "(the", "Yakult", "Agreement)", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market.", "<tag2>", "On", "May", "6,", "2012,", "we", "entered", "into", "a", "long", "term", "commercial", "supply", "agreement", "with", "Hisun", "for", "the", "production", "of", "ThermoDox", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau", "(the", "China", "territory).", "<tag3>"], "wordsA": ["On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.", "(the", "Yakult", "Agreement)", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market."], "wordsB": ["On", "May", "6,", "2012,", "we", "entered", "into", "a", "long", "term", "commercial", "supply", "agreement", "with", "Hisun", "for", "the", "production", "of", "ThermoDox", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau", "(the", "China", "territory)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016351114958524704, 0.35764279961586, 0.40717026591300964, 0.7284789085388184, 0.012779696844518185, 0.01664585806429386, 0.01282675564289093, 0.00824524462223053, 0.33514371514320374, 0.1809842586517334, 0.14124508202075958, 0.17169319093227386, 0.10639894753694534, 0.03178025037050247, 0.42495837807655334, 0.008429717272520065, 0.007133238948881626, 0.030559834092855453, 0.01362964604049921, 0.02243122272193432, 0.018026228994131088, 0.6553127765655518, 0.5727066993713379, 0.4910614490509033, 0.43242621421813965, 0.18435214459896088, 0.3780951201915741, 0.010678503662347794, 0.1135244145989418, 0.16852736473083496, -1]}
{"idB": "749647_13_item1_p16_s1", "idA": "749647_12_item1_p19_s2", "sentA": "Under the Yakult Agreement, we will receive double digit escalating royalties on the sale of ThermoDox in Japan, when and if any such sales occur and we also will be the exclusive supplier of ThermoDox to Yakult.", "sentB": "Hisun will be responsible for providing all of the technical and regulatory support services for the manufacture of ThermoDox in the China territory and we will repay Hisun the related development costs and fees, which we expect to be approximately $2.0 million in total, commencing on the successful completion of three registrational batches of ThermoDox .", "type": 2, "words": ["<tag1>", "Under", "the", "Yakult", "Agreement,", "we", "will", "receive", "double", "digit", "escalating", "royalties", "on", "the", "sale", "of", "ThermoDox", "in", "Japan,", "when", "and", "if", "any", "such", "sales", "occur", "and", "we", "also", "will", "be", "the", "exclusive", "supplier", "of", "ThermoDox", "to", "Yakult.", "<tag2>", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["Under", "the", "Yakult", "Agreement,", "we", "will", "receive", "double", "digit", "escalating", "royalties", "on", "the", "sale", "of", "ThermoDox", "in", "Japan,", "when", "and", "if", "any", "such", "sales", "occur", "and", "we", "also", "will", "be", "the", "exclusive", "supplier", "of", "ThermoDox", "to", "Yakult."], "wordsB": ["Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.16236798465251923, 0.03485899791121483, 0.060360223054885864, 0.3382326066493988, 0.10004442185163498, 0.32465314865112305, 0.16451601684093475, 0.07712113857269287, 0.07637868076562881, 0.2973059415817261, 0.1508117914199829, 0.36689111590385437, 0.6344489455223083, 0.5822156071662903, 0.022121647372841835, 0.015057769604027271, 0.045615412294864655, 0.029625924304127693, 0.04412383213639259, 0.013424635864794254, 0.01110342238098383, 0.3542775511741638, 0.18697074055671692, 0.0003572344721760601, 0.011768877506256104, 0.010636611841619015, 0.13370494544506073, 0.06459077447652817, 0.02241494692862034, 0.03323598578572273, 0.09434189647436142, 0.08802556991577148, 0.04049808531999588, 0.10076644271612167, 0.00030919379787519574, 0.006187789142131805, 0.007236099801957607, 0.005239253863692284, 0.006774036213755608, 0.01598682999610901, 0.05947800353169441, 0.05589665099978447, 0.024169720709323883, 0.020203713327646255, 0.008274375461041927, 0.0071671707555651665, 0.018430110067129135, 0.023479867726564407, 0.019264595583081245, 0.0075689698569476604, 0.03958004713058472, 0.05092671141028404, 0.044164758175611496, 0.0339835099875927, 0.03066963329911232, 9.517502621747553e-05, -1]}
{"idB": "749647_13_item1_p15_s3", "idA": "749647_12_item1_p19_s3", "sentA": "Concurrent with a convertible preferred stock equity financing in January 2011, we amended the Yakult Agreement to provide for up to $4.0 million in an accelerated partial payment to us of a future drug approval milestone.", "sentB": "Concurrent with a convertible preferred stock equity financing in January 2011, we amended the Yakult Agreement to provide for up to $4.0 million in an accelerated partial payment to us of a future drug approval milestone which included $2.0 million paid to us upon the closing of the preferred equity financing and an additional $2.0 million conditioned upon the resumption of enrollment of Japanese patients in the Japan cohort of the HEAT study.", "type": 2, "words": ["<tag1>", "Concurrent", "with", "a", "convertible", "preferred", "stock", "equity", "financing", "in", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone.", "<tag2>", "Concurrent", "with", "a", "convertible", "preferred", "stock", "equity", "financing", "in", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone", "which", "included", "$2.0", "million", "paid", "to", "us", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["Concurrent", "with", "a", "convertible", "preferred", "stock", "equity", "financing", "in", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone."], "wordsB": ["Concurrent", "with", "a", "convertible", "preferred", "stock", "equity", "financing", "in", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone", "which", "included", "$2.0", "million", "paid", "to", "us", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009383154101669788, 0.006071065086871386, 0.004916101228445768, 0.015076139010488987, 0.012662708759307861, 0.01209754217416048, 0.012724367901682854, 0.01387773733586073, 0.006698496174067259, 0.010556639172136784, 0.010011916980147362, 0.00669916532933712, 0.012119508348405361, 0.0059964717365801334, 0.01648719236254692, 0.011105794459581375, 0.006331633776426315, 0.006471582222729921, 0.007104297634214163, 0.009571650996804237, 0.007842735387384892, 0.047794535756111145, 0.011403036303818226, 0.007362124044448137, 0.00612297561019659, 0.010602109134197235, 0.010241997428238392, 0.01074080541729927, 0.007200500462204218, 0.01078251376748085, 0.005425590556114912, 0.0050189015455543995, 0.006596389692276716, 0.0077536143362522125, 0.007851437665522099, 0.008691288530826569, 0.0014600250869989395, 0.00838684756308794, 0.02504519745707512, 0.011136324144899845, 0.013430314138531685, 0.019835639744997025, 0.03818532079458237, 0.034870825707912445, 0.02906750701367855, 0.3940805494785309, 0.02188471518456936, 0.009351427666842937, 0.06906382739543915, 0.02902710996568203, 0.05483231320977211, 0.0009640836506150663, 0.009847745299339294, 0.014918060973286629, 0.030930375680327415, 0.021160120144486427, 0.03048882819712162, 0.03174494951963425, 0.034164734184741974, 0.13662445545196533, 0.06266249716281891, 0.15102353692054749, 0.07344017922878265, 0.19895078241825104, 0.23573964834213257, 0.03650004416704178, 0.02049618400633335, 0.08516015112400055, 0.09989301860332489, 0.06538628786802292, 0.063144750893116, 0.2416827231645584, 0.29880252480506897, -1]}
{"idB": "749647_13_item1_p15_s4", "idA": "749647_12_item1_p19_s5", "sentA": "In consideration of these accelerated milestone payments from Yakult, we have agreed to reduce future drug approval milestone payments by approximately forty percent (40%).", "sentB": "In consideration of these accelerated milestone payments from Yakult, we agreed to reduce future drug approval milestone payments by approximately forty percent (40%).", "type": 2, "words": ["<tag1>", "In", "consideration", "of", "these", "accelerated", "milestone", "payments", "from", "Yakult,", "we", "have", "agreed", "to", "reduce", "future", "drug", "approval", "milestone", "payments", "by", "approximately", "forty", "percent", "(40%).", "<tag2>", "In", "consideration", "of", "these", "accelerated", "milestone", "payments", "from", "Yakult,", "we", "agreed", "to", "reduce", "future", "drug", "approval", "milestone", "payments", "by", "approximately", "forty", "percent", "(40%).", "<tag3>"], "wordsA": ["In", "consideration", "of", "these", "accelerated", "milestone", "payments", "from", "Yakult,", "we", "have", "agreed", "to", "reduce", "future", "drug", "approval", "milestone", "payments", "by", "approximately", "forty", "percent", "(40%)."], "wordsB": ["In", "consideration", "of", "these", "accelerated", "milestone", "payments", "from", "Yakult,", "we", "agreed", "to", "reduce", "future", "drug", "approval", "milestone", "payments", "by", "approximately", "forty", "percent", "(40%)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.042891401797533035, 0.12240850180387497, 0.05916890874505043, 0.06291869282722473, 0.1443062573671341, 0.17407917976379395, 0.24615953862667084, 0.10291440784931183, 0.27239930629730225, 0.06764667481184006, 0.09655570983886719, 0.06846389174461365, 0.378791481256485, 0.11944393068552017, 0.11893677711486816, 0.14934080839157104, 0.1292935311794281, 0.18552283942699432, 0.07077949494123459, 0.07599635422229767, 0.16767489910125732, 0.15008608996868134, 0.1696048080921173, -1]}
{"idB": "749647_13_item1_p1_s0", "idA": "749647_12_item1_p1_s0", "sentA": "In some cases, you can identify forward-looking statements by terminology such as expect , anticipate , estimate , plan , believe and words of similar import regarding the Company s expectations.", "sentB": "In some cases, you can identify forward-looking statements by terminology such as expect, anticipate, estimate, plan, believe, could, intend, predict, may, should, will and words of similar import regarding the Company s expectations.", "type": 2, "words": ["<tag1>", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect", ",", "anticipate", ",", "estimate", ",", "plan", ",", "believe", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations.", "<tag2>", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations.", "<tag3>"], "wordsA": ["In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect", ",", "anticipate", ",", "estimate", ",", "plan", ",", "believe", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations."], "wordsB": ["In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01351253129541874, 0.01926705241203308, 0.030305564403533936, 0.01885436847805977, 0.026545817032456398, 0.028806284070014954, 0.03167906403541565, 0.025893546640872955, 0.017813321202993393, 0.0315733328461647, 0.019057609140872955, 0.014690935611724854, 0.047815028578042984, 0.025234540924429893, 0.020446572452783585, 0.01778673566877842, 0.021097224205732346, 0.06043574586510658, 0.12243480235338211, 0.32414519786834717, 0.31305211782455444, 0.28515157103538513, 0.13085825741291046, 0.017571549862623215, 0.031741805374622345, 0.018421296030282974, 0.022513197734951973, 0.02496429719030857, 0.011535645462572575, 0.012045843526721, 0.019538214430212975, 0.019932037219405174, 0.030839035287499428, -1]}
{"idB": "749647_13_item1_p117_s2", "idA": "749647_12_item1_p20_s2", "sentA": "The recommendation followed a review of safety data from 18 Japanese patients enrolled in the study, when compared to patient data from the rest of the Phase III trial.", "sentB": "We will continue following the patients enrolled in the HEAT study to the secondary endpoint, overall survival.", "type": 2, "words": ["<tag1>", "The", "recommendation", "followed", "a", "review", "of", "safety", "data", "from", "18", "Japanese", "patients", "enrolled", "in", "the", "study,", "when", "compared", "to", "patient", "data", "from", "the", "rest", "of", "the", "Phase", "III", "trial.", "<tag2>", "We", "will", "continue", "following", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag3>"], "wordsA": ["The", "recommendation", "followed", "a", "review", "of", "safety", "data", "from", "18", "Japanese", "patients", "enrolled", "in", "the", "study,", "when", "compared", "to", "patient", "data", "from", "the", "rest", "of", "the", "Phase", "III", "trial."], "wordsB": ["We", "will", "continue", "following", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06509843468666077, 0.02320181019604206, 0.05858130753040314, 0.16210663318634033, 0.026771973818540573, 0.13398012518882751, 0.04545878991484642, 0.020531930029392242, 0.014627602882683277, 0.2765723168849945, 0.4024397134780884, 0.0004623793938662857, 0.010669903829693794, 0.029850607737898827, 0.01876183971762657, 0.10134007781744003, 0.09387627989053726, -1]}
{"idB": "749647_13_item1_p13_s1", "idA": "749647_12_item1_p20_s2", "sentA": "The recommendation followed a review of safety data from 18 Japanese patients enrolled in the study, when compared to patient data from the rest of the Phase III trial.", "sentB": "We will continue to follow the patients enrolled in the HEAT study to the secondary endpoint, overall survival.", "type": 2, "words": ["<tag1>", "The", "recommendation", "followed", "a", "review", "of", "safety", "data", "from", "18", "Japanese", "patients", "enrolled", "in", "the", "study,", "when", "compared", "to", "patient", "data", "from", "the", "rest", "of", "the", "Phase", "III", "trial.", "<tag2>", "We", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag3>"], "wordsA": ["The", "recommendation", "followed", "a", "review", "of", "safety", "data", "from", "18", "Japanese", "patients", "enrolled", "in", "the", "study,", "when", "compared", "to", "patient", "data", "from", "the", "rest", "of", "the", "Phase", "III", "trial."], "wordsB": ["We", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07244345545768738, 0.025419091805815697, 0.0523090735077858, 0.08376524597406387, 0.23111675679683685, 0.03197646513581276, 0.1567368358373642, 0.04243241623044014, 0.021337376907467842, 0.015446364879608154, 0.25180909037590027, 0.3925683796405792, 0.0005402671522460878, 0.013214760459959507, 0.036101724952459335, 0.02139877900481224, 0.09425227344036102, 0.09323655813932419, -1]}
{"idB": "749647_13_item1_p36_s2", "idA": "749647_12_item1_p20_s2", "sentA": "The recommendation followed a review of safety data from 18 Japanese patients enrolled in the study, when compared to patient data from the rest of the Phase III trial.", "sentB": "We will continue following the patients enrolled in the HEAT study to the secondary endpoint, overall survival.", "type": 2, "words": ["<tag1>", "The", "recommendation", "followed", "a", "review", "of", "safety", "data", "from", "18", "Japanese", "patients", "enrolled", "in", "the", "study,", "when", "compared", "to", "patient", "data", "from", "the", "rest", "of", "the", "Phase", "III", "trial.", "<tag2>", "We", "will", "continue", "following", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag3>"], "wordsA": ["The", "recommendation", "followed", "a", "review", "of", "safety", "data", "from", "18", "Japanese", "patients", "enrolled", "in", "the", "study,", "when", "compared", "to", "patient", "data", "from", "the", "rest", "of", "the", "Phase", "III", "trial."], "wordsB": ["We", "will", "continue", "following", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06509843468666077, 0.02320181019604206, 0.05858130753040314, 0.16210663318634033, 0.026771973818540573, 0.13398012518882751, 0.04545878991484642, 0.020531930029392242, 0.014627602882683277, 0.2765723168849945, 0.4024397134780884, 0.0004623793938662857, 0.010669903829693794, 0.029850607737898827, 0.01876183971762657, 0.10134007781744003, 0.09387627989053726, -1]}
{"idB": "749647_13_item1_p39_s0", "idA": "749647_12_item1_p24_s0", "sentA": "Consistent with our global regulatory strategy, we are continuing to enroll patients in the HEAT Study in order to randomize at least 200 patients in the People s Republic of China (PRC), a requirement for registrational filing in the PRC.", "sentB": "Prior to the HEAT study results announced on January 31, 2013, and consistent with our global regulatory strategy, we announced on April 23, 2012, that randomization of at least 200 patients in the People s Republic of China (PRC), a requirement for registrational filing in the PRC, had been completed.", "type": 2, "words": ["<tag1>", "Consistent", "with", "our", "global", "regulatory", "strategy,", "we", "are", "continuing", "to", "enroll", "patients", "in", "the", "HEAT", "Study", "in", "order", "to", "randomize", "at", "least", "200", "patients", "in", "the", "People", "s", "Republic", "of", "China", "(PRC),", "a", "requirement", "for", "registrational", "filing", "in", "the", "PRC.", "<tag2>", "Prior", "to", "the", "HEAT", "study", "results", "announced", "on", "January", "31,", "2013,", "and", "consistent", "with", "our", "global", "regulatory", "strategy,", "we", "announced", "on", "April", "23,", "2012,", "that", "randomization", "of", "at", "least", "200", "patients", "in", "the", "People", "s", "Republic", "of", "China", "(PRC),", "a", "requirement", "for", "registrational", "filing", "in", "the", "PRC,", "had", "been", "completed.", "<tag3>"], "wordsA": ["Consistent", "with", "our", "global", "regulatory", "strategy,", "we", "are", "continuing", "to", "enroll", "patients", "in", "the", "HEAT", "Study", "in", "order", "to", "randomize", "at", "least", "200", "patients", "in", "the", "People", "s", "Republic", "of", "China", "(PRC),", "a", "requirement", "for", "registrational", "filing", "in", "the", "PRC."], "wordsB": ["Prior", "to", "the", "HEAT", "study", "results", "announced", "on", "January", "31,", "2013,", "and", "consistent", "with", "our", "global", "regulatory", "strategy,", "we", "announced", "on", "April", "23,", "2012,", "that", "randomization", "of", "at", "least", "200", "patients", "in", "the", "People", "s", "Republic", "of", "China", "(PRC),", "a", "requirement", "for", "registrational", "filing", "in", "the", "PRC,", "had", "been", "completed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04080512002110481, 0.020604465156793594, 0.01034795492887497, 0.025873662903904915, 0.02517279051244259, 0.02435045875608921, 0.03584351763129234, 0.013339285738766193, 0.06478478759527206, 0.05966007709503174, 0.1150788813829422, 0.006315567065030336, 0.005553117953240871, 0.003972550854086876, 0.0041147624142467976, 0.005566030275076628, 0.008345622569322586, 0.010769013315439224, 0.022025184705853462, 0.03175579756498337, 0.02029174566268921, 0.08859340846538544, 0.07886285334825516, 0.12114182114601135, 0.023943645879626274, 0.038500018417835236, 0.01711258292198181, 0.00674291281029582, 0.010989450849592686, 0.021182509139180183, 0.04631805047392845, 0.003279299708083272, 0.003526059677824378, 0.005885070655494928, 0.005606047809123993, 0.005928483325988054, 0.004858226515352726, 0.005042513832449913, 0.005396831315010786, 0.0031294359359890223, 0.006938085425645113, 0.003466523950919509, 0.005876947194337845, 0.006284748204052448, 0.0034427812788635492, 0.0037754832301288843, 0.007176508195698261, 0.12800471484661102, 0.18643075227737427, 0.4917488098144531, -1]}
{"idB": "749647_13_item1_p39_s1", "idA": "749647_12_item1_p24_s1", "sentA": "The HEAT study has already enrolled a sufficient number to support registrational filings in South Korea and Taiwan, two important markets for ThermoDox .", "sentB": "The HEAT study had already enrolled a sufficient number to support registrational filings in South Korea and Taiwan, two important markets for ThermoDox .", "type": 2, "words": ["<tag1>", "The", "HEAT", "study", "has", "already", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", ".", "<tag2>", "The", "HEAT", "study", "had", "already", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", ".", "<tag3>"], "wordsA": ["The", "HEAT", "study", "has", "already", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", "."], "wordsB": ["The", "HEAT", "study", "had", "already", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01747811958193779, 0.38774776458740234, 0.3471669554710388, 0.11748284101486206, 0.17753823101520538, 0.5593878030776978, 0.09065813571214676, 0.2535611391067505, 0.6018536686897278, 0.08150672912597656, 0.10546106100082397, 0.16813600063323975, 0.10851673036813736, 0.031606193631887436, 0.1122196838259697, 0.09838344901800156, 0.03795981407165527, 0.10416485369205475, 0.03033887781202793, 0.0370994471013546, 0.07283908128738403, 0.03109738603234291, 0.09399927407503128, 0.00014612665108870715, -1]}
{"idB": "749647_13_item1_p116_s1", "idA": "749647_12_item1_p25_s0", "sentA": "In December 2011, Celsion completed the consultative review process with the European Medicines Agency (EMA) for the HEAT Study and received written scientific advice from the EMA confirming that the Company s HEAT Study is acceptable as a basis for submission of a marketing authorization application.", "sentB": "Specifically, we determined, after conferring with the DMC, that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT study.", "type": 2, "words": ["<tag1>", "In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application.", "<tag2>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application."], "wordsB": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0693034827709198, 0.1022343784570694, 0.14385642111301422, 0.02690175361931324, 0.10264097154140472, 0.04309789836406708, 0.04624495655298233, 0.2600644826889038, 0.03960494324564934, 0.01804465986788273, 0.10728347301483154, 0.14445726573467255, 0.24996942281723022, 0.40223610401153564, 0.1823020875453949, 0.03464287891983986, 0.05223149433732033, 0.011155816726386547, 0.09973610192537308, 0.0969962626695633, 0.14776571094989777, 0.05866659805178642, 0.11029018461704254, 0.10925246775150299, 0.0067734490148723125, 0.01166085060685873, 0.012532385997474194, 0.007725950796157122, 0.024157188832759857, 0.01718982681632042, 0.07470528036355972, 0.09466662257909775, 0.0349343866109848, 0.021031687036156654, 0.13702940940856934, 0.01919148862361908, 0.013948493637144566, 0.008631577715277672, 0.03212568908929825, 0.03388712555170059, -1]}
{"idB": "749647_13_item1_p12_s1", "idA": "749647_12_item1_p25_s0", "sentA": "In December 2011, Celsion completed the consultative review process with the European Medicines Agency (EMA) for the HEAT Study and received written scientific advice from the EMA confirming that the Company s HEAT Study is acceptable as a basis for submission of a marketing authorization application.", "sentB": "Specifically, we determined, after conferring with the HEAT study independent Data Monitoring Committee, that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT study.", "type": 2, "words": ["<tag1>", "In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application.", "<tag2>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application."], "wordsB": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05796510726213455, 0.09059710800647736, 0.13107892870903015, 0.023730885237455368, 0.09676423668861389, 0.023391714319586754, 0.01730128563940525, 0.058389779180288315, 0.053919874131679535, 0.251985639333725, 0.3380333185195923, 0.2912767827510834, 0.21689195930957794, 0.024424895644187927, 0.013723094016313553, 0.08118950575590134, 0.10026439279317856, 0.15725746750831604, 0.32696881890296936, 0.11280247569084167, 0.025718266144394875, 0.03725302219390869, 0.011165420524775982, 0.0931171402335167, 0.10879860818386078, 0.11153418570756912, 0.04132167994976044, 0.07730130851268768, 0.07448228448629379, 0.006631610449403524, 0.014615945518016815, 0.01626533269882202, 0.01249524112790823, 0.04043073579668999, 0.027752261608839035, 0.09959560632705688, 0.11749325692653656, 0.033679746091365814, 0.01860414259135723, 0.12562403082847595, 0.015058851800858974, 0.012983718886971474, 0.007928311824798584, 0.02918139286339283, 0.034859802573919296, -1]}
{"idB": "749647_13_item1_p35_s4", "idA": "749647_12_item1_p25_s0", "sentA": "In December 2011, Celsion completed the consultative review process with the European Medicines Agency (EMA) for the HEAT Study and received written scientific advice from the EMA confirming that the Company s HEAT Study is acceptable as a basis for submission of a marketing authorization application.", "sentB": "Specifically, we determined, after conferring with the DMC, that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT study.", "type": 2, "words": ["<tag1>", "In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application.", "<tag2>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application."], "wordsB": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0693034827709198, 0.1022343784570694, 0.14385642111301422, 0.02690175361931324, 0.10264097154140472, 0.04309789836406708, 0.04624495655298233, 0.2600644826889038, 0.03960494324564934, 0.01804465986788273, 0.10728347301483154, 0.14445726573467255, 0.24996942281723022, 0.40223610401153564, 0.1823020875453949, 0.03464287891983986, 0.05223149433732033, 0.011155816726386547, 0.09973610192537308, 0.0969962626695633, 0.14776571094989777, 0.05866659805178642, 0.11029018461704254, 0.10925246775150299, 0.0067734490148723125, 0.01166085060685873, 0.012532385997474194, 0.007725950796157122, 0.024157188832759857, 0.01718982681632042, 0.07470528036355972, 0.09466662257909775, 0.0349343866109848, 0.021031687036156654, 0.13702940940856934, 0.01919148862361908, 0.013948493637144566, 0.008631577715277672, 0.03212568908929825, 0.03388712555170059, -1]}
{"idB": "749647_13_item1_p82_s1", "idA": "749647_12_item1_p25_s0", "sentA": "In December 2011, Celsion completed the consultative review process with the European Medicines Agency (EMA) for the HEAT Study and received written scientific advice from the EMA confirming that the Company s HEAT Study is acceptable as a basis for submission of a marketing authorization application.", "sentB": "Specifically, we determined, after conferring with the DMC, that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT study.", "type": 2, "words": ["<tag1>", "In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application.", "<tag2>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["In", "December", "2011,", "Celsion", "completed", "the", "consultative", "review", "process", "with", "the", "European", "Medicines", "Agency", "(EMA)", "for", "the", "HEAT", "Study", "and", "received", "written", "scientific", "advice", "from", "the", "EMA", "confirming", "that", "the", "Company", "s", "HEAT", "Study", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application."], "wordsB": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0693034827709198, 0.1022343784570694, 0.14385642111301422, 0.02690175361931324, 0.10264097154140472, 0.04309789836406708, 0.04624495655298233, 0.2600644826889038, 0.03960494324564934, 0.01804465986788273, 0.10728347301483154, 0.14445726573467255, 0.24996942281723022, 0.40223610401153564, 0.1823020875453949, 0.03464287891983986, 0.05223149433732033, 0.011155816726386547, 0.09973610192537308, 0.0969962626695633, 0.14776571094989777, 0.05866659805178642, 0.11029018461704254, 0.10925246775150299, 0.0067734490148723125, 0.01166085060685873, 0.012532385997474194, 0.007725950796157122, 0.024157188832759857, 0.01718982681632042, 0.07470528036355972, 0.09466662257909775, 0.0349343866109848, 0.021031687036156654, 0.13702940940856934, 0.01919148862361908, 0.013948493637144566, 0.008631577715277672, 0.03212568908929825, 0.03388712555170059, -1]}
{"idB": "749647_13_item1_p42_s0", "idA": "749647_12_item1_p26_s0", "sentA": "In January 2012, we announced the enrollment of our first patient in the randomized Phase II study of ThermoDox in combination with radiofrequency ablation for the treatment of colorectal liver metastases (the ABLATE Study).", "sentB": "The agreement is initially limited to a percentage of the production requirements of ThermoDox in the China territory with Hisun retaining an option for additional global supply after local regulatory approval in the China territory.", "type": 2, "words": ["<tag1>", "In", "January", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "Study).", "<tag2>", "The", "agreement", "is", "initially", "limited", "to", "a", "percentage", "of", "the", "production", "requirements", "of", "ThermoDox", "in", "the", "China", "territory", "with", "Hisun", "retaining", "an", "option", "for", "additional", "global", "supply", "after", "local", "regulatory", "approval", "in", "the", "China", "territory.", "<tag3>"], "wordsA": ["In", "January", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "Study)."], "wordsB": ["The", "agreement", "is", "initially", "limited", "to", "a", "percentage", "of", "the", "production", "requirements", "of", "ThermoDox", "in", "the", "China", "territory", "with", "Hisun", "retaining", "an", "option", "for", "additional", "global", "supply", "after", "local", "regulatory", "approval", "in", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014753433875739574, 0.20016813278198242, 0.02270864136517048, 0.09536906331777573, 0.17861837148666382, 0.06760638952255249, 0.07839818298816681, 0.23530316352844238, 0.09191811084747314, 0.06115273758769035, 0.3846128284931183, 0.21009334921836853, 0.053591445088386536, 0.08828069269657135, 0.008132082410156727, 0.010395998135209084, 0.025794098153710365, 0.03386123850941658, 0.007227670401334763, 0.13176006078720093, 0.23554104566574097, 0.06078391522169113, 0.13946671783924103, 0.03861693665385246, 0.05780860036611557, 0.1518208235502243, 0.1724129021167755, 0.01570034772157669, 0.040763579308986664, 0.05178966000676155, 0.08136674016714096, 0.005556157790124416, 0.005549122579395771, 0.014738609082996845, 0.01970374584197998, -1]}
{"idB": "749647_13_item1_p46_s0", "idA": "749647_12_item1_p26_s0", "sentA": "In January 2012, we announced the enrollment of our first patient in the randomized Phase II study of ThermoDox in combination with radiofrequency ablation for the treatment of colorectal liver metastases (the ABLATE Study).", "sentB": "In June 2012, we announced a collaboration with the University of Oxford to begin an early phase clinical study of ThermoDox plus HIFU in the treatment of metastatic liver cancer.", "type": 2, "words": ["<tag1>", "In", "January", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "Study).", "<tag2>", "In", "June", "2012,", "we", "announced", "a", "collaboration", "with", "the", "University", "of", "Oxford", "to", "begin", "an", "early", "phase", "clinical", "study", "of", "ThermoDox", "plus", "HIFU", "in", "the", "treatment", "of", "metastatic", "liver", "cancer.", "<tag3>"], "wordsA": ["In", "January", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "Study)."], "wordsB": ["In", "June", "2012,", "we", "announced", "a", "collaboration", "with", "the", "University", "of", "Oxford", "to", "begin", "an", "early", "phase", "clinical", "study", "of", "ThermoDox", "plus", "HIFU", "in", "the", "treatment", "of", "metastatic", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01826186664402485, 0.7912507653236389, 0.07567523419857025, 0.01624615676701069, 0.019934074953198433, 0.012384412810206413, 0.10061243176460266, 0.031187042593955994, 0.031970422714948654, 0.15156814455986023, 0.15770815312862396, 0.49440765380859375, 0.007307193707674742, 0.032394617795944214, 0.014618368819355965, 0.1268836110830307, 0.09688039869070053, 0.1670997142791748, 0.14002197980880737, 0.021298954263329506, 0.04988570138812065, 0.06920067220926285, 0.17942136526107788, 0.008431168273091316, 0.006125297863036394, 0.04924860969185829, 0.01792733184993267, 0.43071264028549194, 0.2796342670917511, 0.2307102382183075, -1]}
{"idB": "749647_13_item1_p63_s1", "idA": "749647_12_item1_p26_s0", "sentA": "In January 2012, we announced the enrollment of our first patient in the randomized Phase II study of ThermoDox in combination with radiofrequency ablation for the treatment of colorectal liver metastases (the ABLATE Study).", "sentB": "In February 2012, we announced the enrollment of our first patient in the randomized Phase II study of ThermoDox , in combination with RFA, for the treatment of colorectal liver metastases (the ABLATE study).", "type": 2, "words": ["<tag1>", "In", "January", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "Study).", "<tag2>", "In", "February", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", ",", "in", "combination", "with", "RFA,", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "study).", "<tag3>"], "wordsA": ["In", "January", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "Study)."], "wordsB": ["In", "February", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", ",", "in", "combination", "with", "RFA,", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015197188593447208, 0.9822227954864502, 0.04675066098570824, 0.0032445723190903664, 0.002449226099997759, 0.0018987193470820785, 0.003946688957512379, 0.0018938131397590041, 0.0019392810063436627, 0.0035229783970862627, 0.008116020821034908, 0.001389137003570795, 0.0014501286204904318, 0.002731842454522848, 0.002602578839287162, 0.0025412405375391245, 0.005438114050775766, 0.0016879771137610078, 0.006293038837611675, 0.00014644900511484593, 0.003460954176262021, 0.018770944327116013, 0.04201675206422806, 0.7981687784194946, 0.0015814133221283555, 0.0017004543915390968, 0.0026732194237411022, 0.001698478008620441, 0.0028805674519389868, 0.004593676421791315, 0.0043210675939917564, 0.0016876437002792954, 0.003567261854186654, 0.005916086491197348, -1]}
{"idB": "749647_13_item1_p63_s4", "idA": "749647_12_item1_p26_s1", "sentA": "The ABLATE Study is expected to enroll up to 88 patients with colorectal cancer metastasized to the liver.", "sentB": "In December 2012, the ABLATE study was amended to an open label study expected to enroll up to 41 patients in combination with thermal ablation.", "type": 2, "words": ["<tag1>", "The", "ABLATE", "Study", "is", "expected", "to", "enroll", "up", "to", "88", "patients", "with", "colorectal", "cancer", "metastasized", "to", "the", "liver.", "<tag2>", "In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation.", "<tag3>"], "wordsA": ["The", "ABLATE", "Study", "is", "expected", "to", "enroll", "up", "to", "88", "patients", "with", "colorectal", "cancer", "metastasized", "to", "the", "liver."], "wordsB": ["In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007678780239075422, 0.019669169560074806, 0.03913510963320732, 0.002312700031325221, 0.02520025707781315, 0.03206440806388855, 0.006293160375207663, 0.023539213463664055, 0.010159707628190517, 0.007506672292947769, 0.26381874084472656, 0.17829222977161407, 0.13258571922779083, 0.0031171580776572227, 0.0027197201270610094, 0.03360164165496826, 0.014516480267047882, 0.015056588687002659, 0.8513904809951782, 0.3787897527217865, 0.006341078784316778, 0.07384409010410309, 0.05005275458097458, 0.35076403617858887, 0.5749543309211731, -1]}
{"idB": "749647_13_item1_p63_s3", "idA": "749647_12_item1_p26_s2", "sentA": "Patients will be randomized to receive either RFA plus ThermoDox or RFA alone for the treatment of their liver tumors.", "sentB": "Patients were to be randomized to receive RFA plus ThermoDox or RFA alone for the treatment of their liver tumors.", "type": 2, "words": ["<tag1>", "Patients", "will", "be", "randomized", "to", "receive", "either", "RFA", "plus", "ThermoDox", "or", "RFA", "alone", "for", "the", "treatment", "of", "their", "liver", "tumors.", "<tag2>", "Patients", "were", "to", "be", "randomized", "to", "receive", "RFA", "plus", "ThermoDox", "or", "RFA", "alone", "for", "the", "treatment", "of", "their", "liver", "tumors.", "<tag3>"], "wordsA": ["Patients", "will", "be", "randomized", "to", "receive", "either", "RFA", "plus", "ThermoDox", "or", "RFA", "alone", "for", "the", "treatment", "of", "their", "liver", "tumors."], "wordsB": ["Patients", "were", "to", "be", "randomized", "to", "receive", "RFA", "plus", "ThermoDox", "or", "RFA", "alone", "for", "the", "treatment", "of", "their", "liver", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6369235515594482, 0.2953264117240906, 0.11966069787740707, 0.09727227687835693, 0.23246850073337555, 0.10045743733644485, 0.26883912086486816, 0.3359094560146332, 0.2189946174621582, 0.09667664766311646, 0.028683826327323914, 0.061852406710386276, 0.11971331387758255, 0.016329722478985786, 0.012257290072739124, 0.027978258207440376, 0.012290090322494507, 0.010487389750778675, 0.04759446531534195, 0.059344418346881866, -1]}
{"idB": "749647_13_item1_p128_s0", "idA": "749647_12_item1_p27_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "To complete the development and commercialization of our products, we will need to raise substantial amounts of additional capital to fund our operations.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "To", "complete", "the", "development", "and", "commercialization", "of", "our", "products,", "we", "will", "need", "to", "raise", "substantial", "amounts", "of", "additional", "capital", "to", "fund", "our", "operations.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["To", "complete", "the", "development", "and", "commercialization", "of", "our", "products,", "we", "will", "need", "to", "raise", "substantial", "amounts", "of", "additional", "capital", "to", "fund", "our", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016098031774163246, 0.0097931744530797, 0.0056015863083302975, 0.005263592582195997, 0.003105565207079053, 0.005008578300476074, 0.004138368181884289, 0.009646978229284286, 0.06570365279912949, 0.033670175820589066, 0.023035870864987373, 0.06501808762550354, 0.037673331797122955, 0.526364266872406, 0.3343300223350525, 0.3081378638744354, 0.23784157633781433, 0.26417791843414307, 0.47940388321876526, 0.01507146842777729, 0.047673553228378296, 0.021212929859757423, 0.06653719395399094, -1]}
{"idB": "749647_13_item1_p18_s0", "idA": "749647_12_item1_p27_s3", "sentA": "We may also apply for subsidies, grants, or government or agency-sponsored studies that could reduce our development costs.", "sentB": "We may also consider and evaluate strategic alternatives, including investment in, or acquisition of, complementary businesses, technologies or products.", "type": 2, "words": ["<tag1>", "We", "may", "also", "apply", "for", "subsidies,", "grants,", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs.", "<tag2>", "We", "may", "also", "consider", "and", "evaluate", "strategic", "alternatives,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products.", "<tag3>"], "wordsA": ["We", "may", "also", "apply", "for", "subsidies,", "grants,", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs."], "wordsB": ["We", "may", "also", "consider", "and", "evaluate", "strategic", "alternatives,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03253092244267464, 0.012534964829683304, 0.011564639396965504, 0.34152156114578247, 0.09668236970901489, 0.3868209421634674, 0.3863392472267151, 0.4281594157218933, 0.010185923427343369, 0.15611235797405243, 0.08778609335422516, 0.0220369603484869, 0.15813080966472626, 0.04076908156275749, 0.06706144660711288, 0.15271782875061035, 0.07208771258592606, 0.019708914682269096, 0.07758383452892303, -1]}
{"idB": "749647_13_item1_p68_s0", "idA": "749647_12_item1_p27_s3", "sentA": "We may also apply for subsidies, grants, or government or agency-sponsored studies that could reduce our development costs.", "sentB": "We may also consider and evaluate strategic alternatives, including investment in, or acquisition of, complementary businesses, technologies or products.", "type": 2, "words": ["<tag1>", "We", "may", "also", "apply", "for", "subsidies,", "grants,", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs.", "<tag2>", "We", "may", "also", "consider", "and", "evaluate", "strategic", "alternatives,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products.", "<tag3>"], "wordsA": ["We", "may", "also", "apply", "for", "subsidies,", "grants,", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs."], "wordsB": ["We", "may", "also", "consider", "and", "evaluate", "strategic", "alternatives,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03253092244267464, 0.012534964829683304, 0.011564639396965504, 0.34152156114578247, 0.09668236970901489, 0.3868209421634674, 0.3863392472267151, 0.4281594157218933, 0.010185923427343369, 0.15611235797405243, 0.08778609335422516, 0.0220369603484869, 0.15813080966472626, 0.04076908156275749, 0.06706144660711288, 0.15271782875061035, 0.07208771258592606, 0.019708914682269096, 0.07758383452892303, -1]}
{"idB": "749647_13_item1_p119_s2", "idA": "749647_12_item1_p32_s3", "sentA": "Currently in a Phase III clinical trial for primary liver cancer and in two Phase II studies for recurrent chest wall breast cancer and CRLM, Celsion has completed animal studies that demonstrate intravenous administration of ThermoDox , in combination with targeted heat to the tumor, can produce doxorubicin drug concentrations in tumor tissue that are much greater than approved liposomal formulations of doxorubicin on the market today.", "sentB": "and we continue to collaborate and are evaluating next steps in relation to ThermoDox , which include the sub-group analysis of the Chinese cohort of patients in the Phase III clinical trial for primary liver cancer and other activities to further the development of ThermoDox for mainland China, Hong Kong and Macau.", "type": 2, "words": ["<tag1>", "Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "in", "two", "Phase", "II", "studies", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "CRLM,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrate", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today.", "<tag2>", "and", "we", "continue", "to", "collaborate", "and", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "mainland", "China,", "Hong", "Kong", "and", "Macau.", "<tag3>"], "wordsA": ["Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "in", "two", "Phase", "II", "studies", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "CRLM,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrate", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today."], "wordsB": ["and", "we", "continue", "to", "collaborate", "and", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "mainland", "China,", "Hong", "Kong", "and", "Macau."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013555407524108887, 0.06072690337896347, 0.04484861344099045, 0.04431824013590813, 0.12831825017929077, 0.015318197198212147, 0.019646093249320984, 0.31721633672714233, 0.1590312123298645, 0.12143831700086594, 0.02839278243482113, 0.06381832808256149, 0.030935782939195633, 0.03393649309873581, 0.00022666656877845526, 0.0006076408899389207, 0.014870235696434975, 0.01075731497257948, 0.2878904938697815, 0.29098445177078247, 0.03364326059818268, 0.01929018460214138, 0.10941877216100693, 0.1472114622592926, 0.11371664702892303, 0.19402386248111725, 0.0058212620206177235, 0.004778583999723196, 0.02285069040954113, 0.014244860038161278, 0.01816939376294613, 0.029304757714271545, 0.0061471424996852875, 0.011918216943740845, 0.0243544764816761, 0.018781578168272972, 0.006204457487910986, 0.014183703809976578, 0.05743372067809105, 0.005391030106693506, 0.010656682774424553, 0.008507046848535538, 0.03300295025110245, 0.013743560761213303, 0.03425264358520508, 0.007964730262756348, 0.07337827235460281, 0.08414167910814285, 0.05110345035791397, 0.038424037396907806, 0.10326460748910904, 0.10924512147903442, -1]}
{"idB": "749647_13_item1_p16_s3", "idA": "749647_12_item1_p32_s3", "sentA": "Currently in a Phase III clinical trial for primary liver cancer and in two Phase II studies for recurrent chest wall breast cancer and CRLM, Celsion has completed animal studies that demonstrate intravenous administration of ThermoDox , in combination with targeted heat to the tumor, can produce doxorubicin drug concentrations in tumor tissue that are much greater than approved liposomal formulations of doxorubicin on the market today.", "sentB": "Following our announcement of the HEAT study results on January 31, 2013, we and Hisun are evaluating next steps in relation to ThermoDox , which include the sub-group analysis of the Chinese cohort of patients in the Phase III clinical trial for primary liver cancer and other activities to further the development of ThermoDox for the China territory.", "type": 2, "words": ["<tag1>", "Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "in", "two", "Phase", "II", "studies", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "CRLM,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrate", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today.", "<tag2>", "Following", "our", "announcement", "of", "the", "HEAT", "study", "results", "on", "January", "31,", "2013,", "we", "and", "Hisun", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag3>"], "wordsA": ["Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "in", "two", "Phase", "II", "studies", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "CRLM,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrate", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today."], "wordsB": ["Following", "our", "announcement", "of", "the", "HEAT", "study", "results", "on", "January", "31,", "2013,", "we", "and", "Hisun", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04147319123148918, 0.05518670380115509, 0.16242091357707977, 0.0475764200091362, 0.034548040479421616, 0.17985795438289642, 0.1958085149526596, 0.09601671248674393, 0.02955944649875164, 0.05468092858791351, 0.06150028854608536, 0.09520478546619415, 0.1573575735092163, 0.050014428794384, 0.2097151130437851, 0.021082470193505287, 0.2621413469314575, 0.1637243926525116, 0.15965408086776733, 0.03939669951796532, 0.06626527011394501, 0.04411917179822922, 0.04019399359822273, 0.00019118851923849434, 0.0009598255855962634, 0.01499114092439413, 0.010423392988741398, 0.4446087181568146, 0.38040587306022644, 0.01885230839252472, 0.01294257864356041, 0.07962388545274734, 0.09317626804113388, 0.0606573112308979, 0.1468486189842224, 0.004834436345845461, 0.004408742301166058, 0.012259865179657936, 0.01094275526702404, 0.013113615103065968, 0.01996667869389057, 0.005632766988128424, 0.011702503077685833, 0.019937461242079735, 0.0171097032725811, 0.005227718036621809, 0.010423875413835049, 0.04840254411101341, 0.005163324996829033, 0.006626658141613007, 0.006026586052030325, 0.02680049277842045, 0.009380675852298737, 0.029376935213804245, 0.006941766478121281, 0.008366010151803493, 0.05113474279642105, 0.047544125467538834, -1]}
{"idB": "749647_13_item1_p44_s2", "idA": "749647_12_item1_p32_s3", "sentA": "Currently in a Phase III clinical trial for primary liver cancer and in two Phase II studies for recurrent chest wall breast cancer and CRLM, Celsion has completed animal studies that demonstrate intravenous administration of ThermoDox , in combination with targeted heat to the tumor, can produce doxorubicin drug concentrations in tumor tissue that are much greater than approved liposomal formulations of doxorubicin on the market today.", "sentB": "and we continue to collaborate and are evaluating next steps in relation to ThermoDox , which include the sub-group analysis of the Chinese cohort of patients in the Phase III clinical trial for primary liver cancer and other activities to further the development of ThermoDox for the China territory.", "type": 2, "words": ["<tag1>", "Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "in", "two", "Phase", "II", "studies", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "CRLM,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrate", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today.", "<tag2>", "and", "we", "continue", "to", "collaborate", "and", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag3>"], "wordsA": ["Currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "in", "two", "Phase", "II", "studies", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "CRLM,", "Celsion", "has", "completed", "animal", "studies", "that", "demonstrate", "intravenous", "administration", "of", "ThermoDox", ",", "in", "combination", "with", "targeted", "heat", "to", "the", "tumor,", "can", "produce", "doxorubicin", "drug", "concentrations", "in", "tumor", "tissue", "that", "are", "much", "greater", "than", "approved", "liposomal", "formulations", "of", "doxorubicin", "on", "the", "market", "today."], "wordsB": ["and", "we", "continue", "to", "collaborate", "and", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013409292325377464, 0.062252871692180634, 0.04582783952355385, 0.043554291129112244, 0.13102194666862488, 0.014765762723982334, 0.01935446448624134, 0.30341479182243347, 0.15057259798049927, 0.11371342092752457, 0.02724345773458481, 0.0619359090924263, 0.02970019169151783, 0.03452057018876076, 0.00022625310521107167, 0.0005676080472767353, 0.014389712363481522, 0.010561625473201275, 0.26621872186660767, 0.2686898112297058, 0.030482472851872444, 0.018034804612398148, 0.12752853333950043, 0.15740340948104858, 0.11432262510061264, 0.21045520901679993, 0.0057951919734478, 0.00484529510140419, 0.02511781081557274, 0.015303509309887886, 0.01966572180390358, 0.03193990886211395, 0.006007874384522438, 0.013220975175499916, 0.026035945862531662, 0.019650494679808617, 0.006681973580271006, 0.01729646511375904, 0.07295998185873032, 0.005888449959456921, 0.011765549890697002, 0.008317512460052967, 0.03350849077105522, 0.014967839233577251, 0.037449195981025696, 0.007426527328789234, 0.010089144110679626, 0.05539006367325783, 0.052592575550079346, -1]}
{"idB": "749647_13_item1_p29_s0", "idA": "749647_12_item1_p36_s0", "sentA": "At an early stage, the standard first line treatment for liver cancer is surgical resection of the tumor, up to 80% of patients are ineligible for surgery or transplantation at time of diagnosis as early stage liver cancer generally has few symptoms and when finally detected the tumor frequently is too large for surgery.", "sentB": "At an early stage, the standard first line treatment for liver cancer is surgical resection of the tumor.", "type": 2, "words": ["<tag1>", "At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor,", "up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery.", "<tag2>", "At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor.", "<tag3>"], "wordsA": ["At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor,", "up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery."], "wordsB": ["At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014472425915300846, 0.008968222886323929, 0.10203327983617783, 0.0935957282781601, 0.010726597160100937, 0.1973266899585724, 0.16790065169334412, 0.1798962652683258, 0.3329755663871765, 0.06172223761677742, 0.4901912808418274, 0.24678701162338257, 0.04280071705579758, 0.28437286615371704, 0.5624328255653381, 0.10226856172084808, 0.12403004616498947, 0.5633298754692078, -1]}
{"idB": "749647_13_item1_p29_s1", "idA": "749647_12_item1_p36_s0", "sentA": "At an early stage, the standard first line treatment for liver cancer is surgical resection of the tumor, up to 80% of patients are ineligible for surgery or transplantation at time of diagnosis as early stage liver cancer generally has few symptoms and when finally detected the tumor frequently is too large for surgery.", "sentB": "Up to 80% of patients are ineligible for surgery or transplantation at time of diagnosis as early stage liver cancer generally has few symptoms and when finally detected the tumor frequently is too large for surgery.", "type": 2, "words": ["<tag1>", "At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor,", "up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery.", "<tag2>", "Up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery.", "<tag3>"], "wordsA": ["At", "an", "early", "stage,", "the", "standard", "first", "line", "treatment", "for", "liver", "cancer", "is", "surgical", "resection", "of", "the", "tumor,", "up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery."], "wordsB": ["Up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006444599479436874, 0.007759639993309975, 0.04649672284722328, 0.02386564202606678, 0.09977879375219345, 0.11741945147514343, 0.9270211458206177, 0.25305885076522827, 0.19076202809810638, 0.052300985902547836, 0.0902155414223671, 0.008036516606807709, 0.004907769151031971, 0.004010304808616638, 0.005492818541824818, 0.0031088090036064386, 0.005848845932632685, 0.005284310784190893, 0.006592584773898125, 0.009420524351298809, 0.009388222359120846, 0.013150249607861042, 0.047863855957984924, 0.02664015255868435, 0.0029093825723975897, 0.004764614626765251, 0.008468017913401127, 0.00842465553432703, 0.0037899953313171864, 0.020530790090560913, 0.01018878910690546, 0.015396060422062874, 0.0654008537530899, 0.042431704699993134, 0.03241908550262451, 0.07625063508749008, -1]}
{"idB": "749647_13_item1_p32_s0", "idA": "749647_12_item1_p39_s0", "sentA": "ThermoDox treatment approach is designed to utilize the ability of RFA devices to ablate the center of the tumor while simultaneously thermally activating the ThermoDox liposome to release its encapsulated doxorubicin to kill remaining viable cancer cells throughout the heated region, including the tumor ablation margins.", "sentB": "Celsion s ThermoDox treatment approach is designed to utilize the ability of RFA devices to ablate the center of the tumor while simultaneously thermally activating the ThermoDox liposome to release its encapsulated doxorubicin to kill remaining viable cancer cells throughout the heated region, including the tumor ablation margins.", "type": 2, "words": ["<tag1>", "ThermoDox", "treatment", "approach", "is", "designed", "to", "utilize", "the", "ability", "of", "RFA", "devices", "to", "ablate", "the", "center", "of", "the", "tumor", "while", "simultaneously", "thermally", "activating", "the", "ThermoDox", "liposome", "to", "release", "its", "encapsulated", "doxorubicin", "to", "kill", "remaining", "viable", "cancer", "cells", "throughout", "the", "heated", "region,", "including", "the", "tumor", "ablation", "margins.", "<tag2>", "Celsion", "s", "ThermoDox", "treatment", "approach", "is", "designed", "to", "utilize", "the", "ability", "of", "RFA", "devices", "to", "ablate", "the", "center", "of", "the", "tumor", "while", "simultaneously", "thermally", "activating", "the", "ThermoDox", "liposome", "to", "release", "its", "encapsulated", "doxorubicin", "to", "kill", "remaining", "viable", "cancer", "cells", "throughout", "the", "heated", "region,", "including", "the", "tumor", "ablation", "margins.", "<tag3>"], "wordsA": ["ThermoDox", "treatment", "approach", "is", "designed", "to", "utilize", "the", "ability", "of", "RFA", "devices", "to", "ablate", "the", "center", "of", "the", "tumor", "while", "simultaneously", "thermally", "activating", "the", "ThermoDox", "liposome", "to", "release", "its", "encapsulated", "doxorubicin", "to", "kill", "remaining", "viable", "cancer", "cells", "throughout", "the", "heated", "region,", "including", "the", "tumor", "ablation", "margins."], "wordsB": ["Celsion", "s", "ThermoDox", "treatment", "approach", "is", "designed", "to", "utilize", "the", "ability", "of", "RFA", "devices", "to", "ablate", "the", "center", "of", "the", "tumor", "while", "simultaneously", "thermally", "activating", "the", "ThermoDox", "liposome", "to", "release", "its", "encapsulated", "doxorubicin", "to", "kill", "remaining", "viable", "cancer", "cells", "throughout", "the", "heated", "region,", "including", "the", "tumor", "ablation", "margins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.9641767740249634, 0.8405855894088745, 0.09933625906705856, 0.05141334608197212, 0.02027006261050701, 0.0030412308406084776, 0.004425194580107927, 0.0029811745043843985, 0.0037644263356924057, 0.005704349372535944, 0.005081675946712494, 0.0031061486806720495, 0.011150757782161236, 0.007099705748260021, 0.002888935385271907, 0.006027665920555592, 0.004186034668236971, 0.007085477467626333, 0.004368844907730818, 0.004582365043461323, 0.009287193417549133, 0.00441998103633523, 0.007674741558730602, 0.011543743312358856, 0.007619958370923996, 0.003753598080947995, 0.010333310812711716, 0.01105846930295229, 0.003934915643185377, 0.005081540904939175, 0.005237869918346405, 0.009500307030975819, 0.014611377380788326, 0.00384143041446805, 0.011963960714638233, 0.014266113750636578, 0.02871272899210453, 0.012062289752066135, 0.01546976063400507, 0.003216348122805357, 0.002811351791024208, 0.006533734500408173, 0.006206610705703497, 0.0035955801140516996, 0.002847272204235196, 0.006549203302711248, 0.006490058731287718, 0.007357320282608271, -1]}
{"idB": "749647_13_item1_p116_s0", "idA": "749647_12_item1_p40_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "On January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma, also known as primary liver cancer.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma,", "also", "known", "as", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma,", "also", "known", "as", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02882469817996025, 0.13587485253810883, 0.1365930289030075, 0.7003013491630554, 0.026527039706707, 0.06757877767086029, 0.014449529349803925, 0.04740922525525093, 0.004173723049461842, 0.0037743786815553904, 0.0037573303561657667, 0.00696892524138093, 0.25292885303497314, 0.4370726943016052, 0.27470722794532776, 0.08973923325538635, 0.15132573246955872, 0.13805867731571198, 0.009625239297747612, 0.015373308211565018, 0.10006142407655716, 0.2790539562702179, 0.006639555562287569, 0.038646455854177475, 0.02724817581474781, 0.2534678280353546, 0.11800200492143631, 0.004299242980778217, 0.0038005709648132324, 0.004384188447147608, 0.0323641300201416, 0.0225633904337883, 0.01835945062339306, -1]}
{"idB": "749647_13_item1_p119_s0", "idA": "749647_12_item1_p40_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "Following our announcement on January 31, 2013 that ThermoDox in combination with RFA did not meet the primary endpoint of the Phase III clinical trial for primary liver cancer, Hisun elected to terminate the exclusive option agreement and not to pursue the option to enter into an exclusive license agreement with us for the China territory, which termination took effect as of February 1, 2013.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "Following", "our", "announcement", "on", "January", "31,", "2013", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer,", "Hisun", "elected", "to", "terminate", "the", "exclusive", "option", "agreement", "and", "not", "to", "pursue", "the", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "China", "territory,", "which", "termination", "took", "effect", "as", "of", "February", "1,", "2013.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["Following", "our", "announcement", "on", "January", "31,", "2013", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer,", "Hisun", "elected", "to", "terminate", "the", "exclusive", "option", "agreement", "and", "not", "to", "pursue", "the", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "China", "territory,", "which", "termination", "took", "effect", "as", "of", "February", "1,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02008339948952198, 0.025556545704603195, 0.07380596548318863, 0.020423520356416702, 0.12047617137432098, 0.12737591564655304, 0.5928044319152832, 0.01598241925239563, 0.07033143937587738, 0.004923118744045496, 0.004214573185890913, 0.004219349008053541, 0.006991972681134939, 0.42426878213882446, 0.5502328872680664, 0.3660082221031189, 0.10466986149549484, 0.1393217146396637, 0.19385193288326263, 0.00895934458822012, 0.010600018315017223, 0.044416483491659164, 0.056569188833236694, 0.08581417798995972, 0.10319119691848755, 0.005708223674446344, 0.06655310094356537, 0.03809826076030731, 0.021322529762983322, 0.020320169627666473, 0.058874890208244324, 0.054868899285793304, 0.18859556317329407, 0.039546746760606766, 0.15390099585056305, 0.20088423788547516, 0.1428634524345398, 0.00013456286978907883, 0.04736647754907608, 0.03895031660795212, 0.10899463295936584, 0.020637447014451027, 0.048905860632658005, 0.017727263271808624, 0.06882678717374802, 0.07874946296215057, 0.03716524317860603, 0.14442935585975647, 0.218740314245224, 0.13821351528167725, 0.015404114499688148, 0.03778406232595444, 0.006578671745955944, 0.009371140971779823, 0.0185735821723938, 0.01927207037806511, 0.00011423594696680084, 0.051436979323625565, 0.010488715022802353, 0.009308231063187122, 0.020354468375444412, 0.01618906855583191, 0.05338826775550842, 0.061321794986724854, 0.23379004001617432, -1]}
{"idB": "749647_13_item1_p35_s3", "idA": "749647_12_item1_p40_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "Following review by the DMC, on January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04897497966885567, 0.11970462650060654, 0.01566511206328869, 0.019539084285497665, 0.06683352589607239, 0.019132038578391075, 0.10812173038721085, 0.12087902426719666, 0.6481537222862244, 0.022366836667060852, 0.05019478127360344, 0.013393637724220753, 0.04826078191399574, 0.004446785431355238, 0.00442767608910799, 0.00395199516788125, 0.008573447354137897, 0.35817787051200867, 0.5437401533126831, 0.3398352563381195, 0.08666225522756577, 0.16433407366275787, 0.14385400712490082, 0.008338719606399536, 0.012244722805917263, 0.0995406061410904, 0.21550112962722778, 0.010087085887789726, 0.059913270175457, 0.046352967619895935, 0.40522778034210205, 0.21940335631370544, 0.10004071146249771, 0.004560163710266352, 0.005921153351664543, 0.0053938329219818115, 0.0367710217833519, 0.02371819131076336, 0.025418151170015335, -1]}
{"idB": "749647_13_item1_p44_s0", "idA": "749647_12_item1_p40_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "Following our announcement on January 31, 2013 that ThermoDox in combination with RFA did not meet the primary endpoint of the Phase III clinical trial for primary liver cancer, Hisun elected to terminate the exclusive option agreement and not to pursue the option to enter into an exclusive license agreement with us for the China territory, which termination took effect as of February 1, 2013.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "Following", "our", "announcement", "on", "January", "31,", "2013", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer,", "Hisun", "elected", "to", "terminate", "the", "exclusive", "option", "agreement", "and", "not", "to", "pursue", "the", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "China", "territory,", "which", "termination", "took", "effect", "as", "of", "February", "1,", "2013.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["Following", "our", "announcement", "on", "January", "31,", "2013", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer,", "Hisun", "elected", "to", "terminate", "the", "exclusive", "option", "agreement", "and", "not", "to", "pursue", "the", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "China", "territory,", "which", "termination", "took", "effect", "as", "of", "February", "1,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02008339948952198, 0.025556545704603195, 0.07380596548318863, 0.020423520356416702, 0.12047617137432098, 0.12737591564655304, 0.5928044319152832, 0.01598241925239563, 0.07033143937587738, 0.004923118744045496, 0.004214573185890913, 0.004219349008053541, 0.006991972681134939, 0.42426878213882446, 0.5502328872680664, 0.3660082221031189, 0.10466986149549484, 0.1393217146396637, 0.19385193288326263, 0.00895934458822012, 0.010600018315017223, 0.044416483491659164, 0.056569188833236694, 0.08581417798995972, 0.10319119691848755, 0.005708223674446344, 0.06655310094356537, 0.03809826076030731, 0.021322529762983322, 0.020320169627666473, 0.058874890208244324, 0.054868899285793304, 0.18859556317329407, 0.039546746760606766, 0.15390099585056305, 0.20088423788547516, 0.1428634524345398, 0.00013456286978907883, 0.04736647754907608, 0.03895031660795212, 0.10899463295936584, 0.020637447014451027, 0.048905860632658005, 0.017727263271808624, 0.06882678717374802, 0.07874946296215057, 0.03716524317860603, 0.14442935585975647, 0.218740314245224, 0.13821351528167725, 0.015404114499688148, 0.03778406232595444, 0.006578671745955944, 0.009371140971779823, 0.0185735821723938, 0.01927207037806511, 0.00011423594696680084, 0.051436979323625565, 0.010488715022802353, 0.009308231063187122, 0.020354468375444412, 0.01618906855583191, 0.05338826775550842, 0.061321794986724854, 0.23379004001617432, -1]}
{"idB": "749647_13_item1_p82_s0", "idA": "749647_12_item1_p40_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "On January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02881770208477974, 0.12821410596370697, 0.13284428417682648, 0.6901416182518005, 0.024850377812981606, 0.06396503746509552, 0.013922600075602531, 0.04311021789908409, 0.0040364740416407585, 0.0037755947560071945, 0.0037305732257664204, 0.007274066563695669, 0.25849419832229614, 0.4454360604286194, 0.26767921447753906, 0.08917930722236633, 0.1617528796195984, 0.13336320221424103, 0.009780975989997387, 0.015048226341605186, 0.1000230461359024, 0.26077109575271606, 0.006988063454627991, 0.046402886509895325, 0.0333518423140049, 0.3154667615890503, 0.15384957194328308, 0.06717284023761749, 0.006890068296343088, 0.004589974880218506, 0.005174736957997084, 0.11632011085748672, 0.058944471180438995, 0.04410332441329956, -1]}
{"idB": "749647_13_item1_p46_s1", "idA": "749647_12_item1_p40_s1", "sentA": "The study was carried out at the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) and Queen Mary Hospital in Hong Kong.", "sentB": "The trial, which is supported by the National Institute for Health Research Oxford Biomedical Research Centre, will be carried out as a multidisciplinary collaboration between us, the Oxford University Institute of Biomedical Engineering and the Oxford University Hospitals NHS Trust.", "type": 2, "words": ["<tag1>", "The", "study", "was", "carried", "out", "at", "the", "National", "Cancer", "Institute", "(NCI),", "which", "is", "part", "of", "the", "National", "Institutes", "of", "Health", "(NIH)", "and", "Queen", "Mary", "Hospital", "in", "Hong", "Kong.", "<tag2>", "The", "trial,", "which", "is", "supported", "by", "the", "National", "Institute", "for", "Health", "Research", "Oxford", "Biomedical", "Research", "Centre,", "will", "be", "carried", "out", "as", "a", "multidisciplinary", "collaboration", "between", "us,", "the", "Oxford", "University", "Institute", "of", "Biomedical", "Engineering", "and", "the", "Oxford", "University", "Hospitals", "NHS", "Trust.", "<tag3>"], "wordsA": ["The", "study", "was", "carried", "out", "at", "the", "National", "Cancer", "Institute", "(NCI),", "which", "is", "part", "of", "the", "National", "Institutes", "of", "Health", "(NIH)", "and", "Queen", "Mary", "Hospital", "in", "Hong", "Kong."], "wordsB": ["The", "trial,", "which", "is", "supported", "by", "the", "National", "Institute", "for", "Health", "Research", "Oxford", "Biomedical", "Research", "Centre,", "will", "be", "carried", "out", "as", "a", "multidisciplinary", "collaboration", "between", "us,", "the", "Oxford", "University", "Institute", "of", "Biomedical", "Engineering", "and", "the", "Oxford", "University", "Hospitals", "NHS", "Trust."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007802857551723719, 0.18343877792358398, 0.004461078438907862, 0.003970826510339975, 0.03376789018511772, 0.02516157180070877, 0.017345843836665154, 0.10293363034725189, 0.1744120568037033, 0.07273125648498535, 0.18439793586730957, 0.1427699327468872, 0.18840886652469635, 0.39444851875305176, 0.44080302119255066, 0.39599689841270447, 0.003472054610028863, 0.0035875942558050156, 0.02072443813085556, 0.01336271408945322, 0.0048469738103449345, 0.005374770145863295, 0.1483387053012848, 0.10126009583473206, 0.031835123896598816, 0.06517753005027771, 0.022841650992631912, 0.4255976378917694, 0.39183369278907776, 0.29479625821113586, 0.08015316724777222, 0.32465243339538574, 0.32929596304893494, 0.034274112433195114, 0.02626359462738037, 0.31505703926086426, 0.37004977464675903, 0.368179589509964, 0.5235622525215149, 0.4724656641483307, -1]}
{"idB": "749647_13_item1_p35_s1", "idA": "749647_12_item1_p42_s0", "sentA": "For primary liver cancer, our HEAT study to evaluate ThermoDox is a pivotal 600 patient double-blinded, placebo-controlled, global Phase III study conducted at 79 clinical sites under a Special Protocol Assessment (SPA) agreement with the FDA.", "sentB": "The Special Protocol Assessment agreed to with the FDA specified Progression Free Survival (PFS) as the HEAT study s primary endpoint.", "type": 2, "words": ["<tag1>", "For", "primary", "liver", "cancer,", "our", "HEAT", "study", "to", "evaluate", "ThermoDox", "is", "a", "pivotal", "600", "patient", "double-blinded,", "placebo-controlled,", "global", "Phase", "III", "study", "conducted", "at", "79", "clinical", "sites", "under", "a", "Special", "Protocol", "Assessment", "(SPA)", "agreement", "with", "the", "FDA.", "<tag2>", "The", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "FDA", "specified", "Progression", "Free", "Survival", "(PFS)", "as", "the", "HEAT", "study", "s", "primary", "endpoint.", "<tag3>"], "wordsA": ["For", "primary", "liver", "cancer,", "our", "HEAT", "study", "to", "evaluate", "ThermoDox", "is", "a", "pivotal", "600", "patient", "double-blinded,", "placebo-controlled,", "global", "Phase", "III", "study", "conducted", "at", "79", "clinical", "sites", "under", "a", "Special", "Protocol", "Assessment", "(SPA)", "agreement", "with", "the", "FDA."], "wordsB": ["The", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "FDA", "specified", "Progression", "Free", "Survival", "(PFS)", "as", "the", "HEAT", "study", "s", "primary", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002785908291116357, 0.024206940084695816, 0.034793488681316376, 0.044511083513498306, 0.014801740646362305, 0.006088742986321449, 0.003639863571152091, 0.005017868243157864, 0.022602569311857224, 0.07926619797945023, 0.892087459564209, 0.9040754437446594, 0.8775550127029419, 0.8363649249076843, 0.025242120027542114, 0.01050981879234314, 0.03358525037765503, 0.04928432032465935, 0.021627170965075493, 0.08821435272693634, 0.08892960846424103, -1]}
{"idB": "749647_13_item1_p117_s0", "idA": "749647_12_item1_p42_s1", "sentA": "The HEAT study is designed to evaluate the efficacy of ThermoDox in combination with RFA when compared to patients who receive RFA alone as the control.", "sentB": "The HEAT study was designed to show a 33 percent improvement in PFS with 80 percent power and a p-value = 0.05.", "type": 2, "words": ["<tag1>", "The", "HEAT", "study", "is", "designed", "to", "evaluate", "the", "efficacy", "of", "ThermoDox", "in", "combination", "with", "RFA", "when", "compared", "to", "patients", "who", "receive", "RFA", "alone", "as", "the", "control.", "<tag2>", "The", "HEAT", "study", "was", "designed", "to", "show", "a", "33", "percent", "improvement", "in", "PFS", "with", "80", "percent", "power", "and", "a", "p-value", "=", "0.05.", "<tag3>"], "wordsA": ["The", "HEAT", "study", "is", "designed", "to", "evaluate", "the", "efficacy", "of", "ThermoDox", "in", "combination", "with", "RFA", "when", "compared", "to", "patients", "who", "receive", "RFA", "alone", "as", "the", "control."], "wordsB": ["The", "HEAT", "study", "was", "designed", "to", "show", "a", "33", "percent", "improvement", "in", "PFS", "with", "80", "percent", "power", "and", "a", "p-value", "=", "0.05."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00253664655610919, 0.022272704169154167, 0.04090336710214615, 0.003689258359372616, 0.0426994189620018, 0.015037374570965767, 0.13788771629333496, 0.06222432851791382, 0.4780328571796417, 0.40297192335128784, 0.42388060688972473, 0.17648755013942719, 0.5780779123306274, 0.02624901756644249, 0.22032380104064941, 0.27698737382888794, 0.2068144530057907, 0.0001735156838549301, 0.030908599495887756, 0.16661925613880157, 0.16933561861515045, 0.5277978777885437, -1]}
{"idB": "749647_13_item1_p36_s0", "idA": "749647_12_item1_p42_s1", "sentA": "The HEAT study is designed to evaluate the efficacy of ThermoDox in combination with RFA when compared to patients who receive RFA alone as the control.", "sentB": "The HEAT study was designed to show a 33 percent improvement in PFS with 80 percent power and a p-value = 0.05.", "type": 2, "words": ["<tag1>", "The", "HEAT", "study", "is", "designed", "to", "evaluate", "the", "efficacy", "of", "ThermoDox", "in", "combination", "with", "RFA", "when", "compared", "to", "patients", "who", "receive", "RFA", "alone", "as", "the", "control.", "<tag2>", "The", "HEAT", "study", "was", "designed", "to", "show", "a", "33", "percent", "improvement", "in", "PFS", "with", "80", "percent", "power", "and", "a", "p-value", "=", "0.05.", "<tag3>"], "wordsA": ["The", "HEAT", "study", "is", "designed", "to", "evaluate", "the", "efficacy", "of", "ThermoDox", "in", "combination", "with", "RFA", "when", "compared", "to", "patients", "who", "receive", "RFA", "alone", "as", "the", "control."], "wordsB": ["The", "HEAT", "study", "was", "designed", "to", "show", "a", "33", "percent", "improvement", "in", "PFS", "with", "80", "percent", "power", "and", "a", "p-value", "=", "0.05."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00253664655610919, 0.022272704169154167, 0.04090336710214615, 0.003689258359372616, 0.0426994189620018, 0.015037374570965767, 0.13788771629333496, 0.06222432851791382, 0.4780328571796417, 0.40297192335128784, 0.42388060688972473, 0.17648755013942719, 0.5780779123306274, 0.02624901756644249, 0.22032380104064941, 0.27698737382888794, 0.2068144530057907, 0.0001735156838549301, 0.030908599495887756, 0.16661925613880157, 0.16933561861515045, 0.5277978777885437, -1]}
{"idB": "749647_13_item1_p104_s5", "idA": "749647_12_item1_p49_s2", "sentA": "In 2011, the European Commission granted orphan drug designation for ThermoDox for the treatment of HCC in Europe.", "sentB": "This extended patent runway to 2026 allows for the evaluation of future development activities for ThermoDox and Celsion's heat-sensitive liposome technology platform.", "type": 2, "words": ["<tag1>", "In", "2011,", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe.", "<tag2>", "This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion's", "heat-sensitive", "liposome", "technology", "platform.", "<tag3>"], "wordsA": ["In", "2011,", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe."], "wordsB": ["This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion's", "heat-sensitive", "liposome", "technology", "platform."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02002289891242981, 0.19317153096199036, 0.3902635872364044, 0.21766401827335358, 0.07187651097774506, 0.33450570702552795, 0.01086744386702776, 0.00979666318744421, 0.009694239124655724, 0.10916382074356079, 0.02543955296278, 0.10349570959806442, 0.2733439803123474, 0.13184505701065063, 0.01605377346277237, 0.03616880252957344, 0.0197922233492136, 0.0531378798186779, 0.1641007959842682, 0.16496671736240387, 0.0689539685845375, 0.08041422814130783, -1]}
{"idB": "749647_13_item1_p12_s0", "idA": "749647_12_item1_p50_s0", "sentA": "In December 2011, the European Medicines Agency (EMA) provided written, scientific advice confirming that the HEAT Study, a multinational, double-blind, placebo controlled pivotal study of ThermoDox in combination with radio frequency ablation (RFA) for the treatment of hepatocellular carcinoma (HCC), or primary liver cancer, is acceptable as a basis for submission of a marketing authorization application (MAA).", "sentB": "On January 31, 2013, we announced that ThermoDox in combination with radio frequency ablation did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma, also known as primary liver cancer.", "type": 2, "words": ["<tag1>", "In", "December", "2011,", "the", "European", "Medicines", "Agency", "(EMA)", "provided", "written,", "scientific", "advice", "confirming", "that", "the", "HEAT", "Study,", "a", "multinational,", "double-blind,", "placebo", "controlled", "pivotal", "study", "of", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "hepatocellular", "carcinoma", "(HCC),", "or", "primary", "liver", "cancer,", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application", "(MAA).", "<tag2>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma,", "also", "known", "as", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["In", "December", "2011,", "the", "European", "Medicines", "Agency", "(EMA)", "provided", "written,", "scientific", "advice", "confirming", "that", "the", "HEAT", "Study,", "a", "multinational,", "double-blind,", "placebo", "controlled", "pivotal", "study", "of", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "hepatocellular", "carcinoma", "(HCC),", "or", "primary", "liver", "cancer,", "is", "acceptable", "as", "a", "basis", "for", "submission", "of", "a", "marketing", "authorization", "application", "(MAA)."], "wordsB": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma,", "also", "known", "as", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024831682443618774, 0.2844145894050598, 0.2630790174007416, 0.6535893082618713, 0.04982510954141617, 0.08779891580343246, 0.018825935199856758, 0.06751987338066101, 0.0048765866085886955, 0.004996975883841515, 0.0029076787177473307, 0.00800691731274128, 0.005183601286262274, 0.007404401898384094, 0.4729647934436798, 0.6833866238594055, 0.39175236225128174, 0.11954712122678757, 0.21855783462524414, 0.17174918949604034, 0.006890139542520046, 0.008476982824504375, 0.028020739555358887, 0.04605141282081604, 0.009869654662907124, 0.059022944420576096, 0.00869053229689598, 0.012512780725955963, 0.010946446098387241, 0.003577658673748374, 0.00565378786996007, 0.005649395752698183, 0.02451200596988201, 0.02333553321659565, 0.01945420168340206, -1]}
{"idB": "749647_13_item1_p52_s0", "idA": "749647_12_item1_p55_s1", "sentA": "ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "sentB": "We have been actively seeking a targeted localized treatment for breast cancer using ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "type": 2, "words": ["<tag1>", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag2>", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "wordsB": ["We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1016000360250473, 0.043932486325502396, 0.0346221849322319, 0.3094862997531891, 0.47709354758262634, 0.12451699376106262, 0.3818260431289673, 0.4020000994205475, 0.4820958375930786, 0.04045134410262108, 0.06642991304397583, 0.08711552619934082, 0.03324901685118675, 0.061261966824531555, 0.007857182063162327, 0.011159847490489483, 0.00836437288671732, 0.029739970341324806, 0.027477731928229332, 0.02367462031543255, 0.005744630470871925, 0.011341127566993237, 0.02414603717625141, 0.01795794814825058, 0.017337694764137268, -1]}
{"idB": "749647_13_item1_p53_s2", "idA": "749647_12_item1_p56_s2", "sentA": "Upon heating to 40 to 42 C, a significant concentration of doxorubicin is released directly to the tumor.", "sentB": "Upon heating to 39.5 to 42 C, a significant concentration of doxorubicin is released directly to the tumor.", "type": 2, "words": ["<tag1>", "Upon", "heating", "to", "40", "to", "42", "C,", "a", "significant", "concentration", "of", "doxorubicin", "is", "released", "directly", "to", "the", "tumor.", "<tag2>", "Upon", "heating", "to", "39.5", "to", "42", "C,", "a", "significant", "concentration", "of", "doxorubicin", "is", "released", "directly", "to", "the", "tumor.", "<tag3>"], "wordsA": ["Upon", "heating", "to", "40", "to", "42", "C,", "a", "significant", "concentration", "of", "doxorubicin", "is", "released", "directly", "to", "the", "tumor."], "wordsB": ["Upon", "heating", "to", "39.5", "to", "42", "C,", "a", "significant", "concentration", "of", "doxorubicin", "is", "released", "directly", "to", "the", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002327660797163844, 0.013402978889644146, 0.012014197185635567, 0.9811751246452332, 0.04802483320236206, 0.011445374228060246, 0.014292343519628048, 0.0015482936287298799, 0.004986772313714027, 0.005809911526739597, 0.0022472089622169733, 0.009119517169892788, 0.0018210688140243292, 0.004631428048014641, 0.0040620798245072365, 0.0023122115526348352, 0.0015721576055511832, 0.006270434707403183, -1]}
{"idB": "749647_13_item1_p37_s4", "idA": "749647_12_item1_p58_s2", "sentA": "We expect that the combination of microwave hyperthermia and ThermoDox will be more efficacious than microwave hyperthermia alone or treatment with existing non-heat activated liposomal formulations.", "sentB": "We expect that the strength of our balance sheet will afford us the opportunity to evaluate our future development plans.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "the", "combination", "of", "microwave", "hyperthermia", "and", "ThermoDox", "will", "be", "more", "efficacious", "than", "microwave", "hyperthermia", "alone", "or", "treatment", "with", "existing", "non-heat", "activated", "liposomal", "formulations.", "<tag2>", "We", "expect", "that", "the", "strength", "of", "our", "balance", "sheet", "will", "afford", "us", "the", "opportunity", "to", "evaluate", "our", "future", "development", "plans.", "<tag3>"], "wordsA": ["We", "expect", "that", "the", "combination", "of", "microwave", "hyperthermia", "and", "ThermoDox", "will", "be", "more", "efficacious", "than", "microwave", "hyperthermia", "alone", "or", "treatment", "with", "existing", "non-heat", "activated", "liposomal", "formulations."], "wordsB": ["We", "expect", "that", "the", "strength", "of", "our", "balance", "sheet", "will", "afford", "us", "the", "opportunity", "to", "evaluate", "our", "future", "development", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018931053578853607, 0.04954586923122406, 0.021098852157592773, 0.025917083024978638, 0.21578764915466309, 0.1577291339635849, 0.2266966849565506, 0.7031661868095398, 0.5910060405731201, 0.03745148330926895, 0.11992418020963669, 0.06017430126667023, 0.043852224946022034, 0.1138622984290123, 0.0636569932103157, 0.22757764160633087, 0.051142819225788116, 0.07584616541862488, 0.2171841710805893, 0.16920030117034912, -1]}
{"idB": "749647_13_item1_p56_s0", "idA": "749647_12_item1_p59_s0", "sentA": "In 2009, the Company commenced a pivotal open label, dose-escalating ThermoDox Phase I/Phase II clinical trial for patients with RCW breast cancer (the DIGNITY Study).", "sentB": "In 2009, the Company commenced an open label, dose-escalating ThermoDox Phase I/Phase II clinical trial for patients with RCW breast cancer (the DIGNITY study).", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "Company", "commenced", "a", "pivotal", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "study).", "<tag3>"], "wordsA": ["In", "2009,", "the", "Company", "commenced", "a", "pivotal", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.22565370798110962, 0.2689957916736603, 0.033588096499443054, 0.3690986633300781, 0.21983985602855682, 0.037730276584625244, 0.1446843445301056, 0.22445261478424072, 0.16533485054969788, 0.1778593808412552, 0.07235228270292282, 0.0814872682094574, 0.05536479502916336, 0.04223417118191719, 0.09310603141784668, 0.04737960174679756, 0.18690389394760132, 0.13010361790657043, 0.3026445209980011, 0.1500529646873474, 0.15647082030773163, 0.034129492938518524, 0.09240101277828217, 0.1269102841615677, -1]}
{"idB": "749647_13_item1_p57_s0", "idA": "749647_12_item1_p60_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010 and an independent Data Safety Monitoring Board declared 50mg/m 2 to be the phase II dose.", "sentB": "The Company completed enrollment of the Phase I portion of the study in 2010 and an independent Data Safety Monitoring Board declared 50mg/m2 to be the Phase II dose.", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m", "2", "to", "be", "the", "phase", "II", "dose.", "<tag2>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose.", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m", "2", "to", "be", "the", "phase", "II", "dose."], "wordsB": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0017184559255838394, 0.012179368175566196, 0.007056851405650377, 0.006643651053309441, 0.0017851755255833268, 0.0015590607654303312, 0.00396794592961669, 0.004981612786650658, 0.006332221440970898, 0.001486043562181294, 0.0015838154358789325, 0.008156664669513702, 0.0017066263826563954, 0.004839722067117691, 0.001891800668090582, 0.0013199036475270987, 0.005062175914645195, 0.006914321333169937, 0.006368218455463648, 0.00939839519560337, 0.00747581385076046, 0.006176111754029989, 0.9909736514091492, 0.0018594550201669335, 0.0020520652178674936, 0.0016442772466689348, 0.004156679846346378, 0.0048122527077794075, 0.008870139718055725, -1]}
{"idB": "749647_13_item1_p57_s1", "idA": "749647_12_item1_p60_s1", "sentA": "The Phase II portion of the DIGNITY Study protocol has been reviewed by the FDA and is planned to commence in 2012 at four to five investigation sites.", "sentB": "The Phase II portion of the DIGNITY study protocol has been reviewed by the FDA and enrollment commenced in the first quarter of 2013.", "type": 2, "words": ["<tag1>", "The", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "is", "planned", "to", "commence", "in", "2012", "at", "four", "to", "five", "investigation", "sites.", "<tag2>", "The", "Phase", "II", "portion", "of", "the", "DIGNITY", "study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["The", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "is", "planned", "to", "commence", "in", "2012", "at", "four", "to", "five", "investigation", "sites."], "wordsB": ["The", "Phase", "II", "portion", "of", "the", "DIGNITY", "study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0022366917692124844, 0.008109397254884243, 0.0074049620889127254, 0.008520611561834812, 0.0018568697851151228, 0.0018805417930707335, 0.007008224260061979, 0.0075250789523124695, 0.011990358121693134, 0.003239875426515937, 0.0033470098860561848, 0.02145540341734886, 0.0025892192497849464, 0.0024639375042170286, 0.01680764928460121, 0.006254178937524557, 0.2404850572347641, 0.06414181739091873, 0.06308265775442123, 0.038181524723768234, 0.2966100871562958, 0.3411814570426941, 0.3697286546230316, 0.9170055389404297, -1]}
{"idB": "749647_13_item1_p58_s0", "idA": "749647_12_item1_p61_s0", "sentA": "Duke University has completed a Phase I dose escalating ThermoDox study in patients with RCW breast cancer and has presented preliminary results from the 16 enrolled patients that characterize the safety of the drug in RCW patients and the feasibility of ThermoDox administration in these patients.", "sentB": "Duke University conducted a Phase I dose escalating ThermoDox study in patients with RCW breast cancer and has presented preliminary results from the 16 enrolled patients that characterize the safety of the drug in RCW patients and the feasibility of ThermoDox administration in these patients.", "type": 2, "words": ["<tag1>", "Duke", "University", "has", "completed", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients.", "<tag2>", "Duke", "University", "conducted", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients.", "<tag3>"], "wordsA": ["Duke", "University", "has", "completed", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients."], "wordsB": ["Duke", "University", "conducted", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.12975798547267914, 0.17927150428295135, 0.5549881458282471, 0.06475452333688736, 0.0949360802769661, 0.09992217272520065, 0.13900431990623474, 0.12284925580024719, 0.15566645562648773, 0.20422691106796265, 0.030305437743663788, 0.04995284229516983, 0.042206212878227234, 0.1630859076976776, 0.12434786558151245, 0.08402582257986069, 0.0004404764622449875, 0.030141033232212067, 0.058896664530038834, 0.06226168945431709, 0.09069909900426865, 0.02479909546673298, 0.020921874791383743, 0.10962048172950745, 0.13845324516296387, 0.1109403595328331, 0.024663519114255905, 0.056146733462810516, 0.030778134241700172, 0.08605712652206421, 0.04379554092884064, 0.04421069473028183, 0.16519713401794434, 0.023680010810494423, 0.08528564125299454, 0.07853507995605469, 0.015546859242022038, 0.022559266537427902, 0.06342588365077972, 0.03255218639969826, 0.10218318551778793, 0.10774129629135132, 0.03710048273205757, 0.03648317977786064, 0.11894577741622925, -1]}
{"idB": "749647_13_item1_p40_s2", "idA": "749647_12_item1_p61_s1", "sentA": "Futhermore, data presented by Duke suggested a beneficial clinical effect of ThermoDox .", "sentB": "We will repay Hisun for the aggregate amount of these development costs and fees commencing on the successful completion of three registrational batches of ThermoDox .", "type": 2, "words": ["<tag1>", "Futhermore,", "data", "presented", "by", "Duke", "suggested", "a", "beneficial", "clinical", "effect", "of", "ThermoDox", ".", "<tag2>", "We", "will", "repay", "Hisun", "for", "the", "aggregate", "amount", "of", "these", "development", "costs", "and", "fees", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["Futhermore,", "data", "presented", "by", "Duke", "suggested", "a", "beneficial", "clinical", "effect", "of", "ThermoDox", "."], "wordsB": ["We", "will", "repay", "Hisun", "for", "the", "aggregate", "amount", "of", "these", "development", "costs", "and", "fees", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.15216891467571259, 0.10295702517032623, 0.739533543586731, 0.30392691493034363, 0.10754809528589249, 0.048575252294540405, 0.24322666227817535, 0.17381031811237335, 0.04068886116147041, 0.04219439625740051, 0.14968810975551605, 0.12440598011016846, 0.03562541678547859, 0.14980964362621307, 0.027147764340043068, 0.008798341266810894, 0.024342050775885582, 0.04578610509634018, 0.03569556772708893, 0.01370776817202568, 0.06080598011612892, 0.12153459340333939, 0.06098165735602379, 0.03133898600935936, 0.033155519515275955, 7.46070800232701e-05, -1]}
{"idB": "749647_13_item1_p58_s1", "idA": "749647_12_item1_p61_s1", "sentA": "Futhermore, data presented by Duke suggested a beneficial clinical effect of ThermoDox .", "sentB": "Furthermore, data presented by Duke suggested a beneficial clinical effect of ThermoDox .", "type": 2, "words": ["<tag1>", "Futhermore,", "data", "presented", "by", "Duke", "suggested", "a", "beneficial", "clinical", "effect", "of", "ThermoDox", ".", "<tag2>", "Furthermore,", "data", "presented", "by", "Duke", "suggested", "a", "beneficial", "clinical", "effect", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["Futhermore,", "data", "presented", "by", "Duke", "suggested", "a", "beneficial", "clinical", "effect", "of", "ThermoDox", "."], "wordsB": ["Furthermore,", "data", "presented", "by", "Duke", "suggested", "a", "beneficial", "clinical", "effect", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.36118391156196594, 0.25720471143722534, 0.15309764444828033, 0.07722882926464081, 0.33643436431884766, 0.146567702293396, 0.01953653059899807, 0.05824220925569534, 0.03185102343559265, 0.04199516400694847, 0.022509954869747162, 0.06475691497325897, 5.422039976110682e-05, -1]}
{"idB": "749647_13_item1_p58_s2", "idA": "749647_12_item1_p61_s2", "sentA": "Duke reported that the combination of ThermoDox with HEAT in all the patients showed evidence of clinical activity and two of the six patients who were treated with the 50mg/m 2 dosage had a complete local response.", "sentB": "Duke reported that the combination of ThermoDox with heat showed evidence in the patients of clinical activity and two of the six patients who were treated with the 30mg/m 2 dosage had a complete local response.", "type": 2, "words": ["<tag1>", "Duke", "reported", "that", "the", "combination", "of", "ThermoDox", "with", "HEAT", "in", "all", "the", "patients", "showed", "evidence", "of", "clinical", "activity", "and", "two", "of", "the", "six", "patients", "who", "were", "treated", "with", "the", "50mg/m", "2", "dosage", "had", "a", "complete", "local", "response.", "<tag2>", "Duke", "reported", "that", "the", "combination", "of", "ThermoDox", "with", "heat", "showed", "evidence", "in", "the", "patients", "of", "clinical", "activity", "and", "two", "of", "the", "six", "patients", "who", "were", "treated", "with", "the", "30mg/m", "2", "dosage", "had", "a", "complete", "local", "response.", "<tag3>"], "wordsA": ["Duke", "reported", "that", "the", "combination", "of", "ThermoDox", "with", "HEAT", "in", "all", "the", "patients", "showed", "evidence", "of", "clinical", "activity", "and", "two", "of", "the", "six", "patients", "who", "were", "treated", "with", "the", "50mg/m", "2", "dosage", "had", "a", "complete", "local", "response."], "wordsB": ["Duke", "reported", "that", "the", "combination", "of", "ThermoDox", "with", "heat", "showed", "evidence", "in", "the", "patients", "of", "clinical", "activity", "and", "two", "of", "the", "six", "patients", "who", "were", "treated", "with", "the", "30mg/m", "2", "dosage", "had", "a", "complete", "local", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003673501778393984, 0.004643295891582966, 0.00178040552418679, 0.0017288512317463756, 0.003961366601288319, 0.001968389842659235, 0.004979249555617571, 0.0023686073254793882, 0.0030418643727898598, 0.0017292735865339637, 0.002232420025393367, 0.0016749461647123098, 0.0020140642300248146, 0.004467645660042763, 0.001328401267528534, 0.0025104123633354902, 0.0034591485746204853, 0.0019133733585476875, 0.004377375356853008, 0.0021996013820171356, 0.0019331310177221894, 0.008015359751880169, 0.017220934852957726, 0.0016953275771811604, 0.0016430611722171307, 0.007861844263970852, 0.0061352974735200405, 0.00606048246845603, 0.9710807204246521, 0.010180704295635223, 0.0073266164399683475, 0.0018493518000468612, 0.0015975108835846186, 0.0033005548175424337, 0.0032728752121329308, 0.00387016125023365, -1]}
{"idB": "749647_13_item1_p60_s2", "idA": "749647_12_item1_p63_s2", "sentA": "While hepatic resection is potentially curative, most CRLM patients are inoperable and therefore radiofrequency ablation (RFA) is a commonly used local treatment modality.", "sentB": "While hepatic resection is potentially curative, most CRLM patients are inoperable and therefore RFA is a commonly used local treatment modality.", "type": 2, "words": ["<tag1>", "While", "hepatic", "resection", "is", "potentially", "curative,", "most", "CRLM", "patients", "are", "inoperable", "and", "therefore", "radiofrequency", "ablation", "(RFA)", "is", "a", "commonly", "used", "local", "treatment", "modality.", "<tag2>", "While", "hepatic", "resection", "is", "potentially", "curative,", "most", "CRLM", "patients", "are", "inoperable", "and", "therefore", "RFA", "is", "a", "commonly", "used", "local", "treatment", "modality.", "<tag3>"], "wordsA": ["While", "hepatic", "resection", "is", "potentially", "curative,", "most", "CRLM", "patients", "are", "inoperable", "and", "therefore", "radiofrequency", "ablation", "(RFA)", "is", "a", "commonly", "used", "local", "treatment", "modality."], "wordsB": ["While", "hepatic", "resection", "is", "potentially", "curative,", "most", "CRLM", "patients", "are", "inoperable", "and", "therefore", "RFA", "is", "a", "commonly", "used", "local", "treatment", "modality."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013018419034779072, 0.10298491269350052, 0.11582759022712708, 0.013519716449081898, 0.020197793841362, 0.08562677353620529, 0.016354534775018692, 0.16595707833766937, 0.17690780758857727, 0.04003773257136345, 0.2607947587966919, 0.010633481666445732, 0.02281229756772518, 0.48200228810310364, 0.08568848669528961, 0.028493493795394897, 0.03794017806649208, 0.0293068028986454, 0.05267355963587761, 0.039481449872255325, 0.039470329880714417, -1]}
{"idB": "749647_13_item1_p45_s2", "idA": "749647_12_item1_p66_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with RFA for the treatment of colorectal liver metastases.", "sentB": "In August 2012, we announced FDA clearance to commence a Phase II study of ThermoDox and Philip s Sonalleve MR-Guided HIFU technology for the palliation of painful metastases to the bone caused by lung, prostate or breast cancers.", "type": 2, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases.", "<tag2>", "In", "August", "2012,", "we", "announced", "FDA", "clearance", "to", "commence", "a", "Phase", "II", "study", "of", "ThermoDox", "and", "Philip", "s", "Sonalleve", "MR-Guided", "HIFU", "technology", "for", "the", "palliation", "of", "painful", "metastases", "to", "the", "bone", "caused", "by", "lung,", "prostate", "or", "breast", "cancers.", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases."], "wordsB": ["In", "August", "2012,", "we", "announced", "FDA", "clearance", "to", "commence", "a", "Phase", "II", "study", "of", "ThermoDox", "and", "Philip", "s", "Sonalleve", "MR-Guided", "HIFU", "technology", "for", "the", "palliation", "of", "painful", "metastases", "to", "the", "bone", "caused", "by", "lung,", "prostate", "or", "breast", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01587429828941822, 0.2346624732017517, 0.5742667317390442, 0.025787347927689552, 0.04840248450636864, 0.054363932460546494, 0.06337769329547882, 0.010166624560952187, 0.022429827600717545, 0.0066055855713784695, 0.022379646077752113, 0.014529488049447536, 0.0322832427918911, 0.007305588573217392, 0.020437072962522507, 0.011168652214109898, 0.05209553614258766, 0.055251408368349075, 0.07565411925315857, 0.09879244118928909, 0.09676393866539001, 0.06341078132390976, 0.005048878490924835, 0.006120776291936636, 0.06473419815301895, 0.015160109847784042, 0.20764899253845215, 0.26453161239624023, 0.0806208997964859, 0.06994131207466125, 0.29758405685424805, 0.013965136371552944, 0.012392436154186726, 0.2839351296424866, 0.26232343912124634, 0.059873420745134354, 0.23873749375343323, 0.16043539345264435, -1]}
{"idB": "749647_13_item1_p47_s0", "idA": "749647_12_item1_p66_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with RFA for the treatment of colorectal liver metastases.", "sentB": "We are also working with the Focused Ultrasound Foundation in preclinical studies designed to explore the use of ThermoDox in combination with MR-guided HIFU for the treatment of pancreatic cancer.", "type": 2, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases.", "<tag2>", "We", "are", "also", "working", "with", "the", "Focused", "Ultrasound", "Foundation", "in", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer.", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases."], "wordsB": ["We", "are", "also", "working", "with", "the", "Focused", "Ultrasound", "Foundation", "in", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021921100094914436, 0.003786835353821516, 0.005994221195578575, 0.07489846646785736, 0.041042301803827286, 0.016787363216280937, 0.08941637724637985, 0.29952535033226013, 0.17094290256500244, 0.01287110149860382, 0.3533385097980499, 0.21128986775875092, 0.002981781028211117, 0.002739019924774766, 0.01303538866341114, 8.976206299848855e-05, 0.019498830661177635, 0.007275013718754053, 0.01784517802298069, 0.010077957063913345, 0.020190322771668434, 0.022707372903823853, 0.48295384645462036, 0.5625450611114502, 0.01239872258156538, 0.008178343065083027, 0.0986812636256218, 0.05801853537559509, 0.5987252593040466, 0.5262280702590942, -1]}
{"idB": "749647_13_item1_p48_s0", "idA": "749647_12_item1_p66_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with RFA for the treatment of colorectal liver metastases.", "sentB": "In addition to the collaborations outlined above, we have two ongoing clinical studies: a Phase II study of ThermoDox in combination with hyperthermia for the treatment of recurrent chest wall (RCW) breast cancer (the DIGNITY study) and a Phase II study of ThermoDox in combination with thermal ablation for the treatment of colorectal liver metastases.", "type": 2, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases.", "<tag2>", "In", "addition", "to", "the", "collaborations", "outlined", "above,", "we", "have", "two", "ongoing", "clinical", "studies:", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "hyperthermia", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "(RCW)", "breast", "cancer", "(the", "DIGNITY", "study)", "and", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "thermal", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases.", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases."], "wordsB": ["In", "addition", "to", "the", "collaborations", "outlined", "above,", "we", "have", "two", "ongoing", "clinical", "studies:", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "hyperthermia", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "(RCW)", "breast", "cancer", "(the", "DIGNITY", "study)", "and", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "thermal", "ablation", "for", "the", "treatment", "of", "colorectal", "liver", "metastases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009560924954712391, 0.03252912312746048, 0.010628537274897099, 0.0077141965739429, 0.05055034160614014, 0.007618841249495745, 0.01646294631063938, 0.015184328891336918, 0.014235173352062702, 0.14908504486083984, 0.23622743785381317, 0.0762394443154335, 0.09934266656637192, 0.003554052207618952, 0.013544502668082714, 0.009817110374569893, 0.03158142790198326, 0.005248399917036295, 0.01755654066801071, 0.007242775522172451, 0.030412428081035614, 0.03133821487426758, 0.8932597041130066, 0.007474186364561319, 0.00489379558712244, 0.06124136224389076, 0.02131205052137375, 0.1962212473154068, 0.17336247861385345, 0.20810900628566742, 0.1390243023633957, 0.15158449113368988, 0.3107057511806488, 0.005207240581512451, 0.032147496938705444, 0.0850839763879776, 0.003895955393090844, 0.002300641965121031, 0.00727843726053834, 0.0067361523397266865, 0.022559242323040962, 0.004586861003190279, 0.01582993008196354, 0.006297298241406679, 0.029605871066451073, 0.03188806027173996, 0.5126132965087891, 0.8608326315879822, 0.0019305595196783543, 0.001750726718455553, 0.00610080873593688, 0.0017039913218468428, 0.0031748944893479347, 0.006876515224575996, 0.004078833386301994, -1]}
{"idB": "749647_13_item1_p63_s5", "idA": "749647_12_item1_p66_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with RFA for the treatment of colorectal liver metastases.", "sentB": "All patients will receive ThermoDox in combination with ablation using either Radiofrequency ablation (RFA) or microwave ablation (MWA) devices.", "type": 2, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases.", "<tag2>", "All", "patients", "will", "receive", "ThermoDox", "in", "combination", "with", "ablation", "using", "either", "Radiofrequency", "ablation", "(RFA)", "or", "microwave", "ablation", "(MWA)", "devices.", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases."], "wordsB": ["All", "patients", "will", "receive", "ThermoDox", "in", "combination", "with", "ablation", "using", "either", "Radiofrequency", "ablation", "(RFA)", "or", "microwave", "ablation", "(MWA)", "devices."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.3339895009994507, 0.3159429430961609, 0.10924773663282394, 0.3543543219566345, 0.1632944643497467, 0.04736486077308655, 0.06166303530335426, 0.043926578015089035, 0.19891022145748138, 0.022038251161575317, 0.016026930883526802, 0.26021450757980347, 0.18818646669387817, 0.031067417934536934, 0.025857362896203995, 0.29868200421333313, 0.3073244094848633, 0.1920163631439209, 0.11153226345777512, -1]}
{"idB": "749647_13_item1_p63_s2", "idA": "749647_12_item1_p66_s1", "sentA": "The ABLATE Study is expected to enroll up to 88 patients with colorectal cancer metastasized to the liver.", "sentB": "The ABLATE Study originally was expected to enroll up to 88 patients with colorectal cancer metastasized to the liver.", "type": 2, "words": ["<tag1>", "The", "ABLATE", "Study", "is", "expected", "to", "enroll", "up", "to", "88", "patients", "with", "colorectal", "cancer", "metastasized", "to", "the", "liver.", "<tag2>", "The", "ABLATE", "Study", "originally", "was", "expected", "to", "enroll", "up", "to", "88", "patients", "with", "colorectal", "cancer", "metastasized", "to", "the", "liver.", "<tag3>"], "wordsA": ["The", "ABLATE", "Study", "is", "expected", "to", "enroll", "up", "to", "88", "patients", "with", "colorectal", "cancer", "metastasized", "to", "the", "liver."], "wordsB": ["The", "ABLATE", "Study", "originally", "was", "expected", "to", "enroll", "up", "to", "88", "patients", "with", "colorectal", "cancer", "metastasized", "to", "the", "liver."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005001359153538942, 0.03255937620997429, 0.06174850836396217, 0.15165486931800842, 0.013684609904885292, 0.022969407960772514, 0.008042319677770138, 0.030938487499952316, 0.011887467466294765, 0.013010076247155666, 0.2898978590965271, 0.1708230823278427, 0.006907972041517496, 0.1340733766555786, 0.032745443284511566, 0.026441102847456932, 0.012154296040534973, 0.01720799319446087, 0.1108628585934639, -1]}
{"idB": "749647_13_item1_p64_s0", "idA": "749647_12_item1_p66_s3", "sentA": "The primary study endpoint is based on one year local tumor recurrence, with secondary endpoints of time to progression and overall survival.", "sentB": "The primary endpoint is based on one year local tumor control, with secondary endpoints of time to progression and overall survival.", "type": 2, "words": ["<tag1>", "The", "primary", "study", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "recurrence,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag2>", "The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag3>"], "wordsA": ["The", "primary", "study", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "recurrence,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "wordsB": ["The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0029653075616806746, 0.060926951467990875, 0.08716126531362534, 0.003348513040691614, 0.01309450063854456, 0.0060784961096942425, 0.019247932359576225, 0.032610245048999786, 0.0332501158118248, 0.20156677067279816, 0.911296546459198, 0.0036381862591952085, 0.018736300989985466, 0.01084950752556324, 0.003971588797867298, 0.004579764325171709, 0.003740905784070492, 0.005115635693073273, 0.0034643616527318954, 0.006334994453936815, 0.011214641854166985, -1]}
{"idB": "749647_13_item1_p104_s0", "idA": "749647_12_item1_p67_s0", "sentA": "On February 13, 2012, we announced that the first patient had been enrolled in the Phase II ABLATE study.", "sentB": "On February 5, 2013, Celsion announced that its proprietary patent application, \"Method of Storing Nanoparticle Formulations,\" had been allowed in China and granted in South Korea and Australia.", "type": 2, "words": ["<tag1>", "On", "February", "13,", "2012,", "we", "announced", "that", "the", "first", "patient", "had", "been", "enrolled", "in", "the", "Phase", "II", "ABLATE", "study.", "<tag2>", "On", "February", "5,", "2013,", "Celsion", "announced", "that", "its", "proprietary", "patent", "application,", "\"Method", "of", "Storing", "Nanoparticle", "Formulations,\"", "had", "been", "allowed", "in", "China", "and", "granted", "in", "South", "Korea", "and", "Australia.", "<tag3>"], "wordsA": ["On", "February", "13,", "2012,", "we", "announced", "that", "the", "first", "patient", "had", "been", "enrolled", "in", "the", "Phase", "II", "ABLATE", "study."], "wordsB": ["On", "February", "5,", "2013,", "Celsion", "announced", "that", "its", "proprietary", "patent", "application,", "\"Method", "of", "Storing", "Nanoparticle", "Formulations,\"", "had", "been", "allowed", "in", "China", "and", "granted", "in", "South", "Korea", "and", "Australia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01151476800441742, 0.06634775549173355, 0.1926174759864807, 0.5805588364601135, 0.10396190732717514, 0.06913125514984131, 0.017476201057434082, 0.02052866667509079, 0.10125986486673355, 0.24053771793842316, 0.23472021520137787, 0.0759962871670723, 0.042221151292324066, 0.19987629354000092, 0.2602505087852478, 0.21269840002059937, 0.02297469973564148, 0.017277847975492477, 0.07509759068489075, 0.01734299771487713, 0.04511663690209389, 0.0015375117072835565, 0.04583800956606865, 0.0143506471067667, 0.0606686994433403, 0.094666987657547, 0.09129481762647629, 0.16123542189598083, -1]}
{"idB": "749647_13_item1_p66_s2", "idA": "749647_12_item1_p69_s2", "sentA": "We received approximately $153,000 from this grant in 2011 to support formulation development and preclinical efficacy studies in collaboration with Duke University.", "sentB": "We received approximately $184,000 collectively from this grant in 2011 and 2012 to support formulation development and preclinical efficacy studies in collaboration with Duke University.", "type": 2, "words": ["<tag1>", "We", "received", "approximately", "$153,000", "from", "this", "grant", "in", "2011", "to", "support", "formulation", "development", "and", "preclinical", "efficacy", "studies", "in", "collaboration", "with", "Duke", "University.", "<tag2>", "We", "received", "approximately", "$184,000", "collectively", "from", "this", "grant", "in", "2011", "and", "2012", "to", "support", "formulation", "development", "and", "preclinical", "efficacy", "studies", "in", "collaboration", "with", "Duke", "University.", "<tag3>"], "wordsA": ["We", "received", "approximately", "$153,000", "from", "this", "grant", "in", "2011", "to", "support", "formulation", "development", "and", "preclinical", "efficacy", "studies", "in", "collaboration", "with", "Duke", "University."], "wordsB": ["We", "received", "approximately", "$184,000", "collectively", "from", "this", "grant", "in", "2011", "and", "2012", "to", "support", "formulation", "development", "and", "preclinical", "efficacy", "studies", "in", "collaboration", "with", "Duke", "University."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0066642542369663715, 0.027276691049337387, 0.03728293627500534, 0.9920401573181152, 0.018420610576868057, 0.0025142652448266745, 0.0021315068006515503, 0.009087196551263332, 0.002058314625173807, 0.007617002818733454, 0.006256721913814545, 0.012081745080649853, 0.001387749332934618, 0.0019334558164700866, 0.002212968422099948, 0.0020357100293040276, 0.0011835966724902391, 0.0020519988611340523, 0.002285646041855216, 0.0024809371680021286, 0.0012703035026788712, 0.0017864700639620423, 0.0014266585931181908, 0.002578126732259989, 0.0024983908515423536, -1]}
{"idB": "749647_13_item1_p35_s2", "idA": "749647_12_item1_p75_s0", "sentA": "If the HEAT Study proves successful, it would add not only one of the most important new chemotherapeutic treatments to the oncologists arsenal, but validate a novel, highly-versatile technology with the potential to affect many cancers.", "sentB": "We scheduled a meeting with the HEAT study independent Data Monitoring Committee (DMC) on January 30, 2013 in order to conduct an analysis of the HEAT study s PFS endpoint.", "type": 2, "words": ["<tag1>", "If", "the", "HEAT", "Study", "proves", "successful,", "it", "would", "add", "not", "only", "one", "of", "the", "most", "important", "new", "chemotherapeutic", "treatments", "to", "the", "oncologists", "arsenal,", "but", "validate", "a", "novel,", "highly-versatile", "technology", "with", "the", "potential", "to", "affect", "many", "cancers.", "<tag2>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint.", "<tag3>"], "wordsA": ["If", "the", "HEAT", "Study", "proves", "successful,", "it", "would", "add", "not", "only", "one", "of", "the", "most", "important", "new", "chemotherapeutic", "treatments", "to", "the", "oncologists", "arsenal,", "but", "validate", "a", "novel,", "highly-versatile", "technology", "with", "the", "potential", "to", "affect", "many", "cancers."], "wordsB": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10110753029584885, 0.2770616412162781, 0.17452755570411682, 0.39614132046699524, 0.08493976294994354, 0.04498261958360672, 0.05899382755160332, 0.08548110723495483, 0.2911008894443512, 0.4653504192829132, 0.41746577620506287, 0.33447641134262085, 0.26127535104751587, 0.04199063405394554, 0.08316142112016678, 0.0864269882440567, 0.11681366711854935, 0.008464143611490726, 0.007257052231580019, 0.00960628967732191, 0.03095695748925209, 0.03200746700167656, 0.12077781558036804, 0.01527779083698988, 0.01014764979481697, 0.046940773725509644, 0.061495859175920486, 0.027418622747063637, 0.07431736588478088, 0.05782020464539528, -1]}
{"idB": "749647_13_item1_p72_s0", "idA": "749647_12_item1_p7_s0", "sentA": "Unless the context requires otherwise or unless otherwise noted, all references in this Annual Report on Form 10-K to Celsion and to the Company .", "sentB": "As a result of the uncertainties discussed previously in this Annual Report on Form 10K, among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product if one of our drug candidates receives regulatory approval for marketing, if at all.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "and", "to", "the", "Company", ".", "<tag2>", "As", "a", "result", "of", "the", "uncertainties", "discussed", "previously", "in", "this", "Annual", "Report", "on", "Form", "10K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "drug", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all.", "<tag3>"], "wordsA": ["Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "and", "to", "the", "Company", "."], "wordsB": ["As", "a", "result", "of", "the", "uncertainties", "discussed", "previously", "in", "this", "Annual", "Report", "on", "Form", "10K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "drug", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010853090323507786, 0.012303363531827927, 0.011858130805194378, 0.007911796681582928, 0.01059201080352068, 0.04566289111971855, 0.009119507856667042, 0.008663502521812916, 0.004966065753251314, 0.0053866030648350716, 0.016010062769055367, 0.020786458626389503, 0.006350429262965918, 0.0277459267526865, 0.06975645571947098, 0.010031843557953835, 0.009210087358951569, 0.03254159539937973, 0.02332127094268799, 0.29132547974586487, 0.12831832468509674, 0.18637783825397491, 0.045299988240003586, 0.058423593640327454, 0.054737575352191925, 0.08997157216072083, 0.08590533584356308, 0.01527473609894514, 0.018446264788508415, 0.07425720989704132, 0.03700989857316017, 0.06329286098480225, 0.07501760870218277, 0.019329607486724854, 0.029457423835992813, 0.027335355058312416, 0.04772336408495903, 0.00917761866003275, 0.015366307459771633, 0.01710965298116207, 0.01641085185110569, 0.021239440888166428, 0.024073658511042595, 0.043691959232091904, 0.05556793138384819, 0.05772258713841438, 0.01250354666262865, 0.012799059972167015, 0.06804613769054413, 0.036639776080846786, 0.06293822824954987, 0.034586355090141296, 0.028978880494832993, 0.06554234772920609, 0.024273352697491646, 0.04492408409714699, 0.03150776028633118, 0.01998204179108143, 0.13588373363018036, 0.1045132577419281, 0.11472781747579575, 0.08700862526893616, 0.1116345152258873, 0.05259418115019798, 0.09133701771497726, 0.07800453901290894, 0.05010857433080673, 0.05406048521399498, -1]}
{"idB": "749647_13_item1_p7_s0", "idA": "749647_12_item1_p7_s0", "sentA": "Unless the context requires otherwise or unless otherwise noted, all references in this Annual Report on Form 10-K to Celsion and to the Company .", "sentB": "Unless the context requires otherwise or unless otherwise noted, all references in this Annual Report on Form 10-K to Celsion the Company , we , us , or our are to Celsion Corporation.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "and", "to", "the", "Company", ".", "<tag2>", "Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation.", "<tag3>"], "wordsA": ["Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "and", "to", "the", "Company", "."], "wordsB": ["Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02340587042272091, 0.012266739271581173, 0.04145929962396622, 0.032563552260398865, 0.028169861063361168, 0.00929941050708294, 0.015719357877969742, 0.022357869893312454, 0.025158338248729706, 0.02373158186674118, 0.13305649161338806, 0.010675239376723766, 0.009572265669703484, 0.016422830522060394, 0.020059071481227875, 0.008098936639726162, 0.01787795126438141, 0.017503486946225166, 0.006760699208825827, 0.04799223318696022, 0.03852333128452301, 0.24604688584804535, 0.013860413804650307, 0.40257319808006287, 0.0027748672291636467, 0.3940417766571045, 0.00014265815843828022, 0.09162209928035736, 0.2929188311100006, 0.2331598550081253, 0.1048993244767189, 0.08155117928981781, 0.2631123960018158, -1]}
{"idB": "749647_13_item1_p72_s1", "idA": "749647_12_item1_p80_s0", "sentA": "We are engaged in a limited amount of research and development in our own facilities and also sponsor research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "sentB": "Our inability to complete our research and development projects in a timely manner or to obtain positive results in our clinical trials, as well as any failure to enter into collaborative agreements when appropriate, could significantly increase our capital requirements and could adversely impact our liquidity.", "type": 2, "words": ["<tag1>", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "also", "sponsor", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag2>", "Our", "inability", "to", "complete", "our", "research", "and", "development", "projects", "in", "a", "timely", "manner", "or", "to", "obtain", "positive", "results", "in", "our", "clinical", "trials,", "as", "well", "as", "any", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate,", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity.", "<tag3>"], "wordsA": ["We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "also", "sponsor", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "wordsB": ["Our", "inability", "to", "complete", "our", "research", "and", "development", "projects", "in", "a", "timely", "manner", "or", "to", "obtain", "positive", "results", "in", "our", "clinical", "trials,", "as", "well", "as", "any", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate,", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02322828769683838, 0.37066522240638733, 0.3374817371368408, 0.3962847888469696, 0.10292923450469971, 0.19177089631557465, 0.0738188847899437, 0.07833483815193176, 0.16200463473796844, 0.02373405545949936, 0.013774646446108818, 0.09058795124292374, 0.03981603682041168, 0.005265952553600073, 0.006182460114359856, 0.02644706889986992, 0.06249517947435379, 0.0657195970416069, 0.012391157448291779, 0.019112545996904373, 0.09128716588020325, 0.09524107724428177, 0.00027318825596012175, 0.005674784071743488, 0.005840888246893883, 0.00928688608109951, 0.11651350557804108, 0.10023357719182968, 0.09521554410457611, 0.12776245176792145, 0.1670498102903366, 0.1391434520483017, 0.011475945822894573, 0.009162836708128452, 0.005769276525825262, 0.009343395940959454, 0.03435247018933296, 0.019944874569773674, 0.08906655013561249, 0.08137757331132889, 0.004466479644179344, 0.007946962490677834, 0.022647518664598465, 0.07826017588376999, 0.03365184739232063, 0.1738670915365219, -1]}
{"idB": "749647_13_item1_p17_s0", "idA": "749647_12_item1_p80_s1", "sentA": "The majority of the spending in research and development is for the funding of ThermoDox clinical trials.", "sentB": "Following the announcement of the HEAT study results, we are assessing our product pipeline and research and development priorities.", "type": 2, "words": ["<tag1>", "The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials.", "<tag2>", "Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "are", "assessing", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag3>"], "wordsA": ["The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials."], "wordsB": ["Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "are", "assessing", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.055480945855379105, 0.01896544359624386, 0.08271846920251846, 0.02605568803846836, 0.030129196122288704, 0.292409747838974, 0.5730680823326111, 0.14537733793258667, 0.043348826467990875, 0.01457859855145216, 0.3291161060333252, 0.06755882501602173, 0.20177346467971802, 0.13386477530002594, 0.017489159479737282, 0.07636044919490814, 0.021347343921661377, 0.04518933594226837, 0.10972997546195984, -1]}
{"idB": "749647_13_item1_p73_s2", "idA": "749647_12_item1_p80_s2", "sentA": "Research and development expenses were approximately $19.9 million and $14.7 million for the years ended December 31, 2011 and 2010, respectively.", "sentB": "Research and development expenses were approximately $15.8 million, $19.9 million and $14.7 million for the years ended December 31, 2012, 2011 and 2010, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$19.9", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2011", "and", "2010,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "were", "approximately", "$15.8", "million,", "$19.9", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2012,", "2011", "and", "2010,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$19.9", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2011", "and", "2010,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "were", "approximately", "$15.8", "million,", "$19.9", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2012,", "2011", "and", "2010,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007638702634721994, 0.0047363038174808025, 0.007390627171844244, 0.011445633135735989, 0.006626293994486332, 0.01742134802043438, 0.8833854794502258, 0.39346086978912354, 0.009875313378870487, 0.008303896524012089, 0.008016800507903099, 0.009215897880494595, 0.00862267054617405, 0.0057482486590743065, 0.005867034196853638, 0.00841259490698576, 0.007361636031419039, 0.008050072006881237, 0.011777215637266636, 0.1687432825565338, 0.0059565044939517975, 0.005817085038870573, 0.0074331872165203094, 0.006947686430066824, -1]}
{"idB": "749647_13_item1_p121_s0", "idA": "749647_12_item1_p81_s0", "sentA": "Our research and development activities, pre-clinical tests and clinical trials are subject to extensive regulation by the FDA as would the manufacturing, marketing and labeling of our products, if any.", "sentB": "Celsion intends to use the net proceeds from the offering for general corporate purposes, including research and development activities, capital expenditures and working capital.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities,", "pre-clinical", "tests", "and", "clinical", "trials", "are", "subject", "to", "extensive", "regulation", "by", "the", "FDA", "as", "would", "the", "manufacturing,", "marketing", "and", "labeling", "of", "our", "products,", "if", "any.", "<tag2>", "Celsion", "intends", "to", "use", "the", "net", "proceeds", "from", "the", "offering", "for", "general", "corporate", "purposes,", "including", "research", "and", "development", "activities,", "capital", "expenditures", "and", "working", "capital.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities,", "pre-clinical", "tests", "and", "clinical", "trials", "are", "subject", "to", "extensive", "regulation", "by", "the", "FDA", "as", "would", "the", "manufacturing,", "marketing", "and", "labeling", "of", "our", "products,", "if", "any."], "wordsB": ["Celsion", "intends", "to", "use", "the", "net", "proceeds", "from", "the", "offering", "for", "general", "corporate", "purposes,", "including", "research", "and", "development", "activities,", "capital", "expenditures", "and", "working", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.31179696321487427, 0.1277756243944168, 0.060315992683172226, 0.19440539181232452, 0.10496880114078522, 0.23847001791000366, 0.2874148488044739, 0.03423548489809036, 0.032351765781641006, 0.14010903239250183, 0.016913898289203644, 0.0826229676604271, 0.21025210618972778, 0.11403748393058777, 0.012491962872445583, 0.02684369497001171, 0.00551327271386981, 0.0165505763143301, 0.033235907554626465, 0.2061438411474228, 0.21098284423351288, 0.015640052035450935, 0.21874649822711945, 0.3481672704219818, -1]}
{"idB": "749647_13_item1_p75_s1", "idA": "749647_12_item1_p82_s1", "sentA": "The steps ordinarily required before such products can be marketed in the U.S. include (a) pre-clinical and clinical studies; (b) the submission to the FDA of an application for, or approval, as IND, which must become effective before human clinical trials may commence; (c) adequate and well-controlled human clinical trials to establish the safety and efficacy of the product; (d) the submission to the FDA of a NDA; and (e) FDA approval of the application, including approval of all product labeling.", "sentB": "The steps ordinarily required before such products can be marketed in the U.S. include (a) pre-clinical and clinical studies; (b) the submission to the FDA of an application for, or approval, as an Investigational New Drug application (IND), which must become effective before human clinical trials may commence; (c) adequate and well-controlled human clinical trials to establish the safety and efficacy of the product; (d) the submission to the FDA of a New Drug Application (NDA); and (e) FDA approval of the application, including approval of all product labeling.", "type": 2, "words": ["<tag1>", "The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "IND,", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "NDA;", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling.", "<tag2>", "The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "New", "Drug", "Application", "(NDA);", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling.", "<tag3>"], "wordsA": ["The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "IND,", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "NDA;", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling."], "wordsB": ["The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "New", "Drug", "Application", "(NDA);", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012620866298675537, 0.09418483823537827, 0.09245944023132324, 0.07356081157922745, 0.1184794083237648, 0.06987760215997696, 0.11477487534284592, 0.08095254004001617, 0.09729435294866562, 0.1266792118549347, 0.0431700125336647, 0.038347307592630386, 0.07651695609092712, 0.027016757056117058, 0.052233267575502396, 0.04796895757317543, 0.029157206416130066, 0.0350893959403038, 0.04062964767217636, 0.04062759131193161, 0.021846452727913857, 0.056861940771341324, 0.03378390148282051, 0.030899882316589355, 0.06096303090453148, 0.024801792576909065, 0.02366824448108673, 0.043848104774951935, 0.027042729780077934, 0.02478964999318123, 0.02654736302793026, 0.01912681944668293, 0.018628831952810287, 0.04337308928370476, 0.13511031866073608, 0.16035152971744537, 0.06710442155599594, 0.038348130881786346, 0.02600555308163166, 0.023515868932008743, 0.024410005658864975, 0.02913694642484188, 0.024399815127253532, 0.029573412612080574, 0.04471656307578087, 0.043921250849962234, 0.016218088567256927, 0.024784056469798088, 0.03549468517303467, 0.03955332562327385, 0.027354203164577484, 0.035879723727703094, 0.02594820037484169, 0.03192264586687088, 0.030216829851269722, 0.02207840420305729, 0.02459329180419445, 0.025191983208060265, 0.033038172870874405, 0.028086019679903984, 0.034089889377355576, 0.018879001960158348, 0.02090858668088913, 0.030725732445716858, 0.04175416752696037, 0.017864342778921127, 0.05240609124302864, 0.027377137914299965, 0.025654025375843048, 0.0603509284555912, 0.026399623602628708, 0.023254292085766792, 0.08204121887683868, 0.06686850637197495, 0.06110451743006706, 0.04459777846932411, 0.01621754840016365, 0.051987722516059875, 0.043869901448488235, 0.0374155230820179, 0.019687851890921593, 0.02201913669705391, 0.04500977322459221, 0.01970253884792328, 0.018975386396050453, 0.020450111478567123, 0.02236327901482582, 0.03254665806889534, 0.0319640189409256, -1]}
{"idB": "749647_13_item1_p13_s2", "idA": "749647_12_item1_p83_s0", "sentA": "Pre-clinical tests include laboratory evaluation of product chemistry, formulation and stability, as well as animal studies, to assess the potential safety and efficacy of the product.", "sentB": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "type": 2, "words": ["<tag1>", "Pre-clinical", "tests", "include", "laboratory", "evaluation", "of", "product", "chemistry,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product.", "<tag2>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["Pre-clinical", "tests", "include", "laboratory", "evaluation", "of", "product", "chemistry,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product."], "wordsB": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04045175760984421, 0.01383645087480545, 0.009308204054832458, 0.06283776462078094, 0.1640871912240982, 0.5008412003517151, 0.037758901715278625, 0.03879892826080322, 0.16736216843128204, 0.04019007086753845, 0.022028207778930664, 0.32090768218040466, 0.5812528133392334, 0.0035585907753556967, 0.013872647657990456, 0.005589956417679787, 0.012278994545340538, 0.027319079264998436, 0.021561570465564728, 0.01229175180196762, 0.042910270392894745, 6.334332283586264e-05, -1]}
{"idB": "749647_13_item1_p37_s0", "idA": "749647_12_item1_p83_s0", "sentA": "Pre-clinical tests include laboratory evaluation of product chemistry, formulation and stability, as well as animal studies, to assess the potential safety and efficacy of the product.", "sentB": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "type": 2, "words": ["<tag1>", "Pre-clinical", "tests", "include", "laboratory", "evaluation", "of", "product", "chemistry,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product.", "<tag2>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["Pre-clinical", "tests", "include", "laboratory", "evaluation", "of", "product", "chemistry,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product."], "wordsB": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04045175760984421, 0.01383645087480545, 0.009308204054832458, 0.06283776462078094, 0.1640871912240982, 0.5008412003517151, 0.037758901715278625, 0.03879892826080322, 0.16736216843128204, 0.04019007086753845, 0.022028207778930664, 0.32090768218040466, 0.5812528133392334, 0.0035585907753556967, 0.013872647657990456, 0.005589956417679787, 0.012278994545340538, 0.027319079264998436, 0.021561570465564728, 0.01229175180196762, 0.042910270392894745, 6.334332283586264e-05, -1]}
{"idB": "749647_13_item1_p128_s1", "idA": "749647_12_item1_p88_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "We do not have any committed sources of financing and cannot give assurance that alternate funding will be available in a timely manner, on acceptable terms or at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "give", "assurance", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "give", "assurance", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.026760971173644066, 0.1416892111301422, 0.2811143398284912, 0.14116989076137543, 0.11897014081478119, 0.40603259205818176, 0.29558655619621277, 0.17821936309337616, 0.4251124858856201, 0.005268548149615526, 0.1354702264070511, 0.08085431903600693, 0.11728394776582718, 0.016671886667609215, 0.2764723002910614, 0.43522879481315613, 0.06534741073846817, 0.06333976984024048, 0.08647926896810532, 0.022284502163529396, 0.02370886318385601, 0.12782777845859528, 0.04768671467900276, 0.01183469220995903, 0.11325652152299881, 0.04235241562128067, 0.011549985967576504, 0.010250193998217583, 0.012482666410505772, -1]}
{"idB": "749647_13_item1_p8_s0", "idA": "749647_12_item1_p8_s0", "sentA": "The Celsion brand and product names, including but not limited to Celsion , contained in this document are trademarks, registered trademarks or service marks of Celsion Corporation in the United States (U.S.) and certain other countries.", "sentB": "The Celsion Corporation ( Celsion or the Company ) brand and product names, including but not limited to Celsion or ThermoDox , contained in this document are trademarks, registered trademarks or service marks of Celsion Corporation in the United States (U.S.) and certain other countries.", "type": 2, "words": ["<tag1>", "The", "Celsion", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries.", "<tag2>", "The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", "or", "ThermoDox", ",", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries.", "<tag3>"], "wordsA": ["The", "Celsion", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries."], "wordsB": ["The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", "or", "ThermoDox", ",", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004751261323690414, 0.0669749528169632, 0.3081274628639221, 0.07066547125577927, 0.055171139538288116, 0.03712291270494461, 0.039895158261060715, 0.251290500164032, 0.00039384173578582704, 0.03455684706568718, 0.009847782552242279, 0.009992236271500587, 0.014433749951422215, 0.010919701308012009, 0.012698856182396412, 0.009973743930459023, 0.015324720181524754, 0.006139409728348255, 0.05608067661523819, 0.14371110498905182, 0.9654555916786194, 0.00025856096181087196, 0.01153525896370411, 0.009186862967908382, 0.008278888650238514, 0.01051987987011671, 0.0059537263587117195, 0.025118425488471985, 0.010685033164918423, 0.01914154924452305, 0.005979383364319801, 0.009111187420785427, 0.010379258543252945, 0.004502755124121904, 0.010523822158575058, 0.006791089661419392, 0.005527817644178867, 0.006452277302742004, 0.012420048005878925, 0.014638446271419525, 0.019910097122192383, 0.005571221932768822, 0.007038572803139687, 0.006875310093164444, 0.010520722717046738, -1]}
{"idB": "749647_13_item1_p88_s0", "idA": "749647_12_item1_p93_s0", "sentA": "After receipt of necessary regulatory approvals for initial manufacturing and sale of our product candidates, our contract manufacturing facilities and products are subject to ongoing review and periodic inspection.", "sentB": "After receipt of necessary regulatory approvals, if any, for initial manufacturing and sale of our product candidates, our contract manufacturing facilities and products are subject to ongoing review and periodic inspection.", "type": 2, "words": ["<tag1>", "After", "receipt", "of", "necessary", "regulatory", "approvals", "for", "initial", "manufacturing", "and", "sale", "of", "our", "product", "candidates,", "our", "contract", "manufacturing", "facilities", "and", "products", "are", "subject", "to", "ongoing", "review", "and", "periodic", "inspection.", "<tag2>", "After", "receipt", "of", "necessary", "regulatory", "approvals,", "if", "any,", "for", "initial", "manufacturing", "and", "sale", "of", "our", "product", "candidates,", "our", "contract", "manufacturing", "facilities", "and", "products", "are", "subject", "to", "ongoing", "review", "and", "periodic", "inspection.", "<tag3>"], "wordsA": ["After", "receipt", "of", "necessary", "regulatory", "approvals", "for", "initial", "manufacturing", "and", "sale", "of", "our", "product", "candidates,", "our", "contract", "manufacturing", "facilities", "and", "products", "are", "subject", "to", "ongoing", "review", "and", "periodic", "inspection."], "wordsB": ["After", "receipt", "of", "necessary", "regulatory", "approvals,", "if", "any,", "for", "initial", "manufacturing", "and", "sale", "of", "our", "product", "candidates,", "our", "contract", "manufacturing", "facilities", "and", "products", "are", "subject", "to", "ongoing", "review", "and", "periodic", "inspection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07585547119379044, 0.12006257474422455, 0.04825349152088165, 0.11891059577465057, 0.14216965436935425, 0.5068871378898621, 0.5483916401863098, 0.6510539650917053, 0.031584616750478745, 0.07639282941818237, 0.07709657400846481, 0.036842357367277145, 0.04062104970216751, 0.03553653508424759, 0.03438153490424156, 0.0494820699095726, 0.07721279561519623, 0.024247460067272186, 0.12048856168985367, 0.11310070008039474, 0.10475386679172516, 0.035768866539001465, 0.06777496635913849, 0.03775031864643097, 0.06479617208242416, 0.0439726822078228, 0.04644894599914551, 0.050297364592552185, 0.031061634421348572, 0.034340448677539825, 0.06520257145166397, -1]}
{"idB": "749647_13_item1_p37_s3", "idA": "749647_12_item1_p96_s1", "sentA": "A governmentally mandated recall, or a voluntary recall by us, could result from a number of events or factors, including component failures, manufacturing errors, instability of product or defects in labeling.", "sentB": "As we evaluate strategic alternatives, we will need to consider a number of factors, including investment in, or acquisition of, complementary businesses, technologies or products, possible capital raising transactions, partnering opportunities and working capital requirements.", "type": 2, "words": ["<tag1>", "A", "governmentally", "mandated", "recall,", "or", "a", "voluntary", "recall", "by", "us,", "could", "result", "from", "a", "number", "of", "events", "or", "factors,", "including", "component", "failures,", "manufacturing", "errors,", "instability", "of", "product", "or", "defects", "in", "labeling.", "<tag2>", "As", "we", "evaluate", "strategic", "alternatives,", "we", "will", "need", "to", "consider", "a", "number", "of", "factors,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products,", "possible", "capital", "raising", "transactions,", "partnering", "opportunities", "and", "working", "capital", "requirements.", "<tag3>"], "wordsA": ["A", "governmentally", "mandated", "recall,", "or", "a", "voluntary", "recall", "by", "us,", "could", "result", "from", "a", "number", "of", "events", "or", "factors,", "including", "component", "failures,", "manufacturing", "errors,", "instability", "of", "product", "or", "defects", "in", "labeling."], "wordsB": ["As", "we", "evaluate", "strategic", "alternatives,", "we", "will", "need", "to", "consider", "a", "number", "of", "factors,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products,", "possible", "capital", "raising", "transactions,", "partnering", "opportunities", "and", "working", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006297769956290722, 0.038353826850652695, 0.07574997842311859, 0.16387292742729187, 0.18305066227912903, 0.009824084118008614, 0.008514825254678726, 0.012036246247589588, 0.008077885955572128, 0.04144769161939621, 0.009600279852747917, 0.02085409313440323, 0.01750379242002964, 0.05186798423528671, 0.006925721187144518, 0.16824987530708313, 0.08819737285375595, 0.0151757150888443, 0.08814457058906555, 0.051600001752376556, 0.08675671368837357, 0.17123156785964966, 0.0784764215350151, 0.017309492453932762, 0.0911136344075203, 0.024433106184005737, 0.27282217144966125, 0.290682852268219, 0.2973962128162384, 0.1111740916967392, 0.11536681652069092, 0.008218931034207344, 0.1499452292919159, 0.19496704638004303, 0.11559709906578064, -1]}
{"idB": "749647_13_item1_p115_s1", "idA": "749647_12_item1_p97_s1", "sentA": "These regulations require, among other things, the reporting to the FDA of adverse events alleged to have been associated with the use of a product or in connection with certain product failures.", "sentB": "This results in 51,370 warrant shares issuable in connection with the Term A Loan.", "type": 2, "words": ["<tag1>", "These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures.", "<tag2>", "This", "results", "in", "51,370", "warrant", "shares", "issuable", "in", "connection", "with", "the", "Term", "A", "Loan.", "<tag3>"], "wordsA": ["These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures."], "wordsB": ["This", "results", "in", "51,370", "warrant", "shares", "issuable", "in", "connection", "with", "the", "Term", "A", "Loan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012590769678354263, 0.061845630407333374, 0.02310076355934143, 0.37653031945228577, 0.6133924722671509, 0.6609321236610413, 0.16644079983234406, 0.011350942775607109, 0.0352470763027668, 0.024636751040816307, 0.022242847830057144, 0.22753864526748657, 0.14021313190460205, 0.32120057940483093, -1]}
{"idB": "749647_13_item1_p9_s0", "idA": "749647_12_item1_p9_s0", "sentA": "Celsion Corporation is an innovative oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer.", "sentB": "Celsion is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer.", "type": 2, "words": ["<tag1>", "Celsion", "Corporation", "is", "an", "innovative", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult", "to", "treat", "forms", "of", "cancer.", "<tag2>", "Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult", "to", "treat", "forms", "of", "cancer.", "<tag3>"], "wordsA": ["Celsion", "Corporation", "is", "an", "innovative", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult", "to", "treat", "forms", "of", "cancer."], "wordsB": ["Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult", "to", "treat", "forms", "of", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7192227840423584, 0.055869024246931076, 0.021540142595767975, 0.6046981811523438, 0.1943187415599823, 0.18538448214530945, 0.3240877389907837, 0.08290473371744156, 0.03264204040169716, 0.015919862315058708, 0.08387631177902222, 0.03352440521121025, 0.11159761995077133, 0.07514272630214691, 0.07119102776050568, 0.08032826334238052, 0.0459313839673996, 0.14609770476818085, 0.0674593523144722, 0.07928404957056046, 0.06023213267326355, 0.04666230082511902, 0.09384274482727051, -1]}
{"idB": "749647_14_item1_p120_s2", "idA": "749647_13_item1_p0_s0", "sentA": "Certain of the statements contained in this Annual Report on Form 10-K are forward-looking and constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.", "sentB": "Unless otherwise expressly stated, the share and per share data in this section and elsewhere in this Annual Report on Form 10-K have been adjusted to reflect the reverse stock split.", "type": 2, "words": ["<tag1>", "Certain", "of", "the", "statements", "contained", "in", "this", "Annual", "Report", "on", "Form", "10-K", "are", "forward-looking", "and", "constitute", "forward-looking", "statements", "within", "the", "meaning", "of", "the", "Private", "Securities", "Litigation", "Reform", "Act", "of", "1995.", "<tag2>", "Unless", "otherwise", "expressly", "stated,", "the", "share", "and", "per", "share", "data", "in", "this", "section", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K", "have", "been", "adjusted", "to", "reflect", "the", "reverse", "stock", "split.", "<tag3>"], "wordsA": ["Certain", "of", "the", "statements", "contained", "in", "this", "Annual", "Report", "on", "Form", "10-K", "are", "forward-looking", "and", "constitute", "forward-looking", "statements", "within", "the", "meaning", "of", "the", "Private", "Securities", "Litigation", "Reform", "Act", "of", "1995."], "wordsB": ["Unless", "otherwise", "expressly", "stated,", "the", "share", "and", "per", "share", "data", "in", "this", "section", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K", "have", "been", "adjusted", "to", "reflect", "the", "reverse", "stock", "split."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08829125016927719, 0.13321533799171448, 0.16107113659381866, 0.192140594124794, 0.01041396427899599, 0.3425690233707428, 0.15636953711509705, 0.4486466646194458, 0.6205371022224426, 0.26329338550567627, 0.006018878426402807, 0.005745551083236933, 0.012935971841216087, 0.008316840045154095, 0.007860053330659866, 0.005157455336302519, 0.00419788621366024, 0.007536045275628567, 0.00887016486376524, 0.0035814661532640457, 0.005065275356173515, 0.004879676271229982, 0.022425588220357895, 0.028510797768831253, 0.20996341109275818, 0.016492312774062157, 0.0673518255352974, 0.03171488270163536, 0.474227637052536, 0.552539050579071, 0.40201336145401, -1]}
{"idB": "749647_14_item1_p0_s3", "idA": "749647_13_item1_p0_s3", "sentA": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost and timing of development and testing, possible changes in capital structure, financial condition, future working capital needs and other financial items; changes in approaches to medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks and uncertainties associated with possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities, as well as those listed under Risk Factors below and elsewhere in this Annual Report on Form 10-K.", "sentB": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost, timing and progress of development, preclinical studies, clinical trials and regulatory submissions; our or our collaborator s ability to obtain and maintain regulatory approval of any of our product candidates; possible changes in capital structure, financial condition, future working capital needs and other financial items; changes in approaches to medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks and uncertainties associated with possible acquisitions of other technologies, assets or businesses; our ability to obtain additional funds for our operations; our ability to obtain and maintain intellectual property protection for our technologies and product candidates and our ability to operate our business without infringing the intellectual property rights of others; our reliance on third parties to conduct preclinical studies or clinical trials; the rate and degree of market acceptance of any approved product candidates; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities; compliance with listing standards of The NASDAQ Capital Market; and those listed under Risk Factors b elow and elsewhere in this Annual Report on Form 10-K. In some cases, you can identify forward-looking statements by terminology such as expect, anticipate, estimate, plan, believe, could, intend, predict, may, should, will, would and words of similar import regarding the Company s expectations.", "type": 2, "words": ["<tag1>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost", "and", "timing", "of", "development", "and", "testing,", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities,", "as", "well", "as", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag2>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "b", "elow", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations.", "<tag3>"], "wordsA": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost", "and", "timing", "of", "development", "and", "testing,", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities,", "as", "well", "as", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K."], "wordsB": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "b", "elow", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009708389639854431, 0.02308151125907898, 0.019100071862339973, 0.012716899625957012, 0.012142559513449669, 0.014697004109621048, 0.020942863076925278, 0.013721559196710587, 0.012283609248697758, 0.013774801976978779, 0.01918657124042511, 0.015978993847966194, 0.015206427313387394, 0.012806345708668232, 0.014310412108898163, 0.013162723742425442, 0.0075736818835139275, 0.009211032651364803, 0.01242173183709383, 0.018681300804018974, 0.008481516502797604, 0.013328570872545242, 0.010650204494595528, 0.0123412711545825, 0.015154422260820866, 0.01181254256516695, 0.0077837612479925156, 0.010924192145466805, 0.010966763831675053, 0.019394807517528534, 0.008706062100827694, 0.007210215087980032, 0.008357707411050797, 0.005387799348682165, 0.008342402055859566, 0.009238356724381447, 0.012117011472582817, 0.018487153574824333, 0.01707226224243641, 0.01730816252529621, 0.021521547809243202, 0.023918049409985542, 0.023713121190667152, 0.03271044045686722, 0.017711270600557327, 0.027586573734879494, 0.034125201404094696, 0.022779203951358795, 0.012372376397252083, 0.015264940448105335, 0.011174891144037247, 0.011829841881990433, 0.011912311427295208, 0.012520992197096348, 0.008274015970528126, 0.009641212411224842, 0.01327984593808651, 0.012584558688104153, 0.013912488706409931, 0.011206326074898243, 0.014085965231060982, 0.013151203282177448, 0.01429237611591816, 0.01532660610973835, 0.01288551464676857, 0.01066584698855877, 0.010419542901217937, 0.011680539697408676, 0.010407557711005211, 0.010402530431747437, 0.01394057460129261, 0.011121955700218678, 0.013777075335383415, 0.013493044301867485, 0.014161757193505764, 0.009385977871716022, 0.011257758364081383, 0.009645962156355381, 0.010063853114843369, 0.010468794032931328, 0.012253989465534687, 0.009069647639989853, 0.015412956476211548, 0.011793471872806549, 0.01168866828083992, 0.009811298921704292, 0.013030776754021645, 0.017087198793888092, 0.01589411124587059, 0.012810434214770794, 0.013273606076836586, 0.009125998243689537, 0.010473069734871387, 0.01312856562435627, 0.011654987931251526, 0.012004104442894459, 0.011258809827268124, 0.010004782117903233, 0.011496991850435734, 0.0112742455676198, 0.012604107148945332, 0.013566468842327595, 0.013499552384018898, 0.02031688764691353, 0.007758381310850382, 0.021382147446274757, 0.006608245894312859, 0.02835165522992611, 0.01923631876707077, 0.015703031793236732, 0.010880152694880962, 0.01271333359181881, 0.01626836135983467, 0.007840815000236034, 0.012832734733819962, 0.010054447688162327, 0.011358617804944515, 0.013202548027038574, 0.013553207740187645, 0.014338971115648746, 0.017715534195303917, 0.012430890463292599, 0.008287771604955196, 0.008593541570007801, 0.008172930218279362, 0.007129275240004063, 0.00791720300912857, 0.007293371018022299, 0.008112138137221336, 0.007381006609648466, 0.009638894349336624, 0.009250866249203682, 0.008514474146068096, 0.009050242602825165, 0.010424553416669369, 0.014818993397057056, 0.014734399504959583, 0.012506737373769283, 0.014333183877170086, 0.014819384552538395, 0.017555059865117073, 0.008956237696111202, 0.027339821681380272, 0.013434712775051594, 0.032996658235788345, 0.08990799635648727, 0.07628802210092545, 0.062318384647369385, 0.028099650517106056, 0.009874995797872543, 0.015873223543167114, 0.011816299520432949, 0.005459779407829046, 0.00986979529261589, 0.016674965620040894, 0.008210854604840279, 0.01062488742172718, 0.00802021473646164, 0.014940458349883556, 0.010491511784493923, 0.016214832663536072, 0.013357574120163918, 0.009682874195277691, 0.00997147522866726, 0.014312919229269028, 0.03614688664674759, 0.021362680941820145, 0.009422152303159237, 0.011620473116636276, 0.008142341859638691, 0.010407557711005211, 0.011236399412155151, 0.010348604992032051, 0.012019999325275421, 0.01038013119250536, 0.010500921867787838, 0.011370121501386166, 0.011024248786270618, 0.009652085602283478, 0.012760070152580738, 0.01369648426771164, 0.02298092655837536, 0.014259329065680504, 0.022759156301617622, 0.03404472768306732, 0.012752942740917206, 0.019330058246850967, 0.03806566074490547, 0.03535906970500946, 0.02920455113053322, 0.007194755598902702, 0.01216450147330761, 0.013374476693570614, 0.011964716017246246, 0.020982472226023674, 0.0394870787858963, 0.02651558443903923, 0.04424817115068436, 0.011931279674172401, 0.014124452136456966, 0.011032331734895706, 0.009842469356954098, 0.01610708236694336, 0.013479012064635754, 0.009726643562316895, 0.013025932013988495, 0.016775906085968018, 0.02632417529821396, 0.05049747973680496, 0.046443793922662735, 0.08940502256155014, 0.035760555416345596, 0.0782775804400444, 0.11756367236375809, 0.15735171735286713, 0.02418975718319416, 0.056392278522253036, 0.017476676031947136, 0.018774444237351418, 0.12036766111850739, 0.10809164494276047, 0.05693507194519043, 0.017863420769572258, 0.040282897651195526, 0.038769446313381195, 0.02470540814101696, 0.016481533646583557, 0.016352947801351547, 0.01938631758093834, 0.017315788194537163, 0.014545357786118984, 0.016729582101106644, 0.036755748093128204, 0.017518600448966026, 0.029737597331404686, 0.0322965569794178, 0.009796439670026302, 0.011718103662133217, 0.038282785564661026, 0.021136188879609108, 0.025844618678092957, -1]}
{"idB": "749647_14_item1_p120_s1", "idA": "749647_13_item1_p100_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "On October 28, 2013, we effected a 4.5-to-1 reverse split of our common stock.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "On", "October", "28,", "2013,", "we", "effected", "a", "4.5-to-1", "reverse", "split", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["On", "October", "28,", "2013,", "we", "effected", "a", "4.5-to-1", "reverse", "split", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.040420129895210266, 0.12581270933151245, 0.10800931602716446, 0.7394345998764038, 0.03446941450238228, 0.06946004927158356, 0.0346260666847229, 0.3649058938026428, 0.4771357774734497, 0.49290135502815247, 0.036078110337257385, 0.03085455857217312, 0.0967416912317276, 0.0933871641755104, -1]}
{"idB": "749647_14_item1_p104_s1", "idA": "749647_13_item1_p103_s3", "sentA": "As established by the European Medicine Agency ( EMA ), orphan drug designation provides for scientific advice and regulatory assistance from the EMA, direct access to centralized marketing authorization and certain financial incentives, such as reduction of fees associated with pre-authorization inspections and marketing authorization application fees.", "sentB": "As established by the EMA, orphan drug designation provides for scientific advice and regulatory assistance from the EMA, direct access to centralized marketing authorization and certain financial incentives, such as reduction of fees associated with pre-authorization inspections and marketing authorization application fees.", "type": 2, "words": ["<tag1>", "As", "established", "by", "the", "European", "Medicine", "Agency", "(", "EMA", "),", "orphan", "drug", "designation", "provides", "for", "scientific", "advice", "and", "regulatory", "assistance", "from", "the", "EMA,", "direct", "access", "to", "centralized", "marketing", "authorization", "and", "certain", "financial", "incentives,", "such", "as", "reduction", "of", "fees", "associated", "with", "pre-authorization", "inspections", "and", "marketing", "authorization", "application", "fees.", "<tag2>", "As", "established", "by", "the", "EMA,", "orphan", "drug", "designation", "provides", "for", "scientific", "advice", "and", "regulatory", "assistance", "from", "the", "EMA,", "direct", "access", "to", "centralized", "marketing", "authorization", "and", "certain", "financial", "incentives,", "such", "as", "reduction", "of", "fees", "associated", "with", "pre-authorization", "inspections", "and", "marketing", "authorization", "application", "fees.", "<tag3>"], "wordsA": ["As", "established", "by", "the", "European", "Medicine", "Agency", "(", "EMA", "),", "orphan", "drug", "designation", "provides", "for", "scientific", "advice", "and", "regulatory", "assistance", "from", "the", "EMA,", "direct", "access", "to", "centralized", "marketing", "authorization", "and", "certain", "financial", "incentives,", "such", "as", "reduction", "of", "fees", "associated", "with", "pre-authorization", "inspections", "and", "marketing", "authorization", "application", "fees."], "wordsB": ["As", "established", "by", "the", "EMA,", "orphan", "drug", "designation", "provides", "for", "scientific", "advice", "and", "regulatory", "assistance", "from", "the", "EMA,", "direct", "access", "to", "centralized", "marketing", "authorization", "and", "certain", "financial", "incentives,", "such", "as", "reduction", "of", "fees", "associated", "with", "pre-authorization", "inspections", "and", "marketing", "authorization", "application", "fees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02286871150135994, 0.056010570377111435, 0.030465155839920044, 0.023311829194426537, 0.3948507606983185, 0.39450371265411377, 0.07943452149629593, 0.08353910595178604, 0.027177870273590088, 0.025354012846946716, 0.04015776515007019, 0.059431981295347214, 0.020635521039366722, 0.042149655520915985, 0.043404608964920044, 0.021333208307623863, 0.031046489253640175, 0.5786390900611877, 0.03351700305938721, 0.032929353415966034, 0.01967766508460045, 0.07054469734430313, 0.05931055173277855, 0.05757850036025047, 0.017180120572447777, 0.021214159205555916, 0.023878302425146103, 0.0401325523853302, 0.016080519184470177, 0.012778542004525661, 0.02034812979400158, 0.020157568156719208, 0.03261522948741913, 0.013906451873481274, 0.01378076896071434, 0.08584225177764893, 0.026768922805786133, 0.011626415885984898, 0.03728907182812691, 0.04299330338835716, 0.02204056642949581, 0.021893400698900223, -1]}
{"idB": "749647_14_item1_p117_s0", "idA": "749647_13_item1_p107_s0", "sentA": "As of March 15, 2013, we employed 19 full-time employees.", "sentB": "As of March 12, 2014, we employed 13 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "15,", "2013,", "we", "employed", "19", "full-time", "employees.", "<tag2>", "As", "of", "March", "12,", "2014,", "we", "employed", "13", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "15,", "2013,", "we", "employed", "19", "full-time", "employees."], "wordsB": ["As", "of", "March", "12,", "2014,", "we", "employed", "13", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00852297991514206, 0.0076378644444048405, 0.09236372262239456, 0.7378912568092346, 0.6264541149139404, 0.004069727845489979, 0.031272079795598984, 0.8379546403884888, 0.15207558870315552, 0.1259911209344864, -1]}
{"idB": "749647_14_item1_p118_s4", "idA": "749647_13_item1_p108_s4", "sentA": "The information contained in, or that can be accessed through, our website is not part of, and is not incorporated in, this Annual Report.", "sentB": "The information contained in, or that can be accessed through, our website is not part of, and is not incorporated in, this Annual Report on Form 10-K.", "type": 2, "words": ["<tag1>", "The", "information", "contained", "in,", "or", "that", "can", "be", "accessed", "through,", "our", "website", "is", "not", "part", "of,", "and", "is", "not", "incorporated", "in,", "this", "Annual", "Report.", "<tag2>", "The", "information", "contained", "in,", "or", "that", "can", "be", "accessed", "through,", "our", "website", "is", "not", "part", "of,", "and", "is", "not", "incorporated", "in,", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag3>"], "wordsA": ["The", "information", "contained", "in,", "or", "that", "can", "be", "accessed", "through,", "our", "website", "is", "not", "part", "of,", "and", "is", "not", "incorporated", "in,", "this", "Annual", "Report."], "wordsB": ["The", "information", "contained", "in,", "or", "that", "can", "be", "accessed", "through,", "our", "website", "is", "not", "part", "of,", "and", "is", "not", "incorporated", "in,", "this", "Annual", "Report", "on", "Form", "10-K."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0037472944241017103, 0.018522396683692932, 0.007453795988112688, 0.005148640368133783, 0.0038970066234469414, 0.0035633284132927656, 0.005209474358707666, 0.005034775473177433, 0.006661767605692148, 0.006004569586366415, 0.004949322436004877, 0.0226933304220438, 0.03912346065044403, 0.3999614715576172, 0.08749543875455856, 0.012081817723810673, 0.0047533633187413216, 0.015668177977204323, 0.20100058615207672, 0.0638270154595375, 0.010766559280455112, 0.004159783944487572, 0.02217916212975979, 0.039450470358133316, 0.04500501602888107, 0.4587356746196747, 0.8297867774963379, -1]}
{"idB": "749647_14_item1_p9_s0", "idA": "749647_13_item1_p10_s0", "sentA": "Our lead product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis (CRLM) and a Phase II clinical trial for recurrent chest wall breast cancer.", "sentB": "Our lead product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the OPTIMA study) starting in the first half of 2014 and is being evaluated in a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study).", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "HEAT", "study),", "a", "Phase", "II", "clinical", "trial", "for", "colorectal", "liver", "metastasis", "(CRLM)", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer.", "<tag2>", "Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "starting", "in", "the", "first", "half", "of", "2014", "and", "is", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag3>"], "wordsA": ["Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "HEAT", "study),", "a", "Phase", "II", "clinical", "trial", "for", "colorectal", "liver", "metastasis", "(CRLM)", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer."], "wordsB": ["Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "starting", "in", "the", "first", "half", "of", "2014", "and", "is", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0017345614032819867, 0.005650775507092476, 0.0037497058510780334, 0.0039725396782159805, 0.001229734974913299, 0.0030568591319024563, 0.008169319480657578, 0.0018989525269716978, 0.0014730673283338547, 0.005397988948971033, 0.004156684037297964, 0.006047404371201992, 0.00803104043006897, 0.0022896237205713987, 0.005115640815347433, 0.010268393903970718, 0.008279232308268547, 0.022944513708353043, 0.8284737467765808, 0.4700896143913269, 0.013926993124186993, 0.01619044877588749, 0.011908169835805893, 0.07466903328895569, 0.11134324222803116, 0.12750644981861115, 0.7661841511726379, 0.00013017373566981405, 0.0011812009615823627, 0.0027154788840562105, 0.008120409213006496, 0.0018126631621271372, 0.0014955357182770967, 0.005593896843492985, 0.004413401708006859, 0.00619880948215723, 0.00815765280276537, 0.001830908702686429, 0.004274701699614525, 0.005163197871297598, 0.0037926826626062393, 0.008376329205930233, 0.011001044884324074, 0.018782176077365875, 0.8933245539665222, 0.5259002447128296, -1]}
{"idB": "749647_14_item1_p125_s2", "idA": "749647_13_item1_p111_s0", "sentA": "On June 27, 2012, the Company entered into a Loan and Security Agreement (the Credit Agreement ) with Oxford Finance LLC ( Oxford ) and Horizon Technology Finance Corporation ( Horizon ).", "sentB": "The Company used approximately $4 million of the first tranche to repay the outstanding obligations under a loan agreement with Oxford Finance LLC and Horizon Technology Finance Corporation.", "type": 2, "words": ["<tag1>", "On", "June", "27,", "2012,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(the", "Credit", "Agreement", ")", "with", "Oxford", "Finance", "LLC", "(", "Oxford", ")", "and", "Horizon", "Technology", "Finance", "Corporation", "(", "Horizon", ").", "<tag2>", "The", "Company", "used", "approximately", "$4", "million", "of", "the", "first", "tranche", "to", "repay", "the", "outstanding", "obligations", "under", "a", "loan", "agreement", "with", "Oxford", "Finance", "LLC", "and", "Horizon", "Technology", "Finance", "Corporation.", "<tag3>"], "wordsA": ["On", "June", "27,", "2012,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(the", "Credit", "Agreement", ")", "with", "Oxford", "Finance", "LLC", "(", "Oxford", ")", "and", "Horizon", "Technology", "Finance", "Corporation", "(", "Horizon", ")."], "wordsB": ["The", "Company", "used", "approximately", "$4", "million", "of", "the", "first", "tranche", "to", "repay", "the", "outstanding", "obligations", "under", "a", "loan", "agreement", "with", "Oxford", "Finance", "LLC", "and", "Horizon", "Technology", "Finance", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00710995402187109, 0.07835769653320312, 0.36221858859062195, 0.2544741928577423, 0.6473988890647888, 0.6299431920051575, 0.1270403414964676, 0.13534760475158691, 0.22704273462295532, 0.37807145714759827, 0.039453741163015366, 0.1358998864889145, 0.013663485646247864, 0.0591440424323082, 0.07945267111063004, 0.021938970312476158, 0.010503086261451244, 0.12225265800952911, 0.07004203647375107, 0.006821925286203623, 0.009829225018620491, 0.012418661266565323, 0.012506990693509579, 0.004019523970782757, 0.008314795792102814, 0.0072283558547496796, 0.01150831114500761, 0.012791615910828114, -1]}
{"idB": "749647_14_item1_p125_s0", "idA": "749647_13_item1_p111_s1", "sentA": "The Credit Agreement provides for a secured term loan of up to $10 million, with 50% of any loans to be funded by Oxford and 50% to be funded by Horizon.", "sentB": "In addition, the Company entered into a loan agreement on November 25, 2013 with Hercules Technology Growth Capital, Inc. (Hercules), pursuant to which the Company may borrow a secured term loan of up to $20 million in multiple tranches (the Hercules Credit Agreement).", "type": 2, "words": ["<tag1>", "The", "Credit", "Agreement", "provides", "for", "a", "secured", "term", "loan", "of", "up", "to", "$10", "million,", "with", "50%", "of", "any", "loans", "to", "be", "funded", "by", "Oxford", "and", "50%", "to", "be", "funded", "by", "Horizon.", "<tag2>", "In", "addition,", "the", "Company", "entered", "into", "a", "loan", "agreement", "on", "November", "25,", "2013", "with", "Hercules", "Technology", "Growth", "Capital,", "Inc.", "(Hercules),", "pursuant", "to", "which", "the", "Company", "may", "borrow", "a", "secured", "term", "loan", "of", "up", "to", "$20", "million", "in", "multiple", "tranches", "(the", "Hercules", "Credit", "Agreement).", "<tag3>"], "wordsA": ["The", "Credit", "Agreement", "provides", "for", "a", "secured", "term", "loan", "of", "up", "to", "$10", "million,", "with", "50%", "of", "any", "loans", "to", "be", "funded", "by", "Oxford", "and", "50%", "to", "be", "funded", "by", "Horizon."], "wordsB": ["In", "addition,", "the", "Company", "entered", "into", "a", "loan", "agreement", "on", "November", "25,", "2013", "with", "Hercules", "Technology", "Growth", "Capital,", "Inc.", "(Hercules),", "pursuant", "to", "which", "the", "Company", "may", "borrow", "a", "secured", "term", "loan", "of", "up", "to", "$20", "million", "in", "multiple", "tranches", "(the", "Hercules", "Credit", "Agreement)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0222573671489954, 0.017389874905347824, 0.005647920537739992, 0.06614447385072708, 0.04994944855570793, 0.07383280992507935, 0.03280087560415268, 0.09004305303096771, 0.09252672642469406, 0.02504837140440941, 0.09833809733390808, 0.07798799127340317, 0.10632467269897461, 0.03684714809060097, 0.5601065754890442, 0.2640230655670166, 0.2797856032848358, 0.26490911841392517, 0.1425667405128479, 0.5422527194023132, 0.0074777486734092236, 0.007920829579234123, 0.0057364655658602715, 0.006263147108256817, 0.03702626749873161, 0.03181779012084007, 0.05567924305796623, 0.006285087205469608, 0.01893104426562786, 0.024323930963873863, 0.031905777752399445, 0.004704553168267012, 0.009245933964848518, 0.008369524031877518, 0.49701884388923645, 0.06694746017456055, 0.029439330101013184, 0.360126793384552, 0.28065335750579834, 0.009532744996249676, 0.05987158790230751, 0.045481134206056595, 0.04345861077308655, -1]}
{"idB": "749647_14_item1_p21_s3", "idA": "749647_13_item1_p112_s1", "sentA": "The proceeds of the Credit Agreement will be used to fund the Company s working capital and general corporate purposes.", "sentB": "In January 2014, the Company raised net proceeds of $14 million through an equity financing and, including its cash, investments and interest receivable totaling $43.1 million at the end 2013, has $57 million to fund its operations in 2014 and beyond.", "type": 2, "words": ["<tag1>", "The", "proceeds", "of", "the", "Credit", "Agreement", "will", "be", "used", "to", "fund", "the", "Company", "s", "working", "capital", "and", "general", "corporate", "purposes.", "<tag2>", "In", "January", "2014,", "the", "Company", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing", "and,", "including", "its", "cash,", "investments", "and", "interest", "receivable", "totaling", "$43.1", "million", "at", "the", "end", "2013,", "has", "$57", "million", "to", "fund", "its", "operations", "in", "2014", "and", "beyond.", "<tag3>"], "wordsA": ["The", "proceeds", "of", "the", "Credit", "Agreement", "will", "be", "used", "to", "fund", "the", "Company", "s", "working", "capital", "and", "general", "corporate", "purposes."], "wordsB": ["In", "January", "2014,", "the", "Company", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing", "and,", "including", "its", "cash,", "investments", "and", "interest", "receivable", "totaling", "$43.1", "million", "at", "the", "end", "2013,", "has", "$57", "million", "to", "fund", "its", "operations", "in", "2014", "and", "beyond."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030174562707543373, 0.09405727684497833, 0.1692257672548294, 0.006968786008656025, 0.0665200725197792, 0.22019870579242706, 0.16488713026046753, 0.3448141813278198, 0.030176369473338127, 0.17799989879131317, 0.20855329930782318, 0.013986531645059586, 0.013003550469875336, 0.18139995634555817, 0.3137570917606354, 0.00023666165361646563, 0.008015595376491547, 0.008201551623642445, 0.14312772452831268, 0.09969988465309143, 0.016671275720000267, 0.09422308206558228, 0.052585043013095856, 0.007744551170617342, 0.042101118713617325, 0.046514738351106644, 0.007470820099115372, 0.00559091055765748, 0.03329930454492569, 0.03435438498854637, 0.018143408000469208, 0.19577020406723022, 0.2399238795042038, 0.012974465265870094, 0.04910719022154808, 0.01653280481696129, 0.054786570370197296, 0.015407398343086243, 0.05278483405709267, 0.04981543868780136, 0.040714848786592484, -1]}
{"idB": "749647_14_item1_p126_s0", "idA": "749647_13_item1_p114_s0", "sentA": "The Term A Loan bears interest at a fixed rate of 11.75%.", "sentB": "The loan bears interest at a floating per annum rate equal to the greater of (i) 11.25 percent and (ii) the sum of 11.25 per cent plus the prime rate minus 3.25 per cent.", "type": 2, "words": ["<tag1>", "The", "Term", "A", "Loan", "bears", "interest", "at", "a", "fixed", "rate", "of", "11.75%.", "<tag2>", "The", "loan", "bears", "interest", "at", "a", "floating", "per", "annum", "rate", "equal", "to", "the", "greater", "of", "(i)", "11.25", "percent", "and", "(ii)", "the", "sum", "of", "11.25", "per", "cent", "plus", "the", "prime", "rate", "minus", "3.25", "per", "cent.", "<tag3>"], "wordsA": ["The", "Term", "A", "Loan", "bears", "interest", "at", "a", "fixed", "rate", "of", "11.75%."], "wordsB": ["The", "loan", "bears", "interest", "at", "a", "floating", "per", "annum", "rate", "equal", "to", "the", "greater", "of", "(i)", "11.25", "percent", "and", "(ii)", "the", "sum", "of", "11.25", "per", "cent", "plus", "the", "prime", "rate", "minus", "3.25", "per", "cent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0032208396587520838, 0.03299104422330856, 0.016090981662273407, 0.01835773140192032, 0.008020306006073952, 0.0074409665539860725, 0.8051811456680298, 0.7389807105064392, 0.7177896499633789, 0.3260875940322876, 0.008752427063882351, 0.005538908764719963, 0.005919800139963627, 0.020176710560917854, 0.008115798234939575, 0.08281581103801727, 0.3804776072502136, 0.25245344638824463, 4.478469054447487e-05, 0.07851774245500565, 0.004811875522136688, 0.057418882846832275, 0.01434897631406784, 0.42858490347862244, 0.4103917181491852, 0.19803078472614288, 0.04919063299894333, 0.0095077995210886, 0.27259179949760437, 0.2817751169204712, 0.27012065052986145, 0.6751002669334412, 0.6362823247909546, 0.5006229877471924, -1]}
{"idB": "749647_14_item1_p130_s0", "idA": "749647_13_item1_p116_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma, also known as primary liver cancer.", "sentB": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, has provided and allowed, subject to compliance with regulatory standards, clearance for our planned pivotal, double-blind, placebo-controlled Phase III trial (the OPTIMA Study) of ThermoDox in combination with RFA in primary liver cancer (HCC).", "type": 2, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma,", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "our", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer", "(HCC).", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma,", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "our", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer", "(HCC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023321155458688736, 0.49321112036705017, 0.3875322937965393, 0.44087767601013184, 0.010602949187159538, 0.020458364859223366, 0.011056611314415932, 0.009616689756512642, 0.04900314286351204, 0.017128052189946175, 0.006367193069308996, 0.03937090188264847, 0.026481112465262413, 0.030928960070014, 0.06169656291604042, 0.025021780282258987, 0.059447031468153, 0.3303888440132141, 0.057972777634859085, 0.36068621277809143, 0.0345689132809639, 0.00031157946796156466, 0.02626551315188408, 0.010735508054494858, 0.02476378343999386, 0.03528553992509842, 0.20133894681930542, 0.010423604398965836, 0.01257662009447813, 0.02896880730986595, 0.050584085285663605, 0.12871943414211273, 0.22247056663036346, 0.04825586453080177, 0.0848480761051178, 0.07132457941770554, 0.0075878119096159935, 0.104220911860466, 0.09171963483095169, 0.011212044395506382, 0.029902692884206772, 0.0048791225999593735, 0.011582148261368275, 0.0071937404572963715, 0.024653000757098198, 0.007848236709833145, 0.02827124111354351, 0.03858540952205658, 0.01882794499397278, 0.36676904559135437, -1]}
{"idB": "749647_14_item1_p46_s1", "idA": "749647_13_item1_p117_s0", "sentA": "The HEAT study was designed to show a 33 percent improvement in PFS with 80 percent power and a p-value = 0.05.", "sentB": "The post-hoc data demonstrated that the patient subgroup in the ThermoDox arm whose RFA procedure lasted longer than 45 minutes, which represents 285 patients or 63 percent of single lesion patients, experienced a 55 percent improvement in overall survival, with a Hazard Ratio of 0.64 (95% CI 0.41 - 1.00) and a P-value = 0.0495.", "type": 2, "words": ["<tag1>", "The", "HEAT", "study", "was", "designed", "to", "show", "a", "33", "percent", "improvement", "in", "PFS", "with", "80", "percent", "power", "and", "a", "p-value", "=", "0.05.", "<tag2>", "The", "post-hoc", "data", "demonstrated", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes,", "which", "represents", "285", "patients", "or", "63", "percent", "of", "single", "lesion", "patients,", "experienced", "a", "55", "percent", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495.", "<tag3>"], "wordsA": ["The", "HEAT", "study", "was", "designed", "to", "show", "a", "33", "percent", "improvement", "in", "PFS", "with", "80", "percent", "power", "and", "a", "p-value", "=", "0.05."], "wordsB": ["The", "post-hoc", "data", "demonstrated", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes,", "which", "represents", "285", "patients", "or", "63", "percent", "of", "single", "lesion", "patients,", "experienced", "a", "55", "percent", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003537988755851984, 0.3412381112575531, 0.1728707253932953, 0.019637757912278175, 0.006800525821745396, 0.004417918622493744, 0.08369924128055573, 0.0413690023124218, 0.008681023493409157, 0.005595833528786898, 0.16253498196601868, 0.0795135349035263, 0.003235833952203393, 0.020470352843403816, 0.022009138017892838, 0.015825022011995316, 0.025447038933634758, 0.02774115465581417, 0.042431168258190155, 0.029159197583794594, 0.00014242086035665125, 0.0038735175039619207, 0.020281583070755005, 0.022648010402917862, 0.0001723816094454378, 0.07788444310426712, 0.03142713010311127, 0.00369283533655107, 0.05972606688737869, 0.0335456058382988, 0.027590351179242134, 0.023836832493543625, 0.007396241184324026, 0.4454551935195923, 0.16204415261745453, 0.06465911120176315, 0.011362426914274693, 0.11775185912847519, 0.0559861995279789, 0.0004194923385512084, 0.003638950642198324, 0.019590094685554504, 0.021278442814946175, 0.01274056825786829, 0.21212559938430786, 0.0365338996052742, 0.03751172125339508, 0.0682716816663742, 0.09099353849887848, 0.0770050436258316, 0.0002469744358677417, 0.003078511683270335, 0.04447118937969208, 0.04302886500954628, 0.7959452867507935, -1]}
{"idB": "749647_14_item1_p121_s0", "idA": "749647_13_item1_p120_s0", "sentA": "On February 1, 2013, the Company entered into a Controlled Equity Offering SM Sales Agreement (the ATM Agreement ) with Cantor Fitzgerald Co., as sales agent ( Cantor ), pursuant to which Celsion may offer and sell, from time to time, through Cantor, shares of our common stock having an aggregate offering price of up to $25.0 million (the ATM Shares ).", "sentB": "On February 1, 2013, we entered into a Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald Co., as sales agent, pursuant to which we may offer and sell, from time to time through at-the-market offerings, shares of our common stock having an aggregate offering price of up to $25.0 million.", "type": 2, "words": ["<tag1>", "On", "February", "1,", "2013,", "the", "Company", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent", "(", "Cantor", "),", "pursuant", "to", "which", "Celsion", "may", "offer", "and", "sell,", "from", "time", "to", "time,", "through", "Cantor,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million", "(the", "ATM", "Shares", ").", "<tag2>", "On", "February", "1,", "2013,", "we", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million.", "<tag3>"], "wordsA": ["On", "February", "1,", "2013,", "the", "Company", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent", "(", "Cantor", "),", "pursuant", "to", "which", "Celsion", "may", "offer", "and", "sell,", "from", "time", "to", "time,", "through", "Cantor,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million", "(the", "ATM", "Shares", ")."], "wordsB": ["On", "February", "1,", "2013,", "we", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008693473413586617, 0.012180046178400517, 0.013084299862384796, 0.012656856328248978, 0.023885633796453476, 0.018149562180042267, 0.01515799481421709, 0.010926855728030205, 0.01381042879074812, 0.02001355029642582, 0.013593046925961971, 0.02195112034678459, 0.020760729908943176, 0.02153678797185421, 0.009218206629157066, 0.1069873571395874, 0.041629042476415634, 0.0199930090457201, 0.009025728330016136, 0.018462475389242172, 0.019612135365605354, 0.015228571370244026, 0.010980400256812572, 0.00901658833026886, 0.008873057551681995, 0.008197099901735783, 0.009090245701372623, 0.00813485961407423, 0.006383335217833519, 0.005471303127706051, 0.007004833314567804, 0.009659428149461746, 0.006535393185913563, 0.008419526740908623, 0.9489255547523499, 0.6816508173942566, 0.07860417664051056, 0.011089717037975788, 0.010237869806587696, 0.03284668177366257, 0.01903521455824375, 0.004948965273797512, 0.006254048086702824, 0.010689894668757915, 0.010917142033576965, 0.008404540829360485, 0.005507792811840773, 0.007488625589758158, 0.0064790272153913975, 0.025105679407715797, 0.018678562715649605, -1]}
{"idB": "749647_14_item1_p121_s1", "idA": "749647_13_item1_p120_s3", "sentA": "From February 1, 2013 through February 25, 2013, the Company sold and issued 5,381,670 ATM shares under the ATM Agreement, receiving approximately $6.8 million in net proceeds.", "sentB": "From February 1, 2013 through February 25, 2013, we sold and issued an aggregate of 1,195,923 shares of common stock under such agreement for approximately $6.8 million in aggregate gross proceeds.", "type": 2, "words": ["<tag1>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "5,381,670", "ATM", "shares", "under", "the", "ATM", "Agreement,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds.", "<tag2>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds.", "<tag3>"], "wordsA": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "5,381,670", "ATM", "shares", "under", "the", "ATM", "Agreement,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds."], "wordsB": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0036542348098009825, 0.002844057511538267, 0.0028726058080792427, 0.0033358761575073004, 0.002955684205517173, 0.0031073936261236668, 0.0030954342801123857, 0.0035783606581389904, 0.006487593520432711, 0.014873755164444447, 0.004854716360569, 0.022667232900857925, 0.010409983806312084, 0.06877411901950836, 0.02723689377307892, 0.6835403442382812, 0.5429425835609436, 0.08291420340538025, 0.7189556956291199, 0.7294058203697205, 0.004805342294275761, 0.009469285607337952, 0.021237066015601158, 0.004968290217220783, 0.005244015716016293, 0.0058229644782841206, 0.004595080390572548, 0.003994747530668974, 0.03519286587834358, 0.060063064098358154, 0.024769920855760574, -1]}
{"idB": "749647_14_item1_p21_s4", "idA": "749647_13_item1_p120_s3", "sentA": "From February 1, 2013 through February 25, 2013, the Company sold and issued 5,381,670 ATM shares under the ATM Agreement, receiving approximately $6.8 million in net proceeds.", "sentB": "During 2012 and 2013, the Company secured two credit facilities totaling $20 million collectively, one of which has been fully repaid, and currently has up to $15 million remaining under the surviving facility.", "type": 2, "words": ["<tag1>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "5,381,670", "ATM", "shares", "under", "the", "ATM", "Agreement,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds.", "<tag2>", "During", "2012", "and", "2013,", "the", "Company", "secured", "two", "credit", "facilities", "totaling", "$20", "million", "collectively,", "one", "of", "which", "has", "been", "fully", "repaid,", "and", "currently", "has", "up", "to", "$15", "million", "remaining", "under", "the", "surviving", "facility.", "<tag3>"], "wordsA": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "5,381,670", "ATM", "shares", "under", "the", "ATM", "Agreement,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds."], "wordsB": ["During", "2012", "and", "2013,", "the", "Company", "secured", "two", "credit", "facilities", "totaling", "$20", "million", "collectively,", "one", "of", "which", "has", "been", "fully", "repaid,", "and", "currently", "has", "up", "to", "$15", "million", "remaining", "under", "the", "surviving", "facility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.029534436762332916, 0.046822689473629, 0.07847625762224197, 0.024297703057527542, 0.0058599552139639854, 0.06431319564580917, 0.34454455971717834, 0.24811439216136932, 0.4850573241710663, 0.4634120464324951, 0.01390745211392641, 0.08421160280704498, 0.0738476812839508, 0.02339909039437771, 0.0016519238706678152, 0.004391154274344444, 0.002103933598846197, 0.011309092864394188, 0.012532953172922134, 0.12481541931629181, 0.20460088551044464, 0.0034676457289606333, 0.012906468473374844, 0.022072236984968185, 0.05209532007575035, 0.03049878031015396, 0.3619135320186615, 0.2886027693748474, 0.1810797154903412, 0.10186220705509186, 0.020284993574023247, 0.2010946422815323, 0.11960777640342712, -1]}
{"idB": "749647_14_item1_p122_s0", "idA": "749647_13_item1_p123_s0", "sentA": "On February 22, 2013, the Company entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company agreed to sell, in a registered offering, an aggregate of 15,000.00422 shares of its Series A 0% convertible preferred stock and the warrants to purchase shares of its common stock, for an aggregate purchase price of approximately $15.0 million (the Preferred Stock Offering).", "sentB": "On February 22, 2013, we entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the we sold, in a registered direct offering, an aggregate of 15,000.00422 shares of our Series A 0% convertible preferred stock and warrants to purchase up to 1,341,382 shares of common stock, for an aggregate purchase price of approximately $15.0 million in gross proceeds.", "type": 2, "words": ["<tag1>", "On", "February", "22,", "2013,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "agreed", "to", "sell,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "its", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "the", "warrants", "to", "purchase", "shares", "of", "its", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "(the", "Preferred", "Stock", "Offering).", "<tag2>", "On", "February", "22,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "our", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,341,382", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "in", "gross", "proceeds.", "<tag3>"], "wordsA": ["On", "February", "22,", "2013,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "agreed", "to", "sell,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "its", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "the", "warrants", "to", "purchase", "shares", "of", "its", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "(the", "Preferred", "Stock", "Offering)."], "wordsB": ["On", "February", "22,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "our", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,341,382", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "in", "gross", "proceeds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006853341590613127, 0.010260778479278088, 0.011912018992006779, 0.00995174702256918, 0.01844283565878868, 0.019911371171474457, 0.013744841329753399, 0.009836206212639809, 0.01382981613278389, 0.022409245371818542, 0.028414759784936905, 0.011133662424981594, 0.020450187847018242, 0.038591254502534866, 0.047576677054166794, 0.009843436069786549, 0.009551357477903366, 0.006799153983592987, 0.0070740338414907455, 0.016249721869826317, 0.010903273709118366, 0.006884159054607153, 0.006128488574177027, 0.030455265194177628, 0.4799225330352783, 0.3701629340648651, 0.009344932623207569, 0.008985361084342003, 0.008278113789856434, 0.017646942287683487, 0.0279989130795002, 0.006442050915211439, 0.006122296676039696, 0.008068804629147053, 0.006569487974047661, 0.020942412316799164, 0.02082134038209915, 0.010032723657786846, 0.012247954495251179, 0.006834259256720543, 0.008686104789376259, 0.006740221753716469, 0.012810922227799892, 0.007711459416896105, 0.00803449098020792, 0.34346795082092285, 0.18595005571842194, 0.006703853141516447, 0.009544354863464832, 0.01457802951335907, 0.00965309888124466, 0.011010419577360153, 0.009743545204401016, 0.00884801521897316, 0.00866046454757452, 0.009881198406219482, 0.008978603407740593, 0.0164751298725605, 0.008938055485486984, 0.01631808653473854, 0.04631997272372246, 0.04662016034126282, -1]}
{"idB": "749647_14_item1_p123_s0", "idA": "749647_13_item1_p123_s0", "sentA": "On February 22, 2013, the Company entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company agreed to sell, in a registered offering, an aggregate of 15,000.00422 shares of its Series A 0% convertible preferred stock and the warrants to purchase shares of its common stock, for an aggregate purchase price of approximately $15.0 million (the Preferred Stock Offering).", "sentB": "On May 30, 2013, we entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which we sold, in a registered direct offering, an aggregate of 1,392,109 shares of our common stock for an aggregate purchase price of approximately $9.8 million in gross proceeds.", "type": 2, "words": ["<tag1>", "On", "February", "22,", "2013,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "agreed", "to", "sell,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "its", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "the", "warrants", "to", "purchase", "shares", "of", "its", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "(the", "Preferred", "Stock", "Offering).", "<tag2>", "On", "May", "30,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "1,392,109", "shares", "of", "our", "common", "stock", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$9.8", "million", "in", "gross", "proceeds.", "<tag3>"], "wordsA": ["On", "February", "22,", "2013,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "agreed", "to", "sell,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "its", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "the", "warrants", "to", "purchase", "shares", "of", "its", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "(the", "Preferred", "Stock", "Offering)."], "wordsB": ["On", "May", "30,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "1,392,109", "shares", "of", "our", "common", "stock", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$9.8", "million", "in", "gross", "proceeds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009532826021313667, 0.7519981265068054, 0.6806461811065674, 0.028927940875291824, 0.006628422532230616, 0.005942767020314932, 0.0037147558759897947, 0.003078564302995801, 0.009239103645086288, 0.010319281369447708, 0.013058900833129883, 0.005032795947045088, 0.008491311222314835, 0.021954694762825966, 0.026189185678958893, 0.003661072812974453, 0.003654364962130785, 0.0031353977974504232, 0.006079279351979494, 0.012600140646100044, 0.002940721809864044, 0.0030305511318147182, 0.035254817456007004, 0.18740487098693848, 0.14693763852119446, 0.0037395304534584284, 0.010975337587296963, 0.007412320002913475, 0.5197963714599609, 0.34162819385528564, 0.006459379568696022, 0.006731291767209768, 0.03942033275961876, 0.03208429366350174, 0.0048742820508778095, 0.004072040319442749, 0.008989837020635605, 0.010133098810911179, 0.011803166009485722, 0.005854071583598852, 0.016131872311234474, 0.6582918763160706, 0.36274388432502747, 0.02825448475778103, 0.1584853082895279, 0.23103654384613037, -1]}
{"idB": "749647_14_item1_p129_s0", "idA": "749647_13_item1_p123_s0", "sentA": "On February 22, 2013, the Company entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company agreed to sell, in a registered offering, an aggregate of 15,000.00422 shares of its Series A 0% convertible preferred stock and the warrants to purchase shares of its common stock, for an aggregate purchase price of approximately $15.0 million (the Preferred Stock Offering).", "sentB": "On January 15, 2014, the Company entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company sold, in a registered offering, an aggregate of 3,603,604 shares of its common stock, par value $0.01 per share, and warrants to purchase up to 1,801,802 shares of Common Stock, for an aggregate purchase price of approximately $15 million.", "type": 2, "words": ["<tag1>", "On", "February", "22,", "2013,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "agreed", "to", "sell,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "its", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "the", "warrants", "to", "purchase", "shares", "of", "its", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "(the", "Preferred", "Stock", "Offering).", "<tag2>", "On", "January", "15,", "2014,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "its", "common", "stock,", "par", "value", "$0.01", "per", "share,", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million.", "<tag3>"], "wordsA": ["On", "February", "22,", "2013,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "agreed", "to", "sell,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "its", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "the", "warrants", "to", "purchase", "shares", "of", "its", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "(the", "Preferred", "Stock", "Offering)."], "wordsB": ["On", "January", "15,", "2014,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "its", "common", "stock,", "par", "value", "$0.01", "per", "share,", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012299534864723682, 0.3417681157588959, 0.33156073093414307, 0.6960232257843018, 0.0027330038137733936, 0.010103145614266396, 0.0054671321995556355, 0.003845070954412222, 0.0031152083538472652, 0.00800765585154295, 0.010146021842956543, 0.011248738504946232, 0.003964525647461414, 0.005948474630713463, 0.01649922877550125, 0.016566820442676544, 0.003623680444434285, 0.003741268301382661, 0.0028061713092029095, 0.0026076931972056627, 0.009838760830461979, 0.00969286635518074, 0.002883246401324868, 0.002871431177482009, 0.0057519725523889065, 0.007468295283615589, 0.0035104905255138874, 0.008714584633708, 0.006262612994760275, 0.6662020087242126, 0.2396945059299469, 0.003515573451295495, 0.0030290528666228056, 0.007842546328902245, 0.006847658660262823, 0.006795645225793123, 0.015201949514448643, 0.37884536385536194, 0.04972527548670769, 0.012797733768820763, 0.0044652922078967094, 0.005628308746963739, 0.0033501212019473314, 0.007952915504574776, 0.01140828337520361, 0.008652382530272007, 0.6317625641822815, 0.23584002256393433, 0.00345098739489913, 0.00831358041614294, 0.011202480643987656, 0.004401234909892082, 0.003454623045399785, 0.0039858100935816765, 0.0048787291161715984, 0.0050327167846262455, 0.0030800809618085623, 0.003890379797667265, 0.019679708406329155, 0.013088123872876167, -1]}
{"idB": "749647_14_item1_p120_s0", "idA": "749647_13_item1_p125_s0", "sentA": "As of March 15, 2013, the Company has issued an aggregate of 8,018,112 shares of common stock upon conversion of 9 ,963 shares of the Series A 0% convertible preferred stock.", "sentB": "During 2013, we issued a total of 5.3 million shares of common stock, including shares of common stock issued upon conversion of the 15,000.00422 shares of Series A 0% convertible preferred stock, in the following equity transactions for an aggregate $31.6 million in gross proceeds.", "type": 2, "words": ["<tag1>", "As", "of", "March", "15,", "2013,", "the", "Company", "has", "issued", "an", "aggregate", "of", "8,018,112", "shares", "of", "common", "stock", "upon", "conversion", "of", "9", ",963", "shares", "of", "the", "Series", "A", "0%", "convertible", "preferred", "stock.", "<tag2>", "During", "2013,", "we", "issued", "a", "total", "of", "5.3", "million", "shares", "of", "common", "stock,", "including", "shares", "of", "common", "stock", "issued", "upon", "conversion", "of", "the", "15,000.00422", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock,", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$31.6", "million", "in", "gross", "proceeds.", "<tag3>"], "wordsA": ["As", "of", "March", "15,", "2013,", "the", "Company", "has", "issued", "an", "aggregate", "of", "8,018,112", "shares", "of", "common", "stock", "upon", "conversion", "of", "9", ",963", "shares", "of", "the", "Series", "A", "0%", "convertible", "preferred", "stock."], "wordsB": ["During", "2013,", "we", "issued", "a", "total", "of", "5.3", "million", "shares", "of", "common", "stock,", "including", "shares", "of", "common", "stock", "issued", "upon", "conversion", "of", "the", "15,000.00422", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock,", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$31.6", "million", "in", "gross", "proceeds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027917521074414253, 0.021596448495984077, 0.028445322066545486, 0.029320262372493744, 0.013197299093008041, 0.04358440637588501, 0.025999050587415695, 0.5753576159477234, 0.6292014122009277, 0.28835543990135193, 0.006522662937641144, 0.011828048154711723, 0.009877840057015419, 0.0035703680478036404, 0.007009200286120176, 0.0023641358129680157, 0.006450504530221224, 0.006201500538736582, 0.0030016961973160505, 0.0024603279307484627, 0.00601301621645689, 0.002903033746406436, 0.003684753319248557, 0.44491133093833923, 0.09225709736347198, 0.0026934659108519554, 0.00435809139162302, 0.0032284418120980263, 0.0074175093322992325, 0.007190179545432329, 0.006642150692641735, 0.007178513333201408, 0.0052405535243451595, 0.005294978618621826, 0.010958615690469742, 0.01641109585762024, 0.03105807863175869, 0.009405762888491154, 0.0067604053765535355, 0.013486604206264019, 0.031090524047613144, 0.016842331737279892, 0.01075536198914051, 0.018373286351561546, 0.017415963113307953, -1]}
{"idB": "749647_14_item1_p122_s1", "idA": "749647_13_item1_p125_s0", "sentA": "As of March 15, 2013, the Company has issued an aggregate of 8,018,112 shares of common stock upon conversion of 9 ,963 shares of the Series A 0% convertible preferred stock.", "sentB": "All of the shares of Series A 0% convertible preferred stock have been converted into 2,682,764 shares of common stock.", "type": 2, "words": ["<tag1>", "As", "of", "March", "15,", "2013,", "the", "Company", "has", "issued", "an", "aggregate", "of", "8,018,112", "shares", "of", "common", "stock", "upon", "conversion", "of", "9", ",963", "shares", "of", "the", "Series", "A", "0%", "convertible", "preferred", "stock.", "<tag2>", "All", "of", "the", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "have", "been", "converted", "into", "2,682,764", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["As", "of", "March", "15,", "2013,", "the", "Company", "has", "issued", "an", "aggregate", "of", "8,018,112", "shares", "of", "common", "stock", "upon", "conversion", "of", "9", ",963", "shares", "of", "the", "Series", "A", "0%", "convertible", "preferred", "stock."], "wordsB": ["All", "of", "the", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "have", "been", "converted", "into", "2,682,764", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1411399394273758, 0.05897246301174164, 0.04695792868733406, 0.19130197167396545, 0.0057515958324074745, 0.0063526141457259655, 0.003645931603386998, 0.009889640845358372, 0.007728854194283485, 0.008917467668652534, 0.010059327818453312, 0.020292330533266068, 0.017772255465388298, 0.061625391244888306, 0.06800432503223419, 0.6979960203170776, 0.4029347598552704, 0.013173890300095081, 0.023218028247356415, 0.025930004194378853, -1]}
{"idB": "749647_14_item1_p124_s0", "idA": "749647_13_item1_p126_s0", "sentA": "During the first quarter of 2013 thus far, we received approximately $0.4 million of gross proceeds from the exercise of warrants and options to purchase 120,516 shares of the Company s common stock.", "sentB": "During 2013, we received gross proceeds of approximately $0.4 million from the exercise of warrants and common stock options to purchase 30,499 shares of common stock.", "type": 2, "words": ["<tag1>", "During", "the", "first", "quarter", "of", "2013", "thus", "far,", "we", "received", "approximately", "$0.4", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "warrants", "and", "options", "to", "purchase", "120,516", "shares", "of", "the", "Company", "s", "common", "stock.", "<tag2>", "During", "2013,", "we", "received", "gross", "proceeds", "of", "approximately", "$0.4", "million", "from", "the", "exercise", "of", "warrants", "and", "common", "stock", "options", "to", "purchase", "30,499", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["During", "the", "first", "quarter", "of", "2013", "thus", "far,", "we", "received", "approximately", "$0.4", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "warrants", "and", "options", "to", "purchase", "120,516", "shares", "of", "the", "Company", "s", "common", "stock."], "wordsB": ["During", "2013,", "we", "received", "gross", "proceeds", "of", "approximately", "$0.4", "million", "from", "the", "exercise", "of", "warrants", "and", "common", "stock", "options", "to", "purchase", "30,499", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018142959102988243, 0.011568603105843067, 0.004723585210740566, 0.007637271657586098, 0.007034334819763899, 0.009371818043291569, 0.003946819808334112, 0.0066605499014258385, 0.007785801775753498, 0.0045328810811042786, 0.0022204171400517225, 0.002514364430680871, 0.003340526483952999, 0.002322861924767494, 0.003053649328649044, 0.0019587231799960136, 0.01064277719706297, 0.0105007728561759, 0.0080531882122159, 0.0022794236429035664, 0.02976088784635067, 0.8581913113594055, 0.3112790286540985, 0.005201814696192741, 0.024880141019821167, 0.019029337912797928, -1]}
{"idB": "749647_14_item1_p38_s0", "idA": "749647_13_item1_p126_s0", "sentA": "During the first quarter of 2013 thus far, we received approximately $0.4 million of gross proceeds from the exercise of warrants and options to purchase 120,516 shares of the Company s common stock.", "sentB": "The data from the Company s 701-patient HEAT Study post-hoc analysis suggests that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their tumors undergo optimal RFA treatment.", "type": 2, "words": ["<tag1>", "During", "the", "first", "quarter", "of", "2013", "thus", "far,", "we", "received", "approximately", "$0.4", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "warrants", "and", "options", "to", "purchase", "120,516", "shares", "of", "the", "Company", "s", "common", "stock.", "<tag2>", "The", "data", "from", "the", "Company", "s", "701-patient", "HEAT", "Study", "post-hoc", "analysis", "suggests", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment.", "<tag3>"], "wordsA": ["During", "the", "first", "quarter", "of", "2013", "thus", "far,", "we", "received", "approximately", "$0.4", "million", "of", "gross", "proceeds", "from", "the", "exercise", "of", "warrants", "and", "options", "to", "purchase", "120,516", "shares", "of", "the", "Company", "s", "common", "stock."], "wordsB": ["The", "data", "from", "the", "Company", "s", "701-patient", "HEAT", "Study", "post-hoc", "analysis", "suggests", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013775242492556572, 0.17085833847522736, 0.021430956199765205, 0.010100945830345154, 0.07513821870088577, 0.03781852126121521, 0.5375359654426575, 0.3992355465888977, 0.46898239850997925, 0.33936312794685364, 0.26023784279823303, 0.0751054659485817, 0.03643195703625679, 0.351388156414032, 0.04960603639483452, 0.07032286375761032, 0.17776919901371002, 0.36110004782676697, 0.3142031729221344, 0.008531168103218079, 0.015370825305581093, 0.010819148272275925, 0.009157183580100536, 0.04350799694657326, 0.05077590420842171, 0.01386489998549223, 0.07938864827156067, 0.011692513711750507, 0.013040752150118351, 0.1545129418373108, 0.06450171768665314, 0.05301846191287041, 0.1374947726726532, 0.1334134042263031, -1]}
{"idB": "749647_14_item1_p127_s0", "idA": "749647_13_item1_p127_s0", "sentA": "We believe that our cash and investment resources of $23.1 million on hand at December 31, 2012, as well as the $26 million of net proceeds the Company collectively received thus far in the first quarter of 2013 from warrant exercises, the non-refundable payment from Hisun under the technology development agreement, the ATM Agreement and the Preferred Stock Offering, is sufficient to fund operations through 2015.", "sentB": "We believe that our cash and investment resources of $43.1 million on hand at December 31, 2013, as well as the $13.8 million of net proceeds the Company received in the first quarter of 2014 from the January 15, 2014 common stock offering, are sufficient to fund operations through 2016.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$23.1", "million", "on", "hand", "at", "December", "31,", "2012,", "as", "well", "as", "the", "$26", "million", "of", "net", "proceeds", "the", "Company", "collectively", "received", "thus", "far", "in", "the", "first", "quarter", "of", "2013", "from", "warrant", "exercises,", "the", "non-refundable", "payment", "from", "Hisun", "under", "the", "technology", "development", "agreement,", "the", "ATM", "Agreement", "and", "the", "Preferred", "Stock", "Offering,", "is", "sufficient", "to", "fund", "operations", "through", "2015.", "<tag2>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$43.1", "million", "on", "hand", "at", "December", "31,", "2013,", "as", "well", "as", "the", "$13.8", "million", "of", "net", "proceeds", "the", "Company", "received", "in", "the", "first", "quarter", "of", "2014", "from", "the", "January", "15,", "2014", "common", "stock", "offering,", "are", "sufficient", "to", "fund", "operations", "through", "2016.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$23.1", "million", "on", "hand", "at", "December", "31,", "2012,", "as", "well", "as", "the", "$26", "million", "of", "net", "proceeds", "the", "Company", "collectively", "received", "thus", "far", "in", "the", "first", "quarter", "of", "2013", "from", "warrant", "exercises,", "the", "non-refundable", "payment", "from", "Hisun", "under", "the", "technology", "development", "agreement,", "the", "ATM", "Agreement", "and", "the", "Preferred", "Stock", "Offering,", "is", "sufficient", "to", "fund", "operations", "through", "2015."], "wordsB": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$43.1", "million", "on", "hand", "at", "December", "31,", "2013,", "as", "well", "as", "the", "$13.8", "million", "of", "net", "proceeds", "the", "Company", "received", "in", "the", "first", "quarter", "of", "2014", "from", "the", "January", "15,", "2014", "common", "stock", "offering,", "are", "sufficient", "to", "fund", "operations", "through", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004667401313781738, 0.006701009348034859, 0.0033437726087868214, 0.002826385200023651, 0.004966386128216982, 0.0022161523811519146, 0.0039074597880244255, 0.007497951854020357, 0.0059020002372562885, 0.8806412220001221, 0.23707106709480286, 0.0032416575122624636, 0.005295284558087587, 0.003090047277510166, 0.00340288900770247, 0.003842021571472287, 0.02567869797348976, 0.005899021867662668, 0.002743607386946678, 0.002904176712036133, 0.004247724544256926, 0.6308008432388306, 0.08414788544178009, 0.009256234392523766, 0.01239797007292509, 0.016384949907660484, 0.002720694290474057, 0.01593744195997715, 0.006381230894476175, 0.005892112851142883, 0.004606860224157572, 0.01931564323604107, 0.035213030874729156, 0.021247176453471184, 0.4462623596191406, 0.010812388733029366, 0.008588033728301525, 0.12075656652450562, 0.2140115648508072, 0.4816146194934845, 0.25205957889556885, 0.3737396001815796, 0.19621649384498596, 0.0025143821258097887, 0.0074622672982513905, 0.002906237496063113, 0.009446599520742893, 0.01539004035294056, 0.06978815048933029, 0.6668416857719421, -1]}
{"idB": "749647_14_item1_p127_s1", "idA": "749647_13_item1_p127_s1", "sentA": "However, our future capital requirements will depend upon numerous unpredictable factors, including, without limitation, the cost, timing and outcomes of clinical studies and regulatory reviews of our proprietary drug candidates, our efforts to implement new collaborations, licenses and strategic transactions, general and administrative expenses, capital expenditures and other uses of cash.", "sentB": "However, our future capital requirements will depend upon numerous unpredictable factors, including, without limitation, the cost, timing, progress and outcomes of clinical studies and regulatory reviews of our proprietary drug candidates, our efforts to implement new collaborations, licenses and strategic transactions, general and administrative expenses, capital expenditures and other unforeseen uses of cash.", "type": 2, "words": ["<tag1>", "However,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "uses", "of", "cash.", "<tag2>", "However,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing,", "progress", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "unforeseen", "uses", "of", "cash.", "<tag3>"], "wordsA": ["However,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "uses", "of", "cash."], "wordsB": ["However,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing,", "progress", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "unforeseen", "uses", "of", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.053158219903707504, 0.028536323457956314, 0.0460641086101532, 0.11203278601169586, 0.11695101112127304, 0.0357310026884079, 0.05988509953022003, 0.03862791135907173, 0.06422502547502518, 0.11202385276556015, 0.06911098957061768, 0.023880690336227417, 0.0837210938334465, 0.15969440340995789, 0.020947810262441635, 0.0645187720656395, 0.03425559401512146, 0.03959786146879196, 0.03238075599074364, 0.028597988188266754, 0.020466255024075508, 0.027224374935030937, 0.02620692364871502, 0.01678326353430748, 0.027407288551330566, 0.035968415439128876, 0.019144613295793533, 0.024769624695181847, 0.05808338150382042, 0.05123291164636612, 0.05194959416985512, 0.02033381722867489, 0.04083779454231262, 0.0018213981529697776, 0.0211399644613266, 0.01668318547308445, 0.023710500448942184, 0.026008518412709236, 0.017169786617159843, 0.02430429868400097, 0.03105979971587658, 0.02354680746793747, 0.02008790895342827, 0.027844922617077827, 0.035607609897851944, 0.02604585886001587, 0.02887001633644104, 0.011612260714173317, 0.011814706958830357, 0.8365337252616882, 0.26541945338249207, 0.02760547772049904, 0.059037432074546814, -1]}
{"idB": "749647_14_item1_p128_s2", "idA": "749647_13_item1_p128_s2", "sentA": "We may need to pursue dilutive equity financings, such as the issuance of shares of common stock, convertible debt or other convertible or exercisable securities, which financings could dilute the percentage ownership of our current common stockholders and could significantly lower the market value of our common stock.", "sentB": "We may need to pursue dilutive equity financings, such as the issuance of shares of common stock, preferred stock, convertible debt or other convertible or exercisable securities, which financings could dilute the percentage ownership of our current common stockholders and could significantly lower the market value of our common stock.", "type": 2, "words": ["<tag1>", "We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities,", "which", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag2>", "We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "preferred", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities,", "which", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities,", "which", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "wordsB": ["We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "preferred", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities,", "which", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024904152378439903, 0.027454480528831482, 0.03004154935479164, 0.014752526767551899, 0.026977647095918655, 0.38649970293045044, 0.08624585717916489, 0.07024861872196198, 0.01868915557861328, 0.013513218611478806, 0.014407970011234283, 0.0344533734023571, 0.023977769538760185, 0.03897395357489586, 0.027418306097388268, 0.05309124290943146, 0.05548707768321037, 0.20757567882537842, 0.10616400092840195, 0.09566369652748108, 0.0794241651892662, 0.018636874854564667, 0.02381356991827488, 0.08401155471801758, 0.012712301686406136, 0.0387660376727581, 0.027906952425837517, 0.012530375272035599, 0.0453488864004612, 0.012426687404513359, 0.015568072907626629, 0.01899263821542263, 0.15074056386947632, 0.0475652702152729, 0.018910609185695648, 0.016791747882962227, 0.028098400682210922, 0.0401330403983593, 0.05167582258582115, 0.001844369457103312, 0.011180608533322811, 0.03870949149131775, 0.08964747190475464, 0.033112265169620514, 0.12428532540798187, 0.19477416574954987, 0.03125990554690361, 0.03208000212907791, 0.12834608554840088, 0.23366016149520874, -1]}
{"idB": "749647_14_item1_p50_s1", "idA": "749647_13_item1_p12_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with radio frequency ablation did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma, also known as primary liver cancer.", "sentB": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, has provided and allowed, subject to compliance with regulatory standards, clearance for the Company's planned pivotal, double-blind, placebo-controlled Phase III trial (the OPTIMA Study) of ThermoDox , its proprietary heat-activated liposomal encapsulation of doxorubicin in combination with radio frequency ablation (RFA) in primary liver cancer.", "type": 2, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma,", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "Company's", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", ",", "its", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "in", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma,", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "Company's", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", ",", "its", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "in", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02197784185409546, 0.4289541244506836, 0.2325591892004013, 0.5216412544250488, 0.007305367384105921, 0.014596556313335896, 0.008167790248990059, 0.012959946878254414, 0.03849657624959946, 0.01736149564385414, 0.007972638122737408, 0.07126051932573318, 0.02355470322072506, 0.02298761159181595, 0.03401713818311691, 0.027300016954541206, 0.03424127399921417, 0.23892375826835632, 0.04492475464940071, 0.29150694608688354, 0.015731260180473328, 0.00014417748025152832, 0.014057373628020287, 0.00916434358805418, 0.011663989163935184, 0.01930481754243374, 0.14092089235782623, 0.006876039318740368, 0.006051679607480764, 0.019477328285574913, 0.0159435011446476, 0.04479153826832771, 0.04556537792086601, 0.1080051138997078, 0.01458708755671978, 0.020102594047784805, 0.02515820413827896, 0.00434503611177206, 0.025656767189502716, 0.04378144070506096, 0.00560983968898654, 0.020289650186896324, 0.003143270732834935, 0.005587486550211906, 0.06987128406763077, 0.22427262365818024, 0.35683247447013855, 0.2254919558763504, 0.07839515060186386, 0.5235445499420166, 0.005116473417729139, 0.009383060969412327, 0.0038629707414656878, 0.009003210812807083, 0.008218550123274326, 0.012469031848013401, 0.4275522530078888, 0.006339167710393667, 0.019240377470850945, 0.017801156267523766, 0.012353995814919472, -1]}
{"idB": "749647_14_item1_p10_s1", "idA": "749647_13_item1_p12_s1", "sentA": "Specifically, we determined, after conferring with the HEAT study independent Data Monitoring Committee, that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT study.", "sentB": "Specifically, we determined, after conferring with the HEAT Study independent Data Monitoring Committee (DMC), that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval.", "type": 2, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study.", "<tag2>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(DMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study."], "wordsB": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(DMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009143064729869366, 0.008075011894106865, 0.01533384621143341, 0.005685216747224331, 0.010103264823555946, 0.005275229923427105, 0.005122294649481773, 0.021175766363739967, 0.02415653131902218, 0.01591653749346733, 0.01636108011007309, 0.017805540934205055, 0.018418997526168823, 0.919340193271637, 0.0074778166599571705, 0.006590645760297775, 0.025137068703770638, 0.030321376398205757, 0.45609426498413086, 0.41692063212394714, 0.024056920781731606, 0.009229540824890137, 0.011849429458379745, 0.006115401163697243, 0.00685914745554328, 0.009076537564396858, 0.006303065922111273, 0.004919474944472313, 0.007830727845430374, 0.009484423324465752, 0.005154018756002188, 0.0059618595987558365, 0.007015754468739033, 0.006271658465266228, 0.013876346871256828, 0.006181390956044197, 0.026759004220366478, 0.02847045287489891, -1]}
{"idB": "749647_14_item1_p38_s1", "idA": "749647_13_item1_p13_s1", "sentA": "We will continue to follow the patients enrolled in the HEAT study to the secondary endpoint, overall survival.", "sentB": "We continue to follow patients in the HEAT Study to the secondary endpoint, overall survival (OS).", "type": 2, "words": ["<tag1>", "We", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag2>", "We", "continue", "to", "follow", "patients", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint,", "overall", "survival", "(OS).", "<tag3>"], "wordsA": ["We", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "wordsB": ["We", "continue", "to", "follow", "patients", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint,", "overall", "survival", "(OS)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016603467985987663, 0.01805843785405159, 0.017723985016345978, 0.08041715621948242, 0.10314009338617325, 0.02070397138595581, 0.007452103774994612, 0.020395224913954735, 0.03259409964084625, 0.012624426744878292, 0.008397461846470833, 0.011665653437376022, 0.012222930788993835, 0.013889617286622524, 0.07600938528776169, 0.9642203450202942, -1]}
{"idB": "749647_14_item1_p44_s0", "idA": "749647_13_item1_p13_s1", "sentA": "We will continue to follow the patients enrolled in the HEAT study to the secondary endpoint, overall survival.", "sentB": "As provided for in the SPA, we continue to follow the patients enrolled in the HEAT study to the secondary endpoint of Overall Survival (OS).", "type": 2, "words": ["<tag1>", "We", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag2>", "As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint", "of", "Overall", "Survival", "(OS).", "<tag3>"], "wordsA": ["We", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "wordsB": ["As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint", "of", "Overall", "Survival", "(OS)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07907568663358688, 0.08398754149675369, 0.07123126089572906, 0.04902619123458862, 0.0537848137319088, 0.1964292824268341, 0.015369728207588196, 0.02429967001080513, 0.020524365827441216, 0.07316798716783524, 0.027566714212298393, 0.15485955774784088, 0.03160285949707031, 0.006499086041003466, 0.005627667997032404, 0.018586620688438416, 0.022317850962281227, 0.0074189528822898865, 0.007462804671376944, 0.011415212415158749, 0.011984620243310928, 0.003990200813859701, 0.020051077008247375, 0.043760526925325394, 0.8571317791938782, -1]}
{"idB": "749647_14_item1_p47_s2", "idA": "749647_13_item1_p13_s1", "sentA": "We will continue to follow the patients enrolled in the HEAT study to the secondary endpoint, overall survival.", "sentB": "The Company continues to follow patients in the HEAT Study to the secondary endpoint of OS.", "type": 2, "words": ["<tag1>", "We", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag2>", "The", "Company", "continues", "to", "follow", "patients", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "OS.", "<tag3>"], "wordsA": ["We", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "wordsB": ["The", "Company", "continues", "to", "follow", "patients", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "OS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004830207675695419, 0.0668511688709259, 0.027344053611159325, 0.018458813428878784, 0.06268260627985, 0.08380888402462006, 0.00909173209220171, 0.004227703437209129, 0.017487389966845512, 0.03696732595562935, 0.009263399988412857, 0.005883276928216219, 0.023796049878001213, 0.11762510985136032, 0.14387185871601105, 0.9595390558242798, -1]}
{"idB": "749647_14_item1_p11_s2", "idA": "749647_13_item1_p13_s2", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "We have conducted a comprehensive analysis of the data from the HEAT study to assess the future strategic value of ThermoDox .", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02023971825838089, 0.009104681201279163, 0.03807026147842407, 0.02193521335721016, 0.9668977856636047, 0.25556132197380066, 0.0071800220757722855, 0.004742034245282412, 0.02345496602356434, 0.002507417229935527, 0.0022503307554870844, 0.005673998035490513, 0.005181727930903435, 0.0026129535399377346, 0.0031375237740576267, 0.002295337850227952, 0.0023829250130802393, 0.002672172151505947, 0.0023362915962934494, 0.0020390634890645742, 0.0034401612356305122, 8.398210047744215e-05, -1]}
{"idB": "749647_14_item1_p12_s0", "idA": "749647_13_item1_p13_s2", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "The data from the HEAT Study post-hoc analysis suggests that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their tumors undergo optimal RFA treatment.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggests", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggests", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006732121109962463, 0.07538886368274689, 0.006732953246682882, 0.004398677963763475, 0.018695726990699768, 0.0221366249024868, 0.48155197501182556, 0.14977189898490906, 0.17035061120986938, 0.06724527478218079, 0.2522532641887665, 0.0803307294845581, 0.14408080279827118, 0.2785501182079315, 0.34487178921699524, 0.2183302938938141, 0.008832678198814392, 0.014822294004261494, 0.011865642853081226, 0.007951853796839714, 0.02036096155643463, 0.02811802551150322, 0.00866582803428173, 0.036018554121255875, 0.011191874742507935, 0.010899771004915237, 0.0747368261218071, 0.04367033392190933, 0.039883725345134735, 0.05801432952284813, 0.06657683849334717, -1]}
{"idB": "749647_14_item1_p47_s0", "idA": "749647_13_item1_p13_s2", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "In January 2014, the Company announced that the latest overall survival data from its post-hoc analysis of results from the HEAT Study supports continued clinical development through a prospective pivotal Phase III Study.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "In", "January", "2014,", "the", "Company", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "its", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["In", "January", "2014,", "the", "Company", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "its", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03140775486826897, 0.10475331544876099, 0.18968409299850464, 0.011252123862504959, 0.09069313108921051, 0.10109201818704605, 0.03559456765651703, 0.015903808176517487, 0.05797306448221207, 0.2643950283527374, 0.3607069253921509, 0.19108086824417114, 0.007917583920061588, 0.00997303705662489, 0.17745725810527802, 0.15033723413944244, 0.008814658038318157, 0.028444241732358932, 0.004284361843019724, 0.004118981771171093, 0.015251257456839085, 0.01785256899893284, 0.057461801916360855, 0.0647612139582634, 0.10823658108711243, 0.0659370943903923, 0.005539324134588242, 0.0051144324243068695, 0.022522931918501854, 0.02886863425374031, 0.027328282594680786, 0.062441010028123856, 0.1081724464893341, -1]}
{"idB": "749647_14_item1_p47_s1", "idA": "749647_13_item1_p13_s2", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "The data from the HEAT Study post-hoc analysis suggests that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their tumors undergo optimal RFA treatment.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggests", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggests", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006732121109962463, 0.07538886368274689, 0.006732953246682882, 0.004398677963763475, 0.018695726990699768, 0.0221366249024868, 0.48155197501182556, 0.14977189898490906, 0.17035061120986938, 0.06724527478218079, 0.2522532641887665, 0.0803307294845581, 0.14408080279827118, 0.2785501182079315, 0.34487178921699524, 0.2183302938938141, 0.008832678198814392, 0.014822294004261494, 0.011865642853081226, 0.007951853796839714, 0.02036096155643463, 0.02811802551150322, 0.00866582803428173, 0.036018554121255875, 0.011191874742507935, 0.010899771004915237, 0.0747368261218071, 0.04367033392190933, 0.039883725345134735, 0.05801432952284813, 0.06657683849334717, -1]}
{"idB": "749647_14_item1_p21_s0", "idA": "749647_13_item1_p14_s1", "sentA": "The Company sold this medical device business to Boston Scientific Corporation (Boston Scientific) in 2007 for net aggregate payments of $43 million, receiving $13 million in 2007 and $15 million in each of 2008 and 2009.", "sentB": "In 2007, the Company sold its medical device franchise to Boston Scientific Corporation for net aggregate payments of $43 million, receiving $13 million in 2007 and $15 million in each of 2008 and 2009.", "type": 2, "words": ["<tag1>", "The", "Company", "sold", "this", "medical", "device", "business", "to", "Boston", "Scientific", "Corporation", "(Boston", "Scientific)", "in", "2007", "for", "net", "aggregate", "payments", "of", "$43", "million,", "receiving", "$13", "million", "in", "2007", "and", "$15", "million", "in", "each", "of", "2008", "and", "2009.", "<tag2>", "In", "2007,", "the", "Company", "sold", "its", "medical", "device", "franchise", "to", "Boston", "Scientific", "Corporation", "for", "net", "aggregate", "payments", "of", "$43", "million,", "receiving", "$13", "million", "in", "2007", "and", "$15", "million", "in", "each", "of", "2008", "and", "2009.", "<tag3>"], "wordsA": ["The", "Company", "sold", "this", "medical", "device", "business", "to", "Boston", "Scientific", "Corporation", "(Boston", "Scientific)", "in", "2007", "for", "net", "aggregate", "payments", "of", "$43", "million,", "receiving", "$13", "million", "in", "2007", "and", "$15", "million", "in", "each", "of", "2008", "and", "2009."], "wordsB": ["In", "2007,", "the", "Company", "sold", "its", "medical", "device", "franchise", "to", "Boston", "Scientific", "Corporation", "for", "net", "aggregate", "payments", "of", "$43", "million,", "receiving", "$13", "million", "in", "2007", "and", "$15", "million", "in", "each", "of", "2008", "and", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009388642385601997, 0.01979384385049343, 0.00311184860765934, 0.0412149503827095, 0.1493871659040451, 0.0470060296356678, 0.20751778781414032, 0.3469805121421814, 0.8794445395469666, 0.00522399740293622, 0.005834241397678852, 0.006986336782574654, 0.008127344772219658, 0.005195269361138344, 0.006160639226436615, 0.006506001576781273, 0.006114125717431307, 0.005525249056518078, 0.007832998409867287, 0.006234327796846628, 0.0066190785728394985, 0.009846113622188568, 0.00704044196754694, 0.0045614647679030895, 0.006077159196138382, 0.001972653903067112, 0.008874542079865932, 0.006335301324725151, 0.0037510560359805822, 0.004992639180272818, 0.004834768828004599, 0.00530892051756382, 0.006438565906137228, 0.005765694193542004, -1]}
{"idB": "749647_14_item1_p21_s2", "idA": "749647_13_item1_p14_s3", "sentA": "To support our research and development, we have raised gross proceeds of approximately $68 million in equity financings, debt financing and warrant and option exercises in the years 2009 through 2012.", "sentB": "To support our research and development, we have raised gross proceeds of approximately $95 million in equity financings and warrant and option exercises in the years 2009 through 2013.", "type": 2, "words": ["<tag1>", "To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$68", "million", "in", "equity", "financings,", "debt", "financing", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2012.", "<tag2>", "To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$95", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2013.", "<tag3>"], "wordsA": ["To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$68", "million", "in", "equity", "financings,", "debt", "financing", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2012."], "wordsB": ["To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$95", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0019404588965699077, 0.004006120376288891, 0.0029032225720584393, 0.0049309032037854195, 0.0034069193061441183, 0.0036161625757813454, 0.0026199636049568653, 0.0025059699546545744, 0.0050077601335942745, 0.004987884778529406, 0.007489454932510853, 0.004037376027554274, 0.014256507158279419, 0.9565190672874451, 0.2436324954032898, 0.0026229151990264654, 0.006984239909797907, 0.011959532275795937, 0.001901210518553853, 0.002924546366557479, 0.0022976689506322145, 0.0038379908073693514, 0.0032291230745613575, 0.00212665437720716, 0.0021105140913277864, 0.008216568268835545, 0.015354054979979992, 0.04656397923827171, 0.8657166957855225, -1]}
{"idB": "749647_14_item1_p22_s0", "idA": "749647_13_item1_p15_s0", "sentA": "On December 5, 2008, we entered into a development, product supply and commercialization agreement with Yakult Honsha Co. (the Yakult Agreement) under which Yakult was granted the exclusive right to commercialize and market ThermoDox for the Japanese market.", "sentB": "On December 5, 2008, we entered into a development, product supply and commercialization agreement with Yakult Honsha Co., Ltd. (the Yakult Agreement) under which we granted Yakult an exclusive right to commercialize and market ThermoDox for the Japanese market.", "type": 2, "words": ["<tag1>", "On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.", "(the", "Yakult", "Agreement)", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market.", "<tag2>", "On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.,", "Ltd.", "(the", "Yakult", "Agreement)", "under", "which", "we", "granted", "Yakult", "an", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market.", "<tag3>"], "wordsA": ["On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.", "(the", "Yakult", "Agreement)", "under", "which", "Yakult", "was", "granted", "the", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market."], "wordsB": ["On", "December", "5,", "2008,", "we", "entered", "into", "a", "development,", "product", "supply", "and", "commercialization", "agreement", "with", "Yakult", "Honsha", "Co.,", "Ltd.", "(the", "Yakult", "Agreement)", "under", "which", "we", "granted", "Yakult", "an", "exclusive", "right", "to", "commercialize", "and", "market", "ThermoDox", "for", "the", "Japanese", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01745442859828472, 0.03372713923454285, 0.034605760127305984, 0.03180216625332832, 0.022029530256986618, 0.032141610980033875, 0.03308849409222603, 0.022788487374782562, 0.0391654409468174, 0.02606845647096634, 0.03601321950554848, 0.02142644301056862, 0.026926951482892036, 0.04522034525871277, 0.028656888753175735, 0.15293839573860168, 0.156520813703537, 0.23699742555618286, 0.6888927221298218, 0.02254578471183777, 0.07986421138048172, 0.044222988188266754, 0.024914149194955826, 0.017298538237810135, 0.03877655789256096, 0.06057433411478996, 0.13699588179588318, 0.03513028845191002, 0.041056547313928604, 0.04431115835905075, 0.030696460977196693, 0.043748095631599426, 0.031721387058496475, 0.03710702434182167, 0.06825973838567734, 0.015963053330779076, 0.019008226692676544, 0.03841479867696762, 0.05820805951952934, -1]}
{"idB": "749647_14_item1_p22_s1", "idA": "749647_13_item1_p15_s1", "sentA": "We were paid a $2.5 million up-front licensing fee and may receive additional payments from Yakult upon receipt of marketing approval by the Japanese Ministry of Health, Labor and Welfare as well as upon the achievement of certain levels of sales and approval for new indications.", "sentB": "We received a $2.5 million upfront licensing fee and may receive additional payments from Yakult upon receipt of marketing approval by the Japanese Ministry of Health, Labor and Welfare as well as upon the achievement of certain levels of sales and approval for new indications.", "type": 2, "words": ["<tag1>", "We", "were", "paid", "a", "$2.5", "million", "up-front", "licensing", "fee", "and", "may", "receive", "additional", "payments", "from", "Yakult", "upon", "receipt", "of", "marketing", "approval", "by", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare", "as", "well", "as", "upon", "the", "achievement", "of", "certain", "levels", "of", "sales", "and", "approval", "for", "new", "indications.", "<tag2>", "We", "received", "a", "$2.5", "million", "upfront", "licensing", "fee", "and", "may", "receive", "additional", "payments", "from", "Yakult", "upon", "receipt", "of", "marketing", "approval", "by", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare", "as", "well", "as", "upon", "the", "achievement", "of", "certain", "levels", "of", "sales", "and", "approval", "for", "new", "indications.", "<tag3>"], "wordsA": ["We", "were", "paid", "a", "$2.5", "million", "up-front", "licensing", "fee", "and", "may", "receive", "additional", "payments", "from", "Yakult", "upon", "receipt", "of", "marketing", "approval", "by", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare", "as", "well", "as", "upon", "the", "achievement", "of", "certain", "levels", "of", "sales", "and", "approval", "for", "new", "indications."], "wordsB": ["We", "received", "a", "$2.5", "million", "upfront", "licensing", "fee", "and", "may", "receive", "additional", "payments", "from", "Yakult", "upon", "receipt", "of", "marketing", "approval", "by", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare", "as", "well", "as", "upon", "the", "achievement", "of", "certain", "levels", "of", "sales", "and", "approval", "for", "new", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10550092160701752, 0.30399107933044434, 0.06257008016109467, 0.105960413813591, 0.1493234783411026, 0.11816604435443878, 0.10012488067150116, 0.09756533056497574, 0.0009641433134675026, 0.024762898683547974, 0.07599719613790512, 0.14486466348171234, 0.18927200138568878, 0.047727249562740326, 0.10141698271036148, 0.03136894479393959, 0.03302600234746933, 0.025440800935029984, 0.040029335767030716, 0.08138160407543182, 0.018612781539559364, 0.022751042619347572, 0.05010088533163071, 0.04528540372848511, 0.0380098931491375, 0.04349060356616974, 0.031298596411943436, 0.028321482241153717, 0.03416639193892479, 0.017781516537070274, 0.015879079699516296, 0.013378610834479332, 0.01901349239051342, 0.017550857737660408, 0.025228120386600494, 0.019450929015874863, 0.026935335248708725, 0.028118200600147247, 0.020095854997634888, 0.02545451745390892, 0.01864466443657875, 0.026149887591600418, 0.018213603645563126, 0.024250563234090805, 0.057299189269542694, -1]}
{"idB": "749647_14_item1_p22_s3", "idA": "749647_13_item1_p15_s3", "sentA": "Concurrent with a convertible preferred stock equity financing in January 2011, we amended the Yakult Agreement to provide for up to $4.0 million in an accelerated partial payment to us of a future drug approval milestone which included $2.0 million paid to us upon the closing of the preferred equity financing and an additional $2.0 million conditioned upon the resumption of enrollment of Japanese patients in the Japan cohort of the HEAT study.", "sentB": "In January 2011, we amended the Yakult Agreement to provide for up to $4.0 million in an accelerated partial payment to us of a future drug approval milestone which included $2.0 million paid to us upon the closing of the preferred equity financing and an additional $2.0 million conditioned upon the resumption of enrollment of Japanese patients in the Japan cohort of the HEAT study.", "type": 2, "words": ["<tag1>", "Concurrent", "with", "a", "convertible", "preferred", "stock", "equity", "financing", "in", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone", "which", "included", "$2.0", "million", "paid", "to", "us", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study.", "<tag2>", "In", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone", "which", "included", "$2.0", "million", "paid", "to", "us", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["Concurrent", "with", "a", "convertible", "preferred", "stock", "equity", "financing", "in", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone", "which", "included", "$2.0", "million", "paid", "to", "us", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study."], "wordsB": ["In", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone", "which", "included", "$2.0", "million", "paid", "to", "us", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015428498387336731, 0.034682366997003555, 0.022604767233133316, 0.01973547227680683, 0.04183635860681534, 0.012200343422591686, 0.04547762870788574, 0.026126230135560036, 0.014157877303659916, 0.011905628256499767, 0.017533214762806892, 0.022162502631545067, 0.020067349076271057, 0.05511876568198204, 0.03198740631341934, 0.012480686418712139, 0.012654251419007778, 0.018265122547745705, 0.027838002890348434, 0.018631350249052048, 0.015458478592336178, 0.019925687462091446, 0.010883970186114311, 0.010481096804141998, 0.016180070117115974, 0.016485508531332016, 0.02305389754474163, 0.021130504086613655, 0.004844706505537033, 0.010863266885280609, 0.06065619736909866, 0.03723924234509468, 0.016083158552646637, 0.020295746624469757, 0.020392663776874542, 0.013367186300456524, 0.010391407646238804, 0.026365328580141068, 0.010818331502377987, 0.008967993780970573, 0.028281178325414658, 0.034000590443611145, 0.021186817437410355, 0.008902885019779205, 0.0124438451603055, 0.033657342195510864, 0.06639121472835541, 0.025200534611940384, 0.012733325362205505, 0.011590082198381424, 0.009853587485849857, 0.016045965254306793, 0.009557430632412434, 0.12442810088396072, 0.012357812374830246, 0.21892526745796204, 0.11735307425260544, 0.006159074604511261, 0.00709641445428133, 0.01792891137301922, 0.017123227939009666, 0.0075841862708330154, 0.006718001328408718, 0.01022488996386528, 0.012325252406299114, -1]}
{"idB": "749647_14_item1_p23_s3", "idA": "749647_13_item1_p16_s3", "sentA": "Following our announcement of the HEAT study results on January 31, 2013, we and Hisun are evaluating next steps in relation to ThermoDox , which include the sub-group analysis of the Chinese cohort of patients in the Phase III clinical trial for primary liver cancer and other activities to further the development of ThermoDox for the China territory.", "sentB": "Following our announcement of the HEAT study results on January 31, 2013, we and Hisun have agreed that the technology development contract entered into on January 18, 2013 will remain in effect while the parties continue to collaborate the next steps in relation to ThermoDox , which include the continued subgroup analysis of the Chinese cohort of patients in the HEAT Study for primary liver cancer and other activities to further the development of ThermoDox for the China territory.", "type": 2, "words": ["<tag1>", "Following", "our", "announcement", "of", "the", "HEAT", "study", "results", "on", "January", "31,", "2013,", "we", "and", "Hisun", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag2>", "Following", "our", "announcement", "of", "the", "HEAT", "study", "results", "on", "January", "31,", "2013,", "we", "and", "Hisun", "have", "agreed", "that", "the", "technology", "development", "contract", "entered", "into", "on", "January", "18,", "2013", "will", "remain", "in", "effect", "while", "the", "parties", "continue", "to", "collaborate", "the", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "continued", "subgroup", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "HEAT", "Study", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag3>"], "wordsA": ["Following", "our", "announcement", "of", "the", "HEAT", "study", "results", "on", "January", "31,", "2013,", "we", "and", "Hisun", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory."], "wordsB": ["Following", "our", "announcement", "of", "the", "HEAT", "study", "results", "on", "January", "31,", "2013,", "we", "and", "Hisun", "have", "agreed", "that", "the", "technology", "development", "contract", "entered", "into", "on", "January", "18,", "2013", "will", "remain", "in", "effect", "while", "the", "parties", "continue", "to", "collaborate", "the", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "continued", "subgroup", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "HEAT", "Study", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007172412239015102, 0.005156290251761675, 0.008642474189400673, 0.004129094537347555, 0.0037074005231261253, 0.006272455211728811, 0.006158742122352123, 0.00588530208915472, 0.004495831206440926, 0.005234412848949432, 0.005978652276098728, 0.004300224594771862, 0.008210360072553158, 0.005499102175235748, 0.009860469959676266, 0.050489749759435654, 0.5414981842041016, 0.13150806725025177, 0.031191445887088776, 0.2195139080286026, 0.3389899432659149, 0.238661527633667, 0.024878257885575294, 0.025134164839982986, 0.014883694238960743, 0.01406043954193592, 0.009620740078389645, 0.013135467655956745, 0.09980909526348114, 0.17883558571338654, 0.21563242375850677, 0.09863101691007614, 0.012751196511089802, 0.016554605215787888, 0.06994646787643433, 0.09675216674804688, 0.11485811322927475, 0.1584995687007904, 0.007329159416258335, 0.009606271050870419, 0.017128894105553627, 0.0038089952431619167, 0.004379192367196083, 0.002979856450110674, 0.004443580284714699, 0.0003050073573831469, 0.0016225776635110378, 0.004044228699058294, 0.003891871077939868, 0.06643369048833847, 0.8094807267189026, 0.2642454206943512, 0.0032532070763409138, 0.003018286544829607, 0.014125542715191841, 0.01230019610375166, 0.004945532884448767, 0.02713775262236595, 0.002328162081539631, 0.0025303566362708807, 0.008139105513691902, 0.012198694050312042, 0.00227695913054049, 0.003857712261378765, 0.003974910359829664, 0.004185927100479603, 0.002254435094073415, 0.0026369858533143997, 0.004356672056019306, 0.002551789628341794, 0.0025306178722530603, 0.003141403663903475, 0.00467732734978199, 0.002475548768416047, 0.004523204639554024, 0.0021423448342829943, 0.002770529594272375, 0.004122940357774496, 0.004121004603803158, -1]}
{"idB": "749647_14_item1_p24_s0", "idA": "749647_13_item1_p16_s3", "sentA": "Following our announcement of the HEAT study results on January 31, 2013, we and Hisun are evaluating next steps in relation to ThermoDox , which include the sub-group analysis of the Chinese cohort of patients in the Phase III clinical trial for primary liver cancer and other activities to further the development of ThermoDox for the China territory.", "sentB": "On July 19, 2013, the Company and Hisun entered into a Memorandum of Understanding to pursue ongoing collaborations for the continued clinical development of ThermoDox as well as the technology transfer relating to the commercial manufacture of ThermoDox for the China territory.", "type": 2, "words": ["<tag1>", "Following", "our", "announcement", "of", "the", "HEAT", "study", "results", "on", "January", "31,", "2013,", "we", "and", "Hisun", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag2>", "On", "July", "19,", "2013,", "the", "Company", "and", "Hisun", "entered", "into", "a", "Memorandum", "of", "Understanding", "to", "pursue", "ongoing", "collaborations", "for", "the", "continued", "clinical", "development", "of", "ThermoDox", "as", "well", "as", "the", "technology", "transfer", "relating", "to", "the", "commercial", "manufacture", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag3>"], "wordsA": ["Following", "our", "announcement", "of", "the", "HEAT", "study", "results", "on", "January", "31,", "2013,", "we", "and", "Hisun", "are", "evaluating", "next", "steps", "in", "relation", "to", "ThermoDox", ",", "which", "include", "the", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "and", "other", "activities", "to", "further", "the", "development", "of", "ThermoDox", "for", "the", "China", "territory."], "wordsB": ["On", "July", "19,", "2013,", "the", "Company", "and", "Hisun", "entered", "into", "a", "Memorandum", "of", "Understanding", "to", "pursue", "ongoing", "collaborations", "for", "the", "continued", "clinical", "development", "of", "ThermoDox", "as", "well", "as", "the", "technology", "transfer", "relating", "to", "the", "commercial", "manufacture", "of", "ThermoDox", "for", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023852208629250526, 0.6220031976699829, 0.4191797971725464, 0.11983107775449753, 0.005131751764565706, 0.07356952130794525, 0.009207603521645069, 0.029747257009148598, 0.0546867698431015, 0.0641130805015564, 0.050906214863061905, 0.16090036928653717, 0.03851880133152008, 0.17796018719673157, 0.005070270970463753, 0.0182604119181633, 0.022458460181951523, 0.04975946620106697, 0.005489440634846687, 0.005522301886230707, 0.020266015082597733, 0.051132313907146454, 0.02402980998158455, 0.010714122094213963, 0.021913724020123482, 0.0013182057300582528, 0.0038967416621744633, 0.004271131008863449, 0.004477650858461857, 0.07677964121103287, 0.08131402730941772, 0.006303931120783091, 0.006836699787527323, 0.0065661584958434105, 0.10321050137281418, 0.06238046661019325, 0.022831425070762634, 0.039950259029865265, 0.0028332569636404514, 0.0032885700929909945, 0.005806816276162863, 0.006717450451105833, -1]}
{"idB": "749647_14_item1_p11_s1", "idA": "749647_13_item1_p17_s0", "sentA": "Following the announcement of the HEAT study results, we are assessing our product pipeline and research and development priorities.", "sentB": "Following the announcement of the HEAT study results, we continue to follow patients for overall survival, the secondary endpoint of the HEAT study, on a quarterly basis.", "type": 2, "words": ["<tag1>", "Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "are", "assessing", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag2>", "Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "continue", "to", "follow", "patients", "for", "overall", "survival,", "the", "secondary", "endpoint", "of", "the", "HEAT", "study,", "on", "a", "quarterly", "basis.", "<tag3>"], "wordsA": ["Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "are", "assessing", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "wordsB": ["Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "continue", "to", "follow", "patients", "for", "overall", "survival,", "the", "secondary", "endpoint", "of", "the", "HEAT", "study,", "on", "a", "quarterly", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008549951016902924, 0.0024899537675082684, 0.007371996063739061, 0.0019160176161676645, 0.002085930434986949, 0.0054246168583631516, 0.006385639775544405, 0.006880977191030979, 0.05630063638091087, 0.23787100613117218, 0.3954155147075653, 0.8128955960273743, 0.6022153496742249, 0.093748077750206, 0.17295220494270325, 0.2064369171857834, 0.007875584997236729, 0.012771121226251125, 0.01307013351470232, 0.0025172578170895576, 0.002650877693668008, 0.010811012238264084, 0.017146090045571327, 0.009646919555962086, 0.007329328916966915, 0.0385555624961853, 0.027719685807824135, -1]}
{"idB": "749647_14_item1_p45_s0", "idA": "749647_13_item1_p17_s0", "sentA": "Following the announcement of the HEAT study results, we are assessing our product pipeline and research and development priorities.", "sentB": "We have evaluated data from four reviews of overall survival since the announcement of the HEAT study s primary endpoint result.", "type": 2, "words": ["<tag1>", "Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "are", "assessing", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag2>", "We", "have", "evaluated", "data", "from", "four", "reviews", "of", "overall", "survival", "since", "the", "announcement", "of", "the", "HEAT", "study", "s", "primary", "endpoint", "result.", "<tag3>"], "wordsA": ["Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "are", "assessing", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "wordsB": ["We", "have", "evaluated", "data", "from", "four", "reviews", "of", "overall", "survival", "since", "the", "announcement", "of", "the", "HEAT", "study", "s", "primary", "endpoint", "result."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02698228508234024, 0.012583954259753227, 0.1725524365901947, 0.19471107423305511, 0.049472179263830185, 0.28013455867767334, 0.41460826992988586, 0.12186209857463837, 0.5184028744697571, 0.4339727759361267, 0.09376439452171326, 0.00549595570191741, 0.027133941650390625, 0.005096703302115202, 0.003953743260353804, 0.025034457445144653, 0.029214458540081978, 0.016896480694413185, 0.05549094080924988, 0.06001219153404236, 0.05241589993238449, -1]}
{"idB": "749647_14_item1_p20_s0", "idA": "749647_13_item1_p19_s0", "sentA": "As demonstrated by the HEAT study results, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "sentB": "As demonstrated by the HEAT Study results in January 2013, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "type": 2, "words": ["<tag1>", "As", "demonstrated", "by", "the", "HEAT", "study", "results,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag2>", "As", "demonstrated", "by", "the", "HEAT", "Study", "results", "in", "January", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag3>"], "wordsA": ["As", "demonstrated", "by", "the", "HEAT", "study", "results,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "wordsB": ["As", "demonstrated", "by", "the", "HEAT", "Study", "results", "in", "January", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005024219397455454, 0.01108806487172842, 0.005101507063955069, 0.003661115886643529, 0.008893822319805622, 0.009465358220040798, 0.013080471195280552, 0.030593352392315865, 0.7500134110450745, 0.8388550877571106, 0.011521739885210991, 0.009981449693441391, 0.007295028306543827, 0.008228631690144539, 0.0039896173402667046, 0.004533092491328716, 0.010608147829771042, 0.026801250874996185, 0.01536839921027422, 0.0013812705874443054, 0.004877984058111906, 0.0051665594801306725, 0.004919340368360281, 0.019521014764904976, 0.023701045662164688, 0.00900946743786335, 0.11897505819797516, 0.006000591907650232, 0.007773040793836117, 0.0101050715893507, 0.005632131360471249, 0.006140836048871279, 0.011333366855978966, -1]}
{"idB": "749647_14_item1_p72_s1", "idA": "749647_13_item1_p20_s1", "sentA": "Clinical development successes and failures can have a disproportionate positive or negative impact on our scientific and medical prospects, financial prospects, financial condition and market value.", "sentB": "The success or failure of any preclinical development and clinical trial can have a disproportionately positive or negative impact on our results of operations, financial condition, prospects and market value.", "type": 2, "words": ["<tag1>", "Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "prospects,", "financial", "condition", "and", "market", "value.", "<tag2>", "The", "success", "or", "failure", "of", "any", "preclinical", "development", "and", "clinical", "trial", "can", "have", "a", "disproportionately", "positive", "or", "negative", "impact", "on", "our", "results", "of", "operations,", "financial", "condition,", "prospects", "and", "market", "value.", "<tag3>"], "wordsA": ["Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "prospects,", "financial", "condition", "and", "market", "value."], "wordsB": ["The", "success", "or", "failure", "of", "any", "preclinical", "development", "and", "clinical", "trial", "can", "have", "a", "disproportionately", "positive", "or", "negative", "impact", "on", "our", "results", "of", "operations,", "financial", "condition,", "prospects", "and", "market", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002187049249187112, 0.046118006110191345, 0.003563463920727372, 0.020583877339959145, 0.0077131520956754684, 0.04233873635530472, 0.9344510436058044, 0.3388592004776001, 0.0033843666315078735, 0.017520995810627937, 0.05823060870170593, 0.0016528425039723516, 0.0018288097344338894, 0.0015382363926619291, 0.0024353363551199436, 0.002590723102912307, 0.0018057988490909338, 0.002933325245976448, 0.002445182064548135, 0.0017892868490889668, 0.0036020195111632347, 0.054792776703834534, 0.020859133452177048, 0.1710522472858429, 0.00500004505738616, 0.002948602195829153, 0.0022914130240678787, 0.0013248632894828916, 0.002085754880681634, 0.002452848246321082, -1]}
{"idB": "749647_14_item1_p66_s2", "idA": "749647_13_item1_p30_s0", "sentA": "There are few alternative treatments, since radiation therapy and chemotherapy are largely ineffective.", "sentB": "The two similarly designed Phase I studies enrolled patients with highly resistant tumors found on the chest wall and who had progressed on previous therapy including chemotherapy, radiation therapy and hormone therapy.", "type": 2, "words": ["<tag1>", "There", "are", "few", "alternative", "treatments,", "since", "radiation", "therapy", "and", "chemotherapy", "are", "largely", "ineffective.", "<tag2>", "The", "two", "similarly", "designed", "Phase", "I", "studies", "enrolled", "patients", "with", "highly", "resistant", "tumors", "found", "on", "the", "chest", "wall", "and", "who", "had", "progressed", "on", "previous", "therapy", "including", "chemotherapy,", "radiation", "therapy", "and", "hormone", "therapy.", "<tag3>"], "wordsA": ["There", "are", "few", "alternative", "treatments,", "since", "radiation", "therapy", "and", "chemotherapy", "are", "largely", "ineffective."], "wordsB": ["The", "two", "similarly", "designed", "Phase", "I", "studies", "enrolled", "patients", "with", "highly", "resistant", "tumors", "found", "on", "the", "chest", "wall", "and", "who", "had", "progressed", "on", "previous", "therapy", "including", "chemotherapy,", "radiation", "therapy", "and", "hormone", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008717035874724388, 0.2697727382183075, 0.5681905746459961, 0.3297005593776703, 0.10246551781892776, 0.13906161487102509, 0.17889226973056793, 0.07683437317609787, 0.1186642274260521, 0.01491956040263176, 0.27045363187789917, 0.2565639019012451, 0.16544628143310547, 0.00943655613809824, 0.010123557411134243, 0.005654253996908665, 0.021390452980995178, 0.01756216771900654, 7.805362110957503e-05, 0.007181027438491583, 0.009652595967054367, 0.0479951873421669, 0.01588830165565014, 0.04309815168380737, 0.058677054941654205, 0.00443689851090312, 0.04097786545753479, 0.031310513615608215, 0.06653375923633575, 0.016620418056845665, 0.1308237761259079, 0.20048788189888, -1]}
{"idB": "749647_14_item1_p42_s0", "idA": "749647_13_item1_p35_s0", "sentA": "The HEAT study for ThermoDox , in combination with radiofrequency ablation (RFA), is being conducted under a Special Protocol Assessment agreed to with the U.S. Food and Drug Administration (FDA).", "sentB": "The HEAT Study for ThermoDox , in combination with RFA, was conducted in patients with primary liver cancer under a Special Protocol Assessment agreed to with the FDA.", "type": 2, "words": ["<tag1>", "The", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "(RFA),", "is", "being", "conducted", "under", "a", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA).", "<tag2>", "The", "HEAT", "Study", "for", "ThermoDox", ",", "in", "combination", "with", "RFA,", "was", "conducted", "in", "patients", "with", "primary", "liver", "cancer", "under", "a", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "FDA.", "<tag3>"], "wordsA": ["The", "HEAT", "study", "for", "ThermoDox", ",", "in", "combination", "with", "radiofrequency", "ablation", "(RFA),", "is", "being", "conducted", "under", "a", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)."], "wordsB": ["The", "HEAT", "Study", "for", "ThermoDox", ",", "in", "combination", "with", "RFA,", "was", "conducted", "in", "patients", "with", "primary", "liver", "cancer", "under", "a", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002114240312948823, 0.017185181379318237, 0.03248056769371033, 0.005963962059468031, 0.00961072277277708, 7.240070408442989e-05, 0.0041936784982681274, 0.004677141085267067, 0.00417565181851387, 0.00700046680867672, 0.00256697041913867, 0.02476528100669384, 0.054500628262758255, 0.28072068095207214, 0.23415786027908325, 0.7122378349304199, 0.8230791091918945, 0.914863646030426, 0.0037646659184247255, 0.0026588421314954758, 0.004918520804494619, 0.005213993135839701, 0.006219011265784502, 0.0035209532361477613, 0.0030031062196940184, 0.003061949275434017, 0.0028662860859185457, 0.013435805216431618, -1]}
{"idB": "749647_14_item1_p42_s1", "idA": "749647_13_item1_p35_s1", "sentA": "The Special Protocol Assessment agreed to with the FDA specified Progression Free Survival (PFS) as the HEAT study s primary endpoint.", "sentB": "The Special Protocol Assessment (SPA) agreed to with the FDA specified PFS as the HEAT Study s primary endpoint.", "type": 2, "words": ["<tag1>", "The", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "FDA", "specified", "Progression", "Free", "Survival", "(PFS)", "as", "the", "HEAT", "study", "s", "primary", "endpoint.", "<tag2>", "The", "Special", "Protocol", "Assessment", "(SPA)", "agreed", "to", "with", "the", "FDA", "specified", "PFS", "as", "the", "HEAT", "Study", "s", "primary", "endpoint.", "<tag3>"], "wordsA": ["The", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "FDA", "specified", "Progression", "Free", "Survival", "(PFS)", "as", "the", "HEAT", "study", "s", "primary", "endpoint."], "wordsB": ["The", "Special", "Protocol", "Assessment", "(SPA)", "agreed", "to", "with", "the", "FDA", "specified", "PFS", "as", "the", "HEAT", "Study", "s", "primary", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.001697829575277865, 0.01218032743781805, 0.023303810507059097, 0.04052332788705826, 0.9786244034767151, 0.004210870712995529, 0.0024620818439871073, 0.002064100466668606, 0.00235048052854836, 0.009287675842642784, 0.007442685309797525, 0.6395844221115112, 0.0025680086109787226, 0.0023101840633898973, 0.006890671793371439, 0.005937729962170124, 0.003751102602109313, 0.008147889748215675, 0.008690581656992435, -1]}
{"idB": "749647_14_item1_p131_s1", "idA": "749647_13_item1_p35_s2", "sentA": "We scheduled a meeting with the HEAT study independent Data Monitoring Committee (DMC) on January 30, 2013 in order to conduct an analysis of the HEAT study s PFS endpoint.", "sentB": "The statistical plan calls for two interim efficacy analyses by an independent Data Monitoring Committee.", "type": 2, "words": ["<tag1>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint.", "<tag2>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee.", "<tag3>"], "wordsA": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint."], "wordsB": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012330856174230576, 0.27085065841674805, 0.17835775017738342, 0.10611620545387268, 0.02951263077557087, 0.22925490140914917, 0.4940759241580963, 0.544391393661499, 0.43869367241859436, 0.009045402519404888, 0.00841462891548872, 0.051721807569265366, 0.049755897372961044, 0.03884001821279526, 0.04704755172133446, -1]}
{"idB": "749647_14_item1_p17_s1", "idA": "749647_13_item1_p35_s2", "sentA": "We scheduled a meeting with the HEAT study independent Data Monitoring Committee (DMC) on January 30, 2013 in order to conduct an analysis of the HEAT study s PFS endpoint.", "sentB": "The statistical plan calls for two interim efficacy analyses by an independent Data Monitoring Committee.", "type": 2, "words": ["<tag1>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint.", "<tag2>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee.", "<tag3>"], "wordsA": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint."], "wordsB": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012330856174230576, 0.27085065841674805, 0.17835775017738342, 0.10611620545387268, 0.02951263077557087, 0.22925490140914917, 0.4940759241580963, 0.544391393661499, 0.43869367241859436, 0.009045402519404888, 0.00841462891548872, 0.051721807569265366, 0.049755897372961044, 0.03884001821279526, 0.04704755172133446, -1]}
{"idB": "749647_14_item1_p42_s2", "idA": "749647_13_item1_p35_s2", "sentA": "We scheduled a meeting with the HEAT study independent Data Monitoring Committee (DMC) on January 30, 2013 in order to conduct an analysis of the HEAT study s PFS endpoint.", "sentB": "We scheduled a meeting with the HEAT Study independent DMC on January 30, 2013 in order to conduct an analysis of the HEAT Study s PFS endpoint.", "type": 2, "words": ["<tag1>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint.", "<tag2>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "Study", "independent", "DMC", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "Study", "s", "PFS", "endpoint.", "<tag3>"], "wordsA": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint."], "wordsB": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "Study", "independent", "DMC", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "Study", "s", "PFS", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10227128118276596, 0.12121403217315674, 0.01662607491016388, 0.18341900408267975, 0.03970145806670189, 0.02105777896940708, 0.5407998561859131, 0.4795801043510437, 0.4974574148654938, 0.5498756170272827, 0.031352657824754715, 0.03920622542500496, 0.04594164714217186, 0.035526093095541, 0.014912140555679798, 0.014866301789879799, 0.010413821786642075, 0.03183337673544884, 0.012761861085891724, 0.1377125382423401, 0.0221567302942276, 0.02220034971833229, 0.5638898611068726, 0.35220882296562195, 0.06786634027957916, 0.18003416061401367, 0.10668123513460159, -1]}
{"idB": "749647_14_item1_p47_s4", "idA": "749647_13_item1_p35_s2", "sentA": "We scheduled a meeting with the HEAT study independent Data Monitoring Committee (DMC) on January 30, 2013 in order to conduct an analysis of the HEAT study s PFS endpoint.", "sentB": "We may choose to end the analysis of OS once the median is reached for either or both arms of the HEAT Study.", "type": 2, "words": ["<tag1>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint.", "<tag2>", "We", "may", "choose", "to", "end", "the", "analysis", "of", "OS", "once", "the", "median", "is", "reached", "for", "either", "or", "both", "arms", "of", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint."], "wordsB": ["We", "may", "choose", "to", "end", "the", "analysis", "of", "OS", "once", "the", "median", "is", "reached", "for", "either", "or", "both", "arms", "of", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03180678188800812, 0.033417657017707825, 0.09666038304567337, 0.07478271424770355, 0.6815634965896606, 0.15997126698493958, 0.31917065382003784, 0.12195312976837158, 0.5138914585113525, 0.04458892345428467, 0.01434174831956625, 0.09554539620876312, 0.07167142629623413, 0.0544646754860878, 0.02302141860127449, 0.10428813844919205, 0.05100085213780403, 0.15559075772762299, 0.09411460161209106, 0.01186242327094078, 0.010029731318354607, 0.05152937397360802, 0.057143840938806534, -1]}
{"idB": "749647_14_item1_p53_s0", "idA": "749647_13_item1_p35_s2", "sentA": "We scheduled a meeting with the HEAT study independent Data Monitoring Committee (DMC) on January 30, 2013 in order to conduct an analysis of the HEAT study s PFS endpoint.", "sentB": "The statistical plan calls for two interim efficacy analyses by an independent Data Monitoring Committee (iDMC).", "type": 2, "words": ["<tag1>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint.", "<tag2>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee", "(iDMC).", "<tag3>"], "wordsA": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint."], "wordsB": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee", "(iDMC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011089387349784374, 0.2365892082452774, 0.15858899056911469, 0.09835457801818848, 0.02809070236980915, 0.2093772292137146, 0.48167145252227783, 0.5086719393730164, 0.39404958486557007, 0.010561131872236729, 0.008482042700052261, 0.046088315546512604, 0.04534147307276726, 0.03142831102013588, 0.034663569182157516, 0.6409747004508972, -1]}
{"idB": "749647_14_item1_p87_s0", "idA": "749647_13_item1_p35_s2", "sentA": "We scheduled a meeting with the HEAT study independent Data Monitoring Committee (DMC) on January 30, 2013 in order to conduct an analysis of the HEAT study s PFS endpoint.", "sentB": "The statistical plan calls for two interim efficacy analyses by an independent Data Monitoring Committee (iDMC).", "type": 2, "words": ["<tag1>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint.", "<tag2>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee", "(iDMC).", "<tag3>"], "wordsA": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "study", "independent", "Data", "Monitoring", "Committee", "(DMC)", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "study", "s", "PFS", "endpoint."], "wordsB": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee", "(iDMC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011089387349784374, 0.2365892082452774, 0.15858899056911469, 0.09835457801818848, 0.02809070236980915, 0.2093772292137146, 0.48167145252227783, 0.5086719393730164, 0.39404958486557007, 0.010561131872236729, 0.008482042700052261, 0.046088315546512604, 0.04534147307276726, 0.03142831102013588, 0.034663569182157516, 0.6409747004508972, -1]}
{"idB": "749647_14_item1_p42_s3", "idA": "749647_13_item1_p35_s3", "sentA": "Following review by the DMC, on January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "sentB": "Following review by the DMC, on January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the HEAT Study s primary endpoint of PFS.", "type": 2, "words": ["<tag1>", "Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "HEAT", "Study", "s", "primary", "endpoint", "of", "PFS.", "<tag3>"], "wordsA": ["Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "HEAT", "Study", "s", "primary", "endpoint", "of", "PFS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004020293243229389, 0.0083798598498106, 0.0024685075040906668, 0.003195140976458788, 0.006286130286753178, 0.0028208065778017044, 0.0038464737590402365, 0.004358070436865091, 0.0037008672952651978, 0.005682067014276981, 0.014855314046144485, 0.006529118400067091, 0.022628553211688995, 0.0047751860693097115, 0.005556874442845583, 0.0034731123596429825, 0.006669047754257917, 0.4122844636440277, 0.6025360226631165, 0.13305139541625977, 0.009738215245306492, 0.026816515251994133, 0.025134427472949028, 0.014782963320612907, 0.05163675919175148, 0.10636905580759048, 0.08390365540981293, 0.922938883304596, -1]}
{"idB": "749647_14_item1_p24_s1", "idA": "749647_13_item1_p35_s4", "sentA": "Specifically, we determined, after conferring with the DMC, that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT study.", "sentB": "This expanded collaboration includes development of the next generation liposomal formulation with the goal of creating safer, more efficacious versions of marketed cancer chemotherapeutics.", "type": 2, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study.", "<tag2>", "This", "expanded", "collaboration", "includes", "development", "of", "the", "next", "generation", "liposomal", "formulation", "with", "the", "goal", "of", "creating", "safer,", "more", "efficacious", "versions", "of", "marketed", "cancer", "chemotherapeutics.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study."], "wordsB": ["This", "expanded", "collaboration", "includes", "development", "of", "the", "next", "generation", "liposomal", "formulation", "with", "the", "goal", "of", "creating", "safer,", "more", "efficacious", "versions", "of", "marketed", "cancer", "chemotherapeutics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01058160699903965, 0.13953478634357452, 0.17512409389019012, 0.02502444013953209, 0.1146244928240776, 0.02854165993630886, 0.021943500265479088, 0.05476197600364685, 0.1122821494936943, 0.3422817289829254, 0.3372647762298584, 0.0011207477655261755, 0.000827718642540276, 0.005948330275714397, 0.004259021487087011, 0.08037126809358597, 0.1593826860189438, 0.07004175335168839, 0.087680883705616, 0.08029767870903015, 0.009848865680396557, 0.04450181499123573, 0.12513890862464905, 0.13515247404575348, -1]}
{"idB": "749647_14_item1_p12_s1", "idA": "749647_13_item1_p37_s0", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "Data from four overall survival sweeps have been conducted since the top line PFS data from the HEAT Study was announced in January 2013, with each showing progressive improvement in statistical significance.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "Data", "from", "four", "overall", "survival", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["Data", "from", "four", "overall", "survival", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.13270917534828186, 0.03107309155166149, 0.2555399537086487, 0.4218536913394928, 0.5425614714622498, 0.5610817074775696, 0.008094988763332367, 0.005513304378837347, 0.02505064196884632, 0.00818652380257845, 0.0053199357353150845, 0.06774227321147919, 0.09557238221168518, 0.11474896967411041, 0.11906886100769043, 0.003827949520200491, 0.003775680437684059, 0.015577233396470547, 0.013675437308847904, 0.004764185752719641, 0.014903654344379902, 0.006852199323475361, 0.015542428940534592, 0.04614150524139404, 0.0002830450248438865, 0.02984033152461052, 0.05008016154170036, 0.07550150901079178, 0.09931003302335739, 0.03325221315026283, 0.07380907982587814, 0.05867428705096245, -1]}
{"idB": "749647_14_item1_p12_s2", "idA": "749647_13_item1_p37_s0", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "In January 2014, we announced that the latest overall survival data from the post-hoc analysis of results from the HEAT Study supports continued clinical development through a prospective pivotal Phase III Study.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024967364966869354, 0.09382066130638123, 0.18026578426361084, 0.045865174382925034, 0.076261505484581, 0.029864264652132988, 0.015769323334097862, 0.06848455965518951, 0.3469354808330536, 0.4081082344055176, 0.21899011731147766, 0.008021359331905842, 0.008221722207963467, 0.11908727139234543, 0.12914535403251648, 0.008453193120658398, 0.028331035748124123, 0.0038353116251528263, 0.0039920201525092125, 0.013404611498117447, 0.015102317556738853, 0.062139712274074554, 0.07079621404409409, 0.10232663154602051, 0.06447942554950714, 0.005544629879295826, 0.005105100106447935, 0.02031584270298481, 0.028733493760228157, 0.028761228546500206, 0.06295529752969742, 0.09875315427780151, -1]}
{"idB": "749647_14_item1_p14_s0", "idA": "749647_13_item1_p37_s0", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "Emerging data from the HEAT Study post-hoc analysis has been presented at three scientific and medical conferences in 2013 by key HEAT Study investigators and leading liver cancer experts.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "Emerging", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "has", "been", "presented", "at", "three", "scientific", "and", "medical", "conferences", "in", "2013", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["Emerging", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "has", "been", "presented", "at", "three", "scientific", "and", "medical", "conferences", "in", "2013", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.23364029824733734, 0.14307457208633423, 0.011799841187894344, 0.007000768091529608, 0.02069108560681343, 0.03064136765897274, 0.6933462023735046, 0.10214217752218246, 0.03568365052342415, 0.02791377529501915, 0.12197858840227127, 0.044474657624959946, 0.19398614764213562, 0.08397166430950165, 0.057182736694812775, 0.17116795480251312, 0.2497113198041916, 0.030019214376807213, 0.10010409355163574, 0.014991874806582928, 0.043077923357486725, 0.03951209411025047, 0.045065637677907944, 0.06075410544872284, 0.014099574647843838, 0.06178279221057892, 0.23785191774368286, 0.28928878903388977, 0.09694921225309372, -1]}
{"idB": "749647_14_item1_p16_s1", "idA": "749647_13_item1_p37_s0", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "The OPTIMA Study trial design is based on the comprehensive analysis of data from the HEAT study, which, as described above, demonstrated that treatment with ThermoDox resulted in a 55 percent improvement in overall survival in a substantial number of HCC patients that received an optimized RFA treatment.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "above,", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55", "percent", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "above,", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55", "percent", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011422112584114075, 0.17561450600624084, 0.30835646390914917, 0.15775860846042633, 0.07899000495672226, 0.010800536721944809, 0.02624041959643364, 0.011483083479106426, 0.011519122868776321, 0.2987546920776367, 0.10866955667734146, 0.01769978366792202, 0.05768803507089615, 0.00576013745740056, 0.005028978921473026, 0.014150291681289673, 0.013584660366177559, 0.002255306113511324, 0.009077961556613445, 0.01462127547711134, 0.015642598271369934, 0.04147852584719658, 0.009342433884739876, 0.05995022505521774, 0.01562056690454483, 0.01423273142427206, 0.030725236982107162, 0.02357390522956848, 0.01903659664094448, 0.12138261646032333, 0.12353923171758652, 0.1324935257434845, 0.0709943100810051, 0.2309434413909912, 0.15446354448795319, 0.009717314504086971, 0.0108548104763031, 0.028757985681295395, 0.015090476721525192, 0.0166966300457716, 0.056687988340854645, 0.08816412836313248, 0.000945383042562753, 0.018722407519817352, 0.007622274104505777, 0.03751413896679878, 0.07084452360868454, 0.05541893467307091, -1]}
{"idB": "749647_14_item1_p38_s2", "idA": "749647_13_item1_p37_s0", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "Data from four overall survival sweeps have been conducted since the top line PFS data from the HEAT Study was announced in January 2013, with each showing progressive improvement in statistical significance.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "Data", "from", "four", "overall", "survival", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["Data", "from", "four", "overall", "survival", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.13270917534828186, 0.03107309155166149, 0.2555399537086487, 0.4218536913394928, 0.5425614714622498, 0.5610817074775696, 0.008094988763332367, 0.005513304378837347, 0.02505064196884632, 0.00818652380257845, 0.0053199357353150845, 0.06774227321147919, 0.09557238221168518, 0.11474896967411041, 0.11906886100769043, 0.003827949520200491, 0.003775680437684059, 0.015577233396470547, 0.013675437308847904, 0.004764185752719641, 0.014903654344379902, 0.006852199323475361, 0.015542428940534592, 0.04614150524139404, 0.0002830450248438865, 0.02984033152461052, 0.05008016154170036, 0.07550150901079178, 0.09931003302335739, 0.03325221315026283, 0.07380907982587814, 0.05867428705096245, -1]}
{"idB": "749647_14_item1_p38_s3", "idA": "749647_13_item1_p37_s0", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "In January 2014, we announced that the latest overall survival data from its post-hoc analysis of results from the HEAT Study supports continued clinical development through a prospective pivotal Phase III Study.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "its", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "its", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023776808753609657, 0.09048131853342056, 0.1751207560300827, 0.046518780291080475, 0.07158157229423523, 0.028519172221422195, 0.014792381785809994, 0.05940818041563034, 0.33379682898521423, 0.4001677632331848, 0.2018500566482544, 0.007150618359446526, 0.008002215065062046, 0.16128653287887573, 0.12679865956306458, 0.009052954614162445, 0.026860006153583527, 0.0037660826928913593, 0.003865334903821349, 0.013107768259942532, 0.014490138739347458, 0.05788375437259674, 0.0680517926812172, 0.10086722671985626, 0.06238837540149689, 0.005405946169048548, 0.005063405726104975, 0.019699828699231148, 0.02776380628347397, 0.02769641950726509, 0.06106657162308693, 0.09480898082256317, -1]}
{"idB": "749647_14_item1_p46_s0", "idA": "749647_13_item1_p37_s0", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "In January 2014, we announced that the latest overall survival data from the post-hoc analysis of results from the HEAT study support continued clinical development of ThermoDox through a prospective pivotal Phase III study, subject to regulatory review and agreement.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "study", "support", "continued", "clinical", "development", "of", "ThermoDox", "through", "a", "prospective", "pivotal", "Phase", "III", "study,", "subject", "to", "regulatory", "review", "and", "agreement.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "study", "support", "continued", "clinical", "development", "of", "ThermoDox", "through", "a", "prospective", "pivotal", "Phase", "III", "study,", "subject", "to", "regulatory", "review", "and", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021934717893600464, 0.08522774279117584, 0.15038006007671356, 0.04153268784284592, 0.06197929382324219, 0.02891237847507, 0.013845185749232769, 0.05058969557285309, 0.27470022439956665, 0.35879239439964294, 0.2148001343011856, 0.008169683627784252, 0.008044264279305935, 0.07901564240455627, 0.11599806696176529, 0.00875498354434967, 0.026748383417725563, 0.003931762184947729, 0.004380273167043924, 0.011129584163427353, 0.011649688705801964, 0.05261925980448723, 0.0549415722489357, 0.07891707867383957, 0.05891995131969452, 0.023456256836652756, 0.031962234526872635, 0.005381452850997448, 0.005598471965640783, 0.01585593819618225, 0.019323304295539856, 0.018707729876041412, 0.0333043709397316, 0.06176267936825752, 0.010962802916765213, 0.009170424193143845, 0.026961002498865128, 0.05911937728524208, 0.030142683535814285, 0.028009291738271713, -1]}
{"idB": "749647_14_item1_p47_s3", "idA": "749647_13_item1_p37_s0", "sentA": "We will also conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox .", "sentB": "Data from four OS sweeps have been conducted since the top line PFS data from the HEAT Study was announced in January 2013, with each showing progressive improvement in statistical significance.", "type": 2, "words": ["<tag1>", "We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "Data", "from", "four", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag3>"], "wordsA": ["We", "will", "also", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["Data", "from", "four", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1468689888715744, 0.0374755896627903, 0.29000338912010193, 0.5443087220191956, 0.6893985867500305, 0.012669333256781101, 0.008386129513382912, 0.0335078127682209, 0.010901190340518951, 0.006656292360275984, 0.08690958470106125, 0.12585651874542236, 0.1322973221540451, 0.12206452339887619, 0.004703854210674763, 0.004408415872603655, 0.02023380808532238, 0.01746669039130211, 0.007316580507904291, 0.021454960107803345, 0.009224480018019676, 0.021683702245354652, 0.0617193728685379, 0.00036003239802084863, 0.037418097257614136, 0.05748133733868599, 0.10515322536230087, 0.14185874164104462, 0.04515249654650688, 0.10244745016098022, 0.07982654869556427, -1]}
{"idB": "749647_14_item1_p48_s0", "idA": "749647_13_item1_p37_s1", "sentA": "We plan to continue with related partnerships, such as our arrangement with Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun) described below, to the extent feasible.", "sentB": "We will continue with partnerships, such as our arrangement with Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun) described below, to the extent feasible.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "with", "related", "partnerships,", "such", "as", "our", "arrangement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "described", "below,", "to", "the", "extent", "feasible.", "<tag2>", "We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "described", "below,", "to", "the", "extent", "feasible.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "with", "related", "partnerships,", "such", "as", "our", "arrangement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "described", "below,", "to", "the", "extent", "feasible."], "wordsB": ["We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "described", "below,", "to", "the", "extent", "feasible."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.3446323573589325, 0.40971556305885315, 0.297961950302124, 0.22450023889541626, 0.3207496106624603, 0.055988162755966187, 0.029652010649442673, 0.03045504167675972, 0.09957454353570938, 0.03963221237063408, 0.39496758580207825, 0.24045641720294952, 0.10006202757358551, 0.0741284117102623, 0.07393452525138855, 0.300974577665329, 0.030997665598988533, 0.05093807354569435, 0.01823878288269043, 0.017491750419139862, 0.03460942581295967, 0.05360565334558487, -1]}
{"idB": "749647_14_item1_p11_s3", "idA": "749647_13_item1_p37_s2", "sentA": "In addition, we will assess our product pipeline and research and development priorities.", "sentB": "As part of this analysis, we are also re-evaluating our product pipeline and research and development priorities.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "will", "assess", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag2>", "As", "part", "of", "this", "analysis,", "we", "are", "also", "re-evaluating", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag3>"], "wordsA": ["In", "addition,", "we", "will", "assess", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "wordsB": ["As", "part", "of", "this", "analysis,", "we", "are", "also", "re-evaluating", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009917219169437885, 0.018108166754245758, 0.009461821988224983, 0.010602864436805248, 0.03864306956529617, 0.03820452839136124, 0.02184896543622017, 0.034821830689907074, 0.9868430495262146, 0.02210555039346218, 0.0296463705599308, 0.008750027976930141, 0.002081124112010002, 0.0024746612180024385, 0.001765396329574287, 0.0026027050334960222, 0.0048449174501001835, -1]}
{"idB": "749647_14_item1_p48_s1", "idA": "749647_13_item1_p37_s2", "sentA": "In addition, we will assess our product pipeline and research and development priorities.", "sentB": "In addition, we have assessed our product pipeline and research and development priorities.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "will", "assess", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag2>", "In", "addition,", "we", "have", "assessed", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag3>"], "wordsA": ["In", "addition,", "we", "will", "assess", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "wordsB": ["In", "addition,", "we", "have", "assessed", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018259720876812935, 0.06391951441764832, 0.194361612200737, 0.6162184476852417, 0.6253488063812256, 0.08509183675050735, 0.26143544912338257, 0.15107201039791107, 0.02026483044028282, 0.027762388810515404, 0.01670440472662449, 0.02228173054754734, 0.041989270597696304, -1]}
{"idB": "749647_14_item1_p48_s4", "idA": "749647_13_item1_p37_s5", "sentA": "However, as demonstrated by the HEAT study results announced on January 31, 2013, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "sentB": "However, as demonstrated by the HEAT Study results on PFS announced on January 31, 2013, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "type": 2, "words": ["<tag1>", "However,", "as", "demonstrated", "by", "the", "HEAT", "study", "results", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag2>", "However,", "as", "demonstrated", "by", "the", "HEAT", "Study", "results", "on", "PFS", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag3>"], "wordsA": ["However,", "as", "demonstrated", "by", "the", "HEAT", "study", "results", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "wordsB": ["However,", "as", "demonstrated", "by", "the", "HEAT", "Study", "results", "on", "PFS", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006918179336935282, 0.003702113637700677, 0.0062516373582184315, 0.0034922375343739986, 0.0027255266904830933, 0.006518489681184292, 0.00592279015108943, 0.03102710470557213, 0.18921050429344177, 0.9723018407821655, 0.008412070572376251, 0.0035581481643021107, 0.004028010182082653, 0.004914711229503155, 0.0038772798143327236, 0.00338946096599102, 0.004041366279125214, 0.0034525389783084393, 0.0038080234080553055, 0.0027613884303718805, 0.003004164434969425, 0.006937961559742689, 0.008861783891916275, 0.007653312291949987, 0.0017481110990047455, 0.003396378131583333, 0.0030519685242325068, 0.0028726249001920223, 0.008151466958224773, 0.007825960405170918, 0.0035166058223694563, 0.015889085829257965, 0.004052553325891495, 0.006770764477550983, 0.012699448503553867, 0.005854121875017881, 0.005881888326257467, 0.009065688587725163, -1]}
{"idB": "749647_14_item1_p132_s0", "idA": "749647_13_item1_p42_s1", "sentA": "In addition, Hisun will collaborate with us in relation to the regulatory approval activities for ThermoDox with the China State Food and Drug Administration (SFDA).", "sentB": "In addition, the Company recently met with the China State Food and Drug Administration (CHINA FDA) to discuss the OPTIMA Phase III trial, including minimum patient enrollment requirements supporting ThermoDox s registration in China.", "type": 2, "words": ["<tag1>", "In", "addition,", "Hisun", "will", "collaborate", "with", "us", "in", "relation", "to", "the", "regulatory", "approval", "activities", "for", "ThermoDox", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(SFDA).", "<tag2>", "In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "trial,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China.", "<tag3>"], "wordsA": ["In", "addition,", "Hisun", "will", "collaborate", "with", "us", "in", "relation", "to", "the", "regulatory", "approval", "activities", "for", "ThermoDox", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(SFDA)."], "wordsB": ["In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "trial,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005687010008841753, 0.021048162132501602, 0.007812975905835629, 0.10088634490966797, 0.09916212409734726, 0.19790998101234436, 0.03750712424516678, 0.018152276054024696, 0.048864129930734634, 0.011424245312809944, 0.02089002914726734, 0.007979210466146469, 0.017305558547377586, 0.054308440536260605, 0.21593767404556274, 0.5613027811050415, 0.017670881003141403, 0.15401595830917358, 0.026296647265553474, 0.08548463881015778, 0.0824202373623848, 0.19258224964141846, 0.18107132613658905, 0.010482056997716427, 0.15628579258918762, 0.2969783544540405, 0.4014996588230133, 0.2095693200826645, 0.06685241311788559, 0.07781445980072021, 0.04651655629277229, 0.0896456241607666, 0.0354427844285965, 0.05503297969698906, -1]}
{"idB": "749647_14_item1_p18_s0", "idA": "749647_13_item1_p42_s1", "sentA": "In addition, Hisun will collaborate with us in relation to the regulatory approval activities for ThermoDox with the China State Food and Drug Administration (SFDA).", "sentB": "In addition, the Company recently met with the China State Food and Drug Administration (CHINA FDA) to discuss the OPTIMA Phase III trial including minimum patient enrollment requirements supporting ThermoDox s registration in China.", "type": 2, "words": ["<tag1>", "In", "addition,", "Hisun", "will", "collaborate", "with", "us", "in", "relation", "to", "the", "regulatory", "approval", "activities", "for", "ThermoDox", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(SFDA).", "<tag2>", "In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "trial", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China.", "<tag3>"], "wordsA": ["In", "addition,", "Hisun", "will", "collaborate", "with", "us", "in", "relation", "to", "the", "regulatory", "approval", "activities", "for", "ThermoDox", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(SFDA)."], "wordsB": ["In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "trial", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005705517716705799, 0.020994799211621284, 0.007998143322765827, 0.10081735253334045, 0.10380015522241592, 0.1994340717792511, 0.03748449310660362, 0.017949314787983894, 0.04639367759227753, 0.011202935129404068, 0.02115369774401188, 0.007944108918309212, 0.017225831747055054, 0.05270501226186752, 0.21179664134979248, 0.5624359846115112, 0.017026346176862717, 0.1498098075389862, 0.025321707129478455, 0.08011852204799652, 0.07949868589639664, 0.180220827460289, 0.17791050672531128, 0.009369516745209694, 0.14604303240776062, 0.2704120874404907, 0.40805694460868835, 0.20087486505508423, 0.0623825266957283, 0.07760684192180634, 0.04666249081492424, 0.08992437273263931, 0.035966288298368454, 0.05794207751750946, -1]}
{"idB": "749647_14_item1_p130_s2", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "The Company expects to launch the study in the first half of 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "The", "Company", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["The", "Company", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007599008735269308, 0.1415363848209381, 0.08081661909818649, 0.05239415913820267, 0.30992263555526733, 0.06197570636868477, 0.15587033331394196, 0.025976546108722687, 0.02070666290819645, 0.05132685974240303, 0.07778938859701157, 0.07690376788377762, 0.7904080152511597, -1]}
{"idB": "749647_14_item1_p132_s2", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "The Company plans to expand its clinical site footprint in Europe and meet with the European Medicines Agency (EMA) in the first half of 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "and", "meet", "with", "the", "European", "Medicines", "Agency", "(EMA)", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "and", "meet", "with", "the", "European", "Medicines", "Agency", "(EMA)", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007257938850671053, 0.12646172940731049, 0.09021700173616409, 0.04935603588819504, 0.20499828457832336, 0.0704057365655899, 0.33944424986839294, 0.38740473985671997, 0.1810731589794159, 0.016371797770261765, 0.05168985575437546, 0.005489995237439871, 0.0760236531496048, 0.06050145626068115, 0.03168024495244026, 0.07857752591371536, 0.14107646048069, 0.09779240936040878, 0.16059058904647827, 0.009784366004168987, 0.0076249935664236546, 0.027361026033759117, 0.03863896057009697, 0.030185189098119736, 0.32131052017211914, -1]}
{"idB": "749647_14_item1_p16_s2", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "The Company expects to launch the study in the first half of 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "The", "Company", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["The", "Company", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007599008735269308, 0.1415363848209381, 0.08081661909818649, 0.05239415913820267, 0.30992263555526733, 0.06197570636868477, 0.15587033331394196, 0.025976546108722687, 0.02070666290819645, 0.05132685974240303, 0.07778938859701157, 0.07690376788377762, 0.7904080152511597, -1]}
{"idB": "749647_14_item1_p18_s2", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "The Company plans to expand its clinical site footprint in Europe and will meet with the European Medicines Agency (EMA) in the first half of 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "and", "will", "meet", "with", "the", "European", "Medicines", "Agency", "(EMA)", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "and", "will", "meet", "with", "the", "European", "Medicines", "Agency", "(EMA)", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008512252010405064, 0.13878509402275085, 0.09886346012353897, 0.04789530858397484, 0.22678138315677643, 0.07750348001718521, 0.37429648637771606, 0.42949360609054565, 0.19477033615112305, 0.015285728499293327, 0.05144419148564339, 0.005147736519575119, 0.011552615091204643, 0.06687561422586441, 0.05507182329893112, 0.03343416750431061, 0.10309059172868729, 0.1808779239654541, 0.14193931221961975, 0.21668563783168793, 0.008235272020101547, 0.0066696167923510075, 0.01981888711452484, 0.028989918529987335, 0.022914815694093704, 0.21146371960639954, -1]}
{"idB": "749647_14_item1_p50_s3", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "The Company expects to launch the study in the first half of 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "The", "Company", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["The", "Company", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007599008735269308, 0.1415363848209381, 0.08081661909818649, 0.05239415913820267, 0.30992263555526733, 0.06197570636868477, 0.15587033331394196, 0.025976546108722687, 0.02070666290819645, 0.05132685974240303, 0.07778938859701157, 0.07690376788377762, 0.7904080152511597, -1]}
{"idB": "749647_14_item1_p54_s2", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "The Company plans to expand its clinical site footprint in Europe for the OPTIMA Study and will meet with the EMA in the first half of 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "for", "the", "OPTIMA", "Study", "and", "will", "meet", "with", "the", "EMA", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "for", "the", "OPTIMA", "Study", "and", "will", "meet", "with", "the", "EMA", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00765888812020421, 0.11554896086454391, 0.09156543761491776, 0.044067516922950745, 0.23185884952545166, 0.08894867449998856, 0.3269123435020447, 0.3281956613063812, 0.18834836781024933, 0.013539012521505356, 0.04108768701553345, 0.00908228661864996, 0.009602021425962448, 0.05216330662369728, 0.10710141807794571, 0.00010531150473980233, 0.007896275259554386, 0.04301029443740845, 0.04462522640824318, 0.02795204147696495, 0.11938586086034775, 0.006409160327166319, 0.0049933260306715965, 0.0142835583537817, 0.02221086248755455, 0.016106652095913887, 0.15004098415374756, -1]}
{"idB": "749647_14_item1_p55_s3", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "Enrollment of the first patient in this clinical study is targeted for 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010058416984975338, 0.0016640566755086184, 0.001716708648018539, 0.008302505128085613, 0.018617313355207443, 0.0016430431278422475, 0.002152127679437399, 0.007901985198259354, 0.00998573936522007, 0.001778339152224362, 0.03296305984258652, 0.0311668012291193, 0.9961748123168945, -1]}
{"idB": "749647_14_item1_p84_s2", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "Celsion expects to launch the study in the first half of 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "Celsion", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["Celsion", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6132717132568359, 0.06541088223457336, 0.025025496259331703, 0.18313685059547424, 0.03573229908943176, 0.11048910021781921, 0.016673043370246887, 0.013115727342665195, 0.03281518816947937, 0.05367530137300491, 0.04927797615528107, 0.5647815465927124, -1]}
{"idB": "749647_14_item1_p88_s2", "idA": "749647_13_item1_p46_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for the first half of 2013.", "sentB": "The Company plans to expand its clinical site footprint in Europe for the OPTIMA Study and will meet with the EMA in the first half of 2014.", "type": 2, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013.", "<tag2>", "The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "for", "the", "OPTIMA", "Study", "and", "will", "meet", "with", "the", "EMA", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "the", "first", "half", "of", "2013."], "wordsB": ["The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "for", "the", "OPTIMA", "Study", "and", "will", "meet", "with", "the", "EMA", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00765888812020421, 0.11554896086454391, 0.09156543761491776, 0.044067516922950745, 0.23185884952545166, 0.08894867449998856, 0.3269123435020447, 0.3281956613063812, 0.18834836781024933, 0.013539012521505356, 0.04108768701553345, 0.00908228661864996, 0.009602021425962448, 0.05216330662369728, 0.10710141807794571, 0.00010531150473980233, 0.007896275259554386, 0.04301029443740845, 0.04462522640824318, 0.02795204147696495, 0.11938586086034775, 0.006409160327166319, 0.0049933260306715965, 0.0142835583537817, 0.02221086248755455, 0.016106652095913887, 0.15004098415374756, -1]}
{"idB": "749647_14_item1_p56_s0", "idA": "749647_13_item1_p47_s0", "sentA": "We are also working with the Focused Ultrasound Foundation in preclinical studies designed to explore the use of ThermoDox in combination with MR-guided HIFU for the treatment of pancreatic cancer.", "sentB": "In collaboration with the Focused Ultrasound Foundation, we are sponsoring preclinical studies designed to explore the use of ThermoDox in combination with MR-guided HIFU for the treatment of pancreatic cancer.", "type": 2, "words": ["<tag1>", "We", "are", "also", "working", "with", "the", "Focused", "Ultrasound", "Foundation", "in", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer.", "<tag2>", "In", "collaboration", "with", "the", "Focused", "Ultrasound", "Foundation,", "we", "are", "sponsoring", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer.", "<tag3>"], "wordsA": ["We", "are", "also", "working", "with", "the", "Focused", "Ultrasound", "Foundation", "in", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer."], "wordsB": ["In", "collaboration", "with", "the", "Focused", "Ultrasound", "Foundation,", "we", "are", "sponsoring", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.058024484664201736, 0.1559671312570572, 0.006614107638597488, 0.0030845734290778637, 0.007903716526925564, 0.007557223550975323, 0.010247480124235153, 0.03248800337314606, 0.013493361882865429, 0.9779894948005676, 0.08204001933336258, 0.04853346571326256, 0.0027774411719292402, 0.0022934142034500837, 0.003435456659644842, 0.0025145928375422955, 0.004577361047267914, 0.0027807028964161873, 0.007150665856897831, 0.0028048476669937372, 0.0029471837915480137, 0.002360770246013999, 0.007290585432201624, 0.005490140989422798, 0.0019023430068045855, 0.0019731009379029274, 0.005379342939704657, 0.0028674991335719824, 0.006785784848034382, 0.008015701547265053, -1]}
{"idB": "749647_14_item1_p74_s1", "idA": "749647_13_item1_p47_s1", "sentA": "The studies are being conducted at the University of Washington (UW) School of Medicine.", "sentB": "We are currently, with minimal cash expenditures, sponsoring clinical and pre-clinical research at the University of Utrecht, Brigham and Women s Hospital and the University of Washington.", "type": 2, "words": ["<tag1>", "The", "studies", "are", "being", "conducted", "at", "the", "University", "of", "Washington", "(UW)", "School", "of", "Medicine.", "<tag2>", "We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington.", "<tag3>"], "wordsA": ["The", "studies", "are", "being", "conducted", "at", "the", "University", "of", "Washington", "(UW)", "School", "of", "Medicine."], "wordsB": ["We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028996441513299942, 0.005705212242901325, 0.008540889248251915, 0.0113418223336339, 0.10569804906845093, 0.05214962735772133, 0.07251539826393127, 0.12901321053504944, 0.15206418931484222, 0.06391493231058121, 0.5376036763191223, 0.24733270704746246, 0.025067823007702827, 0.025191625580191612, 0.16669613122940063, 0.10385259985923767, 0.4010247588157654, 0.3638767898082733, 0.22540195286273956, 0.3638764023780823, 0.3703191578388214, 0.4492686986923218, 0.013625910505652428, 0.010010668076574802, 0.05937693268060684, 0.03309959918260574, 0.07821667194366455, -1]}
{"idB": "749647_14_item1_p56_s2", "idA": "749647_13_item1_p47_s2", "sentA": "The UW research is expected to include animal models to confirm the ability of HIFU to target high concentrations of doxorubicin in proprietary pancreatic cancer cell lines and in vivo studies to assess the response to these tumors treated using ThermoDox with and without HIFU-induced hyperthermia.", "sentB": "The UW research includes animal models to confirm the ability of HIFU to target concentrations of doxorubicin in proprietary pancreatic cancer cell lines and in vivo studies to assess the response to these tumors treated using ThermoDox with and without HIFU-induced hyperthermia.", "type": 2, "words": ["<tag1>", "The", "UW", "research", "is", "expected", "to", "include", "animal", "models", "to", "confirm", "the", "ability", "of", "HIFU", "to", "target", "high", "concentrations", "of", "doxorubicin", "in", "proprietary", "pancreatic", "cancer", "cell", "lines", "and", "in", "vivo", "studies", "to", "assess", "the", "response", "to", "these", "tumors", "treated", "using", "ThermoDox", "with", "and", "without", "HIFU-induced", "hyperthermia.", "<tag2>", "The", "UW", "research", "includes", "animal", "models", "to", "confirm", "the", "ability", "of", "HIFU", "to", "target", "concentrations", "of", "doxorubicin", "in", "proprietary", "pancreatic", "cancer", "cell", "lines", "and", "in", "vivo", "studies", "to", "assess", "the", "response", "to", "these", "tumors", "treated", "using", "ThermoDox", "with", "and", "without", "HIFU-induced", "hyperthermia.", "<tag3>"], "wordsA": ["The", "UW", "research", "is", "expected", "to", "include", "animal", "models", "to", "confirm", "the", "ability", "of", "HIFU", "to", "target", "high", "concentrations", "of", "doxorubicin", "in", "proprietary", "pancreatic", "cancer", "cell", "lines", "and", "in", "vivo", "studies", "to", "assess", "the", "response", "to", "these", "tumors", "treated", "using", "ThermoDox", "with", "and", "without", "HIFU-induced", "hyperthermia."], "wordsB": ["The", "UW", "research", "includes", "animal", "models", "to", "confirm", "the", "ability", "of", "HIFU", "to", "target", "concentrations", "of", "doxorubicin", "in", "proprietary", "pancreatic", "cancer", "cell", "lines", "and", "in", "vivo", "studies", "to", "assess", "the", "response", "to", "these", "tumors", "treated", "using", "ThermoDox", "with", "and", "without", "HIFU-induced", "hyperthermia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010314563289284706, 0.13110730051994324, 0.07006147503852844, 0.13616320490837097, 0.09673956781625748, 0.05418084189295769, 0.017274951562285423, 0.021795904263854027, 0.017257455736398697, 0.019098250195384026, 0.020983019843697548, 0.05506875738501549, 0.014150438830256462, 0.04063368961215019, 0.05162828043103218, 0.03877591714262962, 0.07127721607685089, 0.018753657117486, 0.03251665458083153, 0.057785436511039734, 0.022147858515381813, 0.02911936491727829, 0.024806220084428787, 0.009283359162509441, 0.017204228788614273, 0.03343063220381737, 0.021872730925679207, 0.01183354388922453, 0.0169424656778574, 0.014908702112734318, 0.022570541128516197, 0.01437475997954607, 0.011671147309243679, 0.0315622054040432, 0.019403625279664993, 0.02381524257361889, 0.04947637394070625, 0.04023228958249092, 0.0290615726262331, 0.8194694519042969, 0.6573328971862793, 0.3379800319671631, -1]}
{"idB": "749647_14_item1_p56_s3", "idA": "749647_13_item1_p47_s3", "sentA": "We believe that these collaborations are just the beginning for combining important device technologies such as HIFU with our low heat activated liposomal technology.", "sentB": "We believe that these collaborations are providing important new device technologies such as HIFU to activate our low heat sensitive liposomal technology in difficult-to-treat cancers.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "these", "collaborations", "are", "just", "the", "beginning", "for", "combining", "important", "device", "technologies", "such", "as", "HIFU", "with", "our", "low", "heat", "activated", "liposomal", "technology.", "<tag2>", "We", "believe", "that", "these", "collaborations", "are", "providing", "important", "new", "device", "technologies", "such", "as", "HIFU", "to", "activate", "our", "low", "heat", "sensitive", "liposomal", "technology", "in", "difficult-to-treat", "cancers.", "<tag3>"], "wordsA": ["We", "believe", "that", "these", "collaborations", "are", "just", "the", "beginning", "for", "combining", "important", "device", "technologies", "such", "as", "HIFU", "with", "our", "low", "heat", "activated", "liposomal", "technology."], "wordsB": ["We", "believe", "that", "these", "collaborations", "are", "providing", "important", "new", "device", "technologies", "such", "as", "HIFU", "to", "activate", "our", "low", "heat", "sensitive", "liposomal", "technology", "in", "difficult-to-treat", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016424572095274925, 0.02468855492770672, 0.0074949865229427814, 0.010446052066981792, 0.06062036380171776, 0.021246623247861862, 0.15605781972408295, 0.08920647948980331, 0.10070575773715973, 0.124576136469841, 0.09154549241065979, 0.010140066966414452, 0.015065869316458702, 0.03430132195353508, 0.0043570008128881454, 0.04037619009613991, 0.007503681816160679, 0.030370540916919708, 0.029410148039460182, 0.02054433524608612, 0.03053472749888897, 0.04944224655628204, 0.012889834120869637, 0.2623245120048523, 0.2564542591571808, -1]}
{"idB": "749647_14_item1_p65_s2", "idA": "749647_13_item1_p49_s0", "sentA": "Breast cancer is the most common malignancy in women in both the United States and the world.", "sentB": "The trial will enroll 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world.", "<tag2>", "The", "trial", "will", "enroll", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world."], "wordsB": ["The", "trial", "will", "enroll", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006821715272963047, 0.12813372910022736, 0.011084897443652153, 0.08383770287036896, 0.32355809211730957, 0.40162941813468933, 0.008680982515215874, 0.10854357481002808, 0.13511313498020172, 0.08672519028186798, 0.005657214671373367, 0.00468577491119504, 0.01879234053194523, 0.021531300619244576, 4.6617416955996305e-05, 0.003212238661944866, 0.08742714673280716, 0.46350887417793274, 0.003877416253089905, 0.03994834050536156, 0.021891484037041664, 0.16486310958862305, 0.5463509559631348, -1]}
{"idB": "749647_14_item1_p26_s1", "idA": "749647_13_item1_p4_s0", "sentA": "The discussion of risks and uncertainties set forth in this Annual Report on Form 10-K is not necessarily a complete or exhaustive list of all risks facing the Company at any particular point in time.", "sentB": "Material risks and uncertainties relating to our business and our industry are described in \"Part I, Item 1A. Risk Factors\" in this Annual Report on Form 10-K.", "type": 2, "words": ["<tag1>", "The", "discussion", "of", "risks", "and", "uncertainties", "set", "forth", "in", "this", "Annual", "Report", "on", "Form", "10-K", "is", "not", "necessarily", "a", "complete", "or", "exhaustive", "list", "of", "all", "risks", "facing", "the", "Company", "at", "any", "particular", "point", "in", "time.", "<tag2>", "Material", "risks", "and", "uncertainties", "relating", "to", "our", "business", "and", "our", "industry", "are", "described", "in", "\"Part", "I,", "Item", "1A.", "Risk", "Factors\"", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag3>"], "wordsA": ["The", "discussion", "of", "risks", "and", "uncertainties", "set", "forth", "in", "this", "Annual", "Report", "on", "Form", "10-K", "is", "not", "necessarily", "a", "complete", "or", "exhaustive", "list", "of", "all", "risks", "facing", "the", "Company", "at", "any", "particular", "point", "in", "time."], "wordsB": ["Material", "risks", "and", "uncertainties", "relating", "to", "our", "business", "and", "our", "industry", "are", "described", "in", "\"Part", "I,", "Item", "1A.", "Risk", "Factors\"", "in", "this", "Annual", "Report", "on", "Form", "10-K."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.31366947293281555, 0.16774988174438477, 0.015372976660728455, 0.028555331751704216, 0.03034328483045101, 0.02318759262561798, 0.04373878240585327, 0.10360974818468094, 0.0393112450838089, 0.0341348871588707, 0.09845808893442154, 0.012993591837584972, 0.08378878980875015, 0.010971234180033207, 0.17602790892124176, 0.13304656744003296, 0.1342466175556183, 0.5632873177528381, 0.13380683958530426, 0.08848000317811966, 0.005371434614062309, 0.004200663883239031, 0.011589706875383854, 0.018172884359955788, 0.004383818246424198, 0.009399473667144775, 0.00729186600074172, -1]}
{"idB": "749647_14_item1_p67_s2", "idA": "749647_13_item1_p52_s0", "sentA": "We have been actively seeking a targeted localized treatment for breast cancer using ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "sentB": "These data are consistent with the previously reported positive Phase I data in RCW breast cancer.", "type": 2, "words": ["<tag1>", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag2>", "These", "data", "are", "consistent", "with", "the", "previously", "reported", "positive", "Phase", "I", "data", "in", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "wordsB": ["These", "data", "are", "consistent", "with", "the", "previously", "reported", "positive", "Phase", "I", "data", "in", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.020246848464012146, 0.1697232574224472, 0.04598092660307884, 0.22407197952270508, 0.054229486733675, 0.01960759423673153, 0.043732501566410065, 0.05815436318516731, 0.3799985945224762, 0.44031810760498047, 0.5471426248550415, 0.40251046419143677, 0.02611745148897171, 0.022692084312438965, 0.02580014057457447, 0.026896297931671143, -1]}
{"idB": "749647_14_item1_p132_s1", "idA": "749647_13_item1_p57_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010 and an independent Data Safety Monitoring Board declared 50mg/m2 to be the Phase II dose.", "sentB": "Based on those discussions, the Company is submitting an application for accelerated approval of the study in China.", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose.", "<tag2>", "Based", "on", "those", "discussions,", "the", "Company", "is", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China.", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose."], "wordsB": ["Based", "on", "those", "discussions,", "the", "Company", "is", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028642481192946434, 0.021735763177275658, 0.0799940675497055, 0.2649432420730591, 0.0042670913971960545, 0.05400034785270691, 0.017921674996614456, 0.7553889155387878, 0.33348774909973145, 0.43216389417648315, 0.09327821433544159, 0.3364357352256775, 0.3645297586917877, 0.031415607780218124, 0.027746492996811867, 0.10082634538412094, 0.015438315458595753, 0.03404361009597778, -1]}
{"idB": "749647_14_item1_p18_s1", "idA": "749647_13_item1_p57_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010 and an independent Data Safety Monitoring Board declared 50mg/m2 to be the Phase II dose.", "sentB": "Based on those discussions, we are submitting an application for accelerated approval of the study in China.", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose.", "<tag2>", "Based", "on", "those", "discussions,", "we", "are", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China.", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose."], "wordsB": ["Based", "on", "those", "discussions,", "we", "are", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025127874687314034, 0.017035141587257385, 0.05933096259832382, 0.2253359854221344, 0.12651342153549194, 0.01728484407067299, 0.620395302772522, 0.195411816239357, 0.3432689309120178, 0.051513705402612686, 0.28918135166168213, 0.3068179786205292, 0.029470624402165413, 0.028159715235233307, 0.10855770856142044, 0.01768803969025612, 0.04161437973380089, -1]}
{"idB": "749647_14_item1_p54_s1", "idA": "749647_13_item1_p57_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010 and an independent Data Safety Monitoring Board declared 50mg/m2 to be the Phase II dose.", "sentB": "Based on those discussions, the Company is submitting an application for accelerated approval of the study in China.", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose.", "<tag2>", "Based", "on", "those", "discussions,", "the", "Company", "is", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China.", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose."], "wordsB": ["Based", "on", "those", "discussions,", "the", "Company", "is", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028642481192946434, 0.021735763177275658, 0.0799940675497055, 0.2649432420730591, 0.0042670913971960545, 0.05400034785270691, 0.017921674996614456, 0.7553889155387878, 0.33348774909973145, 0.43216389417648315, 0.09327821433544159, 0.3364357352256775, 0.3645297586917877, 0.031415607780218124, 0.027746492996811867, 0.10082634538412094, 0.015438315458595753, 0.03404361009597778, -1]}
{"idB": "749647_14_item1_p88_s1", "idA": "749647_13_item1_p57_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010 and an independent Data Safety Monitoring Board declared 50mg/m2 to be the Phase II dose.", "sentB": "Based on those discussions, the Company is submitting an application for accelerated approval of the study in China.", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose.", "<tag2>", "Based", "on", "those", "discussions,", "the", "Company", "is", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China.", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose."], "wordsB": ["Based", "on", "those", "discussions,", "the", "Company", "is", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028642481192946434, 0.021735763177275658, 0.0799940675497055, 0.2649432420730591, 0.0042670913971960545, 0.05400034785270691, 0.017921674996614456, 0.7553889155387878, 0.33348774909973145, 0.43216389417648315, 0.09327821433544159, 0.3364357352256775, 0.3645297586917877, 0.031415607780218124, 0.027746492996811867, 0.10082634538412094, 0.015438315458595753, 0.03404361009597778, -1]}
{"idB": "749647_14_item1_p50_s0", "idA": "749647_13_item1_p57_s1", "sentA": "The Phase II portion of the DIGNITY study protocol has been reviewed by the FDA and enrollment commenced in the first quarter of 2013.", "sentB": "Based on the overall survival data from the post-hoc analysis of results from HEAT Study, we submitted our proposed pivotal Phase III clinical protocol for the FDA review in the fourth quarter of 2013.", "type": 2, "words": ["<tag1>", "The", "Phase", "II", "portion", "of", "the", "DIGNITY", "study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013.", "<tag2>", "Based", "on", "the", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "HEAT", "Study,", "we", "submitted", "our", "proposed", "pivotal", "Phase", "III", "clinical", "protocol", "for", "the", "FDA", "review", "in", "the", "fourth", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["The", "Phase", "II", "portion", "of", "the", "DIGNITY", "study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013."], "wordsB": ["Based", "on", "the", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "HEAT", "Study,", "we", "submitted", "our", "proposed", "pivotal", "Phase", "III", "clinical", "protocol", "for", "the", "FDA", "review", "in", "the", "fourth", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011707929894328117, 0.010640889406204224, 0.00921184103935957, 0.1448906511068344, 0.17424708604812622, 0.11149303615093231, 0.006745449732989073, 0.007703239098191261, 0.08288296312093735, 0.13330189883708954, 0.016236646100878716, 0.06164126843214035, 0.019948482513427734, 0.2648760676383972, 0.32548820972442627, 0.016309529542922974, 0.14005430042743683, 0.01169673539698124, 0.03986550495028496, 0.10081388056278229, 0.080605648458004, 0.22536759078502655, 0.07733788341283798, 0.09052928537130356, 0.011779463849961758, 0.009195326827466488, 0.044946521520614624, 0.047803305089473724, 0.005923817399889231, 0.007872686721384525, 0.5090349912643433, 0.08452584594488144, 0.009777965024113655, 0.02071630023419857, -1]}
{"idB": "749647_14_item1_p66_s5", "idA": "749647_13_item1_p57_s1", "sentA": "The Phase II portion of the DIGNITY study protocol has been reviewed by the FDA and enrollment commenced in the first quarter of 2013.", "sentB": "There were 29 patients treated in the two trials, including 11 patients in the DIGNITY study and 18 patients in the Duke study.", "type": 2, "words": ["<tag1>", "The", "Phase", "II", "portion", "of", "the", "DIGNITY", "study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013.", "<tag2>", "There", "were", "29", "patients", "treated", "in", "the", "two", "trials,", "including", "11", "patients", "in", "the", "DIGNITY", "study", "and", "18", "patients", "in", "the", "Duke", "study.", "<tag3>"], "wordsA": ["The", "Phase", "II", "portion", "of", "the", "DIGNITY", "study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013."], "wordsB": ["There", "were", "29", "patients", "treated", "in", "the", "two", "trials,", "including", "11", "patients", "in", "the", "DIGNITY", "study", "and", "18", "patients", "in", "the", "Duke", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007626296486705542, 0.012816797010600567, 0.6381444334983826, 0.4720264971256256, 0.13357898592948914, 0.01402360200881958, 0.011382294818758965, 0.07241886109113693, 0.0795031487941742, 0.0002176541747758165, 0.34375011920928955, 0.20999087393283844, 0.010184490121901035, 0.006185573060065508, 0.032980792224407196, 0.05119266360998154, 0.0001299051655223593, 0.27585309743881226, 0.151703342795372, 0.01786809228360653, 0.016008755192160606, 0.16358044743537903, 0.2053588628768921, -1]}
{"idB": "749647_14_item1_p66_s1", "idA": "749647_13_item1_p58_s0", "sentA": "Duke University conducted a Phase I dose escalating ThermoDox study in patients with RCW breast cancer and has presented preliminary results from the 16 enrolled patients that characterize the safety of the drug in RCW patients and the feasibility of ThermoDox administration in these patients.", "sentB": "In December 2013, we announced combined clinical data from our DIGNITY study and the Duke University sponsored Phase I trial of ThermoDox plus hyperthermia in RCW breast cancer.", "type": 2, "words": ["<tag1>", "Duke", "University", "conducted", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients.", "<tag2>", "In", "December", "2013,", "we", "announced", "combined", "clinical", "data", "from", "our", "DIGNITY", "study", "and", "the", "Duke", "University", "sponsored", "Phase", "I", "trial", "of", "ThermoDox", "plus", "hyperthermia", "in", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["Duke", "University", "conducted", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients."], "wordsB": ["In", "December", "2013,", "we", "announced", "combined", "clinical", "data", "from", "our", "DIGNITY", "study", "and", "the", "Duke", "University", "sponsored", "Phase", "I", "trial", "of", "ThermoDox", "plus", "hyperthermia", "in", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011582362465560436, 0.10721508413553238, 0.1305660903453827, 0.04624407738447189, 0.09116173535585403, 0.19368678331375122, 0.18936742842197418, 0.1810745745897293, 0.010904076509177685, 0.012014441192150116, 0.152035653591156, 0.18553125858306885, 0.005599143449217081, 0.004574997816234827, 0.025939682498574257, 0.02501075156033039, 0.032336361706256866, 0.02664288505911827, 0.03253606706857681, 0.12548856437206268, 0.040001560002565384, 0.09016367048025131, 0.15830989181995392, 0.7163547873497009, 0.008228241465985775, 0.021109551191329956, 0.028864936903119087, 0.02605636604130268, -1]}
{"idB": "749647_14_item1_p11_s4", "idA": "749647_13_item1_p63_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with RFA for the treatment of colorectal liver metastases.", "sentB": "In April 2013, we announced the deferral of expenses associated with the Company s Phase II study of ThermoDox in combination with RFA for the treatment of colorectal liver metastases (The ABLATE Study) until such time as the Company finalizes its plans for the continuation of its development program with ThermoDox in HCC.", "type": 2, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases.", "<tag2>", "In", "April", "2013,", "we", "announced", "the", "deferral", "of", "expenses", "associated", "with", "the", "Company", "s", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(The", "ABLATE", "Study)", "until", "such", "time", "as", "the", "Company", "finalizes", "its", "plans", "for", "the", "continuation", "of", "its", "development", "program", "with", "ThermoDox", "in", "HCC.", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases."], "wordsB": ["In", "April", "2013,", "we", "announced", "the", "deferral", "of", "expenses", "associated", "with", "the", "Company", "s", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(The", "ABLATE", "Study)", "until", "such", "time", "as", "the", "Company", "finalizes", "its", "plans", "for", "the", "continuation", "of", "its", "development", "program", "with", "ThermoDox", "in", "HCC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03149645775556564, 0.3038044273853302, 0.8921718001365662, 0.03546587750315666, 0.15681181848049164, 0.03165590018033981, 0.21468280255794525, 0.1467364877462387, 0.18038970232009888, 0.006462409161031246, 0.0036316686309874058, 0.00316614774055779, 0.02382964827120304, 0.0066293831914663315, 0.012377056293189526, 0.01136734988540411, 0.01934702694416046, 0.004808614030480385, 0.0077929808758199215, 0.0020110474433749914, 0.002937355311587453, 0.0023782411590218544, 0.0038378669414669275, 0.0016461514169350266, 0.002270444994792342, 0.004519608337432146, 0.0021459495183080435, 0.003640977432951331, 0.007819495163857937, 0.007036000024527311, 0.0036055073142051697, 0.02861137129366398, 0.06409946829080582, 0.01009391713887453, 0.007970442995429039, 0.005775274708867073, 0.003932544495910406, 0.0034297930542379618, 0.022580359131097794, 0.028825433924794197, 0.00853272806853056, 0.030636167153716087, 0.008962231688201427, 0.018217075616121292, 0.01586274243891239, 0.006978395860642195, 0.0074746496975421906, 0.053632985800504684, 0.03461243584752083, 0.009500226937234402, 0.020647194236516953, 0.014781768433749676, 0.03207007423043251, -1]}
{"idB": "749647_14_item1_p66_s4", "idA": "749647_13_item1_p63_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with RFA for the treatment of colorectal liver metastases.", "sentB": "Both studies employed an open label 3+3 dose escalation study design to determine the Maximum Tolerated Dose, evaluate safety and determine early effects of ThermoDox in combination with mild hyperthermia.", "type": 2, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases.", "<tag2>", "Both", "studies", "employed", "an", "open", "label", "3+3", "dose", "escalation", "study", "design", "to", "determine", "the", "Maximum", "Tolerated", "Dose,", "evaluate", "safety", "and", "determine", "early", "effects", "of", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "colorectal", "liver", "metastases."], "wordsB": ["Both", "studies", "employed", "an", "open", "label", "3+3", "dose", "escalation", "study", "design", "to", "determine", "the", "Maximum", "Tolerated", "Dose,", "evaluate", "safety", "and", "determine", "early", "effects", "of", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.17580191791057587, 0.120255246758461, 0.04809064790606499, 0.011843322776257992, 0.270452618598938, 0.20938937366008759, 0.6654178500175476, 0.4455921947956085, 0.3918513357639313, 0.20724308490753174, 0.062190137803554535, 0.00011248116061324254, 0.012618744745850563, 0.008668845519423485, 0.019983163103461266, 0.0347086563706398, 0.03330405056476593, 0.01403013151139021, 0.014541576616466045, 0.004238693974912167, 0.007428295910358429, 0.017591793090105057, 0.01306123472750187, 0.0040000746957957745, 0.017928875982761383, 0.004579327534884214, 0.025850046426057816, 0.017890682443976402, 0.19260042905807495, 0.6575150489807129, -1]}
{"idB": "749647_14_item1_p67_s0", "idA": "749647_13_item1_p63_s1", "sentA": "In February 2012, we announced the enrollment of our first patient in the randomized Phase II study of ThermoDox , in combination with RFA, for the treatment of colorectal liver metastases (the ABLATE study).", "sentB": "In February 2014, we announced positive interim data from the ongoing open-label Phase II DIGNITY study.", "type": 2, "words": ["<tag1>", "In", "February", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", ",", "in", "combination", "with", "RFA,", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "study).", "<tag2>", "In", "February", "2014,", "we", "announced", "positive", "interim", "data", "from", "the", "ongoing", "open-label", "Phase", "II", "DIGNITY", "study.", "<tag3>"], "wordsA": ["In", "February", "2012,", "we", "announced", "the", "enrollment", "of", "our", "first", "patient", "in", "the", "randomized", "Phase", "II", "study", "of", "ThermoDox", ",", "in", "combination", "with", "RFA,", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(the", "ABLATE", "study)."], "wordsB": ["In", "February", "2014,", "we", "announced", "positive", "interim", "data", "from", "the", "ongoing", "open-label", "Phase", "II", "DIGNITY", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012777241878211498, 0.12740476429462433, 0.8475167155265808, 0.024350391700863838, 0.049493104219436646, 0.155527263879776, 0.2830416262149811, 0.2203189879655838, 0.00899080466479063, 0.00801932718604803, 0.054948899894952774, 0.2340048998594284, 0.0971115455031395, 0.12368284165859222, 0.23036199808120728, 0.20509028434753418, -1]}
{"idB": "749647_14_item1_p130_s4", "idA": "749647_13_item1_p63_s4", "sentA": "In December 2012, the ABLATE study was amended to an open label study expected to enroll up to 41 patients in combination with thermal ablation.", "sentB": "The OPTIMA study is expected to enroll 550 patients globally, with up to 100 sites in the United States, Europe, China and Asia Pacific, and will evaluate ThermoDox in combination with RFA, which will be standardized to a minimum of 45 minutes across all investigators and sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "type": 2, "words": ["<tag1>", "In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation.", "<tag2>", "The", "OPTIMA", "study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag3>"], "wordsA": ["In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation."], "wordsB": ["The", "OPTIMA", "study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003462514840066433, 0.24584652483463287, 0.13856607675552368, 0.0024471089709550142, 0.019660335034132004, 0.0057280948385596275, 0.07022351026535034, 0.794708788394928, 0.4025154709815979, 0.05853763967752457, 0.0014717044541612267, 0.008883806876838207, 0.006972529459744692, 0.14560940861701965, 0.059569187462329865, 0.005448383279144764, 0.0061021470464766026, 0.01798211596906185, 0.028223471716046333, 0.01809556409716606, 0.01551102101802826, 0.00970406737178564, 0.019878769293427467, 0.012463748455047607, 0.00012999412138015032, 0.003463930217549205, 0.03209204226732254, 0.18139642477035522, 0.009173743426799774, 0.015987295657396317, 0.007111361715942621, 0.17608684301376343, 8.824744872981682e-05, 0.003908446989953518, 0.0035853104200214148, 0.024463368579745293, 0.005133358296006918, 0.006421719677746296, 0.017845353111624718, 0.009133630432188511, 0.13766847550868988, 0.03747306764125824, 0.004802108276635408, 0.027027985081076622, 0.019114306196570396, 0.003394732251763344, 0.018397629261016846, 0.0024436400271952152, 0.03101325035095215, 0.03759053349494934, 0.03361412510275841, 0.020806243643164635, 0.058386653661727905, 0.037345051765441895, 0.0052141714841127396, 0.07182906568050385, 0.058782704174518585, 0.06930620223283768, -1]}
{"idB": "749647_14_item1_p16_s4", "idA": "749647_13_item1_p63_s4", "sentA": "In December 2012, the ABLATE study was amended to an open label study expected to enroll up to 41 patients in combination with thermal ablation.", "sentB": "The OPTIMA Study is expected to enroll approximately 550 patients globally, with up to 100 sites in the United States, Europe, China and Asia Pacific, and will evaluate ThermoDox in combination with RFA, which will be standardized to a minimum of 45 minutes across all investigators and sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "type": 2, "words": ["<tag1>", "In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation.", "<tag2>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "approximately", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag3>"], "wordsA": ["In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation."], "wordsB": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "approximately", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0035404334776103497, 0.2627435028553009, 0.14063498377799988, 0.002639018464833498, 0.019604191184043884, 0.005500560160726309, 0.06456055492162704, 0.16021084785461426, 0.8157467842102051, 0.39475053548812866, 0.06118334084749222, 0.0005992722581140697, 0.007995003834366798, 0.006706502288579941, 0.11233769357204437, 0.05470941588282585, 0.005508834961801767, 0.006199379451572895, 0.01628170907497406, 0.025516198948025703, 0.017828254029154778, 0.01375042088329792, 0.009348013438284397, 0.017231211066246033, 0.012253567576408386, 0.00014269068196881562, 0.0037726399023085833, 0.03672686219215393, 0.18082715570926666, 0.008966561406850815, 0.013817108236253262, 0.006710067391395569, 0.13265907764434814, 9.364135621581227e-05, 0.00394259300082922, 0.003518839133903384, 0.02024184912443161, 0.005208431743085384, 0.006385449320077896, 0.01830214634537697, 0.01025768555700779, 0.15647558867931366, 0.03491983190178871, 0.004819488152861595, 0.028161410242319107, 0.021028608083724976, 0.0034039043821394444, 0.018400607630610466, 0.00240321084856987, 0.030342090874910355, 0.03128591924905777, 0.032286595553159714, 0.01565208099782467, 0.04530254378914833, 0.0303402841091156, 0.00020915891218464822, 0.07070251554250717, 0.06059659644961357, 0.07367872446775436, -1]}
{"idB": "749647_14_item1_p51_s1", "idA": "749647_13_item1_p63_s4", "sentA": "In December 2012, the ABLATE study was amended to an open label study expected to enroll up to 41 patients in combination with thermal ablation.", "sentB": "The OPTIMA Study is expected to enroll 550 patients globally, with up to 100 sites in the United States, Europe, China and Asia Pacific and will evaluate ThermoDox in combination with RFA, which will be standardized to a minimum of 45 minutes across all investigators and sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "type": 2, "words": ["<tag1>", "In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation.", "<tag2>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag3>"], "wordsA": ["In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation."], "wordsB": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003370982827618718, 0.24826723337173462, 0.1362580806016922, 0.0023000389337539673, 0.0187727902084589, 0.005531772039830685, 0.06965699791908264, 0.7953799366950989, 0.4006178677082062, 0.062299493700265884, 0.0004000769986305386, 0.00885814055800438, 0.006934906356036663, 0.15525543689727783, 0.05966109409928322, 0.005606744438409805, 0.006199502851814032, 0.018113989382982254, 0.02887209691107273, 0.02054625190794468, 0.019673287868499756, 0.010512358509004116, 0.024661194533109665, 0.013487118296325207, 0.00016055545711424202, 0.0028726619202643633, 0.026745663955807686, 0.1240260973572731, 0.008245520293712616, 0.014942523092031479, 0.006787166930735111, 0.17530661821365356, 8.677012374391779e-05, 0.003784454194828868, 0.003680739551782608, 0.0215031448751688, 0.005080172326415777, 0.007254468742758036, 0.02091399021446705, 0.009364285506308079, 0.1276324838399887, 0.02997571788728237, 0.005060970783233643, 0.02924051508307457, 0.019199473783373833, 0.0035890042781829834, 0.0209699384868145, 0.0025769472122192383, 0.033099908381700516, 0.037899766117334366, 0.03432712331414223, 0.022550059482455254, 0.06495463848114014, 0.037696968764066696, 0.0003445774200372398, 0.07203681021928787, 0.05761129409074783, 0.07155381143093109, -1]}
{"idB": "749647_14_item1_p66_s3", "idA": "749647_13_item1_p63_s4", "sentA": "In December 2012, the ABLATE study was amended to an open label study expected to enroll up to 41 patients in combination with thermal ablation.", "sentB": "ThermoDox in combination with mild hyperthermia was evaluated in these patients in up to six cycles.", "type": 2, "words": ["<tag1>", "In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation.", "<tag2>", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "was", "evaluated", "in", "these", "patients", "in", "up", "to", "six", "cycles.", "<tag3>"], "wordsA": ["In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation."], "wordsB": ["ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "was", "evaluated", "in", "these", "patients", "in", "up", "to", "six", "cycles."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6392989158630371, 0.022695958614349365, 0.09299784153699875, 0.04905924201011658, 0.45064467191696167, 0.7446519732475281, 0.0067816986702382565, 0.044304464012384415, 0.012317081913352013, 0.011878144927322865, 0.050348229706287384, 0.008782773278653622, 0.04321829974651337, 0.028578121215105057, 0.43499043583869934, 0.31589964032173157, -1]}
{"idB": "749647_14_item1_p85_s1", "idA": "749647_13_item1_p63_s4", "sentA": "In December 2012, the ABLATE study was amended to an open label study expected to enroll up to 41 patients in combination with thermal ablation.", "sentB": "The OPTIMA Study is expected to enroll 550 patients globally, with up to 100 sites in the United States, Europe, China and Asia Pacific and will evaluate ThermoDox in combination with RFA, which will be standardized to a minimum of 45 minutes across all investigators and sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "type": 2, "words": ["<tag1>", "In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation.", "<tag2>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag3>"], "wordsA": ["In", "December", "2012,", "the", "ABLATE", "study", "was", "amended", "to", "an", "open", "label", "study", "expected", "to", "enroll", "up", "to", "41", "patients", "in", "combination", "with", "thermal", "ablation."], "wordsB": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003370982827618718, 0.24826723337173462, 0.1362580806016922, 0.0023000389337539673, 0.0187727902084589, 0.005531772039830685, 0.06965699791908264, 0.7953799366950989, 0.4006178677082062, 0.062299493700265884, 0.0004000769986305386, 0.00885814055800438, 0.006934906356036663, 0.15525543689727783, 0.05966109409928322, 0.005606744438409805, 0.006199502851814032, 0.018113989382982254, 0.02887209691107273, 0.02054625190794468, 0.019673287868499756, 0.010512358509004116, 0.024661194533109665, 0.013487118296325207, 0.00016055545711424202, 0.0028726619202643633, 0.026745663955807686, 0.1240260973572731, 0.008245520293712616, 0.014942523092031479, 0.006787166930735111, 0.17530661821365356, 8.677012374391779e-05, 0.003784454194828868, 0.003680739551782608, 0.0215031448751688, 0.005080172326415777, 0.007254468742758036, 0.02091399021446705, 0.009364285506308079, 0.1276324838399887, 0.02997571788728237, 0.005060970783233643, 0.02924051508307457, 0.019199473783373833, 0.0035890042781829834, 0.0209699384868145, 0.0025769472122192383, 0.033099908381700516, 0.037899766117334366, 0.03432712331414223, 0.022550059482455254, 0.06495463848114014, 0.037696968764066696, 0.0003445774200372398, 0.07203681021928787, 0.05761129409074783, 0.07155381143093109, -1]}
{"idB": "749647_14_item1_p130_s1", "idA": "749647_13_item1_p64_s0", "sentA": "The primary endpoint is based on one year local tumor control, with secondary endpoints of time to progression and overall survival.", "sentB": "The OPTIMA Study trial design is based on the comprehensive analysis of data from the Phase III HEAT study, which demonstrated that treatment with ThermoDox resulted in a 55 percent improvement in overall survival in a substantial number of HCC patients that received an optimized RFA treatment.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag2>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "Phase", "III", "HEAT", "study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55", "percent", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "wordsB": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "Phase", "III", "HEAT", "study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55", "percent", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004633881617337465, 0.17948047816753387, 0.25510793924331665, 0.10159974545240402, 0.050419799983501434, 0.003623487427830696, 0.009787674061954021, 0.004712747409939766, 0.005427319090813398, 0.09925943613052368, 0.1361607015132904, 0.024339305236935616, 0.0960269644856453, 0.016431985422968864, 0.011732685379683971, 0.06374742835760117, 0.11384880542755127, 0.27187949419021606, 0.37959423661231995, 0.00014285458019003272, 0.011092782020568848, 0.004866022150963545, 0.08162615448236465, 0.046169742941856384, 0.12918174266815186, 0.022373827174305916, 0.010563080199062824, 0.011645286343991756, 0.09866943210363388, 0.13459613919258118, 0.09587253630161285, 0.03668265789747238, 0.18333463370800018, 0.14649970829486847, 0.007297204341739416, 0.00583304138854146, 0.020639829337596893, 0.015216419473290443, 0.014151674695312977, 0.08230093121528625, 0.1038755252957344, 0.00011683486809488386, 0.016790496185421944, 0.005103216506540775, 0.04506504163146019, 0.128997802734375, 0.09738180786371231, -1]}
{"idB": "749647_14_item1_p131_s0", "idA": "749647_13_item1_p64_s0", "sentA": "The primary endpoint is based on one year local tumor control, with secondary endpoints of time to progression and overall survival.", "sentB": "The primary endpoint for the trial is overall survival, and the secondary endpoint for the trial is PFS and Safety.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag2>", "The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "wordsB": ["The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0019192685140296817, 0.06382095068693161, 0.08490068465471268, 0.0024729620199650526, 0.0023747931700199842, 0.01943962462246418, 0.01195509359240532, 0.4697762131690979, 0.3971123993396759, 0.003076565684750676, 0.0020557029638439417, 0.05508385971188545, 0.08847105503082275, 0.0026337348390370607, 0.0024117426946759224, 0.02399486117064953, 0.05050095543265343, 0.8302001357078552, 0.49785640835762024, 0.826657772064209, -1]}
{"idB": "749647_14_item1_p17_s0", "idA": "749647_13_item1_p64_s0", "sentA": "The primary endpoint is based on one year local tumor control, with secondary endpoints of time to progression and overall survival.", "sentB": "The primary endpoint for the trial is overall survival, and the secondary endpoint for the trial is PFS and Safety.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag2>", "The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "wordsB": ["The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0019192685140296817, 0.06382095068693161, 0.08490068465471268, 0.0024729620199650526, 0.0023747931700199842, 0.01943962462246418, 0.01195509359240532, 0.4697762131690979, 0.3971123993396759, 0.003076565684750676, 0.0020557029638439417, 0.05508385971188545, 0.08847105503082275, 0.0026337348390370607, 0.0024117426946759224, 0.02399486117064953, 0.05050095543265343, 0.8302001357078552, 0.49785640835762024, 0.826657772064209, -1]}
{"idB": "749647_14_item1_p50_s2", "idA": "749647_13_item1_p64_s0", "sentA": "The primary endpoint is based on one year local tumor control, with secondary endpoints of time to progression and overall survival.", "sentB": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the Company's Phase III HEAT Study, which demonstrated that treatment with ThermoDox resulted in a 55% improvement in overall survival in a substantial number of HCC patients that received an optimized RFA treatment.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag2>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "wordsB": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004783232696354389, 0.16888952255249023, 0.2877483367919922, 0.111300028860569, 0.050995610654354095, 0.0036904921289533377, 0.009891308844089508, 0.005210358649492264, 0.00546951312571764, 0.11826829612255096, 0.144606813788414, 0.03233392909169197, 0.09838663786649704, 0.010586068965494633, 0.00586363160982728, 0.03931720554828644, 0.0575009249150753, 0.08557631075382233, 0.21590155363082886, 0.3324728012084961, 0.00014383379311766475, 0.013083560392260551, 0.004957636818289757, 0.08185313642024994, 0.043567970395088196, 0.13414454460144043, 0.019796181470155716, 0.010829773731529713, 0.011754650622606277, 0.1072717159986496, 0.11674900352954865, 0.04953938350081444, 0.19358175992965698, 0.1604032963514328, 0.007057894486933947, 0.0061272368766367435, 0.020695030689239502, 0.01295512169599533, 0.014369250275194645, 0.09489396959543228, 0.09507958590984344, 0.0001199760808958672, 0.019064947962760925, 0.005218892358243465, 0.05283503979444504, 0.15909507870674133, 0.11254189163446426, -1]}
{"idB": "749647_14_item1_p52_s1", "idA": "749647_13_item1_p64_s0", "sentA": "The primary endpoint is based on one year local tumor control, with secondary endpoints of time to progression and overall survival.", "sentB": "The primary endpoint for the trial is overall survival, and the secondary endpoint for the trial is PFS and Safety.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag2>", "The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "wordsB": ["The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0019192685140296817, 0.06382095068693161, 0.08490068465471268, 0.0024729620199650526, 0.0023747931700199842, 0.01943962462246418, 0.01195509359240532, 0.4697762131690979, 0.3971123993396759, 0.003076565684750676, 0.0020557029638439417, 0.05508385971188545, 0.08847105503082275, 0.0026337348390370607, 0.0024117426946759224, 0.02399486117064953, 0.05050095543265343, 0.8302001357078552, 0.49785640835762024, 0.826657772064209, -1]}
{"idB": "749647_14_item1_p84_s1", "idA": "749647_13_item1_p64_s0", "sentA": "The primary endpoint is based on one year local tumor control, with secondary endpoints of time to progression and overall survival.", "sentB": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the Company's Phase III HEAT Study, which demonstrated that treatment with ThermoDox resulted in a 55% improvement in overall survival in a substantial number of HCC patients that received an optimized RFA treatment.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag2>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "wordsB": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004783232696354389, 0.16888952255249023, 0.2877483367919922, 0.111300028860569, 0.050995610654354095, 0.0036904921289533377, 0.009891308844089508, 0.005210358649492264, 0.00546951312571764, 0.11826829612255096, 0.144606813788414, 0.03233392909169197, 0.09838663786649704, 0.010586068965494633, 0.00586363160982728, 0.03931720554828644, 0.0575009249150753, 0.08557631075382233, 0.21590155363082886, 0.3324728012084961, 0.00014383379311766475, 0.013083560392260551, 0.004957636818289757, 0.08185313642024994, 0.043567970395088196, 0.13414454460144043, 0.019796181470155716, 0.010829773731529713, 0.011754650622606277, 0.1072717159986496, 0.11674900352954865, 0.04953938350081444, 0.19358175992965698, 0.1604032963514328, 0.007057894486933947, 0.0061272368766367435, 0.020695030689239502, 0.01295512169599533, 0.014369250275194645, 0.09489396959543228, 0.09507958590984344, 0.0001199760808958672, 0.019064947962760925, 0.005218892358243465, 0.05283503979444504, 0.15909507870674133, 0.11254189163446426, -1]}
{"idB": "749647_14_item1_p86_s0", "idA": "749647_13_item1_p64_s0", "sentA": "The primary endpoint is based on one year local tumor control, with secondary endpoints of time to progression and overall survival.", "sentB": "The primary endpoint for the trial is OS.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag2>", "The", "primary", "endpoint", "for", "the", "trial", "is", "OS.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "is", "based", "on", "one", "year", "local", "tumor", "control,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "wordsB": ["The", "primary", "endpoint", "for", "the", "trial", "is", "OS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003031904110684991, 0.12594468891620636, 0.18365083634853363, 0.00518699549138546, 0.0045096795074641705, 0.03267425671219826, 0.11620842665433884, 0.9661111831665039, -1]}
{"idB": "749647_14_item1_p68_s1", "idA": "749647_13_item1_p65_s1", "sentA": "We continue to evaluate its formulation.", "sentB": "We will continue to evaluate this formulation following a successful clinical program utilizing ThermoDox .", "type": 2, "words": ["<tag1>", "We", "continue", "to", "evaluate", "its", "formulation.", "<tag2>", "We", "will", "continue", "to", "evaluate", "this", "formulation", "following", "a", "successful", "clinical", "program", "utilizing", "ThermoDox", ".", "<tag3>"], "wordsA": ["We", "continue", "to", "evaluate", "its", "formulation."], "wordsB": ["We", "will", "continue", "to", "evaluate", "this", "formulation", "following", "a", "successful", "clinical", "program", "utilizing", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 0.014886805787682533, 0.008493238128721714, 0.022860120981931686, 0.01522636879235506, 0.13925082981586456, 0.054318010807037354, 0.18982593715190887, 0.16743259131908417, 0.01959834061563015, 0.054521091282367706, 0.10037553310394287, 0.10916212946176529, 0.10420385003089905, 0.5306020379066467, 4.511161750997417e-05, -1]}
{"idB": "749647_14_item1_p54_s0", "idA": "749647_13_item1_p65_s2", "sentA": "In addition, the Company has developed a third stable heat activated liposomal formulation.", "sentB": "In addition, the Company recently met with the China FDA to discuss, among other items, the Phase III OPTIMA Study, including minimum patient enrollment requirements supporting ThermoDox s registration in China.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "has", "developed", "a", "third", "stable", "heat", "activated", "liposomal", "formulation.", "<tag2>", "In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "FDA", "to", "discuss,", "among", "other", "items,", "the", "Phase", "III", "OPTIMA", "Study,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "has", "developed", "a", "third", "stable", "heat", "activated", "liposomal", "formulation."], "wordsB": ["In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "FDA", "to", "discuss,", "among", "other", "items,", "the", "Phase", "III", "OPTIMA", "Study,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005810718517750502, 0.017651572823524475, 0.006477870047092438, 0.09641134738922119, 0.06517902761697769, 0.6351252198219299, 0.1510024517774582, 0.05558786913752556, 0.11772258579730988, 0.1881198287010193, 0.021660467609763145, 0.19161158800125122, 0.006655012257397175, 0.009416405111551285, 0.016919972375035286, 0.01902669481933117, 0.04867802932858467, 0.04945478215813637, 0.08484146744012833, 0.16413266956806183, 0.0010135503252968192, 0.1003221720457077, 0.19557738304138184, 0.18000231683254242, 0.09837774187326431, 0.023658687248826027, 0.16077972948551178, 0.11475328356027603, 0.09007170051336288, 0.013406263664364815, 0.0301514845341444, -1]}
{"idB": "749647_14_item1_p88_s0", "idA": "749647_13_item1_p65_s2", "sentA": "In addition, the Company has developed a third stable heat activated liposomal formulation.", "sentB": "In addition, the Company recently met with the CHINA FDA to discuss the Phase III OPTIMA Study, including minimum patient enrollment requirements supporting ThermoDox s registration in China.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "has", "developed", "a", "third", "stable", "heat", "activated", "liposomal", "formulation.", "<tag2>", "In", "addition,", "the", "Company", "recently", "met", "with", "the", "CHINA", "FDA", "to", "discuss", "the", "Phase", "III", "OPTIMA", "Study,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "has", "developed", "a", "third", "stable", "heat", "activated", "liposomal", "formulation."], "wordsB": ["In", "addition,", "the", "Company", "recently", "met", "with", "the", "CHINA", "FDA", "to", "discuss", "the", "Phase", "III", "OPTIMA", "Study,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006212837062776089, 0.01766831800341606, 0.007072901353240013, 0.09153774380683899, 0.06419927626848221, 0.4596637785434723, 0.11885460466146469, 0.04889451339840889, 0.12752197682857513, 0.18646812438964844, 0.023957842960953712, 0.19996802508831024, 0.02069595828652382, 0.05252024158835411, 0.04983494058251381, 0.09195441007614136, 0.2227780818939209, 0.0008572587976232171, 0.08461903780698776, 0.16183066368103027, 0.12192482501268387, 0.0676538348197937, 0.012293553911149502, 0.10720187425613403, 0.05959212779998779, 0.051556650549173355, 0.011283625848591328, 0.02859206311404705, -1]}
{"idB": "749647_14_item1_p5_s0", "idA": "749647_13_item1_p6_s0", "sentA": "We disclaim any obligation to revise or update any forward-looking statement that may be made from time to time by us or on our behalf.", "sentB": "Except as required by law, we assume no obligation to revise or update any forward-looking statement that may be made from time to time by us or on our behalf for any reason, even if new information becomes available in the future.", "type": 2, "words": ["<tag1>", "We", "disclaim", "any", "obligation", "to", "revise", "or", "update", "any", "forward-looking", "statement", "that", "may", "be", "made", "from", "time", "to", "time", "by", "us", "or", "on", "our", "behalf.", "<tag2>", "Except", "as", "required", "by", "law,", "we", "assume", "no", "obligation", "to", "revise", "or", "update", "any", "forward-looking", "statement", "that", "may", "be", "made", "from", "time", "to", "time", "by", "us", "or", "on", "our", "behalf", "for", "any", "reason,", "even", "if", "new", "information", "becomes", "available", "in", "the", "future.", "<tag3>"], "wordsA": ["We", "disclaim", "any", "obligation", "to", "revise", "or", "update", "any", "forward-looking", "statement", "that", "may", "be", "made", "from", "time", "to", "time", "by", "us", "or", "on", "our", "behalf."], "wordsB": ["Except", "as", "required", "by", "law,", "we", "assume", "no", "obligation", "to", "revise", "or", "update", "any", "forward-looking", "statement", "that", "may", "be", "made", "from", "time", "to", "time", "by", "us", "or", "on", "our", "behalf", "for", "any", "reason,", "even", "if", "new", "information", "becomes", "available", "in", "the", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.048072077333927155, 0.031942371279001236, 0.031326815485954285, 0.024124521762132645, 0.02178666926920414, 0.05687451362609863, 0.6470812559127808, 0.93637615442276, 0.6527543067932129, 0.2826679050922394, 0.15468856692314148, 0.021686982363462448, 0.03123025968670845, 0.007398789748549461, 0.009119373746216297, 0.013117578811943531, 0.0025646714493632317, 0.0038458523340523243, 0.0034060857724398375, 0.003680323250591755, 0.0024074031971395016, 0.0032492096070200205, 0.0024974404368549585, 0.0029239626601338387, 0.0020370627753436565, 0.002785671269521117, 0.00258450536057353, 0.0020776926539838314, 0.0030454902444034815, 0.0030736818443983793, 0.007084309123456478, 0.012812183238565922, 0.009420479647815228, 0.004226842429488897, 0.006994943600147963, 0.027093928307294846, 0.03758556395769119, 0.014454507268965244, 0.010385717265307903, 0.012045418843626976, 0.010691134259104729, 0.009164026938378811, -1]}
{"idB": "749647_14_item1_p20_s2", "idA": "749647_13_item1_p70_s1", "sentA": "Clinical development successes and failures can have a disproportionate positive or negative impact on our scientific and medical prospects, financial prospects, financial condition and market value.", "sentB": "Clinical development successes and failures can have a disproportionate positive or negative impact on our scientific and medical prospects, financial prospects, results of operations, financial condition and market value.", "type": 2, "words": ["<tag1>", "Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "prospects,", "financial", "condition", "and", "market", "value.", "<tag2>", "Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "prospects,", "results", "of", "operations,", "financial", "condition", "and", "market", "value.", "<tag3>"], "wordsA": ["Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "prospects,", "financial", "condition", "and", "market", "value."], "wordsB": ["Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "prospects,", "results", "of", "operations,", "financial", "condition", "and", "market", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013609891757369041, 0.015268403105437756, 0.029769623652100563, 0.007962929084897041, 0.01788553036749363, 0.007320567965507507, 0.007491872645914555, 0.0073660691268742085, 0.011477584950625896, 0.010137720964848995, 0.008848333731293678, 0.011716932989656925, 0.010038290172815323, 0.00490178307518363, 0.005852049216628075, 0.008613630197942257, 0.00807596743106842, 0.00876292772591114, 0.011439387686550617, 0.009793867357075214, 0.011726930737495422, 0.8503046035766602, 0.7211723327636719, 0.9561798572540283, 0.01844896376132965, 0.015609350986778736, 0.007389071397483349, 0.010651887394487858, 0.011767313815653324, -1]}
{"idB": "749647_14_item1_p25_s0", "idA": "749647_13_item1_p72_s0", "sentA": "As a result of the uncertainties discussed previously in this Annual Report on Form 10K, among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product if one of our drug candidates receives regulatory approval for marketing, if at all.", "sentB": "As a result of the risks and uncertainties discussed in this Annual Report on Form 10-K, among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "uncertainties", "discussed", "previously", "in", "this", "Annual", "Report", "on", "Form", "10K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "drug", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all.", "<tag2>", "As", "a", "result", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "uncertainties", "discussed", "previously", "in", "this", "Annual", "Report", "on", "Form", "10K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "drug", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all."], "wordsB": ["As", "a", "result", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0045883068814873695, 0.005631560459733009, 0.006067236885428429, 0.0048879655078053474, 0.004760551732033491, 0.010910202749073505, 0.007000787649303675, 0.009609343484044075, 0.00492826895788312, 0.004559718072414398, 0.004588206764310598, 0.007734612096101046, 0.008292805403470993, 0.0058074998669326305, 0.02205769158899784, 0.7621273994445801, 0.00663066515699029, 0.005094244610518217, 0.008810892701148987, 0.023961832746863365, 0.33744940161705017, 0.036597516387701035, 0.024344870820641518, 0.006336105056107044, 0.01224196795374155, 0.006003641523420811, 0.009002679958939552, 0.009451251477003098, 0.004811640363186598, 0.004661140963435173, 0.007987268269062042, 0.0070645310916006565, 0.007551832124590874, 0.008389964699745178, 0.006794557441025972, 0.006615640129894018, 0.008467433042824268, 0.01445626001805067, 0.0038003562949597836, 0.005932323168963194, 0.009779409505426884, 0.010169907473027706, 0.01148767489939928, 0.01090984232723713, 0.0628344863653183, 0.033615242689847946, 0.049648016691207886, 0.00900118239223957, 0.0055531603284180164, 0.013173351064324379, 0.0048837922513484955, 0.008940370753407478, 0.005051715765148401, 0.005025783088058233, 0.020212654024362564, -1]}
{"idB": "749647_14_item1_p73_s0", "idA": "749647_13_item1_p72_s0", "sentA": "As a result of the uncertainties discussed previously in this Annual Report on Form 10K, among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product if one of our drug candidates receives regulatory approval for marketing, if at all.", "sentB": "As a result of the risks and uncertainties discussed in this Annual Report on Form 10-K, among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product if one of our product candidates receives regulatory approval for marketing, if at all.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "uncertainties", "discussed", "previously", "in", "this", "Annual", "Report", "on", "Form", "10K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "drug", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all.", "<tag2>", "As", "a", "result", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "product", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "uncertainties", "discussed", "previously", "in", "this", "Annual", "Report", "on", "Form", "10K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "drug", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all."], "wordsB": ["As", "a", "result", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "product", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007181204855442047, 0.011113908141851425, 0.009836816228926182, 0.009044795297086239, 0.009191934950649738, 0.015462398529052734, 0.012808709405362606, 0.01956494152545929, 0.008149674162268639, 0.009232481010258198, 0.008679160848259926, 0.016100328415632248, 0.014261193573474884, 0.010924671776592731, 0.03388698771595955, 0.5300191640853882, 0.012593272142112255, 0.009049506857991219, 0.01335811335593462, 0.033960793167352676, 0.3303220272064209, 0.04012032225728035, 0.02869032323360443, 0.01194817665964365, 0.020369216799736023, 0.01065238006412983, 0.017161663621664047, 0.015244848094880581, 0.009398266673088074, 0.009254704229533672, 0.0161911491304636, 0.015520242042839527, 0.014158162288367748, 0.014410475268959999, 0.012606719508767128, 0.012847771868109703, 0.017832346260547638, 0.02362077310681343, 0.007032193709164858, 0.01061644870787859, 0.01317546982318163, 0.016828013584017754, 0.015387910418212414, 0.009892710484564304, 0.03713370859622955, 0.023613935336470604, 0.03519957512617111, 0.008384987711906433, 0.009692934341728687, 0.01694401353597641, 0.010519799776375294, 0.014174371026456356, 0.010387690737843513, 0.009261115454137325, 0.02046758495271206, 0.010927949100732803, 0.03022800385951996, 0.0191277414560318, 0.016143281012773514, 0.05316392332315445, 0.05210369825363159, 0.029179386794567108, 0.033905066549777985, 0.04650719836354256, 0.014517435804009438, 0.028727879747748375, 0.021155791357159615, 0.01938888430595398, 0.030433565378189087, -1]}
{"idB": "749647_14_item1_p25_s1", "idA": "749647_13_item1_p72_s1", "sentA": "Our inability to complete our research and development projects in a timely manner or to obtain positive results in our clinical trials, as well as any failure to enter into collaborative agreements when appropriate, could significantly increase our capital requirements and could adversely impact our liquidity.", "sentB": "Our inability to complete any of our research and development activities, preclinical studies or clinical trials in a timely manner or our failure to enter into collaborative agreements when appropriate could significantly increase our capital requirements and could adversely impact our liquidity.", "type": 2, "words": ["<tag1>", "Our", "inability", "to", "complete", "our", "research", "and", "development", "projects", "in", "a", "timely", "manner", "or", "to", "obtain", "positive", "results", "in", "our", "clinical", "trials,", "as", "well", "as", "any", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate,", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity.", "<tag2>", "Our", "inability", "to", "complete", "any", "of", "our", "research", "and", "development", "activities,", "preclinical", "studies", "or", "clinical", "trials", "in", "a", "timely", "manner", "or", "our", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity.", "<tag3>"], "wordsA": ["Our", "inability", "to", "complete", "our", "research", "and", "development", "projects", "in", "a", "timely", "manner", "or", "to", "obtain", "positive", "results", "in", "our", "clinical", "trials,", "as", "well", "as", "any", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate,", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity."], "wordsB": ["Our", "inability", "to", "complete", "any", "of", "our", "research", "and", "development", "activities,", "preclinical", "studies", "or", "clinical", "trials", "in", "a", "timely", "manner", "or", "our", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010953237302601337, 0.06541675329208374, 0.017138764262199402, 0.014925596304237843, 0.015696795657277107, 0.006593327969312668, 0.010239213705062866, 0.01625019684433937, 0.006470153573900461, 0.01203937642276287, 0.02823563665151596, 0.4484075605869293, 0.1448860764503479, 0.008632169105112553, 0.026160087436437607, 0.047488849610090256, 0.006703783757984638, 0.005827049259096384, 0.011125459335744381, 0.007433025632053614, 0.005453827325254679, 0.004690215922892094, 0.014127400703728199, 0.005885458551347256, 0.009046770632266998, 0.007031566929072142, 0.00794618483632803, 0.009956893511116505, 0.007516355719417334, 0.011166442185640335, 0.0052393339574337006, 0.006966674234718084, 0.009424774907529354, 0.008864925242960453, 0.01535332016646862, 0.022220388054847717, 0.006880202330648899, 0.005410044454038143, 0.012249395251274109, 0.02714286744594574, 0.01857866533100605, 0.06156284734606743, -1]}
{"idB": "749647_14_item1_p73_s1", "idA": "749647_13_item1_p72_s1", "sentA": "Our inability to complete our research and development projects in a timely manner or to obtain positive results in our clinical trials, as well as any failure to enter into collaborative agreements when appropriate, could significantly increase our capital requirements and could adversely impact our liquidity.", "sentB": "Our inability to complete any of our research and development activities, preclinical studies or clinical trials in a timely manner or our failure to enter into collaborative agreements when appropriate could significantly increase our capital requirements and could adversely impact our liquidity.", "type": 2, "words": ["<tag1>", "Our", "inability", "to", "complete", "our", "research", "and", "development", "projects", "in", "a", "timely", "manner", "or", "to", "obtain", "positive", "results", "in", "our", "clinical", "trials,", "as", "well", "as", "any", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate,", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity.", "<tag2>", "Our", "inability", "to", "complete", "any", "of", "our", "research", "and", "development", "activities,", "preclinical", "studies", "or", "clinical", "trials", "in", "a", "timely", "manner", "or", "our", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity.", "<tag3>"], "wordsA": ["Our", "inability", "to", "complete", "our", "research", "and", "development", "projects", "in", "a", "timely", "manner", "or", "to", "obtain", "positive", "results", "in", "our", "clinical", "trials,", "as", "well", "as", "any", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate,", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity."], "wordsB": ["Our", "inability", "to", "complete", "any", "of", "our", "research", "and", "development", "activities,", "preclinical", "studies", "or", "clinical", "trials", "in", "a", "timely", "manner", "or", "our", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010953237302601337, 0.06541675329208374, 0.017138764262199402, 0.014925596304237843, 0.015696795657277107, 0.006593327969312668, 0.010239213705062866, 0.01625019684433937, 0.006470153573900461, 0.01203937642276287, 0.02823563665151596, 0.4484075605869293, 0.1448860764503479, 0.008632169105112553, 0.026160087436437607, 0.047488849610090256, 0.006703783757984638, 0.005827049259096384, 0.011125459335744381, 0.007433025632053614, 0.005453827325254679, 0.004690215922892094, 0.014127400703728199, 0.005885458551347256, 0.009046770632266998, 0.007031566929072142, 0.00794618483632803, 0.009956893511116505, 0.007516355719417334, 0.011166442185640335, 0.0052393339574337006, 0.006966674234718084, 0.009424774907529354, 0.008864925242960453, 0.01535332016646862, 0.022220388054847717, 0.006880202330648899, 0.005410044454038143, 0.012249395251274109, 0.02714286744594574, 0.01857866533100605, 0.06156284734606743, -1]}
{"idB": "749647_14_item1_p25_s2", "idA": "749647_13_item1_p72_s2", "sentA": "While our estimated future capital requirements are uncertain and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research, development and clinical trials or whether we are in a position to pursue manufacturing or commercialization activities, it is clear we will need significant additional capital to develop our product candidates through clinical development, manufacturing and commercialization.", "sentB": "While our estimated future capital requirements are uncertain and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research, development activities, preclinical studies and clinical trials, or if we are in a position to pursue manufacturing or commercialization activities, we will need significant additional capital to develop our product candidates through development and clinical trials, obtain regulatory approvals and manufacture and commercialize approved products, if any.", "type": 2, "words": ["<tag1>", "While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research,", "development", "and", "clinical", "trials", "or", "whether", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "it", "is", "clear", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "clinical", "development,", "manufacturing", "and", "commercialization.", "<tag2>", "While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research,", "development", "activities,", "preclinical", "studies", "and", "clinical", "trials,", "or", "if", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "development", "and", "clinical", "trials,", "obtain", "regulatory", "approvals", "and", "manufacture", "and", "commercialize", "approved", "products,", "if", "any.", "<tag3>"], "wordsA": ["While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research,", "development", "and", "clinical", "trials", "or", "whether", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "it", "is", "clear", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "clinical", "development,", "manufacturing", "and", "commercialization."], "wordsB": ["While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research,", "development", "activities,", "preclinical", "studies", "and", "clinical", "trials,", "or", "if", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "development", "and", "clinical", "trials,", "obtain", "regulatory", "approvals", "and", "manufacture", "and", "commercialize", "approved", "products,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012173037976026535, 0.010633612051606178, 0.014658915810286999, 0.01436004601418972, 0.01806102693080902, 0.02064008079469204, 0.02309105545282364, 0.030272891744971275, 0.01323519553989172, 0.011773304082453251, 0.012154758907854557, 0.0148333003744483, 0.014905201271176338, 0.009734168648719788, 0.010594909079372883, 0.010286960750818253, 0.010343672707676888, 0.01129152812063694, 0.012435315176844597, 0.011474627070128918, 0.012743976898491383, 0.014439808204770088, 0.013831766322255135, 0.011467882432043552, 0.01145290769636631, 0.015129933133721352, 0.01125927735120058, 0.008570383302867413, 0.006540472619235516, 0.009559394791722298, 0.009736886247992516, 0.012851583771407604, 0.5684718489646912, 0.1489296406507492, 0.008918916806578636, 0.013909134082496166, 0.026256738230586052, 0.009640296921133995, 0.026529602706432343, 0.04118332266807556, 0.07285197824239731, 0.05063476413488388, 0.028214508667588234, 0.0571284182369709, 0.034972067922353745, 0.022430166602134705, 0.01632896438241005, 0.008582714945077896, 0.013525339774787426, 0.020227935165166855, 0.0152295446023345, 0.010105758905410767, 0.01540044043213129, 0.013990174978971481, 0.013930869288742542, 0.01761634275317192, 0.008218527771532536, 0.012222654186189175, 0.008733037859201431, 0.014906763099133968, 0.012516934424638748, 0.006505703087896109, 0.010389501228928566, 0.006327691953629255, 0.008974242955446243, 0.013070729561150074, 0.015917502343654633, 0.10393331199884415, 0.14050211012363434, 0.01217410434037447, 0.021232839673757553, 0.011033543385565281, 0.031463105231523514, 0.22862525284290314, 0.22604115307331085, 0.06706852465867996, 0.021519329398870468, -1]}
{"idB": "749647_14_item1_p73_s2", "idA": "749647_13_item1_p72_s2", "sentA": "While our estimated future capital requirements are uncertain and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research, development and clinical trials or whether we are in a position to pursue manufacturing or commercialization activities, it is clear we will need significant additional capital to develop our product candidates through clinical development, manufacturing and commercialization.", "sentB": "While our estimated future capital requirements are uncertain and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research and development activities, preclinical studies and clinical trials, or whether we are in a position to pursue manufacturing or commercialization activities, we will need significant additional capital to develop our product candidates through development and clinical trials, obtain regulatory approvals and manufacture and commercialize approved products, if any.", "type": 2, "words": ["<tag1>", "While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research,", "development", "and", "clinical", "trials", "or", "whether", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "it", "is", "clear", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "clinical", "development,", "manufacturing", "and", "commercialization.", "<tag2>", "While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research", "and", "development", "activities,", "preclinical", "studies", "and", "clinical", "trials,", "or", "whether", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "development", "and", "clinical", "trials,", "obtain", "regulatory", "approvals", "and", "manufacture", "and", "commercialize", "approved", "products,", "if", "any.", "<tag3>"], "wordsA": ["While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research,", "development", "and", "clinical", "trials", "or", "whether", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "it", "is", "clear", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "clinical", "development,", "manufacturing", "and", "commercialization."], "wordsB": ["While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research", "and", "development", "activities,", "preclinical", "studies", "and", "clinical", "trials,", "or", "whether", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "development", "and", "clinical", "trials,", "obtain", "regulatory", "approvals", "and", "manufacture", "and", "commercialize", "approved", "products,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013029452413320541, 0.010672902688384056, 0.015342223457992077, 0.014760470949113369, 0.018431242555379868, 0.021113449707627296, 0.02249552123248577, 0.031055601313710213, 0.01389424130320549, 0.01209031231701374, 0.012608827091753483, 0.015289566479623318, 0.015359297394752502, 0.010370050556957722, 0.010816519148647785, 0.010777749121189117, 0.010665610432624817, 0.011311406269669533, 0.012179117649793625, 0.0116842957213521, 0.012328916229307652, 0.014941525645554066, 0.01354473177343607, 0.011790747754275799, 0.011020460166037083, 0.012846333906054497, 0.009707971476018429, 0.00805065780878067, 0.006831786595284939, 0.009126015938818455, 0.008005977608263493, 0.010725581087172031, 0.011851618997752666, 0.5595107674598694, 0.17522922158241272, 0.008108938112854958, 0.01305489894002676, 0.020713791251182556, 0.009652112610638142, 0.01729802042245865, 0.02444184385240078, 0.02955240197479725, 0.025245241820812225, 0.011999004520475864, 0.03520694747567177, 0.017983539029955864, 0.01585346832871437, 0.01498347707092762, 0.008309614844620228, 0.012676849961280823, 0.015603352338075638, 0.017829587683081627, 0.011305483989417553, 0.016538893803954124, 0.01488338690251112, 0.014621302485466003, 0.018822792917490005, 0.008789455518126488, 0.012537384405732155, 0.00904341135174036, 0.015064036473631859, 0.012886406853795052, 0.006806789897382259, 0.010403139516711235, 0.006547597236931324, 0.00898043718189001, 0.012327457778155804, 0.016275355592370033, 0.11298567801713943, 0.15697379410266876, 0.012088877148926258, 0.020434001460671425, 0.009769962169229984, 0.026347534731030464, 0.22741875052452087, 0.2387862503528595, 0.07190752029418945, 0.022052451968193054, -1]}
{"idB": "749647_14_item1_p74_s0", "idA": "749647_13_item1_p73_s0", "sentA": "We are engaged in a limited amount of research and development in our own facilities and also sponsor research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "sentB": "We are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "type": 2, "words": ["<tag1>", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "also", "sponsor", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag2>", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag3>"], "wordsA": ["We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "also", "sponsor", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "wordsB": ["We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2673896253108978, 0.09597370028495789, 0.2971993386745453, 0.06281697005033493, 0.04289564490318298, 0.22169190645217896, 0.08980204164981842, 0.04538948833942413, 0.08320596814155579, 0.05736112222075462, 0.07687712460756302, 0.039206407964229584, 0.15495793521404266, 0.24319902062416077, 0.1713375449180603, 0.0005663365009240806, 0.05664185807108879, 0.5822128057479858, 0.14034907519817352, 0.10359185934066772, 0.035101886838674545, 0.04948543384671211, 0.02660050243139267, 0.03755880892276764, 0.05000940337777138, 0.05793197080492973, 0.031114907935261726, 0.027395309880375862, 0.06710750609636307, 0.12145885080099106, 0.14614471793174744, 0.028869664296507835, 0.07625675946474075, 0.06817778944969177, -1]}
{"idB": "749647_14_item1_p74_s3", "idA": "749647_13_item1_p73_s2", "sentA": "Research and development expenses were approximately $15.8 million, $19.9 million and $14.7 million for the years ended December 31, 2012, 2011 and 2010, respectively.", "sentB": "Research and development expenses were approximately $9.4 million, $15.8 million and $19.9 million for the years ended December 31, 2013, 2012 and 2011, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$15.8", "million,", "$19.9", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2012,", "2011", "and", "2010,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "were", "approximately", "$9.4", "million,", "$15.8", "million", "and", "$19.9", "million", "for", "the", "years", "ended", "December", "31,", "2013,", "2012", "and", "2011,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$15.8", "million,", "$19.9", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2012,", "2011", "and", "2010,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "were", "approximately", "$9.4", "million,", "$15.8", "million", "and", "$19.9", "million", "for", "the", "years", "ended", "December", "31,", "2013,", "2012", "and", "2011,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006541638169437647, 0.004130608402192593, 0.007096733897924423, 0.012093057855963707, 0.003803453641012311, 0.006340718362480402, 0.0393446683883667, 0.01237837877124548, 0.009497319348156452, 0.008167705498635769, 0.005516049452126026, 0.011180213652551174, 0.007810174021869898, 0.005097123794257641, 0.00470293452963233, 0.0082785002887249, 0.00895532313734293, 0.011425402946770191, 0.0195323396474123, 0.9731258749961853, 0.024955609813332558, 0.00859089381992817, 0.010403119958937168, 0.0064856261014938354, -1]}
{"idB": "749647_14_item1_p6_s0", "idA": "749647_13_item1_p7_s0", "sentA": "Unless the context requires otherwise or unless otherwise noted, all references in this Annual Report on Form 10-K to Celsion the Company , we , us , or our are to Celsion Corporation.", "sentB": "Unless the context requires otherwise or unless otherwise noted, all references in this Annual Report on Form 10-K to Celsion the Company , we , us , or our are to Celsion Corporation, a Delaware corporation.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation.", "<tag2>", "Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation,", "a", "Delaware", "corporation.", "<tag3>"], "wordsA": ["Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation."], "wordsB": ["Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation,", "a", "Delaware", "corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016755610704421997, 0.00742379343137145, 0.014018014073371887, 0.014957001432776451, 0.013232026249170303, 0.010742949321866035, 0.012513110414147377, 0.013737229630351067, 0.01203955803066492, 0.01615043170750141, 0.07840882986783981, 0.007398796733468771, 0.007589938119053841, 0.010426413267850876, 0.011559898033738136, 0.006803412456065416, 0.00880449078977108, 0.009986822493374348, 0.007849528454244137, 0.011646236293017864, 0.0052056750282645226, 0.013350391760468483, 0.0006502671749331057, 0.011722538620233536, 0.003028134349733591, 0.011302249506115913, 0.00027055703685618937, 0.010329235345125198, 0.010123624466359615, 0.01593048870563507, 0.007413062732666731, 0.010493753477931023, 0.013872215524315834, 0.020539123564958572, 0.9633402824401855, 0.8189399242401123, -1]}
{"idB": "749647_14_item1_p10_s0", "idA": "749647_13_item1_p82_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "sentB": "On January 31, 2013, we announced that ThermoDox in combination with radio frequency ablation (RFA) did not meet the primary endpoint of Progression Free Survival (PFS) for the 701 patient clinical trial (the HEAT Study) in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "type": 2, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "did", "not", "meet", "the", "primary", "endpoint", "of", "Progression", "Free", "Survival", "(PFS)", "for", "the", "701", "patient", "clinical", "trial", "(the", "HEAT", "Study)", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "did", "not", "meet", "the", "primary", "endpoint", "of", "Progression", "Free", "Survival", "(PFS)", "for", "the", "701", "patient", "clinical", "trial", "(the", "HEAT", "Study)", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0026147468015551567, 0.004019163083285093, 0.003796754637733102, 0.00446922006085515, 0.004386386834084988, 0.008054966107010841, 0.0042745559476315975, 0.018874971196055412, 0.004185192286968231, 0.018185149878263474, 0.02072921395301819, 0.7899314165115356, 0.8490877151489258, 0.8844031691551208, 0.018321752548217773, 0.0760728269815445, 0.10049517452716827, 0.026519499719142914, 0.00591147830709815, 0.03196445479989052, 0.04504114389419556, 0.021391823887825012, 0.4724818766117096, 0.7300590872764587, 0.516229510307312, 0.3986041247844696, 0.002852562814950943, 0.0037320698611438274, 0.06765040755271912, 0.13413044810295105, 0.018709206953644753, 0.01572924666106701, 0.00235817045904696, 0.008159775286912918, 0.00970862340182066, 0.0018963367911055684, 0.007192943245172501, 0.0018519846489652991, 0.0045103151351213455, 0.005834836512804031, 0.004971313290297985, 0.001928281388245523, 0.0019993619062006474, 0.001597474329173565, 0.005947887897491455, 0.006607049610465765, 0.00502020912244916, -1]}
{"idB": "749647_14_item1_p16_s0", "idA": "749647_13_item1_p82_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "sentB": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, has provided and allowed, subject to compliance with regulatory standards, clearance for the Company's planned pivotal, double-blind, placebo-controlled Phase III trial (the OPTIMA Study) of ThermoDox , its proprietary heat-activated liposomal encapsulation of doxorubicin in combination with RFA in primary liver cancer, also known as hepatocellular carcinoma (HCC).", "type": 2, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "Company's", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", ",", "its", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "hepatocellular", "carcinoma", "(HCC).", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "Company's", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", ",", "its", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "hepatocellular", "carcinoma", "(HCC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018743937835097313, 0.46648502349853516, 0.21690911054611206, 0.35584115982055664, 0.0071901585906744, 0.014265114441514015, 0.012597480788826942, 0.021665947511792183, 0.06391831487417221, 0.022019749507308006, 0.010448685847222805, 0.07240677624940872, 0.03293213993310928, 0.029131175950169563, 0.0409148707985878, 0.031747955828905106, 0.0636344775557518, 0.30088090896606445, 0.08568888157606125, 0.3267560601234436, 0.02228536643087864, 0.0004364160995464772, 0.021639050915837288, 0.011071878485381603, 0.014031020924448967, 0.026298116892576218, 0.21899867057800293, 0.007436804939061403, 0.006061666179448366, 0.022464768961071968, 0.01928715966641903, 0.08282631635665894, 0.0796707272529602, 0.18055321276187897, 0.0208333320915699, 0.025465603917837143, 0.03108508326113224, 0.009136650711297989, 0.03996610268950462, 0.05324827879667282, 0.005775113124400377, 0.015850730240345, 0.009735976345837116, 0.006214751396328211, 0.11011005192995071, 0.3091319799423218, 0.22815826535224915, 0.20585837960243225, 0.09658996015787125, 0.3853842318058014, 0.0045331306755542755, 0.005713552236557007, 0.003736176062375307, 0.0071295322850346565, 0.002964321058243513, 0.005593530833721161, 0.007136424537748098, 0.00444337772205472, 0.0032077529467642307, 0.0029872197192162275, 0.002675238996744156, 0.006509966682642698, 0.004950589966028929, 0.0059952386654913425, -1]}
{"idB": "749647_14_item1_p84_s0", "idA": "749647_13_item1_p82_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "sentB": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, has provided and allowed, subject to compliance with regulatory standards, clearance for the Company's planned pivotal, double-blind, placebo-controlled Phase III trial (the OPTIMA Study) of ThermoDox , its proprietary heat-activated liposomal encapsulation of doxorubicin in combination with RFA in primary liver cancer, also known as hepatocellular carcinoma (HCC).", "type": 2, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "Company's", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", ",", "its", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "hepatocellular", "carcinoma", "(HCC).", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "Company's", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", ",", "its", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "hepatocellular", "carcinoma", "(HCC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018743937835097313, 0.46648502349853516, 0.21690911054611206, 0.35584115982055664, 0.0071901585906744, 0.014265114441514015, 0.012597480788826942, 0.021665947511792183, 0.06391831487417221, 0.022019749507308006, 0.010448685847222805, 0.07240677624940872, 0.03293213993310928, 0.029131175950169563, 0.0409148707985878, 0.031747955828905106, 0.0636344775557518, 0.30088090896606445, 0.08568888157606125, 0.3267560601234436, 0.02228536643087864, 0.0004364160995464772, 0.021639050915837288, 0.011071878485381603, 0.014031020924448967, 0.026298116892576218, 0.21899867057800293, 0.007436804939061403, 0.006061666179448366, 0.022464768961071968, 0.01928715966641903, 0.08282631635665894, 0.0796707272529602, 0.18055321276187897, 0.0208333320915699, 0.025465603917837143, 0.03108508326113224, 0.009136650711297989, 0.03996610268950462, 0.05324827879667282, 0.005775113124400377, 0.015850730240345, 0.009735976345837116, 0.006214751396328211, 0.11011005192995071, 0.3091319799423218, 0.22815826535224915, 0.20585837960243225, 0.09658996015787125, 0.3853842318058014, 0.0045331306755542755, 0.005713552236557007, 0.003736176062375307, 0.0071295322850346565, 0.002964321058243513, 0.005593530833721161, 0.007136424537748098, 0.00444337772205472, 0.0032077529467642307, 0.0029872197192162275, 0.002675238996744156, 0.006509966682642698, 0.004950589966028929, 0.0059952386654913425, -1]}
{"idB": "749647_14_item1_p89_s0", "idA": "749647_13_item1_p83_s0", "sentA": "Either the FDA or we may suspend clinical trials at any time, if the FDA, our Data Monitoring Committee, or we conclude that clinical subjects are being exposed to an unacceptable health risk or for other reasons.", "sentB": "Either the FDA or we may suspend clinical trials at any time, if the FDA, our iDMC, or we conclude that clinical subjects are being exposed to an unacceptable health risk or for other reasons.", "type": 2, "words": ["<tag1>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "Data", "Monitoring", "Committee,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons.", "<tag2>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "iDMC,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons.", "<tag3>"], "wordsA": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "Data", "Monitoring", "Committee,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons."], "wordsB": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "iDMC,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0162156093865633, 0.0037525659427046776, 0.02792905457317829, 0.00486749829724431, 0.005844505969434977, 0.006187416147440672, 0.012970764189958572, 0.008209319785237312, 0.00916893407702446, 0.003835100680589676, 0.005630051251500845, 0.005071315448731184, 0.005738397128880024, 0.00461396761238575, 0.021745214238762856, 0.02334609441459179, 0.9531038403511047, 0.004884710535407066, 0.006139666307717562, 0.01566251553595066, 0.007423687726259232, 0.031880494207143784, 0.1209840252995491, 0.007645414676517248, 0.012040273286402225, 0.019445106387138367, 0.004534594714641571, 0.004177908878773451, 0.007197739090770483, 0.005907460581511259, 0.008532845415174961, 0.005094846244901419, 0.004730165004730225, 0.005710556637495756, 0.014176923781633377, -1]}
{"idB": "749647_14_item1_p101_s0", "idA": "749647_13_item1_p84_s1", "sentA": "The FDA also examines whether there was bias in the conduct of clinical trials.", "sentB": "The approval process and requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from place to place, and the time may be longer or shorter than that required for FDA approval.", "type": 2, "words": ["<tag1>", "The", "FDA", "also", "examines", "whether", "there", "was", "bias", "in", "the", "conduct", "of", "clinical", "trials.", "<tag2>", "The", "approval", "process", "and", "requirements", "governing", "the", "conduct", "of", "clinical", "trials,", "product", "licensing,", "pricing", "and", "reimbursement", "vary", "greatly", "from", "place", "to", "place,", "and", "the", "time", "may", "be", "longer", "or", "shorter", "than", "that", "required", "for", "FDA", "approval.", "<tag3>"], "wordsA": ["The", "FDA", "also", "examines", "whether", "there", "was", "bias", "in", "the", "conduct", "of", "clinical", "trials."], "wordsB": ["The", "approval", "process", "and", "requirements", "governing", "the", "conduct", "of", "clinical", "trials,", "product", "licensing,", "pricing", "and", "reimbursement", "vary", "greatly", "from", "place", "to", "place,", "and", "the", "time", "may", "be", "longer", "or", "shorter", "than", "that", "required", "for", "FDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011475621722638607, 0.2310599535703659, 0.14366140961647034, 0.029921606183052063, 0.26101231575012207, 0.019685201346874237, 0.007635580841451883, 0.01455935463309288, 0.007109018508344889, 0.017360087484121323, 0.02670198120176792, 0.0728922113776207, 0.10978110134601593, 0.10431700944900513, 0.045498475432395935, 0.1376289427280426, 0.078159399330616, 0.07613791525363922, 0.026023736223578453, 0.027236709371209145, 0.019087612628936768, 0.024906553328037262, 0.0006151903653517365, 0.007852883078157902, 0.1184081882238388, 0.017111297696828842, 0.06163685396313667, 0.12954948842525482, 0.10985969752073288, 0.27663910388946533, 0.11947304010391235, 0.0720517635345459, 0.060539018362760544, 0.0296789538115263, 0.05583881959319115, 0.0650068148970604, -1]}
{"idB": "749647_14_item1_p19_s2", "idA": "749647_13_item1_p85_s1", "sentA": "There can be no assurance that the design or the performance of the pivotal clinical trial protocols or any of our current or future product candidates will be successful.", "sentB": "There can be no assurance that the exploration of strategic alternatives will result in any agreements or transactions, or that, if completed, any agreements or transactions will be successful or on attractive terms.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "or", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "the", "exploration", "of", "strategic", "alternatives", "will", "result", "in", "any", "agreements", "or", "transactions,", "or", "that,", "if", "completed,", "any", "agreements", "or", "transactions", "will", "be", "successful", "or", "on", "attractive", "terms.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "or", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "the", "exploration", "of", "strategic", "alternatives", "will", "result", "in", "any", "agreements", "or", "transactions,", "or", "that,", "if", "completed,", "any", "agreements", "or", "transactions", "will", "be", "successful", "or", "on", "attractive", "terms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0030564432963728905, 0.003607287770137191, 0.0033671308774501085, 0.012116738595068455, 0.04047885164618492, 0.018038328737020493, 0.016942689195275307, 0.26131951808929443, 0.06777828186750412, 0.38927996158599854, 0.35815808176994324, 0.030004126951098442, 0.025393575429916382, 0.019513018429279327, 0.042465850710868835, 0.08922183513641357, 0.025039944797754288, 0.0940764769911766, 0.0058578974567353725, 0.007243193220347166, 0.07356834411621094, 0.06459861248731613, 0.01024016086012125, 0.04852278530597687, 0.007401822600513697, 0.039815753698349, 0.015361114405095577, 0.01825466938316822, 0.04690588638186455, 0.0006873537786304951, 0.02403937466442585, 0.11249435693025589, 0.09098998457193375, -1]}
{"idB": "749647_14_item1_p66_s6", "idA": "749647_13_item1_p86_s3", "sentA": "The FDA may also require additional testing for safety and efficacy.", "sentB": "Of the 29 patients, 23 were eligible for evaluation of efficacy.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy.", "<tag2>", "Of", "the", "29", "patients,", "23", "were", "eligible", "for", "evaluation", "of", "efficacy.", "<tag3>"], "wordsA": ["The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy."], "wordsB": ["Of", "the", "29", "patients,", "23", "were", "eligible", "for", "evaluation", "of", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05216445028781891, 0.03620416298508644, 0.43005654215812683, 0.32880499958992004, 0.46139299869537354, 0.12499511986970901, 0.5807138085365295, 0.20792196691036224, 0.33127573132514954, 0.14666198194026947, 0.2656773626804352, -1]}
{"idB": "749647_14_item1_p100_s0", "idA": "749647_13_item1_p89_s1", "sentA": "Manufacturing establishments in the U.S. and abroad are subject to inspections by the FDA and must comply with current good manufacturing practices.", "sentB": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "type": 2, "words": ["<tag1>", "Manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices.", "<tag2>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices."], "wordsB": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013901705853641033, 0.028600970283150673, 0.019504182040691376, 0.07675456255674362, 0.007035133894532919, 0.0060060094110667706, 0.011102890595793724, 0.03912815451622009, 0.020867953076958656, 0.015287435613572598, 0.15136995911598206, 0.06765323877334595, 0.3110547363758087, 0.030912810936570168, 0.14646609127521515, 0.1758110076189041, 0.13866618275642395, 0.0800381749868393, 0.434112012386322, 0.4019397497177124, 0.047522369772195816, 0.21389394998550415, 0.34227311611175537, 0.11120139062404633, 0.30746620893478394, 0.07176605612039566, 0.05535279959440231, 0.14049406349658966, 0.1546848565340042, -1]}
{"idB": "749647_15_item1_p0_s3", "idA": "749647_14_item1_p0_s3", "sentA": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost, timing and progress of development, preclinical studies, clinical trials and regulatory submissions; our or our collaborator s ability to obtain and maintain regulatory approval of any of our product candidates; possible changes in capital structure, financial condition, future working capital needs and other financial items; changes in approaches to medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks and uncertainties associated with possible acquisitions of other technologies, assets or businesses; our ability to obtain additional funds for our operations; our ability to obtain and maintain intellectual property protection for our technologies and product candidates and our ability to operate our business without infringing the intellectual property rights of others; our reliance on third parties to conduct preclinical studies or clinical trials; the rate and degree of market acceptance of any approved product candidates; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities; compliance with listing standards of The NASDAQ Capital Market; and those listed under Risk Factors b elow and elsewhere in this Annual Report on Form 10-K. In some cases, you can identify forward-looking statements by terminology such as expect, anticipate, estimate, plan, believe, could, intend, predict, may, should, will, would and words of similar import regarding the Company s expectations.", "sentB": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost, timing and progress of development, preclinical studies, clinical trials and regulatory submissions; our or our collaborator s ability to obtain and maintain regulatory approval of any of our product candidates; possible changes in capital structure, financial condition, future working capital needs and other financial items; changes in approaches to medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks and uncertainties associated with possible acquisitions of other technologies, assets or businesses; our ability to obtain additional funds for our operations; our ability to obtain and maintain intellectual property protection for our technologies and product candidates and our ability to operate our business without infringing the intellectual property rights of others; our reliance on third parties to conduct preclinical studies or clinical trials; the rate and degree of market acceptance of any approved product candidates; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities; compliance with listing standards of The NASDAQ Capital Market; and those listed under Risk Factors below and elsewhere in this Annual Report on Form 10-K. In some cases, you can identify forward-looking statements by terminology such as expect, anticipate, estimate, plan, believe, could, intend, predict, may, should, will, would and words of similar import regarding the Company s expectations.", "type": 2, "words": ["<tag1>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "b", "elow", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations.", "<tag2>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations.", "<tag3>"], "wordsA": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "b", "elow", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations."], "wordsB": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024527287110686302, 0.032829850912094116, 0.01961836777627468, 0.02982565388083458, 0.027613576501607895, 0.025134269148111343, 0.03810541331768036, 0.023963740095496178, 0.0186481811106205, 0.026250701397657394, 0.029385844245553017, 0.02389846183359623, 0.027613282203674316, 0.026807876303792, 0.02972390316426754, 0.023842575028538704, 0.020630544051527977, 0.02137851156294346, 0.02091177925467491, 0.024934837594628334, 0.02137339487671852, 0.023510001599788666, 0.025333447381854057, 0.030100664123892784, 0.028272943571209908, 0.02789524756371975, 0.028384799137711525, 0.025202510878443718, 0.026085935533046722, 0.0362512469291687, 0.0219893679022789, 0.021115737035870552, 0.02484297566115856, 0.022215774282813072, 0.027534330263733864, 0.025647597387433052, 0.020575761795043945, 0.032017163932323456, 0.02668975479900837, 0.03561043366789818, 0.03488563746213913, 0.02919236198067665, 0.02951750159263611, 0.029211651533842087, 0.03175254538655281, 0.03035830706357956, 0.03164703771471977, 0.028178583830595016, 0.024209143593907356, 0.029003627598285675, 0.02842196822166443, 0.026638275012373924, 0.027434227988123894, 0.02882748655974865, 0.023865900933742523, 0.02917012944817543, 0.0251404270529747, 0.03348555043339729, 0.034407839179039, 0.02624625712633133, 0.031412504613399506, 0.024746723473072052, 0.029953528195619583, 0.033158786594867706, 0.027471542358398438, 0.02058349922299385, 0.022300029173493385, 0.02862044982612133, 0.031106572598218918, 0.02320036105811596, 0.024604428559541702, 0.03183863312005997, 0.024553440511226654, 0.030007878318428993, 0.03313246741890907, 0.02453908696770668, 0.02129369042813778, 0.019970672205090523, 0.02506030723452568, 0.019325999543070793, 0.02236708626151085, 0.024915659800171852, 0.027547447010874748, 0.028141183778643608, 0.024542955681681633, 0.021481409668922424, 0.028970440849661827, 0.028798852115869522, 0.03225582838058472, 0.03184019774198532, 0.03218438848853111, 0.023351317271590233, 0.015934942290186882, 0.03101034089922905, 0.02337982878088951, 0.024507557973265648, 0.02105165459215641, 0.021276550367474556, 0.018972760066390038, 0.01768244057893753, 0.02528706006705761, 0.02560238726437092, 0.01986115053296089, 0.022937249392271042, 0.016304986551404, 0.021884076297283173, 0.02303989976644516, 0.020432237535715103, 0.02086470276117325, 0.027106713503599167, 0.019381310790777206, 0.015900203958153725, 0.02669735811650753, 0.02136256732046604, 0.022693298757076263, 0.0239870622754097, 0.022088441997766495, 0.031018385663628578, 0.02562844753265381, 0.03734038025140762, 0.036084968596696854, 0.03209394961595535, 0.021925397217273712, 0.022833554074168205, 0.023681940510869026, 0.022116757929325104, 0.025936676189303398, 0.02793678268790245, 0.021162783727049828, 0.01970892958343029, 0.023899322375655174, 0.027889925986528397, 0.030609698966145515, 0.023160796612501144, 0.028786011040210724, 0.05877622589468956, 0.037647001445293427, 0.027287764474749565, 0.033944595605134964, 0.04136258736252785, 0.037363097071647644, 0.015651579946279526, 0.021992076188325882, 0.02137288823723793, 0.1121484786272049, 0.061343736946582794, 0.08057501167058945, 0.14469893276691437, 0.02771834470331669, 0.02404891885817051, 0.04661707952618599, 0.02698638290166855, 0.017183970659971237, 0.019456785172224045, 0.027367621660232544, 0.021000796929001808, 0.029574474319815636, 0.024706939235329628, 0.02877066843211651, 0.03081822581589222, 0.03962023928761482, 0.05249100178480148, 0.02093527652323246, 0.02296087145805359, 0.03902999311685562, 0.05452032387256622, 0.04755162075161934, 0.027760395780205727, 0.04726315289735794, 0.016742214560508728, 0.05181586742401123, 0.04381436109542847, 0.02561040408909321, 0.03249582648277283, 0.014496793039143085, 0.026195084676146507, 0.029636969789862633, 0.02608734555542469, 0.017388828098773956, 0.0334530845284462, 0.038615427911281586, 0.06944902241230011, 0.03619389608502388, 0.140945702791214, 0.12477623671293259, 0.02436821162700653, 0.03277215734124184, 0.11152631789445877, 0.08119086176156998, 0.05123995244503021, 0.012968378141522408, 0.020329652354121208, 0.023957297205924988, 0.019162995740771294, 0.02398180402815342, 0.05136836692690849, 0.02170279435813427, 0.026419606059789658, 0.023716820403933525, 0.015934130176901817, 0.01558843906968832, 0.023075910285115242, 0.020488593727350235, 0.012381847947835922, 0.0393386110663414, 0.1608458161354065, 0.020017828792333603, 0.03188741207122803, 0.03746466711163521, 0.0355975441634655, 0.033227451145648956, 0.031951434910297394, 0.06371568143367767, 0.06466458737850189, 0.020583782345056534, 0.03420185670256615, 0.03535759076476097, 0.02827567234635353, 0.030598672106862068, 0.032257333397865295, 0.021050013601779938, 0.022006189450621605, 0.02550189383327961, 0.02155056595802307, 0.02839205227792263, 0.024967100471258163, 0.026041023433208466, 0.030335651710629463, 0.024154046550393105, 0.022119631990790367, 0.026600169017910957, 0.026454469189047813, 0.02073449268937111, 0.01791929267346859, 0.018405526876449585, 0.019344650208950043, 0.02199755609035492, 0.023055708035826683, 0.02783261053264141, 0.023323271423578262, -1]}
{"idB": "749647_15_item1_p141_s0", "idA": "749647_14_item1_p100_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08927059173583984, 0.5239291787147522, 0.7544057965278625, 0.4037545323371887, 0.6671140193939209, 0.31497663259506226, 0.5903804898262024, 0.4483988583087921, 0.4569391906261444, 0.0457439087331295, 0.026794524863362312, 0.049859218299388885, 0.02334466017782688, 0.05534566938877106, 0.024714551866054535, 0.01858917623758316, 0.02063130959868431, 0.025856897234916687, 0.006914314813911915, 0.016149843111634254, 0.008095713332295418, 0.010325638577342033, 0.02137937769293785, 0.021757816895842552, -1]}
{"idB": "749647_15_item1_p141_s1", "idA": "749647_14_item1_p100_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "We currently contract with third party contract manufacturing organizations (CMOs) for our preclinical and clinical trial supplies, and we expect to continue to do so to meet the preclinical and any clinical requirements of our product candidates.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.048573508858680725, 0.05773935467004776, 0.2818157970905304, 0.13554485142230988, 0.3051684498786926, 0.26971420645713806, 0.3424205183982849, 0.3216215670108795, 0.26130908727645874, 0.17578458786010742, 0.03127049282193184, 0.015411175787448883, 0.05465618893504143, 0.012884702533483505, 0.028643375262618065, 0.030686233192682266, 0.05630553886294365, 0.005813776981085539, 0.0103494543582201, 0.019466282799839973, 0.013684894889593124, 0.025312434881925583, 0.03132659196853638, 0.031337253749370575, 0.017323847860097885, 0.0070471493527293205, 0.008080377243459225, 0.00571997556835413, 0.014178250916302204, 0.003561764257028699, 0.004251064732670784, 0.013630409725010395, 0.01645536907017231, 0.0038477254565805197, 0.005722851026803255, 0.027077293023467064, 0.024253079667687416, -1]}
{"idB": "749647_15_item1_p143_s0", "idA": "749647_14_item1_p100_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "Our CMOs manufacture our product candidates under current Good Manufacturing Practice (cGMP) conditions.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "Our", "CMOs", "manufacture", "our", "product", "candidates", "under", "current", "Good", "Manufacturing", "Practice", "(cGMP)", "conditions.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["Our", "CMOs", "manufacture", "our", "product", "candidates", "under", "current", "Good", "Manufacturing", "Practice", "(cGMP)", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.032910026609897614, 0.4328552782535553, 0.3333682715892792, 0.06382579356431961, 0.13981111347675323, 0.1349734216928482, 0.03128517046570778, 0.043323978781700134, 0.2121909260749817, 0.3942320942878723, 0.24426402151584625, 0.366958886384964, 0.15496069192886353, -1]}
{"idB": "749647_15_item1_p144_s0", "idA": "749647_14_item1_p100_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "Our current focus is on the development of our existing portfolio, the completion of clinical trials and, if and where appropriate, the registration of our product candidates.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.035838935524225235, 0.06830736249685287, 0.14863836765289307, 0.02242613583803177, 0.062036722898483276, 0.04748255014419556, 0.27735644578933716, 0.07132837176322937, 0.08125684410333633, 0.1738521307706833, 0.24499715864658356, 0.03642844781279564, 0.22942763566970825, 0.07325049489736557, 0.13275393843650818, 0.16101430356502533, 0.028471823781728745, 0.05654102563858032, 0.05228545516729355, 0.05780220404267311, 0.054623082280159, 0.04205288738012314, 0.32396620512008667, 0.045323312282562256, 0.03481745347380638, 0.08573515713214874, 0.0826057642698288, -1]}
{"idB": "749647_15_item1_p165_s0", "idA": "749647_14_item1_p100_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "We cannot predict with any certainty if any third party U.S. or foreign patent rights, other proprietary rights, will be deemed infringed by the use of our technology.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "We", "cannot", "predict", "with", "any", "certainty", "if", "any", "third", "party", "U.S.", "or", "foreign", "patent", "rights,", "other", "proprietary", "rights,", "will", "be", "deemed", "infringed", "by", "the", "use", "of", "our", "technology.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["We", "cannot", "predict", "with", "any", "certainty", "if", "any", "third", "party", "U.S.", "or", "foreign", "patent", "rights,", "other", "proprietary", "rights,", "will", "be", "deemed", "infringed", "by", "the", "use", "of", "our", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05523211881518364, 0.2349354475736618, 0.25245559215545654, 0.09376605600118637, 0.09871010482311249, 0.15857073664665222, 0.08912944793701172, 0.050241295248270035, 0.14123983681201935, 0.28758564591407776, 0.337620347738266, 0.023126304149627686, 0.06536246091127396, 0.32134246826171875, 0.3535309135913849, 0.008042445406317711, 0.05912823602557182, 0.17668281495571136, 0.05241210758686066, 0.04136592894792557, 0.08462777733802795, 0.14206688106060028, 0.03095117211341858, 0.023335853591561317, 0.06960826367139816, 0.03248218819499016, 0.03987276554107666, 0.09343574196100235, -1]}
{"idB": "749647_15_item1_p183_s1", "idA": "749647_14_item1_p100_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "Under the early access program, Impatients will engage in activities to secure authorization, exemption or waiver from regulatory authorities for patient use of ThermoDox that may otherwise be subject to approvals from such regulatory authorities before the sale and distribution of ThermoDox in the relevant territories.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "Under", "the", "early", "access", "program,", "Impatients", "will", "engage", "in", "activities", "to", "secure", "authorization,", "exemption", "or", "waiver", "from", "regulatory", "authorities", "for", "patient", "use", "of", "ThermoDox", "that", "may", "otherwise", "be", "subject", "to", "approvals", "from", "such", "regulatory", "authorities", "before", "the", "sale", "and", "distribution", "of", "ThermoDox", "in", "the", "relevant", "territories.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["Under", "the", "early", "access", "program,", "Impatients", "will", "engage", "in", "activities", "to", "secure", "authorization,", "exemption", "or", "waiver", "from", "regulatory", "authorities", "for", "patient", "use", "of", "ThermoDox", "that", "may", "otherwise", "be", "subject", "to", "approvals", "from", "such", "regulatory", "authorities", "before", "the", "sale", "and", "distribution", "of", "ThermoDox", "in", "the", "relevant", "territories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08973584324121475, 0.03051345981657505, 0.35094594955444336, 0.3350023329257965, 0.27000656723976135, 0.16626223921775818, 0.017972461879253387, 0.07701072841882706, 0.051339633762836456, 0.18126390874385834, 0.01281417440623045, 0.029539085924625397, 0.038803424686193466, 0.0440310500562191, 0.03786874935030937, 0.06131623312830925, 0.0167376771569252, 0.04217120260000229, 0.05619743838906288, 0.018465498462319374, 0.03471854701638222, 0.045343268662691116, 0.042086321860551834, 0.09287000447511673, 0.00026877198251895607, 0.0068755061365664005, 0.010491189546883106, 0.006416579242795706, 0.010257829912006855, 0.011952039785683155, 0.037255674600601196, 0.011533183045685291, 0.013323592022061348, 0.03907032683491707, 0.05358029529452324, 0.01073587778955698, 0.010439794510602951, 0.025913497433066368, 0.01233121007680893, 0.04446859657764435, 0.026208247989416122, 0.0483294241130352, 0.009473606012761593, 0.010354573838412762, 0.027969175949692726, 0.06365110725164413, -1]}
{"idB": "749647_15_item1_p185_s0", "idA": "749647_14_item1_p100_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "In consideration for Impatients services to implement the early access program and in the event we receive regulatory authorization to sell, distribute or market ThermoDox in the Territory, we will be obligated to pay Impatients, subject to a maximum cap, a low single-digit royalty of net sales of ThermoDox in the countries where such regulatory authorization has been obtained.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "In", "consideration", "for", "Impatients", "services", "to", "implement", "the", "early", "access", "program", "and", "in", "the", "event", "we", "receive", "regulatory", "authorization", "to", "sell,", "distribute", "or", "market", "ThermoDox", "in", "the", "Territory,", "we", "will", "be", "obligated", "to", "pay", "Impatients,", "subject", "to", "a", "maximum", "cap,", "a", "low", "single-digit", "royalty", "of", "net", "sales", "of", "ThermoDox", "in", "the", "countries", "where", "such", "regulatory", "authorization", "has", "been", "obtained.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["In", "consideration", "for", "Impatients", "services", "to", "implement", "the", "early", "access", "program", "and", "in", "the", "event", "we", "receive", "regulatory", "authorization", "to", "sell,", "distribute", "or", "market", "ThermoDox", "in", "the", "Territory,", "we", "will", "be", "obligated", "to", "pay", "Impatients,", "subject", "to", "a", "maximum", "cap,", "a", "low", "single-digit", "royalty", "of", "net", "sales", "of", "ThermoDox", "in", "the", "countries", "where", "such", "regulatory", "authorization", "has", "been", "obtained."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008837404660880566, 0.04094255715608597, 0.02129986323416233, 0.11552315205335617, 0.16493462026119232, 0.006547082215547562, 0.035116445273160934, 0.008556036278605461, 0.03979445621371269, 0.042735505849123, 0.05569565296173096, 0.0006698127835988998, 0.013892479240894318, 0.0007038919720798731, 0.02964252233505249, 0.011194370687007904, 0.020952168852090836, 0.03883865103125572, 0.047200459986925125, 0.02759724296629429, 0.07794714719057083, 0.0657152384519577, 0.020810343325138092, 0.11212624609470367, 0.12273866683244705, 0.013097877614200115, 0.012619624845683575, 0.03510278835892677, 0.009992623701691628, 0.00942657794803381, 0.013620136305689812, 0.1046246737241745, 0.03380914032459259, 0.11534436792135239, 0.04743095859885216, 0.0006103976629674435, 0.0006829085177741945, 0.011679901741445065, 0.0305927786976099, 0.024554673582315445, 0.013619400560855865, 0.054630666971206665, 0.07541395723819733, 0.10899771004915237, 0.02594776824116707, 0.11612892895936966, 0.1400170475244522, 0.07755333185195923, 0.0977715402841568, 0.00846792571246624, 0.013110598549246788, 0.08765766024589539, 0.009423951618373394, 0.018303902819752693, 0.03735693544149399, 0.054011233150959015, 0.018937092274427414, 0.014048771001398563, 0.011573162861168385, -1]}
{"idB": "749647_15_item1_p74_s1", "idA": "749647_14_item1_p100_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "Under the early access program, Impatients will engage in activities to secure authorization, exemption or waiver from regulatory authorities for patient use of ThermoDox that may otherwise be subject to approvals from such regulatory authorities before the sale and distribution of ThermoDox in the relevant territories.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "Under", "the", "early", "access", "program,", "Impatients", "will", "engage", "in", "activities", "to", "secure", "authorization,", "exemption", "or", "waiver", "from", "regulatory", "authorities", "for", "patient", "use", "of", "ThermoDox", "that", "may", "otherwise", "be", "subject", "to", "approvals", "from", "such", "regulatory", "authorities", "before", "the", "sale", "and", "distribution", "of", "ThermoDox", "in", "the", "relevant", "territories.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["Under", "the", "early", "access", "program,", "Impatients", "will", "engage", "in", "activities", "to", "secure", "authorization,", "exemption", "or", "waiver", "from", "regulatory", "authorities", "for", "patient", "use", "of", "ThermoDox", "that", "may", "otherwise", "be", "subject", "to", "approvals", "from", "such", "regulatory", "authorities", "before", "the", "sale", "and", "distribution", "of", "ThermoDox", "in", "the", "relevant", "territories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08973584324121475, 0.03051345981657505, 0.35094594955444336, 0.3350023329257965, 0.27000656723976135, 0.16626223921775818, 0.017972461879253387, 0.07701072841882706, 0.051339633762836456, 0.18126390874385834, 0.01281417440623045, 0.029539085924625397, 0.038803424686193466, 0.0440310500562191, 0.03786874935030937, 0.06131623312830925, 0.0167376771569252, 0.04217120260000229, 0.05619743838906288, 0.018465498462319374, 0.03471854701638222, 0.045343268662691116, 0.042086321860551834, 0.09287000447511673, 0.00026877198251895607, 0.0068755061365664005, 0.010491189546883106, 0.006416579242795706, 0.010257829912006855, 0.011952039785683155, 0.037255674600601196, 0.011533183045685291, 0.013323592022061348, 0.03907032683491707, 0.05358029529452324, 0.01073587778955698, 0.010439794510602951, 0.025913497433066368, 0.01233121007680893, 0.04446859657764435, 0.026208247989416122, 0.0483294241130352, 0.009473606012761593, 0.010354573838412762, 0.027969175949692726, 0.06365110725164413, -1]}
{"idB": "749647_15_item1_p129_s0", "idA": "749647_14_item1_p104_s0", "sentA": "In 2011, the European Commission granted orphan drug designation for ThermoDox for the treatment of HCC in Europe.", "sentB": "Any FDA-approved drug utilizing the patented technologies may also be eligible for regulatory exclusivities, such as new chemical entity exclusivity of five years in the US, and orphan drug exclusivity of seven years in the US and ten years in Europe.", "type": 2, "words": ["<tag1>", "In", "2011,", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe.", "<tag2>", "Any", "FDA-approved", "drug", "utilizing", "the", "patented", "technologies", "may", "also", "be", "eligible", "for", "regulatory", "exclusivities,", "such", "as", "new", "chemical", "entity", "exclusivity", "of", "five", "years", "in", "the", "US,", "and", "orphan", "drug", "exclusivity", "of", "seven", "years", "in", "the", "US", "and", "ten", "years", "in", "Europe.", "<tag3>"], "wordsA": ["In", "2011,", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe."], "wordsB": ["Any", "FDA-approved", "drug", "utilizing", "the", "patented", "technologies", "may", "also", "be", "eligible", "for", "regulatory", "exclusivities,", "such", "as", "new", "chemical", "entity", "exclusivity", "of", "five", "years", "in", "the", "US,", "and", "orphan", "drug", "exclusivity", "of", "seven", "years", "in", "the", "US", "and", "ten", "years", "in", "Europe."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03180389478802681, 0.49814459681510925, 0.2106187641620636, 0.013760660775005817, 0.008373656310141087, 0.04515876993536949, 0.04111570492386818, 0.009932559914886951, 0.005352742038667202, 0.008928408846259117, 0.06858545541763306, 0.02384103089570999, 0.0779799222946167, 0.13746021687984467, 0.0013334131799638271, 0.004926763474941254, 0.044774893671274185, 0.09120065718889236, 0.06132857874035835, 0.04433803632855415, 0.009125938639044762, 0.2183750420808792, 0.0939253643155098, 0.0059828986413776875, 0.009851525537669659, 0.08420693129301071, 0.00023847940610721707, 0.03269962593913078, 0.03857169300317764, 0.03783030807971954, 0.011374495923519135, 0.4539197087287903, 0.17920027673244476, 0.009449116885662079, 0.010633853264153004, 0.1356295496225357, 0.0381421335041523, 0.4851176142692566, 0.17601291835308075, 0.01161747146397829, 0.025019658729434013, -1]}
{"idB": "749647_15_item1_p183_s0", "idA": "749647_14_item1_p104_s0", "sentA": "In 2011, the European Commission granted orphan drug designation for ThermoDox for the treatment of HCC in Europe.", "sentB": "On January 13, 2015, we entered into an Early Access Agreement with Impatients N.V., a Netherlands company (Impatients), pursuant to which Impatients will develop and execute through its brand myTomorrows an early access program for ThermoDox in all countries of the European Union territory, Iceland, Liechtenstein, Norway and Switzerland (the Territory) for the treatment of patients with RCW breast cancer.", "type": 2, "words": ["<tag1>", "In", "2011,", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe.", "<tag2>", "On", "January", "13,", "2015,", "we", "entered", "into", "an", "Early", "Access", "Agreement", "with", "Impatients", "N.V.,", "a", "Netherlands", "company", "(Impatients),", "pursuant", "to", "which", "Impatients", "will", "develop", "and", "execute", "through", "its", "brand", "myTomorrows", "an", "early", "access", "program", "for", "ThermoDox", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Iceland,", "Liechtenstein,", "Norway", "and", "Switzerland", "(the", "Territory)", "for", "the", "treatment", "of", "patients", "with", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["In", "2011,", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe."], "wordsB": ["On", "January", "13,", "2015,", "we", "entered", "into", "an", "Early", "Access", "Agreement", "with", "Impatients", "N.V.,", "a", "Netherlands", "company", "(Impatients),", "pursuant", "to", "which", "Impatients", "will", "develop", "and", "execute", "through", "its", "brand", "myTomorrows", "an", "early", "access", "program", "for", "ThermoDox", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Iceland,", "Liechtenstein,", "Norway", "and", "Switzerland", "(the", "Territory)", "for", "the", "treatment", "of", "patients", "with", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02146291360259056, 0.0886412039399147, 0.08766826242208481, 0.7077023386955261, 0.03977462276816368, 0.04900907725095749, 0.04135487973690033, 0.03184700384736061, 0.13475416600704193, 0.1412229686975479, 0.22663463652133942, 0.03142315149307251, 0.10428927093744278, 0.07533586025238037, 0.008295009844005108, 0.09711407124996185, 0.05878409743309021, 0.0278791394084692, 0.005283102858811617, 0.004501896444708109, 0.006325456313788891, 0.013325147330760956, 0.00634024990722537, 0.029313791543245316, 0.008734969422221184, 0.01835019886493683, 0.00681669358164072, 0.006464693229645491, 0.029592210426926613, 0.039039600640535355, 0.007075929082930088, 0.02493571676313877, 0.025814779102802277, 0.03597698360681534, 0.009232934564352036, 0.02134891413152218, 0.00543099083006382, 0.02952597290277481, 0.031557656824588776, 0.00821655709296465, 0.008895407430827618, 0.014584895223379135, 0.013274230994284153, 0.03624977543950081, 0.11592526733875275, 0.14634810388088226, 0.10168915241956711, 0.045113082975149155, 0.20445552468299866, 0.006493410561233759, 0.03377854824066162, 0.004018655512481928, 0.005580327473580837, 0.06743741780519485, 0.016383109614253044, 0.1147032231092453, 0.061697766184806824, 0.4313799738883972, 0.4351558983325958, 0.49323537945747375, -1]}
{"idB": "749647_15_item1_p74_s0", "idA": "749647_14_item1_p104_s0", "sentA": "In 2011, the European Commission granted orphan drug designation for ThermoDox for the treatment of HCC in Europe.", "sentB": "On January 13, 2015, we entered into an Early Access Agreement with Impatients N.V., a Netherlands company (Impatients), pursuant to which Impatients will develop and execute through its brand myTomorrows an early access program for ThermoDox in all countries of the European Union territory, Iceland, Liechtenstein, Norway and Switzerland (the Territory) for the treatment of patients with RCW breast cancer.", "type": 2, "words": ["<tag1>", "In", "2011,", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe.", "<tag2>", "On", "January", "13,", "2015,", "we", "entered", "into", "an", "Early", "Access", "Agreement", "with", "Impatients", "N.V.,", "a", "Netherlands", "company", "(Impatients),", "pursuant", "to", "which", "Impatients", "will", "develop", "and", "execute", "through", "its", "brand", "myTomorrows", "an", "early", "access", "program", "for", "ThermoDox", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Iceland,", "Liechtenstein,", "Norway", "and", "Switzerland", "(the", "Territory)", "for", "the", "treatment", "of", "patients", "with", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["In", "2011,", "the", "European", "Commission", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC", "in", "Europe."], "wordsB": ["On", "January", "13,", "2015,", "we", "entered", "into", "an", "Early", "Access", "Agreement", "with", "Impatients", "N.V.,", "a", "Netherlands", "company", "(Impatients),", "pursuant", "to", "which", "Impatients", "will", "develop", "and", "execute", "through", "its", "brand", "myTomorrows", "an", "early", "access", "program", "for", "ThermoDox", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Iceland,", "Liechtenstein,", "Norway", "and", "Switzerland", "(the", "Territory)", "for", "the", "treatment", "of", "patients", "with", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02146291360259056, 0.0886412039399147, 0.08766826242208481, 0.7077023386955261, 0.03977462276816368, 0.04900907725095749, 0.04135487973690033, 0.03184700384736061, 0.13475416600704193, 0.1412229686975479, 0.22663463652133942, 0.03142315149307251, 0.10428927093744278, 0.07533586025238037, 0.008295009844005108, 0.09711407124996185, 0.05878409743309021, 0.0278791394084692, 0.005283102858811617, 0.004501896444708109, 0.006325456313788891, 0.013325147330760956, 0.00634024990722537, 0.029313791543245316, 0.008734969422221184, 0.01835019886493683, 0.00681669358164072, 0.006464693229645491, 0.029592210426926613, 0.039039600640535355, 0.007075929082930088, 0.02493571676313877, 0.025814779102802277, 0.03597698360681534, 0.009232934564352036, 0.02134891413152218, 0.00543099083006382, 0.02952597290277481, 0.031557656824588776, 0.00821655709296465, 0.008895407430827618, 0.014584895223379135, 0.013274230994284153, 0.03624977543950081, 0.11592526733875275, 0.14634810388088226, 0.10168915241956711, 0.045113082975149155, 0.20445552468299866, 0.006493410561233759, 0.03377854824066162, 0.004018655512481928, 0.005580327473580837, 0.06743741780519485, 0.016383109614253044, 0.1147032231092453, 0.061697766184806824, 0.4313799738883972, 0.4351558983325958, 0.49323537945747375, -1]}
{"idB": "749647_15_item1_p144_s3", "idA": "749647_14_item1_p108_s2", "sentA": "Our ability to compete successfully with other companies in the pharmaceutical and biotechnology field also depends on the status of our collaborations and on the continuing availability of capital to us.", "sentB": "The ultimate implementation of our strategy for realizing the financial value of our product candidates is dependent on the results of clinical trials for our product candidates, the availability of regulatory approvals and the ability to negotiate acceptable commercial terms with third parties.", "type": 2, "words": ["<tag1>", "Our", "ability", "to", "compete", "successfully", "with", "other", "companies", "in", "the", "pharmaceutical", "and", "biotechnology", "field", "also", "depends", "on", "the", "status", "of", "our", "collaborations", "and", "on", "the", "continuing", "availability", "of", "capital", "to", "us.", "<tag2>", "The", "ultimate", "implementation", "of", "our", "strategy", "for", "realizing", "the", "financial", "value", "of", "our", "product", "candidates", "is", "dependent", "on", "the", "results", "of", "clinical", "trials", "for", "our", "product", "candidates,", "the", "availability", "of", "regulatory", "approvals", "and", "the", "ability", "to", "negotiate", "acceptable", "commercial", "terms", "with", "third", "parties.", "<tag3>"], "wordsA": ["Our", "ability", "to", "compete", "successfully", "with", "other", "companies", "in", "the", "pharmaceutical", "and", "biotechnology", "field", "also", "depends", "on", "the", "status", "of", "our", "collaborations", "and", "on", "the", "continuing", "availability", "of", "capital", "to", "us."], "wordsB": ["The", "ultimate", "implementation", "of", "our", "strategy", "for", "realizing", "the", "financial", "value", "of", "our", "product", "candidates", "is", "dependent", "on", "the", "results", "of", "clinical", "trials", "for", "our", "product", "candidates,", "the", "availability", "of", "regulatory", "approvals", "and", "the", "ability", "to", "negotiate", "acceptable", "commercial", "terms", "with", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007520931772887707, 0.11033709347248077, 0.15398748219013214, 0.015033108182251453, 0.04692230373620987, 0.12000269442796707, 0.011196496896445751, 0.055058568716049194, 0.015807274729013443, 0.1740325540304184, 0.06901874393224716, 0.01689009554684162, 0.020339107140898705, 0.06374626606702805, 0.07471955567598343, 0.00024136716092471033, 0.053561754524707794, 0.006189223378896713, 0.0060382140800356865, 0.02891361713409424, 0.012714779935777187, 0.09011492133140564, 0.09076309204101562, 0.0077581945806741714, 0.009054639376699924, 0.03271865472197533, 0.03549525886774063, 0.004826328717172146, 0.046746689826250076, 0.020062075927853584, 0.11844358593225479, 0.23561635613441467, 0.005086137913167477, 0.00494538526982069, 0.03057410754263401, 0.008544225245714188, 0.17190848290920258, 0.2371383160352707, 0.33862921595573425, 0.38512563705444336, 0.030372310429811478, 0.12836259603500366, 0.1032436341047287, -1]}
{"idB": "749647_15_item1_p99_s0", "idA": "749647_14_item1_p109_s0", "sentA": "Although there are many drugs and devices marketed and under development for the treatment of cancer, the Company is not aware of any other heat activated drug delivery product either being marketed or in human clinical development.", "sentB": "PPC is the delivery component of our lead TheraPlas product, GEN-1, which is in clinical development for the treatment ovarian cancer and in preclinical development for the treatment of glioblastoma.", "type": 2, "words": ["<tag1>", "Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development.", "<tag2>", "PPC", "is", "the", "delivery", "component", "of", "our", "lead", "TheraPlas", "product,", "GEN-1,", "which", "is", "in", "clinical", "development", "for", "the", "treatment", "ovarian", "cancer", "and", "in", "preclinical", "development", "for", "the", "treatment", "of", "glioblastoma.", "<tag3>"], "wordsA": ["Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development."], "wordsB": ["PPC", "is", "the", "delivery", "component", "of", "our", "lead", "TheraPlas", "product,", "GEN-1,", "which", "is", "in", "clinical", "development", "for", "the", "treatment", "ovarian", "cancer", "and", "in", "preclinical", "development", "for", "the", "treatment", "of", "glioblastoma."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2583986818790436, 0.03965339809656143, 0.022204380482435226, 0.11379306018352509, 0.0923771932721138, 0.027635518461465836, 0.05311378091573715, 0.1277395486831665, 0.20447012782096863, 0.2383628934621811, 0.3280363380908966, 6.747966835973784e-05, 0.002609541639685631, 0.00709164934232831, 0.01860443316400051, 0.03779473155736923, 0.008156911469995975, 0.0057113985531032085, 0.08900640904903412, 0.23139290511608124, 0.1639997661113739, 0.0001545417180750519, 0.013791459612548351, 0.28954121470451355, 0.1878773719072342, 0.022791972383856773, 0.014380018226802349, 0.13516493141651154, 0.12294510006904602, 0.8326141834259033, -1]}
{"idB": "749647_15_item1_p11_s1", "idA": "749647_14_item1_p10_s1", "sentA": "Specifically, we determined, after conferring with the HEAT Study independent Data Monitoring Committee (DMC), that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval.", "sentB": "Specifically, we determined, after conferring with the HEAT Study independent Data Monitoring Committee (iDMC), that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval.", "type": 2, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(DMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval.", "<tag2>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(DMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval."], "wordsB": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009202628396451473, 0.007098067551851273, 0.012018239125609398, 0.005214458331465721, 0.0075363232754170895, 0.005345592740923166, 0.004860793240368366, 0.008275311440229416, 0.008415396325290203, 0.00896554533392191, 0.008056608960032463, 0.00731067406013608, 0.0066316137090325356, 0.9088207483291626, 0.007563112303614616, 0.005152813624590635, 0.010951134376227856, 0.012950854375958443, 0.27057087421417236, 0.5046459436416626, 0.027635348960757256, 0.009632033295929432, 0.012913834303617477, 0.007117484696209431, 0.008819250389933586, 0.009784855879843235, 0.006798236630856991, 0.005554103292524815, 0.00614530174061656, 0.006616207771003246, 0.005986898671835661, 0.0057319640181958675, 0.006742958445101976, 0.005792466923594475, 0.01072491891682148, 0.00548761198297143, 0.01322493702173233, 0.013982907868921757, -1]}
{"idB": "749647_15_item1_p153_s0", "idA": "749647_14_item1_p110_s0", "sentA": "In 1999, the Company entered into a license agreement with Duke University under which we received exclusive rights, subject to certain exceptions, to commercialize and use Duke s thermo-liposome technology.", "sentB": "In 1999, we entered into a license agreement with Duke University under which we received exclusive rights, subject to certain exceptions, to commercialize and use Duke s thermo-liposome technology.", "type": 2, "words": ["<tag1>", "In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag2>", "In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag3>"], "wordsA": ["In", "1999,", "the", "Company", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "wordsB": ["In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10957078635692596, 0.23598358035087585, 0.4471648037433624, 0.13882040977478027, 0.0730489194393158, 0.053477250039577484, 0.17541469633579254, 0.20797476172447205, 0.09352646768093109, 0.554218590259552, 0.39346352219581604, 0.07241212576627731, 0.04715171083807945, 0.07087200880050659, 0.10427084565162659, 0.20576854050159454, 0.1549990177154541, 0.06277313828468323, 0.0486966110765934, 0.09127051383256912, 0.1344781368970871, 0.03845204412937164, 0.11278947442770004, 0.03622862696647644, 0.07650411874055862, 0.4543950855731964, 0.23029161989688873, 0.1641509234905243, 0.1337091624736786, -1]}
{"idB": "749647_15_item1_p156_s1", "idA": "749647_14_item1_p113_s1", "sentA": "Currently, the Company has rights to Duke s patent for its thermo-liposome technology in the United States, which expires in 2018, and to future patents received by Duke in Canada, Europe, Japan and Australia, where it has patent applications have been granted.", "sentB": "Currently we have rights to Duke s patent for its thermo-liposome technology in the United States, which expires in 2018, and to future patents received by Duke in Canada, Europe, Japan and Australia, where it has patent applications have been granted.", "type": 2, "words": ["<tag1>", "Currently,", "the", "Company", "has", "rights", "to", "Duke", "s", "patent", "for", "its", "thermo-liposome", "technology", "in", "the", "United", "States,", "which", "expires", "in", "2018,", "and", "to", "future", "patents", "received", "by", "Duke", "in", "Canada,", "Europe,", "Japan", "and", "Australia,", "where", "it", "has", "patent", "applications", "have", "been", "granted.", "<tag2>", "Currently", "we", "have", "rights", "to", "Duke", "s", "patent", "for", "its", "thermo-liposome", "technology", "in", "the", "United", "States,", "which", "expires", "in", "2018,", "and", "to", "future", "patents", "received", "by", "Duke", "in", "Canada,", "Europe,", "Japan", "and", "Australia,", "where", "it", "has", "patent", "applications", "have", "been", "granted.", "<tag3>"], "wordsA": ["Currently,", "the", "Company", "has", "rights", "to", "Duke", "s", "patent", "for", "its", "thermo-liposome", "technology", "in", "the", "United", "States,", "which", "expires", "in", "2018,", "and", "to", "future", "patents", "received", "by", "Duke", "in", "Canada,", "Europe,", "Japan", "and", "Australia,", "where", "it", "has", "patent", "applications", "have", "been", "granted."], "wordsB": ["Currently", "we", "have", "rights", "to", "Duke", "s", "patent", "for", "its", "thermo-liposome", "technology", "in", "the", "United", "States,", "which", "expires", "in", "2018,", "and", "to", "future", "patents", "received", "by", "Duke", "in", "Canada,", "Europe,", "Japan", "and", "Australia,", "where", "it", "has", "patent", "applications", "have", "been", "granted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.039295829832553864, 0.5196443200111389, 0.12306810170412064, 0.20390771329402924, 0.07578632235527039, 0.5327426195144653, 0.34357377886772156, 0.5608683824539185, 0.018478918820619583, 0.014004785567522049, 0.07048530131578445, 0.03355242311954498, 0.01105017401278019, 0.012687956914305687, 0.03471705690026283, 0.04277043044567108, 0.011836214922368526, 0.05503010004758835, 0.022822152823209763, 0.03696046024560928, 0.009102418087422848, 0.010847767814993858, 0.030352460220456123, 0.2182539999485016, 0.019940292462706566, 0.019995341077446938, 0.15521007776260376, 0.014191024005413055, 0.040673207491636276, 0.030114470049738884, 0.02918710745871067, 0.022540666162967682, 0.029272057116031647, 0.015011201612651348, 0.015981385484337807, 0.009196707978844643, 0.3201884925365448, 0.15433035790920258, 0.036135535687208176, 0.050750263035297394, 0.12375403940677643, -1]}
{"idB": "749647_15_item1_p156_s3", "idA": "749647_14_item1_p113_s3", "sentA": "For this technology, the Company s license rights are worldwide, including the United States, Canada, certain European countries, Australia, Hong Kong, and Japan.", "sentB": "For this technology, our license rights are worldwide, including the United States, Canada, certain European countries, Australia, Hong Kong, and Japan.", "type": 2, "words": ["<tag1>", "For", "this", "technology,", "the", "Company", "s", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "certain", "European", "countries,", "Australia,", "Hong", "Kong,", "and", "Japan.", "<tag2>", "For", "this", "technology,", "our", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "certain", "European", "countries,", "Australia,", "Hong", "Kong,", "and", "Japan.", "<tag3>"], "wordsA": ["For", "this", "technology,", "the", "Company", "s", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "certain", "European", "countries,", "Australia,", "Hong", "Kong,", "and", "Japan."], "wordsB": ["For", "this", "technology,", "our", "license", "rights", "are", "worldwide,", "including", "the", "United", "States,", "Canada,", "certain", "European", "countries,", "Australia,", "Hong", "Kong,", "and", "Japan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02751844935119152, 0.015521015971899033, 0.049528736621141434, 0.24716630578041077, 0.7618404626846313, 0.6179762482643127, 0.08987823873758316, 0.26748159527778625, 0.03836139291524887, 0.02020217850804329, 0.18792974948883057, 0.11310532689094543, 0.07142484188079834, 0.018862172961235046, 0.04166369512677193, 0.03983527421951294, 0.08987989276647568, 0.0447416678071022, 0.04618234559893608, 0.01244679931551218, 0.06875928491353989, -1]}
{"idB": "749647_15_item1_p158_s0", "idA": "749647_14_item1_p114_s3", "sentA": "These patents will extend the overall term of the ThermoDox patent portfolio to 2026.", "sentB": "For the ThermoDox technology, we either exclusively license or own US and international patents with claims and methods and compositions of matters that cover various aspects of LTSL technology, with expiration dates ranging from 2019 to 2026.", "type": 2, "words": ["<tag1>", "These", "patents", "will", "extend", "the", "overall", "term", "of", "the", "ThermoDox", "patent", "portfolio", "to", "2026.", "<tag2>", "For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "US", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "LTSL", "technology,", "with", "expiration", "dates", "ranging", "from", "2019", "to", "2026.", "<tag3>"], "wordsA": ["These", "patents", "will", "extend", "the", "overall", "term", "of", "the", "ThermoDox", "patent", "portfolio", "to", "2026."], "wordsB": ["For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "US", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "LTSL", "technology,", "with", "expiration", "dates", "ranging", "from", "2019", "to", "2026."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.020186761394143105, 0.008540271781384945, 0.01724005490541458, 0.03458505496382713, 0.0435718297958374, 0.06361214816570282, 0.18269062042236328, 0.5089435577392578, 0.18758700788021088, 0.5022009611129761, 0.08957229554653168, 0.04266047850251198, 0.07090897858142853, 0.3613649904727936, 0.009531285613775253, 0.02928296849131584, 0.00869876891374588, 0.015292561613023281, 0.0089639350771904, 0.024749381467700005, 0.007486151996999979, 0.021154098212718964, 0.007329620886594057, 0.009793276898562908, 0.011413393542170525, 0.009846207685768604, 0.009105730801820755, 0.01571369171142578, 0.02811305969953537, 0.0010342844761908054, 0.038658373057842255, 0.04532026872038841, 0.020105158910155296, 0.02944296970963478, 0.01464875414967537, 0.027678973972797394, 0.007728356868028641, -1]}
{"idB": "749647_15_item1_p157_s5", "idA": "749647_14_item1_p114_s5", "sentA": "This extended patent runway to 2026 allows for the evaluation of future development activities for ThermoDox and Celsion's heat-sensitive liposome technology platform.", "sentB": "This extended patent runway to 2026 allows for the evaluation of future development activities for ThermoDox and Celsion s heat-sensitive liposome technology platform.", "type": 2, "words": ["<tag1>", "This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion's", "heat-sensitive", "liposome", "technology", "platform.", "<tag2>", "This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion", "s", "heat-sensitive", "liposome", "technology", "platform.", "<tag3>"], "wordsA": ["This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion's", "heat-sensitive", "liposome", "technology", "platform."], "wordsB": ["This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion", "s", "heat-sensitive", "liposome", "technology", "platform."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04829166829586029, 0.3756258189678192, 0.40961992740631104, 0.3933979570865631, 0.11664561927318573, 0.1843777298927307, 0.12171674519777298, 0.0614154078066349, 0.038940656930208206, 0.187394917011261, 0.06776217371225357, 0.11360126733779907, 0.16757351160049438, 0.13378041982650757, 0.06654594838619232, 0.2536812722682953, 0.0506288968026638, 0.1984931230545044, 0.11549723893404007, 0.15165016055107117, 0.1881849467754364, 0.06301721930503845, 0.10734370350837708, -1]}
{"idB": "749647_15_item1_p166_s2", "idA": "749647_14_item1_p116_s0", "sentA": "Please refer to Item 1A, Risk Factors, including, but not limited to, We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "sentB": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024526264518499374, 0.8025492429733276, 0.6230555176734924, 0.552528440952301, 0.4487361013889313, 0.5725120902061462, 0.026804082095623016, 0.03233800828456879, 0.015329096466302872, 0.051600269973278046, 0.11837012320756912, 0.066407211124897, 0.03813987597823143, 0.02769276313483715, 0.0499638132750988, 0.00362228462472558, 0.0024698537308722734, 0.003352723317220807, 0.0019504654919728637, 0.003084508702158928, 0.0029167188331484795, -1]}
{"idB": "749647_15_item1_p144_s2", "idA": "749647_14_item1_p116_s2", "sentA": "Please refer to Item 1A, Risk Factors, including, but not limited to, Our business depends on licensing agreements with third parties to permit us to use patented technologies.", "sentB": "If we receive marketing and commercialization approval for any of our product candidates, we intend to market the product either directly or through strategic alliances and distribution agreements with third parties.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "Our", "business", "depends", "on", "licensing", "agreements", "with", "third", "parties", "to", "permit", "us", "to", "use", "patented", "technologies.", "<tag2>", "If", "we", "receive", "marketing", "and", "commercialization", "approval", "for", "any", "of", "our", "product", "candidates,", "we", "intend", "to", "market", "the", "product", "either", "directly", "or", "through", "strategic", "alliances", "and", "distribution", "agreements", "with", "third", "parties.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "Our", "business", "depends", "on", "licensing", "agreements", "with", "third", "parties", "to", "permit", "us", "to", "use", "patented", "technologies."], "wordsB": ["If", "we", "receive", "marketing", "and", "commercialization", "approval", "for", "any", "of", "our", "product", "candidates,", "we", "intend", "to", "market", "the", "product", "either", "directly", "or", "through", "strategic", "alliances", "and", "distribution", "agreements", "with", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03669256344437599, 0.06095372512936592, 0.19080513715744019, 0.43468865752220154, 0.20207609236240387, 0.6423499584197998, 0.4036341607570648, 0.012022520415484905, 0.025041215121746063, 0.013137204572558403, 0.01587189920246601, 0.08326860517263412, 0.06705211848020554, 0.016029929742217064, 0.04755222797393799, 0.024201709777116776, 0.08787918835878372, 0.03401493281126022, 0.07254339009523392, 0.00873617548495531, 0.05446111410856247, 0.007623377721756697, 0.01123158447444439, 0.038444485515356064, 0.04129299521446228, 0.015345875173807144, 0.11408025771379471, 0.10019803047180176, 0.007973475381731987, 0.015804069116711617, 0.02049923688173294, -1]}
{"idB": "749647_15_item1_p165_s3", "idA": "749647_14_item1_p116_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "Furthermore, parties making such claims may be able to obtain injunctive or other equitable relief, which could effectively block our ability to develop or commercialize some or all of our products in the U.S. and abroad, and could result in the award of substantial damages.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014159553684294224, 0.08850018680095673, 0.08585978299379349, 0.042395737022161484, 0.10615725815296173, 0.012916253879666328, 0.0071091121062636375, 0.009396685287356377, 0.0009772033663466573, 0.028506595641374588, 0.28728610277175903, 0.01881435699760914, 0.01756618171930313, 0.06808869540691376, 0.19155651330947876, 0.00022282707504928112, 0.011989330872893333, 0.013657991774380207, 0.29705509543418884, 0.038334839046001434, 0.09284621477127075, 0.09398353844881058, 0.055512212216854095, 0.0374978668987751, 0.10823565721511841, 0.017419878393411636, 0.014511761255562305, 0.02897626906633377, 0.02671162411570549, 0.04097659885883331, 0.08723822236061096, 0.01153857633471489, 0.012374737299978733, 0.022284887731075287, 0.013840120285749435, 0.01941736973822117, 0.0001956454070750624, 0.007382446434348822, 0.008132489398121834, 0.007858026772737503, 0.0006337735103443265, 0.05094572901725769, 0.03418984264135361, 0.13839735090732574, 0.18368734419345856, -1]}
{"idB": "749647_15_item1_p169_s0", "idA": "749647_14_item1_p117_s0", "sentA": "As of March 12, 2014, we employed 13 full-time employees.", "sentB": "As of March 11, 2015, we employed 28 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "12,", "2014,", "we", "employed", "13", "full-time", "employees.", "<tag2>", "As", "of", "March", "11,", "2015,", "we", "employed", "28", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "12,", "2014,", "we", "employed", "13", "full-time", "employees."], "wordsB": ["As", "of", "March", "11,", "2015,", "we", "employed", "28", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007927059195935726, 0.007444239221513271, 0.07814179360866547, 0.6778762340545654, 0.6675459146499634, 0.004416350740939379, 0.04216895252466202, 0.8209337592124939, 0.13380207121372223, 0.11862379312515259, -1]}
{"idB": "749647_15_item1_p85_s0", "idA": "749647_14_item1_p118_s0", "sentA": "Celsion was founded in 1982 and is a Delaware corporation.", "sentB": "Interleukin-12 (IL-12) is a pluripotent cytokine with potent immune-stimulatory and anti-angiogenic properties.", "type": 2, "words": ["<tag1>", "Celsion", "was", "founded", "in", "1982", "and", "is", "a", "Delaware", "corporation.", "<tag2>", "Interleukin-12", "(IL-12)", "is", "a", "pluripotent", "cytokine", "with", "potent", "immune-stimulatory", "and", "anti-angiogenic", "properties.", "<tag3>"], "wordsA": ["Celsion", "was", "founded", "in", "1982", "and", "is", "a", "Delaware", "corporation."], "wordsB": ["Interleukin-12", "(IL-12)", "is", "a", "pluripotent", "cytokine", "with", "potent", "immune-stimulatory", "and", "anti-angiogenic", "properties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8229336738586426, 0.5025737285614014, 0.05091657117009163, 0.045569080859422684, 0.3311501741409302, 0.5095457434654236, 0.002906908979639411, 0.030023667961359024, 0.09778270125389099, 0.015404823236167431, 0.2286081463098526, 0.07318519055843353, -1]}
{"idB": "749647_15_item1_p165_s1", "idA": "749647_14_item1_p119_s3", "sentA": "Copies of these documents may be obtained, free of charge, from our website.", "sentB": "Nor can we predict with certainty which, if any, of these rights will or may be asserted against us by third parties.", "type": 2, "words": ["<tag1>", "Copies", "of", "these", "documents", "may", "be", "obtained,", "free", "of", "charge,", "from", "our", "website.", "<tag2>", "Nor", "can", "we", "predict", "with", "certainty", "which,", "if", "any,", "of", "these", "rights", "will", "or", "may", "be", "asserted", "against", "us", "by", "third", "parties.", "<tag3>"], "wordsA": ["Copies", "of", "these", "documents", "may", "be", "obtained,", "free", "of", "charge,", "from", "our", "website."], "wordsB": ["Nor", "can", "we", "predict", "with", "certainty", "which,", "if", "any,", "of", "these", "rights", "will", "or", "may", "be", "asserted", "against", "us", "by", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1959191858768463, 0.14851060509681702, 0.19188760221004486, 0.2983490228652954, 0.1872987300157547, 0.2996752858161926, 0.11596439778804779, 0.06913798302412033, 0.1014961525797844, 0.08269539475440979, 0.1160692647099495, 0.17880897223949432, 0.11510179191827774, 0.033722590655088425, 0.06367188692092896, 0.07805908471345901, 0.15729382634162903, 0.09797545522451401, 0.1018296629190445, 0.04540930315852165, 0.16026777029037476, 0.17611688375473022, -1]}
{"idB": "749647_15_item1_p13_s0", "idA": "749647_14_item1_p11_s1", "sentA": "Following the announcement of the HEAT study results, we continue to follow patients for overall survival, the secondary endpoint of the HEAT study, on a quarterly basis.", "sentB": "Following the announcement of the HEAT Study results, we continue to follow patients for overall survival (OS), the secondary endpoint of the HEAT Study, on a quarterly basis.", "type": 2, "words": ["<tag1>", "Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "continue", "to", "follow", "patients", "for", "overall", "survival,", "the", "secondary", "endpoint", "of", "the", "HEAT", "study,", "on", "a", "quarterly", "basis.", "<tag2>", "Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "continue", "to", "follow", "patients", "for", "overall", "survival", "(OS),", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study,", "on", "a", "quarterly", "basis.", "<tag3>"], "wordsA": ["Following", "the", "announcement", "of", "the", "HEAT", "study", "results,", "we", "continue", "to", "follow", "patients", "for", "overall", "survival,", "the", "secondary", "endpoint", "of", "the", "HEAT", "study,", "on", "a", "quarterly", "basis."], "wordsB": ["Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "continue", "to", "follow", "patients", "for", "overall", "survival", "(OS),", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study,", "on", "a", "quarterly", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006048447918146849, 0.003939433488994837, 0.007578861899673939, 0.0033290188293904066, 0.0029323967173695564, 0.014841803349554539, 0.010607251897454262, 0.009458574466407299, 0.007326241582632065, 0.011320316232740879, 0.007399395573884249, 0.032172832638025284, 0.049864739179611206, 0.005877662915736437, 0.014836625196039677, 0.04599125310778618, 0.9699901938438416, 0.004851142410188913, 0.009622235782444477, 0.009252880699932575, 0.0022028209641575813, 0.0026424091774970293, 0.012582661584019661, 0.008813133463263512, 0.0034374783281236887, 0.003242993261665106, 0.006182679906487465, 0.007062360178679228, -1]}
{"idB": "749647_15_item1_p13_s2", "idA": "749647_14_item1_p11_s3", "sentA": "As part of this analysis, we are also re-evaluating our product pipeline and research and development priorities.", "sentB": "As part of this analysis, we also evaluated our product pipeline and research and development priorities.", "type": 2, "words": ["<tag1>", "As", "part", "of", "this", "analysis,", "we", "are", "also", "re-evaluating", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag2>", "As", "part", "of", "this", "analysis,", "we", "also", "evaluated", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag3>"], "wordsA": ["As", "part", "of", "this", "analysis,", "we", "are", "also", "re-evaluating", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "wordsB": ["As", "part", "of", "this", "analysis,", "we", "also", "evaluated", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010906009934842587, 0.015597822144627571, 0.006316836923360825, 0.006198204588145018, 0.02626921981573105, 0.04529266804456711, 0.048134345561265945, 0.6667498350143433, 0.04791242256760597, 0.11981720477342606, 0.0507851168513298, 0.006153878755867481, 0.007525153923779726, 0.004997284151613712, 0.006583725102245808, 0.013026864267885685, -1]}
{"idB": "749647_15_item1_p172_s0", "idA": "749647_14_item1_p120_s0", "sentA": "During 2013, we issued a total of 5.3 million shares of common stock, including shares of common stock issued upon conversion of the 15,000.00422 shares of Series A 0% convertible preferred stock, in the following equity transactions for an aggregate $31.6 million in gross proceeds.", "sentB": "During 2014 and 2013, we issued a total of 8.0 million shares of common stock; including shares of common stock issued upon conversion of the 15,000.00422 shares of Series A 0% convertible preferred stock, in the following equity transactions for an aggregate $46.6 million in gross proceeds.", "type": 2, "words": ["<tag1>", "During", "2013,", "we", "issued", "a", "total", "of", "5.3", "million", "shares", "of", "common", "stock,", "including", "shares", "of", "common", "stock", "issued", "upon", "conversion", "of", "the", "15,000.00422", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock,", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$31.6", "million", "in", "gross", "proceeds.", "<tag2>", "During", "2014", "and", "2013,", "we", "issued", "a", "total", "of", "8.0", "million", "shares", "of", "common", "stock;", "including", "shares", "of", "common", "stock", "issued", "upon", "conversion", "of", "the", "15,000.00422", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock,", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$46.6", "million", "in", "gross", "proceeds.", "<tag3>"], "wordsA": ["During", "2013,", "we", "issued", "a", "total", "of", "5.3", "million", "shares", "of", "common", "stock,", "including", "shares", "of", "common", "stock", "issued", "upon", "conversion", "of", "the", "15,000.00422", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock,", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$31.6", "million", "in", "gross", "proceeds."], "wordsB": ["During", "2014", "and", "2013,", "we", "issued", "a", "total", "of", "8.0", "million", "shares", "of", "common", "stock;", "including", "shares", "of", "common", "stock", "issued", "upon", "conversion", "of", "the", "15,000.00422", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock,", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$46.6", "million", "in", "gross", "proceeds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011943990364670753, 0.7630246877670288, 0.1090802401304245, 0.014136913232505322, 0.003297720104455948, 0.007589901797473431, 0.004156902898102999, 0.0090032322332263, 0.0066674817353487015, 0.9428132176399231, 0.41078540682792664, 0.13489705324172974, 0.0028049731627106667, 0.0036127245984971523, 0.00392187712714076, 0.0028778063133358955, 0.003990655764937401, 0.00286741741001606, 0.003128085285425186, 0.0031567078549414873, 0.003124543931335211, 0.0029314598068594933, 0.0024501255247741938, 0.0029615925159305334, 0.0031073610298335552, 0.0069515095092356205, 0.007073483895510435, 0.0023955763317644596, 0.003440151223912835, 0.0027626752853393555, 0.004970249719917774, 0.005873017478734255, 0.0036493507213890553, 0.0036297128535807133, 0.0023397530894726515, 0.0026501151733100414, 0.002789943479001522, 0.003395776031538844, 0.003385385265573859, 0.0030695160385221243, 0.0034215236082673073, 0.004761400632560253, 0.47507455945014954, 0.046481840312480927, 0.002738058799877763, 0.004301765002310276, 0.00485951965674758, -1]}
{"idB": "749647_15_item1_p173_s0", "idA": "749647_14_item1_p120_s1", "sentA": "On October 28, 2013, we effected a 4.5-to-1 reverse split of our common stock.", "sentB": "On October 28, 2013, we effected a 4.5-to-1 reverse stock split of our common stock.", "type": 2, "words": ["<tag1>", "On", "October", "28,", "2013,", "we", "effected", "a", "4.5-to-1", "reverse", "split", "of", "our", "common", "stock.", "<tag2>", "On", "October", "28,", "2013,", "we", "effected", "a", "4.5-to-1", "reverse", "stock", "split", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["On", "October", "28,", "2013,", "we", "effected", "a", "4.5-to-1", "reverse", "split", "of", "our", "common", "stock."], "wordsB": ["On", "October", "28,", "2013,", "we", "effected", "a", "4.5-to-1", "reverse", "stock", "split", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0377514511346817, 0.07646872848272324, 0.1259225457906723, 0.07076170295476913, 0.03877735510468483, 0.04205246642231941, 0.021114693954586983, 0.7913143038749695, 0.2586155831813812, 0.29399996995925903, 0.10726802796125412, 0.025871193036437035, 0.02406715229153633, 0.0716233104467392, 0.09984797984361649, -1]}
{"idB": "749647_15_item1_p174_s0", "idA": "749647_14_item1_p121_s0", "sentA": "On February 1, 2013, we entered into a Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald Co., as sales agent, pursuant to which we may offer and sell, from time to time through at-the-market offerings, shares of our common stock having an aggregate offering price of up to $25.0 million.", "sentB": "On February 1, 2013, we entered into a Controlled Equity Offering SM Sales Agreement (ATM) with Cantor Fitzgerald Co., as sales agent, pursuant to which we may offer and sell, from time to time through at-the-market offerings, shares of our common stock having an aggregate offering price of up to $25.0 million.", "type": 2, "words": ["<tag1>", "On", "February", "1,", "2013,", "we", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million.", "<tag2>", "On", "February", "1,", "2013,", "we", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(ATM)", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million.", "<tag3>"], "wordsA": ["On", "February", "1,", "2013,", "we", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million."], "wordsB": ["On", "February", "1,", "2013,", "we", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(ATM)", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006987580563873053, 0.009818194434046745, 0.011105017736554146, 0.010610244236886501, 0.008754466660320759, 0.011774036101996899, 0.011034423485398293, 0.009810665622353554, 0.010239653289318085, 0.012700111605226994, 0.01621425338089466, 0.020826192572712898, 0.05611575022339821, 0.13155369460582733, 0.9678416848182678, 0.009822665713727474, 0.019594665616750717, 0.01649819314479828, 0.01080702431499958, 0.008567523211240768, 0.017296917736530304, 0.017543256282806396, 0.01303825993090868, 0.010415645316243172, 0.011059282347559929, 0.007412635255604982, 0.007976810447871685, 0.008446909487247467, 0.0090242400765419, 0.0076225874945521355, 0.008254128508269787, 0.009933754801750183, 0.011232834309339523, 0.01149374432861805, 0.008438840508460999, 0.01463245041668415, 0.012348632328212261, 0.012769426219165325, 0.014393053017556667, 0.01134825125336647, 0.02204233407974243, 0.018665563315153122, 0.008012577891349792, 0.011142662726342678, 0.01515314169228077, 0.012364216148853302, 0.009338505566120148, 0.007884162478148937, 0.009960995987057686, 0.008593923412263393, 0.017912285402417183, 0.01666894555091858, -1]}
{"idB": "749647_15_item1_p179_s1", "idA": "749647_14_item1_p121_s1", "sentA": "From February 1, 2013 through February 25, 2013, we sold and issued an aggregate of 1,195,923 shares of common stock under such agreement for approximately $6.8 million in aggregate gross proceeds.", "sentB": "At the closing, we paid approximately $3.0 million in cash and issued 2,712,188 shares of its common stock to EGEN.", "type": 2, "words": ["<tag1>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds.", "<tag2>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "and", "issued", "2,712,188", "shares", "of", "its", "common", "stock", "to", "EGEN.", "<tag3>"], "wordsA": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds."], "wordsB": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "and", "issued", "2,712,188", "shares", "of", "its", "common", "stock", "to", "EGEN."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.038384854793548584, 0.02303021214902401, 0.33182767033576965, 0.022770320996642113, 0.21711792051792145, 0.03933435678482056, 0.434965044260025, 0.21222257614135742, 0.11278877407312393, 0.3543362617492676, 0.006360679864883423, 0.11158276349306107, 0.5656964778900146, 0.25653785467147827, 0.03599357604980469, 0.024253573268651962, 0.10239820182323456, 0.09965116530656815, 0.021516555920243263, 0.08749954402446747, -1]}
{"idB": "749647_15_item1_p21_s3", "idA": "749647_14_item1_p122_s1", "sentA": "All of the shares of Series A 0% convertible preferred stock have been converted into 2,682,764 shares of common stock.", "sentB": "The consideration of the acquisition include an initial payment of approximately $3.0 million in cash plus 2.7 million shares of Celsion s common stock.", "type": 2, "words": ["<tag1>", "All", "of", "the", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "have", "been", "converted", "into", "2,682,764", "shares", "of", "common", "stock.", "<tag2>", "The", "consideration", "of", "the", "acquisition", "include", "an", "initial", "payment", "of", "approximately", "$3.0", "million", "in", "cash", "plus", "2.7", "million", "shares", "of", "Celsion", "s", "common", "stock.", "<tag3>"], "wordsA": ["All", "of", "the", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "have", "been", "converted", "into", "2,682,764", "shares", "of", "common", "stock."], "wordsB": ["The", "consideration", "of", "the", "acquisition", "include", "an", "initial", "payment", "of", "approximately", "$3.0", "million", "in", "cash", "plus", "2.7", "million", "shares", "of", "Celsion", "s", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0061779324896633625, 0.05806492641568184, 0.010751714929938316, 0.009044504724442959, 0.0423043891787529, 0.02936881221830845, 0.02891632914543152, 0.23954877257347107, 0.3604944944381714, 0.08132622390985489, 0.10554446280002594, 0.5366079211235046, 0.28411054611206055, 0.1745559275150299, 0.39596793055534363, 0.07743184268474579, 0.18065163493156433, 0.21370185911655426, 0.21755772829055786, 0.05091346427798271, 0.28411194682121277, 0.21674737334251404, 0.2867017686367035, 0.27271410822868347, -1]}
{"idB": "749647_15_item1_p180_s0", "idA": "749647_14_item1_p125_s0", "sentA": "In addition, the Company entered into a loan agreement on November 25, 2013 with Hercules Technology Growth Capital, Inc. (Hercules), pursuant to which the Company may borrow a secured term loan of up to $20 million in multiple tranches (the Hercules Credit Agreement).", "sentB": "In addition, we entered into a loan agreement on November 25, 2013 with Hercules Technology Growth Capital, Inc. (Hercules), pursuant to which we may borrow a secured term loan of up to $20 million in multiple tranches (the Hercules Credit Agreement).", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "entered", "into", "a", "loan", "agreement", "on", "November", "25,", "2013", "with", "Hercules", "Technology", "Growth", "Capital,", "Inc.", "(Hercules),", "pursuant", "to", "which", "the", "Company", "may", "borrow", "a", "secured", "term", "loan", "of", "up", "to", "$20", "million", "in", "multiple", "tranches", "(the", "Hercules", "Credit", "Agreement).", "<tag2>", "In", "addition,", "we", "entered", "into", "a", "loan", "agreement", "on", "November", "25,", "2013", "with", "Hercules", "Technology", "Growth", "Capital,", "Inc.", "(Hercules),", "pursuant", "to", "which", "we", "may", "borrow", "a", "secured", "term", "loan", "of", "up", "to", "$20", "million", "in", "multiple", "tranches", "(the", "Hercules", "Credit", "Agreement).", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "entered", "into", "a", "loan", "agreement", "on", "November", "25,", "2013", "with", "Hercules", "Technology", "Growth", "Capital,", "Inc.", "(Hercules),", "pursuant", "to", "which", "the", "Company", "may", "borrow", "a", "secured", "term", "loan", "of", "up", "to", "$20", "million", "in", "multiple", "tranches", "(the", "Hercules", "Credit", "Agreement)."], "wordsB": ["In", "addition,", "we", "entered", "into", "a", "loan", "agreement", "on", "November", "25,", "2013", "with", "Hercules", "Technology", "Growth", "Capital,", "Inc.", "(Hercules),", "pursuant", "to", "which", "we", "may", "borrow", "a", "secured", "term", "loan", "of", "up", "to", "$20", "million", "in", "multiple", "tranches", "(the", "Hercules", "Credit", "Agreement)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.020305728539824486, 0.05506673827767372, 0.5205976963043213, 0.06423570215702057, 0.060238391160964966, 0.028790440410375595, 0.06820233166217804, 0.07494800537824631, 0.030235037207603455, 0.04793058708310127, 0.06994988024234772, 0.04485650360584259, 0.04548224061727524, 0.7253572344779968, 0.1511513590812683, 0.10996992886066437, 0.10282107442617416, 0.06794051826000214, 0.6041305661201477, 0.03886969015002251, 0.03797825425863266, 0.024531591683626175, 0.04731134697794914, 0.043513067066669464, 0.07316160947084427, 0.028133710846304893, 0.06468654423952103, 0.056098151952028275, 0.06278587132692337, 0.027856312692165375, 0.03446013852953911, 0.03793659061193466, 0.08456787467002869, 0.07078228145837784, 0.030017947778105736, 0.04131769388914108, 0.07289959490299225, 0.01705234870314598, 0.0978173092007637, 0.08154978603124619, 0.11428958922624588, -1]}
{"idB": "749647_15_item1_p24_s5", "idA": "749647_14_item1_p125_s0", "sentA": "In addition, the Company entered into a loan agreement on November 25, 2013 with Hercules Technology Growth Capital, Inc. (Hercules), pursuant to which the Company may borrow a secured term loan of up to $20 million in multiple tranches (the Hercules Credit Agreement).", "sentB": "We have one credit facility for a total principle amount of up to $20 million and have drawn down $10 million under this credit facility.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "entered", "into", "a", "loan", "agreement", "on", "November", "25,", "2013", "with", "Hercules", "Technology", "Growth", "Capital,", "Inc.", "(Hercules),", "pursuant", "to", "which", "the", "Company", "may", "borrow", "a", "secured", "term", "loan", "of", "up", "to", "$20", "million", "in", "multiple", "tranches", "(the", "Hercules", "Credit", "Agreement).", "<tag2>", "We", "have", "one", "credit", "facility", "for", "a", "total", "principle", "amount", "of", "up", "to", "$20", "million", "and", "have", "drawn", "down", "$10", "million", "under", "this", "credit", "facility.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "entered", "into", "a", "loan", "agreement", "on", "November", "25,", "2013", "with", "Hercules", "Technology", "Growth", "Capital,", "Inc.", "(Hercules),", "pursuant", "to", "which", "the", "Company", "may", "borrow", "a", "secured", "term", "loan", "of", "up", "to", "$20", "million", "in", "multiple", "tranches", "(the", "Hercules", "Credit", "Agreement)."], "wordsB": ["We", "have", "one", "credit", "facility", "for", "a", "total", "principle", "amount", "of", "up", "to", "$20", "million", "and", "have", "drawn", "down", "$10", "million", "under", "this", "credit", "facility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.052325665950775146, 0.02332228608429432, 0.5235112905502319, 0.6720168590545654, 0.42063233256340027, 0.00898043718189001, 0.01054826844483614, 0.04910286143422127, 0.037348054349422455, 0.04330725967884064, 0.013622679747641087, 0.014745674096047878, 0.010756975039839745, 0.02778755873441696, 0.0334513857960701, 0.0005183388129808009, 0.016893215477466583, 0.2523576617240906, 0.36849331855773926, 0.10336508601903915, 0.13812720775604248, 0.035786330699920654, 0.007507553789764643, 0.06792525947093964, 0.04296741262078285, -1]}
{"idB": "749647_15_item1_p180_s3", "idA": "749647_14_item1_p125_s1", "sentA": "The Company drew the first tranche of $5 million at the closing under the Hercules Credit Agreement on November 25, 2013 and may request, subject to Hercules consent in its sole discretion, an additional $15 million in up to three advances with each advance in a minimum amount of $5 million, unless otherwise agreed upon by the Company and Hercules, before June 30, 2014 unless extended upon Hercules consent.", "sentB": "We drew the first tranche of $5 million on November 25, 2013 and may request, subject to Hercules consent in its sole discretion, an additional $15 million in up to three advances with each advance in a minimum amount of $5 million before June 30, 2014 unless extended upon Hercules consent.", "type": 2, "words": ["<tag1>", "The", "Company", "drew", "the", "first", "tranche", "of", "$5", "million", "at", "the", "closing", "under", "the", "Hercules", "Credit", "Agreement", "on", "November", "25,", "2013", "and", "may", "request,", "subject", "to", "Hercules", "consent", "in", "its", "sole", "discretion,", "an", "additional", "$15", "million", "in", "up", "to", "three", "advances", "with", "each", "advance", "in", "a", "minimum", "amount", "of", "$5", "million,", "unless", "otherwise", "agreed", "upon", "by", "the", "Company", "and", "Hercules,", "before", "June", "30,", "2014", "unless", "extended", "upon", "Hercules", "consent.", "<tag2>", "We", "drew", "the", "first", "tranche", "of", "$5", "million", "on", "November", "25,", "2013", "and", "may", "request,", "subject", "to", "Hercules", "consent", "in", "its", "sole", "discretion,", "an", "additional", "$15", "million", "in", "up", "to", "three", "advances", "with", "each", "advance", "in", "a", "minimum", "amount", "of", "$5", "million", "before", "June", "30,", "2014", "unless", "extended", "upon", "Hercules", "consent.", "<tag3>"], "wordsA": ["The", "Company", "drew", "the", "first", "tranche", "of", "$5", "million", "at", "the", "closing", "under", "the", "Hercules", "Credit", "Agreement", "on", "November", "25,", "2013", "and", "may", "request,", "subject", "to", "Hercules", "consent", "in", "its", "sole", "discretion,", "an", "additional", "$15", "million", "in", "up", "to", "three", "advances", "with", "each", "advance", "in", "a", "minimum", "amount", "of", "$5", "million,", "unless", "otherwise", "agreed", "upon", "by", "the", "Company", "and", "Hercules,", "before", "June", "30,", "2014", "unless", "extended", "upon", "Hercules", "consent."], "wordsB": ["We", "drew", "the", "first", "tranche", "of", "$5", "million", "on", "November", "25,", "2013", "and", "may", "request,", "subject", "to", "Hercules", "consent", "in", "its", "sole", "discretion,", "an", "additional", "$15", "million", "in", "up", "to", "three", "advances", "with", "each", "advance", "in", "a", "minimum", "amount", "of", "$5", "million", "before", "June", "30,", "2014", "unless", "extended", "upon", "Hercules", "consent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.5207570195198059, 0.07415773719549179, 0.016639787703752518, 0.019393840804696083, 0.040046077221632004, 0.01287359744310379, 0.03616145998239517, 0.027910146862268448, 0.013288510031998158, 0.017580078914761543, 0.01950233243405819, 0.017495635896921158, 0.009868503548204899, 0.014309684745967388, 0.01639566384255886, 0.01475019846111536, 0.016405679285526276, 0.07127972692251205, 0.029688334092497826, 0.01055892463773489, 0.0151074742898345, 0.03352423384785652, 0.04651431739330292, 0.008499432355165482, 0.01798914186656475, 0.028981871902942657, 0.023772625252604485, 0.011314691975712776, 0.015895258635282516, 0.017432352527976036, 0.021060260012745857, 0.022632034495472908, 0.01174467895179987, 0.016785521060228348, 0.0226240586489439, 0.009751747362315655, 0.010379591025412083, 0.02334406040608883, 0.015243430621922016, 0.010716638527810574, 0.15623141825199127, 0.06084159016609192, 0.03440931811928749, 0.02483716607093811, 0.04105495661497116, 0.034357596188783646, 0.08011176437139511, 0.11152111738920212, 0.0733841210603714, 0.1679922342300415, 0.1405448168516159, -1]}
{"idB": "749647_15_item1_p180_s4", "idA": "749647_14_item1_p125_s2", "sentA": "The Company used approximately $4 million of the first tranche to repay the outstanding obligations under a loan agreement with Oxford Finance LLC and Horizon Technology Finance Corporation.", "sentB": "We used approximately $4 million of the first tranche to repay the outstanding obligations under a loan agreement with Oxford Finance LLC and Horizon Technology Finance Corporation.", "type": 2, "words": ["<tag1>", "The", "Company", "used", "approximately", "$4", "million", "of", "the", "first", "tranche", "to", "repay", "the", "outstanding", "obligations", "under", "a", "loan", "agreement", "with", "Oxford", "Finance", "LLC", "and", "Horizon", "Technology", "Finance", "Corporation.", "<tag2>", "We", "used", "approximately", "$4", "million", "of", "the", "first", "tranche", "to", "repay", "the", "outstanding", "obligations", "under", "a", "loan", "agreement", "with", "Oxford", "Finance", "LLC", "and", "Horizon", "Technology", "Finance", "Corporation.", "<tag3>"], "wordsA": ["The", "Company", "used", "approximately", "$4", "million", "of", "the", "first", "tranche", "to", "repay", "the", "outstanding", "obligations", "under", "a", "loan", "agreement", "with", "Oxford", "Finance", "LLC", "and", "Horizon", "Technology", "Finance", "Corporation."], "wordsB": ["We", "used", "approximately", "$4", "million", "of", "the", "first", "tranche", "to", "repay", "the", "outstanding", "obligations", "under", "a", "loan", "agreement", "with", "Oxford", "Finance", "LLC", "and", "Horizon", "Technology", "Finance", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8312633633613586, 0.17300713062286377, 0.1481853723526001, 0.37349361181259155, 0.2474978119134903, 0.028285829350352287, 0.015558759681880474, 0.04674377664923668, 0.06927396357059479, 0.023282716050744057, 0.07574285566806793, 0.018812749534845352, 0.05221813544631004, 0.07047998160123825, 0.008090977557003498, 0.007152040023356676, 0.030270958319306374, 0.028194189071655273, 0.008587409742176533, 0.027651922777295113, 0.023551326245069504, 0.036509983241558075, 0.0069738831371068954, 0.018178632482886314, 0.015243038535118103, 0.015548880212008953, 0.015114535577595234, -1]}
{"idB": "749647_15_item1_p180_s1", "idA": "749647_14_item1_p126_s0", "sentA": "The loan bears interest at a floating per annum rate equal to the greater of (i) 11.25 percent and (ii) the sum of 11.25 per cent plus the prime rate minus 3.25 per cent.", "sentB": "The loan bears interest at a floating per annum rate equal to the greater of (i) 11.25 percent and (ii) the sum of 11.25 percent plus the prime rate minus 3.25 percent.", "type": 2, "words": ["<tag1>", "The", "loan", "bears", "interest", "at", "a", "floating", "per", "annum", "rate", "equal", "to", "the", "greater", "of", "(i)", "11.25", "percent", "and", "(ii)", "the", "sum", "of", "11.25", "per", "cent", "plus", "the", "prime", "rate", "minus", "3.25", "per", "cent.", "<tag2>", "The", "loan", "bears", "interest", "at", "a", "floating", "per", "annum", "rate", "equal", "to", "the", "greater", "of", "(i)", "11.25", "percent", "and", "(ii)", "the", "sum", "of", "11.25", "percent", "plus", "the", "prime", "rate", "minus", "3.25", "percent.", "<tag3>"], "wordsA": ["The", "loan", "bears", "interest", "at", "a", "floating", "per", "annum", "rate", "equal", "to", "the", "greater", "of", "(i)", "11.25", "percent", "and", "(ii)", "the", "sum", "of", "11.25", "per", "cent", "plus", "the", "prime", "rate", "minus", "3.25", "per", "cent."], "wordsB": ["The", "loan", "bears", "interest", "at", "a", "floating", "per", "annum", "rate", "equal", "to", "the", "greater", "of", "(i)", "11.25", "percent", "and", "(ii)", "the", "sum", "of", "11.25", "percent", "plus", "the", "prime", "rate", "minus", "3.25", "percent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003845025086775422, 0.019886605441570282, 0.02068510092794895, 0.01990009844303131, 0.007621913682669401, 0.007584020495414734, 0.012732330709695816, 0.011797589249908924, 0.011539740487933159, 0.012515874579548836, 0.011252271011471748, 0.012959067709743977, 0.013202965259552002, 0.02797105349600315, 0.018668776378035545, 0.022593019530177116, 0.030996497720479965, 0.06547162681818008, 0.007406750228255987, 0.013566468842327595, 0.007602511905133724, 0.022611863911151886, 0.017987800762057304, 0.07687012851238251, 0.8005865216255188, 0.01092127151787281, 0.008264737203717232, 0.0115806357935071, 0.01691007800400257, 0.03216835483908653, 0.05841817706823349, 0.1912514865398407, -1]}
{"idB": "749647_15_item1_p181_s0", "idA": "749647_14_item1_p127_s0", "sentA": "We believe that our cash and investment resources of $43.1 million on hand at December 31, 2013, as well as the $13.8 million of net proceeds the Company received in the first quarter of 2014 from the January 15, 2014 common stock offering, are sufficient to fund operations through 2016.", "sentB": "We believe that our cash and investment resources of $37.1 million on hand at December 31, 2014, coupled with our access to the ATM, are sufficient to fund operations through 2016.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$43.1", "million", "on", "hand", "at", "December", "31,", "2013,", "as", "well", "as", "the", "$13.8", "million", "of", "net", "proceeds", "the", "Company", "received", "in", "the", "first", "quarter", "of", "2014", "from", "the", "January", "15,", "2014", "common", "stock", "offering,", "are", "sufficient", "to", "fund", "operations", "through", "2016.", "<tag2>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$37.1", "million", "on", "hand", "at", "December", "31,", "2014,", "coupled", "with", "our", "access", "to", "the", "ATM,", "are", "sufficient", "to", "fund", "operations", "through", "2016.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$43.1", "million", "on", "hand", "at", "December", "31,", "2013,", "as", "well", "as", "the", "$13.8", "million", "of", "net", "proceeds", "the", "Company", "received", "in", "the", "first", "quarter", "of", "2014", "from", "the", "January", "15,", "2014", "common", "stock", "offering,", "are", "sufficient", "to", "fund", "operations", "through", "2016."], "wordsB": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$37.1", "million", "on", "hand", "at", "December", "31,", "2014,", "coupled", "with", "our", "access", "to", "the", "ATM,", "are", "sufficient", "to", "fund", "operations", "through", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005845813546329737, 0.00792415626347065, 0.003242580685764551, 0.0032953480258584023, 0.008266626857221127, 0.0024216060992330313, 0.0068322038277983665, 0.013525262475013733, 0.0054956222884356976, 0.9545367360115051, 0.2051982879638672, 0.004586304072290659, 0.008330916054546833, 0.005449975375086069, 0.005461315158754587, 0.005975167267024517, 0.08476205915212631, 0.007659207098186016, 0.010327943600714207, 0.03858158364892006, 0.24938423931598663, 0.34565994143486023, 0.28870630264282227, 0.6679607629776001, 0.004012476187199354, 0.007471887394785881, 0.0036733325105160475, 0.005893051158636808, 0.008045375347137451, 0.008753304369747639, 0.023191167041659355, -1]}
{"idB": "749647_15_item1_p144_s1", "idA": "749647_14_item1_p128_s1", "sentA": "We do not have any committed sources of financing and cannot give assurance that alternate funding will be available in a timely manner, on acceptable terms or at all.", "sentB": "We currently do not have marketing, sales and distribution capabilities.", "type": 2, "words": ["<tag1>", "We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "give", "assurance", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all.", "<tag2>", "We", "currently", "do", "not", "have", "marketing,", "sales", "and", "distribution", "capabilities.", "<tag3>"], "wordsA": ["We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "give", "assurance", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all."], "wordsB": ["We", "currently", "do", "not", "have", "marketing,", "sales", "and", "distribution", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.039502255618572235, 0.039844393730163574, 0.26519575715065, 0.4562036693096161, 0.3372829556465149, 0.845526397228241, 0.6928234100341797, 0.30814406275749207, 0.6399384140968323, 0.5779592990875244, -1]}
{"idB": "749647_15_item1_p177_s0", "idA": "749647_14_item1_p129_s0", "sentA": "On January 15, 2014, the Company entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company sold, in a registered offering, an aggregate of 3,603,604 shares of its common stock, par value $0.01 per share, and warrants to purchase up to 1,801,802 shares of Common Stock, for an aggregate purchase price of approximately $15 million.", "sentB": "On January 15, 2014, we entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company sold, in a registered offering, an aggregate of 3,603,604 shares of its common stock and warrants to purchase up to 1,801,802 shares of Common Stock, for an aggregate purchase price of approximately $15 million.", "type": 2, "words": ["<tag1>", "On", "January", "15,", "2014,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "its", "common", "stock,", "par", "value", "$0.01", "per", "share,", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million.", "<tag2>", "On", "January", "15,", "2014,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "its", "common", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million.", "<tag3>"], "wordsA": ["On", "January", "15,", "2014,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "its", "common", "stock,", "par", "value", "$0.01", "per", "share,", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million."], "wordsB": ["On", "January", "15,", "2014,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "its", "common", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027433082461357117, 0.04007373005151749, 0.05235316976904869, 0.045909639447927475, 0.0763784870505333, 0.06591378152370453, 0.06296752393245697, 0.03332494571805, 0.06327953189611435, 0.10775293409824371, 0.10607154667377472, 0.03050858899950981, 0.03033307194709778, 0.08560266345739365, 0.09472870826721191, 0.03419700637459755, 0.03382490947842598, 0.01451349351555109, 0.018033359199762344, 0.04448379948735237, 0.057475943118333817, 0.021000906825065613, 0.024587957188487053, 0.04498951882123947, 0.06346085667610168, 0.024050451815128326, 0.05271530896425247, 0.027909601107239723, 0.04289619252085686, 0.08458517491817474, 0.02199181169271469, 0.02642194740474224, 0.04412852227687836, 0.058522406965494156, 0.019349180161952972, 0.036448508501052856, 0.023682503029704094, 0.030593078583478928, 0.03546060249209404, 0.03608943149447441, 0.044267985969781876, 0.05219701677560806, 0.02413894236087799, 0.03467809036374092, 0.04005345329642296, 0.024653760716319084, 0.024088459089398384, 0.029427120462059975, 0.03334610536694527, 0.03400614485144615, 0.02371853217482567, 0.029750918969511986, 0.07484333962202072, 0.06277420371770859, -1]}
{"idB": "749647_15_item1_p48_s1", "idA": "749647_14_item1_p12_s2", "sentA": "In January 2014, we announced that the latest overall survival data from the post-hoc analysis of results from the HEAT Study supports continued clinical development through a prospective pivotal Phase III Study.", "sentB": "In January 2014, we announced that the OS data from the post-hoc analysis of results from the HEAT Study support continued clinical development through a prospective pivotal Phase III Study.", "type": 2, "words": ["<tag1>", "In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study.", "<tag2>", "In", "January", "2014,", "we", "announced", "that", "the", "OS", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "support", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study.", "<tag3>"], "wordsA": ["In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study."], "wordsB": ["In", "January", "2014,", "we", "announced", "that", "the", "OS", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "support", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0016060147900134325, 0.002688515931367874, 0.003246346255764365, 0.003802376799285412, 0.005800001788884401, 0.003981046378612518, 0.00848862249404192, 0.9870391488075256, 0.5120605230331421, 0.0026446206029504538, 0.0015263493405655026, 0.002930574817582965, 0.004370116163045168, 0.0012242385419085622, 0.004345837980508804, 0.0014372968580573797, 0.0012242402881383896, 0.0031523234210908413, 0.0028714914806187153, 0.006571859586983919, 0.0034489149693399668, 0.004479419905692339, 0.004832633305341005, 0.001428748364560306, 0.0011329466942697763, 0.002399957273155451, 0.0023505277931690216, 0.0022374282125383615, 0.002410857006907463, 0.0036172401160001755, -1]}
{"idB": "749647_15_item1_p123_s0", "idA": "749647_14_item1_p130_s0", "sentA": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, has provided and allowed, subject to compliance with regulatory standards, clearance for our planned pivotal, double-blind, placebo-controlled Phase III trial (the OPTIMA Study) of ThermoDox in combination with RFA in primary liver cancer (HCC).", "sentB": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, clearance for the OPTIMA Study our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with RFA in primary liver cancer, also known as HCC.", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "our", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer", "(HCC).", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC.", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "our", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer", "(HCC)."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007781287655234337, 0.01052401028573513, 0.011990268714725971, 0.010665756650269032, 0.01329520158469677, 0.01683896780014038, 0.007578055374324322, 0.007679931819438934, 0.026666518300771713, 0.00746548967435956, 0.010937404818832874, 0.012580160982906818, 0.012300746515393257, 0.012446077540516853, 0.011645159684121609, 0.013063627295196056, 0.2188052237033844, 0.9467551708221436, 0.8755894899368286, 0.01981228217482567, 0.012106919661164284, 0.012156867422163486, 0.010319042019546032, 0.01225382648408413, 0.01564580574631691, 0.022179368883371353, 0.010345113463699818, 0.00756633747369051, 0.02386661246418953, 0.011068125255405903, 0.007910684682428837, 0.012797588482499123, 0.016574902459979057, 0.016222713515162468, 0.013148368336260319, 0.010630943812429905, 0.020007776096463203, 0.010500947013497353, 0.046355728060007095, 0.016415191814303398, 0.01931680180132389, 0.01891132816672325, 0.035592321306467056, 0.008678439073264599, 0.032693203538656235, 0.024661097675561905, 0.020420873537659645, 0.01292081456631422, 0.01777154766023159, 0.020609572529792786, 0.09747019410133362, -1]}
{"idB": "749647_15_item1_p51_s1", "idA": "749647_14_item1_p130_s0", "sentA": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, has provided and allowed, subject to compliance with regulatory standards, clearance for our planned pivotal, double-blind, placebo-controlled Phase III trial (the OPTIMA Study) of ThermoDox in combination with RFA in primary liver cancer (HCC).", "sentB": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, clearance for the OPTIMA Study our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with standardized RFA in primary liver cancer, also known as HCC.", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "our", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer", "(HCC).", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC.", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "our", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer", "(HCC)."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007258660160005093, 0.009746352210640907, 0.011007376946508884, 0.009663902223110199, 0.011925884522497654, 0.014878492802381516, 0.006853738334029913, 0.007185830734670162, 0.025809381157159805, 0.007034494075924158, 0.010255612432956696, 0.011367366649210453, 0.011320658959448338, 0.011288100853562355, 0.010650541633367538, 0.011931262910366058, 0.1729658842086792, 0.9405011534690857, 0.851873517036438, 0.017444055527448654, 0.0114408815279603, 0.01075371727347374, 0.009680775925517082, 0.010475954972207546, 0.013570815324783325, 0.01925704814493656, 0.009653991088271141, 0.007267107721418142, 0.019642449915409088, 0.009755967184901237, 0.0073120445013046265, 0.010746821761131287, 0.014497500844299793, 0.014344990253448486, 0.011429565958678722, 0.00917346216738224, 0.01763281226158142, 0.008642339147627354, 0.027141394093632698, 0.015418868511915207, 0.016171539202332497, 0.016029808670282364, 0.12151177227497101, 0.07878939807415009, 0.007023957557976246, 0.018053298816084862, 0.023243213072419167, 0.014525310136377811, 0.007993354462087154, 0.010177216492593288, 0.009787109680473804, 0.03811539337038994, -1]}
{"idB": "749647_15_item1_p20_s0", "idA": "749647_14_item1_p132_s0", "sentA": "In addition, the Company recently met with the China State Food and Drug Administration (CHINA FDA) to discuss the OPTIMA Phase III trial, including minimum patient enrollment requirements supporting ThermoDox s registration in China.", "sentB": "In addition, the Company has met with the China State Food and Drug Administration (CHINA FDA) to discuss the OPTIMA Phase III Study including minimum patient enrollment requirements supporting the registration of ThermoDox in China.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "trial,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China.", "<tag2>", "In", "addition,", "the", "Company", "has", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "Study", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "the", "registration", "of", "ThermoDox", "in", "China.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "trial,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China."], "wordsB": ["In", "addition,", "the", "Company", "has", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "Study", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "the", "registration", "of", "ThermoDox", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004083907697349787, 0.005526176653802395, 0.0028762139845639467, 0.019733237102627754, 0.007656655739992857, 0.007499105762690306, 0.0035712625831365585, 0.003241956466808915, 0.007348198909312487, 0.007584329694509506, 0.007719213142991066, 0.005639771930873394, 0.006962588522583246, 0.007965701632201672, 0.005986421834677458, 0.008795738220214844, 0.002814488485455513, 0.00832344964146614, 0.0044960747472941875, 0.012525299564003944, 0.01828697882592678, 0.02690127305686474, 0.9170895218849182, 0.005256392061710358, 0.009524617344141006, 0.013957732357084751, 0.01053586509078741, 0.007317494601011276, 0.005529353860765696, 0.004741453565657139, 0.015014339238405228, 0.008162738755345345, 0.013946998864412308, 0.004571754485368729, 0.011401928961277008, -1]}
{"idB": "749647_15_item1_p55_s0", "idA": "749647_14_item1_p132_s0", "sentA": "In addition, the Company recently met with the China State Food and Drug Administration (CHINA FDA) to discuss the OPTIMA Phase III trial, including minimum patient enrollment requirements supporting ThermoDox s registration in China.", "sentB": "In addition, the Company has met with the China State Food and Drug Administration (CHINA FDA) to discuss the OPTIMA Phase III Study including minimum patient enrollment requirements supporting the registration of ThermoDox in China.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "trial,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China.", "<tag2>", "In", "addition,", "the", "Company", "has", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "Study", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "the", "registration", "of", "ThermoDox", "in", "China.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "recently", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "trial,", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "ThermoDox", "s", "registration", "in", "China."], "wordsB": ["In", "addition,", "the", "Company", "has", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "Study", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "the", "registration", "of", "ThermoDox", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004083907697349787, 0.005526176653802395, 0.0028762139845639467, 0.019733237102627754, 0.007656655739992857, 0.007499105762690306, 0.0035712625831365585, 0.003241956466808915, 0.007348198909312487, 0.007584329694509506, 0.007719213142991066, 0.005639771930873394, 0.006962588522583246, 0.007965701632201672, 0.005986421834677458, 0.008795738220214844, 0.002814488485455513, 0.00832344964146614, 0.0044960747472941875, 0.012525299564003944, 0.01828697882592678, 0.02690127305686474, 0.9170895218849182, 0.005256392061710358, 0.009524617344141006, 0.013957732357084751, 0.01053586509078741, 0.007317494601011276, 0.005529353860765696, 0.004741453565657139, 0.015014339238405228, 0.008162738755345345, 0.013946998864412308, 0.004571754485368729, 0.011401928961277008, -1]}
{"idB": "749647_15_item1_p20_s3", "idA": "749647_14_item1_p132_s2", "sentA": "The Company plans to expand its clinical site footprint in Europe and meet with the European Medicines Agency (EMA) in the first half of 2014.", "sentB": "Our request for a VHP in Europe was approved on October 23, 2014.", "type": 2, "words": ["<tag1>", "The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "and", "meet", "with", "the", "European", "Medicines", "Agency", "(EMA)", "in", "the", "first", "half", "of", "2014.", "<tag2>", "Our", "request", "for", "a", "VHP", "in", "Europe", "was", "approved", "on", "October", "23,", "2014.", "<tag3>"], "wordsA": ["The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "and", "meet", "with", "the", "European", "Medicines", "Agency", "(EMA)", "in", "the", "first", "half", "of", "2014."], "wordsB": ["Our", "request", "for", "a", "VHP", "in", "Europe", "was", "approved", "on", "October", "23,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11117435246706009, 0.38239338994026184, 0.16698074340820312, 0.1491788923740387, 0.6833409070968628, 0.03622183948755264, 0.06182201951742172, 0.052950505167245865, 0.2065059095621109, 0.06944551318883896, 0.3297143578529358, 0.29537567496299744, 0.08421102911233902, -1]}
{"idB": "749647_15_item1_p55_s3", "idA": "749647_14_item1_p132_s2", "sentA": "The Company plans to expand its clinical site footprint in Europe and meet with the European Medicines Agency (EMA) in the first half of 2014.", "sentB": "Our request for a VHP in Europe was approved on October 23, 2014.", "type": 2, "words": ["<tag1>", "The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "and", "meet", "with", "the", "European", "Medicines", "Agency", "(EMA)", "in", "the", "first", "half", "of", "2014.", "<tag2>", "Our", "request", "for", "a", "VHP", "in", "Europe", "was", "approved", "on", "October", "23,", "2014.", "<tag3>"], "wordsA": ["The", "Company", "plans", "to", "expand", "its", "clinical", "site", "footprint", "in", "Europe", "and", "meet", "with", "the", "European", "Medicines", "Agency", "(EMA)", "in", "the", "first", "half", "of", "2014."], "wordsB": ["Our", "request", "for", "a", "VHP", "in", "Europe", "was", "approved", "on", "October", "23,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11117435246706009, 0.38239338994026184, 0.16698074340820312, 0.1491788923740387, 0.6833409070968628, 0.03622183948755264, 0.06182201951742172, 0.052950505167245865, 0.2065059095621109, 0.06944551318883896, 0.3297143578529358, 0.29537567496299744, 0.08421102911233902, -1]}
{"idB": "749647_15_item1_p48_s3", "idA": "749647_14_item1_p13_s0", "sentA": "As reported in January 2014, post-hoc data from the HEAT Study demonstrate that the patient subgroup in the ThermoDox arm whose RFA procedure lasted longer than 45 minutes (285 patients or 63% of single lesion patients), experienced a 55% improvement in overall survival, with a Hazard Ratio of 0.64 (95% CI 0.41 - 1.00) and a P-value = 0.0495.", "sentB": "The most recent post-hoc analysis data from the HEAT Study announced in February 2015 demonstrate that the patient subgroup in the ThermoDox arm whose RFA procedure lasted longer than 45 minutes (285 patients or 41% of the study patients), experienced a 59% improvement in overall survival, with a Hazard Ratio of 0.628 (95% CI 0.420 - 0.939) and a P-value of 0.02.", "type": 2, "words": ["<tag1>", "As", "reported", "in", "January", "2014,", "post-hoc", "data", "from", "the", "HEAT", "Study", "demonstrate", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "(285", "patients", "or", "63%", "of", "single", "lesion", "patients),", "experienced", "a", "55%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495.", "<tag2>", "The", "most", "recent", "post-hoc", "analysis", "data", "from", "the", "HEAT", "Study", "announced", "in", "February", "2015", "demonstrate", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "(285", "patients", "or", "41%", "of", "the", "study", "patients),", "experienced", "a", "59%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "and", "a", "P-value", "of", "0.02.", "<tag3>"], "wordsA": ["As", "reported", "in", "January", "2014,", "post-hoc", "data", "from", "the", "HEAT", "Study", "demonstrate", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "(285", "patients", "or", "63%", "of", "single", "lesion", "patients),", "experienced", "a", "55%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495."], "wordsB": ["The", "most", "recent", "post-hoc", "analysis", "data", "from", "the", "HEAT", "Study", "announced", "in", "February", "2015", "demonstrate", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "(285", "patients", "or", "41%", "of", "the", "study", "patients),", "experienced", "a", "59%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "and", "a", "P-value", "of", "0.02."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0043194228783249855, 0.06811223924160004, 0.053819648921489716, 0.005823382176458836, 0.014336896128952503, 0.019625063985586166, 0.002261092886328697, 0.002165742451325059, 0.003868560306727886, 0.004519167821854353, 0.004909119568765163, 0.021657444536685944, 0.4617309868335724, 0.4083607792854309, 0.005883416160941124, 0.0028496587183326483, 0.002550529083237052, 0.02194099873304367, 0.007152250036597252, 0.00217007496394217, 0.001955856801941991, 0.004288114607334137, 0.00590407382696867, 0.0016203458653762937, 0.0031285437289625406, 0.00436837412416935, 0.008592582307755947, 0.02308906987309456, 0.027895459905266762, 0.04783245548605919, 0.01354988757520914, 0.014310291036963463, 0.010170637629926205, 0.00217312085442245, 0.022480471059679985, 0.0028502389322966337, 0.0021928634960204363, 0.015566246584057808, 0.009514582343399525, 0.004957855679094791, 0.003412914928048849, 0.6074545383453369, 0.031231176108121872, 0.0024711466394364834, 0.007636097259819508, 0.014064566232264042, 0.002194544766098261, 0.001833840855397284, 0.0060320389457046986, 0.00802786648273468, 0.004793835803866386, 0.7179006934165955, 0.0198124498128891, 0.009528747759759426, 0.37016910314559937, 0.1251702457666397, 0.4940177798271179, 0.0025628202129155397, 0.0018378604436293244, 0.012044333852827549, 0.004536724183708429, 0.33907535672187805, -1]}
{"idB": "749647_15_item1_p54_s1", "idA": "749647_14_item1_p13_s0", "sentA": "As reported in January 2014, post-hoc data from the HEAT Study demonstrate that the patient subgroup in the ThermoDox arm whose RFA procedure lasted longer than 45 minutes (285 patients or 63% of single lesion patients), experienced a 55% improvement in overall survival, with a Hazard Ratio of 0.64 (95% CI 0.41 - 1.00) and a P-value = 0.0495.", "sentB": "As reported in February 2015, post-hoc data from the HEAT Study demonstrate that a sizable, well bounded subgroup of patients in the ThermoDox arm whose RFA procedure lasted longer than 45 minutes experienced a 59% improvement in overall survival, with a Hazard Ratio of 0.628 (95% CI 0.420 - 0.939) and a P-value = 0.02.", "type": 2, "words": ["<tag1>", "As", "reported", "in", "January", "2014,", "post-hoc", "data", "from", "the", "HEAT", "Study", "demonstrate", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "(285", "patients", "or", "63%", "of", "single", "lesion", "patients),", "experienced", "a", "55%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495.", "<tag2>", "As", "reported", "in", "February", "2015,", "post-hoc", "data", "from", "the", "HEAT", "Study", "demonstrate", "that", "a", "sizable,", "well", "bounded", "subgroup", "of", "patients", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "experienced", "a", "59%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "and", "a", "P-value", "=", "0.02.", "<tag3>"], "wordsA": ["As", "reported", "in", "January", "2014,", "post-hoc", "data", "from", "the", "HEAT", "Study", "demonstrate", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "(285", "patients", "or", "63%", "of", "single", "lesion", "patients),", "experienced", "a", "55%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495."], "wordsB": ["As", "reported", "in", "February", "2015,", "post-hoc", "data", "from", "the", "HEAT", "Study", "demonstrate", "that", "a", "sizable,", "well", "bounded", "subgroup", "of", "patients", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "experienced", "a", "59%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "and", "a", "P-value", "=", "0.02."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0023867948912084103, 0.007603289093822241, 0.009869207628071308, 0.6955569386482239, 0.5954380631446838, 0.0028407436329871416, 0.008493310771882534, 0.0016693613724783063, 0.0016012982232496142, 0.0033321117516607046, 0.003898229682818055, 0.005240037105977535, 0.0031620925292372704, 0.004324603825807571, 0.11771917343139648, 0.30282339453697205, 0.5542208552360535, 0.17541822791099548, 0.03553071245551109, 0.06451023370027542, 0.001964926952496171, 0.0017160499701276422, 0.003555390052497387, 0.005811537150293589, 0.0013372183311730623, 0.003722935914993286, 0.004791125189512968, 0.005391040351241827, 0.007965121418237686, 0.009162351489067078, 0.016684764996170998, 0.007637090515345335, 0.003921558614820242, 0.0030855326913297176, 0.42358672618865967, 0.016643736511468887, 0.002129913307726383, 0.006887014955282211, 0.010604655370116234, 0.0019028481328859925, 0.001523646991699934, 0.0095438864082098, 0.014881891198456287, 0.008531462401151657, 0.7953638434410095, 0.01044074073433876, 0.013929108157753944, 0.4730962812900543, 0.18681573867797852, 0.5520597696304321, 0.0023807971738278866, 0.0015105543425306678, 0.008838214911520481, 0.010925495997071266, 0.5276402235031128, -1]}
{"idB": "749647_15_item1_p91_s2", "idA": "749647_14_item1_p13_s1", "sentA": "Median overall survival for this subgroup has not yet been reached.", "sentB": "The median progression-free survival and overall survival for all treatment groups was 8.8 months and 16.6 months, respectively.", "type": 2, "words": ["<tag1>", "Median", "overall", "survival", "for", "this", "subgroup", "has", "not", "yet", "been", "reached.", "<tag2>", "The", "median", "progression-free", "survival", "and", "overall", "survival", "for", "all", "treatment", "groups", "was", "8.8", "months", "and", "16.6", "months,", "respectively.", "<tag3>"], "wordsA": ["Median", "overall", "survival", "for", "this", "subgroup", "has", "not", "yet", "been", "reached."], "wordsB": ["The", "median", "progression-free", "survival", "and", "overall", "survival", "for", "all", "treatment", "groups", "was", "8.8", "months", "and", "16.6", "months,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006652913521975279, 0.0654076635837555, 0.7774286270141602, 0.38861551880836487, 0.011503322049975395, 0.05261235684156418, 0.1497657299041748, 0.031235037371516228, 0.3076476454734802, 0.41040870547294617, 0.4384833872318268, 0.024431701749563217, 0.6360045075416565, 0.5136241316795349, 0.21497836709022522, 0.6855905652046204, 0.4796443581581116, 0.12156999111175537, -1]}
{"idB": "749647_15_item1_p15_s6", "idA": "749647_14_item1_p13_s2", "sentA": "We may choose to end this analysis of overall survival once the median is reached for either or both arms of the study .", "sentB": "We may choose to end this analysis of overall survival once the median is reached for both arms of the study.", "type": 2, "words": ["<tag1>", "We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "either", "or", "both", "arms", "of", "the", "study", ".", "<tag2>", "We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "both", "arms", "of", "the", "study.", "<tag3>"], "wordsA": ["We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "either", "or", "both", "arms", "of", "the", "study", "."], "wordsB": ["We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "both", "arms", "of", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012266774661839008, 0.01641027256846428, 0.02316424623131752, 0.019272755831480026, 0.5159012675285339, 0.014701781794428825, 0.02729141153395176, 0.012072930112481117, 0.017310019582509995, 0.021244332194328308, 0.017481591552495956, 0.01387016847729683, 0.2241598218679428, 0.058630768209695816, 0.0570768378674984, 0.05706414952874184, 0.6965881586074829, 0.2937876284122467, 0.02455708011984825, 0.02147722989320755, 0.0408628024160862, -1]}
{"idB": "749647_15_item1_p49_s2", "idA": "749647_14_item1_p13_s2", "sentA": "We may choose to end this analysis of overall survival once the median is reached for either or both arms of the study .", "sentB": "We may choose to end this analysis of overall survival once the median is reached for both arms of the study.", "type": 2, "words": ["<tag1>", "We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "either", "or", "both", "arms", "of", "the", "study", ".", "<tag2>", "We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "both", "arms", "of", "the", "study.", "<tag3>"], "wordsA": ["We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "either", "or", "both", "arms", "of", "the", "study", "."], "wordsB": ["We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "both", "arms", "of", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012266774661839008, 0.01641027256846428, 0.02316424623131752, 0.019272755831480026, 0.5159012675285339, 0.014701781794428825, 0.02729141153395176, 0.012072930112481117, 0.017310019582509995, 0.021244332194328308, 0.017481591552495956, 0.01387016847729683, 0.2241598218679428, 0.058630768209695816, 0.0570768378674984, 0.05706414952874184, 0.6965881586074829, 0.2937876284122467, 0.02455708011984825, 0.02147722989320755, 0.0408628024160862, -1]}
{"idB": "749647_15_item1_p16_s0", "idA": "749647_14_item1_p14_s0", "sentA": "Emerging data from the HEAT Study post-hoc analysis has been presented at three scientific and medical conferences in 2013 by key HEAT Study investigators and leading liver cancer experts.", "sentB": "Data from the HEAT Study post-hoc analysis have been presented at five scientific and medical conferences in 2013 and 2014 by key HEAT Study investigators and leading liver cancer experts.", "type": 2, "words": ["<tag1>", "Emerging", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "has", "been", "presented", "at", "three", "scientific", "and", "medical", "conferences", "in", "2013", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts.", "<tag2>", "Data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "have", "been", "presented", "at", "five", "scientific", "and", "medical", "conferences", "in", "2013", "and", "2014", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts.", "<tag3>"], "wordsA": ["Emerging", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "has", "been", "presented", "at", "three", "scientific", "and", "medical", "conferences", "in", "2013", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts."], "wordsB": ["Data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "have", "been", "presented", "at", "five", "scientific", "and", "medical", "conferences", "in", "2013", "and", "2014", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021240081638097763, 0.0023978163953870535, 0.0019357289420440793, 0.006783127319067717, 0.003861987730488181, 0.004167991690337658, 0.004601126071065664, 0.002336839446797967, 0.001997284824028611, 0.009978104382753372, 0.0048125628381967545, 0.9064977765083313, 0.06503038108348846, 0.007609484251588583, 0.009034957736730576, 0.08369892835617065, 0.0062528690323233604, 0.04021323472261429, 0.017082810401916504, 0.05307122692465782, 0.0017506659496575594, 0.003944368567317724, 0.005223350133746862, 0.004760596435517073, 0.007886704057455063, 0.0018262212397530675, 0.002467803191393614, 0.00494477478787303, 0.004175917711108923, 0.005221264902502298, -1]}
{"idB": "749647_15_item1_p18_s1", "idA": "749647_14_item1_p16_s1", "sentA": "The OPTIMA Study trial design is based on the comprehensive analysis of data from the HEAT study, which, as described above, demonstrated that treatment with ThermoDox resulted in a 55 percent improvement in overall survival in a substantial number of HCC patients that received an optimized RFA treatment.", "sentB": "The OPTIMA Study trial design is based on the comprehensive analysis of data from the HEAT study, which, as described previously, demonstrated that treatment with ThermoDox resulted in a 59% improvement in overall survival in a large number of HCC patients that received an optimized RFA treatment for longer than 45 minutes.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "above,", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55", "percent", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment.", "<tag2>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "previously,", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "59%", "improvement", "in", "overall", "survival", "in", "a", "large", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment", "for", "longer", "than", "45", "minutes.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "above,", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55", "percent", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment."], "wordsB": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "previously,", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "59%", "improvement", "in", "overall", "survival", "in", "a", "large", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment", "for", "longer", "than", "45", "minutes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0032378893811255693, 0.006434291135519743, 0.005400505382567644, 0.005548201501369476, 0.00784988421946764, 0.003863501362502575, 0.006835093256086111, 0.006471306085586548, 0.005595234222710133, 0.006945494562387466, 0.007054680958390236, 0.003984401933848858, 0.006531097926199436, 0.0028934429865330458, 0.0030489061027765274, 0.005186811089515686, 0.005475040525197983, 0.007592568174004555, 0.004668150097131729, 0.004557420499622822, 0.003933163359761238, 0.004076842684298754, 0.0032855116296559572, 0.004515254870057106, 0.0029664975591003895, 0.005005841143429279, 0.005977634806185961, 0.005462136119604111, 0.00705516804009676, 0.962536633014679, 0.04625103250145912, 0.004939909093081951, 0.01054727379232645, 0.00965919066220522, 0.002574056386947632, 0.0030052659567445517, 0.019520850852131844, 0.004584390204399824, 0.0031048553064465523, 0.007613233756273985, 0.019816778600215912, 0.002946186577901244, 0.004769791383296251, 0.002324183937162161, 0.0029709336813539267, 0.003815066535025835, 0.008028535172343254, 0.01828712970018387, 0.25854378938674927, 0.5286129713058472, 0.575170636177063, 0.3476100564002991, -1]}
{"idB": "749647_15_item1_p18_s2", "idA": "749647_14_item1_p16_s3", "sentA": "The OPTIMA Study is designed with extensive input from globally recognized HCC researchers and clinicians and after formal written consultation with FDA.", "sentB": "Designed with extensive input from globally recognized HCC researchers and clinicians and, after formal written consultation with the FDA, the OPTIMA Study was launched in the first half of 2014.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "is", "designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "FDA.", "<tag2>", "Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and,", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "is", "designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "FDA."], "wordsB": ["Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and,", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013069001026451588, 0.005849686451256275, 0.014078478328883648, 0.02073475904762745, 0.0047219665721058846, 0.01097867637872696, 0.010013796389102936, 0.03429491072893143, 0.018197618424892426, 0.004528943449258804, 0.013345079496502876, 0.006853627506643534, 0.022407416254281998, 0.020021546632051468, 0.012235027737915516, 0.012315074913203716, 0.005735497921705246, 0.004913004115223885, 0.01432090811431408, 0.0047389748506248, 0.037652045488357544, 0.08855453133583069, 0.028100963681936264, 0.10305638611316681, 0.05312781035900116, 0.04587433114647865, 0.21498098969459534, 0.34483614563941956, 0.36178654432296753, 0.7304308414459229, -1]}
{"idB": "749647_15_item1_p52_s0", "idA": "749647_14_item1_p16_s3", "sentA": "The OPTIMA Study is designed with extensive input from globally recognized HCC researchers and clinicians and after formal written consultation with FDA.", "sentB": "Designed with extensive input from globally recognized HCC researchers and clinicians and after formal written consultation with the FDA, the OPTIMA Study was launched in the first half of 2014.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "is", "designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "FDA.", "<tag2>", "Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "is", "designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "FDA."], "wordsB": ["Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012101760134100914, 0.005612170323729515, 0.015817850828170776, 0.02099466137588024, 0.004731581546366215, 0.011973107233643532, 0.011029554530978203, 0.03772316873073578, 0.01900452934205532, 0.004801953211426735, 0.01341089978814125, 0.0069841044023633, 0.027183527126908302, 0.020311512053012848, 0.012575856409966946, 0.012175651267170906, 0.005584499333053827, 0.004914820194244385, 0.013592829927802086, 0.005664649419486523, 0.042621977627277374, 0.09800928086042404, 0.04170045629143715, 0.15044301748275757, 0.07248511910438538, 0.058831870555877686, 0.23124828934669495, 0.3434917628765106, 0.3465193510055542, 0.7204574346542358, -1]}
{"idB": "749647_15_item1_p53_s1", "idA": "749647_14_item1_p16_s3", "sentA": "The OPTIMA Study is designed with extensive input from globally recognized HCC researchers and clinicians and after formal written consultation with FDA.", "sentB": "The OPTIMA Study is 80% powered to show a 33% improvement in OS.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "is", "designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "FDA.", "<tag2>", "The", "OPTIMA", "Study", "is", "80%", "powered", "to", "show", "a", "33%", "improvement", "in", "OS.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "is", "designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "FDA."], "wordsB": ["The", "OPTIMA", "Study", "is", "80%", "powered", "to", "show", "a", "33%", "improvement", "in", "OS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00375980488024652, 0.07086695730686188, 0.07885754108428955, 0.04138483107089996, 0.7540485858917236, 0.7692019939422607, 0.014329135417938232, 0.037218738347291946, 0.014935421757400036, 0.07087504863739014, 0.09999027848243713, 0.07833413779735565, 0.09035570919513702, -1]}
{"idB": "749647_15_item1_p19_s0", "idA": "749647_14_item1_p17_s0", "sentA": "The primary endpoint for the trial is overall survival, and the secondary endpoint for the trial is PFS and Safety.", "sentB": "The primary endpoint for the trial is overall survival, and the secondary endpoints for the trial are PFS and Safety.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety.", "<tag2>", "The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoints", "for", "the", "trial", "are", "PFS", "and", "Safety.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety."], "wordsB": ["The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoints", "for", "the", "trial", "are", "PFS", "and", "Safety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00639263866469264, 0.5505005121231079, 0.44850823283195496, 0.005841126665472984, 0.005105667281895876, 0.028481274843215942, 0.014358474873006344, 0.10668118298053741, 0.10101429373025894, 0.005721263121813536, 0.008007681928575039, 0.4830251932144165, 0.2693098783493042, 0.006062803324311972, 0.005231523420661688, 0.03700053319334984, 0.04854286462068558, 0.3185895085334778, 0.034953292459249496, 0.06121782958507538, -1]}
{"idB": "749647_15_item1_p53_s0", "idA": "749647_14_item1_p17_s0", "sentA": "The primary endpoint for the trial is overall survival, and the secondary endpoint for the trial is PFS and Safety.", "sentB": "The primary endpoint for the trial is overall survival, and the secondary endpoints for the trial are PFS and Safety.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety.", "<tag2>", "The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoints", "for", "the", "trial", "are", "PFS", "and", "Safety.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoint", "for", "the", "trial", "is", "PFS", "and", "Safety."], "wordsB": ["The", "primary", "endpoint", "for", "the", "trial", "is", "overall", "survival,", "and", "the", "secondary", "endpoints", "for", "the", "trial", "are", "PFS", "and", "Safety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00639263866469264, 0.5505005121231079, 0.44850823283195496, 0.005841126665472984, 0.005105667281895876, 0.028481274843215942, 0.014358474873006344, 0.10668118298053741, 0.10101429373025894, 0.005721263121813536, 0.008007681928575039, 0.4830251932144165, 0.2693098783493042, 0.006062803324311972, 0.005231523420661688, 0.03700053319334984, 0.04854286462068558, 0.3185895085334778, 0.034953292459249496, 0.06121782958507538, -1]}
{"idB": "749647_15_item1_p19_s1", "idA": "749647_14_item1_p17_s1", "sentA": "The statistical plan calls for two interim efficacy analyses by an independent Data Monitoring Committee.", "sentB": "The statistical plan calls for two interim efficacy analyses by an independent DMC.", "type": 2, "words": ["<tag1>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee.", "<tag2>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "DMC.", "<tag3>"], "wordsA": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee."], "wordsB": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "DMC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0014983745058998466, 0.01266444195061922, 0.01304684765636921, 0.008096452802419662, 0.002706663915887475, 0.0038168104365468025, 0.006120045203715563, 0.007037612609565258, 0.0179901123046875, 0.013866327702999115, 0.0115944379940629, 0.08244799077510834, 0.9950674772262573, -1]}
{"idB": "749647_15_item1_p54_s0", "idA": "749647_14_item1_p17_s1", "sentA": "The statistical plan calls for two interim efficacy analyses by an independent Data Monitoring Committee.", "sentB": "The statistical plan calls for two interim efficacy analyses by an independent DMC.", "type": 2, "words": ["<tag1>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee.", "<tag2>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "DMC.", "<tag3>"], "wordsA": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee."], "wordsB": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "DMC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0014983745058998466, 0.01266444195061922, 0.01304684765636921, 0.008096452802419662, 0.002706663915887475, 0.0038168104365468025, 0.006120045203715563, 0.007037612609565258, 0.0179901123046875, 0.013866327702999115, 0.0115944379940629, 0.08244799077510834, 0.9950674772262573, -1]}
{"idB": "749647_15_item1_p20_s1", "idA": "749647_14_item1_p18_s1", "sentA": "Based on those discussions, we are submitting an application for accelerated approval of the study in China.", "sentB": "Based on those discussions, we have submitted an application for accelerated approval of the OPTIMA Study in China.", "type": 2, "words": ["<tag1>", "Based", "on", "those", "discussions,", "we", "are", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China.", "<tag2>", "Based", "on", "those", "discussions,", "we", "have", "submitted", "an", "application", "for", "accelerated", "approval", "of", "the", "OPTIMA", "Study", "in", "China.", "<tag3>"], "wordsA": ["Based", "on", "those", "discussions,", "we", "are", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China."], "wordsB": ["Based", "on", "those", "discussions,", "we", "have", "submitted", "an", "application", "for", "accelerated", "approval", "of", "the", "OPTIMA", "Study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010061151348054409, 0.00435517868027091, 0.004870489705353975, 0.010382079519331455, 0.00804243702441454, 0.005054860841482878, 0.016117356717586517, 0.002785375574603677, 0.013941727578639984, 0.0030752760358154774, 0.0077603161334991455, 0.01158910058438778, 0.00577520951628685, 0.013355216942727566, 0.9921231865882874, 0.1891353577375412, 0.0025074912700802088, 0.004720237106084824, -1]}
{"idB": "749647_15_item1_p55_s1", "idA": "749647_14_item1_p18_s1", "sentA": "Based on those discussions, we are submitting an application for accelerated approval of the study in China.", "sentB": "Based on those discussions, we have submitted an application for accelerated approval of the OPTIMA Study in China.", "type": 2, "words": ["<tag1>", "Based", "on", "those", "discussions,", "we", "are", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China.", "<tag2>", "Based", "on", "those", "discussions,", "we", "have", "submitted", "an", "application", "for", "accelerated", "approval", "of", "the", "OPTIMA", "Study", "in", "China.", "<tag3>"], "wordsA": ["Based", "on", "those", "discussions,", "we", "are", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China."], "wordsB": ["Based", "on", "those", "discussions,", "we", "have", "submitted", "an", "application", "for", "accelerated", "approval", "of", "the", "OPTIMA", "Study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010061151348054409, 0.00435517868027091, 0.004870489705353975, 0.010382079519331455, 0.00804243702441454, 0.005054860841482878, 0.016117356717586517, 0.002785375574603677, 0.013941727578639984, 0.0030752760358154774, 0.0077603161334991455, 0.01158910058438778, 0.00577520951628685, 0.013355216942727566, 0.9921231865882874, 0.1891353577375412, 0.0025074912700802088, 0.004720237106084824, -1]}
{"idB": "749647_15_item1_p111_s0", "idA": "749647_14_item1_p20_s1", "sentA": "The timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "The timing and the outcome of clinical results are extremely difficult to predict.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "are", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "are", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03216440975666046, 0.24583309888839722, 0.04694807529449463, 0.03236444294452667, 0.26060751080513, 0.05049612745642662, 0.16653679311275482, 0.1950923204421997, 0.10567861795425415, 0.3340834081172943, 0.7474030256271362, 0.5115559697151184, 0.6877274513244629, -1]}
{"idB": "749647_15_item1_p24_s0", "idA": "749647_14_item1_p21_s0", "sentA": "In 2007, the Company sold its medical device franchise to Boston Scientific Corporation for net aggregate payments of $43 million, receiving $13 million in 2007 and $15 million in each of 2008 and 2009.", "sentB": "In 2007, we sold our medical device franchise to Boston Scientific Corporation for net aggregate payments of $43 million, receiving $13 million in 2007 and $15 million in each of 2008 and 2009.", "type": 2, "words": ["<tag1>", "In", "2007,", "the", "Company", "sold", "its", "medical", "device", "franchise", "to", "Boston", "Scientific", "Corporation", "for", "net", "aggregate", "payments", "of", "$43", "million,", "receiving", "$13", "million", "in", "2007", "and", "$15", "million", "in", "each", "of", "2008", "and", "2009.", "<tag2>", "In", "2007,", "we", "sold", "our", "medical", "device", "franchise", "to", "Boston", "Scientific", "Corporation", "for", "net", "aggregate", "payments", "of", "$43", "million,", "receiving", "$13", "million", "in", "2007", "and", "$15", "million", "in", "each", "of", "2008", "and", "2009.", "<tag3>"], "wordsA": ["In", "2007,", "the", "Company", "sold", "its", "medical", "device", "franchise", "to", "Boston", "Scientific", "Corporation", "for", "net", "aggregate", "payments", "of", "$43", "million,", "receiving", "$13", "million", "in", "2007", "and", "$15", "million", "in", "each", "of", "2008", "and", "2009."], "wordsB": ["In", "2007,", "we", "sold", "our", "medical", "device", "franchise", "to", "Boston", "Scientific", "Corporation", "for", "net", "aggregate", "payments", "of", "$43", "million,", "receiving", "$13", "million", "in", "2007", "and", "$15", "million", "in", "each", "of", "2008", "and", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.032684631645679474, 0.07636523991823196, 0.7386367917060852, 0.5851811170578003, 0.12678608298301697, 0.3068282902240753, 0.2894715368747711, 0.3200667202472687, 0.01570877991616726, 0.018184693530201912, 0.020920898765325546, 0.029062489047646523, 0.011202575638890266, 0.02020612731575966, 0.020586209371685982, 0.017898300662636757, 0.01310141570866108, 0.02712409757077694, 0.025983387604355812, 0.015334387309849262, 0.029427453875541687, 0.022310685366392136, 0.01216666866093874, 0.012992968782782555, 0.006273879203945398, 0.036394622176885605, 0.03075351007282734, 0.01076215598732233, 0.013685441575944424, 0.014186522923409939, 0.011988879181444645, 0.013419275172054768, 0.010886957868933678, -1]}
{"idB": "749647_15_item1_p24_s1", "idA": "749647_14_item1_p21_s1", "sentA": "Since this divesture, we have dedicated our efforts and resources to the development and commercialization of cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems.", "sentB": "Since this divesture, we have dedicated our efforts and resources to the development and commercialization of cancer drugs including tumor-targeting chemotherapy treatments using focused heat energy in combination with heat-activated drug delivery systems, immunotherapies and RNA-based therapies.", "type": 2, "words": ["<tag1>", "Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems.", "<tag2>", "Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "chemotherapy", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems,", "immunotherapies", "and", "RNA-based", "therapies.", "<tag3>"], "wordsA": ["Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems."], "wordsB": ["Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "chemotherapy", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems,", "immunotherapies", "and", "RNA-based", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007797709200531244, 0.004902506247162819, 0.00749583076685667, 0.004101037047803402, 0.004588141106069088, 0.00747869024053216, 0.005356617737561464, 0.006642474327236414, 0.005030124913901091, 0.006595917511731386, 0.0031730865593999624, 0.00336703984066844, 0.0051470184698700905, 0.00429831026121974, 0.0047847130335867405, 0.0027769566513597965, 0.005226942244917154, 0.008200977928936481, 0.0027519813738763332, 0.01826378144323826, 0.6904208660125732, 0.1262420266866684, 0.0036325003020465374, 0.005847301799803972, 0.007207518443465233, 0.0060872966423630714, 0.004212586674839258, 0.0038698448333889246, 0.0037239796947687864, 0.007353138644248247, 0.008630923926830292, 0.00778148602694273, 0.015106325037777424, 0.618452250957489, 0.019401730969548225, 0.5399071574211121, 0.3318382799625397, -1]}
{"idB": "749647_15_item1_p24_s2", "idA": "749647_14_item1_p21_s2", "sentA": "To support our research and development, we have raised gross proceeds of approximately $95 million in equity financings and warrant and option exercises in the years 2009 through 2013.", "sentB": "To support our research and development, we raised gross proceeds of approximately $95 million in equity financings and warrant and option exercises in the years 2009 through 2013.", "type": 2, "words": ["<tag1>", "To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$95", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2013.", "<tag2>", "To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$95", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2013.", "<tag3>"], "wordsA": ["To", "support", "our", "research", "and", "development,", "we", "have", "raised", "gross", "proceeds", "of", "approximately", "$95", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2013."], "wordsB": ["To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$95", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.058914538472890854, 0.1557084023952484, 0.06922508031129837, 0.13247744739055634, 0.11370482295751572, 0.11426734179258347, 0.07954835146665573, 0.1679655760526657, 0.12415649741888046, 0.17215944826602936, 0.057980507612228394, 0.11113006621599197, 0.22009910643100739, 0.14720766246318817, 0.035960402339696884, 0.08491577953100204, 0.07362957298755646, 0.02708299271762371, 0.04590176045894623, 0.03410957008600235, 0.058191780000925064, 0.05135457217693329, 0.03422057256102562, 0.03301733732223511, 0.06185043975710869, 0.08297687023878098, 0.09465815126895905, 0.1023651584982872, -1]}
{"idB": "749647_15_item1_p24_s3", "idA": "749647_14_item1_p21_s3", "sentA": "In January 2014, the Company raised net proceeds of $14 million through an equity financing and, including its cash, investments and interest receivable totaling $43.1 million at the end 2013, has $57 million to fund its operations in 2014 and beyond.", "sentB": "In January 2014, we raised net proceeds of $14 million through an equity financing.", "type": 2, "words": ["<tag1>", "In", "January", "2014,", "the", "Company", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing", "and,", "including", "its", "cash,", "investments", "and", "interest", "receivable", "totaling", "$43.1", "million", "at", "the", "end", "2013,", "has", "$57", "million", "to", "fund", "its", "operations", "in", "2014", "and", "beyond.", "<tag2>", "In", "January", "2014,", "we", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing.", "<tag3>"], "wordsA": ["In", "January", "2014,", "the", "Company", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing", "and,", "including", "its", "cash,", "investments", "and", "interest", "receivable", "totaling", "$43.1", "million", "at", "the", "end", "2013,", "has", "$57", "million", "to", "fund", "its", "operations", "in", "2014", "and", "beyond."], "wordsB": ["In", "January", "2014,", "we", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030520692467689514, 0.11072205007076263, 0.18851882219314575, 0.7457033395767212, 0.08438514918088913, 0.06107696518301964, 0.17190790176391602, 0.019008828327059746, 0.2821118235588074, 0.201314315199852, 0.010283068753778934, 0.008416279219090939, 0.2026783972978592, 0.2030656337738037, -1]}
{"idB": "749647_15_item1_p24_s4", "idA": "749647_14_item1_p21_s3", "sentA": "In January 2014, the Company raised net proceeds of $14 million through an equity financing and, including its cash, investments and interest receivable totaling $43.1 million at the end 2013, has $57 million to fund its operations in 2014 and beyond.", "sentB": "We had cash, cash equivalents, short-term investments and interest receivable totaling $37 million at the end at December 31, 2014.", "type": 2, "words": ["<tag1>", "In", "January", "2014,", "the", "Company", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing", "and,", "including", "its", "cash,", "investments", "and", "interest", "receivable", "totaling", "$43.1", "million", "at", "the", "end", "2013,", "has", "$57", "million", "to", "fund", "its", "operations", "in", "2014", "and", "beyond.", "<tag2>", "We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$37", "million", "at", "the", "end", "at", "December", "31,", "2014.", "<tag3>"], "wordsA": ["In", "January", "2014,", "the", "Company", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing", "and,", "including", "its", "cash,", "investments", "and", "interest", "receivable", "totaling", "$43.1", "million", "at", "the", "end", "2013,", "has", "$57", "million", "to", "fund", "its", "operations", "in", "2014", "and", "beyond."], "wordsB": ["We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$37", "million", "at", "the", "end", "at", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04332445561885834, 0.009058126248419285, 0.043020132929086685, 0.08477795124053955, 0.05950675904750824, 0.7020522952079773, 0.2710390090942383, 0.003389064921066165, 0.03204326331615448, 0.020016087219119072, 0.018126511946320534, 0.8535878658294678, 0.3038148283958435, 0.005795323755592108, 0.0041045090183615685, 0.031444452702999115, 0.012895721010863781, 0.3735641539096832, 0.5232141017913818, 0.2859899401664734, -1]}
{"idB": "749647_15_item1_p25_s4", "idA": "749647_14_item1_p22_s4", "sentA": "In consideration of these accelerated milestone payments from Yakult, we agreed to reduce future drug approval milestone payments by approximately forty percent (40%).", "sentB": "In consideration of these accelerated milestone payments from Yakult, we agreed to reduce future drug approval milestone payments by approximately 40%.", "type": 2, "words": ["<tag1>", "In", "consideration", "of", "these", "accelerated", "milestone", "payments", "from", "Yakult,", "we", "agreed", "to", "reduce", "future", "drug", "approval", "milestone", "payments", "by", "approximately", "forty", "percent", "(40%).", "<tag2>", "In", "consideration", "of", "these", "accelerated", "milestone", "payments", "from", "Yakult,", "we", "agreed", "to", "reduce", "future", "drug", "approval", "milestone", "payments", "by", "approximately", "40%.", "<tag3>"], "wordsA": ["In", "consideration", "of", "these", "accelerated", "milestone", "payments", "from", "Yakult,", "we", "agreed", "to", "reduce", "future", "drug", "approval", "milestone", "payments", "by", "approximately", "forty", "percent", "(40%)."], "wordsB": ["In", "consideration", "of", "these", "accelerated", "milestone", "payments", "from", "Yakult,", "we", "agreed", "to", "reduce", "future", "drug", "approval", "milestone", "payments", "by", "approximately", "40%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.026547856628894806, 0.06977502256631851, 0.03493130952119827, 0.037718597799539566, 0.07909765839576721, 0.09400708973407745, 0.16342562437057495, 0.052328526973724365, 0.20653995871543884, 0.03487806022167206, 0.061009932309389114, 0.03817066550254822, 0.32513558864593506, 0.06921017915010452, 0.07097244262695312, 0.0879080668091774, 0.06684509664773941, 0.12315099686384201, 0.07999393343925476, 0.08469735831022263, 0.3683890700340271, -1]}
{"idB": "749647_15_item1_p25_s5", "idA": "749647_14_item1_p22_s5", "sentA": "All other milestone payments are unaffected.", "sentB": "All other milestone payments were unaffected.", "type": 2, "words": ["<tag1>", "All", "other", "milestone", "payments", "are", "unaffected.", "<tag2>", "All", "other", "milestone", "payments", "were", "unaffected.", "<tag3>"], "wordsA": ["All", "other", "milestone", "payments", "are", "unaffected."], "wordsB": ["All", "other", "milestone", "payments", "were", "unaffected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 0.03955589607357979, 0.03299615532159805, 0.07415121793746948, 0.10383465141057968, 0.2839795649051666, 0.9738326668739319, -1]}
{"idB": "749647_15_item1_p143_s1", "idA": "749647_14_item1_p23_s0", "sentA": "On May 6, 2012, we entered into a long-term commercial supply agreement with Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun) for the production of ThermoDox in mainland China, Hong Kong and Macau (the China territory).", "sentB": "cGMP is a regulatory standard for the production of pharmaceuticals that will be used in humans.", "type": 2, "words": ["<tag1>", "On", "May", "6,", "2012,", "we", "entered", "into", "a", "long-term", "commercial", "supply", "agreement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "for", "the", "production", "of", "ThermoDox", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau", "(the", "China", "territory).", "<tag2>", "cGMP", "is", "a", "regulatory", "standard", "for", "the", "production", "of", "pharmaceuticals", "that", "will", "be", "used", "in", "humans.", "<tag3>"], "wordsA": ["On", "May", "6,", "2012,", "we", "entered", "into", "a", "long-term", "commercial", "supply", "agreement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "for", "the", "production", "of", "ThermoDox", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau", "(the", "China", "territory)."], "wordsB": ["cGMP", "is", "a", "regulatory", "standard", "for", "the", "production", "of", "pharmaceuticals", "that", "will", "be", "used", "in", "humans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8485086560249329, 0.0448935441672802, 0.03577077016234398, 0.15716654062271118, 0.28752756118774414, 0.02949535846710205, 0.020304348319768906, 0.06506932526826859, 0.049639612436294556, 0.2573658525943756, 0.01187907438725233, 0.040388401597738266, 0.039204828441143036, 0.13782435655593872, 0.2619761824607849, 0.4201265573501587, -1]}
{"idB": "749647_15_item1_p183_s2", "idA": "749647_14_item1_p23_s1", "sentA": "Hisun will be responsible for providing all of the technical and regulatory support services for the manufacture of ThermoDox in the China territory and we will repay Hisun the related development costs and fees, which we expect to be approximately $2.0 million in total, commencing on the successful completion of three registrational batches of ThermoDox .", "sentB": "We will be responsible for the manufacture and supply of quantities of ThermoDox to Impatients for use in the early access program and Impatients will distribute and sell ThermoDox pursuant to such authorization, exemptions or waivers.", "type": 2, "words": ["<tag1>", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", ".", "<tag2>", "We", "will", "be", "responsible", "for", "the", "manufacture", "and", "supply", "of", "quantities", "of", "ThermoDox", "to", "Impatients", "for", "use", "in", "the", "early", "access", "program", "and", "Impatients", "will", "distribute", "and", "sell", "ThermoDox", "pursuant", "to", "such", "authorization,", "exemptions", "or", "waivers.", "<tag3>"], "wordsA": ["Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", "."], "wordsB": ["We", "will", "be", "responsible", "for", "the", "manufacture", "and", "supply", "of", "quantities", "of", "ThermoDox", "to", "Impatients", "for", "use", "in", "the", "early", "access", "program", "and", "Impatients", "will", "distribute", "and", "sell", "ThermoDox", "pursuant", "to", "such", "authorization,", "exemptions", "or", "waivers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.056963011622428894, 0.018649758771061897, 0.019266929477453232, 0.15862956643104553, 0.05384071543812752, 0.03836902603507042, 0.19805820286273956, 0.10418099164962769, 0.5429401397705078, 0.223441481590271, 0.4019376337528229, 0.19870363175868988, 0.24515749514102936, 0.030898287892341614, 0.14066056907176971, 0.014233607798814774, 0.0315408818423748, 0.010110711678862572, 0.007379252929240465, 0.06656365096569061, 0.06123501434922218, 0.07062864303588867, 0.00047277420526370406, 0.07799548655748367, 0.017422277480363846, 0.20285794138908386, 0.11823345720767975, 0.1844286173582077, 0.09353813529014587, 0.014191859401762486, 0.009850827977061272, 0.015259286388754845, 0.0601196214556694, 0.08970901370048523, 0.04209786280989647, 0.07395631819963455, -1]}
{"idB": "749647_15_item1_p74_s2", "idA": "749647_14_item1_p23_s1", "sentA": "Hisun will be responsible for providing all of the technical and regulatory support services for the manufacture of ThermoDox in the China territory and we will repay Hisun the related development costs and fees, which we expect to be approximately $2.0 million in total, commencing on the successful completion of three registrational batches of ThermoDox .", "sentB": "We will be responsible for the manufacture and supply of quantities of ThermoDox to Impatients for use in the Early Access Program and Impatients will distribute and sell ThermoDox pursuant to such authorization, exemptions or waivers.", "type": 2, "words": ["<tag1>", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", ".", "<tag2>", "We", "will", "be", "responsible", "for", "the", "manufacture", "and", "supply", "of", "quantities", "of", "ThermoDox", "to", "Impatients", "for", "use", "in", "the", "Early", "Access", "Program", "and", "Impatients", "will", "distribute", "and", "sell", "ThermoDox", "pursuant", "to", "such", "authorization,", "exemptions", "or", "waivers.", "<tag3>"], "wordsA": ["Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", "."], "wordsB": ["We", "will", "be", "responsible", "for", "the", "manufacture", "and", "supply", "of", "quantities", "of", "ThermoDox", "to", "Impatients", "for", "use", "in", "the", "Early", "Access", "Program", "and", "Impatients", "will", "distribute", "and", "sell", "ThermoDox", "pursuant", "to", "such", "authorization,", "exemptions", "or", "waivers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.056963011622428894, 0.018649758771061897, 0.019266929477453232, 0.15862956643104553, 0.05384071543812752, 0.03836902603507042, 0.19805820286273956, 0.10418099164962769, 0.5429401397705078, 0.223441481590271, 0.4019376337528229, 0.19870363175868988, 0.24515749514102936, 0.030898287892341614, 0.14066056907176971, 0.014233607798814774, 0.0315408818423748, 0.010110711678862572, 0.007379252929240465, 0.06656365096569061, 0.06123501434922218, 0.07062864303588867, 0.00047277420526370406, 0.07799548655748367, 0.017422277480363846, 0.20285794138908386, 0.11823345720767975, 0.1844286173582077, 0.09353813529014587, 0.014191859401762486, 0.009850827977061272, 0.015259286388754845, 0.0601196214556694, 0.08970901370048523, 0.04209786280989647, 0.07395631819963455, -1]}
{"idB": "749647_15_item1_p27_s0", "idA": "749647_14_item1_p23_s2", "sentA": "On January 18, 2013, we broadened our relationship with Hisun by entering into a technology development contract, pursuant to which Hisun paid us a non-refundable research and development fee of $5.0 million to support our development of ThermoDox and we will provide research data and other technical support in relation to a regulatory filing by Hisun in China for approval of ThermoDox .", "sentB": "On January 18, 2013, we broadened our relationship with Hisun by entering into a technology development contract, pursuant to which Hisun paid us a non-refundable research and development fee of $5.0 million to support our development of ThermoDox .", "type": 2, "words": ["<tag1>", "On", "January", "18,", "2013,", "we", "broadened", "our", "relationship", "with", "Hisun", "by", "entering", "into", "a", "technology", "development", "contract,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5.0", "million", "to", "support", "our", "development", "of", "ThermoDox", "and", "we", "will", "provide", "research", "data", "and", "other", "technical", "support", "in", "relation", "to", "a", "regulatory", "filing", "by", "Hisun", "in", "China", "for", "approval", "of", "ThermoDox", ".", "<tag2>", "On", "January", "18,", "2013,", "we", "broadened", "our", "relationship", "with", "Hisun", "by", "entering", "into", "a", "technology", "development", "contract,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5.0", "million", "to", "support", "our", "development", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["On", "January", "18,", "2013,", "we", "broadened", "our", "relationship", "with", "Hisun", "by", "entering", "into", "a", "technology", "development", "contract,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5.0", "million", "to", "support", "our", "development", "of", "ThermoDox", "and", "we", "will", "provide", "research", "data", "and", "other", "technical", "support", "in", "relation", "to", "a", "regulatory", "filing", "by", "Hisun", "in", "China", "for", "approval", "of", "ThermoDox", "."], "wordsB": ["On", "January", "18,", "2013,", "we", "broadened", "our", "relationship", "with", "Hisun", "by", "entering", "into", "a", "technology", "development", "contract,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5.0", "million", "to", "support", "our", "development", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02194640040397644, 0.029813125729560852, 0.04330265894532204, 0.03159567341208458, 0.03292345628142357, 0.034463513642549515, 0.037219107151031494, 0.0643971785902977, 0.06496493518352509, 0.29377129673957825, 0.023757092654705048, 0.03239604830741882, 0.028848426416516304, 0.018712308257818222, 0.023376675322651863, 0.038220349699258804, 0.033777303993701935, 0.025969719514250755, 0.021428098902106285, 0.015615674667060375, 0.09414323419332504, 0.0378674678504467, 0.04295123741030693, 0.020915059372782707, 0.09614725410938263, 0.021992383524775505, 0.024425450712442398, 0.02166060358285904, 0.024373987689614296, 0.018875930458307266, 0.06595241278409958, 0.07882177829742432, 0.04995938763022423, 0.10694326460361481, 0.033709172159433365, 0.07644602656364441, 0.030045051127672195, 0.06524679809808731, 0.00041358586167916656, -1]}
{"idB": "749647_15_item1_p28_s0", "idA": "749647_14_item1_p24_s0", "sentA": "On July 19, 2013, the Company and Hisun entered into a Memorandum of Understanding to pursue ongoing collaborations for the continued clinical development of ThermoDox as well as the technology transfer relating to the commercial manufacture of ThermoDox for the China territory.", "sentB": "On July 19, 2013, we and Hisun entered into a Memorandum of Understanding to pursue ongoing collaborations for the continued clinical development of ThermoDox and the technology transfer relating to the commercial manufacture of ThermoDox for the China territory.", "type": 2, "words": ["<tag1>", "On", "July", "19,", "2013,", "the", "Company", "and", "Hisun", "entered", "into", "a", "Memorandum", "of", "Understanding", "to", "pursue", "ongoing", "collaborations", "for", "the", "continued", "clinical", "development", "of", "ThermoDox", "as", "well", "as", "the", "technology", "transfer", "relating", "to", "the", "commercial", "manufacture", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag2>", "On", "July", "19,", "2013,", "we", "and", "Hisun", "entered", "into", "a", "Memorandum", "of", "Understanding", "to", "pursue", "ongoing", "collaborations", "for", "the", "continued", "clinical", "development", "of", "ThermoDox", "and", "the", "technology", "transfer", "relating", "to", "the", "commercial", "manufacture", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag3>"], "wordsA": ["On", "July", "19,", "2013,", "the", "Company", "and", "Hisun", "entered", "into", "a", "Memorandum", "of", "Understanding", "to", "pursue", "ongoing", "collaborations", "for", "the", "continued", "clinical", "development", "of", "ThermoDox", "as", "well", "as", "the", "technology", "transfer", "relating", "to", "the", "commercial", "manufacture", "of", "ThermoDox", "for", "the", "China", "territory."], "wordsB": ["On", "July", "19,", "2013,", "we", "and", "Hisun", "entered", "into", "a", "Memorandum", "of", "Understanding", "to", "pursue", "ongoing", "collaborations", "for", "the", "continued", "clinical", "development", "of", "ThermoDox", "and", "the", "technology", "transfer", "relating", "to", "the", "commercial", "manufacture", "of", "ThermoDox", "for", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0669412687420845, 0.06158830597996712, 0.11481771618127823, 0.06300560384988785, 0.7416243553161621, 0.2713904082775116, 0.5295091867446899, 0.10579435527324677, 0.06988360732793808, 0.030507482588291168, 0.05052054673433304, 0.029724206775426865, 0.07787488400936127, 0.022471347823739052, 0.03466206416487694, 0.04775368049740791, 0.05685630813241005, 0.02593582309782505, 0.01609339751303196, 0.03925096243619919, 0.04513489082455635, 0.05489734560251236, 0.028695672750473022, 0.09170548617839813, 0.013059422373771667, 0.01322177704423666, 0.026050671935081482, 0.04160228371620178, 0.02137056738138199, 0.01885075867176056, 0.01582571305334568, 0.04783083498477936, 0.046384576708078384, 0.033508434891700745, 0.07552503794431686, 0.014788943342864513, 0.016132961958646774, 0.03059118613600731, 0.050507802516222, -1]}
{"idB": "749647_15_item1_p163_s0", "idA": "749647_14_item1_p25_s3", "sentA": "We do not know whether we will be able to access additional capital when needed or on terms favorable to us or our stockholders.", "sentB": "Competitors may be able to circumvent our patents.", "type": 2, "words": ["<tag1>", "We", "do", "not", "know", "whether", "we", "will", "be", "able", "to", "access", "additional", "capital", "when", "needed", "or", "on", "terms", "favorable", "to", "us", "or", "our", "stockholders.", "<tag2>", "Competitors", "may", "be", "able", "to", "circumvent", "our", "patents.", "<tag3>"], "wordsA": ["We", "do", "not", "know", "whether", "we", "will", "be", "able", "to", "access", "additional", "capital", "when", "needed", "or", "on", "terms", "favorable", "to", "us", "or", "our", "stockholders."], "wordsB": ["Competitors", "may", "be", "able", "to", "circumvent", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.3530828058719635, 0.09950284659862518, 0.05625969544053078, 0.14926138520240784, 0.09463828802108765, 0.6168980598449707, 0.18163041770458221, 0.5391443371772766, -1]}
{"idB": "749647_15_item1_p141_s4", "idA": "749647_14_item1_p25_s4", "sentA": "Our inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.", "sentB": "However, there is a risk that, if supplies are interrupted, it would materially harm our business.", "type": 2, "words": ["<tag1>", "Our", "inability", "to", "raise", "additional", "capital,", "or", "to", "do", "so", "on", "terms", "reasonably", "acceptable", "to", "us,", "would", "jeopardize", "the", "future", "success", "of", "our", "business.", "<tag2>", "However,", "there", "is", "a", "risk", "that,", "if", "supplies", "are", "interrupted,", "it", "would", "materially", "harm", "our", "business.", "<tag3>"], "wordsA": ["Our", "inability", "to", "raise", "additional", "capital,", "or", "to", "do", "so", "on", "terms", "reasonably", "acceptable", "to", "us,", "would", "jeopardize", "the", "future", "success", "of", "our", "business."], "wordsB": ["However,", "there", "is", "a", "risk", "that,", "if", "supplies", "are", "interrupted,", "it", "would", "materially", "harm", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.046878714114427567, 0.005567672196775675, 0.006842258386313915, 0.012845880351960659, 0.14925335347652435, 0.037709444761276245, 0.06898891180753708, 0.38586312532424927, 0.2090555727481842, 0.32636770606040955, 0.029003435745835304, 0.1227288618683815, 0.1816525012254715, 0.5312965512275696, 0.09013822674751282, 0.25718361139297485, -1]}
{"idB": "749647_15_item1_p33_s2", "idA": "749647_14_item1_p29_s2", "sentA": "Through a perpetual, world-wide, exclusive development and commercialization license from Duke University, Celsion has licensed novel, heat-activated liposomal technology that is differentiated from other liposomes through its unique low heat-activated release of encapsulated chemotherapeutic agents.", "sentB": "Through a perpetual, world-wide, exclusive development and commercialization license from Duke University, Celsion has licensed this novel, heat-activated liposomal technology that is differentiated from other liposomes through its unique low heat-activated release of encapsulated chemotherapeutic agents.", "type": 2, "words": ["<tag1>", "Through", "a", "perpetual,", "world-wide,", "exclusive", "development", "and", "commercialization", "license", "from", "Duke", "University,", "Celsion", "has", "licensed", "novel,", "heat-activated", "liposomal", "technology", "that", "is", "differentiated", "from", "other", "liposomes", "through", "its", "unique", "low", "heat-activated", "release", "of", "encapsulated", "chemotherapeutic", "agents.", "<tag2>", "Through", "a", "perpetual,", "world-wide,", "exclusive", "development", "and", "commercialization", "license", "from", "Duke", "University,", "Celsion", "has", "licensed", "this", "novel,", "heat-activated", "liposomal", "technology", "that", "is", "differentiated", "from", "other", "liposomes", "through", "its", "unique", "low", "heat-activated", "release", "of", "encapsulated", "chemotherapeutic", "agents.", "<tag3>"], "wordsA": ["Through", "a", "perpetual,", "world-wide,", "exclusive", "development", "and", "commercialization", "license", "from", "Duke", "University,", "Celsion", "has", "licensed", "novel,", "heat-activated", "liposomal", "technology", "that", "is", "differentiated", "from", "other", "liposomes", "through", "its", "unique", "low", "heat-activated", "release", "of", "encapsulated", "chemotherapeutic", "agents."], "wordsB": ["Through", "a", "perpetual,", "world-wide,", "exclusive", "development", "and", "commercialization", "license", "from", "Duke", "University,", "Celsion", "has", "licensed", "this", "novel,", "heat-activated", "liposomal", "technology", "that", "is", "differentiated", "from", "other", "liposomes", "through", "its", "unique", "low", "heat-activated", "release", "of", "encapsulated", "chemotherapeutic", "agents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.039525218307971954, 0.022676389664411545, 0.07373804599046707, 0.07973429560661316, 0.11140711605548859, 0.06367751955986023, 0.032083116471767426, 0.05489148199558258, 0.08592395484447479, 0.02433011122047901, 0.12271669507026672, 0.09341761469841003, 0.10920504480600357, 0.04570252075791359, 0.12802420556545258, 0.029354726895689964, 0.08086622506380081, 0.1089790090918541, 0.10705498605966568, 0.05353168770670891, 0.017353059723973274, 0.019146710634231567, 0.06648804247379303, 0.051475103944540024, 0.07144399732351303, 0.16219185292720795, 0.014442503452301025, 0.015368112362921238, 0.03351454809308052, 0.3537130653858185, 0.2057631015777588, 0.04357343539595604, 0.014250845648348331, 0.08471963554620743, 0.08788148313760757, 0.12716709077358246, -1]}
{"idB": "749647_15_item1_p34_s0", "idA": "749647_14_item1_p30_s0", "sentA": "We intend to use several available focused-heat technologies, such as radio frequency ablation (RFA), microwave energy and high intensity focused ultrasound (HIFU), to activate the release of drugs from our novel heat-sensitive liposomes.", "sentB": "We are using several available focused-heat technologies, such as radio frequency ablation (RFA), microwave energy and high intensity focused ultrasound (HIFU), to activate the release of drugs from our novel heat-sensitive liposomes.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "use", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(RFA),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat-sensitive", "liposomes.", "<tag2>", "We", "are", "using", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(RFA),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat-sensitive", "liposomes.", "<tag3>"], "wordsA": ["We", "intend", "to", "use", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(RFA),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat-sensitive", "liposomes."], "wordsB": ["We", "are", "using", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(RFA),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat-sensitive", "liposomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2144741415977478, 0.12519468367099762, 0.222938671708107, 0.13384094834327698, 0.18136441707611084, 0.23263414204120636, 0.11344878375530243, 0.04954149201512337, 0.03782804682850838, 0.2544509768486023, 0.21601395308971405, 0.17459645867347717, 0.39642763137817383, 0.1809830516576767, 0.13083040714263916, 0.030506214126944542, 0.21379125118255615, 0.2116018384695053, 0.05960772931575775, 0.07905194163322449, 0.13049891591072083, 0.04499233141541481, 0.09125406295061111, 0.03651852905750275, 0.09740667045116425, 0.06222184747457504, 0.13035334646701813, 0.03932946175336838, 0.028685133904218674, 0.05299941077828407, 0.10969026386737823, 0.08543657511472702, -1]}
{"idB": "749647_15_item1_p38_s1", "idA": "749647_14_item1_p34_s1", "sentA": "Up to 80% of patients are ineligible for surgery or transplantation at time of diagnosis as early stage liver cancer generally has few symptoms and when finally detected the tumor frequently is too large for surgery.", "sentB": "Up to 80% of patients are ineligible for surgery or transplantation at time of diagnosis because early stage liver cancer generally has few symptoms and when finally detected the tumor frequently is too large for surgical resection.", "type": 2, "words": ["<tag1>", "Up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery.", "<tag2>", "Up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "because", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgical", "resection.", "<tag3>"], "wordsA": ["Up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "as", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgery."], "wordsB": ["Up", "to", "80%", "of", "patients", "are", "ineligible", "for", "surgery", "or", "transplantation", "at", "time", "of", "diagnosis", "because", "early", "stage", "liver", "cancer", "generally", "has", "few", "symptoms", "and", "when", "finally", "detected", "the", "tumor", "frequently", "is", "too", "large", "for", "surgical", "resection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006183172110468149, 0.007125037256628275, 0.014369573444128036, 0.007095044478774071, 0.039481934159994125, 0.09097073972225189, 0.919329822063446, 0.13066624104976654, 0.05350593850016594, 0.01811053417623043, 0.028904108330607414, 0.00816822424530983, 0.007636946626007557, 0.007622396573424339, 0.009111480787396431, 0.004904241766780615, 0.007034540642052889, 0.006333715748041868, 0.007936387322843075, 0.007859584875404835, 0.00993614736944437, 0.010149330832064152, 0.07174903899431229, 0.033974532037973404, 0.0005058409296907485, 0.006822597701102495, 0.009865742176771164, 0.009984919801354408, 0.005847185384482145, 0.017657484859228134, 0.011961149051785469, 0.012362394481897354, 0.041212595999240875, 0.019585173577070236, 0.02395949698984623, 0.04485807567834854, 0.03971751034259796, -1]}
{"idB": "749647_15_item1_p40_s0", "idA": "749647_14_item1_p35_s2", "sentA": "Local recurrence rates after RFA directly correlates to the size of the tumor.", "sentB": "Local recurrence rates after RFA directly correlate to the size of the tumor.", "type": 2, "words": ["<tag1>", "Local", "recurrence", "rates", "after", "RFA", "directly", "correlates", "to", "the", "size", "of", "the", "tumor.", "<tag2>", "Local", "recurrence", "rates", "after", "RFA", "directly", "correlate", "to", "the", "size", "of", "the", "tumor.", "<tag3>"], "wordsA": ["Local", "recurrence", "rates", "after", "RFA", "directly", "correlates", "to", "the", "size", "of", "the", "tumor."], "wordsB": ["Local", "recurrence", "rates", "after", "RFA", "directly", "correlate", "to", "the", "size", "of", "the", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07825321704149246, 0.2215312123298645, 0.22555039823055267, 0.5236490964889526, 0.46954259276390076, 0.2560797929763794, 0.1582731455564499, 0.081117182970047, 0.0707615315914154, 0.3495950996875763, 0.12462539225816727, 0.13480594754219055, 0.4000982344150543, -1]}
{"idB": "749647_15_item1_p102_s0", "idA": "749647_14_item1_p37_s2", "sentA": "This approach will also increase the delivery of the doxorubicin at the desired tumor site while potentially reducing drug exposure distant to the tumor site.", "sentB": "One embodiment of the polymer is being developed for in vivo delivery of plasmid DNA and mRNA.", "type": 2, "words": ["<tag1>", "This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site.", "<tag2>", "One", "embodiment", "of", "the", "polymer", "is", "being", "developed", "for", "in", "vivo", "delivery", "of", "plasmid", "DNA", "and", "mRNA.", "<tag3>"], "wordsA": ["This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site."], "wordsB": ["One", "embodiment", "of", "the", "polymer", "is", "being", "developed", "for", "in", "vivo", "delivery", "of", "plasmid", "DNA", "and", "mRNA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07115836441516876, 0.18813355267047882, 0.03720835968852043, 0.034669701009988785, 0.33068013191223145, 0.003748857881873846, 0.01750054396688938, 0.0457511842250824, 0.008972004055976868, 0.062337420880794525, 0.05152268335223198, 0.12297030538320541, 0.03897612541913986, 0.6196033954620361, 0.5267858505249023, 0.21032574772834778, 0.4651373624801636, -1]}
{"idB": "749647_15_item1_p105_s0", "idA": "749647_14_item1_p37_s2", "sentA": "This approach will also increase the delivery of the doxorubicin at the desired tumor site while potentially reducing drug exposure distant to the tumor site.", "sentB": "TheraSilence is a technology platform for the delivery of synthetically-generated inhibitory RNA (RNAi) such as small inhibitory RNAs (siRNAs), microRNAs, microRNA mimics, and related molecules that can regulate protein expression at the transcript level by exploiting endogenous cell mechanisms.", "type": 2, "words": ["<tag1>", "This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site.", "<tag2>", "TheraSilence", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "synthetically-generated", "inhibitory", "RNA", "(RNAi)", "such", "as", "small", "inhibitory", "RNAs", "(siRNAs),", "microRNAs,", "microRNA", "mimics,", "and", "related", "molecules", "that", "can", "regulate", "protein", "expression", "at", "the", "transcript", "level", "by", "exploiting", "endogenous", "cell", "mechanisms.", "<tag3>"], "wordsA": ["This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site."], "wordsB": ["TheraSilence", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "synthetically-generated", "inhibitory", "RNA", "(RNAi)", "such", "as", "small", "inhibitory", "RNAs", "(siRNAs),", "microRNAs,", "microRNA", "mimics,", "and", "related", "molecules", "that", "can", "regulate", "protein", "expression", "at", "the", "transcript", "level", "by", "exploiting", "endogenous", "cell", "mechanisms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.16072916984558105, 0.018111858516931534, 0.017169618979096413, 0.09188862890005112, 0.11711405962705612, 0.016894055530428886, 0.015788553282618523, 0.1282496154308319, 0.08487619459629059, 0.1856706440448761, 0.6939278841018677, 0.7100738883018494, 0.34171831607818604, 0.0002187816717196256, 0.002089783316478133, 0.048280034214258194, 0.08196087181568146, 0.07410880923271179, 0.03650661185383797, 0.10786212980747223, 0.19715368747711182, 0.07223673164844513, 0.00020373542793095112, 0.030861161649227142, 0.09653639793395996, 0.00019189091108273715, 0.007868587039411068, 0.08183995634317398, 0.09343040734529495, 0.06927789747714996, 0.012739608995616436, 0.013579281978309155, 0.025920648127794266, 0.024636153131723404, 0.00018725867266766727, 0.024906253442168236, 0.04276842996478081, 0.09271609783172607, 0.04960041865706444, -1]}
{"idB": "749647_15_item1_p86_s0", "idA": "749647_14_item1_p37_s2", "sentA": "This approach will also increase the delivery of the doxorubicin at the desired tumor site while potentially reducing drug exposure distant to the tumor site.", "sentB": "Celsion s GEN-1 approach for IL-12 delivery is designed to achieve local concentrations of IL-12 at the tumor site with minimal increases in systemic circulation.", "type": 2, "words": ["<tag1>", "This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site.", "<tag2>", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation.", "<tag3>"], "wordsA": ["This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site."], "wordsB": ["Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11255719512701035, 0.05953822284936905, 0.18035493791103363, 0.10877944529056549, 0.00802101194858551, 0.10132189095020294, 0.07710371911525726, 0.00011954065121244639, 0.006954307667911053, 0.005431660450994968, 0.031041650101542473, 0.19364364445209503, 0.13639768958091736, 0.03545631468296051, 0.3176115155220032, 0.008413678035140038, 0.008303177542984486, 0.034189365804195404, 0.027476215735077858, 0.012898409739136696, 0.4739101827144623, 0.2888142466545105, 0.1242077574133873, 0.30308738350868225, 0.179804265499115, -1]}
{"idB": "749647_15_item1_p86_s3", "idA": "749647_14_item1_p37_s2", "sentA": "This approach will also increase the delivery of the doxorubicin at the desired tumor site while potentially reducing drug exposure distant to the tumor site.", "sentB": "Increases in IL-12 concentrations at the tumor site for several days after a single administration will create a potent immune environment against the tumor and a direct killing of the tumor with concomitant use of cytotoxic chemotherapy together will resulting in more robust and durable antitumor response than chemotherapy alone.", "type": 2, "words": ["<tag1>", "This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site.", "<tag2>", "Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "resulting", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone.", "<tag3>"], "wordsA": ["This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site."], "wordsB": ["Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "resulting", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.20228686928749084, 0.13078486919403076, 0.6583074927330017, 0.4853973686695099, 0.020809760317206383, 0.014154082164168358, 0.028930969536304474, 0.031652823090553284, 0.008795451372861862, 0.02173740789294243, 0.03315533325076103, 0.011556907556951046, 0.006082963198423386, 0.07592670619487762, 0.03331945091485977, 0.004807267803698778, 0.00648523960262537, 0.0037952526472508907, 0.04003159701824188, 0.0593208447098732, 0.06345783919095993, 0.00829512719064951, 0.005031518638134003, 0.042730096727609634, 0.00013060218770988286, 0.003347779391333461, 0.03466012328863144, 0.14496129751205444, 0.01577046886086464, 0.013111259788274765, 0.04986565560102463, 0.00011108937178505585, 0.05836202949285507, 0.02561822347342968, 0.007979747839272022, 0.03688911348581314, 0.0760679766535759, 0.0001176301229861565, 0.004061268176883459, 0.005589824635535479, 0.0064463247545063496, 0.04548671096563339, 0.07400829344987869, 0.010302284732460976, 0.11319426447153091, 0.0788702666759491, 0.06613333523273468, 0.019731774926185608, 0.04521847143769264, 0.053413331508636475, -1]}
{"idB": "749647_15_item1_p80_s0", "idA": "749647_14_item1_p38_s1", "sentA": "We continue to follow patients in the HEAT Study to the secondary endpoint, overall survival (OS).", "sentB": "Mortality rates for ovarian cancer declined very little in the last forty years due to the unavailability of detection tests and improved treatments.", "type": 2, "words": ["<tag1>", "We", "continue", "to", "follow", "patients", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint,", "overall", "survival", "(OS).", "<tag2>", "Mortality", "rates", "for", "ovarian", "cancer", "declined", "very", "little", "in", "the", "last", "forty", "years", "due", "to", "the", "unavailability", "of", "detection", "tests", "and", "improved", "treatments.", "<tag3>"], "wordsA": ["We", "continue", "to", "follow", "patients", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint,", "overall", "survival", "(OS)."], "wordsB": ["Mortality", "rates", "for", "ovarian", "cancer", "declined", "very", "little", "in", "the", "last", "forty", "years", "due", "to", "the", "unavailability", "of", "detection", "tests", "and", "improved", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6208275556564331, 0.35478729009628296, 0.04281536489725113, 0.12444454431533813, 0.1332993358373642, 0.3428281247615814, 0.053175538778305054, 0.17258265614509583, 0.00785000342875719, 0.007576599717140198, 0.021480580791831017, 0.03872125223278999, 0.022927597165107727, 0.005557130090892315, 0.004299383610486984, 0.0056184325367212296, 0.026457009837031364, 0.005579332821071148, 0.07821962982416153, 0.07940244674682617, 0.007028302177786827, 0.02554323337972164, 0.05759898200631142, -1]}
{"idB": "749647_15_item1_p23_s1", "idA": "749647_14_item1_p40_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "In February 2015, we announced that the FDA accepted, without comment, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030070379376411438, 0.2624325454235077, 0.7495719194412231, 0.021519659087061882, 0.04882323741912842, 0.006960732862353325, 0.007949471473693848, 0.03158114105463028, 0.10798667371273041, 0.22141927480697632, 0.1761692762374878, 0.00878769438713789, 0.023680169135332108, 0.01089033205062151, 0.04101235792040825, 0.02716551534831524, 0.05105653032660484, 0.014226744882762432, 0.383987694978714, 0.004380110651254654, 0.007914319634437561, 0.003359102876856923, 0.004062448628246784, 0.01984000764787197, 0.009364373981952667, 0.040168002247810364, 0.026823747903108597, 0.3933671712875366, 0.5975659489631653, 0.3364723026752472, -1]}
{"idB": "749647_15_item1_p94_s0", "idA": "749647_14_item1_p40_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "In January 2015, we announced that we submitted to the FDA a Phase I clinical trial protocol for GEN-1 for the treatment of ovarian cancer.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "In", "January", "2015,", "we", "announced", "that", "we", "submitted", "to", "the", "FDA", "a", "Phase", "I", "clinical", "trial", "protocol", "for", "GEN-1", "for", "the", "treatment", "of", "ovarian", "cancer.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["In", "January", "2015,", "we", "announced", "that", "we", "submitted", "to", "the", "FDA", "a", "Phase", "I", "clinical", "trial", "protocol", "for", "GEN-1", "for", "the", "treatment", "of", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02953260764479637, 0.24661949276924133, 0.7730282545089722, 0.023586619645357132, 0.05192677304148674, 0.005236801691353321, 0.023061107844114304, 0.11910027265548706, 0.03203745186328888, 0.022870825603604317, 0.046443793922662735, 0.012788158841431141, 0.038083042949438095, 0.02340666577219963, 0.055622171610593796, 0.05525210127234459, 0.06427709013223648, 0.017806606367230415, 0.2295454889535904, 0.012902258895337582, 0.007613485213369131, 0.07750095427036285, 0.03660985082387924, 0.7457883954048157, 0.3963997960090637, -1]}
{"idB": "749647_15_item1_p94_s3", "idA": "749647_14_item1_p40_s0", "sentA": "In the second quarter of 2007, we completed our first Phase I single dose escalation clinical trial that investigated ThermoDox in combination with RFA for the treatment of primary and metastatic liver cancer.", "sentB": "In February 2015, we announced that the FDA has accepted, without comment, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer.", "<tag2>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "has", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2007,", "we", "completed", "our", "first", "Phase", "I", "single", "dose", "escalation", "clinical", "trial", "that", "investigated", "ThermoDox", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "and", "metastatic", "liver", "cancer."], "wordsB": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "has", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030445346608757973, 0.26788330078125, 0.7472854256629944, 0.021793659776449203, 0.041973087936639786, 0.006274541839957237, 0.008152060210704803, 0.03193318471312523, 0.025152359157800674, 0.10611525923013687, 0.21581286191940308, 0.15575288236141205, 0.008719994686543941, 0.023562926799058914, 0.01108741108328104, 0.0401538722217083, 0.029838163405656815, 0.053945500403642654, 0.013926868326961994, 0.377317875623703, 0.004710801877081394, 0.007823821157217026, 0.003484331304207444, 0.0044702389277517796, 0.022088780999183655, 0.010175601579248905, 0.04418018087744713, 0.02607121504843235, 0.41064363718032837, 0.5827800035476685, 0.3277672529220581, -1]}
{"idB": "749647_15_item1_p47_s0", "idA": "749647_14_item1_p44_s0", "sentA": "As provided for in the SPA, we continue to follow the patients enrolled in the HEAT study to the secondary endpoint of Overall Survival (OS).", "sentB": "As provided for in the SPA, we continue to follow the patients enrolled in the HEAT Study to the secondary endpoint of overall survival.", "type": 2, "words": ["<tag1>", "As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint", "of", "Overall", "Survival", "(OS).", "<tag2>", "As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "overall", "survival.", "<tag3>"], "wordsA": ["As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "study", "to", "the", "secondary", "endpoint", "of", "Overall", "Survival", "(OS)."], "wordsB": ["As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027145396918058395, 0.0238784309476614, 0.020517146214842796, 0.012351063080132008, 0.008254353888332844, 0.02941625565290451, 0.03390010446310043, 0.09077361226081848, 0.053644999861717224, 0.36897075176239014, 0.12110684812068939, 0.484149307012558, 0.07255224138498306, 0.010008599609136581, 0.009440373629331589, 0.03127365559339523, 0.03636767342686653, 0.011295441538095474, 0.012442262843251228, 0.024642761796712875, 0.0257540475577116, 0.00815215241163969, 0.021918432787060738, 0.11453724652528763, -1]}
{"idB": "749647_15_item1_p48_s0", "idA": "749647_14_item1_p45_s0", "sentA": "We have evaluated data from four reviews of overall survival since the announcement of the HEAT study s primary endpoint result.", "sentB": "We have evaluated data from seven sweeps of overall survival since the announcement of the HEAT Study s primary endpoint result, with each showing progressive improvement in statistical significance.", "type": 2, "words": ["<tag1>", "We", "have", "evaluated", "data", "from", "four", "reviews", "of", "overall", "survival", "since", "the", "announcement", "of", "the", "HEAT", "study", "s", "primary", "endpoint", "result.", "<tag2>", "We", "have", "evaluated", "data", "from", "seven", "sweeps", "of", "overall", "survival", "since", "the", "announcement", "of", "the", "HEAT", "Study", "s", "primary", "endpoint", "result,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag3>"], "wordsA": ["We", "have", "evaluated", "data", "from", "four", "reviews", "of", "overall", "survival", "since", "the", "announcement", "of", "the", "HEAT", "study", "s", "primary", "endpoint", "result."], "wordsB": ["We", "have", "evaluated", "data", "from", "seven", "sweeps", "of", "overall", "survival", "since", "the", "announcement", "of", "the", "HEAT", "Study", "s", "primary", "endpoint", "result,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00490619707852602, 0.002510983031243086, 0.02049754373729229, 0.024183906614780426, 0.01860596239566803, 0.8837754130363464, 0.7874024510383606, 0.01180955208837986, 0.03654185310006142, 0.030975092202425003, 0.001524410443380475, 0.0011795805767178535, 0.0017427016282454133, 0.0011129004415124655, 0.0011544922599568963, 0.0031465983483940363, 0.00251178746111691, 0.0015952839748933911, 0.003647043602541089, 0.004170816391706467, 0.0036862974520772696, 6.877821579109877e-05, 0.014453054405748844, 0.019351396709680557, 0.029862191528081894, 0.028784416615962982, 0.009610596112906933, 0.01761513017117977, 0.013861209154129028, -1]}
{"idB": "749647_15_item1_p17_s0", "idA": "749647_14_item1_p45_s1", "sentA": "We also completed computational modeling with supplementary preclinical animal studies supporting the relationship between heating duration and clinical outcomes.", "sentB": "We also completed computational modeling with supplementary prospective preclinical animal studies supporting the relationship between heating duration and clinical outcomes.", "type": 2, "words": ["<tag1>", "We", "also", "completed", "computational", "modeling", "with", "supplementary", "preclinical", "animal", "studies", "supporting", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag2>", "We", "also", "completed", "computational", "modeling", "with", "supplementary", "prospective", "preclinical", "animal", "studies", "supporting", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag3>"], "wordsA": ["We", "also", "completed", "computational", "modeling", "with", "supplementary", "preclinical", "animal", "studies", "supporting", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "wordsB": ["We", "also", "completed", "computational", "modeling", "with", "supplementary", "prospective", "preclinical", "animal", "studies", "supporting", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005016972776502371, 0.0037870691157877445, 0.005815306678414345, 0.006025261245667934, 0.008427429012954235, 0.002608638256788254, 0.01308147981762886, 0.9512122869491577, 0.16193468868732452, 0.07646208256483078, 0.022762542590498924, 0.004120237659662962, 0.0027554675471037626, 0.004416357260197401, 0.003375688102096319, 0.0075376820750534534, 0.006055808626115322, 0.003007928840816021, 0.0038628920447081327, 0.004171275999397039, -1]}
{"idB": "749647_15_item1_p50_s0", "idA": "749647_14_item1_p45_s1", "sentA": "We also completed computational modeling with supplementary preclinical animal studies supporting the relationship between heating duration and clinical outcomes.", "sentB": "We also completed computational modeling with supplementary prospective preclinical animal studies which support the relationship between heating duration and clinical outcomes.", "type": 2, "words": ["<tag1>", "We", "also", "completed", "computational", "modeling", "with", "supplementary", "preclinical", "animal", "studies", "supporting", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag2>", "We", "also", "completed", "computational", "modeling", "with", "supplementary", "prospective", "preclinical", "animal", "studies", "which", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag3>"], "wordsA": ["We", "also", "completed", "computational", "modeling", "with", "supplementary", "preclinical", "animal", "studies", "supporting", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "wordsB": ["We", "also", "completed", "computational", "modeling", "with", "supplementary", "prospective", "preclinical", "animal", "studies", "which", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005988833960145712, 0.004798308480530977, 0.006931377574801445, 0.0071785943582654, 0.010034884326159954, 0.003359501715749502, 0.013989701867103577, 0.9242371916770935, 0.13753710687160492, 0.06857649981975555, 0.02597050741314888, 0.002844203496351838, 0.006990440189838409, 0.004075975157320499, 0.007235866971313953, 0.004795431159436703, 0.00984229613095522, 0.008174438029527664, 0.003903185948729515, 0.004844099748879671, 0.005535356234759092, -1]}
{"idB": "749647_15_item1_p15_s2", "idA": "749647_14_item1_p46_s1", "sentA": "The post-hoc data demonstrated that the patient subgroup in the ThermoDox arm whose RFA procedure lasted longer than 45 minutes, which represents 285 patients or 63 percent of single lesion patients, experienced a 55 percent improvement in overall survival, with a Hazard Ratio of 0.64 (95% CI 0.41 - 1.00) and a P-value = 0.0495.", "sentB": "The Hazard Ratio at this latest quarterly OS analysis is 0.628 (95% CI 0.420 - 0.939) with a p-value of 0.02.", "type": 2, "words": ["<tag1>", "The", "post-hoc", "data", "demonstrated", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes,", "which", "represents", "285", "patients", "or", "63", "percent", "of", "single", "lesion", "patients,", "experienced", "a", "55", "percent", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495.", "<tag2>", "The", "Hazard", "Ratio", "at", "this", "latest", "quarterly", "OS", "analysis", "is", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "with", "a", "p-value", "of", "0.02.", "<tag3>"], "wordsA": ["The", "post-hoc", "data", "demonstrated", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes,", "which", "represents", "285", "patients", "or", "63", "percent", "of", "single", "lesion", "patients,", "experienced", "a", "55", "percent", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495."], "wordsB": ["The", "Hazard", "Ratio", "at", "this", "latest", "quarterly", "OS", "analysis", "is", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "with", "a", "p-value", "of", "0.02."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002220363589003682, 0.04330974817276001, 0.06838696449995041, 0.0031918897293508053, 0.002311009680852294, 0.008682649582624435, 0.03862250968813896, 0.07331744581460953, 0.06143030524253845, 0.009664984419941902, 0.8450859785079956, 0.020549338310956955, 0.03254318609833717, 0.6697073578834534, 0.24568286538124084, 0.6272640824317932, 0.003043608507141471, 0.002604817505925894, 0.023715591058135033, 0.010784965008497238, 0.5398398041725159, -1]}
{"idB": "749647_15_item1_p15_s5", "idA": "749647_14_item1_p46_s2", "sentA": "Median overall survival for this subgroup has not yet been reached.", "sentB": "Median overall survival for the subgroup has not yet been reached.", "type": 2, "words": ["<tag1>", "Median", "overall", "survival", "for", "this", "subgroup", "has", "not", "yet", "been", "reached.", "<tag2>", "Median", "overall", "survival", "for", "the", "subgroup", "has", "not", "yet", "been", "reached.", "<tag3>"], "wordsA": ["Median", "overall", "survival", "for", "this", "subgroup", "has", "not", "yet", "been", "reached."], "wordsB": ["Median", "overall", "survival", "for", "the", "subgroup", "has", "not", "yet", "been", "reached."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04533166438341141, 0.05530567094683647, 0.07807236164808273, 0.008309045806527138, 0.007233647163957357, 0.04792565479874611, 0.06489509344100952, 0.7443574070930481, 0.4796353578567505, 0.4092002809047699, 0.7448948621749878, -1]}
{"idB": "749647_15_item1_p15_s3", "idA": "749647_14_item1_p46_s3", "sentA": "The post-hoc data suggest that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their tumors undergo optimal RFA treatment.", "sentB": "These data continue to strongly suggest that ThermoDox may significantly improve overall survival compared to a RFA control in patients whose lesions undergo optimized RFA treatment for 45 minutes or more.", "type": 2, "words": ["<tag1>", "The", "post-hoc", "data", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment.", "<tag2>", "These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "overall", "survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more.", "<tag3>"], "wordsA": ["The", "post-hoc", "data", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment."], "wordsB": ["These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "overall", "survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007175699807703495, 0.05941574648022652, 0.08097048103809357, 0.03847700357437134, 0.1355808675289154, 0.08005286753177643, 0.008621190674602985, 0.01498989574611187, 0.00942762941122055, 0.01712122932076454, 0.0418068990111351, 0.042424626648426056, 0.024935638532042503, 0.007964677177369595, 0.006096556782722473, 0.006167369429022074, 0.016272032633423805, 0.025449588894844055, 0.0038629742339253426, 0.04683293029665947, 0.011322407983243465, 0.505152702331543, 0.08819103986024857, 0.42798835039138794, 0.05384332686662674, 0.12432127445936203, 0.06358537077903748, 0.4421190023422241, 0.2825792133808136, 0.15438352525234222, 0.19067038595676422, -1]}
{"idB": "749647_15_item1_p48_s2", "idA": "749647_14_item1_p46_s3", "sentA": "The post-hoc data suggest that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their tumors undergo optimal RFA treatment.", "sentB": "The post-hoc data suggest that ThermoDox may substantially improve overall survival, when compared to the control group, in patients whose lesions undergo optimized RFA treatment for 45 minutes or more.", "type": 2, "words": ["<tag1>", "The", "post-hoc", "data", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment.", "<tag2>", "The", "post-hoc", "data", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more.", "<tag3>"], "wordsA": ["The", "post-hoc", "data", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment."], "wordsB": ["The", "post-hoc", "data", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0020806577522307634, 0.0049145943485200405, 0.009813569486141205, 0.008779258467257023, 0.0034121868666261435, 0.007882656529545784, 0.0037798513658344746, 0.005022302735596895, 0.011207067407667637, 0.016135582700371742, 0.010989431291818619, 0.002047087298706174, 0.0037635774351656437, 0.002449469640851021, 0.0026117470115423203, 0.004834837280213833, 0.006295009516179562, 0.002289316849783063, 0.041484661400318146, 0.022177916020154953, 0.6202243566513062, 0.1290329247713089, 0.6990830302238464, 0.07513333857059479, 0.14593815803527832, 0.08011499047279358, 0.6423312425613403, 0.4268198013305664, 0.18526366353034973, 0.28754913806915283, -1]}
{"idB": "749647_15_item1_p14_s0", "idA": "749647_14_item1_p47_s1", "sentA": "The data from the HEAT Study post-hoc analysis suggests that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their tumors undergo optimal RFA treatment.", "sentB": "The data from the HEAT Study post-hoc analysis suggest that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their lesions undergo a 45 minute RFA procedure standardized for a lesion greater than 3 cm in diameter.", "type": 2, "words": ["<tag1>", "The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggests", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment.", "<tag2>", "The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter.", "<tag3>"], "wordsA": ["The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggests", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "tumors", "undergo", "optimal", "RFA", "treatment."], "wordsB": ["The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002991735003888607, 0.017475130036473274, 0.003088877070695162, 0.0027804144192487, 0.005341117735952139, 0.00399289233610034, 0.00387584394775331, 0.005772329401224852, 0.006370903924107552, 0.0032920546364039183, 0.0076039801351726055, 0.0035478028003126383, 0.005229014903306961, 0.007265294436365366, 0.01037061307579279, 0.007540569175034761, 0.003290327964350581, 0.0038659118581563234, 0.0026763922069221735, 0.002518118591979146, 0.005550806876271963, 0.0063158487901091576, 0.001839631819166243, 0.010899628512561321, 0.005409959703683853, 0.012328259646892548, 0.22508464753627777, 0.024117520079016685, 0.014810128137469292, 0.4862928092479706, 0.3269907236099243, 0.049278371036052704, 0.16231511533260345, 0.15373291075229645, 0.05513608455657959, 0.07867731899023056, 0.4496840536594391, 0.5959042906761169, 0.52265465259552, 0.6183631420135498, 0.5100077390670776, 0.354069322347641, 0.4575956165790558, -1]}
{"idB": "749647_15_item1_p15_s0", "idA": "749647_14_item1_p47_s3", "sentA": "Data from four OS sweeps have been conducted since the top line PFS data from the HEAT Study was announced in January 2013, with each showing progressive improvement in statistical significance.", "sentB": "Data from seven OS sweeps have been conducted since the top line PFS data from the HEAT Study were announced in January 2013, with each data set showing progressive improvement in statistical significance.", "type": 2, "words": ["<tag1>", "Data", "from", "four", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag2>", "Data", "from", "seven", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag3>"], "wordsA": ["Data", "from", "four", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance."], "wordsB": ["Data", "from", "seven", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "showing", "progressive", "improvement", "in", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03230719640851021, 0.013499037362635136, 0.9856017231941223, 0.1958000659942627, 0.13013431429862976, 0.0010958105558529496, 0.0010141519596800208, 0.002273713704198599, 0.0014067098964005709, 0.00105930189602077, 0.0028736551757901907, 0.003190003102645278, 0.0053116860799491405, 0.004311136901378632, 0.0012171557173132896, 0.0011738149914890528, 0.0033914558589458466, 0.0028949358966201544, 0.001013606321066618, 0.0019178660586476326, 0.001194280688650906, 0.0018898192793130875, 0.002035859040915966, 0.0015459659043699503, 0.003664707764983177, 0.029506897553801537, 0.008351887576282024, 0.0029199854470789433, 0.0028265640139579773, 0.0037653136532753706, 0.0011243171757087111, 0.0025323466397821903, 0.0025846592616289854, -1]}
{"idB": "749647_15_item1_p15_s1", "idA": "749647_14_item1_p47_s3", "sentA": "Data from four OS sweeps have been conducted since the top line PFS data from the HEAT Study was announced in January 2013, with each showing progressive improvement in statistical significance.", "sentB": "The most recent post-hoc OS analysis data from the HEAT Study (as of January 15, 2015) announced in February 2015 demonstrated that in a large, well bounded, subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and standardized RFA provided a 59% improvement in OS compared to optimized RFA alone.", "type": 2, "words": ["<tag1>", "Data", "from", "four", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag2>", "The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "(as", "of", "January", "15,", "2015)", "announced", "in", "February", "2015", "demonstrated", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "standardized", "RFA", "provided", "a", "59%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag3>"], "wordsA": ["Data", "from", "four", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "was", "announced", "in", "January", "2013,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance."], "wordsB": ["The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "(as", "of", "January", "15,", "2015)", "announced", "in", "February", "2015", "demonstrated", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "standardized", "RFA", "provided", "a", "59%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00648979377001524, 0.1047319695353508, 0.12749293446540833, 0.5077612996101379, 0.222198948264122, 0.34274598956108093, 0.09159917384386063, 0.003458433784544468, 0.002940671518445015, 0.010939299128949642, 0.013373544439673424, 0.012636068277060986, 0.010157904587686062, 0.04337248578667641, 0.05272015184164047, 0.4292425215244293, 0.0055178008042275906, 0.007882104255259037, 0.0546119399368763, 0.49247071146965027, 0.023525074124336243, 0.012834685854613781, 0.007723089307546616, 0.007125061005353928, 0.03291561082005501, 0.060798279941082, 0.09660054743289948, 0.08823324739933014, 0.024416420608758926, 0.049707069993019104, 0.16830040514469147, 0.1405566781759262, 0.012829086743295193, 0.005366622004657984, 0.023712432011961937, 0.029827715829014778, 0.00866504292935133, 0.03552735224366188, 0.026781421154737473, 0.05694124847650528, 0.021678991615772247, 0.12694399058818817, 0.08234751224517822, 0.05064113810658455, 0.02324577607214451, 0.34540021419525146, 0.1729210764169693, 0.025574184954166412, 0.10311843454837799, 0.04270061478018761, 0.010112877935171127, 0.03460283949971199, 0.03155725449323654, 0.09897273033857346, -1]}
{"idB": "749647_15_item1_p15_s4", "idA": "749647_14_item1_p47_s4", "sentA": "We may choose to end the analysis of OS once the median is reached for either or both arms of the HEAT Study.", "sentB": "These findings apply to patients with single HCC lesions (64.4% of the HEAT Study population) from both size cohorts of the HEAT Study (3-5 cm and 5-7 cm) and represent a subgroup of 285 patients.", "type": 2, "words": ["<tag1>", "We", "may", "choose", "to", "end", "the", "analysis", "of", "OS", "once", "the", "median", "is", "reached", "for", "either", "or", "both", "arms", "of", "the", "HEAT", "Study.", "<tag2>", "These", "findings", "apply", "to", "patients", "with", "single", "HCC", "lesions", "(64.4%", "of", "the", "HEAT", "Study", "population)", "from", "both", "size", "cohorts", "of", "the", "HEAT", "Study", "(3-5", "cm", "and", "5-7", "cm)", "and", "represent", "a", "subgroup", "of", "285", "patients.", "<tag3>"], "wordsA": ["We", "may", "choose", "to", "end", "the", "analysis", "of", "OS", "once", "the", "median", "is", "reached", "for", "either", "or", "both", "arms", "of", "the", "HEAT", "Study."], "wordsB": ["These", "findings", "apply", "to", "patients", "with", "single", "HCC", "lesions", "(64.4%", "of", "the", "HEAT", "Study", "population)", "from", "both", "size", "cohorts", "of", "the", "HEAT", "Study", "(3-5", "cm", "and", "5-7", "cm)", "and", "represent", "a", "subgroup", "of", "285", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03039226122200489, 0.12479633837938309, 0.14069879055023193, 0.029249612241983414, 0.1148485541343689, 0.025340113788843155, 0.7241637110710144, 0.4141954779624939, 0.258074015378952, 0.12042194604873657, 0.010410897433757782, 0.006903517991304398, 0.02765708975493908, 0.02421579882502556, 0.02504500187933445, 0.007173566613346338, 0.13026322424411774, 0.07378257811069489, 0.046517714858055115, 0.004835330881178379, 0.004034143872559071, 0.018611274659633636, 0.018607184290885925, 0.44317522644996643, 0.31680575013160706, 0.09714542329311371, 0.5601181387901306, 0.2750379145145416, 0.00024934898829087615, 0.02234472520649433, 0.00726480595767498, 0.0537569485604763, 0.01485828123986721, 0.20355358719825745, 0.13935352861881256, -1]}
{"idB": "749647_15_item1_p56_s0", "idA": "749647_14_item1_p48_s0", "sentA": "We will continue with partnerships, such as our arrangement with Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun) described below, to the extent feasible.", "sentB": "We will continue with partnerships, such as our arrangement with Hisun to the extent feasible.", "type": 2, "words": ["<tag1>", "We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "described", "below,", "to", "the", "extent", "feasible.", "<tag2>", "We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "to", "the", "extent", "feasible.", "<tag3>"], "wordsA": ["We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "described", "below,", "to", "the", "extent", "feasible."], "wordsB": ["We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "to", "the", "extent", "feasible."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2407163381576538, 0.07502580434083939, 0.11135052889585495, 0.10319161415100098, 0.22807663679122925, 0.040901586413383484, 0.02932763285934925, 0.03323546051979065, 0.20176544785499573, 0.11898015439510345, 0.7533663511276245, 0.01917664147913456, 0.014208006672561169, 0.08602079004049301, 0.08778908848762512, -1]}
{"idB": "749647_15_item1_p141_s3", "idA": "749647_14_item1_p48_s1", "sentA": "In addition, we have assessed our product pipeline and research and development priorities.", "sentB": "In addition, we believe that adequate alternative sources for such supplies exist.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "assessed", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag2>", "In", "addition,", "we", "believe", "that", "adequate", "alternative", "sources", "for", "such", "supplies", "exist.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "assessed", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "wordsB": ["In", "addition,", "we", "believe", "that", "adequate", "alternative", "sources", "for", "such", "supplies", "exist."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005127779673784971, 0.022684544324874878, 0.055320870131254196, 0.2596070170402527, 0.11164333671331406, 0.5106229186058044, 0.7639474868774414, 0.8129603862762451, 0.09324222058057785, 0.0880090743303299, 0.1796511709690094, 0.21307401359081268, -1]}
{"idB": "749647_15_item1_p184_s1", "idA": "749647_14_item1_p48_s1", "sentA": "In addition, we have assessed our product pipeline and research and development priorities.", "sentB": "In addition, we granted to Impatients an option to negotiate an exclusive license to distribute ThermoDox in the Territory after ThermoDox receives regulatory approval in a country within the Territory.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "assessed", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag2>", "In", "addition,", "we", "granted", "to", "Impatients", "an", "option", "to", "negotiate", "an", "exclusive", "license", "to", "distribute", "ThermoDox", "in", "the", "Territory", "after", "ThermoDox", "receives", "regulatory", "approval", "in", "a", "country", "within", "the", "Territory.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "assessed", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "wordsB": ["In", "addition,", "we", "granted", "to", "Impatients", "an", "option", "to", "negotiate", "an", "exclusive", "license", "to", "distribute", "ThermoDox", "in", "the", "Territory", "after", "ThermoDox", "receives", "regulatory", "approval", "in", "a", "country", "within", "the", "Territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004727025516331196, 0.016508564352989197, 0.0407865010201931, 0.40882760286331177, 0.05362296104431152, 0.12293049693107605, 0.1378064602613449, 0.17981787025928497, 0.09253586083650589, 0.31495511531829834, 0.16107630729675293, 0.25717437267303467, 0.44666120409965515, 0.15056824684143066, 0.23029816150665283, 0.10088419169187546, 0.01276445109397173, 0.015527209267020226, 0.03536560758948326, 0.007922514341771603, 0.02919948101043701, 0.0182721596211195, 0.021985575556755066, 0.028737640008330345, 0.007374260574579239, 0.005657536443322897, 0.016471505165100098, 0.006403620820492506, 0.006005144212394953, 0.014156985096633434, -1]}
{"idB": "749647_15_item1_p56_s4", "idA": "749647_14_item1_p48_s4", "sentA": "However, as demonstrated by the HEAT Study results on PFS announced on January 31, 2013, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "sentB": "However, as demonstrated by the HEAT Study results announced on January 31, 2013, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "type": 2, "words": ["<tag1>", "However,", "as", "demonstrated", "by", "the", "HEAT", "Study", "results", "on", "PFS", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag2>", "However,", "as", "demonstrated", "by", "the", "HEAT", "Study", "results", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag3>"], "wordsA": ["However,", "as", "demonstrated", "by", "the", "HEAT", "Study", "results", "on", "PFS", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "wordsB": ["However,", "as", "demonstrated", "by", "the", "HEAT", "Study", "results", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.15095224976539612, 0.045039378106594086, 0.06376245617866516, 0.028580060228705406, 0.017339764162898064, 0.14285880327224731, 0.08777365833520889, 0.14112478494644165, 0.05099668353796005, 0.03486357256770134, 0.09712354838848114, 0.15647296607494354, 0.077828548848629, 0.08429332077503204, 0.06758903712034225, 0.024621261283755302, 0.06705029308795929, 0.016359101980924606, 0.016507547348737717, 0.09123171865940094, 0.24547813832759857, 0.10169454663991928, 0.0008061958942562342, 0.013525771908462048, 0.01752193085849285, 0.0147971510887146, 0.20261012017726898, 0.11910771578550339, 0.038721002638339996, 0.4276142418384552, 0.02876618318259716, 0.055323559790849686, 0.09088846296072006, 0.051886219531297684, 0.04727303236722946, 0.22118130326271057, -1]}
{"idB": "749647_15_item1_p123_s1", "idA": "749647_14_item1_p50_s2", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the Company's Phase III HEAT Study, which demonstrated that treatment with ThermoDox resulted in a 55% improvement in overall survival in a substantial number of HCC patients that received an optimized RFA treatment.", "sentB": "The OPTIMA Study trial design is based on a comprehensive analysis of data from our Phase III HEAT Study.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment.", "<tag2>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment."], "wordsB": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005975524429231882, 0.058759041130542755, 0.05506907403469086, 0.053339846432209015, 0.11616715788841248, 0.01338946633040905, 0.0716731995344162, 0.020576413720846176, 0.009258236736059189, 0.06727612018585205, 0.11983709037303925, 0.03589366376399994, 0.28716015815734863, 0.08212015777826309, 0.5782924294471741, 0.4174180030822754, 0.3909038007259369, 0.380995512008667, 0.6839189529418945, -1]}
{"idB": "749647_15_item1_p49_s1", "idA": "749647_14_item1_p50_s2", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the Company's Phase III HEAT Study, which demonstrated that treatment with ThermoDox resulted in a 55% improvement in overall survival in a substantial number of HCC patients that received an optimized RFA treatment.", "sentB": "This information should be viewed with caution since it is based on a retrospective analysis of a subgroup that has not reached its median point for the overall survival analysis.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment.", "<tag2>", "This", "information", "should", "be", "viewed", "with", "caution", "since", "it", "is", "based", "on", "a", "retrospective", "analysis", "of", "a", "subgroup", "that", "has", "not", "reached", "its", "median", "point", "for", "the", "overall", "survival", "analysis.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment."], "wordsB": ["This", "information", "should", "be", "viewed", "with", "caution", "since", "it", "is", "based", "on", "a", "retrospective", "analysis", "of", "a", "subgroup", "that", "has", "not", "reached", "its", "median", "point", "for", "the", "overall", "survival", "analysis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010296305641531944, 0.09108863025903702, 0.051691874861717224, 0.04247298464179039, 0.10207200050354004, 0.09869769215583801, 0.2381231039762497, 0.007189416326582432, 0.004725482314825058, 0.005909514147788286, 0.025191716849803925, 0.009168244898319244, 0.006216082256287336, 0.43657171726226807, 0.30275580286979675, 0.014006483368575573, 0.021125663071870804, 0.21453642845153809, 0.00011953427019761875, 0.0630858987569809, 0.3511597812175751, 0.1495688557624817, 0.04796430841088295, 0.25394874811172485, 0.22365505993366241, 0.014513900503516197, 0.010108073242008686, 0.05456661060452461, 0.06393535435199738, 0.09620936959981918, -1]}
{"idB": "749647_15_item1_p51_s2", "idA": "749647_14_item1_p50_s2", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the Company's Phase III HEAT Study, which demonstrated that treatment with ThermoDox resulted in a 55% improvement in overall survival in a substantial number of HCC patients that received an optimized RFA treatment.", "sentB": "The OPTIMA Study trial design is based on a comprehensive analysis of data from our Phase III HEAT Study.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment.", "<tag2>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "Company's", "Phase", "III", "HEAT", "Study,", "which", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "55%", "improvement", "in", "overall", "survival", "in", "a", "substantial", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment."], "wordsB": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005975524429231882, 0.058759041130542755, 0.05506907403469086, 0.053339846432209015, 0.11616715788841248, 0.01338946633040905, 0.0716731995344162, 0.020576413720846176, 0.009258236736059189, 0.06727612018585205, 0.11983709037303925, 0.03589366376399994, 0.28716015815734863, 0.08212015777826309, 0.5782924294471741, 0.4174180030822754, 0.3909038007259369, 0.380995512008667, 0.6839189529418945, -1]}
{"idB": "749647_15_item1_p18_s3", "idA": "749647_14_item1_p51_s1", "sentA": "The OPTIMA Study is expected to enroll 550 patients globally, with up to 100 sites in the United States, Europe, China and Asia Pacific and will evaluate ThermoDox in combination with RFA, which will be standardized to a minimum of 45 minutes across all investigators and sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "sentB": "The OPTIMA Study is expected to enroll up to 550 patients globally at up to 100 sites in the United States, Europe, China and elsewhere in the Asia Pacific region, and will evaluate ThermoDox in combination with standardized RFA, which will require a minimum of 45 minutes across all investigators and clinical sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag2>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "elsewhere", "in", "the", "Asia", "Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "wordsB": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "elsewhere", "in", "the", "Asia", "Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015570537187159061, 0.06306958198547363, 0.059759266674518585, 0.02582562156021595, 0.05900823324918747, 0.03935804218053818, 0.09602408111095428, 0.06603822112083435, 0.0593472458422184, 0.12496961653232574, 0.11883512884378433, 0.04817964509129524, 0.03158988803625107, 0.041550226509571075, 0.04822526499629021, 0.04230274632573128, 0.04560507461428642, 0.029331747442483902, 0.030974935740232468, 0.040599483996629715, 0.04247492551803589, 0.04049627482891083, 0.03721512854099274, 0.027449805289506912, 0.02999100089073181, 0.02346380427479744, 0.02494046837091446, 0.04952602833509445, 0.057607464492321014, 0.03944232314825058, 0.011033792980015278, 0.0244591161608696, 0.05654588341712952, 0.09277398884296417, 0.04402979090809822, 0.045639436691999435, 0.04451017081737518, 0.0730777457356453, 0.08618464320898056, 0.006048683077096939, 0.02532879263162613, 0.04942964017391205, 0.049868930131196976, 0.09021332114934921, 0.08361903578042984, 0.30761662125587463, 0.25447505712509155, 0.02903144806623459, 0.03579378500580788, 0.08606158941984177, 0.023008879274129868, 0.024211987853050232, 0.09873562306165695, 0.04058085009455681, 0.044869132339954376, 0.07655307650566101, 0.044876694679260254, 0.04245826229453087, 0.06553857773542404, 0.06583498418331146, 0.03178805857896805, 0.1652376651763916, 0.14853182435035706, 0.061140283942222595, -1]}
{"idB": "749647_15_item1_p52_s1", "idA": "749647_14_item1_p51_s1", "sentA": "The OPTIMA Study is expected to enroll 550 patients globally, with up to 100 sites in the United States, Europe, China and Asia Pacific and will evaluate ThermoDox in combination with RFA, which will be standardized to a minimum of 45 minutes across all investigators and sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "sentB": "The OPTIMA Study is expected to enroll up to 550 patients globally at up to 100 sites in the United States, Europe, China and elsewhere in the Asia Pacific region, and will evaluate ThermoDox in combination with standardized RFA, which will require a minimum of 45 minutes across all investigators and clinical sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag2>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "elsewhere", "in", "the", "Asia", "Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "wordsB": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "elsewhere", "in", "the", "Asia", "Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015570537187159061, 0.06306958198547363, 0.059759266674518585, 0.02582562156021595, 0.05900823324918747, 0.03935804218053818, 0.09602408111095428, 0.06603822112083435, 0.0593472458422184, 0.12496961653232574, 0.11883512884378433, 0.04817964509129524, 0.03158988803625107, 0.041550226509571075, 0.04822526499629021, 0.04230274632573128, 0.04560507461428642, 0.029331747442483902, 0.030974935740232468, 0.040599483996629715, 0.04247492551803589, 0.04049627482891083, 0.03721512854099274, 0.027449805289506912, 0.02999100089073181, 0.02346380427479744, 0.02494046837091446, 0.04952602833509445, 0.057607464492321014, 0.03944232314825058, 0.011033792980015278, 0.0244591161608696, 0.05654588341712952, 0.09277398884296417, 0.04402979090809822, 0.045639436691999435, 0.04451017081737518, 0.0730777457356453, 0.08618464320898056, 0.006048683077096939, 0.02532879263162613, 0.04942964017391205, 0.049868930131196976, 0.09021332114934921, 0.08361903578042984, 0.30761662125587463, 0.25447505712509155, 0.02903144806623459, 0.03579378500580788, 0.08606158941984177, 0.023008879274129868, 0.024211987853050232, 0.09873562306165695, 0.04058085009455681, 0.044869132339954376, 0.07655307650566101, 0.044876694679260254, 0.04245826229453087, 0.06553857773542404, 0.06583498418331146, 0.03178805857896805, 0.1652376651763916, 0.14853182435035706, 0.061140283942222595, -1]}
{"idB": "749647_15_item1_p152_s1", "idA": "749647_14_item1_p56_s0", "sentA": "In collaboration with the Focused Ultrasound Foundation, we are sponsoring preclinical studies designed to explore the use of ThermoDox in combination with MR-guided HIFU for the treatment of pancreatic cancer.", "sentB": "To support these cases, we have conducted clinical studies in combination with chemotherapy for ovarian cancer, and preclinical studies in combination with both temozolomide and Bevacizumab-Avastin .", "type": 2, "words": ["<tag1>", "In", "collaboration", "with", "the", "Focused", "Ultrasound", "Foundation,", "we", "are", "sponsoring", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer.", "<tag2>", "To", "support", "these", "cases,", "we", "have", "conducted", "clinical", "studies", "in", "combination", "with", "chemotherapy", "for", "ovarian", "cancer,", "and", "preclinical", "studies", "in", "combination", "with", "both", "temozolomide", "and", "Bevacizumab-Avastin", ".", "<tag3>"], "wordsA": ["In", "collaboration", "with", "the", "Focused", "Ultrasound", "Foundation,", "we", "are", "sponsoring", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer."], "wordsB": ["To", "support", "these", "cases,", "we", "have", "conducted", "clinical", "studies", "in", "combination", "with", "chemotherapy", "for", "ovarian", "cancer,", "and", "preclinical", "studies", "in", "combination", "with", "both", "temozolomide", "and", "Bevacizumab-Avastin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0041218968108296394, 0.01757029816508293, 0.007303714752197266, 0.03421669453382492, 0.016325481235980988, 0.006871957331895828, 0.034912459552288055, 0.059497982263565063, 0.05443418398499489, 0.009435897693037987, 0.019040467217564583, 0.015659354627132416, 0.12689314782619476, 0.028520915657281876, 0.7927106022834778, 0.41127267479896545, 0.0035324220079928637, 0.02623766101896763, 0.059170182794332504, 0.008771874941885471, 0.0306645929813385, 0.04023201763629913, 0.0993054136633873, 0.7847486734390259, 0.15136109292507172, 0.5640496015548706, 4.377392906462774e-05, -1]}
{"idB": "749647_15_item1_p104_s1", "idA": "749647_14_item1_p56_s3", "sentA": "We believe that these collaborations are providing important new device technologies such as HIFU to activate our low heat sensitive liposomal technology in difficult-to-treat cancers.", "sentB": "We believe that these advantages place Celsion in an excellent position to capitalize on the technology.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "these", "collaborations", "are", "providing", "important", "new", "device", "technologies", "such", "as", "HIFU", "to", "activate", "our", "low", "heat", "sensitive", "liposomal", "technology", "in", "difficult-to-treat", "cancers.", "<tag2>", "We", "believe", "that", "these", "advantages", "place", "Celsion", "in", "an", "excellent", "position", "to", "capitalize", "on", "the", "technology.", "<tag3>"], "wordsA": ["We", "believe", "that", "these", "collaborations", "are", "providing", "important", "new", "device", "technologies", "such", "as", "HIFU", "to", "activate", "our", "low", "heat", "sensitive", "liposomal", "technology", "in", "difficult-to-treat", "cancers."], "wordsB": ["We", "believe", "that", "these", "advantages", "place", "Celsion", "in", "an", "excellent", "position", "to", "capitalize", "on", "the", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018870631232857704, 0.04186345264315605, 0.016947541385889053, 0.02579900063574314, 0.10579901933670044, 0.10222557932138443, 0.517245888710022, 0.12592367827892303, 0.07436518371105194, 0.16508804261684418, 0.2615610361099243, 0.023161383345723152, 0.15566575527191162, 0.06239854171872139, 0.03226376324892044, 0.13201776146888733, -1]}
{"idB": "749647_15_item1_p106_s4", "idA": "749647_14_item1_p56_s3", "sentA": "We believe that these collaborations are providing important new device technologies such as HIFU to activate our low heat sensitive liposomal technology in difficult-to-treat cancers.", "sentB": "We believe that these features can provide high specificity for RNAi delivery to select tissue, enhance stability and reduce in vivo toxicity.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "these", "collaborations", "are", "providing", "important", "new", "device", "technologies", "such", "as", "HIFU", "to", "activate", "our", "low", "heat", "sensitive", "liposomal", "technology", "in", "difficult-to-treat", "cancers.", "<tag2>", "We", "believe", "that", "these", "features", "can", "provide", "high", "specificity", "for", "RNAi", "delivery", "to", "select", "tissue,", "enhance", "stability", "and", "reduce", "in", "vivo", "toxicity.", "<tag3>"], "wordsA": ["We", "believe", "that", "these", "collaborations", "are", "providing", "important", "new", "device", "technologies", "such", "as", "HIFU", "to", "activate", "our", "low", "heat", "sensitive", "liposomal", "technology", "in", "difficult-to-treat", "cancers."], "wordsB": ["We", "believe", "that", "these", "features", "can", "provide", "high", "specificity", "for", "RNAi", "delivery", "to", "select", "tissue,", "enhance", "stability", "and", "reduce", "in", "vivo", "toxicity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016218261793255806, 0.031007682904601097, 0.015541357919573784, 0.02414826489984989, 0.11724282801151276, 0.024282513186335564, 0.07452921569347382, 0.3308204710483551, 0.42826735973358154, 0.12243682146072388, 0.4559645652770996, 0.2796722650527954, 0.008464467711746693, 0.05114006996154785, 0.059816937893629074, 0.05844760313630104, 0.061646200716495514, 0.009787831455469131, 0.15364032983779907, 0.03315497934818268, 0.062394168227910995, 0.08092163503170013, -1]}
{"idB": "749647_15_item1_p78_s0", "idA": "749647_14_item1_p57_s0", "sentA": "Breast cancer is the most common malignancy in women in both the United States and the world.", "sentB": "Ovarian cancer is the most lethal of gynecological malignancies among women with an overall five year survival rate of 44.6% between the years 2004 to 2010.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world.", "<tag2>", "Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "44.6%", "between", "the", "years", "2004", "to", "2010.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world."], "wordsB": ["Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "44.6%", "between", "the", "years", "2004", "to", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8880549669265747, 0.588090181350708, 0.006012600380927324, 0.005157146602869034, 0.039560772478580475, 0.10529381781816483, 0.008686873130500317, 0.1878996342420578, 0.10891743749380112, 0.0138556445017457, 0.02562697045505047, 5.448162119137123e-05, 0.0036706742830574512, 0.01684180274605751, 0.031068308278918266, 0.017896104604005814, 0.01953505538403988, 0.01182901207357645, 0.006684477906674147, 0.06048080325126648, 0.00861706305295229, 0.0040177470073103905, 0.01843208074569702, 0.041889891028404236, 0.023697368800640106, 0.0258612260222435, -1]}
{"idB": "749647_15_item1_p90_s2", "idA": "749647_14_item1_p60_s0", "sentA": "We have been actively seeking a targeted localized treatment for breast cancer using ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "sentB": "Increasing the GEN-1 dosing frequency from 4 treatments to 8 treatments in conjunction with chemotherapy was also well tolerated.", "type": 2, "words": ["<tag1>", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag2>", "Increasing", "the", "GEN-1", "dosing", "frequency", "from", "4", "treatments", "to", "8", "treatments", "in", "conjunction", "with", "chemotherapy", "was", "also", "well", "tolerated.", "<tag3>"], "wordsA": ["We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "wordsB": ["Increasing", "the", "GEN-1", "dosing", "frequency", "from", "4", "treatments", "to", "8", "treatments", "in", "conjunction", "with", "chemotherapy", "was", "also", "well", "tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10665016621351242, 0.02648322656750679, 0.555916965007782, 0.3905656337738037, 0.13857145607471466, 0.02692132443189621, 0.4017281234264374, 0.3989008963108063, 0.019612329080700874, 0.4705532193183899, 0.34892502427101135, 0.004036796744912863, 0.007914278656244278, 0.004609554540365934, 0.04472191259264946, 0.006501429248601198, 0.005299237556755543, 0.04599045217037201, 0.08905870467424393, -1]}
{"idB": "749647_15_item1_p107_s0", "idA": "749647_14_item1_p62_s0", "sentA": "Microwave hyperthermia as a separate standalone treatment has been found to have the ability to kill breast cancer cells.", "sentB": "In-vivo proof-of-concept studies of our most advanced system have shown the ability to deliver RNAi molecules specifically to the pulmonary vascular following intravenous administration.", "type": 2, "words": ["<tag1>", "Microwave", "hyperthermia", "as", "a", "separate", "standalone", "treatment", "has", "been", "found", "to", "have", "the", "ability", "to", "kill", "breast", "cancer", "cells.", "<tag2>", "In-vivo", "proof-of-concept", "studies", "of", "our", "most", "advanced", "system", "have", "shown", "the", "ability", "to", "deliver", "RNAi", "molecules", "specifically", "to", "the", "pulmonary", "vascular", "following", "intravenous", "administration.", "<tag3>"], "wordsA": ["Microwave", "hyperthermia", "as", "a", "separate", "standalone", "treatment", "has", "been", "found", "to", "have", "the", "ability", "to", "kill", "breast", "cancer", "cells."], "wordsB": ["In-vivo", "proof-of-concept", "studies", "of", "our", "most", "advanced", "system", "have", "shown", "the", "ability", "to", "deliver", "RNAi", "molecules", "specifically", "to", "the", "pulmonary", "vascular", "following", "intravenous", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4839189350605011, 0.3321915566921234, 0.20328883826732635, 0.008644926361739635, 0.013444790616631508, 0.018658123910427094, 0.025169994682073593, 0.0492522232234478, 0.0037816257681697607, 0.011263896711170673, 0.0049439044669270515, 0.027102714404463768, 0.015493499115109444, 0.1253565102815628, 0.23302574455738068, 0.17661303281784058, 0.03459642082452774, 0.0278161633759737, 0.040992919355630875, 0.4536078870296478, 0.3758205473423004, 0.03442936763167381, 0.08864124119281769, 0.09801796823740005, -1]}
{"idB": "749647_15_item1_p23_s3", "idA": "749647_14_item1_p64_s1", "sentA": "The DIGNITY study is designed to establish a safe therapeutic dose in Phase I, and in Phase II to demonstrate local control, including complete and partial responses, and stable disease as its primary endpoint.", "sentB": "The trial is designed to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose to carry forward into a Phase II trial.", "type": 2, "words": ["<tag1>", "The", "DIGNITY", "study", "is", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "in", "Phase", "II", "to", "demonstrate", "local", "control,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint.", "<tag2>", "The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial.", "<tag3>"], "wordsA": ["The", "DIGNITY", "study", "is", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "in", "Phase", "II", "to", "demonstrate", "local", "control,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint."], "wordsB": ["The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004206625744700432, 0.2078758180141449, 0.0041552274487912655, 0.009771162644028664, 0.004653013776987791, 0.10129638016223907, 0.4588591456413269, 0.11703024804592133, 0.559386134147644, 0.4214479625225067, 0.039831873029470444, 0.0817783996462822, 0.03806423768401146, 0.00013229995965957642, 0.0033559626899659634, 0.05966660752892494, 0.03997043892741203, 0.013832059688866138, 0.028675571084022522, 0.003671152051538229, 0.009076675400137901, 0.0019446847727522254, 0.07918516546487808, 0.015228278934955597, 0.22550079226493835, 0.3229219317436218, 0.00541651202365756, 0.008084643632173538, 0.010843956843018532, 0.003785680513828993, 0.002842354355379939, 0.02081126719713211, 0.017934031784534454, 0.025695860385894775, -1]}
{"idB": "749647_15_item1_p94_s1", "idA": "749647_14_item1_p64_s1", "sentA": "The DIGNITY study is designed to establish a safe therapeutic dose in Phase I, and in Phase II to demonstrate local control, including complete and partial responses, and stable disease as its primary endpoint.", "sentB": "The protocol, developed with guidance from the Company s Medical Advisory Board, is designed to establish a safe dose and biological activity of GEN-1 in newly diagnosed ovarian cancer patients who will be undergoing neoadjuvant chemotherapy.", "type": 2, "words": ["<tag1>", "The", "DIGNITY", "study", "is", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "in", "Phase", "II", "to", "demonstrate", "local", "control,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint.", "<tag2>", "The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy.", "<tag3>"], "wordsA": ["The", "DIGNITY", "study", "is", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "in", "Phase", "II", "to", "demonstrate", "local", "control,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint."], "wordsB": ["The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004842012654989958, 0.23768611252307892, 0.02433626540005207, 0.004267918411642313, 0.027510058134794235, 0.007334430702030659, 0.006988143548369408, 0.05371680110692978, 0.02194444090127945, 0.06972189992666245, 0.09088447690010071, 0.07044001668691635, 0.003206636756658554, 0.00567791098728776, 0.0036547209601849318, 0.014136800542473793, 0.003818555036559701, 0.025445114821195602, 0.042802002280950546, 0.007789118215441704, 0.1696150153875351, 0.09326454252004623, 0.05196918174624443, 0.4067600965499878, 0.02034911885857582, 0.08932160586118698, 0.14078961312770844, 0.20716752111911774, 0.28250864148139954, 0.14632292091846466, 0.00029285973869264126, 0.00580611452460289, 0.005461530294269323, 0.09600330144166946, 0.5309453010559082, 0.27963727712631226, -1]}
{"idB": "749647_15_item1_p94_s4", "idA": "749647_14_item1_p64_s1", "sentA": "The DIGNITY study is designed to establish a safe therapeutic dose in Phase I, and in Phase II to demonstrate local control, including complete and partial responses, and stable disease as its primary endpoint.", "sentB": "The trial is designed to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose to carry forward into a Phase II trial.", "type": 2, "words": ["<tag1>", "The", "DIGNITY", "study", "is", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "in", "Phase", "II", "to", "demonstrate", "local", "control,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint.", "<tag2>", "The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial.", "<tag3>"], "wordsA": ["The", "DIGNITY", "study", "is", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "in", "Phase", "II", "to", "demonstrate", "local", "control,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint."], "wordsB": ["The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004206625744700432, 0.2078758180141449, 0.0041552274487912655, 0.009771162644028664, 0.004653013776987791, 0.10129638016223907, 0.4588591456413269, 0.11703024804592133, 0.559386134147644, 0.4214479625225067, 0.039831873029470444, 0.0817783996462822, 0.03806423768401146, 0.00013229995965957642, 0.0033559626899659634, 0.05966660752892494, 0.03997043892741203, 0.013832059688866138, 0.028675571084022522, 0.003671152051538229, 0.009076675400137901, 0.0019446847727522254, 0.07918516546487808, 0.015228278934955597, 0.22550079226493835, 0.3229219317436218, 0.00541651202365756, 0.008084643632173538, 0.010843956843018532, 0.003785680513828993, 0.002842354355379939, 0.02081126719713211, 0.017934031784534454, 0.025695860385894775, -1]}
{"idB": "749647_15_item1_p68_s2", "idA": "749647_14_item1_p65_s2", "sentA": "The trial will enroll 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "sentB": "The trial is designed to enroll up to 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "type": 2, "words": ["<tag1>", "The", "trial", "will", "enroll", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag3>"], "wordsA": ["The", "trial", "will", "enroll", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003944833297282457, 0.040128909051418304, 0.01258590817451477, 0.026080019772052765, 0.021768931299448013, 0.12482166290283203, 0.8362455368041992, 0.8161501288414001, 0.8093194961547852, 0.36897653341293335, 0.0035372895654290915, 0.01576775312423706, 0.01025399100035429, 0.013436469249427319, 0.003060354385524988, 0.0034189035650342703, 0.006347415037453175, 0.006542524788528681, 0.0002691756235435605, 0.005819402169436216, 0.017169473692774773, 0.010876520536839962, 0.0034649986773729324, 0.004053818061947823, 0.0032001170329749584, 0.007439536973834038, 0.008033852092921734, -1]}
{"idB": "749647_15_item1_p73_s0", "idA": "749647_14_item1_p66_s0", "sentA": "Duke University conducted a Phase I dose escalating ThermoDox study in patients with RCW breast cancer and has presented preliminary results from the 16 enrolled patients that characterize the safety of the drug in RCW patients and the feasibility of ThermoDox administration in these patients .", "sentB": "Secondary objectives of the Euro-DIGNITY Study will be (i) to evaluate the safety of the combination of ThermoDox/Hyperthermia/Radiotherapy among patients with LRR breast cancer, (ii) to evaluate the duration of local control complete response (CR), partial response (PR) and stable disease (SD) following treatment with ThermoDox/Hyperthermia/Radiotherapy up to 24 months among patients with LRR breast cancer and (iii) to assess Patient Reported Quality of Life using the FACT-B and Brief Pain Inventory (BPI) following treatment with ThermoDox/Hyperthermia/Radiotherapy among patients with LRR breast cancer.", "type": 2, "words": ["<tag1>", "Duke", "University", "conducted", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients", ".", "<tag2>", "Secondary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "the", "safety", "of", "the", "combination", "of", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer,", "(ii)", "to", "evaluate", "the", "duration", "of", "local", "control", "complete", "response", "(CR),", "partial", "response", "(PR)", "and", "stable", "disease", "(SD)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "up", "to", "24", "months", "among", "patients", "with", "LRR", "breast", "cancer", "and", "(iii)", "to", "assess", "Patient", "Reported", "Quality", "of", "Life", "using", "the", "FACT-B", "and", "Brief", "Pain", "Inventory", "(BPI)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer.", "<tag3>"], "wordsA": ["Duke", "University", "conducted", "a", "Phase", "I", "dose", "escalating", "ThermoDox", "study", "in", "patients", "with", "RCW", "breast", "cancer", "and", "has", "presented", "preliminary", "results", "from", "the", "16", "enrolled", "patients", "that", "characterize", "the", "safety", "of", "the", "drug", "in", "RCW", "patients", "and", "the", "feasibility", "of", "ThermoDox", "administration", "in", "these", "patients", "."], "wordsB": ["Secondary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "the", "safety", "of", "the", "combination", "of", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer,", "(ii)", "to", "evaluate", "the", "duration", "of", "local", "control", "complete", "response", "(CR),", "partial", "response", "(PR)", "and", "stable", "disease", "(SD)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "up", "to", "24", "months", "among", "patients", "with", "LRR", "breast", "cancer", "and", "(iii)", "to", "assess", "Patient", "Reported", "Quality", "of", "Life", "using", "the", "FACT-B", "and", "Brief", "Pain", "Inventory", "(BPI)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.12809570133686066, 0.044818516820669174, 0.008739999495446682, 0.007060046773403883, 0.1370851695537567, 0.08096715062856674, 0.00736980838701129, 0.00698921550065279, 0.08315731585025787, 0.008642616681754589, 0.052156127989292145, 0.009463252499699593, 0.0367896594107151, 0.009084015153348446, 0.011320284567773342, 0.04452343285083771, 0.014799326658248901, 0.030290057882666588, 0.003153062192723155, 0.015882255509495735, 0.00378782139159739, 0.03396314010024071, 0.013910624198615551, 0.012237193062901497, 0.1286410242319107, 0.006105566397309303, 0.07035239040851593, 0.016728045418858528, 0.12784406542778015, 0.07371170073747635, 0.22487671673297882, 0.1555902510881424, 0.29977947473526, 0.31561279296875, 0.3348613381385803, 0.5458313226699829, 0.5961682200431824, 0.28269049525260925, 0.044310200959444046, 0.37755969166755676, 0.4134143590927124, 0.2767508327960968, 0.009878166019916534, 0.03179659694433212, 0.007229751441627741, 0.04605516046285629, 0.0070210108533501625, 0.010782807134091854, 0.1286945790052414, 0.05029148980975151, 0.004093814175575972, 0.019669683650135994, 0.003994645085185766, 0.08455514162778854, 0.01825041137635708, 0.01413231622427702, 0.0018624619115144014, 0.2303336262702942, 0.0031612662132829428, 0.027227751910686493, 0.04980439692735672, 0.03763044252991676, 0.060122277587652206, 0.01997441239655018, 0.033187054097652435, 0.006112263072282076, 0.005220279097557068, 0.18795987963676453, 0.014598531648516655, 0.20505768060684204, 0.3223612308502197, 0.16314885020256042, 0.14734934270381927, 0.004187998827546835, 0.019870849326252937, 0.003632576670497656, 0.023963687941432, 0.0029203351587057114, 0.02158442512154579, 0.0032623037695884705, 0.048107732087373734, 0.029964253306388855, 0.02123863808810711, -1]}
{"idB": "749647_15_item1_p71_s1", "idA": "749647_14_item1_p66_s2", "sentA": "The two similarly designed Phase I studies enrolled patients with highly resistant tumors found on the chest wall and who had progressed on previous therapy including chemotherapy, radiation therapy and hormone therapy.", "sentB": "The Euro-DIGNITY Study will be Phase II study enrolling up to 100 patients affected by recurrent breast adenocarcinoma on the chest wall with/without nodes over a period of two years.", "type": 2, "words": ["<tag1>", "The", "two", "similarly", "designed", "Phase", "I", "studies", "enrolled", "patients", "with", "highly", "resistant", "tumors", "found", "on", "the", "chest", "wall", "and", "who", "had", "progressed", "on", "previous", "therapy", "including", "chemotherapy,", "radiation", "therapy", "and", "hormone", "therapy.", "<tag2>", "The", "Euro-DIGNITY", "Study", "will", "be", "Phase", "II", "study", "enrolling", "up", "to", "100", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years.", "<tag3>"], "wordsA": ["The", "two", "similarly", "designed", "Phase", "I", "studies", "enrolled", "patients", "with", "highly", "resistant", "tumors", "found", "on", "the", "chest", "wall", "and", "who", "had", "progressed", "on", "previous", "therapy", "including", "chemotherapy,", "radiation", "therapy", "and", "hormone", "therapy."], "wordsB": ["The", "Euro-DIGNITY", "Study", "will", "be", "Phase", "II", "study", "enrolling", "up", "to", "100", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0055133202113211155, 0.20729292929172516, 0.05047944560647011, 0.0036145723424851894, 0.0027155340649187565, 0.01511386875063181, 0.012771938927471638, 0.026082295924425125, 0.032425034791231155, 0.046963244676589966, 0.03314095363020897, 0.2695586085319519, 0.27454158663749695, 0.10263780504465103, 0.06105051562190056, 0.27233901619911194, 0.3313046097755432, 0.7190966606140137, 0.005998567212373018, 0.005062805023044348, 0.017979994416236877, 0.01593056321144104, 0.46622079610824585, 0.6095467805862427, 0.005976362619549036, 0.003874827641993761, 0.008602996356785297, 0.0039548808708786964, 0.014609978534281254, 0.016401194036006927, -1]}
{"idB": "749647_15_item1_p90_s1", "idA": "749647_14_item1_p66_s3", "sentA": "ThermoDox in combination with mild hyperthermia was evaluated in these patients in up to six cycles.", "sentB": "The GEN-1 treatment administered in combination with carboplatin/docetaxel was well tolerated.", "type": 2, "words": ["<tag1>", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "was", "evaluated", "in", "these", "patients", "in", "up", "to", "six", "cycles.", "<tag2>", "The", "GEN-1", "treatment", "administered", "in", "combination", "with", "carboplatin/docetaxel", "was", "well", "tolerated.", "<tag3>"], "wordsA": ["ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "was", "evaluated", "in", "these", "patients", "in", "up", "to", "six", "cycles."], "wordsB": ["The", "GEN-1", "treatment", "administered", "in", "combination", "with", "carboplatin/docetaxel", "was", "well", "tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008778092451393604, 0.5823068022727966, 0.3773665428161621, 0.023106060922145844, 0.009885397739708424, 0.022948497906327248, 0.03506910428404808, 0.8061342239379883, 0.024683507159352303, 0.22760093212127686, 0.3205418884754181, -1]}
{"idB": "749647_15_item1_p79_s0", "idA": "749647_14_item1_p66_s5", "sentA": "There were 29 patients treated in the two trials, including 11 patients in the DIGNITY study and 18 patients in the Duke study.", "sentB": "There were approximately 22,000 new cases of ovarian cancer in the US in 2014 with an estimated 14,000 deaths.", "type": 2, "words": ["<tag1>", "There", "were", "29", "patients", "treated", "in", "the", "two", "trials,", "including", "11", "patients", "in", "the", "DIGNITY", "study", "and", "18", "patients", "in", "the", "Duke", "study.", "<tag2>", "There", "were", "approximately", "22,000", "new", "cases", "of", "ovarian", "cancer", "in", "the", "US", "in", "2014", "with", "an", "estimated", "14,000", "deaths.", "<tag3>"], "wordsA": ["There", "were", "29", "patients", "treated", "in", "the", "two", "trials,", "including", "11", "patients", "in", "the", "DIGNITY", "study", "and", "18", "patients", "in", "the", "Duke", "study."], "wordsB": ["There", "were", "approximately", "22,000", "new", "cases", "of", "ovarian", "cancer", "in", "the", "US", "in", "2014", "with", "an", "estimated", "14,000", "deaths."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005655101966112852, 0.0050391461700201035, 0.09531880915164948, 0.4260137677192688, 0.3225116431713104, 0.29985782504081726, 0.09835496544837952, 0.37727633118629456, 0.29595649242401123, 0.028348583728075027, 0.024306582286953926, 0.08070426434278488, 0.016130443662405014, 0.0510876327753067, 0.009675724431872368, 0.007210361771285534, 0.054809581488370895, 0.3153223693370819, 0.4356321394443512, -1]}
{"idB": "749647_15_item1_p70_s1", "idA": "749647_14_item1_p66_s6", "sentA": "Of the 29 patients, 23 were eligible for evaluation of efficacy.", "sentB": "Of the 14 patients enrolled and treated, ten were eligible for evaluation of efficacy.", "type": 2, "words": ["<tag1>", "Of", "the", "29", "patients,", "23", "were", "eligible", "for", "evaluation", "of", "efficacy.", "<tag2>", "Of", "the", "14", "patients", "enrolled", "and", "treated,", "ten", "were", "eligible", "for", "evaluation", "of", "efficacy.", "<tag3>"], "wordsA": ["Of", "the", "29", "patients,", "23", "were", "eligible", "for", "evaluation", "of", "efficacy."], "wordsB": ["Of", "the", "14", "patients", "enrolled", "and", "treated,", "ten", "were", "eligible", "for", "evaluation", "of", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014624325558543205, 0.010798724368214607, 0.9210398197174072, 0.3773365020751953, 0.016693489626049995, 0.004500818904489279, 0.012609170749783516, 0.4049985408782959, 0.0030187671072781086, 0.006830473430454731, 0.002253195270895958, 0.0039194803684949875, 0.0017175504472106695, 0.005369273945689201, -1]}
{"idB": "749647_15_item1_p70_s0", "idA": "749647_14_item1_p67_s0", "sentA": "In February 2014, we announced positive interim data from the ongoing open-label Phase II DIGNITY study.", "sentB": "On July 24, 2014, we announced interim data from the DIGNITY Study of ThermoDox in RCW Breast Cancer.", "type": 2, "words": ["<tag1>", "In", "February", "2014,", "we", "announced", "positive", "interim", "data", "from", "the", "ongoing", "open-label", "Phase", "II", "DIGNITY", "study.", "<tag2>", "On", "July", "24,", "2014,", "we", "announced", "interim", "data", "from", "the", "DIGNITY", "Study", "of", "ThermoDox", "in", "RCW", "Breast", "Cancer.", "<tag3>"], "wordsA": ["In", "February", "2014,", "we", "announced", "positive", "interim", "data", "from", "the", "ongoing", "open-label", "Phase", "II", "DIGNITY", "study."], "wordsB": ["On", "July", "24,", "2014,", "we", "announced", "interim", "data", "from", "the", "DIGNITY", "Study", "of", "ThermoDox", "in", "RCW", "Breast", "Cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03656109422445297, 0.842732310295105, 0.6802553534507751, 0.08537555485963821, 0.011228698305785656, 0.012995787896215916, 0.02061353251338005, 0.03680836036801338, 0.005716031417250633, 0.003609821666032076, 0.03044285625219345, 0.13509798049926758, 0.08302627503871918, 0.8107355833053589, 0.2212614119052887, 0.2453295737504959, 0.1516246199607849, 0.20376485586166382, -1]}
{"idB": "749647_15_item1_p70_s2", "idA": "749647_14_item1_p67_s1", "sentA": "Based on the data available to date, a local response rate of approximately 80 percent has been observed in the five evaluable patients with refractory disease, notably two complete responses, two partial responses and one patient with stable disease.", "sentB": "Based on data available to date, approximately 60% of patients experienced a stabilization of their highly refractory disease with a local response rate of 50% observed in the ten evaluable patients, notably three complete responses, two partial responses and one patient with stable disease.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "data", "available", "to", "date,", "a", "local", "response", "rate", "of", "approximately", "80", "percent", "has", "been", "observed", "in", "the", "five", "evaluable", "patients", "with", "refractory", "disease,", "notably", "two", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease.", "<tag2>", "Based", "on", "data", "available", "to", "date,", "approximately", "60%", "of", "patients", "experienced", "a", "stabilization", "of", "their", "highly", "refractory", "disease", "with", "a", "local", "response", "rate", "of", "50%", "observed", "in", "the", "ten", "evaluable", "patients,", "notably", "three", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease.", "<tag3>"], "wordsA": ["Based", "on", "the", "data", "available", "to", "date,", "a", "local", "response", "rate", "of", "approximately", "80", "percent", "has", "been", "observed", "in", "the", "five", "evaluable", "patients", "with", "refractory", "disease,", "notably", "two", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease."], "wordsB": ["Based", "on", "data", "available", "to", "date,", "approximately", "60%", "of", "patients", "experienced", "a", "stabilization", "of", "their", "highly", "refractory", "disease", "with", "a", "local", "response", "rate", "of", "50%", "observed", "in", "the", "ten", "evaluable", "patients,", "notably", "three", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00334081519395113, 0.002664875239133835, 0.0069949631579220295, 0.0034230619203299284, 0.0024435436353087425, 0.002784955548122525, 0.03363144397735596, 0.6661275625228882, 0.08526228368282318, 0.1482975035905838, 0.03279462456703186, 0.016028057783842087, 0.10949641466140747, 0.012960805557668209, 0.013405418954789639, 0.06852854043245316, 0.09031783789396286, 0.05882938951253891, 0.0028010227251797915, 0.003030421445146203, 0.009463767521083355, 0.015738453716039658, 0.011575878597795963, 0.007166879251599312, 0.5452002286911011, 0.004751304630190134, 0.003018283750861883, 0.003265013452619314, 0.1959787905216217, 0.008146552368998528, 0.04912640154361725, 0.0026681902818381786, 0.15416964888572693, 0.04949813336133957, 0.036036986857652664, 0.039445649832487106, 0.02592260204255581, 0.02491251938045025, 0.004095607437193394, 0.07740963995456696, 0.1001628041267395, 0.002173457760363817, 0.004041321575641632, 0.004197164438664913, -1]}
{"idB": "749647_15_item1_p93_s1", "idA": "749647_14_item1_p67_s1", "sentA": "Based on the data available to date, a local response rate of approximately 80 percent has been observed in the five evaluable patients with refractory disease, notably two complete responses, two partial responses and one patient with stable disease.", "sentB": "Of these 16 evaluable patients on this study, a clinical benefit of 57.1% (PR=21.4%; SD=35.7%) was found in the 14 patients with a measurable disease.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "data", "available", "to", "date,", "a", "local", "response", "rate", "of", "approximately", "80", "percent", "has", "been", "observed", "in", "the", "five", "evaluable", "patients", "with", "refractory", "disease,", "notably", "two", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease.", "<tag2>", "Of", "these", "16", "evaluable", "patients", "on", "this", "study,", "a", "clinical", "benefit", "of", "57.1%", "(PR=21.4%;", "SD=35.7%)", "was", "found", "in", "the", "14", "patients", "with", "a", "measurable", "disease.", "<tag3>"], "wordsA": ["Based", "on", "the", "data", "available", "to", "date,", "a", "local", "response", "rate", "of", "approximately", "80", "percent", "has", "been", "observed", "in", "the", "five", "evaluable", "patients", "with", "refractory", "disease,", "notably", "two", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease."], "wordsB": ["Of", "these", "16", "evaluable", "patients", "on", "this", "study,", "a", "clinical", "benefit", "of", "57.1%", "(PR=21.4%;", "SD=35.7%)", "was", "found", "in", "the", "14", "patients", "with", "a", "measurable", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013444910757243633, 0.008941283449530602, 0.3916793167591095, 0.16759920120239258, 0.11793266981840134, 0.003345560748130083, 0.0029971017502248287, 0.018282979726791382, 0.0052817221730947495, 0.03397771716117859, 0.03564527630805969, 0.024968888610601425, 0.22975195944309235, 0.35401520133018494, 0.35882848501205444, 0.0037703218404203653, 0.009395452216267586, 0.0052525862120091915, 0.004970232956111431, 0.2805255651473999, 0.11555299907922745, 0.024152332916855812, 0.023116307333111763, 0.778999924659729, 0.3785484731197357, -1]}
{"idB": "749647_15_item1_p70_s3", "idA": "749647_14_item1_p67_s2", "sentA": "These data are consistent with the previously reported positive Phase I data in RCW breast cancer.", "sentB": "These data are consistent with the combined clinical data from the two Phase I trials discussed above.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "previously", "reported", "positive", "Phase", "I", "data", "in", "RCW", "breast", "cancer.", "<tag2>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "previously", "reported", "positive", "Phase", "I", "data", "in", "RCW", "breast", "cancer."], "wordsB": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002938662888482213, 0.03558608889579773, 0.004885275382548571, 0.028064005076885223, 0.01168861798942089, 0.008529558777809143, 0.32813510298728943, 0.2857850193977356, 0.4100903570652008, 0.011355754919350147, 0.011737076565623283, 0.27331364154815674, 0.12312475591897964, 0.07986411452293396, 0.17455506324768066, 0.008160585537552834, 0.018624044954776764, -1]}
{"idB": "749647_15_item1_p6_s0", "idA": "749647_14_item1_p6_s0", "sentA": "Unless the context requires otherwise or unless otherwise noted, all references in this Annual Report on Form 10-K to Celsion the Company , we , us , or our are to Celsion Corporation, a Delaware corporation.", "sentB": "Unless the context requires otherwise or unless otherwise noted, all references in this Annual Report on Form 10-K to Celsion the Company , we , us , or our are to Celsion Corporation, a Delaware corporation and its wholly owned subsidiary, CLSN Laboratories, Inc., also a Delaware Corporation.", "type": 2, "words": ["<tag1>", "Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation,", "a", "Delaware", "corporation.", "<tag2>", "Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation,", "a", "Delaware", "corporation", "and", "its", "wholly", "owned", "subsidiary,", "CLSN", "Laboratories,", "Inc.,", "also", "a", "Delaware", "Corporation.", "<tag3>"], "wordsA": ["Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation,", "a", "Delaware", "corporation."], "wordsB": ["Unless", "the", "context", "requires", "otherwise", "or", "unless", "otherwise", "noted,", "all", "references", "in", "this", "Annual", "Report", "on", "Form", "10-K", "to", "Celsion", "the", "Company", ",", "we", ",", "us", ",", "or", "our", "are", "to", "Celsion", "Corporation,", "a", "Delaware", "corporation", "and", "its", "wholly", "owned", "subsidiary,", "CLSN", "Laboratories,", "Inc.,", "also", "a", "Delaware", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03830289468169212, 0.016897574067115784, 0.050072506070137024, 0.043253522366285324, 0.04392193257808685, 0.014104348607361317, 0.02866518869996071, 0.04859454557299614, 0.042616043239831924, 0.024411208927631378, 0.13357503712177277, 0.013774982653558254, 0.01306814607232809, 0.017670368775725365, 0.017978865653276443, 0.012392932549118996, 0.01881382055580616, 0.0223345085978508, 0.013570648618042469, 0.027508551254868507, 0.012327643111348152, 0.033359989523887634, 0.0018293773755431175, 0.021068627014756203, 0.01170961931347847, 0.018872777000069618, 0.0006917474674992263, 0.014908842742443085, 0.012445321306586266, 0.015856919810175896, 0.012189781293272972, 0.019072942435741425, 0.015750180929899216, 0.008037779480218887, 0.017269916832447052, 0.020340800285339355, 0.024151310324668884, 0.024980371817946434, 0.25079789757728577, 0.2310331165790558, 0.2198079228401184, 0.5446957349777222, 0.6310511231422424, 0.2962838113307953, 0.010883965529501438, 0.013674356043338776, 0.053985346108675, 0.03904077783226967, -1]}
{"idB": "749647_15_item1_p113_s1", "idA": "749647_14_item1_p74_s1", "sentA": "We are currently, with minimal cash expenditures, sponsoring clinical and pre-clinical research at the University of Utrecht, Brigham and Women s Hospital and the University of Washington.", "sentB": "We are currently, with minimal cash expenditures, sponsoring clinical and pre-clinical research at the University of Oxford, University of Utrecht, Brigham and Women s Hospital and the University of Washington.", "type": 2, "words": ["<tag1>", "We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington.", "<tag2>", "We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington.", "<tag3>"], "wordsA": ["We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington."], "wordsB": ["We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006941674742847681, 0.004635813180357218, 0.005280246492475271, 0.00437132827937603, 0.06899625808000565, 0.01368738617748022, 0.008264357224106789, 0.005276371259242296, 0.004402054473757744, 0.004662554245442152, 0.0061953384429216385, 0.005716331768780947, 0.005734540987759829, 0.00456737307831645, 0.25693079829216003, 0.2656407952308655, 0.8973381519317627, 0.01719621755182743, 0.008331049233675003, 0.00901347491890192, 0.006600750144571066, 0.006472360342741013, 0.007969439961016178, 0.006172691471874714, 0.004894208628684282, 0.0036341750528663397, 0.0041925120167434216, 0.0046958159655332565, 0.004597239661961794, 0.004472560714930296, -1]}
{"idB": "749647_15_item1_p113_s3", "idA": "749647_14_item1_p74_s3", "sentA": "Research and development expenses were approximately $9.4 million, $15.8 million and $19.9 million for the years ended December 31, 2013, 2012 and 2011, respectively.", "sentB": "Research and development expenses were approximately $15.0 million, $9.4 million and $15.8 million for the years ended December 31, 2014, 2013 and 2012, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$9.4", "million,", "$15.8", "million", "and", "$19.9", "million", "for", "the", "years", "ended", "December", "31,", "2013,", "2012", "and", "2011,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "were", "approximately", "$15.0", "million,", "$9.4", "million", "and", "$15.8", "million", "for", "the", "years", "ended", "December", "31,", "2014,", "2013", "and", "2012,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$9.4", "million,", "$15.8", "million", "and", "$19.9", "million", "for", "the", "years", "ended", "December", "31,", "2013,", "2012", "and", "2011,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "were", "approximately", "$15.0", "million,", "$9.4", "million", "and", "$15.8", "million", "for", "the", "years", "ended", "December", "31,", "2014,", "2013", "and", "2012,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006348461844027042, 0.004295499064028263, 0.007184571120887995, 0.012150569818913937, 0.0047807591035962105, 0.008601776324212551, 0.7992036938667297, 0.04176444187760353, 0.009940050542354584, 0.00856115110218525, 0.005528206005692482, 0.01412295177578926, 0.008344370871782303, 0.004886481910943985, 0.005019832868129015, 0.007375147193670273, 0.008739768527448177, 0.009874287061393261, 0.01600189320743084, 0.8732462525367737, 0.011931532062590122, 0.006979042664170265, 0.0080441078171134, 0.006656348239630461, -1]}
{"idB": "749647_15_item1_p7_s0", "idA": "749647_14_item1_p7_s0", "sentA": "The Celsion Corporation ( Celsion or the Company ) brand and product names, including but not limited to Celsion or ThermoDox , contained in this document are trademarks, registered trademarks or service marks of Celsion Corporation in the United States (U.S.) and certain other countries.", "sentB": "The Celsion Corporation ( Celsion or the Company ) brand and product names, including but not limited to Celsion , ThermoDox , EGEN , TheraPlas and TheraSilence contained in this document are trademarks, registered trademarks or service marks of Celsion Corporation or its subsidiary in the United States (U.S.) and certain other countries.", "type": 2, "words": ["<tag1>", "The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", "or", "ThermoDox", ",", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries.", "<tag2>", "The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "ThermoDox", ",", "EGEN", ",", "TheraPlas", "and", "TheraSilence", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries.", "<tag3>"], "wordsA": ["The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", "or", "ThermoDox", ",", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries."], "wordsB": ["The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "ThermoDox", ",", "EGEN", ",", "TheraPlas", "and", "TheraSilence", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01023987028747797, 0.1239624172449112, 0.042750194668769836, 0.02294790744781494, 0.06177152320742607, 0.023539520800113678, 0.015026740729808807, 0.026314688846468925, 0.0008895458304323256, 0.030477961525321007, 0.02250787802040577, 0.025424353778362274, 0.02729974128305912, 0.02392568252980709, 0.030034227296710014, 0.030889982357621193, 0.03576117753982544, 0.014785713516175747, 0.03698881343007088, 0.002096225041896105, 0.0670991986989975, 0.0011229877127334476, 0.7699089646339417, 0.0006578281754627824, 0.6078091263771057, 0.1532164216041565, 0.701383113861084, 0.0227253008633852, 0.020129980519413948, 0.016572585329413414, 0.0372687429189682, 0.01790020242333412, 0.0864330530166626, 0.025010574609041214, 0.05497334152460098, 0.009531192481517792, 0.02635291777551174, 0.04647279903292656, 0.01596895605325699, 0.14189346134662628, 0.09601254016160965, 0.04555993527173996, 0.15791472792625427, 0.44482848048210144, 0.017602667212486267, 0.01770477555692196, 0.0393231138586998, 0.043861616402864456, 0.046133846044540405, 0.012340201996266842, 0.015130913816392422, 0.014932770282030106, 0.03423360735177994, -1]}
{"idB": "749647_15_item1_p92_s0", "idA": "749647_14_item1_p81_s0", "sentA": "In the case of drugs and biological products, Phase II clinical trials generally are conducted in a target patient population to gather evidence about the pharmacokinetics, safety and biological or clinical efficacy of the drug for specific indications, to determine dosage tolerance and optimal dosage and to identify possible adverse effects and safety risks.", "sentB": "Based on encouraging results from GEN-1 monotherapy Phase I and Phase II clinical trials in platinum resistant ovarian cancer patients, a Phase Ib combination trial of GEN-1 plus Doxil initiated in this patient population was conducted.", "type": 2, "words": ["<tag1>", "In", "the", "case", "of", "drugs", "and", "biological", "products,", "Phase", "II", "clinical", "trials", "generally", "are", "conducted", "in", "a", "target", "patient", "population", "to", "gather", "evidence", "about", "the", "pharmacokinetics,", "safety", "and", "biological", "or", "clinical", "efficacy", "of", "the", "drug", "for", "specific", "indications,", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag2>", "Based", "on", "encouraging", "results", "from", "GEN-1", "monotherapy", "Phase", "I", "and", "Phase", "II", "clinical", "trials", "in", "platinum", "resistant", "ovarian", "cancer", "patients,", "a", "Phase", "Ib", "combination", "trial", "of", "GEN-1", "plus", "Doxil", "initiated", "in", "this", "patient", "population", "was", "conducted.", "<tag3>"], "wordsA": ["In", "the", "case", "of", "drugs", "and", "biological", "products,", "Phase", "II", "clinical", "trials", "generally", "are", "conducted", "in", "a", "target", "patient", "population", "to", "gather", "evidence", "about", "the", "pharmacokinetics,", "safety", "and", "biological", "or", "clinical", "efficacy", "of", "the", "drug", "for", "specific", "indications,", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks."], "wordsB": ["Based", "on", "encouraging", "results", "from", "GEN-1", "monotherapy", "Phase", "I", "and", "Phase", "II", "clinical", "trials", "in", "platinum", "resistant", "ovarian", "cancer", "patients,", "a", "Phase", "Ib", "combination", "trial", "of", "GEN-1", "plus", "Doxil", "initiated", "in", "this", "patient", "population", "was", "conducted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00772851100191474, 0.008004623465240002, 0.06328549236059189, 0.0431002676486969, 0.0077724638395011425, 0.2603585124015808, 0.3470887243747711, 0.022654877975583076, 0.01253761537373066, 0.004306440241634846, 0.014510301873087883, 0.013865903951227665, 0.037515826523303986, 0.04210824519395828, 0.015151705592870712, 0.38613224029541016, 0.2943212389945984, 0.4805663824081421, 0.4487378001213074, 0.27288883924484253, 0.005282661411911249, 0.03501739725470543, 0.1036917045712471, 0.11108982563018799, 0.10112346708774567, 0.046220432966947556, 0.2783089280128479, 0.14410419762134552, 0.17284178733825684, 0.011346828192472458, 0.0056413463316857815, 0.007528545334935188, 0.058808669447898865, 0.0451628714799881, 0.004904982168227434, 0.012415516190230846, -1]}
{"idB": "749647_15_item1_p162_s0", "idA": "749647_14_item1_p82_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "There can be no assurance that an issued patent will remain valid and enforceable in a court of law through the entire patent term.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "an", "issued", "patent", "will", "remain", "valid", "and", "enforceable", "in", "a", "court", "of", "law", "through", "the", "entire", "patent", "term.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "an", "issued", "patent", "will", "remain", "valid", "and", "enforceable", "in", "a", "court", "of", "law", "through", "the", "entire", "patent", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002456396585330367, 0.004317862447351217, 0.002784084528684616, 0.014047371223568916, 0.03922035172581673, 0.01672622375190258, 0.03756789118051529, 0.24898038804531097, 0.6585831046104431, 0.12403476238250732, 0.2568817734718323, 0.332070529460907, 0.17804881930351257, 0.4834010899066925, 0.062284912914037704, 0.052532706409692764, 0.10008436441421509, 0.0623122863471508, 0.1240144595503807, 0.06622043997049332, 0.023438969627022743, 0.12151709944009781, 0.1240183413028717, 0.12406868487596512, -1]}
{"idB": "749647_15_item1_p166_s1", "idA": "749647_14_item1_p82_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "There can be no assurance that we can obtain a license on a reasonable basis should we deem it necessary to obtain rights to an alternative technology that meets our needs.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "on", "a", "reasonable", "basis", "should", "we", "deem", "it", "necessary", "to", "obtain", "rights", "to", "an", "alternative", "technology", "that", "meets", "our", "needs.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "on", "a", "reasonable", "basis", "should", "we", "deem", "it", "necessary", "to", "obtain", "rights", "to", "an", "alternative", "technology", "that", "meets", "our", "needs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0027184062637388706, 0.0036020739935338497, 0.002922703744843602, 0.010824251919984818, 0.03424510732293129, 0.009821292012929916, 0.03812913969159126, 0.07912377268075943, 0.4641965627670288, 0.4409288465976715, 0.8111486434936523, 0.05874956026673317, 0.03340696170926094, 0.10534647852182388, 0.10309471189975739, 0.012284095399081707, 0.008803924545645714, 0.011149569414556026, 0.008973971009254456, 0.010723243467509747, 0.0003591840504668653, 0.011101432144641876, 0.028465989977121353, 0.017986955121159554, 0.006306716240942478, 0.03153189271688461, 0.05037983879446983, 8.384583634324372e-05, 0.010111174546182156, 0.008024252019822598, 0.01753401942551136, -1]}
{"idB": "749647_15_item1_p122_s0", "idA": "749647_14_item1_p83_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "sentB": "On January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with HCC, also known as primary liver cancer.", "type": 2, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "HCC,", "also", "known", "as", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "HCC,", "also", "known", "as", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004998405463993549, 0.006356040481477976, 0.00796984788030386, 0.006687014829367399, 0.0061577968299388885, 0.023282798007130623, 0.009548722766339779, 0.11376786977052689, 0.008645404130220413, 0.012046139687299728, 0.007872414775192738, 0.019058730453252792, 0.9499067068099976, 0.9723668694496155, 0.5118504166603088, 0.0758417397737503, 0.22377319633960724, 0.121919646859169, 0.006651400588452816, 0.00808157678693533, 0.019200138747692108, 0.020748620852828026, 0.005739592015743256, 0.011212710291147232, 0.007408531382679939, 0.015044450759887695, 0.0043173558078706264, 0.004443702287971973, 0.004373980686068535, 0.04647334665060043, 0.03989674523472786, 0.02001780830323696, -1]}
{"idB": "749647_15_item1_p18_s0", "idA": "749647_14_item1_p84_s0", "sentA": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, has provided and allowed, subject to compliance with regulatory standards, clearance for the Company's planned pivotal, double-blind, placebo-controlled Phase III trial (the OPTIMA Study) of ThermoDox , its proprietary heat-activated liposomal encapsulation of doxorubicin in combination with RFA in primary liver cancer, also known as hepatocellular carcinoma (HCC).", "sentB": "On February 24, 2014, we announced that the U.S. Food and Drug Administration (FDA), after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox , our proprietary heat-activated liposomal encapsulation of doxorubicin in combination with RFA in primary liver cancer, also known as HCC (the OPTIMA Study).", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "Company's", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", ",", "its", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "hepatocellular", "carcinoma", "(HCC).", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA),", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", ",", "our", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC", "(the", "OPTIMA", "Study).", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "has", "provided", "and", "allowed,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "Company's", "planned", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "(the", "OPTIMA", "Study)", "of", "ThermoDox", ",", "its", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "hepatocellular", "carcinoma", "(HCC)."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA),", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", ",", "our", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC", "(the", "OPTIMA", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006606900133192539, 0.008977580815553665, 0.008965600281953812, 0.007940554991364479, 0.01125204935669899, 0.020453402772545815, 0.01638597808778286, 0.01655467599630356, 0.5519939064979553, 0.8240980505943298, 0.8338584899902344, 0.6838693618774414, 0.8274872303009033, 0.11676938831806183, 0.006021897774189711, 0.006422900594770908, 0.008567904122173786, 0.006922108121216297, 0.007126507814973593, 0.006916530895978212, 0.006699565332382917, 0.05726171284914017, 0.9209015965461731, 0.770428478717804, 0.006919941399246454, 0.005883834790438414, 0.006444938015192747, 0.004944648593664169, 0.0058767045848071575, 0.0067009711638092995, 0.0038157447706907988, 0.005945655982941389, 0.0069183362647891045, 0.006516072899103165, 0.005473415832966566, 0.004390697926282883, 0.005398275796324015, 0.0035311663523316383, 0.007436172105371952, 0.000662680366076529, 0.0037714610807597637, 0.005104862619191408, 0.007088221609592438, 0.008226320147514343, 0.0063079590909183025, 0.004203802905976772, 0.009157695807516575, 0.004332020413130522, 0.0050507280975580215, 0.004608928691595793, 0.010370711795985699, 0.003534560790285468, 0.0057537127286195755, 0.0073088956996798515, 0.0052717006765306, 0.005513826850801706, 0.005049113649874926, 0.004437883850187063, 0.008772606030106544, 0.0031626326963305473, 0.005408308003097773, 0.005612804088741541, -1]}
{"idB": "749647_15_item1_p152_s2", "idA": "749647_14_item1_p84_s2", "sentA": "Celsion expects to launch the study in the first half of 2014.", "sentB": "We plan to initiate clinical studies in the second half of 2015 for both indications.", "type": 2, "words": ["<tag1>", "Celsion", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014.", "<tag2>", "We", "plan", "to", "initiate", "clinical", "studies", "in", "the", "second", "half", "of", "2015", "for", "both", "indications.", "<tag3>"], "wordsA": ["Celsion", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014."], "wordsB": ["We", "plan", "to", "initiate", "clinical", "studies", "in", "the", "second", "half", "of", "2015", "for", "both", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0689990445971489, 0.0663742795586586, 0.02722642756998539, 0.23731981217861176, 0.2615809440612793, 0.266205370426178, 0.023036709055304527, 0.016052404418587685, 0.04808339849114418, 0.06571667641401291, 0.059962641447782516, 0.6057933568954468, 0.026821225881576538, 0.2463456094264984, 0.15529081225395203, -1]}
{"idB": "749647_15_item1_p68_s3", "idA": "749647_14_item1_p84_s2", "sentA": "Celsion expects to launch the study in the first half of 2014.", "sentB": "Enrollment is expected to be completed in mid-2015 with final clinical results to be reported in the second half of 2015.", "type": 2, "words": ["<tag1>", "Celsion", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014.", "<tag2>", "Enrollment", "is", "expected", "to", "be", "completed", "in", "mid-2015", "with", "final", "clinical", "results", "to", "be", "reported", "in", "the", "second", "half", "of", "2015.", "<tag3>"], "wordsA": ["Celsion", "expects", "to", "launch", "the", "study", "in", "the", "first", "half", "of", "2014."], "wordsB": ["Enrollment", "is", "expected", "to", "be", "completed", "in", "mid-2015", "with", "final", "clinical", "results", "to", "be", "reported", "in", "the", "second", "half", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.40094858407974243, 0.010672692209482193, 0.038046885281801224, 0.024394441395998, 0.05652865022420883, 0.4510764479637146, 0.0312584787607193, 0.5052486062049866, 0.005973584484308958, 0.15679731965065002, 0.20457367599010468, 0.13116131722927094, 0.0063253482803702354, 0.009480347856879234, 0.039320629090070724, 0.007071156520396471, 0.006538035348057747, 0.015982389450073242, 0.03286147117614746, 0.028204672038555145, 0.26742106676101685, -1]}
{"idB": "749647_15_item1_p23_s4", "idA": "749647_14_item1_p86_s0", "sentA": "The primary endpoint for the trial is OS.", "sentB": "We expect to initiate enrollment for the trial in the second half of 2015 at five to six U.S. clinical centers.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "the", "trial", "is", "OS.", "<tag2>", "We", "expect", "to", "initiate", "enrollment", "for", "the", "trial", "in", "the", "second", "half", "of", "2015", "at", "five", "to", "six", "U.S.", "clinical", "centers.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "the", "trial", "is", "OS."], "wordsB": ["We", "expect", "to", "initiate", "enrollment", "for", "the", "trial", "in", "the", "second", "half", "of", "2015", "at", "five", "to", "six", "U.S.", "clinical", "centers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07599277049303055, 0.12028954178094864, 0.059552013874053955, 0.5695829391479492, 0.7046181559562683, 0.035878073424100876, 0.02544335275888443, 0.08287223428487778, 0.013562302105128765, 0.014833703637123108, 0.03941655904054642, 0.0475623682141304, 0.03324927017092705, 0.08562610298395157, 0.011683139018714428, 0.06846983730792999, 0.02182764746248722, 0.13667099177837372, 0.03948821499943733, 0.0779513493180275, 0.07006070017814636, -1]}
{"idB": "749647_15_item1_p94_s5", "idA": "749647_14_item1_p86_s0", "sentA": "The primary endpoint for the trial is OS.", "sentB": "We expect to initiate enrollment for the trial in the second half of 2015 at five to six U.S. clinical centers.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "the", "trial", "is", "OS.", "<tag2>", "We", "expect", "to", "initiate", "enrollment", "for", "the", "trial", "in", "the", "second", "half", "of", "2015", "at", "five", "to", "six", "U.S.", "clinical", "centers.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "the", "trial", "is", "OS."], "wordsB": ["We", "expect", "to", "initiate", "enrollment", "for", "the", "trial", "in", "the", "second", "half", "of", "2015", "at", "five", "to", "six", "U.S.", "clinical", "centers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07599277049303055, 0.12028954178094864, 0.059552013874053955, 0.5695829391479492, 0.7046181559562683, 0.035878073424100876, 0.02544335275888443, 0.08287223428487778, 0.013562302105128765, 0.014833703637123108, 0.03941655904054642, 0.0475623682141304, 0.03324927017092705, 0.08562610298395157, 0.011683139018714428, 0.06846983730792999, 0.02182764746248722, 0.13667099177837372, 0.03948821499943733, 0.0779513493180275, 0.07006070017814636, -1]}
{"idB": "749647_15_item1_p124_s0", "idA": "749647_14_item1_p89_s0", "sentA": "Either the FDA or we may suspend clinical trials at any time, if the FDA, our iDMC, or we conclude that clinical subjects are being exposed to an unacceptable health risk or for other reasons.", "sentB": "Either the FDA or we may suspend clinical trials at any time, if the FDA, our independent DMC, or we conclude that clinical subjects are being exposed to an unacceptable health risk or for other reasons.", "type": 2, "words": ["<tag1>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "iDMC,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons.", "<tag2>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "independent", "DMC,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons.", "<tag3>"], "wordsA": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "iDMC,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons."], "wordsB": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "independent", "DMC,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008298548869788647, 0.002999660326167941, 0.01596672460436821, 0.0032487327698618174, 0.004227670840919018, 0.004364036954939365, 0.007073523942381144, 0.00520670460537076, 0.005834114272147417, 0.0024533593095839024, 0.0033024409785866737, 0.0037331371568143368, 0.004897442180663347, 0.005428781267255545, 0.021930968388915062, 0.027405109256505966, 0.8609861731529236, 0.9026978611946106, 0.004216957837343216, 0.004582419525831938, 0.007331400644034147, 0.004219577647745609, 0.007984542287886143, 0.017306093126535416, 0.003121181856840849, 0.004836923908442259, 0.006509673316031694, 0.002997227245941758, 0.002868549432605505, 0.0037463796325027943, 0.003699875669553876, 0.004531220532953739, 0.003172911936417222, 0.002766133053228259, 0.0029899717774242163, 0.005543701350688934, -1]}
{"idB": "749647_15_item1_p23_s0", "idA": "749647_14_item1_p8_s0", "sentA": "Celsion is an oncology drug development company focused on the development of treatments for those suffering with difficult-to-treat forms of cancer.", "sentB": "With the acquisition, we purchased GEN-1 (formerly known as EGEN-001), a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers, and three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "type": 2, "words": ["<tag1>", "Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer.", "<tag2>", "With", "the", "acquisition,", "we", "purchased", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag3>"], "wordsA": ["Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer."], "wordsB": ["With", "the", "acquisition,", "we", "purchased", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018082991242408752, 0.012213791720569134, 0.06083592772483826, 0.049723945558071136, 0.12345431745052338, 0.5802344083786011, 0.0070439958944916725, 0.008577975444495678, 0.008883697912096977, 0.19386501610279083, 0.008047837764024734, 0.1656920313835144, 0.23490484058856964, 0.002443108009174466, 0.0031821962911635637, 0.021780867129564285, 0.025567570701241493, 0.008449972607195377, 0.2573530375957489, 0.07488208264112473, 0.1560831516981125, 0.1625095158815384, 0.000293738063191995, 0.013943097554147243, 0.023866424337029457, 0.033406734466552734, 0.003351477673277259, 0.0038387600798159838, 0.008401202969253063, 0.0028217111248522997, 0.013337579555809498, 0.0025912849232554436, 0.0024016108363866806, 0.002831426914781332, 0.0005621481104753911, 0.002755897119641304, 0.0032703098841011524, 0.0022258993703871965, 0.005369788967072964, 0.0169500932097435, 0.11571244895458221, 0.2259761393070221, 0.1254054754972458, 0.004043178167194128, 0.0037098778411746025, 0.10390497744083405, 0.09269026666879654, 0.06107275187969208, 0.12674203515052795, 0.08886252343654633, 0.006519123446196318, 0.3755970597267151, 0.1728084683418274, 0.4284808933734894, 8.262951450888067e-05, -1]}
{"idB": "749647_15_item1_p77_s0", "idA": "749647_14_item1_p8_s0", "sentA": "Celsion is an oncology drug development company focused on the development of treatments for those suffering with difficult-to-treat forms of cancer.", "sentB": "In the acquisition, we purchased GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers, and three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "type": 2, "words": ["<tag1>", "Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer.", "<tag2>", "In", "the", "acquisition,", "we", "purchased", "GEN-1,", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag3>"], "wordsA": ["Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer."], "wordsB": ["In", "the", "acquisition,", "we", "purchased", "GEN-1,", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010331857018172741, 0.009579257108271122, 0.06849299371242523, 0.0395243875682354, 0.10276442766189575, 0.5599928498268127, 0.010141660459339619, 0.3968559801578522, 0.2236512005329132, 0.0025339468847960234, 0.0030598975718021393, 0.014109042473137379, 0.02142094261944294, 0.007309262175112963, 0.2760635316371918, 0.06922470033168793, 0.14354759454727173, 0.20088502764701843, 0.00019852463447023183, 0.011602402664721012, 0.02658982388675213, 0.03536325320601463, 0.003213545773178339, 0.0045294915325939655, 0.011061379685997963, 0.004309770185500383, 0.024696247652173042, 0.003341731382533908, 0.002616563346236944, 0.002850035671144724, 0.0028667249716818333, 0.0038977060467004776, 0.0036465968005359173, 0.0027954769320786, 0.008731337264180183, 0.014468222856521606, 0.11432484537363052, 0.15100114047527313, 0.03380785137414932, 0.0037586726248264313, 0.004110474139451981, 0.09642307460308075, 0.08800709992647171, 0.04379554092884064, 0.12357574701309204, 0.08785485476255417, 0.005773024167865515, 0.3222111165523529, 0.1292368322610855, 0.24757961928844452, 7.704685413045809e-05, -1]}
{"idB": "749647_15_item1_p8_s0", "idA": "749647_14_item1_p8_s0", "sentA": "Celsion is an oncology drug development company focused on the development of treatments for those suffering with difficult-to-treat forms of cancer.", "sentB": "Celsion is a fully-integrated oncology drug development company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.", "type": 2, "words": ["<tag1>", "Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer.", "<tag2>", "Celsion", "is", "a", "fully-integrated", "oncology", "drug", "development", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "immunotherapies", "and", "RNA-", "or", "DNA-based", "therapies.", "<tag3>"], "wordsA": ["Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer."], "wordsB": ["Celsion", "is", "a", "fully-integrated", "oncology", "drug", "development", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "immunotherapies", "and", "RNA-", "or", "DNA-based", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012953036464750767, 0.003970457706600428, 0.006637021899223328, 0.9232421517372131, 0.11406713724136353, 0.07828916609287262, 0.021023161709308624, 0.04131679981946945, 0.004545913077890873, 0.0037414231337606907, 0.028875375166535378, 0.00940350629389286, 0.045914165675640106, 0.016719918698072433, 0.08248493075370789, 0.08153800666332245, 0.10116950422525406, 0.0071903495118021965, 0.20224565267562866, 0.3135814964771271, 0.48675042390823364, 0.018457964062690735, 0.4055299758911133, 0.17847119271755219, 0.4935622215270996, 0.1550007313489914, -1]}
{"idB": "749647_15_item1_p8_s3", "idA": "749647_14_item1_p8_s0", "sentA": "Celsion is an oncology drug development company focused on the development of treatments for those suffering with difficult-to-treat forms of cancer.", "sentB": "We have three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "type": 2, "words": ["<tag1>", "Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer.", "<tag2>", "We", "have", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag3>"], "wordsA": ["Celsion", "is", "an", "oncology", "drug", "development", "company", "focused", "on", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer."], "wordsB": ["We", "have", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04936477541923523, 0.012481311336159706, 0.280196875333786, 0.29754573106765747, 0.23983217775821686, 0.006406288594007492, 0.0051686386577785015, 0.017199456691741943, 0.005467918701469898, 0.032078638672828674, 0.004334695171564817, 0.003288182895630598, 0.0044629573822021484, 0.002794272731989622, 0.0032423892989754677, 0.004582282621413469, 0.003318766364827752, 0.011055005714297295, 0.03777240216732025, 0.1498602330684662, 0.16847701370716095, 0.33138346672058105, 0.005360424984246492, 0.004752321168780327, 0.0794835239648819, 0.12718647718429565, 0.06068766489624977, 0.1968640834093094, 0.12860827147960663, 0.007580490782856941, 0.4272044003009796, 0.16185873746871948, 0.4152444303035736, 6.973212293814868e-05, -1]}
{"idB": "749647_15_item1_p8_s4", "idA": "749647_14_item1_p8_s1", "sentA": "We are working to develop and commercialize more efficient, effective and targeted chemotherapeutic oncology drugs based on our proprietary heat-activated liposomal technology.", "sentB": "We are working to develop and commercialize more efficient, effective and targeted oncology therapies based on our technologies, with the goal to develop novel therapeutics that maximize efficacy while minimizing side-effects common to cancer treatments.", "type": 2, "words": ["<tag1>", "We", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "chemotherapeutic", "oncology", "drugs", "based", "on", "our", "proprietary", "heat-activated", "liposomal", "technology.", "<tag2>", "We", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "based", "on", "our", "technologies,", "with", "the", "goal", "to", "develop", "novel", "therapeutics", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments.", "<tag3>"], "wordsA": ["We", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "chemotherapeutic", "oncology", "drugs", "based", "on", "our", "proprietary", "heat-activated", "liposomal", "technology."], "wordsB": ["We", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "based", "on", "our", "technologies,", "with", "the", "goal", "to", "develop", "novel", "therapeutics", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007009829860180616, 0.002827222226187587, 0.012423516251146793, 0.003990359604358673, 0.008525649085640907, 0.0037186089903116226, 0.0075234305113554, 0.0054501816630363464, 0.006649133283644915, 0.005225085187703371, 0.003256511641666293, 0.00752484705299139, 0.0970689132809639, 0.5231173038482666, 0.0030846407171338797, 0.003334497567266226, 0.003911225125193596, 0.014205262064933777, 0.00030273088486865163, 0.0004154787166044116, 0.0040980312041938305, 0.0003033769316971302, 0.01800704561173916, 0.1316780000925064, 0.3853495419025421, 0.00025573125458322465, 0.09291931986808777, 0.06761357933282852, 0.010315998457372189, 0.19548603892326355, 0.16231314837932587, 0.013470671139657497, 0.00751161202788353, 0.058600377291440964, 0.10014684498310089, -1]}
{"idB": "749647_15_item1_p107_s3", "idA": "749647_14_item1_p93_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox for the treatment of HCC.", "sentB": "This suggests that this delivery system can effective deliver numerous potentially therapeutic molecular targets and may have application for the treatment of numerous lung diseases.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC.", "<tag2>", "This", "suggests", "that", "this", "delivery", "system", "can", "effective", "deliver", "numerous", "potentially", "therapeutic", "molecular", "targets", "and", "may", "have", "application", "for", "the", "treatment", "of", "numerous", "lung", "diseases.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC."], "wordsB": ["This", "suggests", "that", "this", "delivery", "system", "can", "effective", "deliver", "numerous", "potentially", "therapeutic", "molecular", "targets", "and", "may", "have", "application", "for", "the", "treatment", "of", "numerous", "lung", "diseases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02026425488293171, 0.10235637426376343, 0.02571875788271427, 0.019078915938735008, 0.13173961639404297, 0.1490858644247055, 0.03280811011791229, 0.06148036569356918, 0.126267671585083, 0.05817609652876854, 0.058727510273456573, 0.0806855857372284, 0.22449350357055664, 0.14909136295318604, 9.00954837561585e-05, 0.014790465123951435, 0.015994848683476448, 0.041477903723716736, 0.02099830098450184, 0.013257558457553387, 0.1102699413895607, 0.052798327058553696, 0.13267609477043152, 0.7436369061470032, 0.6567066311836243, -1]}
{"idB": "749647_15_item1_p184_s0", "idA": "749647_14_item1_p93_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox for the treatment of HCC.", "sentB": "Under the Early Access Agreement, we granted to Impatients, specifically for the treatment of RCW breast cancer in the Territory, an exclusive, royalty-free right to perform the early access program activities, reference regulatory documentation and approvals that we own, and use our trademarks relating to ThermoDox .", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC.", "<tag2>", "Under", "the", "Early", "Access", "Agreement,", "we", "granted", "to", "Impatients,", "specifically", "for", "the", "treatment", "of", "RCW", "breast", "cancer", "in", "the", "Territory,", "an", "exclusive,", "royalty-free", "right", "to", "perform", "the", "early", "access", "program", "activities,", "reference", "regulatory", "documentation", "and", "approvals", "that", "we", "own,", "and", "use", "our", "trademarks", "relating", "to", "ThermoDox", ".", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC."], "wordsB": ["Under", "the", "Early", "Access", "Agreement,", "we", "granted", "to", "Impatients,", "specifically", "for", "the", "treatment", "of", "RCW", "breast", "cancer", "in", "the", "Territory,", "an", "exclusive,", "royalty-free", "right", "to", "perform", "the", "early", "access", "program", "activities,", "reference", "regulatory", "documentation", "and", "approvals", "that", "we", "own,", "and", "use", "our", "trademarks", "relating", "to", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07825390994548798, 0.018712274730205536, 0.10259824246168137, 0.13765659928321838, 0.25692346692085266, 0.030068377032876015, 0.10372243076562881, 0.0619281530380249, 0.16779039800167084, 0.01664969138801098, 0.019582541659474373, 0.012561576440930367, 0.10180836170911789, 0.05472861975431442, 0.261552631855011, 0.3952775299549103, 0.46602997183799744, 0.00657805148512125, 0.008697929792106152, 0.03313613682985306, 0.01908693090081215, 0.09866230934858322, 0.30664071440696716, 0.07405690103769302, 0.02446243166923523, 0.025917889550328255, 0.015784509479999542, 0.022272692993283272, 0.026577042415738106, 0.026239896193146706, 0.035679519176483154, 0.04901503399014473, 0.0557531863451004, 0.1067802757024765, 0.014379781670868397, 0.05887317657470703, 0.006810130551457405, 0.016649708151817322, 0.014014625921845436, 0.00024888344341889024, 0.04445731267333031, 0.027311207726597786, 0.2951645851135254, 0.018148964270949364, 0.03882291167974472, 0.02994076907634735, 6.709314038744196e-05, -1]}
{"idB": "749647_15_item1_p84_s0", "idA": "749647_14_item1_p93_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox for the treatment of HCC.", "sentB": "Immunotherapy is an attractive novel approach for the treatment of ovarian cancer particularly since ovarian cancers are considered immunogenic tumors.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC.", "<tag2>", "Immunotherapy", "is", "an", "attractive", "novel", "approach", "for", "the", "treatment", "of", "ovarian", "cancer", "particularly", "since", "ovarian", "cancers", "are", "considered", "immunogenic", "tumors.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC."], "wordsB": ["Immunotherapy", "is", "an", "attractive", "novel", "approach", "for", "the", "treatment", "of", "ovarian", "cancer", "particularly", "since", "ovarian", "cancers", "are", "considered", "immunogenic", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4987536072731018, 0.010834912769496441, 0.010013259015977383, 0.037089310586452484, 0.0619896836578846, 0.0800323635339737, 0.012641032226383686, 0.011040762066841125, 0.10525143891572952, 0.0594279021024704, 0.6847663521766663, 0.7253238558769226, 4.8697951569920406e-05, 0.006578780710697174, 0.17326633632183075, 0.2324296236038208, 0.01681908592581749, 0.029890963807702065, 0.16637343168258667, 0.2514971196651459, -1]}
{"idB": "749647_15_item1_p128_s1", "idA": "749647_14_item1_p93_s1", "sentA": "Orphan drug designation entitles the Company to seven years of market exclusivity following FDA approval, if any, FDA assistance in clinical trial design, a reduction in FDA user fees, U.S. tax credits related to development expenses as well as the opportunity to apply for funding from the U.S. government to defray the costs of clinical trial expenses.", "sentB": "Orphan drug designation entitles the Company to seven years of market exclusivity following regulatory approval, if any, FDA assistance in clinical trial design, a reduction in FDA user fees, U.S. tax credits related to development expenses and the opportunity to apply for funding from the U.S. government to defray the costs of clinical trial expenses.", "type": 2, "words": ["<tag1>", "Orphan", "drug", "designation", "entitles", "the", "Company", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "if", "any,", "FDA", "assistance", "in", "clinical", "trial", "design,", "a", "reduction", "in", "FDA", "user", "fees,", "U.S.", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "the", "costs", "of", "clinical", "trial", "expenses.", "<tag2>", "Orphan", "drug", "designation", "entitles", "the", "Company", "to", "seven", "years", "of", "market", "exclusivity", "following", "regulatory", "approval,", "if", "any,", "FDA", "assistance", "in", "clinical", "trial", "design,", "a", "reduction", "in", "FDA", "user", "fees,", "U.S.", "tax", "credits", "related", "to", "development", "expenses", "and", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "the", "costs", "of", "clinical", "trial", "expenses.", "<tag3>"], "wordsA": ["Orphan", "drug", "designation", "entitles", "the", "Company", "to", "seven", "years", "of", "market", "exclusivity", "following", "FDA", "approval,", "if", "any,", "FDA", "assistance", "in", "clinical", "trial", "design,", "a", "reduction", "in", "FDA", "user", "fees,", "U.S.", "tax", "credits", "related", "to", "development", "expenses", "as", "well", "as", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "the", "costs", "of", "clinical", "trial", "expenses."], "wordsB": ["Orphan", "drug", "designation", "entitles", "the", "Company", "to", "seven", "years", "of", "market", "exclusivity", "following", "regulatory", "approval,", "if", "any,", "FDA", "assistance", "in", "clinical", "trial", "design,", "a", "reduction", "in", "FDA", "user", "fees,", "U.S.", "tax", "credits", "related", "to", "development", "expenses", "and", "the", "opportunity", "to", "apply", "for", "funding", "from", "the", "U.S.", "government", "to", "defray", "the", "costs", "of", "clinical", "trial", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.22708038985729218, 0.12008626759052277, 0.13697904348373413, 0.12404084205627441, 0.04437077417969704, 0.18135695159435272, 0.050022657960653305, 0.1181241124868393, 0.09629184007644653, 0.04433482140302658, 0.07526308298110962, 0.08562827110290527, 0.0412026084959507, 0.09798736125230789, 0.1311352252960205, 0.07275550812482834, 0.0984443873167038, 0.08258408308029175, 0.16630218923091888, 0.03735479339957237, 0.09077692776918411, 0.09061647206544876, 0.09158819168806076, 0.02879387140274048, 0.10555802285671234, 0.040260862559080124, 0.20654866099357605, 0.23123227059841156, 0.22338025271892548, 0.10421764850616455, 0.11462127417325974, 0.11980927735567093, 0.03674378618597984, 0.04437629505991936, 0.07404879480600357, 0.09531576931476593, 0.017912285402417183, 0.0266135074198246, 0.06948219239711761, 0.07206525653600693, 0.19332420825958252, 0.12608171999454498, 0.17814521491527557, 0.06017960235476494, 0.0458255410194397, 0.2133961319923401, 0.20048823952674866, 0.05239657312631607, 0.12782737612724304, 0.051255255937576294, 0.1399531215429306, 0.041022393852472305, 0.13640600442886353, 0.19324563443660736, 0.2320397049188614, -1]}
{"idB": "749647_15_item1_p132_s1", "idA": "749647_14_item1_p96_s1", "sentA": "Following such inspections, the FDA may issue notices on Form 483 and warning letters that could cause us to modify certain activities identified during the inspection.", "sentB": "Following such inspections, the FDA may issue notices on Form 483 and warning letters that require certain activities identified during the inspection to be modified.", "type": 2, "words": ["<tag1>", "Following", "such", "inspections,", "the", "FDA", "may", "issue", "notices", "on", "Form", "483", "and", "warning", "letters", "that", "could", "cause", "us", "to", "modify", "certain", "activities", "identified", "during", "the", "inspection.", "<tag2>", "Following", "such", "inspections,", "the", "FDA", "may", "issue", "notices", "on", "Form", "483", "and", "warning", "letters", "that", "require", "certain", "activities", "identified", "during", "the", "inspection", "to", "be", "modified.", "<tag3>"], "wordsA": ["Following", "such", "inspections,", "the", "FDA", "may", "issue", "notices", "on", "Form", "483", "and", "warning", "letters", "that", "could", "cause", "us", "to", "modify", "certain", "activities", "identified", "during", "the", "inspection."], "wordsB": ["Following", "such", "inspections,", "the", "FDA", "may", "issue", "notices", "on", "Form", "483", "and", "warning", "letters", "that", "require", "certain", "activities", "identified", "during", "the", "inspection", "to", "be", "modified."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01182370726019144, 0.009252234362065792, 0.013626755215227604, 0.004704680293798447, 0.018878433853387833, 0.007621584925800562, 0.010190526023507118, 0.021176934242248535, 0.005663864780217409, 0.014250216074287891, 0.010866540484130383, 0.003952293656766415, 0.008680330589413643, 0.020239630714058876, 0.011408009566366673, 0.8654048442840576, 0.4262048006057739, 0.3984244763851166, 0.06720547378063202, 0.010820729658007622, 0.02603486366569996, 0.03216321021318436, 0.41218626499176025, 0.25651729106903076, 0.42058899998664856, -1]}
{"idB": "749647_15_item1_p186_s0", "idA": "749647_14_item1_p97_s0", "sentA": "The FDA has the authority to require the recall of our products in the event of material deficiencies or defects in manufacture.", "sentB": "The Early Access Agreement has a term of five years, with automatic renewals for consecutive two-year periods, unless earlier terminated by either party with notice or in the event of material breach, bankruptcy, or insolvency without notice.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture.", "<tag2>", "The", "Early", "Access", "Agreement", "has", "a", "term", "of", "five", "years,", "with", "automatic", "renewals", "for", "consecutive", "two-year", "periods,", "unless", "earlier", "terminated", "by", "either", "party", "with", "notice", "or", "in", "the", "event", "of", "material", "breach,", "bankruptcy,", "or", "insolvency", "without", "notice.", "<tag3>"], "wordsA": ["The", "FDA", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture."], "wordsB": ["The", "Early", "Access", "Agreement", "has", "a", "term", "of", "five", "years,", "with", "automatic", "renewals", "for", "consecutive", "two-year", "periods,", "unless", "earlier", "terminated", "by", "either", "party", "with", "notice", "or", "in", "the", "event", "of", "material", "breach,", "bankruptcy,", "or", "insolvency", "without", "notice."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006461190525442362, 0.16829977929592133, 0.19463767111301422, 0.2596880793571472, 0.00954608153551817, 0.01054035872220993, 0.03983034938573837, 0.04298761487007141, 0.34351325035095215, 0.230569526553154, 0.010277746245265007, 0.19983868300914764, 0.37723055481910706, 0.011953076347708702, 0.051500555127859116, 0.1264018565416336, 0.10934688150882721, 0.01883331872522831, 0.03663384169340134, 0.06105314940214157, 0.03264360874891281, 0.05748717859387398, 0.0831129252910614, 0.04402707889676094, 0.03197208419442177, 0.0002883127308450639, 0.004710515961050987, 0.008823761716485023, 0.010384971275925636, 0.0064586009830236435, 0.032648004591464996, 0.09233072400093079, 0.19762057065963745, 0.017588645219802856, 0.21965807676315308, 0.5486655831336975, 0.5490657687187195, -1]}
{"idB": "749647_15_item1_p180_s5", "idA": "749647_14_item1_p98_s1", "sentA": "These regulations require, among other things, the reporting to the FDA of adverse events alleged to have been associated with the use of a product or in connection with certain product failures.", "sentB": "On June 9, 2014, we borrowed an additional $5 million and used the loan proceeds to pay the upfront cash payment to EGEN at closing and certain transaction costs incurred in connection with the acquisition.", "type": 2, "words": ["<tag1>", "These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures.", "<tag2>", "On", "June", "9,", "2014,", "we", "borrowed", "an", "additional", "$5", "million", "and", "used", "the", "loan", "proceeds", "to", "pay", "the", "upfront", "cash", "payment", "to", "EGEN", "at", "closing", "and", "certain", "transaction", "costs", "incurred", "in", "connection", "with", "the", "acquisition.", "<tag3>"], "wordsA": ["These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures."], "wordsB": ["On", "June", "9,", "2014,", "we", "borrowed", "an", "additional", "$5", "million", "and", "used", "the", "loan", "proceeds", "to", "pay", "the", "upfront", "cash", "payment", "to", "EGEN", "at", "closing", "and", "certain", "transaction", "costs", "incurred", "in", "connection", "with", "the", "acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023333854973316193, 0.04964257776737213, 0.0372302308678627, 0.0726652517914772, 0.12258594483137131, 0.4517747461795807, 0.05929700657725334, 0.08160276710987091, 0.16669082641601562, 0.20946435630321503, 0.00021402299171313643, 0.06954020261764526, 0.02086307294666767, 0.09571550041437149, 0.07492785900831223, 0.0063215941190719604, 0.04178726300597191, 0.01009591855108738, 0.035221345722675323, 0.06333635747432709, 0.06656502932310104, 0.02131412737071514, 0.09668197482824326, 0.008986635133624077, 0.04530002921819687, 0.0002070803166134283, 0.006851719226688147, 0.10067827254533768, 0.07495319098234177, 0.009154916740953922, 0.00631078751757741, 0.01098004262894392, 0.009614050388336182, 0.01573149673640728, 0.10999627411365509, -1]}
{"idB": "749647_15_item1_p71_s0", "idA": "749647_14_item1_p9_s0", "sentA": "Our lead product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the OPTIMA study) starting in the first half of 2014 and is being evaluated in a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study).", "sentB": "The Company anticipates a Phase II study of RadioTherapy (RT), HyperThermia (HT) and ThermoDox to treat patients with local-regional recurrent chest wall breast cancer will be initiated by six to eight physicians and institutions located in Italy, Israel, the Netherlands, Poland and the Czech Republic (the Euro-DIGNITY Study).", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "starting", "in", "the", "first", "half", "of", "2014", "and", "is", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "The", "Company", "anticipates", "a", "Phase", "II", "study", "of", "RadioTherapy", "(RT),", "HyperThermia", "(HT)", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "physicians", "and", "institutions", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study).", "<tag3>"], "wordsA": ["Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "starting", "in", "the", "first", "half", "of", "2014", "and", "is", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["The", "Company", "anticipates", "a", "Phase", "II", "study", "of", "RadioTherapy", "(RT),", "HyperThermia", "(HT)", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "physicians", "and", "institutions", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005020570941269398, 0.05386761203408241, 0.12610562145709991, 0.02180854231119156, 0.047619499266147614, 0.0917275995016098, 0.2147136926651001, 0.05144849419593811, 0.5808693170547485, 0.2284337282180786, 0.6447784304618835, 0.27488988637924194, 0.006642364431172609, 0.03533118963241577, 0.003272352274507284, 0.018864426761865616, 0.035453882068395615, 0.00493339728564024, 0.1241643875837326, 0.017936451360583305, 0.029128422960639, 0.01480618305504322, 0.018800057470798492, 0.021779876202344894, 0.003915377426892519, 0.0041740876622498035, 0.022227466106414795, 0.011659795418381691, 0.051653534173965454, 0.021576793864369392, 0.09497904032468796, 0.08328457176685333, 0.023440347984433174, 0.055825117975473404, 0.01802583411335945, 0.014983060769736767, 0.293026864528656, 0.2999611496925354, 0.035362359136343, 0.24479278922080994, 0.1998172253370285, 0.05107053741812706, 0.033968616276979446, 0.2306148260831833, 0.21456682682037354, 0.004745182115584612, 0.19995619356632233, 0.06033431366086006, -1]}
{"idB": "749647_15_item1_p8_s1", "idA": "749647_14_item1_p9_s0", "sentA": "Our lead product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the OPTIMA study) starting in the first half of 2014 and is being evaluated in a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study).", "sentB": "Our lead program is ThermoDox , a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in a Phase III clinical trial for the treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer (the DIGNITY Study).", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "starting", "in", "the", "first", "half", "of", "2014", "and", "is", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "Our", "lead", "program", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag3>"], "wordsA": ["Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "starting", "in", "the", "first", "half", "of", "2014", "and", "is", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["Our", "lead", "program", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005227331537753344, 0.07469691336154938, 0.1062789112329483, 0.020065881311893463, 0.05551208555698395, 0.000297688995487988, 0.019813023507595062, 0.13118726015090942, 0.5578293204307556, 0.44850149750709534, 0.42465266585350037, 0.23262405395507812, 0.4595288932323456, 0.0076849088072776794, 0.010484163649380207, 0.004625158850103617, 0.00729722436517477, 0.007138225249946117, 0.007931897416710854, 0.012540149502456188, 0.0034338016994297504, 0.004062945488840342, 0.011636299081146717, 0.004171208944171667, 0.008271695114672184, 0.010831969790160656, 0.00908809807151556, 0.0032555798534303904, 0.005633343942463398, 0.007927780039608479, 0.004106712061911821, 0.0053390152752399445, 0.0075553846545517445, 0.008171661756932735, 0.008119269274175167, 0.014887548051774502, 0.0038535860367119312, 0.004811941646039486, 0.00960236694663763, 0.004106185864657164, 0.006525834556668997, 0.006105056498199701, 0.0061493017710745335, 0.005822349805384874, 0.007298856042325497, 0.0030777405481785536, 0.007178485859185457, 0.01168900914490223, -1]}
{"idB": "749647_15_item1_p8_s2", "idA": "749647_14_item1_p9_s1", "sentA": "ThermoDox is a liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers.", "sentB": "Our pipeline also includes GEN-1 (formerly known as EGEN-001), a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers.", "type": 2, "words": ["<tag1>", "ThermoDox", "is", "a", "liposomal", "encapsulation", "of", "doxorubicin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "the", "treatment", "of", "a", "wide", "range", "of", "cancers.", "<tag2>", "Our", "pipeline", "also", "includes", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers.", "<tag3>"], "wordsA": ["ThermoDox", "is", "a", "liposomal", "encapsulation", "of", "doxorubicin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "the", "treatment", "of", "a", "wide", "range", "of", "cancers."], "wordsB": ["Our", "pipeline", "also", "includes", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021889369934797287, 0.08671080321073532, 0.005706821568310261, 0.027293162420392036, 0.4694296717643738, 0.00590846361592412, 0.009629985317587852, 0.01098778285086155, 0.25193625688552856, 0.007262079976499081, 0.3129168152809143, 0.3131744861602783, 0.0029858893249183893, 0.0030937630217522383, 0.07004287093877792, 0.03795965760946274, 0.012592672370374203, 0.452083557844162, 0.13815584778785706, 0.2846621572971344, 0.24980983138084412, -1]}
{"idB": "749647_16_item1_p114_s0", "idA": "749647_15_item1_p105_s0", "sentA": "TheraSilence is a technology platform for the delivery of synthetically-generated inhibitory RNA (RNAi) such as small inhibitory RNAs (siRNAs), microRNAs, microRNA mimics, and related molecules that can regulate protein expression at the transcript level by exploiting endogenous cell mechanisms.", "sentB": "THERASILENCE TECHNOLOGY PLATFORM TheraSilence is a technology platform for the delivery of synthetically-generated inhibitory RNA (RNAi) such as small inhibitory RNAs (siRNAs), microRNAs, anti-microRNAs, microRNA mimics, and related molecules that can regulate protein expression at the transcript level by exploiting endogenous cell mechanisms.", "type": 2, "words": ["<tag1>", "TheraSilence", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "synthetically-generated", "inhibitory", "RNA", "(RNAi)", "such", "as", "small", "inhibitory", "RNAs", "(siRNAs),", "microRNAs,", "microRNA", "mimics,", "and", "related", "molecules", "that", "can", "regulate", "protein", "expression", "at", "the", "transcript", "level", "by", "exploiting", "endogenous", "cell", "mechanisms.", "<tag2>", "THERASILENCE", "TECHNOLOGY", "PLATFORM", "TheraSilence", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "synthetically-generated", "inhibitory", "RNA", "(RNAi)", "such", "as", "small", "inhibitory", "RNAs", "(siRNAs),", "microRNAs,", "anti-microRNAs,", "microRNA", "mimics,", "and", "related", "molecules", "that", "can", "regulate", "protein", "expression", "at", "the", "transcript", "level", "by", "exploiting", "endogenous", "cell", "mechanisms.", "<tag3>"], "wordsA": ["TheraSilence", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "synthetically-generated", "inhibitory", "RNA", "(RNAi)", "such", "as", "small", "inhibitory", "RNAs", "(siRNAs),", "microRNAs,", "microRNA", "mimics,", "and", "related", "molecules", "that", "can", "regulate", "protein", "expression", "at", "the", "transcript", "level", "by", "exploiting", "endogenous", "cell", "mechanisms."], "wordsB": ["THERASILENCE", "TECHNOLOGY", "PLATFORM", "TheraSilence", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "synthetically-generated", "inhibitory", "RNA", "(RNAi)", "such", "as", "small", "inhibitory", "RNAs", "(siRNAs),", "microRNAs,", "anti-microRNAs,", "microRNA", "mimics,", "and", "related", "molecules", "that", "can", "regulate", "protein", "expression", "at", "the", "transcript", "level", "by", "exploiting", "endogenous", "cell", "mechanisms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.35745176672935486, 0.12219177931547165, 0.2258843183517456, 0.2115916609764099, 0.029006969183683395, 0.028712688013911247, 0.05917748436331749, 0.16499154269695282, 0.03037005104124546, 0.005733856000006199, 0.07781007140874863, 0.03501331806182861, 0.08841226994991302, 0.13527299463748932, 0.1104583591222763, 0.17064686119556427, 0.03733803331851959, 0.029351994395256042, 0.24851267039775848, 0.18532206118106842, 0.11357702314853668, 0.11770711094141006, 0.12957178056240082, 0.5107231140136719, 0.13555192947387695, 0.1200449988245964, 0.02523892931640148, 0.0712258592247963, 0.12835374474525452, 0.03244689479470253, 0.03934982046484947, 0.13744091987609863, 0.10913108289241791, 0.12099344283342361, 0.06536974012851715, 0.04876253753900528, 0.06767672300338745, 0.10345648229122162, 0.036360569298267365, 0.08205125480890274, 0.17146036028862, 0.0746222585439682, 0.09745068103075027, -1]}
{"idB": "749647_16_item1_p114_s1", "idA": "749647_15_item1_p105_s1", "sentA": "Inhibitory RNA based therapies have tremendous potential for targeting virtually any disease related gene with a high degree of specificity and thus eliminating so called non-drugable target classes.", "sentB": "Inhibitory RNA-based therapies have tremendous potential for targeting virtually any disease related gene with a high degree of specificity and thus eliminating so called non-drugable target classes.", "type": 2, "words": ["<tag1>", "Inhibitory", "RNA", "based", "therapies", "have", "tremendous", "potential", "for", "targeting", "virtually", "any", "disease", "related", "gene", "with", "a", "high", "degree", "of", "specificity", "and", "thus", "eliminating", "so", "called", "non-drugable", "target", "classes.", "<tag2>", "Inhibitory", "RNA-based", "therapies", "have", "tremendous", "potential", "for", "targeting", "virtually", "any", "disease", "related", "gene", "with", "a", "high", "degree", "of", "specificity", "and", "thus", "eliminating", "so", "called", "non-drugable", "target", "classes.", "<tag3>"], "wordsA": ["Inhibitory", "RNA", "based", "therapies", "have", "tremendous", "potential", "for", "targeting", "virtually", "any", "disease", "related", "gene", "with", "a", "high", "degree", "of", "specificity", "and", "thus", "eliminating", "so", "called", "non-drugable", "target", "classes."], "wordsB": ["Inhibitory", "RNA-based", "therapies", "have", "tremendous", "potential", "for", "targeting", "virtually", "any", "disease", "related", "gene", "with", "a", "high", "degree", "of", "specificity", "and", "thus", "eliminating", "so", "called", "non-drugable", "target", "classes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6770726442337036, 0.5387991070747375, 0.15430848300457, 0.03382308408617973, 0.07610800117254257, 0.07018651813268661, 0.02640342526137829, 0.12899242341518402, 0.15449418127536774, 0.054875582456588745, 0.07792305946350098, 0.08022495359182358, 0.11137576401233673, 0.04170863330364227, 0.027040019631385803, 0.08241155743598938, 0.041051220148801804, 0.03176454082131386, 0.04625355824828148, 0.016055995598435402, 0.030866367742419243, 0.6427314281463623, 0.05899028107523918, 0.038736846297979355, 0.34181779623031616, 0.10106886923313141, 0.11772389709949493, -1]}
{"idB": "749647_16_item1_p11_s1", "idA": "749647_15_item1_p10_s1", "sentA": "Localized heat at mild hyperthermia temperatures (greater than 39.5 Celsius) releases the encapsulated doxorubicin from the liposome enabling high concentrations of doxorubicin to be deposited preferentially in and around the targeted tumor.", "sentB": "Localized heat at hyperthermia temperatures (greater than 40 Celsius) releases the encapsulated doxorubicin from the liposome enabling high concentrations of doxorubicin to be deposited preferentially in and around the targeted tumor while minimizing systemic side effects common with chemotherapy treatments like doxorubicin.", "type": 2, "words": ["<tag1>", "Localized", "heat", "at", "mild", "hyperthermia", "temperatures", "(greater", "than", "39.5", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor.", "<tag2>", "Localized", "heat", "at", "hyperthermia", "temperatures", "(greater", "than", "40", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor", "while", "minimizing", "systemic", "side", "effects", "common", "with", "chemotherapy", "treatments", "like", "doxorubicin.", "<tag3>"], "wordsA": ["Localized", "heat", "at", "mild", "hyperthermia", "temperatures", "(greater", "than", "39.5", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor."], "wordsB": ["Localized", "heat", "at", "hyperthermia", "temperatures", "(greater", "than", "40", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor", "while", "minimizing", "systemic", "side", "effects", "common", "with", "chemotherapy", "treatments", "like", "doxorubicin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00976832490414381, 0.010212225839495659, 0.001696514431387186, 0.002708452520892024, 0.003266882849857211, 0.030870260670781136, 0.06687765568494797, 0.9787286520004272, 0.29132187366485596, 0.0038132404442876577, 0.0016716389218345284, 0.002734420821070671, 0.0032976765651255846, 0.0014678987208753824, 0.0014556588139384985, 0.0025758983101695776, 0.0019490793347358704, 0.09079372882843018, 0.010989772155880928, 0.0015440571587532759, 0.005253707990050316, 0.0012648404808714986, 0.0013929323758929968, 0.002907365094870329, 0.00202541914768517, 0.0013753349194303155, 0.0020481054671108723, 0.00248888460919261, 0.0013955303002148867, 0.00419273879379034, 0.004920847713947296, 0.00012789435277227312, 0.009703705087304115, 0.010350617580115795, 0.014969863928854465, 0.015395634807646275, 0.002949979156255722, 0.00338992802426219, 0.012195018120110035, 0.016764191910624504, 0.0057743387296795845, 0.005497707054018974, -1]}
{"idB": "749647_16_item1_p122_s0", "idA": "749647_15_item1_p113_s0", "sentA": "We are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "sentB": "RESEARCH AND DEVELOPMENT EXPENDITURES We are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "type": 2, "words": ["<tag1>", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag2>", "RESEARCH", "AND", "DEVELOPMENT", "EXPENDITURES", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag3>"], "wordsA": ["We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "wordsB": ["RESEARCH", "AND", "DEVELOPMENT", "EXPENDITURES", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4625597894191742, 0.11638408154249191, 0.2816556394100189, 0.970619261264801, 0.008750928565859795, 0.004790442995727062, 0.018731344491243362, 0.003925085533410311, 0.0038739279843866825, 0.01021968387067318, 0.005403762683272362, 0.003779758233577013, 0.0063957287929952145, 0.005016639828681946, 0.006861908361315727, 0.0032208673655986786, 0.015275302343070507, 0.016863852739334106, 0.011907153762876987, 0.001115871244110167, 0.00360517343506217, 0.006536025088280439, 0.008581159636378288, 0.006047897506505251, 0.0031392720993608236, 0.0036391266621649265, 0.0029299964662641287, 0.004861433990299702, 0.00736645981669426, 0.008823086507618427, 0.003787114517763257, 0.002942396095022559, 0.008875885047018528, 0.009108208119869232, 0.00901506282389164, 0.003235375974327326, 0.007614447269588709, 0.007020160090178251, -1]}
{"idB": "749647_16_item1_p27_s0", "idA": "749647_15_item1_p113_s1", "sentA": "We are currently, with minimal cash expenditures, sponsoring clinical and pre-clinical research at the University of Oxford, University of Utrecht, Brigham and Women s Hospital and the University of Washington.", "sentB": "We have initiated the study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "type": 2, "words": ["<tag1>", "We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington.", "<tag2>", "We", "have", "initiated", "the", "study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag3>"], "wordsA": ["We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington."], "wordsB": ["We", "have", "initiated", "the", "study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0307527557015419, 0.010384432040154934, 0.12221147865056992, 0.05864711105823517, 0.14627355337142944, 0.022608907893300056, 0.15845675766468048, 0.1620446741580963, 0.13137148320674896, 0.027925843372941017, 0.026264239102602005, 0.28919804096221924, 0.21293513476848602, 0.5423426032066345, 0.07076234370470047, 0.46702226996421814, 0.31334879994392395, 0.2659400999546051, 0.1889040321111679, 0.1794120967388153, 0.14754575490951538, 0.10709785670042038, 0.03604411706328392, 0.12635700404644012, 0.18266631662845612, 0.026108158752322197, 0.01796858198940754, 0.2200448364019394, 0.3144316077232361, 0.10087002068758011, 0.36847999691963196, -1]}
{"idB": "749647_16_item1_p122_s3", "idA": "749647_15_item1_p113_s3", "sentA": "Research and development expenses were approximately $15.0 million, $9.4 million and $15.8 million for the years ended December 31, 2014, 2013 and 2012, respectively.", "sentB": "Research and development expenses were approximately $14.7 million, $15.0 million and $9.4 million for the years ended December 31, 2015, 2014 and 2013, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$15.0", "million,", "$9.4", "million", "and", "$15.8", "million", "for", "the", "years", "ended", "December", "31,", "2014,", "2013", "and", "2012,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "were", "approximately", "$14.7", "million,", "$15.0", "million", "and", "$9.4", "million", "for", "the", "years", "ended", "December", "31,", "2015,", "2014", "and", "2013,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$15.0", "million,", "$9.4", "million", "and", "$15.8", "million", "for", "the", "years", "ended", "December", "31,", "2014,", "2013", "and", "2012,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "were", "approximately", "$14.7", "million,", "$15.0", "million", "and", "$9.4", "million", "for", "the", "years", "ended", "December", "31,", "2015,", "2014", "and", "2013,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007421870715916157, 0.005792104639112949, 0.007960308343172073, 0.016703670844435692, 0.006818598601967096, 0.011305020190775394, 0.8984431028366089, 0.10384164750576019, 0.026541750878095627, 0.010475767776370049, 0.008284159936010838, 0.02743951976299286, 0.011018667370080948, 0.005997210741043091, 0.0068913474678993225, 0.00992235541343689, 0.010545731522142887, 0.009720793925225735, 0.015414156951010227, 0.03862392529845238, 0.00869031809270382, 0.007216319907456636, 0.008125139400362968, 0.009579709731042385, -1]}
{"idB": "749647_16_item1_p122_s4", "idA": "749647_15_item1_p113_s4", "sentA": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operation for additional information regarding expenditures related to our research and development programs.", "sentB": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operation s for additional information regarding expenditures related to our research and development programs.", "type": 2, "words": ["<tag1>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs.", "<tag2>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs.", "<tag3>"], "wordsA": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs."], "wordsB": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.12932196259498596, 0.19420628249645233, 0.2890113890171051, 0.21784856915473938, 0.5577520132064819, 0.13790956139564514, 0.034457914531230927, 0.05443992465734482, 0.03930303826928139, 0.09954173862934113, 0.08994819223880768, 0.025392625480890274, 0.03371835872530937, 0.026405125856399536, 0.1265404373407364, 0.3415844738483429, 0.027446269989013672, 0.03053225949406624, 0.024808378890156746, 0.018483739346265793, 0.025935929268598557, 0.01746482402086258, 0.02227201871573925, 0.012349214404821396, 0.025997919961810112, 0.02509404718875885, 0.025183197110891342, 0.02786918915808201, -1]}
{"idB": "749647_16_item1_p135_s1", "idA": "749647_15_item1_p115_s0", "sentA": "Under these statutes, our heat-activated liposomes will be regulated as a new drug.", "sentB": "A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety.", "type": 2, "words": ["<tag1>", "Under", "these", "statutes,", "our", "heat-activated", "liposomes", "will", "be", "regulated", "as", "a", "new", "drug.", "<tag2>", "A", "drug", "is", "a", "new", "chemical", "entity", "if", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "new", "drug", "containing", "the", "same", "active", "moiety.", "<tag3>"], "wordsA": ["Under", "these", "statutes,", "our", "heat-activated", "liposomes", "will", "be", "regulated", "as", "a", "new", "drug."], "wordsB": ["A", "drug", "is", "a", "new", "chemical", "entity", "if", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "new", "drug", "containing", "the", "same", "active", "moiety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010978811420500278, 0.14230887591838837, 0.03417905792593956, 0.022052133455872536, 0.12415136396884918, 0.17869102954864502, 0.1355786919593811, 0.012059067375957966, 0.009294996038079262, 0.12133976072072983, 0.052524324506521225, 0.2592533528804779, 0.09543957561254501, 0.18197931349277496, 0.0163656547665596, 0.02369595691561699, 0.09347353130578995, 0.15588077902793884, 0.011851226910948753, 0.01308507565408945, 0.04470442607998848, 0.09413933008909225, 0.050995733588933945, -1]}
{"idB": "749647_16_item1_p135_s2", "idA": "749647_15_item1_p115_s0", "sentA": "Under these statutes, our heat-activated liposomes will be regulated as a new drug.", "sentB": "During the exclusivity period, the FDA generally may not accept for review an abbreviated new drug application (ANDA) or a 505(b)(2) NDA submitted by another company that references the previously approved drug.", "type": 2, "words": ["<tag1>", "Under", "these", "statutes,", "our", "heat-activated", "liposomes", "will", "be", "regulated", "as", "a", "new", "drug.", "<tag2>", "During", "the", "exclusivity", "period,", "the", "FDA", "generally", "may", "not", "accept", "for", "review", "an", "abbreviated", "new", "drug", "application", "(ANDA)", "or", "a", "505(b)(2)", "NDA", "submitted", "by", "another", "company", "that", "references", "the", "previously", "approved", "drug.", "<tag3>"], "wordsA": ["Under", "these", "statutes,", "our", "heat-activated", "liposomes", "will", "be", "regulated", "as", "a", "new", "drug."], "wordsB": ["During", "the", "exclusivity", "period,", "the", "FDA", "generally", "may", "not", "accept", "for", "review", "an", "abbreviated", "new", "drug", "application", "(ANDA)", "or", "a", "505(b)(2)", "NDA", "submitted", "by", "another", "company", "that", "references", "the", "previously", "approved", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01913682371377945, 0.01334588322788477, 0.10216110944747925, 0.06346708536148071, 0.01624850183725357, 0.11016041785478592, 0.06657988578081131, 0.07904642820358276, 0.3750852048397064, 0.27757346630096436, 0.15551523864269257, 0.1960955113172531, 0.035936012864112854, 0.060840606689453125, 0.08375604450702667, 0.21330861747264862, 0.12922725081443787, 0.2205713838338852, 0.007947980426251888, 0.013851906172931194, 0.11671695858240128, 0.06366116553544998, 0.020074861124157906, 0.008875028230249882, 0.017860068008303642, 0.0769706591963768, 0.006999889854341745, 0.04834551364183426, 0.010919271968305111, 0.02914547175168991, 0.04576294496655464, 0.09652779251337051, -1]}
{"idB": "749647_16_item1_p125_s1", "idA": "749647_15_item1_p115_s1", "sentA": "The steps ordinarily required before such products can be marketed in the U.S. include (a) pre-clinical and clinical studies; (b) the submission to the FDA of an application for, or approval, as an Investigational New Drug application (IND), which must become effective before human clinical trials may commence; (c) adequate and well-controlled human clinical trials to establish the safety and efficacy of the product; (d) the submission to the FDA of a New Drug Application (NDA); and (e) FDA approval of the application, including approval of all product labeling.", "sentB": "The steps ordinarily required before a new drug can be marketed in the U.S. include (a) completion of pre-clinical and clinical studies; (b) submission and FDA acceptance of an Investigational New Drug application (IND), which must become effective before human clinical trials may commence; (c) completion of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product to support each of its proposed indications; (d) submission and FDA acceptance of a NDA; and (e) FDA review and approval of the NDA.", "type": 2, "words": ["<tag1>", "The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "New", "Drug", "Application", "(NDA);", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling.", "<tag2>", "The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "a", "NDA;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA.", "<tag3>"], "wordsA": ["The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "New", "Drug", "Application", "(NDA);", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling."], "wordsB": ["The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "a", "NDA;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008878200314939022, 0.05753861367702484, 0.08215281367301941, 0.049997467547655106, 0.04828909784555435, 0.021452831104397774, 0.04552788659930229, 0.07146774977445602, 0.031099488958716393, 0.025408584624528885, 0.03417424112558365, 0.018149584531784058, 0.016956130042672157, 0.04499796777963638, 0.0124391233548522, 0.019739434123039246, 0.056788451969623566, 0.013125310651957989, 0.03341575711965561, 0.013629968278110027, 0.020146848633885384, 0.026856543496251106, 0.02277868613600731, 0.029603775590658188, 0.01267557218670845, 0.03241657093167305, 0.04383007809519768, 0.015633797273039818, 0.014907680451869965, 0.030641067773103714, 0.026154471561312675, 0.03380579128861427, 0.03041762113571167, 0.02936449833214283, 0.014862678945064545, 0.014879697002470493, 0.018606580793857574, 0.023836182430386543, 0.015165649354457855, 0.016739703714847565, 0.01985766552388668, 0.026495596393942833, 0.013444569893181324, 0.018915574997663498, 0.023058738559484482, 0.0227131936699152, 0.012847748585045338, 0.03940218314528465, 0.0192877147346735, 0.030572324991226196, 0.02248871885240078, 0.020968373864889145, 0.024719689041376114, 0.015520883724093437, 0.01773783564567566, 0.01513758022338152, 0.023524673655629158, 0.01953049935400486, 0.020256612449884415, 0.012097466737031937, 0.012636111117899418, 0.020377831533551216, 0.01417367160320282, 0.01381983608007431, 0.01984827034175396, 0.015125207602977753, 0.012609528377652168, 0.019389940425753593, 0.030851228162646294, 0.019360700622200966, 0.020183056592941284, 0.01064849179238081, 0.021185820922255516, 0.0248042494058609, 0.011586026288568974, 0.013493604026734829, 0.05237553268671036, 0.00893351249396801, 0.02238105982542038, 0.019673829898238182, 0.017013659700751305, 0.012872028164565563, 0.0201138686388731, 0.01229702215641737, 0.015278522856533527, 0.13002286851406097, -1]}
{"idB": "749647_16_item1_p136_s0", "idA": "749647_15_item1_p115_s1", "sentA": "The steps ordinarily required before such products can be marketed in the U.S. include (a) pre-clinical and clinical studies; (b) the submission to the FDA of an application for, or approval, as an Investigational New Drug application (IND), which must become effective before human clinical trials may commence; (c) adequate and well-controlled human clinical trials to establish the safety and efficacy of the product; (d) the submission to the FDA of a New Drug Application (NDA); and (e) FDA approval of the application, including approval of all product labeling.", "sentB": "Post-Approval Requirements After FDA approval of a product is obtained, we and our contract manufacturers are required to comply with various post-approval requirements, including establishment registration and product listing, record-keeping requirements, reporting of adverse reactions and production problems to the FDA, providing updated safety and efficacy information, and complying with requirements concerning advertising and promotional labeling.", "type": 2, "words": ["<tag1>", "The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "New", "Drug", "Application", "(NDA);", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling.", "<tag2>", "Post-Approval", "Requirements", "After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling.", "<tag3>"], "wordsA": ["The", "steps", "ordinarily", "required", "before", "such", "products", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "pre-clinical", "and", "clinical", "studies;", "(b)", "the", "submission", "to", "the", "FDA", "of", "an", "application", "for,", "or", "approval,", "as", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product;", "(d)", "the", "submission", "to", "the", "FDA", "of", "a", "New", "Drug", "Application", "(NDA);", "and", "(e)", "FDA", "approval", "of", "the", "application,", "including", "approval", "of", "all", "product", "labeling."], "wordsB": ["Post-Approval", "Requirements", "After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.12145859748125076, 0.14108167588710785, 0.030530355870723724, 0.06741295009851456, 0.09390727430582047, 0.01105119101703167, 0.017786787822842598, 0.08664409071207047, 0.04381592944264412, 0.04355208948254585, 0.035568077117204666, 0.01336700189858675, 0.016542110592126846, 0.08932454138994217, 0.08565709739923477, 0.0059320200234651566, 0.03782602399587631, 0.010118488222360611, 0.043282147496938705, 0.008461975492537022, 0.018506962805986404, 0.05852597951889038, 0.03931647166609764, 0.0037558989133685827, 0.12766115367412567, 0.29166239500045776, 0.037396255880594254, 0.21256525814533234, 0.12060686945915222, 0.1764548122882843, 0.10236945003271103, 0.06725012511014938, 0.018759727478027344, 0.09768401831388474, 0.12669292092323303, 0.023173857480287552, 0.15551215410232544, 0.07809451967477798, 0.015636969357728958, 0.011759270913898945, 0.03614683821797371, 0.01672033593058586, 0.06376520544290543, 0.017493437975645065, 0.0035193178337067366, 0.011811457574367523, 0.044738832861185074, 0.0009692074963822961, 0.022281862795352936, 0.004954411182552576, 0.03232279047369957, 0.010181544348597527, 0.028252704069018364, 0.0073762438260018826, 0.07470636814832687, 0.04933620244264603, -1]}
{"idB": "749647_16_item1_p126_s0", "idA": "749647_15_item1_p116_s0", "sentA": "Pre-clinical tests include laboratory evaluation of product chemistry, formulation and stability, as well as animal studies, to assess the potential safety and efficacy of the product.", "sentB": "Pre-clinical tests include laboratory evaluations of product chemistry, toxicity, formulation and stability, as well as animal studies, to assess the potential safety and efficacy of the product.", "type": 2, "words": ["<tag1>", "Pre-clinical", "tests", "include", "laboratory", "evaluation", "of", "product", "chemistry,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product.", "<tag2>", "Pre-clinical", "tests", "include", "laboratory", "evaluations", "of", "product", "chemistry,", "toxicity,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product.", "<tag3>"], "wordsA": ["Pre-clinical", "tests", "include", "laboratory", "evaluation", "of", "product", "chemistry,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product."], "wordsB": ["Pre-clinical", "tests", "include", "laboratory", "evaluations", "of", "product", "chemistry,", "toxicity,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03844150900840759, 0.05787648260593414, 0.013735206797719002, 0.019857341423630714, 0.0912255197763443, 0.015558079816401005, 0.10724334418773651, 0.16022361814975739, 0.8480432629585266, 0.016846012324094772, 0.015126848593354225, 0.014407902956008911, 0.0105834836140275, 0.007554527372121811, 0.007120633032172918, 0.031320177018642426, 0.038597144186496735, 0.007509976625442505, 0.013034616596996784, 0.010661236941814423, 0.015115976333618164, 0.015114948153495789, 0.010559731163084507, 0.0123188691213727, 0.006991168484091759, 0.008274715393781662, 0.0308755524456501, -1]}
{"idB": "749647_16_item1_p127_s0", "idA": "749647_15_item1_p117_s0", "sentA": "Clinical trials involve the administration of therapy to humans under the supervision of a qualified principal investigator.", "sentB": "Clinical trials involve the administration of the investigational product to human subjects under the supervision of a qualified principal investigator.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "involve", "the", "administration", "of", "therapy", "to", "humans", "under", "the", "supervision", "of", "a", "qualified", "principal", "investigator.", "<tag2>", "Clinical", "trials", "involve", "the", "administration", "of", "the", "investigational", "product", "to", "human", "subjects", "under", "the", "supervision", "of", "a", "qualified", "principal", "investigator.", "<tag3>"], "wordsA": ["Clinical", "trials", "involve", "the", "administration", "of", "therapy", "to", "humans", "under", "the", "supervision", "of", "a", "qualified", "principal", "investigator."], "wordsB": ["Clinical", "trials", "involve", "the", "administration", "of", "the", "investigational", "product", "to", "human", "subjects", "under", "the", "supervision", "of", "a", "qualified", "principal", "investigator."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010487012565135956, 0.010289321653544903, 0.005570709705352783, 0.0018758453661575913, 0.03867349773645401, 0.02666444703936577, 0.030524620786309242, 0.9799422025680542, 0.8883863091468811, 0.011084132827818394, 0.03435756638646126, 0.03495257347822189, 0.0018141596810892224, 0.0009481333545409143, 0.0027426721062511206, 0.001634349930100143, 0.0015056889969855547, 0.0041525173000991344, 0.004092416726052761, 0.004201096948236227, -1]}
{"idB": "749647_16_item1_p127_s1", "idA": "749647_15_item1_p117_s1", "sentA": "Clinical trials must be conducted in accordance with good clinical practices under protocols submitted to the FDA as part of an IND.", "sentB": "Clinical trials must be conducted in accordance with good clinical practices under protocols submitted to the FDA as part of an IND and with patient informed consent.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND.", "<tag2>", "Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "with", "patient", "informed", "consent.", "<tag3>"], "wordsA": ["Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND."], "wordsB": ["Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "with", "patient", "informed", "consent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03667540103197098, 0.06155725568532944, 0.0136317890137434, 0.009165313094854355, 0.020086806267499924, 0.01095267478376627, 0.011513205245137215, 0.007909080013632774, 0.013181745074689388, 0.010099340230226517, 0.011870138347148895, 0.007717124652117491, 0.013193835504353046, 0.010048000141978264, 0.008592892438173294, 0.007606355007737875, 0.010829977691173553, 0.009894008748233318, 0.013854427263140678, 0.01032545231282711, 0.011407637968659401, 0.023511767387390137, 0.007651633117347956, 0.04529796540737152, 0.6475520730018616, 0.9555447697639465, 0.9549546241760254, -1]}
{"idB": "749647_16_item1_p127_s2", "idA": "749647_15_item1_p117_s2", "sentA": "Also, each clinical trial must be approved and conducted under the auspices of an internal review board (IRB), and with patient informed consent.", "sentB": "Also, each clinical trial must be approved by an Institutional Review Board (IRB), and is subject to ongoing IRB monitoring.", "type": 2, "words": ["<tag1>", "Also,", "each", "clinical", "trial", "must", "be", "approved", "and", "conducted", "under", "the", "auspices", "of", "an", "internal", "review", "board", "(IRB),", "and", "with", "patient", "informed", "consent.", "<tag2>", "Also,", "each", "clinical", "trial", "must", "be", "approved", "by", "an", "Institutional", "Review", "Board", "(IRB),", "and", "is", "subject", "to", "ongoing", "IRB", "monitoring.", "<tag3>"], "wordsA": ["Also,", "each", "clinical", "trial", "must", "be", "approved", "and", "conducted", "under", "the", "auspices", "of", "an", "internal", "review", "board", "(IRB),", "and", "with", "patient", "informed", "consent."], "wordsB": ["Also,", "each", "clinical", "trial", "must", "be", "approved", "by", "an", "Institutional", "Review", "Board", "(IRB),", "and", "is", "subject", "to", "ongoing", "IRB", "monitoring."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0037680622190237045, 0.008222834207117558, 0.02683836966753006, 0.03200144320726395, 0.01593557372689247, 0.021638303995132446, 0.0939350351691246, 0.08616143465042114, 0.03486147150397301, 0.9206104278564453, 0.2981702387332916, 0.19467677175998688, 0.04007105156779289, 0.00019717433315236121, 0.005030039232224226, 0.14486084878444672, 0.08247025310993195, 0.36323848366737366, 0.13626223802566528, 0.48820367455482483, -1]}
{"idB": "749647_16_item1_p128_s0", "idA": "749647_15_item1_p118_s0", "sentA": "Clinical trials are typically conducted in two or three sequential phases, but the phases may overlap.", "sentB": "Clinical trials are typically conducted in three sequential phases, but the phases may overlap or be combined.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "are", "typically", "conducted", "in", "two", "or", "three", "sequential", "phases,", "but", "the", "phases", "may", "overlap.", "<tag2>", "Clinical", "trials", "are", "typically", "conducted", "in", "three", "sequential", "phases,", "but", "the", "phases", "may", "overlap", "or", "be", "combined.", "<tag3>"], "wordsA": ["Clinical", "trials", "are", "typically", "conducted", "in", "two", "or", "three", "sequential", "phases,", "but", "the", "phases", "may", "overlap."], "wordsB": ["Clinical", "trials", "are", "typically", "conducted", "in", "three", "sequential", "phases,", "but", "the", "phases", "may", "overlap", "or", "be", "combined."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013581594452261925, 0.027477240189909935, 0.0035862650256603956, 0.01322127878665924, 0.016647450625896454, 0.010436809621751308, 0.5482028722763062, 0.10200066864490509, 0.04571813344955444, 0.004850332625210285, 0.005531252361834049, 0.11522600054740906, 0.031590286642313004, 0.1943734884262085, 0.11293751746416092, 0.1774929016828537, 0.7022332549095154, -1]}
{"idB": "749647_16_item1_p128_s3", "idA": "749647_15_item1_p118_s0", "sentA": "Clinical trials are typically conducted in two or three sequential phases, but the phases may overlap.", "sentB": "Phase III clinical trials are typically conducted in a significantly larger patient population and are intended to further evaluate safety and efficacy, establish the overall risk-benefit profile of the product, and provide an adequate basis for physician labeling.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "are", "typically", "conducted", "in", "two", "or", "three", "sequential", "phases,", "but", "the", "phases", "may", "overlap.", "<tag2>", "Phase", "III", "clinical", "trials", "are", "typically", "conducted", "in", "a", "significantly", "larger", "patient", "population", "and", "are", "intended", "to", "further", "evaluate", "safety", "and", "efficacy,", "establish", "the", "overall", "risk-benefit", "profile", "of", "the", "product,", "and", "provide", "an", "adequate", "basis", "for", "physician", "labeling.", "<tag3>"], "wordsA": ["Clinical", "trials", "are", "typically", "conducted", "in", "two", "or", "three", "sequential", "phases,", "but", "the", "phases", "may", "overlap."], "wordsB": ["Phase", "III", "clinical", "trials", "are", "typically", "conducted", "in", "a", "significantly", "larger", "patient", "population", "and", "are", "intended", "to", "further", "evaluate", "safety", "and", "efficacy,", "establish", "the", "overall", "risk-benefit", "profile", "of", "the", "product,", "and", "provide", "an", "adequate", "basis", "for", "physician", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1082107424736023, 0.561603844165802, 0.07305753231048584, 0.06977140158414841, 0.0023343260399997234, 0.005607158876955509, 0.013967144303023815, 0.01294651534408331, 0.013388841412961483, 0.2617608606815338, 0.5324995517730713, 0.3117015063762665, 0.2591770589351654, 0.0003664525575004518, 0.0029126571025699377, 0.004058512393385172, 0.004653530661016703, 0.022527767345309258, 0.08289653062820435, 0.041023559868335724, 0.034468963742256165, 0.022428644821047783, 0.06272310763597488, 0.015723053365945816, 0.09188354760408401, 0.08100711554288864, 0.06717804074287415, 0.011088525876402855, 0.010939385741949081, 0.02965691313147545, 0.009213896468281746, 0.05099141225218773, 0.02265140414237976, 0.17372001707553864, 0.17458167672157288, 0.0484524741768837, 0.12819267809391022, 0.15186479687690735, -1]}
{"idB": "749647_16_item1_p128_s1", "idA": "749647_15_item1_p119_s0", "sentA": "Phase I clinical trials involve the initial introduction of the therapy to a small number of subjects.", "sentB": "Phase I clinical trials may be conducted in patients or healthy volunteers to evaluate the product s safety, dosage tolerance and pharmacokinetics and, if possible, seek to gain an early indication of its effectiveness.", "type": 2, "words": ["<tag1>", "Phase", "I", "clinical", "trials", "involve", "the", "initial", "introduction", "of", "the", "therapy", "to", "a", "small", "number", "of", "subjects.", "<tag2>", "Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product", "s", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness.", "<tag3>"], "wordsA": ["Phase", "I", "clinical", "trials", "involve", "the", "initial", "introduction", "of", "the", "therapy", "to", "a", "small", "number", "of", "subjects."], "wordsB": ["Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product", "s", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01137384120374918, 0.006502457894384861, 0.024023734033107758, 0.0701172724366188, 0.019171196967363358, 0.014175756834447384, 0.04560999199748039, 0.06828630715608597, 0.2677440345287323, 0.06277035176753998, 0.6284986138343811, 0.48012208938598633, 0.005940703675150871, 0.055997591465711594, 0.006487338338047266, 0.06336274743080139, 0.020871601998806, 0.055690012872219086, 0.055245496332645416, 0.04544927552342415, 0.008623998612165451, 0.047511857002973557, 0.0066816192120313644, 0.011847742833197117, 0.012856289744377136, 0.01561991311609745, 0.007019568234682083, 0.016132675111293793, 0.010236906819045544, 0.04843396693468094, 0.04354240000247955, 0.016189947724342346, 0.02690102905035019, 0.06791115552186966, -1]}
{"idB": "749647_16_item1_p136_s1", "idA": "749647_15_item1_p119_s3", "sentA": "However, the FDA may require additional, post-market trials as a condition of approval.", "sentB": "As a condition of approval of an NDA, the FDA may require the applicant to conduct additional clinical trials or other post market testing and surveillance to further monitor and assess the drug s safety and efficacy.", "type": 2, "words": ["<tag1>", "However,", "the", "FDA", "may", "require", "additional,", "post-market", "trials", "as", "a", "condition", "of", "approval.", "<tag2>", "As", "a", "condition", "of", "approval", "of", "an", "NDA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug", "s", "safety", "and", "efficacy.", "<tag3>"], "wordsA": ["However,", "the", "FDA", "may", "require", "additional,", "post-market", "trials", "as", "a", "condition", "of", "approval."], "wordsB": ["As", "a", "condition", "of", "approval", "of", "an", "NDA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug", "s", "safety", "and", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004809527192264795, 0.004952563904225826, 0.011185701936483383, 0.004453234374523163, 0.022195246070623398, 0.010788972489535809, 0.020646896213293076, 0.12378424406051636, 0.0034242349211126566, 0.025386914610862732, 0.009703000076115131, 0.06420876830816269, 0.015409136191010475, 0.25513190031051636, 0.1269417256116867, 0.2177114486694336, 0.19868254661560059, 0.2203831523656845, 0.458110511302948, 0.012586631812155247, 0.008563612587749958, 0.045684438198804855, 0.027581676840782166, 0.10848161578178406, 0.04409079998731613, 0.10526131093502045, 0.010153671726584435, 0.007613535970449448, 0.018434712663292885, 0.008613072335720062, 0.015269349329173565, 0.0066205901093780994, 0.02256685681641102, 0.008872848935425282, 0.01308396179229021, 0.009726537391543388, 0.012332475744187832, -1]}
{"idB": "749647_16_item1_p12_s1", "idA": "749647_15_item1_p11_s1", "sentA": "Specifically, we determined, after conferring with the HEAT Study independent Data Monitoring Committee (iDMC), that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval.", "sentB": "We determined, after conferring with the HEAT Study s independent Data Monitoring Committee (iDMC), that the HEAT Study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness, that being a clinically meaningful improvement in progression free survival (PFS), that could form the basis for regulatory approval.", "type": 2, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval.", "<tag2>", "We", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "s", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness,", "that", "being", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival", "(PFS),", "that", "could", "form", "the", "basis", "for", "regulatory", "approval.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval."], "wordsB": ["We", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "s", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness,", "that", "being", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival", "(PFS),", "that", "could", "form", "the", "basis", "for", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01222784910351038, 0.020061083137989044, 0.008095541037619114, 0.010304584167897701, 0.0067245750688016415, 0.005075720138847828, 0.008657959289848804, 0.008502012118697166, 0.008796213194727898, 0.009340218268334866, 0.008117126300930977, 0.009732014499604702, 0.008151181042194366, 0.013003410771489143, 0.005071363411843777, 0.003699377877637744, 0.015071693807840347, 0.0169602632522583, 0.04698747396469116, 0.053302112966775894, 0.010217662900686264, 0.005073279142379761, 0.006094286218285561, 0.0040394626557827, 0.006449477281421423, 0.007917338982224464, 0.005139996763318777, 0.004187014885246754, 0.005711856763809919, 0.007037366274744272, 0.0045294915325939655, 0.03670606017112732, 0.027433911338448524, 0.11047977954149246, 0.11797229945659637, 0.34764933586120605, 0.3555760681629181, 0.5109930634498596, 0.7088513374328613, 0.6056615114212036, 0.6799382567405701, 0.007912343367934227, 0.00521747674793005, 0.005911276210099459, 0.004406377673149109, 0.008424521423876286, 0.0036699557676911354, 0.00639414694160223, 0.007772000040858984, -1]}
{"idB": "749647_16_item1_p19_s3", "idA": "749647_15_item1_p11_s1", "sentA": "Specifically, we determined, after conferring with the HEAT Study independent Data Monitoring Committee (iDMC), that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval.", "sentB": "Results from the OPTIMA Study, if successful, will provide the basis for a global registration filing and marketing approval.", "type": 2, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval.", "<tag2>", "Results", "from", "the", "OPTIMA", "Study,", "if", "successful,", "will", "provide", "the", "basis", "for", "a", "global", "registration", "filing", "and", "marketing", "approval.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval."], "wordsB": ["Results", "from", "the", "OPTIMA", "Study,", "if", "successful,", "will", "provide", "the", "basis", "for", "a", "global", "registration", "filing", "and", "marketing", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10032905638217926, 0.026696238666772842, 0.013126051053404808, 0.266191691160202, 0.16510212421417236, 0.06421315670013428, 0.06255728751420975, 0.02732003852725029, 0.06858167797327042, 0.020319031551480293, 0.15070001780986786, 0.027814803645014763, 0.025785787031054497, 0.2810434103012085, 0.42212411761283875, 0.32523113489151, 0.053313661366701126, 0.374713271856308, 0.4701314866542816, -1]}
{"idB": "749647_16_item1_p63_s3", "idA": "749647_15_item1_p11_s1", "sentA": "Specifically, we determined, after conferring with the HEAT Study independent Data Monitoring Committee (iDMC), that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval.", "sentB": "Results from the OPTIMA Study, if successful, will provide the basis for a global registration filing and marketing approval.", "type": 2, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval.", "<tag2>", "Results", "from", "the", "OPTIMA", "Study,", "if", "successful,", "will", "provide", "the", "basis", "for", "a", "global", "registration", "filing", "and", "marketing", "approval.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval."], "wordsB": ["Results", "from", "the", "OPTIMA", "Study,", "if", "successful,", "will", "provide", "the", "basis", "for", "a", "global", "registration", "filing", "and", "marketing", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10032905638217926, 0.026696238666772842, 0.013126051053404808, 0.266191691160202, 0.16510212421417236, 0.06421315670013428, 0.06255728751420975, 0.02732003852725029, 0.06858167797327042, 0.020319031551480293, 0.15070001780986786, 0.027814803645014763, 0.025785787031054497, 0.2810434103012085, 0.42212411761283875, 0.32523113489151, 0.053313661366701126, 0.374713271856308, 0.4701314866542816, -1]}
{"idB": "749647_16_item1_p128_s2", "idA": "749647_15_item1_p120_s0", "sentA": "In the case of drugs and biological products, Phase II clinical trials generally are conducted in a target patient population to gather evidence about the pharmacokinetics, safety and biological or clinical efficacy of the drug for specific indications, to determine dosage tolerance and optimal dosage and to identify possible adverse effects and safety risks.", "sentB": "Phase II clinical trials usually involve controlled trials in a larger but still relatively small number of subjects from the relevant patient population to evaluate dosage tolerance and appropriate dosage; identify possible short-term adverse effects and safety risks; and provide a preliminary evaluation of the efficacy of the drug for specific indications.", "type": 2, "words": ["<tag1>", "In", "the", "case", "of", "drugs", "and", "biological", "products,", "Phase", "II", "clinical", "trials", "generally", "are", "conducted", "in", "a", "target", "patient", "population", "to", "gather", "evidence", "about", "the", "pharmacokinetics,", "safety", "and", "biological", "or", "clinical", "efficacy", "of", "the", "drug", "for", "specific", "indications,", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag2>", "Phase", "II", "clinical", "trials", "usually", "involve", "controlled", "trials", "in", "a", "larger", "but", "still", "relatively", "small", "number", "of", "subjects", "from", "the", "relevant", "patient", "population", "to", "evaluate", "dosage", "tolerance", "and", "appropriate", "dosage;", "identify", "possible", "short-term", "adverse", "effects", "and", "safety", "risks;", "and", "provide", "a", "preliminary", "evaluation", "of", "the", "efficacy", "of", "the", "drug", "for", "specific", "indications.", "<tag3>"], "wordsA": ["In", "the", "case", "of", "drugs", "and", "biological", "products,", "Phase", "II", "clinical", "trials", "generally", "are", "conducted", "in", "a", "target", "patient", "population", "to", "gather", "evidence", "about", "the", "pharmacokinetics,", "safety", "and", "biological", "or", "clinical", "efficacy", "of", "the", "drug", "for", "specific", "indications,", "to", "determine", "dosage", "tolerance", "and", "optimal", "dosage", "and", "to", "identify", "possible", "adverse", "effects", "and", "safety", "risks."], "wordsB": ["Phase", "II", "clinical", "trials", "usually", "involve", "controlled", "trials", "in", "a", "larger", "but", "still", "relatively", "small", "number", "of", "subjects", "from", "the", "relevant", "patient", "population", "to", "evaluate", "dosage", "tolerance", "and", "appropriate", "dosage;", "identify", "possible", "short-term", "adverse", "effects", "and", "safety", "risks;", "and", "provide", "a", "preliminary", "evaluation", "of", "the", "efficacy", "of", "the", "drug", "for", "specific", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01052809227257967, 0.009395407512784004, 0.018310541287064552, 0.025297898799180984, 0.018366431817412376, 0.02967369556427002, 0.5117268562316895, 0.5309920310974121, 0.013508311472833157, 0.008185179904103279, 0.05117469280958176, 0.0049354201182723045, 0.011129436083137989, 0.03571293503046036, 0.2539895176887512, 0.1743054986000061, 0.11166791617870331, 0.19318068027496338, 0.004021450411528349, 0.0055360859259963036, 0.025665998458862305, 0.05363265797495842, 0.03931023180484772, 0.004579699132591486, 0.00425963057205081, 0.004814701154828072, 0.004549216013401747, 0.0034576088655740023, 0.007961438037455082, 0.009086131118237972, 0.007927186787128448, 0.008236094377934933, 0.585337221622467, 0.04771597683429718, 0.020642835646867752, 0.0022841456811875105, 0.005149089731276035, 0.005345197394490242, 0.004139692056924105, 0.015793222934007645, 0.007357546593993902, 0.23758818209171295, 0.1886908859014511, 0.012104791589081287, 0.006125828716903925, 0.016823044046759605, 0.006632577162235975, 0.0066049471497535706, 0.022762227803468704, 0.0027349514421075583, 0.004064455162733793, 0.004791848361492157, -1]}
{"idB": "749647_16_item1_p130_s0", "idA": "749647_15_item1_p124_s0", "sentA": "Either the FDA or we may suspend clinical trials at any time, if the FDA, our independent DMC, or we conclude that clinical subjects are being exposed to an unacceptable health risk or for other reasons.", "sentB": "Either the FDA or we may suspend clinical trials at any time on various grounds, including among other things, if we, the FDA, or our independent DMC conclude that clinical subjects are being exposed to an unacceptable health risk.", "type": 2, "words": ["<tag1>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "independent", "DMC,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons.", "<tag2>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time", "on", "various", "grounds,", "including", "among", "other", "things,", "if", "we,", "the", "FDA,", "or", "our", "independent", "DMC", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk.", "<tag3>"], "wordsA": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time,", "if", "the", "FDA,", "our", "independent", "DMC,", "or", "we", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk", "or", "for", "other", "reasons."], "wordsB": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time", "on", "various", "grounds,", "including", "among", "other", "things,", "if", "we,", "the", "FDA,", "or", "our", "independent", "DMC", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11362738162279129, 0.015352001413702965, 0.18557366728782654, 0.04468787461519241, 0.0541495680809021, 0.054646946489810944, 0.20523318648338318, 0.0870119035243988, 0.14041925966739655, 0.05947481840848923, 0.06267605721950531, 0.05784985423088074, 0.06209876015782356, 0.07228647917509079, 0.15742330253124237, 0.029742639511823654, 0.033461857587099075, 0.05344767868518829, 0.09373200684785843, 0.06898745149374008, 0.11371468007564545, 0.029398318380117416, 0.1202734187245369, 0.0315643809735775, 0.041867420077323914, 0.0965854823589325, 0.1248023509979248, 0.25672027468681335, 0.09272108227014542, 0.11574262380599976, 0.32330137491226196, 0.05186107009649277, 0.09543967992067337, 0.12919767200946808, 0.05068691447377205, 0.04903694614768028, 0.08739468455314636, 0.06502009183168411, 0.11802928149700165, -1]}
{"idB": "749647_16_item1_p132_s0", "idA": "749647_15_item1_p126_s1", "sentA": "There can be no assurance that the design or the performance of the pivotal clinical trial protocols or any of our current or future product candidates will be successful.", "sentB": "The conduct of clinical trials is complex and difficult, and there can be no assurance that the design or the performance of the pivotal clinical trial protocols of any of our current or future product candidates will be successful.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "or", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful.", "<tag2>", "The", "conduct", "of", "clinical", "trials", "is", "complex", "and", "difficult,", "and", "there", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "of", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "or", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful."], "wordsB": ["The", "conduct", "of", "clinical", "trials", "is", "complex", "and", "difficult,", "and", "there", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "of", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009512865915894508, 0.04854031652212143, 0.01377477589994669, 0.07444984465837479, 0.21925483644008636, 0.07181419432163239, 0.5052048563957214, 0.288942813873291, 0.41137298941612244, 0.011864413507282734, 0.005416796542704105, 0.006351379677653313, 0.005945450160652399, 0.020685330033302307, 0.03363073617219925, 0.006801975425332785, 0.007495025172829628, 0.030030975118279457, 0.009905927814543247, 0.008634890429675579, 0.018160073086619377, 0.009179198183119297, 0.008660905994474888, 0.016962552443146706, 0.014463232830166817, 0.014989550225436687, 0.013022402301430702, 0.007232469506561756, 0.015179494395852089, 0.011197896674275398, 0.010423265397548676, 0.014132182113826275, 0.01151183806359768, 0.012674524448812008, 0.013884210959076881, 0.0177677683532238, 0.01094510406255722, 0.019359154626727104, 0.11987040191888809, -1]}
{"idB": "749647_16_item1_p133_s0", "idA": "749647_15_item1_p127_s0", "sentA": "The results of pre-clinical studies and clinical trials, if successful, are submitted in an application for FDA approval to market the drug or biological product for a specified use.", "sentB": "The results of pre-clinical studies and clinical trials, if successful, are submitted to FDA in the form of an NDA.", "type": 2, "words": ["<tag1>", "The", "results", "of", "pre-clinical", "studies", "and", "clinical", "trials,", "if", "successful,", "are", "submitted", "in", "an", "application", "for", "FDA", "approval", "to", "market", "the", "drug", "or", "biological", "product", "for", "a", "specified", "use.", "<tag2>", "The", "results", "of", "pre-clinical", "studies", "and", "clinical", "trials,", "if", "successful,", "are", "submitted", "to", "FDA", "in", "the", "form", "of", "an", "NDA.", "<tag3>"], "wordsA": ["The", "results", "of", "pre-clinical", "studies", "and", "clinical", "trials,", "if", "successful,", "are", "submitted", "in", "an", "application", "for", "FDA", "approval", "to", "market", "the", "drug", "or", "biological", "product", "for", "a", "specified", "use."], "wordsB": ["The", "results", "of", "pre-clinical", "studies", "and", "clinical", "trials,", "if", "successful,", "are", "submitted", "to", "FDA", "in", "the", "form", "of", "an", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0017133865039795637, 0.010501447133719921, 0.0016638078959658742, 0.005886568687856197, 0.005339020863175392, 0.0015729265287518501, 0.005007114261388779, 0.005617068149149418, 0.003370238235220313, 0.006620119791477919, 0.0027389535680413246, 0.06950902938842773, 0.017054876312613487, 0.048349738121032715, 0.07889293134212494, 0.04884153977036476, 0.22115525603294373, 0.2504214644432068, 0.24611696600914001, 0.9864295721054077, -1]}
{"idB": "749647_16_item1_p133_s1", "idA": "749647_15_item1_p127_s1", "sentA": "The testing and approval process requires substantial time and effort, and there can be no assurance that any approval will be granted for any product at any time, according to any schedule, or at all.", "sentB": "The testing and approval process requires substantial time, effort, and financial resources, and there can be no assurance that any approval will be granted for any product at any time, according to any schedule, or at all.", "type": 2, "words": ["<tag1>", "The", "testing", "and", "approval", "process", "requires", "substantial", "time", "and", "effort,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all.", "<tag2>", "The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all.", "<tag3>"], "wordsA": ["The", "testing", "and", "approval", "process", "requires", "substantial", "time", "and", "effort,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all."], "wordsB": ["The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00992641318589449, 0.10926787555217743, 0.023599686101078987, 0.05792747810482979, 0.07666294276714325, 0.05077904462814331, 0.06907259672880173, 0.07325262576341629, 0.09330316632986069, 0.05945029482245445, 0.6769341230392456, 0.7452241778373718, 0.014915384352207184, 0.0170265045017004, 0.025270657613873482, 0.021622763946652412, 0.12344639748334885, 0.13656534254550934, 0.038291580975055695, 0.2888161242008209, 0.5512926578521729, 0.08615165948867798, 0.08835252374410629, 0.21502117812633514, 0.09709944576025009, 0.18572568893432617, 0.22779060900211334, 0.04327068850398064, 0.06120821461081505, 0.0779917985200882, 0.03648862615227699, 0.03713502734899521, 0.04829161614179611, 0.09137173742055893, 0.03316516429185867, 0.061351969838142395, 0.11038274317979813, -1]}
{"idB": "749647_16_item1_p133_s2", "idA": "749647_15_item1_p127_s2", "sentA": "The FDA may refuse to accept or approve an application if it believes that applicable regulatory criteria are not satisfied.", "sentB": "The FDA may refuse to accept or approve an application if it determines that applicable regulatory criteria are not satisfied.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "refuse", "to", "accept", "or", "approve", "an", "application", "if", "it", "believes", "that", "applicable", "regulatory", "criteria", "are", "not", "satisfied.", "<tag2>", "The", "FDA", "may", "refuse", "to", "accept", "or", "approve", "an", "application", "if", "it", "determines", "that", "applicable", "regulatory", "criteria", "are", "not", "satisfied.", "<tag3>"], "wordsA": ["The", "FDA", "may", "refuse", "to", "accept", "or", "approve", "an", "application", "if", "it", "believes", "that", "applicable", "regulatory", "criteria", "are", "not", "satisfied."], "wordsB": ["The", "FDA", "may", "refuse", "to", "accept", "or", "approve", "an", "application", "if", "it", "determines", "that", "applicable", "regulatory", "criteria", "are", "not", "satisfied."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003845911007374525, 0.018804486840963364, 0.022904524579644203, 0.18685920536518097, 0.0683831200003624, 0.023675965145230293, 0.015448988415300846, 0.01615009270608425, 0.010814561508595943, 0.018587499856948853, 0.01751723699271679, 0.01012162584811449, 0.07178992033004761, 0.02367556281387806, 0.01824272610247135, 0.025938445702195168, 0.041969332844018936, 0.07992886006832123, 0.40848860144615173, 0.2948148250579834, -1]}
{"idB": "749647_16_item1_p133_s4", "idA": "749647_15_item1_p127_s4", "sentA": "Moreover, if regulatory approval is granted, the approval will be limited to specific indications.", "sentB": "Even, if regulatory approval is granted, the approval will be limited to specific indications.", "type": 2, "words": ["<tag1>", "Moreover,", "if", "regulatory", "approval", "is", "granted,", "the", "approval", "will", "be", "limited", "to", "specific", "indications.", "<tag2>", "Even,", "if", "regulatory", "approval", "is", "granted,", "the", "approval", "will", "be", "limited", "to", "specific", "indications.", "<tag3>"], "wordsA": ["Moreover,", "if", "regulatory", "approval", "is", "granted,", "the", "approval", "will", "be", "limited", "to", "specific", "indications."], "wordsB": ["Even,", "if", "regulatory", "approval", "is", "granted,", "the", "approval", "will", "be", "limited", "to", "specific", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.50384122133255, 0.05114024877548218, 0.2046593427658081, 0.34325680136680603, 0.15328852832317352, 0.3282455503940582, 0.01022864505648613, 0.2951059937477112, 0.05953263118863106, 0.06672616302967072, 0.5718544721603394, 0.10538805276155472, 0.367143839597702, 0.27813440561294556, -1]}
{"idB": "749647_16_item1_p134_s2", "idA": "749647_15_item1_p128_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox for the treatment of HCC.", "sentB": "However, if a product which has an orphan drug designation subsequently receives the first FDA approval for the indication for which it has such designation, the product is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drug for the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC.", "<tag2>", "However,", "if", "a", "product", "which", "has", "an", "orphan", "drug", "designation", "subsequently", "receives", "the", "first", "FDA", "approval", "for", "the", "indication", "for", "which", "it", "has", "such", "designation,", "the", "product", "is", "entitled", "to", "orphan", "drug", "exclusivity,", "which", "means", "the", "FDA", "may", "not", "approve", "any", "other", "application", "to", "market", "the", "same", "drug", "for", "the", "same", "indication", "for", "a", "period", "of", "seven", "years,", "except", "in", "limited", "circumstances,", "such", "as", "a", "showing", "of", "clinical", "superiority", "to", "the", "product", "with", "orphan", "exclusivity.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC."], "wordsB": ["However,", "if", "a", "product", "which", "has", "an", "orphan", "drug", "designation", "subsequently", "receives", "the", "first", "FDA", "approval", "for", "the", "indication", "for", "which", "it", "has", "such", "designation,", "the", "product", "is", "entitled", "to", "orphan", "drug", "exclusivity,", "which", "means", "the", "FDA", "may", "not", "approve", "any", "other", "application", "to", "market", "the", "same", "drug", "for", "the", "same", "indication", "for", "a", "period", "of", "seven", "years,", "except", "in", "limited", "circumstances,", "such", "as", "a", "showing", "of", "clinical", "superiority", "to", "the", "product", "with", "orphan", "exclusivity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04875582829117775, 0.046038221567869186, 0.032892029732465744, 0.12944020330905914, 0.007479027844965458, 0.01775066927075386, 0.009053891524672508, 0.023537175729870796, 0.016642823815345764, 0.02086045779287815, 0.0628477931022644, 0.10651905834674835, 0.05318453162908554, 0.12228279560804367, 0.23534008860588074, 0.21302659809589386, 0.013914837501943111, 0.01736028492450714, 0.08401240408420563, 0.010745199397206306, 0.00565728172659874, 0.010095345787703991, 0.008695915341377258, 0.011933173052966595, 0.041503988206386566, 0.013564362190663815, 0.07253826409578323, 0.024837085977196693, 0.055627480149269104, 0.032161276787519455, 0.0436532236635685, 0.032397862523794174, 0.06359527260065079, 0.00018005580932367593, 0.007108998019248247, 0.00786216463893652, 0.04701739177107811, 0.029249195009469986, 0.134520024061203, 0.08645504713058472, 0.02335304394364357, 0.0313800685107708, 0.10545765608549118, 0.01783830299973488, 0.05198483169078827, 0.025087561458349228, 0.04643087461590767, 0.09679345786571503, 0.01060064323246479, 0.013885869644582272, 0.03347866237163544, 0.07171393185853958, 0.010777417570352554, 0.007798760663717985, 0.011749139986932278, 0.010350036434829235, 0.03157627582550049, 0.031284041702747345, 0.00021045259200036526, 0.013020612299442291, 0.05421924218535423, 0.03701934590935707, 0.0002849210286512971, 0.008041558787226677, 0.008308302611112595, 0.025583067908883095, 0.021595777943730354, 0.08421975374221802, 0.07557763159275055, 0.0498369038105011, 0.028038227930665016, 0.1161513701081276, 0.018482638522982597, 0.04919273033738136, 0.04666770622134209, -1]}
{"idB": "749647_16_item1_p137_s0", "idA": "749647_15_item1_p131_s1", "sentA": "Manufacturing establishments in the U.S. and abroad are subject to inspections by the FDA and must comply with current good manufacturing practices.", "sentB": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "type": 2, "words": ["<tag1>", "Manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices.", "<tag2>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag3>"], "wordsA": ["Manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices."], "wordsB": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01575007662177086, 0.014222652651369572, 0.01309655886143446, 0.012518049217760563, 0.0032148074824362993, 0.0037145691458135843, 0.01069458108395338, 0.004843802656978369, 0.005269083194434643, 0.003953428007662296, 0.04279138520359993, 0.022832529619336128, 0.9380913376808167, 0.477247953414917, 0.004501644056290388, 0.004694621078670025, 0.011865967884659767, 0.0010511415312066674, 0.004332715179771185, 0.008650791831314564, 0.003855751594528556, 0.004538728855550289, 0.008092233911156654, 0.012205447070300579, 0.01631326414644718, 0.7606736421585083, -1]}
{"idB": "749647_16_item1_p137_s1", "idA": "749647_15_item1_p131_s2", "sentA": "In order to ensure full technical compliance with such practices, manufacturers must expend funds, time and effort in the areas of production and quality control.", "sentB": "To maintain compliance with cGMP, manufacturers must expend funds, time and effort in the areas of production and quality control.", "type": 2, "words": ["<tag1>", "In", "order", "to", "ensure", "full", "technical", "compliance", "with", "such", "practices,", "manufacturers", "must", "expend", "funds,", "time", "and", "effort", "in", "the", "areas", "of", "production", "and", "quality", "control.", "<tag2>", "To", "maintain", "compliance", "with", "cGMP,", "manufacturers", "must", "expend", "funds,", "time", "and", "effort", "in", "the", "areas", "of", "production", "and", "quality", "control.", "<tag3>"], "wordsA": ["In", "order", "to", "ensure", "full", "technical", "compliance", "with", "such", "practices,", "manufacturers", "must", "expend", "funds,", "time", "and", "effort", "in", "the", "areas", "of", "production", "and", "quality", "control."], "wordsB": ["To", "maintain", "compliance", "with", "cGMP,", "manufacturers", "must", "expend", "funds,", "time", "and", "effort", "in", "the", "areas", "of", "production", "and", "quality", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01315401867032051, 0.07223270833492279, 0.11149459332227707, 0.101425901055336, 0.9248307347297668, 0.04440728574991226, 0.0123737882822752, 0.03559955209493637, 0.024728266522288322, 0.007192357908934355, 0.010990146547555923, 0.009817508980631828, 0.004965971689671278, 0.006042614579200745, 0.012114393524825573, 0.006658247206360102, 0.011715292930603027, 0.007506099995225668, 0.010924763046205044, 0.012128313072025776, -1]}
{"idB": "749647_16_item1_p136_s3", "idA": "749647_15_item1_p133_s0", "sentA": "The FDA has the authority to require the recall of our products in the event of material deficiencies or defects in manufacture.", "sentB": "The FDA also has the authority to require the recall of our products in the event of material deficiencies or defects in manufacture.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture.", "<tag2>", "The", "FDA", "also", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture.", "<tag3>"], "wordsA": ["The", "FDA", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture."], "wordsB": ["The", "FDA", "also", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027719903737306595, 0.30093568563461304, 0.18876177072525024, 0.07696879655122757, 0.02508731558918953, 0.15418456494808197, 0.05869527906179428, 0.15330806374549866, 0.06466822326183319, 0.578946053981781, 0.20627355575561523, 0.22990475594997406, 0.49131137132644653, 0.10046353191137314, 0.05468698963522911, 0.10279534012079239, 0.05195815488696098, 0.09685956686735153, 0.12271787226200104, 0.03883088752627373, 0.08901229500770569, 0.042894311249256134, 0.07593587040901184, -1]}
{"idB": "749647_16_item1_p136_s2", "idA": "749647_15_item1_p135_s2", "sentA": "The FDA can impose other post-marketing controls on us as well as our products including, but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise.", "sentB": "The FDA can also impose other post-marketing controls on us as well as our products including, but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise.", "type": 2, "words": ["<tag1>", "The", "FDA", "can", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise.", "<tag2>", "The", "FDA", "can", "also", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise.", "<tag3>"], "wordsA": ["The", "FDA", "can", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise."], "wordsB": ["The", "FDA", "can", "also", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.041000887751579285, 0.5235543251037598, 0.2097204029560089, 0.2388201802968979, 0.17932285368442535, 0.08059269934892654, 0.11611547321081161, 0.15429118275642395, 0.14605002105236053, 0.31397515535354614, 0.07969062030315399, 0.0678883045911789, 0.07100972533226013, 0.05932885780930519, 0.10673486441373825, 0.08210275322198868, 0.06757555156946182, 0.11368521302938461, 0.14247801899909973, 0.04634270444512367, 0.08973214030265808, 0.0621245913207531, 0.0983017086982727, 0.06812332570552826, 0.10740332305431366, 0.0470673069357872, 0.03608032688498497, 0.09725727140903473, 0.09554451704025269, 0.07133156061172485, 0.0551321804523468, 0.05290357023477554, -1]}
{"idB": "749647_16_item1_p14_s0", "idA": "749647_15_item1_p13_s0", "sentA": "Following the announcement of the HEAT Study results, we continue to follow patients for overall survival (OS), the secondary endpoint of the HEAT Study, on a quarterly basis.", "sentB": "Following the announcement of the HEAT Study results, we have continued to follow patients for Overall Survival (OS), the secondary endpoint of the HEAT Study.", "type": 2, "words": ["<tag1>", "Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "continue", "to", "follow", "patients", "for", "overall", "survival", "(OS),", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study,", "on", "a", "quarterly", "basis.", "<tag2>", "Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "have", "continued", "to", "follow", "patients", "for", "Overall", "Survival", "(OS),", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "continue", "to", "follow", "patients", "for", "overall", "survival", "(OS),", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study,", "on", "a", "quarterly", "basis."], "wordsB": ["Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "have", "continued", "to", "follow", "patients", "for", "Overall", "Survival", "(OS),", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02001003734767437, 0.005547830369323492, 0.036129795014858246, 0.00495503144338727, 0.004563383758068085, 0.06319881230592728, 0.03049597516655922, 0.03584032133221626, 0.04426083713769913, 0.056629810482263565, 0.5203776359558105, 0.16969674825668335, 0.6022412180900574, 0.200065016746521, 0.012374433688819408, 0.042134564369916916, 0.03676696494221687, 0.14530247449874878, 0.008002222515642643, 0.05952112004160881, 0.019494062289595604, 0.003941067028790712, 0.005711092613637447, 0.04069597274065018, 0.039514195173978806, -1]}
{"idB": "749647_16_item1_p14_s1", "idA": "749647_15_item1_p13_s1", "sentA": "We have conducted a comprehensive analysis of the data from the HEAT Study to assess the future strategic value of ThermoDox .", "sentB": "We have conducted a comprehensive analysis of the data from the HEAT Study to assess the future strategic value and development strategy for ThermoDox .", "type": 2, "words": ["<tag1>", "We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "and", "development", "strategy", "for", "ThermoDox", ".", "<tag3>"], "wordsA": ["We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "and", "development", "strategy", "for", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06949208676815033, 0.0427471287548542, 0.06620407849550247, 0.01821277104318142, 0.06719503551721573, 0.09307771921157837, 0.039170145988464355, 0.030474144965410233, 0.238039031624794, 0.032309308648109436, 0.017418377101421356, 0.15926045179367065, 0.15250812470912933, 0.022974371910095215, 0.05280275270342827, 0.017547840252518654, 0.058355871587991714, 0.10618682205677032, 0.11061534285545349, 0.03921690210700035, 0.5188170671463013, 0.3349530100822449, 0.10403136163949966, 0.20572932064533234, 0.00022345257457345724, -1]}
{"idB": "749647_16_item1_p124_s1", "idA": "749647_15_item1_p148_s0", "sentA": "Mergers and acquisitions in the pharmaceutical industry may result in even more resources being concentrated among our competitors.", "sentB": "Failure to comply with the applicable FDA requirements at any time pre- or post-approval may result in a delay of approval or administrative or judicial sanctions.", "type": 2, "words": ["<tag1>", "Mergers", "and", "acquisitions", "in", "the", "pharmaceutical", "industry", "may", "result", "in", "even", "more", "resources", "being", "concentrated", "among", "our", "competitors.", "<tag2>", "Failure", "to", "comply", "with", "the", "applicable", "FDA", "requirements", "at", "any", "time", "pre-", "or", "post-approval", "may", "result", "in", "a", "delay", "of", "approval", "or", "administrative", "or", "judicial", "sanctions.", "<tag3>"], "wordsA": ["Mergers", "and", "acquisitions", "in", "the", "pharmaceutical", "industry", "may", "result", "in", "even", "more", "resources", "being", "concentrated", "among", "our", "competitors."], "wordsB": ["Failure", "to", "comply", "with", "the", "applicable", "FDA", "requirements", "at", "any", "time", "pre-", "or", "post-approval", "may", "result", "in", "a", "delay", "of", "approval", "or", "administrative", "or", "judicial", "sanctions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.36028844118118286, 0.3324812352657318, 0.40344250202178955, 0.14775733649730682, 0.048526886850595474, 0.10644466429948807, 0.26711925864219666, 0.2656797468662262, 0.008344553411006927, 0.015582630410790443, 0.02431739680469036, 0.17737610638141632, 0.05729244276881218, 0.3202610909938812, 0.006406242959201336, 0.00833147019147873, 0.009307642467319965, 0.012000145390629768, 0.15724563598632812, 0.0805988535284996, 0.18770760297775269, 0.011066303588449955, 0.05379246175289154, 0.024509631097316742, 0.12678468227386475, 0.20550401508808136, -1]}
{"idB": "749647_16_item1_p152_s0", "idA": "749647_15_item1_p149_s0", "sentA": "Although there are many drugs and devices marketed and under development for the treatment of cancer, the Company is not aware of any other heat activated drug delivery product either being marketed or in human clinical development.", "sentB": "ThermoDox Although there are many drugs and devices marketed and under development for the treatment of cancer, the Company is not aware of any other heat activated drug delivery product either being marketed or in human clinical development.", "type": 2, "words": ["<tag1>", "Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development.", "<tag2>", "ThermoDox", "Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development.", "<tag3>"], "wordsA": ["Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development."], "wordsB": ["ThermoDox", "Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.9862608313560486, 0.008232280611991882, 0.001834517577663064, 0.0019947553519159555, 0.003366190241649747, 0.004901989828795195, 0.0020557655952870846, 0.0028461988549679518, 0.0027019791305065155, 0.0023325798101723194, 0.0022348708007484674, 0.0027741400990635157, 0.0017962517449632287, 0.0017423334065824747, 0.002667611464858055, 0.0018044173484668136, 0.0025369133800268173, 0.0020609323401004076, 0.010589931160211563, 0.015357502736151218, 0.0687902644276619, 0.05026990547776222, 0.004924472887068987, 0.006506386678665876, 0.008137568831443787, 0.0066229612566530704, 0.01094180066138506, 0.010870497673749924, 0.004008817486464977, 0.006504272576421499, 0.004036762285977602, 0.003608760191127658, 0.004040492232888937, 0.002382576232776046, 0.0019436420407146215, 0.0028246266301721334, 0.0027545359916985035, 0.0035996073856949806, -1]}
{"idB": "749647_16_item1_p152_s1", "idA": "749647_15_item1_p149_s0", "sentA": "Although there are many drugs and devices marketed and under development for the treatment of cancer, the Company is not aware of any other heat activated drug delivery product either being marketed or in human clinical development.", "sentB": "In addition, the Company is not aware of any other Phase III clinical trial for the treatment of HCC or primary liver cancer.", "type": 2, "words": ["<tag1>", "Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development.", "<tag2>", "In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development."], "wordsB": ["In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012572702020406723, 0.017701350152492523, 0.0038806037046015263, 0.04296902194619179, 0.0341288298368454, 0.19863711297512054, 0.22150100767612457, 0.02946677803993225, 0.03583294525742531, 0.04115794226527214, 0.1269807368516922, 0.26060962677001953, 0.13107310235500336, 0.1749286651611328, 0.021318290382623672, 0.014587758108973503, 0.09129588305950165, 0.05287624150514603, 0.6583651304244995, 0.1219353973865509, 0.4629025161266327, 0.6583343148231506, 0.5888993740081787, -1]}
{"idB": "749647_16_item1_p102_s2", "idA": "749647_15_item1_p14_s0", "sentA": "The data from the HEAT Study post-hoc analysis suggest that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their lesions undergo a 45 minute RFA procedure standardized for a lesion greater than 3 cm in diameter.", "sentB": "Results from the comprehensive preclinical studies showed that GEN-1 when combined with Avastin and Doxil , standard of care for platinum resistant patients, indicated a greater than 98% reduction in tumor burden when compared to the untreated control group.", "type": 2, "words": ["<tag1>", "The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter.", "<tag2>", "Results", "from", "the", "comprehensive", "preclinical", "studies", "showed", "that", "GEN-1", "when", "combined", "with", "Avastin", "and", "Doxil", ",", "standard", "of", "care", "for", "platinum", "resistant", "patients,", "indicated", "a", "greater", "than", "98%", "reduction", "in", "tumor", "burden", "when", "compared", "to", "the", "untreated", "control", "group.", "<tag3>"], "wordsA": ["The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter."], "wordsB": ["Results", "from", "the", "comprehensive", "preclinical", "studies", "showed", "that", "GEN-1", "when", "combined", "with", "Avastin", "and", "Doxil", ",", "standard", "of", "care", "for", "platinum", "resistant", "patients,", "indicated", "a", "greater", "than", "98%", "reduction", "in", "tumor", "burden", "when", "compared", "to", "the", "untreated", "control", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04726385697722435, 0.006029054522514343, 0.00396945234388113, 0.05527486279606819, 0.32974234223365784, 0.1529514342546463, 0.02216952294111252, 0.010774779133498669, 0.29907816648483276, 0.009932591579854488, 0.033773671835660934, 0.026423607021570206, 0.28579211235046387, 0.06668493151664734, 0.3378608822822571, 5.1102008001180366e-05, 0.024892639368772507, 0.016552206128835678, 0.02382291667163372, 0.0054528298787772655, 0.057926569133996964, 0.03463122621178627, 0.04241085797548294, 0.028674205765128136, 0.021935123950242996, 0.3514576554298401, 0.25187912583351135, 0.370665580034256, 0.5765849947929382, 0.2551659643650055, 0.410297691822052, 0.40337541699409485, 0.004486369900405407, 0.008781760931015015, 0.0046853236854076385, 0.004415522795170546, 0.2606605887413025, 0.02239665761590004, 0.03916720300912857, -1]}
{"idB": "749647_16_item1_p15_s0", "idA": "749647_15_item1_p14_s0", "sentA": "The data from the HEAT Study post-hoc analysis suggest that ThermoDox may substantially improve overall survival, when compared to the control group, in patients if their lesions undergo a 45 minute RFA procedure standardized for a lesion greater than 3 cm in diameter.", "sentB": "Findings from the HEAT Study post-hoc data analysis suggest that ThermoDox may substantially improve Overall Survival, when compared to the control group, in patients if their lesions undergo a 45 minute RFA procedure standardized for a lesion greater than 3 cm in diameter.", "type": 2, "words": ["<tag1>", "The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter.", "<tag2>", "Findings", "from", "the", "HEAT", "Study", "post-hoc", "data", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "Overall", "Survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter.", "<tag3>"], "wordsA": ["The", "data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter."], "wordsB": ["Findings", "from", "the", "HEAT", "Study", "post-hoc", "data", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "Overall", "Survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10055311769247055, 0.021846268326044083, 0.01824541762471199, 0.04536544531583786, 0.031958356499671936, 0.035370927304029465, 0.03768223896622658, 0.04217332601547241, 0.035064492374658585, 0.030049316585063934, 0.17896947264671326, 0.03833853453397751, 0.06322453916072845, 0.0542452335357666, 0.07801077514886856, 0.08943761140108109, 0.03195176273584366, 0.030506085604429245, 0.06826077401638031, 0.04328377917408943, 0.11916562914848328, 0.1162506714463234, 0.016338717192411423, 0.03756382316350937, 0.030287697911262512, 0.025280263274908066, 0.07440618425607681, 0.027062902227044106, 0.027773775160312653, 0.05953321233391762, 0.04159307852387428, 0.03675955906510353, 0.029120130464434624, 0.02881021983921528, 0.021473020315170288, 0.022251509130001068, 0.04425393417477608, 0.44751811027526855, 0.2623552680015564, 0.14861778914928436, 0.14770710468292236, 0.0611068494617939, 0.0705944150686264, -1]}
{"idB": "749647_16_item1_p153_s0", "idA": "749647_15_item1_p150_s0", "sentA": "GEN-1 s studied indications include ovarian cancer and glioblastoma multiforme (GBM) brain cancer.", "sentB": "GEN-1 Studied indications for GEN-1 include ovarian cancer and glioblastoma multiforme (GBM) brain cancer.", "type": 2, "words": ["<tag1>", "GEN-1", "s", "studied", "indications", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer.", "<tag2>", "GEN-1", "Studied", "indications", "for", "GEN-1", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer.", "<tag3>"], "wordsA": ["GEN-1", "s", "studied", "indications", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer."], "wordsB": ["GEN-1", "Studied", "indications", "for", "GEN-1", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6701681017875671, 0.21904660761356354, 0.3076203763484955, 0.011065458878874779, 0.05710941180586815, 0.01851649209856987, 0.08708890527486801, 0.05254029482603073, 0.0062763020396232605, 0.09240066260099411, 0.032614123076200485, 0.07598710060119629, 0.014620010741055012, 0.03710765391588211, -1]}
{"idB": "749647_16_item1_p29_s0", "idA": "749647_15_item1_p152_s1", "sentA": "To support these cases, we have conducted clinical studies in combination with chemotherapy for ovarian cancer, and preclinical studies in combination with both temozolomide and Bevacizumab-Avastin .", "sentB": "In two preclinical studies using an animal model of disseminated ovarian cancer, GEN-1 in combination with Avastin led to a significant reduction in tumor burden and disease progression.", "type": 2, "words": ["<tag1>", "To", "support", "these", "cases,", "we", "have", "conducted", "clinical", "studies", "in", "combination", "with", "chemotherapy", "for", "ovarian", "cancer,", "and", "preclinical", "studies", "in", "combination", "with", "both", "temozolomide", "and", "Bevacizumab-Avastin", ".", "<tag2>", "In", "two", "preclinical", "studies", "using", "an", "animal", "model", "of", "disseminated", "ovarian", "cancer,", "GEN-1", "in", "combination", "with", "Avastin", "led", "to", "a", "significant", "reduction", "in", "tumor", "burden", "and", "disease", "progression.", "<tag3>"], "wordsA": ["To", "support", "these", "cases,", "we", "have", "conducted", "clinical", "studies", "in", "combination", "with", "chemotherapy", "for", "ovarian", "cancer,", "and", "preclinical", "studies", "in", "combination", "with", "both", "temozolomide", "and", "Bevacizumab-Avastin", "."], "wordsB": ["In", "two", "preclinical", "studies", "using", "an", "animal", "model", "of", "disseminated", "ovarian", "cancer,", "GEN-1", "in", "combination", "with", "Avastin", "led", "to", "a", "significant", "reduction", "in", "tumor", "burden", "and", "disease", "progression."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007584864739328623, 0.08515564352273941, 0.05924500524997711, 0.13079755008220673, 0.023419102653861046, 0.01476726122200489, 0.29965001344680786, 0.2526419460773468, 0.0176232997328043, 0.2611123323440552, 0.1351262480020523, 0.15011215209960938, 0.34264570474624634, 0.018779385834932327, 0.020596547052264214, 0.014598456211388111, 0.014805230312049389, 0.030030546709895134, 0.013837321661412716, 0.016985779628157616, 0.08138459175825119, 0.3580462634563446, 0.06738772243261337, 0.21332688629627228, 0.21748609840869904, 0.03370288759469986, 0.10253578424453735, 0.0726860761642456, -1]}
{"idB": "749647_16_item1_p98_s0", "idA": "749647_15_item1_p152_s1", "sentA": "To support these cases, we have conducted clinical studies in combination with chemotherapy for ovarian cancer, and preclinical studies in combination with both temozolomide and Bevacizumab-Avastin .", "sentB": "In two preclinical studies using an animal model of disseminated ovarian cancer, GEN-1 in combination with Avastin led to a significant reduction in tumor burden and disease progression.", "type": 2, "words": ["<tag1>", "To", "support", "these", "cases,", "we", "have", "conducted", "clinical", "studies", "in", "combination", "with", "chemotherapy", "for", "ovarian", "cancer,", "and", "preclinical", "studies", "in", "combination", "with", "both", "temozolomide", "and", "Bevacizumab-Avastin", ".", "<tag2>", "In", "two", "preclinical", "studies", "using", "an", "animal", "model", "of", "disseminated", "ovarian", "cancer,", "GEN-1", "in", "combination", "with", "Avastin", "led", "to", "a", "significant", "reduction", "in", "tumor", "burden", "and", "disease", "progression.", "<tag3>"], "wordsA": ["To", "support", "these", "cases,", "we", "have", "conducted", "clinical", "studies", "in", "combination", "with", "chemotherapy", "for", "ovarian", "cancer,", "and", "preclinical", "studies", "in", "combination", "with", "both", "temozolomide", "and", "Bevacizumab-Avastin", "."], "wordsB": ["In", "two", "preclinical", "studies", "using", "an", "animal", "model", "of", "disseminated", "ovarian", "cancer,", "GEN-1", "in", "combination", "with", "Avastin", "led", "to", "a", "significant", "reduction", "in", "tumor", "burden", "and", "disease", "progression."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007584864739328623, 0.08515564352273941, 0.05924500524997711, 0.13079755008220673, 0.023419102653861046, 0.01476726122200489, 0.29965001344680786, 0.2526419460773468, 0.0176232997328043, 0.2611123323440552, 0.1351262480020523, 0.15011215209960938, 0.34264570474624634, 0.018779385834932327, 0.020596547052264214, 0.014598456211388111, 0.014805230312049389, 0.030030546709895134, 0.013837321661412716, 0.016985779628157616, 0.08138459175825119, 0.3580462634563446, 0.06738772243261337, 0.21332688629627228, 0.21748609840869904, 0.03370288759469986, 0.10253578424453735, 0.0726860761642456, -1]}
{"idB": "749647_16_item1_p154_s2", "idA": "749647_15_item1_p152_s2", "sentA": "We plan to initiate clinical studies in the second half of 2015 for both indications.", "sentB": "We plan to initiate a clinical study in platinum resistant ovarian cancer in the second half of 2016.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "initiate", "clinical", "studies", "in", "the", "second", "half", "of", "2015", "for", "both", "indications.", "<tag2>", "We", "plan", "to", "initiate", "a", "clinical", "study", "in", "platinum", "resistant", "ovarian", "cancer", "in", "the", "second", "half", "of", "2016.", "<tag3>"], "wordsA": ["We", "plan", "to", "initiate", "clinical", "studies", "in", "the", "second", "half", "of", "2015", "for", "both", "indications."], "wordsB": ["We", "plan", "to", "initiate", "a", "clinical", "study", "in", "platinum", "resistant", "ovarian", "cancer", "in", "the", "second", "half", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005399842280894518, 0.007421460468322039, 0.0033767633140087128, 0.0113685242831707, 0.00467631546780467, 0.02527395822107792, 0.06282610446214676, 0.06948242336511612, 0.6261608600616455, 0.5216663479804993, 0.818054735660553, 0.7999696135520935, 0.006190947722643614, 0.004679929465055466, 0.012521056458353996, 0.02151646837592125, 0.024321526288986206, 0.9206256866455078, -1]}
{"idB": "749647_16_item1_p155_s0", "idA": "749647_15_item1_p153_s0", "sentA": "In 1999, we entered into a license agreement with Duke University under which we received exclusive rights, subject to certain exceptions, to commercialize and use Duke s thermo-liposome technology.", "sentB": "Duke University License Agreement In 1999, we entered into a license agreement with Duke University under which we received exclusive rights, subject to certain exceptions, to commercialize and use Duke s thermo-liposome technology.", "type": 2, "words": ["<tag1>", "In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag2>", "Duke", "University", "License", "Agreement", "In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag3>"], "wordsA": ["In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "wordsB": ["Duke", "University", "License", "Agreement", "In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8564388751983643, 0.5338780283927917, 0.5245493054389954, 0.37892475724220276, 0.188210591673851, 0.14770318567752838, 0.08818672597408295, 0.0909247174859047, 0.004298693500459194, 0.03879312425851822, 0.16823332011699677, 0.17132870852947235, 0.06924569606781006, 0.34957289695739746, 0.1790177971124649, 0.07337966561317444, 0.03847290948033333, 0.05427761375904083, 0.11711831390857697, 0.21993747353553772, 0.1555788516998291, 0.06058717519044876, 0.04708268865942955, 0.10658767819404602, 0.15496011078357697, 0.04935552924871445, 0.12357853353023529, 0.03905981779098511, 0.08204591274261475, 0.2984200716018677, 0.1785994917154312, 0.15552359819412231, 0.14323565363883972, -1]}
{"idB": "749647_16_item1_p135_s0", "idA": "749647_15_item1_p155_s0", "sentA": "In conjunction with the patent holder, we have filed international applications for a certain number of the United States patents.", "sentB": "The FDCA provides a five-year period of non-patent data exclusivity within the United States to the first applicant to gain approval of an NDA for a new chemical entity.", "type": 2, "words": ["<tag1>", "In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "United", "States", "patents.", "<tag2>", "The", "FDCA", "provides", "a", "five-year", "period", "of", "non-patent", "data", "exclusivity", "within", "the", "United", "States", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "a", "new", "chemical", "entity.", "<tag3>"], "wordsA": ["In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "United", "States", "patents."], "wordsB": ["The", "FDCA", "provides", "a", "five-year", "period", "of", "non-patent", "data", "exclusivity", "within", "the", "United", "States", "to", "the", "first", "applicant", "to", "gain", "approval", "of", "an", "NDA", "for", "a", "new", "chemical", "entity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010235749185085297, 0.17007634043693542, 0.08183270692825317, 0.022474566474556923, 0.11168138682842255, 0.12141196429729462, 0.06551854312419891, 0.8508756756782532, 0.40062639117240906, 0.31420111656188965, 0.013685897924005985, 0.009773866273462772, 0.020406080409884453, 0.028372274711728096, 0.007635082583874464, 0.005539993289858103, 0.02596219629049301, 0.08008230477571487, 0.006146455183625221, 0.010256842710077763, 0.0272970050573349, 0.005372027866542339, 0.006199350580573082, 0.037847813218832016, 0.004475160036236048, 0.004098440054804087, 0.007932453416287899, 0.01616710238158703, 0.014895759522914886, -1]}
{"idB": "749647_16_item1_p159_s0", "idA": "749647_15_item1_p157_s1", "sentA": "Celsion holds an exclusive license agreement with Duke University for its temperature-sensitive liposome technology that covers the ThermoDox formulation.", "sentB": "Patents and Proprietary Rights Celsion holds an exclusive license agreement with Duke University for its temperature-sensitive liposome technology that covers the ThermoDox formulation.", "type": 2, "words": ["<tag1>", "Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation.", "<tag2>", "Patents", "and", "Proprietary", "Rights", "Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation.", "<tag3>"], "wordsA": ["Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation."], "wordsB": ["Patents", "and", "Proprietary", "Rights", "Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8900671601295471, 0.1621936708688736, 0.6523550748825073, 0.7325291037559509, 0.015512187965214252, 0.01048116572201252, 0.00426171999424696, 0.020129568874835968, 0.02123279869556427, 0.017282819375395775, 0.007692086510360241, 0.03098027966916561, 0.02520511858165264, 0.004806984681636095, 0.0038944468833506107, 0.010792250744998455, 0.011851483955979347, 0.008099187165498734, 0.004888334311544895, 0.008522311225533485, 0.004123768303543329, 0.0148429274559021, 0.021713873371481895, -1]}
{"idB": "749647_16_item1_p93_s0", "idA": "749647_15_item1_p157_s2", "sentA": "Celsion s newly issued patents pertain specifically to methods of storing stabilized, temperature-sensitive liposomal formulations and will assist in the protection of global rights.", "sentB": "These extensive mechanistic studies will assist in the design of novel combination approaches with immunotherapies and other anti-cancer agents driven by potential synergistic action mechanisms, and define an enhanced patient population based on molecular characteristics inherent to tumor tissue or the immune system.", "type": 2, "words": ["<tag1>", "Celsion", "s", "newly", "issued", "patents", "pertain", "specifically", "to", "methods", "of", "storing", "stabilized,", "temperature-sensitive", "liposomal", "formulations", "and", "will", "assist", "in", "the", "protection", "of", "global", "rights.", "<tag2>", "These", "extensive", "mechanistic", "studies", "will", "assist", "in", "the", "design", "of", "novel", "combination", "approaches", "with", "immunotherapies", "and", "other", "anti-cancer", "agents", "driven", "by", "potential", "synergistic", "action", "mechanisms,", "and", "define", "an", "enhanced", "patient", "population", "based", "on", "molecular", "characteristics", "inherent", "to", "tumor", "tissue", "or", "the", "immune", "system.", "<tag3>"], "wordsA": ["Celsion", "s", "newly", "issued", "patents", "pertain", "specifically", "to", "methods", "of", "storing", "stabilized,", "temperature-sensitive", "liposomal", "formulations", "and", "will", "assist", "in", "the", "protection", "of", "global", "rights."], "wordsB": ["These", "extensive", "mechanistic", "studies", "will", "assist", "in", "the", "design", "of", "novel", "combination", "approaches", "with", "immunotherapies", "and", "other", "anti-cancer", "agents", "driven", "by", "potential", "synergistic", "action", "mechanisms,", "and", "define", "an", "enhanced", "patient", "population", "based", "on", "molecular", "characteristics", "inherent", "to", "tumor", "tissue", "or", "the", "immune", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012105939909815788, 0.08643375337123871, 0.4564204514026642, 0.4935762286186218, 0.007610437925904989, 0.01556732039898634, 0.0065858084708452225, 0.008811600506305695, 0.03844638913869858, 0.011634709313511848, 0.05456152930855751, 0.1762026846408844, 0.1810842603445053, 0.019492384046316147, 0.2676582634449005, 0.016140304505825043, 0.017956452444195747, 0.2538204491138458, 0.19152115285396576, 0.0004788620281033218, 0.003246659180149436, 0.006469393149018288, 0.017362399026751518, 0.02875611186027527, 0.022184118628501892, 0.000524593866430223, 0.025056440383195877, 0.007292549591511488, 0.04371146857738495, 0.23009635508060455, 0.09533219039440155, 0.005066034849733114, 0.005209098570048809, 0.03933877497911453, 0.055437956005334854, 0.026749948039650917, 0.0148796821013093, 0.10752130299806595, 0.11645354330539703, 0.045806944370269775, 0.021894613280892372, 0.09562492370605469, 0.17117735743522644, -1]}
{"idB": "749647_16_item1_p160_s0", "idA": "749647_15_item1_p158_s0", "sentA": "For the ThermoDox technology, we either exclusively license or own US and international patents with claims and methods and compositions of matters that cover various aspects of LTSL technology, with expiration dates ranging from 2019 to 2026.", "sentB": "For the ThermoDox technology, we either exclusively license or own US and international patents with claims and methods and compositions of matters that cover various aspects of lysolipid thermally-sensitive liposomes technology, with expiration dates ranging from 2019 to 2026.", "type": 2, "words": ["<tag1>", "For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "US", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "LTSL", "technology,", "with", "expiration", "dates", "ranging", "from", "2019", "to", "2026.", "<tag2>", "For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "US", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "lysolipid", "thermally-sensitive", "liposomes", "technology,", "with", "expiration", "dates", "ranging", "from", "2019", "to", "2026.", "<tag3>"], "wordsA": ["For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "US", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "LTSL", "technology,", "with", "expiration", "dates", "ranging", "from", "2019", "to", "2026."], "wordsB": ["For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "US", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "lysolipid", "thermally-sensitive", "liposomes", "technology,", "with", "expiration", "dates", "ranging", "from", "2019", "to", "2026."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003374979365617037, 0.0019745936151593924, 0.008645404130220413, 0.006672185845673084, 0.0032279505394399166, 0.00500937644392252, 0.004882597364485264, 0.003841390833258629, 0.004595889709889889, 0.003830981906503439, 0.0029446992557495832, 0.0029278546571731567, 0.0025834732223302126, 0.003685099771246314, 0.002777634421363473, 0.0027432304341346025, 0.0026855769101530313, 0.002509254729375243, 0.0025484785437583923, 0.002546291798353195, 0.0019966443069279194, 0.0030307976994663477, 0.002390845911577344, 0.005628853105008602, 0.0041810800321400166, 0.009399828501045704, 0.013258244842290878, 0.8738673329353333, 0.7566779851913452, 0.892510712146759, 0.10106004029512405, 0.0028780056163668633, 0.003618532558903098, 0.0038242656737565994, 0.0032992279157042503, 0.003830945584923029, 0.004116826690733433, 0.004505543038249016, 0.0042814575135707855, -1]}
{"idB": "749647_16_item1_p15_s1", "idA": "749647_15_item1_p15_s0", "sentA": "Data from seven OS sweeps have been conducted since the top line PFS data from the HEAT Study were announced in January 2013, with each data set showing progressive improvement in statistical significance.", "sentB": "Data from eight OS sweeps have been conducted since the top line PFS data from the HEAT Study were announced in January 2013, with each data set showing progressive improvement in statistical significance.", "type": 2, "words": ["<tag1>", "Data", "from", "seven", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag2>", "Data", "from", "eight", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag3>"], "wordsA": ["Data", "from", "seven", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "showing", "progressive", "improvement", "in", "statistical", "significance."], "wordsB": ["Data", "from", "eight", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "showing", "progressive", "improvement", "in", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02217758633196354, 0.008946473710238934, 0.993857204914093, 0.22178587317466736, 0.11529822647571564, 0.0014711580006405711, 0.0013654263457283378, 0.002478859620168805, 0.001623999560251832, 0.001329287071712315, 0.0027163284830749035, 0.0026532462798058987, 0.0041717104613780975, 0.0032363031059503555, 0.0013796074781566858, 0.0013619207311421633, 0.0033625811338424683, 0.002927677007392049, 0.0012161319609731436, 0.0020330504048615694, 0.001525182742625475, 0.002241233829408884, 0.002322267508134246, 0.001408675336278975, 0.0022347664926201105, 0.005842070560902357, 0.003443916793912649, 0.0023151703644543886, 0.002477629343047738, 0.0036261016502976418, 0.001435919781215489, 0.0029195244424045086, 0.0030394154600799084, -1]}
{"idB": "749647_16_item1_p15_s2", "idA": "749647_15_item1_p15_s1", "sentA": "The most recent post-hoc OS analysis data from the HEAT Study (as of January 15, 2015) announced in February 2015 demonstrated that in a large, well bounded, subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and standardized RFA provided a 59% improvement in OS compared to optimized RFA alone.", "sentB": "The most recent post-hoc OS analysis from the HEAT Study as of July 15, 2015 showed that in a large, well bounded, subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and optimized RFA provided a 58% improvement in OS compared to optimized RFA alone.", "type": 2, "words": ["<tag1>", "The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "(as", "of", "January", "15,", "2015)", "announced", "in", "February", "2015", "demonstrated", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "standardized", "RFA", "provided", "a", "59%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag2>", "The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "as", "of", "July", "15,", "2015", "showed", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag3>"], "wordsA": ["The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "(as", "of", "January", "15,", "2015)", "announced", "in", "February", "2015", "demonstrated", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "standardized", "RFA", "provided", "a", "59%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "wordsB": ["The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "as", "of", "July", "15,", "2015", "showed", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003063273848965764, 0.005597776733338833, 0.005782600957900286, 0.007048434112221003, 0.006340351887047291, 0.009114562533795834, 0.0036365273408591747, 0.0038807494565844536, 0.008013881742954254, 0.006755309645086527, 0.003781200386583805, 0.006014353595674038, 0.7039339542388916, 0.05160823091864586, 0.02024589478969574, 0.007806272711604834, 0.004836680367588997, 0.003781593404710293, 0.004208427853882313, 0.013495557941496372, 0.013493681326508522, 0.016076121479272842, 0.009966796264052391, 0.005358279217034578, 0.008120582439005375, 0.030194604769349098, 0.01084697525948286, 0.006216948851943016, 0.0061604054644703865, 0.009775406681001186, 0.01260661892592907, 0.004200226627290249, 0.01821913756430149, 0.004921434447169304, 0.01692456379532814, 0.0043236203491687775, 0.024707764387130737, 0.015800733119249344, 0.006228679325431585, 0.00618861336261034, 0.8855321407318115, 0.04689333215355873, 0.004641061648726463, 0.013639080338180065, 0.005892389919608831, 0.004025544039905071, 0.00824902392923832, 0.01095464825630188, 0.007410733494907618, -1]}
{"idB": "749647_16_item1_p56_s1", "idA": "749647_15_item1_p15_s1", "sentA": "The most recent post-hoc OS analysis data from the HEAT Study (as of January 15, 2015) announced in February 2015 demonstrated that in a large, well bounded, subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and standardized RFA provided a 59% improvement in OS compared to optimized RFA alone.", "sentB": "The most recent post-hoc OS analysis from the HEAT Study (as of July 15, 2015 and announced on August 6, 2015) demonstrated that in a large, well bounded subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and optimized RFA provided a 58% improvement in OS compared to optimized RFA alone.", "type": 2, "words": ["<tag1>", "The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "(as", "of", "January", "15,", "2015)", "announced", "in", "February", "2015", "demonstrated", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "standardized", "RFA", "provided", "a", "59%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag2>", "The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "(as", "of", "July", "15,", "2015", "and", "announced", "on", "August", "6,", "2015)", "demonstrated", "that", "in", "a", "large,", "well", "bounded", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag3>"], "wordsA": ["The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "(as", "of", "January", "15,", "2015)", "announced", "in", "February", "2015", "demonstrated", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "standardized", "RFA", "provided", "a", "59%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "wordsB": ["The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "(as", "of", "July", "15,", "2015", "and", "announced", "on", "August", "6,", "2015)", "demonstrated", "that", "in", "a", "large,", "well", "bounded", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0025493770372122526, 0.004145769402384758, 0.004533449187874794, 0.004785971250385046, 0.005079872440546751, 0.007918311282992363, 0.0029354847501963377, 0.0030127959325909615, 0.005557822994887829, 0.005075768101960421, 0.004672641400247812, 0.005573269445449114, 0.4062808156013489, 0.023420004174113274, 0.009023546241223812, 0.006506713107228279, 0.006236008834093809, 0.008750664070248604, 0.784882664680481, 0.5055835843086243, 0.023560045287013054, 0.005619855597615242, 0.0038957661017775536, 0.00285281497053802, 0.0032884315587580204, 0.008767826482653618, 0.01150637585669756, 0.01519542746245861, 0.009809928014874458, 0.004055952187627554, 0.008449333719909191, 0.02172883041203022, 0.007203616201877594, 0.004089721944183111, 0.003877213690429926, 0.008872147649526596, 0.012504981830716133, 0.0031222826801240444, 0.010058967396616936, 0.0037403409369289875, 0.008796827867627144, 0.0035042595118284225, 0.005639244802296162, 0.007664684671908617, 0.0054588112980127335, 0.005000305827707052, 0.9205130934715271, 0.05637005716562271, 0.004379841033369303, 0.011987082660198212, 0.004644486121833324, 0.003368310397490859, 0.005477663595229387, 0.009069614112377167, 0.007213779259473085, -1]}
{"idB": "749647_16_item1_p15_s3", "idA": "749647_15_item1_p15_s2", "sentA": "The Hazard Ratio at this latest quarterly OS analysis is 0.628 (95% CI 0.420 - 0.939) with a p-value of 0.02.", "sentB": "The Hazard Ratio at this latest OS analysis is 0.63 (95% CI 0.43 - 0.93) with a p-value of 0.0198.", "type": 2, "words": ["<tag1>", "The", "Hazard", "Ratio", "at", "this", "latest", "quarterly", "OS", "analysis", "is", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "with", "a", "p-value", "of", "0.02.", "<tag2>", "The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.63", "(95%", "CI", "0.43", "-", "0.93)", "with", "a", "p-value", "of", "0.0198.", "<tag3>"], "wordsA": ["The", "Hazard", "Ratio", "at", "this", "latest", "quarterly", "OS", "analysis", "is", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "with", "a", "p-value", "of", "0.02."], "wordsB": ["The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.63", "(95%", "CI", "0.43", "-", "0.93)", "with", "a", "p-value", "of", "0.0198."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0018923914758488536, 0.013398648239672184, 0.023521026596426964, 0.002465527504682541, 0.002266466850414872, 0.005774655845016241, 0.005589201580733061, 0.008414998650550842, 0.00615837424993515, 0.8965548872947693, 0.023906182497739792, 0.02418053150177002, 0.6659956574440002, 0.1807868629693985, 0.1628396213054657, 0.002747373888269067, 0.0025095243472605944, 0.01811113953590393, 0.0103054353967309, 0.6588374972343445, -1]}
{"idB": "749647_16_item1_p56_s2", "idA": "749647_15_item1_p15_s2", "sentA": "The Hazard Ratio at this latest quarterly OS analysis is 0.628 (95% CI 0.420 - 0.939) with a p-value of 0.02.", "sentB": "The Hazard Ratio at this latest OS analysis is 0.63 (95% CI 0.43 - 0.93) with a p-value of 0.0198.", "type": 2, "words": ["<tag1>", "The", "Hazard", "Ratio", "at", "this", "latest", "quarterly", "OS", "analysis", "is", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "with", "a", "p-value", "of", "0.02.", "<tag2>", "The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.63", "(95%", "CI", "0.43", "-", "0.93)", "with", "a", "p-value", "of", "0.0198.", "<tag3>"], "wordsA": ["The", "Hazard", "Ratio", "at", "this", "latest", "quarterly", "OS", "analysis", "is", "0.628", "(95%", "CI", "0.420", "-", "0.939)", "with", "a", "p-value", "of", "0.02."], "wordsB": ["The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.63", "(95%", "CI", "0.43", "-", "0.93)", "with", "a", "p-value", "of", "0.0198."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0018923914758488536, 0.013398648239672184, 0.023521026596426964, 0.002465527504682541, 0.002266466850414872, 0.005774655845016241, 0.005589201580733061, 0.008414998650550842, 0.00615837424993515, 0.8965548872947693, 0.023906182497739792, 0.02418053150177002, 0.6659956574440002, 0.1807868629693985, 0.1628396213054657, 0.002747373888269067, 0.0025095243472605944, 0.01811113953590393, 0.0103054353967309, 0.6588374972343445, -1]}
{"idB": "749647_16_item1_p56_s4", "idA": "749647_15_item1_p15_s3", "sentA": "These data continue to strongly suggest that ThermoDox may significantly improve overall survival compared to a RFA control in patients whose lesions undergo optimized RFA treatment for 45 minutes or more.", "sentB": "These data continue to strongly suggest that ThermoDox may significantly improve Overall Survival compared to a RFA control in patients whose lesions undergo optimized RFA treatment for 45 minutes or more as well as support the protocol for our Phase III OPTIMA Study as described below.", "type": 2, "words": ["<tag1>", "These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "overall", "survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more.", "<tag2>", "These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "Overall", "Survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below.", "<tag3>"], "wordsA": ["These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "overall", "survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more."], "wordsB": ["These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "Overall", "Survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0066699073649942875, 0.05002066120505333, 0.012938938103616238, 0.007840209640562534, 0.01632094755768776, 0.0245952308177948, 0.010920710861682892, 0.1526191085577011, 0.019532635807991028, 0.034937869757413864, 0.06442765146493912, 0.08923636376857758, 0.08114105463027954, 0.013920753262937069, 0.012064465321600437, 0.008369848132133484, 0.05110115930438042, 0.055743321776390076, 0.008522887714207172, 0.05066037178039551, 0.012051224708557129, 0.2413608878850937, 0.03286263346672058, 0.0371987521648407, 0.05466065928339958, 0.03848619759082794, 0.013868381269276142, 0.028979677706956863, 0.023878563195466995, 0.02493658848106861, 0.022962575778365135, 0.0023037493228912354, 0.013350059278309345, 0.01225960161536932, 0.10464612394571304, 0.0287433173507452, 0.08596712350845337, 0.015242078341543674, 0.01422481331974268, 0.049976203590631485, 0.08013280481100082, 0.08284225314855576, 0.07903528958559036, 0.014690679498016834, 0.02099757269024849, 0.03772430494427681, -1]}
{"idB": "749647_16_item1_p15_s4", "idA": "749647_15_item1_p15_s5", "sentA": "Median overall survival for the subgroup has not yet been reached.", "sentB": "Median overall survival has been reached in this 285 patient subgroup which translates into a 25.4 month (2.1 year) survival benefit for the ThermoDox group over the optimized RFA only group (79 months for the ThermoDox plus optimized RFA group versus 53.6 months for the optimized RFA only group).", "type": 2, "words": ["<tag1>", "Median", "overall", "survival", "for", "the", "subgroup", "has", "not", "yet", "been", "reached.", "<tag2>", "Median", "overall", "survival", "has", "been", "reached", "in", "this", "285", "patient", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "for", "the", "ThermoDox", "group", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group).", "<tag3>"], "wordsA": ["Median", "overall", "survival", "for", "the", "subgroup", "has", "not", "yet", "been", "reached."], "wordsB": ["Median", "overall", "survival", "has", "been", "reached", "in", "this", "285", "patient", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "for", "the", "ThermoDox", "group", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023579981178045273, 0.034964729100465775, 0.052821896970272064, 0.17112238705158234, 0.21398359537124634, 0.3194356858730316, 0.014460908249020576, 0.010771435685455799, 0.07611872255802155, 0.08629625290632248, 0.056199248880147934, 0.00011496220395201817, 0.06763210892677307, 0.025278793647885323, 0.010165401734411716, 0.4155745208263397, 0.18219637870788574, 0.19598694145679474, 0.15576253831386566, 0.11797959357500076, 0.05344683304429054, 0.009631932713091373, 0.007634005509316921, 0.02478596195578575, 0.05369231104850769, 0.014153817668557167, 0.007206941954791546, 0.04937869682908058, 0.029276825487613678, 0.05411503463983536, 0.053190041333436966, 0.5775235295295715, 0.2510259747505188, 0.009401800110936165, 0.006329119671136141, 0.02857300266623497, 0.10802935808897018, 0.07627084106206894, 0.045177213847637177, 0.08086705207824707, 0.17669230699539185, 0.6260192394256592, 0.42324480414390564, 0.02133343555033207, 0.010684309527277946, 0.08352291584014893, 0.06598597764968872, 0.08964015543460846, 0.08588778972625732, -1]}
{"idB": "749647_16_item1_p56_s3", "idA": "749647_15_item1_p15_s5", "sentA": "Median overall survival for the subgroup has not yet been reached.", "sentB": "Median overall survival for the ThermoDox group has been reached in this subgroup which translates into a 25.4 month (2.1 year) survival benefit over the optimized RFA only group (79 months for the ThermoDox plus optimized RFA group versus 53.6 months for the optimized RFA only group).", "type": 2, "words": ["<tag1>", "Median", "overall", "survival", "for", "the", "subgroup", "has", "not", "yet", "been", "reached.", "<tag2>", "Median", "overall", "survival", "for", "the", "ThermoDox", "group", "has", "been", "reached", "in", "this", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group).", "<tag3>"], "wordsA": ["Median", "overall", "survival", "for", "the", "subgroup", "has", "not", "yet", "been", "reached."], "wordsB": ["Median", "overall", "survival", "for", "the", "ThermoDox", "group", "has", "been", "reached", "in", "this", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023101938888430595, 0.031342390924692154, 0.0532335601747036, 0.015710432082414627, 0.02004065550863743, 0.2811625599861145, 0.1868392527103424, 0.04304104298353195, 0.04008127748966217, 0.09342624992132187, 0.008081224747002125, 0.006934577599167824, 0.02620038203895092, 0.00015762598195578903, 0.06539995968341827, 0.030861038714647293, 0.012304965406656265, 0.5397240519523621, 0.19882701337337494, 0.17810262739658356, 0.15182963013648987, 0.1351308971643448, 0.05771031975746155, 0.014142763800919056, 0.0067402697168290615, 0.046257901936769485, 0.039373405277729034, 0.047290727496147156, 0.06032612547278404, 0.5691115260124207, 0.3369658887386322, 0.011261570267379284, 0.006624950561672449, 0.025954511016607285, 0.11753275990486145, 0.07502381503582001, 0.03270760178565979, 0.05470205470919609, 0.1843734085559845, 0.5955479145050049, 0.42168548703193665, 0.019527265802025795, 0.010340891778469086, 0.07951853424310684, 0.05363941937685013, 0.059646621346473694, 0.06069484353065491, -1]}
{"idB": "749647_16_item1_p170_s0", "idA": "749647_15_item1_p169_s0", "sentA": "As of March 11, 2015, we employed 28 full-time employees.", "sentB": "As of March 29, 2016, we employed 25 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "11,", "2015,", "we", "employed", "28", "full-time", "employees.", "<tag2>", "As", "of", "March", "29,", "2016,", "we", "employed", "25", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "11,", "2015,", "we", "employed", "28", "full-time", "employees."], "wordsB": ["As", "of", "March", "29,", "2016,", "we", "employed", "25", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007875194773077965, 0.0075884656980633736, 0.1129692867398262, 0.8694755434989929, 0.5686755776405334, 0.003783512394875288, 0.03847982734441757, 0.7434475421905518, 0.10340803116559982, 0.11410783231258392, -1]}
{"idB": "749647_16_item1_p16_s0", "idA": "749647_15_item1_p16_s0", "sentA": "Data from the HEAT Study post-hoc analysis have been presented at five scientific and medical conferences in 2013 and 2014 by key HEAT Study investigators and leading liver cancer experts.", "sentB": "Findings from the HEAT Study post-hoc data have shown to be well balanced and not diminished in anyway by other factors.", "type": 2, "words": ["<tag1>", "Data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "have", "been", "presented", "at", "five", "scientific", "and", "medical", "conferences", "in", "2013", "and", "2014", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts.", "<tag2>", "Findings", "from", "the", "HEAT", "Study", "post-hoc", "data", "have", "shown", "to", "be", "well", "balanced", "and", "not", "diminished", "in", "anyway", "by", "other", "factors.", "<tag3>"], "wordsA": ["Data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "have", "been", "presented", "at", "five", "scientific", "and", "medical", "conferences", "in", "2013", "and", "2014", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts."], "wordsB": ["Findings", "from", "the", "HEAT", "Study", "post-hoc", "data", "have", "shown", "to", "be", "well", "balanced", "and", "not", "diminished", "in", "anyway", "by", "other", "factors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08789964020252228, 0.007706032134592533, 0.004872045945376158, 0.016274400055408478, 0.014756151475012302, 0.0168880857527256, 0.03157535940408707, 0.04077344387769699, 0.13886716961860657, 0.08091972023248672, 0.17790013551712036, 0.6377244591712952, 0.7876143455505371, 0.0213610902428627, 0.3607179820537567, 0.5966452360153198, 0.09294936805963516, 0.06852559000253677, 0.04494359344244003, 0.04692576080560684, 0.07289785146713257, -1]}
{"idB": "749647_16_item1_p16_s2", "idA": "749647_15_item1_p16_s0", "sentA": "Data from the HEAT Study post-hoc analysis have been presented at five scientific and medical conferences in 2013 and 2014 by key HEAT Study investigators and leading liver cancer experts.", "sentB": "These data analysis have been presented, without objection, at multiple scientific and medical conferences in 2013, 2014 and 2015 by key HEAT Study investigators and leading liver cancer experts.", "type": 2, "words": ["<tag1>", "Data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "have", "been", "presented", "at", "five", "scientific", "and", "medical", "conferences", "in", "2013", "and", "2014", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts.", "<tag2>", "These", "data", "analysis", "have", "been", "presented,", "without", "objection,", "at", "multiple", "scientific", "and", "medical", "conferences", "in", "2013,", "2014", "and", "2015", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts.", "<tag3>"], "wordsA": ["Data", "from", "the", "HEAT", "Study", "post-hoc", "analysis", "have", "been", "presented", "at", "five", "scientific", "and", "medical", "conferences", "in", "2013", "and", "2014", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts."], "wordsB": ["These", "data", "analysis", "have", "been", "presented,", "without", "objection,", "at", "multiple", "scientific", "and", "medical", "conferences", "in", "2013,", "2014", "and", "2015", "by", "key", "HEAT", "Study", "investigators", "and", "leading", "liver", "cancer", "experts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005419453606009483, 0.0702451542019844, 0.0805782899260521, 0.013281034305691719, 0.015357826836407185, 0.07162131369113922, 0.7004596590995789, 0.6013385653495789, 0.006664911285042763, 0.7066421508789062, 0.04510590434074402, 0.008981510065495968, 0.01260540820658207, 0.07332678884267807, 0.008477547205984592, 0.02529720403254032, 0.013082625344395638, 0.010351045988500118, 0.012055767700076103, 0.0038523725233972073, 0.006748015061020851, 0.010586488991975784, 0.007359036710113287, 0.011274999938905239, 0.0031371540389955044, 0.004536269698292017, 0.008667033165693283, 0.007536608260124922, 0.010487765073776245, -1]}
{"idB": "749647_16_item1_p173_s0", "idA": "749647_15_item1_p172_s0", "sentA": "During 2014 and 2013, we issued a total of 8.0 million shares of common stock; including shares of common stock issued upon conversion of the 15,000.00422 shares of Series A 0% convertible preferred stock, in the following equity transactions for an aggregate $46.6 million in gross proceeds.", "sentB": "During 2015 and 2014, we issued a total of 6.9 million shares of common stock in the following equity transactions for an aggregate $23.6 million in gross proceeds.", "type": 2, "words": ["<tag1>", "During", "2014", "and", "2013,", "we", "issued", "a", "total", "of", "8.0", "million", "shares", "of", "common", "stock;", "including", "shares", "of", "common", "stock", "issued", "upon", "conversion", "of", "the", "15,000.00422", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock,", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$46.6", "million", "in", "gross", "proceeds.", "<tag2>", "During", "2015", "and", "2014,", "we", "issued", "a", "total", "of", "6.9", "million", "shares", "of", "common", "stock", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$23.6", "million", "in", "gross", "proceeds.", "<tag3>"], "wordsA": ["During", "2014", "and", "2013,", "we", "issued", "a", "total", "of", "8.0", "million", "shares", "of", "common", "stock;", "including", "shares", "of", "common", "stock", "issued", "upon", "conversion", "of", "the", "15,000.00422", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock,", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$46.6", "million", "in", "gross", "proceeds."], "wordsB": ["During", "2015", "and", "2014,", "we", "issued", "a", "total", "of", "6.9", "million", "shares", "of", "common", "stock", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$23.6", "million", "in", "gross", "proceeds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017391156405210495, 0.9074448347091675, 0.08406630903482437, 0.029533302411437035, 0.003265886101871729, 0.010277226567268372, 0.004430663306266069, 0.012608885765075684, 0.008158343844115734, 0.8400173187255859, 0.4426644444465637, 0.20602066814899445, 0.004638661630451679, 0.013524461537599564, 0.018522178754210472, 0.002073029289022088, 0.0023721333127468824, 0.003134693019092083, 0.005594152025878429, 0.005714292172342539, 0.0029816110618412495, 0.0032700079027563334, 0.007045241072773933, 0.6432737112045288, 0.04044899344444275, 0.0023659709841012955, 0.004858145955950022, 0.005215710029006004, -1]}
{"idB": "749647_16_item1_p177_s0", "idA": "749647_15_item1_p174_s0", "sentA": "On February 1, 2013, we entered into a Controlled Equity Offering SM Sales Agreement (ATM) with Cantor Fitzgerald Co., as sales agent, pursuant to which we may offer and sell, from time to time through at-the-market offerings, shares of our common stock having an aggregate offering price of up to $25.0 million.", "sentB": "We are a party to a Controlled Equity Offering SM Sales Agreement (ATM) dated as of February 1, 2013 with Cantor Fitzgerald Co., pursuant to which we may sell additional shares of our common stock having an aggregate offering price of up to $25 million through at-the-market equity offerings from time to time.", "type": 2, "words": ["<tag1>", "On", "February", "1,", "2013,", "we", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(ATM)", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million.", "<tag2>", "We", "are", "a", "party", "to", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(ATM)", "dated", "as", "of", "February", "1,", "2013", "with", "Cantor", "Fitzgerald", "Co.,", "pursuant", "to", "which", "we", "may", "sell", "additional", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25", "million", "through", "at-the-market", "equity", "offerings", "from", "time", "to", "time.", "<tag3>"], "wordsA": ["On", "February", "1,", "2013,", "we", "entered", "into", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(ATM)", "with", "Cantor", "Fitzgerald", "Co.,", "as", "sales", "agent,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million."], "wordsB": ["We", "are", "a", "party", "to", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(ATM)", "dated", "as", "of", "February", "1,", "2013", "with", "Cantor", "Fitzgerald", "Co.,", "pursuant", "to", "which", "we", "may", "sell", "additional", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25", "million", "through", "at-the-market", "equity", "offerings", "from", "time", "to", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.19987405836582184, 0.49997711181640625, 0.3373556137084961, 0.743213951587677, 0.1547621637582779, 0.0550716407597065, 0.049801409244537354, 0.061942435801029205, 0.034332625567913055, 0.018459949642419815, 0.02408526837825775, 0.03832018002867699, 0.02752956934273243, 0.01504462119191885, 0.023402808234095573, 0.03138625994324684, 0.03855893388390541, 0.027906354516744614, 0.019755560904741287, 0.01671811006963253, 0.029571490362286568, 0.036669667810201645, 0.02756681852042675, 0.019525405019521713, 0.023038428276777267, 0.019260400906205177, 0.01677367277443409, 0.016802558675408363, 0.03568536043167114, 0.22650498151779175, 0.14666974544525146, 0.028000731021165848, 0.022625794634222984, 0.029256390407681465, 0.0401327982544899, 0.015101864002645016, 0.017049791291356087, 0.020197371020913124, 0.022785399109125137, 0.013543164357542992, 0.015516004525125027, 0.01626872830092907, 0.022150134667754173, 0.029367240145802498, 0.018747158348560333, 0.011257302947342396, 0.02116619236767292, 0.03051232546567917, 0.017072709277272224, 0.03297585994005203, 0.024749185889959335, 0.026069745421409607, 0.0212260615080595, -1]}
{"idB": "749647_16_item1_p177_s1", "idA": "749647_15_item1_p174_s1", "sentA": "From February 1, 2013 through February 25, 2013, we sold and issued an aggregate of 1,195,923 shares of common stock under such agreement for approximately $6.8 million in aggregate gross proceeds.", "sentB": "From February 1, 2013 through February 25, 2013, the Company sold and issued an aggregate of 1,195,927 shares of common stock under the ATM, receiving approximately $6.8 million in net proceeds.", "type": 2, "words": ["<tag1>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds.", "<tag2>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "an", "aggregate", "of", "1,195,927", "shares", "of", "common", "stock", "under", "the", "ATM,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds.", "<tag3>"], "wordsA": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds."], "wordsB": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "an", "aggregate", "of", "1,195,927", "shares", "of", "common", "stock", "under", "the", "ATM,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005615084897726774, 0.0035243441816419363, 0.003896336304023862, 0.003961596637964249, 0.00430368073284626, 0.0039708493277430534, 0.004326452035456896, 0.005353826098144054, 0.004287972114980221, 0.02481621317565441, 0.014044465497136116, 0.0036587147042155266, 0.007200189400464296, 0.003966789226979017, 0.011262208223342896, 0.0049193911254405975, 0.8933486342430115, 0.285081684589386, 0.009034129790961742, 0.03734000772237778, 0.03161018341779709, 0.02978130429983139, 0.03544192388653755, 0.2831245958805084, 0.03384637460112572, 0.0077422792091965675, 0.01070642750710249, 0.007516903802752495, 0.012923416681587696, 0.2598223090171814, 0.22506190836429596, -1]}
{"idB": "749647_16_item1_p177_s4", "idA": "749647_15_item1_p174_s1", "sentA": "From February 1, 2013 through February 25, 2013, we sold and issued an aggregate of 1,195,923 shares of common stock under such agreement for approximately $6.8 million in aggregate gross proceeds.", "sentB": "During the fourth quarter of 2015, the Company sold an aggregate of 283,608 shares for gross proceeds of $0.6 million.", "type": 2, "words": ["<tag1>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds.", "<tag2>", "During", "the", "fourth", "quarter", "of", "2015,", "the", "Company", "sold", "an", "aggregate", "of", "283,608", "shares", "for", "gross", "proceeds", "of", "$0.6", "million.", "<tag3>"], "wordsA": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds."], "wordsB": ["During", "the", "fourth", "quarter", "of", "2015,", "the", "Company", "sold", "an", "aggregate", "of", "283,608", "shares", "for", "gross", "proceeds", "of", "$0.6", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.034732576459646225, 0.01081982720643282, 0.18291693925857544, 0.1540534347295761, 0.2068190723657608, 0.7107380032539368, 0.004451286513358355, 0.04836370050907135, 0.060716092586517334, 0.007826389744877815, 0.029832642525434494, 0.011621678248047829, 0.5886088609695435, 0.3726457953453064, 0.002741721458733082, 0.007878085598349571, 0.008697752840816975, 0.0032029144931584597, 0.07318133860826492, 0.01654396578669548, -1]}
{"idB": "749647_16_item1_p176_s0", "idA": "749647_15_item1_p176_s0", "sentA": "On May 30, 2013, we entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which we sold, in a registered direct offering, an aggregate of 1,392,109 shares of our common stock for an aggregate purchase price of approximately $9.8 million in gross proceeds.", "sentB": "On May 27, 2015, the Company entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company sold, in a registered direct offering, an aggregate of 3,000,000 shares of common stock, for an aggregate purchase price of approximately $8.0 million.", "type": 2, "words": ["<tag1>", "On", "May", "30,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "1,392,109", "shares", "of", "our", "common", "stock", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$9.8", "million", "in", "gross", "proceeds.", "<tag2>", "On", "May", "27,", "2015,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "3,000,000", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$8.0", "million.", "<tag3>"], "wordsA": ["On", "May", "30,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "1,392,109", "shares", "of", "our", "common", "stock", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$9.8", "million", "in", "gross", "proceeds."], "wordsB": ["On", "May", "27,", "2015,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "3,000,000", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$8.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006970238406211138, 0.16038723289966583, 0.6014244556427002, 0.9321342706680298, 0.0027776737697422504, 0.02519819512963295, 0.003856876865029335, 0.002526405733078718, 0.0020472772885113955, 0.004145456477999687, 0.004355096258223057, 0.004960670135915279, 0.0018892957596108317, 0.002231205115094781, 0.004739535506814718, 0.0061476207338273525, 0.0023054673802107573, 0.0024288855493068695, 0.002275167964398861, 0.0017688651569187641, 0.00719121377915144, 0.005681304261088371, 0.0020160239655524492, 0.0019323657033964992, 0.0032322865445166826, 0.0037631497252732515, 0.004185913130640984, 0.00209891889244318, 0.005998874083161354, 0.0042195492424070835, 0.7146824598312378, 0.23143135011196136, 0.003804859472438693, 0.005027776584029198, 0.008070812560617924, 0.002376371994614601, 0.0022033322602510452, 0.00365838292054832, 0.004433146212249994, 0.00472285458818078, 0.0028383040335029364, 0.0047837961465120316, 0.13353615999221802, 0.014473158866167068, -1]}
{"idB": "749647_16_item1_p176_s1", "idA": "749647_15_item1_p178_s0", "sentA": "During 2013, we received gross proceeds of approximately $0.4 million from the exercise of warrants and common stock options to purchase 30,499 shares of common stock.", "sentB": "In a concurrent private placement, the Company issued to the same investors warrants to purchase up to 1,950,000 shares of common stock.", "type": 2, "words": ["<tag1>", "During", "2013,", "we", "received", "gross", "proceeds", "of", "approximately", "$0.4", "million", "from", "the", "exercise", "of", "warrants", "and", "common", "stock", "options", "to", "purchase", "30,499", "shares", "of", "common", "stock.", "<tag2>", "In", "a", "concurrent", "private", "placement,", "the", "Company", "issued", "to", "the", "same", "investors", "warrants", "to", "purchase", "up", "to", "1,950,000", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["During", "2013,", "we", "received", "gross", "proceeds", "of", "approximately", "$0.4", "million", "from", "the", "exercise", "of", "warrants", "and", "common", "stock", "options", "to", "purchase", "30,499", "shares", "of", "common", "stock."], "wordsB": ["In", "a", "concurrent", "private", "placement,", "the", "Company", "issued", "to", "the", "same", "investors", "warrants", "to", "purchase", "up", "to", "1,950,000", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014496507123112679, 0.013127668760716915, 0.29700061678886414, 0.38972118496894836, 0.3783319294452667, 0.004474875517189503, 0.04127580299973488, 0.041718028485774994, 0.007184452377259731, 0.008200109004974365, 0.049533769488334656, 0.08250810205936432, 0.10281063616275787, 0.004739832133054733, 0.027754083275794983, 0.05792631953954697, 0.01786516234278679, 0.47888994216918945, 0.13514220714569092, 0.006300097331404686, 0.01397212315350771, 0.019850069656968117, -1]}
{"idB": "749647_16_item1_p180_s0", "idA": "749647_15_item1_p181_s0", "sentA": "We believe that our cash and investment resources of $37.1 million on hand at December 31, 2014, coupled with our access to the ATM, are sufficient to fund operations through 2016.", "sentB": "We believe that our cash and investment resources of $20.1 million on hand at December 31, 2015, coupled with the remaining availability of $17.4 million under the ATM, are sufficient to fund operations into the second quarter of 2017.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$37.1", "million", "on", "hand", "at", "December", "31,", "2014,", "coupled", "with", "our", "access", "to", "the", "ATM,", "are", "sufficient", "to", "fund", "operations", "through", "2016.", "<tag2>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$20.1", "million", "on", "hand", "at", "December", "31,", "2015,", "coupled", "with", "the", "remaining", "availability", "of", "$17.4", "million", "under", "the", "ATM,", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "quarter", "of", "2017.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$37.1", "million", "on", "hand", "at", "December", "31,", "2014,", "coupled", "with", "our", "access", "to", "the", "ATM,", "are", "sufficient", "to", "fund", "operations", "through", "2016."], "wordsB": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$20.1", "million", "on", "hand", "at", "December", "31,", "2015,", "coupled", "with", "the", "remaining", "availability", "of", "$17.4", "million", "under", "the", "ATM,", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "quarter", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004054761957377195, 0.005930276587605476, 0.0021756761707365513, 0.0023487983271479607, 0.005891057662665844, 0.0017331814160570502, 0.0037125928793102503, 0.008114305324852467, 0.003479843959212303, 0.8516904711723328, 0.0803489163517952, 0.0025124154053628445, 0.008437070995569229, 0.0033181672915816307, 0.00929997768253088, 0.010653641074895859, 0.7193434238433838, 0.0018916261615231633, 0.0015818148385733366, 0.0036768284626305103, 0.11705299466848373, 0.10832468420267105, 0.011283908039331436, 0.446490615606308, 0.17961229383945465, 0.18566836416721344, 0.033148143440485, 0.10124923288822174, 0.0014833458699285984, 0.003826787695288658, 0.0015592684503644705, 0.004783119540661573, 0.014795198105275631, 0.12705908715724945, 0.01696985401213169, 0.10344663262367249, 0.15777570009231567, 0.23440946638584137, 0.6252387166023254, -1]}
{"idB": "749647_16_item1_p32_s3", "idA": "749647_15_item1_p183_s0", "sentA": "On January 13, 2015, we entered into an Early Access Agreement with Impatients N.V., a Netherlands company (Impatients), pursuant to which Impatients will develop and execute through its brand myTomorrows an early access program for ThermoDox in all countries of the European Union territory, Iceland, Liechtenstein, Norway and Switzerland (the Territory) for the treatment of patients with RCW breast cancer.", "sentB": "On August 10, 2015, we expanded the Early Access Program with Impatients to include patients with primary liver cancer, also known as hepatocellular carcinoma, and liver cancer metastases, in all countries of the European Union territory, Switzerland, Turkey and Israel.", "type": 2, "words": ["<tag1>", "On", "January", "13,", "2015,", "we", "entered", "into", "an", "Early", "Access", "Agreement", "with", "Impatients", "N.V.,", "a", "Netherlands", "company", "(Impatients),", "pursuant", "to", "which", "Impatients", "will", "develop", "and", "execute", "through", "its", "brand", "myTomorrows", "an", "early", "access", "program", "for", "ThermoDox", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Iceland,", "Liechtenstein,", "Norway", "and", "Switzerland", "(the", "Territory)", "for", "the", "treatment", "of", "patients", "with", "RCW", "breast", "cancer.", "<tag2>", "On", "August", "10,", "2015,", "we", "expanded", "the", "Early", "Access", "Program", "with", "Impatients", "to", "include", "patients", "with", "primary", "liver", "cancer,", "also", "known", "as", "hepatocellular", "carcinoma,", "and", "liver", "cancer", "metastases,", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Switzerland,", "Turkey", "and", "Israel.", "<tag3>"], "wordsA": ["On", "January", "13,", "2015,", "we", "entered", "into", "an", "Early", "Access", "Agreement", "with", "Impatients", "N.V.,", "a", "Netherlands", "company", "(Impatients),", "pursuant", "to", "which", "Impatients", "will", "develop", "and", "execute", "through", "its", "brand", "myTomorrows", "an", "early", "access", "program", "for", "ThermoDox", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Iceland,", "Liechtenstein,", "Norway", "and", "Switzerland", "(the", "Territory)", "for", "the", "treatment", "of", "patients", "with", "RCW", "breast", "cancer."], "wordsB": ["On", "August", "10,", "2015,", "we", "expanded", "the", "Early", "Access", "Program", "with", "Impatients", "to", "include", "patients", "with", "primary", "liver", "cancer,", "also", "known", "as", "hepatocellular", "carcinoma,", "and", "liver", "cancer", "metastases,", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Switzerland,", "Turkey", "and", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015136918984353542, 0.7355385422706604, 0.49285435676574707, 0.03689989820122719, 0.02390095219016075, 0.14460662007331848, 0.023711854591965675, 0.06776195764541626, 0.062144212424755096, 0.12076130509376526, 0.009225612506270409, 0.0260564424097538, 0.0035111811012029648, 0.022406045347452164, 0.10825204849243164, 0.055685073137283325, 0.38751477003097534, 0.526466965675354, 0.4443027079105377, 0.005230877548456192, 0.01769311912357807, 0.01670609787106514, 0.16911274194717407, 0.2719171941280365, 0.010044537484645844, 0.15298067033290863, 0.21184273064136505, 0.22706621885299683, 0.0022087711840867996, 0.007556471973657608, 0.014752144925296307, 0.0019077191827818751, 0.002101162215694785, 0.006318536587059498, 0.006480380427092314, 0.019098425284028053, 0.21714363992214203, 0.6998266577720642, 0.2706703245639801, 0.7165084481239319, -1]}
{"idB": "749647_16_item1_p17_s0", "idA": "749647_15_item1_p18_s0", "sentA": "On February 24, 2014, we announced that the U.S. Food and Drug Administration (FDA), after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox , our proprietary heat-activated liposomal encapsulation of doxorubicin in combination with RFA in primary liver cancer, also known as HCC (the OPTIMA Study).", "sentB": "On February 24, 2014, we announced that the U.S. Food and Drug Administration (FDA), after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with RFA in primary liver cancer, also known as HCC (the OPTIMA Study).", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA),", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", ",", "our", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC", "(the", "OPTIMA", "Study).", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA),", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC", "(the", "OPTIMA", "Study).", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA),", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", ",", "our", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC", "(the", "OPTIMA", "Study)."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA),", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC", "(the", "OPTIMA", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.036902204155921936, 0.046733442693948746, 0.06883121281862259, 0.042519066482782364, 0.05445887893438339, 0.06496473401784897, 0.03008994087576866, 0.020854011178016663, 0.07466307282447815, 0.03987518325448036, 0.03891361504793167, 0.0386461541056633, 0.05833642929792404, 0.09770140051841736, 0.03915542736649513, 0.026068050414323807, 0.06317280232906342, 0.04501265287399292, 0.04135903716087341, 0.030296318233013153, 0.03760891407728195, 0.03845415636897087, 0.23965805768966675, 0.11738883703947067, 0.03740473836660385, 0.03212108463048935, 0.04284099489450455, 0.039556585252285004, 0.042049989104270935, 0.06121417135000229, 0.014526319690048695, 0.048859115689992905, 0.05982096865773201, 0.041230082511901855, 0.02772303856909275, 0.024059586226940155, 0.027793483808636665, 0.028079597279429436, 0.1052304282784462, 0.026958970353007317, 0.03881927952170372, 0.03733266890048981, 0.12641742825508118, 0.020474042743444443, 0.10136166214942932, 0.05697453022003174, 0.05745285004377365, 0.026738429442048073, 0.024839526042342186, 0.024022787809371948, 0.0843067392706871, 0.022273585200309753, 0.03695476055145264, 0.025677936151623726, -1]}
{"idB": "749647_16_item1_p63_s2", "idA": "749647_15_item1_p18_s2", "sentA": "Designed with extensive input from globally recognized HCC researchers and clinicians and, after formal written consultation with the FDA, the OPTIMA Study was launched in the first half of 2014.", "sentB": "With the addition of these Chinese clinical sites, the Company expects to complete enrollment in the OPTIMA Study around the end of 2017.", "type": 2, "words": ["<tag1>", "Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and,", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014.", "<tag2>", "With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "around", "the", "end", "of", "2017.", "<tag3>"], "wordsA": ["Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and,", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014."], "wordsB": ["With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "around", "the", "end", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009914755821228027, 0.010168102569878101, 0.1007135733962059, 0.024600666016340256, 0.05153688043355942, 0.47303807735443115, 0.23950645327568054, 0.2568136155605316, 0.005458798259496689, 0.07241162657737732, 0.045074913650751114, 0.021363772451877594, 0.1393582820892334, 0.19310356676578522, 0.03745698556303978, 0.02258860506117344, 0.05003993585705757, 0.07606945186853409, 0.03402748331427574, 0.018609989434480667, 0.14283713698387146, 0.1402905136346817, 0.5739549994468689, -1]}
{"idB": "749647_16_item1_p142_s0", "idA": "749647_15_item1_p20_s2", "sentA": "We also filed a request for a Voluntary Harmonization Procedure (VHP) in Europe, which provides for the assessment of multinational clinical trial applications across several European countries, including Germany, Italy and Spain.", "sentB": "In 2014, we filed a request for a Voluntary Harmonization Procedure (VHP) in Europe for the OPTIMA Study, which provides for the assessment of multinational clinical trial applications across several European countries, including Germany, Italy and Spain.", "type": 2, "words": ["<tag1>", "We", "also", "filed", "a", "request", "for", "a", "Voluntary", "Harmonization", "Procedure", "(VHP)", "in", "Europe,", "which", "provides", "for", "the", "assessment", "of", "multinational", "clinical", "trial", "applications", "across", "several", "European", "countries,", "including", "Germany,", "Italy", "and", "Spain.", "<tag2>", "In", "2014,", "we", "filed", "a", "request", "for", "a", "Voluntary", "Harmonization", "Procedure", "(VHP)", "in", "Europe", "for", "the", "OPTIMA", "Study,", "which", "provides", "for", "the", "assessment", "of", "multinational", "clinical", "trial", "applications", "across", "several", "European", "countries,", "including", "Germany,", "Italy", "and", "Spain.", "<tag3>"], "wordsA": ["We", "also", "filed", "a", "request", "for", "a", "Voluntary", "Harmonization", "Procedure", "(VHP)", "in", "Europe,", "which", "provides", "for", "the", "assessment", "of", "multinational", "clinical", "trial", "applications", "across", "several", "European", "countries,", "including", "Germany,", "Italy", "and", "Spain."], "wordsB": ["In", "2014,", "we", "filed", "a", "request", "for", "a", "Voluntary", "Harmonization", "Procedure", "(VHP)", "in", "Europe", "for", "the", "OPTIMA", "Study,", "which", "provides", "for", "the", "assessment", "of", "multinational", "clinical", "trial", "applications", "across", "several", "European", "countries,", "including", "Germany,", "Italy", "and", "Spain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06842004507780075, 0.7258365750312805, 0.007640315219759941, 0.006490753497928381, 0.002956960815936327, 0.007470974698662758, 0.0040662470273673534, 0.0027904538437724113, 0.00548521289601922, 0.005315463989973068, 0.006385366898030043, 0.007853697054088116, 0.003080211114138365, 0.006049520336091518, 0.00537546630948782, 0.012512852437794209, 0.9451240301132202, 0.7063841223716736, 0.011719898320734501, 0.003559814766049385, 0.004504546523094177, 0.0031282310374081135, 0.0049849702045321465, 0.002658725716173649, 0.0049761272966861725, 0.004971596412360668, 0.00517270527780056, 0.0038372762501239777, 0.0028892620466649532, 0.0034332009963691235, 0.004744332749396563, 0.007088912650942802, 0.004395981319248676, 0.00809340551495552, 0.007830961607396603, 0.005203502718359232, 0.007488235365599394, -1]}
{"idB": "749647_16_item1_p20_s1", "idA": "749647_15_item1_p21_s1", "sentA": "CLSN Laboratories, Inc., a Delaware corporation and a wholly-owned subsidiary of ours (CLSN Laboratories), acquired all of EGEN s right, title and interest in and to substantially all of the assets of EGEN, including cash and cash equivalents, patents, trademarks and other intellectual property rights, clinical data, certain contracts, licenses and permits, equipment, furniture, office equipment, furnishings, supplies and other tangible personal property.", "sentB": "CLSN Laboratories, Inc., a Delaware corporation and a wholly-owned subsidiary of Celsion (CLSN Laboratories), acquired all of EGEN s right, title and interest in and to substantially all of the assets of EGEN, including cash and cash equivalents, patents, trademarks and other intellectual property rights, clinical data, certain contracts, licenses and permits, equipment, furniture, office equipment, furnishings, supplies and other tangible personal property.", "type": 2, "words": ["<tag1>", "CLSN", "Laboratories,", "Inc.,", "a", "Delaware", "corporation", "and", "a", "wholly-owned", "subsidiary", "of", "ours", "(CLSN", "Laboratories),", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property.", "<tag2>", "CLSN", "Laboratories,", "Inc.,", "a", "Delaware", "corporation", "and", "a", "wholly-owned", "subsidiary", "of", "Celsion", "(CLSN", "Laboratories),", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property.", "<tag3>"], "wordsA": ["CLSN", "Laboratories,", "Inc.,", "a", "Delaware", "corporation", "and", "a", "wholly-owned", "subsidiary", "of", "ours", "(CLSN", "Laboratories),", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property."], "wordsB": ["CLSN", "Laboratories,", "Inc.,", "a", "Delaware", "corporation", "and", "a", "wholly-owned", "subsidiary", "of", "Celsion", "(CLSN", "Laboratories),", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0546242892742157, 0.037828247994184494, 0.015401728451251984, 0.005794379394501448, 0.025169434025883675, 0.01830473355948925, 0.00866129994392395, 0.007778574246913195, 0.0366026870906353, 0.0688796192407608, 0.124661885201931, 0.9374012351036072, 0.12358776479959488, 0.04137682914733887, 0.04687122628092766, 0.041802119463682175, 0.038526393473148346, 0.03522199019789696, 0.021634278818964958, 0.026073524728417397, 0.01613609679043293, 0.01471797563135624, 0.01614607684314251, 0.011892363429069519, 0.015194213949143887, 0.011153118684887886, 0.02588721551001072, 0.0199747271835804, 0.014141062274575233, 0.016749154776334763, 0.03363921493291855, 0.012050634250044823, 0.04325591027736664, 0.013709437102079391, 0.015981273725628853, 0.012169568799436092, 0.01770150102674961, 0.015430460684001446, 0.013448663055896759, 0.0175712201744318, 0.009014492854475975, 0.009292577393352985, 0.018085744231939316, 0.016243161633610725, 0.013906635344028473, 0.012182720005512238, 0.013252120465040207, 0.012084481306374073, 0.01523442193865776, 0.013866269029676914, 0.01438402570784092, 0.01385427638888359, 0.011162367649376392, 0.012599925510585308, 0.012604101561009884, 0.011148576624691486, 0.012271663174033165, 0.012113720178604126, 0.009394991211593151, 0.009840507991611958, 0.014193934388458729, 0.013210482895374298, 0.013618838042020798, -1]}
{"idB": "749647_16_item1_p20_s4", "idA": "749647_15_item1_p21_s4", "sentA": "Additional consideration included contingent value rights totaling $30.4 million, payable in cash, shares of Celsion common stock or a combination thereof, at Celsion s option, upon acheivement of three major milestone events as follows:", "sentB": "Additional consideration included contingent value rights totaling $30.4 million, payable in cash, shares of Celsion common stock or a combination thereof, at Celsion s option, upon achievement of three major milestone events as follows:", "type": 2, "words": ["<tag1>", "Additional", "consideration", "included", "contingent", "value", "rights", "totaling", "$30.4", "million,", "payable", "in", "cash,", "shares", "of", "Celsion", "common", "stock", "or", "a", "combination", "thereof,", "at", "Celsion", "s", "option,", "upon", "acheivement", "of", "three", "major", "milestone", "events", "as", "follows:", "<tag2>", "Additional", "consideration", "included", "contingent", "value", "rights", "totaling", "$30.4", "million,", "payable", "in", "cash,", "shares", "of", "Celsion", "common", "stock", "or", "a", "combination", "thereof,", "at", "Celsion", "s", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:", "<tag3>"], "wordsA": ["Additional", "consideration", "included", "contingent", "value", "rights", "totaling", "$30.4", "million,", "payable", "in", "cash,", "shares", "of", "Celsion", "common", "stock", "or", "a", "combination", "thereof,", "at", "Celsion", "s", "option,", "upon", "acheivement", "of", "three", "major", "milestone", "events", "as", "follows:"], "wordsB": ["Additional", "consideration", "included", "contingent", "value", "rights", "totaling", "$30.4", "million,", "payable", "in", "cash,", "shares", "of", "Celsion", "common", "stock", "or", "a", "combination", "thereof,", "at", "Celsion", "s", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030820414423942566, 0.07217037677764893, 0.029662083834409714, 0.11906832456588745, 0.061169907450675964, 0.08371546119451523, 0.05949913337826729, 0.07183237373828888, 0.06789617985486984, 0.06135111674666405, 0.04201403632760048, 0.06325472891330719, 0.1439565271139145, 0.05773911625146866, 0.08068523555994034, 0.0552985705435276, 0.05034045875072479, 0.02162904478609562, 0.022111374884843826, 0.040490373969078064, 0.03833654522895813, 0.026892313733696938, 0.06563062965869904, 0.03712830692529678, 0.06299467384815216, 0.026751089841127396, 0.4619879126548767, 0.06943817436695099, 0.06088879704475403, 0.05168046057224274, 0.06147252023220062, 0.04344344884157181, 0.04102667048573494, 0.22818617522716522, -1]}
{"idB": "749647_16_item1_p21_s0", "idA": "749647_15_item1_p22_s0", "sentA": "A self-liquidating payment of 50% of all fees received from the licensing of TherSilence (up to $6.0 million).", "sentB": "Up to $6.0 million will become payable upon achieving certain specified milestones relating to the TheraSilence technology.", "type": 2, "words": ["<tag1>", "A", "self-liquidating", "payment", "of", "50%", "of", "all", "fees", "received", "from", "the", "licensing", "of", "TherSilence", "(up", "to", "$6.0", "million).", "<tag2>", "Up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology.", "<tag3>"], "wordsA": ["A", "self-liquidating", "payment", "of", "50%", "of", "all", "fees", "received", "from", "the", "licensing", "of", "TherSilence", "(up", "to", "$6.0", "million)."], "wordsB": ["Up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028421465307474136, 0.01515226624906063, 0.04815211147069931, 0.08069421350955963, 0.02143259532749653, 0.09604422003030777, 0.3122549057006836, 0.015756480395793915, 0.046138130128383636, 0.03416600823402405, 0.063660629093647, 0.12572839856147766, 0.027182303369045258, 0.026402784511446953, 0.01921140030026436, 0.068355493247509, 0.06073440611362457, -1]}
{"idB": "749647_16_item1_p22_s0", "idA": "749647_15_item1_p23_s0", "sentA": "With the acquisition, we purchased GEN-1 (formerly known as EGEN-001), a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers, and three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "sentB": "With the acquisition, we acquired GEN-1 (formerly known as EGEN-001), a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers, and three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "type": 2, "words": ["<tag1>", "With", "the", "acquisition,", "we", "purchased", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag2>", "With", "the", "acquisition,", "we", "acquired", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag3>"], "wordsA": ["With", "the", "acquisition,", "we", "purchased", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "wordsB": ["With", "the", "acquisition,", "we", "acquired", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.22357802093029022, 0.04285180941224098, 0.24078406393527985, 0.15785424411296844, 0.38920801877975464, 0.5836448073387146, 0.04353226721286774, 0.03582211956381798, 0.032719433307647705, 0.258749783039093, 0.014520040713250637, 0.11718996614217758, 0.05397218093276024, 0.017644282430410385, 0.01566835306584835, 0.05976680666208267, 0.046545371413230896, 0.01962059922516346, 0.04598863050341606, 0.02233535423874855, 0.03595437854528427, 0.03937917947769165, 0.018566470593214035, 0.030811499804258347, 0.049805305898189545, 0.053551238030195236, 0.019615091383457184, 0.014786011539399624, 0.03349415212869644, 0.017852984368801117, 0.041298069059848785, 0.021940946578979492, 0.031528912484645844, 0.038496680557727814, 0.038721997290849686, 0.046794138848781586, 0.04584134742617607, 0.021847883239388466, 0.04119143262505531, 0.030593331903219223, 0.09304666519165039, 0.05718901380896568, 0.03275882825255394, 0.013963257893919945, 0.019423073157668114, 0.0684298425912857, 0.048305876553058624, 0.022620685398578644, 0.0427059642970562, 0.034846335649490356, 0.017456570640206337, 0.04536084085702896, 0.014638734981417656, 0.04606182500720024, 0.00044463243102654815, -1]}
{"idB": "749647_16_item1_p101_s0", "idA": "749647_15_item1_p23_s1", "sentA": "In February 2015, we announced that the FDA accepted, without comment, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer.", "sentB": "In a 16-patient Phase 1b study of GEN-1 in combination study in platinum-resistant ovarian cancer, there were no overlapping toxicities between GEN-1 and pegylated doxorubicin (Doxil ).", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer.", "<tag2>", "In", "a", "16-patient", "Phase", "1b", "study", "of", "GEN-1", "in", "combination", "study", "in", "platinum-resistant", "ovarian", "cancer,", "there", "were", "no", "overlapping", "toxicities", "between", "GEN-1", "and", "pegylated", "doxorubicin", "(Doxil", ").", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer."], "wordsB": ["In", "a", "16-patient", "Phase", "1b", "study", "of", "GEN-1", "in", "combination", "study", "in", "platinum-resistant", "ovarian", "cancer,", "there", "were", "no", "overlapping", "toxicities", "between", "GEN-1", "and", "pegylated", "doxorubicin", "(Doxil", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01157238706946373, 0.011022361926734447, 0.2717781066894531, 0.07961685210466385, 0.15261957049369812, 0.12137988954782486, 0.008405795320868492, 0.02196509763598442, 0.006183691322803497, 0.020480796694755554, 0.05981472507119179, 0.010953562334179878, 0.24131634831428528, 0.05043802037835121, 0.062263935804367065, 0.009646959602832794, 0.02938114106655121, 0.41444623470306396, 0.461527943611145, 0.4999011754989624, 0.045377589762210846, 0.06806419044733047, 0.05730806291103363, 0.2370813488960266, 0.3224095106124878, 0.2170264571905136, 5.166891423868947e-05, -1]}
{"idB": "749647_16_item1_p25_s0", "idA": "749647_15_item1_p23_s1", "sentA": "In February 2015, we announced that the FDA accepted, without comment, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer.", "sentB": "In February 2015, we announced that the FDA accepted, without objection, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study).", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer.", "<tag2>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study).", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer."], "wordsB": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0035285032354295254, 0.005384891759604216, 0.0057847751304507256, 0.005252419505268335, 0.008928658440709114, 0.0031483699567615986, 0.0029379671905189753, 0.036309801042079926, 0.07982926070690155, 0.26278549432754517, 0.9739218354225159, 0.004297102801501751, 0.006895254831761122, 0.005512520205229521, 0.0070109982043504715, 0.00734085263684392, 0.01057242788374424, 0.002981525845825672, 0.00846083089709282, 0.0028918818570673466, 0.00531803397461772, 0.0031179923098534346, 0.0030044601298868656, 0.005566674750298262, 0.0036150533705949783, 0.005240146070718765, 0.00217239698395133, 0.006747315637767315, 0.005033879540860653, 0.008720926940441132, 0.03699571639299393, 0.3792935013771057, 0.5558295845985413, -1]}
{"idB": "749647_16_item1_p28_s1", "idA": "749647_15_item1_p23_s1", "sentA": "In February 2015, we announced that the FDA accepted, without comment, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer.", "sentB": "On April 29, 2015, we announced the expansion of our ovarian cancer development program to include a Phase I dose escalating trial to evaluate GEN-1 in combination with Avastin and Doxil in platinum-resistant ovarian cancer patients.", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer.", "<tag2>", "On", "April", "29,", "2015,", "we", "announced", "the", "expansion", "of", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "I", "dose", "escalating", "trial", "to", "evaluate", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients.", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer."], "wordsB": ["On", "April", "29,", "2015,", "we", "announced", "the", "expansion", "of", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "I", "dose", "escalating", "trial", "to", "evaluate", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03360363841056824, 0.7066289186477661, 0.5371320247650146, 0.05680761858820915, 0.02167596109211445, 0.04305640608072281, 0.017727479338645935, 0.21702927350997925, 0.05413685366511345, 0.031229084357619286, 0.047963764518499374, 0.06225239485502243, 0.06707164645195007, 0.15969444811344147, 0.007377126719802618, 0.02538243867456913, 0.011054984293878078, 0.02221711352467537, 0.014975209720432758, 0.02988714538514614, 0.018808122724294662, 0.06008056551218033, 0.0042934236116707325, 0.05873952805995941, 0.01892673783004284, 0.008673878386616707, 0.038566458970308304, 0.05383536219596863, 0.6104665994644165, 0.2243129312992096, 0.622272253036499, 0.013430623337626457, 0.4276091158390045, 0.04413788020610809, 0.04916660115122795, 0.10424081236124039, -1]}
{"idB": "749647_16_item1_p91_s0", "idA": "749647_15_item1_p23_s1", "sentA": "In February 2015, we announced that the FDA accepted, without comment, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer.", "sentB": "GEN-1 OVATION Study We have initiated a Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study) at four clinical sites, including the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer.", "<tag2>", "GEN-1", "OVATION", "Study", "We", "have", "initiated", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study)", "at", "four", "clinical", "sites,", "including", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer."], "wordsB": ["GEN-1", "OVATION", "Study", "We", "have", "initiated", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study)", "at", "four", "clinical", "sites,", "including", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.22013622522354126, 0.13299629092216492, 0.23073996603488922, 0.009326665662229061, 0.03195152431726456, 0.11771196126937866, 0.0142971808090806, 0.00829792208969593, 0.008155195973813534, 0.010821149684488773, 0.011524477042257786, 0.017859576269984245, 0.005734540987759829, 0.012884077616035938, 0.004574200604110956, 0.0061668348498642445, 0.004961216356605291, 0.00502255093306303, 0.007779122330248356, 0.004926800727844238, 0.00782964937388897, 0.003397479187697172, 0.007603620178997517, 0.005781509447842836, 0.0068620191887021065, 0.004920182283967733, 0.010755213908851147, 0.014403372071683407, 0.026813929900527, 0.20011915266513824, 0.1391386240720749, 0.10124329477548599, 0.0388653464615345, 0.03889662027359009, 0.24893440306186676, 0.1784696877002716, 0.29672491550445557, 0.16799430549144745, 0.25811970233917236, 0.25262102484703064, 0.3265433609485626, 0.18807286024093628, 0.16069242358207703, 0.19785679876804352, 0.2552456259727478, 0.061771247535943985, 0.10260771214962006, 0.16653738915920258, 0.04726565629243851, 0.028580110520124435, 0.2915438115596771, 0.43557295203208923, 0.21032962203025818, 0.44303423166275024, -1]}
{"idB": "749647_16_item1_p96_s0", "idA": "749647_15_item1_p23_s1", "sentA": "In February 2015, we announced that the FDA accepted, without comment, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer.", "sentB": "GEN-1 + Avastin + Doxil Combination Study in Platinum Resistant Ovarian Cancer In April 2015, we announced plans to expand our ovarian cancer development program to include a Phase 1 dose escalating trial evaluating GEN-1 in combination with Avastin and Doxil in platinum-resistant ovarian cancer patients.", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer.", "<tag2>", "GEN-1", "+", "Avastin", "+", "Doxil", "Combination", "Study", "in", "Platinum", "Resistant", "Ovarian", "Cancer", "In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients.", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "comment,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer."], "wordsB": ["GEN-1", "+", "Avastin", "+", "Doxil", "Combination", "Study", "in", "Platinum", "Resistant", "Ovarian", "Cancer", "In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4182649850845337, 0.1419430524110794, 0.43411871790885925, 0.09696295112371445, 0.43297213315963745, 0.11693934351205826, 0.1243269294500351, 0.007191547192633152, 0.1175081878900528, 0.02341493032872677, 0.013323674909770489, 0.035359010100364685, 0.008701651357114315, 0.628282368183136, 0.05779644474387169, 0.015156885609030724, 0.023875178769230843, 0.09373690187931061, 0.04276752099394798, 0.24503697454929352, 0.0368417352437973, 0.05068310350179672, 0.07454756647348404, 0.08133404701948166, 0.12606340646743774, 0.0020558321848511696, 0.01600879430770874, 0.007640257012099028, 0.02369997836649418, 0.04012680426239967, 0.04202337935566902, 0.01616007275879383, 0.05392181873321533, 0.06006002426147461, 0.03330885246396065, 0.008874962106347084, 0.02292032539844513, 0.01563309319317341, 0.08126892149448395, 0.024033691734075546, 0.19455677270889282, 0.005895884707570076, 0.0657312273979187, 0.011223512701690197, 0.014572961255908012, 0.048055101186037064, -1]}
{"idB": "749647_16_item1_p25_s2", "idA": "749647_15_item1_p23_s2", "sentA": "The clinical trial will identify a safe, tolerable and potentially therapeutically active dose of GEN-1 while maximizing an immune response.", "sentB": "The OVATION Study will seek to identify a safe, tolerable and potentially therapeutically active dose of GEN-1 by recruiting and maximizing an immune response.", "type": 2, "words": ["<tag1>", "The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response.", "<tag2>", "The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response.", "<tag3>"], "wordsA": ["The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response."], "wordsB": ["The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02622983418405056, 0.8685232400894165, 0.545763373374939, 0.003848820459097624, 0.0073045166209340096, 0.003183295950293541, 0.006957193836569786, 0.002396124415099621, 0.005227286834269762, 0.0028595211915671825, 0.0023468248546123505, 0.0020275020506232977, 0.0027973491232842207, 0.0033557552378624678, 0.005781153216958046, 0.0020682860631495714, 0.006943483371287584, 0.005368872545659542, 0.042593423277139664, 0.009954636916518211, 0.009029332548379898, 0.0035542461555451155, 0.008726951666176319, 0.008390008471906185, -1]}
{"idB": "749647_16_item1_p27_s2", "idA": "749647_15_item1_p23_s2", "sentA": "The clinical trial will identify a safe, tolerable and potentially therapeutically active dose of GEN-1 while maximizing an immune response.", "sentB": "The OVATION Study will continue into 2016 at higher doses of GEN-1 with the goal to identify a safe, tolerable and therapeutically active dose of GEN-1 by recruiting and maximizing an immune response.", "type": 2, "words": ["<tag1>", "The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response.", "<tag2>", "The", "OVATION", "Study", "will", "continue", "into", "2016", "at", "higher", "doses", "of", "GEN-1", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response.", "<tag3>"], "wordsA": ["The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response."], "wordsB": ["The", "OVATION", "Study", "will", "continue", "into", "2016", "at", "higher", "doses", "of", "GEN-1", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014275234192609787, 0.5269249081611633, 0.39915725588798523, 0.007899678312242031, 0.030925247818231583, 0.07943876832723618, 0.06924133747816086, 0.01410957332700491, 0.2742355465888977, 0.20988528430461884, 0.014689017087221146, 0.023668967187404633, 0.000746296311262995, 0.000874705146998167, 0.0074878595769405365, 0.0038868242409080267, 0.009807233698666096, 0.003462278051301837, 0.006035647355020046, 0.004573842976242304, 0.0067733582109212875, 0.0043685478158295155, 0.004874291364103556, 0.006891901604831219, 0.003160162130370736, 0.010293313302099705, 0.004426848143339157, 0.0667031779885292, 0.020876925438642502, 0.016879569739103317, 0.009416614659130573, 0.017191646620631218, 0.015304593369364738, -1]}
{"idB": "749647_16_item1_p95_s0", "idA": "749647_15_item1_p23_s2", "sentA": "The clinical trial will identify a safe, tolerable and potentially therapeutically active dose of GEN-1 while maximizing an immune response.", "sentB": "The OVATION Study will continue into 2016 at higher doses of GEN-1 with the goal to identify a safe, tolerable and therapeutically active dose of GEN-1 by recruiting and maximizing an immune response.", "type": 2, "words": ["<tag1>", "The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response.", "<tag2>", "The", "OVATION", "Study", "will", "continue", "into", "2016", "at", "higher", "doses", "of", "GEN-1", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response.", "<tag3>"], "wordsA": ["The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response."], "wordsB": ["The", "OVATION", "Study", "will", "continue", "into", "2016", "at", "higher", "doses", "of", "GEN-1", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014275234192609787, 0.5269249081611633, 0.39915725588798523, 0.007899678312242031, 0.030925247818231583, 0.07943876832723618, 0.06924133747816086, 0.01410957332700491, 0.2742355465888977, 0.20988528430461884, 0.014689017087221146, 0.023668967187404633, 0.000746296311262995, 0.000874705146998167, 0.0074878595769405365, 0.0038868242409080267, 0.009807233698666096, 0.003462278051301837, 0.006035647355020046, 0.004573842976242304, 0.0067733582109212875, 0.0043685478158295155, 0.004874291364103556, 0.006891901604831219, 0.003160162130370736, 0.010293313302099705, 0.004426848143339157, 0.0667031779885292, 0.020876925438642502, 0.016879569739103317, 0.009416614659130573, 0.017191646620631218, 0.015304593369364738, -1]}
{"idB": "749647_16_item1_p25_s3", "idA": "749647_15_item1_p23_s3", "sentA": "The trial is designed to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose to carry forward into a Phase II trial.", "sentB": "The OVATION Study is designed to enroll three to six patients per dose cohort and will evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study combining GEN-1 with Avastin and Doxil .", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial.", "<tag2>", "The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial."], "wordsB": ["The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03418360650539398, 0.8345996141433716, 0.6481295228004456, 0.0024818398524075747, 0.004193626344203949, 0.0018796988297253847, 0.008649303577840328, 0.004431337118148804, 0.0018443061271682382, 0.006420861929655075, 0.017569508403539658, 0.0043580662459135056, 0.018985245376825333, 0.03979349136352539, 8.6005158664193e-05, 0.0014320564223453403, 0.004295282531529665, 0.004178523551672697, 0.0020258259028196335, 0.003360431408509612, 0.0022409013472497463, 0.0017089953180402517, 0.0001873972942121327, 0.0027863862924277782, 0.001727698720060289, 0.007878809235990047, 0.019272148609161377, 0.0034514893777668476, 0.003980536013841629, 0.04147334024310112, 0.029993301257491112, 0.019623350352048874, 0.09223344177007675, 0.06519534438848495, 0.10833495110273361, 0.07603805512189865, 0.09930702298879623, 0.09163795411586761, 0.08364879339933395, 4.69480874016881e-05, -1]}
{"idB": "749647_16_item1_p91_s2", "idA": "749647_15_item1_p23_s3", "sentA": "The trial is designed to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose to carry forward into a Phase II trial.", "sentB": "The trial is expected to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study combining GEN-1 with Avastin and Doxil .", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial.", "<tag2>", "The", "trial", "is", "expected", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial."], "wordsB": ["The", "trial", "is", "expected", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0044602337293326855, 0.04047076404094696, 0.013190488331019878, 0.027760105207562447, 0.008345566689968109, 0.01509623322635889, 0.008995072916150093, 0.005974096711724997, 0.011602096259593964, 0.022010646760463715, 0.006077220197767019, 0.008406528271734715, 0.0068102334626019, 0.0005218051373958588, 0.0055662598460912704, 0.008513814769685268, 0.0074513982981443405, 0.006189241074025631, 0.0066781481727957726, 0.006972667295485735, 0.006478956434875727, 0.00040838209679350257, 0.006580980494618416, 0.005244070198386908, 0.00933576375246048, 0.013729051686823368, 0.004077710211277008, 0.004931181203573942, 0.11419616639614105, 0.058700770139694214, 0.03175918012857437, 0.11942935734987259, 0.21926338970661163, 0.3955216407775879, 0.22874584794044495, 0.4192814826965332, 0.20477409660816193, 0.39744704961776733, 0.00016459330799989402, -1]}
{"idB": "749647_16_item1_p37_s0", "idA": "749647_15_item1_p24_s1", "sentA": "Since this divesture, we have dedicated our efforts and resources to the development and commercialization of cancer drugs including tumor-targeting chemotherapy treatments using focused heat energy in combination with heat-activated drug delivery systems, immunotherapies and RNA-based therapies.", "sentB": "Our current efforts and resources are applied on the development and commercialization of cancer drugs including tumor-targeting chemotherapy treatments using focused heat energy in combination with heat-activated drug delivery systems, immunotherapies and RNA-based therapies.", "type": 2, "words": ["<tag1>", "Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "chemotherapy", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems,", "immunotherapies", "and", "RNA-based", "therapies.", "<tag2>", "Our", "current", "efforts", "and", "resources", "are", "applied", "on", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "chemotherapy", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems,", "immunotherapies", "and", "RNA-based", "therapies.", "<tag3>"], "wordsA": ["Since", "this", "divesture,", "we", "have", "dedicated", "our", "efforts", "and", "resources", "to", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "chemotherapy", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems,", "immunotherapies", "and", "RNA-based", "therapies."], "wordsB": ["Our", "current", "efforts", "and", "resources", "are", "applied", "on", "the", "development", "and", "commercialization", "of", "cancer", "drugs", "including", "tumor-targeting", "chemotherapy", "treatments", "using", "focused", "heat", "energy", "in", "combination", "with", "heat-activated", "drug", "delivery", "systems,", "immunotherapies", "and", "RNA-based", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08655233681201935, 0.23691849410533905, 0.19672586023807526, 0.031097518280148506, 0.11779158562421799, 0.06509840488433838, 0.31777241826057434, 0.2736528813838959, 0.07595377415418625, 0.13756047189235687, 0.031930673867464066, 0.10890337079763412, 0.03765367716550827, 0.10140381008386612, 0.13589225709438324, 0.0134568577632308, 0.10872915387153625, 0.05768973380327225, 0.04183419793844223, 0.015443739481270313, 0.030984891578555107, 0.03717461973428726, 0.03473152220249176, 0.02052837237715721, 0.02122671715915203, 0.0180438794195652, 0.07126695662736893, 0.04512668401002884, 0.030488083139061928, 0.02485494501888752, 0.04779740422964096, 0.008072919212281704, 0.06568752229213715, 0.02593914419412613, -1]}
{"idB": "749647_16_item1_p37_s1", "idA": "749647_15_item1_p24_s2", "sentA": "To support our research and development, we raised gross proceeds of approximately $95 million in equity financings and warrant and option exercises in the years 2009 through 2013.", "sentB": "To support our research and development, we raised gross proceeds of approximately $125 million in equity financings and warrant and option exercises in the years 2009 through 2014.", "type": 2, "words": ["<tag1>", "To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$95", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2013.", "<tag2>", "To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$125", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2014.", "<tag3>"], "wordsA": ["To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$95", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2013."], "wordsB": ["To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$125", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002105367835611105, 0.003474672557786107, 0.002562703099101782, 0.003802655031904578, 0.0031490700785070658, 0.00326176593080163, 0.0029441772494465113, 0.005262157414108515, 0.004561705514788628, 0.00622767535969615, 0.003715815022587776, 0.010283499956130981, 0.9722207188606262, 0.15445208549499512, 0.0023902636021375656, 0.003974623046815395, 0.004860188812017441, 0.0018774851923808455, 0.0027426539454609156, 0.002258626278489828, 0.0034891380928456783, 0.003480366664007306, 0.002342032268643379, 0.002280603861436248, 0.0060028876177966595, 0.009370853193104267, 0.038048144429922104, 0.9064332246780396, -1]}
{"idB": "749647_16_item1_p37_s2", "idA": "749647_15_item1_p24_s3", "sentA": "In January 2014, we raised net proceeds of $14 million through an equity financing.", "sentB": "During 2015, we raised gross proceeds of $8.0 million through a registered direct equity financing with two institutional investors and raised an additional $0.6 million through the utilization of our at-the-market equity facility.", "type": 2, "words": ["<tag1>", "In", "January", "2014,", "we", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing.", "<tag2>", "During", "2015,", "we", "raised", "gross", "proceeds", "of", "$8.0", "million", "through", "a", "registered", "direct", "equity", "financing", "with", "two", "institutional", "investors", "and", "raised", "an", "additional", "$0.6", "million", "through", "the", "utilization", "of", "our", "at-the-market", "equity", "facility.", "<tag3>"], "wordsA": ["In", "January", "2014,", "we", "raised", "net", "proceeds", "of", "$14", "million", "through", "an", "equity", "financing."], "wordsB": ["During", "2015,", "we", "raised", "gross", "proceeds", "of", "$8.0", "million", "through", "a", "registered", "direct", "equity", "financing", "with", "two", "institutional", "investors", "and", "raised", "an", "additional", "$0.6", "million", "through", "the", "utilization", "of", "our", "at-the-market", "equity", "facility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1270991563796997, 0.8085257411003113, 0.003091068472713232, 0.00745534198358655, 0.036882974207401276, 0.02333885431289673, 0.0063980198465287685, 0.5948304533958435, 0.07014207541942596, 0.0026008030399680138, 0.00223940028809011, 0.05667167901992798, 0.20079940557479858, 0.12201061099767685, 0.08777818828821182, 0.002444247016683221, 0.04087143391370773, 0.06094873324036598, 0.044756218791007996, 0.00010224602010566741, 0.011877898126840591, 0.004533503204584122, 0.020835626870393753, 0.5436809659004211, 0.08874516189098358, 0.0025504417717456818, 0.0022822385653853416, 0.0155186103656888, 0.0027071184013038874, 0.007485957350581884, 0.08704846352338791, 0.11223191767930984, 0.02692808024585247, -1]}
{"idB": "749647_16_item1_p37_s3", "idA": "749647_15_item1_p24_s4", "sentA": "We had cash, cash equivalents, short-term investments and interest receivable totaling $37 million at the end at December 31, 2014.", "sentB": "We had cash, cash equivalents, short-term investments and interest receivable totaling $20.1 million at December 31, 2015.", "type": 2, "words": ["<tag1>", "We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$37", "million", "at", "the", "end", "at", "December", "31,", "2014.", "<tag2>", "We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$20.1", "million", "at", "December", "31,", "2015.", "<tag3>"], "wordsA": ["We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$37", "million", "at", "the", "end", "at", "December", "31,", "2014."], "wordsB": ["We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$20.1", "million", "at", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003996656741946936, 0.0026330535765737295, 0.004969431087374687, 0.0039428179152309895, 0.0032866268884390593, 0.004016594495624304, 0.004959896206855774, 0.0019473141292110085, 0.0039496407844126225, 0.0052109225653111935, 0.008484004065394402, 0.8577010631561279, 0.16743923723697662, 0.006449251901358366, 0.01775999926030636, 0.01980656012892723, 0.9821240305900574, -1]}
{"idB": "749647_16_item1_p27_s1", "idA": "749647_15_item1_p25_s3", "sentA": "In January 2011, we amended the Yakult Agreement to provide for up to $4.0 million in an accelerated partial payment to us of a future drug approval milestone, which included $2.0 million paid to us upon the closing of the preferred equity financing and an additional $2.0 million conditioned upon the resumption of enrollment of Japanese patients in the Japan cohort of the HEAT study.", "sentB": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "type": 2, "words": ["<tag1>", "In", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone,", "which", "included", "$2.0", "million", "paid", "to", "us", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study.", "<tag2>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag3>"], "wordsA": ["In", "January", "2011,", "we", "amended", "the", "Yakult", "Agreement", "to", "provide", "for", "up", "to", "$4.0", "million", "in", "an", "accelerated", "partial", "payment", "to", "us", "of", "a", "future", "drug", "approval", "milestone,", "which", "included", "$2.0", "million", "paid", "to", "us", "upon", "the", "closing", "of", "the", "preferred", "equity", "financing", "and", "an", "additional", "$2.0", "million", "conditioned", "upon", "the", "resumption", "of", "enrollment", "of", "Japanese", "patients", "in", "the", "Japan", "cohort", "of", "the", "HEAT", "study."], "wordsB": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024915149435400963, 0.39340075850486755, 0.823422372341156, 0.029980666935443878, 0.059605635702610016, 0.017226461321115494, 0.12258368730545044, 0.04255728796124458, 0.1265655905008316, 0.02588319405913353, 0.020587584003806114, 0.1091563031077385, 0.135640949010849, 0.022682180628180504, 0.36229047179222107, 0.17005480825901031, 0.012061219662427902, 0.013419818133115768, 0.3309068977832794, 0.15493519604206085, -1]}
{"idB": "749647_16_item1_p34_s1", "idA": "749647_15_item1_p26_s1", "sentA": "Hisun will be responsible for providing all of the technical and regulatory support services for the manufacture of ThermoDox in the China territory and we will repay Hisun the related development costs and fees, which we expect to be approximately $1.2 million in total, commencing on the successful completion of three registrational batches of ThermoDox .", "sentB": "Hisun will be responsible for providing all of the technical and regulatory support services for the manufacture of ThermoDox in the China territory.", "type": 2, "words": ["<tag1>", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$1.2", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", ".", "<tag2>", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory.", "<tag3>"], "wordsA": ["Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$1.2", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", "."], "wordsB": ["Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.5682022571563721, 0.11238478124141693, 0.11739730834960938, 0.5304238796234131, 0.2358824908733368, 0.26575005054473877, 0.5931987762451172, 0.12292084097862244, 0.06518454104661942, 0.09847036004066467, 0.053793683648109436, 0.07570382952690125, 0.14223819971084595, 0.11514899879693985, 0.01682237535715103, 0.013802923262119293, 0.04880184680223465, 0.03051576390862465, 0.0981869325041771, 0.013050501234829426, 0.012341411784291267, 0.030297916382551193, 0.05716662108898163, -1]}
{"idB": "749647_16_item1_p34_s2", "idA": "749647_15_item1_p26_s2", "sentA": "In March 2015, results of stability tests performed by Hisun demonstrated it successfully completed three registration batches of ThermoDox , all of which show substantial chemical equivalence with investigational product produced by the Company s current contract manufacturer.", "sentB": "In March 2015, the results of stability tests performed by Hisun demonstrated it successfully manufactured three registration batches of ThermoDox all of which show chemical equivalence with investigational product produced by the Company s current contract manufacturer in the U.S. and we reimbursed Hisun for direct development costs and fees totaling $1.2 million as a result of their successful completion of these three registration batches of ThermoDox .", "type": 2, "words": ["<tag1>", "In", "March", "2015,", "results", "of", "stability", "tests", "performed", "by", "Hisun", "demonstrated", "it", "successfully", "completed", "three", "registration", "batches", "of", "ThermoDox", ",", "all", "of", "which", "show", "substantial", "chemical", "equivalence", "with", "investigational", "product", "produced", "by", "the", "Company", "s", "current", "contract", "manufacturer.", "<tag2>", "In", "March", "2015,", "the", "results", "of", "stability", "tests", "performed", "by", "Hisun", "demonstrated", "it", "successfully", "manufactured", "three", "registration", "batches", "of", "ThermoDox", "all", "of", "which", "show", "chemical", "equivalence", "with", "investigational", "product", "produced", "by", "the", "Company", "s", "current", "contract", "manufacturer", "in", "the", "U.S.", "and", "we", "reimbursed", "Hisun", "for", "direct", "development", "costs", "and", "fees", "totaling", "$1.2", "million", "as", "a", "result", "of", "their", "successful", "completion", "of", "these", "three", "registration", "batches", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["In", "March", "2015,", "results", "of", "stability", "tests", "performed", "by", "Hisun", "demonstrated", "it", "successfully", "completed", "three", "registration", "batches", "of", "ThermoDox", ",", "all", "of", "which", "show", "substantial", "chemical", "equivalence", "with", "investigational", "product", "produced", "by", "the", "Company", "s", "current", "contract", "manufacturer."], "wordsB": ["In", "March", "2015,", "the", "results", "of", "stability", "tests", "performed", "by", "Hisun", "demonstrated", "it", "successfully", "manufactured", "three", "registration", "batches", "of", "ThermoDox", "all", "of", "which", "show", "chemical", "equivalence", "with", "investigational", "product", "produced", "by", "the", "Company", "s", "current", "contract", "manufacturer", "in", "the", "U.S.", "and", "we", "reimbursed", "Hisun", "for", "direct", "development", "costs", "and", "fees", "totaling", "$1.2", "million", "as", "a", "result", "of", "their", "successful", "completion", "of", "these", "three", "registration", "batches", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007903947494924068, 0.012974641285836697, 0.017311139032244682, 0.007790680974721909, 0.015194028615951538, 0.00965113751590252, 0.015741776674985886, 0.0235508494079113, 0.00962893944233656, 0.008526664227247238, 0.018015863373875618, 0.01322320755571127, 0.012301058508455753, 0.031039860099554062, 0.2784763276576996, 0.13154767453670502, 0.0730811282992363, 0.13146159052848816, 0.024743907153606415, 0.05805648863315582, 0.009094967506825924, 0.011498020961880684, 0.012074784375727177, 0.01119069755077362, 0.013284334912896156, 0.013793788850307465, 0.00803736038506031, 0.01354250218719244, 0.01725073717534542, 0.009362862445414066, 0.007950681261718273, 0.009236098267138004, 0.015831083059310913, 0.011076713912189007, 0.012372219003736973, 0.01617291383445263, 0.021232523024082184, 0.02129133604466915, 0.03885834291577339, 0.06336232274770737, 0.007219669409096241, 0.032455820590257645, 0.5961490869522095, 0.15341797471046448, 0.053400952368974686, 0.12301146984100342, 0.16487549245357513, 0.09846463799476624, 0.04899146035313606, 0.09592457860708237, 0.028371067717671394, 0.09627123922109604, 0.04728926345705986, 0.010932453908026218, 0.018352268263697624, 0.014073966071009636, 0.012190813198685646, 0.012644579634070396, 0.026114799082279205, 0.021150946617126465, 0.006000966764986515, 0.006255417596548796, 0.014915937557816505, 0.023129364475607872, 0.020947245880961418, 0.006879499182105064, 0.03450183570384979, 0.00031391679658554494, -1]}
{"idB": "749647_16_item1_p34_s3", "idA": "749647_15_item1_p26_s3", "sentA": "We plan to qualify and seek regulatory approval for HISUN to serve as an approved manufacturer for China and Europe.", "sentB": "We plan to qualify and seek regulatory approval for Hisun to serve as an approved global manufacturer of ThermoDox .", "type": 2, "words": ["<tag1>", "We", "plan", "to", "qualify", "and", "seek", "regulatory", "approval", "for", "HISUN", "to", "serve", "as", "an", "approved", "manufacturer", "for", "China", "and", "Europe.", "<tag2>", "We", "plan", "to", "qualify", "and", "seek", "regulatory", "approval", "for", "Hisun", "to", "serve", "as", "an", "approved", "global", "manufacturer", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["We", "plan", "to", "qualify", "and", "seek", "regulatory", "approval", "for", "HISUN", "to", "serve", "as", "an", "approved", "manufacturer", "for", "China", "and", "Europe."], "wordsB": ["We", "plan", "to", "qualify", "and", "seek", "regulatory", "approval", "for", "Hisun", "to", "serve", "as", "an", "approved", "global", "manufacturer", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003692861646413803, 0.0044633811339735985, 0.002170388586819172, 0.0059740603901445866, 0.002261319663375616, 0.003522827522829175, 0.003963072318583727, 0.00417274609208107, 0.0018991007236763835, 0.004381729755550623, 0.0015367988962680101, 0.003960640635341406, 0.002959790639579296, 0.0025491174310445786, 0.032166123390197754, 0.0790681317448616, 0.12331751734018326, 0.09214413166046143, 0.9602826833724976, 2.3947637600940652e-05, -1]}
{"idB": "749647_16_item1_p24_s0", "idA": "749647_15_item1_p35_s0", "sentA": "Primary liver cancer (hepatocellular carcinoma or HCC) is one of the most common and deadliest forms of cancer worldwide.", "sentB": "IL-12 is one of the most active cytokines for the induction of potent anti-cancer immunity acting through the induction of T-lymphocyte and natural killer cell proliferation .", "type": 2, "words": ["<tag1>", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag2>", "IL-12", "is", "one", "of", "the", "most", "active", "cytokines", "for", "the", "induction", "of", "potent", "anti-cancer", "immunity", "acting", "through", "the", "induction", "of", "T-lymphocyte", "and", "natural", "killer", "cell", "proliferation", ".", "<tag3>"], "wordsA": ["Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "wordsB": ["IL-12", "is", "one", "of", "the", "most", "active", "cytokines", "for", "the", "induction", "of", "potent", "anti-cancer", "immunity", "acting", "through", "the", "induction", "of", "T-lymphocyte", "and", "natural", "killer", "cell", "proliferation", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7509390711784363, 0.021322863176465034, 0.017090050503611565, 0.011623792350292206, 0.011687953025102615, 0.0566394068300724, 0.12134703248739243, 0.29261234402656555, 0.0036211025435477495, 0.006584460847079754, 0.020357241854071617, 0.00804097019135952, 0.020881613716483116, 0.06830458343029022, 0.09730462729930878, 0.007549570873379707, 0.0061535523273050785, 8.852574683260173e-05, 0.026018768548965454, 0.01329901721328497, 0.17633330821990967, 0.023176442831754684, 0.14751021564006805, 0.16320256888866425, 0.20046056807041168, 0.08857300132513046, 4.194216671749018e-05, -1]}
{"idB": "749647_16_item1_p44_s0", "idA": "749647_15_item1_p35_s0", "sentA": "Primary liver cancer (hepatocellular carcinoma or HCC) is one of the most common and deadliest forms of cancer worldwide.", "sentB": "Liver Cancer Overview Primary liver cancer (hepatocellular carcinoma or HCC) is one of the most common and deadliest forms of cancer worldwide.", "type": 2, "words": ["<tag1>", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag2>", "Liver", "Cancer", "Overview", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag3>"], "wordsA": ["Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "wordsB": ["Liver", "Cancer", "Overview", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.52985018491745, 0.5640758872032166, 0.9162176251411438, 0.11446020752191544, 0.11993832141160965, 0.12058580666780472, 0.06513895094394684, 0.04246687889099121, 0.01004080194979906, 0.025928474962711334, 0.008972699753940105, 0.008125669322907925, 0.009178850799798965, 0.010414190590381622, 0.014003468677401543, 0.02468777447938919, 0.008836823515594006, 0.040154457092285156, 0.03693071007728577, 0.01751653105020523, 0.0324162095785141, 0.01441627461463213, -1]}
{"idB": "749647_16_item1_p88_s0", "idA": "749647_15_item1_p35_s0", "sentA": "Primary liver cancer (hepatocellular carcinoma or HCC) is one of the most common and deadliest forms of cancer worldwide.", "sentB": "IL-12 is one of the most active cytokines for the induction of potent anti-cancer immunity acting through the induction of T-lymphocyte and natural killer cell proliferation.", "type": 2, "words": ["<tag1>", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag2>", "IL-12", "is", "one", "of", "the", "most", "active", "cytokines", "for", "the", "induction", "of", "potent", "anti-cancer", "immunity", "acting", "through", "the", "induction", "of", "T-lymphocyte", "and", "natural", "killer", "cell", "proliferation.", "<tag3>"], "wordsA": ["Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "wordsB": ["IL-12", "is", "one", "of", "the", "most", "active", "cytokines", "for", "the", "induction", "of", "potent", "anti-cancer", "immunity", "acting", "through", "the", "induction", "of", "T-lymphocyte", "and", "natural", "killer", "cell", "proliferation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7509390711784363, 0.021322863176465034, 0.017090050503611565, 0.011623792350292206, 0.011687953025102615, 0.0566394068300724, 0.12134703248739243, 0.29261234402656555, 0.0036211025435477495, 0.006584460847079754, 0.020357241854071617, 0.00804097019135952, 0.020881613716483116, 0.06830458343029022, 0.09730462729930878, 0.007549570873379707, 0.0061535523273050785, 8.852574683260173e-05, 0.026018768548965454, 0.01329901721328497, 0.17633330821990967, 0.023176442831754684, 0.14751021564006805, 0.16320256888866425, 0.20046056807041168, 0.08857300132513046, -1]}
{"idB": "749647_16_item1_p48_s0", "idA": "749647_15_item1_p39_s0", "sentA": "There are few alternative treatments, since radiation therapy and chemotherapy are largely ineffective.", "sentB": "There are few alternative treatments, since radiation therapy and chemotherapy are largely ineffective in treating liver cancer.", "type": 2, "words": ["<tag1>", "There", "are", "few", "alternative", "treatments,", "since", "radiation", "therapy", "and", "chemotherapy", "are", "largely", "ineffective.", "<tag2>", "There", "are", "few", "alternative", "treatments,", "since", "radiation", "therapy", "and", "chemotherapy", "are", "largely", "ineffective", "in", "treating", "liver", "cancer.", "<tag3>"], "wordsA": ["There", "are", "few", "alternative", "treatments,", "since", "radiation", "therapy", "and", "chemotherapy", "are", "largely", "ineffective."], "wordsB": ["There", "are", "few", "alternative", "treatments,", "since", "radiation", "therapy", "and", "chemotherapy", "are", "largely", "ineffective", "in", "treating", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005421720910817385, 0.005630312953144312, 0.05135245621204376, 0.03233081474900246, 0.03350257873535156, 0.0039331065490841866, 0.022225184366106987, 0.035489123314619064, 0.0035579348914325237, 0.017986640334129333, 0.04889184609055519, 0.08339175581932068, 0.7289523482322693, 0.02069110982120037, 0.13977159559726715, 0.4604630470275879, 0.33606913685798645, -1]}
{"idB": "749647_16_item1_p50_s0", "idA": "749647_15_item1_p41_s0", "sentA": "While RFA uses extremely high temperatures (greater than 80 Celsius) to ablate the tumor, it may fail to treat micro-metastases in the outer margins of the ablation zone because temperatures in the periphery may not be high enough to destroy the cancer cells.", "sentB": "Celsion s Approach While RFA uses extremely high temperatures (greater than 80 Celsius) to ablate the tumor, it may fail to treat micro-metastases in the outer margins of the ablation zone because temperatures in the periphery may not be high enough to destroy cancer cells.", "type": 2, "words": ["<tag1>", "While", "RFA", "uses", "extremely", "high", "temperatures", "(greater", "than", "80", "Celsius)", "to", "ablate", "the", "tumor,", "it", "may", "fail", "to", "treat", "micro-metastases", "in", "the", "outer", "margins", "of", "the", "ablation", "zone", "because", "temperatures", "in", "the", "periphery", "may", "not", "be", "high", "enough", "to", "destroy", "the", "cancer", "cells.", "<tag2>", "Celsion", "s", "Approach", "While", "RFA", "uses", "extremely", "high", "temperatures", "(greater", "than", "80", "Celsius)", "to", "ablate", "the", "tumor,", "it", "may", "fail", "to", "treat", "micro-metastases", "in", "the", "outer", "margins", "of", "the", "ablation", "zone", "because", "temperatures", "in", "the", "periphery", "may", "not", "be", "high", "enough", "to", "destroy", "cancer", "cells.", "<tag3>"], "wordsA": ["While", "RFA", "uses", "extremely", "high", "temperatures", "(greater", "than", "80", "Celsius)", "to", "ablate", "the", "tumor,", "it", "may", "fail", "to", "treat", "micro-metastases", "in", "the", "outer", "margins", "of", "the", "ablation", "zone", "because", "temperatures", "in", "the", "periphery", "may", "not", "be", "high", "enough", "to", "destroy", "the", "cancer", "cells."], "wordsB": ["Celsion", "s", "Approach", "While", "RFA", "uses", "extremely", "high", "temperatures", "(greater", "than", "80", "Celsius)", "to", "ablate", "the", "tumor,", "it", "may", "fail", "to", "treat", "micro-metastases", "in", "the", "outer", "margins", "of", "the", "ablation", "zone", "because", "temperatures", "in", "the", "periphery", "may", "not", "be", "high", "enough", "to", "destroy", "cancer", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7810496687889099, 0.7344191670417786, 0.36844542622566223, 0.0056158811785280704, 0.012258965522050858, 0.01002449169754982, 0.020921701565384865, 0.04470823332667351, 0.02143273502588272, 0.031078273430466652, 0.013680956326425076, 0.02626245841383934, 0.013008282519876957, 0.003896452719345689, 0.00808375608175993, 0.003943133167922497, 0.013251585885882378, 0.004463606048375368, 0.008742788806557655, 0.10304686427116394, 0.011460491456091404, 0.01736716739833355, 0.015121592208743095, 0.0035654555540531874, 0.0033882048446685076, 0.007747820112854242, 0.008604314178228378, 0.0029163267463445663, 0.003296501003205776, 0.00762525387108326, 0.006555380765348673, 0.004363022278994322, 0.01161404512822628, 0.003550834720954299, 0.003477100282907486, 0.009340722113847733, 0.015550645999610424, 0.10311713069677353, 0.02436695247888565, 0.04677913710474968, 0.04442519694566727, 0.015865279361605644, 0.05439222231507301, 0.02549843303859234, 0.030928002670407295, -1]}
{"idB": "749647_16_item1_p102_s3", "idA": "749647_15_item1_p48_s2", "sentA": "The post-hoc data suggest that ThermoDox may substantially improve overall survival, when compared to the control group, in patients whose lesions undergo optimized RFA treatment for 45 minutes or more.", "sentB": "The findings represent a reduction in tumor burden and disease progression when compared to the combination of Avastin and Doxil in a SKOV3 human cell line implanted into immunocompromised (nude) mice.", "type": 2, "words": ["<tag1>", "The", "post-hoc", "data", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more.", "<tag2>", "The", "findings", "represent", "a", "reduction", "in", "tumor", "burden", "and", "disease", "progression", "when", "compared", "to", "the", "combination", "of", "Avastin", "and", "Doxil", "in", "a", "SKOV3", "human", "cell", "line", "implanted", "into", "immunocompromised", "(nude)", "mice.", "<tag3>"], "wordsA": ["The", "post-hoc", "data", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "overall", "survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more."], "wordsB": ["The", "findings", "represent", "a", "reduction", "in", "tumor", "burden", "and", "disease", "progression", "when", "compared", "to", "the", "combination", "of", "Avastin", "and", "Doxil", "in", "a", "SKOV3", "human", "cell", "line", "implanted", "into", "immunocompromised", "(nude)", "mice."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0043791173957288265, 0.06275386363267899, 0.033434461802244186, 0.02897804044187069, 0.5210173726081848, 0.18380574882030487, 0.46729910373687744, 0.45285534858703613, 0.09795121103525162, 0.29865214228630066, 0.307158499956131, 0.004985244479030371, 0.010218840092420578, 0.007383033633232117, 0.00618504174053669, 0.0631515383720398, 0.043135035783052444, 0.18377700448036194, 0.08402740210294724, 0.21010752022266388, 0.009663027711212635, 0.00688138185068965, 0.06997061520814896, 0.06842704862356186, 0.09620288759469986, 0.05794375017285347, 0.08589586615562439, 0.041447702795267105, 0.36035892367362976, 0.14465075731277466, 0.11168035119771957, -1]}
{"idB": "749647_16_item1_p25_s1", "idA": "749647_15_item1_p49_s2", "sentA": "We may choose to end this analysis of overall survival once the median is reached for both arms of the study.", "sentB": "On September 30, 2015, we announced enrollment of the first patient in this study.", "type": 2, "words": ["<tag1>", "We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "both", "arms", "of", "the", "study.", "<tag2>", "On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "this", "study.", "<tag3>"], "wordsA": ["We", "may", "choose", "to", "end", "this", "analysis", "of", "overall", "survival", "once", "the", "median", "is", "reached", "for", "both", "arms", "of", "the", "study."], "wordsB": ["On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.060738615691661835, 0.16365864872932434, 0.13848936557769775, 0.1997583508491516, 0.07894696295261383, 0.4068777561187744, 0.6221728920936584, 0.2621363699436188, 0.22362233698368073, 0.3462982475757599, 0.49981653690338135, 0.05573044717311859, 0.03207530826330185, 0.10717537999153137, -1]}
{"idB": "749647_16_item1_p16_s1", "idA": "749647_15_item1_p50_s0", "sentA": "We also completed computational modeling with supplementary prospective preclinical animal studies which support the relationship between heating duration and clinical outcomes.", "sentB": "Supplementary computational modeling and prospective preclinical animal studies have shown additional support the relationship between heating duration and clinical outcomes.", "type": 2, "words": ["<tag1>", "We", "also", "completed", "computational", "modeling", "with", "supplementary", "prospective", "preclinical", "animal", "studies", "which", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag2>", "Supplementary", "computational", "modeling", "and", "prospective", "preclinical", "animal", "studies", "have", "shown", "additional", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag3>"], "wordsA": ["We", "also", "completed", "computational", "modeling", "with", "supplementary", "prospective", "preclinical", "animal", "studies", "which", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "wordsB": ["Supplementary", "computational", "modeling", "and", "prospective", "preclinical", "animal", "studies", "have", "shown", "additional", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2622286379337311, 0.03304364159703255, 0.03629016503691673, 0.003969716373831034, 0.00821958389133215, 0.013838091865181923, 0.009089339524507523, 0.010875051841139793, 0.06075320392847061, 0.16365842521190643, 0.42159804701805115, 0.17064005136489868, 0.011556885205209255, 0.02382434718310833, 0.010107667185366154, 0.017063261941075325, 0.015759631991386414, 0.00616729911416769, 0.007653848268091679, 0.011649403721094131, -1]}
{"idB": "749647_16_item1_p58_s1", "idA": "749647_15_item1_p51_s1", "sentA": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, clearance for the OPTIMA Study our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with standardized RFA in primary liver cancer, also known as HCC.", "sentB": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, clearance for the OPTIMA Study, our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with standardized RFA in primary liver cancer.", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC.", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer,", "also", "known", "as", "HCC."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.049306806176900864, 0.06951994448900223, 0.09365643560886383, 0.07265477627515793, 0.06989458948373795, 0.09503236413002014, 0.04743775352835655, 0.034466732293367386, 0.23683083057403564, 0.05629298835992813, 0.0374443493783474, 0.06372629851102829, 0.06457437574863434, 0.058086030185222626, 0.05728930979967117, 0.0559656098484993, 0.056725144386291504, 0.24792835116386414, 0.13594144582748413, 0.04838309809565544, 0.04195694997906685, 0.05756768956780434, 0.04955972358584404, 0.054013676941394806, 0.07687487453222275, 0.11759596318006516, 0.05920429155230522, 0.03453070670366287, 0.11629068851470947, 0.13099104166030884, 0.027817457914352417, 0.09337371587753296, 0.1396028697490692, 0.07918396592140198, 0.05863482132554054, 0.07061812281608582, 0.10972151160240173, 0.07140348106622696, 0.33807361125946045, 0.07831700891256332, 0.09591297060251236, 0.0663544312119484, 0.1441790610551834, 0.17202548682689667, 0.04393857717514038, 0.17880919575691223, 0.2152930200099945, 0.19874779880046844, -1]}
{"idB": "749647_16_item1_p15_s5", "idA": "749647_15_item1_p51_s2", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from our Phase III HEAT Study.", "sentB": "These data continue to support the protocol for our Phase III OPTIMA Study as described below.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study.", "<tag2>", "These", "data", "continue", "to", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study."], "wordsB": ["These", "data", "continue", "to", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030113818123936653, 0.22970491647720337, 0.3670938313007355, 0.20698173344135284, 0.36233994364738464, 0.20738177001476288, 0.4726940989494324, 0.03753829747438431, 0.016195181757211685, 0.04034705087542534, 0.03607115522027016, 0.14009782671928406, 0.1137373149394989, 0.014941412955522537, 0.03413890302181244, 0.06014233082532883, -1]}
{"idB": "749647_16_item1_p182_s0", "idA": "749647_15_item1_p51_s2", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from our Phase III HEAT Study.", "sentB": "On January 7, 2016, we reported translational research data from our Phase Ib study of GEN-1 immunotherapy in recurrent ovarian cancer.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study.", "<tag2>", "On", "January", "7,", "2016,", "we", "reported", "translational", "research", "data", "from", "our", "Phase", "Ib", "study", "of", "GEN-1", "immunotherapy", "in", "recurrent", "ovarian", "cancer.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study."], "wordsB": ["On", "January", "7,", "2016,", "we", "reported", "translational", "research", "data", "from", "our", "Phase", "Ib", "study", "of", "GEN-1", "immunotherapy", "in", "recurrent", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010322481393814087, 0.05826645344495773, 0.051986824721097946, 0.10112747550010681, 0.026862069964408875, 0.10279384255409241, 0.42382434010505676, 0.28119605779647827, 0.15606659650802612, 0.007407395634800196, 0.007986615411937237, 0.055079393088817596, 0.2461358904838562, 0.20870892703533173, 0.028309183195233345, 0.35761934518814087, 0.4849744141101837, 0.06052021309733391, 0.1032613068819046, 0.23517566919326782, 0.29508841037750244, -1]}
{"idB": "749647_16_item1_p59_s0", "idA": "749647_15_item1_p51_s2", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from our Phase III HEAT Study.", "sentB": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study.", "<tag2>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "our", "Phase", "III", "HEAT", "Study."], "wordsB": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012784307822585106, 0.3378702998161316, 0.38277801871299744, 0.22158031165599823, 0.24624770879745483, 0.015433506108820438, 0.14700858294963837, 0.025997618213295937, 0.010666138492524624, 0.09380281716585159, 0.08235029131174088, 0.03881518170237541, 0.21513321995735168, 0.11087293922901154, 0.07218824326992035, 0.5784664154052734, 0.42355209589004517, -1]}
{"idB": "749647_16_item1_p19_s0", "idA": "749647_15_item1_p55_s0", "sentA": "In addition, the Company has met with the China State Food and Drug Administration (CHINA FDA) to discuss the OPTIMA Phase III Study including minimum patient enrollment requirements supporting the registration of ThermoDox in China.", "sentB": "On December 16, 2015, we announced that we received the clinical trial application approval from the China Food and Drug Administration (CFDA) to conduct the OPTIMA Study in China.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "has", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "Study", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "the", "registration", "of", "ThermoDox", "in", "China.", "<tag2>", "On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "China", "Food", "and", "Drug", "Administration", "(CFDA)", "to", "conduct", "the", "OPTIMA", "Study", "in", "China.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "has", "met", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(CHINA", "FDA)", "to", "discuss", "the", "OPTIMA", "Phase", "III", "Study", "including", "minimum", "patient", "enrollment", "requirements", "supporting", "the", "registration", "of", "ThermoDox", "in", "China."], "wordsB": ["On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "China", "Food", "and", "Drug", "Administration", "(CFDA)", "to", "conduct", "the", "OPTIMA", "Study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02764161117374897, 0.09075566381216049, 0.09201859682798386, 0.14320291578769684, 0.06403660774230957, 0.11197996884584427, 0.01516431849449873, 0.05870829522609711, 0.2510700523853302, 0.05779699236154556, 0.2899441719055176, 0.3173755407333374, 0.2970997989177704, 0.27279722690582275, 0.026879293844103813, 0.022339746356010437, 0.025037240236997604, 0.022467946633696556, 0.017833195626735687, 0.017632581293582916, 0.04950858652591705, 0.5590209364891052, 0.011739062145352364, 0.10880394279956818, 0.0193516593426466, 0.04421629756689072, 0.06587885320186615, 0.00820049736648798, 0.023315517231822014, -1]}
{"idB": "749647_16_item1_p63_s0", "idA": "749647_15_item1_p55_s1", "sentA": "Based on those discussions, we have submitted an application for accelerated approval of the OPTIMA Study in China.", "sentB": "On December 16, 2015, we announced that we received approval from the CFDA to conduct the OPTIMA Study in China.", "type": 2, "words": ["<tag1>", "Based", "on", "those", "discussions,", "we", "have", "submitted", "an", "application", "for", "accelerated", "approval", "of", "the", "OPTIMA", "Study", "in", "China.", "<tag2>", "On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "approval", "from", "the", "CFDA", "to", "conduct", "the", "OPTIMA", "Study", "in", "China.", "<tag3>"], "wordsA": ["Based", "on", "those", "discussions,", "we", "have", "submitted", "an", "application", "for", "accelerated", "approval", "of", "the", "OPTIMA", "Study", "in", "China."], "wordsB": ["On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "approval", "from", "the", "CFDA", "to", "conduct", "the", "OPTIMA", "Study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03788887709379196, 0.1345345377922058, 0.09545174241065979, 0.25335004925727844, 0.04141493886709213, 0.2902073264122009, 0.03195555508136749, 0.05155308172106743, 0.22269125282764435, 0.25398170948028564, 0.0515902154147625, 0.05484822392463684, 0.17415258288383484, 0.03633595630526543, 0.09101022779941559, 0.02064518630504608, 0.03295620530843735, 0.04186364263296127, 0.0073555405251681805, 0.013994041830301285, -1]}
{"idB": "749647_16_item1_p142_s1", "idA": "749647_15_item1_p55_s3", "sentA": "Our request for a VHP in Europe was approved on October 23, 2014.", "sentB": "Our request for a VHP in Europe for the OPTIMA Study was approved on October 23, 2014.", "type": 2, "words": ["<tag1>", "Our", "request", "for", "a", "VHP", "in", "Europe", "was", "approved", "on", "October", "23,", "2014.", "<tag2>", "Our", "request", "for", "a", "VHP", "in", "Europe", "for", "the", "OPTIMA", "Study", "was", "approved", "on", "October", "23,", "2014.", "<tag3>"], "wordsA": ["Our", "request", "for", "a", "VHP", "in", "Europe", "was", "approved", "on", "October", "23,", "2014."], "wordsB": ["Our", "request", "for", "a", "VHP", "in", "Europe", "for", "the", "OPTIMA", "Study", "was", "approved", "on", "October", "23,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0028509830590337515, 0.024115117266774178, 0.0033108016941696405, 0.0024697445333003998, 0.025758272036910057, 0.0031486558727920055, 0.021686701104044914, 0.03738405555486679, 0.056294023990631104, 0.983873188495636, 0.6236090064048767, 0.003257733304053545, 0.00983311515301466, 0.0034360934514552355, 0.003137849038466811, 0.003413964295759797, 0.004721971228718758, -1]}
{"idB": "749647_16_item1_p64_s0", "idA": "749647_15_item1_p56_s0", "sentA": "We will continue with partnerships, such as our arrangement with Hisun to the extent feasible.", "sentB": "We will continue with partnerships, such as our arrangement with Hisun and Yakult Pharmaceuticals to the extent feasible.", "type": 2, "words": ["<tag1>", "We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "to", "the", "extent", "feasible.", "<tag2>", "We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "and", "Yakult", "Pharmaceuticals", "to", "the", "extent", "feasible.", "<tag3>"], "wordsA": ["We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "to", "the", "extent", "feasible."], "wordsB": ["We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "and", "Yakult", "Pharmaceuticals", "to", "the", "extent", "feasible."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006434796378016472, 0.005131116136908531, 0.006983797065913677, 0.004771065898239613, 0.01196894608438015, 0.0039000618271529675, 0.00321146915666759, 0.0035614531952887774, 0.024123484268784523, 0.011788525618612766, 0.04387374222278595, 0.04976927116513252, 0.9288618564605713, 0.945495069026947, 0.0028815907426178455, 0.003779790597036481, 0.005500575993210077, 0.005208614282310009, -1]}
{"idB": "749647_16_item1_p66_s0", "idA": "749647_15_item1_p60_s0", "sentA": "Breast cancer is the most common malignancy in women in both the United States and the world.", "sentB": "Recurrent Chest Wall (RCW) Breast Cancer Overview Breast cancer is the most common malignancy in women in both the United States and the world.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world.", "<tag2>", "Recurrent", "Chest", "Wall", "(RCW)", "Breast", "Cancer", "Overview", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world."], "wordsB": ["Recurrent", "Chest", "Wall", "(RCW)", "Breast", "Cancer", "Overview", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7259804010391235, 0.7126199007034302, 0.798820436000824, 0.6461799144744873, 0.15131382644176483, 0.1648465096950531, 0.294152170419693, 0.11248418688774109, 0.11259467154741287, 0.005641817580908537, 0.004608158953487873, 0.010520832613110542, 0.011160756461322308, 0.019518226385116577, 0.005004353821277618, 0.01567278429865837, 0.0024976329877972603, 0.0033499044366180897, 0.002961392281576991, 0.0041741575114429, 0.0041813780553638935, 0.002612845040857792, 0.0023657302372157574, 0.003964005969464779, -1]}
{"idB": "749647_16_item1_p68_s0", "idA": "749647_15_item1_p63_s0", "sentA": "We have been actively seeking a targeted localized treatment for breast cancer using ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "sentB": "Celsion s Approach We have been actively seeking a targeted localized treatment for breast cancer using ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "type": 2, "words": ["<tag1>", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag2>", "Celsion", "s", "Approach", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "wordsB": ["Celsion", "s", "Approach", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.9748470783233643, 0.9067499041557312, 0.313955694437027, 0.004817997105419636, 0.0021454019006341696, 0.002124334452673793, 0.00491185300052166, 0.004783569369465113, 0.001694726524874568, 0.003759558778256178, 0.004513218998908997, 0.007648388855159283, 0.0017080934485420585, 0.002795192413032055, 0.00341882836073637, 0.0019354342948645353, 0.0032307521905750036, 0.001579671516083181, 0.0018026618054136634, 0.0014876561472192407, 0.00343756633810699, 0.0029885531403124332, 0.0027226884849369526, 0.001327242818661034, 0.002694234484806657, 0.002558988519012928, 0.002548455260694027, 0.0024762670509517193, -1]}
{"idB": "749647_16_item1_p28_s3", "idA": "749647_15_item1_p66_s2", "sentA": "We expect that the combination of microwave hyperthermia and ThermoDox will be more efficacious than microwave hyperthermia alone or treatment with existing non-heat activated liposomal formulations.", "sentB": "This new combination study in platinum-resistant ovarian cancer is supported by three preclinical studies indicating that the combination of GEN-1 with Avastin may result in significant clinical benefit with a favorable safety profile.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "the", "combination", "of", "microwave", "hyperthermia", "and", "ThermoDox", "will", "be", "more", "efficacious", "than", "microwave", "hyperthermia", "alone", "or", "treatment", "with", "existing", "non-heat", "activated", "liposomal", "formulations.", "<tag2>", "This", "new", "combination", "study", "in", "platinum-resistant", "ovarian", "cancer", "is", "supported", "by", "three", "preclinical", "studies", "indicating", "that", "the", "combination", "of", "GEN-1", "with", "Avastin", "may", "result", "in", "significant", "clinical", "benefit", "with", "a", "favorable", "safety", "profile.", "<tag3>"], "wordsA": ["We", "expect", "that", "the", "combination", "of", "microwave", "hyperthermia", "and", "ThermoDox", "will", "be", "more", "efficacious", "than", "microwave", "hyperthermia", "alone", "or", "treatment", "with", "existing", "non-heat", "activated", "liposomal", "formulations."], "wordsB": ["This", "new", "combination", "study", "in", "platinum-resistant", "ovarian", "cancer", "is", "supported", "by", "three", "preclinical", "studies", "indicating", "that", "the", "combination", "of", "GEN-1", "with", "Avastin", "may", "result", "in", "significant", "clinical", "benefit", "with", "a", "favorable", "safety", "profile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007319885306060314, 0.057844892144203186, 0.13001421093940735, 0.0888570174574852, 0.0263435710221529, 0.38060668110847473, 0.40465250611305237, 0.32673197984695435, 0.0005675139254890382, 0.033509835600852966, 0.006665138527750969, 0.1068362444639206, 0.29824283719062805, 0.14851512014865875, 0.013397864997386932, 0.006630755960941315, 0.005917483475059271, 0.08190049976110458, 0.044985879212617874, 0.37638458609580994, 0.07830321788787842, 0.22075524926185608, 0.016535084694623947, 0.012794499285519123, 0.008757277391850948, 0.03309452161192894, 0.03362833708524704, 0.037365201860666275, 0.005828963592648506, 0.00622376287356019, 0.054940469563007355, 0.04889686033129692, 0.03629570081830025, -1]}
{"idB": "749647_16_item1_p72_s0", "idA": "749647_15_item1_p67_s0", "sentA": "In 2009, the Company commenced an open label, dose-escalating ThermoDox Phase I/Phase II clinical trial for patients with RCW breast cancer (the DIGNITY Study).", "sentB": "The DIGNITY Study In 2009, the Company commenced an open label, dose-escalating ThermoDox Phase I/Phase II clinical trial for patients with RCW breast cancer (the DIGNITY Study).", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "The", "DIGNITY", "Study", "In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag3>"], "wordsA": ["In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["The", "DIGNITY", "Study", "In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01990722492337227, 0.8886110186576843, 0.9472910761833191, 0.08319155871868134, 0.0497896671295166, 0.007477996405214071, 0.09395764768123627, 0.04718910902738571, 0.00961416494101286, 0.025666069239377975, 0.042492084205150604, 0.03216509521007538, 0.03117670863866806, 0.017303945496678352, 0.018681710585951805, 0.017051277682185173, 0.013537470251321793, 0.029918063431978226, 0.012278207577764988, 0.05853200703859329, 0.023790497332811356, 0.07582075148820877, 0.03242899850010872, 0.02722013369202614, 0.00670227874070406, 0.027074364945292473, 0.04760972782969475, -1]}
{"idB": "749647_16_item1_p73_s0", "idA": "749647_15_item1_p68_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010 and an independent Data Safety Monitoring Board declared 50mg/m2 to be the Phase II dose.", "sentB": "The Company completed enrollment of the Phase I portion of the study in 2010.", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose.", "<tag2>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010.", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010", "and", "an", "independent", "Data", "Safety", "Monitoring", "Board", "declared", "50mg/m2", "to", "be", "the", "Phase", "II", "dose."], "wordsB": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014578974805772305, 0.2760925590991974, 0.535207986831665, 0.4436081349849701, 0.026052575558423996, 0.021146263927221298, 0.4628193974494934, 0.6274510622024536, 0.0861993208527565, 0.01218119915574789, 0.01954958215355873, 0.13849391043186188, 0.03695197403430939, 0.06434795260429382, -1]}
{"idB": "749647_16_item1_p19_s2", "idA": "749647_15_item1_p68_s1", "sentA": "The Phase II portion of the DIGNITY Study protocol has been reviewed by the FDA and enrollment commenced in the first quarter of 2013.", "sentB": "With the addition of these Chinese clinical sites, the Company expects to complete enrollment in the OPTIMA Study during the first quarter of 2018.", "type": 2, "words": ["<tag1>", "The", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013.", "<tag2>", "With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "quarter", "of", "2018.", "<tag3>"], "wordsA": ["The", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013."], "wordsB": ["With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "quarter", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009305126965045929, 0.00895742978900671, 0.0471850149333477, 0.016288261860609055, 0.03431317210197449, 0.3858086168766022, 0.1621074378490448, 0.1947522908449173, 0.00617262115702033, 0.09914648532867432, 0.0427154116332531, 0.020570838823914528, 0.09045814722776413, 0.11544065177440643, 0.02989247813820839, 0.028851406648755074, 0.35808202624320984, 0.22234106063842773, 0.013185344636440277, 0.008210656233131886, 0.040330544114112854, 0.06366492062807083, 0.06870251893997192, 0.7466102838516235, -1]}
{"idB": "749647_16_item1_p73_s1", "idA": "749647_15_item1_p68_s1", "sentA": "The Phase II portion of the DIGNITY Study protocol has been reviewed by the FDA and enrollment commenced in the first quarter of 2013.", "sentB": "The enrollment of the DIGNITY Study commenced in the first quarter of 2013 and completed in mid-2015.", "type": 2, "words": ["<tag1>", "The", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013.", "<tag2>", "The", "enrollment", "of", "the", "DIGNITY", "Study", "commenced", "in", "the", "first", "quarter", "of", "2013", "and", "completed", "in", "mid-2015.", "<tag3>"], "wordsA": ["The", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "protocol", "has", "been", "reviewed", "by", "the", "FDA", "and", "enrollment", "commenced", "in", "the", "first", "quarter", "of", "2013."], "wordsB": ["The", "enrollment", "of", "the", "DIGNITY", "Study", "commenced", "in", "the", "first", "quarter", "of", "2013", "and", "completed", "in", "mid-2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00985778495669365, 0.39558684825897217, 0.028374221175909042, 0.017948247492313385, 0.05297457054257393, 0.06805680692195892, 0.03135429322719574, 0.0047666640020906925, 0.0049197059124708176, 0.008946896530687809, 0.011743493378162384, 0.005634925328195095, 0.016263432800769806, 0.01350710541009903, 0.12048793584108353, 0.07344124466180801, 0.7227877378463745, -1]}
{"idB": "749647_16_item1_p102_s1", "idA": "749647_15_item1_p68_s2", "sentA": "The trial is designed to enroll up to 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "sentB": "The study will be designed to optimize the dosing regimen for GEN-1 in combination with Avastin + Doxil and is expected to enroll approximately 12 to 18 patients.", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "The", "study", "will", "be", "designed", "to", "optimize", "the", "dosing", "regimen", "for", "GEN-1", "in", "combination", "with", "Avastin", "+", "Doxil", "and", "is", "expected", "to", "enroll", "approximately", "12", "to", "18", "patients.", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["The", "study", "will", "be", "designed", "to", "optimize", "the", "dosing", "regimen", "for", "GEN-1", "in", "combination", "with", "Avastin", "+", "Doxil", "and", "is", "expected", "to", "enroll", "approximately", "12", "to", "18", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0036586937494575977, 0.08754688501358032, 0.0062991539016366005, 0.0029492261819541454, 0.02195698581635952, 0.009424779564142227, 0.22452734410762787, 0.045309536159038544, 0.22458016872406006, 0.14965608716011047, 0.0472794733941555, 0.17999930679798126, 0.013647801242768764, 0.053193215280771255, 0.0421474315226078, 0.3724311590194702, 0.23172548413276672, 0.2790621221065521, 5.547617911361158e-05, 0.0024870724882930517, 0.019358813762664795, 0.0057966094464063644, 0.055922385305166245, 0.12391043454408646, 0.7239590883255005, 0.24256014823913574, 0.7521446943283081, 0.38434574007987976, -1]}
{"idB": "749647_16_item1_p124_s0", "idA": "749647_15_item1_p68_s2", "sentA": "The trial is designed to enroll up to 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "sentB": "Regulation in the United States In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (FDCA) and implementing regulations.", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "Regulation", "in", "the", "United", "States", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations.", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["Regulation", "in", "the", "United", "States", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.327119916677475, 0.015836201608181, 0.011672561056911945, 0.0223385002464056, 0.030741408467292786, 0.005738941021263599, 0.005913981236517429, 0.01403789035975933, 0.02325892075896263, 0.012486560270190239, 0.18993166089057922, 0.3117603361606598, 0.3685198426246643, 0.04361530765891075, 0.027813011780381203, 0.09120814502239227, 0.11030823737382889, 0.09119565039873123, 0.06576699018478394, 0.1255245804786682, 0.13582344353199005, 0.13840137422084808, 0.0003365142911206931, 0.09299934655427933, 0.06466378271579742, -1]}
{"idB": "749647_16_item1_p125_s0", "idA": "749647_15_item1_p68_s2", "sentA": "The trial is designed to enroll up to 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "sentB": "Research and Development The vehicle by which FDA approves a new pharmaceutical product for sale and marketing in the United States is a New Drug Application (NDA).", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "Research", "and", "Development", "The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "United", "States", "is", "a", "New", "Drug", "Application", "(NDA).", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["Research", "and", "Development", "The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "United", "States", "is", "a", "New", "Drug", "Application", "(NDA)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2660657465457916, 0.2546346187591553, 0.3547661006450653, 0.012432072311639786, 0.18542371690273285, 0.01812642253935337, 0.00726578664034605, 0.08160508424043655, 0.09161125123500824, 0.01926523633301258, 0.055120084434747696, 0.1808117926120758, 0.11269810050725937, 0.008580105379223824, 0.0267604012042284, 0.010996365919709206, 0.05048195272684097, 0.005441184155642986, 0.005672551225870848, 0.014684214256703854, 0.019794886931777, 0.006209723185747862, 0.015517475083470345, 0.1581699401140213, 0.3722292184829712, 0.44628211855888367, 0.6756523251533508, -1]}
{"idB": "749647_16_item1_p19_s1", "idA": "749647_15_item1_p68_s2", "sentA": "The trial is designed to enroll up to 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "sentB": "The approval will allow Celsion to enroll patients at up to 20 clinical sites in China.", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "The", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China.", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["The", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009974798187613487, 0.2959987223148346, 0.024248428642749786, 0.1120610162615776, 0.8090216517448425, 0.03365794196724892, 0.06071455776691437, 0.03883397579193115, 0.005835851188749075, 0.01096714660525322, 0.005021111574023962, 0.018754050135612488, 0.019113050773739815, 0.023746445775032043, 0.04757925122976303, 0.7181280851364136, -1]}
{"idB": "749647_16_item1_p63_s1", "idA": "749647_15_item1_p68_s2", "sentA": "The trial is designed to enroll up to 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "sentB": "This clinical trial application approval will allow Celsion to enroll patients at up to 20 clinical sites in China.", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China.", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005017249379307032, 0.03779347985982895, 0.04590246453881264, 0.06671622395515442, 0.0924874097108841, 0.015318433754146099, 0.10277282446622849, 0.671168327331543, 0.02274259366095066, 0.048233188688755035, 0.031082209199666977, 0.005055815447121859, 0.008125970140099525, 0.004946575034409761, 0.018104098737239838, 0.020265771076083183, 0.02918616682291031, 0.06254220008850098, 0.8123219013214111, -1]}
{"idB": "749647_16_item1_p73_s2", "idA": "749647_15_item1_p68_s2", "sentA": "The trial is designed to enroll up to 20 patients at five clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia.", "sentB": "The trial evaluated ThermoDox in combination with mild hyperthermia and enrolled 28 patients at five clinical sites in the United States in both phases of the study.", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "The", "trial", "evaluated", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "and", "enrolled", "28", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "in", "both", "phases", "of", "the", "study.", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["The", "trial", "evaluated", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "and", "enrolled", "28", "patients", "at", "five", "clinical", "sites", "in", "the", "United", "States", "in", "both", "phases", "of", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002439162228256464, 0.01880696974694729, 0.0193080585449934, 0.0058447434566915035, 0.0019042586209252477, 0.0024909579660743475, 0.001668867887929082, 0.0035922795068472624, 0.003321768017485738, 0.0031758665572851896, 0.05685892701148987, 0.8023294806480408, 0.3515484929084778, 0.0023559716064482927, 0.0048449039459228516, 0.007260323502123356, 0.017544735223054886, 0.001804413041099906, 0.0018092816462740302, 0.003447692608460784, 0.004303031601011753, 0.003356101457029581, 0.043247587978839874, 0.09990660846233368, 0.02603641152381897, 0.011156274937093258, 0.023016585037112236, -1]}
{"idB": "749647_16_item1_p94_s1", "idA": "749647_15_item1_p69_s5", "sentA": "There were 29 patients treated in the two trials, including 11 patients in the DIGNITY Study and 18 patients in the Duke study.", "sentB": "The first two patients in the OVATION Study who completed treatment have shown promising results.", "type": 2, "words": ["<tag1>", "There", "were", "29", "patients", "treated", "in", "the", "two", "trials,", "including", "11", "patients", "in", "the", "DIGNITY", "Study", "and", "18", "patients", "in", "the", "Duke", "study.", "<tag2>", "The", "first", "two", "patients", "in", "the", "OVATION", "Study", "who", "completed", "treatment", "have", "shown", "promising", "results.", "<tag3>"], "wordsA": ["There", "were", "29", "patients", "treated", "in", "the", "two", "trials,", "including", "11", "patients", "in", "the", "DIGNITY", "Study", "and", "18", "patients", "in", "the", "Duke", "study."], "wordsB": ["The", "first", "two", "patients", "in", "the", "OVATION", "Study", "who", "completed", "treatment", "have", "shown", "promising", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011677887290716171, 0.153283953666687, 0.4055732488632202, 0.2078656703233719, 0.015046825632452965, 0.011902683414518833, 0.29573479294776917, 0.19138669967651367, 0.020177148282527924, 0.5277761816978455, 0.2749328911304474, 0.013499470427632332, 0.06425990164279938, 0.188731849193573, 0.10094553232192993, -1]}
{"idB": "749647_16_item1_p73_s5", "idA": "749647_15_item1_p69_s7", "sentA": "A local response rate of over 60 percent was reported in 14 of the 23 evaluable patients with five complete responses and nine partial responses.", "sentB": "Thirteen patients, representing approximately 62% of the evaluable patients, experienced a local response, including six complete responses and seven partial responses.", "type": 2, "words": ["<tag1>", "A", "local", "response", "rate", "of", "over", "60", "percent", "was", "reported", "in", "14", "of", "the", "23", "evaluable", "patients", "with", "five", "complete", "responses", "and", "nine", "partial", "responses.", "<tag2>", "Thirteen", "patients,", "representing", "approximately", "62%", "of", "the", "evaluable", "patients,", "experienced", "a", "local", "response,", "including", "six", "complete", "responses", "and", "seven", "partial", "responses.", "<tag3>"], "wordsA": ["A", "local", "response", "rate", "of", "over", "60", "percent", "was", "reported", "in", "14", "of", "the", "23", "evaluable", "patients", "with", "five", "complete", "responses", "and", "nine", "partial", "responses."], "wordsB": ["Thirteen", "patients,", "representing", "approximately", "62%", "of", "the", "evaluable", "patients,", "experienced", "a", "local", "response,", "including", "six", "complete", "responses", "and", "seven", "partial", "responses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.666731595993042, 0.206787571310997, 0.0323493629693985, 0.05467597767710686, 0.5579724311828613, 0.012751225382089615, 0.007721864618360996, 0.025716951116919518, 0.04385748133063316, 0.04579462483525276, 0.011539679951965809, 0.020971540361642838, 0.030353868380188942, 0.0055775949731469154, 0.5815202593803406, 0.11803349107503891, 0.0998506173491478, 0.008661938831210136, 0.3796617388725281, 0.08214390277862549, 0.08117293566465378, -1]}
{"idB": "749647_16_item1_p73_s3", "idA": "749647_15_item1_p70_s0", "sentA": "On July 24, 2014, we announced interim data from the DIGNITY Study of ThermoDox in RCW Breast Cancer.", "sentB": "On December 14, 2015, we announced final data from the DIGNITY Study of ThermoDox in RCW Breast Cancer at the San Antonio Breast Cancer Symposium.", "type": 2, "words": ["<tag1>", "On", "July", "24,", "2014,", "we", "announced", "interim", "data", "from", "the", "DIGNITY", "Study", "of", "ThermoDox", "in", "RCW", "Breast", "Cancer.", "<tag2>", "On", "December", "14,", "2015,", "we", "announced", "final", "data", "from", "the", "DIGNITY", "Study", "of", "ThermoDox", "in", "RCW", "Breast", "Cancer", "at", "the", "San", "Antonio", "Breast", "Cancer", "Symposium.", "<tag3>"], "wordsA": ["On", "July", "24,", "2014,", "we", "announced", "interim", "data", "from", "the", "DIGNITY", "Study", "of", "ThermoDox", "in", "RCW", "Breast", "Cancer."], "wordsB": ["On", "December", "14,", "2015,", "we", "announced", "final", "data", "from", "the", "DIGNITY", "Study", "of", "ThermoDox", "in", "RCW", "Breast", "Cancer", "at", "the", "San", "Antonio", "Breast", "Cancer", "Symposium."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03531302884221077, 0.6835570931434631, 0.647404134273529, 0.771228551864624, 0.00718588475137949, 0.02161664515733719, 0.6756195425987244, 0.19391222298145294, 0.0068291109055280685, 0.0033012109342962503, 0.011441792361438274, 0.01448407955467701, 0.002612382872030139, 0.005352259613573551, 0.0022808967623859644, 0.00486750528216362, 0.005361391231417656, 0.006583512760698795, 0.00537825096398592, 0.006242137402296066, 0.03360477089881897, 0.05242133140563965, 0.027355726808309555, 0.03131953626871109, 0.034465398639440536, -1]}
{"idB": "749647_16_item1_p73_s4", "idA": "749647_15_item1_p70_s1", "sentA": "Of the 14 patients enrolled and treated, ten were eligible for evaluation of efficacy.", "sentB": "Of the 28 patients enrolled and treated, 21 patients were eligible for evaluation of efficacy.", "type": 2, "words": ["<tag1>", "Of", "the", "14", "patients", "enrolled", "and", "treated,", "ten", "were", "eligible", "for", "evaluation", "of", "efficacy.", "<tag2>", "Of", "the", "28", "patients", "enrolled", "and", "treated,", "21", "patients", "were", "eligible", "for", "evaluation", "of", "efficacy.", "<tag3>"], "wordsA": ["Of", "the", "14", "patients", "enrolled", "and", "treated,", "ten", "were", "eligible", "for", "evaluation", "of", "efficacy."], "wordsB": ["Of", "the", "28", "patients", "enrolled", "and", "treated,", "21", "patients", "were", "eligible", "for", "evaluation", "of", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01213112473487854, 0.008550068363547325, 0.9057121276855469, 0.3464403748512268, 0.0068371533416211605, 0.0019454327411949635, 0.013021385297179222, 0.6794816851615906, 0.3219163119792938, 0.0016826854553073645, 0.004469831008464098, 0.001666691736318171, 0.0034028049558401108, 0.0014738081954419613, 0.004542750772088766, -1]}
{"idB": "749647_16_item1_p94_s2", "idA": "749647_15_item1_p70_s2", "sentA": "Based on data available to date, approximately 60% of patients experienced a stabilization of their highly refractory disease with a local response rate of 50% observed in the ten evaluable patients, notably three complete responses, two partial responses and one patient with stable disease.", "sentB": "Both patients reported stable disease with a drop in their cancer antigen 125 (CA-125) protein levels of 89% and 98% respectively.", "type": 2, "words": ["<tag1>", "Based", "on", "data", "available", "to", "date,", "approximately", "60%", "of", "patients", "experienced", "a", "stabilization", "of", "their", "highly", "refractory", "disease", "with", "a", "local", "response", "rate", "of", "50%", "observed", "in", "the", "ten", "evaluable", "patients,", "notably", "three", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease.", "<tag2>", "Both", "patients", "reported", "stable", "disease", "with", "a", "drop", "in", "their", "cancer", "antigen", "125", "(CA-125)", "protein", "levels", "of", "89%", "and", "98%", "respectively.", "<tag3>"], "wordsA": ["Based", "on", "data", "available", "to", "date,", "approximately", "60%", "of", "patients", "experienced", "a", "stabilization", "of", "their", "highly", "refractory", "disease", "with", "a", "local", "response", "rate", "of", "50%", "observed", "in", "the", "ten", "evaluable", "patients,", "notably", "three", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease."], "wordsB": ["Both", "patients", "reported", "stable", "disease", "with", "a", "drop", "in", "their", "cancer", "antigen", "125", "(CA-125)", "protein", "levels", "of", "89%", "and", "98%", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.15225297212600708, 0.11807236820459366, 0.09357470273971558, 0.16380465030670166, 0.10122198611497879, 0.04319128394126892, 0.05054166913032532, 0.5051231384277344, 0.2267342060804367, 0.08745093643665314, 0.1900869905948639, 0.2460632026195526, 0.20478381216526031, 0.24152632057666779, 0.2932508587837219, 0.34341561794281006, 0.025358350947499275, 0.5354374051094055, 0.11069191247224808, 0.573691725730896, 0.06878890097141266, -1]}
{"idB": "749647_16_item1_p103_s0", "idA": "749647_15_item1_p70_s3", "sentA": "These data are consistent with the combined clinical data from the two Phase I trials discussed above.", "sentB": "Analysis of serum chemistry and hematology suggested no overt toxicities associated with the combined treatments.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above.", "<tag2>", "Analysis", "of", "serum", "chemistry", "and", "hematology", "suggested", "no", "overt", "toxicities", "associated", "with", "the", "combined", "treatments.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above."], "wordsB": ["Analysis", "of", "serum", "chemistry", "and", "hematology", "suggested", "no", "overt", "toxicities", "associated", "with", "the", "combined", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1221139132976532, 0.03814106062054634, 0.40545889735221863, 0.3505087196826935, 0.09208909422159195, 0.32257041335105896, 0.08836643397808075, 0.6786584854125977, 0.5055585503578186, 0.5771297216415405, 0.07253390550613403, 0.01782546564936638, 0.013220245949923992, 0.05984801426529884, 0.05939890816807747, -1]}
{"idB": "749647_16_item1_p103_s1", "idA": "749647_15_item1_p70_s3", "sentA": "These data are consistent with the combined clinical data from the two Phase I trials discussed above.", "sentB": "The preclinical data are consistent with the mechanism of action for GEN-1, which exhibits certain anti-angiogenic properties in addition to its well-characterized immunomodulatory activities.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above.", "<tag2>", "The", "preclinical", "data", "are", "consistent", "with", "the", "mechanism", "of", "action", "for", "GEN-1,", "which", "exhibits", "certain", "anti-angiogenic", "properties", "in", "addition", "to", "its", "well-characterized", "immunomodulatory", "activities.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above."], "wordsB": ["The", "preclinical", "data", "are", "consistent", "with", "the", "mechanism", "of", "action", "for", "GEN-1,", "which", "exhibits", "certain", "anti-angiogenic", "properties", "in", "addition", "to", "its", "well-characterized", "immunomodulatory", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005906004924327135, 0.6834347248077393, 0.190347820520401, 0.005158022977411747, 0.034092556685209274, 0.018054967746138573, 0.020884675905108452, 0.2995672821998596, 0.26054370403289795, 0.21722659468650818, 0.14752338826656342, 0.26325279474258423, 0.00013527651026379317, 0.03209824860095978, 0.014515934512019157, 0.17466796934604645, 0.03891979530453682, 0.0001681543217273429, 0.00108874321449548, 0.003274728311225772, 0.005324569996446371, 0.019175933673977852, 0.054241377860307693, 0.03682989999651909, -1]}
{"idB": "749647_16_item1_p30_s0", "idA": "749647_15_item1_p70_s3", "sentA": "These data are consistent with the combined clinical data from the two Phase I trials discussed above.", "sentB": "The preclinical studies indicated that no obvious overt toxicities were associated with the combined treatments.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above.", "<tag2>", "The", "preclinical", "studies", "indicated", "that", "no", "obvious", "overt", "toxicities", "were", "associated", "with", "the", "combined", "treatments.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above."], "wordsB": ["The", "preclinical", "studies", "indicated", "that", "no", "obvious", "overt", "toxicities", "were", "associated", "with", "the", "combined", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011017878539860249, 0.3592020273208618, 0.22819265723228455, 0.07533247023820877, 0.04182210564613342, 0.6296032667160034, 0.44560667872428894, 0.6158439517021179, 0.7237749099731445, 0.09013664722442627, 0.14305296540260315, 0.02673787996172905, 0.017388971522450447, 0.08370309323072433, 0.08403745293617249, -1]}
{"idB": "749647_16_item1_p30_s1", "idA": "749647_15_item1_p70_s3", "sentA": "These data are consistent with the combined clinical data from the two Phase I trials discussed above.", "sentB": "The preclinical data are also consistent with the mechanism of action for GEN-1, which exhibits certain anti-angiogenic properties and suggests that combining GEN-1 with lower doses of Avastin may enhance efficacy and help reduce the known toxicities associated with this anti-VEGF drug.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above.", "<tag2>", "The", "preclinical", "data", "are", "also", "consistent", "with", "the", "mechanism", "of", "action", "for", "GEN-1,", "which", "exhibits", "certain", "anti-angiogenic", "properties", "and", "suggests", "that", "combining", "GEN-1", "with", "lower", "doses", "of", "Avastin", "may", "enhance", "efficacy", "and", "help", "reduce", "the", "known", "toxicities", "associated", "with", "this", "anti-VEGF", "drug.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above."], "wordsB": ["The", "preclinical", "data", "are", "also", "consistent", "with", "the", "mechanism", "of", "action", "for", "GEN-1,", "which", "exhibits", "certain", "anti-angiogenic", "properties", "and", "suggests", "that", "combining", "GEN-1", "with", "lower", "doses", "of", "Avastin", "may", "enhance", "efficacy", "and", "help", "reduce", "the", "known", "toxicities", "associated", "with", "this", "anti-VEGF", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004692451097071171, 0.6372963190078735, 0.15665119886398315, 0.0047775618731975555, 0.004083077423274517, 0.024002086371183395, 0.012479082681238651, 0.015370522625744343, 0.20372211933135986, 0.18317671120166779, 0.10828397423028946, 0.08387825638055801, 0.11716482043266296, 0.00022260240803007036, 0.020015083253383636, 0.013890604488551617, 0.16808947920799255, 0.028440946713089943, 0.00010244560689898208, 0.011648163199424744, 0.005771158263087273, 0.05899776518344879, 0.07343677431344986, 0.012830945663154125, 0.0973735898733139, 0.054391227662563324, 0.04862276464700699, 0.10245120525360107, 0.013213958591222763, 0.03575124964118004, 0.03054715320467949, 0.008558221161365509, 0.015952885150909424, 0.06540500372648239, 0.008588172495365143, 0.027906181290745735, 0.06789147108793259, 0.007551589049398899, 0.007051934953778982, 0.008694218471646309, 0.28393879532814026, 0.08911773562431335, -1]}
{"idB": "749647_16_item1_p73_s6", "idA": "749647_15_item1_p70_s3", "sentA": "These data are consistent with the combined clinical data from the two Phase I trials discussed above.", "sentB": "These data are consistent with the combined clinical data from the two previous Phase I trials discussed below.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above.", "<tag2>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above."], "wordsB": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0039412155747413635, 0.04336334392428398, 0.0094686858355999, 0.020252352580428123, 0.004970662761479616, 0.004799553658813238, 0.01231058593839407, 0.017042873427271843, 0.02495790831744671, 0.006350073963403702, 0.006405093241482973, 0.02325388975441456, 0.6142382621765137, 0.10451960563659668, 0.024154355749487877, 0.055330466479063034, 0.007096852175891399, 0.009156318381428719, -1]}
{"idB": "749647_16_item1_p99_s0", "idA": "749647_15_item1_p70_s3", "sentA": "These data are consistent with the combined clinical data from the two Phase I trials discussed above.", "sentB": "The preclinical studies indicated that no obvious overt toxicities were associated with the combined treatments.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above.", "<tag2>", "The", "preclinical", "studies", "indicated", "that", "no", "obvious", "overt", "toxicities", "were", "associated", "with", "the", "combined", "treatments.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above."], "wordsB": ["The", "preclinical", "studies", "indicated", "that", "no", "obvious", "overt", "toxicities", "were", "associated", "with", "the", "combined", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011017878539860249, 0.3592020273208618, 0.22819265723228455, 0.07533247023820877, 0.04182210564613342, 0.6296032667160034, 0.44560667872428894, 0.6158439517021179, 0.7237749099731445, 0.09013664722442627, 0.14305296540260315, 0.02673787996172905, 0.017388971522450447, 0.08370309323072433, 0.08403745293617249, -1]}
{"idB": "749647_16_item1_p99_s1", "idA": "749647_15_item1_p70_s3", "sentA": "These data are consistent with the combined clinical data from the two Phase I trials discussed above.", "sentB": "The preclinical data are also consistent with the mechanism of action for GEN-1, which exhibits certain anti-angiogenic properties and suggests that combining GEN-1 with lower doses of Avastin may enhance efficacy and help reduce the known toxicities associated with this anti-VEGF drug.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above.", "<tag2>", "The", "preclinical", "data", "are", "also", "consistent", "with", "the", "mechanism", "of", "action", "for", "GEN-1,", "which", "exhibits", "certain", "anti-angiogenic", "properties", "and", "suggests", "that", "combining", "GEN-1", "with", "lower", "doses", "of", "Avastin", "may", "enhance", "efficacy", "and", "help", "reduce", "the", "known", "toxicities", "associated", "with", "this", "anti-VEGF", "drug.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "Phase", "I", "trials", "discussed", "above."], "wordsB": ["The", "preclinical", "data", "are", "also", "consistent", "with", "the", "mechanism", "of", "action", "for", "GEN-1,", "which", "exhibits", "certain", "anti-angiogenic", "properties", "and", "suggests", "that", "combining", "GEN-1", "with", "lower", "doses", "of", "Avastin", "may", "enhance", "efficacy", "and", "help", "reduce", "the", "known", "toxicities", "associated", "with", "this", "anti-VEGF", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004692451097071171, 0.6372963190078735, 0.15665119886398315, 0.0047775618731975555, 0.004083077423274517, 0.024002086371183395, 0.012479082681238651, 0.015370522625744343, 0.20372211933135986, 0.18317671120166779, 0.10828397423028946, 0.08387825638055801, 0.11716482043266296, 0.00022260240803007036, 0.020015083253383636, 0.013890604488551617, 0.16808947920799255, 0.028440946713089943, 0.00010244560689898208, 0.011648163199424744, 0.005771158263087273, 0.05899776518344879, 0.07343677431344986, 0.012830945663154125, 0.0973735898733139, 0.054391227662563324, 0.04862276464700699, 0.10245120525360107, 0.013213958591222763, 0.03575124964118004, 0.03054715320467949, 0.008558221161365509, 0.015952885150909424, 0.06540500372648239, 0.008588172495365143, 0.027906181290745735, 0.06789147108793259, 0.007551589049398899, 0.007051934953778982, 0.008694218471646309, 0.28393879532814026, 0.08911773562431335, -1]}
{"idB": "749647_16_item1_p75_s0", "idA": "749647_15_item1_p71_s0", "sentA": "The Company anticipates a Phase II study of RadioTherapy (RT), HyperThermia (HT) and ThermoDox to treat patients with local-regional recurrent chest wall breast cancer will be initiated by six to eight physicians and institutions located in Italy, Israel, the Netherlands, Poland and the Czech Republic (the Euro-DIGNITY Study).", "sentB": "The Euro-DIGNITY Study The Company anticipates that a Phase II study of RadioTherapy, HyperThermia and ThermoDox to treat patients with local-regional recurrent chest wall breast cancer will be initiated by six to eight clinical sites located in Italy, Israel, the Netherlands, Poland and the Czech Republic (the Euro-DIGNITY Study).", "type": 2, "words": ["<tag1>", "The", "Company", "anticipates", "a", "Phase", "II", "study", "of", "RadioTherapy", "(RT),", "HyperThermia", "(HT)", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "physicians", "and", "institutions", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study).", "<tag2>", "The", "Euro-DIGNITY", "Study", "The", "Company", "anticipates", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "clinical", "sites", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study).", "<tag3>"], "wordsA": ["The", "Company", "anticipates", "a", "Phase", "II", "study", "of", "RadioTherapy", "(RT),", "HyperThermia", "(HT)", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "physicians", "and", "institutions", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study)."], "wordsB": ["The", "Euro-DIGNITY", "Study", "The", "Company", "anticipates", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "clinical", "sites", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0043789055198431015, 0.054526809602975845, 0.030581174418330193, 0.003210703143849969, 0.01388009823858738, 0.015392244793474674, 0.004118731245398521, 0.0041117193177342415, 0.008163364604115486, 0.00713227316737175, 0.00603095768019557, 0.003871479071676731, 0.015239237807691097, 0.027497215196490288, 0.004937837831676006, 0.01319382805377245, 0.0037908561062067747, 0.006654439028352499, 0.010110023431479931, 0.004026847891509533, 0.010761339217424393, 0.008128959685564041, 0.007803533226251602, 0.008140548132359982, 0.008923875167965889, 0.007456605788320303, 0.0036674633156508207, 0.0037403013557195663, 0.0058565204963088036, 0.003461409593001008, 0.006494420114904642, 0.004814621526747942, 0.020465292036533356, 0.7021012902259827, 0.8508804440498352, 0.006947818212211132, 0.004881005268543959, 0.01891053095459938, 0.01324621681123972, 0.00520582078024745, 0.011418613605201244, 0.009317716583609581, 0.00528951920568943, 0.004450157750397921, 0.009976813569664955, 0.009152287617325783, 0.004482665099203587, 0.027763787657022476, 0.026604458689689636, -1]}
{"idB": "749647_16_item1_p75_s1", "idA": "749647_15_item1_p71_s1", "sentA": "The Euro-DIGNITY Study will be Phase II study enrolling up to 100 patients affected by recurrent breast adenocarcinoma on the chest wall with/without nodes over a period of two years.", "sentB": "The Euro-DIGNITY Study is expected to commence in the second half of 2016 and should enroll up to 70 patients affected by recurrent breast adenocarcinoma on the chest wall with/without nodes over a period of two years.", "type": 2, "words": ["<tag1>", "The", "Euro-DIGNITY", "Study", "will", "be", "Phase", "II", "study", "enrolling", "up", "to", "100", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years.", "<tag2>", "The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "the", "second", "half", "of", "2016", "and", "should", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years.", "<tag3>"], "wordsA": ["The", "Euro-DIGNITY", "Study", "will", "be", "Phase", "II", "study", "enrolling", "up", "to", "100", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years."], "wordsB": ["The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "the", "second", "half", "of", "2016", "and", "should", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0031610496807843447, 0.012361514382064342, 0.03472169116139412, 0.006036562845110893, 0.06496836245059967, 0.021378224715590477, 0.043388769030570984, 0.02311834506690502, 0.010821872390806675, 0.0327322855591774, 0.03757617622613907, 0.06060291454195976, 0.19906850159168243, 0.00015927750791888684, 0.007190100383013487, 0.04032336175441742, 0.0236815195530653, 0.024387424811720848, 0.9493911862373352, 0.307198703289032, 0.003990450873970985, 0.0015779712703078985, 0.002710068365558982, 0.0026196336839348078, 0.00268063903786242, 0.0014770608395338058, 0.001465377165004611, 0.0020170356146991253, 0.0019298373954370618, 0.0034087803214788437, 0.0030933087691664696, 0.0016148024005815387, 0.0013764905743300915, 0.00243363156914711, 0.0017709461972117424, 0.00221235235221684, 0.003151488723233342, -1]}
{"idB": "749647_16_item1_p77_s0", "idA": "749647_15_item1_p73_s0", "sentA": "Secondary objectives of the Euro-DIGNITY Study will be (i) to evaluate the safety of the combination of ThermoDox/Hyperthermia/Radiotherapy among patients with LRR breast cancer, (ii) to evaluate the duration of local control complete response (CR), partial response (PR) and stable disease (SD) following treatment with ThermoDox/Hyperthermia/Radiotherapy up to 24 months among patients with LRR breast cancer and (iii) to assess Patient Reported Quality of Life using the FACT-B and Brief Pain Inventory (BPI) following treatment with ThermoDox/Hyperthermia/Radiotherapy among patients with LRR breast cancer.", "sentB": "Secondary objectives of the Euro-DIGNITY Study will be (i) to evaluate the safety of the combination of ThermoDox/Hyperthermia/Radiotherapy among patients with local-regional recurrence (LRR) breast cancer, (ii) to evaluate the duration of local control complete response, partial response and stable disease following treatment with ThermoDox/Hyperthermia/Radiotherapy up to 24 months among patients with LRR breast cancer and (iii) to assess Patient Reported Quality of Life using the FACT-B and Brief Pain Inventory following treatment with ThermoDox/Hyperthermia/Radiotherapy among patients with LRR breast cancer.", "type": 2, "words": ["<tag1>", "Secondary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "the", "safety", "of", "the", "combination", "of", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer,", "(ii)", "to", "evaluate", "the", "duration", "of", "local", "control", "complete", "response", "(CR),", "partial", "response", "(PR)", "and", "stable", "disease", "(SD)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "up", "to", "24", "months", "among", "patients", "with", "LRR", "breast", "cancer", "and", "(iii)", "to", "assess", "Patient", "Reported", "Quality", "of", "Life", "using", "the", "FACT-B", "and", "Brief", "Pain", "Inventory", "(BPI)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer.", "<tag2>", "Secondary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "the", "safety", "of", "the", "combination", "of", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "local-regional", "recurrence", "(LRR)", "breast", "cancer,", "(ii)", "to", "evaluate", "the", "duration", "of", "local", "control", "complete", "response,", "partial", "response", "and", "stable", "disease", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "up", "to", "24", "months", "among", "patients", "with", "LRR", "breast", "cancer", "and", "(iii)", "to", "assess", "Patient", "Reported", "Quality", "of", "Life", "using", "the", "FACT-B", "and", "Brief", "Pain", "Inventory", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer.", "<tag3>"], "wordsA": ["Secondary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "the", "safety", "of", "the", "combination", "of", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer,", "(ii)", "to", "evaluate", "the", "duration", "of", "local", "control", "complete", "response", "(CR),", "partial", "response", "(PR)", "and", "stable", "disease", "(SD)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "up", "to", "24", "months", "among", "patients", "with", "LRR", "breast", "cancer", "and", "(iii)", "to", "assess", "Patient", "Reported", "Quality", "of", "Life", "using", "the", "FACT-B", "and", "Brief", "Pain", "Inventory", "(BPI)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer."], "wordsB": ["Secondary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "the", "safety", "of", "the", "combination", "of", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "local-regional", "recurrence", "(LRR)", "breast", "cancer,", "(ii)", "to", "evaluate", "the", "duration", "of", "local", "control", "complete", "response,", "partial", "response", "and", "stable", "disease", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "up", "to", "24", "months", "among", "patients", "with", "LRR", "breast", "cancer", "and", "(iii)", "to", "assess", "Patient", "Reported", "Quality", "of", "Life", "using", "the", "FACT-B", "and", "Brief", "Pain", "Inventory", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07088252902030945, 0.1078294962644577, 0.02132723294198513, 0.02038879692554474, 0.05700718238949776, 0.043575841933488846, 0.030975600704550743, 0.027350572869181633, 0.0820014625787735, 0.022882748395204544, 0.037330418825149536, 0.03265030309557915, 0.054755259305238724, 0.0320885144174099, 0.030262211337685585, 0.043334610760211945, 0.02914595976471901, 0.12321262061595917, 0.016026005148887634, 0.03039359301328659, 0.022506874054670334, 0.16837021708488464, 0.14013993740081787, 0.0761682391166687, 0.04134603589773178, 0.045498430728912354, 0.05541054531931877, 0.019829856231808662, 0.03020946867763996, 0.02443867176771164, 0.046453699469566345, 0.030860062688589096, 0.05116073042154312, 0.047359224408864975, 0.04348747804760933, 0.04016182944178581, 0.03873328119516373, 0.03436718508601189, 0.01830301620066166, 0.03373394533991814, 0.030916286632418633, 0.021780038252472878, 0.02387072518467903, 0.022009368985891342, 0.05009566992521286, 0.023021290078759193, 0.02584141306579113, 0.03602411597967148, 0.03932659327983856, 0.021680820733308792, 0.0317574106156826, 0.03192606940865517, 0.06542959064245224, 0.037960562855005264, 0.03573773801326752, 0.019706586375832558, 0.051390890032052994, 0.020434614270925522, 0.026289230212569237, 0.02723396196961403, 0.032797347754240036, 0.03287109360098839, 0.03205643594264984, 0.03712053969502449, 0.02126014418900013, 0.023038556799292564, 0.03516307473182678, 0.020313212648034096, 0.027647199109196663, 0.02962212823331356, 0.04157956689596176, 0.02117796242237091, 0.024746747687458992, 0.026806002482771873, 0.05011877417564392, 0.017922623082995415, 0.033754587173461914, 0.03462129458785057, 0.09625186771154404, 0.06780703365802765, 0.06793352216482162, -1]}
{"idB": "749647_16_item1_p81_s0", "idA": "749647_15_item1_p78_s0", "sentA": "Ovarian cancer is the most lethal of gynecological malignancies among women with an overall five year survival rate of 44.6% between the years 2004 to 2010.", "sentB": "Ovarian Cancer Overview Ovarian cancer is the most lethal of gynecological malignancies among women with an overall five year survival rate of 45%.", "type": 2, "words": ["<tag1>", "Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "44.6%", "between", "the", "years", "2004", "to", "2010.", "<tag2>", "Ovarian", "Cancer", "Overview", "Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "45%.", "<tag3>"], "wordsA": ["Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "44.6%", "between", "the", "years", "2004", "to", "2010."], "wordsB": ["Ovarian", "Cancer", "Overview", "Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "45%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011450502090156078, 0.02574039064347744, 0.2622978389263153, 0.015180536545813084, 0.015476859174668789, 0.0036334360484033823, 0.003007927443832159, 0.009001748636364937, 0.011217006482183933, 0.002672296715900302, 0.0042693535797297955, 0.0058869593776762486, 0.0023293509148061275, 0.009753967635333538, 0.0024457962717860937, 0.0019324927125126123, 0.005724489688873291, 0.005370547994971275, 0.005698678083717823, 0.007376107387244701, 0.015697665512561798, 0.015013867057859898, 0.9697829484939575, -1]}
{"idB": "749647_16_item1_p82_s0", "idA": "749647_15_item1_p79_s0", "sentA": "There were approximately 22,000 new cases of ovarian cancer in the US in 2014 with an estimated 14,000 deaths.", "sentB": "There were approximately 22,000 new cases of ovarian cancer in the U.S. in 2014 with an estimated 14,000 deaths.", "type": 2, "words": ["<tag1>", "There", "were", "approximately", "22,000", "new", "cases", "of", "ovarian", "cancer", "in", "the", "US", "in", "2014", "with", "an", "estimated", "14,000", "deaths.", "<tag2>", "There", "were", "approximately", "22,000", "new", "cases", "of", "ovarian", "cancer", "in", "the", "U.S.", "in", "2014", "with", "an", "estimated", "14,000", "deaths.", "<tag3>"], "wordsA": ["There", "were", "approximately", "22,000", "new", "cases", "of", "ovarian", "cancer", "in", "the", "US", "in", "2014", "with", "an", "estimated", "14,000", "deaths."], "wordsB": ["There", "were", "approximately", "22,000", "new", "cases", "of", "ovarian", "cancer", "in", "the", "U.S.", "in", "2014", "with", "an", "estimated", "14,000", "deaths."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003398570930585265, 0.003974239807575941, 0.009103945456445217, 0.02199338935315609, 0.021513713523745537, 0.026672467589378357, 0.008044064976274967, 0.017480559647083282, 0.021491389721632004, 0.013236268423497677, 0.01621878705918789, 0.9661575555801392, 0.0075461952947080135, 0.008256189525127411, 0.003876125207170844, 0.004308002535253763, 0.008802101947367191, 0.01032340619713068, 0.04778115078806877, -1]}
{"idB": "749647_16_item1_p94_s3", "idA": "749647_15_item1_p85_s1", "sentA": "The precedence for a therapeutic role of IL-12 in ovarian cancer is based on epidemiologic and preclinical data.", "sentB": "CA-125 is used to monitor certain cancers during and after treatment and is present in greater concentrations in ovarian cancer cells than in other cells.", "type": 2, "words": ["<tag1>", "The", "precedence", "for", "a", "therapeutic", "role", "of", "IL-12", "in", "ovarian", "cancer", "is", "based", "on", "epidemiologic", "and", "preclinical", "data.", "<tag2>", "CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells.", "<tag3>"], "wordsA": ["The", "precedence", "for", "a", "therapeutic", "role", "of", "IL-12", "in", "ovarian", "cancer", "is", "based", "on", "epidemiologic", "and", "preclinical", "data."], "wordsB": ["CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7984707355499268, 0.025959650054574013, 0.05948496609926224, 0.030472876504063606, 0.08401905000209808, 0.04523206129670143, 0.11430266499519348, 0.01650054380297661, 0.05074940621852875, 0.08143288642168045, 0.0415378212928772, 6.983872299315408e-05, 0.022149933502078056, 0.12662898004055023, 0.09800423681735992, 0.3176368176937103, 0.28097274899482727, 0.04962070658802986, 0.024148128926753998, 0.036268457770347595, 0.04438837990164757, 0.036942459642887115, 0.036786291748285294, 0.08302459865808487, 0.0812634751200676, -1]}
{"idB": "749647_16_item1_p90_s0", "idA": "749647_15_item1_p86_s0", "sentA": "Celsion s GEN-1 approach for IL-12 delivery is designed to achieve local concentrations of IL-12 at the tumor site with minimal increases in systemic circulation.", "sentB": "Celsion s Approach Celsion s GEN-1 approach for IL-12 delivery is designed to achieve local concentrations of IL-12 at the tumor site with minimal increases in systemic circulation.", "type": 2, "words": ["<tag1>", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation.", "<tag2>", "Celsion", "s", "Approach", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation.", "<tag3>"], "wordsA": ["Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation."], "wordsB": ["Celsion", "s", "Approach", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07024937868118286, 0.352483868598938, 0.05632782727479935, 0.03990902379155159, 0.011928984895348549, 0.0767856016755104, 0.03245188295841217, 0.004395480267703533, 0.465006560087204, 0.02670740894973278, 0.005015337839722633, 0.006841369904577732, 0.003963211551308632, 0.005603603087365627, 0.009067553095519543, 0.014456220902502537, 0.013179438188672066, 0.6966550946235657, 0.0036854411009699106, 0.004201292060315609, 0.007990890182554722, 0.007261395454406738, 0.007428453769534826, 0.4136864244937897, 0.19945894181728363, 0.014821681194007397, 0.01756453886628151, 0.02233600802719593, -1]}
{"idB": "749647_16_item1_p90_s1", "idA": "749647_15_item1_p86_s1", "sentA": "This DNA-based approach involves intraperitoneal (IP) administration of an IL-12 plasmid formulated with a proprietary lipopolymer delivery system PEG-PEI-Cholesterol.", "sentB": "This DNA-based approach involves intraperitoneal administration of an IL-12 plasmid formulated with a proprietary lipopolymer delivery system PEG-PEI-Cholesterol.", "type": 2, "words": ["<tag1>", "This", "DNA-based", "approach", "involves", "intraperitoneal", "(IP)", "administration", "of", "an", "IL-12", "plasmid", "formulated", "with", "a", "proprietary", "lipopolymer", "delivery", "system", "PEG-PEI-Cholesterol.", "<tag2>", "This", "DNA-based", "approach", "involves", "intraperitoneal", "administration", "of", "an", "IL-12", "plasmid", "formulated", "with", "a", "proprietary", "lipopolymer", "delivery", "system", "PEG-PEI-Cholesterol.", "<tag3>"], "wordsA": ["This", "DNA-based", "approach", "involves", "intraperitoneal", "(IP)", "administration", "of", "an", "IL-12", "plasmid", "formulated", "with", "a", "proprietary", "lipopolymer", "delivery", "system", "PEG-PEI-Cholesterol."], "wordsB": ["This", "DNA-based", "approach", "involves", "intraperitoneal", "administration", "of", "an", "IL-12", "plasmid", "formulated", "with", "a", "proprietary", "lipopolymer", "delivery", "system", "PEG-PEI-Cholesterol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011368383653461933, 0.07386744022369385, 0.10452904552221298, 0.0196844395250082, 0.19491687417030334, 0.10477849841117859, 0.030461059883236885, 0.027784079313278198, 0.8524012565612793, 0.14325274527072906, 0.03882969543337822, 0.02445230633020401, 0.017561549320816994, 0.22480343282222748, 0.14153960347175598, 0.044737834483385086, 0.039412327110767365, 0.24989557266235352, -1]}
{"idB": "749647_16_item1_p182_s1", "idA": "749647_15_item1_p86_s3", "sentA": "Increases in IL-12 concentrations at the tumor site for several days after a single administration will create a potent immune environment against the tumor and a direct killing of the tumor with concomitant use of cytotoxic chemotherapy together will resulting in more robust and durable antitumor response than chemotherapy alone.", "sentB": "The translational research data indicate that intraperitoneally-administered GEN-1 produces an immunologically distinct IL-12 protein that is localized at the tumor site and lasts for up to one week after a single treatment.", "type": 2, "words": ["<tag1>", "Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "resulting", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone.", "<tag2>", "The", "translational", "research", "data", "indicate", "that", "intraperitoneally-administered", "GEN-1", "produces", "an", "immunologically", "distinct", "IL-12", "protein", "that", "is", "localized", "at", "the", "tumor", "site", "and", "lasts", "for", "up", "to", "one", "week", "after", "a", "single", "treatment.", "<tag3>"], "wordsA": ["Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "resulting", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone."], "wordsB": ["The", "translational", "research", "data", "indicate", "that", "intraperitoneally-administered", "GEN-1", "produces", "an", "immunologically", "distinct", "IL-12", "protein", "that", "is", "localized", "at", "the", "tumor", "site", "and", "lasts", "for", "up", "to", "one", "week", "after", "a", "single", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007177575491368771, 0.30663245916366577, 0.271973192691803, 0.1213747039437294, 0.0361800454556942, 0.01271874364465475, 0.4546869695186615, 0.3173682987689972, 0.0792938694357872, 0.01953808404505253, 0.1306937038898468, 0.11101430654525757, 0.06351451575756073, 0.15571589767932892, 0.00011170473590027541, 0.00591706857085228, 0.03356935828924179, 0.006433760281652212, 0.0061075203120708466, 0.025968967005610466, 0.02101844549179077, 0.00010870321420952678, 0.08309952169656754, 0.02902843803167343, 0.05371369421482086, 0.021192049607634544, 0.17422595620155334, 0.1309390515089035, 0.041637104004621506, 0.010883605107665062, 0.07593473047018051, 0.09852328896522522, -1]}
{"idB": "749647_16_item1_p90_s3", "idA": "749647_15_item1_p86_s3", "sentA": "Increases in IL-12 concentrations at the tumor site for several days after a single administration will create a potent immune environment against the tumor and a direct killing of the tumor with concomitant use of cytotoxic chemotherapy together will resulting in more robust and durable antitumor response than chemotherapy alone.", "sentB": "Increases in IL-12 concentrations at the tumor site for several days (up to one week) after a single administration will create a potent immune environment against the tumor and a direct killing of the tumor with concomitant use of cytotoxic chemotherapy together will result in more robust and durable antitumor response than chemotherapy alone.", "type": 2, "words": ["<tag1>", "Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "resulting", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone.", "<tag2>", "Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "(up", "to", "one", "week)", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "result", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone.", "<tag3>"], "wordsA": ["Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "resulting", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone."], "wordsB": ["Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "(up", "to", "one", "week)", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "result", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0666547492146492, 0.018150201067328453, 0.2590668499469757, 0.12798377871513367, 0.00942991767078638, 0.011980521492660046, 0.033976878970861435, 0.04150097817182541, 0.010388931259512901, 0.029137814417481422, 0.022278357297182083, 0.083641417324543, 0.20548130571842194, 0.8172785043716431, 0.8340213298797607, 0.02242692932486534, 0.019177686423063278, 0.09397927671670914, 0.12592504918575287, 0.0088109839707613, 0.010550747625529766, 0.01148549746721983, 0.018618708476424217, 0.024998541921377182, 0.026484772562980652, 0.017389917746186256, 0.019406627863645554, 0.07121788710355759, 0.008051599375903606, 0.008570120669901371, 0.025551002472639084, 0.042321063578128815, 0.01266761589795351, 0.014464504085481167, 0.04090476781129837, 0.009245604276657104, 0.01750892400741577, 0.01498196367174387, 0.009999597445130348, 0.05301094427704811, 0.04101720452308655, 0.011358828283846378, 0.009120507165789604, 0.010250807739794254, 0.00993388518691063, 0.02832159958779812, 0.024761907756328583, 0.014825134538114071, 0.0281497985124588, 0.06697319447994232, 0.039512861520051956, 0.06843999028205872, 0.36701178550720215, 0.22679099440574646, -1]}
{"idB": "749647_16_item1_p183_s0", "idA": "749647_15_item1_p87_s0", "sentA": "The First-In-Man, Phase 1 clinical trial of GEN-1 monotherapy was conducted to determine the safety/tolerability of IP administered GEN-1 in platinum-resistant (Stage III and IV) ovarian cancer patients who had received 2-6 prior chemotherapy treatments.", "sentB": "Intraperitoneal administration of GEN-1 in platinum-resistant ovarian cancer patients resulted in a significant increase in IL-12 levels in peritoneal fluid samples.", "type": 2, "words": ["<tag1>", "The", "First-In-Man,", "Phase", "1", "clinical", "trial", "of", "GEN-1", "monotherapy", "was", "conducted", "to", "determine", "the", "safety/tolerability", "of", "IP", "administered", "GEN-1", "in", "platinum-resistant", "(Stage", "III", "and", "IV)", "ovarian", "cancer", "patients", "who", "had", "received", "2-6", "prior", "chemotherapy", "treatments.", "<tag2>", "Intraperitoneal", "administration", "of", "GEN-1", "in", "platinum-resistant", "ovarian", "cancer", "patients", "resulted", "in", "a", "significant", "increase", "in", "IL-12", "levels", "in", "peritoneal", "fluid", "samples.", "<tag3>"], "wordsA": ["The", "First-In-Man,", "Phase", "1", "clinical", "trial", "of", "GEN-1", "monotherapy", "was", "conducted", "to", "determine", "the", "safety/tolerability", "of", "IP", "administered", "GEN-1", "in", "platinum-resistant", "(Stage", "III", "and", "IV)", "ovarian", "cancer", "patients", "who", "had", "received", "2-6", "prior", "chemotherapy", "treatments."], "wordsB": ["Intraperitoneal", "administration", "of", "GEN-1", "in", "platinum-resistant", "ovarian", "cancer", "patients", "resulted", "in", "a", "significant", "increase", "in", "IL-12", "levels", "in", "peritoneal", "fluid", "samples."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6445913910865784, 0.39606180787086487, 0.038241468369960785, 0.1358829140663147, 0.006990327499806881, 0.019776849076151848, 0.013114893808960915, 0.01683873124420643, 0.025538668036460876, 0.024028152227401733, 0.013460541144013405, 0.009982760064303875, 0.05433809757232666, 0.1461871713399887, 0.06583145260810852, 0.3644532263278961, 0.3218482434749603, 0.04275704175233841, 0.2223077267408371, 0.20128417015075684, 0.18405047059059143, -1]}
{"idB": "749647_16_item1_p8_s0", "idA": "749647_15_item1_p8_s0", "sentA": "Celsion is a fully-integrated oncology drug development company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.", "sentB": "Celsion Corporation is a fully-integrated oncology drug development company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA- based therapies.", "type": 2, "words": ["<tag1>", "Celsion", "is", "a", "fully-integrated", "oncology", "drug", "development", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "immunotherapies", "and", "RNA-", "or", "DNA-based", "therapies.", "<tag2>", "Celsion", "Corporation", "is", "a", "fully-integrated", "oncology", "drug", "development", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA-", "based", "therapies.", "<tag3>"], "wordsA": ["Celsion", "is", "a", "fully-integrated", "oncology", "drug", "development", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "immunotherapies", "and", "RNA-", "or", "DNA-based", "therapies."], "wordsB": ["Celsion", "Corporation", "is", "a", "fully-integrated", "oncology", "drug", "development", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA-", "based", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11939245462417603, 0.8459412455558777, 0.0069257766008377075, 0.008647684939205647, 0.0513082854449749, 0.0846959725022316, 0.03204380348324776, 0.01691659353673458, 0.03681696951389313, 0.009339101612567902, 0.005927143152803183, 0.010004928335547447, 0.005508240312337875, 0.012326615862548351, 0.005605383776128292, 0.015666060149669647, 0.022034436464309692, 0.03208047151565552, 0.006846711505204439, 0.01977013237774372, 0.02391117811203003, 0.3199072480201721, 0.09667784720659256, 0.005519932601600885, 0.0312172994017601, 0.014754099771380424, 0.015446096658706665, -1]}
{"idB": "749647_16_item1_p8_s1", "idA": "749647_15_item1_p8_s1", "sentA": "Our lead program is ThermoDox , a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in a Phase III clinical trial for the treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer (the DIGNITY Study).", "sentB": "Our lead product candidate is ThermoDox , a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in a Phase III clinical trial for the treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer (the DIGNITY Study).", "type": 2, "words": ["<tag1>", "Our", "lead", "program", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag3>"], "wordsA": ["Our", "lead", "program", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02139914408326149, 0.23706963658332825, 0.8649203181266785, 0.8318126797676086, 0.01150021143257618, 0.08443508297204971, 0.00033102292218245566, 0.009134126827120781, 0.026926182210445404, 0.040005747228860855, 0.03895164653658867, 0.028981920331716537, 0.009726445190608501, 0.10286515206098557, 0.010559498332440853, 0.0062941089272499084, 0.006999880075454712, 0.02367222122848034, 0.02387182228267193, 0.016493991017341614, 0.027258239686489105, 0.006363235879689455, 0.00620513129979372, 0.01732552796602249, 0.010819565504789352, 0.060316890478134155, 0.05452931299805641, 0.03382158651947975, 0.007323187310248613, 0.021163633093237877, 0.01796778291463852, 0.007021788973361254, 0.006421305704861879, 0.01639406383037567, 0.02173212729394436, 0.01602320745587349, 0.030720213428139687, 0.0058866641484200954, 0.00613459711894393, 0.024970637634396553, 0.010258843190968037, 0.03750095143914223, 0.03129974752664566, 0.034158941358327866, 0.02208162285387516, 0.02554791048169136, 0.006297757849097252, 0.019440706819295883, 0.0349978543817997, -1]}
{"idB": "749647_16_item1_p8_s2", "idA": "749647_15_item1_p8_s2", "sentA": "Our pipeline also includes GEN-1 (formerly known as EGEN-001), a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers.", "sentB": "Second in our pipeline is GEN-1 (formerly known as EGEN-001), a DNA mediated immunotherapy for the localized treatment of ovarian and brain cancers.", "type": 2, "words": ["<tag1>", "Our", "pipeline", "also", "includes", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers.", "<tag2>", "Second", "in", "our", "pipeline", "is", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA", "mediated", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers.", "<tag3>"], "wordsA": ["Our", "pipeline", "also", "includes", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers."], "wordsB": ["Second", "in", "our", "pipeline", "is", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA", "mediated", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7322579622268677, 0.06465954333543777, 0.026580780744552612, 0.07107187062501907, 0.008756209164857864, 0.3185875415802002, 0.008892141282558441, 0.008748323656618595, 0.00476116081699729, 0.11753110587596893, 0.003855709685012698, 0.331950843334198, 0.8099122643470764, 0.07590383291244507, 0.0022079686168581247, 0.0022208071313798428, 0.007057861424982548, 0.008798203431069851, 0.002336235949769616, 0.007468019146472216, 0.003255504183471203, 0.00656127417460084, 0.007847157306969166, -1]}
{"idB": "749647_16_item1_p80_s0", "idA": "749647_15_item1_p8_s3", "sentA": "We have three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "sentB": "In the acquisition, we acquired GEN-1, an IL-12 DNA plasmid vector encased in a nanoparticle delivery system which enables cell transfection followed by persistent, local secretion of the IL-12 protein, and three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "type": 2, "words": ["<tag1>", "We", "have", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag2>", "In", "the", "acquisition,", "we", "acquired", "GEN-1,", "an", "IL-12", "DNA", "plasmid", "vector", "encased", "in", "a", "nanoparticle", "delivery", "system", "which", "enables", "cell", "transfection", "followed", "by", "persistent,", "local", "secretion", "of", "the", "IL-12", "protein,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag3>"], "wordsA": ["We", "have", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "wordsB": ["In", "the", "acquisition,", "we", "acquired", "GEN-1,", "an", "IL-12", "DNA", "plasmid", "vector", "encased", "in", "a", "nanoparticle", "delivery", "system", "which", "enables", "cell", "transfection", "followed", "by", "persistent,", "local", "secretion", "of", "the", "IL-12", "protein,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03281320258975029, 0.02957950532436371, 0.10251321643590927, 0.053403016179800034, 0.22918489575386047, 0.29843297600746155, 0.023467235267162323, 0.08102025091648102, 0.19671721756458282, 0.172061026096344, 0.13308577239513397, 0.015134195797145367, 0.012408222071826458, 0.010766127146780491, 0.0853259339928627, 0.03429613634943962, 0.028997616842389107, 0.0021081925369799137, 0.01293993555009365, 0.17411774396896362, 0.13199177384376526, 0.0013762492453679442, 0.021488821133971214, 0.02559983916580677, 0.04309583455324173, 0.05261218175292015, 0.021686987951397896, 0.019557572901248932, 0.06879037618637085, 0.07018071413040161, 0.012704978697001934, 0.010236275382339954, 0.016840096563100815, 0.025049801915884018, 0.008683666586875916, 0.011684802360832691, 0.010660610161721706, 0.00879171583801508, 0.01495631318539381, 0.010570270009338856, 0.012120911851525307, 0.016184572130441666, 0.021975595504045486, 0.024262581020593643, 0.023621629923582077, 0.012083195149898529, 0.019831741228699684, 0.01838911511003971, 0.047737907618284225, 0.034072402864694595, 0.023278215900063515, 0.009852190501987934, 0.013374319300055504, 0.028931811451911926, 0.022667916491627693, 0.012734100222587585, 0.019098762422800064, 0.01651613600552082, 0.012979320250451565, 0.03396517410874367, 0.009981421753764153, 0.026849258691072464, 0.0007427785312756896, -1]}
{"idB": "749647_16_item1_p9_s0", "idA": "749647_15_item1_p8_s4", "sentA": "We are working to develop and commercialize more efficient, effective and targeted oncology therapies based on our technologies, with the goal to develop novel therapeutics that maximize efficacy while minimizing side-effects common to cancer treatments.", "sentB": "We have three platform technologies providing the basis for the future development of a range of therapeutics for difficult-to-treat forms of cancer including: Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat, TheraPlas, a novel nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer RNA With these technologies we are working to develop and commercialize more efficient, effective and targeted oncology therapies that maximize efficacy while minimizing side-effects common to cancer treatments.", "type": 2, "words": ["<tag1>", "We", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "based", "on", "our", "technologies,", "with", "the", "goal", "to", "develop", "novel", "therapeutics", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments.", "<tag2>", "We", "have", "three", "platform", "technologies", "providing", "the", "basis", "for", "the", "future", "development", "of", "a", "range", "of", "therapeutics", "for", "difficult-to-treat", "forms", "of", "cancer", "including:", "Lysolipid", "Thermally", "Sensitive", "Liposomes,", "a", "heat", "sensitive", "liposomal", "based", "dosage", "form", "that", "targets", "disease", "with", "known", "therapeutics", "in", "the", "presence", "of", "mild", "heat,", "TheraPlas,", "a", "novel", "nucleic", "acid-based", "treatment", "for", "local", "transfection", "of", "therapeutic", "plasmids,", "and", "TheraSilence,", "a", "systemic", "dosage", "form", "for", "lung", "directed", "anti-cancer", "RNA", "With", "these", "technologies", "we", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments.", "<tag3>"], "wordsA": ["We", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "based", "on", "our", "technologies,", "with", "the", "goal", "to", "develop", "novel", "therapeutics", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments."], "wordsB": ["We", "have", "three", "platform", "technologies", "providing", "the", "basis", "for", "the", "future", "development", "of", "a", "range", "of", "therapeutics", "for", "difficult-to-treat", "forms", "of", "cancer", "including:", "Lysolipid", "Thermally", "Sensitive", "Liposomes,", "a", "heat", "sensitive", "liposomal", "based", "dosage", "form", "that", "targets", "disease", "with", "known", "therapeutics", "in", "the", "presence", "of", "mild", "heat,", "TheraPlas,", "a", "novel", "nucleic", "acid-based", "treatment", "for", "local", "transfection", "of", "therapeutic", "plasmids,", "and", "TheraSilence,", "a", "systemic", "dosage", "form", "for", "lung", "directed", "anti-cancer", "RNA", "With", "these", "technologies", "we", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01925509236752987, 0.01344633474946022, 0.1518709361553192, 0.09300219267606735, 0.087703175842762, 0.03129320964217186, 0.017248734831809998, 0.024550488218665123, 0.010885905474424362, 0.011443260125815868, 0.010268054902553558, 0.021123342216014862, 0.007534201722592115, 0.006089378148317337, 0.009517611004412174, 0.008042003959417343, 0.08596410602331161, 0.005604224745184183, 0.06384726613759995, 0.042566344141960144, 0.015706311911344528, 0.04702529311180115, 0.015592978335916996, 0.2616104781627655, 0.13261368870735168, 0.11322638392448425, 0.13794150948524475, 0.006965111941099167, 0.09845367819070816, 0.16890153288841248, 0.08232961595058441, 0.03832877427339554, 0.03903413936495781, 0.02550795115530491, 0.0017365622334182262, 0.027628472074866295, 0.04082692414522171, 0.00798298604786396, 0.02145659364759922, 0.039464693516492844, 0.014338904060423374, 0.0012108738301321864, 0.03703973814845085, 0.014808004721999168, 0.12250996381044388, 0.06649751961231232, 0.2372143566608429, 0.0033881179988384247, 0.05825885385274887, 0.2721059024333954, 0.3127351999282837, 0.1050468161702156, 0.006314160767942667, 0.06252768635749817, 0.05744926258921623, 0.006485829129815102, 0.04400027170777321, 0.04096980765461922, 0.004857785999774933, 0.03491373732686043, 0.0026672906242311, 0.03704617917537689, 0.030188972130417824, 0.01682889088988304, 0.004744683858007193, 0.02715497463941574, 0.014544208534061909, 0.018380096182227135, 0.04060995951294899, 0.0031532524153590202, 0.0025133369490504265, 0.006117493845522404, 0.0028068171814084053, 0.003482712432742119, 0.0051268027164042, 0.00413802545517683, 0.004105900879949331, 0.0043433248065412045, 0.004700760822743177, 0.0031930096447467804, 0.003887004917487502, 0.0035660210996866226, 0.006366540677845478, 0.0032899086363613605, 0.004388439003378153, 0.005196476820856333, 0.004667447879910469, 0.0031403913162648678, 0.0034842980094254017, 0.004240191541612148, 0.0037640549708157778, 0.0034266295842826366, 0.002225435571745038, 0.002186584984883666, 0.004628689493983984, 0.00678049074485898, -1]}
{"idB": "749647_16_item1_p97_s0", "idA": "749647_15_item1_p92_s0", "sentA": "Based on encouraging results from GEN-1 monotherapy Phase I and Phase II clinical trials in platinum resistant ovarian cancer patients, a Phase Ib combination trial of GEN-1 plus Doxil initiated in this patient population was conducted.", "sentB": "This new combination study in platinum-resistant ovarian cancer is supported by three preclinical studies indicating that the combination of GEN-1 with Avastin may result in clinical benefit with a favorable safety profile, as well as the prior Phase 1b trial of GEN-1 plus Doxil in platinum resistant ovarian cancer patients.", "type": 2, "words": ["<tag1>", "Based", "on", "encouraging", "results", "from", "GEN-1", "monotherapy", "Phase", "I", "and", "Phase", "II", "clinical", "trials", "in", "platinum", "resistant", "ovarian", "cancer", "patients,", "a", "Phase", "Ib", "combination", "trial", "of", "GEN-1", "plus", "Doxil", "initiated", "in", "this", "patient", "population", "was", "conducted.", "<tag2>", "This", "new", "combination", "study", "in", "platinum-resistant", "ovarian", "cancer", "is", "supported", "by", "three", "preclinical", "studies", "indicating", "that", "the", "combination", "of", "GEN-1", "with", "Avastin", "may", "result", "in", "clinical", "benefit", "with", "a", "favorable", "safety", "profile,", "as", "well", "as", "the", "prior", "Phase", "1b", "trial", "of", "GEN-1", "plus", "Doxil", "in", "platinum", "resistant", "ovarian", "cancer", "patients.", "<tag3>"], "wordsA": ["Based", "on", "encouraging", "results", "from", "GEN-1", "monotherapy", "Phase", "I", "and", "Phase", "II", "clinical", "trials", "in", "platinum", "resistant", "ovarian", "cancer", "patients,", "a", "Phase", "Ib", "combination", "trial", "of", "GEN-1", "plus", "Doxil", "initiated", "in", "this", "patient", "population", "was", "conducted."], "wordsB": ["This", "new", "combination", "study", "in", "platinum-resistant", "ovarian", "cancer", "is", "supported", "by", "three", "preclinical", "studies", "indicating", "that", "the", "combination", "of", "GEN-1", "with", "Avastin", "may", "result", "in", "clinical", "benefit", "with", "a", "favorable", "safety", "profile,", "as", "well", "as", "the", "prior", "Phase", "1b", "trial", "of", "GEN-1", "plus", "Doxil", "in", "platinum", "resistant", "ovarian", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004601833876222372, 0.07854162901639938, 0.11297034472227097, 0.11559676378965378, 0.00408187136054039, 0.012061402201652527, 0.006003988441079855, 0.0076437401585280895, 0.0046250466257333755, 0.04011792689561844, 0.005237154196947813, 0.35129237174987793, 0.5672821998596191, 0.29213717579841614, 0.017988575622439384, 0.005442350637167692, 0.005541181191802025, 0.04528219252824783, 0.013151957653462887, 0.0225190632045269, 0.01851256936788559, 0.1265900880098343, 0.011398930102586746, 0.01642465591430664, 0.007827122695744038, 0.030105948448181152, 0.02468780428171158, 0.004576344043016434, 0.0050295619294047356, 0.07919059693813324, 0.06984803825616837, 0.033486779779195786, 0.00020678354485426098, 0.004376706201583147, 0.0043970076367259026, 0.005622195079922676, 0.15029624104499817, 0.1041635125875473, 0.37521904706954956, 0.07047197967767715, 0.00628688046708703, 0.011166505515575409, 0.004631770774722099, 0.010940227657556534, 0.003226557979360223, 0.010393952950835228, 0.005493698641657829, 0.005505883600562811, 0.006637087091803551, 0.016828812658786774, -1]}
{"idB": "749647_16_item1_p102_s4", "idA": "749647_15_item1_p93_s0", "sentA": "This trial, which was a standard 3 + 3 Phase I, three cohort, dose escalation study in three cohorts which enrolled 16 evaluable patients receiving increasing doses of Doxil and GEN-1.", "sentB": "The study was designed to evaluate in a mouse model of disseminated ovarian cancer, the efficacy of a combined treatment regimen that consisted of weekly administrations of GEN-1 with therapeutically relevant doses of Doxil and Avastin .", "type": 2, "words": ["<tag1>", "This", "trial,", "which", "was", "a", "standard", "3", "+", "3", "Phase", "I,", "three", "cohort,", "dose", "escalation", "study", "in", "three", "cohorts", "which", "enrolled", "16", "evaluable", "patients", "receiving", "increasing", "doses", "of", "Doxil", "and", "GEN-1.", "<tag2>", "The", "study", "was", "designed", "to", "evaluate", "in", "a", "mouse", "model", "of", "disseminated", "ovarian", "cancer,", "the", "efficacy", "of", "a", "combined", "treatment", "regimen", "that", "consisted", "of", "weekly", "administrations", "of", "GEN-1", "with", "therapeutically", "relevant", "doses", "of", "Doxil", "and", "Avastin", ".", "<tag3>"], "wordsA": ["This", "trial,", "which", "was", "a", "standard", "3", "+", "3", "Phase", "I,", "three", "cohort,", "dose", "escalation", "study", "in", "three", "cohorts", "which", "enrolled", "16", "evaluable", "patients", "receiving", "increasing", "doses", "of", "Doxil", "and", "GEN-1."], "wordsB": ["The", "study", "was", "designed", "to", "evaluate", "in", "a", "mouse", "model", "of", "disseminated", "ovarian", "cancer,", "the", "efficacy", "of", "a", "combined", "treatment", "regimen", "that", "consisted", "of", "weekly", "administrations", "of", "GEN-1", "with", "therapeutically", "relevant", "doses", "of", "Doxil", "and", "Avastin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004379936493933201, 0.10487902909517288, 0.006475851405411959, 0.021306196227669716, 0.008928194642066956, 0.08430125564336777, 0.013629717752337456, 0.012789856642484665, 0.08067847788333893, 0.10064926743507385, 0.0210538562387228, 0.09922691434621811, 0.1481892317533493, 0.11430145800113678, 0.009749721735715866, 0.048479482531547546, 0.00706178555265069, 0.008065477944910526, 0.0777515172958374, 0.10712326318025589, 0.06871557980775833, 0.000332011841237545, 0.008198758587241173, 0.007024848368018866, 0.27832967042922974, 0.08292905241250992, 0.014584413729608059, 0.03378896415233612, 0.010051476769149303, 0.05329681187868118, 0.04976537451148033, 0.03779914975166321, 0.014870542101562023, 0.02173864282667637, 0.01751258224248886, 0.08994019031524658, 0.00010245340672554448, -1]}
{"idB": "749647_16_item1_p102_s0", "idA": "749647_15_item1_p94_s0", "sentA": "In January 2015, we announced that we submitted to the FDA a Phase I clinical trial protocol for GEN-1 for the treatment of ovarian cancer.", "sentB": "On October 12, 2015, we announced the results of an additional preclinical study to support an Investigational New Drug filing with the FDA for the planned Phase I/II combination study.", "type": 2, "words": ["<tag1>", "In", "January", "2015,", "we", "announced", "that", "we", "submitted", "to", "the", "FDA", "a", "Phase", "I", "clinical", "trial", "protocol", "for", "GEN-1", "for", "the", "treatment", "of", "ovarian", "cancer.", "<tag2>", "On", "October", "12,", "2015,", "we", "announced", "the", "results", "of", "an", "additional", "preclinical", "study", "to", "support", "an", "Investigational", "New", "Drug", "filing", "with", "the", "FDA", "for", "the", "planned", "Phase", "I/II", "combination", "study.", "<tag3>"], "wordsA": ["In", "January", "2015,", "we", "announced", "that", "we", "submitted", "to", "the", "FDA", "a", "Phase", "I", "clinical", "trial", "protocol", "for", "GEN-1", "for", "the", "treatment", "of", "ovarian", "cancer."], "wordsB": ["On", "October", "12,", "2015,", "we", "announced", "the", "results", "of", "an", "additional", "preclinical", "study", "to", "support", "an", "Investigational", "New", "Drug", "filing", "with", "the", "FDA", "for", "the", "planned", "Phase", "I/II", "combination", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017329158261418343, 0.809998631477356, 0.5583712458610535, 0.06048781797289848, 0.012314187362790108, 0.051728323101997375, 0.0216705109924078, 0.11660538613796234, 0.018860407173633575, 0.021364619955420494, 0.1100347712635994, 0.47996294498443604, 0.43909791111946106, 0.00016842053446453065, 0.007344682700932026, 0.0032246876507997513, 0.014991134405136108, 0.014541195705533028, 0.043850377202034, 0.045279353857040405, 0.0033160452730953693, 0.003274876158684492, 0.018409285694360733, 0.00384696526452899, 0.003939070273190737, 0.0295797698199749, 0.0330021008849144, 0.05756257846951485, 0.14261722564697266, 0.20073318481445312, -1]}
{"idB": "749647_16_item1_p25_s4", "idA": "749647_15_item1_p94_s1", "sentA": "The protocol, developed with guidance from the Company s Medical Advisory Board, is designed to establish a safe dose and biological activity of GEN-1 in newly diagnosed ovarian cancer patients who will be undergoing neoadjuvant chemotherapy.", "sentB": "In addition, the OVATION Study establishes a unique opportunity to assess how cytokine-based compounds such as GEN-1, directly affect ovarian cancer cells and the tumor microenvironment in newly diagnosed patients.", "type": 2, "words": ["<tag1>", "The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy.", "<tag2>", "In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affect", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients.", "<tag3>"], "wordsA": ["The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy."], "wordsB": ["In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affect", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012390819378197193, 0.006168270017951727, 0.006562564056366682, 0.1637115627527237, 0.2768324613571167, 0.016490818932652473, 0.006745353806763887, 0.0281755980104208, 0.03329092264175415, 0.009359939023852348, 0.11448948085308075, 0.06331378221511841, 0.513401985168457, 0.4609295725822449, 0.014537299983203411, 0.017681486904621124, 0.038638580590486526, 0.14615286886692047, 0.2626418173313141, 0.05515282601118088, 0.06715996563434601, 0.10825114697217941, 0.016175325959920883, 0.019656075164675713, 0.12811079621315002, 0.3132767081260681, 0.00593458442017436, 0.007888923399150372, 0.010746375657618046, 0.03146746754646301, -1]}
{"idB": "749647_16_item1_p91_s1", "idA": "749647_15_item1_p94_s1", "sentA": "The protocol, developed with guidance from the Company s Medical Advisory Board, is designed to establish a safe dose and biological activity of GEN-1 in newly diagnosed ovarian cancer patients who will be undergoing neoadjuvant chemotherapy.", "sentB": "The OVATION Study will seek to identify a safe, tolerable and therapeutically active dose of GEN-1 in newly diagnosed ovarian cancer patients who will be undergoing neo-adjuvant chemotherapy followed by surgical resection of their tumors.", "type": 2, "words": ["<tag1>", "The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy.", "<tag2>", "The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neo-adjuvant", "chemotherapy", "followed", "by", "surgical", "resection", "of", "their", "tumors.", "<tag3>"], "wordsA": ["The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy."], "wordsB": ["The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neo-adjuvant", "chemotherapy", "followed", "by", "surgical", "resection", "of", "their", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007191738113760948, 0.4643751382827759, 0.40787404775619507, 0.007507216185331345, 0.026751242578029633, 0.008601845242083073, 0.027559323236346245, 0.008896657265722752, 0.017445331439375877, 0.048978179693222046, 0.003951051272451878, 0.11393178999423981, 0.08897976577281952, 0.054026223719120026, 0.012153626419603825, 0.04281551018357277, 0.003319823881611228, 0.007457945961505175, 0.0073808329179883, 0.011181331239640713, 0.01206306740641594, 0.02384057641029358, 0.007437283638864756, 0.0033685697708278894, 0.0035632485523819923, 0.010152498260140419, 0.011776444502174854, 0.022638879716396332, 0.010390207171440125, 0.01938260905444622, 0.2698574960231781, 0.5320789813995361, 0.008372990414500237, 0.009846332482993603, 0.06010337173938751, -1]}
{"idB": "749647_16_item1_p91_s3", "idA": "749647_15_item1_p94_s1", "sentA": "The protocol, developed with guidance from the Company s Medical Advisory Board, is designed to establish a safe dose and biological activity of GEN-1 in newly diagnosed ovarian cancer patients who will be undergoing neoadjuvant chemotherapy.", "sentB": "In addition, the OVATION Study establishes a unique opportunity to assess how cytokine-based compounds such as GEN-1, directly affects ovarian cancer cells and the tumor microenvironment in newly diagnosed patients.", "type": 2, "words": ["<tag1>", "The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy.", "<tag2>", "In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affects", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients.", "<tag3>"], "wordsA": ["The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy."], "wordsB": ["In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affects", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012499989941716194, 0.0062531717121601105, 0.006602016277611256, 0.16935621201992035, 0.27859920263290405, 0.016439877450466156, 0.006839876063168049, 0.02860923670232296, 0.03328422084450722, 0.009317541494965553, 0.11094176024198532, 0.04528011009097099, 0.5087734460830688, 0.46153584122657776, 0.013819017447531223, 0.017856331542134285, 0.03802577778697014, 0.15177394449710846, 0.23275132477283478, 0.04805329442024231, 0.06485826522111893, 0.10687506198883057, 0.0166478268802166, 0.021076634526252747, 0.1307985484600067, 0.32325029373168945, 0.0060404264368116856, 0.00807290431112051, 0.010755066759884357, 0.03184086084365845, -1]}
{"idB": "749647_16_item1_p94_s0", "idA": "749647_15_item1_p94_s1", "sentA": "The protocol, developed with guidance from the Company s Medical Advisory Board, is designed to establish a safe dose and biological activity of GEN-1 in newly diagnosed ovarian cancer patients who will be undergoing neoadjuvant chemotherapy.", "sentB": "On February 12, 2016, we announced the completion of enrollment of the first cohort of patients in the OVATION Study combining GEN-1, the Company s DNA-based immunotherapy, with the standard of care for the treatment of newly-diagnosed ovarian cancer patients who will undergo neoadjuvant chemotherapy followed by surgical resection of their tumor.", "type": 2, "words": ["<tag1>", "The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy.", "<tag2>", "On", "February", "12,", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "patients", "in", "the", "OVATION", "Study", "combining", "GEN-1,", "the", "Company", "s", "DNA-based", "immunotherapy,", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "ovarian", "cancer", "patients", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection", "of", "their", "tumor.", "<tag3>"], "wordsA": ["The", "protocol,", "developed", "with", "guidance", "from", "the", "Company", "s", "Medical", "Advisory", "Board,", "is", "designed", "to", "establish", "a", "safe", "dose", "and", "biological", "activity", "of", "GEN-1", "in", "newly", "diagnosed", "ovarian", "cancer", "patients", "who", "will", "be", "undergoing", "neoadjuvant", "chemotherapy."], "wordsB": ["On", "February", "12,", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "patients", "in", "the", "OVATION", "Study", "combining", "GEN-1,", "the", "Company", "s", "DNA-based", "immunotherapy,", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "ovarian", "cancer", "patients", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection", "of", "their", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022023411467671394, 0.06219136342406273, 0.060233525931835175, 0.09634997695684433, 0.07115691900253296, 0.13987460732460022, 0.03557996824383736, 0.149754136800766, 0.07751612365245819, 0.22304432094097137, 0.020222339779138565, 0.013031776994466782, 0.06689951568841934, 0.06829951703548431, 0.041171446442604065, 0.12720021605491638, 0.008657263591885567, 0.008019517175853252, 0.06052049994468689, 0.12703050673007965, 0.021589577198028564, 0.03585215285420418, 0.00467746052891016, 0.028583064675331116, 0.011363905854523182, 0.09077367931604385, 0.08038217574357986, 0.007206256501376629, 0.006844934541732073, 0.025590362027287483, 0.018079645931720734, 0.030438916757702827, 0.0044311098754405975, 0.005322590935975313, 0.014975575730204582, 0.005061599425971508, 0.009419127367436886, 0.01209243107587099, 0.013360262848436832, 0.0320064052939415, 0.002449060557410121, 0.005014526657760143, 0.012857004068791866, 0.013744518160820007, 0.037505872547626495, 0.011515242047607899, 0.01965269260108471, 0.19788779318332672, 0.5812510251998901, 0.017546534538269043, 0.015795106068253517, 0.08158915489912033, -1]}
{"idB": "749647_16_item1_p28_s2", "idA": "749647_15_item1_p94_s5", "sentA": "We expect to initiate enrollment for the trial in the second half of 2015 at five to six U.S. clinical centers.", "sentB": "We expect to enroll patients beginning in the second half of 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "enrollment", "for", "the", "trial", "in", "the", "second", "half", "of", "2015", "at", "five", "to", "six", "U.S.", "clinical", "centers.", "<tag2>", "We", "expect", "to", "enroll", "patients", "beginning", "in", "the", "second", "half", "of", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "enrollment", "for", "the", "trial", "in", "the", "second", "half", "of", "2015", "at", "five", "to", "six", "U.S.", "clinical", "centers."], "wordsB": ["We", "expect", "to", "enroll", "patients", "beginning", "in", "the", "second", "half", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007088842336088419, 0.016892695799469948, 0.009286666288971901, 0.203727588057518, 0.21183370053768158, 0.05522400140762329, 0.015010954812169075, 0.01198469940572977, 0.027222890406847, 0.08049959689378738, 0.09201361238956451, 0.966816782951355, -1]}
{"idB": "749647_16_item1_p104_s0", "idA": "749647_15_item1_p95_s0", "sentA": "TheraPlas is a technology platform for the delivery of DNA and messenger RNA (mRNA) therapeutics via synthetic non-viral carriers and is capable of providing cell transfection for double-stranded DNA plasmids and large therapeutic RNA segments such as mRNA.", "sentB": "THERAPLAS TECHNOLOGY PLATFORM TheraPlas is a technology platform for the delivery of DNA and messenger RNA (mRNA) therapeutics via synthetic non-viral carriers and is capable of providing cell transfection for double-stranded DNA plasmids and large therapeutic RNA segments such as mRNA.", "type": 2, "words": ["<tag1>", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(mRNA)", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA.", "<tag2>", "THERAPLAS", "TECHNOLOGY", "PLATFORM", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(mRNA)", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA.", "<tag3>"], "wordsA": ["TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(mRNA)", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA."], "wordsB": ["THERAPLAS", "TECHNOLOGY", "PLATFORM", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(mRNA)", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6848956346511841, 0.1863500028848648, 0.4149177372455597, 0.4113263189792633, 0.09672175347805023, 0.0464024655520916, 0.11190799623727798, 0.2772834599018097, 0.06502290815114975, 0.0334223210811615, 0.09166944026947021, 0.05851425975561142, 0.15621091425418854, 0.06066026911139488, 0.12752370536327362, 0.09051813185214996, 0.08447869122028351, 0.05101342871785164, 0.042503442615270615, 0.1256931573152542, 0.3562706410884857, 0.1255411058664322, 0.0007421071059070528, 0.0314251147210598, 0.0826563611626625, 0.0017787825781852007, 0.10409214347600937, 0.11733142286539078, 0.1253296285867691, 0.04467897489666939, 0.13634909689426422, 0.07949186116456985, 0.06983093917369843, 0.02262272499501705, 0.06632722169160843, 0.060921549797058105, 0.07352836430072784, 0.04932855814695358, 0.036061543971300125, 0.04014278203248978, 0.10473314672708511, -1]}
{"idB": "749647_16_item1_p25_s5", "idA": "749647_15_item1_p95_s2", "sentA": "The delivery system is designed to protect the DNA/RNA from degradation and promote trafficking into cells and through intracellular compartments.", "sentB": "The study is designed to characterize the nature of the immune response triggered by GEN-1 at various levels of the patients immune system, including:", "type": 2, "words": ["<tag1>", "The", "delivery", "system", "is", "designed", "to", "protect", "the", "DNA/RNA", "from", "degradation", "and", "promote", "trafficking", "into", "cells", "and", "through", "intracellular", "compartments.", "<tag2>", "The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patients", "immune", "system,", "including:", "<tag3>"], "wordsA": ["The", "delivery", "system", "is", "designed", "to", "protect", "the", "DNA/RNA", "from", "degradation", "and", "promote", "trafficking", "into", "cells", "and", "through", "intracellular", "compartments."], "wordsB": ["The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patients", "immune", "system,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011324009858071804, 0.25680088996887207, 0.005992022808641195, 0.023051908239722252, 0.016309132799506187, 0.1753101646900177, 0.033314112573862076, 0.11359339207410812, 0.08018379658460617, 0.05170542374253273, 0.4439980983734131, 0.4044325053691864, 0.11315076053142548, 0.07711226493120193, 0.1727428138256073, 0.030958015471696854, 0.06041610613465309, 0.08957377076148987, 0.040715500712394714, 0.02461935579776764, 0.1304231882095337, 0.1700330674648285, 0.15822894871234894, 0.14480458199977875, -1]}
{"idB": "749647_16_item1_p91_s4", "idA": "749647_15_item1_p95_s2", "sentA": "The delivery system is designed to protect the DNA/RNA from degradation and promote trafficking into cells and through intracellular compartments.", "sentB": "The study is designed to characterize the nature of the immune response triggered by GEN-1 at various levels of the patients immune system, including:", "type": 2, "words": ["<tag1>", "The", "delivery", "system", "is", "designed", "to", "protect", "the", "DNA/RNA", "from", "degradation", "and", "promote", "trafficking", "into", "cells", "and", "through", "intracellular", "compartments.", "<tag2>", "The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patients", "immune", "system,", "including:", "<tag3>"], "wordsA": ["The", "delivery", "system", "is", "designed", "to", "protect", "the", "DNA/RNA", "from", "degradation", "and", "promote", "trafficking", "into", "cells", "and", "through", "intracellular", "compartments."], "wordsB": ["The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patients", "immune", "system,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011324009858071804, 0.25680088996887207, 0.005992022808641195, 0.023051908239722252, 0.016309132799506187, 0.1753101646900177, 0.033314112573862076, 0.11359339207410812, 0.08018379658460617, 0.05170542374253273, 0.4439980983734131, 0.4044325053691864, 0.11315076053142548, 0.07711226493120193, 0.1727428138256073, 0.030958015471696854, 0.06041610613465309, 0.08957377076148987, 0.040715500712394714, 0.02461935579776764, 0.1304231882095337, 0.1700330674648285, 0.15822894871234894, 0.14480458199977875, -1]}
{"idB": "749647_16_item1_p10_s0", "idA": "749647_15_item1_p9_s0", "sentA": "Our lead product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the OPTIMA study) starting in the first half of 2014 and a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study).", "sentB": "ThermoDox , is being evaluated in a Phase III clinical trial for primary liver cancer (the OPTIMA study) which was initiated in 2014 and a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study).", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "starting", "in", "the", "first", "half", "of", "2014", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "ThermoDox", ",", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "which", "was", "initiated", "in", "2014", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag3>"], "wordsA": ["Our", "lead", "product", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "starting", "in", "the", "first", "half", "of", "2014", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["ThermoDox", ",", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "which", "was", "initiated", "in", "2014", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6539018154144287, 0.00014993215154390782, 0.022485390305519104, 0.03155934065580368, 0.11628064513206482, 0.01498330757021904, 0.010528530925512314, 0.03615851327776909, 0.031198754906654358, 0.04118560627102852, 0.09223787486553192, 0.01713131181895733, 0.2634713351726532, 0.12935827672481537, 0.11115561425685883, 0.011088947765529156, 0.03201080858707428, 0.05336843803524971, 0.0007558160577900708, 0.027410823851823807, 0.30059608817100525, 0.18530015647411346, 0.09328845888376236, 0.0039307610131800175, 0.011475864797830582, 0.04167736694216728, 0.032197073101997375, 0.03425782546401024, 0.06335699558258057, 0.012894203886389732, 0.0381251685321331, 0.03423969820141792, 0.036503493785858154, 0.04911622032523155, 0.06152027100324631, 0.010215976275503635, 0.03674601763486862, 0.058896541595458984, -1]}
{"idB": "749647_17_item1_p0_s3", "idA": "749647_16_item1_p0_s3", "sentA": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost, timing and progress of development, preclinical studies, clinical trials and regulatory submissions; our or our collaborator s ability to obtain and maintain regulatory approval of any of our product candidates; possible changes in capital structure, financial condition, future working capital needs and other financial items; changes in approaches to medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks and uncertainties associated with possible acquisitions of other technologies, assets or businesses; our ability to obtain additional funds for our operations; our ability to obtain and maintain intellectual property protection for our technologies and product candidates and our ability to operate our business without infringing the intellectual property rights of others; our reliance on third parties to conduct preclinical studies or clinical trials; the rate and degree of market acceptance of any approved product candidates; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities; compliance with listing standards of The NASDAQ Capital Market; and those listed under Risk Factors below and elsewhere in this Annual Report on Form 10-K. In some cases, you can identify forward-looking statements by terminology such as expect, anticipate, estimate, plan, believe, could, intend, predict, may, should, will, would and words of similar import regarding the Company s expectations.", "sentB": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost, timing and progress of development, preclinical studies, clinical trials and regulatory submissions; our collaborators ability to obtain and maintain regulatory approval of any of our product candidates; possible changes in capital structure, financial condition, future working capital needs and other financial items; changes in approaches to medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks and uncertainties associated with possible acquisitions of other technologies, assets or businesses; our ability to obtain additional funds for our operations; our ability to obtain and maintain intellectual property protection for our technologies and product candidates and our ability to operate our business without infringing the intellectual property rights of others; our reliance on third parties to conduct preclinical studies or clinical trials; the rate and degree of market acceptance of any approved product candidates; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities; compliance with listing standards of The NASDAQ Capital Market; and those listed under Risk Factors below and elsewhere in this Annual Report on Form 10-K.", "type": 2, "words": ["<tag1>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations.", "<tag2>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "collaborators", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag3>"], "wordsA": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations."], "wordsB": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "collaborators", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.039125408977270126, 0.08744166791439056, 0.031106673181056976, 0.042604416608810425, 0.042434655129909515, 0.036522701382637024, 0.06632855534553528, 0.03412333503365517, 0.02783854305744171, 0.032032452523708344, 0.041190553456544876, 0.03200269490480423, 0.03892441466450691, 0.041463106870651245, 0.04785403609275818, 0.03650517016649246, 0.02233269065618515, 0.027341151610016823, 0.03609403595328331, 0.04498467221856117, 0.032396890223026276, 0.04834822565317154, 0.03900451213121414, 0.05746007338166237, 0.04843110963702202, 0.0425630584359169, 0.04475883021950722, 0.03735863417387009, 0.047753870487213135, 0.05357106402516365, 0.03655429184436798, 0.03693785518407822, 0.04295490309596062, 0.028405800461769104, 0.059454504400491714, 0.061360716819763184, 0.025105802342295647, 0.0549212284386158, 0.05037384107708931, 0.041211653500795364, 0.049572885036468506, 0.045073702931404114, 0.045546356588602066, 0.05936167761683464, 0.057998478412628174, 0.03397753834724426, 0.03497881814837456, 0.04038049653172493, 0.02711765468120575, 0.04963025823235512, 0.07107196748256683, 0.037770699709653854, 0.038001712411642075, 0.04559403657913208, 0.04914754629135132, 0.05227156728506088, 0.03762390464544296, 0.04221978411078453, 0.03415374085307121, 0.051457133144140244, 0.04624369367957115, 0.044084228575229645, 0.028829557821154594, 0.031561460345983505, 0.04222468286752701, 0.045396722853183746, 0.03450055047869682, 0.04507958143949509, 0.04745832830667496, 0.04609993100166321, 0.04624466225504875, 0.05083358660340309, 0.035544756799936295, 0.03806362673640251, 0.03741593286395073, 0.04651004448533058, 0.03118547983467579, 0.03868700936436653, 0.04172193631529808, 0.04785001277923584, 0.04529396444559097, 0.034258510917425156, 0.030365794897079468, 0.044583067297935486, 0.045097194612026215, 0.04276599735021591, 0.04659586399793625, 0.05073746293783188, 0.03851216286420822, 0.03215162828564644, 0.05808868631720543, 0.03044116124510765, 0.034915365278720856, 0.03370310366153717, 0.05179338529706001, 0.030100775882601738, 0.038579825311899185, 0.06038413569331169, 0.05269439145922661, 0.034846823662519455, 0.05307568237185478, 0.036372143775224686, 0.07906269282102585, 0.0629134327173233, 0.062155790627002716, 0.04939365014433861, 0.05809164047241211, 0.03886920586228371, 0.031179113313555717, 0.05844791233539581, 0.03304160758852959, 0.060996778309345245, 0.05959423631429672, 0.0650944635272026, 0.0557183101773262, 0.059819310903549194, 0.12557105720043182, 0.10772451013326645, 0.10460793972015381, 0.035980723798274994, 0.03402654454112053, 0.056452225893735886, 0.03395821154117584, 0.046157293021678925, 0.052565447986125946, 0.024273933842778206, 0.02434595674276352, 0.03075600415468216, 0.03816321864724159, 0.0358775295317173, 0.029583768919110298, 0.04823724180459976, 0.0726296529173851, 0.07937295734882355, 0.0473710373044014, 0.05780470371246338, 0.06757890433073044, 0.06253937631845474, 0.02320469357073307, 0.041062742471694946, 0.037425827234983444, 0.22970585525035858, 0.09948009252548218, 0.08430211246013641, 0.33026352524757385, 0.044021233916282654, 0.04301947355270386, 0.0727066919207573, 0.0569302998483181, 0.02788834273815155, 0.03677034378051758, 0.046297524124383926, 0.027236714959144592, 0.04729388281702995, 0.03980536386370659, 0.042955197393894196, 0.044185757637023926, 0.05791763961315155, 0.05542365461587906, 0.038479648530483246, 0.03770818933844566, 0.04813341796398163, 0.05726737156510353, 0.054481107741594315, 0.04013000428676605, 0.055363573133945465, 0.032692402601242065, 0.0619005411863327, 0.06684762239456177, 0.04478617385029793, 0.052983660250902176, 0.0383128896355629, 0.04739895462989807, 0.043783221393823624, 0.04435335099697113, 0.034871719777584076, 0.04433735832571983, 0.047555144876241684, 0.046990375965833664, 0.0388178825378418, 0.05060991272330284, 0.05188219994306564, 0.030319085344672203, 0.03754929453134537, 0.05590656399726868, 0.04180171713232994, 0.04442892223596573, 0.027297325432300568, 0.03706946223974228, 0.040102675557136536, 0.03210275247693062, 0.04034344479441643, 0.05004686117172241, 0.03580595552921295, 0.04120780900120735, 0.03834623098373413, 0.03170311450958252, 0.033945098519325256, 0.039473116397857666, 0.04063696041703224, 0.03461173176765442, 0.03716931492090225, 0.06686471402645111, -1]}
{"idB": "749647_17_item1_p1_s0", "idA": "749647_16_item1_p0_s3", "sentA": "Such factors include, among other things, unforeseen changes in the course of research and development activities and in clinical trials; possible changes in cost, timing and progress of development, preclinical studies, clinical trials and regulatory submissions; our or our collaborator s ability to obtain and maintain regulatory approval of any of our product candidates; possible changes in capital structure, financial condition, future working capital needs and other financial items; changes in approaches to medical treatment; introduction of new products by others; success or failure of our current or future collaboration arrangements, risks and uncertainties associated with possible acquisitions of other technologies, assets or businesses; our ability to obtain additional funds for our operations; our ability to obtain and maintain intellectual property protection for our technologies and product candidates and our ability to operate our business without infringing the intellectual property rights of others; our reliance on third parties to conduct preclinical studies or clinical trials; the rate and degree of market acceptance of any approved product candidates; possible actions by customers, suppliers, strategic partners, potential strategic partners, competitors and regulatory authorities; compliance with listing standards of The NASDAQ Capital Market; and those listed under Risk Factors below and elsewhere in this Annual Report on Form 10-K. In some cases, you can identify forward-looking statements by terminology such as expect, anticipate, estimate, plan, believe, could, intend, predict, may, should, will, would and words of similar import regarding the Company s expectations.", "sentB": "In some cases, you can identify forward-looking statements by terminology such as expect, anticipate, estimate, plan, believe, could, intend, predict , may, should, will, would and words of similar import regarding the Company s expectations.", "type": 2, "words": ["<tag1>", "Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations.", "<tag2>", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict", ",", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations.", "<tag3>"], "wordsA": ["Such", "factors", "include,", "among", "other", "things,", "unforeseen", "changes", "in", "the", "course", "of", "research", "and", "development", "activities", "and", "in", "clinical", "trials;", "possible", "changes", "in", "cost,", "timing", "and", "progress", "of", "development,", "preclinical", "studies,", "clinical", "trials", "and", "regulatory", "submissions;", "our", "or", "our", "collaborator", "s", "ability", "to", "obtain", "and", "maintain", "regulatory", "approval", "of", "any", "of", "our", "product", "candidates;", "possible", "changes", "in", "capital", "structure,", "financial", "condition,", "future", "working", "capital", "needs", "and", "other", "financial", "items;", "changes", "in", "approaches", "to", "medical", "treatment;", "introduction", "of", "new", "products", "by", "others;", "success", "or", "failure", "of", "our", "current", "or", "future", "collaboration", "arrangements,", "risks", "and", "uncertainties", "associated", "with", "possible", "acquisitions", "of", "other", "technologies,", "assets", "or", "businesses;", "our", "ability", "to", "obtain", "additional", "funds", "for", "our", "operations;", "our", "ability", "to", "obtain", "and", "maintain", "intellectual", "property", "protection", "for", "our", "technologies", "and", "product", "candidates", "and", "our", "ability", "to", "operate", "our", "business", "without", "infringing", "the", "intellectual", "property", "rights", "of", "others;", "our", "reliance", "on", "third", "parties", "to", "conduct", "preclinical", "studies", "or", "clinical", "trials;", "the", "rate", "and", "degree", "of", "market", "acceptance", "of", "any", "approved", "product", "candidates;", "possible", "actions", "by", "customers,", "suppliers,", "strategic", "partners,", "potential", "strategic", "partners,", "competitors", "and", "regulatory", "authorities;", "compliance", "with", "listing", "standards", "of", "The", "NASDAQ", "Capital", "Market;", "and", "those", "listed", "under", "Risk", "Factors", "below", "and", "elsewhere", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict,", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations."], "wordsB": ["In", "some", "cases,", "you", "can", "identify", "forward-looking", "statements", "by", "terminology", "such", "as", "expect,", "anticipate,", "estimate,", "plan,", "believe,", "could,", "intend,", "predict", ",", "may,", "should,", "will,", "would", "and", "words", "of", "similar", "import", "regarding", "the", "Company", "s", "expectations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007098209112882614, 0.02001194655895233, 0.02066170424222946, 0.018091682344675064, 0.017081240192055702, 0.03712834417819977, 0.0192940104752779, 0.01976635865867138, 0.006646707653999329, 0.013638977892696857, 0.008652697317302227, 0.0073473709635436535, 0.01455683819949627, 0.010219419375061989, 0.008723952807486057, 0.008465880528092384, 0.00846472755074501, 0.008944833651185036, 0.010830201208591461, 0.008688905276358128, 0.0005144951865077019, 0.006797737441956997, 0.005641405936330557, 0.00524791469797492, 0.004113910719752312, 0.0038042450323700905, 0.008081081323325634, 0.004741542041301727, 0.02587554231286049, 0.015637805685400963, 0.007077986840158701, 0.00532895140349865, 0.04611574485898018, 0.020984308794140816, 0.037074532359838486, -1]}
{"idB": "749647_17_item1_p56_s0", "idA": "749647_16_item1_p100_s0", "sentA": "The distinct biological activities of GEN-1 (immune stimulation) and Avastin (inhibition of tumor blood vessel formation) makes a sound scientific rationale for this combination approach.", "sentB": "The distinct biological activities of GEN-1 (immune stimulation) and Avastin (inhibition of tumor blood vessel formation) also suggests scientific rationale for this combination approach.", "type": 2, "words": ["<tag1>", "The", "distinct", "biological", "activities", "of", "GEN-1", "(immune", "stimulation)", "and", "Avastin", "(inhibition", "of", "tumor", "blood", "vessel", "formation)", "makes", "a", "sound", "scientific", "rationale", "for", "this", "combination", "approach.", "<tag2>", "The", "distinct", "biological", "activities", "of", "GEN-1", "(immune", "stimulation)", "and", "Avastin", "(inhibition", "of", "tumor", "blood", "vessel", "formation)", "also", "suggests", "scientific", "rationale", "for", "this", "combination", "approach.", "<tag3>"], "wordsA": ["The", "distinct", "biological", "activities", "of", "GEN-1", "(immune", "stimulation)", "and", "Avastin", "(inhibition", "of", "tumor", "blood", "vessel", "formation)", "makes", "a", "sound", "scientific", "rationale", "for", "this", "combination", "approach."], "wordsB": ["The", "distinct", "biological", "activities", "of", "GEN-1", "(immune", "stimulation)", "and", "Avastin", "(inhibition", "of", "tumor", "blood", "vessel", "formation)", "also", "suggests", "scientific", "rationale", "for", "this", "combination", "approach."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.026707304641604424, 0.1277773082256317, 0.23124906420707703, 0.2703544795513153, 0.0437566339969635, 0.2560575306415558, 0.10405438393354416, 0.12180615961551666, 0.02291058748960495, 0.1794583946466446, 0.44807669520378113, 0.047794971615076065, 0.09607024490833282, 0.09892933070659637, 0.08704200387001038, 0.0844222903251648, 0.08132057636976242, 0.7231534719467163, 0.2279626876115799, 0.24363037943840027, 0.06755401939153671, 0.030858123674988747, 0.050445470958948135, 0.09468575567007065, -1]}
{"idB": "749647_17_item1_p145_s0", "idA": "749647_16_item1_p104_s0", "sentA": "THERAPLAS TECHNOLOGY PLATFORM TheraPlas is a technology platform for the delivery of DNA and messenger RNA (mRNA) therapeutics via synthetic non-viral carriers and is capable of providing cell transfection for double-stranded DNA plasmids and large therapeutic RNA segments such as mRNA.", "sentB": "TheraPlas is a technology platform for the delivery of DNA and mRNA therapeutics via synthetic non-viral carriers and is capable of providing cell transfection for double-stranded DNA plasmids and large therapeutic RNA segments such as mRNA.", "type": 2, "words": ["<tag1>", "THERAPLAS", "TECHNOLOGY", "PLATFORM", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(mRNA)", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA.", "<tag2>", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "mRNA", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA.", "<tag3>"], "wordsA": ["THERAPLAS", "TECHNOLOGY", "PLATFORM", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(mRNA)", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA."], "wordsB": ["TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "mRNA", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6183182001113892, 0.10053152590990067, 0.037829168140888214, 0.12804757058620453, 0.34984204173088074, 0.08634984493255615, 0.029401304200291634, 0.10662855952978134, 0.08715686947107315, 0.3290911614894867, 0.1273224949836731, 0.17068925499916077, 0.08289690315723419, 0.04794186353683472, 0.08794309943914413, 0.24027122557163239, 0.14821408689022064, 0.0004452073771972209, 0.027323240414261818, 0.07426454871892929, 0.0003070139791816473, 0.07605446875095367, 0.09389741718769073, 0.09962568432092667, 0.041089978069067, 0.21783173084259033, 0.15236176550388336, 0.08254014700651169, 0.020067084580659866, 0.062202293425798416, 0.053210414946079254, 0.05466771498322487, 0.036054760217666626, 0.0260427538305521, 0.027973031625151634, 0.09067979454994202, -1]}
{"idB": "749647_17_item1_p57_s0", "idA": "749647_16_item1_p104_s0", "sentA": "THERAPLAS TECHNOLOGY PLATFORM TheraPlas is a technology platform for the delivery of DNA and messenger RNA (mRNA) therapeutics via synthetic non-viral carriers and is capable of providing cell transfection for double-stranded DNA plasmids and large therapeutic RNA segments such as mRNA.", "sentB": "TheraPlas is a technology platform for the delivery of DNA and messenger RNA ( mRNA ) therapeutics via synthetic non-viral carriers and is capable of providing cell transfection for double-stranded DNA plasmids and large therapeutic RNA segments such as mRNA.", "type": 2, "words": ["<tag1>", "THERAPLAS", "TECHNOLOGY", "PLATFORM", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(mRNA)", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA.", "<tag2>", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(", "mRNA", ")", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA.", "<tag3>"], "wordsA": ["THERAPLAS", "TECHNOLOGY", "PLATFORM", "TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(mRNA)", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA."], "wordsB": ["TheraPlas", "is", "a", "technology", "platform", "for", "the", "delivery", "of", "DNA", "and", "messenger", "RNA", "(", "mRNA", ")", "therapeutics", "via", "synthetic", "non-viral", "carriers", "and", "is", "capable", "of", "providing", "cell", "transfection", "for", "double-stranded", "DNA", "plasmids", "and", "large", "therapeutic", "RNA", "segments", "such", "as", "mRNA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4410058259963989, 0.04700927063822746, 0.02753513492643833, 0.0883885994553566, 0.2584224045276642, 0.04668563976883888, 0.0259720329195261, 0.06695666164159775, 0.054289717227220535, 0.17923451960086823, 0.08427505940198898, 0.18638703227043152, 0.13363531231880188, 0.06391660124063492, 0.09291905164718628, 0.0002668852102942765, 0.041814275085926056, 0.03391648456454277, 0.09545822441577911, 0.40078505873680115, 0.15242843329906464, 0.0007097285706549883, 0.021104073151946068, 0.05096888542175293, 0.0005718615720979869, 0.06108324974775314, 0.10010544210672379, 0.12904876470565796, 0.02921884134411812, 0.16399617493152618, 0.09061525762081146, 0.0668383240699768, 0.016661157831549644, 0.04169018939137459, 0.056868307292461395, 0.07511678338050842, 0.036226462572813034, 0.025144105777144432, 0.03195282444357872, 0.11443808674812317, -1]}
{"idB": "749647_17_item1_p9_s0", "idA": "749647_16_item1_p10_s0", "sentA": "ThermoDox , is being evaluated in a Phase III clinical trial for primary liver cancer (the OPTIMA study) which was initiated in 2014 and a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study).", "sentB": "ThermoDox is being evaluated in a Phase III clinical trial, in combination with a standardized radiofrequency ablation ( RFA ), for primary liver cancer (the OPTIMA Study ) and a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study ).", "type": 2, "words": ["<tag1>", "ThermoDox", ",", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "which", "was", "initiated", "in", "2014", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ").", "<tag3>"], "wordsA": ["ThermoDox", ",", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "study)", "which", "was", "initiated", "in", "2014", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05610354244709015, 0.005990225821733475, 0.006670943461358547, 0.025340912863612175, 0.004945040680468082, 0.003752881195396185, 0.006360890343785286, 0.005848424509167671, 0.006296223495155573, 0.01073825266212225, 0.04712624475359917, 0.4217320680618286, 0.07215337455272675, 0.05561152473092079, 0.5151848196983337, 0.9118639826774597, 0.6777524352073669, 0.07724136859178543, 0.40583905577659607, 0.0001722585438983515, 0.004618020728230476, 0.008390302769839764, 0.011627801693975925, 0.013451154343783855, 0.003257375443354249, 0.006687159184366465, 0.008810975588858128, 0.00014859542716294527, 0.0035806631203740835, 0.0036110535729676485, 0.006590227130800486, 0.0059676216915249825, 0.007932281121611595, 0.014331667684018612, 0.0031108222901821136, 0.008149084635078907, 0.008141238242387772, 0.009087256155908108, 0.008130982518196106, 0.009680149145424366, 0.0030994745902717113, 0.00831020437180996, 0.018160484731197357, 0.00016050341946538538, -1]}
{"idB": "749647_17_item1_p159_s3", "idA": "749647_16_item1_p118_s0", "sentA": "We may also consider and evaluate strategic alternatives, including investment in, or acquisition of, complementary businesses, technologies or products.", "sentB": "We may also apply for subsidies, grants or government or agency-sponsored studies that could reduce our development costs.", "type": 2, "words": ["<tag1>", "We", "may", "also", "consider", "and", "evaluate", "strategic", "alternatives,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products.", "<tag2>", "We", "may", "also", "apply", "for", "subsidies,", "grants", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs.", "<tag3>"], "wordsA": ["We", "may", "also", "consider", "and", "evaluate", "strategic", "alternatives,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products."], "wordsB": ["We", "may", "also", "apply", "for", "subsidies,", "grants", "or", "government", "or", "agency-sponsored", "studies", "that", "could", "reduce", "our", "development", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028334299102425575, 0.010251518338918686, 0.0071127754636108875, 0.38618192076683044, 0.20348410308361053, 0.3770016133785248, 0.15438617765903473, 0.017721286043524742, 0.046390242874622345, 0.014931290410459042, 0.1246085837483406, 0.3555597960948944, 0.0002903957793023437, 0.005513309966772795, 0.019339067861437798, 0.008645432069897652, 0.07768657058477402, 0.042085323482751846, -1]}
{"idB": "749647_17_item1_p10_s0", "idA": "749647_16_item1_p11_s0", "sentA": "ThermoDox is a liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers.", "sentB": "ThermoDox is a heat sensitive liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers.", "type": 2, "words": ["<tag1>", "ThermoDox", "is", "a", "liposomal", "encapsulation", "of", "doxorubicin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "the", "treatment", "of", "a", "wide", "range", "of", "cancers.", "<tag2>", "ThermoDox", "is", "a", "heat", "sensitive", "liposomal", "encapsulation", "of", "doxorubicin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "the", "treatment", "of", "a", "wide", "range", "of", "cancers.", "<tag3>"], "wordsA": ["ThermoDox", "is", "a", "liposomal", "encapsulation", "of", "doxorubicin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "the", "treatment", "of", "a", "wide", "range", "of", "cancers."], "wordsB": ["ThermoDox", "is", "a", "heat", "sensitive", "liposomal", "encapsulation", "of", "doxorubicin,", "an", "approved", "and", "frequently", "used", "oncology", "drug", "for", "the", "treatment", "of", "a", "wide", "range", "of", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05021684244275093, 0.006112746428698301, 0.009547091089189053, 0.9844277501106262, 0.939016580581665, 0.10073243826627731, 0.02448170632123947, 0.006653297692537308, 0.0444859117269516, 0.0037864644546061754, 0.00586003577336669, 0.0052265082485973835, 0.005123700015246868, 0.004616451449692249, 0.006429396569728851, 0.010967498645186424, 0.0028200370725244284, 0.0028439548332244158, 0.006246561650186777, 0.0030519512947648764, 0.002920817118138075, 0.005594740156084299, 0.004981685429811478, 0.0033677229657769203, 0.007556983735412359, -1]}
{"idB": "749647_17_item1_p10_s1", "idA": "749647_16_item1_p11_s1", "sentA": "Localized heat at hyperthermia temperatures (greater than 40 Celsius) releases the encapsulated doxorubicin from the liposome enabling high concentrations of doxorubicin to be deposited preferentially in and around the targeted tumor while minimizing systemic side effects common with chemotherapy treatments like doxorubicin.", "sentB": "Localized heat at hyperthermia temperatures (greater than 40 degrees Celsius) releases the encapsulated doxorubicin from the liposome enabling high concentrations of doxorubicin to be deposited preferentially in and around the targeted tumor.", "type": 2, "words": ["<tag1>", "Localized", "heat", "at", "hyperthermia", "temperatures", "(greater", "than", "40", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor", "while", "minimizing", "systemic", "side", "effects", "common", "with", "chemotherapy", "treatments", "like", "doxorubicin.", "<tag2>", "Localized", "heat", "at", "hyperthermia", "temperatures", "(greater", "than", "40", "degrees", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor.", "<tag3>"], "wordsA": ["Localized", "heat", "at", "hyperthermia", "temperatures", "(greater", "than", "40", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor", "while", "minimizing", "systemic", "side", "effects", "common", "with", "chemotherapy", "treatments", "like", "doxorubicin."], "wordsB": ["Localized", "heat", "at", "hyperthermia", "temperatures", "(greater", "than", "40", "degrees", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "and", "around", "the", "targeted", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015074568800628185, 0.022043069824576378, 0.0049577453173696995, 0.019645800814032555, 0.011098631657660007, 0.05484442412853241, 0.03536396846175194, 0.05804380774497986, 0.8964362144470215, 0.3055087625980377, 0.03903483971953392, 0.014857611618936062, 0.06333155930042267, 0.07499492913484573, 0.007334927562624216, 0.007463610265403986, 0.022037865594029427, 0.006971294526010752, 0.01885596476495266, 0.023416291922330856, 0.007744111120700836, 0.07801147550344467, 0.006761573720723391, 0.00784253515303135, 0.015998806804418564, 0.02272009663283825, 0.007123877294361591, 0.011328537948429585, 0.010329419746994972, 0.006817413493990898, 0.020310519263148308, 0.03606008365750313, -1]}
{"idB": "749647_17_item1_p163_s0", "idA": "749647_16_item1_p122_s0", "sentA": "RESEARCH AND DEVELOPMENT EXPENDITURES We are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "sentB": "We are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "type": 2, "words": ["<tag1>", "RESEARCH", "AND", "DEVELOPMENT", "EXPENDITURES", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag2>", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag3>"], "wordsA": ["RESEARCH", "AND", "DEVELOPMENT", "EXPENDITURES", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "wordsB": ["We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.35067322850227356, 0.06480298936367035, 0.3674084544181824, 0.05106140673160553, 0.028818240389227867, 0.3007061779499054, 0.15023602545261383, 0.03779793530702591, 0.10366682708263397, 0.0692206546664238, 0.10686209052801132, 0.031505487859249115, 0.13143953680992126, 0.16126522421836853, 0.10311949998140335, 0.0009762084810063243, 0.017445189878344536, 0.12339796125888824, 0.09644613415002823, 0.06537656486034393, 0.017037274315953255, 0.03149321302771568, 0.01928558014333248, 0.026094963774085045, 0.058720603585243225, 0.07045431435108185, 0.020563466474413872, 0.01566401682794094, 0.0671442523598671, 0.11738049238920212, 0.08509982377290726, 0.0181184820830822, 0.07127854973077774, 0.057260267436504364, -1]}
{"idB": "749647_17_item1_p23_s1", "idA": "749647_16_item1_p122_s1", "sentA": "We are currently, with minimal cash expenditures, sponsoring clinical and pre-clinical research at the University of Oxford, University of Utrecht, Brigham and Women s Hospital and the University of Washington.", "sentB": "We commissioned an independent computational model at the University of South Carolina Medical School.", "type": 2, "words": ["<tag1>", "We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington.", "<tag2>", "We", "commissioned", "an", "independent", "computational", "model", "at", "the", "University", "of", "South", "Carolina", "Medical", "School.", "<tag3>"], "wordsA": ["We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington."], "wordsB": ["We", "commissioned", "an", "independent", "computational", "model", "at", "the", "University", "of", "South", "Carolina", "Medical", "School."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.032858770340681076, 0.2311139553785324, 0.077309250831604, 0.32912787795066833, 0.43644389510154724, 0.35807090997695923, 0.030508801341056824, 0.026379965245723724, 0.16638632118701935, 0.107559435069561, 0.7423781156539917, 0.7341257333755493, 0.36208024621009827, 0.41236257553100586, -1]}
{"idB": "749647_17_item1_p83_s1", "idA": "749647_16_item1_p122_s1", "sentA": "We are currently, with minimal cash expenditures, sponsoring clinical and pre-clinical research at the University of Oxford, University of Utrecht, Brigham and Women s Hospital and the University of Washington.", "sentB": "We commissioned an independent computational model at the University of South Carolina Medical School.", "type": 2, "words": ["<tag1>", "We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington.", "<tag2>", "We", "commissioned", "an", "independent", "computational", "model", "at", "the", "University", "of", "South", "Carolina", "Medical", "School.", "<tag3>"], "wordsA": ["We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington."], "wordsB": ["We", "commissioned", "an", "independent", "computational", "model", "at", "the", "University", "of", "South", "Carolina", "Medical", "School."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.032858770340681076, 0.2311139553785324, 0.077309250831604, 0.32912787795066833, 0.43644389510154724, 0.35807090997695923, 0.030508801341056824, 0.026379965245723724, 0.16638632118701935, 0.107559435069561, 0.7423781156539917, 0.7341257333755493, 0.36208024621009827, 0.41236257553100586, -1]}
{"idB": "749647_17_item1_p163_s3", "idA": "749647_16_item1_p122_s3", "sentA": "Research and development expenses were approximately $14.7 million, $15.0 million and $9.4 million for the years ended December 31, 2015, 2014 and 2013, respectively.", "sentB": "Research and development expenses were approximately $14.6 million and $14.7 million for the years ended December 31, 2016 and 2015, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$14.7", "million,", "$15.0", "million", "and", "$9.4", "million", "for", "the", "years", "ended", "December", "31,", "2015,", "2014", "and", "2013,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "were", "approximately", "$14.6", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$14.7", "million,", "$15.0", "million", "and", "$9.4", "million", "for", "the", "years", "ended", "December", "31,", "2015,", "2014", "and", "2013,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "were", "approximately", "$14.6", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004216300323605537, 0.003013343084603548, 0.004433677066117525, 0.007785941939800978, 0.002779761329293251, 0.004896247759461403, 0.17524057626724243, 0.009875299409031868, 0.00473850267007947, 0.10915909707546234, 0.013333224691450596, 0.003076943103224039, 0.0032833758741617203, 0.006582328118383884, 0.00722546735778451, 0.006563391536474228, 0.008223838172852993, 0.9604058265686035, 0.02554595284163952, 0.09161865711212158, 0.005350010935217142, -1]}
{"idB": "749647_17_item1_p162_s7", "idA": "749647_16_item1_p122_s4", "sentA": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operation s for additional information regarding expenditures related to our research and development programs.", "sentB": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operation s for additional information regarding the Company s financial condition, liquidity and capital resources.", "type": 2, "words": ["<tag1>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs.", "<tag2>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "the", "Company", "s", "financial", "condition,", "liquidity", "and", "capital", "resources.", "<tag3>"], "wordsA": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs."], "wordsB": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "the", "Company", "s", "financial", "condition,", "liquidity", "and", "capital", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010041186586022377, 0.012204453349113464, 0.01143432967364788, 0.008950135670602322, 0.00616554357111454, 0.006638027261942625, 0.0034768658224493265, 0.005443651229143143, 0.004241530783474445, 0.005650057923048735, 0.0053313979879021645, 0.0029353704303503036, 0.004064231179654598, 0.0032213940285146236, 0.0065893568098545074, 0.005350041668862104, 0.002614811761304736, 0.004555337131023407, 0.028140608221292496, 0.01700841262936592, 0.015229801647365093, 0.12681610882282257, 0.07838818430900574, 0.1102883517742157, 0.15106655657291412, 0.9088765382766724, 0.2915198504924774, 0.7977541089057922, 0.8093587160110474, -1]}
{"idB": "749647_17_item1_p164_s0", "idA": "749647_16_item1_p123_s0", "sentA": "GOVERNMENT REGULATION Government authorities in the United States, at the federal, state and local level, and in other countries extensively regulate, among other things, the research, development, testing, quality control, approval, manufacturing, labeling, post-approval monitoring and reporting, recordkeeping, packaging, promotion, storage, advertising, distribution, marketing and export and import of pharmaceutical products such as those we are developing.", "sentB": "Government authorities in the U.S., at the federal, state and local level, and in other countries extensively regulate, among other things, the research, development, testing, quality control, approval, manufacturing, labeling, post-approval monitoring and reporting, recordkeeping, packaging, promotion, storage, advertising, distribution, marketing and export and import of pharmaceutical products such as those we are developing.", "type": 2, "words": ["<tag1>", "GOVERNMENT", "REGULATION", "Government", "authorities", "in", "the", "United", "States,", "at", "the", "federal,", "state", "and", "local", "level,", "and", "in", "other", "countries", "extensively", "regulate,", "among", "other", "things,", "the", "research,", "development,", "testing,", "quality", "control,", "approval,", "manufacturing,", "labeling,", "post-approval", "monitoring", "and", "reporting,", "recordkeeping,", "packaging,", "promotion,", "storage,", "advertising,", "distribution,", "marketing", "and", "export", "and", "import", "of", "pharmaceutical", "products", "such", "as", "those", "we", "are", "developing.", "<tag2>", "Government", "authorities", "in", "the", "U.S.,", "at", "the", "federal,", "state", "and", "local", "level,", "and", "in", "other", "countries", "extensively", "regulate,", "among", "other", "things,", "the", "research,", "development,", "testing,", "quality", "control,", "approval,", "manufacturing,", "labeling,", "post-approval", "monitoring", "and", "reporting,", "recordkeeping,", "packaging,", "promotion,", "storage,", "advertising,", "distribution,", "marketing", "and", "export", "and", "import", "of", "pharmaceutical", "products", "such", "as", "those", "we", "are", "developing.", "<tag3>"], "wordsA": ["GOVERNMENT", "REGULATION", "Government", "authorities", "in", "the", "United", "States,", "at", "the", "federal,", "state", "and", "local", "level,", "and", "in", "other", "countries", "extensively", "regulate,", "among", "other", "things,", "the", "research,", "development,", "testing,", "quality", "control,", "approval,", "manufacturing,", "labeling,", "post-approval", "monitoring", "and", "reporting,", "recordkeeping,", "packaging,", "promotion,", "storage,", "advertising,", "distribution,", "marketing", "and", "export", "and", "import", "of", "pharmaceutical", "products", "such", "as", "those", "we", "are", "developing."], "wordsB": ["Government", "authorities", "in", "the", "U.S.,", "at", "the", "federal,", "state", "and", "local", "level,", "and", "in", "other", "countries", "extensively", "regulate,", "among", "other", "things,", "the", "research,", "development,", "testing,", "quality", "control,", "approval,", "manufacturing,", "labeling,", "post-approval", "monitoring", "and", "reporting,", "recordkeeping,", "packaging,", "promotion,", "storage,", "advertising,", "distribution,", "marketing", "and", "export", "and", "import", "of", "pharmaceutical", "products", "such", "as", "those", "we", "are", "developing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06499424576759338, 0.1616024225950241, 0.02120397984981537, 0.01757555827498436, 0.17796912789344788, 0.020354386419057846, 0.017725719138979912, 0.03360932320356369, 0.030233420431613922, 0.025695819407701492, 0.030744245275855064, 0.035774532705545425, 0.013273587450385094, 0.018428122624754906, 0.03516145423054695, 0.049823109060525894, 0.03609972447156906, 0.1584266722202301, 0.033675987273454666, 0.030188219621777534, 0.03843022882938385, 0.01775350421667099, 0.04555491358041763, 0.03490385040640831, 0.03655131906270981, 0.02842213585972786, 0.03212983161211014, 0.030810657888650894, 0.0310689564794302, 0.04759863391518593, 0.04956936091184616, 0.0363524854183197, 0.022418225184082985, 0.034134771674871445, 0.029749618843197823, 0.054921720176935196, 0.03657463192939758, 0.035284899175167084, 0.03867536038160324, 0.03752944990992546, 0.032970163971185684, 0.020173557102680206, 0.03082890436053276, 0.016378754749894142, 0.03164365887641907, 0.016759924590587616, 0.029675962403416634, 0.028293948620557785, 0.016326045617461205, 0.013314781710505486, 0.011901909485459328, 0.01611824706196785, 0.0227894876152277, 0.08149474114179611, -1]}
{"idB": "749647_17_item1_p165_s0", "idA": "749647_16_item1_p124_s0", "sentA": "Regulation in the United States In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (FDCA) and implementing regulations.", "sentB": "In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (FDCA) and implementing regulations.", "type": 2, "words": ["<tag1>", "Regulation", "in", "the", "United", "States", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations.", "<tag2>", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations.", "<tag3>"], "wordsA": ["Regulation", "in", "the", "United", "States", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations."], "wordsB": ["In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016329877078533173, 0.013986393809318542, 0.04328042268753052, 0.06516670435667038, 0.011994143016636372, 0.7543765902519226, 0.4156076908111572, 0.5395278334617615, 0.032013364136219025, 0.01943565346300602, 0.048248834908008575, 0.06769145280122757, 0.037791430950164795, 0.031440433114767075, 0.053778212517499924, 0.10534173995256424, 0.09999322146177292, 0.0144386887550354, 0.022299522534012794, 0.030203357338905334, -1]}
{"idB": "749647_17_item1_p166_s0", "idA": "749647_16_item1_p125_s0", "sentA": "Research and Development The vehicle by which FDA approves a new pharmaceutical product for sale and marketing in the United States is a New Drug Application (NDA).", "sentB": "The vehicle by which FDA approves a new pharmaceutical product for sale and marketing in the U.S. is a New Drug Application ( NDA ).", "type": 2, "words": ["<tag1>", "Research", "and", "Development", "The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "United", "States", "is", "a", "New", "Drug", "Application", "(NDA).", "<tag2>", "The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "U.S.", "is", "a", "New", "Drug", "Application", "(", "NDA", ").", "<tag3>"], "wordsA": ["Research", "and", "Development", "The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "United", "States", "is", "a", "New", "Drug", "Application", "(NDA)."], "wordsB": ["The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "U.S.", "is", "a", "New", "Drug", "Application", "(", "NDA", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007240149192512035, 0.10399860888719559, 0.038230907171964645, 0.011726860888302326, 0.4931873679161072, 0.5688503384590149, 0.016977382823824883, 0.038803581148386, 0.06507179886102676, 0.04312528297305107, 0.008395565673708916, 0.00956228468567133, 0.007493227254599333, 0.008256407454609871, 0.009747005999088287, 0.015620535239577293, 0.7415048480033875, 0.012635069899260998, 0.009677745401859283, 0.031054891645908356, 0.0344998799264431, 0.024916132912039757, 0.009848438203334808, 0.03784841671586037, 0.00012744453852064908, -1]}
{"idB": "749647_17_item1_p169_s1", "idA": "749647_16_item1_p128_s1", "sentA": "Phase I clinical trials may be conducted in patients or healthy volunteers to evaluate the product s safety, dosage tolerance and pharmacokinetics and, if possible, seek to gain an early indication of its effectiveness.", "sentB": "Phase I clinical trials may be conducted in patients or healthy volunteers to evaluate the product's safety, dosage tolerance and pharmacokinetics and, if possible, seek to gain an early indication of its effectiveness.", "type": 2, "words": ["<tag1>", "Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product", "s", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness.", "<tag2>", "Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product's", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness.", "<tag3>"], "wordsA": ["Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product", "s", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness."], "wordsB": ["Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product's", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.19976048171520233, 0.29731693863868713, 0.12837068736553192, 0.21351629495620728, 0.07012048363685608, 0.04926168918609619, 0.10455349832773209, 0.12159235775470734, 0.19864130020141602, 0.09511677920818329, 0.5972605347633362, 0.317389577627182, 0.08414016664028168, 0.12391999363899231, 0.06801381707191467, 0.21837231516838074, 0.15540830790996552, 0.0985955148935318, 0.17016275227069855, 0.057126011699438095, 0.09254282712936401, 0.032587721943855286, 0.09156389534473419, 0.10903923958539963, 0.08329298347234726, 0.0674106553196907, 0.1193208172917366, 0.06195088103413582, 0.10363451391458511, 0.11315302550792694, 0.05490073561668396, 0.06791528314352036, 0.1500309556722641, -1]}
{"idB": "749647_17_item1_p25_s0", "idA": "749647_16_item1_p12_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with radio frequency ablation (RFA) did not meet the primary endpoint of progression free survival (PFS) for the 701 patient clinical trial in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer (the HEAT Study).", "sentB": "On January 31, 2013, the Company announced that the HEAT Study, ThermoDox in combination with RFA, did not meet the primary endpoint, PFS, of a Phase III clinical trial enrolling 701 patients with primary liver cancer.", "type": 2, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "did", "not", "meet", "the", "primary", "endpoint", "of", "progression", "free", "survival", "(PFS)", "for", "the", "701", "patient", "clinical", "trial", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer", "(the", "HEAT", "Study).", "<tag2>", "On", "January", "31,", "2013,", "the", "Company", "announced", "that", "the", "HEAT", "Study,", "ThermoDox", "in", "combination", "with", "RFA,", "did", "not", "meet", "the", "primary", "endpoint,", "PFS,", "of", "a", "Phase", "III", "clinical", "trial", "enrolling", "701", "patients", "with", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "did", "not", "meet", "the", "primary", "endpoint", "of", "progression", "free", "survival", "(PFS)", "for", "the", "701", "patient", "clinical", "trial", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer", "(the", "HEAT", "Study)."], "wordsB": ["On", "January", "31,", "2013,", "the", "Company", "announced", "that", "the", "HEAT", "Study,", "ThermoDox", "in", "combination", "with", "RFA,", "did", "not", "meet", "the", "primary", "endpoint,", "PFS,", "of", "a", "Phase", "III", "clinical", "trial", "enrolling", "701", "patients", "with", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0035090914461761713, 0.004533737897872925, 0.004979753401130438, 0.005935817025601864, 0.003352946601808071, 0.04924796521663666, 0.03547896817326546, 0.0055800629779696465, 0.002687513828277588, 0.00966738536953926, 0.029624594375491142, 0.011356252245604992, 0.003791969269514084, 0.005848939996212721, 0.005628808401525021, 0.02166805975139141, 0.19093962013721466, 0.28014132380485535, 0.10845309495925903, 0.016157275065779686, 0.03897032141685486, 0.045651875436306, 0.049987610429525375, 0.002974976086989045, 0.005367410834878683, 0.04301145300269127, 0.13699716329574585, 0.04132179170846939, 0.06268000602722168, 0.027906304225325584, 0.015485258772969246, 0.05714595690369606, 0.021478913724422455, 0.06682801991701126, 0.07306448370218277, 0.07204067707061768, -1]}
{"idB": "749647_17_item1_p25_s1", "idA": "749647_16_item1_p12_s1", "sentA": "We determined, after conferring with the HEAT Study s independent Data Monitoring Committee (iDMC), that the HEAT Study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness, that being a clinically meaningful improvement in progression free survival (PFS), that could form the basis for regulatory approval.", "sentB": "This determination was made after conferring with the HEAT Study independent Data Monitoring Committee, that the HEAT Study did not meet the goal of demonstrating a clinically meaningful improvement in progression free survival.", "type": 2, "words": ["<tag1>", "We", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "s", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness,", "that", "being", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival", "(PFS),", "that", "could", "form", "the", "basis", "for", "regulatory", "approval.", "<tag2>", "This", "determination", "was", "made", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival.", "<tag3>"], "wordsA": ["We", "determined,", "after", "conferring", "with", "the", "HEAT", "Study", "s", "independent", "Data", "Monitoring", "Committee", "(iDMC),", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness,", "that", "being", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival", "(PFS),", "that", "could", "form", "the", "basis", "for", "regulatory", "approval."], "wordsB": ["This", "determination", "was", "made", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004691279958933592, 0.05149524658918381, 0.008481841534376144, 0.008852788247168064, 0.013228185474872589, 0.010666883550584316, 0.0035071312449872494, 0.0035274233669042587, 0.01311514712870121, 0.015285017900168896, 0.008506136946380138, 0.009597093798220158, 0.01170315220952034, 0.011911316774785519, 0.010627955198287964, 0.006599048618227243, 0.02501535415649414, 0.079990915954113, 0.7632067799568176, 0.8319814801216125, 0.41191771626472473, 0.09933280199766159, 0.11618446558713913, 0.035434409976005554, 0.218609020113945, 0.10485992580652237, 0.12002995610237122, 0.09086815267801285, 0.130613312125206, 0.026718275621533394, 0.0576593354344368, 0.033622581511735916, 0.08164947479963303, -1]}
{"idB": "749647_17_item1_p176_s0", "idA": "749647_16_item1_p136_s0", "sentA": "Post-Approval Requirements After FDA approval of a product is obtained, we and our contract manufacturers are required to comply with various post-approval requirements, including establishment registration and product listing, record-keeping requirements, reporting of adverse reactions and production problems to the FDA, providing updated safety and efficacy information, and complying with requirements concerning advertising and promotional labeling.", "sentB": "After FDA approval of a product is obtained, we and our contract manufacturers are required to comply with various post-approval requirements, including establishment registration and product listing, record-keeping requirements, reporting of adverse reactions and production problems to the FDA, providing updated safety and efficacy information, and complying with requirements concerning advertising and promotional labeling.", "type": 2, "words": ["<tag1>", "Post-Approval", "Requirements", "After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling.", "<tag2>", "After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling.", "<tag3>"], "wordsA": ["Post-Approval", "Requirements", "After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling."], "wordsB": ["After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.17503060400485992, 0.26852089166641235, 0.39864614605903625, 0.08648273348808289, 0.08109849691390991, 0.1383311152458191, 0.07571858167648315, 0.13692234456539154, 0.11566545069217682, 0.09212487936019897, 0.06182396784424782, 0.15895168483257294, 0.30759119987487793, 0.0533919557929039, 0.20805445313453674, 0.087050661444664, 0.09797130525112152, 0.0589604526758194, 0.05879298970103264, 0.097773976624012, 0.07043599337339401, 0.040084682404994965, 0.06991182267665863, 0.13080300390720367, 0.05760691687464714, 0.08421682566404343, 0.10844563692808151, 0.06848043948411942, 0.06766361743211746, 0.0664086565375328, 0.06671416014432907, 0.10382744669914246, 0.10919699817895889, 0.04983903467655182, 0.06691747158765793, 0.08315696567296982, 0.0558239221572876, 0.05245300009846687, 0.07769782096147537, 0.06189734488725662, 0.07056290656328201, 0.08692973107099533, 0.05890053138136864, 0.0717778131365776, 0.08029746264219284, 0.02879282645881176, 0.17843104898929596, 0.09447045624256134, 0.11779206991195679, 0.06508748978376389, 0.0945642739534378, 0.06419350206851959, 0.07837913185358047, 0.10278390347957611, -1]}
{"idB": "749647_17_item1_p182_s1", "idA": "749647_16_item1_p143_s1", "sentA": "As established by the EMA, orphan drug designation provides for scientific advice and regulatory assistance from the EMA, direct access to centralized marketing authorization and certain financial incentives, such as reduction of fees associated with pre-authorization inspections and marketing authorization application fees.", "sentB": "As established by the European Medicines Agency ( EMA ), orphan drug designation provides for scientific advice and regulatory assistance from the EMA, direct access to centralized marketing authorization and certain financial incentives, such as reduction of fees associated with pre-authorization inspections and marketing authorization application fees.", "type": 2, "words": ["<tag1>", "As", "established", "by", "the", "EMA,", "orphan", "drug", "designation", "provides", "for", "scientific", "advice", "and", "regulatory", "assistance", "from", "the", "EMA,", "direct", "access", "to", "centralized", "marketing", "authorization", "and", "certain", "financial", "incentives,", "such", "as", "reduction", "of", "fees", "associated", "with", "pre-authorization", "inspections", "and", "marketing", "authorization", "application", "fees.", "<tag2>", "As", "established", "by", "the", "European", "Medicines", "Agency", "(", "EMA", "),", "orphan", "drug", "designation", "provides", "for", "scientific", "advice", "and", "regulatory", "assistance", "from", "the", "EMA,", "direct", "access", "to", "centralized", "marketing", "authorization", "and", "certain", "financial", "incentives,", "such", "as", "reduction", "of", "fees", "associated", "with", "pre-authorization", "inspections", "and", "marketing", "authorization", "application", "fees.", "<tag3>"], "wordsA": ["As", "established", "by", "the", "EMA,", "orphan", "drug", "designation", "provides", "for", "scientific", "advice", "and", "regulatory", "assistance", "from", "the", "EMA,", "direct", "access", "to", "centralized", "marketing", "authorization", "and", "certain", "financial", "incentives,", "such", "as", "reduction", "of", "fees", "associated", "with", "pre-authorization", "inspections", "and", "marketing", "authorization", "application", "fees."], "wordsB": ["As", "established", "by", "the", "European", "Medicines", "Agency", "(", "EMA", "),", "orphan", "drug", "designation", "provides", "for", "scientific", "advice", "and", "regulatory", "assistance", "from", "the", "EMA,", "direct", "access", "to", "centralized", "marketing", "authorization", "and", "certain", "financial", "incentives,", "such", "as", "reduction", "of", "fees", "associated", "with", "pre-authorization", "inspections", "and", "marketing", "authorization", "application", "fees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006143880542367697, 0.01737178862094879, 0.012381820008158684, 0.01598110795021057, 0.8230017423629761, 0.80046546459198, 0.8499161601066589, 0.07852336764335632, 0.1754777580499649, 0.0007727628690190613, 0.022650346159934998, 0.015916544944047928, 0.014819050207734108, 0.00832539051771164, 0.010768779553472996, 0.009855973534286022, 0.012340981513261795, 0.008318284526467323, 0.00958411768078804, 0.010063487105071545, 0.004761865828186274, 0.00783414114266634, 0.024945732206106186, 0.008585874922573566, 0.009749652817845345, 0.007530027534812689, 0.00911606103181839, 0.010619184002280235, 0.01045500673353672, 0.007777039427310228, 0.006552757229655981, 0.007754751015454531, 0.009927701205015182, 0.008694879710674286, 0.007332559674978256, 0.00625196285545826, 0.0067148106172680855, 0.008461054414510727, 0.00462369667366147, 0.005083093419671059, 0.012687573209404945, 0.007715802639722824, 0.005069294478744268, 0.007430728524923325, 0.008805880323052406, 0.008270949125289917, 0.009386792778968811, -1]}
{"idB": "749647_17_item1_p188_s1", "idA": "749647_16_item1_p149_s1", "sentA": "We face, and will continue to face, intense competition from pharmaceutical and biotechnology companies, as well as academic and research institutions and government agencies both in the U.S. and abroad.", "sentB": "We face, and will continue to face, competition from pharmaceutical and biotechnology companies, as well as academic and research institutions and government agencies both in the U.S. and abroad.", "type": 2, "words": ["<tag1>", "We", "face,", "and", "will", "continue", "to", "face,", "intense", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad.", "<tag2>", "We", "face,", "and", "will", "continue", "to", "face,", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad.", "<tag3>"], "wordsA": ["We", "face,", "and", "will", "continue", "to", "face,", "intense", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad."], "wordsB": ["We", "face,", "and", "will", "continue", "to", "face,", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.48677101731300354, 0.31370705366134644, 0.06786014884710312, 0.10469164699316025, 0.1856071501970291, 0.07913631200790405, 0.12653325498104095, 0.3841763138771057, 0.06228558346629143, 0.17510776221752167, 0.07705499976873398, 0.10367437452077866, 0.183783158659935, 0.030398188158869743, 0.023147210478782654, 0.01826608180999756, 0.05856713280081749, 0.03017827309668064, 0.052370306104421616, 0.07230851799249649, 0.01631181128323078, 0.04468685761094093, 0.07475212961435318, 0.06982449442148209, 0.062199145555496216, 0.04792509973049164, 0.1371874064207077, 0.05160433053970337, 0.097882941365242, -1]}
{"idB": "749647_17_item1_p27_s0", "idA": "749647_16_item1_p14_s0", "sentA": "Following the announcement of the HEAT Study results, we have continued to follow patients for Overall Survival (OS), the secondary endpoint of the HEAT Study.", "sentB": "Following the announcement of the HEAT Study results, we continued to follow patients for OS, the secondary endpoint of the HEAT Study.", "type": 2, "words": ["<tag1>", "Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "have", "continued", "to", "follow", "patients", "for", "Overall", "Survival", "(OS),", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study.", "<tag2>", "Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "continued", "to", "follow", "patients", "for", "OS,", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "have", "continued", "to", "follow", "patients", "for", "Overall", "Survival", "(OS),", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study."], "wordsB": ["Following", "the", "announcement", "of", "the", "HEAT", "Study", "results,", "we", "continued", "to", "follow", "patients", "for", "OS,", "the", "secondary", "endpoint", "of", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01472126692533493, 0.00455203652381897, 0.021081775426864624, 0.004279045853763819, 0.0044935476034879684, 0.09643351286649704, 0.029955174773931503, 0.034457799047231674, 0.02445237524807453, 0.10737799853086472, 0.06601163744926453, 0.34704652428627014, 0.3159657418727875, 0.08446609228849411, 0.6464275121688843, 0.007746449671685696, 0.02337939664721489, 0.02191161923110485, 0.002484778640791774, 0.004279275890439749, 0.03247276321053505, 0.03974851220846176, -1]}
{"idB": "749647_17_item1_p135_s0", "idA": "749647_16_item1_p14_s1", "sentA": "We have conducted a comprehensive analysis of the data from the HEAT Study to assess the future strategic value and development strategy for ThermoDox .", "sentB": "Additional immune analysis of biological tissue including cytokine ELISA from the first two patient cohorts and a complete analysis of the two higher dose cohorts is in progress.", "type": 2, "words": ["<tag1>", "We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "and", "development", "strategy", "for", "ThermoDox", ".", "<tag2>", "Additional", "immune", "analysis", "of", "biological", "tissue", "including", "cytokine", "ELISA", "from", "the", "first", "two", "patient", "cohorts", "and", "a", "complete", "analysis", "of", "the", "two", "higher", "dose", "cohorts", "is", "in", "progress.", "<tag3>"], "wordsA": ["We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "and", "development", "strategy", "for", "ThermoDox", "."], "wordsB": ["Additional", "immune", "analysis", "of", "biological", "tissue", "including", "cytokine", "ELISA", "from", "the", "first", "two", "patient", "cohorts", "and", "a", "complete", "analysis", "of", "the", "two", "higher", "dose", "cohorts", "is", "in", "progress."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03853034973144531, 0.5946377515792847, 0.6160247325897217, 0.02185693383216858, 0.26735004782676697, 0.24113701283931732, 0.011437921784818172, 0.138809472322464, 0.2338617593050003, 0.0037626761477440596, 0.00427882419899106, 0.027409352362155914, 0.05257096886634827, 0.10649442672729492, 0.039783164858818054, 0.0008251599501818419, 0.003491833107545972, 0.19715754687786102, 0.06200340762734413, 0.003937727306038141, 0.004071514122188091, 0.0407034307718277, 0.21905337274074554, 0.30158621072769165, 0.09390176087617874, 0.0030490029603242874, 0.008150803856551647, 0.016100993379950523, -1]}
{"idB": "749647_17_item1_p52_s0", "idA": "749647_16_item1_p14_s1", "sentA": "We have conducted a comprehensive analysis of the data from the HEAT Study to assess the future strategic value and development strategy for ThermoDox .", "sentB": "Additional immune analysis of biological tissue including cytokine ELISA from the first two patient cohorts and a complete analysis of the two higher dose cohorts is in progress.", "type": 2, "words": ["<tag1>", "We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "and", "development", "strategy", "for", "ThermoDox", ".", "<tag2>", "Additional", "immune", "analysis", "of", "biological", "tissue", "including", "cytokine", "ELISA", "from", "the", "first", "two", "patient", "cohorts", "and", "a", "complete", "analysis", "of", "the", "two", "higher", "dose", "cohorts", "is", "in", "progress.", "<tag3>"], "wordsA": ["We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "and", "development", "strategy", "for", "ThermoDox", "."], "wordsB": ["Additional", "immune", "analysis", "of", "biological", "tissue", "including", "cytokine", "ELISA", "from", "the", "first", "two", "patient", "cohorts", "and", "a", "complete", "analysis", "of", "the", "two", "higher", "dose", "cohorts", "is", "in", "progress."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03853034973144531, 0.5946377515792847, 0.6160247325897217, 0.02185693383216858, 0.26735004782676697, 0.24113701283931732, 0.011437921784818172, 0.138809472322464, 0.2338617593050003, 0.0037626761477440596, 0.00427882419899106, 0.027409352362155914, 0.05257096886634827, 0.10649442672729492, 0.039783164858818054, 0.0008251599501818419, 0.003491833107545972, 0.19715754687786102, 0.06200340762734413, 0.003937727306038141, 0.004071514122188091, 0.0407034307718277, 0.21905337274074554, 0.30158621072769165, 0.09390176087617874, 0.0030490029603242874, 0.008150803856551647, 0.016100993379950523, -1]}
{"idB": "749647_17_item1_p191_s0", "idA": "749647_16_item1_p152_s0", "sentA": "ThermoDox Although there are many drugs and devices marketed and under development for the treatment of cancer, the Company is not aware of any other heat activated drug delivery product either being marketed or in human clinical development.", "sentB": "Although there are many drugs and devices marketed and under development for the treatment of cancer, the Company is not aware of any other heat activated drug delivery product either being marketed or in human clinical development.", "type": 2, "words": ["<tag1>", "ThermoDox", "Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development.", "<tag2>", "Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development.", "<tag3>"], "wordsA": ["ThermoDox", "Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development."], "wordsB": ["Although", "there", "are", "many", "drugs", "and", "devices", "marketed", "and", "under", "development", "for", "the", "treatment", "of", "cancer,", "the", "Company", "is", "not", "aware", "of", "any", "other", "heat", "activated", "drug", "delivery", "product", "either", "being", "marketed", "or", "in", "human", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012807968072593212, 0.00655008852481842, 0.0068467180244624615, 0.021857736632227898, 0.025279829278588295, 0.009767097420990467, 0.01651041954755783, 0.012450920417904854, 0.008093535900115967, 0.00903170183300972, 0.014536411501467228, 0.008271797560155392, 0.007999739609658718, 0.011219908483326435, 0.008047794923186302, 0.01213440578430891, 0.005202115047723055, 0.03758395463228226, 0.0980195626616478, 0.741455078125, 0.46345603466033936, 0.03509000688791275, 0.056596238166093826, 0.06318992376327515, 0.048738282173871994, 0.06834054738283157, 0.05053148418664932, 0.02216307632625103, 0.0289621464908123, 0.021344779059290886, 0.015327037312090397, 0.018202463164925575, 0.010865198448300362, 0.008779266849160194, 0.013664557598531246, 0.012615050189197063, 0.016931550577282906, -1]}
{"idB": "749647_17_item1_p192_s0", "idA": "749647_16_item1_p153_s0", "sentA": "GEN-1 Studied indications for GEN-1 include ovarian cancer and glioblastoma multiforme (GBM) brain cancer.", "sentB": "Studied indications for GEN-1 include ovarian cancer and glioblastoma multiforme (GBM) brain cancer.", "type": 2, "words": ["<tag1>", "GEN-1", "Studied", "indications", "for", "GEN-1", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer.", "<tag2>", "Studied", "indications", "for", "GEN-1", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer.", "<tag3>"], "wordsA": ["GEN-1", "Studied", "indications", "for", "GEN-1", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer."], "wordsB": ["Studied", "indications", "for", "GEN-1", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.27652186155319214, 0.24875503778457642, 0.02958131767809391, 0.35340240597724915, 0.07057973742485046, 0.2981266379356384, 0.21900619566440582, 0.016666414216160774, 0.22581011056900024, 0.09505361318588257, 0.28563299775123596, 0.04027803987264633, 0.16268831491470337, -1]}
{"idB": "749647_17_item1_p62_s0", "idA": "749647_16_item1_p153_s2", "sentA": "Avastin is currently also being evaluated for early stage disease.", "sentB": "GEN-1 is currently being evaluated by Celsion in first line ovarian cancer patients.", "type": 2, "words": ["<tag1>", "Avastin", "is", "currently", "also", "being", "evaluated", "for", "early", "stage", "disease.", "<tag2>", "GEN-1", "is", "currently", "being", "evaluated", "by", "Celsion", "in", "first", "line", "ovarian", "cancer", "patients.", "<tag3>"], "wordsA": ["Avastin", "is", "currently", "also", "being", "evaluated", "for", "early", "stage", "disease."], "wordsB": ["GEN-1", "is", "currently", "being", "evaluated", "by", "Celsion", "in", "first", "line", "ovarian", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7821570634841919, 0.0029577084351330996, 0.004630856215953827, 0.006688985042273998, 0.03644753620028496, 0.08246034383773804, 0.30728957056999207, 0.0231131911277771, 0.31170687079429626, 0.28471648693084717, 0.5378949046134949, 0.38797110319137573, 0.23476357758045197, -1]}
{"idB": "749647_17_item1_p194_s0", "idA": "749647_16_item1_p155_s0", "sentA": "Duke University License Agreement In 1999, we entered into a license agreement with Duke University under which we received exclusive rights, subject to certain exceptions, to commercialize and use Duke s thermo-liposome technology.", "sentB": "In 1999, we entered into a license agreement with Duke University under which we received exclusive rights, subject to certain exceptions, to commercialize and use Duke s thermo-liposome technology.", "type": 2, "words": ["<tag1>", "Duke", "University", "License", "Agreement", "In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag2>", "In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag3>"], "wordsA": ["Duke", "University", "License", "Agreement", "In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "wordsB": ["In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.14635884761810303, 0.23248662054538727, 0.17729778587818146, 0.14761507511138916, 0.13230180740356445, 0.06894569098949432, 0.37550899386405945, 0.34599369764328003, 0.1039043664932251, 0.5673222541809082, 0.3241771459579468, 0.0979587510228157, 0.048730164766311646, 0.07876801490783691, 0.12681685388088226, 0.28870508074760437, 0.2112002968788147, 0.07908440381288528, 0.06400435417890549, 0.1520203799009323, 0.24385754764080048, 0.06204906851053238, 0.1519344300031662, 0.04882422089576721, 0.08976195007562637, 0.3882366716861725, 0.18913795053958893, 0.22180084884166718, 0.1817520409822464, -1]}
{"idB": "749647_17_item1_p196_s0", "idA": "749647_16_item1_p157_s0", "sentA": "In conjunction with the patent holder, we have filed international applications for a certain number of the United States patents.", "sentB": "In conjunction with the patent holder, we have filed international applications for a certain number of the U.S. patents.", "type": 2, "words": ["<tag1>", "In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "United", "States", "patents.", "<tag2>", "In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "U.S.", "patents.", "<tag3>"], "wordsA": ["In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "United", "States", "patents."], "wordsB": ["In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "U.S.", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01748623512685299, 0.04071732610464096, 0.014787728898227215, 0.011394034139811993, 0.11376220732927322, 0.20581413805484772, 0.007463143672794104, 0.007965502329170704, 0.01448411401361227, 0.012738710269331932, 0.016861023381352425, 0.007696338929235935, 0.0052893259562551975, 0.007716441061347723, 0.012146391905844212, 0.008818562142550945, 0.011103694327175617, 0.9638588428497314, 0.7630078196525574, -1]}
{"idB": "749647_17_item1_p198_s0", "idA": "749647_16_item1_p159_s0", "sentA": "Patents and Proprietary Rights Celsion holds an exclusive license agreement with Duke University for its temperature-sensitive liposome technology that covers the ThermoDox formulation.", "sentB": "Celsion holds an exclusive license agreement with Duke University for its temperature-sensitive liposome technology that covers the ThermoDox formulation.", "type": 2, "words": ["<tag1>", "Patents", "and", "Proprietary", "Rights", "Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation.", "<tag2>", "Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation.", "<tag3>"], "wordsA": ["Patents", "and", "Proprietary", "Rights", "Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation."], "wordsB": ["Celsion", "holds", "an", "exclusive", "license", "agreement", "with", "Duke", "University", "for", "its", "temperature-sensitive", "liposome", "technology", "that", "covers", "the", "ThermoDox", "formulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6576020121574402, 0.07863735407590866, 0.02235446684062481, 0.6635426878929138, 0.36599043011665344, 0.15918944776058197, 0.035128552466630936, 0.3293014466762543, 0.17249548435211182, 0.012636330910027027, 0.008556174114346504, 0.05752658098936081, 0.13951915502548218, 0.03867471218109131, 0.006247035227715969, 0.024331049993634224, 0.009714667685329914, 0.12708398699760437, 0.08174586296081543, -1]}
{"idB": "749647_17_item1_p198_s1", "idA": "749647_16_item1_p159_s1", "sentA": "Celsion s newly issued patents pertain specifically to methods of storing stabilized, temperature-sensitive liposomal formulations and will assist in the protection of global rights.", "sentB": "Celsion also has issued patents which pertain specifically to methods of storing stabilized, temperature-sensitive liposomal formulations and will assist in the protection of global rights.", "type": 2, "words": ["<tag1>", "Celsion", "s", "newly", "issued", "patents", "pertain", "specifically", "to", "methods", "of", "storing", "stabilized,", "temperature-sensitive", "liposomal", "formulations", "and", "will", "assist", "in", "the", "protection", "of", "global", "rights.", "<tag2>", "Celsion", "also", "has", "issued", "patents", "which", "pertain", "specifically", "to", "methods", "of", "storing", "stabilized,", "temperature-sensitive", "liposomal", "formulations", "and", "will", "assist", "in", "the", "protection", "of", "global", "rights.", "<tag3>"], "wordsA": ["Celsion", "s", "newly", "issued", "patents", "pertain", "specifically", "to", "methods", "of", "storing", "stabilized,", "temperature-sensitive", "liposomal", "formulations", "and", "will", "assist", "in", "the", "protection", "of", "global", "rights."], "wordsB": ["Celsion", "also", "has", "issued", "patents", "which", "pertain", "specifically", "to", "methods", "of", "storing", "stabilized,", "temperature-sensitive", "liposomal", "formulations", "and", "will", "assist", "in", "the", "protection", "of", "global", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.46402519941329956, 0.5218933820724487, 0.4328633248806, 0.5186458826065063, 0.2893769145011902, 0.01526118628680706, 0.04490431025624275, 0.040769174695014954, 0.01722761057317257, 0.05267960950732231, 0.013464841060340405, 0.028981070965528488, 0.05097755789756775, 0.02579660341143608, 0.036943864077329636, 0.03674938529729843, 0.008938228711485863, 0.009333858266472816, 0.022383185103535652, 0.014420555904507637, 0.012336008250713348, 0.01918618567287922, 0.01075583416968584, 0.013561670668423176, 0.023325394839048386, -1]}
{"idB": "749647_17_item1_p198_s3", "idA": "749647_16_item1_p159_s3", "sentA": "The patents in these three countries are the first in this family, which includes pending applications in the U.S., Europe and additional key commercial geographies in Asia.", "sentB": "These patents are the first in this family, which includes pending applications in the U.S., Europe and additional key commercial geographies in Asia.", "type": 2, "words": ["<tag1>", "The", "patents", "in", "these", "three", "countries", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia.", "<tag2>", "These", "patents", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia.", "<tag3>"], "wordsA": ["The", "patents", "in", "these", "three", "countries", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia."], "wordsB": ["These", "patents", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09397473186254501, 0.7015090584754944, 0.13269439339637756, 0.1124897375702858, 0.5247633457183838, 0.08449644595384598, 0.04070581495761871, 0.22997915744781494, 0.012296819128096104, 0.021165845915675163, 0.051116589456796646, 0.03911103680729866, 0.017182715237140656, 0.015099388547241688, 0.47923603653907776, 0.07711438834667206, 0.013334724120795727, 0.023364506661891937, 0.026659373193979263, 0.021832425147294998, 0.022273492068052292, 0.010607587173581123, 0.025281617417931557, -1]}
{"idB": "749647_17_item1_p61_s1", "idA": "749647_16_item1_p159_s3", "sentA": "The patents in these three countries are the first in this family, which includes pending applications in the U.S., Europe and additional key commercial geographies in Asia.", "sentB": "The GEN-1 Agreement will help to support supply for both ongoing and planned clinical studies in the U.S., and for potential future studies of GEN-1 in China.", "type": 2, "words": ["<tag1>", "The", "patents", "in", "these", "three", "countries", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia.", "<tag2>", "The", "GEN-1", "Agreement", "will", "help", "to", "support", "supply", "for", "both", "ongoing", "and", "planned", "clinical", "studies", "in", "the", "U.S.,", "and", "for", "potential", "future", "studies", "of", "GEN-1", "in", "China.", "<tag3>"], "wordsA": ["The", "patents", "in", "these", "three", "countries", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia."], "wordsB": ["The", "GEN-1", "Agreement", "will", "help", "to", "support", "supply", "for", "both", "ongoing", "and", "planned", "clinical", "studies", "in", "the", "U.S.,", "and", "for", "potential", "future", "studies", "of", "GEN-1", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025513803586363792, 0.3399428725242615, 0.4161307215690613, 0.032875485718250275, 0.06628191471099854, 0.030567491427063942, 0.1722593456506729, 0.13058069348335266, 0.025433572009205818, 0.018338428810238838, 0.11767358332872391, 0.02568190172314644, 0.10517500340938568, 0.3005894124507904, 0.24169251322746277, 0.01592235639691353, 0.014982652850449085, 0.03388673812150955, 0.006924871820956469, 0.009897371754050255, 0.0711883008480072, 0.12289712578058243, 0.198154017329216, 0.04650481790304184, 0.07318489998579025, 0.05275556072592735, 0.31793951988220215, -1]}
{"idB": "749647_17_item1_p198_s4", "idA": "749647_16_item1_p159_s4", "sentA": "This extended patent runway to 2026 allows for the evaluation of future development activities for ThermoDox and Celsion s heat-sensitive liposome technology platform.", "sentB": "This extended patent runway to 2026 allows for the evaluation of future development activities for ThermoDox and Celsion's heat-sensitive liposome technology platform.", "type": 2, "words": ["<tag1>", "This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion", "s", "heat-sensitive", "liposome", "technology", "platform.", "<tag2>", "This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion's", "heat-sensitive", "liposome", "technology", "platform.", "<tag3>"], "wordsA": ["This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion", "s", "heat-sensitive", "liposome", "technology", "platform."], "wordsB": ["This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion's", "heat-sensitive", "liposome", "technology", "platform."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.044104933738708496, 0.3051167130470276, 0.34627416729927063, 0.35361090302467346, 0.10605759918689728, 0.20856639742851257, 0.10411612689495087, 0.05805061385035515, 0.0359773226082325, 0.15689139068126678, 0.06739464402198792, 0.11542727798223495, 0.16362276673316956, 0.12501047551631927, 0.0618775449693203, 0.2261689305305481, 0.05303432419896126, 0.4042727053165436, 0.17729152739048004, 0.1704917550086975, 0.05640419200062752, 0.09181851148605347, -1]}
{"idB": "749647_17_item1_p19_s0", "idA": "749647_16_item1_p15_s0", "sentA": "Findings from the HEAT Study post-hoc data analysis suggest that ThermoDox may substantially improve Overall Survival, when compared to the control group, in patients if their lesions undergo a 45 minute RFA procedure standardized for a lesion greater than 3 cm in diameter.", "sentB": "Post-hoc data analysis from the Company s earlier Phase III HEAT Study suggest that ThermoDox may substantially improve OS, when compared to the control group, in patients if their lesions undergo a 45 minute RFA procedure standardized for a lesion greater than 3 cm in diameter.", "type": 2, "words": ["<tag1>", "Findings", "from", "the", "HEAT", "Study", "post-hoc", "data", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "Overall", "Survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter.", "<tag2>", "Post-hoc", "data", "analysis", "from", "the", "Company", "s", "earlier", "Phase", "III", "HEAT", "Study", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "OS,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter.", "<tag3>"], "wordsA": ["Findings", "from", "the", "HEAT", "Study", "post-hoc", "data", "analysis", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "Overall", "Survival,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter."], "wordsB": ["Post-hoc", "data", "analysis", "from", "the", "Company", "s", "earlier", "Phase", "III", "HEAT", "Study", "suggest", "that", "ThermoDox", "may", "substantially", "improve", "OS,", "when", "compared", "to", "the", "control", "group,", "in", "patients", "if", "their", "lesions", "undergo", "a", "45", "minute", "RFA", "procedure", "standardized", "for", "a", "lesion", "greater", "than", "3", "cm", "in", "diameter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004641828127205372, 0.006792324595153332, 0.009661616757512093, 0.0026607050094753504, 0.004297485575079918, 0.055397629737854004, 0.021533824503421783, 0.07397082448005676, 0.03215537220239639, 0.1589251309633255, 0.02727297879755497, 0.01912289671599865, 0.004821511916816235, 0.00308375246822834, 0.011829118244349957, 0.004429536405950785, 0.012621598318219185, 0.11766526848077774, 0.673245906829834, 0.0031542654614895582, 0.00546194426715374, 0.00391096156090498, 0.002737493719905615, 0.005562542472034693, 0.006635623052716255, 0.0025385222397744656, 0.006705905310809612, 0.002788854530081153, 0.0027974091935902834, 0.014262036420404911, 0.0038147622253745794, 0.0028917938470840454, 0.005561237223446369, 0.004377693869173527, 0.004545595962554216, 0.008365764282643795, 0.0054314699955284595, 0.002913492266088724, 0.003708799835294485, 0.008877125568687916, 0.024965789169073105, 0.021084139123558998, 0.014641836285591125, 0.013292054645717144, 0.008576520718634129, 0.010923074558377266, -1]}
{"idB": "749647_17_item1_p19_s1", "idA": "749647_16_item1_p15_s1", "sentA": "Data from eight OS sweeps have been conducted since the top line PFS data from the HEAT Study were announced in January 2013, with each data set showing progressive improvement in statistical significance.", "sentB": "Data from nine OS sweeps have been conducted since the top line progression free survival ( PFS ) data from the HEAT Study were announced in January 2013, with each data set demonstrating substantial improvement in clinical benefit over the control group with statistical significance.", "type": 2, "words": ["<tag1>", "Data", "from", "eight", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag2>", "Data", "from", "nine", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "progression", "free", "survival", "(", "PFS", ")", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "demonstrating", "substantial", "improvement", "in", "clinical", "benefit", "over", "the", "control", "group", "with", "statistical", "significance.", "<tag3>"], "wordsA": ["Data", "from", "eight", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "PFS", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "showing", "progressive", "improvement", "in", "statistical", "significance."], "wordsB": ["Data", "from", "nine", "OS", "sweeps", "have", "been", "conducted", "since", "the", "top", "line", "progression", "free", "survival", "(", "PFS", ")", "data", "from", "the", "HEAT", "Study", "were", "announced", "in", "January", "2013,", "with", "each", "data", "set", "demonstrating", "substantial", "improvement", "in", "clinical", "benefit", "over", "the", "control", "group", "with", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022747280076146126, 0.005124358460307121, 0.9486663937568665, 0.18459302186965942, 0.07800818979740143, 0.0011127616744488478, 0.0011694211279973388, 0.002846064977347851, 0.0014697228325530887, 0.0012796730734407902, 0.006343536544591188, 0.014545582234859467, 0.4094278812408447, 0.6525444984436035, 0.623548150062561, 0.009609391912817955, 0.14457443356513977, 3.9905371522763744e-05, 0.053441040217876434, 0.0013211759505793452, 0.001398094347678125, 0.004522814881056547, 0.003570400644093752, 0.0010545257246121764, 0.0017586412141099572, 0.0012504510814324021, 0.0016980253858491778, 0.0022154187317937613, 0.0014757856260985136, 0.004087485373020172, 0.0650872066617012, 0.020282479003071785, 0.060680367052555084, 0.3584669828414917, 0.12236039340496063, 0.022028720006346703, 0.08487188816070557, 0.07753454893827438, 0.008467225357890129, 0.006436046678572893, 0.018122535198926926, 0.019147012382745743, 0.0033569708466529846, 0.007394343614578247, 0.0046117124147713184, -1]}
{"idB": "749647_17_item1_p19_s3", "idA": "749647_16_item1_p15_s2", "sentA": "The most recent post-hoc OS analysis from the HEAT Study as of July 15, 2015 showed that in a large, well bounded, subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and optimized RFA provided a 58% improvement in OS compared to optimized RFA alone.", "sentB": "These results demonstrated that in a large, well bounded, subgroup of patients with a single lesion (n=285, 41% of the HEAT Study patients), treatment with a combination of ThermoDox and optimized RFA provided an average 54% risk improvement in OS compared to optimized RFA alone.", "type": 2, "words": ["<tag1>", "The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "as", "of", "July", "15,", "2015", "showed", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag2>", "These", "results", "demonstrated", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "with", "a", "single", "lesion", "(n=285,", "41%", "of", "the", "HEAT", "Study", "patients),", "treatment", "with", "a", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "an", "average", "54%", "risk", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag3>"], "wordsA": ["The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "as", "of", "July", "15,", "2015", "showed", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "wordsB": ["These", "results", "demonstrated", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "with", "a", "single", "lesion", "(n=285,", "41%", "of", "the", "HEAT", "Study", "patients),", "treatment", "with", "a", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "an", "average", "54%", "risk", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004937123041599989, 0.030830271542072296, 0.017354071140289307, 0.004532601684331894, 0.0029530832543969154, 0.0023246551863849163, 0.003128388896584511, 0.00384288327768445, 0.003981530666351318, 0.006688207853585482, 0.0022592581808567047, 0.01599135622382164, 0.035943713039159775, 0.03308437392115593, 0.8182655572891235, 0.8169859051704407, 0.007991191931068897, 0.003160313470289111, 0.0022290516644716263, 0.002242281101644039, 0.004054490011185408, 0.00403819652274251, 0.006569929886609316, 0.013595962896943092, 0.0026352733839303255, 0.0021633387077599764, 0.004397333599627018, 0.0022455661091953516, 0.0037982806097716093, 0.0020350466948002577, 0.0030990811064839363, 0.004081274848431349, 0.006659269332885742, 0.0035664753522723913, 0.05096058174967766, 0.7738091349601746, 0.14186106622219086, 0.08447249233722687, 0.0032196533866226673, 0.005258212797343731, 0.0036966900806874037, 0.0022894451394677162, 0.0027271280996501446, 0.0037204197142273188, 0.004569144919514656, -1]}
{"idB": "749647_17_item1_p19_s4", "idA": "749647_16_item1_p15_s3", "sentA": "The Hazard Ratio at this latest OS analysis is 0.63 (95% CI 0.43 - 0.93) with a p-value of 0.0198.", "sentB": "The Hazard Ratio ( HR ) at this analysis is 0.65 (95% CI 0.45 - 0.94) with a p-value of 0.02.", "type": 2, "words": ["<tag1>", "The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.63", "(95%", "CI", "0.43", "-", "0.93)", "with", "a", "p-value", "of", "0.0198.", "<tag2>", "The", "Hazard", "Ratio", "(", "HR", ")", "at", "this", "analysis", "is", "0.65", "(95%", "CI", "0.45", "-", "0.94)", "with", "a", "p-value", "of", "0.02.", "<tag3>"], "wordsA": ["The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.63", "(95%", "CI", "0.43", "-", "0.93)", "with", "a", "p-value", "of", "0.0198."], "wordsB": ["The", "Hazard", "Ratio", "(", "HR", ")", "at", "this", "analysis", "is", "0.65", "(95%", "CI", "0.45", "-", "0.94)", "with", "a", "p-value", "of", "0.02."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002265110844746232, 0.03425374627113342, 0.10120933502912521, 0.07504571974277496, 0.5433674454689026, 3.131662015221082e-05, 0.0027359090745449066, 0.0021902485750615597, 0.008974989876151085, 0.007460516411811113, 0.938805341720581, 0.019198916852474213, 0.019619552418589592, 0.42049676179885864, 0.10813786834478378, 0.06462745368480682, 0.0027512251399457455, 0.002076836535707116, 0.014836602844297886, 0.008058423176407814, 0.495517373085022, -1]}
{"idB": "749647_17_item1_p82_s3", "idA": "749647_16_item1_p15_s3", "sentA": "The Hazard Ratio at this latest OS analysis is 0.63 (95% CI 0.43 - 0.93) with a p-value of 0.0198.", "sentB": "The Hazard Ratio at this latest OS analysis is 0.65 (95% CI 0.45 - 0.94) with a p-value of 0.02.", "type": 2, "words": ["<tag1>", "The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.63", "(95%", "CI", "0.43", "-", "0.93)", "with", "a", "p-value", "of", "0.0198.", "<tag2>", "The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.65", "(95%", "CI", "0.45", "-", "0.94)", "with", "a", "p-value", "of", "0.02.", "<tag3>"], "wordsA": ["The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.63", "(95%", "CI", "0.43", "-", "0.93)", "with", "a", "p-value", "of", "0.0198."], "wordsB": ["The", "Hazard", "Ratio", "at", "this", "latest", "OS", "analysis", "is", "0.65", "(95%", "CI", "0.45", "-", "0.94)", "with", "a", "p-value", "of", "0.02."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.001492378069087863, 0.010360365733504295, 0.02769024483859539, 0.0015993744600564241, 0.0015946074854582548, 0.002659242833033204, 0.0031965007074177265, 0.005548306740820408, 0.007225392386317253, 0.9482141733169556, 0.02035950869321823, 0.023834940046072006, 0.6397498846054077, 0.173631489276886, 0.11280890554189682, 0.002383037470281124, 0.001871477346867323, 0.015502817928791046, 0.009234761819243431, 0.5315300822257996, -1]}
{"idB": "749647_17_item1_p199_s0", "idA": "749647_16_item1_p160_s0", "sentA": "For the ThermoDox technology, we either exclusively license or own US and international patents with claims and methods and compositions of matters that cover various aspects of lysolipid thermally-sensitive liposomes technology, with expiration dates ranging from 2019 to 2026.", "sentB": "For the ThermoDox technology, we either exclusively license or own U.S. and international patents with claims and methods and compositions of matters that cover various aspects of lysolipid thermally-sensitive liposomes technology, with expiration dates ranging from 2018 to 2026.", "type": 2, "words": ["<tag1>", "For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "US", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "lysolipid", "thermally-sensitive", "liposomes", "technology,", "with", "expiration", "dates", "ranging", "from", "2019", "to", "2026.", "<tag2>", "For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "U.S.", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "lysolipid", "thermally-sensitive", "liposomes", "technology,", "with", "expiration", "dates", "ranging", "from", "2018", "to", "2026.", "<tag3>"], "wordsA": ["For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "US", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "lysolipid", "thermally-sensitive", "liposomes", "technology,", "with", "expiration", "dates", "ranging", "from", "2019", "to", "2026."], "wordsB": ["For", "the", "ThermoDox", "technology,", "we", "either", "exclusively", "license", "or", "own", "U.S.", "and", "international", "patents", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "lysolipid", "thermally-sensitive", "liposomes", "technology,", "with", "expiration", "dates", "ranging", "from", "2018", "to", "2026."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006158029660582542, 0.004673411138355732, 0.009075886569917202, 0.006607125047594309, 0.008496812544763088, 0.01738898828625679, 0.02483190968632698, 0.026269683614373207, 0.01858976110816002, 0.04985901713371277, 0.33297649025917053, 0.02310319058597088, 0.007447322830557823, 0.01451888121664524, 0.004527007229626179, 0.004853366874158382, 0.0046408213675022125, 0.0048193372786045074, 0.0046577006578445435, 0.004934654571115971, 0.0043537975288927555, 0.004906537011265755, 0.0057549974881112576, 0.0047833784483373165, 0.005276651121675968, 0.0051606264896690845, 0.00434116180986166, 0.007730361074209213, 0.007278640754520893, 0.008366369642317295, 0.005827165208756924, 0.00392035162076354, 0.0063592009246349335, 0.006448206026107073, 0.006725002080202103, 0.019706210121512413, 0.9269076585769653, 0.2503446340560913, 0.09823472052812576, -1]}
{"idB": "749647_17_item1_p200_s0", "idA": "749647_16_item1_p161_s0", "sentA": "For the TheraPlas technology, we own three US and international patent families and related applications with claims and methods and compositions of matters that cover various aspects of TheraPlas and GEN-1 technologies, with expiration dates ranging from 2020 to 2028.", "sentB": "For the TheraPlas technology, we own three U.S. and international patents and related applications with claims and methods and compositions of matters that cover various aspects of TheraPlas and GEN-1 technologies, with expiration dates ranging from 2020 to 2028.", "type": 2, "words": ["<tag1>", "For", "the", "TheraPlas", "technology,", "we", "own", "three", "US", "and", "international", "patent", "families", "and", "related", "applications", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "TheraPlas", "and", "GEN-1", "technologies,", "with", "expiration", "dates", "ranging", "from", "2020", "to", "2028.", "<tag2>", "For", "the", "TheraPlas", "technology,", "we", "own", "three", "U.S.", "and", "international", "patents", "and", "related", "applications", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "TheraPlas", "and", "GEN-1", "technologies,", "with", "expiration", "dates", "ranging", "from", "2020", "to", "2028.", "<tag3>"], "wordsA": ["For", "the", "TheraPlas", "technology,", "we", "own", "three", "US", "and", "international", "patent", "families", "and", "related", "applications", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "TheraPlas", "and", "GEN-1", "technologies,", "with", "expiration", "dates", "ranging", "from", "2020", "to", "2028."], "wordsB": ["For", "the", "TheraPlas", "technology,", "we", "own", "three", "U.S.", "and", "international", "patents", "and", "related", "applications", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "TheraPlas", "and", "GEN-1", "technologies,", "with", "expiration", "dates", "ranging", "from", "2020", "to", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017825882881879807, 0.017742877826094627, 0.07468600571155548, 0.04059857130050659, 0.029348857700824738, 0.05980241671204567, 0.07331470400094986, 0.5483672022819519, 0.07479821145534515, 0.0516640841960907, 0.13629506528377533, 0.026667477563023567, 0.03144316375255585, 0.028492948040366173, 0.022507112473249435, 0.02970260940492153, 0.02393021434545517, 0.02442590706050396, 0.019924994558095932, 0.024427270516753197, 0.019076839089393616, 0.024423010647296906, 0.0194719098508358, 0.023870673030614853, 0.03280962258577347, 0.02795460820198059, 0.01759258471429348, 0.05813388153910637, 0.015584546141326427, 0.07190670818090439, 0.06070388853549957, 0.014659976586699486, 0.04316258057951927, 0.028667574748396873, 0.01957564242184162, 0.026341741904616356, 0.054684657603502274, 0.05087760090827942, 0.06413812190294266, -1]}
{"idB": "749647_17_item1_p159_s2", "idA": "749647_16_item1_p166_s0", "sentA": "We cannot predict with any certainty if any third party U.S. or foreign patent rights, other proprietary rights, will be deemed infringed by the use of our technology.", "sentB": "We cannot forecast with any degree of certainty which proprietary products or indications, if any, will be subject to future collaborative arrangements, in whole or in part, and how such arrangements would affect our development plan or capital requirements.", "type": 2, "words": ["<tag1>", "We", "cannot", "predict", "with", "any", "certainty", "if", "any", "third", "party", "U.S.", "or", "foreign", "patent", "rights,", "other", "proprietary", "rights,", "will", "be", "deemed", "infringed", "by", "the", "use", "of", "our", "technology.", "<tag2>", "We", "cannot", "forecast", "with", "any", "degree", "of", "certainty", "which", "proprietary", "products", "or", "indications,", "if", "any,", "will", "be", "subject", "to", "future", "collaborative", "arrangements,", "in", "whole", "or", "in", "part,", "and", "how", "such", "arrangements", "would", "affect", "our", "development", "plan", "or", "capital", "requirements.", "<tag3>"], "wordsA": ["We", "cannot", "predict", "with", "any", "certainty", "if", "any", "third", "party", "U.S.", "or", "foreign", "patent", "rights,", "other", "proprietary", "rights,", "will", "be", "deemed", "infringed", "by", "the", "use", "of", "our", "technology."], "wordsB": ["We", "cannot", "forecast", "with", "any", "degree", "of", "certainty", "which", "proprietary", "products", "or", "indications,", "if", "any,", "will", "be", "subject", "to", "future", "collaborative", "arrangements,", "in", "whole", "or", "in", "part,", "and", "how", "such", "arrangements", "would", "affect", "our", "development", "plan", "or", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008657976053655148, 0.02030954137444496, 0.025233056396245956, 0.007904830388724804, 0.00727900629863143, 0.00880487635731697, 0.0043160077184438705, 0.021273095160722733, 0.014475362375378609, 0.16066989302635193, 0.2560693919658661, 0.050968144088983536, 0.18904738128185272, 0.016699165105819702, 0.030634114518761635, 0.028080672025680542, 0.025578876957297325, 0.1488676518201828, 0.08976458758115768, 0.06439350545406342, 0.225136861205101, 0.2964898347854614, 0.08594543486833572, 0.12072374671697617, 0.08970586210489273, 0.09886439889669418, 0.10844054818153381, 0.006764017976820469, 0.02158471941947937, 0.02704884670674801, 0.09930092096328735, 0.04093169793486595, 0.13978779315948486, 0.021664563566446304, 0.09046228229999542, 0.061926908791065216, 0.03745003417134285, 0.08321225643157959, 0.13110043108463287, -1]}
{"idB": "749647_17_item1_p159_s1", "idA": "749647_16_item1_p167_s0", "sentA": "In the event of a claim of infringement, we or our partners may be required to obtain one or more licenses from a third party.", "sentB": "In the event that third parties take over the clinical trial process for one or more of our product candidates, the estimated completion date would largely be under the control of that third party rather than us.", "type": 2, "words": ["<tag1>", "In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party.", "<tag2>", "In", "the", "event", "that", "third", "parties", "take", "over", "the", "clinical", "trial", "process", "for", "one", "or", "more", "of", "our", "product", "candidates,", "the", "estimated", "completion", "date", "would", "largely", "be", "under", "the", "control", "of", "that", "third", "party", "rather", "than", "us.", "<tag3>"], "wordsA": ["In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party."], "wordsB": ["In", "the", "event", "that", "third", "parties", "take", "over", "the", "clinical", "trial", "process", "for", "one", "or", "more", "of", "our", "product", "candidates,", "the", "estimated", "completion", "date", "would", "largely", "be", "under", "the", "control", "of", "that", "third", "party", "rather", "than", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0032670472282916307, 0.002945150015875697, 0.02269553579390049, 0.00441822549328208, 0.041784364730119705, 0.09057608991861343, 0.4799768626689911, 0.640286922454834, 0.22792653739452362, 0.4239094853401184, 0.6372223496437073, 0.5512691736221313, 0.018953705206513405, 0.016073353588581085, 0.006668933667242527, 0.014051981270313263, 0.012806050479412079, 0.015660636126995087, 0.033188384026288986, 0.07831670343875885, 0.007221761159598827, 0.04677022248506546, 0.06409180164337158, 0.04235239326953888, 0.012904135510325432, 0.03125076740980148, 0.009488625451922417, 0.07623027265071869, 0.03156105801463127, 0.08510880917310715, 0.027703357860445976, 0.01211692113429308, 0.057174745947122574, 0.0626923218369484, 0.05157376825809479, 0.04737091809511185, 0.053945884108543396, -1]}
{"idB": "749647_17_item1_p162_s6", "idA": "749647_16_item1_p169_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "The report of our independent registered public accounting firm for the year ended December 31, 2016 includes an explanatory paragraph which expresses substantial doubt about our ability to continue as a going concern.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "The", "report", "of", "our", "independent", "registered", "public", "accounting", "firm", "for", "the", "year", "ended", "December", "31,", "2016", "includes", "an", "explanatory", "paragraph", "which", "expresses", "substantial", "doubt", "about", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["The", "report", "of", "our", "independent", "registered", "public", "accounting", "firm", "for", "the", "year", "ended", "December", "31,", "2016", "includes", "an", "explanatory", "paragraph", "which", "expresses", "substantial", "doubt", "about", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011045439168810844, 0.14047393202781677, 0.021902792155742645, 0.032627884298563004, 0.11232084035873413, 0.15013286471366882, 0.28203102946281433, 0.4910475015640259, 0.1727495938539505, 0.009494731202721596, 0.009577845223248005, 0.0249272920191288, 0.022349324077367783, 0.02641921490430832, 0.024716999381780624, 0.055869001895189285, 0.009814422577619553, 0.011981830932199955, 0.09959979355335236, 0.12208148837089539, 0.0002643232874106616, 0.05106213688850403, 0.10555129498243332, 0.34887146949768066, 0.049768149852752686, 0.06893805414438248, 0.15597936511039734, 0.06727076321840286, 0.10115337371826172, 0.02979549765586853, 0.02470420114696026, 0.0625418946146965, 0.07414009422063828, -1]}
{"idB": "749647_17_item1_p23_s3", "idA": "749647_16_item1_p16_s1", "sentA": "Supplementary computational modeling and prospective preclinical animal studies have shown additional support the relationship between heating duration and clinical outcomes.", "sentB": "In addition, we conducted a prospective preclinical study in 21 pigs using two different manufacturers of RFA and human equivalent doses of ThermoDox that clearly support the relationship between increased heating duration and doxorubicin concentrations.", "type": 2, "words": ["<tag1>", "Supplementary", "computational", "modeling", "and", "prospective", "preclinical", "animal", "studies", "have", "shown", "additional", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag2>", "In", "addition,", "we", "conducted", "a", "prospective", "preclinical", "study", "in", "21", "pigs", "using", "two", "different", "manufacturers", "of", "RFA", "and", "human", "equivalent", "doses", "of", "ThermoDox", "that", "clearly", "support", "the", "relationship", "between", "increased", "heating", "duration", "and", "doxorubicin", "concentrations.", "<tag3>"], "wordsA": ["Supplementary", "computational", "modeling", "and", "prospective", "preclinical", "animal", "studies", "have", "shown", "additional", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "wordsB": ["In", "addition,", "we", "conducted", "a", "prospective", "preclinical", "study", "in", "21", "pigs", "using", "two", "different", "manufacturers", "of", "RFA", "and", "human", "equivalent", "doses", "of", "ThermoDox", "that", "clearly", "support", "the", "relationship", "between", "increased", "heating", "duration", "and", "doxorubicin", "concentrations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009415390901267529, 0.007857907563447952, 0.02951429970562458, 0.0181119441986084, 0.005042406264692545, 0.01425175741314888, 0.021646633744239807, 0.04819957911968231, 0.0683179721236229, 0.4732664227485657, 0.5038489699363708, 0.023887038230895996, 0.0973050445318222, 0.11048915237188339, 0.1072051078081131, 0.04151085391640663, 0.05923004075884819, 0.009396987967193127, 0.07063086330890656, 0.057893555611371994, 0.06358067691326141, 0.04744304344058037, 0.09105969220399857, 0.0002893425989896059, 0.012998472899198532, 0.010280361399054527, 0.0032928413711488247, 0.022049741819500923, 0.007990043610334396, 0.1473885029554367, 0.10565118491649628, 0.048547957092523575, 0.03511316701769829, 0.33951377868652344, 0.3556559383869171, -1]}
{"idB": "749647_17_item1_p83_s3", "idA": "749647_16_item1_p16_s1", "sentA": "Supplementary computational modeling and prospective preclinical animal studies have shown additional support the relationship between heating duration and clinical outcomes.", "sentB": "In addition, we conducted a prospective preclinical study in 21 pigs using two different manufacturers of RFA and human equivalent doses of ThermoDox that clearly support the relationship between increased heating duration and doxorubicin concentrations.", "type": 2, "words": ["<tag1>", "Supplementary", "computational", "modeling", "and", "prospective", "preclinical", "animal", "studies", "have", "shown", "additional", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag2>", "In", "addition,", "we", "conducted", "a", "prospective", "preclinical", "study", "in", "21", "pigs", "using", "two", "different", "manufacturers", "of", "RFA", "and", "human", "equivalent", "doses", "of", "ThermoDox", "that", "clearly", "support", "the", "relationship", "between", "increased", "heating", "duration", "and", "doxorubicin", "concentrations.", "<tag3>"], "wordsA": ["Supplementary", "computational", "modeling", "and", "prospective", "preclinical", "animal", "studies", "have", "shown", "additional", "support", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "wordsB": ["In", "addition,", "we", "conducted", "a", "prospective", "preclinical", "study", "in", "21", "pigs", "using", "two", "different", "manufacturers", "of", "RFA", "and", "human", "equivalent", "doses", "of", "ThermoDox", "that", "clearly", "support", "the", "relationship", "between", "increased", "heating", "duration", "and", "doxorubicin", "concentrations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009415390901267529, 0.007857907563447952, 0.02951429970562458, 0.0181119441986084, 0.005042406264692545, 0.01425175741314888, 0.021646633744239807, 0.04819957911968231, 0.0683179721236229, 0.4732664227485657, 0.5038489699363708, 0.023887038230895996, 0.0973050445318222, 0.11048915237188339, 0.1072051078081131, 0.04151085391640663, 0.05923004075884819, 0.009396987967193127, 0.07063086330890656, 0.057893555611371994, 0.06358067691326141, 0.04744304344058037, 0.09105969220399857, 0.0002893425989896059, 0.012998472899198532, 0.010280361399054527, 0.0032928413711488247, 0.022049741819500923, 0.007990043610334396, 0.1473885029554367, 0.10565118491649628, 0.048547957092523575, 0.03511316701769829, 0.33951377868652344, 0.3556559383869171, -1]}
{"idB": "749647_17_item1_p160_s0", "idA": "749647_16_item1_p170_s0", "sentA": "As of March 29, 2016, we employed 25 full-time employees.", "sentB": "As of December 31, 2016, we have $4.3 million dollars in cash and short term investments.", "type": 2, "words": ["<tag1>", "As", "of", "March", "29,", "2016,", "we", "employed", "25", "full-time", "employees.", "<tag2>", "As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments.", "<tag3>"], "wordsA": ["As", "of", "March", "29,", "2016,", "we", "employed", "25", "full-time", "employees."], "wordsB": ["As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023935630917549133, 0.01851227693259716, 0.883467972278595, 0.8717634081840515, 0.05555710941553116, 0.026243550702929497, 0.027002448216080666, 0.17802296578884125, 0.14388501644134521, 0.11304062604904175, 0.051577262580394745, 0.22385865449905396, 0.04767701402306557, 0.4672941565513611, 0.37496593594551086, 0.3793596923351288, -1]}
{"idB": "749647_17_item1_p208_s0", "idA": "749647_16_item1_p170_s0", "sentA": "As of March 29, 2016, we employed 25 full-time employees.", "sentB": "As of March 23, 2017, we employed 19 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "29,", "2016,", "we", "employed", "25", "full-time", "employees.", "<tag2>", "As", "of", "March", "23,", "2017,", "we", "employed", "19", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "29,", "2016,", "we", "employed", "25", "full-time", "employees."], "wordsB": ["As", "of", "March", "23,", "2017,", "we", "employed", "19", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007263589650392532, 0.006027305964380503, 0.06444626301527023, 0.567048966884613, 0.6148948669433594, 0.004581223241984844, 0.039812128990888596, 0.83242267370224, 0.14531587064266205, 0.12224334478378296, -1]}
{"idB": "749647_17_item1_p211_s4", "idA": "749647_16_item1_p173_s0", "sentA": "During 2015 and 2014, we issued a total of 6.9 million shares of common stock in the following equity transactions for an aggregate $23.6 million in gross proceeds.", "sentB": "The Company received approximately $5.0 million in gross proceeds (excluding the proceeds, if any, from the exercise of the warrants) in the February 14, 2017 Public Offering.", "type": 2, "words": ["<tag1>", "During", "2015", "and", "2014,", "we", "issued", "a", "total", "of", "6.9", "million", "shares", "of", "common", "stock", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$23.6", "million", "in", "gross", "proceeds.", "<tag2>", "The", "Company", "received", "approximately", "$5.0", "million", "in", "gross", "proceeds", "(excluding", "the", "proceeds,", "if", "any,", "from", "the", "exercise", "of", "the", "warrants)", "in", "the", "February", "14,", "2017", "Public", "Offering.", "<tag3>"], "wordsA": ["During", "2015", "and", "2014,", "we", "issued", "a", "total", "of", "6.9", "million", "shares", "of", "common", "stock", "in", "the", "following", "equity", "transactions", "for", "an", "aggregate", "$23.6", "million", "in", "gross", "proceeds."], "wordsB": ["The", "Company", "received", "approximately", "$5.0", "million", "in", "gross", "proceeds", "(excluding", "the", "proceeds,", "if", "any,", "from", "the", "exercise", "of", "the", "warrants)", "in", "the", "February", "14,", "2017", "Public", "Offering."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006165055558085442, 0.06484250724315643, 0.09752625226974487, 0.09478430449962616, 0.6096810698509216, 0.3316725194454193, 0.027780497446656227, 0.05429712310433388, 0.1001410260796547, 0.2264017015695572, 0.028103064745664597, 0.12093208730220795, 0.02945612370967865, 0.026824800297617912, 0.008502575568854809, 0.006646827328950167, 0.043263860046863556, 0.030516454949975014, 0.026856888085603714, 0.11368430405855179, 0.00959987286478281, 0.009660959243774414, 0.11404741555452347, 0.14974340796470642, 0.7178756594657898, 0.10773954540491104, 0.1533551961183548, -1]}
{"idB": "749647_17_item1_p211_s0", "idA": "749647_16_item1_p176_s0", "sentA": "On May 27, 2015, the Company entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company sold, in a registered direct offering, an aggregate of 3,000,000 shares of common stock, for an aggregate purchase price of approximately $8.0 million.", "sentB": "On February 14, 2017, the Company entered into a securities purchase agreement whereby it sold, in a public offering (the February 14, 2017 Public Offering ), an aggregate of 19,385,869 shares of common stock of the Company at an offering price of $0.23 per share.", "type": 2, "words": ["<tag1>", "On", "May", "27,", "2015,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "3,000,000", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$8.0", "million.", "<tag2>", "On", "February", "14,", "2017,", "the", "Company", "entered", "into", "a", "securities", "purchase", "agreement", "whereby", "it", "sold,", "in", "a", "public", "offering", "(the", "February", "14,", "2017", "Public", "Offering", "),", "an", "aggregate", "of", "19,385,869", "shares", "of", "common", "stock", "of", "the", "Company", "at", "an", "offering", "price", "of", "$0.23", "per", "share.", "<tag3>"], "wordsA": ["On", "May", "27,", "2015,", "the", "Company", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "Company", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "3,000,000", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$8.0", "million."], "wordsB": ["On", "February", "14,", "2017,", "the", "Company", "entered", "into", "a", "securities", "purchase", "agreement", "whereby", "it", "sold,", "in", "a", "public", "offering", "(the", "February", "14,", "2017", "Public", "Offering", "),", "an", "aggregate", "of", "19,385,869", "shares", "of", "common", "stock", "of", "the", "Company", "at", "an", "offering", "price", "of", "$0.23", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017098816111683846, 0.3783557415008545, 0.4454196095466614, 0.8738602995872498, 0.00258335517719388, 0.018876338377594948, 0.005283002741634846, 0.0031607700511813164, 0.0024679559282958508, 0.008454129099845886, 0.007421642541885376, 0.009390043094754219, 0.002843504538759589, 0.00415181927382946, 0.009113943204283714, 0.003278769552707672, 0.003231527516618371, 0.05483534559607506, 0.020862961187958717, 0.003177415579557419, 0.008440612815320492, 0.011510416865348816, 0.06410566717386246, 0.056940387934446335, 0.032238952815532684, 8.106335735647008e-05, 0.003053358756005764, 0.009411060251295567, 0.005032678600400686, 0.6498319506645203, 0.20152975618839264, 0.010199056938290596, 0.01724885404109955, 0.0206920076161623, 0.004095039330422878, 0.0045447698794305325, 0.01927933655679226, 0.0029595443047583103, 0.0031948680989444256, 0.007347397971898317, 0.006652667187154293, 0.004784077405929565, 0.6133264899253845, 0.25166186690330505, 0.09013768285512924, -1]}
{"idB": "749647_17_item1_p211_s1", "idA": "749647_16_item1_p176_s1", "sentA": "In a concurrent private placement, the Company issued to the same investors warrants to purchase up to 1,950,000 shares of common stock.", "sentB": "In addition, the Company sold Series AA Warrants (the Series AA Warrants ) to purchase up to 16,489,402 shares of common stock and Pre-Funded Series BB Warrants (the Pre-Funded Series BB Warrants ) to purchase up to 2,600,000 shares of common stock.", "type": 2, "words": ["<tag1>", "In", "a", "concurrent", "private", "placement,", "the", "Company", "issued", "to", "the", "same", "investors", "warrants", "to", "purchase", "up", "to", "1,950,000", "shares", "of", "common", "stock.", "<tag2>", "In", "addition,", "the", "Company", "sold", "Series", "AA", "Warrants", "(the", "Series", "AA", "Warrants", ")", "to", "purchase", "up", "to", "16,489,402", "shares", "of", "common", "stock", "and", "Pre-Funded", "Series", "BB", "Warrants", "(the", "Pre-Funded", "Series", "BB", "Warrants", ")", "to", "purchase", "up", "to", "2,600,000", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["In", "a", "concurrent", "private", "placement,", "the", "Company", "issued", "to", "the", "same", "investors", "warrants", "to", "purchase", "up", "to", "1,950,000", "shares", "of", "common", "stock."], "wordsB": ["In", "addition,", "the", "Company", "sold", "Series", "AA", "Warrants", "(the", "Series", "AA", "Warrants", ")", "to", "purchase", "up", "to", "16,489,402", "shares", "of", "common", "stock", "and", "Pre-Funded", "Series", "BB", "Warrants", "(the", "Pre-Funded", "Series", "BB", "Warrants", ")", "to", "purchase", "up", "to", "2,600,000", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016560064628720284, 0.015768487006425858, 0.0041954112239181995, 0.06544523686170578, 0.2280135303735733, 0.15233959257602692, 0.4148290753364563, 0.4882104694843292, 0.0068679265677928925, 0.022875696420669556, 0.031806670129299164, 0.04306565970182419, 7.889368134783581e-05, 0.00311289937235415, 0.012051480822265148, 0.012029753997921944, 0.006023935973644257, 0.3338578939437866, 0.07373462617397308, 0.0031111505813896656, 0.00791388563811779, 0.007815253920853138, 0.003931396175175905, 0.037269819527864456, 0.02191375009715557, 0.03026580810546875, 0.04079139605164528, 0.0029614458326250315, 0.09977743029594421, 0.017693491652607918, 0.028616314753890038, 0.025028450414538383, 7.767582428641617e-05, 0.002799818990752101, 0.00765541335567832, 0.007393111474812031, 0.005932461004704237, 0.5740419030189514, 0.041318364441394806, 0.0025940346531569958, 0.005387135315686464, 0.006549563258886337, -1]}
{"idB": "749647_17_item1_p161_s0", "idA": "749647_16_item1_p177_s0", "sentA": "We are a party to a Controlled Equity Offering SM Sales Agreement (ATM) dated as of February 1, 2013 with Cantor Fitzgerald Co., pursuant to which we may sell additional shares of our common stock having an aggregate offering price of up to $25 million through at-the-market equity offerings from time to time.", "sentB": "The Company has a Controlled Equity Offering SM Sales Agreement (the ATM Agreement ) with Cantor Fitzgerald Co. (see Note 10).", "type": 2, "words": ["<tag1>", "We", "are", "a", "party", "to", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(ATM)", "dated", "as", "of", "February", "1,", "2013", "with", "Cantor", "Fitzgerald", "Co.,", "pursuant", "to", "which", "we", "may", "sell", "additional", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25", "million", "through", "at-the-market", "equity", "offerings", "from", "time", "to", "time.", "<tag2>", "The", "Company", "has", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.", "(see", "Note", "10).", "<tag3>"], "wordsA": ["We", "are", "a", "party", "to", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(ATM)", "dated", "as", "of", "February", "1,", "2013", "with", "Cantor", "Fitzgerald", "Co.,", "pursuant", "to", "which", "we", "may", "sell", "additional", "shares", "of", "our", "common", "stock", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25", "million", "through", "at-the-market", "equity", "offerings", "from", "time", "to", "time."], "wordsB": ["The", "Company", "has", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.", "(see", "Note", "10)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01966521330177784, 0.5450665354728699, 0.1037428230047226, 0.03872160241007805, 0.3866940438747406, 0.6350592970848083, 0.18683363497257233, 0.07186665385961533, 0.0955801010131836, 0.11209313571453094, 0.02632007747888565, 0.12156769633293152, 0.1244387999176979, 9.895078983390704e-05, 0.023972537368535995, 0.07102106511592865, 0.07190891355276108, 0.10115505009889603, 0.08015844970941544, 0.28127095103263855, 0.5879948735237122, -1]}
{"idB": "749647_17_item1_p34_s0", "idA": "749647_16_item1_p177_s1", "sentA": "From February 1, 2013 through February 25, 2013, the Company sold and issued an aggregate of 1,195,927 shares of common stock under the ATM, receiving approximately $6.8 million in net proceeds.", "sentB": "The shares of common stock were issued in a private transaction exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(2) thereof.", "type": 2, "words": ["<tag1>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "an", "aggregate", "of", "1,195,927", "shares", "of", "common", "stock", "under", "the", "ATM,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds.", "<tag2>", "The", "shares", "of", "common", "stock", "were", "issued", "in", "a", "private", "transaction", "exempt", "from", "registration", "under", "the", "Securities", "Act", "of", "1933,", "as", "amended,", "pursuant", "to", "Section", "4(2)", "thereof.", "<tag3>"], "wordsA": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "an", "aggregate", "of", "1,195,927", "shares", "of", "common", "stock", "under", "the", "ATM,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds."], "wordsB": ["The", "shares", "of", "common", "stock", "were", "issued", "in", "a", "private", "transaction", "exempt", "from", "registration", "under", "the", "Securities", "Act", "of", "1933,", "as", "amended,", "pursuant", "to", "Section", "4(2)", "thereof."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01526735071092844, 0.1678173542022705, 0.02204289101064205, 0.046113353222608566, 0.03092195838689804, 0.03813459724187851, 0.17236468195915222, 0.03822110965847969, 0.03300326317548752, 0.438114732503891, 0.41114944219589233, 0.20963400602340698, 0.11345415562391281, 0.18709588050842285, 0.04357415810227394, 0.028737863525748253, 0.09416843205690384, 0.07063272595405579, 0.04849321022629738, 0.25289687514305115, 0.013550978153944016, 0.033429116010665894, 0.023384535685181618, 0.019172973930835724, 0.04880143702030182, 0.07207300513982773, 0.020205024629831314, -1]}
{"idB": "749647_17_item1_p34_s1", "idA": "749647_16_item1_p177_s1", "sentA": "From February 1, 2013 through February 25, 2013, the Company sold and issued an aggregate of 1,195,927 shares of common stock under the ATM, receiving approximately $6.8 million in net proceeds.", "sentB": "In addition, 670,070 shares of common stock were held back by us at the closing and are issuable to EGEN pending certain potential adjustments for expenses or in relation to EGEN s indemnification obligations under the Asset Purchase Agreement.", "type": 2, "words": ["<tag1>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "an", "aggregate", "of", "1,195,927", "shares", "of", "common", "stock", "under", "the", "ATM,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds.", "<tag2>", "In", "addition,", "670,070", "shares", "of", "common", "stock", "were", "held", "back", "by", "us", "at", "the", "closing", "and", "are", "issuable", "to", "EGEN", "pending", "certain", "potential", "adjustments", "for", "expenses", "or", "in", "relation", "to", "EGEN", "s", "indemnification", "obligations", "under", "the", "Asset", "Purchase", "Agreement.", "<tag3>"], "wordsA": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "the", "Company", "sold", "and", "issued", "an", "aggregate", "of", "1,195,927", "shares", "of", "common", "stock", "under", "the", "ATM,", "receiving", "approximately", "$6.8", "million", "in", "net", "proceeds."], "wordsB": ["In", "addition,", "670,070", "shares", "of", "common", "stock", "were", "held", "back", "by", "us", "at", "the", "closing", "and", "are", "issuable", "to", "EGEN", "pending", "certain", "potential", "adjustments", "for", "expenses", "or", "in", "relation", "to", "EGEN", "s", "indemnification", "obligations", "under", "the", "Asset", "Purchase", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012035622261464596, 0.03884332254528999, 0.5841352939605713, 0.4136407971382141, 0.06836618483066559, 0.11057885736227036, 0.10095387697219849, 0.02508605644106865, 0.22783263027668, 0.25437843799591064, 0.03488076105713844, 0.034462179988622665, 0.009736030362546444, 0.00730659905821085, 0.0678214430809021, 0.0005647005164064467, 0.021964458748698235, 0.11016245931386948, 0.03247174993157387, 0.06201450154185295, 0.005302392411977053, 0.005363690201193094, 0.006382603198289871, 0.010452413000166416, 0.006770395208150148, 0.010291059501469135, 0.00015069553046487272, 0.0005478073144331574, 0.005330477841198444, 0.004161573946475983, 0.007897675968706608, 0.006522229872643948, 0.039203349500894547, 0.019784653559327126, 0.0061036283150315285, 0.006290635094046593, 0.047876130789518356, 0.06333855539560318, 0.05509026721119881, -1]}
{"idB": "749647_17_item1_p107_s0", "idA": "749647_16_item1_p178_s0", "sentA": "On June 20, 2014, we completed the acquisition of substantially all of the assets of EGEN, Inc.", "sentB": "On June 20, 2014, we completed the acquisition of substantially all of the assets of EGEN.", "type": 2, "words": ["<tag1>", "On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "Inc.", "<tag2>", "On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN.", "<tag3>"], "wordsA": ["On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "Inc."], "wordsB": ["On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07098425179719925, 0.10230076313018799, 0.17267732322216034, 0.09225817769765854, 0.05775540694594383, 0.14627131819725037, 0.024301348254084587, 0.13130676746368408, 0.05260395631194115, 0.1027555912733078, 0.12173157930374146, 0.048842135816812515, 0.06053262948989868, 0.21663638949394226, 0.15652087330818176, 0.6593443751335144, -1]}
{"idB": "749647_17_item1_p33_s1", "idA": "749647_16_item1_p178_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash and issued 2,712,188 shares of its common stock to EGEN.", "sentB": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "and", "issued", "2,712,188", "shares", "of", "its", "common", "stock", "to", "EGEN.", "<tag2>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "and", "issued", "2,712,188", "shares", "of", "its", "common", "stock", "to", "EGEN."], "wordsB": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0056492057628929615, 0.0065335058607161045, 0.0682721883058548, 0.03230437636375427, 0.08525074273347855, 0.06256966292858124, 0.08519112318754196, 0.06369423121213913, 0.036568667739629745, 0.08624143153429031, 0.599769115447998, 0.1540185958147049, 0.3370738923549652, 0.5277255177497864, 0.010609108954668045, 0.1604725569486618, 0.07325761020183563, 0.043151892721652985, 0.010976533405482769, 0.02439754270017147, 0.049739155918359756, 0.06405040621757507, 0.012082979083061218, 0.05000142753124237, -1]}
{"idB": "749647_17_item1_p22_s1", "idA": "749647_16_item1_p17_s1", "sentA": "The OPTIMA Study trial design is based on the comprehensive analysis of data from the HEAT study, which, as described previously, showed that treatment with ThermoDox resulted in a 58% improvement in overall survival in a large number of HCC patients that received an optimized RFA treatment for longer than 45 minutes.", "sentB": "The clinical benefit seen in the intent-to-treat Chinese patient cohort further confirms the importance of RFA heating time as 72% of patients in this large patient cohort in China received an optimized RFA treatment.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "previously,", "showed", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "58%", "improvement", "in", "overall", "survival", "in", "a", "large", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment", "for", "longer", "than", "45", "minutes.", "<tag2>", "The", "clinical", "benefit", "seen", "in", "the", "intent-to-treat", "Chinese", "patient", "cohort", "further", "confirms", "the", "importance", "of", "RFA", "heating", "time", "as", "72%", "of", "patients", "in", "this", "large", "patient", "cohort", "in", "China", "received", "an", "optimized", "RFA", "treatment.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "previously,", "showed", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "58%", "improvement", "in", "overall", "survival", "in", "a", "large", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment", "for", "longer", "than", "45", "minutes."], "wordsB": ["The", "clinical", "benefit", "seen", "in", "the", "intent-to-treat", "Chinese", "patient", "cohort", "further", "confirms", "the", "importance", "of", "RFA", "heating", "time", "as", "72%", "of", "patients", "in", "this", "large", "patient", "cohort", "in", "China", "received", "an", "optimized", "RFA", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007295988965779543, 0.19485099613666534, 0.1824522167444229, 0.011569878086447716, 0.007114526815712452, 0.005685432348400354, 0.3367350697517395, 0.14066822826862335, 0.12277735024690628, 0.044341810047626495, 0.005564083345234394, 0.038491297513246536, 0.006603552028536797, 0.024185357615351677, 0.006659490056335926, 0.024043051525950432, 0.07351477444171906, 0.041805118322372437, 0.004290929064154625, 0.5379238128662109, 0.043546486645936966, 0.10823400318622589, 0.00410484429448843, 0.0038332680705934763, 0.010790929198265076, 0.06980517506599426, 0.025402143597602844, 0.007139350287616253, 0.023527735844254494, 0.05144954472780228, 0.009754571132361889, 0.018315833061933517, 0.030519261956214905, 0.08225113153457642, -1]}
{"idB": "749647_17_item1_p16_s0", "idA": "749647_16_item1_p17_s2", "sentA": "Designed with extensive input from globally recognized HCC researchers and clinicians and, after formal written consultation with the FDA, the OPTIMA Study was launched in the first half of 2014.", "sentB": "We initiated the OPTIMA Study in the first half of 2014.", "type": 2, "words": ["<tag1>", "Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and,", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014.", "<tag2>", "We", "initiated", "the", "OPTIMA", "Study", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and,", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014."], "wordsB": ["We", "initiated", "the", "OPTIMA", "Study", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1656865030527115, 0.9632833003997803, 0.1477094441652298, 0.2840970754623413, 0.25212159752845764, 0.021612070500850677, 0.021538473665714264, 0.02757011540234089, 0.016904253512620926, 0.01153518259525299, 0.020549768581986427, -1]}
{"idB": "749647_17_item1_p159_s0", "idA": "749647_16_item1_p181_s0", "sentA": "To complete the development and commercialization of our products, we will need to raise substantial amounts of additional capital to fund our operations.", "sentB": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "type": 2, "words": ["<tag1>", "To", "complete", "the", "development", "and", "commercialization", "of", "our", "products,", "we", "will", "need", "to", "raise", "substantial", "amounts", "of", "additional", "capital", "to", "fund", "our", "operations.", "<tag2>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["To", "complete", "the", "development", "and", "commercialization", "of", "our", "products,", "we", "will", "need", "to", "raise", "substantial", "amounts", "of", "additional", "capital", "to", "fund", "our", "operations."], "wordsB": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03235016390681267, 0.03673452511429787, 0.10675036907196045, 0.08585493266582489, 0.02023681439459324, 0.013858623802661896, 0.03909322991967201, 0.018056154251098633, 0.20167095959186554, 0.2604246139526367, 0.5651879906654358, 0.5573726892471313, 0.1355753391981125, 0.3870755136013031, 0.4160594940185547, 0.010455355979502201, 0.013615814037621021, 0.004379088059067726, 0.009892629459500313, 0.0022723188158124685, 0.006705555599182844, 0.004420178011059761, 0.007453154772520065, 0.04924760386347771, 0.08383108675479889, -1]}
{"idB": "749647_17_item1_p160_s1", "idA": "749647_16_item1_p181_s0", "sentA": "To complete the development and commercialization of our products, we will need to raise substantial amounts of additional capital to fund our operations.", "sentB": "Given our development plans, we anticipate cash resources will be sufficient to fund our operations into mid-2017 and the Company has no committed sources of additional capital.", "type": 2, "words": ["<tag1>", "To", "complete", "the", "development", "and", "commercialization", "of", "our", "products,", "we", "will", "need", "to", "raise", "substantial", "amounts", "of", "additional", "capital", "to", "fund", "our", "operations.", "<tag2>", "Given", "our", "development", "plans,", "we", "anticipate", "cash", "resources", "will", "be", "sufficient", "to", "fund", "our", "operations", "into", "mid-2017", "and", "the", "Company", "has", "no", "committed", "sources", "of", "additional", "capital.", "<tag3>"], "wordsA": ["To", "complete", "the", "development", "and", "commercialization", "of", "our", "products,", "we", "will", "need", "to", "raise", "substantial", "amounts", "of", "additional", "capital", "to", "fund", "our", "operations."], "wordsB": ["Given", "our", "development", "plans,", "we", "anticipate", "cash", "resources", "will", "be", "sufficient", "to", "fund", "our", "operations", "into", "mid-2017", "and", "the", "Company", "has", "no", "committed", "sources", "of", "additional", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.032499901950359344, 0.013554930686950684, 0.04987657815217972, 0.03875996917486191, 0.021878251805901527, 0.10481253266334534, 0.26343825459480286, 0.3066282272338867, 0.034393828362226486, 0.04064737260341644, 0.07503281533718109, 0.01931927166879177, 0.06164248287677765, 0.01607167348265648, 0.06736593693494797, 0.015317477285861969, 0.040637463331222534, 0.003931515850126743, 0.0073042092844843864, 0.05024286359548569, 0.06150515750050545, 0.5452604293823242, 0.4167586863040924, 0.4391248822212219, 0.2596393823623657, 0.34588173031806946, 0.4097009003162384, -1]}
{"idB": "749647_17_item1_p155_s0", "idA": "749647_16_item1_p181_s1", "sentA": "We do not have any committed sources of financing and cannot give assurance that alternate funding will be available in a timely manner, on acceptable terms or at all.", "sentB": "We have not generated and do not expect to generate any revenue from product sales in the next several years, if at all.", "type": 2, "words": ["<tag1>", "We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "give", "assurance", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all.", "<tag2>", "We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all.", "<tag3>"], "wordsA": ["We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "give", "assurance", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all."], "wordsB": ["We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04385512322187424, 0.07826337218284607, 0.47251003980636597, 0.5174784064292908, 0.025379642844200134, 0.24578243494033813, 0.4042567014694214, 0.26717472076416016, 0.2516341805458069, 0.38063034415245056, 0.2866944372653961, 0.4165005683898926, 0.12598204612731934, 0.22365552186965942, 0.30627018213272095, 0.024932565167546272, 0.015210791490972042, 0.021075859665870667, 0.01609070785343647, 0.022981004789471626, 0.042297620326280594, 0.02176627703011036, 0.02406938001513481, -1]}
{"idB": "749647_17_item1_p211_s3", "idA": "749647_16_item1_p181_s2", "sentA": "We may need to pursue dilutive equity financings, such as the issuance of shares of common stock, preferred stock, convertible debt or other convertible or exercisable securities, which financings could dilute the percentage ownership of our current common stockholders and could significantly lower the market value of our common stock.", "sentB": "The Pre-Funded Series BB Warrants were offered at $0.22 per share, are immediately exercisable for $0.01 per share of common stock, do not have an expiration date and were issued in lieu of shares of common stock to the extent that the purchase of common stock would cause the beneficial ownership of the purchaser of such shares, together with its affiliates and certain related parties, to exceed 9.99% of our common stock.", "type": 2, "words": ["<tag1>", "We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "preferred", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities,", "which", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag2>", "The", "Pre-Funded", "Series", "BB", "Warrants", "were", "offered", "at", "$0.22", "per", "share,", "are", "immediately", "exercisable", "for", "$0.01", "per", "share", "of", "common", "stock,", "do", "not", "have", "an", "expiration", "date", "and", "were", "issued", "in", "lieu", "of", "shares", "of", "common", "stock", "to", "the", "extent", "that", "the", "purchase", "of", "common", "stock", "would", "cause", "the", "beneficial", "ownership", "of", "the", "purchaser", "of", "such", "shares,", "together", "with", "its", "affiliates", "and", "certain", "related", "parties,", "to", "exceed", "9.99%", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "preferred", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities,", "which", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "wordsB": ["The", "Pre-Funded", "Series", "BB", "Warrants", "were", "offered", "at", "$0.22", "per", "share,", "are", "immediately", "exercisable", "for", "$0.01", "per", "share", "of", "common", "stock,", "do", "not", "have", "an", "expiration", "date", "and", "were", "issued", "in", "lieu", "of", "shares", "of", "common", "stock", "to", "the", "extent", "that", "the", "purchase", "of", "common", "stock", "would", "cause", "the", "beneficial", "ownership", "of", "the", "purchaser", "of", "such", "shares,", "together", "with", "its", "affiliates", "and", "certain", "related", "parties,", "to", "exceed", "9.99%", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005275474861264229, 0.20808419585227966, 0.05836406350135803, 0.09369808435440063, 0.2913333475589752, 0.003840516321361065, 0.025464709848165512, 0.01436997763812542, 0.21238309144973755, 0.1090446338057518, 0.03682404011487961, 0.003726570401340723, 0.021414918825030327, 0.0259499903768301, 0.016324132680892944, 0.299795925617218, 0.1256302446126938, 0.06450139731168747, 0.02079911343753338, 0.04223300516605377, 0.03516042232513428, 0.06047114357352257, 0.20904554426670074, 0.2760255038738251, 0.30110037326812744, 0.6028417348861694, 0.23519547283649445, 0.0035102986730635166, 0.008185261860489845, 0.03893470764160156, 0.08627339452505112, 0.2252860814332962, 0.09933718293905258, 0.162135511636734, 0.052210111171007156, 0.10188955813646317, 0.10090252012014389, 0.00029856726177968085, 0.00021053328237030655, 0.008241808973252773, 0.006195960100740194, 0.007993255741894245, 0.09953825920820236, 0.040519870817661285, 0.06533502787351608, 0.05574140325188637, 0.024868136271834373, 0.06143921613693237, 0.013192730024456978, 0.17324815690517426, 0.26259809732437134, 0.04213479533791542, 0.022730616852641106, 0.10174762457609177, 0.05529259145259857, 0.055493567138910294, 0.08819965273141861, 0.004444419872015715, 0.0046835653483867645, 0.005409926641732454, 0.022368667647242546, 0.007026112638413906, 0.008845548145473003, 0.021110890433192253, 0.04008759558200836, 0.014306100085377693, 0.16126565635204315, 0.25820910930633545, 0.09355220943689346, 0.04297623410820961, 0.19617275893688202, 0.17652077972888947, -1]}
{"idB": "749647_17_item1_p23_s2", "idA": "749647_16_item1_p182_s2", "sentA": "Furthermore, concomitant increases in IFN- and TNF- indicate that t he IL-12 produced following treatment with GEN-1 treatment is immunologically active.", "sentB": "The results unequivocally indicate that longer RFA heating times correlate with significant increases in doxorubicin concentration around the RFA treated tissue.", "type": 2, "words": ["<tag1>", "Furthermore,", "concomitant", "increases", "in", "IFN-", "and", "TNF-", "indicate", "that", "t", "he", "IL-12", "produced", "following", "treatment", "with", "GEN-1", "treatment", "is", "immunologically", "active.", "<tag2>", "The", "results", "unequivocally", "indicate", "that", "longer", "RFA", "heating", "times", "correlate", "with", "significant", "increases", "in", "doxorubicin", "concentration", "around", "the", "RFA", "treated", "tissue.", "<tag3>"], "wordsA": ["Furthermore,", "concomitant", "increases", "in", "IFN-", "and", "TNF-", "indicate", "that", "t", "he", "IL-12", "produced", "following", "treatment", "with", "GEN-1", "treatment", "is", "immunologically", "active."], "wordsB": ["The", "results", "unequivocally", "indicate", "that", "longer", "RFA", "heating", "times", "correlate", "with", "significant", "increases", "in", "doxorubicin", "concentration", "around", "the", "RFA", "treated", "tissue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006401109509170055, 0.04572560265660286, 0.14199607074260712, 0.040477097034454346, 0.012872214429080486, 0.16448530554771423, 0.4085405170917511, 0.23404580354690552, 0.1998443752527237, 0.05673379823565483, 0.012149607762694359, 0.0975155159831047, 0.21910348534584045, 0.07255853712558746, 0.5842673778533936, 0.3613590896129608, 0.02110464498400688, 0.007322109770029783, 0.08665305376052856, 0.03945973888039589, 0.04370460286736488, -1]}
{"idB": "749647_17_item1_p83_s2", "idA": "749647_16_item1_p182_s2", "sentA": "Furthermore, concomitant increases in IFN- and TNF- indicate that t he IL-12 produced following treatment with GEN-1 treatment is immunologically active.", "sentB": "The results unequivocally indicate that longer RFA heating times correlate with significant increases in doxorubicin concentration around the RFA treated tissue.", "type": 2, "words": ["<tag1>", "Furthermore,", "concomitant", "increases", "in", "IFN-", "and", "TNF-", "indicate", "that", "t", "he", "IL-12", "produced", "following", "treatment", "with", "GEN-1", "treatment", "is", "immunologically", "active.", "<tag2>", "The", "results", "unequivocally", "indicate", "that", "longer", "RFA", "heating", "times", "correlate", "with", "significant", "increases", "in", "doxorubicin", "concentration", "around", "the", "RFA", "treated", "tissue.", "<tag3>"], "wordsA": ["Furthermore,", "concomitant", "increases", "in", "IFN-", "and", "TNF-", "indicate", "that", "t", "he", "IL-12", "produced", "following", "treatment", "with", "GEN-1", "treatment", "is", "immunologically", "active."], "wordsB": ["The", "results", "unequivocally", "indicate", "that", "longer", "RFA", "heating", "times", "correlate", "with", "significant", "increases", "in", "doxorubicin", "concentration", "around", "the", "RFA", "treated", "tissue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006401109509170055, 0.04572560265660286, 0.14199607074260712, 0.040477097034454346, 0.012872214429080486, 0.16448530554771423, 0.4085405170917511, 0.23404580354690552, 0.1998443752527237, 0.05673379823565483, 0.012149607762694359, 0.0975155159831047, 0.21910348534584045, 0.07255853712558746, 0.5842673778533936, 0.3613590896129608, 0.02110464498400688, 0.007322109770029783, 0.08665305376052856, 0.03945973888039589, 0.04370460286736488, -1]}
{"idB": "749647_17_item1_p134_s1", "idA": "749647_16_item1_p183_s0", "sentA": "Intraperitoneal administration of GEN-1 in platinum-resistant ovarian cancer patients resulted in a significant increase in IL-12 levels in peritoneal fluid samples.", "sentB": "The density of myeloid derived suppressor cells that are associated with immunosuppression in ovarian cancer were either decreased or did not increase in post-treatment samples.", "type": 2, "words": ["<tag1>", "Intraperitoneal", "administration", "of", "GEN-1", "in", "platinum-resistant", "ovarian", "cancer", "patients", "resulted", "in", "a", "significant", "increase", "in", "IL-12", "levels", "in", "peritoneal", "fluid", "samples.", "<tag2>", "The", "density", "of", "myeloid", "derived", "suppressor", "cells", "that", "are", "associated", "with", "immunosuppression", "in", "ovarian", "cancer", "were", "either", "decreased", "or", "did", "not", "increase", "in", "post-treatment", "samples.", "<tag3>"], "wordsA": ["Intraperitoneal", "administration", "of", "GEN-1", "in", "platinum-resistant", "ovarian", "cancer", "patients", "resulted", "in", "a", "significant", "increase", "in", "IL-12", "levels", "in", "peritoneal", "fluid", "samples."], "wordsB": ["The", "density", "of", "myeloid", "derived", "suppressor", "cells", "that", "are", "associated", "with", "immunosuppression", "in", "ovarian", "cancer", "were", "either", "decreased", "or", "did", "not", "increase", "in", "post-treatment", "samples."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011814752593636513, 0.20056797564029694, 0.07736912369728088, 0.7131234407424927, 0.31540635228157043, 0.4824559688568115, 0.4229225218296051, 7.190078031271696e-05, 0.004553575534373522, 0.014126656576991081, 0.015271471813321114, 0.2236991822719574, 0.004479942377656698, 0.006633221637457609, 0.010728505440056324, 0.008115760050714016, 0.007077422924339771, 0.1526227444410324, 0.008437588810920715, 0.10138484090566635, 0.1972782015800476, 0.18496115505695343, 0.02038448676466942, 0.3034939169883728, 0.17170259356498718, -1]}
{"idB": "749647_17_item1_p51_s1", "idA": "749647_16_item1_p183_s0", "sentA": "Intraperitoneal administration of GEN-1 in platinum-resistant ovarian cancer patients resulted in a significant increase in IL-12 levels in peritoneal fluid samples.", "sentB": "The density of myeloid derived suppressor cells that are associated with immunosuppression in ovarian cancer were either decreased or did not increase in post-treatment samples.", "type": 2, "words": ["<tag1>", "Intraperitoneal", "administration", "of", "GEN-1", "in", "platinum-resistant", "ovarian", "cancer", "patients", "resulted", "in", "a", "significant", "increase", "in", "IL-12", "levels", "in", "peritoneal", "fluid", "samples.", "<tag2>", "The", "density", "of", "myeloid", "derived", "suppressor", "cells", "that", "are", "associated", "with", "immunosuppression", "in", "ovarian", "cancer", "were", "either", "decreased", "or", "did", "not", "increase", "in", "post-treatment", "samples.", "<tag3>"], "wordsA": ["Intraperitoneal", "administration", "of", "GEN-1", "in", "platinum-resistant", "ovarian", "cancer", "patients", "resulted", "in", "a", "significant", "increase", "in", "IL-12", "levels", "in", "peritoneal", "fluid", "samples."], "wordsB": ["The", "density", "of", "myeloid", "derived", "suppressor", "cells", "that", "are", "associated", "with", "immunosuppression", "in", "ovarian", "cancer", "were", "either", "decreased", "or", "did", "not", "increase", "in", "post-treatment", "samples."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011814752593636513, 0.20056797564029694, 0.07736912369728088, 0.7131234407424927, 0.31540635228157043, 0.4824559688568115, 0.4229225218296051, 7.190078031271696e-05, 0.004553575534373522, 0.014126656576991081, 0.015271471813321114, 0.2236991822719574, 0.004479942377656698, 0.006633221637457609, 0.010728505440056324, 0.008115760050714016, 0.007077422924339771, 0.1526227444410324, 0.008437588810920715, 0.10138484090566635, 0.1972782015800476, 0.18496115505695343, 0.02038448676466942, 0.3034939169883728, 0.17170259356498718, -1]}
{"idB": "749647_17_item1_p17_s0", "idA": "749647_16_item1_p18_s1", "sentA": "The statistical plan calls for two interim efficacy analyses by an independent DMC.", "sentB": "The statistical plan calls for two interim efficacy analyses by an independent Data Monitoring Committee.", "type": 2, "words": ["<tag1>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "DMC.", "<tag2>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee.", "<tag3>"], "wordsA": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "DMC."], "wordsB": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "Data", "Monitoring", "Committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0014585714088752866, 0.011014164425432682, 0.011730887927114964, 0.008074172772467136, 0.002348504727706313, 0.0034137116745114326, 0.0054539465345442295, 0.006929272785782814, 0.015201921574771404, 0.009397104382514954, 0.010782971046864986, 0.08466745913028717, 0.9599647521972656, 0.968590497970581, 0.8920045495033264, -1]}
{"idB": "749647_17_item1_p89_s0", "idA": "749647_16_item1_p18_s1", "sentA": "The statistical plan calls for two interim efficacy analyses by an independent DMC.", "sentB": "The statistical plan calls for two interim efficacy analyses by an independent iDMC.", "type": 2, "words": ["<tag1>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "DMC.", "<tag2>", "The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "iDMC.", "<tag3>"], "wordsA": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "DMC."], "wordsB": ["The", "statistical", "plan", "calls", "for", "two", "interim", "efficacy", "analyses", "by", "an", "independent", "iDMC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0014232777757570148, 0.008719674311578274, 0.009111231192946434, 0.005447091069072485, 0.002071299823001027, 0.0027652911376208067, 0.004463796503841877, 0.005648734048008919, 0.011630658060312271, 0.005969267804175615, 0.005473285913467407, 0.039484381675720215, 0.9930786490440369, -1]}
{"idB": "749647_17_item1_p18_s0", "idA": "749647_16_item1_p19_s0", "sentA": "On December 16, 2015, we announced that we received the clinical trial application approval from the China Food and Drug Administration (CFDA) to conduct the OPTIMA Study in China.", "sentB": "On December 16, 2015, we announced that we had received the clinical trial application approval from the China Food and Drug Administration (the CFDA ) to conduct the OPTIMA Study in China.", "type": 2, "words": ["<tag1>", "On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "China", "Food", "and", "Drug", "Administration", "(CFDA)", "to", "conduct", "the", "OPTIMA", "Study", "in", "China.", "<tag2>", "On", "December", "16,", "2015,", "we", "announced", "that", "we", "had", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "China", "Food", "and", "Drug", "Administration", "(the", "CFDA", ")", "to", "conduct", "the", "OPTIMA", "Study", "in", "China.", "<tag3>"], "wordsA": ["On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "China", "Food", "and", "Drug", "Administration", "(CFDA)", "to", "conduct", "the", "OPTIMA", "Study", "in", "China."], "wordsB": ["On", "December", "16,", "2015,", "we", "announced", "that", "we", "had", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "China", "Food", "and", "Drug", "Administration", "(the", "CFDA", ")", "to", "conduct", "the", "OPTIMA", "Study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.14624018967151642, 0.1665545552968979, 0.27081623673439026, 0.1303572952747345, 0.11823205649852753, 0.17420969903469086, 0.0357222817838192, 0.2588511109352112, 0.22203396260738373, 0.3992493748664856, 0.06934339553117752, 0.2270687371492386, 0.26356804370880127, 0.34487104415893555, 0.4210054874420166, 0.05815785005688667, 0.03820782154798508, 0.11716128885746002, 0.11698076874017715, 0.0760514885187149, 0.07768066972494125, 0.10972869396209717, 0.05041653290390968, 0.09650150686502457, 0.0002393717149971053, 0.03795192390680313, 0.053767114877700806, 0.036541298031806946, 0.09103613346815109, 0.09740590304136276, 0.045362118631601334, 0.10247413069009781, -1]}
{"idB": "749647_17_item1_p18_s2", "idA": "749647_16_item1_p19_s2", "sentA": "With the addition of these Chinese clinical sites, the Company expects to complete enrollment in the OPTIMA Study during the first quarter of 2018.", "sentB": "With the addition of these Chinese clinical sites, the Company expects to complete enrollment in the OPTIMA Study during the first half of 2018.", "type": 2, "words": ["<tag1>", "With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "quarter", "of", "2018.", "<tag2>", "With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "half", "of", "2018.", "<tag3>"], "wordsA": ["With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "quarter", "of", "2018."], "wordsB": ["With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "half", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014422710984945297, 0.013034517876803875, 0.03663676977157593, 0.015315866097807884, 0.014693432487547398, 0.02352849580347538, 0.021064575761556625, 0.0339638814330101, 0.006827846635133028, 0.034886810928583145, 0.03177652880549431, 0.016009656712412834, 0.042206328362226486, 0.05825064703822136, 0.0075558386743068695, 0.0071523613296449184, 0.019182229414582253, 0.01818249374628067, 0.014711705036461353, 0.015513518825173378, 0.11868440359830856, 0.9324107766151428, 0.33128952980041504, 0.08184218406677246, -1]}
{"idB": "749647_17_item1_p90_s2", "idA": "749647_16_item1_p19_s2", "sentA": "With the addition of these Chinese clinical sites, the Company expects to complete enrollment in the OPTIMA Study during the first quarter of 2018.", "sentB": "With the addition of these Chinese clinical sites, the Company expects to complete enrollment in the OPTIMA Study during the first half of 2018.", "type": 2, "words": ["<tag1>", "With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "quarter", "of", "2018.", "<tag2>", "With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "half", "of", "2018.", "<tag3>"], "wordsA": ["With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "quarter", "of", "2018."], "wordsB": ["With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "half", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014422710984945297, 0.013034517876803875, 0.03663676977157593, 0.015315866097807884, 0.014693432487547398, 0.02352849580347538, 0.021064575761556625, 0.0339638814330101, 0.006827846635133028, 0.034886810928583145, 0.03177652880549431, 0.016009656712412834, 0.042206328362226486, 0.05825064703822136, 0.0075558386743068695, 0.0071523613296449184, 0.019182229414582253, 0.01818249374628067, 0.014711705036461353, 0.015513518825173378, 0.11868440359830856, 0.9324107766151428, 0.33128952980041504, 0.08184218406677246, -1]}
{"idB": "749647_17_item1_p32_s0", "idA": "749647_16_item1_p20_s0", "sentA": "On June 20, 2014, we completed the acquisition of substantially all of the assets of EGEN, Inc., an Alabama corporation (EGEN), pursuant to an Asset Purchase Agreement.", "sentB": "On June 20, 2014, we completed the acquisition of substantially all of the assets of Egen, Inc., an Alabama corporation, which has changed its company name to EGWU, Inc. after the closing of the acquisition ( EGEN ), pursuant to an asset purchase agreement dated as of June 6, 2014, by and between EGEN and Celsion (the Asset Purchase Agreement).", "type": 2, "words": ["<tag1>", "On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "Inc.,", "an", "Alabama", "corporation", "(EGEN),", "pursuant", "to", "an", "Asset", "Purchase", "Agreement.", "<tag2>", "On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "Egen,", "Inc.,", "an", "Alabama", "corporation,", "which", "has", "changed", "its", "company", "name", "to", "EGWU,", "Inc.", "after", "the", "closing", "of", "the", "acquisition", "(", "EGEN", "),", "pursuant", "to", "an", "asset", "purchase", "agreement", "dated", "as", "of", "June", "6,", "2014,", "by", "and", "between", "EGEN", "and", "Celsion", "(the", "Asset", "Purchase", "Agreement).", "<tag3>"], "wordsA": ["On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "Inc.,", "an", "Alabama", "corporation", "(EGEN),", "pursuant", "to", "an", "Asset", "Purchase", "Agreement."], "wordsB": ["On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "Egen,", "Inc.,", "an", "Alabama", "corporation,", "which", "has", "changed", "its", "company", "name", "to", "EGWU,", "Inc.", "after", "the", "closing", "of", "the", "acquisition", "(", "EGEN", "),", "pursuant", "to", "an", "asset", "purchase", "agreement", "dated", "as", "of", "June", "6,", "2014,", "by", "and", "between", "EGEN", "and", "Celsion", "(the", "Asset", "Purchase", "Agreement)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0067574214190244675, 0.009328366257250309, 0.012301917187869549, 0.011433101259171963, 0.011237342841923237, 0.0150535823777318, 0.009716915898025036, 0.020300446078181267, 0.012840015813708305, 0.014358109794557095, 0.014365535229444504, 0.010432550683617592, 0.014017142355442047, 0.03817873075604439, 0.008470420725643635, 0.013684984296560287, 0.008952835574746132, 0.005422343499958515, 0.014715202152729034, 0.017902784049510956, 0.01099005714058876, 0.02622484229505062, 0.1774982511997223, 0.09093496948480606, 0.19973523914813995, 0.14463898539543152, 0.04669801518321037, 0.3487481474876404, 0.1662467122077942, 0.03387254849076271, 0.04106144607067108, 0.10879833996295929, 0.043260566890239716, 0.040336448699235916, 0.10449250787496567, 0.01735222525894642, 0.020702609792351723, 0.00043299226672388613, 0.009502475149929523, 0.009885184466838837, 0.006717005744576454, 0.019459359347820282, 0.016625890508294106, 0.025740398094058037, 0.007488228380680084, 0.013910029083490372, 0.020705508068203926, 0.016844959929585457, 0.01158871315419674, 0.014750468544661999, 0.020072024315595627, 0.061543237417936325, 0.06895946711301804, 0.2981206774711609, 0.175682932138443, 0.5073110461235046, 0.028984198346734047, 0.03171483054757118, 0.021277498453855515, 0.04351436346769333, -1]}
{"idB": "749647_17_item1_p37_s0", "idA": "749647_16_item1_p20_s2", "sentA": "In addition, CLSN Laboratories assumed certain specified liabilities of EGEN, including the liabilities arising out of the acquired contracts and other assets relating to periods after the closing date.", "sentB": "Our obligations to make the earnout payments will terminate on the seventh anniversary of the closing date.", "type": 2, "words": ["<tag1>", "In", "addition,", "CLSN", "Laboratories", "assumed", "certain", "specified", "liabilities", "of", "EGEN,", "including", "the", "liabilities", "arising", "out", "of", "the", "acquired", "contracts", "and", "other", "assets", "relating", "to", "periods", "after", "the", "closing", "date.", "<tag2>", "Our", "obligations", "to", "make", "the", "earnout", "payments", "will", "terminate", "on", "the", "seventh", "anniversary", "of", "the", "closing", "date.", "<tag3>"], "wordsA": ["In", "addition,", "CLSN", "Laboratories", "assumed", "certain", "specified", "liabilities", "of", "EGEN,", "including", "the", "liabilities", "arising", "out", "of", "the", "acquired", "contracts", "and", "other", "assets", "relating", "to", "periods", "after", "the", "closing", "date."], "wordsB": ["Our", "obligations", "to", "make", "the", "earnout", "payments", "will", "terminate", "on", "the", "seventh", "anniversary", "of", "the", "closing", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09807101637125015, 0.37976402044296265, 0.11177805811166763, 0.12817981839179993, 0.07862429320812225, 0.25845402479171753, 0.2457185536623001, 0.11041748523712158, 0.315483957529068, 0.07312379777431488, 0.04748431593179703, 0.23077718913555145, 0.27445971965789795, 0.0925518274307251, 0.05901032313704491, 0.11125421524047852, 0.1035478487610817, -1]}
{"idB": "749647_17_item1_p33_s0", "idA": "749647_16_item1_p20_s4", "sentA": "Additional consideration included contingent value rights totaling $30.4 million, payable in cash, shares of Celsion common stock or a combination thereof, at Celsion s option, upon achievement of three major milestone events as follows:", "sentB": "The total purchase price for the asset acquisition is up to $44.4 million, including potential future earnout payments of up to $30.4 million contingent upon achievement of certain earnout milestones set forth in the Asset Purchase Agreement.", "type": 2, "words": ["<tag1>", "Additional", "consideration", "included", "contingent", "value", "rights", "totaling", "$30.4", "million,", "payable", "in", "cash,", "shares", "of", "Celsion", "common", "stock", "or", "a", "combination", "thereof,", "at", "Celsion", "s", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:", "<tag2>", "The", "total", "purchase", "price", "for", "the", "asset", "acquisition", "is", "up", "to", "$44.4", "million,", "including", "potential", "future", "earnout", "payments", "of", "up", "to", "$30.4", "million", "contingent", "upon", "achievement", "of", "certain", "earnout", "milestones", "set", "forth", "in", "the", "Asset", "Purchase", "Agreement.", "<tag3>"], "wordsA": ["Additional", "consideration", "included", "contingent", "value", "rights", "totaling", "$30.4", "million,", "payable", "in", "cash,", "shares", "of", "Celsion", "common", "stock", "or", "a", "combination", "thereof,", "at", "Celsion", "s", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:"], "wordsB": ["The", "total", "purchase", "price", "for", "the", "asset", "acquisition", "is", "up", "to", "$44.4", "million,", "including", "potential", "future", "earnout", "payments", "of", "up", "to", "$30.4", "million", "contingent", "upon", "achievement", "of", "certain", "earnout", "milestones", "set", "forth", "in", "the", "Asset", "Purchase", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010161572135984898, 0.19116301834583282, 0.5164169073104858, 0.4250335395336151, 0.01115958858281374, 0.008933188393712044, 0.04738319292664528, 0.035035841166973114, 0.008248914033174515, 0.016622312366962433, 0.023365505039691925, 0.042261529713869095, 0.12051510065793991, 0.008042528294026852, 0.035799626260995865, 0.054821938276290894, 0.22033105790615082, 0.3115726411342621, 0.005920499097555876, 0.01395038329064846, 0.011404799297451973, 0.01431156788021326, 0.013486362993717194, 0.005457972642034292, 0.00665956549346447, 0.00596762727946043, 0.004943309351801872, 0.022641681134700775, 0.01749880611896515, 0.025358157232403755, 0.004797031171619892, 0.005559372715651989, 0.0057038734667003155, 0.005793104413896799, 0.031770847737789154, 0.03720822185277939, 0.036523252725601196, -1]}
{"idB": "749647_17_item1_p35_s0", "idA": "749647_16_item1_p20_s4", "sentA": "Additional consideration included contingent value rights totaling $30.4 million, payable in cash, shares of Celsion common stock or a combination thereof, at Celsion s option, upon achievement of three major milestone events as follows:", "sentB": "The earnout payments of up to $30.4 million will become payable, in cash, shares of our common stock or a combination thereof, at our option, upon achievement of three major milestone events as follows:", "type": 2, "words": ["<tag1>", "Additional", "consideration", "included", "contingent", "value", "rights", "totaling", "$30.4", "million,", "payable", "in", "cash,", "shares", "of", "Celsion", "common", "stock", "or", "a", "combination", "thereof,", "at", "Celsion", "s", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:", "<tag2>", "The", "earnout", "payments", "of", "up", "to", "$30.4", "million", "will", "become", "payable,", "in", "cash,", "shares", "of", "our", "common", "stock", "or", "a", "combination", "thereof,", "at", "our", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:", "<tag3>"], "wordsA": ["Additional", "consideration", "included", "contingent", "value", "rights", "totaling", "$30.4", "million,", "payable", "in", "cash,", "shares", "of", "Celsion", "common", "stock", "or", "a", "combination", "thereof,", "at", "Celsion", "s", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:"], "wordsB": ["The", "earnout", "payments", "of", "up", "to", "$30.4", "million", "will", "become", "payable,", "in", "cash,", "shares", "of", "our", "common", "stock", "or", "a", "combination", "thereof,", "at", "our", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017734253779053688, 0.8494595289230347, 0.8686067461967468, 0.015577904880046844, 0.040456775575876236, 0.039594557136297226, 0.011731192469596863, 0.0058021084405481815, 0.004494042601436377, 0.005735571030527353, 0.01079184003174305, 0.0034947015810757875, 0.00487037468701601, 0.0058027636259794235, 0.002234820509329438, 0.006731259636580944, 0.008263492956757545, 0.0062137204222381115, 0.0029449567664414644, 0.0033727395348250866, 0.0038718637079000473, 0.00366479461081326, 0.002600827720016241, 0.0028667564038187265, 0.003656297456473112, 0.0032088386360555887, 0.0032681156881153584, 0.0002493611245881766, 0.0029266830533742905, 0.002834442537277937, 0.002943596104159951, 0.002784325275570154, 0.0030998014844954014, 0.014532840810716152, -1]}
{"idB": "749647_17_item1_p36_s0", "idA": "749647_16_item1_p21_s0", "sentA": "Up to $6.0 million will become payable upon achieving certain specified milestones relating to the TheraSilence technology.", "sentB": "up to $6.0 million will become payable upon achieving certain specified milestones relating to the TheraSilence technology acquired from EGEN in the acquisition.", "type": 2, "words": ["<tag1>", "Up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology.", "<tag2>", "up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology", "acquired", "from", "EGEN", "in", "the", "acquisition.", "<tag3>"], "wordsA": ["Up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology."], "wordsB": ["up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology", "acquired", "from", "EGEN", "in", "the", "acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07041327655315399, 0.04132523760199547, 0.2567126750946045, 0.2075015753507614, 0.022330960258841515, 0.031232669949531555, 0.07917547971010208, 0.04936577007174492, 0.01968471333384514, 0.023337148129940033, 0.023365067318081856, 0.03366009145975113, 0.01551867090165615, 0.012747888453304768, 0.010059165768325329, 0.06891317665576935, 0.19580072164535522, 0.12314742803573608, 0.13702742755413055, 0.6669626832008362, 0.07679596543312073, 0.043459560722112656, 0.1680830866098404, -1]}
{"idB": "749647_17_item1_p37_s1", "idA": "749647_16_item1_p22_s0", "sentA": "With the acquisition, we acquired GEN-1 (formerly known as EGEN-001), a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers, and three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "sentB": "In the acquisition, we purchased GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers, and two platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "type": 2, "words": ["<tag1>", "With", "the", "acquisition,", "we", "acquired", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag2>", "In", "the", "acquisition,", "we", "purchased", "GEN-1,", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "two", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag3>"], "wordsA": ["With", "the", "acquisition,", "we", "acquired", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "wordsB": ["In", "the", "acquisition,", "we", "purchased", "GEN-1,", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "two", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07111290097236633, 0.03265093266963959, 0.13840603828430176, 0.07984525710344315, 0.4782796800136566, 0.36807024478912354, 0.007113543804734945, 0.04244004935026169, 0.019041696563363075, 0.008418691344559193, 0.007927107624709606, 0.017125345766544342, 0.017650041729211807, 0.009314609691500664, 0.02306780405342579, 0.009965978562831879, 0.015765992924571037, 0.017607111483812332, 0.009794718585908413, 0.15036629140377045, 0.05383540689945221, 0.04857458919286728, 0.011097407899796963, 0.009351123124361038, 0.012693524360656738, 0.009383618831634521, 0.016062453389167786, 0.01148313656449318, 0.011372028850018978, 0.01733180321753025, 0.019910477101802826, 0.02200392633676529, 0.01928916946053505, 0.012871615588665009, 0.017780207097530365, 0.013541572727262974, 0.026085343211889267, 0.025245675817131996, 0.016336802393198013, 0.00666465237736702, 0.008701680228114128, 0.02520523965358734, 0.018429061397910118, 0.009028270840644836, 0.01676100306212902, 0.014406880363821983, 0.009168592281639576, 0.02222403511404991, 0.009904660284519196, 0.021566621959209442, 0.0004021469794679433, -1]}
{"idB": "749647_17_item1_p8_s3", "idA": "749647_16_item1_p22_s0", "sentA": "With the acquisition, we acquired GEN-1 (formerly known as EGEN-001), a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers, and three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "sentB": "GEN-1 is based on a platform technology for the development of treatments using novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.", "type": 2, "words": ["<tag1>", "With", "the", "acquisition,", "we", "acquired", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag2>", "GEN-1", "is", "based", "on", "a", "platform", "technology", "for", "the", "development", "of", "treatments", "using", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies.", "<tag3>"], "wordsA": ["With", "the", "acquisition,", "we", "acquired", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "three", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "wordsB": ["GEN-1", "is", "based", "on", "a", "platform", "technology", "for", "the", "development", "of", "treatments", "using", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.3109983801841736, 0.07025344669818878, 0.18113048374652863, 0.04376820847392082, 0.012817677110433578, 0.06887204945087433, 0.038312628865242004, 0.003988633863627911, 0.004719076678156853, 0.01927950233221054, 0.006084138993173838, 0.043560899794101715, 0.0089194867759943, 0.030050361528992653, 0.053912870585918427, 0.03666294738650322, 0.021416058763861656, 0.00402890145778656, 0.007011164911091328, 0.2563822567462921, 0.034788914024829865, 0.01921018585562706, 0.04366467893123627, 0.03984696790575981, -1]}
{"idB": "749647_17_item1_p39_s1", "idA": "749647_16_item1_p25_s1", "sentA": "On September 30, 2015, we announced enrollment of the first patient in this study.", "sentB": "On September 30, 2015, we announced enrollment of the first patient in the OVATION Study.", "type": 2, "words": ["<tag1>", "On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "this", "study.", "<tag2>", "On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "the", "OVATION", "Study.", "<tag3>"], "wordsA": ["On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "this", "study."], "wordsB": ["On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "the", "OVATION", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0020763324573636055, 0.0034736471716314554, 0.0033434645738452673, 0.004418579861521721, 0.003636617213487625, 0.005468496587127447, 0.013126964680850506, 0.00276148016564548, 0.0029642346780747175, 0.014995930716395378, 0.032563671469688416, 0.014907113276422024, 0.014889701269567013, 0.9906792044639587, 0.5365263223648071, -1]}
{"idB": "749647_17_item1_p39_s2", "idA": "749647_16_item1_p25_s3", "sentA": "The OVATION Study is designed to enroll three to six patients per dose cohort and will evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study combining GEN-1 with Avastin and Doxil .", "sentB": "The OVATION Study will seek to identify a safe, tolerable and potentially therapeutically active dose of GEN-1 by recruiting and maximizing an immune response and is designed to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study combining GEN-1 with Avastin and Doxil .", "type": 2, "words": ["<tag1>", "The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag2>", "The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag3>"], "wordsA": ["The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "wordsB": ["The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004631779622286558, 0.02473577670753002, 0.04060312360525131, 0.007303417660295963, 0.012793711386620998, 0.008087373338639736, 0.011889955028891563, 0.010947891511023045, 0.03329211845993996, 0.03897989168763161, 0.00341556454077363, 0.02268175594508648, 0.14141157269477844, 0.13480594754219055, 0.11182580143213272, 0.015786688774824142, 0.06647194921970367, 0.010184664279222488, 0.1800132840871811, 0.08267217129468918, 0.14880242943763733, 0.1098453551530838, 0.3529641628265381, 0.30084946751594543, 0.0019316981779411435, 0.005936391185969114, 0.0063545373268425465, 0.006830569822341204, 0.008461469784379005, 0.008648690767586231, 0.008153922855854034, 0.012297472916543484, 0.02339479699730873, 0.007295477204024792, 0.022108135744929314, 0.01109359785914421, 0.0018029416678473353, 0.006061375606805086, 0.008742413483560085, 0.015801526606082916, 0.01035775151103735, 0.011736317537724972, 0.007395077962428331, 0.007783812936395407, 0.008274277672171593, 0.00828844215720892, 0.006937485188245773, 0.013180971145629883, 0.027054468169808388, 0.005827800370752811, 0.006051263771951199, 0.014162342064082623, 0.012691128998994827, 0.013385932892560959, 0.009894494898617268, 0.009782351553440094, 0.08814651519060135, 0.012011146172881126, 0.048662230372428894, 0.010068172588944435, 0.03615401312708855, 0.00042327705887146294, -1]}
{"idB": "749647_17_item1_p41_s0", "idA": "749647_16_item1_p27_s0", "sentA": "We have initiated the study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "sentB": "We have initiated the OVATION Study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "type": 2, "words": ["<tag1>", "We", "have", "initiated", "the", "study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag2>", "We", "have", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag3>"], "wordsA": ["We", "have", "initiated", "the", "study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "wordsB": ["We", "have", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004674045369029045, 0.0030679081100970507, 0.03597698360681534, 0.019520806148648262, 0.991780698299408, 0.5073996186256409, 0.0023887178394943476, 0.0059659481048583984, 0.006041583139449358, 0.005894702393561602, 0.0018452106742188334, 0.0018367951270192862, 0.0038665065076202154, 0.002548016607761383, 0.003967373166233301, 0.0022788511123508215, 0.004048031289130449, 0.005529977846890688, 0.004298710264265537, 0.0032850916031748056, 0.003569170366972685, 0.003383461618795991, 0.0036135215777903795, 0.0020675440318882465, 0.0030238127801567316, 0.0031365486793220043, 0.002149243839085102, 0.0019313930533826351, 0.007065761834383011, 0.004855453968048096, 0.0027171100955456495, 0.004074382595717907, -1]}
{"idB": "749647_17_item1_p123_s0", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "In 2016 and early 2017, we announced data from the first four cohorts of patients in the OVATION Study.", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study.", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.043449513614177704, 0.12650816142559052, 0.1424102634191513, 0.4412427246570587, 0.6389856934547424, 0.013398092240095139, 0.10231868177652359, 0.3090824484825134, 0.0746832937002182, 0.024008136242628098, 0.12143447995185852, 0.6478816270828247, 0.41920948028564453, 0.08706706017255783, 0.1386583149433136, 0.004290388897061348, 0.0041109309531748295, 0.007374518550932407, 0.0138176791369915, -1]}
{"idB": "749647_17_item1_p124_s1", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "Enrollment of three additional patients in the fourth cohort is ongoing, and Celsion expects to complete the OVATION Study in the first half of 2017.", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017.", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.047656815499067307, 0.0066508399322628975, 0.05512723699212074, 0.1322903335094452, 0.1055835410952568, 0.002977075520902872, 0.003529893234372139, 0.14020654559135437, 0.10181187838315964, 0.008396556600928307, 0.06074899807572365, 0.007539526093751192, 0.06795583665370941, 0.02468341588973999, 0.00829577911645174, 0.014566320925951004, 0.004069695249199867, 0.009669973514974117, 0.013012221083045006, 0.008641848340630531, 0.006960736587643623, 0.04007076099514961, 0.10822995752096176, 0.08783178776502609, 0.3932745158672333, -1]}
{"idB": "749647_17_item1_p124_s3", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "The results of the OVATION Study to date are as follows:", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0818156823515892, 0.39255326986312866, 0.05440748482942581, 0.030617129057645798, 0.1104905977845192, 0.10514505952596664, 0.03289227560162544, 0.04579916223883629, 0.09175968170166016, 0.36743977665901184, 0.5971106290817261, -1]}
{"idB": "749647_17_item1_p131_s0", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "Tumor and blood samples collected before the start of the neoadjuvant chemotherapy ( NACT ) and after the completion of GEN-1 treatment at debulking surgery are being analyzed for immune cell populations.", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "Tumor", "and", "blood", "samples", "collected", "before", "the", "start", "of", "the", "neoadjuvant", "chemotherapy", "(", "NACT", ")", "and", "after", "the", "completion", "of", "GEN-1", "treatment", "at", "debulking", "surgery", "are", "being", "analyzed", "for", "immune", "cell", "populations.", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["Tumor", "and", "blood", "samples", "collected", "before", "the", "start", "of", "the", "neoadjuvant", "chemotherapy", "(", "NACT", ")", "and", "after", "the", "completion", "of", "GEN-1", "treatment", "at", "debulking", "surgery", "are", "being", "analyzed", "for", "immune", "cell", "populations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.307552695274353, 0.14058025181293488, 0.36320677399635315, 0.30385544896125793, 0.07280735671520233, 0.03856734186410904, 0.010479850694537163, 0.03272533044219017, 0.014182095415890217, 0.018055599182844162, 0.1769043356180191, 0.09950454533100128, 0.008167825639247894, 0.11639977246522903, 6.325724098132923e-05, 0.00019667560991365463, 0.030540557578206062, 0.0074568623676896095, 0.039523351937532425, 0.012615548446774483, 0.12238645553588867, 0.08860865235328674, 0.019149016588926315, 0.2171223908662796, 0.10875564813613892, 0.008441290818154812, 0.06561693549156189, 0.17856863141059875, 0.04933222383260727, 0.2433248609304428, 0.2391151636838913, 0.21588987112045288, -1]}
{"idB": "749647_17_item1_p41_s1", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "During 2016 and 2017, we announced data from the first four cohorts of patients in the OVATION Study, respectively.", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively.", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06804755330085754, 0.11029317229986191, 0.2829214930534363, 0.5267716646194458, 0.015922416001558304, 0.15337595343589783, 0.36572495102882385, 0.08006824553012848, 0.02477983944118023, 0.12215082347393036, 0.6816797852516174, 0.4490339457988739, 0.10005421191453934, 0.14957505464553833, 0.004144464153796434, 0.004179567564278841, 0.008450292982161045, 0.014501127414405346, 0.03963169828057289, -1]}
{"idB": "749647_17_item1_p41_s3", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "Enrollment of three additional patients in the fourth cohort is ongoing, and Celsion expects to complete the OVATION Study in the first half of 2017.", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017.", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.047656815499067307, 0.0066508399322628975, 0.05512723699212074, 0.1322903335094452, 0.1055835410952568, 0.002977075520902872, 0.003529893234372139, 0.14020654559135437, 0.10181187838315964, 0.008396556600928307, 0.06074899807572365, 0.007539526093751192, 0.06795583665370941, 0.02468341588973999, 0.00829577911645174, 0.014566320925951004, 0.004069695249199867, 0.009669973514974117, 0.013012221083045006, 0.008641848340630531, 0.006960736587643623, 0.04007076099514961, 0.10822995752096176, 0.08783178776502609, 0.3932745158672333, -1]}
{"idB": "749647_17_item1_p41_s5", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "The results of the OVATION Study to date are as follows:", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0818156823515892, 0.39255326986312866, 0.05440748482942581, 0.030617129057645798, 0.1104905977845192, 0.10514505952596664, 0.03289227560162544, 0.04579916223883629, 0.09175968170166016, 0.36743977665901184, 0.5971106290817261, -1]}
{"idB": "749647_17_item1_p48_s0", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "Tumor and blood samples collected before the start of the neoadjuvant chemotherapy ( NACT ) and after the completion of GEN-1 treatment at debulking surgery are being analyzed for immune cell populations.", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "Tumor", "and", "blood", "samples", "collected", "before", "the", "start", "of", "the", "neoadjuvant", "chemotherapy", "(", "NACT", ")", "and", "after", "the", "completion", "of", "GEN-1", "treatment", "at", "debulking", "surgery", "are", "being", "analyzed", "for", "immune", "cell", "populations.", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["Tumor", "and", "blood", "samples", "collected", "before", "the", "start", "of", "the", "neoadjuvant", "chemotherapy", "(", "NACT", ")", "and", "after", "the", "completion", "of", "GEN-1", "treatment", "at", "debulking", "surgery", "are", "being", "analyzed", "for", "immune", "cell", "populations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.307552695274353, 0.14058025181293488, 0.36320677399635315, 0.30385544896125793, 0.07280735671520233, 0.03856734186410904, 0.010479850694537163, 0.03272533044219017, 0.014182095415890217, 0.018055599182844162, 0.1769043356180191, 0.09950454533100128, 0.008167825639247894, 0.11639977246522903, 6.325724098132923e-05, 0.00019667560991365463, 0.030540557578206062, 0.0074568623676896095, 0.039523351937532425, 0.012615548446774483, 0.12238645553588867, 0.08860865235328674, 0.019149016588926315, 0.2171223908662796, 0.10875564813613892, 0.008441290818154812, 0.06561693549156189, 0.17856863141059875, 0.04933222383260727, 0.2433248609304428, 0.2391151636838913, 0.21588987112045288, -1]}
{"idB": "749647_17_item1_p90_s3", "idA": "749647_16_item1_p27_s1", "sentA": "In February 2016, we announced the completion of enrollment of the first cohort of three patients in the OVATION Study.", "sentB": "On April 26, 2016, we announced that the first patient in China has been enrolled in the OPTIMA Study.", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "has", "been", "enrolled", "in", "the", "OPTIMA", "Study.", "<tag3>"], "wordsA": ["In", "February", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "three", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "has", "been", "enrolled", "in", "the", "OPTIMA", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030014418065547943, 0.8421281576156616, 0.537710428237915, 0.050045523792505264, 0.011130002327263355, 0.02433246560394764, 0.010437440127134323, 0.020489124581217766, 0.32991111278533936, 0.33094778656959534, 0.03654436022043228, 0.13061168789863586, 0.032454073429107666, 0.028068114072084427, 0.10431218892335892, 0.030993036925792694, 0.025466447696089745, 0.6742468476295471, 0.2245609164237976, -1]}
{"idB": "749647_17_item1_p53_s0", "idA": "749647_16_item1_p28_s0", "sentA": "GEN-1 Plus Avastin and Doxil Trial.", "sentB": "GEN-1 Plus Doxil and Avastin Trial.", "type": 2, "words": ["<tag1>", "GEN-1", "Plus", "Avastin", "and", "Doxil", "Trial.", "<tag2>", "GEN-1", "Plus", "Doxil", "and", "Avastin", "Trial.", "<tag3>"], "wordsA": ["GEN-1", "Plus", "Avastin", "and", "Doxil", "Trial."], "wordsB": ["GEN-1", "Plus", "Doxil", "and", "Avastin", "Trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 0.8723382353782654, 0.3072848618030548, 0.5823903679847717, 0.061871614307165146, 0.1898290514945984, 0.2616289258003235, -1]}
{"idB": "749647_17_item1_p135_s1", "idA": "749647_16_item1_p28_s2", "sentA": "We expect to enroll patients beginning in the second half of 2016.", "sentB": "We expect to report the final clinical and translational data from the OVATION Study in mid-2017.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "enroll", "patients", "beginning", "in", "the", "second", "half", "of", "2016.", "<tag2>", "We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017.", "<tag3>"], "wordsA": ["We", "expect", "to", "enroll", "patients", "beginning", "in", "the", "second", "half", "of", "2016."], "wordsB": ["We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015921685844659805, 0.02094496414065361, 0.02298911102116108, 0.4830869138240814, 0.08841370046138763, 0.20798180997371674, 0.17070844769477844, 0.04327288269996643, 0.17796112596988678, 0.24352702498435974, 0.025113815441727638, 0.011574624106287956, 0.03810027241706848, 0.08319538086652756, 0.04268418624997139, 0.7115972638130188, -1]}
{"idB": "749647_17_item1_p52_s1", "idA": "749647_16_item1_p28_s2", "sentA": "We expect to enroll patients beginning in the second half of 2016.", "sentB": "We expect to report the final clinical and translational data from the OVATION Study in mid-2017.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "enroll", "patients", "beginning", "in", "the", "second", "half", "of", "2016.", "<tag2>", "We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017.", "<tag3>"], "wordsA": ["We", "expect", "to", "enroll", "patients", "beginning", "in", "the", "second", "half", "of", "2016."], "wordsB": ["We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015921685844659805, 0.02094496414065361, 0.02298911102116108, 0.4830869138240814, 0.08841370046138763, 0.20798180997371674, 0.17070844769477844, 0.04327288269996643, 0.17796112596988678, 0.24352702498435974, 0.025113815441727638, 0.011574624106287956, 0.03810027241706848, 0.08319538086652756, 0.04268418624997139, 0.7115972638130188, -1]}
{"idB": "749647_17_item1_p55_s0", "idA": "749647_16_item1_p30_s0", "sentA": "The preclinical studies indicated that no obvious overt toxicities were associated with the combined treatments.", "sentB": "The preclinical studies indicated that no obvious overt toxicities were associated with the combined treatments of GEN-1 and Avastin .", "type": 2, "words": ["<tag1>", "The", "preclinical", "studies", "indicated", "that", "no", "obvious", "overt", "toxicities", "were", "associated", "with", "the", "combined", "treatments.", "<tag2>", "The", "preclinical", "studies", "indicated", "that", "no", "obvious", "overt", "toxicities", "were", "associated", "with", "the", "combined", "treatments", "of", "GEN-1", "and", "Avastin", ".", "<tag3>"], "wordsA": ["The", "preclinical", "studies", "indicated", "that", "no", "obvious", "overt", "toxicities", "were", "associated", "with", "the", "combined", "treatments."], "wordsB": ["The", "preclinical", "studies", "indicated", "that", "no", "obvious", "overt", "toxicities", "were", "associated", "with", "the", "combined", "treatments", "of", "GEN-1", "and", "Avastin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002042556880041957, 0.007817679084837437, 0.014190210960805416, 0.009362888522446156, 0.003969925455749035, 0.02836841531097889, 0.0081121064722538, 0.011129477992653847, 0.011038106866180897, 0.0025503106880933046, 0.011771167628467083, 0.005608164239674807, 0.003921389579772949, 0.040286991745233536, 0.1273537427186966, 0.09466453641653061, 0.9362055063247681, 0.5078967213630676, 0.8954967856407166, 3.273765105404891e-05, -1]}
{"idB": "749647_17_item1_p60_s3", "idA": "749647_16_item1_p32_s0", "sentA": "On January 13, 2015, we entered into an Early Access Agreement with Impatients N.V., a Netherlands company (Impatients), pursuant to which Impatients will develop and execute through its brand myTomorrows an early access program for ThermoDox in all countries of the European Union territory, Iceland, Liechtenstein, Norway and Switzerland for the treatment of patients with RCW breast cancer.", "sentB": "During 2015, Hisun successfully completed the manufacture of three registration batches for ThermoDox and has obtained regulatory approvals to supply ThermoDox to participating clinical trial sites in all of the countries of South East Asia, Europe and North America, as well as to the European Union countries allowing for early access to ThermoDox .", "type": 2, "words": ["<tag1>", "On", "January", "13,", "2015,", "we", "entered", "into", "an", "Early", "Access", "Agreement", "with", "Impatients", "N.V.,", "a", "Netherlands", "company", "(Impatients),", "pursuant", "to", "which", "Impatients", "will", "develop", "and", "execute", "through", "its", "brand", "myTomorrows", "an", "early", "access", "program", "for", "ThermoDox", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Iceland,", "Liechtenstein,", "Norway", "and", "Switzerland", "for", "the", "treatment", "of", "patients", "with", "RCW", "breast", "cancer.", "<tag2>", "During", "2015,", "Hisun", "successfully", "completed", "the", "manufacture", "of", "three", "registration", "batches", "for", "ThermoDox", "and", "has", "obtained", "regulatory", "approvals", "to", "supply", "ThermoDox", "to", "participating", "clinical", "trial", "sites", "in", "all", "of", "the", "countries", "of", "South", "East", "Asia,", "Europe", "and", "North", "America,", "as", "well", "as", "to", "the", "European", "Union", "countries", "allowing", "for", "early", "access", "to", "ThermoDox", ".", "<tag3>"], "wordsA": ["On", "January", "13,", "2015,", "we", "entered", "into", "an", "Early", "Access", "Agreement", "with", "Impatients", "N.V.,", "a", "Netherlands", "company", "(Impatients),", "pursuant", "to", "which", "Impatients", "will", "develop", "and", "execute", "through", "its", "brand", "myTomorrows", "an", "early", "access", "program", "for", "ThermoDox", "in", "all", "countries", "of", "the", "European", "Union", "territory,", "Iceland,", "Liechtenstein,", "Norway", "and", "Switzerland", "for", "the", "treatment", "of", "patients", "with", "RCW", "breast", "cancer."], "wordsB": ["During", "2015,", "Hisun", "successfully", "completed", "the", "manufacture", "of", "three", "registration", "batches", "for", "ThermoDox", "and", "has", "obtained", "regulatory", "approvals", "to", "supply", "ThermoDox", "to", "participating", "clinical", "trial", "sites", "in", "all", "of", "the", "countries", "of", "South", "East", "Asia,", "Europe", "and", "North", "America,", "as", "well", "as", "to", "the", "European", "Union", "countries", "allowing", "for", "early", "access", "to", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023435108363628387, 0.0293984804302454, 0.16679468750953674, 0.0965203195810318, 0.14271490275859833, 0.040163539350032806, 0.14778019487857819, 0.061198778450489044, 0.12794116139411926, 0.1706608086824417, 0.1531977355480194, 0.024253711104393005, 0.03304124251008034, 0.008497544564306736, 0.03256741166114807, 0.08730220049619675, 0.11932572722434998, 0.18538004159927368, 0.023113422095775604, 0.09865350276231766, 0.05871965363621712, 0.015502950176596642, 0.05724655091762543, 0.12602107226848602, 0.12869378924369812, 0.09419663995504379, 0.007878846488893032, 0.029808253049850464, 0.012689173221588135, 0.011752119287848473, 0.07564788311719894, 0.013085777871310711, 0.17060230672359467, 0.13692647218704224, 0.22452841699123383, 0.06038753688335419, 0.044360727071762085, 0.20506612956523895, 0.21380743384361267, 0.00928418431431055, 0.006832045037299395, 0.004794097505509853, 0.006114195566624403, 0.006000944413244724, 0.02698972262442112, 0.02882782183587551, 0.0508873276412487, 0.06173596903681755, 0.03296717256307602, 0.15356720983982086, 0.18522129952907562, 0.04773326963186264, 0.07173793762922287, 0.00016203883569687605, -1]}
{"idB": "749647_17_item1_p60_s0", "idA": "749647_16_item1_p34_s0", "sentA": "On May 6, 2012, we entered into a long-term commercial supply agreement with Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun) for the production of ThermoDox in mainland China, Hong Kong and Macau (the China territory).", "sentB": "In June 2012, Celsion and Zhejiand Hisun Pharmaceutical Co. Ltd ( Hisun ) signed a long-term commercial supply agreement for the production of ThermoDox .", "type": 2, "words": ["<tag1>", "On", "May", "6,", "2012,", "we", "entered", "into", "a", "long-term", "commercial", "supply", "agreement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "for", "the", "production", "of", "ThermoDox", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau", "(the", "China", "territory).", "<tag2>", "In", "June", "2012,", "Celsion", "and", "Zhejiand", "Hisun", "Pharmaceutical", "Co.", "Ltd", "(", "Hisun", ")", "signed", "a", "long-term", "commercial", "supply", "agreement", "for", "the", "production", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["On", "May", "6,", "2012,", "we", "entered", "into", "a", "long-term", "commercial", "supply", "agreement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "for", "the", "production", "of", "ThermoDox", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau", "(the", "China", "territory)."], "wordsB": ["In", "June", "2012,", "Celsion", "and", "Zhejiand", "Hisun", "Pharmaceutical", "Co.", "Ltd", "(", "Hisun", ")", "signed", "a", "long-term", "commercial", "supply", "agreement", "for", "the", "production", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021941477432847023, 0.8929846882820129, 0.10082459449768066, 0.5755012035369873, 0.0694018080830574, 0.6759255528450012, 0.08939613401889801, 0.05081569403409958, 0.0140167735517025, 0.007771544624119997, 0.003101186826825142, 0.014815625734627247, 5.211075040278956e-05, 0.027795711532235146, 0.0029895054176449776, 0.0050795110873878, 0.005100437439978123, 0.0063798450864851475, 0.008373071439564228, 0.001575298490934074, 0.0016098808264359832, 0.004414874594658613, 0.002028735587373376, 0.0052252584137022495, 4.1799496102612466e-05, -1]}
{"idB": "749647_17_item1_p61_s0", "idA": "749647_16_item1_p36_s0", "sentA": "On July 19, 2013, we and Hisun entered into a Memorandum of Understanding to pursue ongoing collaborations for the continued clinical development of ThermoDox and the technology transfer relating to the commercial manufacture of ThermoDox for the China territory.", "sentB": "On August 8, 2016, we signed a Technology Transfer, Manufacturing and Commercial Supply Agreement (the GEN-1 Agreement ) with Hisun to pursue an expanded partnership for the technology transfer relating to the clinical and commercial manufacture and supply of GEN-1, for the greater China territory, with the option to expand into other countries in the rest of the world after all necessary regulatory approvals are obtained.", "type": 2, "words": ["<tag1>", "On", "July", "19,", "2013,", "we", "and", "Hisun", "entered", "into", "a", "Memorandum", "of", "Understanding", "to", "pursue", "ongoing", "collaborations", "for", "the", "continued", "clinical", "development", "of", "ThermoDox", "and", "the", "technology", "transfer", "relating", "to", "the", "commercial", "manufacture", "of", "ThermoDox", "for", "the", "China", "territory.", "<tag2>", "On", "August", "8,", "2016,", "we", "signed", "a", "Technology", "Transfer,", "Manufacturing", "and", "Commercial", "Supply", "Agreement", "(the", "GEN-1", "Agreement", ")", "with", "Hisun", "to", "pursue", "an", "expanded", "partnership", "for", "the", "technology", "transfer", "relating", "to", "the", "clinical", "and", "commercial", "manufacture", "and", "supply", "of", "GEN-1,", "for", "the", "greater", "China", "territory,", "with", "the", "option", "to", "expand", "into", "other", "countries", "in", "the", "rest", "of", "the", "world", "after", "all", "necessary", "regulatory", "approvals", "are", "obtained.", "<tag3>"], "wordsA": ["On", "July", "19,", "2013,", "we", "and", "Hisun", "entered", "into", "a", "Memorandum", "of", "Understanding", "to", "pursue", "ongoing", "collaborations", "for", "the", "continued", "clinical", "development", "of", "ThermoDox", "and", "the", "technology", "transfer", "relating", "to", "the", "commercial", "manufacture", "of", "ThermoDox", "for", "the", "China", "territory."], "wordsB": ["On", "August", "8,", "2016,", "we", "signed", "a", "Technology", "Transfer,", "Manufacturing", "and", "Commercial", "Supply", "Agreement", "(the", "GEN-1", "Agreement", ")", "with", "Hisun", "to", "pursue", "an", "expanded", "partnership", "for", "the", "technology", "transfer", "relating", "to", "the", "clinical", "and", "commercial", "manufacture", "and", "supply", "of", "GEN-1,", "for", "the", "greater", "China", "territory,", "with", "the", "option", "to", "expand", "into", "other", "countries", "in", "the", "rest", "of", "the", "world", "after", "all", "necessary", "regulatory", "approvals", "are", "obtained."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02899095043540001, 0.5488123893737793, 0.3523920178413391, 0.8421802520751953, 0.01649095118045807, 0.050169941037893295, 0.012789640575647354, 0.027572209015488625, 0.017830844968557358, 0.028491294011473656, 0.007680492475628853, 0.06140318140387535, 0.37638092041015625, 0.24447360634803772, 0.00857887975871563, 0.29380640387535095, 0.2935532331466675, 0.0001565100537845865, 0.0043425243347883224, 0.014769592322409153, 0.003509622998535633, 0.005254634656012058, 0.004020883236080408, 0.05649293214082718, 0.03555603697896004, 0.0027320943772792816, 0.0032486736308783293, 0.017346883192658424, 0.017530322074890137, 0.002221840899437666, 0.0019738944247365, 0.002518796594813466, 0.005159424617886543, 0.002213435946032405, 0.004439009353518486, 0.007386032026261091, 0.003105822019279003, 0.009015821851789951, 0.005344310309737921, 0.1452414095401764, 0.0022754212841391563, 0.002633186522871256, 0.01519168820232153, 0.015407182276248932, 0.013336054049432278, 0.0003145675000268966, 0.00940597616136074, 0.018814507871866226, 0.007761527318507433, 0.024847213178873062, 0.00804905965924263, 0.016460977494716644, 0.04738863930106163, 0.00449525099247694, 0.004271094687283039, 0.007103911135345697, 0.005103583913296461, 0.005748395808041096, 0.010867012664675713, 0.0034092243295162916, 0.010927784256637096, 0.023678865283727646, 0.03821565955877304, 0.06175427883863449, 0.012669834308326244, 0.012212635017931461, -1]}
{"idB": "749647_17_item1_p60_s2", "idA": "749647_16_item1_p36_s1", "sentA": "This expanded collaboration includes development of the next generation liposomal formulation with the goal of creating safer, more efficacious versions of marketed cancer chemotherapeutics.", "sentB": "In July 2013, the ThermoDox collaboration was expanded to focus on next generation liposomal formulation development with the goal of creating safer, more efficacious versions of marketed cancer chemotherapeutics.", "type": 2, "words": ["<tag1>", "This", "expanded", "collaboration", "includes", "development", "of", "the", "next", "generation", "liposomal", "formulation", "with", "the", "goal", "of", "creating", "safer,", "more", "efficacious", "versions", "of", "marketed", "cancer", "chemotherapeutics.", "<tag2>", "In", "July", "2013,", "the", "ThermoDox", "collaboration", "was", "expanded", "to", "focus", "on", "next", "generation", "liposomal", "formulation", "development", "with", "the", "goal", "of", "creating", "safer,", "more", "efficacious", "versions", "of", "marketed", "cancer", "chemotherapeutics.", "<tag3>"], "wordsA": ["This", "expanded", "collaboration", "includes", "development", "of", "the", "next", "generation", "liposomal", "formulation", "with", "the", "goal", "of", "creating", "safer,", "more", "efficacious", "versions", "of", "marketed", "cancer", "chemotherapeutics."], "wordsB": ["In", "July", "2013,", "the", "ThermoDox", "collaboration", "was", "expanded", "to", "focus", "on", "next", "generation", "liposomal", "formulation", "development", "with", "the", "goal", "of", "creating", "safer,", "more", "efficacious", "versions", "of", "marketed", "cancer", "chemotherapeutics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021802181378006935, 0.11671734601259232, 0.26140913367271423, 0.006729908753186464, 0.9438011050224304, 0.22702734172344208, 0.007701351772993803, 0.022186167538166046, 0.011613328009843826, 0.06825728714466095, 0.009885640814900398, 0.01688981242477894, 0.02008460834622383, 0.034216754138469696, 0.027584729716181755, 0.012702276930212975, 0.003531091148033738, 0.0011925253784283996, 0.003708112519234419, 0.005826778244227171, 0.004079774487763643, 0.06171269714832306, 0.004970232956111431, 0.009113891050219536, 0.01131431758403778, 0.002268405631184578, 0.006461074110120535, 0.008170410059392452, 0.009780291467905045, -1]}
{"idB": "749647_17_item1_p59_s1", "idA": "749647_16_item1_p37_s1", "sentA": "To support our research and development, we raised gross proceeds of approximately $125 million in equity financings and warrant and option exercises in the years 2009 through 2014.", "sentB": "To support our research and development, we raised gross proceeds of approximately $127.2 million in equity financings and warrant and option exercises in the years 2010 through 2015.", "type": 2, "words": ["<tag1>", "To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$125", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2014.", "<tag2>", "To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$127.2", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2010", "through", "2015.", "<tag3>"], "wordsA": ["To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$125", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2009", "through", "2014."], "wordsB": ["To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$127.2", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2010", "through", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.001854068716056645, 0.0030151403043419123, 0.002167399972677231, 0.0034279662650078535, 0.002553821075707674, 0.0028042104095220566, 0.0026013634633272886, 0.0042450749315321445, 0.004057466052472591, 0.005095760338008404, 0.002722722478210926, 0.005442360881716013, 0.5110005140304565, 0.024344490841031075, 0.002076156670227647, 0.0038990352768450975, 0.005305451340973377, 0.0016840085154399276, 0.002616294426843524, 0.002298138104379177, 0.0031801986042410135, 0.0037240677047520876, 0.0022805561311542988, 0.002104781800881028, 0.025313692167401314, 0.9259960055351257, 0.3619728982448578, 0.8636795878410339, -1]}
{"idB": "749647_17_item1_p59_s2", "idA": "749647_16_item1_p37_s2", "sentA": "During 2015, we raised gross proceeds of $8.0 million through a registered direct equity financing with two institutional investors and raised an additional $0.6 million through the utilization of our at-the-market equity facility.", "sentB": "During 2016, we raised gross proceeds of $7.8 million through two registered direct equity financings with several institutional investors.", "type": 2, "words": ["<tag1>", "During", "2015,", "we", "raised", "gross", "proceeds", "of", "$8.0", "million", "through", "a", "registered", "direct", "equity", "financing", "with", "two", "institutional", "investors", "and", "raised", "an", "additional", "$0.6", "million", "through", "the", "utilization", "of", "our", "at-the-market", "equity", "facility.", "<tag2>", "During", "2016,", "we", "raised", "gross", "proceeds", "of", "$7.8", "million", "through", "two", "registered", "direct", "equity", "financings", "with", "several", "institutional", "investors.", "<tag3>"], "wordsA": ["During", "2015,", "we", "raised", "gross", "proceeds", "of", "$8.0", "million", "through", "a", "registered", "direct", "equity", "financing", "with", "two", "institutional", "investors", "and", "raised", "an", "additional", "$0.6", "million", "through", "the", "utilization", "of", "our", "at-the-market", "equity", "facility."], "wordsB": ["During", "2016,", "we", "raised", "gross", "proceeds", "of", "$7.8", "million", "through", "two", "registered", "direct", "equity", "financings", "with", "several", "institutional", "investors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07604002952575684, 0.9760674834251404, 0.0036717380862683058, 0.005638560280203819, 0.005989472847431898, 0.007487463299185038, 0.003072847845032811, 0.04159475490450859, 0.008056133054196835, 0.0018645302625373006, 0.002280554035678506, 0.0036357848439365625, 0.0039007840678095818, 0.004581865388900042, 0.006847658660262823, 0.0016655338695272803, 0.010208495892584324, 0.008382554166018963, 0.011301449500024319, -1]}
{"idB": "749647_17_item1_p59_s3", "idA": "749647_16_item1_p37_s3", "sentA": "We had cash, cash equivalents, short-term investments and interest receivable totaling $20.1 million at December 31, 2015.", "sentB": "We had cash, cash equivalents, short-term investments and interest receivable totaling $4.3 million at December 31, 2016.", "type": 2, "words": ["<tag1>", "We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$20.1", "million", "at", "December", "31,", "2015.", "<tag2>", "We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$4.3", "million", "at", "December", "31,", "2016.", "<tag3>"], "wordsA": ["We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$20.1", "million", "at", "December", "31,", "2015."], "wordsB": ["We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$4.3", "million", "at", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0031675263307988644, 0.0023346205707639456, 0.004286469891667366, 0.003802071325480938, 0.002950980793684721, 0.0035942753311246634, 0.004003845155239105, 0.0020269444212317467, 0.0034768590703606606, 0.004216436762362719, 0.005909455008804798, 0.8661993741989136, 0.209895521402359, 0.002740242052823305, 0.012559772469103336, 0.01534532755613327, 0.9776376485824585, -1]}
{"idB": "749647_17_item1_p71_s0", "idA": "749647_16_item1_p44_s0", "sentA": "Liver Cancer Overview Primary liver cancer (hepatocellular carcinoma or HCC) is one of the most common and deadliest forms of cancer worldwide.", "sentB": "Primary liver cancer (hepatocellular carcinoma or HCC) is one of the most common and deadliest forms of cancer worldwide.", "type": 2, "words": ["<tag1>", "Liver", "Cancer", "Overview", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag2>", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag3>"], "wordsA": ["Liver", "Cancer", "Overview", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "wordsB": ["Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6567560434341431, 0.6685469150543213, 0.45115742087364197, 0.5898252725601196, 0.17130528390407562, 0.03195864334702492, 0.19696776568889618, 0.021414432674646378, 0.0239725261926651, 0.02764175646007061, 0.024145890027284622, 0.07244483381509781, 0.07460470497608185, 0.022011427208781242, 0.3474738299846649, 0.11608995497226715, 0.053440701216459274, 0.10003205388784409, 0.05496770516037941, -1]}
{"idB": "749647_17_item1_p71_s1", "idA": "749647_16_item1_p44_s1", "sentA": "It ranks as the fifth most common solid tumor cancer.", "sentB": "It ranks as the third most common solid tumor cancer.", "type": 2, "words": ["<tag1>", "It", "ranks", "as", "the", "fifth", "most", "common", "solid", "tumor", "cancer.", "<tag2>", "It", "ranks", "as", "the", "third", "most", "common", "solid", "tumor", "cancer.", "<tag3>"], "wordsA": ["It", "ranks", "as", "the", "fifth", "most", "common", "solid", "tumor", "cancer."], "wordsB": ["It", "ranks", "as", "the", "third", "most", "common", "solid", "tumor", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0025428037624806166, 0.017716530710458755, 0.006367820780724287, 0.005588372237980366, 0.9938963055610657, 0.08524482697248459, 0.03139721229672432, 0.02275475487112999, 0.022463450208306313, 0.02533186972141266, -1]}
{"idB": "749647_17_item1_p12_s0", "idA": "749647_16_item1_p45_s0", "sentA": "The incidence of primary liver cancer is approximately 30,000 cases per year in the United States, approximately 40,000 cases per year in Europe and is rapidly growing worldwide at approximately 800,000 cases per year.", "sentB": "HCC incidence globally is approximately 850,000 new cases per year and is the third largest cancer indication globally.", "type": 2, "words": ["<tag1>", "The", "incidence", "of", "primary", "liver", "cancer", "is", "approximately", "30,000", "cases", "per", "year", "in", "the", "United", "States,", "approximately", "40,000", "cases", "per", "year", "in", "Europe", "and", "is", "rapidly", "growing", "worldwide", "at", "approximately", "800,000", "cases", "per", "year.", "<tag2>", "HCC", "incidence", "globally", "is", "approximately", "850,000", "new", "cases", "per", "year", "and", "is", "the", "third", "largest", "cancer", "indication", "globally.", "<tag3>"], "wordsA": ["The", "incidence", "of", "primary", "liver", "cancer", "is", "approximately", "30,000", "cases", "per", "year", "in", "the", "United", "States,", "approximately", "40,000", "cases", "per", "year", "in", "Europe", "and", "is", "rapidly", "growing", "worldwide", "at", "approximately", "800,000", "cases", "per", "year."], "wordsB": ["HCC", "incidence", "globally", "is", "approximately", "850,000", "new", "cases", "per", "year", "and", "is", "the", "third", "largest", "cancer", "indication", "globally."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6012486219406128, 0.06696806848049164, 0.027045590803027153, 0.006923796143382788, 0.04585930332541466, 0.46714916825294495, 0.4310877025127411, 0.39489471912384033, 0.011023136787116528, 0.03122437559068203, 6.295904313446954e-05, 0.004376640077680349, 0.007031137589365244, 0.05506082624197006, 0.0801914781332016, 0.1443735808134079, 0.05266979709267616, 0.02846394293010235, -1]}
{"idB": "749647_17_item1_p85_s0", "idA": "749647_16_item1_p45_s0", "sentA": "The incidence of primary liver cancer is approximately 30,000 cases per year in the United States, approximately 40,000 cases per year in Europe and is rapidly growing worldwide at approximately 800,000 cases per year.", "sentB": "HCC incidence globally is approximately 800,000 new cases per year.", "type": 2, "words": ["<tag1>", "The", "incidence", "of", "primary", "liver", "cancer", "is", "approximately", "30,000", "cases", "per", "year", "in", "the", "United", "States,", "approximately", "40,000", "cases", "per", "year", "in", "Europe", "and", "is", "rapidly", "growing", "worldwide", "at", "approximately", "800,000", "cases", "per", "year.", "<tag2>", "HCC", "incidence", "globally", "is", "approximately", "800,000", "new", "cases", "per", "year.", "<tag3>"], "wordsA": ["The", "incidence", "of", "primary", "liver", "cancer", "is", "approximately", "30,000", "cases", "per", "year", "in", "the", "United", "States,", "approximately", "40,000", "cases", "per", "year", "in", "Europe", "and", "is", "rapidly", "growing", "worldwide", "at", "approximately", "800,000", "cases", "per", "year."], "wordsB": ["HCC", "incidence", "globally", "is", "approximately", "800,000", "new", "cases", "per", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7444076538085938, 0.10906562954187393, 0.04680173099040985, 0.005503242369741201, 0.02221197634935379, 0.07207395881414413, 0.5503047108650208, 0.5130764245986938, 0.009498266503214836, 0.03531830385327339, -1]}
{"idB": "749647_17_item1_p126_s1", "idA": "749647_16_item1_p49_s0", "sentA": "Local recurrence rates after RFA directly correlate to the size of the tumor.", "sentB": "One patient had an R2, indicating macroscopic residual tumor.", "type": 2, "words": ["<tag1>", "Local", "recurrence", "rates", "after", "RFA", "directly", "correlate", "to", "the", "size", "of", "the", "tumor.", "<tag2>", "One", "patient", "had", "an", "R2,", "indicating", "macroscopic", "residual", "tumor.", "<tag3>"], "wordsA": ["Local", "recurrence", "rates", "after", "RFA", "directly", "correlate", "to", "the", "size", "of", "the", "tumor."], "wordsB": ["One", "patient", "had", "an", "R2,", "indicating", "macroscopic", "residual", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.23862190544605255, 0.30115893483161926, 0.06876007467508316, 0.056076738983392715, 0.5980523228645325, 0.03856268525123596, 0.35640013217926025, 0.32672396302223206, 0.30842724442481995, -1]}
{"idB": "749647_17_item1_p43_s1", "idA": "749647_16_item1_p49_s0", "sentA": "Local recurrence rates after RFA directly correlate to the size of the tumor.", "sentB": "One patient had an R2, indicating macroscopic residual tumor.", "type": 2, "words": ["<tag1>", "Local", "recurrence", "rates", "after", "RFA", "directly", "correlate", "to", "the", "size", "of", "the", "tumor.", "<tag2>", "One", "patient", "had", "an", "R2,", "indicating", "macroscopic", "residual", "tumor.", "<tag3>"], "wordsA": ["Local", "recurrence", "rates", "after", "RFA", "directly", "correlate", "to", "the", "size", "of", "the", "tumor."], "wordsB": ["One", "patient", "had", "an", "R2,", "indicating", "macroscopic", "residual", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.23862190544605255, 0.30115893483161926, 0.06876007467508316, 0.056076738983392715, 0.5980523228645325, 0.03856268525123596, 0.35640013217926025, 0.32672396302223206, 0.30842724442481995, -1]}
{"idB": "749647_17_item1_p76_s0", "idA": "749647_16_item1_p50_s0", "sentA": "Celsion s Approach While RFA uses extremely high temperatures (greater than 80 Celsius) to ablate the tumor, it may fail to treat micro-metastases in the outer margins of the ablation zone because temperatures in the periphery may not be high enough to destroy cancer cells.", "sentB": "While RFA uses extremely high temperatures (greater than 80 Celsius) to ablate the tumor, it may fail to treat micro-metastases in the outer margins of the ablation zone because temperatures in the periphery may not be high enough to destroy cancer cells.", "type": 2, "words": ["<tag1>", "Celsion", "s", "Approach", "While", "RFA", "uses", "extremely", "high", "temperatures", "(greater", "than", "80", "Celsius)", "to", "ablate", "the", "tumor,", "it", "may", "fail", "to", "treat", "micro-metastases", "in", "the", "outer", "margins", "of", "the", "ablation", "zone", "because", "temperatures", "in", "the", "periphery", "may", "not", "be", "high", "enough", "to", "destroy", "cancer", "cells.", "<tag2>", "While", "RFA", "uses", "extremely", "high", "temperatures", "(greater", "than", "80", "Celsius)", "to", "ablate", "the", "tumor,", "it", "may", "fail", "to", "treat", "micro-metastases", "in", "the", "outer", "margins", "of", "the", "ablation", "zone", "because", "temperatures", "in", "the", "periphery", "may", "not", "be", "high", "enough", "to", "destroy", "cancer", "cells.", "<tag3>"], "wordsA": ["Celsion", "s", "Approach", "While", "RFA", "uses", "extremely", "high", "temperatures", "(greater", "than", "80", "Celsius)", "to", "ablate", "the", "tumor,", "it", "may", "fail", "to", "treat", "micro-metastases", "in", "the", "outer", "margins", "of", "the", "ablation", "zone", "because", "temperatures", "in", "the", "periphery", "may", "not", "be", "high", "enough", "to", "destroy", "cancer", "cells."], "wordsB": ["While", "RFA", "uses", "extremely", "high", "temperatures", "(greater", "than", "80", "Celsius)", "to", "ablate", "the", "tumor,", "it", "may", "fail", "to", "treat", "micro-metastases", "in", "the", "outer", "margins", "of", "the", "ablation", "zone", "because", "temperatures", "in", "the", "periphery", "may", "not", "be", "high", "enough", "to", "destroy", "cancer", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006635251920670271, 0.028656505048274994, 0.01582232676446438, 0.08999501913785934, 0.5287767648696899, 0.25126442313194275, 0.04707830026745796, 0.04332786053419113, 0.0692933201789856, 0.02804689109325409, 0.0033481870777904987, 0.006613720208406448, 0.003379093948751688, 0.009374155662953854, 0.004187024664133787, 0.007822096347808838, 0.048226408660411835, 0.0094033507630229, 0.0077838534489274025, 0.011561347171664238, 0.003081841394305229, 0.003016335889697075, 0.007738093379884958, 0.00876652542501688, 0.002939420286566019, 0.003086107550188899, 0.007649619597941637, 0.007792096585035324, 0.0038496137131005526, 0.008035250939428806, 0.003291600849479437, 0.0032070986926555634, 0.0077777463011443615, 0.01061064563691616, 0.07627476751804352, 0.015163000673055649, 0.02639114297926426, 0.028652245178818703, 0.012634945102036, 0.0296084675937891, 0.01837562397122383, 0.02447768859565258, -1]}
{"idB": "749647_17_item1_p77_s2", "idA": "749647_16_item1_p50_s3", "sentA": "This approach will also increase the delivery of the doxorubicin at the desired tumor site while potentially reducing drug exposure distant to the tumor site.", "sentB": "This approach is designed to increase the delivery of the doxorubicin at the desired tumor site while potentially reducing drug exposure distant to the tumor site.", "type": 2, "words": ["<tag1>", "This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site.", "<tag2>", "This", "approach", "is", "designed", "to", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site.", "<tag3>"], "wordsA": ["This", "approach", "will", "also", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site."], "wordsB": ["This", "approach", "is", "designed", "to", "increase", "the", "delivery", "of", "the", "doxorubicin", "at", "the", "desired", "tumor", "site", "while", "potentially", "reducing", "drug", "exposure", "distant", "to", "the", "tumor", "site."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010147237218916416, 0.1720651388168335, 0.030862856656312943, 0.12946221232414246, 0.1710909605026245, 0.6003059148788452, 0.15231291949748993, 0.5021411180496216, 0.18016323447227478, 0.1406250298023224, 0.5780736804008484, 0.03733125701546669, 0.024952534586191177, 0.04420040547847748, 0.05713989585638046, 0.07211039960384369, 0.0012440526625141501, 0.041966360062360764, 0.21074223518371582, 0.10451210290193558, 0.09917635470628738, 0.07848434150218964, 0.016815578565001488, 0.016746822744607925, 0.028646592050790787, 0.05374990403652191, -1]}
{"idB": "749647_17_item1_p124_s0", "idA": "749647_16_item1_p52_s1", "sentA": "The study also permitted multiple dosing in liver cancer patients.", "sentB": "The first four cohorts each enrolled three patients.", "type": 2, "words": ["<tag1>", "The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients.", "<tag2>", "The", "first", "four", "cohorts", "each", "enrolled", "three", "patients.", "<tag3>"], "wordsA": ["The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients."], "wordsB": ["The", "first", "four", "cohorts", "each", "enrolled", "three", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006018091458827257, 0.08218439668416977, 0.16119663417339325, 0.14495547115802765, 0.023692702874541283, 0.17209571599960327, 0.8663605451583862, 0.5383796691894531, -1]}
{"idB": "749647_17_item1_p132_s2", "idA": "749647_16_item1_p52_s1", "sentA": "The study also permitted multiple dosing in liver cancer patients.", "sentB": "The ratio of CD8+/FoxP3+ cells was increased in all four evaluable patients.", "type": 2, "words": ["<tag1>", "The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients.", "<tag2>", "The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients.", "<tag3>"], "wordsA": ["The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients."], "wordsB": ["The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014873589389026165, 0.36891254782676697, 0.09332714974880219, 0.7685812711715698, 0.3773428797721863, 0.029688259586691856, 0.23291634023189545, 0.011301562190055847, 0.0340443029999733, 0.17486919462680817, 0.18418742716312408, 0.14563614130020142, -1]}
{"idB": "749647_17_item1_p41_s2", "idA": "749647_16_item1_p52_s1", "sentA": "The study also permitted multiple dosing in liver cancer patients.", "sentB": "The first four cohorts each enrolled three patients.", "type": 2, "words": ["<tag1>", "The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients.", "<tag2>", "The", "first", "four", "cohorts", "each", "enrolled", "three", "patients.", "<tag3>"], "wordsA": ["The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients."], "wordsB": ["The", "first", "four", "cohorts", "each", "enrolled", "three", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006018091458827257, 0.08218439668416977, 0.16119663417339325, 0.14495547115802765, 0.023692702874541283, 0.17209571599960327, 0.8663605451583862, 0.5383796691894531, -1]}
{"idB": "749647_17_item1_p49_s2", "idA": "749647_16_item1_p52_s1", "sentA": "The study also permitted multiple dosing in liver cancer patients.", "sentB": "The ratio of CD8+/FoxP3+ cells was increased in all four evaluable patients.", "type": 2, "words": ["<tag1>", "The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients.", "<tag2>", "The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients.", "<tag3>"], "wordsA": ["The", "study", "also", "permitted", "multiple", "dosing", "in", "liver", "cancer", "patients."], "wordsB": ["The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014873589389026165, 0.36891254782676697, 0.09332714974880219, 0.7685812711715698, 0.3773428797721863, 0.029688259586691856, 0.23291634023189545, 0.011301562190055847, 0.0340443029999733, 0.17486919462680817, 0.18418742716312408, 0.14563614130020142, -1]}
{"idB": "749647_17_item1_p80_s2", "idA": "749647_16_item1_p53_s2", "sentA": "We scheduled a meeting with the HEAT Study independent DMC on January 30, 2013 in order to conduct an analysis of the HEAT Study s PFS endpoint.", "sentB": "We scheduled a meeting with the HEAT Study independent Data Monitoring Committee ( iDMC ) on January 30, 2013 in order to conduct an analysis of the HEAT Study s PFS endpoint.", "type": 2, "words": ["<tag1>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "Study", "independent", "DMC", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "Study", "s", "PFS", "endpoint.", "<tag2>", "We", "scheduled", "a", "meeting", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(", "iDMC", ")", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "Study", "s", "PFS", "endpoint.", "<tag3>"], "wordsA": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "Study", "independent", "DMC", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "Study", "s", "PFS", "endpoint."], "wordsB": ["We", "scheduled", "a", "meeting", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee", "(", "iDMC", ")", "on", "January", "30,", "2013", "in", "order", "to", "conduct", "an", "analysis", "of", "the", "HEAT", "Study", "s", "PFS", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003361411625519395, 0.005345202516764402, 0.0015958629082888365, 0.011680491268634796, 0.005290806293487549, 0.003711990313604474, 0.012845690362155437, 0.016048850491642952, 0.07906372100114822, 0.9201333522796631, 0.9572024941444397, 0.7538225054740906, 0.05564839765429497, 0.9251701831817627, 4.719979187939316e-05, 0.0021382521372288465, 0.002691311063244939, 0.0025963354855775833, 0.002563200891017914, 0.001710095559246838, 0.001717601204290986, 0.0016064889496192336, 0.002001745393499732, 0.0013766216579824686, 0.0036368004512041807, 0.0014059103559702635, 0.0018357080407440662, 0.011612008325755596, 0.007249182090163231, 0.0041335951536893845, 0.006167554296553135, 0.004289225675165653, -1]}
{"idB": "749647_17_item1_p80_s3", "idA": "749647_16_item1_p53_s3", "sentA": "Following review by the DMC, on January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the HEAT Study s primary endpoint of PFS.", "sentB": "Following review by the iDMC, on January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the HEAT Study s primary endpoint of PFS.", "type": 2, "words": ["<tag1>", "Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "HEAT", "Study", "s", "primary", "endpoint", "of", "PFS.", "<tag2>", "Following", "review", "by", "the", "iDMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "HEAT", "Study", "s", "primary", "endpoint", "of", "PFS.", "<tag3>"], "wordsA": ["Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "HEAT", "Study", "s", "primary", "endpoint", "of", "PFS."], "wordsB": ["Following", "review", "by", "the", "iDMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "HEAT", "Study", "s", "primary", "endpoint", "of", "PFS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003101252019405365, 0.006569951772689819, 0.004250114783644676, 0.009077399037778378, 0.9825154542922974, 0.0027923271991312504, 0.003623656230047345, 0.004043035674840212, 0.0036318725906312466, 0.003645034274086356, 0.009229405783116817, 0.006117888260632753, 0.023591110482811928, 0.003953919280320406, 0.005244169384241104, 0.0033069548662751913, 0.011124031618237495, 0.599266767501831, 0.7897091507911682, 0.14600735902786255, 0.017573779448866844, 0.03925199806690216, 0.0241231806576252, 0.010328357107937336, 0.020710356533527374, 0.015633659437298775, 0.00967127550393343, 0.04006752744317055, -1]}
{"idB": "749647_17_item1_p80_s4", "idA": "749647_16_item1_p53_s4", "sentA": "Specifically, we determined, after conferring with the DMC, that the HEAT Study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT Study.", "sentB": "Specifically, we determined, after conferring with the iDMC, that the HEAT Study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT Study.", "type": 2, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "Study.", "<tag2>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "iDMC,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "Study."], "wordsB": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "iDMC,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009948003105819225, 0.007865252904593945, 0.01606368087232113, 0.005557396449148655, 0.009724057279527187, 0.006111918017268181, 0.0066521442495286465, 0.8661845922470093, 0.007657050620764494, 0.0057777645997703075, 0.019550543278455734, 0.029894350096583366, 0.6576793193817139, 0.6389146447181702, 0.04116254299879074, 0.011753779835999012, 0.017726358026266098, 0.008296736516058445, 0.010188682936131954, 0.01226010825484991, 0.009196661412715912, 0.00683978945016861, 0.008501305244863033, 0.009274610318243504, 0.007337257731705904, 0.007715323939919472, 0.00810196902602911, 0.007471293210983276, 0.009880821220576763, 0.006509074941277504, 0.008154192939400673, 0.00811768788844347, 0.004670355468988419, 0.005335967522114515, 0.008388461545109749, 0.006316920276731253, 0.0050154211930930614, 0.005001117009669542, 0.01927931420505047, 0.01372321043163538, -1]}
{"idB": "749647_17_item1_p24_s0", "idA": "749647_16_item1_p55_s0", "sentA": "As provided for in the SPA, we continue to follow the patients enrolled in the HEAT Study to the secondary endpoint of overall survival.", "sentB": "On November 29, 2016, the Company announced the results of an independent analysis conducted by the National Institutes of Health (the NIH ) from the HEAT Study which reaffirmed the correlation between increased RFA burn time per tumor volume and improvements in overall survival.", "type": 2, "words": ["<tag1>", "As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "overall", "survival.", "<tag2>", "On", "November", "29,", "2016,", "the", "Company", "announced", "the", "results", "of", "an", "independent", "analysis", "conducted", "by", "the", "National", "Institutes", "of", "Health", "(the", "NIH", ")", "from", "the", "HEAT", "Study", "which", "reaffirmed", "the", "correlation", "between", "increased", "RFA", "burn", "time", "per", "tumor", "volume", "and", "improvements", "in", "overall", "survival.", "<tag3>"], "wordsA": ["As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "overall", "survival."], "wordsB": ["On", "November", "29,", "2016,", "the", "Company", "announced", "the", "results", "of", "an", "independent", "analysis", "conducted", "by", "the", "National", "Institutes", "of", "Health", "(the", "NIH", ")", "from", "the", "HEAT", "Study", "which", "reaffirmed", "the", "correlation", "between", "increased", "RFA", "burn", "time", "per", "tumor", "volume", "and", "improvements", "in", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025694211944937706, 0.10823274403810501, 0.07670080661773682, 0.14315222203731537, 0.012996086850762367, 0.1492663472890854, 0.1697242110967636, 0.025571195408701897, 0.08872190862894058, 0.017372343689203262, 0.024264918640255928, 0.2538911998271942, 0.21946409344673157, 0.020573925226926804, 0.017517097294330597, 0.02696596458554268, 0.10406715422868729, 0.04910270497202873, 0.03903886303305626, 0.06360658258199692, 0.03481731191277504, 0.2072688639163971, 0.00012812322529498488, 0.013222934678196907, 0.00794515386223793, 0.036126673221588135, 0.049712885171175, 0.00215168297290802, 0.05324072390794754, 0.013633377850055695, 0.04721765220165253, 0.027947617694735527, 0.15741436183452606, 0.15512751042842865, 0.2467736303806305, 0.154023215174675, 0.03775555640459061, 0.09651828557252884, 0.05165840685367584, 0.013139004819095135, 0.09008675068616867, 0.013847476802766323, 0.05479760840535164, 0.05606764554977417, -1]}
{"idB": "749647_17_item1_p82_s0", "idA": "749647_16_item1_p55_s0", "sentA": "As provided for in the SPA, we continue to follow the patients enrolled in the HEAT Study to the secondary endpoint of overall survival.", "sentB": "As provided for in the SPA, we continued to follow patients enrolled in the HEAT Study to the secondary endpoint of Overall Survival (OS).", "type": 2, "words": ["<tag1>", "As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "overall", "survival.", "<tag2>", "As", "provided", "for", "in", "the", "SPA,", "we", "continued", "to", "follow", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "Overall", "Survival", "(OS).", "<tag3>"], "wordsA": ["As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "overall", "survival."], "wordsB": ["As", "provided", "for", "in", "the", "SPA,", "we", "continued", "to", "follow", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "Overall", "Survival", "(OS)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007165807764977217, 0.008375177159905434, 0.007683116011321545, 0.004852441139519215, 0.004304538946598768, 0.006413017399609089, 0.007043659221380949, 0.020482810214161873, 0.021634092554450035, 0.07617921382188797, 0.20120152831077576, 0.01828186959028244, 0.004479368217289448, 0.0048704301007092, 0.010156206786632538, 0.01113739050924778, 0.005792115814983845, 0.00583738973364234, 0.0068923006765544415, 0.007152839098125696, 0.003528251778334379, 0.007889184169471264, 0.028791077435016632, 0.8917466402053833, -1]}
{"idB": "749647_17_item1_p91_s0", "idA": "749647_16_item1_p55_s0", "sentA": "As provided for in the SPA, we continue to follow the patients enrolled in the HEAT Study to the secondary endpoint of overall survival.", "sentB": "On November 29, 2016, the Company announced the results of an independent analysis conducted by the National Institutes of Health (the NIH ) from the HEAT Study which reaffirmed the correlation between increased RFA burn time per tumor volume and improvements in overall survival.", "type": 2, "words": ["<tag1>", "As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "overall", "survival.", "<tag2>", "On", "November", "29,", "2016,", "the", "Company", "announced", "the", "results", "of", "an", "independent", "analysis", "conducted", "by", "the", "National", "Institutes", "of", "Health", "(the", "NIH", ")", "from", "the", "HEAT", "Study", "which", "reaffirmed", "the", "correlation", "between", "increased", "RFA", "burn", "time", "per", "tumor", "volume", "and", "improvements", "in", "overall", "survival.", "<tag3>"], "wordsA": ["As", "provided", "for", "in", "the", "SPA,", "we", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "overall", "survival."], "wordsB": ["On", "November", "29,", "2016,", "the", "Company", "announced", "the", "results", "of", "an", "independent", "analysis", "conducted", "by", "the", "National", "Institutes", "of", "Health", "(the", "NIH", ")", "from", "the", "HEAT", "Study", "which", "reaffirmed", "the", "correlation", "between", "increased", "RFA", "burn", "time", "per", "tumor", "volume", "and", "improvements", "in", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025694211944937706, 0.10823274403810501, 0.07670080661773682, 0.14315222203731537, 0.012996086850762367, 0.1492663472890854, 0.1697242110967636, 0.025571195408701897, 0.08872190862894058, 0.017372343689203262, 0.024264918640255928, 0.2538911998271942, 0.21946409344673157, 0.020573925226926804, 0.017517097294330597, 0.02696596458554268, 0.10406715422868729, 0.04910270497202873, 0.03903886303305626, 0.06360658258199692, 0.03481731191277504, 0.2072688639163971, 0.00012812322529498488, 0.013222934678196907, 0.00794515386223793, 0.036126673221588135, 0.049712885171175, 0.00215168297290802, 0.05324072390794754, 0.013633377850055695, 0.04721765220165253, 0.027947617694735527, 0.15741436183452606, 0.15512751042842865, 0.2467736303806305, 0.154023215174675, 0.03775555640459061, 0.09651828557252884, 0.05165840685367584, 0.013139004819095135, 0.09008675068616867, 0.013847476802766323, 0.05479760840535164, 0.05606764554977417, -1]}
{"idB": "749647_17_item1_p82_s1", "idA": "749647_16_item1_p56_s0", "sentA": "We have evaluated data from eight sweeps of Overall Survival since the announcement of the HEAT Study s primary endpoint result, with each showing progressive improvement in statistical significance.", "sentB": "We have evaluated data from nine sweeps of OS since the announcement of the HEAT Study s primary endpoint result, with each showing progressive improvement in statistical significance.", "type": 2, "words": ["<tag1>", "We", "have", "evaluated", "data", "from", "eight", "sweeps", "of", "Overall", "Survival", "since", "the", "announcement", "of", "the", "HEAT", "Study", "s", "primary", "endpoint", "result,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag2>", "We", "have", "evaluated", "data", "from", "nine", "sweeps", "of", "OS", "since", "the", "announcement", "of", "the", "HEAT", "Study", "s", "primary", "endpoint", "result,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance.", "<tag3>"], "wordsA": ["We", "have", "evaluated", "data", "from", "eight", "sweeps", "of", "Overall", "Survival", "since", "the", "announcement", "of", "the", "HEAT", "Study", "s", "primary", "endpoint", "result,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance."], "wordsB": ["We", "have", "evaluated", "data", "from", "nine", "sweeps", "of", "OS", "since", "the", "announcement", "of", "the", "HEAT", "Study", "s", "primary", "endpoint", "result,", "with", "each", "showing", "progressive", "improvement", "in", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002211928367614746, 0.0014910526806488633, 0.009759685024619102, 0.021333258599042892, 0.012011085636913776, 0.9657939672470093, 0.31776124238967896, 0.19176533818244934, 0.6039416790008545, 0.0022910654079169035, 0.0011467098956927657, 0.0020110520999878645, 0.0010950873838737607, 0.0010965686524286866, 0.0029183821752667427, 0.0026420950889587402, 0.0013231642078608274, 0.0027752129826694727, 0.0022659911774098873, 0.0027440653648227453, 0.0014222478494048119, 0.001648245262913406, 0.002356800017878413, 0.0027209387626498938, 0.0036303442902863026, 0.0012512636603787541, 0.0027185019571334124, 0.0027890773490071297, -1]}
{"idB": "749647_17_item1_p82_s2", "idA": "749647_16_item1_p56_s1", "sentA": "The most recent post-hoc OS analysis from the HEAT Study (as of July 15, 2015 and announced on August 6, 2015) demonstrated that in a large, well bounded subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and optimized RFA provided a 58% improvement in OS compared to optimized RFA alone.", "sentB": "The most recent post-hoc OS analysis from the HEAT Study (as of July 15, 2016 and announced on August 15, 2016) demonstrated that in a large, well bounded subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and optimized RFA provided a 54% risk improvement in OS compared to optimized RFA alone.", "type": 2, "words": ["<tag1>", "The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "(as", "of", "July", "15,", "2015", "and", "announced", "on", "August", "6,", "2015)", "demonstrated", "that", "in", "a", "large,", "well", "bounded", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag2>", "The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "(as", "of", "July", "15,", "2016", "and", "announced", "on", "August", "15,", "2016)", "demonstrated", "that", "in", "a", "large,", "well", "bounded", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "54%", "risk", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag3>"], "wordsA": ["The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "(as", "of", "July", "15,", "2015", "and", "announced", "on", "August", "6,", "2015)", "demonstrated", "that", "in", "a", "large,", "well", "bounded", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "wordsB": ["The", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study", "(as", "of", "July", "15,", "2016", "and", "announced", "on", "August", "15,", "2016)", "demonstrated", "that", "in", "a", "large,", "well", "bounded", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "54%", "risk", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0032886501867324114, 0.006201718468219042, 0.006053845398128033, 0.008534408174455166, 0.00853697769343853, 0.007511220872402191, 0.004748572129756212, 0.004635232500731945, 0.007887125015258789, 0.006823069415986538, 0.006409748923033476, 0.009448028169572353, 0.014762143604457378, 0.014372192323207855, 0.3596205413341522, 0.009724901989102364, 0.007758407387882471, 0.006602257024496794, 0.01055642869323492, 0.010547438636422157, 0.3184412717819214, 0.006952300667762756, 0.005525584332644939, 0.004286221694201231, 0.005192189943045378, 0.008949484676122665, 0.01126743946224451, 0.01381532009691, 0.011224337853491306, 0.0054184147156775, 0.008577144704759121, 0.03477933630347252, 0.01043856143951416, 0.005659425165504217, 0.00547471409663558, 0.01036760862916708, 0.013466128148138523, 0.004762485157698393, 0.010571157559752464, 0.006515227258205414, 0.010847225785255432, 0.004475971683859825, 0.007049204781651497, 0.008949925191700459, 0.006389283109456301, 0.008166597224771976, 0.8933014273643494, 0.19854982197284698, 0.11182823032140732, 0.0059542604722082615, 0.010042143985629082, 0.005274544470012188, 0.003775212448090315, 0.0061926813796162605, 0.00938529521226883, 0.00802819337695837, -1]}
{"idB": "749647_17_item1_p19_s5", "idA": "749647_16_item1_p56_s3", "sentA": "Median overall survival for the ThermoDox group has been reached in this subgroup which translates into a 25.4 month (2.1 year) survival benefit over the optimized RFA only group (79 months for the ThermoDox plus optimized RFA group versus 53.6 months for the optimized RFA only group).", "sentB": "Median OS for the ThermoDox group has been reached which translates into a two year survival benefit over the optimized RFA group (projected to be greater than 80 months for the ThermoDox plus optimized RFA group compared to less than 60 months projection for the optimized RFA only group).", "type": 2, "words": ["<tag1>", "Median", "overall", "survival", "for", "the", "ThermoDox", "group", "has", "been", "reached", "in", "this", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group).", "<tag2>", "Median", "OS", "for", "the", "ThermoDox", "group", "has", "been", "reached", "which", "translates", "into", "a", "two", "year", "survival", "benefit", "over", "the", "optimized", "RFA", "group", "(projected", "to", "be", "greater", "than", "80", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "compared", "to", "less", "than", "60", "months", "projection", "for", "the", "optimized", "RFA", "only", "group).", "<tag3>"], "wordsA": ["Median", "overall", "survival", "for", "the", "ThermoDox", "group", "has", "been", "reached", "in", "this", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group)."], "wordsB": ["Median", "OS", "for", "the", "ThermoDox", "group", "has", "been", "reached", "which", "translates", "into", "a", "two", "year", "survival", "benefit", "over", "the", "optimized", "RFA", "group", "(projected", "to", "be", "greater", "than", "80", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "compared", "to", "less", "than", "60", "months", "projection", "for", "the", "optimized", "RFA", "only", "group)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027318576350808144, 0.07563451677560806, 0.003249106230214238, 0.002120688557624817, 0.003971766214817762, 0.009497647173702717, 0.0017258436419069767, 0.0018878127448260784, 0.00235462817363441, 0.001967878546565771, 0.002282771747559309, 0.001955002546310425, 0.0023085428401827812, 0.08178452402353287, 0.05075003579258919, 0.008925038389861584, 0.010123614221811295, 0.0020547867752611637, 0.0018307814607396722, 0.0035978599917143583, 0.005116818472743034, 0.011910436674952507, 0.029756009578704834, 0.0135769322514534, 0.029033903032541275, 0.3352733254432678, 0.34270092844963074, 0.853434145450592, 0.5472252368927002, 0.0037795817479491234, 0.002079573692753911, 0.004047006834298372, 0.0025803211610764265, 0.0027824577409774065, 0.004576769657433033, 0.01030381117016077, 0.07824616879224777, 0.02222548797726631, 0.4440312385559082, 0.5210556387901306, 0.8199974298477173, 0.6013593673706055, 0.03144751489162445, 0.00270249554887414, 0.002131239278241992, 0.0031072888523340225, 0.004718270618468523, 0.004604656714946032, 0.047882165759801865, -1]}
{"idB": "749647_17_item1_p82_s4", "idA": "749647_16_item1_p56_s3", "sentA": "Median overall survival for the ThermoDox group has been reached in this subgroup which translates into a 25.4 month (2.1 year) survival benefit over the optimized RFA only group (79 months for the ThermoDox plus optimized RFA group versus 53.6 months for the optimized RFA only group).", "sentB": "Median OS for the ThermoDox group has been reached which translates into a two year survival benefit over the optimized RFA group (projected to be greater than 80 months for the ThermoDox plus optimized RFA group compared to less than 60 months projection for the optimized RFA only group).", "type": 2, "words": ["<tag1>", "Median", "overall", "survival", "for", "the", "ThermoDox", "group", "has", "been", "reached", "in", "this", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group).", "<tag2>", "Median", "OS", "for", "the", "ThermoDox", "group", "has", "been", "reached", "which", "translates", "into", "a", "two", "year", "survival", "benefit", "over", "the", "optimized", "RFA", "group", "(projected", "to", "be", "greater", "than", "80", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "compared", "to", "less", "than", "60", "months", "projection", "for", "the", "optimized", "RFA", "only", "group).", "<tag3>"], "wordsA": ["Median", "overall", "survival", "for", "the", "ThermoDox", "group", "has", "been", "reached", "in", "this", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group)."], "wordsB": ["Median", "OS", "for", "the", "ThermoDox", "group", "has", "been", "reached", "which", "translates", "into", "a", "two", "year", "survival", "benefit", "over", "the", "optimized", "RFA", "group", "(projected", "to", "be", "greater", "than", "80", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "compared", "to", "less", "than", "60", "months", "projection", "for", "the", "optimized", "RFA", "only", "group)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027318576350808144, 0.07563451677560806, 0.003249106230214238, 0.002120688557624817, 0.003971766214817762, 0.009497647173702717, 0.0017258436419069767, 0.0018878127448260784, 0.00235462817363441, 0.001967878546565771, 0.002282771747559309, 0.001955002546310425, 0.0023085428401827812, 0.08178452402353287, 0.05075003579258919, 0.008925038389861584, 0.010123614221811295, 0.0020547867752611637, 0.0018307814607396722, 0.0035978599917143583, 0.005116818472743034, 0.011910436674952507, 0.029756009578704834, 0.0135769322514534, 0.029033903032541275, 0.3352733254432678, 0.34270092844963074, 0.853434145450592, 0.5472252368927002, 0.0037795817479491234, 0.002079573692753911, 0.004047006834298372, 0.0025803211610764265, 0.0027824577409774065, 0.004576769657433033, 0.01030381117016077, 0.07824616879224777, 0.02222548797726631, 0.4440312385559082, 0.5210556387901306, 0.8199974298477173, 0.6013593673706055, 0.03144751489162445, 0.00270249554887414, 0.002131239278241992, 0.0031072888523340225, 0.004718270618468523, 0.004604656714946032, 0.047882165759801865, -1]}
{"idB": "749647_17_item1_p21_s0", "idA": "749647_16_item1_p56_s4", "sentA": "These data continue to strongly suggest that ThermoDox may significantly improve Overall Survival compared to a RFA control in patients whose lesions undergo optimized RFA treatment for 45 minutes or more as well as support the protocol for our Phase III OPTIMA Study as described below.", "sentB": "In the population of 154 patients with a single lesion who received optimized RFA treatment for 45 minutes or more showed a 53% risk improvement in OS (HR = 0.66) when treated with ThermoDox plus optimized RFA.", "type": 2, "words": ["<tag1>", "These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "Overall", "Survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below.", "<tag2>", "In", "the", "population", "of", "154", "patients", "with", "a", "single", "lesion", "who", "received", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "showed", "a", "53%", "risk", "improvement", "in", "OS", "(HR", "=", "0.66)", "when", "treated", "with", "ThermoDox", "plus", "optimized", "RFA.", "<tag3>"], "wordsA": ["These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "Overall", "Survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below."], "wordsB": ["In", "the", "population", "of", "154", "patients", "with", "a", "single", "lesion", "who", "received", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "showed", "a", "53%", "risk", "improvement", "in", "OS", "(HR", "=", "0.66)", "when", "treated", "with", "ThermoDox", "plus", "optimized", "RFA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008800778537988663, 0.006134651601314545, 0.049837760627269745, 0.012310980819165707, 0.21491970121860504, 0.27308788895606995, 0.04559388756752014, 0.036869000643491745, 0.5046424269676208, 0.6075398325920105, 0.0004890523850917816, 0.025450194254517555, 0.012614147737622261, 0.010263122618198395, 0.02003195695579052, 0.003801144892349839, 0.005581050179898739, 0.006840877700597048, 0.0038933318573981524, 0.00478777289390564, 0.008335273712873459, 0.0058930907398462296, 0.2084602266550064, 0.10416873544454575, 0.11667240411043167, 0.021503841504454613, 0.0797487273812294, 0.07775859534740448, 0.07891277968883514, 0.14005617797374725, 0.003859687829390168, 0.025492768734693527, 0.014140929095447063, 0.02487468160688877, 0.06119023635983467, 0.03401961550116539, 0.049372054636478424, -1]}
{"idB": "749647_17_item1_p22_s0", "idA": "749647_16_item1_p56_s4", "sentA": "These data continue to strongly suggest that ThermoDox may significantly improve Overall Survival compared to a RFA control in patients whose lesions undergo optimized RFA treatment for 45 minutes or more as well as support the protocol for our Phase III OPTIMA Study as described below.", "sentB": "These data continue to support and further strengthen ThermoDox s potential to significantly improve OS compared to an RFA control in patients with lesions that undergo optimized RFA treatment for 45 minutes or more.", "type": 2, "words": ["<tag1>", "These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "Overall", "Survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below.", "<tag2>", "These", "data", "continue", "to", "support", "and", "further", "strengthen", "ThermoDox", "s", "potential", "to", "significantly", "improve", "OS", "compared", "to", "an", "RFA", "control", "in", "patients", "with", "lesions", "that", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more.", "<tag3>"], "wordsA": ["These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "Overall", "Survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below."], "wordsB": ["These", "data", "continue", "to", "support", "and", "further", "strengthen", "ThermoDox", "s", "potential", "to", "significantly", "improve", "OS", "compared", "to", "an", "RFA", "control", "in", "patients", "with", "lesions", "that", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00469972612336278, 0.0262254998087883, 0.012464171275496483, 0.010474205017089844, 0.03420412540435791, 0.010295432060956955, 0.02446974255144596, 0.23484893143177032, 0.11987408995628357, 0.12260039150714874, 0.1179773360490799, 0.014452382922172546, 0.06511050462722778, 0.11703582853078842, 0.5835326910018921, 0.014810892753303051, 0.00551903760060668, 0.0039202384650707245, 0.01281452365219593, 0.013927397318184376, 0.0032871796283870935, 0.022427113726735115, 0.003999542910605669, 0.015909316018223763, 0.004050968214869499, 0.00446716696023941, 0.00501801585778594, 0.007409211713820696, 0.00762634351849556, 0.0036508888006210327, 0.00514132110401988, 0.005310356616973877, 0.0064872861839830875, 0.005341656971722841, -1]}
{"idB": "749647_17_item1_p82_s5", "idA": "749647_16_item1_p56_s4", "sentA": "These data continue to strongly suggest that ThermoDox may significantly improve Overall Survival compared to a RFA control in patients whose lesions undergo optimized RFA treatment for 45 minutes or more as well as support the protocol for our Phase III OPTIMA Study as described below.", "sentB": "These data continue to strongly suggest that ThermoDox may significantly improve OS compared to a RFA control in patients whose lesions undergo optimized RFA treatment for 45 minutes or more as well as support the protocol for our Phase III OPTIMA Study as described below.", "type": 2, "words": ["<tag1>", "These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "Overall", "Survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below.", "<tag2>", "These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "OS", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below.", "<tag3>"], "wordsA": ["These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "Overall", "Survival", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below."], "wordsB": ["These", "data", "continue", "to", "strongly", "suggest", "that", "ThermoDox", "may", "significantly", "improve", "OS", "compared", "to", "a", "RFA", "control", "in", "patients", "whose", "lesions", "undergo", "optimized", "RFA", "treatment", "for", "45", "minutes", "or", "more", "as", "well", "as", "support", "the", "protocol", "for", "our", "Phase", "III", "OPTIMA", "Study", "as", "described", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0031070036347955465, 0.009918393567204475, 0.004872279241681099, 0.003679889952763915, 0.00477176159620285, 0.006413942202925682, 0.0036982411984354258, 0.02469668909907341, 0.008732043206691742, 0.026228994131088257, 0.1770375519990921, 0.9434877634048462, 0.021696392446756363, 0.005075209308415651, 0.0033707665279507637, 0.007483998313546181, 0.006458249408751726, 0.0023018112406134605, 0.014037462882697582, 0.0031579697970300913, 0.03291105851531029, 0.00552370073273778, 0.005949731916189194, 0.0059789749793708324, 0.005596895236521959, 0.003993048332631588, 0.006064867600798607, 0.005335738882422447, 0.006316022947430611, 0.00617622584104538, 0.0059666321612894535, 0.00363594526425004, 0.003989226650446653, 0.006214810069650412, 0.00395676726475358, 0.00996086560189724, 0.002581255277618766, 0.003224662970751524, 0.004475755151361227, 0.004391362890601158, 0.005796549841761589, 0.004953783471137285, 0.0037616719491779804, 0.004262118600308895, 0.004842430353164673, -1]}
{"idB": "749647_17_item1_p84_s0", "idA": "749647_16_item1_p58_s0", "sentA": "Based on the Overall Survival data from the post-hoc analysis of results from the HEAT Study, we submitted our proposed pivotal Phase III clinical protocol for FDA review in the fourth quarter of 2013.", "sentB": "Based on the OS data from the post-hoc analysis of results from the HEAT Study discussed above, we submitted our proposed pivotal Phase III clinical protocol for FDA review in the fourth quarter of 2013.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "Overall", "Survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study,", "we", "submitted", "our", "proposed", "pivotal", "Phase", "III", "clinical", "protocol", "for", "FDA", "review", "in", "the", "fourth", "quarter", "of", "2013.", "<tag2>", "Based", "on", "the", "OS", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "discussed", "above,", "we", "submitted", "our", "proposed", "pivotal", "Phase", "III", "clinical", "protocol", "for", "FDA", "review", "in", "the", "fourth", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["Based", "on", "the", "Overall", "Survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study,", "we", "submitted", "our", "proposed", "pivotal", "Phase", "III", "clinical", "protocol", "for", "FDA", "review", "in", "the", "fourth", "quarter", "of", "2013."], "wordsB": ["Based", "on", "the", "OS", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "discussed", "above,", "we", "submitted", "our", "proposed", "pivotal", "Phase", "III", "clinical", "protocol", "for", "FDA", "review", "in", "the", "fourth", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011728484183549881, 0.015108773484826088, 0.015519681386649609, 0.9948186278343201, 0.5047509074211121, 0.0016699687112122774, 0.0014693709090352058, 0.0020089230965822935, 0.003433956764638424, 0.0013015592703595757, 0.003739292500540614, 0.001881870673969388, 0.0017681581666693091, 0.005269313231110573, 0.005885910242795944, 0.002592621371150017, 0.003756609046831727, 0.001637194538488984, 0.0030548120848834515, 0.0016411968972533941, 0.002329458249732852, 0.0031789958011358976, 0.002532404847443104, 0.002227486576884985, 0.0029273536056280136, 0.0031376266852021217, 0.0013760147849097848, 0.00228847935795784, 0.003380334237590432, 0.0013278668047860265, 0.001362859969958663, 0.002187777776271105, 0.0023335847072303295, 0.0015559011371806264, 0.0024874843657016754, -1]}
{"idB": "749647_17_item1_p13_s0", "idA": "749647_16_item1_p58_s1", "sentA": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, clearance for the OPTIMA Study, our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with standardized RFA in primary liver cancer.", "sentB": "On February 24, 2014, we announced that the United States Food and Drug Administration (the FDA ), after its customary 30-day review period, provided clearance for the OPTIMA Study, which is a pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox , in combination with standardized RFA, for the treatment of primary liver cancer.", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer.", "<tag2>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "United", "States", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "after", "its", "customary", "30-day", "review", "period,", "provided", "clearance", "for", "the", "OPTIMA", "Study,", "which", "is", "a", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", ",", "in", "combination", "with", "standardized", "RFA,", "for", "the", "treatment", "of", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer."], "wordsB": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "United", "States", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "after", "its", "customary", "30-day", "review", "period,", "provided", "clearance", "for", "the", "OPTIMA", "Study,", "which", "is", "a", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", ",", "in", "combination", "with", "standardized", "RFA,", "for", "the", "treatment", "of", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007004598155617714, 0.009125934913754463, 0.009352350607514381, 0.009422029368579388, 0.010334251448512077, 0.01653740182518959, 0.016648543998599052, 0.02420329675078392, 0.5742363333702087, 0.7371225357055664, 0.8180825114250183, 0.8337622880935669, 0.4376334547996521, 0.901868999004364, 0.09132637828588486, 0.08004458248615265, 0.0005079814582131803, 0.00876865815371275, 0.009767378680408001, 0.012224439531564713, 0.010938023217022419, 0.010063198395073414, 0.00879012793302536, 0.1278848797082901, 0.046869322657585144, 0.0061749559827148914, 0.005080928560346365, 0.011752389371395111, 0.008733632043004036, 0.011682577431201935, 0.0057756416499614716, 0.005911181215196848, 0.015303020365536213, 0.017985569313168526, 0.012146862223744392, 0.010489932261407375, 0.008682705461978912, 0.013222149573266506, 0.006206916179507971, 0.024075550958514214, 0.0005325053352862597, 0.009005858562886715, 0.010104414075613022, 0.00866281520575285, 0.012415128760039806, 0.010844728909432888, 0.004452742636203766, 0.00508242379873991, 0.010233353823423386, 0.0049400050193071365, 0.01943833939731121, 0.022806771099567413, 0.012548300437629223, -1]}
{"idB": "749647_17_item1_p130_s0", "idA": "749647_16_item1_p59_s0", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "sentB": "Celsion also reported initial translational data from the first two cohorts of patients.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag2>", "Celsion", "also", "reported", "initial", "translational", "data", "from", "the", "first", "two", "cohorts", "of", "patients.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "wordsB": ["Celsion", "also", "reported", "initial", "translational", "data", "from", "the", "first", "two", "cohorts", "of", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.354021817445755, 0.01634455844759941, 0.10963690280914307, 0.18401797115802765, 0.6549303531646729, 0.40866926312446594, 0.009204663336277008, 0.009384416975080967, 0.05391746759414673, 0.13458682596683502, 0.12301349639892578, 0.03438510745763779, 0.1359771490097046, -1]}
{"idB": "749647_17_item1_p14_s0", "idA": "749647_16_item1_p59_s0", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "sentB": "The trial design of the OPTIMA Study is based on the comprehensive analysis of data from an earlier clinical trial called the HEAT Study (the HEAT Study ), which is described below.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag2>", "The", "trial", "design", "of", "the", "OPTIMA", "Study", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "an", "earlier", "clinical", "trial", "called", "the", "HEAT", "Study", "(the", "HEAT", "Study", "),", "which", "is", "described", "below.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "wordsB": ["The", "trial", "design", "of", "the", "OPTIMA", "Study", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "an", "earlier", "clinical", "trial", "called", "the", "HEAT", "Study", "(the", "HEAT", "Study", "),", "which", "is", "described", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0028328855987638235, 0.029443761333823204, 0.0213436558842659, 0.0026082536205649376, 0.0031602447852492332, 0.01528527494519949, 0.018520673736929893, 0.0026319704484194517, 0.008612941950559616, 0.003612995846197009, 0.004583665635436773, 0.009863137267529964, 0.012366370297968388, 0.00367901218123734, 0.033104196190834045, 0.017887331545352936, 0.02438519336283207, 0.5310652852058411, 0.36084192991256714, 0.3320525884628296, 0.005759951658546925, 0.0067856754176318645, 0.058057378977537155, 0.08206664025783539, 0.008192848414182663, 0.03445734456181526, 0.056095343083143234, 0.00017327064415439963, 0.0005437256186269224, 0.006262737326323986, 0.023514270782470703, 0.038275908678770065, -1]}
{"idB": "749647_17_item1_p15_s0", "idA": "749647_16_item1_p59_s0", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "sentB": "The OPTIMA Study is supported by a hypothesis developed from an overall survival analysis of a large subgroup of patients from the HEAT Study.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag2>", "The", "OPTIMA", "Study", "is", "supported", "by", "a", "hypothesis", "developed", "from", "an", "overall", "survival", "analysis", "of", "a", "large", "subgroup", "of", "patients", "from", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "wordsB": ["The", "OPTIMA", "Study", "is", "supported", "by", "a", "hypothesis", "developed", "from", "an", "overall", "survival", "analysis", "of", "a", "large", "subgroup", "of", "patients", "from", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005366255063563585, 0.06884684413671494, 0.15025211870670319, 0.015466536395251751, 0.17580576241016388, 0.03969591483473778, 0.022559160366654396, 0.27423667907714844, 0.05640731751918793, 0.017149699851870537, 0.014848148450255394, 0.4473378360271454, 0.47378644347190857, 0.335082083940506, 0.01691448502242565, 0.012654190883040428, 0.037469759583473206, 0.09951493889093399, 0.07884737104177475, 0.17521779239177704, 0.008113456889986992, 0.00658424524590373, 0.024714693427085876, 0.025130219757556915, -1]}
{"idB": "749647_17_item1_p19_s2", "idA": "749647_16_item1_p59_s0", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "sentB": "On August 15, 2016, the Company announced updated results from its final retrospective OS analysis of the data from the HEAT Study.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag2>", "On", "August", "15,", "2016,", "the", "Company", "announced", "updated", "results", "from", "its", "final", "retrospective", "OS", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "wordsB": ["On", "August", "15,", "2016,", "the", "Company", "announced", "updated", "results", "from", "its", "final", "retrospective", "OS", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023046590387821198, 0.10577447712421417, 0.06256979703903198, 0.168641597032547, 0.006160668563097715, 0.10957615822553635, 0.20560257136821747, 0.26123857498168945, 0.14559949934482574, 0.013138634152710438, 0.017246276140213013, 0.08438360691070557, 0.4191459119319916, 0.3328065574169159, 0.22567889094352722, 0.00841082539409399, 0.013050549663603306, 0.052907198667526245, 0.00721324235200882, 0.006526606623083353, 0.02808298170566559, 0.032738830894231796, -1]}
{"idB": "749647_17_item1_p23_s0", "idA": "749647_16_item1_p59_s0", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "sentB": "While this information should be viewed with caution since it is based on a retrospective analysis of a subgroup, we also conducted additional analyses that further strengthen the evidence for the HEAT Study sub-group.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag2>", "While", "this", "information", "should", "be", "viewed", "with", "caution", "since", "it", "is", "based", "on", "a", "retrospective", "analysis", "of", "a", "subgroup,", "we", "also", "conducted", "additional", "analyses", "that", "further", "strengthen", "the", "evidence", "for", "the", "HEAT", "Study", "sub-group.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "wordsB": ["While", "this", "information", "should", "be", "viewed", "with", "caution", "since", "it", "is", "based", "on", "a", "retrospective", "analysis", "of", "a", "subgroup,", "we", "also", "conducted", "additional", "analyses", "that", "further", "strengthen", "the", "evidence", "for", "the", "HEAT", "Study", "sub-group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022487126290798187, 0.00953931175172329, 0.10180916637182236, 0.05573391169309616, 0.04175569489598274, 0.08877181261777878, 0.06282935291528702, 0.14466597139835358, 0.0066277040168643, 0.005059453193098307, 0.005936531350016594, 0.013525262475013733, 0.006995798088610172, 0.006957075092941523, 0.3078688383102417, 0.2105962485074997, 0.01779714599251747, 0.01732828840613365, 0.09215549379587173, 0.02390296570956707, 0.010002939961850643, 0.04998571053147316, 0.13001888990402222, 0.2755763828754425, 0.0008258468005806208, 0.008576642721891403, 0.07711432129144669, 0.013813084922730923, 0.10088842362165451, 0.019372111186385155, 0.013886405155062675, 0.07416123896837234, 0.1113395020365715, 0.0893588736653328, -1]}
{"idB": "749647_17_item1_p47_s0", "idA": "749647_16_item1_p59_s0", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "sentB": "Celsion also reported initial translational data from the first two cohorts of patients.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag2>", "Celsion", "also", "reported", "initial", "translational", "data", "from", "the", "first", "two", "cohorts", "of", "patients.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "wordsB": ["Celsion", "also", "reported", "initial", "translational", "data", "from", "the", "first", "two", "cohorts", "of", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.354021817445755, 0.01634455844759941, 0.10963690280914307, 0.18401797115802765, 0.6549303531646729, 0.40866926312446594, 0.009204663336277008, 0.009384416975080967, 0.05391746759414673, 0.13458682596683502, 0.12301349639892578, 0.03438510745763779, 0.1359771490097046, -1]}
{"idB": "749647_17_item1_p83_s0", "idA": "749647_16_item1_p59_s0", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "sentB": "While this information should be viewed with caution since it is based on a retrospective analysis of a subgroup, we also conducted additional analyses that may further strengthen the evidence for the HEAT Study sub-group.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag2>", "While", "this", "information", "should", "be", "viewed", "with", "caution", "since", "it", "is", "based", "on", "a", "retrospective", "analysis", "of", "a", "subgroup,", "we", "also", "conducted", "additional", "analyses", "that", "may", "further", "strengthen", "the", "evidence", "for", "the", "HEAT", "Study", "sub-group.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "wordsB": ["While", "this", "information", "should", "be", "viewed", "with", "caution", "since", "it", "is", "based", "on", "a", "retrospective", "analysis", "of", "a", "subgroup,", "we", "also", "conducted", "additional", "analyses", "that", "may", "further", "strengthen", "the", "evidence", "for", "the", "HEAT", "Study", "sub-group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022171756252646446, 0.00952712818980217, 0.09949024766683578, 0.05554397031664848, 0.040420591831207275, 0.08366774767637253, 0.05992130935192108, 0.13517102599143982, 0.006841467227786779, 0.005037281662225723, 0.005814135540276766, 0.012887020595371723, 0.006754195783287287, 0.006823450326919556, 0.2983657717704773, 0.21150797605514526, 0.018392128869891167, 0.01714235357940197, 0.0928448736667633, 0.024306373670697212, 0.010274176485836506, 0.054108887910842896, 0.12861214578151703, 0.2759902775287628, 0.00033142237225547433, 0.00908499862998724, 0.008151624351739883, 0.04690733924508095, 0.013433853164315224, 0.07286994904279709, 0.018548188731074333, 0.01357949897646904, 0.07494331151247025, 0.10744397342205048, 0.08778597414493561, -1]}
{"idB": "749647_17_item1_p86_s0", "idA": "749647_16_item1_p59_s0", "sentA": "The OPTIMA Study trial design is based on a comprehensive analysis of data from the HEAT Study.", "sentB": "The OPTIMA Study is supported with a convincing hypothesis developed from an overall survival analysis of a large subgroup of patients from the HEAT Study.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study.", "<tag2>", "The", "OPTIMA", "Study", "is", "supported", "with", "a", "convincing", "hypothesis", "developed", "from", "an", "overall", "survival", "analysis", "of", "a", "large", "subgroup", "of", "patients", "from", "the", "HEAT", "Study.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "a", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "Study."], "wordsB": ["The", "OPTIMA", "Study", "is", "supported", "with", "a", "convincing", "hypothesis", "developed", "from", "an", "overall", "survival", "analysis", "of", "a", "large", "subgroup", "of", "patients", "from", "the", "HEAT", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005112615879625082, 0.05830086022615433, 0.12909039855003357, 0.012126433663070202, 0.16069315373897552, 0.032775696367025375, 0.019467581063508987, 0.19182652235031128, 0.2683752775192261, 0.03596840426325798, 0.012255189009010792, 0.011735130101442337, 0.3985641300678253, 0.4787919819355011, 0.34596744179725647, 0.01966995932161808, 0.012876772321760654, 0.036952245980501175, 0.09864845126867294, 0.08282138407230377, 0.17409853637218475, 0.00817660242319107, 0.006464044563472271, 0.023294327780604362, 0.02524556964635849, -1]}
{"idB": "749647_17_item1_p16_s1", "idA": "749647_16_item1_p60_s0", "sentA": "Designed with extensive input from globally recognized HCC researchers and clinicians and after formal written consultation with the FDA, the OPTIMA Study was launched in the first half of 2014.", "sentB": "The OPTIMA Study was designed with extensive input from globally recognized hepatocellular carcinoma ( HCC ) researchers and expert clinicians and after receiving formal written consultation from the FDA.", "type": 2, "words": ["<tag1>", "Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014.", "<tag2>", "The", "OPTIMA", "Study", "was", "designed", "with", "extensive", "input", "from", "globally", "recognized", "hepatocellular", "carcinoma", "(", "HCC", ")", "researchers", "and", "expert", "clinicians", "and", "after", "receiving", "formal", "written", "consultation", "from", "the", "FDA.", "<tag3>"], "wordsA": ["Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014."], "wordsB": ["The", "OPTIMA", "Study", "was", "designed", "with", "extensive", "input", "from", "globally", "recognized", "hepatocellular", "carcinoma", "(", "HCC", ")", "researchers", "and", "expert", "clinicians", "and", "after", "receiving", "formal", "written", "consultation", "from", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0027672972064465284, 0.027631960809230804, 0.04672493785619736, 0.004413404036313295, 0.009937821887433529, 0.0033798166550695896, 0.006218298338353634, 0.013971421867609024, 0.0045362175442278385, 0.007686586119234562, 0.02205565571784973, 0.9172295331954956, 0.908470630645752, 0.09548704326152802, 0.06570295989513397, 6.415708048734814e-05, 0.05149850994348526, 0.002717450028285384, 0.008131636306643486, 0.013194853439927101, 0.00337795726954937, 0.005877991672605276, 0.005215185694396496, 0.005361777730286121, 0.005962990690022707, 0.011120988987386227, 0.0030304628890007734, 0.003211942268535495, 0.008716417476534843, -1]}
{"idB": "749647_17_item1_p16_s2", "idA": "749647_16_item1_p60_s1", "sentA": "The OPTIMA Study is expected to enroll up to 550 patients globally at up to 75 sites in the United States, Canada, Europe, China and elsewhere in the Asia Pacific region, and will evaluate ThermoDox in combination with standardized RFA, which will require a minimum of 45 minutes across all investigators and clinical sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "sentB": "The OPTIMA Study is expected to enroll up to 550 patients globally at up to 65 sites in the U.S., Canada, European Union, China and other countries in the Asia-Pacific region, and will evaluate ThermoDox in combination with standardized RFA, which will require a minimum of 45 minutes across all investigators and clinical sites for treating lesions three to seven centimeters, versus standardized RFA alone.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "75", "sites", "in", "the", "United", "States,", "Canada,", "Europe,", "China", "and", "elsewhere", "in", "the", "Asia", "Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag2>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "65", "sites", "in", "the", "U.S.,", "Canada,", "European", "Union,", "China", "and", "other", "countries", "in", "the", "Asia-Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "three", "to", "seven", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "75", "sites", "in", "the", "United", "States,", "Canada,", "Europe,", "China", "and", "elsewhere", "in", "the", "Asia", "Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "wordsB": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "65", "sites", "in", "the", "U.S.,", "Canada,", "European", "Union,", "China", "and", "other", "countries", "in", "the", "Asia-Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "three", "to", "seven", "centimeters,", "versus", "standardized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004540771711617708, 0.008365274406969547, 0.00841614417731762, 0.004893709905445576, 0.008377362973988056, 0.0054768165573477745, 0.007889154367148876, 0.005865883082151413, 0.00766768166795373, 0.01667557656764984, 0.012238324619829655, 0.005135294981300831, 0.0047346907667815685, 0.006736452691257, 0.007536936551332474, 0.7319071888923645, 0.16637790203094482, 0.004870906472206116, 0.00509221013635397, 0.02089487388730049, 0.008749142289161682, 0.007805829867720604, 0.008396183140575886, 0.008124801330268383, 0.0056894076988101006, 0.006036954931914806, 0.008482998237013817, 0.005724115297198296, 0.005857363808900118, 0.009514141827821732, 0.006861927919089794, 0.01088065467774868, 0.00602432107552886, 0.007692880462855101, 0.009086500853300095, 0.008533358573913574, 0.00886839535087347, 0.008096352219581604, 0.009274912066757679, 0.008101753890514374, 0.010486924089491367, 0.006472277920693159, 0.00623856857419014, 0.007508093025535345, 0.009664975106716156, 0.009718244895339012, 0.01518397219479084, 0.009018199518322945, 0.005569573026150465, 0.005319370422512293, 0.009238292463123798, 0.006278480403125286, 0.005822733044624329, 0.008111554197967052, 0.005824773572385311, 0.004918959457427263, 0.007080393377691507, 0.007485812064260244, 0.006172527093440294, 0.27772217988967896, 0.05474024638533592, 0.007425493095070124, 0.009386287070810795, 0.008395182900130749, 0.007801983039826155, -1]}
{"idB": "749647_17_item1_p16_s3", "idA": "749647_16_item1_p61_s0", "sentA": "The primary endpoint for the trial is Overall Survival, and the secondary endpoints for the trial are PFS and safety.", "sentB": "The primary endpoint for this clinical trial is overall survival ( OS ), and the secondary endpoints are progression free survival and safety.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "the", "trial", "is", "Overall", "Survival,", "and", "the", "secondary", "endpoints", "for", "the", "trial", "are", "PFS", "and", "safety.", "<tag2>", "The", "primary", "endpoint", "for", "this", "clinical", "trial", "is", "overall", "survival", "(", "OS", "),", "and", "the", "secondary", "endpoints", "are", "progression", "free", "survival", "and", "safety.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "the", "trial", "is", "Overall", "Survival,", "and", "the", "secondary", "endpoints", "for", "the", "trial", "are", "PFS", "and", "safety."], "wordsB": ["The", "primary", "endpoint", "for", "this", "clinical", "trial", "is", "overall", "survival", "(", "OS", "),", "and", "the", "secondary", "endpoints", "are", "progression", "free", "survival", "and", "safety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0016936451429501176, 0.01670651324093342, 0.028373461216688156, 0.001978101674467325, 0.0021538669243454933, 0.013164824806153774, 0.01298403088003397, 0.0032420253846794367, 0.06170142441987991, 0.19648215174674988, 0.11866161227226257, 0.6653892397880554, 3.334609209559858e-05, 0.002340143546462059, 0.0016106809489428997, 0.0165457334369421, 0.021716739982366562, 0.012048931792378426, 0.8321215510368347, 0.9060452580451965, 0.5199508666992188, 0.011903631500899792, 0.03422330319881439, -1]}
{"idB": "749647_17_item1_p18_s3", "idA": "749647_16_item1_p63_s0", "sentA": "On December 16, 2015, we announced that we received approval from the CFDA to conduct the OPTIMA Study in China.", "sentB": "On April 26, 2016, we announced that the first patient in China had been enrolled in the OPTIMA Study.", "type": 2, "words": ["<tag1>", "On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "approval", "from", "the", "CFDA", "to", "conduct", "the", "OPTIMA", "Study", "in", "China.", "<tag2>", "On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "had", "been", "enrolled", "in", "the", "OPTIMA", "Study.", "<tag3>"], "wordsA": ["On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "approval", "from", "the", "CFDA", "to", "conduct", "the", "OPTIMA", "Study", "in", "China."], "wordsB": ["On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "had", "been", "enrolled", "in", "the", "OPTIMA", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030179370194673538, 0.6221132874488831, 0.6583993434906006, 0.7318821549415588, 0.011085942387580872, 0.028596123680472374, 0.011643161065876484, 0.026990022510290146, 0.3445471227169037, 0.4104323089122772, 0.027911672368645668, 0.042845677584409714, 0.07932940125465393, 0.06977276504039764, 0.411348432302475, 0.08741341531276703, 0.03444947674870491, 0.04391360282897949, 0.060962241142988205, -1]}
{"idB": "749647_17_item1_p90_s0", "idA": "749647_16_item1_p63_s0", "sentA": "On December 16, 2015, we announced that we received approval from the CFDA to conduct the OPTIMA Study in China.", "sentB": "On December 16, 2015, we announced that we had received the clinical trial application approval from the CFDA to conduct the OPTIMA Study in China.", "type": 2, "words": ["<tag1>", "On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "approval", "from", "the", "CFDA", "to", "conduct", "the", "OPTIMA", "Study", "in", "China.", "<tag2>", "On", "December", "16,", "2015,", "we", "announced", "that", "we", "had", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "CFDA", "to", "conduct", "the", "OPTIMA", "Study", "in", "China.", "<tag3>"], "wordsA": ["On", "December", "16,", "2015,", "we", "announced", "that", "we", "received", "approval", "from", "the", "CFDA", "to", "conduct", "the", "OPTIMA", "Study", "in", "China."], "wordsB": ["On", "December", "16,", "2015,", "we", "announced", "that", "we", "had", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "CFDA", "to", "conduct", "the", "OPTIMA", "Study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003712607081979513, 0.005624645389616489, 0.006452998612076044, 0.004926828667521477, 0.004072144627571106, 0.006036251317709684, 0.004275663755834103, 0.011069952510297298, 0.007512941490858793, 0.025839461013674736, 0.02189718931913376, 0.8056009411811829, 0.9481557607650757, 0.9068753719329834, 0.11781979352235794, 0.00431975070387125, 0.0032211842481046915, 0.0072447434067726135, 0.002582134213298559, 0.0030134404078125954, 0.002515701809898019, 0.0043862247839570045, 0.006217290181666613, 0.002363217296078801, 0.003733754623681307, -1]}
{"idB": "749647_17_item1_p90_s1", "idA": "749647_16_item1_p63_s1", "sentA": "This clinical trial application approval will allow Celsion to enroll patients at up to 20 clinical sites in China.", "sentB": "This clinical trial application approval will now allow Celsion to enroll patients at up to 20 clinical sites in China.", "type": 2, "words": ["<tag1>", "This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China.", "<tag2>", "This", "clinical", "trial", "application", "approval", "will", "now", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China.", "<tag3>"], "wordsA": ["This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China."], "wordsB": ["This", "clinical", "trial", "application", "approval", "will", "now", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.035207539796829224, 0.17066556215286255, 0.1989607959985733, 0.13908995687961578, 0.16756491363048553, 0.06862141937017441, 0.06728313118219376, 0.08601686358451843, 0.273969441652298, 0.08072064071893692, 0.47760507464408875, 0.4339289963245392, 0.058986544609069824, 0.12417185306549072, 0.05605163797736168, 0.11419378221035004, 0.06356297433376312, 0.1184355616569519, 0.04729962348937988, 0.07999522984027863, -1]}
{"idB": "749647_17_item1_p92_s0", "idA": "749647_16_item1_p64_s0", "sentA": "We will continue with partnerships, such as our arrangement with Hisun and Yakult Pharmaceuticals to the extent feasible.", "sentB": "We will continue with partnerships, such as our arrangement with Hisun and Yakult Honsha Co., Ltd. ( Yakult ) to the extent feasible.", "type": 2, "words": ["<tag1>", "We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "and", "Yakult", "Pharmaceuticals", "to", "the", "extent", "feasible.", "<tag2>", "We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "and", "Yakult", "Honsha", "Co.,", "Ltd.", "(", "Yakult", ")", "to", "the", "extent", "feasible.", "<tag3>"], "wordsA": ["We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "and", "Yakult", "Pharmaceuticals", "to", "the", "extent", "feasible."], "wordsB": ["We", "will", "continue", "with", "partnerships,", "such", "as", "our", "arrangement", "with", "Hisun", "and", "Yakult", "Honsha", "Co.,", "Ltd.", "(", "Yakult", ")", "to", "the", "extent", "feasible."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004064586479216814, 0.0029814792796969414, 0.004005477298051119, 0.003012692555785179, 0.0045198178850114346, 0.0023906631395220757, 0.002056133234873414, 0.0018593320855870843, 0.006696357391774654, 0.0066247908398509026, 0.010855128057301044, 0.0067857070825994015, 0.033072587102651596, 0.9502567648887634, 0.923463761806488, 0.7063078284263611, 0.057025764137506485, 0.06014508381485939, 0.00011789468408096582, 0.0020424285903573036, 0.0021778512746095657, 0.003534275107085705, 0.0041389926336705685, -1]}
{"idB": "749647_17_item1_p94_s0", "idA": "749647_16_item1_p66_s0", "sentA": "Recurrent Chest Wall (RCW) Breast Cancer Overview Breast cancer is the most common malignancy in women in both the United States and the world.", "sentB": "Breast cancer is the most common malignancy in women in both the U.S. and the world.", "type": 2, "words": ["<tag1>", "Recurrent", "Chest", "Wall", "(RCW)", "Breast", "Cancer", "Overview", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world.", "<tag2>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world.", "<tag3>"], "wordsA": ["Recurrent", "Chest", "Wall", "(RCW)", "Breast", "Cancer", "Overview", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "United", "States", "and", "the", "world."], "wordsB": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.9025585055351257, 0.8513726592063904, 0.04093820974230766, 0.02108871005475521, 0.06073753908276558, 0.09921649098396301, 0.2426636666059494, 0.06319217383861542, 0.12924766540527344, 0.009718907065689564, 0.018593216314911842, 0.008414051495492458, 0.07406158000230789, 0.015556290745735168, 0.007761465385556221, 0.01937972567975521, -1]}
{"idB": "749647_17_item1_p95_s0", "idA": "749647_16_item1_p66_s1", "sentA": "Despite a variety of therapeutic approaches, up to 40% of the estimated 95,000 patients in the United States undergoing a mastectomy as their primary treatment will develop locally recurrent RCW breast cancer.", "sentB": "Despite a variety of therapeutic approaches, up to 40% of the estimated 95,000 patients in the U.S. undergoing a mastectomy as their primary treatment will develop locally recurrent RCW breast cancer.", "type": 2, "words": ["<tag1>", "Despite", "a", "variety", "of", "therapeutic", "approaches,", "up", "to", "40%", "of", "the", "estimated", "95,000", "patients", "in", "the", "United", "States", "undergoing", "a", "mastectomy", "as", "their", "primary", "treatment", "will", "develop", "locally", "recurrent", "RCW", "breast", "cancer.", "<tag2>", "Despite", "a", "variety", "of", "therapeutic", "approaches,", "up", "to", "40%", "of", "the", "estimated", "95,000", "patients", "in", "the", "U.S.", "undergoing", "a", "mastectomy", "as", "their", "primary", "treatment", "will", "develop", "locally", "recurrent", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["Despite", "a", "variety", "of", "therapeutic", "approaches,", "up", "to", "40%", "of", "the", "estimated", "95,000", "patients", "in", "the", "United", "States", "undergoing", "a", "mastectomy", "as", "their", "primary", "treatment", "will", "develop", "locally", "recurrent", "RCW", "breast", "cancer."], "wordsB": ["Despite", "a", "variety", "of", "therapeutic", "approaches,", "up", "to", "40%", "of", "the", "estimated", "95,000", "patients", "in", "the", "U.S.", "undergoing", "a", "mastectomy", "as", "their", "primary", "treatment", "will", "develop", "locally", "recurrent", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.046881187707185745, 0.013538037426769733, 0.03172718733549118, 0.01751294545829296, 0.026666704565286636, 0.03480508551001549, 0.013379045762121677, 0.019479775801301003, 0.06224264204502106, 0.013117838650941849, 0.011419199407100677, 0.02614179439842701, 0.04854224994778633, 0.04676257073879242, 0.010572532191872597, 0.012516068294644356, 0.8275664448738098, 0.025201043114066124, 0.013708213344216347, 0.06361303478479385, 0.013824308291077614, 0.012572144158184528, 0.03473667800426483, 0.026546111330389977, 0.009921340271830559, 0.013991800136864185, 0.019612019881606102, 0.015193643048405647, 0.02863425388932228, 0.022674545645713806, 0.02666422538459301, -1]}
{"idB": "749647_17_item1_p97_s0", "idA": "749647_16_item1_p68_s0", "sentA": "Celsion s Approach We have been actively seeking a targeted localized treatment for breast cancer using ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "sentB": "We have been actively seeking a targeted localized treatment for breast cancer using ThermoDox in conjunction with localized microwave hyperthermia to treat RCW breast cancer.", "type": 2, "words": ["<tag1>", "Celsion", "s", "Approach", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag2>", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer.", "<tag3>"], "wordsA": ["Celsion", "s", "Approach", "We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "wordsB": ["We", "have", "been", "actively", "seeking", "a", "targeted", "localized", "treatment", "for", "breast", "cancer", "using", "ThermoDox", "in", "conjunction", "with", "localized", "microwave", "hyperthermia", "to", "treat", "RCW", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.20510679483413696, 0.0556250624358654, 0.019487924873828888, 0.1777835488319397, 0.16409209370613098, 0.016750356182456017, 0.1499532014131546, 0.2980520725250244, 0.2453625649213791, 0.04758889600634575, 0.17772091925144196, 0.23338501155376434, 0.054720018059015274, 0.23909986019134521, 0.03934381902217865, 0.0892070084810257, 0.03109235130250454, 0.20294584333896637, 0.10408791154623032, 0.0937289446592331, 0.020298294723033905, 0.053970422595739365, 0.12362736463546753, 0.07076919823884964, 0.09408740699291229, -1]}
{"idB": "749647_17_item1_p162_s5", "idA": "749647_16_item1_p70_s0", "sentA": "Microwave hyperthermia as a separate standalone treatment has been found to have the ability to kill breast cancer cells.", "sentB": "Based on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern.", "type": 2, "words": ["<tag1>", "Microwave", "hyperthermia", "as", "a", "separate", "standalone", "treatment", "has", "been", "found", "to", "have", "the", "ability", "to", "kill", "breast", "cancer", "cells.", "<tag2>", "Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag3>"], "wordsA": ["Microwave", "hyperthermia", "as", "a", "separate", "standalone", "treatment", "has", "been", "found", "to", "have", "the", "ability", "to", "kill", "breast", "cancer", "cells."], "wordsB": ["Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01840762235224247, 0.013359044678509235, 0.010525192134082317, 0.023399842903017998, 0.19511689245700836, 0.04414436221122742, 0.053763363510370255, 0.019752124324440956, 0.018722128123044968, 0.05893347039818764, 0.4277673661708832, 0.04730215668678284, 0.12195607274770737, 0.2098267525434494, 0.09538070857524872, 0.12272348999977112, 0.05329429358243942, 0.030273722484707832, 0.09999163448810577, 0.10758944600820541, -1]}
{"idB": "749647_17_item1_p101_s0", "idA": "749647_16_item1_p72_s0", "sentA": "The DIGNITY Study In 2009, the Company commenced an open label, dose-escalating ThermoDox Phase I/Phase II clinical trial for patients with RCW breast cancer (the DIGNITY Study).", "sentB": "In 2009, the Company commenced an open label, dose-escalating ThermoDox Phase I/Phase II clinical trial for patients with RCW breast cancer (the DIGNITY Study).", "type": 2, "words": ["<tag1>", "The", "DIGNITY", "Study", "In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag3>"], "wordsA": ["The", "DIGNITY", "Study", "In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["In", "2009,", "the", "Company", "commenced", "an", "open", "label,", "dose-escalating", "ThermoDox", "Phase", "I/Phase", "II", "clinical", "trial", "for", "patients", "with", "RCW", "breast", "cancer", "(the", "DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.21549510955810547, 0.2562924325466156, 0.023291828110814095, 0.5224950909614563, 0.15852409601211548, 0.034703150391578674, 0.15136049687862396, 0.22538404166698456, 0.17595967650413513, 0.17640341818332672, 0.06395244598388672, 0.07545645534992218, 0.06204751506447792, 0.04108252748847008, 0.09336701780557632, 0.04694167524576187, 0.1756601333618164, 0.13615810871124268, 0.30765777826309204, 0.21562236547470093, 0.1796630173921585, 0.030573906376957893, 0.1841018944978714, 0.20134100317955017, -1]}
{"idB": "749647_17_item1_p28_s1", "idA": "749647_16_item1_p72_s1", "sentA": "The DIGNITY Study is designed to establish a safe therapeutic dose in Phase I, and in Phase II to demonstrate local control, including complete and partial responses, and stable disease as its primary endpoint.", "sentB": "The DIGNITY Study was designed to establish a safe therapeutic dose in Phase I, and to demonstrate local control in Phase II, including complete and partial responses, and stable disease as its primary endpoint.", "type": 2, "words": ["<tag1>", "The", "DIGNITY", "Study", "is", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "in", "Phase", "II", "to", "demonstrate", "local", "control,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint.", "<tag2>", "The", "DIGNITY", "Study", "was", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "to", "demonstrate", "local", "control", "in", "Phase", "II,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint.", "<tag3>"], "wordsA": ["The", "DIGNITY", "Study", "is", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "in", "Phase", "II", "to", "demonstrate", "local", "control,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint."], "wordsB": ["The", "DIGNITY", "Study", "was", "designed", "to", "establish", "a", "safe", "therapeutic", "dose", "in", "Phase", "I,", "and", "to", "demonstrate", "local", "control", "in", "Phase", "II,", "including", "complete", "and", "partial", "responses,", "and", "stable", "disease", "as", "its", "primary", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01885783113539219, 0.2752101421356201, 0.33905497193336487, 0.044707298278808594, 0.10434934496879578, 0.06213920935988426, 0.07592616975307465, 0.045712973922491074, 0.11797571182250977, 0.15835368633270264, 0.219676211476326, 0.044660866260528564, 0.120383620262146, 0.1288309246301651, 0.02216828055679798, 0.04248088225722313, 0.06438995897769928, 0.09125115722417831, 0.08454601466655731, 0.035670824348926544, 0.0883527621626854, 0.12431906908750534, 0.042002156376838684, 0.07669544965028763, 0.05338691920042038, 0.08908255398273468, 0.07743790745735168, 0.027005167677998543, 0.0998738557100296, 0.09441976994276047, 0.041357580572366714, 0.039560042321681976, 0.07853627949953079, 0.09036292135715485, -1]}
{"idB": "749647_17_item1_p28_s2", "idA": "749647_16_item1_p72_s2", "sentA": "The DIGNITY Study is also planned to evaluate kinetics in ThermoDox produced from more than one manufacturing site.", "sentB": "The DIGNITY Study was also designed to evaluate kinetics in ThermoDox produced from more than one manufacturing site.", "type": 2, "words": ["<tag1>", "The", "DIGNITY", "Study", "is", "also", "planned", "to", "evaluate", "kinetics", "in", "ThermoDox", "produced", "from", "more", "than", "one", "manufacturing", "site.", "<tag2>", "The", "DIGNITY", "Study", "was", "also", "designed", "to", "evaluate", "kinetics", "in", "ThermoDox", "produced", "from", "more", "than", "one", "manufacturing", "site.", "<tag3>"], "wordsA": ["The", "DIGNITY", "Study", "is", "also", "planned", "to", "evaluate", "kinetics", "in", "ThermoDox", "produced", "from", "more", "than", "one", "manufacturing", "site."], "wordsB": ["The", "DIGNITY", "Study", "was", "also", "designed", "to", "evaluate", "kinetics", "in", "ThermoDox", "produced", "from", "more", "than", "one", "manufacturing", "site."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009572166018188, 0.08391861617565155, 0.23501743376255035, 0.06432315707206726, 0.11723873019218445, 0.49345704913139343, 0.120074562728405, 0.1777729094028473, 0.308398962020874, 0.022317765280604362, 0.0988822877407074, 0.021173158660531044, 0.01816815510392189, 0.06011461094021797, 0.061020493507385254, 0.15979841351509094, 0.054796237498521805, 0.06382673978805542, -1]}
{"idB": "749647_17_item1_p63_s0", "idA": "749647_16_item1_p73_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010.", "sentB": "Key provisions of the GEN-1 Agreement are as follows:", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010.", "<tag2>", "Key", "provisions", "of", "the", "GEN-1", "Agreement", "are", "as", "follows:", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010."], "wordsB": ["Key", "provisions", "of", "the", "GEN-1", "Agreement", "are", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.21592243015766144, 0.2680171728134155, 0.03578363358974457, 0.030098697170615196, 0.3896107077598572, 0.3038487732410431, 0.04349740967154503, 0.19773133099079132, 0.27276411652565, -1]}
{"idB": "749647_17_item1_p102_s1", "idA": "749647_16_item1_p73_s1", "sentA": "The enrollment of the DIGNITY Study commenced in the first quarter of 2013 and completed in mid-2015.", "sentB": "The enrollment of the Phase II portion of the DIGNITY Study commenced in the first quarter of 2013 and completed in mid-2015.", "type": 2, "words": ["<tag1>", "The", "enrollment", "of", "the", "DIGNITY", "Study", "commenced", "in", "the", "first", "quarter", "of", "2013", "and", "completed", "in", "mid-2015.", "<tag2>", "The", "enrollment", "of", "the", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "commenced", "in", "the", "first", "quarter", "of", "2013", "and", "completed", "in", "mid-2015.", "<tag3>"], "wordsA": ["The", "enrollment", "of", "the", "DIGNITY", "Study", "commenced", "in", "the", "first", "quarter", "of", "2013", "and", "completed", "in", "mid-2015."], "wordsB": ["The", "enrollment", "of", "the", "Phase", "II", "portion", "of", "the", "DIGNITY", "Study", "commenced", "in", "the", "first", "quarter", "of", "2013", "and", "completed", "in", "mid-2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0022787319030612707, 0.049839217215776443, 0.018028661608695984, 0.01950129307806492, 0.9348359107971191, 0.9861658811569214, 0.42595362663269043, 0.009765101596713066, 0.004658629186451435, 0.018184687942266464, 0.016300713643431664, 0.002881692023947835, 0.0017454446060582995, 0.0017175170360133052, 0.0024452311918139458, 0.003276791190728545, 0.001995712285861373, 0.002499608090147376, 0.0020288601517677307, 0.003926238510757685, 0.001929595018737018, 0.003019695868715644, -1]}
{"idB": "749647_17_item1_p28_s0", "idA": "749647_16_item1_p73_s3", "sentA": "On December 14, 2015, we announced final data from the DIGNITY Study of ThermoDox in RCW Breast Cancer at the San Antonio Breast Cancer Symposium.", "sentB": "On December 14, 2015, we announced final data from our ongoing DIGNITY study, which is an open-label, dose-escalating Phase II trial of ThermoDox in patients with recurrent chest wall ( RCW ) breast cancer.", "type": 2, "words": ["<tag1>", "On", "December", "14,", "2015,", "we", "announced", "final", "data", "from", "the", "DIGNITY", "Study", "of", "ThermoDox", "in", "RCW", "Breast", "Cancer", "at", "the", "San", "Antonio", "Breast", "Cancer", "Symposium.", "<tag2>", "On", "December", "14,", "2015,", "we", "announced", "final", "data", "from", "our", "ongoing", "DIGNITY", "study,", "which", "is", "an", "open-label,", "dose-escalating", "Phase", "II", "trial", "of", "ThermoDox", "in", "patients", "with", "recurrent", "chest", "wall", "(", "RCW", ")", "breast", "cancer.", "<tag3>"], "wordsA": ["On", "December", "14,", "2015,", "we", "announced", "final", "data", "from", "the", "DIGNITY", "Study", "of", "ThermoDox", "in", "RCW", "Breast", "Cancer", "at", "the", "San", "Antonio", "Breast", "Cancer", "Symposium."], "wordsB": ["On", "December", "14,", "2015,", "we", "announced", "final", "data", "from", "our", "ongoing", "DIGNITY", "study,", "which", "is", "an", "open-label,", "dose-escalating", "Phase", "II", "trial", "of", "ThermoDox", "in", "patients", "with", "recurrent", "chest", "wall", "(", "RCW", ")", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0033856877125799656, 0.004294799640774727, 0.004187348298728466, 0.004987245425581932, 0.007698640692979097, 0.008949206210672855, 0.007355234585702419, 0.02053024433553219, 0.002886225236579776, 0.0057754479348659515, 0.02160213515162468, 0.015635104849934578, 0.04299582913517952, 0.00037443259498104453, 0.004701513331383467, 0.00715017830953002, 0.3558487892150879, 0.5053409934043884, 0.15933002531528473, 0.3715816140174866, 0.2928781807422638, 0.009613864123821259, 0.024068333208560944, 0.02208925411105156, 0.2907334864139557, 0.11272840946912766, 0.6551954746246338, 0.5297852754592896, 0.5226253271102905, 0.026293082162737846, 0.06286626309156418, 6.382998981280252e-05, 0.14960959553718567, 0.20000088214874268, -1]}
{"idB": "749647_17_item1_p28_s4", "idA": "749647_16_item1_p73_s5", "sentA": "Thirteen patients, representing approximately 62% of the evaluable patients, experienced a local response, including six complete responses and seven partial responses.", "sentB": "Approximately 62% of evaluable patients experienced a local response, including six complete responses and seven partial responses.", "type": 2, "words": ["<tag1>", "Thirteen", "patients,", "representing", "approximately", "62%", "of", "the", "evaluable", "patients,", "experienced", "a", "local", "response,", "including", "six", "complete", "responses", "and", "seven", "partial", "responses.", "<tag2>", "Approximately", "62%", "of", "evaluable", "patients", "experienced", "a", "local", "response,", "including", "six", "complete", "responses", "and", "seven", "partial", "responses.", "<tag3>"], "wordsA": ["Thirteen", "patients,", "representing", "approximately", "62%", "of", "the", "evaluable", "patients,", "experienced", "a", "local", "response,", "including", "six", "complete", "responses", "and", "seven", "partial", "responses."], "wordsB": ["Approximately", "62%", "of", "evaluable", "patients", "experienced", "a", "local", "response,", "including", "six", "complete", "responses", "and", "seven", "partial", "responses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07574423402547836, 0.8068870306015015, 0.07002989202737808, 0.09485404193401337, 0.1359657645225525, 0.0535588264465332, 0.011635641567409039, 0.01609925739467144, 0.022672872990369797, 0.006341483909636736, 0.037946462631225586, 0.02823757380247116, 0.019385118037462234, 0.00478286761790514, 0.01735650934278965, 0.028908152133226395, 0.026551473885774612, -1]}
{"idB": "749647_17_item1_p131_s1", "idA": "749647_16_item1_p73_s6", "sentA": "These data are consistent with the combined clinical data from the two previous Phase I trials discussed below.", "sentB": "Top line data demonstrates intriguing immunological changes in the tumor that are consistent with the activation of the immune system.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below.", "<tag2>", "Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below."], "wordsB": ["Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1018570140004158, 0.17428350448608398, 0.13815756142139435, 0.023439446464180946, 0.08459503948688507, 0.37329187989234924, 0.2564147710800171, 0.092257060110569, 0.09331623464822769, 0.25171971321105957, 0.005799430422484875, 0.005294616799801588, 0.03512569144368172, 0.021252330392599106, 0.01719783805310726, 0.2504911422729492, 0.16251182556152344, 0.14614379405975342, 0.4300161302089691, 0.5187400579452515, -1]}
{"idB": "749647_17_item1_p48_s1", "idA": "749647_16_item1_p73_s6", "sentA": "These data are consistent with the combined clinical data from the two previous Phase I trials discussed below.", "sentB": "Top line data demonstrates intriguing immunological changes in the tumor that are consistent with the activation of the immune system.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below.", "<tag2>", "Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below."], "wordsB": ["Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1018570140004158, 0.17428350448608398, 0.13815756142139435, 0.023439446464180946, 0.08459503948688507, 0.37329187989234924, 0.2564147710800171, 0.092257060110569, 0.09331623464822769, 0.25171971321105957, 0.005799430422484875, 0.005294616799801588, 0.03512569144368172, 0.021252330392599106, 0.01719783805310726, 0.2504911422729492, 0.16251182556152344, 0.14614379405975342, 0.4300161302089691, 0.5187400579452515, -1]}
{"idB": "749647_17_item1_p11_s0", "idA": "749647_16_item1_p74_s3", "sentA": "ThermoDox in combination with mild hyperthermia was evaluated in these patients in up to six cycles.", "sentB": "The OPTIMA Study represents an evaluation of ThermoDox in combination with a first line therapy, RFA, for newly diagnosed, intermediate stage HCC patients.", "type": 2, "words": ["<tag1>", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "was", "evaluated", "in", "these", "patients", "in", "up", "to", "six", "cycles.", "<tag2>", "The", "OPTIMA", "Study", "represents", "an", "evaluation", "of", "ThermoDox", "in", "combination", "with", "a", "first", "line", "therapy,", "RFA,", "for", "newly", "diagnosed,", "intermediate", "stage", "HCC", "patients.", "<tag3>"], "wordsA": ["ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "was", "evaluated", "in", "these", "patients", "in", "up", "to", "six", "cycles."], "wordsB": ["The", "OPTIMA", "Study", "represents", "an", "evaluation", "of", "ThermoDox", "in", "combination", "with", "a", "first", "line", "therapy,", "RFA,", "for", "newly", "diagnosed,", "intermediate", "stage", "HCC", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006257137283682823, 0.626971960067749, 0.26468178629875183, 0.010065427049994469, 0.003970094956457615, 0.03380298987030983, 0.005466997157782316, 0.01741529442369938, 0.0061599561013281345, 0.017411377280950546, 0.013629287481307983, 0.009309639222919941, 0.4241980016231537, 0.5350313782691956, 0.37303870916366577, 0.2914159297943115, 0.0071734176017344, 0.09500256180763245, 0.08023073524236679, 0.34496012330055237, 0.2756849229335785, 0.35760435461997986, 0.19515760242938995, -1]}
{"idB": "749647_17_item1_p84_s2", "idA": "749647_16_item1_p74_s3", "sentA": "ThermoDox in combination with mild hyperthermia was evaluated in these patients in up to six cycles.", "sentB": "The OPTIMA Study represents an evaluation of ThermoDox in combination with a first line therapy, RFA, for newly diagnosed, intermediate stage HCC patients.", "type": 2, "words": ["<tag1>", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "was", "evaluated", "in", "these", "patients", "in", "up", "to", "six", "cycles.", "<tag2>", "The", "OPTIMA", "Study", "represents", "an", "evaluation", "of", "ThermoDox", "in", "combination", "with", "a", "first", "line", "therapy,", "RFA,", "for", "newly", "diagnosed,", "intermediate", "stage", "HCC", "patients.", "<tag3>"], "wordsA": ["ThermoDox", "in", "combination", "with", "mild", "hyperthermia", "was", "evaluated", "in", "these", "patients", "in", "up", "to", "six", "cycles."], "wordsB": ["The", "OPTIMA", "Study", "represents", "an", "evaluation", "of", "ThermoDox", "in", "combination", "with", "a", "first", "line", "therapy,", "RFA,", "for", "newly", "diagnosed,", "intermediate", "stage", "HCC", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006257137283682823, 0.626971960067749, 0.26468178629875183, 0.010065427049994469, 0.003970094956457615, 0.03380298987030983, 0.005466997157782316, 0.01741529442369938, 0.0061599561013281345, 0.017411377280950546, 0.013629287481307983, 0.009309639222919941, 0.4241980016231537, 0.5350313782691956, 0.37303870916366577, 0.2914159297943115, 0.0071734176017344, 0.09500256180763245, 0.08023073524236679, 0.34496012330055237, 0.2756849229335785, 0.35760435461997986, 0.19515760242938995, -1]}
{"idB": "749647_17_item1_p104_s0", "idA": "749647_16_item1_p75_s0", "sentA": "The Euro-DIGNITY Study The Company anticipates that a Phase II study of RadioTherapy, HyperThermia and ThermoDox to treat patients with local-regional recurrent chest wall breast cancer will be initiated by six to eight clinical sites located in Italy, Israel, the Netherlands, Poland and the Czech Republic (the Euro-DIGNITY Study).", "sentB": "The Company anticipates that a Phase II study of RadioTherapy, HyperThermia and ThermoDox to treat patients with local-regional recurrent chest wall breast cancer will be initiated by five to six clinical sites located in Italy, Israel, the Netherlands, Poland, and the Czech Republic (the Euro-DIGNITY Study).", "type": 2, "words": ["<tag1>", "The", "Euro-DIGNITY", "Study", "The", "Company", "anticipates", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "clinical", "sites", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study).", "<tag2>", "The", "Company", "anticipates", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "five", "to", "six", "clinical", "sites", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland,", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study).", "<tag3>"], "wordsA": ["The", "Euro-DIGNITY", "Study", "The", "Company", "anticipates", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "clinical", "sites", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study)."], "wordsB": ["The", "Company", "anticipates", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "five", "to", "six", "clinical", "sites", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland,", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0052169025875627995, 0.01975869946181774, 0.02212410420179367, 0.007223289459943771, 0.00699628097936511, 0.01142077799886465, 0.015399009920656681, 0.009878456592559814, 0.009752493351697922, 0.021022168919444084, 0.03579135239124298, 0.011607822962105274, 0.03125883638858795, 0.008562474511563778, 0.010393261909484863, 0.013551824726164341, 0.009835829958319664, 0.020604604855179787, 0.016839055344462395, 0.016954081133008003, 0.017667066305875778, 0.01540383417159319, 0.013667418621480465, 0.007296962663531303, 0.006244400981813669, 0.008220493793487549, 0.009065406396985054, 0.31226491928100586, 0.08336968719959259, 0.1869077831506729, 0.01982194371521473, 0.0352947860956192, 0.012023703195154667, 0.010363563895225525, 0.03286895155906677, 0.027198120951652527, 0.010308751836419106, 0.036166246980428696, 0.026534343138337135, 0.01383716706186533, 0.010828301310539246, 0.027174245566129684, 0.03814341127872467, 0.008508985862135887, 0.04842808097600937, 0.02933756448328495, -1]}
{"idB": "749647_17_item1_p29_s0", "idA": "749647_16_item1_p75_s0", "sentA": "The Euro-DIGNITY Study The Company anticipates that a Phase II study of RadioTherapy, HyperThermia and ThermoDox to treat patients with local-regional recurrent chest wall breast cancer will be initiated by six to eight clinical sites located in Italy, Israel, the Netherlands, Poland and the Czech Republic (the Euro-DIGNITY Study).", "sentB": "The Euro-DIGNITY Stud y. We anticipate that a Phase II study of RadioTherapy, HyperThermia and ThermoDox to treat patients with local-regional recurrent chest wall breast cancer will be initiated by five to six clinical sites located in Italy, Israel, Poland and the Czech Republic (the Euro-DIGNITY Study ).", "type": 2, "words": ["<tag1>", "The", "Euro-DIGNITY", "Study", "The", "Company", "anticipates", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "clinical", "sites", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study).", "<tag2>", "The", "Euro-DIGNITY", "Stud", "y.", "We", "anticipate", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "five", "to", "six", "clinical", "sites", "located", "in", "Italy,", "Israel,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study", ").", "<tag3>"], "wordsA": ["The", "Euro-DIGNITY", "Study", "The", "Company", "anticipates", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "six", "to", "eight", "clinical", "sites", "located", "in", "Italy,", "Israel,", "the", "Netherlands,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study)."], "wordsB": ["The", "Euro-DIGNITY", "Stud", "y.", "We", "anticipate", "that", "a", "Phase", "II", "study", "of", "RadioTherapy,", "HyperThermia", "and", "ThermoDox", "to", "treat", "patients", "with", "local-regional", "recurrent", "chest", "wall", "breast", "cancer", "will", "be", "initiated", "by", "five", "to", "six", "clinical", "sites", "located", "in", "Italy,", "Israel,", "Poland", "and", "the", "Czech", "Republic", "(the", "Euro-DIGNITY", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002296256134286523, 0.06370142847299576, 0.9536022543907166, 0.8629629015922546, 0.02405964396893978, 0.011075654067099094, 0.002860943553969264, 0.0021680849604308605, 0.0037807708140462637, 0.0038201732095330954, 0.005280850455164909, 0.002513760467991233, 0.005383293144404888, 0.008716018870472908, 0.002631818875670433, 0.005911786109209061, 0.002301348140463233, 0.003809246700257063, 0.004754870198667049, 0.002393009141087532, 0.004871613346040249, 0.004411370027810335, 0.003942349459975958, 0.0039980425499379635, 0.0039054967928677797, 0.003821458201855421, 0.0019992694724351168, 0.001984734321013093, 0.004018714651465416, 0.0030340682715177536, 0.2784860134124756, 0.06637416779994965, 0.2673913538455963, 0.03407411649823189, 0.04676448926329613, 0.003513162489980459, 0.002591869095340371, 0.01357033010572195, 0.008263915777206421, 0.009835867211222649, 0.00382787873968482, 0.003129178425297141, 0.008988392539322376, 0.009554407559335232, 0.0030456639360636473, 0.01002590637654066, 0.016842765733599663, 0.00034591523581184447, -1]}
{"idB": "749647_17_item1_p104_s1", "idA": "749647_16_item1_p75_s1", "sentA": "The Euro-DIGNITY Study is expected to commence in the second half of 2016 and should enroll up to 70 patients affected by recurrent breast adenocarcinoma on the chest wall with/without nodes over a period of two years.", "sentB": "The Euro-DIGNITY Study is expected to commence in 2017 and is expected to enroll up to 70 patients affected by recurrent breast adenocarcinoma on the chest wall with/without nodes over a period of two years.", "type": 2, "words": ["<tag1>", "The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "the", "second", "half", "of", "2016", "and", "should", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years.", "<tag2>", "The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "2017", "and", "is", "expected", "to", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years.", "<tag3>"], "wordsA": ["The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "the", "second", "half", "of", "2016", "and", "should", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years."], "wordsB": ["The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "2017", "and", "is", "expected", "to", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002537268213927746, 0.008428378030657768, 0.012887534685432911, 0.0025354463141411543, 0.006309602875262499, 0.0028859174344688654, 0.007618509698659182, 0.023453913629055023, 0.9758460521697998, 0.004883588291704655, 0.0027309509459882975, 0.003229808062314987, 0.0025271016638725996, 0.005707790609449148, 0.003285989398136735, 0.002845698269084096, 0.008092463947832584, 0.013409114442765713, 0.004083031322807074, 0.0027975409757345915, 0.004087850917130709, 0.003963572438806295, 0.0051055168733000755, 0.0024101347662508488, 0.002384791849181056, 0.0035051200538873672, 0.004008164629340172, 0.00940060243010521, 0.006437468342483044, 0.003274328541010618, 0.0030805584974586964, 0.003632335225120187, 0.0031552223954349756, 0.00420332932844758, 0.004667888395488262, -1]}
{"idB": "749647_17_item1_p29_s1", "idA": "749647_16_item1_p75_s1", "sentA": "The Euro-DIGNITY Study is expected to commence in the second half of 2016 and should enroll up to 70 patients affected by recurrent breast adenocarcinoma on the chest wall with/without nodes over a period of two years.", "sentB": "The Euro-DIGNITY Study is expected to commence in 2017 and is expected to enroll up to 70 patients affected by recurrent breast adenocarcinoma on the chest wall with/without nodes over a period of two years.", "type": 2, "words": ["<tag1>", "The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "the", "second", "half", "of", "2016", "and", "should", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years.", "<tag2>", "The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "2017", "and", "is", "expected", "to", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years.", "<tag3>"], "wordsA": ["The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "the", "second", "half", "of", "2016", "and", "should", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years."], "wordsB": ["The", "Euro-DIGNITY", "Study", "is", "expected", "to", "commence", "in", "2017", "and", "is", "expected", "to", "enroll", "up", "to", "70", "patients", "affected", "by", "recurrent", "breast", "adenocarcinoma", "on", "the", "chest", "wall", "with/without", "nodes", "over", "a", "period", "of", "two", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002537268213927746, 0.008428378030657768, 0.012887534685432911, 0.0025354463141411543, 0.006309602875262499, 0.0028859174344688654, 0.007618509698659182, 0.023453913629055023, 0.9758460521697998, 0.004883588291704655, 0.0027309509459882975, 0.003229808062314987, 0.0025271016638725996, 0.005707790609449148, 0.003285989398136735, 0.002845698269084096, 0.008092463947832584, 0.013409114442765713, 0.004083031322807074, 0.0027975409757345915, 0.004087850917130709, 0.003963572438806295, 0.0051055168733000755, 0.0024101347662508488, 0.002384791849181056, 0.0035051200538873672, 0.004008164629340172, 0.00940060243010521, 0.006437468342483044, 0.003274328541010618, 0.0030805584974586964, 0.003632335225120187, 0.0031552223954349756, 0.00420332932844758, 0.004667888395488262, -1]}
{"idB": "749647_17_item1_p107_s1", "idA": "749647_16_item1_p78_s1", "sentA": "CLSN Laboratories acquired all of EGEN s right, title and interest in and to substantially all of the assets of EGEN, including cash and cash equivalents, patents, trademarks and other intellectual property rights, clinical data, certain contracts, licenses and permits, equipment, furniture, office equipment, furnishings, supplies and other tangible personal property.", "sentB": "Pursuant to the Asset Purchase Agreement, CLSN Laboratories acquired all of EGEN s right, title and interest in and to substantially all of the assets of EGEN, including cash and cash equivalents, patents, trademarks and other intellectual property rights, clinical data, certain contracts, licenses and permits, equipment, furniture, office equipment, furnishings, supplies and other tangible personal property.", "type": 2, "words": ["<tag1>", "CLSN", "Laboratories", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property.", "<tag2>", "Pursuant", "to", "the", "Asset", "Purchase", "Agreement,", "CLSN", "Laboratories", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property.", "<tag3>"], "wordsA": ["CLSN", "Laboratories", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property."], "wordsB": ["Pursuant", "to", "the", "Asset", "Purchase", "Agreement,", "CLSN", "Laboratories", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0753449946641922, 0.04317227378487587, 0.03684063255786896, 0.33127841353416443, 0.34701988101005554, 0.1928005814552307, 0.12409168481826782, 0.1773310750722885, 0.3449040949344635, 0.07262507826089859, 0.06416955590248108, 0.06912195682525635, 0.05198123678565025, 0.06085006520152092, 0.04582451656460762, 0.04030559957027435, 0.039496973156929016, 0.02850259654223919, 0.037800002843141556, 0.032086387276649475, 0.07836370170116425, 0.03672058880329132, 0.04189453274011612, 0.049719639122486115, 0.05041909217834473, 0.03392220661044121, 0.06383442878723145, 0.029009385034441948, 0.04693156108260155, 0.031530074775218964, 0.052652645856142044, 0.047781702131032944, 0.051007989794015884, 0.05893442779779434, 0.03196723759174347, 0.031058236956596375, 0.052024781703948975, 0.049595627933740616, 0.042653679847717285, 0.0407152995467186, 0.07208655029535294, 0.0392485149204731, 0.06181936338543892, 0.054942935705184937, 0.04327143728733063, 0.05622738599777222, 0.051937948912382126, 0.06307518482208252, 0.05103962868452072, 0.06405127793550491, 0.06204044073820114, 0.051728323101997375, 0.03176405280828476, 0.033832110464572906, 0.05450773984193802, 0.048131197690963745, 0.057070162147283554, -1]}
{"idB": "749647_17_item1_p32_s1", "idA": "749647_16_item1_p78_s1", "sentA": "CLSN Laboratories acquired all of EGEN s right, title and interest in and to substantially all of the assets of EGEN, including cash and cash equivalents, patents, trademarks and other intellectual property rights, clinical data, certain contracts, licenses and permits, equipment, furniture, office equipment, furnishings, supplies and other tangible personal property.", "sentB": "We acquired all of EGEN s right, title and interest in and to substantially all of the assets of EGEN, including cash and cash equivalents, patents, trademarks and other intellectual property rights, clinical data, certain contracts, licenses and permits, equipment, furniture, office equipment, furnishings, supplies and other tangible personal property.", "type": 2, "words": ["<tag1>", "CLSN", "Laboratories", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property.", "<tag2>", "We", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property.", "<tag3>"], "wordsA": ["CLSN", "Laboratories", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property."], "wordsB": ["We", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.7893049120903015, 0.2282646745443344, 0.06938774138689041, 0.046781063079833984, 0.043037861585617065, 0.03317635506391525, 0.04209108650684357, 0.026056084781885147, 0.025437459349632263, 0.027894623577594757, 0.017119158059358597, 0.021350864320993423, 0.0188447255641222, 0.03186868131160736, 0.02054535038769245, 0.024567991495132446, 0.02298683673143387, 0.021116869524121284, 0.017367102205753326, 0.0281683336943388, 0.018265273422002792, 0.023633891716599464, 0.0194620992988348, 0.026908282190561295, 0.024523315951228142, 0.022347619757056236, 0.030117159709334373, 0.013578055426478386, 0.016270581632852554, 0.0285914596170187, 0.023414524272084236, 0.021532731130719185, 0.017228998243808746, 0.023524222895503044, 0.01894306391477585, 0.02431473694741726, 0.019975263625383377, 0.018449701368808746, 0.020586391910910606, 0.021033311262726784, 0.03518909588456154, 0.027807220816612244, 0.02583802305161953, 0.028755169361829758, 0.02433045022189617, 0.015917623415589333, 0.017904041334986687, 0.02631506323814392, 0.021905355155467987, 0.02201918140053749, -1]}
{"idB": "749647_17_item1_p108_s0", "idA": "749647_16_item1_p79_s0", "sentA": "The EGEN Purchase Agreement contains customary representations and warranties regarding EGEN and Celsion, covenants regarding the conduct of EGEN s business prior to the consummation of the Acquisition, indemnification provisions, termination and other provisions customary for transactions of this nature.", "sentB": "The Asset Purchase Agreement contains customary representations and warranties regarding EGEN and Celsion, covenants regarding the conduct of EGEN s business prior to the consummation of the Acquisition, indemnification provisions, termination and other provisions customary for transactions of this nature.", "type": 2, "words": ["<tag1>", "The", "EGEN", "Purchase", "Agreement", "contains", "customary", "representations", "and", "warranties", "regarding", "EGEN", "and", "Celsion,", "covenants", "regarding", "the", "conduct", "of", "EGEN", "s", "business", "prior", "to", "the", "consummation", "of", "the", "Acquisition,", "indemnification", "provisions,", "termination", "and", "other", "provisions", "customary", "for", "transactions", "of", "this", "nature.", "<tag2>", "The", "Asset", "Purchase", "Agreement", "contains", "customary", "representations", "and", "warranties", "regarding", "EGEN", "and", "Celsion,", "covenants", "regarding", "the", "conduct", "of", "EGEN", "s", "business", "prior", "to", "the", "consummation", "of", "the", "Acquisition,", "indemnification", "provisions,", "termination", "and", "other", "provisions", "customary", "for", "transactions", "of", "this", "nature.", "<tag3>"], "wordsA": ["The", "EGEN", "Purchase", "Agreement", "contains", "customary", "representations", "and", "warranties", "regarding", "EGEN", "and", "Celsion,", "covenants", "regarding", "the", "conduct", "of", "EGEN", "s", "business", "prior", "to", "the", "consummation", "of", "the", "Acquisition,", "indemnification", "provisions,", "termination", "and", "other", "provisions", "customary", "for", "transactions", "of", "this", "nature."], "wordsB": ["The", "Asset", "Purchase", "Agreement", "contains", "customary", "representations", "and", "warranties", "regarding", "EGEN", "and", "Celsion,", "covenants", "regarding", "the", "conduct", "of", "EGEN", "s", "business", "prior", "to", "the", "consummation", "of", "the", "Acquisition,", "indemnification", "provisions,", "termination", "and", "other", "provisions", "customary", "for", "transactions", "of", "this", "nature."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02489878237247467, 0.9364484548568726, 0.6952552795410156, 0.36228248476982117, 0.03091786615550518, 0.09303992241621017, 0.07215661555528641, 0.024159280583262444, 0.048798900097608566, 0.021890852600336075, 0.057089913636446, 0.020320294424891472, 0.042830344289541245, 0.03851177170872688, 0.021167200058698654, 0.017715418711304665, 0.03574015572667122, 0.020307978615164757, 0.08115589618682861, 0.0458655022084713, 0.04810785502195358, 0.02620808593928814, 0.021363822743296623, 0.020283475518226624, 0.04097064211964607, 0.016889778897166252, 0.01657022349536419, 0.05114683881402016, 0.06421292573213577, 0.02386651188135147, 0.0323556624352932, 0.01387551799416542, 0.017643678933382034, 0.017041170969605446, 0.019907932728528976, 0.013087606057524681, 0.02029506117105484, 0.016780437901616096, 0.018028130754828453, 0.03781314939260483, -1]}
{"idB": "749647_17_item1_p7_s0", "idA": "749647_16_item1_p7_s0", "sentA": "The Celsion Corporation ( Celsion or the Company ) brand and product names, including but not limited to Celsion , ThermoDox , EGEN , TheraPlas and TheraSilence contained in this document are trademarks, registered trademarks or service marks of Celsion Corporation or its subsidiary in the United States (U.S.) and certain other countries.", "sentB": "The Celsion Corporation ( Celsion or the Company ) brand and product names, including but not limited to Celsion , and ThermoDox contained in this document are trademarks, registered trademarks or service marks of Celsion Corporation or its subsidiary in the United States (U.S.) and certain other countries.", "type": 2, "words": ["<tag1>", "The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "ThermoDox", ",", "EGEN", ",", "TheraPlas", "and", "TheraSilence", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries.", "<tag2>", "The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "and", "ThermoDox", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries.", "<tag3>"], "wordsA": ["The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "ThermoDox", ",", "EGEN", ",", "TheraPlas", "and", "TheraSilence", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries."], "wordsB": ["The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "and", "ThermoDox", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01502874493598938, 0.28272148966789246, 0.1089058443903923, 0.10261380672454834, 0.15876467525959015, 0.05361086502671242, 0.03050643764436245, 0.0775260180234909, 0.0007682618452236056, 0.08337613940238953, 0.031243355944752693, 0.03732603043317795, 0.039790891110897064, 0.04332350566983223, 0.03567938134074211, 0.10125334560871124, 0.21692349016666412, 0.06324391067028046, 0.09495279937982559, 0.00026925725978799164, 0.01627490296959877, 0.14114803075790405, 0.03553516045212746, 0.026784809306263924, 0.027765242382884026, 0.05905052274465561, 0.04899853467941284, 0.48971855640411377, 0.15864261984825134, 0.2833409011363983, 0.019783739000558853, 0.11157194525003433, 0.11212468892335892, 0.025057652965188026, 0.11928219348192215, 0.07601533830165863, 0.034651290625333786, 0.04652188718318939, 0.09926870465278625, 0.02745477668941021, 0.026708567515015602, 0.06542456895112991, 0.07774064689874649, 0.12263168394565582, 0.018640611320734024, 0.035991061478853226, 0.03457913175225258, 0.05253792926669121, -1]}
{"idB": "749647_17_item1_p110_s0", "idA": "749647_16_item1_p81_s0", "sentA": "Ovarian Cancer Overview Ovarian cancer is the most lethal of gynecological malignancies among women with an overall five year survival rate of 45%.", "sentB": "Ovarian cancer is the most lethal of gynecological malignancies among women with an overall five year survival rate of 45%.", "type": 2, "words": ["<tag1>", "Ovarian", "Cancer", "Overview", "Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "45%.", "<tag2>", "Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "45%.", "<tag3>"], "wordsA": ["Ovarian", "Cancer", "Overview", "Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "45%."], "wordsB": ["Ovarian", "cancer", "is", "the", "most", "lethal", "of", "gynecological", "malignancies", "among", "women", "with", "an", "overall", "five", "year", "survival", "rate", "of", "45%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.47749289870262146, 0.41133421659469604, 0.07022301852703094, 0.04190601781010628, 0.23102085292339325, 0.7952542901039124, 0.0266106054186821, 0.06280018389225006, 0.04623791202902794, 0.016695495694875717, 0.05788131058216095, 0.008116382174193859, 0.008294311352074146, 0.024504592642188072, 0.021201569586992264, 0.022709928452968597, 0.02058270573616028, 0.017879165709018707, 0.011099730618298054, 0.05676554515957832, -1]}
{"idB": "749647_17_item1_p126_s2", "idA": "749647_16_item1_p83_s0", "sentA": "Mortality rates for ovarian cancer declined very little in the last forty years due to the unavailability of detection tests and improved treatments.", "sentB": "One patient in the second cohort was ineligible for debulking surgery due to a medical complication unrelated to the study or the study drug.", "type": 2, "words": ["<tag1>", "Mortality", "rates", "for", "ovarian", "cancer", "declined", "very", "little", "in", "the", "last", "forty", "years", "due", "to", "the", "unavailability", "of", "detection", "tests", "and", "improved", "treatments.", "<tag2>", "One", "patient", "in", "the", "second", "cohort", "was", "ineligible", "for", "debulking", "surgery", "due", "to", "a", "medical", "complication", "unrelated", "to", "the", "study", "or", "the", "study", "drug.", "<tag3>"], "wordsA": ["Mortality", "rates", "for", "ovarian", "cancer", "declined", "very", "little", "in", "the", "last", "forty", "years", "due", "to", "the", "unavailability", "of", "detection", "tests", "and", "improved", "treatments."], "wordsB": ["One", "patient", "in", "the", "second", "cohort", "was", "ineligible", "for", "debulking", "surgery", "due", "to", "a", "medical", "complication", "unrelated", "to", "the", "study", "or", "the", "study", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.19202755391597748, 0.26868191361427307, 0.004606094677001238, 0.004340844694525003, 0.025142965838313103, 0.0358317531645298, 0.04268818348646164, 0.508507490158081, 0.3039531707763672, 0.5479686260223389, 0.5255591869354248, 5.308844265528023e-05, 0.0036277766339480877, 0.003891662461683154, 0.02110223099589348, 0.022303689271211624, 0.011651312932372093, 0.007885483093559742, 0.005029332358390093, 0.01867501065135002, 0.006283717695623636, 0.004064416512846947, 0.01834123395383358, 0.020581480115652084, -1]}
{"idB": "749647_17_item1_p43_s2", "idA": "749647_16_item1_p83_s0", "sentA": "Mortality rates for ovarian cancer declined very little in the last forty years due to the unavailability of detection tests and improved treatments.", "sentB": "One patient in the second cohort was ineligible for debulking surgery due to a medical complication unrelated to the study or the study drug.", "type": 2, "words": ["<tag1>", "Mortality", "rates", "for", "ovarian", "cancer", "declined", "very", "little", "in", "the", "last", "forty", "years", "due", "to", "the", "unavailability", "of", "detection", "tests", "and", "improved", "treatments.", "<tag2>", "One", "patient", "in", "the", "second", "cohort", "was", "ineligible", "for", "debulking", "surgery", "due", "to", "a", "medical", "complication", "unrelated", "to", "the", "study", "or", "the", "study", "drug.", "<tag3>"], "wordsA": ["Mortality", "rates", "for", "ovarian", "cancer", "declined", "very", "little", "in", "the", "last", "forty", "years", "due", "to", "the", "unavailability", "of", "detection", "tests", "and", "improved", "treatments."], "wordsB": ["One", "patient", "in", "the", "second", "cohort", "was", "ineligible", "for", "debulking", "surgery", "due", "to", "a", "medical", "complication", "unrelated", "to", "the", "study", "or", "the", "study", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.19202755391597748, 0.26868191361427307, 0.004606094677001238, 0.004340844694525003, 0.025142965838313103, 0.0358317531645298, 0.04268818348646164, 0.508507490158081, 0.3039531707763672, 0.5479686260223389, 0.5255591869354248, 5.308844265528023e-05, 0.0036277766339480877, 0.003891662461683154, 0.02110223099589348, 0.022303689271211624, 0.011651312932372093, 0.007885483093559742, 0.005029332358390093, 0.01867501065135002, 0.006283717695623636, 0.004064416512846947, 0.01834123395383358, 0.020581480115652084, -1]}
{"idB": "749647_17_item1_p127_s2", "idA": "749647_16_item1_p86_s1", "sentA": "The overall response rate for these therapies is 10 to 20 percent with median overall survival of eleven to twelve months.", "sentB": "cPRs have been associated with a median overall survival of 72 months, which is more than three years longer than those who do not experience a cPR.", "type": 2, "words": ["<tag1>", "The", "overall", "response", "rate", "for", "these", "therapies", "is", "10", "to", "20", "percent", "with", "median", "overall", "survival", "of", "eleven", "to", "twelve", "months.", "<tag2>", "cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR.", "<tag3>"], "wordsA": ["The", "overall", "response", "rate", "for", "these", "therapies", "is", "10", "to", "20", "percent", "with", "median", "overall", "survival", "of", "eleven", "to", "twelve", "months."], "wordsB": ["cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.18655559420585632, 0.012024512514472008, 0.008569683879613876, 0.025748081505298615, 0.008245006203651428, 0.007184190675616264, 0.020822769030928612, 0.023172179237008095, 0.043389592319726944, 0.022151123732328415, 0.8586820960044861, 0.5572376251220703, 3.4943783248309046e-05, 0.0001869149273261428, 0.047708846628665924, 0.0696592703461647, 0.19882453978061676, 0.12493379414081573, 0.08138604462146759, 0.017136072739958763, 0.015654467046260834, 0.03557344153523445, 0.22228333353996277, 0.458276629447937, 0.29311516880989075, 0.09980668127536774, 0.08042328804731369, -1]}
{"idB": "749647_17_item1_p127_s3", "idA": "749647_16_item1_p86_s1", "sentA": "The overall response rate for these therapies is 10 to 20 percent with median overall survival of eleven to twelve months.", "sentB": "In addition, microPRs are seen in approximately 30% of patients, and are associated with a median overall survival of 38 months.", "type": 2, "words": ["<tag1>", "The", "overall", "response", "rate", "for", "these", "therapies", "is", "10", "to", "20", "percent", "with", "median", "overall", "survival", "of", "eleven", "to", "twelve", "months.", "<tag2>", "In", "addition,", "microPRs", "are", "seen", "in", "approximately", "30%", "of", "patients,", "and", "are", "associated", "with", "a", "median", "overall", "survival", "of", "38", "months.", "<tag3>"], "wordsA": ["The", "overall", "response", "rate", "for", "these", "therapies", "is", "10", "to", "20", "percent", "with", "median", "overall", "survival", "of", "eleven", "to", "twelve", "months."], "wordsB": ["In", "addition,", "microPRs", "are", "seen", "in", "approximately", "30%", "of", "patients,", "and", "are", "associated", "with", "a", "median", "overall", "survival", "of", "38", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007968347519636154, 0.009025780484080315, 0.6791925430297852, 0.014316339045763016, 0.018267057836055756, 0.022621508687734604, 0.04740648716688156, 0.5436078310012817, 0.028565894812345505, 0.07693198323249817, 9.372373460792005e-05, 0.003968315664678812, 0.011442666873335838, 0.005166975781321526, 0.003803106490522623, 0.01868976466357708, 0.020930541679263115, 0.038720082491636276, 0.021722180768847466, 0.8440383076667786, 0.38893669843673706, -1]}
{"idB": "749647_17_item1_p44_s2", "idA": "749647_16_item1_p86_s1", "sentA": "The overall response rate for these therapies is 10 to 20 percent with median overall survival of eleven to twelve months.", "sentB": "cPRs have been associated with a median overall survival of 72 months, which is more than three years longer than those who do not experience a cPR.", "type": 2, "words": ["<tag1>", "The", "overall", "response", "rate", "for", "these", "therapies", "is", "10", "to", "20", "percent", "with", "median", "overall", "survival", "of", "eleven", "to", "twelve", "months.", "<tag2>", "cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR.", "<tag3>"], "wordsA": ["The", "overall", "response", "rate", "for", "these", "therapies", "is", "10", "to", "20", "percent", "with", "median", "overall", "survival", "of", "eleven", "to", "twelve", "months."], "wordsB": ["cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.18655559420585632, 0.012024512514472008, 0.008569683879613876, 0.025748081505298615, 0.008245006203651428, 0.007184190675616264, 0.020822769030928612, 0.023172179237008095, 0.043389592319726944, 0.022151123732328415, 0.8586820960044861, 0.5572376251220703, 3.4943783248309046e-05, 0.0001869149273261428, 0.047708846628665924, 0.0696592703461647, 0.19882453978061676, 0.12493379414081573, 0.08138604462146759, 0.017136072739958763, 0.015654467046260834, 0.03557344153523445, 0.22228333353996277, 0.458276629447937, 0.29311516880989075, 0.09980668127536774, 0.08042328804731369, -1]}
{"idB": "749647_17_item1_p44_s3", "idA": "749647_16_item1_p86_s1", "sentA": "The overall response rate for these therapies is 10 to 20 percent with median overall survival of eleven to twelve months.", "sentB": "In addition, microPRs are seen in approximately 30% of patients, and are associated with a median overall survival of 38 months.", "type": 2, "words": ["<tag1>", "The", "overall", "response", "rate", "for", "these", "therapies", "is", "10", "to", "20", "percent", "with", "median", "overall", "survival", "of", "eleven", "to", "twelve", "months.", "<tag2>", "In", "addition,", "microPRs", "are", "seen", "in", "approximately", "30%", "of", "patients,", "and", "are", "associated", "with", "a", "median", "overall", "survival", "of", "38", "months.", "<tag3>"], "wordsA": ["The", "overall", "response", "rate", "for", "these", "therapies", "is", "10", "to", "20", "percent", "with", "median", "overall", "survival", "of", "eleven", "to", "twelve", "months."], "wordsB": ["In", "addition,", "microPRs", "are", "seen", "in", "approximately", "30%", "of", "patients,", "and", "are", "associated", "with", "a", "median", "overall", "survival", "of", "38", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007968347519636154, 0.009025780484080315, 0.6791925430297852, 0.014316339045763016, 0.018267057836055756, 0.022621508687734604, 0.04740648716688156, 0.5436078310012817, 0.028565894812345505, 0.07693198323249817, 9.372373460792005e-05, 0.003968315664678812, 0.011442666873335838, 0.005166975781321526, 0.003803106490522623, 0.01868976466357708, 0.020930541679263115, 0.038720082491636276, 0.021722180768847466, 0.8440383076667786, 0.38893669843673706, -1]}
{"idB": "749647_17_item1_p8_s0", "idA": "749647_16_item1_p8_s0", "sentA": "Celsion Corporation is a fully-integrated oncology drug development company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA- based therapies.", "sentB": "Celsion is a fully-integrated , development stage oncology drug company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA based therapies.", "type": 2, "words": ["<tag1>", "Celsion", "Corporation", "is", "a", "fully-integrated", "oncology", "drug", "development", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA-", "based", "therapies.", "<tag2>", "Celsion", "is", "a", "fully-integrated", ",", "development", "stage", "oncology", "drug", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA", "based", "therapies.", "<tag3>"], "wordsA": ["Celsion", "Corporation", "is", "a", "fully-integrated", "oncology", "drug", "development", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA-", "based", "therapies."], "wordsB": ["Celsion", "is", "a", "fully-integrated", ",", "development", "stage", "oncology", "drug", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA", "based", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6949665546417236, 0.023017065599560738, 0.013980207964777946, 0.14203333854675293, 0.0002541568537708372, 0.08362672477960587, 0.16688582301139832, 0.10576723515987396, 0.13894087076187134, 0.1944398134946823, 0.029510993510484695, 0.01916458085179329, 0.06061225384473801, 0.017557742074131966, 0.06830637902021408, 0.018254900351166725, 0.06474047899246216, 0.09704404324293137, 0.11422476917505264, 0.020104050636291504, 0.06621959805488586, 0.06754684448242188, 0.08710627257823944, 0.05578251928091049, 0.011863329447805882, 0.0804746150970459, 0.020903022959828377, 0.03280569985508919, -1]}
{"idB": "749647_17_item1_p8_s1", "idA": "749647_16_item1_p8_s1", "sentA": "Our lead product candidate is ThermoDox , a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in a Phase III clinical trial for the treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer (the DIGNITY Study).", "sentB": "Our lead product candidate is ThermoDox , a proprietary dosage form of doxorubicin based on a heat-activated liposomal platform technology, currently in a Phase III clinical trial for the treatment of non-resectable hepatocellular carcinoma ( HCC ), also known as primary liver cancer, and a Phase II clinical trial for recurrent chest wall breast cancer.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "dosage", "form", "of", "doxorubicin", "based", "on", "a", "heat-activated", "liposomal", "platform", "technology,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "non-resectable", "hepatocellular", "carcinoma", "(", "HCC", "),", "also", "known", "as", "primary", "liver", "cancer,", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "dosage", "form", "of", "doxorubicin", "based", "on", "a", "heat-activated", "liposomal", "platform", "technology,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "non-resectable", "hepatocellular", "carcinoma", "(", "HCC", "),", "also", "known", "as", "primary", "liver", "cancer,", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0021534489933401346, 0.007962288334965706, 0.007653420325368643, 0.013257671147584915, 0.002300182357430458, 0.00794906821101904, 9.853535448201001e-05, 0.0026546320877969265, 0.016226748004555702, 0.027313830330967903, 0.04863796755671501, 0.007173794321715832, 0.008932042866945267, 0.005048692226409912, 0.005978170782327652, 0.004582489375025034, 0.018868006765842438, 0.030340859666466713, 0.1225011944770813, 0.08274834603071213, 0.0023332927376031876, 0.0022239508107304573, 0.0020249062217772007, 0.004226073622703552, 0.004365011118352413, 0.005334313027560711, 0.01463304739445448, 0.0024666262324899435, 0.0026908654253929853, 0.025133734568953514, 0.022525658831000328, 0.917935311794281, 0.7567571997642517, 0.7721940875053406, 0.09063490480184555, 0.8521650433540344, 7.328558422159404e-05, 0.002616488840430975, 0.003654897678643465, 0.0024646008387207985, 0.005182091612368822, 0.007256265729665756, 0.009710465557873249, 0.0030792567413300276, 0.0019261423731222749, 0.00381010421551764, 0.0035237919073551893, 0.005934500135481358, 0.01478347647935152, 0.0023137915413826704, 0.003794484306126833, 0.0036228299140930176, 0.0033839053940027952, 0.004942708648741245, 0.00811819452792406, -1]}
{"idB": "749647_17_item1_p8_s2", "idA": "749647_16_item1_p8_s1", "sentA": "Our lead product candidate is ThermoDox , a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in a Phase III clinical trial for the treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer (the DIGNITY Study).", "sentB": "Our pipeline also includes GEN-1, a DNA-based immunotherapy currently in a Phase I clinical trial for the localized treatment of ovarian cancer and pre-clinical development for brain cancer.", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study).", "<tag2>", "Our", "pipeline", "also", "includes", "GEN-1,", "a", "DNA-based", "immunotherapy", "currently", "in", "a", "Phase", "I", "clinical", "trial", "for", "the", "localized", "treatment", "of", "ovarian", "cancer", "and", "pre-clinical", "development", "for", "brain", "cancer.", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study)", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study)."], "wordsB": ["Our", "pipeline", "also", "includes", "GEN-1,", "a", "DNA-based", "immunotherapy", "currently", "in", "a", "Phase", "I", "clinical", "trial", "for", "the", "localized", "treatment", "of", "ovarian", "cancer", "and", "pre-clinical", "development", "for", "brain", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009744906798005104, 0.08944427967071533, 0.004509741440415382, 0.022087475284934044, 0.35971036553382874, 0.011456051841378212, 0.299533486366272, 0.32132455706596375, 0.0017330195987597108, 0.0020243381150066853, 0.0019760383293032646, 0.013561014086008072, 0.04771870747208595, 0.014493428170681, 0.018890779465436935, 0.004994996823370457, 0.004958844278007746, 0.1147821918129921, 0.12873299419879913, 0.041187893599271774, 0.7140137553215027, 0.5115848183631897, 0.0004179915995337069, 0.1334715187549591, 0.048185352236032486, 0.037374962121248245, 0.5641680359840393, 0.49252650141716003, -1]}
{"idB": "749647_17_item1_p38_s0", "idA": "749647_16_item1_p8_s2", "sentA": "Second in our pipeline is GEN-1 (formerly known as EGEN-001), a DNA mediated immunotherapy for the localized treatment of ovarian and brain cancers.", "sentB": "GEN-1 is a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers by intraperitoneally administering an Interleukin-12 ( IL-12 ) plasmid formulated with our proprietary TheraPlas delivery system.", "type": 2, "words": ["<tag1>", "Second", "in", "our", "pipeline", "is", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA", "mediated", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers.", "<tag2>", "GEN-1", "is", "a", "DNA-based", "immunotherapeutic", "product", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers", "by", "intraperitoneally", "administering", "an", "Interleukin-12", "(", "IL-12", ")", "plasmid", "formulated", "with", "our", "proprietary", "TheraPlas", "delivery", "system.", "<tag3>"], "wordsA": ["Second", "in", "our", "pipeline", "is", "GEN-1", "(formerly", "known", "as", "EGEN-001),", "a", "DNA", "mediated", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers."], "wordsB": ["GEN-1", "is", "a", "DNA-based", "immunotherapeutic", "product", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers", "by", "intraperitoneally", "administering", "an", "Interleukin-12", "(", "IL-12", ")", "plasmid", "formulated", "with", "our", "proprietary", "TheraPlas", "delivery", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06082824617624283, 0.011289404705166817, 0.008859958499670029, 0.11181212216615677, 0.11103362590074539, 0.10658495128154755, 0.0030621998012065887, 0.004936001263558865, 0.005192788317799568, 0.005856620147824287, 0.0023627239279448986, 0.003941107075661421, 0.0026100396644324064, 0.004654064774513245, 0.005612878128886223, 0.009523744694888592, 0.19872649013996124, 0.2170860320329666, 0.05202239006757736, 0.5089377164840698, 0.07246633619070053, 0.37803012132644653, 0.1580761820077896, 0.29155150055885315, 0.008086073212325573, 0.0048473370261490345, 0.006898184772580862, 0.0216347835958004, 0.07080653309822083, 0.03965853899717331, 0.053591638803482056, -1]}
{"idB": "749647_17_item1_p119_s0", "idA": "749647_16_item1_p90_s0", "sentA": "Celsion s Approach Celsion s GEN-1 approach for IL-12 delivery is designed to achieve local concentrations of IL-12 at the tumor site with minimal increases in systemic circulation.", "sentB": "Celsion s GEN-1 approach for IL-12 delivery is designed to achieve local concentrations of IL-12 at the tumor site with minimal increases in systemic circulation.", "type": 2, "words": ["<tag1>", "Celsion", "s", "Approach", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation.", "<tag2>", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation.", "<tag3>"], "wordsA": ["Celsion", "s", "Approach", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation."], "wordsB": ["Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08363474160432816, 0.028815021738409996, 0.19993607699871063, 0.05453580617904663, 0.004273760598152876, 0.5120974183082581, 0.04291249439120293, 0.0039937617257237434, 0.007130241021513939, 0.004153751768171787, 0.005744543392211199, 0.01177989598363638, 0.01683243364095688, 0.014093701727688313, 0.44921058416366577, 0.003914329223334789, 0.004605675581842661, 0.009102770127356052, 0.00970936007797718, 0.007622151635587215, 0.48026469349861145, 0.24149303138256073, 0.014814769849181175, 0.025984449312090874, 0.029351146891713142, -1]}
{"idB": "749647_17_item1_p38_s1", "idA": "749647_16_item1_p90_s2", "sentA": "In this approach, our GEN-1 immunotherapy is combined with standard chemotherapy drugs to achieve better clinical outcome than with chemotherapy alone.", "sentB": "In this DNA-based approach, the immunotherapy is combined with a standard chemotherapy drug, which can potentially achieve better clinical outcomes than with chemotherapy alone.", "type": 2, "words": ["<tag1>", "In", "this", "approach,", "our", "GEN-1", "immunotherapy", "is", "combined", "with", "standard", "chemotherapy", "drugs", "to", "achieve", "better", "clinical", "outcome", "than", "with", "chemotherapy", "alone.", "<tag2>", "In", "this", "DNA-based", "approach,", "the", "immunotherapy", "is", "combined", "with", "a", "standard", "chemotherapy", "drug,", "which", "can", "potentially", "achieve", "better", "clinical", "outcomes", "than", "with", "chemotherapy", "alone.", "<tag3>"], "wordsA": ["In", "this", "approach,", "our", "GEN-1", "immunotherapy", "is", "combined", "with", "standard", "chemotherapy", "drugs", "to", "achieve", "better", "clinical", "outcome", "than", "with", "chemotherapy", "alone."], "wordsB": ["In", "this", "DNA-based", "approach,", "the", "immunotherapy", "is", "combined", "with", "a", "standard", "chemotherapy", "drug,", "which", "can", "potentially", "achieve", "better", "clinical", "outcomes", "than", "with", "chemotherapy", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002753201872110367, 0.008787238039076328, 0.9493697285652161, 0.2452688366174698, 0.001930720405653119, 0.19661450386047363, 0.0026397162582725286, 0.012831212021410465, 0.007260835263878107, 0.005954929627478123, 0.03101038746535778, 0.07297657430171967, 0.033511433750391006, 5.783347660326399e-05, 0.002133353613317013, 0.0038486961275339127, 0.0040208264254033566, 0.011750180274248123, 0.007354593835771084, 0.007521992549300194, 0.0035591996274888515, 0.0026708762161433697, 0.0106201758608222, 0.006669982802122831, -1]}
{"idB": "749647_17_item1_p38_s2", "idA": "749647_16_item1_p90_s3", "sentA": "Increases in IL-12 concentrations at the tumor site for several days (up to one week) after a single administration will create a potent immune environment against the tumor and a direct killing of the tumor with concomitant use of cytotoxic chemotherapy together will result in more robust and durable antitumor response than chemotherapy alone.", "sentB": "We believe that increases in IL-12 concentrations at tumor sites for several days after a single administration could create a potent immune environment against tumor activity and that a direct killing of the tumor with concomitant use of cytotoxic chemotherapy could result in a more robust and durable antitumor response than chemotherapy alone.", "type": 2, "words": ["<tag1>", "Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "(up", "to", "one", "week)", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "result", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone.", "<tag2>", "We", "believe", "that", "increases", "in", "IL-12", "concentrations", "at", "tumor", "sites", "for", "several", "days", "after", "a", "single", "administration", "could", "create", "a", "potent", "immune", "environment", "against", "tumor", "activity", "and", "that", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "could", "result", "in", "a", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone.", "<tag3>"], "wordsA": ["Increases", "in", "IL-12", "concentrations", "at", "the", "tumor", "site", "for", "several", "days", "(up", "to", "one", "week)", "after", "a", "single", "administration", "will", "create", "a", "potent", "immune", "environment", "against", "the", "tumor", "and", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "together", "will", "result", "in", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone."], "wordsB": ["We", "believe", "that", "increases", "in", "IL-12", "concentrations", "at", "tumor", "sites", "for", "several", "days", "after", "a", "single", "administration", "could", "create", "a", "potent", "immune", "environment", "against", "tumor", "activity", "and", "that", "a", "direct", "killing", "of", "the", "tumor", "with", "concomitant", "use", "of", "cytotoxic", "chemotherapy", "could", "result", "in", "a", "more", "robust", "and", "durable", "antitumor", "response", "than", "chemotherapy", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.23938770592212677, 0.16818487644195557, 0.0479993112385273, 0.07001714408397675, 0.02441171370446682, 0.08799557387828827, 0.06717478483915329, 0.017474524676799774, 0.055677901953458786, 0.09894394874572754, 0.013595789670944214, 0.03303445875644684, 0.04266616702079773, 0.017344405874609947, 0.019100071862339973, 0.06756219267845154, 0.06945045292377472, 0.013605288229882717, 0.014370112679898739, 0.013190054334700108, 0.019726494327187538, 0.03023046813905239, 0.0330330990254879, 0.018693428486585617, 0.10307707637548447, 0.1027008444070816, 0.0007457659230567515, 0.010973179712891579, 0.013008111156523228, 0.05072035267949104, 0.13203293085098267, 0.03260936960577965, 0.03209778666496277, 0.09986914694309235, 0.016883866861462593, 0.030312178656458855, 0.022161321714520454, 0.015515456907451153, 0.055413488298654556, 0.05358334258198738, 0.012589086778461933, 0.013134134002029896, 0.011178769171237946, 0.015139948576688766, 0.05758173391222954, 0.04820796102285385, 0.009474854916334152, 0.038422953337430954, 0.07711611688137054, 0.04511478915810585, 0.05843993276357651, 0.3115798234939575, 0.18728423118591309, -1]}
{"idB": "749647_17_item1_p120_s0", "idA": "749647_16_item1_p91_s0", "sentA": "GEN-1 OVATION Study We have initiated a Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study) at four clinical sites, including the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "sentB": "We have initiated a Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study) at four clinical sites, including the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "type": 2, "words": ["<tag1>", "GEN-1", "OVATION", "Study", "We", "have", "initiated", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study)", "at", "four", "clinical", "sites,", "including", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag2>", "We", "have", "initiated", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study)", "at", "four", "clinical", "sites,", "including", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag3>"], "wordsA": ["GEN-1", "OVATION", "Study", "We", "have", "initiated", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study)", "at", "four", "clinical", "sites,", "including", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "wordsB": ["We", "have", "initiated", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study)", "at", "four", "clinical", "sites,", "including", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03575414419174194, 0.0213080495595932, 0.04208901524543762, 0.01826198771595955, 0.038977425545454025, 0.03637333959341049, 0.048843201249837875, 0.02363976277410984, 0.036703310906887054, 0.016170164570212364, 0.3653807044029236, 0.033731814473867416, 0.055420927703380585, 0.03116501308977604, 0.021438997238874435, 0.08456644415855408, 0.034884028136730194, 0.05693421885371208, 0.012396177276968956, 0.08746460825204849, 0.05304085090756416, 0.04581628367304802, 0.014631630852818489, 0.046588920056819916, 0.04252322390675545, 0.01185797993093729, 0.025435911491513252, 0.03396490961313248, 0.0802680179476738, 0.020517341792583466, 0.018002217635512352, 0.14786997437477112, 0.06979161500930786, 0.12353651225566864, 0.022686250507831573, 0.0678546354174614, 0.08303773403167725, 0.10184480249881744, 0.05519124120473862, 0.07271255552768707, 0.09979264438152313, 0.1638178676366806, 0.02085312455892563, 0.06578892469406128, 0.07028752565383911, 0.014499041251838207, 0.01234013307839632, 0.0802839919924736, 0.11184482276439667, 0.033045630902051926, 0.13218753039836884, -1]}
{"idB": "749647_17_item1_p124_s2", "idA": "749647_16_item1_p91_s2", "sentA": "The trial is expected to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study combining GEN-1 with Avastin and Doxil .", "sentB": "Future studies of GEN-1 will include a Phase I/II study combining GEN-1 with Avastin and Doxil .", "type": 2, "words": ["<tag1>", "The", "trial", "is", "expected", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag2>", "Future", "studies", "of", "GEN-1", "will", "include", "a", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag3>"], "wordsA": ["The", "trial", "is", "expected", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "wordsB": ["Future", "studies", "of", "GEN-1", "will", "include", "a", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.31579381227493286, 0.2776038348674774, 0.02751792222261429, 0.04974416270852089, 0.012480697594583035, 0.025266112759709358, 0.007320993579924107, 0.02043108269572258, 0.011382139287889004, 0.06945722550153732, 0.03289877623319626, 0.6436492204666138, 0.011690177954733372, 0.01646999828517437, 0.006252904888242483, 0.013456958346068859, 9.02525061974302e-05, -1]}
{"idB": "749647_17_item1_p41_s4", "idA": "749647_16_item1_p91_s2", "sentA": "The trial is expected to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study combining GEN-1 with Avastin and Doxil .", "sentB": "Future studies of GEN-1 may include a Phase I/II study combining GEN-1 with Avastin and Doxil .", "type": 2, "words": ["<tag1>", "The", "trial", "is", "expected", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag2>", "Future", "studies", "of", "GEN-1", "may", "include", "a", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag3>"], "wordsA": ["The", "trial", "is", "expected", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "wordsB": ["Future", "studies", "of", "GEN-1", "may", "include", "a", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.3615327775478363, 0.29849880933761597, 0.027799976989626884, 0.05061596632003784, 0.019595520570874214, 0.0271346066147089, 0.006897407583892345, 0.020135650411248207, 0.010747871361672878, 0.060064710676670074, 0.030931195244193077, 0.5550119280815125, 0.010791436769068241, 0.015993259847164154, 0.005846246145665646, 0.012967662885785103, 9.549738751957193e-05, -1]}
{"idB": "749647_17_item1_p12_s1", "idA": "749647_16_item1_p91_s3", "sentA": "In addition, the OVATION Study establishes a unique opportunity to assess how cytokine-based compounds such as GEN-1, directly affects ovarian cancer cells and the tumor microenvironment in newly diagnosed patients.", "sentB": "Approximately 30% of newly diagnosed patients can be addressed with RFA alone.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affects", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients.", "<tag2>", "Approximately", "30%", "of", "newly", "diagnosed", "patients", "can", "be", "addressed", "with", "RFA", "alone.", "<tag3>"], "wordsA": ["In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affects", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients."], "wordsB": ["Approximately", "30%", "of", "newly", "diagnosed", "patients", "can", "be", "addressed", "with", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09641019254922867, 0.2811475098133087, 0.018555819988250732, 0.031156830489635468, 0.04870464652776718, 0.12382195144891739, 0.03954323008656502, 0.034915462136268616, 0.1051255539059639, 0.06869927793741226, 0.5305213332176208, 0.6688472032546997, -1]}
{"idB": "749647_17_item1_p85_s1", "idA": "749647_16_item1_p91_s3", "sentA": "In addition, the OVATION Study establishes a unique opportunity to assess how cytokine-based compounds such as GEN-1, directly affects ovarian cancer cells and the tumor microenvironment in newly diagnosed patients.", "sentB": "Approximately only 30% of newly diagnosed patients can be addressed with RFA alone.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affects", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients.", "<tag2>", "Approximately", "only", "30%", "of", "newly", "diagnosed", "patients", "can", "be", "addressed", "with", "RFA", "alone.", "<tag3>"], "wordsA": ["In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affects", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients."], "wordsB": ["Approximately", "only", "30%", "of", "newly", "diagnosed", "patients", "can", "be", "addressed", "with", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04753745719790459, 0.1438068449497223, 0.4622603952884674, 0.020478680729866028, 0.035329919308423996, 0.05507552623748779, 0.1201980784535408, 0.08643323928117752, 0.06398553401231766, 0.11366036534309387, 0.08541331440210342, 0.5077508091926575, 0.5861208438873291, -1]}
{"idB": "749647_17_item1_p120_s4", "idA": "749647_16_item1_p91_s4", "sentA": "The study is designed to characterize the nature of the immune response triggered by GEN-1 at various levels of the patients immune system, including:", "sentB": "The study is designed to characterize the nature of the immune response triggered by GEN-1 at various levels of the patient s immune system, including:", "type": 2, "words": ["<tag1>", "The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patients", "immune", "system,", "including:", "<tag2>", "The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patient", "s", "immune", "system,", "including:", "<tag3>"], "wordsA": ["The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patients", "immune", "system,", "including:"], "wordsB": ["The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patient", "s", "immune", "system,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007409561891108751, 0.05315801501274109, 0.008594679646193981, 0.019049063324928284, 0.010092543438076973, 0.05169792100787163, 0.013756145723164082, 0.04931684210896492, 0.015616334043443203, 0.014935378916561604, 0.18398526310920715, 0.19439268112182617, 0.05775550752878189, 0.024965615943074226, 0.12614792585372925, 0.020090771839022636, 0.03603103756904602, 0.06155954301357269, 0.022850902751088142, 0.02868693321943283, 0.7898293137550354, 0.619219183921814, 0.3788664937019348, 0.3021429479122162, 0.12506414949893951, -1]}
{"idB": "749647_17_item1_p127_s1", "idA": "749647_16_item1_p94_s0", "sentA": "On February 12, 2016, we announced the completion of enrollment of the first cohort of patients in the OVATION Study combining GEN-1, the Company s DNA-based immunotherapy, with the standard of care for the treatment of newly-diagnosed ovarian cancer patients who will undergo neoadjuvant chemotherapy followed by surgical resection of their tumor.", "sentB": "These data compare favorably to historical data, which indicate that cPRs are typically seen in less than 7% of patients receiving neoadjuvant chemotherapy followed by surgical resection.", "type": 2, "words": ["<tag1>", "On", "February", "12,", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "patients", "in", "the", "OVATION", "Study", "combining", "GEN-1,", "the", "Company", "s", "DNA-based", "immunotherapy,", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "ovarian", "cancer", "patients", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection", "of", "their", "tumor.", "<tag2>", "These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection.", "<tag3>"], "wordsA": ["On", "February", "12,", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "patients", "in", "the", "OVATION", "Study", "combining", "GEN-1,", "the", "Company", "s", "DNA-based", "immunotherapy,", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "ovarian", "cancer", "patients", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection", "of", "their", "tumor."], "wordsB": ["These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018773173913359642, 0.16352134943008423, 0.12467905133962631, 0.040435630828142166, 0.017109109088778496, 0.10573475062847137, 0.10502593964338303, 0.008144260384142399, 0.016778990626335144, 0.009793147444725037, 0.3825698792934418, 0.037600889801979065, 0.052936241030693054, 0.05216694995760918, 0.04423583671450615, 0.39476215839385986, 0.43943995237350464, 0.5413592457771301, 0.08517272770404816, 0.23412664234638214, 0.060790274292230606, 0.03216499090194702, 0.044729385524988174, 0.009676387533545494, 0.004248474258929491, 0.022348996251821518, 0.025220312178134918, -1]}
{"idB": "749647_17_item1_p44_s1", "idA": "749647_16_item1_p94_s0", "sentA": "On February 12, 2016, we announced the completion of enrollment of the first cohort of patients in the OVATION Study combining GEN-1, the Company s DNA-based immunotherapy, with the standard of care for the treatment of newly-diagnosed ovarian cancer patients who will undergo neoadjuvant chemotherapy followed by surgical resection of their tumor.", "sentB": "These data compare favorably to historical data, which indicate that cPRs are typically seen in less than 7% of patients receiving neoadjuvant chemotherapy followed by surgical resection.", "type": 2, "words": ["<tag1>", "On", "February", "12,", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "patients", "in", "the", "OVATION", "Study", "combining", "GEN-1,", "the", "Company", "s", "DNA-based", "immunotherapy,", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "ovarian", "cancer", "patients", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection", "of", "their", "tumor.", "<tag2>", "These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection.", "<tag3>"], "wordsA": ["On", "February", "12,", "2016,", "we", "announced", "the", "completion", "of", "enrollment", "of", "the", "first", "cohort", "of", "patients", "in", "the", "OVATION", "Study", "combining", "GEN-1,", "the", "Company", "s", "DNA-based", "immunotherapy,", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "ovarian", "cancer", "patients", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection", "of", "their", "tumor."], "wordsB": ["These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018773173913359642, 0.16352134943008423, 0.12467905133962631, 0.040435630828142166, 0.017109109088778496, 0.10573475062847137, 0.10502593964338303, 0.008144260384142399, 0.016778990626335144, 0.009793147444725037, 0.3825698792934418, 0.037600889801979065, 0.052936241030693054, 0.05216694995760918, 0.04423583671450615, 0.39476215839385986, 0.43943995237350464, 0.5413592457771301, 0.08517272770404816, 0.23412664234638214, 0.060790274292230606, 0.03216499090194702, 0.044729385524988174, 0.009676387533545494, 0.004248474258929491, 0.022348996251821518, 0.025220312178134918, -1]}
{"idB": "749647_17_item1_p128_s0", "idA": "749647_16_item1_p94_s2", "sentA": "Both patients reported stable disease with a drop in their cancer antigen 125 (CA-125) protein levels of 89% and 98% respectively.", "sentB": "All eleven patients who completed treatment follow-up experienced a dramatic (greater than 90%) drop in their CA-125 protein levels as of their most recent study visit.", "type": 2, "words": ["<tag1>", "Both", "patients", "reported", "stable", "disease", "with", "a", "drop", "in", "their", "cancer", "antigen", "125", "(CA-125)", "protein", "levels", "of", "89%", "and", "98%", "respectively.", "<tag2>", "All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit.", "<tag3>"], "wordsA": ["Both", "patients", "reported", "stable", "disease", "with", "a", "drop", "in", "their", "cancer", "antigen", "125", "(CA-125)", "protein", "levels", "of", "89%", "and", "98%", "respectively."], "wordsB": ["All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10978322476148605, 0.2906780242919922, 0.13303062319755554, 0.010868920013308525, 0.08147639036178589, 0.10538876801729202, 0.06524421274662018, 0.05034260079264641, 0.016476556658744812, 0.13419827818870544, 0.16295208036899567, 0.15536463260650635, 0.5408898591995239, 0.16989542543888092, 0.02741875685751438, 0.021085912361741066, 0.3504070043563843, 0.15709252655506134, 0.12356127798557281, 0.00308150309138, 0.0031851669773459435, 0.004599811974912882, 0.013494492508471012, 0.009685124270617962, 0.0199724193662405, 0.02074887417256832, -1]}
{"idB": "749647_17_item1_p45_s0", "idA": "749647_16_item1_p94_s2", "sentA": "Both patients reported stable disease with a drop in their cancer antigen 125 (CA-125) protein levels of 89% and 98% respectively.", "sentB": "All eleven patients who completed treatment follow-up experienced a dramatic (greater than 90%) drop in their CA-125 protein levels as of their most recent study visit.", "type": 2, "words": ["<tag1>", "Both", "patients", "reported", "stable", "disease", "with", "a", "drop", "in", "their", "cancer", "antigen", "125", "(CA-125)", "protein", "levels", "of", "89%", "and", "98%", "respectively.", "<tag2>", "All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit.", "<tag3>"], "wordsA": ["Both", "patients", "reported", "stable", "disease", "with", "a", "drop", "in", "their", "cancer", "antigen", "125", "(CA-125)", "protein", "levels", "of", "89%", "and", "98%", "respectively."], "wordsB": ["All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10978322476148605, 0.2906780242919922, 0.13303062319755554, 0.010868920013308525, 0.08147639036178589, 0.10538876801729202, 0.06524421274662018, 0.05034260079264641, 0.016476556658744812, 0.13419827818870544, 0.16295208036899567, 0.15536463260650635, 0.5408898591995239, 0.16989542543888092, 0.02741875685751438, 0.021085912361741066, 0.3504070043563843, 0.15709252655506134, 0.12356127798557281, 0.00308150309138, 0.0031851669773459435, 0.004599811974912882, 0.013494492508471012, 0.009685124270617962, 0.0199724193662405, 0.02074887417256832, -1]}
{"idB": "749647_17_item1_p129_s0", "idA": "749647_16_item1_p94_s3", "sentA": "CA-125 is used to monitor certain cancers during and after treatment and is present in greater concentrations in ovarian cancer cells than in other cells.", "sentB": "CA-125 is used to monitor certain cancers during and after treatment.", "type": 2, "words": ["<tag1>", "CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells.", "<tag2>", "CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment.", "<tag3>"], "wordsA": ["CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells."], "wordsB": ["CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4979909360408783, 0.0920979455113411, 0.14866048097610474, 0.05204508453607559, 0.1480407863855362, 0.19223830103874207, 0.26641854643821716, 0.05704917386174202, 0.04508576914668083, 0.11868488788604736, 0.2338670790195465, -1]}
{"idB": "749647_17_item1_p129_s1", "idA": "749647_16_item1_p94_s3", "sentA": "CA-125 is used to monitor certain cancers during and after treatment and is present in greater concentrations in ovarian cancer cells than in other cells.", "sentB": "CA-125 is present in greater concentrations in ovarian cancer cells than in other cells.", "type": 2, "words": ["<tag1>", "CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells.", "<tag2>", "CA-125", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells.", "<tag3>"], "wordsA": ["CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells."], "wordsB": ["CA-125", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05926137790083885, 0.02897331677377224, 0.06061672419309616, 0.05131009966135025, 0.936522364616394, 0.4251711368560791, 0.02467007003724575, 0.04926031082868576, 0.03703158721327782, 0.05532002076506615, 0.03932277858257294, 0.03797437623143196, 0.05047924071550369, 0.07023689895868301, -1]}
{"idB": "749647_17_item1_p46_s0", "idA": "749647_16_item1_p94_s3", "sentA": "CA-125 is used to monitor certain cancers during and after treatment and is present in greater concentrations in ovarian cancer cells than in other cells.", "sentB": "CA-125 is used to monitor certain cancers during and after treatment.", "type": 2, "words": ["<tag1>", "CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells.", "<tag2>", "CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment.", "<tag3>"], "wordsA": ["CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells."], "wordsB": ["CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4979909360408783, 0.0920979455113411, 0.14866048097610474, 0.05204508453607559, 0.1480407863855362, 0.19223830103874207, 0.26641854643821716, 0.05704917386174202, 0.04508576914668083, 0.11868488788604736, 0.2338670790195465, -1]}
{"idB": "749647_17_item1_p46_s1", "idA": "749647_16_item1_p94_s3", "sentA": "CA-125 is used to monitor certain cancers during and after treatment and is present in greater concentrations in ovarian cancer cells than in other cells.", "sentB": "CA-125 is present in greater concentrations in ovarian cancer cells than in other cells.", "type": 2, "words": ["<tag1>", "CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells.", "<tag2>", "CA-125", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells.", "<tag3>"], "wordsA": ["CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment", "and", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells."], "wordsB": ["CA-125", "is", "present", "in", "greater", "concentrations", "in", "ovarian", "cancer", "cells", "than", "in", "other", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05926137790083885, 0.02897331677377224, 0.06061672419309616, 0.05131009966135025, 0.936522364616394, 0.4251711368560791, 0.02467007003724575, 0.04926031082868576, 0.03703158721327782, 0.05532002076506615, 0.03932277858257294, 0.03797437623143196, 0.05047924071550369, 0.07023689895868301, -1]}
{"idB": "749647_17_item1_p126_s0", "idA": "749647_16_item1_p94_s5", "sentA": "Both patients CA-125 levels were below the normal healthy level of 35 U/mL. In addition, both patients experienced successful surgical resections of their tumors with one patient reporting a R0 resection which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed.", "sentB": "Eleven patients had successful resections of their tumors, with six (6) patients having an R0 resection, which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed, and four (4) patients with a R1 resection, indicating microscopic residual tumor.", "type": 2, "words": ["<tag1>", "Both", "patients", "CA-125", "levels", "were", "below", "the", "normal", "healthy", "level", "of", "35", "U/mL.", "In", "addition,", "both", "patients", "experienced", "successful", "surgical", "resections", "of", "their", "tumors", "with", "one", "patient", "reporting", "a", "R0", "resection", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed.", "<tag2>", "Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor.", "<tag3>"], "wordsA": ["Both", "patients", "CA-125", "levels", "were", "below", "the", "normal", "healthy", "level", "of", "35", "U/mL.", "In", "addition,", "both", "patients", "experienced", "successful", "surgical", "resections", "of", "their", "tumors", "with", "one", "patient", "reporting", "a", "R0", "resection", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed."], "wordsB": ["Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8963205218315125, 0.3927229940891266, 0.008954121731221676, 0.020565034821629524, 0.02163226529955864, 0.0027491918299347162, 0.002953293966129422, 0.013422267511487007, 0.007622404024004936, 0.7065940499305725, 0.44782426953315735, 0.31339871883392334, 0.012708676978945732, 0.0033364980481565, 0.01845160499215126, 0.009939083829522133, 5.931325722485781e-05, 0.0018058358691632748, 0.0014041534159332514, 0.0031029239762574434, 0.004213298670947552, 0.007759177591651678, 0.0013626833679154515, 0.0014014561893418431, 0.0077180806547403336, 0.005669187288731337, 0.002926953136920929, 0.0074418047443032265, 0.013458850793540478, 0.006046819966286421, 0.002403727499768138, 0.002094605704769492, 0.006205663550645113, 0.008473385125398636, 6.81806995999068e-05, 0.6099970936775208, 0.3925296664237976, 0.26314660906791687, 0.002824443858116865, 0.0024569411762058735, 0.16457240283489227, 0.027986660599708557, 0.0061204694211483, 0.01643200032413006, 0.10062634199857712, 0.05197249352931976, -1]}
{"idB": "749647_17_item1_p43_s0", "idA": "749647_16_item1_p94_s5", "sentA": "Both patients CA-125 levels were below the normal healthy level of 35 U/mL. In addition, both patients experienced successful surgical resections of their tumors with one patient reporting a R0 resection which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed.", "sentB": "Eleven patients had successful resections of their tumors, with six (6) patients having an R0 resection, which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed, and four (4) patients with a R1 resection, indicating microscopic residual tumor.", "type": 2, "words": ["<tag1>", "Both", "patients", "CA-125", "levels", "were", "below", "the", "normal", "healthy", "level", "of", "35", "U/mL.", "In", "addition,", "both", "patients", "experienced", "successful", "surgical", "resections", "of", "their", "tumors", "with", "one", "patient", "reporting", "a", "R0", "resection", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed.", "<tag2>", "Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor.", "<tag3>"], "wordsA": ["Both", "patients", "CA-125", "levels", "were", "below", "the", "normal", "healthy", "level", "of", "35", "U/mL.", "In", "addition,", "both", "patients", "experienced", "successful", "surgical", "resections", "of", "their", "tumors", "with", "one", "patient", "reporting", "a", "R0", "resection", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed."], "wordsB": ["Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8963205218315125, 0.3927229940891266, 0.008954121731221676, 0.020565034821629524, 0.02163226529955864, 0.0027491918299347162, 0.002953293966129422, 0.013422267511487007, 0.007622404024004936, 0.7065940499305725, 0.44782426953315735, 0.31339871883392334, 0.012708676978945732, 0.0033364980481565, 0.01845160499215126, 0.009939083829522133, 5.931325722485781e-05, 0.0018058358691632748, 0.0014041534159332514, 0.0031029239762574434, 0.004213298670947552, 0.007759177591651678, 0.0013626833679154515, 0.0014014561893418431, 0.0077180806547403336, 0.005669187288731337, 0.002926953136920929, 0.0074418047443032265, 0.013458850793540478, 0.006046819966286421, 0.002403727499768138, 0.002094605704769492, 0.006205663550645113, 0.008473385125398636, 6.81806995999068e-05, 0.6099970936775208, 0.3925296664237976, 0.26314660906791687, 0.002824443858116865, 0.0024569411762058735, 0.16457240283489227, 0.027986660599708557, 0.0061204694211483, 0.01643200032413006, 0.10062634199857712, 0.05197249352931976, -1]}
{"idB": "749647_17_item1_p123_s1", "idA": "749647_16_item1_p95_s0", "sentA": "The OVATION Study will continue into 2016 at higher doses of GEN-1 with the goal to identify a safe, tolerable and therapeutically active dose of GEN-1 by recruiting and maximizing an immune response.", "sentB": "The OVATION Study is designed to enroll three to six patients per dose cohort and will continue into 2017 with the goal to identify a safe, tolerable and therapeutically active dose of GEN-1 by recruiting and maximizing an immune response.", "type": 2, "words": ["<tag1>", "The", "OVATION", "Study", "will", "continue", "into", "2016", "at", "higher", "doses", "of", "GEN-1", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response.", "<tag2>", "The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "continue", "into", "2017", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response.", "<tag3>"], "wordsA": ["The", "OVATION", "Study", "will", "continue", "into", "2016", "at", "higher", "doses", "of", "GEN-1", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response."], "wordsB": ["The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "continue", "into", "2017", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0017520005349069834, 0.008425779640674591, 0.01623186469078064, 0.0016892312560230494, 0.009295564144849777, 0.006731177214533091, 0.11246566474437714, 0.8019758462905884, 0.25664377212524414, 0.8861512541770935, 0.6626182794570923, 0.034025244414806366, 0.05059139057993889, 0.016851050779223442, 0.00018724333494901657, 0.0016788577195256948, 0.003564629005268216, 0.006145628169178963, 0.18666958808898926, 0.002234366722404957, 0.0045957304537296295, 0.002795075299218297, 0.0016572087770327926, 0.0026760203763842583, 0.0016585743287578225, 0.0027192337438464165, 0.003047277219593525, 0.0033544034231454134, 0.0027521096635609865, 0.0035399894695729017, 0.007210460491478443, 0.0023462711833417416, 0.007379170041531324, 0.001637641922570765, 0.0026525144930928946, 0.0020823196973651648, 0.0025271535851061344, 0.0018697271589189768, 0.0029181656427681446, 0.0032669352367520332, -1]}
{"idB": "749647_17_item1_p136_s0", "idA": "749647_16_item1_p96_s0", "sentA": "GEN-1 + Avastin + Doxil Combination Study in Platinum Resistant Ovarian Cancer In April 2015, we announced plans to expand our ovarian cancer development program to include a Phase 1 dose escalating trial evaluating GEN-1 in combination with Avastin and Doxil in platinum-resistant ovarian cancer patients.", "sentB": "In April 2015, we announced plans to expand our ovarian cancer development program to include a Phase 1 dose escalating trial evaluating GEN-1 in combination with Avastin and Doxil in platinum-resistant ovarian cancer patients.", "type": 2, "words": ["<tag1>", "GEN-1", "+", "Avastin", "+", "Doxil", "Combination", "Study", "in", "Platinum", "Resistant", "Ovarian", "Cancer", "In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients.", "<tag2>", "In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients.", "<tag3>"], "wordsA": ["GEN-1", "+", "Avastin", "+", "Doxil", "Combination", "Study", "in", "Platinum", "Resistant", "Ovarian", "Cancer", "In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients."], "wordsB": ["In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.026856431737542152, 0.05040503293275833, 0.0626019686460495, 0.031866271048784256, 0.022237611934542656, 0.03832288458943367, 0.014008223079144955, 0.043779466301202774, 0.018517296761274338, 0.16151252388954163, 0.039872586727142334, 0.0328473336994648, 0.034623485058546066, 0.01303445640951395, 0.012555025517940521, 0.016464222222566605, 0.05200614780187607, 0.6907451748847961, 0.062401942908763885, 0.03527494892477989, 0.044368330389261246, 0.0205362681299448, 0.13507819175720215, 0.025845127180218697, 0.04544574022293091, 0.04526616260409355, 0.08673985302448273, 0.022748319432139397, 0.07119011878967285, 0.008050126023590565, 0.2652221620082855, 0.03290097415447235, 0.01965237222611904, 0.03159943222999573, -1]}
{"idB": "749647_17_item1_p8_s4", "idA": "749647_16_item1_p9_s0", "sentA": "We have three platform technologies providing the basis for the future development of a range of therapeutics for difficult-to-treat forms of cancer including: Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat, TheraPlas, a novel nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer RNA With these technologies we are working to develop and commercialize more efficient, effective and targeted oncology therapies that maximize efficacy while minimizing side-effects common to cancer treatments.", "sentB": "We are working to develop and commercialize more efficient, effective and targeted oncology therapies based on our technologies, with the goal of developing novel therapeutics that maximize efficacy while minimizing side-effects common to cancer treatments.", "type": 2, "words": ["<tag1>", "We", "have", "three", "platform", "technologies", "providing", "the", "basis", "for", "the", "future", "development", "of", "a", "range", "of", "therapeutics", "for", "difficult-to-treat", "forms", "of", "cancer", "including:", "Lysolipid", "Thermally", "Sensitive", "Liposomes,", "a", "heat", "sensitive", "liposomal", "based", "dosage", "form", "that", "targets", "disease", "with", "known", "therapeutics", "in", "the", "presence", "of", "mild", "heat,", "TheraPlas,", "a", "novel", "nucleic", "acid-based", "treatment", "for", "local", "transfection", "of", "therapeutic", "plasmids,", "and", "TheraSilence,", "a", "systemic", "dosage", "form", "for", "lung", "directed", "anti-cancer", "RNA", "With", "these", "technologies", "we", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments.", "<tag2>", "We", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "based", "on", "our", "technologies,", "with", "the", "goal", "of", "developing", "novel", "therapeutics", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments.", "<tag3>"], "wordsA": ["We", "have", "three", "platform", "technologies", "providing", "the", "basis", "for", "the", "future", "development", "of", "a", "range", "of", "therapeutics", "for", "difficult-to-treat", "forms", "of", "cancer", "including:", "Lysolipid", "Thermally", "Sensitive", "Liposomes,", "a", "heat", "sensitive", "liposomal", "based", "dosage", "form", "that", "targets", "disease", "with", "known", "therapeutics", "in", "the", "presence", "of", "mild", "heat,", "TheraPlas,", "a", "novel", "nucleic", "acid-based", "treatment", "for", "local", "transfection", "of", "therapeutic", "plasmids,", "and", "TheraSilence,", "a", "systemic", "dosage", "form", "for", "lung", "directed", "anti-cancer", "RNA", "With", "these", "technologies", "we", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments."], "wordsB": ["We", "are", "working", "to", "develop", "and", "commercialize", "more", "efficient,", "effective", "and", "targeted", "oncology", "therapies", "based", "on", "our", "technologies,", "with", "the", "goal", "of", "developing", "novel", "therapeutics", "that", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008824920281767845, 0.007127129007130861, 0.02135806530714035, 0.008852420374751091, 0.01818671263754368, 0.0062499335035681725, 0.015704071149230003, 0.023427067324519157, 0.02699681743979454, 0.012612580321729183, 0.004576222505420446, 0.016948215663433075, 0.1484675407409668, 0.07215110957622528, 0.00621318444609642, 0.008278347551822662, 0.011630658060312271, 0.030451029539108276, 0.0008293853024952114, 0.001173265976831317, 0.005135901737958193, 0.005054189823567867, 0.011994324624538422, 0.011306151747703552, 0.02831883728504181, 0.006273632403463125, 0.013812734745442867, 0.0105171799659729, 0.004867754876613617, 0.006391784641891718, 0.006724772974848747, 0.0036931727081537247, 0.0033600544556975365, 0.013680929318070412, 0.0270624328404665, -1]}
{"idB": "749647_18_item1_p0_s0", "idA": "749647_17_item1_p0_s0", "sentA": "Certain of the statements contained in this Annual Report on Form 10-K are forward-looking and constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.", "sentB": "Certain of the statements contained in this Annual Report on Form 10-K are forward-looking and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act ) and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act ) .", "type": 2, "words": ["<tag1>", "Certain", "of", "the", "statements", "contained", "in", "this", "Annual", "Report", "on", "Form", "10-K", "are", "forward-looking", "and", "constitute", "forward-looking", "statements", "within", "the", "meaning", "of", "the", "Private", "Securities", "Litigation", "Reform", "Act", "of", "1995.", "<tag2>", "Certain", "of", "the", "statements", "contained", "in", "this", "Annual", "Report", "on", "Form", "10-K", "are", "forward-looking", "and", "constitute", "forward-looking", "statements", "within", "the", "meaning", "of", "Section", "27A", "of", "the", "Securities", "Act", "of", "1933,", "as", "amended", "(the", "Securities", "Act", ")", "and", "Section", "21E", "of", "the", "Securities", "Exchange", "Act", "of", "1934,", "as", "amended", "(the", "Exchange", "Act", ")", ".", "<tag3>"], "wordsA": ["Certain", "of", "the", "statements", "contained", "in", "this", "Annual", "Report", "on", "Form", "10-K", "are", "forward-looking", "and", "constitute", "forward-looking", "statements", "within", "the", "meaning", "of", "the", "Private", "Securities", "Litigation", "Reform", "Act", "of", "1995."], "wordsB": ["Certain", "of", "the", "statements", "contained", "in", "this", "Annual", "Report", "on", "Form", "10-K", "are", "forward-looking", "and", "constitute", "forward-looking", "statements", "within", "the", "meaning", "of", "Section", "27A", "of", "the", "Securities", "Act", "of", "1933,", "as", "amended", "(the", "Securities", "Act", ")", "and", "Section", "21E", "of", "the", "Securities", "Exchange", "Act", "of", "1934,", "as", "amended", "(the", "Exchange", "Act", ")", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007358180824667215, 0.002256362233310938, 0.0017787563847377896, 0.021941732615232468, 0.004855262115597725, 0.0017626237822696567, 0.002008340787142515, 0.004097237251698971, 0.005740611348301172, 0.0018200782360509038, 0.0032658022828400135, 0.0038320503663271666, 0.001557809067890048, 0.003966766409575939, 0.0019660494290292263, 0.0019702231511473656, 0.0023952138144522905, 0.004152010194957256, 0.003169713309034705, 0.0018931140657514334, 0.018641937524080276, 0.008463623002171516, 0.30977094173431396, 0.606706976890564, 0.03445158898830414, 0.014572720974683762, 0.16188175976276398, 0.15215738117694855, 0.0840640515089035, 0.8647406697273254, 0.0040036765858531, 0.011889596469700336, 0.003025446552783251, 0.021995363757014275, 0.027856385335326195, 6.5946216636803e-05, 0.01606741175055504, 0.07855748385190964, 0.39942803978919983, 0.026006650179624557, 0.016493434086441994, 0.22707624733448029, 0.40722838044166565, 0.2338978499174118, 0.11097896099090576, 0.719358503818512, 0.002823074348270893, 0.010548388585448265, 0.004231507424265146, 0.035796038806438446, 0.06346966326236725, 5.699008033843711e-05, 5.3278225095709786e-05, -1]}
{"idB": "749647_18_item1_p134_s2", "idA": "749647_17_item1_p102_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010.", "sentB": "The Phase I portion of the study will be followed by a continuation at the selected dose in 90 patient randomized Phase II study.", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010.", "<tag2>", "The", "Phase", "I", "portion", "of", "the", "study", "will", "be", "followed", "by", "a", "continuation", "at", "the", "selected", "dose", "in", "90", "patient", "randomized", "Phase", "II", "study.", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010."], "wordsB": ["The", "Phase", "I", "portion", "of", "the", "study", "will", "be", "followed", "by", "a", "continuation", "at", "the", "selected", "dose", "in", "90", "patient", "randomized", "Phase", "II", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01014824490994215, 0.04337109997868538, 0.0315285362303257, 0.06022866442799568, 0.01627756655216217, 0.013657708652317524, 0.07864580303430557, 0.051970306783914566, 0.03628699854016304, 0.18413379788398743, 0.11406929790973663, 0.08984220772981644, 0.387114942073822, 0.11301055550575256, 0.04803972691297531, 0.20591431856155396, 0.2665446102619171, 0.029046006500720978, 0.3647876977920532, 0.2543904185295105, 0.14927853643894196, 0.05928955227136612, 0.029402492567896843, 0.16989856958389282, -1]}
{"idB": "749647_18_item1_p60_s2", "idA": "749647_17_item1_p102_s0", "sentA": "The Company completed enrollment of the Phase I portion of the study in 2010.", "sentB": "The Phase I portion of the study will be followed by a continuation at the selected dose in 90 patient randomized Phase II study.", "type": 2, "words": ["<tag1>", "The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010.", "<tag2>", "The", "Phase", "I", "portion", "of", "the", "study", "will", "be", "followed", "by", "a", "continuation", "at", "the", "selected", "dose", "in", "90", "patient", "randomized", "Phase", "II", "study.", "<tag3>"], "wordsA": ["The", "Company", "completed", "enrollment", "of", "the", "Phase", "I", "portion", "of", "the", "study", "in", "2010."], "wordsB": ["The", "Phase", "I", "portion", "of", "the", "study", "will", "be", "followed", "by", "a", "continuation", "at", "the", "selected", "dose", "in", "90", "patient", "randomized", "Phase", "II", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01014824490994215, 0.04337109997868538, 0.0315285362303257, 0.06022866442799568, 0.01627756655216217, 0.013657708652317524, 0.07864580303430557, 0.051970306783914566, 0.03628699854016304, 0.18413379788398743, 0.11406929790973663, 0.08984220772981644, 0.387114942073822, 0.11301055550575256, 0.04803972691297531, 0.20591431856155396, 0.2665446102619171, 0.029046006500720978, 0.3647876977920532, 0.2543904185295105, 0.14927853643894196, 0.05928955227136612, 0.029402492567896843, 0.16989856958389282, -1]}
{"idB": "749647_18_item1_p123_s1", "idA": "749647_17_item1_p102_s6", "sentA": "These data are consistent with the combined clinical data from the two previous Phase I trials discussed below.", "sentB": "These and other post-treatment changes including decreases in VEGF levels in peritoneal fluid are consistent with an IL-12 based immune mechanism.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below.", "<tag2>", "These", "and", "other", "post-treatment", "changes", "including", "decreases", "in", "VEGF", "levels", "in", "peritoneal", "fluid", "are", "consistent", "with", "an", "IL-12", "based", "immune", "mechanism.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below."], "wordsB": ["These", "and", "other", "post-treatment", "changes", "including", "decreases", "in", "VEGF", "levels", "in", "peritoneal", "fluid", "are", "consistent", "with", "an", "IL-12", "based", "immune", "mechanism."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016283005475997925, 0.016699472442269325, 0.019312674179673195, 0.17976674437522888, 0.20123906433582306, 0.011017773300409317, 0.20291227102279663, 0.14061330258846283, 0.5036928653717041, 0.3738133907318115, 0.08051763474941254, 0.19729922711849213, 0.16506245732307434, 0.004557917360216379, 0.05127312242984772, 0.023554237559437752, 0.02163008600473404, 0.20629633963108063, 0.14504291117191315, 0.410116583108902, 0.32104411721229553, -1]}
{"idB": "749647_18_item1_p49_s1", "idA": "749647_17_item1_p102_s6", "sentA": "These data are consistent with the combined clinical data from the two previous Phase I trials discussed below.", "sentB": "These and other post-treatment changes including decreases in VEGF levels in peritoneal fluid are consistent with an IL-12 based immune mechanism.", "type": 2, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below.", "<tag2>", "These", "and", "other", "post-treatment", "changes", "including", "decreases", "in", "VEGF", "levels", "in", "peritoneal", "fluid", "are", "consistent", "with", "an", "IL-12", "based", "immune", "mechanism.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "the", "two", "previous", "Phase", "I", "trials", "discussed", "below."], "wordsB": ["These", "and", "other", "post-treatment", "changes", "including", "decreases", "in", "VEGF", "levels", "in", "peritoneal", "fluid", "are", "consistent", "with", "an", "IL-12", "based", "immune", "mechanism."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016283005475997925, 0.016699472442269325, 0.019312674179673195, 0.17976674437522888, 0.20123906433582306, 0.011017773300409317, 0.20291227102279663, 0.14061330258846283, 0.5036928653717041, 0.3738133907318115, 0.08051763474941254, 0.19729922711849213, 0.16506245732307434, 0.004557917360216379, 0.05127312242984772, 0.023554237559437752, 0.02163008600473404, 0.20629633963108063, 0.14504291117191315, 0.410116583108902, 0.32104411721229553, -1]}
{"idB": "749647_18_item1_p35_s0", "idA": "749647_17_item1_p103_s1", "sentA": "In December 2013, we announced combined clinical data from our DIGNITY study and the Duke University sponsored Phase I trial of ThermoDox plus hyperthermia in RCW breast cancer.", "sentB": "In order for us to focus on our most immediate registrational opportunities, our research in RCW breast cancer has been suspended.", "type": 2, "words": ["<tag1>", "In", "December", "2013,", "we", "announced", "combined", "clinical", "data", "from", "our", "DIGNITY", "study", "and", "the", "Duke", "University", "sponsored", "Phase", "I", "trial", "of", "ThermoDox", "plus", "hyperthermia", "in", "RCW", "breast", "cancer.", "<tag2>", "In", "order", "for", "us", "to", "focus", "on", "our", "most", "immediate", "registrational", "opportunities,", "our", "research", "in", "RCW", "breast", "cancer", "has", "been", "suspended.", "<tag3>"], "wordsA": ["In", "December", "2013,", "we", "announced", "combined", "clinical", "data", "from", "our", "DIGNITY", "study", "and", "the", "Duke", "University", "sponsored", "Phase", "I", "trial", "of", "ThermoDox", "plus", "hyperthermia", "in", "RCW", "breast", "cancer."], "wordsB": ["In", "order", "for", "us", "to", "focus", "on", "our", "most", "immediate", "registrational", "opportunities,", "our", "research", "in", "RCW", "breast", "cancer", "has", "been", "suspended."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01273827813565731, 0.012263898737728596, 0.008564356714487076, 0.026969553902745247, 0.010655461810529232, 0.03455190733075142, 0.014692813158035278, 0.018743306398391724, 0.021284783259034157, 0.06956992298364639, 0.1481596678495407, 0.06973856687545776, 0.015546531416475773, 0.48232975602149963, 0.033793192356824875, 0.027822205796837807, 0.06294532120227814, 0.03153476491570473, 0.29664233326911926, 0.3453028202056885, 0.9294232726097107, -1]}
{"idB": "749647_18_item1_p135_s0", "idA": "749647_17_item1_p103_s4", "sentA": "Both studies employed an open label 3+3 dose escalation study design to determine the Maximum Tolerated Dose, evaluate safety and determine early effects of ThermoDox in combination with mild hyperthermia.", "sentB": "GEN-1 has demonstrated positive safety and efficacy data in the recently completed dose escalation Phase IB trial in combination with neoadjuvant chemotherapy.", "type": 2, "words": ["<tag1>", "Both", "studies", "employed", "an", "open", "label", "3+3", "dose", "escalation", "study", "design", "to", "determine", "the", "Maximum", "Tolerated", "Dose,", "evaluate", "safety", "and", "determine", "early", "effects", "of", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "GEN-1", "has", "demonstrated", "positive", "safety", "and", "efficacy", "data", "in", "the", "recently", "completed", "dose", "escalation", "Phase", "IB", "trial", "in", "combination", "with", "neoadjuvant", "chemotherapy.", "<tag3>"], "wordsA": ["Both", "studies", "employed", "an", "open", "label", "3+3", "dose", "escalation", "study", "design", "to", "determine", "the", "Maximum", "Tolerated", "Dose,", "evaluate", "safety", "and", "determine", "early", "effects", "of", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["GEN-1", "has", "demonstrated", "positive", "safety", "and", "efficacy", "data", "in", "the", "recently", "completed", "dose", "escalation", "Phase", "IB", "trial", "in", "combination", "with", "neoadjuvant", "chemotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.37047696113586426, 0.014936362393200397, 0.05619020387530327, 0.2487824708223343, 0.11704801023006439, 0.03902096301317215, 0.14666324853897095, 0.11125165224075317, 0.005774240475147963, 0.005943221505731344, 0.015216276980936527, 0.04686150327324867, 0.06664974987506866, 0.03227353096008301, 0.03471934422850609, 0.07131167501211166, 0.07592829316854477, 0.001286330516450107, 0.022517705336213112, 0.014505828730762005, 0.43672147393226624, 0.3283975422382355, -1]}
{"idB": "749647_18_item1_p61_s0", "idA": "749647_17_item1_p103_s4", "sentA": "Both studies employed an open label 3+3 dose escalation study design to determine the Maximum Tolerated Dose, evaluate safety and determine early effects of ThermoDox in combination with mild hyperthermia.", "sentB": "GEN-1 has demonstrated positive safety and efficacy data in the recently completed dose escalation Phase IB trial in combination with neoadjuvant chemotherapy.", "type": 2, "words": ["<tag1>", "Both", "studies", "employed", "an", "open", "label", "3+3", "dose", "escalation", "study", "design", "to", "determine", "the", "Maximum", "Tolerated", "Dose,", "evaluate", "safety", "and", "determine", "early", "effects", "of", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "GEN-1", "has", "demonstrated", "positive", "safety", "and", "efficacy", "data", "in", "the", "recently", "completed", "dose", "escalation", "Phase", "IB", "trial", "in", "combination", "with", "neoadjuvant", "chemotherapy.", "<tag3>"], "wordsA": ["Both", "studies", "employed", "an", "open", "label", "3+3", "dose", "escalation", "study", "design", "to", "determine", "the", "Maximum", "Tolerated", "Dose,", "evaluate", "safety", "and", "determine", "early", "effects", "of", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["GEN-1", "has", "demonstrated", "positive", "safety", "and", "efficacy", "data", "in", "the", "recently", "completed", "dose", "escalation", "Phase", "IB", "trial", "in", "combination", "with", "neoadjuvant", "chemotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.37047696113586426, 0.014936362393200397, 0.05619020387530327, 0.2487824708223343, 0.11704801023006439, 0.03902096301317215, 0.14666324853897095, 0.11125165224075317, 0.005774240475147963, 0.005943221505731344, 0.015216276980936527, 0.04686150327324867, 0.06664974987506866, 0.03227353096008301, 0.03471934422850609, 0.07131167501211166, 0.07592829316854477, 0.001286330516450107, 0.022517705336213112, 0.014505828730762005, 0.43672147393226624, 0.3283975422382355, -1]}
{"idB": "749647_18_item1_p123_s0", "idA": "749647_17_item1_p119_s0", "sentA": "Celsion s GEN-1 approach for IL-12 delivery is designed to achieve local concentrations of IL-12 at the tumor site with minimal increases in systemic circulation.", "sentB": "The intraperitoneal treatment of GEN-1 in conjunction with neoadjuvant chemotherapy resulted in dose dependent increases in IL-12 and Interferon-gamma (IFN-g) levels that were predominantly in the peritoneal fluid compartment with little to no changes observed in the patients systemic circulation.", "type": 2, "words": ["<tag1>", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation.", "<tag2>", "The", "intraperitoneal", "treatment", "of", "GEN-1", "in", "conjunction", "with", "neoadjuvant", "chemotherapy", "resulted", "in", "dose", "dependent", "increases", "in", "IL-12", "and", "Interferon-gamma", "(IFN-g)", "levels", "that", "were", "predominantly", "in", "the", "peritoneal", "fluid", "compartment", "with", "little", "to", "no", "changes", "observed", "in", "the", "patients", "systemic", "circulation.", "<tag3>"], "wordsA": ["Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation."], "wordsB": ["The", "intraperitoneal", "treatment", "of", "GEN-1", "in", "conjunction", "with", "neoadjuvant", "chemotherapy", "resulted", "in", "dose", "dependent", "increases", "in", "IL-12", "and", "Interferon-gamma", "(IFN-g)", "levels", "that", "were", "predominantly", "in", "the", "peritoneal", "fluid", "compartment", "with", "little", "to", "no", "changes", "observed", "in", "the", "patients", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0071347858756780624, 0.34961044788360596, 0.2429298758506775, 0.011827775277197361, 0.03970422223210335, 0.006497005000710487, 0.015551762655377388, 0.010491300374269485, 0.25911110639572144, 0.18255099654197693, 0.011464521288871765, 0.009236769750714302, 0.19547289609909058, 0.20474861562252045, 0.1563439667224884, 0.03731771931052208, 0.08742032200098038, 0.04320331662893295, 0.37951910495758057, 0.3136366903781891, 0.12332271784543991, 9.362841956317425e-05, 0.008703358471393585, 0.023314114660024643, 0.013804773800075054, 0.01027942355722189, 0.0626092180609703, 0.04829816147685051, 0.05138187110424042, 0.00017067184671759605, 0.3147595524787903, 0.10433509200811386, 0.5040780901908875, 0.23293520510196686, 0.10578685253858566, 0.027745399624109268, 0.010814603418111801, 0.06705135107040405, 0.088088758289814, 0.09197694808244705, -1]}
{"idB": "749647_18_item1_p49_s0", "idA": "749647_17_item1_p119_s0", "sentA": "Celsion s GEN-1 approach for IL-12 delivery is designed to achieve local concentrations of IL-12 at the tumor site with minimal increases in systemic circulation.", "sentB": "The intraperitoneal treatment of GEN-1 in conjunction with neoadjuvant chemotherapy resulted in dose dependent increases in IL-12 and Interferon-gamma (IFN-g) levels that were predominantly in the peritoneal fluid compartment with little to no changes observed in the patients systemic circulation.", "type": 2, "words": ["<tag1>", "Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation.", "<tag2>", "The", "intraperitoneal", "treatment", "of", "GEN-1", "in", "conjunction", "with", "neoadjuvant", "chemotherapy", "resulted", "in", "dose", "dependent", "increases", "in", "IL-12", "and", "Interferon-gamma", "(IFN-g)", "levels", "that", "were", "predominantly", "in", "the", "peritoneal", "fluid", "compartment", "with", "little", "to", "no", "changes", "observed", "in", "the", "patients", "systemic", "circulation.", "<tag3>"], "wordsA": ["Celsion", "s", "GEN-1", "approach", "for", "IL-12", "delivery", "is", "designed", "to", "achieve", "local", "concentrations", "of", "IL-12", "at", "the", "tumor", "site", "with", "minimal", "increases", "in", "systemic", "circulation."], "wordsB": ["The", "intraperitoneal", "treatment", "of", "GEN-1", "in", "conjunction", "with", "neoadjuvant", "chemotherapy", "resulted", "in", "dose", "dependent", "increases", "in", "IL-12", "and", "Interferon-gamma", "(IFN-g)", "levels", "that", "were", "predominantly", "in", "the", "peritoneal", "fluid", "compartment", "with", "little", "to", "no", "changes", "observed", "in", "the", "patients", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0071347858756780624, 0.34961044788360596, 0.2429298758506775, 0.011827775277197361, 0.03970422223210335, 0.006497005000710487, 0.015551762655377388, 0.010491300374269485, 0.25911110639572144, 0.18255099654197693, 0.011464521288871765, 0.009236769750714302, 0.19547289609909058, 0.20474861562252045, 0.1563439667224884, 0.03731771931052208, 0.08742032200098038, 0.04320331662893295, 0.37951910495758057, 0.3136366903781891, 0.12332271784543991, 9.362841956317425e-05, 0.008703358471393585, 0.023314114660024643, 0.013804773800075054, 0.01027942355722189, 0.0626092180609703, 0.04829816147685051, 0.05138187110424042, 0.00017067184671759605, 0.3147595524787903, 0.10433509200811386, 0.5040780901908875, 0.23293520510196686, 0.10578685253858566, 0.027745399624109268, 0.010814603418111801, 0.06705135107040405, 0.088088758289814, 0.09197694808244705, -1]}
{"idB": "749647_18_item1_p137_s0", "idA": "749647_17_item1_p119_s2", "sentA": "In this approach, our GEN-1 immunotherapy is combined with standard chemotherapy drugs to achieve better clinical outcome than with chemotherapy alone.", "sentB": "Primary endpoint of improvement in progression-free survival (PFS) comparing GEN-1 with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone.", "type": 2, "words": ["<tag1>", "In", "this", "approach,", "our", "GEN-1", "immunotherapy", "is", "combined", "with", "standard", "chemotherapy", "drugs", "to", "achieve", "better", "clinical", "outcome", "than", "with", "chemotherapy", "alone.", "<tag2>", "Primary", "endpoint", "of", "improvement", "in", "progression-free", "survival", "(PFS)", "comparing", "GEN-1", "with", "neoadjuvant", "chemotherapy", "versus", "neoadjuvant", "chemotherapy", "alone.", "<tag3>"], "wordsA": ["In", "this", "approach,", "our", "GEN-1", "immunotherapy", "is", "combined", "with", "standard", "chemotherapy", "drugs", "to", "achieve", "better", "clinical", "outcome", "than", "with", "chemotherapy", "alone."], "wordsB": ["Primary", "endpoint", "of", "improvement", "in", "progression-free", "survival", "(PFS)", "comparing", "GEN-1", "with", "neoadjuvant", "chemotherapy", "versus", "neoadjuvant", "chemotherapy", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05699100345373154, 0.11519075185060501, 0.03415284305810928, 0.17556479573249817, 0.08967020362615585, 0.6790058612823486, 0.513714075088501, 0.23357245326042175, 0.03309556096792221, 0.034708574414253235, 0.012117731384932995, 0.43967679142951965, 0.19411244988441467, 0.04978238418698311, 0.3828956186771393, 0.14591646194458008, 0.051244720816612244, -1]}
{"idB": "749647_18_item1_p63_s0", "idA": "749647_17_item1_p119_s2", "sentA": "In this approach, our GEN-1 immunotherapy is combined with standard chemotherapy drugs to achieve better clinical outcome than with chemotherapy alone.", "sentB": "Primary endpoint of improvement in progression-free survival (PFS) comparing GEN-1 with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone.", "type": 2, "words": ["<tag1>", "In", "this", "approach,", "our", "GEN-1", "immunotherapy", "is", "combined", "with", "standard", "chemotherapy", "drugs", "to", "achieve", "better", "clinical", "outcome", "than", "with", "chemotherapy", "alone.", "<tag2>", "Primary", "endpoint", "of", "improvement", "in", "progression-free", "survival", "(PFS)", "comparing", "GEN-1", "with", "neoadjuvant", "chemotherapy", "versus", "neoadjuvant", "chemotherapy", "alone.", "<tag3>"], "wordsA": ["In", "this", "approach,", "our", "GEN-1", "immunotherapy", "is", "combined", "with", "standard", "chemotherapy", "drugs", "to", "achieve", "better", "clinical", "outcome", "than", "with", "chemotherapy", "alone."], "wordsB": ["Primary", "endpoint", "of", "improvement", "in", "progression-free", "survival", "(PFS)", "comparing", "GEN-1", "with", "neoadjuvant", "chemotherapy", "versus", "neoadjuvant", "chemotherapy", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05699100345373154, 0.11519075185060501, 0.03415284305810928, 0.17556479573249817, 0.08967020362615585, 0.6790058612823486, 0.513714075088501, 0.23357245326042175, 0.03309556096792221, 0.034708574414253235, 0.012117731384932995, 0.43967679142951965, 0.19411244988441467, 0.04978238418698311, 0.3828956186771393, 0.14591646194458008, 0.051244720816612244, -1]}
{"idB": "749647_18_item1_p342_s0", "idA": "749647_17_item1_p120_s3", "sentA": "In addition, the OVATION Study establishes a unique opportunity to assess how cytokine-based compounds such as GEN-1, directly affects ovarian cancer cells and the tumor microenvironment in newly diagnosed patients.", "sentB": "In addition, the stock markets, in general, The NASDAQ Capital Market and the market for pharmaceutical companies in particular, may experience a loss of investor confidence.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affects", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients.", "<tag2>", "In", "addition,", "the", "stock", "markets,", "in", "general,", "The", "NASDAQ", "Capital", "Market", "and", "the", "market", "for", "pharmaceutical", "companies", "in", "particular,", "may", "experience", "a", "loss", "of", "investor", "confidence.", "<tag3>"], "wordsA": ["In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affects", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients."], "wordsB": ["In", "addition,", "the", "stock", "markets,", "in", "general,", "The", "NASDAQ", "Capital", "Market", "and", "the", "market", "for", "pharmaceutical", "companies", "in", "particular,", "may", "experience", "a", "loss", "of", "investor", "confidence."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005363354459404945, 0.011262627318501472, 0.04313824698328972, 0.8285576105117798, 0.8138717412948608, 0.0135042704641819, 0.012709036469459534, 0.015285052359104156, 0.23306965827941895, 0.16816987097263336, 0.2669530510902405, 0.006998083088546991, 0.008863837458193302, 0.059853702783584595, 0.023033663630485535, 0.19533832371234894, 0.09900239109992981, 0.007036203518509865, 0.008609464392066002, 0.0084066828712821, 0.03411884605884552, 0.0144328149035573, 0.1265256255865097, 0.026350488886237144, 0.14869093894958496, 0.15398003160953522, -1]}
{"idB": "749647_18_item1_p127_s0", "idA": "749647_17_item1_p123_s0", "sentA": "In 2016 and early 2017, we announced data from the first four cohorts of patients in the OVATION Study.", "sentB": "The Company also reported positive clinical data from the first fourteen patients who have completed treatment in the OVATION Study.", "type": 2, "words": ["<tag1>", "In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "The", "Company", "also", "reported", "positive", "clinical", "data", "from", "the", "first", "fourteen", "patients", "who", "have", "completed", "treatment", "in", "the", "OVATION", "Study.", "<tag3>"], "wordsA": ["In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["The", "Company", "also", "reported", "positive", "clinical", "data", "from", "the", "first", "fourteen", "patients", "who", "have", "completed", "treatment", "in", "the", "OVATION", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0052368915639817715, 0.069779172539711, 0.02320566587150097, 0.13841289281845093, 0.4469614326953888, 0.25863122940063477, 0.28761133551597595, 0.018345946446061134, 0.011969057843089104, 0.06966041028499603, 0.7155358195304871, 0.2892051637172699, 0.013042507693171501, 0.027910273522138596, 0.32669517397880554, 0.09904956072568893, 0.004629006143659353, 0.004030050244182348, 0.0093493377789855, 0.014714987948536873, -1]}
{"idB": "749647_18_item1_p132_s1", "idA": "749647_17_item1_p123_s0", "sentA": "In 2016 and early 2017, we announced data from the first four cohorts of patients in the OVATION Study.", "sentB": "Median PFS for all 13 patients in the OVATION Study is 21.4 months as of March 15, 2018 and counting.", "type": 2, "words": ["<tag1>", "In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "Median", "PFS", "for", "all", "13", "patients", "in", "the", "OVATION", "Study", "is", "21.4", "months", "as", "of", "March", "15,", "2018", "and", "counting.", "<tag3>"], "wordsA": ["In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["Median", "PFS", "for", "all", "13", "patients", "in", "the", "OVATION", "Study", "is", "21.4", "months", "as", "of", "March", "15,", "2018", "and", "counting."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.29453030228614807, 0.4046754539012909, 0.03771424666047096, 0.0768505334854126, 0.38513025641441345, 0.1618819385766983, 0.0043876031413674355, 0.00352277560159564, 0.00811387225985527, 0.020204925909638405, 0.03104628250002861, 0.4653860330581665, 0.24056097865104675, 0.08695340901613235, 0.05970579758286476, 0.2153724879026413, 0.15878039598464966, 0.3854067325592041, 0.06917402893304825, 0.13531552255153656, -1]}
{"idB": "749647_18_item1_p53_s0", "idA": "749647_17_item1_p123_s0", "sentA": "In 2016 and early 2017, we announced data from the first four cohorts of patients in the OVATION Study.", "sentB": "The Company also reported positive clinical data from the first fourteen patients who have completed treatment in the OVATION Study.", "type": 2, "words": ["<tag1>", "In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "The", "Company", "also", "reported", "positive", "clinical", "data", "from", "the", "first", "fourteen", "patients", "who", "have", "completed", "treatment", "in", "the", "OVATION", "Study.", "<tag3>"], "wordsA": ["In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["The", "Company", "also", "reported", "positive", "clinical", "data", "from", "the", "first", "fourteen", "patients", "who", "have", "completed", "treatment", "in", "the", "OVATION", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0052368915639817715, 0.069779172539711, 0.02320566587150097, 0.13841289281845093, 0.4469614326953888, 0.25863122940063477, 0.28761133551597595, 0.018345946446061134, 0.011969057843089104, 0.06966041028499603, 0.7155358195304871, 0.2892051637172699, 0.013042507693171501, 0.027910273522138596, 0.32669517397880554, 0.09904956072568893, 0.004629006143659353, 0.004030050244182348, 0.0093493377789855, 0.014714987948536873, -1]}
{"idB": "749647_18_item1_p58_s1", "idA": "749647_17_item1_p123_s0", "sentA": "In 2016 and early 2017, we announced data from the first four cohorts of patients in the OVATION Study.", "sentB": "Median PFS for all 13 patients in the OVATION Study is 21.4 months as of March 15, 2018 and counting.", "type": 2, "words": ["<tag1>", "In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "Median", "PFS", "for", "all", "13", "patients", "in", "the", "OVATION", "Study", "is", "21.4", "months", "as", "of", "March", "15,", "2018", "and", "counting.", "<tag3>"], "wordsA": ["In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["Median", "PFS", "for", "all", "13", "patients", "in", "the", "OVATION", "Study", "is", "21.4", "months", "as", "of", "March", "15,", "2018", "and", "counting."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.29453030228614807, 0.4046754539012909, 0.03771424666047096, 0.0768505334854126, 0.38513025641441345, 0.1618819385766983, 0.0043876031413674355, 0.00352277560159564, 0.00811387225985527, 0.020204925909638405, 0.03104628250002861, 0.4653860330581665, 0.24056097865104675, 0.08695340901613235, 0.05970579758286476, 0.2153724879026413, 0.15878039598464966, 0.3854067325592041, 0.06917402893304825, 0.13531552255153656, -1]}
{"idB": "749647_18_item1_p64_s2", "idA": "749647_17_item1_p123_s0", "sentA": "In 2016 and early 2017, we announced data from the first four cohorts of patients in the OVATION Study.", "sentB": "Given the very promising results from the OVATION Study, priority for this combination trial has been replaced by the OVATION II Study.", "type": 2, "words": ["<tag1>", "In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study.", "<tag2>", "Given", "the", "very", "promising", "results", "from", "the", "OVATION", "Study,", "priority", "for", "this", "combination", "trial", "has", "been", "replaced", "by", "the", "OVATION", "II", "Study.", "<tag3>"], "wordsA": ["In", "2016", "and", "early", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study."], "wordsB": ["Given", "the", "very", "promising", "results", "from", "the", "OVATION", "Study,", "priority", "for", "this", "combination", "trial", "has", "been", "replaced", "by", "the", "OVATION", "II", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016523635014891624, 0.010928370989859104, 0.01956252008676529, 0.04684898257255554, 0.029063086956739426, 0.0066539025865495205, 0.00527300825342536, 0.016432123258709908, 0.02798912487924099, 0.19221560657024384, 0.022361280396580696, 0.012740161269903183, 0.0822276771068573, 0.08000301569700241, 0.05172920599579811, 0.043199386447668076, 0.18354596197605133, 0.04193129017949104, 0.017370445653796196, 0.07576647400856018, 0.23692654073238373, 0.13838516175746918, -1]}
{"idB": "749647_18_item1_p134_s1", "idA": "749647_17_item1_p123_s1", "sentA": "The OVATION Study is designed to enroll three to six patients per dose cohort and will continue into 2017 with the goal to identify a safe, tolerable and therapeutically active dose of GEN-1 by recruiting and maximizing an immune response.", "sentB": "The protocol is designed with a single dose escalation phase to 100 mg/m to identify a safe and tolerable dose of GEN-1 while maximizing an immune response.", "type": 2, "words": ["<tag1>", "The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "continue", "into", "2017", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response.", "<tag2>", "The", "protocol", "is", "designed", "with", "a", "single", "dose", "escalation", "phase", "to", "100", "mg/m", "to", "identify", "a", "safe", "and", "tolerable", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response.", "<tag3>"], "wordsA": ["The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "continue", "into", "2017", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response."], "wordsB": ["The", "protocol", "is", "designed", "with", "a", "single", "dose", "escalation", "phase", "to", "100", "mg/m", "to", "identify", "a", "safe", "and", "tolerable", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0056595164351165295, 0.19961144030094147, 0.0023804958909749985, 0.01437169499695301, 0.009368321858346462, 0.008647704496979713, 0.7998237013816833, 0.62981778383255, 0.38523247838020325, 0.19879810512065887, 0.00615416094660759, 0.15202733874320984, 0.17958776652812958, 0.0019333562813699245, 0.004736407194286585, 0.0024823874700814486, 0.005054791923612356, 0.001743569504469633, 0.0034153014421463013, 0.005671685561537743, 0.0020599213894456625, 0.005690890830010176, 0.0014728134265169501, 0.009162156842648983, 0.004011752083897591, 0.007811342366039753, 0.007024961058050394, -1]}
{"idB": "749647_18_item1_p60_s1", "idA": "749647_17_item1_p123_s1", "sentA": "The OVATION Study is designed to enroll three to six patients per dose cohort and will continue into 2017 with the goal to identify a safe, tolerable and therapeutically active dose of GEN-1 by recruiting and maximizing an immune response.", "sentB": "The protocol is designed with a single dose escalation phase to 100 mg/m to identify a safe and tolerable dose of GEN-1 while maximizing an immune response.", "type": 2, "words": ["<tag1>", "The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "continue", "into", "2017", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response.", "<tag2>", "The", "protocol", "is", "designed", "with", "a", "single", "dose", "escalation", "phase", "to", "100", "mg/m", "to", "identify", "a", "safe", "and", "tolerable", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response.", "<tag3>"], "wordsA": ["The", "OVATION", "Study", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "cohort", "and", "will", "continue", "into", "2017", "with", "the", "goal", "to", "identify", "a", "safe,", "tolerable", "and", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response."], "wordsB": ["The", "protocol", "is", "designed", "with", "a", "single", "dose", "escalation", "phase", "to", "100", "mg/m", "to", "identify", "a", "safe", "and", "tolerable", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0056595164351165295, 0.19961144030094147, 0.0023804958909749985, 0.01437169499695301, 0.009368321858346462, 0.008647704496979713, 0.7998237013816833, 0.62981778383255, 0.38523247838020325, 0.19879810512065887, 0.00615416094660759, 0.15202733874320984, 0.17958776652812958, 0.0019333562813699245, 0.004736407194286585, 0.0024823874700814486, 0.005054791923612356, 0.001743569504469633, 0.0034153014421463013, 0.005671685561537743, 0.0020599213894456625, 0.005690890830010176, 0.0014728134265169501, 0.009162156842648983, 0.004011752083897591, 0.007811342366039753, 0.007024961058050394, -1]}
{"idB": "749647_18_item1_p240_s3", "idA": "749647_17_item1_p124_s3", "sentA": "The results of the OVATION Study to date are as follows:", "sentB": "The results from preclinical testing or early clinical trials of a product candidate may not predict the results that will be obtained in later phase clinical trials of the product candidate.", "type": 2, "words": ["<tag1>", "The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:", "<tag2>", "The", "results", "from", "preclinical", "testing", "or", "early", "clinical", "trials", "of", "a", "product", "candidate", "may", "not", "predict", "the", "results", "that", "will", "be", "obtained", "in", "later", "phase", "clinical", "trials", "of", "the", "product", "candidate.", "<tag3>"], "wordsA": ["The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:"], "wordsB": ["The", "results", "from", "preclinical", "testing", "or", "early", "clinical", "trials", "of", "a", "product", "candidate", "may", "not", "predict", "the", "results", "that", "will", "be", "obtained", "in", "later", "phase", "clinical", "trials", "of", "the", "product", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010838419198989868, 0.12445514649152756, 0.022383851930499077, 0.7143492698669434, 0.5054342746734619, 0.015260197222232819, 0.14655062556266785, 0.33570143580436707, 0.2673909068107605, 0.008387434296309948, 0.007750225719064474, 0.038033705204725266, 0.040036726742982864, 0.035653214901685715, 0.30281272530555725, 0.14977848529815674, 0.017374517396092415, 0.08248911052942276, 0.0037919403985142708, 0.008041881956160069, 0.005425100680440664, 0.015165969729423523, 0.007077550981193781, 0.06456464529037476, 0.10215266793966293, 0.2188647985458374, 0.17153024673461914, 0.004661092534661293, 0.00467732734978199, 0.027918295934796333, 0.03562512248754501, -1]}
{"idB": "749647_18_item1_p128_s0", "idA": "749647_17_item1_p125_s0", "sentA": "Of the first twelve patients dosed, one (1) patient demonstrated a complete response ( CR ), eight (8) patients demonstrated partial response ( PR ) and three patients demonstrated stable disease ( SD ), as measured by RECIST criteria.", "sentB": "Of the fourteen patients treated in the entire study, two patients demonstrated a complete response, ten patients demonstrated a partial response and two patients demonstrated stable disease, as measured by RECIST criteria.", "type": 2, "words": ["<tag1>", "Of", "the", "first", "twelve", "patients", "dosed,", "one", "(1)", "patient", "demonstrated", "a", "complete", "response", "(", "CR", "),", "eight", "(8)", "patients", "demonstrated", "partial", "response", "(", "PR", ")", "and", "three", "patients", "demonstrated", "stable", "disease", "(", "SD", "),", "as", "measured", "by", "RECIST", "criteria.", "<tag2>", "Of", "the", "fourteen", "patients", "treated", "in", "the", "entire", "study,", "two", "patients", "demonstrated", "a", "complete", "response,", "ten", "patients", "demonstrated", "a", "partial", "response", "and", "two", "patients", "demonstrated", "stable", "disease,", "as", "measured", "by", "RECIST", "criteria.", "<tag3>"], "wordsA": ["Of", "the", "first", "twelve", "patients", "dosed,", "one", "(1)", "patient", "demonstrated", "a", "complete", "response", "(", "CR", "),", "eight", "(8)", "patients", "demonstrated", "partial", "response", "(", "PR", ")", "and", "three", "patients", "demonstrated", "stable", "disease", "(", "SD", "),", "as", "measured", "by", "RECIST", "criteria."], "wordsB": ["Of", "the", "fourteen", "patients", "treated", "in", "the", "entire", "study,", "two", "patients", "demonstrated", "a", "complete", "response,", "ten", "patients", "demonstrated", "a", "partial", "response", "and", "two", "patients", "demonstrated", "stable", "disease,", "as", "measured", "by", "RECIST", "criteria."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012935617938637733, 0.009345930069684982, 0.7450711131095886, 0.32398220896720886, 0.031681545078754425, 0.003482729196548462, 0.0032601631246507168, 0.0096123106777668, 0.022515809163451195, 0.5306561589241028, 0.29287806153297424, 0.006510876584798098, 0.002656617434695363, 0.013235656544566154, 0.01254367921501398, 0.6797937154769897, 0.2598373293876648, 0.009996341541409492, 0.0035792309790849686, 0.017814980819821358, 0.023262696340680122, 0.0048728566616773605, 0.5723854303359985, 0.2909941077232361, 0.004463817458599806, 0.007309864275157452, 0.009869654662907124, 0.0031833036337047815, 0.003759104758501053, 0.0014040973037481308, 0.003472250886261463, 0.006275790277868509, -1]}
{"idB": "749647_18_item1_p54_s0", "idA": "749647_17_item1_p125_s0", "sentA": "Of the first twelve patients dosed, one (1) patient demonstrated a complete response ( CR ), eight (8) patients demonstrated partial response ( PR ) and three patients demonstrated stable disease ( SD ), as measured by RECIST criteria.", "sentB": "Of the fourteen patients treated in the entire study, two patients demonstrated a complete response, ten patients demonstrated a partial response and two patients demonstrated stable disease, as measured by RECIST criteria.", "type": 2, "words": ["<tag1>", "Of", "the", "first", "twelve", "patients", "dosed,", "one", "(1)", "patient", "demonstrated", "a", "complete", "response", "(", "CR", "),", "eight", "(8)", "patients", "demonstrated", "partial", "response", "(", "PR", ")", "and", "three", "patients", "demonstrated", "stable", "disease", "(", "SD", "),", "as", "measured", "by", "RECIST", "criteria.", "<tag2>", "Of", "the", "fourteen", "patients", "treated", "in", "the", "entire", "study,", "two", "patients", "demonstrated", "a", "complete", "response,", "ten", "patients", "demonstrated", "a", "partial", "response", "and", "two", "patients", "demonstrated", "stable", "disease,", "as", "measured", "by", "RECIST", "criteria.", "<tag3>"], "wordsA": ["Of", "the", "first", "twelve", "patients", "dosed,", "one", "(1)", "patient", "demonstrated", "a", "complete", "response", "(", "CR", "),", "eight", "(8)", "patients", "demonstrated", "partial", "response", "(", "PR", ")", "and", "three", "patients", "demonstrated", "stable", "disease", "(", "SD", "),", "as", "measured", "by", "RECIST", "criteria."], "wordsB": ["Of", "the", "fourteen", "patients", "treated", "in", "the", "entire", "study,", "two", "patients", "demonstrated", "a", "complete", "response,", "ten", "patients", "demonstrated", "a", "partial", "response", "and", "two", "patients", "demonstrated", "stable", "disease,", "as", "measured", "by", "RECIST", "criteria."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012935617938637733, 0.009345930069684982, 0.7450711131095886, 0.32398220896720886, 0.031681545078754425, 0.003482729196548462, 0.0032601631246507168, 0.0096123106777668, 0.022515809163451195, 0.5306561589241028, 0.29287806153297424, 0.006510876584798098, 0.002656617434695363, 0.013235656544566154, 0.01254367921501398, 0.6797937154769897, 0.2598373293876648, 0.009996341541409492, 0.0035792309790849686, 0.017814980819821358, 0.023262696340680122, 0.0048728566616773605, 0.5723854303359985, 0.2909941077232361, 0.004463817458599806, 0.007309864275157452, 0.009869654662907124, 0.0031833036337047815, 0.003759104758501053, 0.0014040973037481308, 0.003472250886261463, 0.006275790277868509, -1]}
{"idB": "749647_18_item1_p128_s2", "idA": "749647_17_item1_p125_s1", "sentA": "This translates to a 100% disease control rate ( DCR ) and 75% objective response rate ( ORR ).", "sentB": "Of the five patients treated in the highest dose cohort, there was a 100% objective response rate with one complete response and four partial responses.", "type": 2, "words": ["<tag1>", "This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ").", "<tag2>", "Of", "the", "five", "patients", "treated", "in", "the", "highest", "dose", "cohort,", "there", "was", "a", "100%", "objective", "response", "rate", "with", "one", "complete", "response", "and", "four", "partial", "responses.", "<tag3>"], "wordsA": ["This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ")."], "wordsB": ["Of", "the", "five", "patients", "treated", "in", "the", "highest", "dose", "cohort,", "there", "was", "a", "100%", "objective", "response", "rate", "with", "one", "complete", "response", "and", "four", "partial", "responses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009228634648025036, 0.006303991191089153, 0.10713580250740051, 0.08215241879224777, 0.013970429077744484, 0.003787518944591284, 0.004665260203182697, 0.0678965300321579, 0.08834033459424973, 0.03062514029443264, 0.0025803137104958296, 0.0029544776771217585, 0.0037959087640047073, 0.05077251419425011, 0.11185622215270996, 0.0823683887720108, 0.03547435626387596, 0.011653603985905647, 0.37944602966308594, 0.6758611798286438, 0.6014779806137085, 0.029814962297677994, 0.4422861933708191, 0.7205003499984741, 0.679164707660675, -1]}
{"idB": "749647_18_item1_p54_s2", "idA": "749647_17_item1_p125_s1", "sentA": "This translates to a 100% disease control rate ( DCR ) and 75% objective response rate ( ORR ).", "sentB": "Of the five patients treated in the highest dose cohort, there was a 100% objective response rate with one complete response and four partial responses.", "type": 2, "words": ["<tag1>", "This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ").", "<tag2>", "Of", "the", "five", "patients", "treated", "in", "the", "highest", "dose", "cohort,", "there", "was", "a", "100%", "objective", "response", "rate", "with", "one", "complete", "response", "and", "four", "partial", "responses.", "<tag3>"], "wordsA": ["This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ")."], "wordsB": ["Of", "the", "five", "patients", "treated", "in", "the", "highest", "dose", "cohort,", "there", "was", "a", "100%", "objective", "response", "rate", "with", "one", "complete", "response", "and", "four", "partial", "responses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009228634648025036, 0.006303991191089153, 0.10713580250740051, 0.08215241879224777, 0.013970429077744484, 0.003787518944591284, 0.004665260203182697, 0.0678965300321579, 0.08834033459424973, 0.03062514029443264, 0.0025803137104958296, 0.0029544776771217585, 0.0037959087640047073, 0.05077251419425011, 0.11185622215270996, 0.0823683887720108, 0.03547435626387596, 0.011653603985905647, 0.37944602966308594, 0.6758611798286438, 0.6014779806137085, 0.029814962297677994, 0.4422861933708191, 0.7205003499984741, 0.679164707660675, -1]}
{"idB": "749647_18_item1_p129_s0", "idA": "749647_17_item1_p126_s0", "sentA": "Eleven patients had successful resections of their tumors, with six (6) patients having an R0 resection, which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed, and four (4) patients with a R1 resection, indicating microscopic residual tumor.", "sentB": "Fourteen patients had successful resections of their tumors, with nine patients (64%) having an R0 resection, which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed.", "type": 2, "words": ["<tag1>", "Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor.", "<tag2>", "Fourteen", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "nine", "patients", "(64%)", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed.", "<tag3>"], "wordsA": ["Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor."], "wordsB": ["Fourteen", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "nine", "patients", "(64%)", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.9688215255737305, 0.372185617685318, 0.002134777372702956, 0.004745740443468094, 0.006192062981426716, 0.001316459965892136, 0.0014015776105225086, 0.005349535029381514, 0.003761033760383725, 0.6421565413475037, 0.24365386366844177, 0.3454941511154175, 0.0023770786356180906, 0.0013698419788852334, 0.008125131018459797, 0.003127220319584012, 0.000145890808198601, 0.0012945985654368997, 0.000959452532697469, 0.002046362729743123, 0.002420145785436034, 0.0034432392567396164, 0.0010615593055263162, 0.001036119763739407, 0.004658996127545834, 0.0038050436414778233, 0.0018658955814316869, 0.0032237712293863297, 0.011289671063423157, 0.006987990811467171, 0.002033940050750971, 0.001763825654052198, 0.005488618277013302, 0.005753090605139732, -1]}
{"idB": "749647_18_item1_p55_s0", "idA": "749647_17_item1_p126_s0", "sentA": "Eleven patients had successful resections of their tumors, with six (6) patients having an R0 resection, which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed, and four (4) patients with a R1 resection, indicating microscopic residual tumor.", "sentB": "Fourteen patients had successful resections of their tumors, with nine patients (64%) having an R0 resection, which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed.", "type": 2, "words": ["<tag1>", "Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor.", "<tag2>", "Fourteen", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "nine", "patients", "(64%)", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed.", "<tag3>"], "wordsA": ["Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor."], "wordsB": ["Fourteen", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "nine", "patients", "(64%)", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.9688215255737305, 0.372185617685318, 0.002134777372702956, 0.004745740443468094, 0.006192062981426716, 0.001316459965892136, 0.0014015776105225086, 0.005349535029381514, 0.003761033760383725, 0.6421565413475037, 0.24365386366844177, 0.3454941511154175, 0.0023770786356180906, 0.0013698419788852334, 0.008125131018459797, 0.003127220319584012, 0.000145890808198601, 0.0012945985654368997, 0.000959452532697469, 0.002046362729743123, 0.002420145785436034, 0.0034432392567396164, 0.0010615593055263162, 0.001036119763739407, 0.004658996127545834, 0.0038050436414778233, 0.0018658955814316869, 0.0032237712293863297, 0.011289671063423157, 0.006987990811467171, 0.002033940050750971, 0.001763825654052198, 0.005488618277013302, 0.005753090605139732, -1]}
{"idB": "749647_18_item1_p302_s1", "idA": "749647_17_item1_p127_s2", "sentA": "cPRs have been associated with a median overall survival of 72 months, which is more than three years longer than those who do not experience a cPR.", "sentB": "These regulations require, among other things, the reporting to the FDA of adverse events alleged to have been associated with the use of a product or in connection with certain product failures.", "type": 2, "words": ["<tag1>", "cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR.", "<tag2>", "These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures.", "<tag3>"], "wordsA": ["cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR."], "wordsB": ["These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.029081422835588455, 0.14771628379821777, 0.19096337258815765, 0.011867455206811428, 0.016521790996193886, 0.031617846339941025, 0.04952044039964676, 0.47916704416275024, 0.087287038564682, 0.06917504966259003, 0.13144832849502563, 0.14182139933109283, 0.2517542541027069, 0.2979731857776642, 0.030834337696433067, 0.017124680802226067, 0.023914625868201256, 0.019130660220980644, 0.019477717578411102, 0.016653181985020638, 0.02127368189394474, 0.042574040591716766, 0.03084653429687023, 0.026601292192935944, 0.04794558882713318, 0.0003684186958707869, 0.00935400277376175, 0.014771883375942707, 0.013571607880294323, 0.029036758467555046, 0.11237277090549469, 0.24872899055480957, -1]}
{"idB": "749647_18_item1_p310_s1", "idA": "749647_17_item1_p127_s2", "sentA": "cPRs have been associated with a median overall survival of 72 months, which is more than three years longer than those who do not experience a cPR.", "sentB": "However, we may not experience a faster development process, review, or approval compared to conventional FDA procedures.", "type": 2, "words": ["<tag1>", "cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR.", "<tag2>", "However,", "we", "may", "not", "experience", "a", "faster", "development", "process,", "review,", "or", "approval", "compared", "to", "conventional", "FDA", "procedures.", "<tag3>"], "wordsA": ["cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR."], "wordsB": ["However,", "we", "may", "not", "experience", "a", "faster", "development", "process,", "review,", "or", "approval", "compared", "to", "conventional", "FDA", "procedures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03570476174354553, 0.10906216502189636, 0.1656636893749237, 0.5144681930541992, 0.40158361196517944, 0.16730426251888275, 0.46148979663848877, 0.46598678827285767, 0.37851187586784363, 0.33434364199638367, 0.16153864562511444, 0.39600685238838196, 0.05526347830891609, 0.012374579906463623, 0.06288424879312515, 0.09228752553462982, 0.07037234306335449, -1]}
{"idB": "749647_18_item1_p130_s0", "idA": "749647_17_item1_p128_s0", "sentA": "All eleven patients who completed treatment follow-up experienced a dramatic (greater than 90%) drop in their CA-125 protein levels as of their most recent study visit.", "sentB": "All patients experienced a clinically significant decrease in their CA-125 protein levels as of their most recent study visit.", "type": 2, "words": ["<tag1>", "All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit.", "<tag2>", "All", "patients", "experienced", "a", "clinically", "significant", "decrease", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit.", "<tag3>"], "wordsA": ["All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit."], "wordsB": ["All", "patients", "experienced", "a", "clinically", "significant", "decrease", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05216774716973305, 0.07543659955263138, 0.11086628586053848, 0.05964213237166405, 0.08715328574180603, 0.3098250925540924, 0.9358565211296082, 0.2129746824502945, 0.0961134135723114, 0.08749696612358093, 0.06846433132886887, 0.10652414709329605, 0.002985443454235792, 0.0023332838900387287, 0.0035552075132727623, 0.005691824480891228, 0.005269733257591724, 0.011263376101851463, 0.01221846416592598, -1]}
{"idB": "749647_18_item1_p56_s0", "idA": "749647_17_item1_p128_s0", "sentA": "All eleven patients who completed treatment follow-up experienced a dramatic (greater than 90%) drop in their CA-125 protein levels as of their most recent study visit.", "sentB": "All patients experienced a clinically significant decrease in their CA-125 protein levels as of their most recent study visit.", "type": 2, "words": ["<tag1>", "All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit.", "<tag2>", "All", "patients", "experienced", "a", "clinically", "significant", "decrease", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit.", "<tag3>"], "wordsA": ["All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit."], "wordsB": ["All", "patients", "experienced", "a", "clinically", "significant", "decrease", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05216774716973305, 0.07543659955263138, 0.11086628586053848, 0.05964213237166405, 0.08715328574180603, 0.3098250925540924, 0.9358565211296082, 0.2129746824502945, 0.0961134135723114, 0.08749696612358093, 0.06846433132886887, 0.10652414709329605, 0.002985443454235792, 0.0023332838900387287, 0.0035552075132727623, 0.005691824480891228, 0.005269733257591724, 0.011263376101851463, 0.01221846416592598, -1]}
{"idB": "749647_18_item1_p102_s1", "idA": "749647_17_item1_p131_s1", "sentA": "Top line data demonstrates intriguing immunological changes in the tumor that are consistent with the activation of the immune system.", "sentB": "The DMC reviewed study data at regular intervals, with the primary responsibilities of ensuring the safety of all patients enrolled in the study, the quality of the data collected, and the continued scientific validity of the study design.", "type": 2, "words": ["<tag1>", "Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system.", "<tag2>", "The", "DMC", "reviewed", "study", "data", "at", "regular", "intervals,", "with", "the", "primary", "responsibilities", "of", "ensuring", "the", "safety", "of", "all", "patients", "enrolled", "in", "the", "study,", "the", "quality", "of", "the", "data", "collected,", "and", "the", "continued", "scientific", "validity", "of", "the", "study", "design.", "<tag3>"], "wordsA": ["Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system."], "wordsB": ["The", "DMC", "reviewed", "study", "data", "at", "regular", "intervals,", "with", "the", "primary", "responsibilities", "of", "ensuring", "the", "safety", "of", "all", "patients", "enrolled", "in", "the", "study,", "the", "quality", "of", "the", "data", "collected,", "and", "the", "continued", "scientific", "validity", "of", "the", "study", "design."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009865162894129753, 0.2024007886648178, 0.24513037502765656, 0.19579656422138214, 0.151102215051651, 0.01590804010629654, 0.2276298701763153, 0.1275026649236679, 0.00039271096466109157, 0.009668033570051193, 0.015342488884925842, 0.035151638090610504, 0.009309666231274605, 0.09219799190759659, 0.015606128610670567, 0.19750511646270752, 0.03815952688455582, 0.1414768099784851, 0.19824913144111633, 0.024547116830945015, 0.016156958416104317, 0.007737518288195133, 0.0540957972407341, 0.0072427066043019295, 0.02325822226703167, 0.007589805405586958, 0.006513942964375019, 0.057265572249889374, 0.011860220693051815, 0.009406233206391335, 0.00670199329033494, 0.021694423630833626, 0.04154329001903534, 0.024341199547052383, 0.004769687075167894, 0.0046994853764772415, 0.06115555763244629, 0.03292118385434151, -1]}
{"idB": "749647_18_item1_p18_s1", "idA": "749647_17_item1_p131_s1", "sentA": "Top line data demonstrates intriguing immunological changes in the tumor that are consistent with the activation of the immune system.", "sentB": "The DMC reviewed study data at regular intervals, with the primary responsibilities of ensuring the safety of all patients enrolled in the study, the quality of the data collected, and the continued scientific validity of the study design.", "type": 2, "words": ["<tag1>", "Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system.", "<tag2>", "The", "DMC", "reviewed", "study", "data", "at", "regular", "intervals,", "with", "the", "primary", "responsibilities", "of", "ensuring", "the", "safety", "of", "all", "patients", "enrolled", "in", "the", "study,", "the", "quality", "of", "the", "data", "collected,", "and", "the", "continued", "scientific", "validity", "of", "the", "study", "design.", "<tag3>"], "wordsA": ["Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system."], "wordsB": ["The", "DMC", "reviewed", "study", "data", "at", "regular", "intervals,", "with", "the", "primary", "responsibilities", "of", "ensuring", "the", "safety", "of", "all", "patients", "enrolled", "in", "the", "study,", "the", "quality", "of", "the", "data", "collected,", "and", "the", "continued", "scientific", "validity", "of", "the", "study", "design."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009865162894129753, 0.2024007886648178, 0.24513037502765656, 0.19579656422138214, 0.151102215051651, 0.01590804010629654, 0.2276298701763153, 0.1275026649236679, 0.00039271096466109157, 0.009668033570051193, 0.015342488884925842, 0.035151638090610504, 0.009309666231274605, 0.09219799190759659, 0.015606128610670567, 0.19750511646270752, 0.03815952688455582, 0.1414768099784851, 0.19824913144111633, 0.024547116830945015, 0.016156958416104317, 0.007737518288195133, 0.0540957972407341, 0.0072427066043019295, 0.02325822226703167, 0.007589805405586958, 0.006513942964375019, 0.057265572249889374, 0.011860220693051815, 0.009406233206391335, 0.00670199329033494, 0.021694423630833626, 0.04154329001903534, 0.024341199547052383, 0.004769687075167894, 0.0046994853764772415, 0.06115555763244629, 0.03292118385434151, -1]}
{"idB": "749647_18_item1_p121_s2", "idA": "749647_17_item1_p135_s1", "sentA": "We expect to report the final clinical and translational data from the OVATION Study in mid-2017.", "sentB": "On October 3, 2017, we announced final clinical and translational research data from the OVATION Study, a Phase Ib dose escalating clinical trial combining GEN-1 with the standard of care for the treatment of newly-diagnosed patients with advanced Stage III/IV ovarian cancer who will undergo neoadjuvant chemotherapy followed by interval debulking surgery.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017.", "<tag2>", "On", "October", "3,", "2017,", "we", "announced", "final", "clinical", "and", "translational", "research", "data", "from", "the", "OVATION", "Study,", "a", "Phase", "Ib", "dose", "escalating", "clinical", "trial", "combining", "GEN-1", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "patients", "with", "advanced", "Stage", "III/IV", "ovarian", "cancer", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "interval", "debulking", "surgery.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017."], "wordsB": ["On", "October", "3,", "2017,", "we", "announced", "final", "clinical", "and", "translational", "research", "data", "from", "the", "OVATION", "Study,", "a", "Phase", "Ib", "dose", "escalating", "clinical", "trial", "combining", "GEN-1", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "patients", "with", "advanced", "Stage", "III/IV", "ovarian", "cancer", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "interval", "debulking", "surgery."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.061187196522951126, 0.5016038417816162, 0.3655858337879181, 0.09151684492826462, 0.02733231522142887, 0.20480427145957947, 0.016293810680508614, 0.007774898316711187, 0.0033321212977170944, 0.00417499803006649, 0.00744117796421051, 0.036250606179237366, 0.0035532317124307156, 0.003025919897481799, 0.01101695280522108, 0.015907494351267815, 0.0052695381455123425, 0.029929690062999725, 0.03485582023859024, 0.03324320539832115, 0.03159583732485771, 0.02609729953110218, 0.03011324442923069, 0.018260318785905838, 0.036874160170555115, 0.006583063397556543, 0.006542270537465811, 0.013884929940104485, 0.011935428716242313, 0.024406326934695244, 0.00981732364743948, 0.0031005972996354103, 0.023984897881746292, 0.009151267819106579, 0.05737907439470291, 0.07937958091497421, 0.013533498160541058, 0.04149571433663368, 0.04637554660439491, 0.06464962661266327, 0.09028635919094086, 0.04930863529443741, 0.0002577740524429828, 0.005899664014577866, 0.04181278124451637, 0.12527629733085632, 0.09795317053794861, 0.009810216724872589, 0.02545294538140297, 0.18125265836715698, 0.3276323974132538, 0.2161381095647812, -1]}
{"idB": "749647_18_item1_p133_s0", "idA": "749647_17_item1_p135_s1", "sentA": "We expect to report the final clinical and translational data from the OVATION Study in mid-2017.", "sentB": "The Company held an Advisory Board Meeting on September 27, 2017 with the clinical investigators and scientific experts including those from Roswell Park Cancer Institute, Vanderbilt University Medical School, and M.D. Anderson Cancer Center to review and finalize clinical, translational research and safety data from the Phase IB OVATION Study in order to determine the next steps forward for our GEN-1 immunotherapy program.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017.", "<tag2>", "The", "Company", "held", "an", "Advisory", "Board", "Meeting", "on", "September", "27,", "2017", "with", "the", "clinical", "investigators", "and", "scientific", "experts", "including", "those", "from", "Roswell", "Park", "Cancer", "Institute,", "Vanderbilt", "University", "Medical", "School,", "and", "M.D.", "Anderson", "Cancer", "Center", "to", "review", "and", "finalize", "clinical,", "translational", "research", "and", "safety", "data", "from", "the", "Phase", "IB", "OVATION", "Study", "in", "order", "to", "determine", "the", "next", "steps", "forward", "for", "our", "GEN-1", "immunotherapy", "program.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017."], "wordsB": ["The", "Company", "held", "an", "Advisory", "Board", "Meeting", "on", "September", "27,", "2017", "with", "the", "clinical", "investigators", "and", "scientific", "experts", "including", "those", "from", "Roswell", "Park", "Cancer", "Institute,", "Vanderbilt", "University", "Medical", "School,", "and", "M.D.", "Anderson", "Cancer", "Center", "to", "review", "and", "finalize", "clinical,", "translational", "research", "and", "safety", "data", "from", "the", "Phase", "IB", "OVATION", "Study", "in", "order", "to", "determine", "the", "next", "steps", "forward", "for", "our", "GEN-1", "immunotherapy", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011841660365462303, 0.0790359154343605, 0.14374421536922455, 0.08070001751184464, 0.1939462572336197, 0.20956753194332123, 0.3768112361431122, 0.044035449624061584, 0.45422959327697754, 0.33186575770378113, 0.07340682297945023, 0.02321106381714344, 0.008280626498162746, 0.03242490813136101, 0.029366835951805115, 0.008522014133632183, 0.0202593132853508, 0.04140337556600571, 0.005482843145728111, 0.00815935805439949, 0.016019780188798904, 0.1664128601551056, 0.14999979734420776, 0.19689030945301056, 0.21864622831344604, 0.12086332589387894, 0.126869797706604, 0.09481974691152573, 0.11881618201732635, 0.009418986737728119, 0.07447625696659088, 0.07621334493160248, 0.10997707396745682, 0.14194943010807037, 0.016379622742533684, 0.08344869315624237, 0.017692208290100098, 0.04195862263441086, 0.011866772547364235, 0.00619527930393815, 0.008184564299881458, 0.0036851067561656237, 0.009059814736247063, 0.030160823836922646, 0.0050727203488349915, 0.005146798677742481, 0.026847174391150475, 0.026917025446891785, 0.034183718264102936, 0.0386192686855793, 0.0022037748713046312, 0.009628517553210258, 0.007488270755857229, 0.03251643106341362, 0.014001316390931606, 0.024823103100061417, 0.043827205896377563, 0.02344442345201969, 0.006910896860063076, 0.006892222445458174, 0.058629054576158524, 0.06652769446372986, 0.04675786942243576, -1]}
{"idB": "749647_18_item1_p136_s0", "idA": "749647_17_item1_p135_s1", "sentA": "We expect to report the final clinical and translational data from the OVATION Study in mid-2017.", "sentB": "The study protocol was unanimously supported by an expert medical advisory board and lead investigators from the Phase IB OVATION Study and is summarized below:", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017.", "<tag2>", "The", "study", "protocol", "was", "unanimously", "supported", "by", "an", "expert", "medical", "advisory", "board", "and", "lead", "investigators", "from", "the", "Phase", "IB", "OVATION", "Study", "and", "is", "summarized", "below:", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017."], "wordsB": ["The", "study", "protocol", "was", "unanimously", "supported", "by", "an", "expert", "medical", "advisory", "board", "and", "lead", "investigators", "from", "the", "Phase", "IB", "OVATION", "Study", "and", "is", "summarized", "below:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.019633742049336433, 0.24299511313438416, 0.27884966135025024, 0.04620543494820595, 0.24016115069389343, 0.14826640486717224, 0.025396015495061874, 0.020545855164527893, 0.09662516415119171, 0.15439236164093018, 0.10874861478805542, 0.1129976361989975, 0.010086686350405216, 0.07735705375671387, 0.1260012686252594, 0.011410650797188282, 0.00975386705249548, 0.0561266727745533, 0.0909738764166832, 0.041752394288778305, 0.04793296381831169, 0.00016846712969709188, 0.03167035058140755, 0.1420857459306717, 0.13719266653060913, -1]}
{"idB": "749647_18_item1_p47_s2", "idA": "749647_17_item1_p135_s1", "sentA": "We expect to report the final clinical and translational data from the OVATION Study in mid-2017.", "sentB": "On October 3, 2017, we announced final clinical and translational research data from the OVATION Study, a Phase Ib dose escalating clinical trial combining GEN-1 with the standard of care for the treatment of newly-diagnosed patients with advanced Stage III/IV ovarian cancer who will undergo neoadjuvant chemotherapy followed by interval debulking surgery.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017.", "<tag2>", "On", "October", "3,", "2017,", "we", "announced", "final", "clinical", "and", "translational", "research", "data", "from", "the", "OVATION", "Study,", "a", "Phase", "Ib", "dose", "escalating", "clinical", "trial", "combining", "GEN-1", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "patients", "with", "advanced", "Stage", "III/IV", "ovarian", "cancer", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "interval", "debulking", "surgery.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017."], "wordsB": ["On", "October", "3,", "2017,", "we", "announced", "final", "clinical", "and", "translational", "research", "data", "from", "the", "OVATION", "Study,", "a", "Phase", "Ib", "dose", "escalating", "clinical", "trial", "combining", "GEN-1", "with", "the", "standard", "of", "care", "for", "the", "treatment", "of", "newly-diagnosed", "patients", "with", "advanced", "Stage", "III/IV", "ovarian", "cancer", "who", "will", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "interval", "debulking", "surgery."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.061187196522951126, 0.5016038417816162, 0.3655858337879181, 0.09151684492826462, 0.02733231522142887, 0.20480427145957947, 0.016293810680508614, 0.007774898316711187, 0.0033321212977170944, 0.00417499803006649, 0.00744117796421051, 0.036250606179237366, 0.0035532317124307156, 0.003025919897481799, 0.01101695280522108, 0.015907494351267815, 0.0052695381455123425, 0.029929690062999725, 0.03485582023859024, 0.03324320539832115, 0.03159583732485771, 0.02609729953110218, 0.03011324442923069, 0.018260318785905838, 0.036874160170555115, 0.006583063397556543, 0.006542270537465811, 0.013884929940104485, 0.011935428716242313, 0.024406326934695244, 0.00981732364743948, 0.0031005972996354103, 0.023984897881746292, 0.009151267819106579, 0.05737907439470291, 0.07937958091497421, 0.013533498160541058, 0.04149571433663368, 0.04637554660439491, 0.06464962661266327, 0.09028635919094086, 0.04930863529443741, 0.0002577740524429828, 0.005899664014577866, 0.04181278124451637, 0.12527629733085632, 0.09795317053794861, 0.009810216724872589, 0.02545294538140297, 0.18125265836715698, 0.3276323974132538, 0.2161381095647812, -1]}
{"idB": "749647_18_item1_p59_s0", "idA": "749647_17_item1_p135_s1", "sentA": "We expect to report the final clinical and translational data from the OVATION Study in mid-2017.", "sentB": "The Company held an Advisory Board Meeting on September 27, 2017 with the clinical investigators and scientific experts including those from Roswell Park Cancer Institute, Vanderbilt University Medical School, and M.D. Anderson Cancer Center to review and finalize clinical, translational research and safety data from the Phase IB OVATION Study in order to determine the next steps forward for our GEN-1 immunotherapy program.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017.", "<tag2>", "The", "Company", "held", "an", "Advisory", "Board", "Meeting", "on", "September", "27,", "2017", "with", "the", "clinical", "investigators", "and", "scientific", "experts", "including", "those", "from", "Roswell", "Park", "Cancer", "Institute,", "Vanderbilt", "University", "Medical", "School,", "and", "M.D.", "Anderson", "Cancer", "Center", "to", "review", "and", "finalize", "clinical,", "translational", "research", "and", "safety", "data", "from", "the", "Phase", "IB", "OVATION", "Study", "in", "order", "to", "determine", "the", "next", "steps", "forward", "for", "our", "GEN-1", "immunotherapy", "program.", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017."], "wordsB": ["The", "Company", "held", "an", "Advisory", "Board", "Meeting", "on", "September", "27,", "2017", "with", "the", "clinical", "investigators", "and", "scientific", "experts", "including", "those", "from", "Roswell", "Park", "Cancer", "Institute,", "Vanderbilt", "University", "Medical", "School,", "and", "M.D.", "Anderson", "Cancer", "Center", "to", "review", "and", "finalize", "clinical,", "translational", "research", "and", "safety", "data", "from", "the", "Phase", "IB", "OVATION", "Study", "in", "order", "to", "determine", "the", "next", "steps", "forward", "for", "our", "GEN-1", "immunotherapy", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011841660365462303, 0.0790359154343605, 0.14374421536922455, 0.08070001751184464, 0.1939462572336197, 0.20956753194332123, 0.3768112361431122, 0.044035449624061584, 0.45422959327697754, 0.33186575770378113, 0.07340682297945023, 0.02321106381714344, 0.008280626498162746, 0.03242490813136101, 0.029366835951805115, 0.008522014133632183, 0.0202593132853508, 0.04140337556600571, 0.005482843145728111, 0.00815935805439949, 0.016019780188798904, 0.1664128601551056, 0.14999979734420776, 0.19689030945301056, 0.21864622831344604, 0.12086332589387894, 0.126869797706604, 0.09481974691152573, 0.11881618201732635, 0.009418986737728119, 0.07447625696659088, 0.07621334493160248, 0.10997707396745682, 0.14194943010807037, 0.016379622742533684, 0.08344869315624237, 0.017692208290100098, 0.04195862263441086, 0.011866772547364235, 0.00619527930393815, 0.008184564299881458, 0.0036851067561656237, 0.009059814736247063, 0.030160823836922646, 0.0050727203488349915, 0.005146798677742481, 0.026847174391150475, 0.026917025446891785, 0.034183718264102936, 0.0386192686855793, 0.0022037748713046312, 0.009628517553210258, 0.007488270755857229, 0.03251643106341362, 0.014001316390931606, 0.024823103100061417, 0.043827205896377563, 0.02344442345201969, 0.006910896860063076, 0.006892222445458174, 0.058629054576158524, 0.06652769446372986, 0.04675786942243576, -1]}
{"idB": "749647_18_item1_p62_s0", "idA": "749647_17_item1_p135_s1", "sentA": "We expect to report the final clinical and translational data from the OVATION Study in mid-2017.", "sentB": "The study protocol was unanimously supported by an expert medical advisory board and lead investigators from the Phase IB OVATION Study and is summarized below:", "type": 2, "words": ["<tag1>", "We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017.", "<tag2>", "The", "study", "protocol", "was", "unanimously", "supported", "by", "an", "expert", "medical", "advisory", "board", "and", "lead", "investigators", "from", "the", "Phase", "IB", "OVATION", "Study", "and", "is", "summarized", "below:", "<tag3>"], "wordsA": ["We", "expect", "to", "report", "the", "final", "clinical", "and", "translational", "data", "from", "the", "OVATION", "Study", "in", "mid-2017."], "wordsB": ["The", "study", "protocol", "was", "unanimously", "supported", "by", "an", "expert", "medical", "advisory", "board", "and", "lead", "investigators", "from", "the", "Phase", "IB", "OVATION", "Study", "and", "is", "summarized", "below:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.019633742049336433, 0.24299511313438416, 0.27884966135025024, 0.04620543494820595, 0.24016115069389343, 0.14826640486717224, 0.025396015495061874, 0.020545855164527893, 0.09662516415119171, 0.15439236164093018, 0.10874861478805542, 0.1129976361989975, 0.010086686350405216, 0.07735705375671387, 0.1260012686252594, 0.011410650797188282, 0.00975386705249548, 0.0561266727745533, 0.0909738764166832, 0.041752394288778305, 0.04793296381831169, 0.00016846712969709188, 0.03167035058140755, 0.1420857459306717, 0.13719266653060913, -1]}
{"idB": "749647_18_item1_p239_s2", "idA": "749647_17_item1_p136_s0", "sentA": "In April 2015, we announced plans to expand our ovarian cancer development program to include a Phase 1 dose escalating trial evaluating GEN-1 in combination with Avastin and Doxil in platinum-resistant ovarian cancer patients.", "sentB": "In addition, we have initiated a Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer, known as the OVATION Study, and plan to expand our ovarian cancer development program to include a Phase I /II dose escalating trial evaluating GEN-1, known as the OVATION II Study, in ovarian cancer patients.", "type": 2, "words": ["<tag1>", "In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients.", "<tag2>", "In", "addition,", "we", "have", "initiated", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer,", "known", "as", "the", "OVATION", "Study,", "and", "plan", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "I", "/II", "dose", "escalating", "trial", "evaluating", "GEN-1,", "known", "as", "the", "OVATION", "II", "Study,", "in", "ovarian", "cancer", "patients.", "<tag3>"], "wordsA": ["In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients."], "wordsB": ["In", "addition,", "we", "have", "initiated", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer,", "known", "as", "the", "OVATION", "Study,", "and", "plan", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "I", "/II", "dose", "escalating", "trial", "evaluating", "GEN-1,", "known", "as", "the", "OVATION", "II", "Study,", "in", "ovarian", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012899443507194519, 0.008874784223735332, 0.01201810222119093, 0.00607718201354146, 0.018506702035665512, 0.0034172823652625084, 0.015864558517932892, 0.3577183187007904, 0.035280659794807434, 0.02130693383514881, 0.012858341448009014, 0.003284996375441551, 0.026405220851302147, 0.002555835759267211, 0.005299936048686504, 0.003085362259298563, 0.0027590624522417784, 0.03313658758997917, 0.013222361914813519, 0.06586271524429321, 0.010496844537556171, 0.6459312438964844, 0.07316801697015762, 0.06289667636156082, 0.0020347568206489086, 0.0018465126631781459, 0.0022862530313432217, 0.026615802198648453, 0.06380146741867065, 0.0002882799890358001, 0.0035531404428184032, 0.00011050912144128233, 0.0042367540299892426, 0.00229412829503417, 0.00400137435644865, 0.004613503813743591, 0.0043723550625145435, 0.006251997780054808, 0.0020355279557406902, 0.003664652118459344, 0.002397462958469987, 0.04101401939988136, 0.3993196189403534, 0.902539849281311, 0.05118532106280327, 0.006797680165618658, 0.009815867990255356, 0.00372568191960454, 0.006550755351781845, 0.0023991812486201525, 0.0020198000129312277, 0.0021806443110108376, 0.048596709966659546, 0.38540300726890564, 0.15863105654716492, 0.0020970110781490803, 0.007115274202078581, 0.007797420956194401, 0.013112839311361313, -1]}
{"idB": "749647_18_item1_p268_s2", "idA": "749647_17_item1_p136_s0", "sentA": "In April 2015, we announced plans to expand our ovarian cancer development program to include a Phase 1 dose escalating trial evaluating GEN-1 in combination with Avastin and Doxil in platinum-resistant ovarian cancer patients.", "sentB": "We also plan to expand our ovarian cancer development program to include a Phase I/II dose escalating trial evaluating GEN-1 in ovarian cancer patients.", "type": 2, "words": ["<tag1>", "In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients.", "<tag2>", "We", "also", "plan", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "I/II", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "ovarian", "cancer", "patients.", "<tag3>"], "wordsA": ["In", "April", "2015,", "we", "announced", "plans", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "1", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "combination", "with", "Avastin", "and", "Doxil", "in", "platinum-resistant", "ovarian", "cancer", "patients."], "wordsB": ["We", "also", "plan", "to", "expand", "our", "ovarian", "cancer", "development", "program", "to", "include", "a", "Phase", "I/II", "dose", "escalating", "trial", "evaluating", "GEN-1", "in", "ovarian", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0062708621844649315, 0.003682247130200267, 0.009504261426627636, 0.0029214543756097555, 0.004636473022401333, 0.0021475183311849833, 0.007981874980032444, 0.004226009361445904, 0.0034666259307414293, 0.004127487540245056, 0.0015356774674728513, 0.003948466386646032, 0.002801816910505295, 0.07272669672966003, 0.9841070175170898, 0.1086694747209549, 0.006895486731082201, 0.009496785700321198, 0.004661388695240021, 0.00811106339097023, 0.00219676923006773, 0.0041559855453670025, 0.006328088231384754, 0.0108247771859169, -1]}
{"idB": "749647_18_item1_p236_s3", "idA": "749647_17_item1_p13_s0", "sentA": "On February 24, 2014, we announced that the United States Food and Drug Administration (the FDA ), after its customary 30-day review period, provided clearance for the OPTIMA Study, which is a pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox , in combination with standardized RFA, for the treatment of primary liver cancer.", "sentB": "Because we are committed to continuing our product research, development, clinical trial and commercialization programs, we will continue to incur significant operating losses unless and until we complete the development of ThermoDox , GEN-1 and other new product candidates and these product candidates have been clinically tested, approved by the United States Food and Drug Administration (FDA) and successfully marketed.", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "United", "States", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "after", "its", "customary", "30-day", "review", "period,", "provided", "clearance", "for", "the", "OPTIMA", "Study,", "which", "is", "a", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", ",", "in", "combination", "with", "standardized", "RFA,", "for", "the", "treatment", "of", "primary", "liver", "cancer.", "<tag2>", "Because", "we", "are", "committed", "to", "continuing", "our", "product", "research,", "development,", "clinical", "trial", "and", "commercialization", "programs,", "we", "will", "continue", "to", "incur", "significant", "operating", "losses", "unless", "and", "until", "we", "complete", "the", "development", "of", "ThermoDox", ",", "GEN-1", "and", "other", "new", "product", "candidates", "and", "these", "product", "candidates", "have", "been", "clinically", "tested,", "approved", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA)", "and", "successfully", "marketed.", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "United", "States", "Food", "and", "Drug", "Administration", "(the", "FDA", "),", "after", "its", "customary", "30-day", "review", "period,", "provided", "clearance", "for", "the", "OPTIMA", "Study,", "which", "is", "a", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", ",", "in", "combination", "with", "standardized", "RFA,", "for", "the", "treatment", "of", "primary", "liver", "cancer."], "wordsB": ["Because", "we", "are", "committed", "to", "continuing", "our", "product", "research,", "development,", "clinical", "trial", "and", "commercialization", "programs,", "we", "will", "continue", "to", "incur", "significant", "operating", "losses", "unless", "and", "until", "we", "complete", "the", "development", "of", "ThermoDox", ",", "GEN-1", "and", "other", "new", "product", "candidates", "and", "these", "product", "candidates", "have", "been", "clinically", "tested,", "approved", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA)", "and", "successfully", "marketed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01165893767029047, 0.02838900126516819, 0.015697944909334183, 0.03176117315888405, 0.015887219458818436, 0.029241614043712616, 0.014917305670678616, 0.04669196158647537, 0.03585335612297058, 0.02861073613166809, 0.028928162530064583, 0.030528148636221886, 0.011388542130589485, 0.10513900965452194, 0.05911673977971077, 0.02085670828819275, 0.026347903534770012, 0.039588265120983124, 0.03387818485498428, 0.09961117804050446, 0.1600336730480194, 0.318636417388916, 0.47433966398239136, 0.0721738412976265, 0.035880763083696365, 0.03736269846558571, 0.038951002061367035, 0.09858603030443192, 0.0318007692694664, 0.09039580821990967, 0.02466655895113945, 0.04320976510643959, 0.000886766763869673, 0.18200242519378662, 0.01498742401599884, 0.013892634771764278, 0.05596118047833443, 0.1258605271577835, 0.0824812650680542, 0.005790161434561014, 0.005516646429896355, 0.07165618240833282, 0.07833952456712723, 0.01615089364349842, 0.026892531663179398, 0.09629509598016739, 0.08671747893095016, 0.06776361167430878, 0.006469013635069132, 0.006688617169857025, 0.006916292477399111, 0.005835544317960739, 0.007806720212101936, 0.0046561043709516525, 0.006669173948466778, 0.010391040705144405, 0.015724994242191315, 0.008354363963007927, 0.3415363132953644, 0.4788835942745209, -1]}
{"idB": "749647_18_item1_p329_s1", "idA": "749647_17_item1_p144_s0", "sentA": "Analysis of serum chemistry and hematology suggested no overt toxicities associated with the combined treatments.", "sentB": "Our operations associated with the EGEN acquisition are located in Huntsville, Alabama.", "type": 2, "words": ["<tag1>", "Analysis", "of", "serum", "chemistry", "and", "hematology", "suggested", "no", "overt", "toxicities", "associated", "with", "the", "combined", "treatments.", "<tag2>", "Our", "operations", "associated", "with", "the", "EGEN", "acquisition", "are", "located", "in", "Huntsville,", "Alabama.", "<tag3>"], "wordsA": ["Analysis", "of", "serum", "chemistry", "and", "hematology", "suggested", "no", "overt", "toxicities", "associated", "with", "the", "combined", "treatments."], "wordsB": ["Our", "operations", "associated", "with", "the", "EGEN", "acquisition", "are", "located", "in", "Huntsville,", "Alabama."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07925926893949509, 0.27297502756118774, 0.034742213785648346, 0.023438742384314537, 0.020876972004771233, 0.16995656490325928, 0.13700099289417267, 0.017918704077601433, 0.047405704855918884, 0.06910651177167892, 0.562841534614563, 0.422862708568573, -1]}
{"idB": "749647_18_item1_p356_s4", "idA": "749647_17_item1_p147_s1", "sentA": "The transfection activity and toxicity of PEI is tightly coupled to its molecular weight therefore the clinical application of PEI is limited.", "sentB": "As a result, the utilization of our federal tax net operating loss carry forwards generated prior to the ownership changes is limited.", "type": 2, "words": ["<tag1>", "The", "transfection", "activity", "and", "toxicity", "of", "PEI", "is", "tightly", "coupled", "to", "its", "molecular", "weight", "therefore", "the", "clinical", "application", "of", "PEI", "is", "limited.", "<tag2>", "As", "a", "result,", "the", "utilization", "of", "our", "federal", "tax", "net", "operating", "loss", "carry", "forwards", "generated", "prior", "to", "the", "ownership", "changes", "is", "limited.", "<tag3>"], "wordsA": ["The", "transfection", "activity", "and", "toxicity", "of", "PEI", "is", "tightly", "coupled", "to", "its", "molecular", "weight", "therefore", "the", "clinical", "application", "of", "PEI", "is", "limited."], "wordsB": ["As", "a", "result,", "the", "utilization", "of", "our", "federal", "tax", "net", "operating", "loss", "carry", "forwards", "generated", "prior", "to", "the", "ownership", "changes", "is", "limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008207705803215504, 0.009448184631764889, 0.019377758726477623, 0.011986596509814262, 0.16436314582824707, 0.030999785289168358, 0.02958650141954422, 0.17437772452831268, 0.2511425018310547, 0.21215705573558807, 0.2862508296966553, 0.32630616426467896, 0.12608341872692108, 0.1263560950756073, 0.016016367822885513, 0.013177045620977879, 0.009772665798664093, 0.00859089381992817, 0.11137289553880692, 0.08795884251594543, 0.026311596855521202, 0.212123304605484, -1]}
{"idB": "749647_18_item1_p239_s0", "idA": "749647_17_item1_p14_s0", "sentA": "The trial design of the OPTIMA Study is based on the comprehensive analysis of data from an earlier clinical trial called the HEAT Study (the HEAT Study ), which is described below.", "sentB": "The trial design of the OPTIMA study is based on the overall survival data from the post-hoc analysis of results from the HEAT study.", "type": 2, "words": ["<tag1>", "The", "trial", "design", "of", "the", "OPTIMA", "Study", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "an", "earlier", "clinical", "trial", "called", "the", "HEAT", "Study", "(the", "HEAT", "Study", "),", "which", "is", "described", "below.", "<tag2>", "The", "trial", "design", "of", "the", "OPTIMA", "study", "is", "based", "on", "the", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["The", "trial", "design", "of", "the", "OPTIMA", "Study", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "an", "earlier", "clinical", "trial", "called", "the", "HEAT", "Study", "(the", "HEAT", "Study", "),", "which", "is", "described", "below."], "wordsB": ["The", "trial", "design", "of", "the", "OPTIMA", "study", "is", "based", "on", "the", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002694926457479596, 0.03247610107064247, 0.023676998913288116, 0.0021704980172216892, 0.002327005146071315, 0.011348229832947254, 0.01338139921426773, 0.002127306070178747, 0.02248142473399639, 0.009601703844964504, 0.007953517138957977, 0.6423223614692688, 0.4330100417137146, 0.24634583294391632, 0.016730813309550285, 0.012070166878402233, 0.5931596159934998, 0.3567955493927002, 0.024715110659599304, 0.09624040126800537, 0.012257428839802742, 0.006600518710911274, 0.06148364767432213, 0.04987543821334839, -1]}
{"idB": "749647_18_item1_p147_s1", "idA": "749647_17_item1_p154_s1", "sentA": "We believe that these advantages place Celsion in an excellent position to capitalize on the technology.", "sentB": "We believe that these advantages place Celsion in strong position to capitalize on the technology.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "these", "advantages", "place", "Celsion", "in", "an", "excellent", "position", "to", "capitalize", "on", "the", "technology.", "<tag2>", "We", "believe", "that", "these", "advantages", "place", "Celsion", "in", "strong", "position", "to", "capitalize", "on", "the", "technology.", "<tag3>"], "wordsA": ["We", "believe", "that", "these", "advantages", "place", "Celsion", "in", "an", "excellent", "position", "to", "capitalize", "on", "the", "technology."], "wordsB": ["We", "believe", "that", "these", "advantages", "place", "Celsion", "in", "strong", "position", "to", "capitalize", "on", "the", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005012590903788805, 0.007753375917673111, 0.002450020518153906, 0.0023857858031988144, 0.00964187178760767, 0.008518634364008904, 0.008600913919508457, 0.015445900149643421, 0.9926086068153381, 0.3613972067832947, 0.002232755534350872, 0.006739407777786255, 0.002103334991261363, 0.0017502408009022474, 0.007632474415004253, -1]}
{"idB": "749647_18_item1_p333_s1", "idA": "749647_17_item1_p154_s1", "sentA": "We believe that these advantages place Celsion in an excellent position to capitalize on the technology.", "sentB": "We believe that the level of interest by others in investigating the potential of possible competitive treatments and alternative technologies will continue and may increase.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "these", "advantages", "place", "Celsion", "in", "an", "excellent", "position", "to", "capitalize", "on", "the", "technology.", "<tag2>", "We", "believe", "that", "the", "level", "of", "interest", "by", "others", "in", "investigating", "the", "potential", "of", "possible", "competitive", "treatments", "and", "alternative", "technologies", "will", "continue", "and", "may", "increase.", "<tag3>"], "wordsA": ["We", "believe", "that", "these", "advantages", "place", "Celsion", "in", "an", "excellent", "position", "to", "capitalize", "on", "the", "technology."], "wordsB": ["We", "believe", "that", "the", "level", "of", "interest", "by", "others", "in", "investigating", "the", "potential", "of", "possible", "competitive", "treatments", "and", "alternative", "technologies", "will", "continue", "and", "may", "increase."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027197767049074173, 0.0735141709446907, 0.039382800459861755, 0.039312396198511124, 0.24578849971294403, 0.19558265805244446, 0.30338558554649353, 0.061971187591552734, 0.12379301339387894, 0.03559060022234917, 0.10382948815822601, 0.03906511515378952, 0.04799237474799156, 0.020801294595003128, 0.029353931546211243, 0.1069348007440567, 0.16365033388137817, 0.00939403660595417, 0.08431533724069595, 0.12642015516757965, 0.06764005869626999, 0.19421440362930298, 0.0783289298415184, 0.09972618520259857, 0.2759891152381897, -1]}
{"idB": "749647_18_item1_p236_s2", "idA": "749647_17_item1_p155_s0", "sentA": "We have not generated and do not expect to generate any revenue from product sales in the next several years, if at all.", "sentB": "We currently have no product revenue and do not expect to generate any product revenue for the foreseeable future.", "type": 2, "words": ["<tag1>", "We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all.", "<tag2>", "We", "currently", "have", "no", "product", "revenue", "and", "do", "not", "expect", "to", "generate", "any", "product", "revenue", "for", "the", "foreseeable", "future.", "<tag3>"], "wordsA": ["We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all."], "wordsB": ["We", "currently", "have", "no", "product", "revenue", "and", "do", "not", "expect", "to", "generate", "any", "product", "revenue", "for", "the", "foreseeable", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02278371900320053, 0.0750286728143692, 0.2146352082490921, 0.932820737361908, 0.8321921229362488, 0.7603916525840759, 0.005474474746733904, 0.1153349056839943, 0.1358400583267212, 0.06760867685079575, 0.0542495921254158, 0.0961298868060112, 0.07965509593486786, 0.11454958468675613, 0.11694827675819397, 0.02526763826608658, 0.011641960591077805, 0.019393226131796837, 0.051014937460422516, -1]}
{"idB": "749647_18_item1_p242_s0", "idA": "749647_17_item1_p155_s0", "sentA": "We have not generated and do not expect to generate any revenue from product sales in the next several years, if at all.", "sentB": "We have not generated significant revenue and have incurred significant net losses in each year since our inception.", "type": 2, "words": ["<tag1>", "We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all.", "<tag2>", "We", "have", "not", "generated", "significant", "revenue", "and", "have", "incurred", "significant", "net", "losses", "in", "each", "year", "since", "our", "inception.", "<tag3>"], "wordsA": ["We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all."], "wordsB": ["We", "have", "not", "generated", "significant", "revenue", "and", "have", "incurred", "significant", "net", "losses", "in", "each", "year", "since", "our", "inception."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03131858631968498, 0.06996976584196091, 0.5012736916542053, 0.25153055787086487, 0.34342846274375916, 0.23476138710975647, 0.011000942438840866, 0.0839739516377449, 0.3770521581172943, 0.3434886932373047, 0.3305876851081848, 0.5711180567741394, 0.04285682365298271, 0.059463948011398315, 0.06464224308729172, 0.04237620532512665, 0.01311576459556818, 0.028701839968562126, -1]}
{"idB": "749647_18_item1_p266_s0", "idA": "749647_17_item1_p155_s0", "sentA": "We have not generated and do not expect to generate any revenue from product sales in the next several years, if at all.", "sentB": "We do not expect to generate revenue for the foreseeable future.", "type": 2, "words": ["<tag1>", "We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all.", "<tag2>", "We", "do", "not", "expect", "to", "generate", "revenue", "for", "the", "foreseeable", "future.", "<tag3>"], "wordsA": ["We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all."], "wordsB": ["We", "do", "not", "expect", "to", "generate", "revenue", "for", "the", "foreseeable", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03256407007575035, 0.5853902697563171, 0.8103473782539368, 0.4393201172351837, 0.158282071352005, 0.17887865006923676, 0.34212934970855713, 0.13151665031909943, 0.08910887688398361, 0.5609025359153748, 0.5247139930725098, -1]}
{"idB": "749647_18_item1_p292_s1", "idA": "749647_17_item1_p155_s0", "sentA": "We have not generated and do not expect to generate any revenue from product sales in the next several years, if at all.", "sentB": "We do not expect to significantly increase our personnel in the foreseeable future and may continue to rely on third parties to conduct all of our future clinical trials.", "type": 2, "words": ["<tag1>", "We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all.", "<tag2>", "We", "do", "not", "expect", "to", "significantly", "increase", "our", "personnel", "in", "the", "foreseeable", "future", "and", "may", "continue", "to", "rely", "on", "third", "parties", "to", "conduct", "all", "of", "our", "future", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all."], "wordsB": ["We", "do", "not", "expect", "to", "significantly", "increase", "our", "personnel", "in", "the", "foreseeable", "future", "and", "may", "continue", "to", "rely", "on", "third", "parties", "to", "conduct", "all", "of", "our", "future", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03152231499552727, 0.09424443542957306, 0.2104959338903427, 0.1382322907447815, 0.09261124581098557, 0.3742053806781769, 0.556765079498291, 0.24757421016693115, 0.32441896200180054, 0.01269017904996872, 0.0099459458142519, 0.019970491528511047, 0.031017720699310303, 0.00015616242308169603, 0.021501624956727028, 0.0944375991821289, 0.03965579718351364, 0.14201588928699493, 0.03909521549940109, 0.1162051409482956, 0.14176125824451447, 0.007826678454875946, 0.041859667748212814, 0.02886636182665825, 0.012521703727543354, 0.0114503288641572, 0.04215158149600029, 0.07021644711494446, 0.1061209887266159, -1]}
{"idB": "749647_18_item1_p357_s0", "idA": "749647_17_item1_p155_s0", "sentA": "We have not generated and do not expect to generate any revenue from product sales in the next several years, if at all.", "sentB": "We have never paid cash dividends on our common stock in the past and do not anticipate paying cash dividends on our common stock in the foreseeable future.", "type": 2, "words": ["<tag1>", "We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all.", "<tag2>", "We", "have", "never", "paid", "cash", "dividends", "on", "our", "common", "stock", "in", "the", "past", "and", "do", "not", "anticipate", "paying", "cash", "dividends", "on", "our", "common", "stock", "in", "the", "foreseeable", "future.", "<tag3>"], "wordsA": ["We", "have", "not", "generated", "and", "do", "not", "expect", "to", "generate", "any", "revenue", "from", "product", "sales", "in", "the", "next", "several", "years,", "if", "at", "all."], "wordsB": ["We", "have", "never", "paid", "cash", "dividends", "on", "our", "common", "stock", "in", "the", "past", "and", "do", "not", "anticipate", "paying", "cash", "dividends", "on", "our", "common", "stock", "in", "the", "foreseeable", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04055994004011154, 0.053966011852025986, 0.5279902815818787, 0.5484946370124817, 0.506375789642334, 0.4639330506324768, 0.05802595242857933, 0.03218892961740494, 0.07784874737262726, 0.08493587374687195, 0.04932480305433273, 0.03239740431308746, 0.08769524842500687, 0.006083946209400892, 0.12904033064842224, 0.24229764938354492, 0.18246540427207947, 0.38944190740585327, 0.47547972202301025, 0.406020849943161, 0.028035275638103485, 0.014610645361244678, 0.029073668643832207, 0.030357811599969864, 0.023488027974963188, 0.018811440095305443, 0.04196369647979736, 0.07431463152170181, -1]}
{"idB": "749647_18_item1_p288_s1", "idA": "749647_17_item1_p155_s2", "sentA": "We may also evaluate licensing cancer products from third parties for cancer treatments to expand our current product pipeline.", "sentB": "We may unintentionally infringe upon valid patent rights of third parties.", "type": 2, "words": ["<tag1>", "We", "may", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "current", "product", "pipeline.", "<tag2>", "We", "may", "unintentionally", "infringe", "upon", "valid", "patent", "rights", "of", "third", "parties.", "<tag3>"], "wordsA": ["We", "may", "also", "evaluate", "licensing", "cancer", "products", "from", "third", "parties", "for", "cancer", "treatments", "to", "expand", "our", "current", "product", "pipeline."], "wordsB": ["We", "may", "unintentionally", "infringe", "upon", "valid", "patent", "rights", "of", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03240949660539627, 0.022309763357043266, 0.1860579252243042, 0.3498344421386719, 0.14753425121307373, 0.3206983804702759, 0.8380773663520813, 0.7011356353759766, 0.02051706239581108, 0.05472114309668541, 0.06357941031455994, -1]}
{"idB": "749647_18_item1_p237_s0", "idA": "749647_17_item1_p157_s0", "sentA": "As demonstrated by the HEAT Study results, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "sentB": "Drug development is an inherently uncertain process with a high risk of failure at every stage of development.", "type": 2, "words": ["<tag1>", "As", "demonstrated", "by", "the", "HEAT", "Study", "results,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag2>", "Drug", "development", "is", "an", "inherently", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development.", "<tag3>"], "wordsA": ["As", "demonstrated", "by", "the", "HEAT", "Study", "results,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "wordsB": ["Drug", "development", "is", "an", "inherently", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.12452749162912369, 0.6702925562858582, 0.009418255649507046, 0.004948556423187256, 0.015120756812393665, 0.0370456837117672, 0.048293180763721466, 0.003701976500451565, 0.007414599880576134, 0.05555347725749016, 0.053529057651758194, 0.04199117422103882, 0.44925811886787415, 0.01856238767504692, 0.021063726395368576, 0.034852948039770126, 0.08508367836475372, 0.2901792824268341, -1]}
{"idB": "749647_18_item1_p319_s0", "idA": "749647_17_item1_p158_s0", "sentA": "The timing and the outcome of clinical results are extremely difficult to predict.", "sentB": "The commercial potential of a drug candidate in development is difficult to predict.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "are", "extremely", "difficult", "to", "predict.", "<tag2>", "The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "are", "extremely", "difficult", "to", "predict."], "wordsB": ["The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04233879595994949, 0.7969457507133484, 0.5467570424079895, 0.08362322300672531, 0.09962419420480728, 0.3448300063610077, 0.3726544678211212, 0.058554939925670624, 0.09537556767463684, 0.008980155922472477, 0.02906365692615509, 0.017699478194117546, 0.039765771478414536, -1]}
{"idB": "749647_18_item1_p353_s1", "idA": "749647_17_item1_p158_s1", "sentA": "The success or failure of any preclinical development and clinical trial can have a disproportionately positive or negative impact on our results of operations, financial condition, prospects and market value.", "sentB": "Our results of operations, financial condition, cash flows and capital position could be materially adversely affected by continued disruptions in the capital and credit markets.", "type": 2, "words": ["<tag1>", "The", "success", "or", "failure", "of", "any", "preclinical", "development", "and", "clinical", "trial", "can", "have", "a", "disproportionately", "positive", "or", "negative", "impact", "on", "our", "results", "of", "operations,", "financial", "condition,", "prospects", "and", "market", "value.", "<tag2>", "Our", "results", "of", "operations,", "financial", "condition,", "cash", "flows", "and", "capital", "position", "could", "be", "materially", "adversely", "affected", "by", "continued", "disruptions", "in", "the", "capital", "and", "credit", "markets.", "<tag3>"], "wordsA": ["The", "success", "or", "failure", "of", "any", "preclinical", "development", "and", "clinical", "trial", "can", "have", "a", "disproportionately", "positive", "or", "negative", "impact", "on", "our", "results", "of", "operations,", "financial", "condition,", "prospects", "and", "market", "value."], "wordsB": ["Our", "results", "of", "operations,", "financial", "condition,", "cash", "flows", "and", "capital", "position", "could", "be", "materially", "adversely", "affected", "by", "continued", "disruptions", "in", "the", "capital", "and", "credit", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007255527190864086, 0.03192446008324623, 0.004175223875790834, 0.014654797501862049, 0.013710908591747284, 0.013186722062528133, 0.23899675905704498, 0.30067113041877747, 0.011792026460170746, 0.23228110373020172, 0.25176572799682617, 0.00960665661841631, 0.008138400502502918, 0.05391170084476471, 0.11083944141864777, 0.1406102180480957, 0.028330568224191666, 0.10508625209331512, 0.4267907738685608, 0.07066220790147781, 0.05569910630583763, 0.278695285320282, 0.11540695279836655, 0.37197089195251465, 0.3899109959602356, -1]}
{"idB": "749647_18_item1_p177_s3", "idA": "749647_17_item1_p159_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "For example, Fast Track is a process designed to facilitate the development and expedite the review of product candidates to treat serious or life-threatening diseases or conditions and fill unmet medical needs.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "For", "example,", "Fast", "Track", "is", "a", "process", "designed", "to", "facilitate", "the", "development", "and", "expedite", "the", "review", "of", "product", "candidates", "to", "treat", "serious", "or", "life-threatening", "diseases", "or", "conditions", "and", "fill", "unmet", "medical", "needs.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["For", "example,", "Fast", "Track", "is", "a", "process", "designed", "to", "facilitate", "the", "development", "and", "expedite", "the", "review", "of", "product", "candidates", "to", "treat", "serious", "or", "life-threatening", "diseases", "or", "conditions", "and", "fill", "unmet", "medical", "needs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017702611163258553, 0.017450666055083275, 0.6856793761253357, 0.7890702486038208, 0.008131290785968304, 0.00968010351061821, 0.0983436331152916, 0.009776921011507511, 0.00799301452934742, 0.029311934486031532, 0.007765450980514288, 0.06481114029884338, 0.008456330746412277, 0.060722172260284424, 0.022885682061314583, 0.11767541617155075, 0.03139456361532211, 0.07565441727638245, 0.08945633471012115, 0.004627281799912453, 0.01328407134860754, 0.012548688799142838, 0.008106111548841, 0.018711833283305168, 0.013081374578177929, 0.0090058334171772, 0.009782033041119576, 0.0049962811172008514, 0.00989396683871746, 0.023556431755423546, 0.03529536724090576, 0.037536539137363434, -1]}
{"idB": "749647_18_item1_p241_s1", "idA": "749647_17_item1_p159_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "If we are not able to raise additional capital, we may not be able to complete the development, testing and commercialization of our product candidates.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "If", "we", "are", "not", "able", "to", "raise", "additional", "capital,", "we", "may", "not", "be", "able", "to", "complete", "the", "development,", "testing", "and", "commercialization", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["If", "we", "are", "not", "able", "to", "raise", "additional", "capital,", "we", "may", "not", "be", "able", "to", "complete", "the", "development,", "testing", "and", "commercialization", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03306727856397629, 0.05844791233539581, 0.050368960946798325, 0.25047731399536133, 0.2333492487668991, 0.16699276864528656, 0.3837551176548004, 0.2855815887451172, 0.3218911588191986, 0.04609724134206772, 0.07231788337230682, 0.47933635115623474, 0.16351546347141266, 0.3059711158275604, 0.26652759313583374, 0.2504400610923767, 0.061466798186302185, 0.04257146641612053, 0.024399027228355408, 0.011699998751282692, 0.022500110790133476, 0.00838561449199915, 0.01246066763997078, 0.026703383773565292, 0.03395137935876846, -1]}
{"idB": "749647_18_item1_p244_s0", "idA": "749647_17_item1_p159_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "To complete the development and commercialization of our product candidates, we will need to raise substantial amounts of additional capital to fund our operations.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "To", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates,", "we", "will", "need", "to", "raise", "substantial", "amounts", "of", "additional", "capital", "to", "fund", "our", "operations.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["To", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates,", "we", "will", "need", "to", "raise", "substantial", "amounts", "of", "additional", "capital", "to", "fund", "our", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01801452226936817, 0.01024308055639267, 0.006459035445004702, 0.004530663602054119, 0.0037762026768177748, 0.004265525843948126, 0.0031906082294881344, 0.00369063438847661, 0.008181406185030937, 0.009541564621031284, 0.036647338420152664, 0.024889450520277023, 0.06351341307163239, 0.037236593663692474, 0.5287892818450928, 0.33000442385673523, 0.31416240334510803, 0.21965263783931732, 0.21880389750003815, 0.383161336183548, 0.018148576840758324, 0.044342316687107086, 0.01937466487288475, 0.058366965502500534, -1]}
{"idB": "749647_18_item1_p245_s1", "idA": "749647_17_item1_p159_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "We also could be required to seek funds through arrangements with collaborators or others that may require us to relinquish rights to some of our technologies, product candidates or potential markets or that could impose onerous financial or other terms.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "We", "also", "could", "be", "required", "to", "seek", "funds", "through", "arrangements", "with", "collaborators", "or", "others", "that", "may", "require", "us", "to", "relinquish", "rights", "to", "some", "of", "our", "technologies,", "product", "candidates", "or", "potential", "markets", "or", "that", "could", "impose", "onerous", "financial", "or", "other", "terms.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["We", "also", "could", "be", "required", "to", "seek", "funds", "through", "arrangements", "with", "collaborators", "or", "others", "that", "may", "require", "us", "to", "relinquish", "rights", "to", "some", "of", "our", "technologies,", "product", "candidates", "or", "potential", "markets", "or", "that", "could", "impose", "onerous", "financial", "or", "other", "terms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03543490171432495, 0.0121601652354002, 0.02175966091454029, 0.015445987693965435, 0.0807579904794693, 0.05735991522669792, 0.2563173174858093, 0.3771449327468872, 0.03692198544740677, 0.1441502869129181, 0.057706303894519806, 0.10904988646507263, 0.012661963701248169, 0.03419168293476105, 0.00025463494239374995, 0.006517195608466864, 0.009444218128919601, 0.02528201788663864, 0.012474089860916138, 0.15471825003623962, 0.0930279940366745, 0.03941535949707031, 0.012290246784687042, 0.019612370058894157, 0.01693630963563919, 0.060360055416822433, 0.03695704787969589, 0.03158704191446304, 0.00528602534905076, 0.018155228346586227, 0.028653612360358238, 0.00026915513444691896, 0.00017152263899333775, 0.008491672575473785, 0.010363905690610409, 0.01823299005627632, 0.017638348042964935, 0.008936679922044277, 0.012148463167250156, 0.02103070169687271, -1]}
{"idB": "749647_18_item1_p260_s3", "idA": "749647_17_item1_p159_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "Such committee and advisory group reviews and any new guidelines they promulgate may lengthen the regulatory review process, require us to perform additional studies, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of our product candidates or lead to significant post-approval limitations or restrictions.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "Such", "committee", "and", "advisory", "group", "reviews", "and", "any", "new", "guidelines", "they", "promulgate", "may", "lengthen", "the", "regulatory", "review", "process,", "require", "us", "to", "perform", "additional", "studies,", "increase", "our", "development", "costs,", "lead", "to", "changes", "in", "regulatory", "positions", "and", "interpretations,", "delay", "or", "prevent", "approval", "and", "commercialization", "of", "our", "product", "candidates", "or", "lead", "to", "significant", "post-approval", "limitations", "or", "restrictions.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["Such", "committee", "and", "advisory", "group", "reviews", "and", "any", "new", "guidelines", "they", "promulgate", "may", "lengthen", "the", "regulatory", "review", "process,", "require", "us", "to", "perform", "additional", "studies,", "increase", "our", "development", "costs,", "lead", "to", "changes", "in", "regulatory", "positions", "and", "interpretations,", "delay", "or", "prevent", "approval", "and", "commercialization", "of", "our", "product", "candidates", "or", "lead", "to", "significant", "post-approval", "limitations", "or", "restrictions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02089567482471466, 0.20432350039482117, 0.03425506502389908, 0.15580283105373383, 0.1980116069316864, 0.14015322923660278, 0.010807758197188377, 0.008879896253347397, 0.050587430596351624, 0.12438883632421494, 0.008550036698579788, 0.01641148142516613, 0.013666929677128792, 0.047106336802244186, 0.013570674695074558, 0.09835515916347504, 0.1209486797451973, 0.06430673599243164, 0.014860627241432667, 0.020005371421575546, 0.009845453314483166, 0.03257188946008682, 0.04153694957494736, 0.08755668252706528, 0.01598610170185566, 0.011165046133100986, 0.08817074447870255, 0.04837305471301079, 0.012629431672394276, 0.009179539978504181, 0.04605861008167267, 0.01884891651570797, 0.09490541368722916, 0.0791504830121994, 0.020402606576681137, 0.04527001082897186, 0.11912880837917328, 0.053528767079114914, 0.20543159544467926, 0.053127069026231766, 0.017092972993850708, 0.05470605939626694, 0.009772703051567078, 0.007745005190372467, 0.04596851021051407, 0.04882628843188286, 0.0009966015350073576, 0.010022224858403206, 0.008197899907827377, 0.025047501549124718, 0.11878341436386108, 0.199599489569664, 0.07707254588603973, 0.13574723899364471, -1]}
{"idB": "749647_18_item1_p271_s0", "idA": "749647_17_item1_p159_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "In the future, we may consider strategic alternatives intended to further the development of our business, which may include acquiring businesses, technologies or products, out- or in-licensing product candidates or technologies or entering into a business combination with another company.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "In", "the", "future,", "we", "may", "consider", "strategic", "alternatives", "intended", "to", "further", "the", "development", "of", "our", "business,", "which", "may", "include", "acquiring", "businesses,", "technologies", "or", "products,", "out-", "or", "in-licensing", "product", "candidates", "or", "technologies", "or", "entering", "into", "a", "business", "combination", "with", "another", "company.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["In", "the", "future,", "we", "may", "consider", "strategic", "alternatives", "intended", "to", "further", "the", "development", "of", "our", "business,", "which", "may", "include", "acquiring", "businesses,", "technologies", "or", "products,", "out-", "or", "in-licensing", "product", "candidates", "or", "technologies", "or", "entering", "into", "a", "business", "combination", "with", "another", "company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05280362442135811, 0.045451175421476364, 0.10632281005382538, 0.020974431186914444, 0.014887386001646519, 0.04033607989549637, 0.09528271108865738, 0.15502864122390747, 0.01616465300321579, 0.007169506978243589, 0.029213041067123413, 0.007771632168442011, 0.03487653657793999, 0.008847137913107872, 0.014720574952661991, 0.04650026932358742, 0.00012709744623862207, 0.00788517389446497, 0.0065868631936609745, 0.19997571408748627, 0.23551572859287262, 0.05979764834046364, 0.015707865357398987, 0.05441756919026375, 0.41279855370521545, 0.14173313975334167, 0.5265441536903381, 0.0970269963145256, 0.08313749730587006, 0.006852819584310055, 0.02393682859838009, 0.004678996745496988, 0.04006305709481239, 0.014185916632413864, 0.012520760297775269, 0.09693481773138046, 0.05387421324849129, 0.015232534147799015, 0.0505082793533802, 0.09676270931959152, -1]}
{"idB": "749647_18_item1_p271_s4", "idA": "749647_17_item1_p159_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "Conversely, any failure to enter any strategic transaction that would be beneficial to us could delay the development and potential commercialization of our product candidates and have a negative impact on the competitiveness of any product candidate that reaches market.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "Conversely,", "any", "failure", "to", "enter", "any", "strategic", "transaction", "that", "would", "be", "beneficial", "to", "us", "could", "delay", "the", "development", "and", "potential", "commercialization", "of", "our", "product", "candidates", "and", "have", "a", "negative", "impact", "on", "the", "competitiveness", "of", "any", "product", "candidate", "that", "reaches", "market.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["Conversely,", "any", "failure", "to", "enter", "any", "strategic", "transaction", "that", "would", "be", "beneficial", "to", "us", "could", "delay", "the", "development", "and", "potential", "commercialization", "of", "our", "product", "candidates", "and", "have", "a", "negative", "impact", "on", "the", "competitiveness", "of", "any", "product", "candidate", "that", "reaches", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017796697095036507, 0.035540621727705, 0.5422394275665283, 0.5509183406829834, 0.4466569125652313, 0.08500047773122787, 0.24613416194915771, 0.2770267128944397, 0.0002303265646332875, 0.008220217190682888, 0.0075468700379133224, 0.009474223479628563, 0.010534900240600109, 0.021909119561314583, 0.008689546957612038, 0.19000571966171265, 0.03280588239431381, 0.06659016758203506, 0.004762209951877594, 0.014869892038404942, 0.018519680947065353, 0.004433677066117525, 0.006891974247992039, 0.0233673807233572, 0.024735920131206512, 0.006077501457184553, 0.012340424582362175, 0.007472764700651169, 0.07601768523454666, 0.020330263301730156, 0.017485685646533966, 0.011155937798321247, 0.03852764889597893, 0.010536083951592445, 0.03932143375277519, 0.10861220210790634, 0.1150631457567215, 0.005800667684525251, 0.02096579782664776, 0.022815238684415817, -1]}
{"idB": "749647_18_item1_p328_s0", "idA": "749647_17_item1_p159_s0", "sentA": "Our current business strategy includes the possibility of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates.", "sentB": "We may not be able to hire or retain key officers or employees that we need to implement our business strategy and develop our product candidates and business, including those purchased in the EGEN asset acquisition.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates.", "<tag2>", "We", "may", "not", "be", "able", "to", "hire", "or", "retain", "key", "officers", "or", "employees", "that", "we", "need", "to", "implement", "our", "business", "strategy", "and", "develop", "our", "product", "candidates", "and", "business,", "including", "those", "purchased", "in", "the", "EGEN", "asset", "acquisition.", "<tag3>"], "wordsA": ["Our", "current", "business", "strategy", "includes", "the", "possibility", "of", "entering", "into", "collaborative", "arrangements", "with", "third", "parties", "to", "complete", "the", "development", "and", "commercialization", "of", "our", "product", "candidates."], "wordsB": ["We", "may", "not", "be", "able", "to", "hire", "or", "retain", "key", "officers", "or", "employees", "that", "we", "need", "to", "implement", "our", "business", "strategy", "and", "develop", "our", "product", "candidates", "and", "business,", "including", "those", "purchased", "in", "the", "EGEN", "asset", "acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03492668271064758, 0.06513892859220505, 0.3411719501018524, 0.1359855979681015, 0.3143104910850525, 0.2812041938304901, 0.6223872303962708, 0.2996130883693695, 0.5211349129676819, 0.25578609108924866, 0.2146632820367813, 0.17121122777462006, 0.17229686677455902, 0.006755744572728872, 0.008914357051253319, 0.016905512660741806, 0.018772682175040245, 0.03457169607281685, 0.008421987295150757, 0.02653304673731327, 0.0217026025056839, 0.0036407040897756815, 0.016541466116905212, 0.00553717790171504, 0.02021895907819271, 0.02013569325208664, 0.0038262063171714544, 0.01788083277642727, 0.004605775699019432, 0.010927800089120865, 0.0319688580930233, 0.016281766816973686, 0.009395577013492584, 0.030479412525892258, 0.044293224811553955, 0.04225510358810425, -1]}
{"idB": "749647_18_item1_p254_s0", "idA": "749647_17_item1_p159_s1", "sentA": "In the event that third parties take over the clinical trial process for one or more of our product candidates, the estimated completion date would largely be under the control of that third party rather than us.", "sentB": "In addition, information generated during the clinical trial process is susceptible to varying interpretations that could delay, limit, or prevent marketing approval at any stage of the approval process.", "type": 2, "words": ["<tag1>", "In", "the", "event", "that", "third", "parties", "take", "over", "the", "clinical", "trial", "process", "for", "one", "or", "more", "of", "our", "product", "candidates,", "the", "estimated", "completion", "date", "would", "largely", "be", "under", "the", "control", "of", "that", "third", "party", "rather", "than", "us.", "<tag2>", "In", "addition,", "information", "generated", "during", "the", "clinical", "trial", "process", "is", "susceptible", "to", "varying", "interpretations", "that", "could", "delay,", "limit,", "or", "prevent", "marketing", "approval", "at", "any", "stage", "of", "the", "approval", "process.", "<tag3>"], "wordsA": ["In", "the", "event", "that", "third", "parties", "take", "over", "the", "clinical", "trial", "process", "for", "one", "or", "more", "of", "our", "product", "candidates,", "the", "estimated", "completion", "date", "would", "largely", "be", "under", "the", "control", "of", "that", "third", "party", "rather", "than", "us."], "wordsB": ["In", "addition,", "information", "generated", "during", "the", "clinical", "trial", "process", "is", "susceptible", "to", "varying", "interpretations", "that", "could", "delay,", "limit,", "or", "prevent", "marketing", "approval", "at", "any", "stage", "of", "the", "approval", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030068766325712204, 0.030672185122966766, 0.24792391061782837, 0.09669434279203415, 0.025978071615099907, 0.013065631501376629, 0.030287370085716248, 0.03444036841392517, 0.04733328893780708, 0.0297484640032053, 0.10675077885389328, 0.037143196910619736, 0.13697299361228943, 0.2166368067264557, 0.000908726011402905, 0.016979357227683067, 0.09889589995145798, 0.07633140683174133, 0.033046796917915344, 0.14536750316619873, 0.14594152569770813, 0.16661784052848816, 0.013278885744512081, 0.030154123902320862, 0.030383866280317307, 0.011313294991850853, 0.011745104566216469, 0.09072354435920715, 0.06297063827514648, -1]}
{"idB": "749647_18_item1_p327_s2", "idA": "749647_17_item1_p159_s1", "sentA": "In the event that third parties take over the clinical trial process for one or more of our product candidates, the estimated completion date would largely be under the control of that third party rather than us.", "sentB": "The successful development and acceptance of any one or more of these alternative forms of treatment could render our technology obsolete as a cancer treatment method.", "type": 2, "words": ["<tag1>", "In", "the", "event", "that", "third", "parties", "take", "over", "the", "clinical", "trial", "process", "for", "one", "or", "more", "of", "our", "product", "candidates,", "the", "estimated", "completion", "date", "would", "largely", "be", "under", "the", "control", "of", "that", "third", "party", "rather", "than", "us.", "<tag2>", "The", "successful", "development", "and", "acceptance", "of", "any", "one", "or", "more", "of", "these", "alternative", "forms", "of", "treatment", "could", "render", "our", "technology", "obsolete", "as", "a", "cancer", "treatment", "method.", "<tag3>"], "wordsA": ["In", "the", "event", "that", "third", "parties", "take", "over", "the", "clinical", "trial", "process", "for", "one", "or", "more", "of", "our", "product", "candidates,", "the", "estimated", "completion", "date", "would", "largely", "be", "under", "the", "control", "of", "that", "third", "party", "rather", "than", "us."], "wordsB": ["The", "successful", "development", "and", "acceptance", "of", "any", "one", "or", "more", "of", "these", "alternative", "forms", "of", "treatment", "could", "render", "our", "technology", "obsolete", "as", "a", "cancer", "treatment", "method."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012976089492440224, 0.15550018846988678, 0.1569918394088745, 0.044298991560935974, 0.18733327090740204, 0.0337359718978405, 0.0380006842315197, 0.031185386702418327, 0.010469288565218449, 0.01641075871884823, 0.016640176996588707, 0.021362626925110817, 0.12135203182697296, 0.11539681255817413, 0.10770635306835175, 0.24743767082691193, 0.01757475920021534, 0.16875644028186798, 0.06293662637472153, 0.2043841928243637, 0.29079821705818176, 0.015045356936752796, 0.015814071521162987, 0.06824295222759247, 0.11258284747600555, 0.10086614638566971, -1]}
{"idB": "749647_18_item1_p304_s0", "idA": "749647_17_item1_p159_s2", "sentA": "We cannot forecast with any degree of certainty which proprietary products or indications, if any, will be subject to future collaborative arrangements, in whole or in part, and how such arrangements would affect our development plan or capital requirements.", "sentB": "In many of the foreign countries in which we may do business or in which our products may be sold, we will be subject to regulation by national governments and supranational agencies as well as by local agencies affecting, among other things, product standards, packaging requirements, labeling requirements, import restrictions, tariff regulations, duties and tax requirements.", "type": 2, "words": ["<tag1>", "We", "cannot", "forecast", "with", "any", "degree", "of", "certainty", "which", "proprietary", "products", "or", "indications,", "if", "any,", "will", "be", "subject", "to", "future", "collaborative", "arrangements,", "in", "whole", "or", "in", "part,", "and", "how", "such", "arrangements", "would", "affect", "our", "development", "plan", "or", "capital", "requirements.", "<tag2>", "In", "many", "of", "the", "foreign", "countries", "in", "which", "we", "may", "do", "business", "or", "in", "which", "our", "products", "may", "be", "sold,", "we", "will", "be", "subject", "to", "regulation", "by", "national", "governments", "and", "supranational", "agencies", "as", "well", "as", "by", "local", "agencies", "affecting,", "among", "other", "things,", "product", "standards,", "packaging", "requirements,", "labeling", "requirements,", "import", "restrictions,", "tariff", "regulations,", "duties", "and", "tax", "requirements.", "<tag3>"], "wordsA": ["We", "cannot", "forecast", "with", "any", "degree", "of", "certainty", "which", "proprietary", "products", "or", "indications,", "if", "any,", "will", "be", "subject", "to", "future", "collaborative", "arrangements,", "in", "whole", "or", "in", "part,", "and", "how", "such", "arrangements", "would", "affect", "our", "development", "plan", "or", "capital", "requirements."], "wordsB": ["In", "many", "of", "the", "foreign", "countries", "in", "which", "we", "may", "do", "business", "or", "in", "which", "our", "products", "may", "be", "sold,", "we", "will", "be", "subject", "to", "regulation", "by", "national", "governments", "and", "supranational", "agencies", "as", "well", "as", "by", "local", "agencies", "affecting,", "among", "other", "things,", "product", "standards,", "packaging", "requirements,", "labeling", "requirements,", "import", "restrictions,", "tariff", "regulations,", "duties", "and", "tax", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013336260803043842, 0.04044492170214653, 0.010034107603132725, 0.012858740985393524, 0.05412896350026131, 0.05766366422176361, 0.010254262015223503, 0.006924032233655453, 0.02570832520723343, 0.01776192896068096, 0.04011436924338341, 0.0548061728477478, 0.013587312772870064, 0.015883315354585648, 0.009579393081367016, 0.023891087621450424, 0.11084344983100891, 0.052195627242326736, 0.052724070847034454, 0.1281748116016388, 0.02090076357126236, 0.01698228344321251, 0.01810183748602867, 0.14938683807849884, 0.06600549072027206, 0.2621220648288727, 0.021933017298579216, 0.09868942201137543, 0.13552574813365936, 0.04759705811738968, 0.0969567820429802, 0.13943564891815186, 0.0007069985149428248, 0.004736276809126139, 0.00558551587164402, 0.008361125364899635, 0.057231370359659195, 0.07184945046901703, 0.02950797602534294, 0.006086204666644335, 0.00798776838928461, 0.010278547182679176, 0.08829915523529053, 0.060267701745033264, 0.10945448279380798, 0.09581585228443146, 0.2332909256219864, 0.20553451776504517, 0.19304832816123962, 0.28894051909446716, 0.16333472728729248, 0.1865486055612564, 0.10432996600866318, 0.02034098096191883, 0.19367216527462006, 0.26384589076042175, -1]}
{"idB": "749647_18_item1_p153_s0", "idA": "749647_17_item1_p160_s0", "sentA": "As of December 31, 2016, we have $4.3 million dollars in cash and short term investments.", "sentB": "As of December 3 1, 2017, we had $24.2 million dollars in cash and short-term investments including interest receivable.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments.", "<tag2>", "As", "of", "December", "3", "1,", "2017,", "we", "had", "$24.2", "million", "dollars", "in", "cash", "and", "short-term", "investments", "including", "interest", "receivable.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments."], "wordsB": ["As", "of", "December", "3", "1,", "2017,", "we", "had", "$24.2", "million", "dollars", "in", "cash", "and", "short-term", "investments", "including", "interest", "receivable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0055196029134094715, 0.005000500474125147, 0.022193681448698044, 0.08639755100011826, 0.4183177351951599, 0.7898765206336975, 0.0032208000775426626, 0.0042764716781675816, 0.8657388687133789, 0.23828765749931335, 0.029551060870289803, 0.002939730416983366, 0.004049026872962713, 0.001641540671698749, 0.005460178013890982, 0.01514381542801857, 0.023078348487615585, 0.07950714975595474, 0.0702134445309639, -1]}
{"idB": "749647_18_item1_p232_s2", "idA": "749647_17_item1_p160_s0", "sentA": "As of December 31, 2016, we have $4.3 million dollars in cash and short term investments.", "sentB": "As of the date of this filing, we have approximately $12.2 million available for future sales under the ATM.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments.", "<tag2>", "As", "of", "the", "date", "of", "this", "filing,", "we", "have", "approximately", "$12.2", "million", "available", "for", "future", "sales", "under", "the", "ATM.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments."], "wordsB": ["As", "of", "the", "date", "of", "this", "filing,", "we", "have", "approximately", "$12.2", "million", "available", "for", "future", "sales", "under", "the", "ATM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018993277102708817, 0.015724005177617073, 0.006422304082661867, 0.030840909108519554, 0.011769221164286137, 0.02471696212887764, 0.0630088672041893, 0.010861534625291824, 0.012445885688066483, 0.09401213377714157, 0.8659029603004456, 0.5244268178939819, 0.1833292841911316, 0.05748395249247551, 0.21469834446907043, 0.27434566617012024, 0.08429393172264099, 0.04181241616606712, 0.11395449191331863, -1]}
{"idB": "749647_18_item1_p242_s3", "idA": "749647_17_item1_p160_s0", "sentA": "As of December 31, 2016, we have $4.3 million dollars in cash and short term investments.", "sentB": "As of December 31, 2017, we had approximately $24.2 million in cash and short-term investments including interest receivable.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments.", "<tag2>", "As", "of", "December", "31,", "2017,", "we", "had", "approximately", "$24.2", "million", "in", "cash", "and", "short-term", "investments", "including", "interest", "receivable.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments."], "wordsB": ["As", "of", "December", "31,", "2017,", "we", "had", "approximately", "$24.2", "million", "in", "cash", "and", "short-term", "investments", "including", "interest", "receivable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007594041060656309, 0.007593502290546894, 0.01889771968126297, 0.022069087252020836, 0.8395203948020935, 0.006581342779099941, 0.004818193148821592, 0.0763741210103035, 0.8978474140167236, 0.38608625531196594, 0.0060395789332687855, 0.006249137222766876, 0.0021947671193629503, 0.006583849899470806, 0.01963385008275509, 0.019641702994704247, 0.0922340378165245, 0.08610410243272781, -1]}
{"idB": "749647_18_item1_p350_s4", "idA": "749647_17_item1_p160_s0", "sentA": "As of December 31, 2016, we have $4.3 million dollars in cash and short term investments.", "sentB": "As of December 31, 2017, we had stockholders equity of approximately $26.7 million.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments.", "<tag2>", "As", "of", "December", "31,", "2017,", "we", "had", "stockholders", "equity", "of", "approximately", "$26.7", "million.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2016,", "we", "have", "$4.3", "million", "dollars", "in", "cash", "and", "short", "term", "investments."], "wordsB": ["As", "of", "December", "31,", "2017,", "we", "had", "stockholders", "equity", "of", "approximately", "$26.7", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00959499180316925, 0.008701018057763577, 0.02544376254081726, 0.02774422988295555, 0.8662680387496948, 0.008486414328217506, 0.008523206226527691, 0.3925447463989258, 0.38954925537109375, 0.023563841357827187, 0.0952843651175499, 0.6488374471664429, 0.34572547674179077, -1]}
{"idB": "749647_18_item1_p153_s1", "idA": "749647_17_item1_p160_s1", "sentA": "Given our development plans, we anticipate cash resources will be sufficient to fund our operations into mid-2017 and the Company has no committed sources of additional capital.", "sentB": "Given our development plans, we anticipate cash resources will be sufficient to fund our operations into the third quarter of 2019.", "type": 2, "words": ["<tag1>", "Given", "our", "development", "plans,", "we", "anticipate", "cash", "resources", "will", "be", "sufficient", "to", "fund", "our", "operations", "into", "mid-2017", "and", "the", "Company", "has", "no", "committed", "sources", "of", "additional", "capital.", "<tag2>", "Given", "our", "development", "plans,", "we", "anticipate", "cash", "resources", "will", "be", "sufficient", "to", "fund", "our", "operations", "into", "the", "third", "quarter", "of", "2019.", "<tag3>"], "wordsA": ["Given", "our", "development", "plans,", "we", "anticipate", "cash", "resources", "will", "be", "sufficient", "to", "fund", "our", "operations", "into", "mid-2017", "and", "the", "Company", "has", "no", "committed", "sources", "of", "additional", "capital."], "wordsB": ["Given", "our", "development", "plans,", "we", "anticipate", "cash", "resources", "will", "be", "sufficient", "to", "fund", "our", "operations", "into", "the", "third", "quarter", "of", "2019."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004599935840815306, 0.0021392942871898413, 0.004104532767087221, 0.005587884224951267, 0.0029978142119944096, 0.005044770427048206, 0.005725250579416752, 0.006706286687403917, 0.0020813371520489454, 0.00208014203235507, 0.005097138229757547, 0.0019908889662474394, 0.008692282252013683, 0.004869935102760792, 0.029805000871419907, 0.048624373972415924, 0.021091287955641747, 0.4557679295539856, 0.5171418190002441, 0.5684447288513184, 0.9577771425247192, -1]}
{"idB": "749647_18_item1_p241_s0", "idA": "749647_17_item1_p160_s1", "sentA": "Given our development plans, we anticipate cash resources will be sufficient to fund our operations into mid-2017 and the Company has no committed sources of additional capital.", "sentB": "We will need to raise additional capital to fund our planned future operations, and we may be unable to secure such capital without dilutive financing transactions.", "type": 2, "words": ["<tag1>", "Given", "our", "development", "plans,", "we", "anticipate", "cash", "resources", "will", "be", "sufficient", "to", "fund", "our", "operations", "into", "mid-2017", "and", "the", "Company", "has", "no", "committed", "sources", "of", "additional", "capital.", "<tag2>", "We", "will", "need", "to", "raise", "additional", "capital", "to", "fund", "our", "planned", "future", "operations,", "and", "we", "may", "be", "unable", "to", "secure", "such", "capital", "without", "dilutive", "financing", "transactions.", "<tag3>"], "wordsA": ["Given", "our", "development", "plans,", "we", "anticipate", "cash", "resources", "will", "be", "sufficient", "to", "fund", "our", "operations", "into", "mid-2017", "and", "the", "Company", "has", "no", "committed", "sources", "of", "additional", "capital."], "wordsB": ["We", "will", "need", "to", "raise", "additional", "capital", "to", "fund", "our", "planned", "future", "operations,", "and", "we", "may", "be", "unable", "to", "secure", "such", "capital", "without", "dilutive", "financing", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024982940405607224, 0.01640474796295166, 0.08052384853363037, 0.08415678143501282, 0.5661664605140686, 0.3649333119392395, 0.3727859854698181, 0.00946890003979206, 0.033234935253858566, 0.008438162505626678, 0.034174248576164246, 0.05834838002920151, 0.038882412016391754, 9.805516310734674e-05, 0.016716426238417625, 0.015284126624464989, 0.020347602665424347, 0.19440530240535736, 0.08617936074733734, 0.19312772154808044, 0.05994505062699318, 0.1447470784187317, 0.01488745678216219, 0.15365563333034515, 0.1466750055551529, 0.07586376368999481, -1]}
{"idB": "749647_18_item1_p153_s2", "idA": "749647_17_item1_p161_s0", "sentA": "The Company has a Controlled Equity Offering SM Sales Agreement (the ATM Agreement ) with Cantor Fitzgerald Co. (see Note 10).", "sentB": "Other than the Controlled Equity Offering SM Sales Agreement (the ATM Agreement ) the Company has with Cantor Fitzgerald Co. (see Note 10), we have no other committed sources of additional capital.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.", "(see", "Note", "10).", "<tag2>", "Other", "than", "the", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "the", "Company", "has", "with", "Cantor", "Fitzgerald", "Co.", "(see", "Note", "10),", "we", "have", "no", "other", "committed", "sources", "of", "additional", "capital.", "<tag3>"], "wordsA": ["The", "Company", "has", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.", "(see", "Note", "10)."], "wordsB": ["Other", "than", "the", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "the", "Company", "has", "with", "Cantor", "Fitzgerald", "Co.", "(see", "Note", "10),", "we", "have", "no", "other", "committed", "sources", "of", "additional", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2154528796672821, 0.1578165739774704, 0.019244205206632614, 0.03883683308959007, 0.025847014039754868, 0.0100173344835639, 0.008265935815870762, 0.00960590410977602, 0.013560272753238678, 0.005992519669234753, 0.009419199079275131, 0.01660030707716942, 0.0067389062605798244, 0.005923151969909668, 0.027937844395637512, 0.0132353650406003, 0.007611154578626156, 0.014321325346827507, 0.01346820592880249, 0.013708258979022503, 0.0059123472310602665, 0.007924063131213188, 0.009816642850637436, 0.09462067484855652, 0.21009601652622223, 0.7353382706642151, 0.3515256345272064, 0.5103378891944885, 0.5373408198356628, 0.26924994587898254, 0.38675209879875183, 0.49135395884513855, -1]}
{"idB": "749647_18_item1_p348_s1", "idA": "749647_17_item1_p161_s0", "sentA": "The Company has a Controlled Equity Offering SM Sales Agreement (the ATM Agreement ) with Cantor Fitzgerald Co. (see Note 10).", "sentB": "Under the Controlled Equity Offering SM Sales Agreement entered into with Cantor Fitzgerald Co. on February 1, 2013, we may offer and sell, from time to time through at-the-market offerings, up to an aggregate of $25 million of shares of our common stock.", "type": 2, "words": ["<tag1>", "The", "Company", "has", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.", "(see", "Note", "10).", "<tag2>", "Under", "the", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "entered", "into", "with", "Cantor", "Fitzgerald", "Co.", "on", "February", "1,", "2013,", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "up", "to", "an", "aggregate", "of", "$25", "million", "of", "shares", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["The", "Company", "has", "a", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "(the", "ATM", "Agreement", ")", "with", "Cantor", "Fitzgerald", "Co.", "(see", "Note", "10)."], "wordsB": ["Under", "the", "Controlled", "Equity", "Offering", "SM", "Sales", "Agreement", "entered", "into", "with", "Cantor", "Fitzgerald", "Co.", "on", "February", "1,", "2013,", "we", "may", "offer", "and", "sell,", "from", "time", "to", "time", "through", "at-the-market", "offerings,", "up", "to", "an", "aggregate", "of", "$25", "million", "of", "shares", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.21538542211055756, 0.04495805874466896, 0.07706053555011749, 0.049707233905792236, 0.07321963459253311, 0.017681894823908806, 0.021055949851870537, 0.03969161584973335, 0.0252031609416008, 0.062431447207927704, 0.04788552224636078, 0.02625972591340542, 0.030122453346848488, 0.05063524842262268, 0.04324876144528389, 0.1056622639298439, 0.10058026015758514, 0.1930716633796692, 0.039378780871629715, 0.0277039036154747, 0.07942203432321548, 0.05060809478163719, 0.10329249501228333, 0.014036267064511776, 0.016153275966644287, 0.012129862792789936, 0.019695637747645378, 0.012282938696444035, 0.08121979236602783, 0.13198506832122803, 0.013920975849032402, 0.01261516846716404, 0.016897303983569145, 0.021078800782561302, 0.022072684019804, 0.06317078322172165, 0.07191842794418335, 0.06350740045309067, 0.08233653008937836, 0.03371284157037735, 0.04041565582156181, 0.09473898261785507, 0.15340067446231842, -1]}
{"idB": "749647_18_item1_p290_s1", "idA": "749647_17_item1_p162_s0", "sentA": "As a result of the risks and uncertainties discussed in this Annual Report on Form 10-K, among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product if one of our product candidates receives regulatory approval for marketing, if at all.", "sentB": "If these third parties are unable to carry out their contractual duties in a manner that is consistent with our expectations, comply with budgets and other financial obligations or meet expected deadlines, we may not receive certain development milestone payments or be able to obtain regulatory approval for or commercialize our product candidates in a timely or cost-effective manner.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "product", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all.", "<tag2>", "If", "these", "third", "parties", "are", "unable", "to", "carry", "out", "their", "contractual", "duties", "in", "a", "manner", "that", "is", "consistent", "with", "our", "expectations,", "comply", "with", "budgets", "and", "other", "financial", "obligations", "or", "meet", "expected", "deadlines,", "we", "may", "not", "receive", "certain", "development", "milestone", "payments", "or", "be", "able", "to", "obtain", "regulatory", "approval", "for", "or", "commercialize", "our", "product", "candidates", "in", "a", "timely", "or", "cost-effective", "manner.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product", "if", "one", "of", "our", "product", "candidates", "receives", "regulatory", "approval", "for", "marketing,", "if", "at", "all."], "wordsB": ["If", "these", "third", "parties", "are", "unable", "to", "carry", "out", "their", "contractual", "duties", "in", "a", "manner", "that", "is", "consistent", "with", "our", "expectations,", "comply", "with", "budgets", "and", "other", "financial", "obligations", "or", "meet", "expected", "deadlines,", "we", "may", "not", "receive", "certain", "development", "milestone", "payments", "or", "be", "able", "to", "obtain", "regulatory", "approval", "for", "or", "commercialize", "our", "product", "candidates", "in", "a", "timely", "or", "cost-effective", "manner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021651802584528923, 0.011133823543787003, 0.06684090942144394, 0.07931267470121384, 0.04573450982570648, 0.26431652903556824, 0.13885743916034698, 0.13576385378837585, 0.13044002652168274, 0.07949521392583847, 0.1393897533416748, 0.133689284324646, 0.0005730389966629446, 0.000271675264229998, 0.003241667989641428, 0.00023247106582857668, 0.00864679366350174, 0.013103808276355267, 0.010549244470894337, 0.011589428409934044, 0.01936645619571209, 0.014058972708880901, 0.012313601560890675, 0.025772269815206528, 0.00811137817800045, 0.00849898997694254, 0.02028210088610649, 0.031963177025318146, 0.00044707904453389347, 0.010025172494351864, 0.021817678585648537, 0.04887913167476654, 0.019987959414720535, 0.060854699462652206, 0.3292432129383087, 0.3106987774372101, 0.18053020536899567, 0.19949232041835785, 0.15493273735046387, 0.23072344064712524, 0.0070027573965489864, 0.07385200262069702, 0.18152287602424622, 0.10537434369325638, 0.15891411900520325, 0.14306429028511047, 0.16948650777339935, 0.02225172147154808, 0.03957376256585121, 0.13258446753025055, 0.013832307420670986, 0.05456019937992096, 0.055276304483413696, 0.01837792806327343, 0.015947585925459862, 0.17049740254878998, 0.01361185684800148, 0.1507289856672287, 0.05683056265115738, -1]}
{"idB": "749647_18_item1_p245_s0", "idA": "749647_17_item1_p162_s1", "sentA": "Our inability to complete any of our research and development activities, preclinical studies or clinical trials in a timely manner or our failure to enter into collaborative agreements when appropriate could significantly increase our capital requirements and could adversely impact our liquidity.", "sentB": "If we are unable to obtain additional capital on a timely basis or on acceptable terms, we may be required to delay, reduce or terminate our research and development programs and preclinical studies or clinical trials, if any, limit strategic opportunities or undergo corporate restructuring activities.", "type": 2, "words": ["<tag1>", "Our", "inability", "to", "complete", "any", "of", "our", "research", "and", "development", "activities,", "preclinical", "studies", "or", "clinical", "trials", "in", "a", "timely", "manner", "or", "our", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity.", "<tag2>", "If", "we", "are", "unable", "to", "obtain", "additional", "capital", "on", "a", "timely", "basis", "or", "on", "acceptable", "terms,", "we", "may", "be", "required", "to", "delay,", "reduce", "or", "terminate", "our", "research", "and", "development", "programs", "and", "preclinical", "studies", "or", "clinical", "trials,", "if", "any,", "limit", "strategic", "opportunities", "or", "undergo", "corporate", "restructuring", "activities.", "<tag3>"], "wordsA": ["Our", "inability", "to", "complete", "any", "of", "our", "research", "and", "development", "activities,", "preclinical", "studies", "or", "clinical", "trials", "in", "a", "timely", "manner", "or", "our", "failure", "to", "enter", "into", "collaborative", "agreements", "when", "appropriate", "could", "significantly", "increase", "our", "capital", "requirements", "and", "could", "adversely", "impact", "our", "liquidity."], "wordsB": ["If", "we", "are", "unable", "to", "obtain", "additional", "capital", "on", "a", "timely", "basis", "or", "on", "acceptable", "terms,", "we", "may", "be", "required", "to", "delay,", "reduce", "or", "terminate", "our", "research", "and", "development", "programs", "and", "preclinical", "studies", "or", "clinical", "trials,", "if", "any,", "limit", "strategic", "opportunities", "or", "undergo", "corporate", "restructuring", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025219300761818886, 0.039294254034757614, 0.03634604066610336, 0.2303648144006729, 0.14295955002307892, 0.19737659394741058, 0.2039785236120224, 0.2006690502166748, 0.010526333935558796, 0.010133338160812855, 0.03519155830144882, 0.01337457075715065, 0.0004329431685619056, 0.01671477220952511, 0.04844939708709717, 0.04617711529135704, 0.008906315080821514, 0.009408198297023773, 0.010399064980447292, 0.031576160341501236, 0.041938818991184235, 0.2903617024421692, 0.2282501608133316, 0.12665420770645142, 0.29569852352142334, 0.02553061582148075, 0.05135967582464218, 0.0085596339777112, 0.017435334622859955, 0.030104568228125572, 0.0036978423595428467, 0.010586180724203587, 0.01806776225566864, 0.0031250445172190666, 0.009407881647348404, 0.013318528421223164, 0.004860968329012394, 0.006838830653578043, 0.0485742911696434, 0.06523852050304413, 0.05197321996092796, 0.008532882668077946, 0.08116131275892258, 0.10858340561389923, 0.17890003323554993, 0.1240103542804718, -1]}
{"idB": "749647_18_item1_p243_s0", "idA": "749647_17_item1_p162_s2", "sentA": "While our estimated future capital requirements are uncertain and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research and development activities, preclinical studies and clinical trials, or whether we are in a position to pursue manufacturing or commercialization activities, we will need significant additional capital to develop our product candidates through development and clinical trials, obtain regulatory approvals and manufacture and commercialize approved products, if any.", "sentB": "We have substantial future capital requirements to continue our research and development activities and advance our product candidates through various development stages.", "type": 2, "words": ["<tag1>", "While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research", "and", "development", "activities,", "preclinical", "studies", "and", "clinical", "trials,", "or", "whether", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "development", "and", "clinical", "trials,", "obtain", "regulatory", "approvals", "and", "manufacture", "and", "commercialize", "approved", "products,", "if", "any.", "<tag2>", "We", "have", "substantial", "future", "capital", "requirements", "to", "continue", "our", "research", "and", "development", "activities", "and", "advance", "our", "product", "candidates", "through", "various", "development", "stages.", "<tag3>"], "wordsA": ["While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research", "and", "development", "activities,", "preclinical", "studies", "and", "clinical", "trials,", "or", "whether", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "development", "and", "clinical", "trials,", "obtain", "regulatory", "approvals", "and", "manufacture", "and", "commercialize", "approved", "products,", "if", "any."], "wordsB": ["We", "have", "substantial", "future", "capital", "requirements", "to", "continue", "our", "research", "and", "development", "activities", "and", "advance", "our", "product", "candidates", "through", "various", "development", "stages."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02653389982879162, 0.0238447617739439, 0.5223509073257446, 0.16653959453105927, 0.25018271803855896, 0.21696235239505768, 0.007862473838031292, 0.10087580978870392, 0.012227728962898254, 0.03706076368689537, 0.009774364531040192, 0.017271649092435837, 0.028427623212337494, 0.003819881472736597, 0.020283959805965424, 0.008195278234779835, 0.031180566176772118, 0.021890342235565186, 0.006111422553658485, 0.07127778232097626, 0.10008499771356583, 0.10593519359827042, -1]}
{"idB": "749647_18_item1_p329_s7", "idA": "749647_17_item1_p162_s4", "sentA": "Our inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.", "sentB": "The competition for such qualified personnel is intense, and the loss of services of certain key personnel or our inability to attract additional personnel to fill critical positions could adversely affect our business.", "type": 2, "words": ["<tag1>", "Our", "inability", "to", "raise", "additional", "capital,", "or", "to", "do", "so", "on", "terms", "reasonably", "acceptable", "to", "us,", "would", "jeopardize", "the", "future", "success", "of", "our", "business.", "<tag2>", "The", "competition", "for", "such", "qualified", "personnel", "is", "intense,", "and", "the", "loss", "of", "services", "of", "certain", "key", "personnel", "or", "our", "inability", "to", "attract", "additional", "personnel", "to", "fill", "critical", "positions", "could", "adversely", "affect", "our", "business.", "<tag3>"], "wordsA": ["Our", "inability", "to", "raise", "additional", "capital,", "or", "to", "do", "so", "on", "terms", "reasonably", "acceptable", "to", "us,", "would", "jeopardize", "the", "future", "success", "of", "our", "business."], "wordsB": ["The", "competition", "for", "such", "qualified", "personnel", "is", "intense,", "and", "the", "loss", "of", "services", "of", "certain", "key", "personnel", "or", "our", "inability", "to", "attract", "additional", "personnel", "to", "fill", "critical", "positions", "could", "adversely", "affect", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007664321921765804, 0.32872238755226135, 0.053116969764232635, 0.04175964742898941, 0.12108567357063293, 0.22374524176120758, 0.014176237396895885, 0.16457130014896393, 0.00024175914586521685, 0.006290206220000982, 0.28491997718811035, 0.2092183530330658, 0.34539830684661865, 0.010977071709930897, 0.01901068352162838, 0.04030126705765724, 0.07335112988948822, 0.0034977116156369448, 0.005871892441064119, 0.09846210479736328, 0.03421902656555176, 0.20926019549369812, 0.13307438790798187, 0.16302219033241272, 0.005052151624113321, 0.006310458295047283, 0.024505702778697014, 0.03797520697116852, 0.012044697068631649, 0.05370074138045311, 0.1512465626001358, 0.011812279932200909, 0.045812882483005524, -1]}
{"idB": "749647_18_item1_p358_s2", "idA": "749647_17_item1_p162_s4", "sentA": "Our inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.", "sentB": "We currently intend to retain all available funds and any future earnings to fund the development and growth of our business.", "type": 2, "words": ["<tag1>", "Our", "inability", "to", "raise", "additional", "capital,", "or", "to", "do", "so", "on", "terms", "reasonably", "acceptable", "to", "us,", "would", "jeopardize", "the", "future", "success", "of", "our", "business.", "<tag2>", "We", "currently", "intend", "to", "retain", "all", "available", "funds", "and", "any", "future", "earnings", "to", "fund", "the", "development", "and", "growth", "of", "our", "business.", "<tag3>"], "wordsA": ["Our", "inability", "to", "raise", "additional", "capital,", "or", "to", "do", "so", "on", "terms", "reasonably", "acceptable", "to", "us,", "would", "jeopardize", "the", "future", "success", "of", "our", "business."], "wordsB": ["We", "currently", "intend", "to", "retain", "all", "available", "funds", "and", "any", "future", "earnings", "to", "fund", "the", "development", "and", "growth", "of", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0312152449041605, 0.06073734536767006, 0.25176432728767395, 0.1590718924999237, 0.6809157729148865, 0.21076691150665283, 0.2432236671447754, 0.48860985040664673, 0.08885257691144943, 0.08747725933790207, 0.19352969527244568, 0.2929893732070923, 0.007540511898696423, 0.039777882397174835, 0.009320121258497238, 0.05062217265367508, 0.0194994006305933, 0.04751952737569809, 0.005130473989993334, 0.004873229656368494, 0.025520268827676773, -1]}
{"idB": "749647_18_item1_p240_s5", "idA": "749647_17_item1_p162_s5", "sentA": "Based on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern.", "sentB": "We may not have the financial resources to continue development of, or to enter into collaborations for, a product candidate if we experience any problems or other unforeseen events that delay or prevent regulatory approval of, or our ability to commercialize, product candidates.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag2>", "We", "may", "not", "have", "the", "financial", "resources", "to", "continue", "development", "of,", "or", "to", "enter", "into", "collaborations", "for,", "a", "product", "candidate", "if", "we", "experience", "any", "problems", "or", "other", "unforeseen", "events", "that", "delay", "or", "prevent", "regulatory", "approval", "of,", "or", "our", "ability", "to", "commercialize,", "product", "candidates.", "<tag3>"], "wordsA": ["Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "wordsB": ["We", "may", "not", "have", "the", "financial", "resources", "to", "continue", "development", "of,", "or", "to", "enter", "into", "collaborations", "for,", "a", "product", "candidate", "if", "we", "experience", "any", "problems", "or", "other", "unforeseen", "events", "that", "delay", "or", "prevent", "regulatory", "approval", "of,", "or", "our", "ability", "to", "commercialize,", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06645269691944122, 0.022619057446718216, 0.17566357553005219, 0.2781217098236084, 0.1597650945186615, 0.39633265137672424, 0.4581826329231262, 0.06707991659641266, 0.09113894402980804, 0.0790817067027092, 0.03301325440406799, 0.008294546976685524, 0.043008532375097275, 0.11207997053861618, 0.15443943440914154, 0.23266729712486267, 0.03715135157108307, 0.021583249792456627, 0.05115609988570213, 0.0621858611702919, 0.0066075632348656654, 0.0076045203022658825, 0.008622417226433754, 0.010740775614976883, 0.014144119806587696, 0.006144427694380283, 0.0048513226211071014, 0.01736290380358696, 0.024768806993961334, 0.0002760868228506297, 0.015142912045121193, 0.010601143352687359, 0.019637580960989, 0.01702476292848587, 0.018806660547852516, 0.007097799330949783, 0.005437423009425402, 0.007260656915605068, 0.019962886348366737, 0.032692961394786835, 0.07042747735977173, 0.04776386171579361, 0.05281087011098862, -1]}
{"idB": "749647_18_item1_p249_s4", "idA": "749647_17_item1_p162_s5", "sentA": "Based on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern.", "sentB": "This could limit our ability to realize their full market potential.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag2>", "This", "could", "limit", "our", "ability", "to", "realize", "their", "full", "market", "potential.", "<tag3>"], "wordsA": ["Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "wordsB": ["This", "could", "limit", "our", "ability", "to", "realize", "their", "full", "market", "potential."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02704627998173237, 0.09210126101970673, 0.4960205852985382, 0.11671432107686996, 0.20734816789627075, 0.13468830287456512, 0.24159134924411774, 0.10832995921373367, 0.32600370049476624, 0.4367697238922119, 0.28088322281837463, -1]}
{"idB": "749647_18_item1_p287_s0", "idA": "749647_17_item1_p162_s5", "sentA": "Based on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern.", "sentB": "Our commercial success depends on our ability to operate without infringing the patents and other proprietary rights of third parties.", "type": 2, "words": ["<tag1>", "Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag2>", "Our", "commercial", "success", "depends", "on", "our", "ability", "to", "operate", "without", "infringing", "the", "patents", "and", "other", "proprietary", "rights", "of", "third", "parties.", "<tag3>"], "wordsA": ["Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "wordsB": ["Our", "commercial", "success", "depends", "on", "our", "ability", "to", "operate", "without", "infringing", "the", "patents", "and", "other", "proprietary", "rights", "of", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03105268068611622, 0.20495787262916565, 0.2126625031232834, 0.1479324847459793, 0.024631435051560402, 0.05578671023249626, 0.10608039051294327, 0.062450140714645386, 0.13286860287189484, 0.20988419651985168, 0.41535845398902893, 0.10330846905708313, 0.28469526767730713, 0.01376151479780674, 0.0168024729937315, 0.12352374941110611, 0.14470593631267548, 0.020610002800822258, 0.1093134954571724, 0.1615382581949234, -1]}
{"idB": "749647_18_item1_p153_s8", "idA": "749647_17_item1_p162_s7", "sentA": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operation s for additional information regarding the Company s financial condition, liquidity and capital resources.", "sentB": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operations for additional information regarding the Company s financial condition, liquidity and capital resources.", "type": 2, "words": ["<tag1>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "the", "Company", "s", "financial", "condition,", "liquidity", "and", "capital", "resources.", "<tag2>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operations", "for", "additional", "information", "regarding", "the", "Company", "s", "financial", "condition,", "liquidity", "and", "capital", "resources.", "<tag3>"], "wordsA": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "the", "Company", "s", "financial", "condition,", "liquidity", "and", "capital", "resources."], "wordsB": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operations", "for", "additional", "information", "regarding", "the", "Company", "s", "financial", "condition,", "liquidity", "and", "capital", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.3715059757232666, 0.3801423907279968, 0.4765458106994629, 0.3820291757583618, 0.32187938690185547, 0.37979066371917725, 0.06049404293298721, 0.3169381022453308, 0.15643595159053802, 0.24115784466266632, 0.27197957038879395, 0.06334543228149414, 0.12965980172157288, 0.05938811972737312, 0.15738607943058014, 0.06765278428792953, 0.07526952773332596, 0.13511092960834503, 0.09082885086536407, 0.0732078030705452, 0.46555936336517334, 0.18775716423988342, 0.19661839306354523, 0.2517333924770355, 0.21781164407730103, 0.04450986534357071, 0.08726266026496887, 0.11766853928565979, -1]}
{"idB": "749647_18_item1_p154_s0", "idA": "749647_17_item1_p163_s0", "sentA": "We are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "sentB": "We are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership with various research institutions, including the NCI and Duke University.", "type": 2, "words": ["<tag1>", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag2>", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "NCI", "and", "Duke", "University.", "<tag3>"], "wordsA": ["We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "wordsB": ["We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "NCI", "and", "Duke", "University."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00909854844212532, 0.0030844879802316427, 0.016471657902002335, 0.0035054965410381556, 0.002802008530125022, 0.006682799197733402, 0.003871019696816802, 0.002865160582587123, 0.003932279068976641, 0.0039496030658483505, 0.003886495716869831, 0.0026548116002231836, 0.005329199135303497, 0.009161571972072124, 0.00795193761587143, 0.0003852253721561283, 0.0027861453127115965, 0.007105767726898193, 0.00801131222397089, 0.006801350507885218, 0.0024472728837281466, 0.0037291948683559895, 0.0025008448865264654, 0.0035866296384483576, 0.009038959629833698, 0.010485820472240448, 0.010404625907540321, 0.05353015661239624, 0.9757272005081177, 0.02482321858406067, 0.031076867133378983, 0.03478974848985672, -1]}
{"idB": "749647_18_item1_p154_s1", "idA": "749647_17_item1_p163_s1", "sentA": "We are currently, with minimal cash expenditures, sponsoring clinical and pre-clinical research at the University of Oxford, University of Utrecht, Brigham and Women s Hospital and the University of Washington.", "sentB": "We are currently, with minimal cash expenditures, sponsoring clinical and pre-clinical research at the University of Oxford, University of Utrecht and the Children s Research Institute.", "type": 2, "words": ["<tag1>", "We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington.", "<tag2>", "We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht", "and", "the", "Children", "s", "Research", "Institute.", "<tag3>"], "wordsA": ["We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht,", "Brigham", "and", "Women", "s", "Hospital", "and", "the", "University", "of", "Washington."], "wordsB": ["We", "are", "currently,", "with", "minimal", "cash", "expenditures,", "sponsoring", "clinical", "and", "pre-clinical", "research", "at", "the", "University", "of", "Oxford,", "University", "of", "Utrecht", "and", "the", "Children", "s", "Research", "Institute."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006451733410358429, 0.0017247702926397324, 0.003252563998103142, 0.0018217467004433274, 0.01153457909822464, 0.004263982642441988, 0.0036361769307404757, 0.003337408183142543, 0.0037105409428477287, 0.001585927326232195, 0.004780328366905451, 0.008409310132265091, 0.0018187109380960464, 0.0018739044899120927, 0.006961655803024769, 0.0029212881345301867, 0.006087681278586388, 0.0059477780014276505, 0.003827395150437951, 0.014446115121245384, 0.03010443039238453, 0.034166499972343445, 0.9585638642311096, 0.926696240901947, 0.8214287757873535, 0.8660613894462585, -1]}
{"idB": "749647_18_item1_p240_s1", "idA": "749647_17_item1_p163_s2", "sentA": "The majority of the spending in research and development is for the funding of ThermoDox clinical trials.", "sentB": "Drug development is inherently risky and clinical trials take us several years to complete.", "type": 2, "words": ["<tag1>", "The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials.", "<tag2>", "Drug", "development", "is", "inherently", "risky", "and", "clinical", "trials", "take", "us", "several", "years", "to", "complete.", "<tag3>"], "wordsA": ["The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials."], "wordsB": ["Drug", "development", "is", "inherently", "risky", "and", "clinical", "trials", "take", "us", "several", "years", "to", "complete."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.17537660896778107, 0.22311149537563324, 0.058737341314554214, 0.12114185094833374, 0.3269582688808441, 0.010185693390667439, 0.11897449940443039, 0.1057799756526947, 0.09807179868221283, 0.06775547564029694, 0.1926458328962326, 0.24020367860794067, 0.23707574605941772, 0.3149237334728241, -1]}
{"idB": "749647_18_item1_p254_s1", "idA": "749647_17_item1_p163_s2", "sentA": "The majority of the spending in research and development is for the funding of ThermoDox clinical trials.", "sentB": "Moreover, early positive preclinical or clinical trial results may not be replicated in later clinical trials.", "type": 2, "words": ["<tag1>", "The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials.", "<tag2>", "Moreover,", "early", "positive", "preclinical", "or", "clinical", "trial", "results", "may", "not", "be", "replicated", "in", "later", "clinical", "trials.", "<tag3>"], "wordsA": ["The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials."], "wordsB": ["Moreover,", "early", "positive", "preclinical", "or", "clinical", "trial", "results", "may", "not", "be", "replicated", "in", "later", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011298904195427895, 0.13982370495796204, 0.2677798271179199, 0.21599321067333221, 0.023528024554252625, 0.14713460206985474, 0.14243902266025543, 0.13724596798419952, 0.06775414943695068, 0.26249948143959045, 0.095076784491539, 0.19035273790359497, 0.028915565460920334, 0.242814302444458, 0.210728719830513, 0.19338324666023254, -1]}
{"idB": "749647_18_item1_p333_s0", "idA": "749647_17_item1_p163_s2", "sentA": "The majority of the spending in research and development is for the funding of ThermoDox clinical trials.", "sentB": "There are many companies and other institutions engaged in research and development of various technologies for cancer treatment products that seek treatment outcomes similar to those that we are pursuing.", "type": 2, "words": ["<tag1>", "The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials.", "<tag2>", "There", "are", "many", "companies", "and", "other", "institutions", "engaged", "in", "research", "and", "development", "of", "various", "technologies", "for", "cancer", "treatment", "products", "that", "seek", "treatment", "outcomes", "similar", "to", "those", "that", "we", "are", "pursuing.", "<tag3>"], "wordsA": ["The", "majority", "of", "the", "spending", "in", "research", "and", "development", "is", "for", "the", "funding", "of", "ThermoDox", "clinical", "trials."], "wordsB": ["There", "are", "many", "companies", "and", "other", "institutions", "engaged", "in", "research", "and", "development", "of", "various", "technologies", "for", "cancer", "treatment", "products", "that", "seek", "treatment", "outcomes", "similar", "to", "those", "that", "we", "are", "pursuing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003971477970480919, 0.004210494924336672, 0.21985092759132385, 0.25321096181869507, 0.04821738973259926, 0.08700068295001984, 0.1584543138742447, 0.05596299469470978, 0.022794673219323158, 0.06812691688537598, 0.00783421378582716, 0.05645882338285446, 0.03812771663069725, 0.12199076265096664, 0.2584618628025055, 0.021460870280861855, 0.1806488335132599, 0.21733248233795166, 0.1630987673997879, 9.858141129370779e-05, 0.01701035164296627, 0.03739822655916214, 0.017274456098675728, 0.006364388391375542, 0.005432763136923313, 0.00625390000641346, 0.0052908435463905334, 0.007464910391718149, 0.007766096852719784, 0.012601029127836227, -1]}
{"idB": "749647_18_item1_p154_s3", "idA": "749647_17_item1_p163_s3", "sentA": "Research and development expenses were approximately $14.6 million and $14.7 million for the years ended December 31, 2016 and 2015, respectively.", "sentB": "Research and development expenses were approximately $13.1 million and $14.6 million for the years ended December 31, 2017 and 2016, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$14.6", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively.", "<tag2>", "Research", "and", "development", "expenses", "were", "approximately", "$13.1", "million", "and", "$14.6", "million", "for", "the", "years", "ended", "December", "31,", "2017", "and", "2016,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$14.6", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively."], "wordsB": ["Research", "and", "development", "expenses", "were", "approximately", "$13.1", "million", "and", "$14.6", "million", "for", "the", "years", "ended", "December", "31,", "2017", "and", "2016,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004737445618957281, 0.003088856814429164, 0.0044820611365139484, 0.007505045272409916, 0.003802028251811862, 0.0073603191412985325, 0.8105296492576599, 0.03511796519160271, 0.005209543276578188, 0.01759742945432663, 0.008621292188763618, 0.003400065004825592, 0.003634484251961112, 0.010682664811611176, 0.012075739912688732, 0.017942750826478004, 0.0206585843116045, 0.906389057636261, 0.03322342038154602, 0.03284813091158867, 0.006962981075048447, -1]}
{"idB": "749647_18_item1_p236_s1", "idA": "749647_17_item1_p163_s3", "sentA": "Research and development expenses were approximately $14.6 million and $14.7 million for the years ended December 31, 2016 and 2015, respectively.", "sentB": "For the years ended December 31, 2017 and 2016, we incurred a net loss of $20.4 million, and $22.1 million, respectively.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$14.6", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively.", "<tag2>", "For", "the", "years", "ended", "December", "31,", "2017", "and", "2016,", "we", "incurred", "a", "net", "loss", "of", "$20.4", "million,", "and", "$22.1", "million,", "respectively.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$14.6", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively."], "wordsB": ["For", "the", "years", "ended", "December", "31,", "2017", "and", "2016,", "we", "incurred", "a", "net", "loss", "of", "$20.4", "million,", "and", "$22.1", "million,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005114520434290171, 0.003630885621532798, 0.015693018212914467, 0.01206445973366499, 0.023318875581026077, 0.04472493752837181, 0.671704888343811, 0.0610111802816391, 0.12528182566165924, 0.017639636993408203, 0.056979719549417496, 0.01776966080069542, 0.08160734921693802, 0.4599129855632782, 0.024998221546411514, 0.7072219252586365, 0.3198951482772827, 0.007178944535553455, 0.7017064690589905, 0.42141908407211304, 0.01014972385019064, -1]}
{"idB": "749647_18_item1_p242_s1", "idA": "749647_17_item1_p163_s3", "sentA": "Research and development expenses were approximately $14.6 million and $14.7 million for the years ended December 31, 2016 and 2015, respectively.", "sentB": "For the year ended December 31, 201 7, we had a net loss of $20.4 million and used $16.6 million to fund operations.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "approximately", "$14.6", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "201", "7,", "we", "had", "a", "net", "loss", "of", "$20.4", "million", "and", "used", "$16.6", "million", "to", "fund", "operations.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "approximately", "$14.6", "million", "and", "$14.7", "million", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "201", "7,", "we", "had", "a", "net", "loss", "of", "$20.4", "million", "and", "used", "$16.6", "million", "to", "fund", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0070050121285021305, 0.005160675849765539, 0.028955630958080292, 0.023893287405371666, 0.07450725883245468, 0.06470600515604019, 0.13577616214752197, 0.1704360544681549, 0.027305778115987778, 0.01409659069031477, 0.01069442369043827, 0.10190152376890182, 0.5010743141174316, 0.03245803713798523, 0.5326263308525085, 0.256469190120697, 0.00028841415769420564, 0.04351089894771576, 0.45585042238235474, 0.15194007754325867, 0.014516317285597324, 0.0896415039896965, 0.1149521917104721, -1]}
{"idB": "749647_18_item1_p154_s4", "idA": "749647_17_item1_p163_s4", "sentA": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operation s for additional information regarding expenditures related to our research and development programs.", "sentB": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operations for additional information regarding expenditures related to our research and development programs.", "type": 2, "words": ["<tag1>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs.", "<tag2>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operations", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs.", "<tag3>"], "wordsA": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs."], "wordsB": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operations", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2905452251434326, 0.38624170422554016, 0.48814451694488525, 0.3322913646697998, 0.4384467899799347, 0.18550091981887817, 0.05378333479166031, 0.09746462106704712, 0.07282499223947525, 0.2192203402519226, 0.16109827160835266, 0.0431550070643425, 0.06612580269575119, 0.04715186357498169, 0.13546715676784515, 0.04726654291152954, 0.03880676254630089, 0.03785689175128937, 0.025831956416368484, 0.04483432322740555, 0.02524402178823948, 0.03332936391234398, 0.016713274642825127, 0.03839111328125, 0.036488115787506104, 0.03480096906423569, 0.04068036377429962, -1]}
{"idB": "749647_18_item1_p183_s3", "idA": "749647_17_item1_p163_s4", "sentA": "See Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operation s for additional information regarding expenditures related to our research and development programs.", "sentB": "Competitors may use this publicly available information to gain knowledge regarding the progress of development programs.", "type": 2, "words": ["<tag1>", "See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs.", "<tag2>", "Competitors", "may", "use", "this", "publicly", "available", "information", "to", "gain", "knowledge", "regarding", "the", "progress", "of", "development", "programs.", "<tag3>"], "wordsA": ["See", "Item", "7", "Management", "s", "Discussion", "and", "Analysis", "of", "Financial", "Condition", "and", "Results", "of", "Operation", "s", "for", "additional", "information", "regarding", "expenditures", "related", "to", "our", "research", "and", "development", "programs."], "wordsB": ["Competitors", "may", "use", "this", "publicly", "available", "information", "to", "gain", "knowledge", "regarding", "the", "progress", "of", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.529397189617157, 0.03127439320087433, 0.05959488824009895, 0.026320965960621834, 0.23613788187503815, 0.2619953155517578, 0.3330425024032593, 0.018572933971881866, 0.10104520618915558, 0.2033991515636444, 0.05627930909395218, 0.032364919781684875, 0.11986126750707626, 0.04208919033408165, 0.1347137838602066, 0.12654732167720795, -1]}
{"idB": "749647_18_item1_p256_s1", "idA": "749647_17_item1_p164_s0", "sentA": "Government authorities in the U.S., at the federal, state and local level, and in other countries extensively regulate, among other things, the research, development, testing, quality control, approval, manufacturing, labeling, post-approval monitoring and reporting, recordkeeping, packaging, promotion, storage, advertising, distribution, marketing and export and import of pharmaceutical products such as those we are developing.", "sentB": "The precise regulatory requirements with which we will have to comply, now and in the future, are uncertain due to the novelty of the gene-based products we are developing.", "type": 2, "words": ["<tag1>", "Government", "authorities", "in", "the", "U.S.,", "at", "the", "federal,", "state", "and", "local", "level,", "and", "in", "other", "countries", "extensively", "regulate,", "among", "other", "things,", "the", "research,", "development,", "testing,", "quality", "control,", "approval,", "manufacturing,", "labeling,", "post-approval", "monitoring", "and", "reporting,", "recordkeeping,", "packaging,", "promotion,", "storage,", "advertising,", "distribution,", "marketing", "and", "export", "and", "import", "of", "pharmaceutical", "products", "such", "as", "those", "we", "are", "developing.", "<tag2>", "The", "precise", "regulatory", "requirements", "with", "which", "we", "will", "have", "to", "comply,", "now", "and", "in", "the", "future,", "are", "uncertain", "due", "to", "the", "novelty", "of", "the", "gene-based", "products", "we", "are", "developing.", "<tag3>"], "wordsA": ["Government", "authorities", "in", "the", "U.S.,", "at", "the", "federal,", "state", "and", "local", "level,", "and", "in", "other", "countries", "extensively", "regulate,", "among", "other", "things,", "the", "research,", "development,", "testing,", "quality", "control,", "approval,", "manufacturing,", "labeling,", "post-approval", "monitoring", "and", "reporting,", "recordkeeping,", "packaging,", "promotion,", "storage,", "advertising,", "distribution,", "marketing", "and", "export", "and", "import", "of", "pharmaceutical", "products", "such", "as", "those", "we", "are", "developing."], "wordsB": ["The", "precise", "regulatory", "requirements", "with", "which", "we", "will", "have", "to", "comply,", "now", "and", "in", "the", "future,", "are", "uncertain", "due", "to", "the", "novelty", "of", "the", "gene-based", "products", "we", "are", "developing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01530634704977274, 0.14253680408000946, 0.1694875806570053, 0.14365343749523163, 0.024462401866912842, 0.00808345340192318, 0.020798351615667343, 0.013226867653429508, 0.040795568376779556, 0.041288189589977264, 0.04694220423698425, 0.010562900453805923, 0.015103884041309357, 0.022429924458265305, 0.015382933430373669, 0.0212627574801445, 0.01889093779027462, 0.11858934164047241, 0.01035346370190382, 0.009489710442721844, 0.01050085760653019, 0.05015163496136665, 0.017524532973766327, 0.014066523872315884, 0.17883846163749695, 0.11289633810520172, 0.006607431452721357, 0.009844713844358921, 0.03640133515000343, -1]}
{"idB": "749647_18_item1_p156_s0", "idA": "749647_17_item1_p165_s0", "sentA": "In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (FDCA) and implementing regulations.", "sentB": "In the United States, the FDA regulates drugs and biological products under the Federal Food, Drug, and Cosmetic Act (FDCA), the Public Health Service Act (PHSA) and implementing regulations.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations.", "<tag2>", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "and", "biological", "products", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA),", "the", "Public", "Health", "Service", "Act", "(PHSA)", "and", "implementing", "regulations.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations."], "wordsB": ["In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "and", "biological", "products", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA),", "the", "Public", "Health", "Service", "Act", "(PHSA)", "and", "implementing", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0026035220362246037, 0.0031136954203248024, 0.006441785022616386, 0.007600634824484587, 0.0025435825809836388, 0.029561469331383705, 0.04258687049150467, 0.15552182495594025, 0.09193996340036392, 0.808398962020874, 0.8288112878799438, 0.004460008814930916, 0.0039641656912863255, 0.006020533386617899, 0.005794675555080175, 0.004566367249935865, 0.004310492426156998, 0.00505596911534667, 0.006777876988053322, 0.006374971941113472, 0.0060690026730299, 0.519541323184967, 0.7001558542251587, 0.8301936388015747, 0.6752462387084961, 0.6600053310394287, 0.0042336853221058846, 0.003914072178304195, 0.004436175804585218, -1]}
{"idB": "749647_18_item1_p172_s2", "idA": "749647_17_item1_p165_s0", "sentA": "In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (FDCA) and implementing regulations.", "sentB": "Gene-based products are subject to extensive regulation under the FDCA, the PHSA, and their implementing regulations.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations.", "<tag2>", "Gene-based", "products", "are", "subject", "to", "extensive", "regulation", "under", "the", "FDCA,", "the", "PHSA,", "and", "their", "implementing", "regulations.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations."], "wordsB": ["Gene-based", "products", "are", "subject", "to", "extensive", "regulation", "under", "the", "FDCA,", "the", "PHSA,", "and", "their", "implementing", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.8871331810951233, 0.5751683115959167, 0.004904093220829964, 0.02479553036391735, 0.012564492411911488, 0.044896502047777176, 0.10135585069656372, 0.013454596512019634, 0.009555833414196968, 0.040390416979789734, 0.02419092319905758, 0.23717060685157776, 0.0024983363691717386, 0.0030478190165013075, 0.009064862504601479, 0.01180915255099535, -1]}
{"idB": "749647_18_item1_p321_s0", "idA": "749647_17_item1_p165_s0", "sentA": "In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (FDCA) and implementing regulations.", "sentB": "Several of our current clinical trials are being conducted outside the United States, and the FDA may not accept data from trials conducted in foreign locations.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations.", "<tag2>", "Several", "of", "our", "current", "clinical", "trials", "are", "being", "conducted", "outside", "the", "United", "States,", "and", "the", "FDA", "may", "not", "accept", "data", "from", "trials", "conducted", "in", "foreign", "locations.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations."], "wordsB": ["Several", "of", "our", "current", "clinical", "trials", "are", "being", "conducted", "outside", "the", "United", "States,", "and", "the", "FDA", "may", "not", "accept", "data", "from", "trials", "conducted", "in", "foreign", "locations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05831163749098778, 0.017604481428861618, 0.05129294842481613, 0.04744461551308632, 0.29668229818344116, 0.3341394364833832, 0.00909724086523056, 0.04068592190742493, 0.09882962703704834, 0.5218431353569031, 0.3073619306087494, 0.31572461128234863, 0.39792904257774353, 0.0004279419663362205, 0.006432645488530397, 0.06869833171367645, 0.042899858206510544, 0.17684949934482574, 0.2014879286289215, 0.21880900859832764, 0.043134093284606934, 0.12962912023067474, 0.04389825090765953, 0.04706213250756264, 0.1864261031150818, 0.16876308619976044, -1]}
{"idB": "749647_18_item1_p323_s0", "idA": "749647_17_item1_p165_s0", "sentA": "In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (FDCA) and implementing regulations.", "sentB": "Although the FDA may accept data from clinical trials conducted outside the United States, acceptance of these data is subject to certain conditions imposed by the FDA.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations.", "<tag2>", "Although", "the", "FDA", "may", "accept", "data", "from", "clinical", "trials", "conducted", "outside", "the", "United", "States,", "acceptance", "of", "these", "data", "is", "subject", "to", "certain", "conditions", "imposed", "by", "the", "FDA.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations."], "wordsB": ["Although", "the", "FDA", "may", "accept", "data", "from", "clinical", "trials", "conducted", "outside", "the", "United", "States,", "acceptance", "of", "these", "data", "is", "subject", "to", "certain", "conditions", "imposed", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02375931665301323, 0.010475949384272099, 0.08618848025798798, 0.048082780092954636, 0.3013884127140045, 0.35349375009536743, 0.0709550753235817, 0.3498258590698242, 0.3965836465358734, 0.07184455543756485, 0.434363454580307, 0.2313041388988495, 0.3184173107147217, 0.3601321578025818, 0.22189880907535553, 0.09439250081777573, 0.06611873209476471, 0.18906351923942566, 0.030828360468149185, 0.051954302936792374, 0.02226210944354534, 0.0525883287191391, 0.08964572846889496, 0.06126849353313446, 0.03462376445531845, 0.02902798168361187, 0.07094570994377136, -1]}
{"idB": "749647_18_item1_p323_s5", "idA": "749647_17_item1_p165_s0", "sentA": "In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (FDCA) and implementing regulations.", "sentB": "We cannot assure you that the FDA will accept data from trials conducted outside of the United States.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations.", "<tag2>", "We", "cannot", "assure", "you", "that", "the", "FDA", "will", "accept", "data", "from", "trials", "conducted", "outside", "of", "the", "United", "States.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "the", "FDA", "regulates", "drugs", "under", "the", "Federal", "Food,", "Drug,", "and", "Cosmetic", "Act", "(FDCA)", "and", "implementing", "regulations."], "wordsB": ["We", "cannot", "assure", "you", "that", "the", "FDA", "will", "accept", "data", "from", "trials", "conducted", "outside", "of", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08929529786109924, 0.19766192138195038, 0.1304243803024292, 0.12044879794120789, 0.056733060628175735, 0.036932870745658875, 0.15369652211666107, 0.2122507244348526, 0.4885275065898895, 0.44888290762901306, 0.09401705861091614, 0.3440839648246765, 0.12409470975399017, 0.636227548122406, 0.3185921609401703, 0.3280322551727295, 0.3946326971054077, 0.46064260601997375, -1]}
{"idB": "749647_18_item1_p194_s2", "idA": "749647_17_item1_p165_s1", "sentA": "Failure to comply with the applicable FDA requirements at any time pre- or post-approval may result in a delay of approval or administrative or judicial sanctions.", "sentB": "Failure to comply with the EU requirements may subject a company to the rejection of the request and the prohibition to start a clinical trial.", "type": 2, "words": ["<tag1>", "Failure", "to", "comply", "with", "the", "applicable", "FDA", "requirements", "at", "any", "time", "pre-", "or", "post-approval", "may", "result", "in", "a", "delay", "of", "approval", "or", "administrative", "or", "judicial", "sanctions.", "<tag2>", "Failure", "to", "comply", "with", "the", "EU", "requirements", "may", "subject", "a", "company", "to", "the", "rejection", "of", "the", "request", "and", "the", "prohibition", "to", "start", "a", "clinical", "trial.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "the", "applicable", "FDA", "requirements", "at", "any", "time", "pre-", "or", "post-approval", "may", "result", "in", "a", "delay", "of", "approval", "or", "administrative", "or", "judicial", "sanctions."], "wordsB": ["Failure", "to", "comply", "with", "the", "EU", "requirements", "may", "subject", "a", "company", "to", "the", "rejection", "of", "the", "request", "and", "the", "prohibition", "to", "start", "a", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01659896783530712, 0.004621348809450865, 0.022968487814068794, 0.015377097763121128, 0.01132983062416315, 0.8602388501167297, 0.3932993412017822, 0.006608752999454737, 0.13441775739192963, 0.029255632311105728, 0.09080246835947037, 0.09104468673467636, 0.04324571415781975, 0.2825988829135895, 0.0666363313794136, 0.05770666524767876, 0.13986577093601227, 0.001971913268789649, 0.027721382677555084, 0.35621383786201477, 0.05780945345759392, 0.07593158632516861, 0.05032245069742203, 0.08790761232376099, 0.08288590610027313, -1]}
{"idB": "749647_18_item1_p293_s3", "idA": "749647_17_item1_p165_s1", "sentA": "Failure to comply with the applicable FDA requirements at any time pre- or post-approval may result in a delay of approval or administrative or judicial sanctions.", "sentB": "Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.", "type": 2, "words": ["<tag1>", "Failure", "to", "comply", "with", "the", "applicable", "FDA", "requirements", "at", "any", "time", "pre-", "or", "post-approval", "may", "result", "in", "a", "delay", "of", "approval", "or", "administrative", "or", "judicial", "sanctions.", "<tag2>", "Failure", "to", "do", "so", "can", "result", "in", "fines,", "adverse", "publicity", "and", "civil", "and", "criminal", "sanctions.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "the", "applicable", "FDA", "requirements", "at", "any", "time", "pre-", "or", "post-approval", "may", "result", "in", "a", "delay", "of", "approval", "or", "administrative", "or", "judicial", "sanctions."], "wordsB": ["Failure", "to", "do", "so", "can", "result", "in", "fines,", "adverse", "publicity", "and", "civil", "and", "criminal", "sanctions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08976922929286957, 0.05908827856183052, 0.1256902515888214, 0.07701945304870605, 0.013015490025281906, 0.05190159007906914, 0.060680076479911804, 0.6270813345909119, 0.2770971357822418, 0.3088807463645935, 0.01949952356517315, 0.45807549357414246, 0.13931813836097717, 0.5330683588981628, 0.5136159658432007, -1]}
{"idB": "749647_18_item1_p300_s0", "idA": "749647_17_item1_p165_s2", "sentA": "These sanctions could include the FDA's imposition of a clinical hold on trials, refusal to approve pending applications, withdrawal of an approval, issuance of warning or untitled letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties or criminal prosecution.", "sentB": "Failure to comply with the FDA and other governmental regulations can result in fines, unanticipated compliance expenditures, recall or seizure of products, total or partial suspension of production and/or distribution, suspension of the FDA s review of product applications, enforcement actions, injunctions and criminal prosecution.", "type": 2, "words": ["<tag1>", "These", "sanctions", "could", "include", "the", "FDA's", "imposition", "of", "a", "clinical", "hold", "on", "trials,", "refusal", "to", "approve", "pending", "applications,", "withdrawal", "of", "an", "approval,", "issuance", "of", "warning", "or", "untitled", "letters,", "product", "recalls,", "product", "seizures,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "injunctions,", "fines,", "civil", "penalties", "or", "criminal", "prosecution.", "<tag2>", "Failure", "to", "comply", "with", "the", "FDA", "and", "other", "governmental", "regulations", "can", "result", "in", "fines,", "unanticipated", "compliance", "expenditures,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "and/or", "distribution,", "suspension", "of", "the", "FDA", "s", "review", "of", "product", "applications,", "enforcement", "actions,", "injunctions", "and", "criminal", "prosecution.", "<tag3>"], "wordsA": ["These", "sanctions", "could", "include", "the", "FDA's", "imposition", "of", "a", "clinical", "hold", "on", "trials,", "refusal", "to", "approve", "pending", "applications,", "withdrawal", "of", "an", "approval,", "issuance", "of", "warning", "or", "untitled", "letters,", "product", "recalls,", "product", "seizures,", "total", "or", "partial", "suspension", "of", "production", "or", "distribution,", "injunctions,", "fines,", "civil", "penalties", "or", "criminal", "prosecution."], "wordsB": ["Failure", "to", "comply", "with", "the", "FDA", "and", "other", "governmental", "regulations", "can", "result", "in", "fines,", "unanticipated", "compliance", "expenditures,", "recall", "or", "seizure", "of", "products,", "total", "or", "partial", "suspension", "of", "production", "and/or", "distribution,", "suspension", "of", "the", "FDA", "s", "review", "of", "product", "applications,", "enforcement", "actions,", "injunctions", "and", "criminal", "prosecution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6217088103294373, 0.63873291015625, 0.6534595489501953, 0.17733269929885864, 0.07286294549703598, 0.15802238881587982, 0.013767553493380547, 0.009221944957971573, 0.032676178961992264, 0.15025977790355682, 0.004545589443296194, 0.007095340173691511, 0.006632410921156406, 0.027195224538445473, 0.03619672358036041, 0.17284566164016724, 0.11698093265295029, 0.003880596486851573, 0.0027263774536550045, 0.003600476309657097, 0.0026243748143315315, 0.0066470010206103325, 0.0042856065556406975, 0.002694746945053339, 0.00526115158572793, 0.010873446241021156, 0.0034573113080114126, 0.006804353557527065, 0.004347130190581083, 0.006435086484998465, 0.03006337769329548, 0.002916529309004545, 0.004995561204850674, 0.0601315014064312, 0.006087745539844036, 0.013758246786892414, 0.008253069594502449, 0.03704788163304329, 0.02081112191081047, 0.05758325383067131, 0.10037259757518768, 0.004870115779340267, 0.002199314534664154, 0.0067960890009999275, 0.012089503929018974, -1]}
{"idB": "749647_18_item1_p157_s0", "idA": "749647_17_item1_p166_s0", "sentA": "The vehicle by which FDA approves a new pharmaceutical product for sale and marketing in the U.S. is a New Drug Application ( NDA ).", "sentB": "The vehicle by which FDA approves a new pharmaceutical product for sale and marketing in the U.S. is a New Drug Application ( NDA ) or a Biologics License Application (BLA).", "type": 2, "words": ["<tag1>", "The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "U.S.", "is", "a", "New", "Drug", "Application", "(", "NDA", ").", "<tag2>", "The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "U.S.", "is", "a", "New", "Drug", "Application", "(", "NDA", ")", "or", "a", "Biologics", "License", "Application", "(BLA).", "<tag3>"], "wordsA": ["The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "U.S.", "is", "a", "New", "Drug", "Application", "(", "NDA", ")."], "wordsB": ["The", "vehicle", "by", "which", "FDA", "approves", "a", "new", "pharmaceutical", "product", "for", "sale", "and", "marketing", "in", "the", "U.S.", "is", "a", "New", "Drug", "Application", "(", "NDA", ")", "or", "a", "Biologics", "License", "Application", "(BLA)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005490073934197426, 0.024439126253128052, 0.010236439295113087, 0.0075272987596690655, 0.01642141491174698, 0.023459143936634064, 0.0057764360681176186, 0.012159107252955437, 0.02182937040925026, 0.017768017947673798, 0.005767302121967077, 0.008395755663514137, 0.006747820880264044, 0.007400495000183582, 0.0055966004729270935, 0.0057898699305951595, 0.025473715737462044, 0.00613481504842639, 0.005834224633872509, 0.015573833137750626, 0.025241246446967125, 0.025408195331692696, 0.006736229173839092, 0.027142401784658432, 0.00021727244893554598, 0.0238376222550869, 0.016553504392504692, 0.8207048177719116, 0.8147101998329163, 0.6475115418434143, 0.7888520956039429, -1]}
{"idB": "749647_18_item1_p157_s1", "idA": "749647_17_item1_p166_s1", "sentA": "The steps ordinarily required before a new drug can be marketed in the U.S. include (a) completion of pre-clinical and clinical studies; (b) submission and FDA acceptance of an Investigational New Drug application (IND), which must become effective before human clinical trials may commence; (c) completion of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product to support each of its proposed indications; (d) submission and FDA acceptance of a NDA; and (e) FDA review and approval of the NDA.", "sentB": "A new drug or biological product cannot be marketed in the United States without FDA s approval of an NDA/BLA.", "type": 2, "words": ["<tag1>", "The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "a", "NDA;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA.", "<tag2>", "A", "new", "drug", "or", "biological", "product", "cannot", "be", "marketed", "in", "the", "United", "States", "without", "FDA", "s", "approval", "of", "an", "NDA/BLA.", "<tag3>"], "wordsA": ["The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "a", "NDA;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA."], "wordsB": ["A", "new", "drug", "or", "biological", "product", "cannot", "be", "marketed", "in", "the", "United", "States", "without", "FDA", "s", "approval", "of", "an", "NDA/BLA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011142647825181484, 0.11149077862501144, 0.20691551268100739, 0.02094268798828125, 0.260318785905838, 0.30809876322746277, 0.5949721932411194, 0.2464655339717865, 0.3225346505641937, 0.04456989839673042, 0.03567943722009659, 0.050884462893009186, 0.06185926869511604, 0.4704495966434479, 0.260135680437088, 0.23726165294647217, 0.3456972539424896, 0.04056524857878685, 0.09752728044986725, 0.2538776397705078, -1]}
{"idB": "749647_18_item1_p157_s2", "idA": "749647_17_item1_p166_s1", "sentA": "The steps ordinarily required before a new drug can be marketed in the U.S. include (a) completion of pre-clinical and clinical studies; (b) submission and FDA acceptance of an Investigational New Drug application (IND), which must become effective before human clinical trials may commence; (c) completion of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product to support each of its proposed indications; (d) submission and FDA acceptance of a NDA; and (e) FDA review and approval of the NDA.", "sentB": "The steps ordinarily required before a new drug can be marketed in the U.S. include (a) completion of pre-clinical and clinical studies; (b) submission and FDA acceptance of an Investigational New Drug application (IND), which must become effective before human clinical trials may commence; (c) completion of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product to support each of its proposed indications; (d) submission and FDA acceptance of an NDA/BLA; (e) c ompletion of an FDA inspection and potential audits of the facilities where the drug or biological product is manufactured to assess compliance with the current good manufacturing practices (cGMP) and to assure adequate identity, strength, quality, purity, and potency; and (e) FDA review and approval of the NDA/BLA.", "type": 2, "words": ["<tag1>", "The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "a", "NDA;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA.", "<tag2>", "The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "an", "NDA/BLA;", "(e)", "c", "ompletion", "of", "an", "FDA", "inspection", "and", "potential", "audits", "of", "the", "facilities", "where", "the", "drug", "or", "biological", "product", "is", "manufactured", "to", "assess", "compliance", "with", "the", "current", "good", "manufacturing", "practices", "(cGMP)", "and", "to", "assure", "adequate", "identity,", "strength,", "quality,", "purity,", "and", "potency;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA/BLA.", "<tag3>"], "wordsA": ["The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "a", "NDA;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA."], "wordsB": ["The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "an", "NDA/BLA;", "(e)", "c", "ompletion", "of", "an", "FDA", "inspection", "and", "potential", "audits", "of", "the", "facilities", "where", "the", "drug", "or", "biological", "product", "is", "manufactured", "to", "assess", "compliance", "with", "the", "current", "good", "manufacturing", "practices", "(cGMP)", "and", "to", "assure", "adequate", "identity,", "strength,", "quality,", "purity,", "and", "potency;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA/BLA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017865916714072227, 0.10320750623941422, 0.1350877732038498, 0.18586207926273346, 0.21749398112297058, 0.06469123810529709, 0.13762134313583374, 0.16728170216083527, 0.131829634308815, 0.11065685003995895, 0.1291690617799759, 0.03871797397732735, 0.03916538879275322, 0.11926942318677902, 0.03550557792186737, 0.05314580351114273, 0.04274359345436096, 0.030410224571824074, 0.06568107008934021, 0.02973419427871704, 0.03993701562285423, 0.050630614161491394, 0.05508718639612198, 0.050160106271505356, 0.019128793850541115, 0.04341462627053261, 0.05486910417675972, 0.02606511302292347, 0.028142642229795456, 0.053413331508636475, 0.05530993267893791, 0.0664825364947319, 0.05263366922736168, 0.05110929533839226, 0.02753143385052681, 0.03113337978720665, 0.03927411511540413, 0.054359935224056244, 0.03600963205099106, 0.041012994945049286, 0.05459464713931084, 0.06357458233833313, 0.0260191448032856, 0.0346754714846611, 0.03889184817671776, 0.022184552624821663, 0.020586829632520676, 0.03489082306623459, 0.02330719120800495, 0.0379386730492115, 0.029059384018182755, 0.034033458679914474, 0.04246815666556358, 0.024692993611097336, 0.03173398971557617, 0.02965700998902321, 0.041668303310871124, 0.032165512442588806, 0.03616578131914139, 0.020409995689988136, 0.027867887169122696, 0.03244888037443161, 0.023214496672153473, 0.02655007503926754, 0.02487950026988983, 0.023028884083032608, 0.023791538551449776, 0.028279712423682213, 0.037186313420534134, 0.024213703349232674, 0.030829016119241714, 0.01597415842115879, 0.02493983507156372, 0.02559490315616131, 0.016981614753603935, 0.01327168382704258, 0.05463079363107681, 0.018524978309869766, 0.009921793825924397, 0.027730001136660576, 0.010583418421447277, 0.011236663907766342, 0.022422848269343376, 0.015665406361222267, 0.00874376017600298, 0.011831040494143963, 0.024411428719758987, 0.017552856355905533, 0.01733713410794735, 0.024368159472942352, 0.01612403243780136, 0.014856759458780289, 0.03136640042066574, 0.021165775135159492, 0.024989783763885498, 0.04302886500954628, 0.020504578948020935, 0.020848510786890984, 0.019809845834970474, 0.017568783834576607, 0.024379240348935127, 0.018003566190600395, 0.017329741269350052, 0.014472022652626038, 0.014181029982864857, 0.02116391994059086, 0.026738129556179047, 0.023038294166326523, 0.015622266568243504, 0.018861349672079086, 0.012616273947060108, 0.013628749176859856, 0.014231875538825989, 0.014985917136073112, 0.01479248609393835, 0.016612641513347626, 0.02048533223569393, 0.024444183334708214, 0.01975971646606922, 0.026952754706144333, 0.016706762835383415, 0.021134858950972557, 0.018192170187830925, 0.029867425560951233, 0.02083178609609604, 0.022165246307849884, 0.13774193823337555, -1]}
{"idB": "749647_18_item1_p251_s0", "idA": "749647_17_item1_p166_s1", "sentA": "The steps ordinarily required before a new drug can be marketed in the U.S. include (a) completion of pre-clinical and clinical studies; (b) submission and FDA acceptance of an Investigational New Drug application (IND), which must become effective before human clinical trials may commence; (c) completion of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product to support each of its proposed indications; (d) submission and FDA acceptance of a NDA; and (e) FDA review and approval of the NDA.", "sentB": "Securing FDA or comparable foreign regulatory approval requires the submission of extensive preclinical and clinical data and supporting information for each therapeutic indication to establish the product candidate s safety and efficacy for its intended use.", "type": 2, "words": ["<tag1>", "The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "a", "NDA;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA.", "<tag2>", "Securing", "FDA", "or", "comparable", "foreign", "regulatory", "approval", "requires", "the", "submission", "of", "extensive", "preclinical", "and", "clinical", "data", "and", "supporting", "information", "for", "each", "therapeutic", "indication", "to", "establish", "the", "product", "candidate", "s", "safety", "and", "efficacy", "for", "its", "intended", "use.", "<tag3>"], "wordsA": ["The", "steps", "ordinarily", "required", "before", "a", "new", "drug", "can", "be", "marketed", "in", "the", "U.S.", "include", "(a)", "completion", "of", "pre-clinical", "and", "clinical", "studies;", "(b)", "submission", "and", "FDA", "acceptance", "of", "an", "Investigational", "New", "Drug", "application", "(IND),", "which", "must", "become", "effective", "before", "human", "clinical", "trials", "may", "commence;", "(c)", "completion", "of", "adequate", "and", "well-controlled", "human", "clinical", "trials", "to", "establish", "the", "safety", "and", "efficacy", "of", "the", "product", "to", "support", "each", "of", "its", "proposed", "indications;", "(d)", "submission", "and", "FDA", "acceptance", "of", "a", "NDA;", "and", "(e)", "FDA", "review", "and", "approval", "of", "the", "NDA."], "wordsB": ["Securing", "FDA", "or", "comparable", "foreign", "regulatory", "approval", "requires", "the", "submission", "of", "extensive", "preclinical", "and", "clinical", "data", "and", "supporting", "information", "for", "each", "therapeutic", "indication", "to", "establish", "the", "product", "candidate", "s", "safety", "and", "efficacy", "for", "its", "intended", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.044274479150772095, 0.03441467136144638, 0.011727389879524708, 0.07097916305065155, 0.19567479193210602, 0.2654254734516144, 0.31616470217704773, 0.021528683602809906, 0.00732159661129117, 0.04940085858106613, 0.007668667938560247, 0.1424233764410019, 0.11580787599086761, 0.012822047807276249, 0.07222076505422592, 0.14310654997825623, 0.004047400783747435, 0.03317563980817795, 0.0502668060362339, 0.007723487447947264, 0.009521766565740108, 0.03894595056772232, 0.050706811249256134, 0.004099652636796236, 0.004994155373424292, 0.004022730514407158, 0.015543662011623383, 0.011548140086233616, 0.006845096591860056, 0.007169455289840698, 0.0031701084226369858, 0.006236257031559944, 0.0029136519879102707, 0.003108744276687503, 0.02446848712861538, 0.019094686955213547, -1]}
{"idB": "749647_18_item1_p276_s3", "idA": "749647_17_item1_p167_s0", "sentA": "Pre-clinical tests include laboratory evaluations of product chemistry, toxicity, formulation and stability, as well as animal studies, to assess the potential safety and efficacy of the product.", "sentB": "If we breach any provisions of the license and research agreements, we may lose our ability to use the subject technology, as well as compensation for our efforts in developing or exploiting the technology.", "type": 2, "words": ["<tag1>", "Pre-clinical", "tests", "include", "laboratory", "evaluations", "of", "product", "chemistry,", "toxicity,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product.", "<tag2>", "If", "we", "breach", "any", "provisions", "of", "the", "license", "and", "research", "agreements,", "we", "may", "lose", "our", "ability", "to", "use", "the", "subject", "technology,", "as", "well", "as", "compensation", "for", "our", "efforts", "in", "developing", "or", "exploiting", "the", "technology.", "<tag3>"], "wordsA": ["Pre-clinical", "tests", "include", "laboratory", "evaluations", "of", "product", "chemistry,", "toxicity,", "formulation", "and", "stability,", "as", "well", "as", "animal", "studies,", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product."], "wordsB": ["If", "we", "breach", "any", "provisions", "of", "the", "license", "and", "research", "agreements,", "we", "may", "lose", "our", "ability", "to", "use", "the", "subject", "technology,", "as", "well", "as", "compensation", "for", "our", "efforts", "in", "developing", "or", "exploiting", "the", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05712824687361717, 0.1120726615190506, 0.21857962012290955, 0.07088007777929306, 0.08136957138776779, 0.034186504781246185, 0.041100263595581055, 0.1412653923034668, 0.06160854175686836, 0.1471191644668579, 0.15732347965240479, 0.05953875929117203, 0.05387358367443085, 0.2507724463939667, 0.11921317130327225, 0.2596103549003601, 0.22008970379829407, 0.21881835162639618, 0.06325823068618774, 0.13550680875778198, 0.17084352672100067, 0.0003143609210383147, 0.0005952675128355622, 0.010759475640952587, 0.037343092262744904, 0.009326502680778503, 0.017372652888298035, 0.025124087929725647, 0.010400517843663692, 0.06803610175848007, 0.034815676510334015, 0.14159119129180908, 0.03437715768814087, 0.10627005994319916, -1]}
{"idB": "749647_18_item1_p189_s3", "idA": "749647_17_item1_p167_s1", "sentA": "Pre-clinical safety tests must be conducted by laboratories that comply with FDA regulations regarding good laboratory practice.", "sentB": "Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its proposed shelf-life.", "type": 2, "words": ["<tag1>", "Pre-clinical", "safety", "tests", "must", "be", "conducted", "by", "laboratories", "that", "comply", "with", "FDA", "regulations", "regarding", "good", "laboratory", "practice.", "<tag2>", "Additionally,", "appropriate", "packaging", "must", "be", "selected", "and", "tested", "and", "stability", "studies", "must", "be", "conducted", "to", "demonstrate", "that", "the", "product", "candidate", "does", "not", "undergo", "unacceptable", "deterioration", "over", "its", "proposed", "shelf-life.", "<tag3>"], "wordsA": ["Pre-clinical", "safety", "tests", "must", "be", "conducted", "by", "laboratories", "that", "comply", "with", "FDA", "regulations", "regarding", "good", "laboratory", "practice."], "wordsB": ["Additionally,", "appropriate", "packaging", "must", "be", "selected", "and", "tested", "and", "stability", "studies", "must", "be", "conducted", "to", "demonstrate", "that", "the", "product", "candidate", "does", "not", "undergo", "unacceptable", "deterioration", "over", "its", "proposed", "shelf-life."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005803398322314024, 0.13617931306362152, 0.3427110016345978, 0.007737676613032818, 0.009497027844190598, 0.040159258991479874, 0.007644441444426775, 0.049559637904167175, 0.0031907251104712486, 0.34443363547325134, 0.49482694268226624, 0.003467540256679058, 0.003001011209562421, 0.013783828355371952, 0.007333285640925169, 0.008897639811038971, 0.008049927651882172, 0.008320018649101257, 0.09339798241853714, 0.12447627633810043, 0.0798935517668724, 0.05866680666804314, 0.10354338586330414, 0.11902175098657608, 0.24647711217403412, 0.006088642403483391, 0.009156526997685432, 0.02284436672925949, 0.023671908304095268, -1]}
{"idB": "749647_18_item1_p175_s1", "idA": "749647_17_item1_p167_s2", "sentA": "The results of pre-clinical tests are submitted to the FDA as part of an IND and are reviewed by the FDA before the commencement of human clinical trials.", "sentB": "If the product is subject to official release by the FDA, the manufacturer submits samples of each lot of product to the FDA together with a release protocol showing a summary of the history of manufacture of the lot and the results of all of the manufacturer s tests performed on the lot.", "type": 2, "words": ["<tag1>", "The", "results", "of", "pre-clinical", "tests", "are", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "are", "reviewed", "by", "the", "FDA", "before", "the", "commencement", "of", "human", "clinical", "trials.", "<tag2>", "If", "the", "product", "is", "subject", "to", "official", "release", "by", "the", "FDA,", "the", "manufacturer", "submits", "samples", "of", "each", "lot", "of", "product", "to", "the", "FDA", "together", "with", "a", "release", "protocol", "showing", "a", "summary", "of", "the", "history", "of", "manufacture", "of", "the", "lot", "and", "the", "results", "of", "all", "of", "the", "manufacturer", "s", "tests", "performed", "on", "the", "lot.", "<tag3>"], "wordsA": ["The", "results", "of", "pre-clinical", "tests", "are", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "are", "reviewed", "by", "the", "FDA", "before", "the", "commencement", "of", "human", "clinical", "trials."], "wordsB": ["If", "the", "product", "is", "subject", "to", "official", "release", "by", "the", "FDA,", "the", "manufacturer", "submits", "samples", "of", "each", "lot", "of", "product", "to", "the", "FDA", "together", "with", "a", "release", "protocol", "showing", "a", "summary", "of", "the", "history", "of", "manufacture", "of", "the", "lot", "and", "the", "results", "of", "all", "of", "the", "manufacturer", "s", "tests", "performed", "on", "the", "lot."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.031547144055366516, 0.009396685287356377, 0.09455360472202301, 0.09004224836826324, 0.44055020809173584, 0.2974940538406372, 0.6222817301750183, 0.6276981234550476, 0.02955269068479538, 0.01590164564549923, 0.06474665552377701, 0.005621560383588076, 0.058840155601501465, 0.19066157937049866, 0.23420362174510956, 0.03414377570152283, 0.08408785611391068, 0.13753056526184082, 0.04979002848267555, 0.08355914056301117, 0.009182914160192013, 0.009420596063137054, 0.04436182230710983, 0.00023486492864321917, 0.004347056150436401, 0.0050379084423184395, 0.04298977181315422, 0.04540221765637398, 0.007637914270162582, 0.008319846354424953, 0.03986966982483864, 0.010022465139627457, 0.010889959521591663, 0.07011080533266068, 0.0393475666642189, 0.043249353766441345, 0.014852475374937057, 0.012716085650026798, 0.04156915470957756, 0.0027702078223228455, 0.007329086307436228, 0.04072675481438637, 0.011005752719938755, 0.11337824165821075, 0.029569651931524277, 0.0189797505736351, 0.1695202738046646, 0.12107398360967636, 0.34944334626197815, 0.03845192864537239, 0.03518997132778168, 0.021256113424897194, 0.047356978058815, -1]}
{"idB": "749647_18_item1_p190_s1", "idA": "749647_17_item1_p167_s2", "sentA": "The results of pre-clinical tests are submitted to the FDA as part of an IND and are reviewed by the FDA before the commencement of human clinical trials.", "sentB": "A sponsor or applicant who wishes to rely on a non-IND foreign clinical trial to support an IND must submit supporting information to the FDA to demonstrate that the trial conformed to GCP .", "type": 2, "words": ["<tag1>", "The", "results", "of", "pre-clinical", "tests", "are", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "are", "reviewed", "by", "the", "FDA", "before", "the", "commencement", "of", "human", "clinical", "trials.", "<tag2>", "A", "sponsor", "or", "applicant", "who", "wishes", "to", "rely", "on", "a", "non-IND", "foreign", "clinical", "trial", "to", "support", "an", "IND", "must", "submit", "supporting", "information", "to", "the", "FDA", "to", "demonstrate", "that", "the", "trial", "conformed", "to", "GCP", ".", "<tag3>"], "wordsA": ["The", "results", "of", "pre-clinical", "tests", "are", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "are", "reviewed", "by", "the", "FDA", "before", "the", "commencement", "of", "human", "clinical", "trials."], "wordsB": ["A", "sponsor", "or", "applicant", "who", "wishes", "to", "rely", "on", "a", "non-IND", "foreign", "clinical", "trial", "to", "support", "an", "IND", "must", "submit", "supporting", "information", "to", "the", "FDA", "to", "demonstrate", "that", "the", "trial", "conformed", "to", "GCP", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009089061059057713, 0.09420764446258545, 0.032152846455574036, 0.06439927965402603, 9.207243419950828e-05, 0.02676384337246418, 0.009748746640980244, 0.05881085991859436, 0.04315086826682091, 0.01980026438832283, 0.7524339556694031, 0.18940117955207825, 0.2638480067253113, 0.3192681074142456, 0.0038122134283185005, 0.026362769305706024, 0.004281372297555208, 0.029293637722730637, 0.007826349698007107, 0.06618080288171768, 0.06339487433433533, 0.08896685391664505, 0.007266910746693611, 0.0040250965394079685, 0.02789112739264965, 0.005204544402658939, 0.007935712113976479, 0.005154358223080635, 0.0038096571806818247, 0.09261253476142883, 0.0502622053027153, 0.039365991950035095, 0.09478206932544708, 4.29851352237165e-05, -1]}
{"idB": "749647_18_item1_p158_s3", "idA": "749647_17_item1_p167_s3", "sentA": "Submission of an IND will not necessarily result in FDA authorization to commence clinical trials, and the absence of FDA objection to an IND does not necessarily mean that the FDA will ultimately approve an NDA or that a product candidate otherwise will come to market.", "sentB": "Submission of an IND will not necessarily result in FDA authorization to commence clinical trials, and the absence of FDA objection to an IND does not necessarily mean that the FDA will ultimately approve an NDA/BLA or that a product candidate otherwise will come to market.", "type": 2, "words": ["<tag1>", "Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market.", "<tag2>", "Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA/BLA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market.", "<tag3>"], "wordsA": ["Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market."], "wordsB": ["Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA/BLA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03135674074292183, 0.008009751327335835, 0.007076233625411987, 0.02931271307170391, 0.0194704607129097, 0.22651267051696777, 0.03436990827322006, 0.019118014723062515, 0.012520312331616879, 0.020238114520907402, 0.03319501876831055, 0.01214677095413208, 0.020155059173703194, 0.015280503779649734, 0.015817953273653984, 0.002869086805731058, 0.01019269973039627, 0.10377037525177002, 0.011303719133138657, 0.02971554361283779, 0.05883534252643585, 0.008939179591834545, 0.008823584765195847, 0.02554178610444069, 0.018694287165999413, 0.05884462967514992, 0.01746896654367447, 0.018061935901641846, 0.007709529250860214, 0.005571686662733555, 0.03424512967467308, 0.016969744116067886, 0.019738418981432915, 0.033758215606212616, 0.039246030151844025, 0.6365490555763245, 0.01663990505039692, 0.007064446806907654, 0.009013266302645206, 0.03739407658576965, 0.03276192396879196, 0.016274254769086838, 0.006998113356530666, 0.008212318643927574, 0.008329548873007298, 0.01300986297428608, -1]}
{"idB": "749647_18_item1_p171_s0", "idA": "749647_17_item1_p167_s3", "sentA": "Submission of an IND will not necessarily result in FDA authorization to commence clinical trials, and the absence of FDA objection to an IND does not necessarily mean that the FDA will ultimately approve an NDA or that a product candidate otherwise will come to market.", "sentB": "Priority review are applied to a product candidate that the FDA determines has the potential to treat a serious or life-threatening condition and, if approved, would be a significant improvement in safety or effectiveness compared to available therapies.", "type": 2, "words": ["<tag1>", "Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market.", "<tag2>", "Priority", "review", "are", "applied", "to", "a", "product", "candidate", "that", "the", "FDA", "determines", "has", "the", "potential", "to", "treat", "a", "serious", "or", "life-threatening", "condition", "and,", "if", "approved,", "would", "be", "a", "significant", "improvement", "in", "safety", "or", "effectiveness", "compared", "to", "available", "therapies.", "<tag3>"], "wordsA": ["Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market."], "wordsB": ["Priority", "review", "are", "applied", "to", "a", "product", "candidate", "that", "the", "FDA", "determines", "has", "the", "potential", "to", "treat", "a", "serious", "or", "life-threatening", "condition", "and,", "if", "approved,", "would", "be", "a", "significant", "improvement", "in", "safety", "or", "effectiveness", "compared", "to", "available", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4040030241012573, 0.6280153393745422, 0.012373683042824268, 0.05568714067339897, 0.016856534406542778, 0.014955837279558182, 0.13925480842590332, 0.10698036849498749, 0.004944702610373497, 0.0037766636814922094, 0.027811642736196518, 0.011678295210003853, 0.017061248421669006, 0.009444261901080608, 0.06127322092652321, 0.05181992053985596, 0.12316763401031494, 0.045566339045763016, 0.09876459091901779, 0.03862953931093216, 0.21293552219867706, 0.11365623027086258, 0.00017617139383219182, 0.027919048443436623, 0.04713121056556702, 0.025802133604884148, 0.017316801473498344, 0.01474123913794756, 0.08233579993247986, 0.13415656983852386, 0.07043439149856567, 0.09057742357254028, 0.08104962855577469, 0.09652333706617355, 0.024641815572977066, 0.011550994589924812, 0.028621843084692955, 0.042505595833063126, -1]}
{"idB": "749647_18_item1_p177_s1", "idA": "749647_17_item1_p167_s3", "sentA": "Submission of an IND will not necessarily result in FDA authorization to commence clinical trials, and the absence of FDA objection to an IND does not necessarily mean that the FDA will ultimately approve an NDA or that a product candidate otherwise will come to market.", "sentB": "Even if a product candidate qualifies for one or more of these programs, the FDA may later decide that the product candidate no longer meets the conditions for qualification or that the time period for FDA review or approval will be lengthened.", "type": 2, "words": ["<tag1>", "Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market.", "<tag2>", "Even", "if", "a", "product", "candidate", "qualifies", "for", "one", "or", "more", "of", "these", "programs,", "the", "FDA", "may", "later", "decide", "that", "the", "product", "candidate", "no", "longer", "meets", "the", "conditions", "for", "qualification", "or", "that", "the", "time", "period", "for", "FDA", "review", "or", "approval", "will", "be", "lengthened.", "<tag3>"], "wordsA": ["Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market."], "wordsB": ["Even", "if", "a", "product", "candidate", "qualifies", "for", "one", "or", "more", "of", "these", "programs,", "the", "FDA", "may", "later", "decide", "that", "the", "product", "candidate", "no", "longer", "meets", "the", "conditions", "for", "qualification", "or", "that", "the", "time", "period", "for", "FDA", "review", "or", "approval", "will", "be", "lengthened."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.037804558873176575, 0.020748278126120567, 0.013860532082617283, 0.12117037922143936, 0.15886925160884857, 0.19972018897533417, 0.08879324793815613, 0.10030516982078552, 0.02503000758588314, 0.07578343152999878, 0.04023181274533272, 0.09429839998483658, 0.2881614565849304, 0.005166715942323208, 0.05460333079099655, 0.042784906923770905, 0.044453710317611694, 0.12061632424592972, 0.04431452229619026, 0.01187580544501543, 0.1538364291191101, 0.2201434224843979, 0.5632274150848389, 0.41802453994750977, 0.4219985902309418, 0.14827173948287964, 0.27235308289527893, 0.13417604565620422, 0.26233211159706116, 0.008022342808544636, 0.027715470641851425, 0.014757247641682625, 0.09901424497365952, 0.09599672257900238, 0.03186754509806633, 0.06297343224287033, 0.06675446033477783, 0.03232228383421898, 0.08396097272634506, 0.14841124415397644, 0.14309243857860565, 0.25980350375175476, -1]}
{"idB": "749647_18_item1_p178_s0", "idA": "749647_17_item1_p167_s3", "sentA": "Submission of an IND will not necessarily result in FDA authorization to commence clinical trials, and the absence of FDA objection to an IND does not necessarily mean that the FDA will ultimately approve an NDA or that a product candidate otherwise will come to market.", "sentB": "Although Fast Track and priority review do not affect the standards for approval, the FDA will attempt to facilitate early and frequent meetings with a sponsor of a Fast Track designated product candidate and expedite review of the application for a product candidate designated for priority review.", "type": 2, "words": ["<tag1>", "Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market.", "<tag2>", "Although", "Fast", "Track", "and", "priority", "review", "do", "not", "affect", "the", "standards", "for", "approval,", "the", "FDA", "will", "attempt", "to", "facilitate", "early", "and", "frequent", "meetings", "with", "a", "sponsor", "of", "a", "Fast", "Track", "designated", "product", "candidate", "and", "expedite", "review", "of", "the", "application", "for", "a", "product", "candidate", "designated", "for", "priority", "review.", "<tag3>"], "wordsA": ["Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market."], "wordsB": ["Although", "Fast", "Track", "and", "priority", "review", "do", "not", "affect", "the", "standards", "for", "approval,", "the", "FDA", "will", "attempt", "to", "facilitate", "early", "and", "frequent", "meetings", "with", "a", "sponsor", "of", "a", "Fast", "Track", "designated", "product", "candidate", "and", "expedite", "review", "of", "the", "application", "for", "a", "product", "candidate", "designated", "for", "priority", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021014545112848282, 0.12251016497612, 0.1377224177122116, 0.02193867601454258, 0.18542911112308502, 0.3010116219520569, 0.04628263786435127, 0.11118274182081223, 0.11539079993963242, 0.03208354115486145, 0.11461729556322098, 0.07307116687297821, 0.09257399290800095, 0.005424853879958391, 0.06415627151727676, 0.031211860477924347, 0.05667408928275108, 0.019002830609679222, 0.09150515496730804, 0.16833814978599548, 0.020840870216488838, 0.20637322962284088, 0.3455384075641632, 0.05199464038014412, 0.03192519396543503, 0.09128938615322113, 0.009320036508142948, 0.01175633817911148, 0.03217299282550812, 0.03817958012223244, 0.02858707495033741, 0.054871104657649994, 0.05847279727458954, 0.007147734519094229, 0.07627882063388824, 0.17980565130710602, 0.02984810620546341, 0.028788015246391296, 0.17351914942264557, 0.03365541249513626, 0.022988473996520042, 0.08773223310709, 0.09363093227148056, 0.006779424846172333, 0.010424632579088211, 0.06366852670907974, 0.07080266624689102, -1]}
{"idB": "749647_18_item1_p253_s0", "idA": "749647_17_item1_p167_s3", "sentA": "Submission of an IND will not necessarily result in FDA authorization to commence clinical trials, and the absence of FDA objection to an IND does not necessarily mean that the FDA will ultimately approve an NDA or that a product candidate otherwise will come to market.", "sentB": "we may encounter delays or rejections based on changes in FDA policies or the policies of comparable foreign regulatory authorities during the period in which we develop a product candidate or the period required for review of any final marketing approval before we are able to market any product candidate.", "type": 2, "words": ["<tag1>", "Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market.", "<tag2>", "we", "may", "encounter", "delays", "or", "rejections", "based", "on", "changes", "in", "FDA", "policies", "or", "the", "policies", "of", "comparable", "foreign", "regulatory", "authorities", "during", "the", "period", "in", "which", "we", "develop", "a", "product", "candidate", "or", "the", "period", "required", "for", "review", "of", "any", "final", "marketing", "approval", "before", "we", "are", "able", "to", "market", "any", "product", "candidate.", "<tag3>"], "wordsA": ["Submission", "of", "an", "IND", "will", "not", "necessarily", "result", "in", "FDA", "authorization", "to", "commence", "clinical", "trials,", "and", "the", "absence", "of", "FDA", "objection", "to", "an", "IND", "does", "not", "necessarily", "mean", "that", "the", "FDA", "will", "ultimately", "approve", "an", "NDA", "or", "that", "a", "product", "candidate", "otherwise", "will", "come", "to", "market."], "wordsB": ["we", "may", "encounter", "delays", "or", "rejections", "based", "on", "changes", "in", "FDA", "policies", "or", "the", "policies", "of", "comparable", "foreign", "regulatory", "authorities", "during", "the", "period", "in", "which", "we", "develop", "a", "product", "candidate", "or", "the", "period", "required", "for", "review", "of", "any", "final", "marketing", "approval", "before", "we", "are", "able", "to", "market", "any", "product", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05419709533452988, 0.05269161984324455, 0.08506827801465988, 0.28305381536483765, 0.10854662209749222, 0.27225461602211, 0.01079885195940733, 0.011867308989167213, 0.03782583400607109, 0.013249414041638374, 0.045728567987680435, 0.03798557445406914, 0.013076168484985828, 0.008263000287115574, 0.05601697787642479, 0.009427450597286224, 0.04628823697566986, 0.05027366057038307, 0.05006951466202736, 0.051093995571136475, 0.0074744271114468575, 0.005968498531728983, 0.018705056980252266, 0.005157472565770149, 0.004551911726593971, 0.016997478902339935, 0.11469490826129913, 0.008941461332142353, 0.055263012647628784, 0.06249687820672989, 0.00044335133861750364, 0.006240543443709612, 0.017257602885365486, 0.02618233673274517, 0.01797403395175934, 0.044293519109487534, 0.009368658065795898, 0.012402227148413658, 0.04837258160114288, 0.04236505925655365, 0.06050236150622368, 0.06750696152448654, 0.03641614690423012, 0.063299261033535, 0.13363178074359894, 0.16295893490314484, 0.25587156414985657, 0.11689449101686478, 0.15437950193881989, 0.16842779517173767, -1]}
{"idB": "749647_18_item1_p194_s3", "idA": "749647_17_item1_p168_s1", "sentA": "Clinical trials must be conducted in accordance with good clinical practices under protocols submitted to the FDA as part of an IND and with patient informed consent.", "sentB": "Clinical trials conducted in the EU (or used for marketing authorization application in the EU) must be conducted in accordance with applicable Good Clinical Practice ( GCP ) and Good Manufacturing Practice ( GMP ) rules, ICH guidelines and be consistent with ethical principles.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "with", "patient", "informed", "consent.", "<tag2>", "Clinical", "trials", "conducted", "in", "the", "EU", "(or", "used", "for", "marketing", "authorization", "application", "in", "the", "EU)", "must", "be", "conducted", "in", "accordance", "with", "applicable", "Good", "Clinical", "Practice", "(", "GCP", ")", "and", "Good", "Manufacturing", "Practice", "(", "GMP", ")", "rules,", "ICH", "guidelines", "and", "be", "consistent", "with", "ethical", "principles.", "<tag3>"], "wordsA": ["Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "with", "patient", "informed", "consent."], "wordsB": ["Clinical", "trials", "conducted", "in", "the", "EU", "(or", "used", "for", "marketing", "authorization", "application", "in", "the", "EU)", "must", "be", "conducted", "in", "accordance", "with", "applicable", "Good", "Clinical", "Practice", "(", "GCP", ")", "and", "Good", "Manufacturing", "Practice", "(", "GMP", ")", "rules,", "ICH", "guidelines", "and", "be", "consistent", "with", "ethical", "principles."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03393297642469406, 0.03585939109325409, 0.028380610048770905, 0.07360272109508514, 0.09074945002794266, 0.302886426448822, 0.0010632494231685996, 0.09385253489017487, 0.06976759433746338, 0.14320313930511475, 0.17359532415866852, 0.15333794057369232, 0.020826485008001328, 0.019977722316980362, 0.053069815039634705, 0.0041829547844827175, 0.003571450710296631, 0.014904186129570007, 0.010826259851455688, 0.01592317968606949, 0.011543119326233864, 0.03965263441205025, 0.07217332720756531, 0.052019618451595306, 0.067997045814991, 0.040272172540426254, 0.3610955774784088, 0.00012916603009216487, 0.021533476188778877, 0.10132597386837006, 0.4558851420879364, 0.2344384342432022, 0.015404513105750084, 0.27887627482414246, 0.0001335739070782438, 0.20956210792064667, 0.10449612140655518, 0.192051962018013, 0.0005962040740996599, 0.015816550701856613, 0.09753239899873734, 0.06579097360372543, 0.2433861792087555, 0.315385639667511, -1]}
{"idB": "749647_18_item1_p293_s1", "idA": "749647_17_item1_p168_s1", "sentA": "Clinical trials must be conducted in accordance with good clinical practices under protocols submitted to the FDA as part of an IND and with patient informed consent.", "sentB": "Moreover, the FDA requires clinical trials to be conducted in accordance with good clinical practices for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of clinical trial participants are protected.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "with", "patient", "informed", "consent.", "<tag2>", "Moreover,", "the", "FDA", "requires", "clinical", "trials", "to", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "for", "conducting,", "recording", "and", "reporting", "the", "results", "of", "clinical", "trials", "to", "assure", "that", "data", "and", "reported", "results", "are", "credible", "and", "accurate", "and", "that", "the", "rights,", "integrity", "and", "confidentiality", "of", "clinical", "trial", "participants", "are", "protected.", "<tag3>"], "wordsA": ["Clinical", "trials", "must", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "under", "protocols", "submitted", "to", "the", "FDA", "as", "part", "of", "an", "IND", "and", "with", "patient", "informed", "consent."], "wordsB": ["Moreover,", "the", "FDA", "requires", "clinical", "trials", "to", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices", "for", "conducting,", "recording", "and", "reporting", "the", "results", "of", "clinical", "trials", "to", "assure", "that", "data", "and", "reported", "results", "are", "credible", "and", "accurate", "and", "that", "the", "rights,", "integrity", "and", "confidentiality", "of", "clinical", "trial", "participants", "are", "protected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02512008510529995, 0.020730741322040558, 0.12287797033786774, 0.3768559992313385, 0.13122352957725525, 0.1632722169160843, 0.12348726391792297, 0.08009612560272217, 0.06706251949071884, 0.020241957157850266, 0.024398595094680786, 0.012358802370727062, 0.015973903238773346, 0.015108233317732811, 0.03097418323159218, 0.023224806413054466, 0.09947158396244049, 0.2881382405757904, 0.09552120417356491, 0.3546060621738434, 0.05278707668185234, 0.03579811006784439, 0.01484029833227396, 0.030115390196442604, 0.04161546006798744, 0.0002927807217929512, 0.00033084338065236807, 0.0005833185277879238, 0.02250496856868267, 0.007629332132637501, 0.01980970799922943, 0.01912895031273365, 0.02505389042198658, 0.029101384803652763, 0.017824295908212662, 0.025604935362935066, 0.00028612534515559673, 0.015397274866700172, 0.0072764805518090725, 0.08594827353954315, 0.05844447761774063, 0.023079780861735344, 0.16584891080856323, 0.03556649386882782, 0.0314137265086174, 0.06301778554916382, 0.0551794096827507, 0.03368472680449486, 0.07386504858732224, -1]}
{"idB": "749647_18_item1_p315_s0", "idA": "749647_17_item1_p168_s2", "sentA": "Also, each clinical trial must be approved by an Institutional Review Board (IRB), and is subject to ongoing IRB monitoring.", "sentB": "The reimbursement status of newly approved medical products is subject to significant uncertainty.", "type": 2, "words": ["<tag1>", "Also,", "each", "clinical", "trial", "must", "be", "approved", "by", "an", "Institutional", "Review", "Board", "(IRB),", "and", "is", "subject", "to", "ongoing", "IRB", "monitoring.", "<tag2>", "The", "reimbursement", "status", "of", "newly", "approved", "medical", "products", "is", "subject", "to", "significant", "uncertainty.", "<tag3>"], "wordsA": ["Also,", "each", "clinical", "trial", "must", "be", "approved", "by", "an", "Institutional", "Review", "Board", "(IRB),", "and", "is", "subject", "to", "ongoing", "IRB", "monitoring."], "wordsB": ["The", "reimbursement", "status", "of", "newly", "approved", "medical", "products", "is", "subject", "to", "significant", "uncertainty."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011381682008504868, 0.36373525857925415, 0.14290949702262878, 0.03217926248908043, 0.2239302545785904, 0.18674516677856445, 0.24176989495754242, 0.3759593665599823, 0.00482495641335845, 0.035527799278497696, 0.013535281643271446, 0.07409150153398514, 0.1996477246284485, -1]}
{"idB": "749647_18_item1_p323_s1", "idA": "749647_17_item1_p168_s2", "sentA": "Also, each clinical trial must be approved by an Institutional Review Board (IRB), and is subject to ongoing IRB monitoring.", "sentB": "For example, the clinical trial must be well designed and conducted and performed by qualified investigators in accordance with ethical principles.", "type": 2, "words": ["<tag1>", "Also,", "each", "clinical", "trial", "must", "be", "approved", "by", "an", "Institutional", "Review", "Board", "(IRB),", "and", "is", "subject", "to", "ongoing", "IRB", "monitoring.", "<tag2>", "For", "example,", "the", "clinical", "trial", "must", "be", "well", "designed", "and", "conducted", "and", "performed", "by", "qualified", "investigators", "in", "accordance", "with", "ethical", "principles.", "<tag3>"], "wordsA": ["Also,", "each", "clinical", "trial", "must", "be", "approved", "by", "an", "Institutional", "Review", "Board", "(IRB),", "and", "is", "subject", "to", "ongoing", "IRB", "monitoring."], "wordsB": ["For", "example,", "the", "clinical", "trial", "must", "be", "well", "designed", "and", "conducted", "and", "performed", "by", "qualified", "investigators", "in", "accordance", "with", "ethical", "principles."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014901064336299896, 0.026303520426154137, 0.007450558245182037, 0.08518904447555542, 0.08565246313810349, 0.05319593846797943, 0.054421521723270416, 0.5032256245613098, 0.41618070006370544, 0.239771768450737, 0.441743403673172, 0.10029090940952301, 0.2875060737133026, 0.05703376978635788, 0.26722604036331177, 0.2530421018600464, 0.0001447403192287311, 0.015504573471844196, 0.009874898009002209, 0.039496634155511856, 0.04769885912537575, -1]}
{"idB": "749647_18_item1_p160_s1", "idA": "749647_17_item1_p169_s1", "sentA": "Phase I clinical trials may be conducted in patients or healthy volunteers to evaluate the product's safety, dosage tolerance and pharmacokinetics and, if possible, seek to gain an early indication of its effectiveness.", "sentB": "Phase I clinical trials may be conducted in patients or healthy volunteers to evaluate the product s safety, dosage tolerance and pharmacokinetics and, if possible, seek to gain an early indication of its effectiveness.", "type": 2, "words": ["<tag1>", "Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product's", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness.", "<tag2>", "Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product", "s", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness.", "<tag3>"], "wordsA": ["Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product's", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness."], "wordsB": ["Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product", "s", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.17449848353862762, 0.28036466240882874, 0.11843688786029816, 0.19359703361988068, 0.05758659914135933, 0.04203968122601509, 0.08607093244791031, 0.09440343827009201, 0.16687405109405518, 0.08278894424438477, 0.6009309887886047, 0.34507811069488525, 0.07398360222578049, 0.11058202385902405, 0.0624130479991436, 0.2333555668592453, 0.12194312363862991, 0.13760589063167572, 0.08217448741197586, 0.1441209614276886, 0.05045074224472046, 0.07783824950456619, 0.028777996078133583, 0.07811728864908218, 0.09287690371274948, 0.07028253376483917, 0.05767597630620003, 0.09727397561073303, 0.053841982036828995, 0.08841965347528458, 0.09571223706007004, 0.047515738755464554, 0.05694297328591347, 0.13089542090892792, -1]}
{"idB": "749647_18_item1_p161_s0", "idA": "749647_17_item1_p169_s1", "sentA": "Phase I clinical trials may be conducted in patients or healthy volunteers to evaluate the product's safety, dosage tolerance and pharmacokinetics and, if possible, seek to gain an early indication of its effectiveness.", "sentB": "I n certain circumstances, a therapeutic product candidate being studied in clinical trials may be made available for treatment of individual patients.", "type": 2, "words": ["<tag1>", "Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product's", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness.", "<tag2>", "I", "n", "certain", "circumstances,", "a", "therapeutic", "product", "candidate", "being", "studied", "in", "clinical", "trials", "may", "be", "made", "available", "for", "treatment", "of", "individual", "patients.", "<tag3>"], "wordsA": ["Phase", "I", "clinical", "trials", "may", "be", "conducted", "in", "patients", "or", "healthy", "volunteers", "to", "evaluate", "the", "product's", "safety,", "dosage", "tolerance", "and", "pharmacokinetics", "and,", "if", "possible,", "seek", "to", "gain", "an", "early", "indication", "of", "its", "effectiveness."], "wordsB": ["I", "n", "certain", "circumstances,", "a", "therapeutic", "product", "candidate", "being", "studied", "in", "clinical", "trials", "may", "be", "made", "available", "for", "treatment", "of", "individual", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.053263936191797256, 0.0596323125064373, 0.08297386020421982, 0.08082977682352066, 0.008298929780721664, 0.16004176437854767, 0.1939517855644226, 0.10253717005252838, 0.012488771229982376, 0.03731602802872658, 0.007039078511297703, 0.03316950052976608, 0.02666320838034153, 0.01242874190211296, 0.012996381148695946, 0.04079701751470566, 0.1005382314324379, 0.010277793742716312, 0.24516113102436066, 0.06796988099813461, 0.469758540391922, 0.4641726613044739, -1]}
{"idB": "749647_18_item1_p196_s0", "idA": "749647_17_item1_p169_s3", "sentA": "Phase III clinical trials are typically conducted in a significantly larger patient population and are intended to further evaluate safety and efficacy, establish the overall risk-benefit profile of the product, and provide an adequate basis for physician labeling.", "sentB": "The way clinical trials are conducted in the EU will undergo a major change when the new EU Clinical Trial Regulation (Regulation 536/2014) comes into application in 2019.", "type": 2, "words": ["<tag1>", "Phase", "III", "clinical", "trials", "are", "typically", "conducted", "in", "a", "significantly", "larger", "patient", "population", "and", "are", "intended", "to", "further", "evaluate", "safety", "and", "efficacy,", "establish", "the", "overall", "risk-benefit", "profile", "of", "the", "product,", "and", "provide", "an", "adequate", "basis", "for", "physician", "labeling.", "<tag2>", "The", "way", "clinical", "trials", "are", "conducted", "in", "the", "EU", "will", "undergo", "a", "major", "change", "when", "the", "new", "EU", "Clinical", "Trial", "Regulation", "(Regulation", "536/2014)", "comes", "into", "application", "in", "2019.", "<tag3>"], "wordsA": ["Phase", "III", "clinical", "trials", "are", "typically", "conducted", "in", "a", "significantly", "larger", "patient", "population", "and", "are", "intended", "to", "further", "evaluate", "safety", "and", "efficacy,", "establish", "the", "overall", "risk-benefit", "profile", "of", "the", "product,", "and", "provide", "an", "adequate", "basis", "for", "physician", "labeling."], "wordsB": ["The", "way", "clinical", "trials", "are", "conducted", "in", "the", "EU", "will", "undergo", "a", "major", "change", "when", "the", "new", "EU", "Clinical", "Trial", "Regulation", "(Regulation", "536/2014)", "comes", "into", "application", "in", "2019."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028611982241272926, 0.062341347336769104, 0.13635744154453278, 0.14065514504909515, 0.03202040120959282, 0.09958107024431229, 0.054285984486341476, 0.0513014942407608, 0.1868058294057846, 0.016772164031863213, 0.03879132494330406, 0.019901420921087265, 0.0481124147772789, 0.08330248296260834, 0.014257124625146389, 0.02184116467833519, 0.07084970921278, 0.12492990493774414, 0.19548527896404266, 0.294005811214447, 0.1092783585190773, 0.13756754994392395, 0.11558777093887329, 0.036909319460392, 0.06622420996427536, 0.06573594361543655, 0.055700890719890594, 0.20879070460796356, -1]}
{"idB": "749647_18_item1_p16_s0", "idA": "749647_17_item1_p16_s0", "sentA": "We initiated the OPTIMA Study in the first half of 2014.", "sentB": "We initiated the OPTIMA Study in 2014.", "type": 2, "words": ["<tag1>", "We", "initiated", "the", "OPTIMA", "Study", "in", "the", "first", "half", "of", "2014.", "<tag2>", "We", "initiated", "the", "OPTIMA", "Study", "in", "2014.", "<tag3>"], "wordsA": ["We", "initiated", "the", "OPTIMA", "Study", "in", "the", "first", "half", "of", "2014."], "wordsB": ["We", "initiated", "the", "OPTIMA", "Study", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11231976747512817, 0.15856952965259552, 0.019786983728408813, 0.14342783391475677, 0.1619419902563095, 0.4847482442855835, 0.5633459091186523, -1]}
{"idB": "749647_18_item1_p16_s1", "idA": "749647_17_item1_p16_s1", "sentA": "The OPTIMA Study was designed with extensive input from globally recognized hepatocellular carcinoma ( HCC ) researchers and expert clinicians and after receiving formal written consultation from the FDA.", "sentB": "The OPTIMA Study was designed with extensive input from globally recognized hepatocellular carcinoma researchers and expert clinicians and after receiving formal written consultation from the FDA.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "was", "designed", "with", "extensive", "input", "from", "globally", "recognized", "hepatocellular", "carcinoma", "(", "HCC", ")", "researchers", "and", "expert", "clinicians", "and", "after", "receiving", "formal", "written", "consultation", "from", "the", "FDA.", "<tag2>", "The", "OPTIMA", "Study", "was", "designed", "with", "extensive", "input", "from", "globally", "recognized", "hepatocellular", "carcinoma", "researchers", "and", "expert", "clinicians", "and", "after", "receiving", "formal", "written", "consultation", "from", "the", "FDA.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "was", "designed", "with", "extensive", "input", "from", "globally", "recognized", "hepatocellular", "carcinoma", "(", "HCC", ")", "researchers", "and", "expert", "clinicians", "and", "after", "receiving", "formal", "written", "consultation", "from", "the", "FDA."], "wordsB": ["The", "OPTIMA", "Study", "was", "designed", "with", "extensive", "input", "from", "globally", "recognized", "hepatocellular", "carcinoma", "researchers", "and", "expert", "clinicians", "and", "after", "receiving", "formal", "written", "consultation", "from", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011033901944756508, 0.14401353895664215, 0.22554098069667816, 0.02354509010910988, 0.08609351515769958, 0.03696320578455925, 0.14754712581634521, 0.1900142878293991, 0.035587117075920105, 0.09873723983764648, 0.0935671478509903, 0.3099828362464905, 0.21107959747314453, 0.09521788358688354, 0.019297758117318153, 0.07218317687511444, 0.06634977459907532, 0.013013837859034538, 0.1181408017873764, 0.06039104610681534, 0.09246662259101868, 0.08658453822135925, 0.11198332905769348, 0.029814235866069794, 0.02485690452158451, 0.1413763016462326, -1]}
{"idB": "749647_18_item1_p32_s4", "idA": "749647_17_item1_p16_s2", "sentA": "The OPTIMA Study is expected to enroll up to 550 patients globally at up to 65 sites in the U.S., Canada, European Union, China and other countries in the Asia-Pacific region, and will evaluate ThermoDox in combination with standardized RFA, which will require a minimum of 45 minutes across all investigators and clinical sites for treating lesions three to seven centimeters, versus standardized RFA alone.", "sentB": "Additionally, the article explores a new hypothesis prompted by these findings: ThermoDox when used in combination with Radiofrequency Ablation (RFA) standardized to a minimum dwell time of 45 minutes (sRFA 45 minutes), may increase the overall survival (OS) of patients with HCC.", "type": 2, "words": ["<tag1>", "The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "65", "sites", "in", "the", "U.S.,", "Canada,", "European", "Union,", "China", "and", "other", "countries", "in", "the", "Asia-Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "three", "to", "seven", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag2>", "Additionally,", "the", "article", "explores", "a", "new", "hypothesis", "prompted", "by", "these", "findings:", "ThermoDox", "when", "used", "in", "combination", "with", "Radiofrequency", "Ablation", "(RFA)", "standardized", "to", "a", "minimum", "dwell", "time", "of", "45", "minutes", "(sRFA", "45", "minutes),", "may", "increase", "the", "overall", "survival", "(OS)", "of", "patients", "with", "HCC.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "is", "expected", "to", "enroll", "up", "to", "550", "patients", "globally", "at", "up", "to", "65", "sites", "in", "the", "U.S.,", "Canada,", "European", "Union,", "China", "and", "other", "countries", "in", "the", "Asia-Pacific", "region,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "standardized", "RFA,", "which", "will", "require", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "clinical", "sites", "for", "treating", "lesions", "three", "to", "seven", "centimeters,", "versus", "standardized", "RFA", "alone."], "wordsB": ["Additionally,", "the", "article", "explores", "a", "new", "hypothesis", "prompted", "by", "these", "findings:", "ThermoDox", "when", "used", "in", "combination", "with", "Radiofrequency", "Ablation", "(RFA)", "standardized", "to", "a", "minimum", "dwell", "time", "of", "45", "minutes", "(sRFA", "45", "minutes),", "may", "increase", "the", "overall", "survival", "(OS)", "of", "patients", "with", "HCC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007706513162702322, 0.0073990970849990845, 0.09912234544754028, 0.06827088445425034, 0.015124199911952019, 0.046535469591617584, 0.10275524854660034, 0.014341963455080986, 0.006812520325183868, 0.008303857408463955, 0.02457583136856556, 0.05747099965810776, 0.009005416184663773, 0.029172483831644058, 0.012420754879713058, 0.021994661539793015, 0.02752794697880745, 0.677933931350708, 0.6661280393600464, 0.04053376987576485, 0.017012888565659523, 0.009394076652824879, 0.008930730633437634, 0.10304500162601471, 0.42497238516807556, 0.23603682219982147, 0.030474228784441948, 0.13661806285381317, 0.21264508366584778, 0.26042044162750244, 0.10032732784748077, 0.12971395254135132, 0.02247212827205658, 0.19282056391239166, 0.05105508118867874, 0.35637369751930237, 0.19448132812976837, 0.11952050030231476, 0.024211756885051727, 0.11669287830591202, 0.022142702713608742, 0.08614283055067062, -1]}
{"idB": "749647_18_item1_p244_s2", "idA": "749647_17_item1_p170_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "We do not have any committed sources of financing and cannot assure you that alternate funding will be available in a timely manner, on acceptable terms or at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "assure", "you", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "assure", "you", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028125910088419914, 0.13148006796836853, 0.28290313482284546, 0.14916706085205078, 0.11345827579498291, 0.4410354793071747, 0.31511402130126953, 0.19336360692977905, 0.4775792360305786, 0.004673799034208059, 0.043818555772304535, 0.06606098264455795, 0.017121262848377228, 0.022980861365795135, 0.27465569972991943, 0.4247448444366455, 0.0676325112581253, 0.05565382167696953, 0.07895366102457047, 0.018303493037819862, 0.01955401711165905, 0.11207260191440582, 0.04444614797830582, 0.009531818330287933, 0.1141742467880249, 0.043015748262405396, 0.011492901481688023, 0.009785447269678116, 0.012707431800663471, -1]}
{"idB": "749647_18_item1_p255_s2", "idA": "749647_17_item1_p170_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "We cannot assure you that if clinical trials are completed, either we or our potential collaborators will submit applications for required authorizations to manufacture or market potential products or that any such application will be reviewed and approved by appropriate regulatory authorities in a timely manner, if at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "We", "cannot", "assure", "you", "that", "if", "clinical", "trials", "are", "completed,", "either", "we", "or", "our", "potential", "collaborators", "will", "submit", "applications", "for", "required", "authorizations", "to", "manufacture", "or", "market", "potential", "products", "or", "that", "any", "such", "application", "will", "be", "reviewed", "and", "approved", "by", "appropriate", "regulatory", "authorities", "in", "a", "timely", "manner,", "if", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["We", "cannot", "assure", "you", "that", "if", "clinical", "trials", "are", "completed,", "either", "we", "or", "our", "potential", "collaborators", "will", "submit", "applications", "for", "required", "authorizations", "to", "manufacture", "or", "market", "potential", "products", "or", "that", "any", "such", "application", "will", "be", "reviewed", "and", "approved", "by", "appropriate", "regulatory", "authorities", "in", "a", "timely", "manner,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04308024048805237, 0.39572572708129883, 0.12809297442436218, 0.04579785838723183, 0.05367140471935272, 0.04485190659761429, 0.04469654709100723, 0.05730169638991356, 0.07828523218631744, 0.11068848520517349, 0.07802369445562363, 0.050022002309560776, 0.02701939083635807, 0.019626811146736145, 0.07648426294326782, 0.08619769662618637, 0.08702294528484344, 0.29697856307029724, 0.2804935872554779, 0.02315276488661766, 0.07206235080957413, 0.07784122228622437, 0.012481093406677246, 0.025329522788524628, 0.012519428506493568, 0.023496681824326515, 0.022045111283659935, 0.026886124163866043, 0.00999405700713396, 0.018336547538638115, 0.023657191544771194, 0.04003830626606941, 0.07406184077262878, 0.018089808523654938, 0.023901216685771942, 0.10384193062782288, 0.08681672811508179, 0.11461193114519119, 0.0290464386343956, 0.07559802383184433, 0.05023706331849098, 0.08485644310712814, 0.012043982744216919, 0.0326472632586956, 0.2157624512910843, 0.08705160766839981, 0.0454944483935833, 0.053998228162527084, 0.06655373424291611, -1]}
{"idB": "749647_18_item1_p269_s2", "idA": "749647_17_item1_p170_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "We cannot guarantee that any of our product candidates will be approved by the FDA or any foreign regulatory agency or marketed, successfully or otherwise, at any time in the foreseeable future or at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "We", "cannot", "guarantee", "that", "any", "of", "our", "product", "candidates", "will", "be", "approved", "by", "the", "FDA", "or", "any", "foreign", "regulatory", "agency", "or", "marketed,", "successfully", "or", "otherwise,", "at", "any", "time", "in", "the", "foreseeable", "future", "or", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["We", "cannot", "guarantee", "that", "any", "of", "our", "product", "candidates", "will", "be", "approved", "by", "the", "FDA", "or", "any", "foreign", "regulatory", "agency", "or", "marketed,", "successfully", "or", "otherwise,", "at", "any", "time", "in", "the", "foreseeable", "future", "or", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.033999767154455185, 0.5804973244667053, 0.22334010899066925, 0.056220971047878265, 0.09412974119186401, 0.026630284264683723, 0.03489730879664421, 0.32073184847831726, 0.31153231859207153, 0.2029392272233963, 0.20542234182357788, 0.38841450214385986, 0.051090043038129807, 0.04603085666894913, 0.08950261771678925, 0.04339449107646942, 0.04536920040845871, 0.1675955206155777, 0.1587539166212082, 0.14915461838245392, 0.01513642817735672, 0.11877076327800751, 0.12801717221736908, 0.030547576025128365, 0.03134432062506676, 0.01814291626214981, 0.026641350239515305, 0.02916324883699417, 0.013454964384436607, 0.010396866127848625, 0.030730437487363815, 0.05291038006544113, 0.012671838514506817, 0.019270436838269234, 0.017027167603373528, -1]}
{"idB": "749647_18_item1_p280_s1", "idA": "749647_17_item1_p170_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "There can be no assurance that the patent applications for which we apply would actually issue as patents or do so with commercially relevant or broad coverage.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "the", "patent", "applications", "for", "which", "we", "apply", "would", "actually", "issue", "as", "patents", "or", "do", "so", "with", "commercially", "relevant", "or", "broad", "coverage.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "the", "patent", "applications", "for", "which", "we", "apply", "would", "actually", "issue", "as", "patents", "or", "do", "so", "with", "commercially", "relevant", "or", "broad", "coverage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002595737809315324, 0.0035842941142618656, 0.0026475111953914165, 0.01398460566997528, 0.035726916044950485, 0.01329481229186058, 0.025637580081820488, 0.6270737648010254, 0.6060206294059753, 0.02719806879758835, 0.006315232254564762, 0.011042854748666286, 0.02146090753376484, 0.1313537210226059, 0.2340780645608902, 0.20200788974761963, 0.14181368052959442, 0.3990830183029175, 0.0001089654688257724, 0.06283078342676163, 0.03448158875107765, 0.020794754847884178, 0.08110158145427704, 0.061588551849126816, 0.017784705385565758, 0.08527068793773651, 0.07868029177188873, -1]}
{"idB": "749647_18_item1_p289_s1", "idA": "749647_17_item1_p170_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "A license may not be available from such third party on commercially reasonable terms, or may not be available at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "A", "license", "may", "not", "be", "available", "from", "such", "third", "party", "on", "commercially", "reasonable", "terms,", "or", "may", "not", "be", "available", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["A", "license", "may", "not", "be", "available", "from", "such", "third", "party", "on", "commercially", "reasonable", "terms,", "or", "may", "not", "be", "available", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.042044498026371, 0.5485587120056152, 0.0793423131108284, 0.37651151418685913, 0.1632007360458374, 0.2901644706726074, 0.0421745628118515, 0.047896355390548706, 0.1702081263065338, 0.19476214051246643, 0.02859850786626339, 0.09528603404760361, 0.07975462079048157, 0.11977113783359528, 0.003964363131672144, 0.054825346916913986, 0.4060027599334717, 0.14472174644470215, 0.22682423889636993, 0.052324529737234116, 0.04191415011882782, -1]}
{"idB": "749647_18_item1_p290_s0", "idA": "749647_17_item1_p170_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "We rely on third parties to conduct all of our clinical trials.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "We", "rely", "on", "third", "parties", "to", "conduct", "all", "of", "our", "clinical", "trials.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["We", "rely", "on", "third", "parties", "to", "conduct", "all", "of", "our", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04130683094263077, 0.2134038656949997, 0.14948996901512146, 0.8112174868583679, 0.8206711411476135, 0.05515574663877487, 0.1818426251411438, 0.1289648413658142, 0.04022775962948799, 0.03086944669485092, 0.11018820852041245, 0.11788250505924225, -1]}
{"idB": "749647_18_item1_p293_s0", "idA": "749647_17_item1_p170_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "Despite our reliance on third parties to conduct our clinical trials, we are ultimately responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "Despite", "our", "reliance", "on", "third", "parties", "to", "conduct", "our", "clinical", "trials,", "we", "are", "ultimately", "responsible", "for", "ensuring", "that", "each", "of", "our", "clinical", "trials", "is", "conducted", "in", "accordance", "with", "the", "general", "investigational", "plan", "and", "protocols", "for", "the", "trial.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["Despite", "our", "reliance", "on", "third", "parties", "to", "conduct", "our", "clinical", "trials,", "we", "are", "ultimately", "responsible", "for", "ensuring", "that", "each", "of", "our", "clinical", "trials", "is", "conducted", "in", "accordance", "with", "the", "general", "investigational", "plan", "and", "protocols", "for", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0732896700501442, 0.021934710443019867, 0.0874006599187851, 0.06642400473356247, 0.333280473947525, 0.39401280879974365, 0.05944235250353813, 0.08126901090145111, 0.019274787977337837, 0.06145554780960083, 0.08628078550100327, 0.0321849063038826, 0.027906909584999084, 0.060939956456422806, 0.15840865671634674, 0.026518667116761208, 0.11584785580635071, 0.03006870485842228, 0.1267237365245819, 0.022721536457538605, 0.02153049409389496, 0.10982750356197357, 0.11784318089485168, 0.13158918917179108, 0.23869279026985168, 0.041559863835573196, 0.08065925538539886, 0.022647108882665634, 0.010441657155752182, 0.03416885808110237, 0.038443855941295624, 0.03499734029173851, 0.011137920431792736, 0.04250144213438034, 0.009555220603942871, 0.009766640141606331, 0.023873234167695045, -1]}
{"idB": "749647_18_item1_p295_s4", "idA": "749647_17_item1_p170_s0", "sentA": "There can be no assurance that any of our clinical trials will be completed successfully within any specified time period or at all.", "sentB": "In the event that any of our suppliers or manufacturers fails to comply with such requirements or to perform its obligations to us in relation to quality, timing or otherwise, or if our supply of components or other materials becomes limited or interrupted for other reasons, we may be forced to manufacture the materials ourselves, for which we currently do not have the capabilities or resources, or enter into an agreement with another third party, which we may not be able to do on reasonable terms, if at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all.", "<tag2>", "In", "the", "event", "that", "any", "of", "our", "suppliers", "or", "manufacturers", "fails", "to", "comply", "with", "such", "requirements", "or", "to", "perform", "its", "obligations", "to", "us", "in", "relation", "to", "quality,", "timing", "or", "otherwise,", "or", "if", "our", "supply", "of", "components", "or", "other", "materials", "becomes", "limited", "or", "interrupted", "for", "other", "reasons,", "we", "may", "be", "forced", "to", "manufacture", "the", "materials", "ourselves,", "for", "which", "we", "currently", "do", "not", "have", "the", "capabilities", "or", "resources,", "or", "enter", "into", "an", "agreement", "with", "another", "third", "party,", "which", "we", "may", "not", "be", "able", "to", "do", "on", "reasonable", "terms,", "if", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "clinical", "trials", "will", "be", "completed", "successfully", "within", "any", "specified", "time", "period", "or", "at", "all."], "wordsB": ["In", "the", "event", "that", "any", "of", "our", "suppliers", "or", "manufacturers", "fails", "to", "comply", "with", "such", "requirements", "or", "to", "perform", "its", "obligations", "to", "us", "in", "relation", "to", "quality,", "timing", "or", "otherwise,", "or", "if", "our", "supply", "of", "components", "or", "other", "materials", "becomes", "limited", "or", "interrupted", "for", "other", "reasons,", "we", "may", "be", "forced", "to", "manufacture", "the", "materials", "ourselves,", "for", "which", "we", "currently", "do", "not", "have", "the", "capabilities", "or", "resources,", "or", "enter", "into", "an", "agreement", "with", "another", "third", "party,", "which", "we", "may", "not", "be", "able", "to", "do", "on", "reasonable", "terms,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009288842789828777, 0.0007616131915710866, 0.027284447103738785, 0.01344950869679451, 0.022867897525429726, 0.010619688779115677, 0.017491526901721954, 0.07066085189580917, 0.011714266613125801, 0.05601806193590164, 0.15658877789974213, 0.19858944416046143, 0.294111430644989, 0.14629024267196655, 0.043730612844228745, 0.12356538325548172, 0.0071122972294688225, 0.021328222006559372, 0.037764985114336014, 0.020275576040148735, 0.04931095987558365, 0.014277449809014797, 0.023152094334363937, 0.009351528249680996, 0.008855725638568401, 0.008246051147580147, 0.013709135353565216, 0.015457745641469955, 0.010968108661472797, 0.00826546736061573, 0.0008088697795756161, 0.008825880475342274, 0.007344088517129421, 0.05019561946392059, 0.04986611008644104, 0.046253304928541183, 0.007458637468516827, 0.01000527199357748, 0.024230508133769035, 0.021718665957450867, 0.04224129021167755, 0.02012178674340248, 0.0356125608086586, 0.002275343518704176, 0.009248235262930393, 0.010317995212972164, 0.023941418156027794, 0.01841505616903305, 0.02546653337776661, 0.07015200704336166, 0.10082940757274628, 0.1829235553741455, 0.04745354503393173, 0.12898172438144684, 0.06241235509514809, 0.007666549179702997, 0.0004380173922982067, 0.009313659742474556, 0.012186025269329548, 0.04928339645266533, 0.07403907924890518, 0.08077317476272583, 0.05707501992583275, 0.05994248390197754, 0.05546506121754646, 0.08108833432197571, 0.011869177222251892, 0.04499468952417374, 0.0831865444779396, 0.05448071286082268, 0.156992569565773, 0.023970410227775574, 0.017157848924398422, 0.062405720353126526, 0.08766546100378036, 0.0006960093160159886, 0.014804089441895485, 0.01976017840206623, 0.08312160521745682, 0.0322316512465477, 0.05806056782603264, 0.07039228826761246, 0.057367563247680664, 0.048762958496809006, 0.1639527827501297, 0.10780339688062668, 0.027506109327077866, 0.020058562979102135, 0.018613506108522415, -1]}
{"idB": "749647_18_item1_p163_s1", "idA": "749647_17_item1_p170_s1", "sentA": "Either the FDA or we may suspend clinical trials at any time on various grounds, including among other things, if we, the FDA, or our independent DMC conclude that clinical subjects are being exposed to an unacceptable health risk.", "sentB": "Either the FDA or we may suspend clinical trials at any time on various grounds, including among other things, if we, the FDA, our independent DMC, or the IRB conclude that clinical subjects are being exposed to an unacceptable health risk.", "type": 2, "words": ["<tag1>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time", "on", "various", "grounds,", "including", "among", "other", "things,", "if", "we,", "the", "FDA,", "or", "our", "independent", "DMC", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk.", "<tag2>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time", "on", "various", "grounds,", "including", "among", "other", "things,", "if", "we,", "the", "FDA,", "our", "independent", "DMC,", "or", "the", "IRB", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk.", "<tag3>"], "wordsA": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time", "on", "various", "grounds,", "including", "among", "other", "things,", "if", "we,", "the", "FDA,", "or", "our", "independent", "DMC", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk."], "wordsB": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time", "on", "various", "grounds,", "including", "among", "other", "things,", "if", "we,", "the", "FDA,", "our", "independent", "DMC,", "or", "the", "IRB", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09338781237602234, 0.009377521462738514, 0.06936697661876678, 0.015409005805850029, 0.017040442675352097, 0.01501326635479927, 0.028652090579271317, 0.017044326290488243, 0.02253202721476555, 0.012574494816362858, 0.01806677132844925, 0.015957361087203026, 0.014607514254748821, 0.01804249919950962, 0.0220517348498106, 0.014272250235080719, 0.013669313862919807, 0.013412975706160069, 0.015622679144144058, 0.01742042601108551, 0.017720911651849747, 0.008916101418435574, 0.030086001381278038, 0.011731933802366257, 0.032967932522296906, 0.02330094575881958, 0.017734680324792862, 0.036412835121154785, 0.9484533667564392, 0.027822963893413544, 0.013897059485316277, 0.018249139189720154, 0.03250603750348091, 0.009019683115184307, 0.014908365905284882, 0.01894889399409294, 0.011585194617509842, 0.010155986063182354, 0.012071315199136734, 0.011925872415304184, 0.016737772151827812, -1]}
{"idB": "749647_18_item1_p240_s4", "idA": "749647_17_item1_p170_s1", "sentA": "Either the FDA or we may suspend clinical trials at any time on various grounds, including among other things, if we, the FDA, or our independent DMC conclude that clinical subjects are being exposed to an unacceptable health risk.", "sentB": "We, the FDA or other applicable regulatory authorities may suspend clinical trials of a product candidate at any time for various reasons, including a belief that subjects participating in such trials are being exposed to unacceptable health risks or adverse side effects.", "type": 2, "words": ["<tag1>", "Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time", "on", "various", "grounds,", "including", "among", "other", "things,", "if", "we,", "the", "FDA,", "or", "our", "independent", "DMC", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk.", "<tag2>", "We,", "the", "FDA", "or", "other", "applicable", "regulatory", "authorities", "may", "suspend", "clinical", "trials", "of", "a", "product", "candidate", "at", "any", "time", "for", "various", "reasons,", "including", "a", "belief", "that", "subjects", "participating", "in", "such", "trials", "are", "being", "exposed", "to", "unacceptable", "health", "risks", "or", "adverse", "side", "effects.", "<tag3>"], "wordsA": ["Either", "the", "FDA", "or", "we", "may", "suspend", "clinical", "trials", "at", "any", "time", "on", "various", "grounds,", "including", "among", "other", "things,", "if", "we,", "the", "FDA,", "or", "our", "independent", "DMC", "conclude", "that", "clinical", "subjects", "are", "being", "exposed", "to", "an", "unacceptable", "health", "risk."], "wordsB": ["We,", "the", "FDA", "or", "other", "applicable", "regulatory", "authorities", "may", "suspend", "clinical", "trials", "of", "a", "product", "candidate", "at", "any", "time", "for", "various", "reasons,", "including", "a", "belief", "that", "subjects", "participating", "in", "such", "trials", "are", "being", "exposed", "to", "unacceptable", "health", "risks", "or", "adverse", "side", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02369561418890953, 0.009031979367136955, 0.04667732119560242, 0.011658279225230217, 0.010925063863396645, 0.03442886099219322, 0.05730867758393288, 0.08542829006910324, 0.011226306669414043, 0.13175639510154724, 0.04374314844608307, 0.08927991986274719, 0.06229029968380928, 0.11627849191427231, 0.42001035809516907, 0.5268956422805786, 0.008701030164957047, 0.012958011589944363, 0.011883009225130081, 0.01182298269122839, 0.01554818730801344, 0.022276315838098526, 0.006657843943685293, 0.011146861128509045, 0.14371652901172638, 0.02922903560101986, 0.3491940200328827, 0.07398251444101334, 0.02950180508196354, 0.02791879139840603, 0.05257318913936615, 0.079378142952919, 0.059540316462516785, 0.0789371207356453, 0.021430760622024536, 0.042408786714076996, 0.026523174718022346, 0.034370604902505875, 0.00841702800244093, 0.0619271956384182, 0.06516102701425552, 0.10397983342409134, -1]}
{"idB": "749647_18_item1_p183_s1", "idA": "749647_17_item1_p171_s0", "sentA": "The FDA inspects and reviews clinical trial sites, informed consent forms, data from the clinical trial sites (including case report forms and record keeping procedures) and the performance of the protocols by clinical trial personnel to determine compliance with good clinical practices.", "sentB": "Information related to the product, patient population, phase of investigation, trial sites and investigators, and other aspects of the clinical trial is then made public as part of the registration.", "type": 2, "words": ["<tag1>", "The", "FDA", "inspects", "and", "reviews", "clinical", "trial", "sites,", "informed", "consent", "forms,", "data", "from", "the", "clinical", "trial", "sites", "(including", "case", "report", "forms", "and", "record", "keeping", "procedures)", "and", "the", "performance", "of", "the", "protocols", "by", "clinical", "trial", "personnel", "to", "determine", "compliance", "with", "good", "clinical", "practices.", "<tag2>", "Information", "related", "to", "the", "product,", "patient", "population,", "phase", "of", "investigation,", "trial", "sites", "and", "investigators,", "and", "other", "aspects", "of", "the", "clinical", "trial", "is", "then", "made", "public", "as", "part", "of", "the", "registration.", "<tag3>"], "wordsA": ["The", "FDA", "inspects", "and", "reviews", "clinical", "trial", "sites,", "informed", "consent", "forms,", "data", "from", "the", "clinical", "trial", "sites", "(including", "case", "report", "forms", "and", "record", "keeping", "procedures)", "and", "the", "performance", "of", "the", "protocols", "by", "clinical", "trial", "personnel", "to", "determine", "compliance", "with", "good", "clinical", "practices."], "wordsB": ["Information", "related", "to", "the", "product,", "patient", "population,", "phase", "of", "investigation,", "trial", "sites", "and", "investigators,", "and", "other", "aspects", "of", "the", "clinical", "trial", "is", "then", "made", "public", "as", "part", "of", "the", "registration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.23508040606975555, 0.05748588591814041, 0.027700068429112434, 0.013840856030583382, 0.07585256546735764, 0.09897859394550323, 0.07391372323036194, 0.04569733887910843, 0.04624946042895317, 0.2020092010498047, 0.047159191220998764, 0.058509524911642075, 0.015344773419201374, 0.1259729415178299, 0.0080400500446558, 0.013232345692813396, 0.05488789454102516, 0.011300032958388329, 0.01162796188145876, 0.08892245590686798, 0.09190800786018372, 0.027723882347345352, 0.05129280686378479, 0.1748485118150711, 0.41849178075790405, 0.016728045418858528, 0.03524776175618172, 0.022832954302430153, 0.02114168368279934, 0.25459128618240356, -1]}
{"idB": "749647_18_item1_p190_s0", "idA": "749647_17_item1_p171_s0", "sentA": "The FDA inspects and reviews clinical trial sites, informed consent forms, data from the clinical trial sites (including case report forms and record keeping procedures) and the performance of the protocols by clinical trial personnel to determine compliance with good clinical practices.", "sentB": "The FDA will accept as support for an IND, NDA, or BLA a well-designed, well-conducted, non-IND foreign clinical trial if it was conducted in accordance with GCP and the FDA is able to validate the data from the trial through an on-site inspection, if necessary.", "type": 2, "words": ["<tag1>", "The", "FDA", "inspects", "and", "reviews", "clinical", "trial", "sites,", "informed", "consent", "forms,", "data", "from", "the", "clinical", "trial", "sites", "(including", "case", "report", "forms", "and", "record", "keeping", "procedures)", "and", "the", "performance", "of", "the", "protocols", "by", "clinical", "trial", "personnel", "to", "determine", "compliance", "with", "good", "clinical", "practices.", "<tag2>", "The", "FDA", "will", "accept", "as", "support", "for", "an", "IND,", "NDA,", "or", "BLA", "a", "well-designed,", "well-conducted,", "non-IND", "foreign", "clinical", "trial", "if", "it", "was", "conducted", "in", "accordance", "with", "GCP", "and", "the", "FDA", "is", "able", "to", "validate", "the", "data", "from", "the", "trial", "through", "an", "on-site", "inspection,", "if", "necessary.", "<tag3>"], "wordsA": ["The", "FDA", "inspects", "and", "reviews", "clinical", "trial", "sites,", "informed", "consent", "forms,", "data", "from", "the", "clinical", "trial", "sites", "(including", "case", "report", "forms", "and", "record", "keeping", "procedures)", "and", "the", "performance", "of", "the", "protocols", "by", "clinical", "trial", "personnel", "to", "determine", "compliance", "with", "good", "clinical", "practices."], "wordsB": ["The", "FDA", "will", "accept", "as", "support", "for", "an", "IND,", "NDA,", "or", "BLA", "a", "well-designed,", "well-conducted,", "non-IND", "foreign", "clinical", "trial", "if", "it", "was", "conducted", "in", "accordance", "with", "GCP", "and", "the", "FDA", "is", "able", "to", "validate", "the", "data", "from", "the", "trial", "through", "an", "on-site", "inspection,", "if", "necessary."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00608742143958807, 0.05484791845083237, 0.0432041771709919, 0.15760450065135956, 0.04336785897612572, 0.06934324651956558, 0.01444435678422451, 0.012384874746203423, 0.06728619337081909, 0.13569238781929016, 0.008213918656110764, 0.0888114646077156, 0.010501259006559849, 0.04636343941092491, 0.1235772892832756, 0.654788076877594, 0.04831124469637871, 0.11778851598501205, 0.1361471265554428, 0.009440543130040169, 0.0008042675908654928, 0.007259673904627562, 0.010014459490776062, 0.007135870400816202, 0.009105592034757137, 0.009600034914910793, 0.05694982409477234, 0.0063402848318219185, 0.005203413777053356, 0.027069639414548874, 0.011958163231611252, 0.016835283488035202, 0.0317382849752903, 0.11871156096458435, 0.027464723214507103, 0.10617192089557648, 0.014384790323674679, 0.007764190901070833, 0.03927226737141609, 0.01953439973294735, 0.011212886311113834, 0.5986610054969788, 0.21628478169441223, 0.024186352267861366, 0.03931254521012306, -1]}
{"idB": "749647_18_item1_p183_s0", "idA": "749647_17_item1_p172_s0", "sentA": "The conduct of clinical trials is complex and difficult, and there can be no assurance that the design or the performance of the pivotal clinical trial protocols of any of our current or future product candidates will be successful.", "sentB": "Sponsors of clinical trials of FDA-regulated products are required to register and disclose certain clinical trial information.", "type": 2, "words": ["<tag1>", "The", "conduct", "of", "clinical", "trials", "is", "complex", "and", "difficult,", "and", "there", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "of", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful.", "<tag2>", "Sponsors", "of", "clinical", "trials", "of", "FDA-regulated", "products", "are", "required", "to", "register", "and", "disclose", "certain", "clinical", "trial", "information.", "<tag3>"], "wordsA": ["The", "conduct", "of", "clinical", "trials", "is", "complex", "and", "difficult,", "and", "there", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "of", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful."], "wordsB": ["Sponsors", "of", "clinical", "trials", "of", "FDA-regulated", "products", "are", "required", "to", "register", "and", "disclose", "certain", "clinical", "trial", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2581142485141754, 0.03659599646925926, 0.0778142437338829, 0.0638396143913269, 0.011184653267264366, 0.15097716450691223, 0.10299942642450333, 0.018268387764692307, 0.24951177835464478, 0.21853496134281158, 0.5663812160491943, 0.184975728392601, 0.5090194344520569, 0.15321829915046692, 0.1635221540927887, 0.1564587652683258, 0.326768159866333, -1]}
{"idB": "749647_18_item1_p322_s0", "idA": "749647_17_item1_p172_s0", "sentA": "The conduct of clinical trials is complex and difficult, and there can be no assurance that the design or the performance of the pivotal clinical trial protocols of any of our current or future product candidates will be successful.", "sentB": "Several of our current clinical trials are being conducted outside the United States.", "type": 2, "words": ["<tag1>", "The", "conduct", "of", "clinical", "trials", "is", "complex", "and", "difficult,", "and", "there", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "of", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful.", "<tag2>", "Several", "of", "our", "current", "clinical", "trials", "are", "being", "conducted", "outside", "the", "United", "States.", "<tag3>"], "wordsA": ["The", "conduct", "of", "clinical", "trials", "is", "complex", "and", "difficult,", "and", "there", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "of", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful."], "wordsB": ["Several", "of", "our", "current", "clinical", "trials", "are", "being", "conducted", "outside", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1303761750459671, 0.01601286418735981, 0.025493290275335312, 0.06212586909532547, 0.11290449649095535, 0.11260516941547394, 0.012257014401257038, 0.052890680730342865, 0.15280982851982117, 0.9352574944496155, 0.6454885601997375, 0.5830001831054688, 0.6615296006202698, -1]}
{"idB": "749647_18_item1_p325_s5", "idA": "749647_17_item1_p172_s0", "sentA": "The conduct of clinical trials is complex and difficult, and there can be no assurance that the design or the performance of the pivotal clinical trial protocols of any of our current or future product candidates will be successful.", "sentB": "In entering into third-party marketing or distribution arrangements, we expect to incur significant additional expenses and there can be no assurance that such third parties will establish adequate sales and distribution capabilities or be successful in gaining market acceptance for our products and services.", "type": 2, "words": ["<tag1>", "The", "conduct", "of", "clinical", "trials", "is", "complex", "and", "difficult,", "and", "there", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "of", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful.", "<tag2>", "In", "entering", "into", "third-party", "marketing", "or", "distribution", "arrangements,", "we", "expect", "to", "incur", "significant", "additional", "expenses", "and", "there", "can", "be", "no", "assurance", "that", "such", "third", "parties", "will", "establish", "adequate", "sales", "and", "distribution", "capabilities", "or", "be", "successful", "in", "gaining", "market", "acceptance", "for", "our", "products", "and", "services.", "<tag3>"], "wordsA": ["The", "conduct", "of", "clinical", "trials", "is", "complex", "and", "difficult,", "and", "there", "can", "be", "no", "assurance", "that", "the", "design", "or", "the", "performance", "of", "the", "pivotal", "clinical", "trial", "protocols", "of", "any", "of", "our", "current", "or", "future", "product", "candidates", "will", "be", "successful."], "wordsB": ["In", "entering", "into", "third-party", "marketing", "or", "distribution", "arrangements,", "we", "expect", "to", "incur", "significant", "additional", "expenses", "and", "there", "can", "be", "no", "assurance", "that", "such", "third", "parties", "will", "establish", "adequate", "sales", "and", "distribution", "capabilities", "or", "be", "successful", "in", "gaining", "market", "acceptance", "for", "our", "products", "and", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006118224933743477, 0.08932644128799438, 0.07076910138130188, 0.38246703147888184, 0.40775027871131897, 0.1124253123998642, 0.4271077513694763, 0.42404302954673767, 0.0012193146394565701, 0.008771070279181004, 0.005819507408887148, 0.014800021424889565, 0.024345915764570236, 0.02786005660891533, 0.07330673933029175, 0.005197673104703426, 0.002893149619922042, 0.0032946402207016945, 0.002736632013693452, 0.008367272093892097, 0.022168995812535286, 0.005116014741361141, 0.012900657020509243, 0.1232069730758667, 0.15313030779361725, 0.019220631569623947, 0.09415543079376221, 0.30444470047950745, 0.353969931602478, 0.1467425376176834, 0.3493102192878723, 0.25294673442840576, 0.010123576037585735, 0.019007382914423943, 0.04667273908853531, 0.007431664504110813, 0.05315355956554413, 0.13837391138076782, 0.10787546634674072, 0.013166707009077072, 0.011631481349468231, 0.03673028573393822, 0.015207434073090553, 0.030168065801262856, -1]}
{"idB": "749647_18_item1_p166_s0", "idA": "749647_17_item1_p173_s0", "sentA": "The results of pre-clinical studies and clinical trials, if successful, are submitted to FDA in the form of an NDA.", "sentB": "The results of pre-clinical studies and clinical trials, if successful, are submitted to FDA in the form of an NDA or BLA.", "type": 2, "words": ["<tag1>", "The", "results", "of", "pre-clinical", "studies", "and", "clinical", "trials,", "if", "successful,", "are", "submitted", "to", "FDA", "in", "the", "form", "of", "an", "NDA.", "<tag2>", "The", "results", "of", "pre-clinical", "studies", "and", "clinical", "trials,", "if", "successful,", "are", "submitted", "to", "FDA", "in", "the", "form", "of", "an", "NDA", "or", "BLA.", "<tag3>"], "wordsA": ["The", "results", "of", "pre-clinical", "studies", "and", "clinical", "trials,", "if", "successful,", "are", "submitted", "to", "FDA", "in", "the", "form", "of", "an", "NDA."], "wordsB": ["The", "results", "of", "pre-clinical", "studies", "and", "clinical", "trials,", "if", "successful,", "are", "submitted", "to", "FDA", "in", "the", "form", "of", "an", "NDA", "or", "BLA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0034693763591349125, 0.013983374461531639, 0.003301171353086829, 0.008160801604390144, 0.007464139722287655, 0.003211005125194788, 0.0071692075580358505, 0.008227444253861904, 0.0077810147777199745, 0.018627667799592018, 0.003955806139856577, 0.014170540496706963, 0.008438577875494957, 0.01273947861045599, 0.008162499405443668, 0.006489683873951435, 0.014503136277198792, 0.008152777329087257, 0.012850518338382244, 0.09993106871843338, 0.17153938114643097, 0.9601936340332031, -1]}
{"idB": "749647_18_item1_p167_s0", "idA": "749647_17_item1_p173_s1", "sentA": "The testing and approval process requires substantial time, effort, and financial resources, and there can be no assurance that any approval will be granted for any product at any time, according to any schedule, or at all.", "sentB": "The testing, submission, and approval process requires substantial time, effort, and financial resources, including substantial application user fees and annual product and establishment user fees.", "type": 2, "words": ["<tag1>", "The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all.", "<tag2>", "The", "testing,", "submission,", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "including", "substantial", "application", "user", "fees", "and", "annual", "product", "and", "establishment", "user", "fees.", "<tag3>"], "wordsA": ["The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all."], "wordsB": ["The", "testing,", "submission,", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "including", "substantial", "application", "user", "fees", "and", "annual", "product", "and", "establishment", "user", "fees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0050107501447200775, 0.01877083070576191, 0.03552187979221344, 0.004627841524779797, 0.016328521072864532, 0.020385270938277245, 0.011792748235166073, 0.007920057512819767, 0.006429217755794525, 0.0065807499922811985, 0.0042373985052108765, 0.007171298377215862, 0.008676338940858841, 0.005267429165542126, 0.21485641598701477, 0.27915292978286743, 0.4079868495464325, 0.48352402448654175, 0.02332904003560543, 0.31978490948677063, 0.24282975494861603, 0.10081528127193451, 0.31857195496559143, 0.44829025864601135, 0.5200669169425964, -1]}
{"idB": "749647_18_item1_p168_s0", "idA": "749647_17_item1_p173_s1", "sentA": "The testing and approval process requires substantial time, effort, and financial resources, and there can be no assurance that any approval will be granted for any product at any time, according to any schedule, or at all.", "sentB": "T here can be no assurance that any approval will be granted for any product at any time, according to any schedule, or at all.", "type": 2, "words": ["<tag1>", "The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all.", "<tag2>", "T", "here", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all.", "<tag3>"], "wordsA": ["The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all."], "wordsB": ["T", "here", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09969346225261688, 0.11569684743881226, 0.04092613235116005, 0.008522444404661655, 0.2638724744319916, 0.37150081992149353, 0.030675247311592102, 0.2832011878490448, 0.6285491585731506, 0.06350291520357132, 0.046489451080560684, 0.07156210392713547, 0.020504992455244064, 0.04349547252058983, 0.05389467999339104, 0.012383854016661644, 0.01956377923488617, 0.023742178454995155, 0.01015347521752119, 0.007728843484073877, 0.013193996623158455, 0.04008040577173233, 0.015325232408940792, 0.019705943763256073, 0.03302603214979172, -1]}
{"idB": "749647_18_item1_p248_s0", "idA": "749647_17_item1_p173_s1", "sentA": "The testing and approval process requires substantial time, effort, and financial resources, and there can be no assurance that any approval will be granted for any product at any time, according to any schedule, or at all.", "sentB": "The testing and approval process requires substantial time, effort and resources, and generally takes a number of years to complete.", "type": 2, "words": ["<tag1>", "The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all.", "<tag2>", "The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort", "and", "resources,", "and", "generally", "takes", "a", "number", "of", "years", "to", "complete.", "<tag3>"], "wordsA": ["The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all."], "wordsB": ["The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort", "and", "resources,", "and", "generally", "takes", "a", "number", "of", "years", "to", "complete."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004557848442345858, 0.012494263239204884, 0.0037470099050551653, 0.007617100141942501, 0.032997045665979385, 0.013344841077923775, 0.007756945677101612, 0.007681909948587418, 0.004705072846263647, 0.0045238276943564415, 0.006247366778552532, 0.004955746233463287, 0.08711475133895874, 0.19008471071720123, 0.20307978987693787, 0.5615517497062683, 0.5866372585296631, 0.829482913017273, 0.6479388475418091, 0.6380715370178223, -1]}
{"idB": "749647_18_item1_p325_s3", "idA": "749647_17_item1_p173_s1", "sentA": "The testing and approval process requires substantial time, effort, and financial resources, and there can be no assurance that any approval will be granted for any product at any time, according to any schedule, or at all.", "sentB": "If we rely on third parties with such capabilities to market our products, we will need to establish and maintain partnership arrangements, and there can be no assurance that we will be able to enter into third-party marketing or distribution arrangements on acceptable terms or at all.", "type": 2, "words": ["<tag1>", "The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all.", "<tag2>", "If", "we", "rely", "on", "third", "parties", "with", "such", "capabilities", "to", "market", "our", "products,", "we", "will", "need", "to", "establish", "and", "maintain", "partnership", "arrangements,", "and", "there", "can", "be", "no", "assurance", "that", "we", "will", "be", "able", "to", "enter", "into", "third-party", "marketing", "or", "distribution", "arrangements", "on", "acceptable", "terms", "or", "at", "all.", "<tag3>"], "wordsA": ["The", "testing", "and", "approval", "process", "requires", "substantial", "time,", "effort,", "and", "financial", "resources,", "and", "there", "can", "be", "no", "assurance", "that", "any", "approval", "will", "be", "granted", "for", "any", "product", "at", "any", "time,", "according", "to", "any", "schedule,", "or", "at", "all."], "wordsB": ["If", "we", "rely", "on", "third", "parties", "with", "such", "capabilities", "to", "market", "our", "products,", "we", "will", "need", "to", "establish", "and", "maintain", "partnership", "arrangements,", "and", "there", "can", "be", "no", "assurance", "that", "we", "will", "be", "able", "to", "enter", "into", "third-party", "marketing", "or", "distribution", "arrangements", "on", "acceptable", "terms", "or", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0159949641674757, 0.043390609323978424, 0.0972285270690918, 0.06700007617473602, 0.27608025074005127, 0.34633365273475647, 0.06805596500635147, 0.07435795664787292, 0.12208373099565506, 0.04942159354686737, 0.15470850467681885, 0.04247066006064415, 0.08169008046388626, 0.010795398615300655, 0.008580828085541725, 0.020159341394901276, 0.02191087231040001, 0.11517096310853958, 0.14451006054878235, 0.26352325081825256, 0.3049839437007904, 0.39478832483291626, 0.0007462806534022093, 0.004148701671510935, 0.005755109246820211, 0.004364567343145609, 0.03312774375081062, 0.05294140428304672, 0.013517224229872227, 0.0260812658816576, 0.03715731203556061, 0.03224809095263481, 0.09634992480278015, 0.07928304374217987, 0.10283149778842926, 0.07718577980995178, 0.10600898414850235, 0.19398300349712372, 0.1398937851190567, 0.20291253924369812, 0.22429053485393524, 0.06477086246013641, 0.1845322847366333, 0.07907386869192123, 0.10388478636741638, 0.0710332840681076, 0.07175884395837784, -1]}
{"idB": "749647_18_item1_p175_s2", "idA": "749647_17_item1_p173_s3", "sentA": "The FDA may also require additional testing for safety and efficacy.", "sentB": "The FDA may also perform certain confirmatory tests on lots of some products, such as viral vaccines, before releasing the lots for distribution by the manufacturer.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy.", "<tag2>", "The", "FDA", "may", "also", "perform", "certain", "confirmatory", "tests", "on", "lots", "of", "some", "products,", "such", "as", "viral", "vaccines,", "before", "releasing", "the", "lots", "for", "distribution", "by", "the", "manufacturer.", "<tag3>"], "wordsA": ["The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy."], "wordsB": ["The", "FDA", "may", "also", "perform", "certain", "confirmatory", "tests", "on", "lots", "of", "some", "products,", "such", "as", "viral", "vaccines,", "before", "releasing", "the", "lots", "for", "distribution", "by", "the", "manufacturer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002589985029771924, 0.02415960468351841, 0.016136974096298218, 0.015783486887812614, 0.212641641497612, 0.24930819869041443, 0.7190932035446167, 0.4462498128414154, 0.036548830568790436, 0.06533359736204147, 0.03580036759376526, 0.03965708985924721, 0.1033807098865509, 0.011307861655950546, 0.02088601514697075, 0.10736709833145142, 0.23093216121196747, 0.006640540901571512, 0.030245229601860046, 0.011076739989221096, 0.025572441518306732, 0.013521847315132618, 0.017160888761281967, 0.005717454012483358, 0.004913680721074343, 0.02116928994655609, -1]}
{"idB": "749647_18_item1_p197_s5", "idA": "749647_17_item1_p173_s3", "sentA": "The FDA may also require additional testing for safety and efficacy.", "sentB": "The CHMP assesses, inter alia, whether a medicine meets the necessary quality, safety and efficacy requirements and whether it has a positive risk-benefit balance.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy.", "<tag2>", "The", "CHMP", "assesses,", "inter", "alia,", "whether", "a", "medicine", "meets", "the", "necessary", "quality,", "safety", "and", "efficacy", "requirements", "and", "whether", "it", "has", "a", "positive", "risk-benefit", "balance.", "<tag3>"], "wordsA": ["The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy."], "wordsB": ["The", "CHMP", "assesses,", "inter", "alia,", "whether", "a", "medicine", "meets", "the", "necessary", "quality,", "safety", "and", "efficacy", "requirements", "and", "whether", "it", "has", "a", "positive", "risk-benefit", "balance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023457763716578484, 0.49125534296035767, 0.32024314999580383, 0.016041819006204605, 0.04252836853265762, 0.05166821926832199, 0.023191554471850395, 0.15882784128189087, 0.1258891224861145, 0.02608589641749859, 0.059036917984485626, 0.06805414706468582, 0.01388140395283699, 0.0044634402729570866, 0.012952828779816628, 0.038508012890815735, 0.00030779646476730704, 0.021530505269765854, 0.014440270140767097, 0.03571068495512009, 0.021181203424930573, 0.12417501956224442, 0.15772034227848053, 0.11348658055067062, -1]}
{"idB": "749647_18_item1_p258_s0", "idA": "749647_17_item1_p173_s3", "sentA": "The FDA may also require additional testing for safety and efficacy.", "sentB": "Limited data exist regarding the safety and efficacy of DNA-based therapeutics compared with conventional therapeutics, and government regulation of DNA-based therapeutics is evolving.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy.", "<tag2>", "Limited", "data", "exist", "regarding", "the", "safety", "and", "efficacy", "of", "DNA-based", "therapeutics", "compared", "with", "conventional", "therapeutics,", "and", "government", "regulation", "of", "DNA-based", "therapeutics", "is", "evolving.", "<tag3>"], "wordsA": ["The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy."], "wordsB": ["Limited", "data", "exist", "regarding", "the", "safety", "and", "efficacy", "of", "DNA-based", "therapeutics", "compared", "with", "conventional", "therapeutics,", "and", "government", "regulation", "of", "DNA-based", "therapeutics", "is", "evolving."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.5516160726547241, 0.503776490688324, 0.0891684964299202, 0.041305214166641235, 0.019958719611167908, 0.0344172827899456, 0.008952759206295013, 0.022106541320681572, 0.01521820668131113, 0.10798635333776474, 0.1416129618883133, 0.039285559207201004, 0.014969400130212307, 0.10925567150115967, 0.10720869153738022, 0.005469555035233498, 0.11643949896097183, 0.19527417421340942, 0.014017895795404911, 0.0375509150326252, 0.07330403476953506, 0.017528854310512543, 0.1199256107211113, -1]}
{"idB": "749647_18_item1_p298_s0", "idA": "749647_17_item1_p173_s3", "sentA": "The FDA may also require additional testing for safety and efficacy.", "sentB": "The FDA and foreign regulatory agencies require that the safety and efficacy of product candidates be supported through adequate and well-controlled clinical trials.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy.", "<tag2>", "The", "FDA", "and", "foreign", "regulatory", "agencies", "require", "that", "the", "safety", "and", "efficacy", "of", "product", "candidates", "be", "supported", "through", "adequate", "and", "well-controlled", "clinical", "trials.", "<tag3>"], "wordsA": ["The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy."], "wordsB": ["The", "FDA", "and", "foreign", "regulatory", "agencies", "require", "that", "the", "safety", "and", "efficacy", "of", "product", "candidates", "be", "supported", "through", "adequate", "and", "well-controlled", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004800957161933184, 0.04005863517522812, 0.01407779660075903, 0.056839149445295334, 0.09591404348611832, 0.05574043467640877, 0.05648225545883179, 0.014640660025179386, 0.009873718023300171, 0.054909467697143555, 0.0076272753067314625, 0.0416715033352375, 0.024673888459801674, 0.0748085230588913, 0.07888289541006088, 0.046237219125032425, 0.09606484323740005, 0.0446486622095108, 0.4521227180957794, 0.10898543894290924, 0.5929551720619202, 0.510994553565979, 0.616266131401062, -1]}
{"idB": "749647_18_item1_p310_s2", "idA": "749647_17_item1_p173_s3", "sentA": "The FDA may also require additional testing for safety and efficacy.", "sentB": "The FDA may withdraw our Fast Track designation if the FDA believes that the designation is no longer supported by data from our clinical or pivotal development program.", "type": 2, "words": ["<tag1>", "The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy.", "<tag2>", "The", "FDA", "may", "withdraw", "our", "Fast", "Track", "designation", "if", "the", "FDA", "believes", "that", "the", "designation", "is", "no", "longer", "supported", "by", "data", "from", "our", "clinical", "or", "pivotal", "development", "program.", "<tag3>"], "wordsA": ["The", "FDA", "may", "also", "require", "additional", "testing", "for", "safety", "and", "efficacy."], "wordsB": ["The", "FDA", "may", "withdraw", "our", "Fast", "Track", "designation", "if", "the", "FDA", "believes", "that", "the", "designation", "is", "no", "longer", "supported", "by", "data", "from", "our", "clinical", "or", "pivotal", "development", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00380152789875865, 0.04971139878034592, 0.04424931854009628, 0.8238319754600525, 0.18421109020709991, 0.40305742621421814, 0.5981321334838867, 0.5716302990913391, 0.007379588205367327, 0.0038992036134004593, 0.01720060221850872, 0.008378242142498493, 9.649048297433183e-05, 0.004574385471642017, 0.033094990998506546, 0.009836597368121147, 0.013775378465652466, 0.014199627563357353, 0.010802875272929668, 0.004483597353100777, 0.011283381842076778, 0.0033907550387084484, 0.0033643748611211777, 0.00980853009968996, 0.005899116862565279, 0.011471657082438469, 0.016037188470363617, 0.012390738353133202, -1]}
{"idB": "749647_18_item1_p249_s0", "idA": "749647_17_item1_p173_s4", "sentA": "Even, if regulatory approval is granted, the approval will be limited to specific indications.", "sentB": "Even if we receive regulatory approval of a product, the approval may limit the indicated uses for which the drug may be marketed.", "type": 2, "words": ["<tag1>", "Even,", "if", "regulatory", "approval", "is", "granted,", "the", "approval", "will", "be", "limited", "to", "specific", "indications.", "<tag2>", "Even", "if", "we", "receive", "regulatory", "approval", "of", "a", "product,", "the", "approval", "may", "limit", "the", "indicated", "uses", "for", "which", "the", "drug", "may", "be", "marketed.", "<tag3>"], "wordsA": ["Even,", "if", "regulatory", "approval", "is", "granted,", "the", "approval", "will", "be", "limited", "to", "specific", "indications."], "wordsB": ["Even", "if", "we", "receive", "regulatory", "approval", "of", "a", "product,", "the", "approval", "may", "limit", "the", "indicated", "uses", "for", "which", "the", "drug", "may", "be", "marketed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017021846026182175, 0.01778431236743927, 0.13895925879478455, 0.3909706473350525, 0.19447050988674164, 0.32759416103363037, 0.019445471465587616, 0.02747339755296707, 0.08555679768323898, 0.006275228690356016, 0.12965883314609528, 0.04124784842133522, 0.4017806053161621, 0.08494916558265686, 0.35412800312042236, 0.4319390654563904, 0.03493921831250191, 0.010311711579561234, 0.017580177634954453, 0.06628737598657608, 0.04203498736023903, 0.02834758721292019, 0.05398281291127205, -1]}
{"idB": "749647_18_item1_p298_s2", "idA": "749647_17_item1_p173_s4", "sentA": "Even, if regulatory approval is granted, the approval will be limited to specific indications.", "sentB": "Even if regulatory approval of a product candidate is granted, the approval may include significant limitations on the indicated uses for which the product may be marketed.", "type": 2, "words": ["<tag1>", "Even,", "if", "regulatory", "approval", "is", "granted,", "the", "approval", "will", "be", "limited", "to", "specific", "indications.", "<tag2>", "Even", "if", "regulatory", "approval", "of", "a", "product", "candidate", "is", "granted,", "the", "approval", "may", "include", "significant", "limitations", "on", "the", "indicated", "uses", "for", "which", "the", "product", "may", "be", "marketed.", "<tag3>"], "wordsA": ["Even,", "if", "regulatory", "approval", "is", "granted,", "the", "approval", "will", "be", "limited", "to", "specific", "indications."], "wordsB": ["Even", "if", "regulatory", "approval", "of", "a", "product", "candidate", "is", "granted,", "the", "approval", "may", "include", "significant", "limitations", "on", "the", "indicated", "uses", "for", "which", "the", "product", "may", "be", "marketed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008283799514174461, 0.005559572950005531, 0.01592106558382511, 0.05130353942513466, 0.022444913163781166, 0.07036957889795303, 0.30155134201049805, 0.3952191472053528, 0.009246439673006535, 0.020511452108621597, 0.0029285592027008533, 0.04990583285689354, 0.030149029567837715, 0.16899645328521729, 0.3736954927444458, 0.728851318359375, 0.13309212028980255, 0.08172190189361572, 0.19657762348651886, 0.27544066309928894, 0.03568480163812637, 0.010968041606247425, 0.02042737975716591, 0.07150288671255112, 0.020656829699873924, 0.014982879161834717, 0.02714710868895054, -1]}
{"idB": "749647_18_item1_p310_s3", "idA": "749647_17_item1_p173_s5", "sentA": "There can be no assurance that any of our current product candidates will receive regulatory approvals for marketing or, if approved, that approval will be for any or all of the indications that we request.", "sentB": "Our Fast Track designation does not guarantee that we will qualify for or be able to take advantage of the FDA s expedited review procedures or that any application that we may submit to the FDA for regulatory approval will be accepted for filing or ultimately approved.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "current", "product", "candidates", "will", "receive", "regulatory", "approvals", "for", "marketing", "or,", "if", "approved,", "that", "approval", "will", "be", "for", "any", "or", "all", "of", "the", "indications", "that", "we", "request.", "<tag2>", "Our", "Fast", "Track", "designation", "does", "not", "guarantee", "that", "we", "will", "qualify", "for", "or", "be", "able", "to", "take", "advantage", "of", "the", "FDA", "s", "expedited", "review", "procedures", "or", "that", "any", "application", "that", "we", "may", "submit", "to", "the", "FDA", "for", "regulatory", "approval", "will", "be", "accepted", "for", "filing", "or", "ultimately", "approved.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "current", "product", "candidates", "will", "receive", "regulatory", "approvals", "for", "marketing", "or,", "if", "approved,", "that", "approval", "will", "be", "for", "any", "or", "all", "of", "the", "indications", "that", "we", "request."], "wordsB": ["Our", "Fast", "Track", "designation", "does", "not", "guarantee", "that", "we", "will", "qualify", "for", "or", "be", "able", "to", "take", "advantage", "of", "the", "FDA", "s", "expedited", "review", "procedures", "or", "that", "any", "application", "that", "we", "may", "submit", "to", "the", "FDA", "for", "regulatory", "approval", "will", "be", "accepted", "for", "filing", "or", "ultimately", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015476183034479618, 0.21658602356910706, 0.22362971305847168, 0.21573442220687866, 0.14870144426822662, 0.3285393714904785, 0.17548376321792603, 0.03026806190609932, 0.06911599636077881, 0.08054567128419876, 0.19915559887886047, 0.10107003897428513, 0.012804790399968624, 0.06438011676073074, 0.08091121166944504, 0.04385632276535034, 0.05814020708203316, 0.037074726074934006, 0.009054511785507202, 0.008125762455165386, 0.028665533289313316, 0.015782279893755913, 0.10830140113830566, 0.09261233359575272, 0.04502742365002632, 0.009654304943978786, 0.018431752920150757, 0.052938297390937805, 0.2273317575454712, 0.004284548573195934, 0.020695827901363373, 0.028298132121562958, 0.05100296065211296, 0.016965052112936974, 0.01696939393877983, 0.05860721692442894, 0.016003897413611412, 0.0717693641781807, 0.08638934046030045, 0.04403458163142204, 0.0469011515378952, 0.11770305037498474, 0.027927666902542114, 0.12100011110305786, 0.015558050945401192, 0.1636553704738617, 0.2155928909778595, -1]}
{"idB": "749647_18_item1_p308_s0", "idA": "749647_17_item1_p174_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox for the treatment of HCC.", "sentB": "Even though we have obtained Orphan Drug Designation for ThermoDox and may obtain such designation for other product candidates in specific indications, we may not be the first to obtain marketing approval of these product candidates for the orphan-designated indication due to the uncertainties associated with developing pharmaceutical products.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC.", "<tag2>", "Even", "though", "we", "have", "obtained", "Orphan", "Drug", "Designation", "for", "ThermoDox", "and", "may", "obtain", "such", "designation", "for", "other", "product", "candidates", "in", "specific", "indications,", "we", "may", "not", "be", "the", "first", "to", "obtain", "marketing", "approval", "of", "these", "product", "candidates", "for", "the", "orphan-designated", "indication", "due", "to", "the", "uncertainties", "associated", "with", "developing", "pharmaceutical", "products.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC."], "wordsB": ["Even", "though", "we", "have", "obtained", "Orphan", "Drug", "Designation", "for", "ThermoDox", "and", "may", "obtain", "such", "designation", "for", "other", "product", "candidates", "in", "specific", "indications,", "we", "may", "not", "be", "the", "first", "to", "obtain", "marketing", "approval", "of", "these", "product", "candidates", "for", "the", "orphan-designated", "indication", "due", "to", "the", "uncertainties", "associated", "with", "developing", "pharmaceutical", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012626519426703453, 0.020529212430119514, 0.05228184536099434, 0.03643002361059189, 0.10424977540969849, 0.07784739136695862, 0.042380910366773605, 0.040505655109882355, 0.009053711779415607, 0.014850004576146603, 0.003373471787199378, 0.01904374547302723, 0.044058606028556824, 0.024195311591029167, 0.06769593060016632, 0.011983118019998074, 0.04307670518755913, 0.18374787271022797, 0.18405474722385406, 0.0064506204798817635, 0.024660857394337654, 0.07426751405000687, 0.04029637947678566, 0.059101786464452744, 0.28479334712028503, 0.06402798742055893, 0.07100789994001389, 0.20172712206840515, 0.12917526066303253, 0.22965392470359802, 0.17426778376102448, 0.2769026756286621, 0.021721288561820984, 0.020226430147886276, 0.08427639305591583, 0.07290865480899811, 0.018929975107312202, 0.01663150265812874, 0.06701113283634186, 0.06833414733409882, 0.006708529777824879, 0.005694153718650341, 0.006034112069755793, 0.031541332602500916, 0.00516137620434165, 0.0051740496419370174, 0.03148091584444046, 0.049760933965444565, 0.06898394972085953, -1]}
{"idB": "749647_18_item1_p326_s0", "idA": "749647_17_item1_p174_s0", "sentA": "In 2009, the FDA granted orphan drug designation for ThermoDox for the treatment of HCC.", "sentB": "Technologies for the treatment of cancer are subject to rapid change, and the development of treatment strategies that are more effective than our technologies could render our technologies obsolete.", "type": 2, "words": ["<tag1>", "In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC.", "<tag2>", "Technologies", "for", "the", "treatment", "of", "cancer", "are", "subject", "to", "rapid", "change,", "and", "the", "development", "of", "treatment", "strategies", "that", "are", "more", "effective", "than", "our", "technologies", "could", "render", "our", "technologies", "obsolete.", "<tag3>"], "wordsA": ["In", "2009,", "the", "FDA", "granted", "orphan", "drug", "designation", "for", "ThermoDox", "for", "the", "treatment", "of", "HCC."], "wordsB": ["Technologies", "for", "the", "treatment", "of", "cancer", "are", "subject", "to", "rapid", "change,", "and", "the", "development", "of", "treatment", "strategies", "that", "are", "more", "effective", "than", "our", "technologies", "could", "render", "our", "technologies", "obsolete."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.14779534935951233, 0.029814470559358597, 0.012497395277023315, 0.16218145191669464, 0.11761077493429184, 0.7286204099655151, 0.007713627070188522, 0.03153127059340477, 0.01917223632335663, 0.057930707931518555, 0.06785666942596436, 0.005195012781769037, 0.005820175167173147, 0.03451614826917648, 0.011564319021999836, 0.13252203166484833, 0.06975042074918747, 0.00018339052621740848, 0.006890701595693827, 0.01142070721834898, 0.018988650292158127, 0.004072766751050949, 0.008532349951565266, 0.023617828264832497, 0.005372749175876379, 0.0425041988492012, 0.00870797224342823, 0.14835675060749054, 0.31759417057037354, -1]}
{"idB": "749647_18_item1_p308_s4", "idA": "749647_17_item1_p174_s1", "sentA": "Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.", "sentB": "Orphan Drug Designation neither shortens the development time or regulatory review time of a drug nor gives the drug any advantage in the regulatory review or approval process.", "type": 2, "words": ["<tag1>", "Orphan", "drug", "designation", "does", "not", "convey", "any", "advantage", "in,", "or", "shorten", "the", "duration", "of,", "the", "regulatory", "review", "and", "approval", "process.", "<tag2>", "Orphan", "Drug", "Designation", "neither", "shortens", "the", "development", "time", "or", "regulatory", "review", "time", "of", "a", "drug", "nor", "gives", "the", "drug", "any", "advantage", "in", "the", "regulatory", "review", "or", "approval", "process.", "<tag3>"], "wordsA": ["Orphan", "drug", "designation", "does", "not", "convey", "any", "advantage", "in,", "or", "shorten", "the", "duration", "of,", "the", "regulatory", "review", "and", "approval", "process."], "wordsB": ["Orphan", "Drug", "Designation", "neither", "shortens", "the", "development", "time", "or", "regulatory", "review", "time", "of", "a", "drug", "nor", "gives", "the", "drug", "any", "advantage", "in", "the", "regulatory", "review", "or", "approval", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01933920755982399, 0.015584341250360012, 0.04874049499630928, 0.8034719824790955, 0.3955956697463989, 0.10315056890249252, 0.13921557366847992, 0.17408233880996704, 0.03052525781095028, 0.024003511294722557, 0.028557932004332542, 0.06781814992427826, 0.014336274936795235, 0.014107358641922474, 0.07090499997138977, 0.328083872795105, 0.22461192309856415, 0.04060447961091995, 0.08925442397594452, 0.15476404130458832, 0.15936607122421265, 0.017903899773955345, 0.012476527132093906, 0.011013710871338844, 0.010658573359251022, 0.00808346550911665, 0.008259309455752373, 0.019363155588507652, -1]}
{"idB": "749647_18_item1_p309_s0", "idA": "749647_17_item1_p174_s1", "sentA": "Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.", "sentB": "Fast Track designation may not actually lead to a faster development or regulatory review or approval process.", "type": 2, "words": ["<tag1>", "Orphan", "drug", "designation", "does", "not", "convey", "any", "advantage", "in,", "or", "shorten", "the", "duration", "of,", "the", "regulatory", "review", "and", "approval", "process.", "<tag2>", "Fast", "Track", "designation", "may", "not", "actually", "lead", "to", "a", "faster", "development", "or", "regulatory", "review", "or", "approval", "process.", "<tag3>"], "wordsA": ["Orphan", "drug", "designation", "does", "not", "convey", "any", "advantage", "in,", "or", "shorten", "the", "duration", "of,", "the", "regulatory", "review", "and", "approval", "process."], "wordsB": ["Fast", "Track", "designation", "may", "not", "actually", "lead", "to", "a", "faster", "development", "or", "regulatory", "review", "or", "approval", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.5544999837875366, 0.7805899977684021, 0.418181836605072, 0.0430489145219326, 0.10734713822603226, 0.04262422025203705, 0.05881538242101669, 0.03442484140396118, 0.021007444709539413, 0.3161843717098236, 0.07193013280630112, 0.0038264517206698656, 0.01191770564764738, 0.011166257783770561, 0.0029148184694349766, 0.010366660542786121, 0.015258362516760826, -1]}
{"idB": "749647_18_item1_p308_s2", "idA": "749647_17_item1_p174_s2", "sentA": "However, if a product which has an orphan drug designation subsequently receives the first FDA approval for the indication for which it has such designation, the product is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drug for the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity.", "sentB": "Further, even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs with different active moieties can be approved for the same condition.", "type": 2, "words": ["<tag1>", "However,", "if", "a", "product", "which", "has", "an", "orphan", "drug", "designation", "subsequently", "receives", "the", "first", "FDA", "approval", "for", "the", "indication", "for", "which", "it", "has", "such", "designation,", "the", "product", "is", "entitled", "to", "orphan", "drug", "exclusivity,", "which", "means", "the", "FDA", "may", "not", "approve", "any", "other", "application", "to", "market", "the", "same", "drug", "for", "the", "same", "indication", "for", "a", "period", "of", "seven", "years,", "except", "in", "limited", "circumstances,", "such", "as", "a", "showing", "of", "clinical", "superiority", "to", "the", "product", "with", "orphan", "exclusivity.", "<tag2>", "Further,", "even", "if", "we", "obtain", "orphan", "drug", "exclusivity", "for", "a", "product,", "that", "exclusivity", "may", "not", "effectively", "protect", "the", "product", "from", "competition", "because", "different", "drugs", "with", "different", "active", "moieties", "can", "be", "approved", "for", "the", "same", "condition.", "<tag3>"], "wordsA": ["However,", "if", "a", "product", "which", "has", "an", "orphan", "drug", "designation", "subsequently", "receives", "the", "first", "FDA", "approval", "for", "the", "indication", "for", "which", "it", "has", "such", "designation,", "the", "product", "is", "entitled", "to", "orphan", "drug", "exclusivity,", "which", "means", "the", "FDA", "may", "not", "approve", "any", "other", "application", "to", "market", "the", "same", "drug", "for", "the", "same", "indication", "for", "a", "period", "of", "seven", "years,", "except", "in", "limited", "circumstances,", "such", "as", "a", "showing", "of", "clinical", "superiority", "to", "the", "product", "with", "orphan", "exclusivity."], "wordsB": ["Further,", "even", "if", "we", "obtain", "orphan", "drug", "exclusivity", "for", "a", "product,", "that", "exclusivity", "may", "not", "effectively", "protect", "the", "product", "from", "competition", "because", "different", "drugs", "with", "different", "active", "moieties", "can", "be", "approved", "for", "the", "same", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018728023394942284, 0.01082152035087347, 0.01682942546904087, 0.055912084877491, 0.11154478788375854, 0.11639875918626785, 0.06632297486066818, 0.09068508446216583, 0.016790354624390602, 0.013471899554133415, 0.046275585889816284, 0.006968743167817593, 0.04247232899069786, 0.042135871946811676, 0.10880323499441147, 0.08890993148088455, 0.2612311542034149, 0.02815842255949974, 0.12276218831539154, 0.16298674046993256, 0.23326624929904938, 0.007517052814364433, 0.17398303747177124, 0.1687694638967514, 0.02958621270954609, 0.09679199010133743, 0.07722077518701553, 0.09422636032104492, 0.029538387432694435, 0.020053066313266754, 0.06281324476003647, 0.010338909924030304, 0.009271936491131783, 0.06078801676630974, 0.09759115427732468, -1]}
{"idB": "749647_18_item1_p260_s1", "idA": "749647_17_item1_p175_s1", "sentA": "A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety.", "sentB": "If undertaken, RAC can delay the initiation of a clinical trial, even if the FDA has reviewed the trial design and details and approved its initiation.", "type": 2, "words": ["<tag1>", "A", "drug", "is", "a", "new", "chemical", "entity", "if", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "new", "drug", "containing", "the", "same", "active", "moiety.", "<tag2>", "If", "undertaken,", "RAC", "can", "delay", "the", "initiation", "of", "a", "clinical", "trial,", "even", "if", "the", "FDA", "has", "reviewed", "the", "trial", "design", "and", "details", "and", "approved", "its", "initiation.", "<tag3>"], "wordsA": ["A", "drug", "is", "a", "new", "chemical", "entity", "if", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "new", "drug", "containing", "the", "same", "active", "moiety."], "wordsB": ["If", "undertaken,", "RAC", "can", "delay", "the", "initiation", "of", "a", "clinical", "trial,", "even", "if", "the", "FDA", "has", "reviewed", "the", "trial", "design", "and", "details", "and", "approved", "its", "initiation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04744919389486313, 0.16373352706432343, 0.17691773176193237, 0.08160869777202606, 0.3155706524848938, 0.10634873062372208, 0.20511889457702637, 0.06901233643293381, 0.08846749365329742, 0.22099527716636658, 0.2602289319038391, 0.008626448921859264, 0.009304467588663101, 0.007614256348460913, 0.07007431238889694, 0.08781430870294571, 0.29016736149787903, 0.032562486827373505, 0.11895956844091415, 0.07941260933876038, 0.03936019167304039, 0.08505819737911224, 0.03989512845873833, 0.19094312191009521, 0.03953820839524269, 0.1270129680633545, -1]}
{"idB": "749647_18_item1_p260_s2", "idA": "749647_17_item1_p175_s1", "sentA": "A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety.", "sentB": "Conversely, the FDA can put an investigational new drug (IND) application on a clinical hold even if the RAC has provided a favorable review or an exemption from in-depth, public review.", "type": 2, "words": ["<tag1>", "A", "drug", "is", "a", "new", "chemical", "entity", "if", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "new", "drug", "containing", "the", "same", "active", "moiety.", "<tag2>", "Conversely,", "the", "FDA", "can", "put", "an", "investigational", "new", "drug", "(IND)", "application", "on", "a", "clinical", "hold", "even", "if", "the", "RAC", "has", "provided", "a", "favorable", "review", "or", "an", "exemption", "from", "in-depth,", "public", "review.", "<tag3>"], "wordsA": ["A", "drug", "is", "a", "new", "chemical", "entity", "if", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "new", "drug", "containing", "the", "same", "active", "moiety."], "wordsB": ["Conversely,", "the", "FDA", "can", "put", "an", "investigational", "new", "drug", "(IND)", "application", "on", "a", "clinical", "hold", "even", "if", "the", "RAC", "has", "provided", "a", "favorable", "review", "or", "an", "exemption", "from", "in-depth,", "public", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05680835619568825, 0.0077203745022416115, 0.056474991142749786, 0.051816992461681366, 0.145595982670784, 0.04836452752351761, 0.3224717974662781, 0.2529120147228241, 0.2544206380844116, 0.3002837598323822, 0.2846856713294983, 0.41896653175354004, 0.23766914010047913, 0.3930716812610626, 0.4320952594280243, 6.749202293576673e-05, 0.012371729128062725, 0.00887248758226633, 0.07387511432170868, 0.04612266644835472, 0.07940322905778885, 0.018092943355441093, 0.12043915688991547, 0.09328446537256241, 7.608027954120189e-05, 0.01745259016752243, 0.18375374376773834, 0.046034570783376694, 0.18221765756607056, 0.08570418506860733, 0.14679411053657532, -1]}
{"idB": "749647_18_item1_p308_s3", "idA": "749647_17_item1_p175_s1", "sentA": "A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety.", "sentB": "Even after an orphan product is approved, the FDA can subsequently approve the same drug with the same active moiety for the same condition if the FDA concludes that the later drug is safer, more effective or makes a major contribution to patient care.", "type": 2, "words": ["<tag1>", "A", "drug", "is", "a", "new", "chemical", "entity", "if", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "new", "drug", "containing", "the", "same", "active", "moiety.", "<tag2>", "Even", "after", "an", "orphan", "product", "is", "approved,", "the", "FDA", "can", "subsequently", "approve", "the", "same", "drug", "with", "the", "same", "active", "moiety", "for", "the", "same", "condition", "if", "the", "FDA", "concludes", "that", "the", "later", "drug", "is", "safer,", "more", "effective", "or", "makes", "a", "major", "contribution", "to", "patient", "care.", "<tag3>"], "wordsA": ["A", "drug", "is", "a", "new", "chemical", "entity", "if", "the", "FDA", "has", "not", "previously", "approved", "any", "other", "new", "drug", "containing", "the", "same", "active", "moiety."], "wordsB": ["Even", "after", "an", "orphan", "product", "is", "approved,", "the", "FDA", "can", "subsequently", "approve", "the", "same", "drug", "with", "the", "same", "active", "moiety", "for", "the", "same", "condition", "if", "the", "FDA", "concludes", "that", "the", "later", "drug", "is", "safer,", "more", "effective", "or", "makes", "a", "major", "contribution", "to", "patient", "care."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.060080964118242264, 0.02384803630411625, 0.016339661553502083, 0.49203139543533325, 0.30085650086402893, 0.03328562155365944, 0.10535206645727158, 0.0038343826308846474, 0.0346052460372448, 0.05269218981266022, 0.08796773105859756, 0.12342999130487442, 0.020170001313090324, 0.38355112075805664, 0.27970749139785767, 0.006437751464545727, 0.007446398492902517, 0.03516603261232376, 0.022488029673695564, 0.021838953718543053, 0.006591313984245062, 0.007280339486896992, 0.05611814931035042, 0.08039472252130508, 0.005733643192797899, 0.004000101704150438, 0.026195935904979706, 0.053883325308561325, 0.0003844978054985404, 0.007155732251703739, 0.08639998733997345, 0.0651259794831276, 0.018258647993206978, 0.09824046492576599, 0.0558876134455204, 0.04452307149767876, 0.009430727921426296, 0.04649500921368599, 0.024902785196900368, 0.047705791890621185, 0.05863633379340172, 0.023141907528042793, 0.05298445373773575, 0.04417246952652931, -1]}
{"idB": "749647_18_item1_p188_s0", "idA": "749647_17_item1_p176_s0", "sentA": "After FDA approval of a product is obtained, we and our contract manufacturers are required to comply with various post-approval requirements, including establishment registration and product listing, record-keeping requirements, reporting of adverse reactions and production problems to the FDA, providing updated safety and efficacy information, and complying with requirements concerning advertising and promotional labeling.", "sentB": "After FDA approval of a product is obtained, we and our contract manufacturers are required to comply with various post-approval requirements, including establishment registration and product listing, record-keeping requirements, reporting of adverse reactions and production problems to the FDA, providing updated safety and efficacy information for drugs, or safety, purity, and potency for biological products, and complying with requirements concerning advertising and promotional labeling.", "type": 2, "words": ["<tag1>", "After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling.", "<tag2>", "After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information", "for", "drugs,", "or", "safety,", "purity,", "and", "potency", "for", "biological", "products,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling.", "<tag3>"], "wordsA": ["After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling."], "wordsB": ["After", "FDA", "approval", "of", "a", "product", "is", "obtained,", "we", "and", "our", "contract", "manufacturers", "are", "required", "to", "comply", "with", "various", "post-approval", "requirements,", "including", "establishment", "registration", "and", "product", "listing,", "record-keeping", "requirements,", "reporting", "of", "adverse", "reactions", "and", "production", "problems", "to", "the", "FDA,", "providing", "updated", "safety", "and", "efficacy", "information", "for", "drugs,", "or", "safety,", "purity,", "and", "potency", "for", "biological", "products,", "and", "complying", "with", "requirements", "concerning", "advertising", "and", "promotional", "labeling."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03250797465443611, 0.10739271342754364, 0.1852923184633255, 0.02062205784022808, 0.01618180051445961, 0.0332823321223259, 0.022782593965530396, 0.04535255953669548, 0.030132735148072243, 0.02683992311358452, 0.01689561828970909, 0.0360233299434185, 0.06458869576454163, 0.0226779542863369, 0.06491069495677948, 0.027202211320400238, 0.02835468016564846, 0.023061595857143402, 0.023137066513299942, 0.027225082740187645, 0.026520011946558952, 0.016914375126361847, 0.020702235400676727, 0.03906317055225372, 0.018156062811613083, 0.022438887506723404, 0.02673150599002838, 0.019982196390628815, 0.019460078328847885, 0.014652649872004986, 0.01964263990521431, 0.01862438954412937, 0.02950178273022175, 0.017174847424030304, 0.017562570050358772, 0.02158023789525032, 0.017423421144485474, 0.015066167339682579, 0.017873013392090797, 0.017059238627552986, 0.017079127952456474, 0.02281181700527668, 0.02027098648250103, 0.02132665552198887, 0.018067386001348495, 0.014619543217122555, 0.1137833297252655, 0.0135818375274539, 0.029929207637906075, 0.18166302144527435, 0.057140450924634933, 0.0741690918803215, 0.07291529327630997, 0.5448715686798096, 0.7840191125869751, 0.014953012578189373, 0.02857961133122444, 0.022843601182103157, 0.022577842697501183, 0.015314864926040173, 0.023158276453614235, 0.013931832276284695, 0.020597057417035103, 0.021824883297085762, -1]}
{"idB": "749647_18_item1_p180_s1", "idA": "749647_17_item1_p176_s1", "sentA": "As a condition of approval of an NDA, the FDA may require the applicant to conduct additional clinical trials or other post market testing and surveillance to further monitor and assess the drug's safety and efficacy.", "sentB": "As a condition of approval, the FDA may require that a sponsor of a product candidate receiving accelerated approval perform post-marketing clinical trials to verify and describe the predicted effect on irreversible morbidity or mortality or other clinical endpoint, and the product may be subject to accelerated withdrawal procedures.", "type": 2, "words": ["<tag1>", "As", "a", "condition", "of", "approval", "of", "an", "NDA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug's", "safety", "and", "efficacy.", "<tag2>", "As", "a", "condition", "of", "approval,", "the", "FDA", "may", "require", "that", "a", "sponsor", "of", "a", "product", "candidate", "receiving", "accelerated", "approval", "perform", "post-marketing", "clinical", "trials", "to", "verify", "and", "describe", "the", "predicted", "effect", "on", "irreversible", "morbidity", "or", "mortality", "or", "other", "clinical", "endpoint,", "and", "the", "product", "may", "be", "subject", "to", "accelerated", "withdrawal", "procedures.", "<tag3>"], "wordsA": ["As", "a", "condition", "of", "approval", "of", "an", "NDA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug's", "safety", "and", "efficacy."], "wordsB": ["As", "a", "condition", "of", "approval,", "the", "FDA", "may", "require", "that", "a", "sponsor", "of", "a", "product", "candidate", "receiving", "accelerated", "approval", "perform", "post-marketing", "clinical", "trials", "to", "verify", "and", "describe", "the", "predicted", "effect", "on", "irreversible", "morbidity", "or", "mortality", "or", "other", "clinical", "endpoint,", "and", "the", "product", "may", "be", "subject", "to", "accelerated", "withdrawal", "procedures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002579983789473772, 0.002407808555290103, 0.006678584963083267, 0.0028008443769067526, 0.010706822387874126, 0.0021401208359748125, 0.019083034247159958, 0.0049045211635529995, 0.03569405525922775, 0.016604341566562653, 0.021354949101805687, 0.30859318375587463, 0.04082997888326645, 0.025914615020155907, 0.10157717764377594, 0.062393125146627426, 0.029066016897559166, 0.10894808173179626, 0.09311076253652573, 0.08084197342395782, 0.16815941035747528, 0.19013123214244843, 0.299075722694397, 0.003055931767448783, 0.06152569502592087, 0.012663554400205612, 0.11694677174091339, 0.005931721534579992, 0.02568441443145275, 0.025320932269096375, 0.009544485248625278, 0.045307036489248276, 0.10277777910232544, 0.03203288093209267, 0.08230540156364441, 0.0035777383018285036, 0.003857386065647006, 0.019734587520360947, 0.010666756890714169, 0.0003019635332748294, 0.002919403836131096, 0.045170653611421585, 0.005016844253987074, 0.0056307059712708, 0.04601508006453514, 0.014426236972212791, 0.20213526487350464, 0.43666914105415344, 0.18043678998947144, -1]}
{"idB": "749647_18_item1_p188_s1", "idA": "749647_17_item1_p176_s1", "sentA": "As a condition of approval of an NDA, the FDA may require the applicant to conduct additional clinical trials or other post market testing and surveillance to further monitor and assess the drug's safety and efficacy.", "sentB": "As a condition of approval of an NDA/BLA, the FDA may require the applicant to conduct additional clinical trials or other post market testing and surveillance to further monitor and assess the drug s safety and efficacy.", "type": 2, "words": ["<tag1>", "As", "a", "condition", "of", "approval", "of", "an", "NDA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug's", "safety", "and", "efficacy.", "<tag2>", "As", "a", "condition", "of", "approval", "of", "an", "NDA/BLA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug", "s", "safety", "and", "efficacy.", "<tag3>"], "wordsA": ["As", "a", "condition", "of", "approval", "of", "an", "NDA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug's", "safety", "and", "efficacy."], "wordsB": ["As", "a", "condition", "of", "approval", "of", "an", "NDA/BLA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug", "s", "safety", "and", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0038586945738643408, 0.005135490093380213, 0.007980928756296635, 0.0059563289396464825, 0.01160595752298832, 0.005877320189028978, 0.007573327515274286, 0.9794868230819702, 0.0042096273973584175, 0.01090295985341072, 0.008941245265305042, 0.012067482806742191, 0.005487470887601376, 0.01757817529141903, 0.006238615605980158, 0.005919763818383217, 0.005972002167254686, 0.006669578608125448, 0.007730829529464245, 0.003991857171058655, 0.004434349946677685, 0.005850897636264563, 0.006755488459020853, 0.004992562811821699, 0.00503599364310503, 0.004927453119307756, 0.0038337018340826035, 0.00411023385822773, 0.004930788651108742, 0.004483831115067005, 0.00639371108263731, 0.00336318532936275, 0.018370743840932846, 0.005939581897109747, 0.007063504308462143, 0.005368576850742102, 0.005989152006804943, -1]}
{"idB": "749647_18_item1_p248_s1", "idA": "749647_17_item1_p176_s1", "sentA": "As a condition of approval of an NDA, the FDA may require the applicant to conduct additional clinical trials or other post market testing and surveillance to further monitor and assess the drug's safety and efficacy.", "sentB": "The time to complete testing and obtaining approvals is uncertain, and the FDA and foreign regulatory agencies have substantial discretion, at any phase of development, to terminate clinical studies, require additional clinical studies or other testing, delay or withhold approval, and mandate product withdrawals, including recalls.", "type": 2, "words": ["<tag1>", "As", "a", "condition", "of", "approval", "of", "an", "NDA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug's", "safety", "and", "efficacy.", "<tag2>", "The", "time", "to", "complete", "testing", "and", "obtaining", "approvals", "is", "uncertain,", "and", "the", "FDA", "and", "foreign", "regulatory", "agencies", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "studies", "or", "other", "testing,", "delay", "or", "withhold", "approval,", "and", "mandate", "product", "withdrawals,", "including", "recalls.", "<tag3>"], "wordsA": ["As", "a", "condition", "of", "approval", "of", "an", "NDA,", "the", "FDA", "may", "require", "the", "applicant", "to", "conduct", "additional", "clinical", "trials", "or", "other", "post", "market", "testing", "and", "surveillance", "to", "further", "monitor", "and", "assess", "the", "drug's", "safety", "and", "efficacy."], "wordsB": ["The", "time", "to", "complete", "testing", "and", "obtaining", "approvals", "is", "uncertain,", "and", "the", "FDA", "and", "foreign", "regulatory", "agencies", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "studies", "or", "other", "testing,", "delay", "or", "withhold", "approval,", "and", "mandate", "product", "withdrawals,", "including", "recalls."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010025149211287498, 0.12503021955490112, 0.10164234042167664, 0.26155561208724976, 0.2574039697647095, 0.010740602388978004, 0.09631854295730591, 0.14846499264240265, 0.014160512015223503, 0.11601302772760391, 0.007105559576302767, 0.004586677998304367, 0.033301789313554764, 0.003952600061893463, 0.019065069034695625, 0.02340463362634182, 0.03418387845158577, 0.012805123813450336, 0.02941904589533806, 0.05085648596286774, 0.006332305260002613, 0.01171860657632351, 0.017914511263370514, 0.00730246352031827, 0.029327308759093285, 0.01516781561076641, 0.39261528849601746, 0.19001519680023193, 0.25451022386550903, 0.031199127435684204, 0.025881197303533554, 0.0577889159321785, 0.05276385694742203, 0.004844126757234335, 0.009341251105070114, 0.04255571588873863, 0.08971084654331207, 0.021402230486273766, 0.14743925631046295, 0.11189866811037064, 0.006890283431857824, 0.17095400393009186, 0.15097421407699585, 0.29498162865638733, 0.021421240642666817, 0.18085594475269318, -1]}
{"idB": "749647_18_item1_p302_s3", "idA": "749647_17_item1_p176_s2", "sentA": "The FDA can also impose other post-marketing controls on us as well as our products including, but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise.", "sentB": "We must also comply with record keeping requirements as well as requirements to report certain adverse events involving our products.", "type": 2, "words": ["<tag1>", "The", "FDA", "can", "also", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise.", "<tag2>", "We", "must", "also", "comply", "with", "record", "keeping", "requirements", "as", "well", "as", "requirements", "to", "report", "certain", "adverse", "events", "involving", "our", "products.", "<tag3>"], "wordsA": ["The", "FDA", "can", "also", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise."], "wordsB": ["We", "must", "also", "comply", "with", "record", "keeping", "requirements", "as", "well", "as", "requirements", "to", "report", "certain", "adverse", "events", "involving", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06144050508737564, 0.05350567772984505, 0.018471581861376762, 0.17114083468914032, 0.07967960834503174, 0.8763866424560547, 0.8931151032447815, 0.6086507439613342, 0.0024415047373622656, 0.005106199998408556, 0.0025540299247950315, 0.21162275969982147, 0.010401175357401371, 0.05576508492231369, 0.014680626802146435, 0.06435952335596085, 0.11861098557710648, 0.03411588445305824, 0.01178173441439867, 0.05337783321738243, -1]}
{"idB": "749647_18_item1_p302_s4", "idA": "749647_17_item1_p176_s2", "sentA": "The FDA can also impose other post-marketing controls on us as well as our products including, but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise.", "sentB": "The FDA can impose other post-marketing controls on us as well as our products including, but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise.", "type": 2, "words": ["<tag1>", "The", "FDA", "can", "also", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise.", "<tag2>", "The", "FDA", "can", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise.", "<tag3>"], "wordsA": ["The", "FDA", "can", "also", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise."], "wordsB": ["The", "FDA", "can", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04749201610684395, 0.7091140747070312, 0.20341667532920837, 0.1825433373451233, 0.07867569476366043, 0.10317403823137283, 0.13389454782009125, 0.11934581398963928, 0.2648429274559021, 0.07512983679771423, 0.06158506125211716, 0.0641007199883461, 0.057606298476457596, 0.10505443811416626, 0.08473525196313858, 0.07024973630905151, 0.12193949520587921, 0.16825193166732788, 0.05210009962320328, 0.0907583236694336, 0.055834654718637466, 0.09776085615158081, 0.06186594441533089, 0.10696335136890411, 0.044736798852682114, 0.035255316644907, 0.09385531395673752, 0.09005578607320786, 0.069834403693676, 0.05519672855734825, 0.05679582431912422, -1]}
{"idB": "749647_18_item1_p352_s0", "idA": "749647_17_item1_p176_s2", "sentA": "The FDA can also impose other post-marketing controls on us as well as our products including, but not limited to, restrictions on sale and use, through the approval process, regulations and otherwise.", "sentB": "Adverse capital and credit market conditions could affect our ability to meet liquidity needs, as well as our access to capital and cost of capital.", "type": 2, "words": ["<tag1>", "The", "FDA", "can", "also", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise.", "<tag2>", "Adverse", "capital", "and", "credit", "market", "conditions", "could", "affect", "our", "ability", "to", "meet", "liquidity", "needs,", "as", "well", "as", "our", "access", "to", "capital", "and", "cost", "of", "capital.", "<tag3>"], "wordsA": ["The", "FDA", "can", "also", "impose", "other", "post-marketing", "controls", "on", "us", "as", "well", "as", "our", "products", "including,", "but", "not", "limited", "to,", "restrictions", "on", "sale", "and", "use,", "through", "the", "approval", "process,", "regulations", "and", "otherwise."], "wordsB": ["Adverse", "capital", "and", "credit", "market", "conditions", "could", "affect", "our", "ability", "to", "meet", "liquidity", "needs,", "as", "well", "as", "our", "access", "to", "capital", "and", "cost", "of", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.19964599609375, 0.6387743353843689, 0.17468537390232086, 0.6042761206626892, 0.6332033276557922, 0.3160499632358551, 0.01131028775125742, 0.08206760883331299, 0.06219653785228729, 0.11309045553207397, 0.06471753120422363, 0.11433646082878113, 0.3358630836009979, 0.17881393432617188, 0.00034164238604716957, 0.004687692504376173, 0.00562818069010973, 0.01942567154765129, 0.06100912392139435, 0.0674782544374466, 0.18436802923679352, 0.008117948658764362, 0.055936701595783234, 0.058731935918331146, 0.15602993965148926, -1]}
{"idB": "749647_18_item1_p169_s0", "idA": "749647_17_item1_p176_s3", "sentA": "The FDA also has the authority to require the recall of our products in the event of material deficiencies or defects in manufacture.", "sentB": "The FDA has agreed to certain performance goals in the review of NDAs and BLAs.", "type": 2, "words": ["<tag1>", "The", "FDA", "also", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture.", "<tag2>", "The", "FDA", "has", "agreed", "to", "certain", "performance", "goals", "in", "the", "review", "of", "NDAs", "and", "BLAs.", "<tag3>"], "wordsA": ["The", "FDA", "also", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture."], "wordsB": ["The", "FDA", "has", "agreed", "to", "certain", "performance", "goals", "in", "the", "review", "of", "NDAs", "and", "BLAs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006487519480288029, 0.05585385859012604, 0.03888559713959694, 0.2804023027420044, 0.10049956291913986, 0.1269245445728302, 0.2523103654384613, 0.23691411316394806, 0.0878952294588089, 0.1077333390712738, 0.3545016348361969, 0.14663928747177124, 0.25785255432128906, 0.16171124577522278, 0.26761800050735474, -1]}
{"idB": "749647_18_item1_p173_s1", "idA": "749647_17_item1_p176_s3", "sentA": "The FDA also has the authority to require the recall of our products in the event of material deficiencies or defects in manufacture.", "sentB": "The PHSA also provides authority to the FDA to immediately suspend licenses in situations where there exists a danger to public health, to prepare or procure products in the event of shortages and critical public health needs, and to authorize the creation and enforcement of regulations to prevent the introduction or spread of communicable diseases in the United States and between states.", "type": 2, "words": ["<tag1>", "The", "FDA", "also", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture.", "<tag2>", "The", "PHSA", "also", "provides", "authority", "to", "the", "FDA", "to", "immediately", "suspend", "licenses", "in", "situations", "where", "there", "exists", "a", "danger", "to", "public", "health,", "to", "prepare", "or", "procure", "products", "in", "the", "event", "of", "shortages", "and", "critical", "public", "health", "needs,", "and", "to", "authorize", "the", "creation", "and", "enforcement", "of", "regulations", "to", "prevent", "the", "introduction", "or", "spread", "of", "communicable", "diseases", "in", "the", "United", "States", "and", "between", "states.", "<tag3>"], "wordsA": ["The", "FDA", "also", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture."], "wordsB": ["The", "PHSA", "also", "provides", "authority", "to", "the", "FDA", "to", "immediately", "suspend", "licenses", "in", "situations", "where", "there", "exists", "a", "danger", "to", "public", "health,", "to", "prepare", "or", "procure", "products", "in", "the", "event", "of", "shortages", "and", "critical", "public", "health", "needs,", "and", "to", "authorize", "the", "creation", "and", "enforcement", "of", "regulations", "to", "prevent", "the", "introduction", "or", "spread", "of", "communicable", "diseases", "in", "the", "United", "States", "and", "between", "states."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0050797914154827595, 0.06753852218389511, 0.005760912783443928, 0.014657276682555676, 0.029936393722891808, 0.0038592664059251547, 0.003814381780102849, 0.02198011241853237, 0.035044655203819275, 0.34382128715515137, 0.8461480140686035, 0.819978654384613, 0.003972819074988365, 0.008973530493676662, 0.003468899754807353, 0.004423127509653568, 0.004355152603238821, 8.78922946867533e-05, 0.006533270701766014, 0.004677658434957266, 0.007789722643792629, 0.008846971206367016, 0.002193418564274907, 0.015757767483592033, 0.008874299004673958, 0.018144793808460236, 0.017764955759048462, 0.0017680436139926314, 0.005120409652590752, 0.002964415354654193, 0.0022092233411967754, 0.027665184810757637, 0.0024782547261565924, 0.01185011025518179, 0.010729183442890644, 0.017598247155547142, 0.025497015565633774, 0.0029547640588134527, 0.0034747945610433817, 0.03242582827806473, 0.00010877859313040972, 0.02555358223617077, 0.014139306731522083, 0.09435203671455383, 0.02645893208682537, 0.031111445277929306, 0.001079792040400207, 0.017229709774255753, 9.14354677661322e-05, 0.028045345097780228, 0.016989706084132195, 0.03785156458616257, 0.01791982166469097, 0.16324378550052643, 0.10323977470397949, 0.00340444827452302, 0.0043828776106238365, 0.00832731556147337, 0.014195515774190426, 0.015256169252097607, 0.05005962774157524, 0.04436124116182327, -1]}
{"idB": "749647_18_item1_p300_s1", "idA": "749647_17_item1_p176_s3", "sentA": "The FDA also has the authority to require the recall of our products in the event of material deficiencies or defects in manufacture.", "sentB": "Under certain circumstances, the FDA also has the authority to revoke previously granted product approvals.", "type": 2, "words": ["<tag1>", "The", "FDA", "also", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture.", "<tag2>", "Under", "certain", "circumstances,", "the", "FDA", "also", "has", "the", "authority", "to", "revoke", "previously", "granted", "product", "approvals.", "<tag3>"], "wordsA": ["The", "FDA", "also", "has", "the", "authority", "to", "require", "the", "recall", "of", "our", "products", "in", "the", "event", "of", "material", "deficiencies", "or", "defects", "in", "manufacture."], "wordsB": ["Under", "certain", "circumstances,", "the", "FDA", "also", "has", "the", "authority", "to", "revoke", "previously", "granted", "product", "approvals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015446798875927925, 0.03308167681097984, 0.03713560476899147, 0.001922793802805245, 0.015509272925555706, 0.004013147670775652, 0.00686211371794343, 0.003310304367914796, 0.044140905141830444, 0.12007182836532593, 0.9343438148498535, 0.23349447548389435, 0.268886536359787, 0.32941359281539917, 0.4700992703437805, -1]}
{"idB": "749647_18_item1_p171_s1", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "The review process for both standard and priority review may be extended by the FDA for three additional months to consider certain late-submitted information, or information intended to clarify information already provided in the submission.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "The", "review", "process", "for", "both", "standard", "and", "priority", "review", "may", "be", "extended", "by", "the", "FDA", "for", "three", "additional", "months", "to", "consider", "certain", "late-submitted", "information,", "or", "information", "intended", "to", "clarify", "information", "already", "provided", "in", "the", "submission.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["The", "review", "process", "for", "both", "standard", "and", "priority", "review", "may", "be", "extended", "by", "the", "FDA", "for", "three", "additional", "months", "to", "consider", "certain", "late-submitted", "information,", "or", "information", "intended", "to", "clarify", "information", "already", "provided", "in", "the", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012393645010888577, 0.33497554063796997, 0.18598367273807526, 0.015718944370746613, 0.03896539658308029, 0.2028171420097351, 0.08956306427717209, 0.25368955731391907, 0.34305229783058167, 0.02617798186838627, 0.018354417756199837, 0.048463236540555954, 0.010469242930412292, 0.010539942421019077, 0.06720496714115143, 0.01681852713227272, 0.04601208493113518, 0.03025098331272602, 0.05210772901773453, 0.003035248490050435, 0.014992401003837585, 0.008178714662790298, 0.05646302551031113, 0.0421786792576313, 0.00034914707066491246, 0.036306459456682205, 0.006481528747826815, 0.009461907669901848, 0.05245252326130867, 0.04152246564626694, 0.00915656890720129, 0.006624511443078518, 0.0086081987246871, 0.0073668574914336205, 0.03897719457745552, -1]}
{"idB": "749647_18_item1_p176_s1", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "As with drugs, after approval of biological products, manufacturers must address any safety issues that arise, are subject to recalls or a halt in manufacturing, and are subject to periodic inspection after approval.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "As", "with", "drugs,", "after", "approval", "of", "biological", "products,", "manufacturers", "must", "address", "any", "safety", "issues", "that", "arise,", "are", "subject", "to", "recalls", "or", "a", "halt", "in", "manufacturing,", "and", "are", "subject", "to", "periodic", "inspection", "after", "approval.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["As", "with", "drugs,", "after", "approval", "of", "biological", "products,", "manufacturers", "must", "address", "any", "safety", "issues", "that", "arise,", "are", "subject", "to", "recalls", "or", "a", "halt", "in", "manufacturing,", "and", "are", "subject", "to", "periodic", "inspection", "after", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030289707705378532, 0.05169600620865822, 0.08045952022075653, 0.031844645738601685, 0.11037294566631317, 0.04618959128856659, 0.2826616168022156, 0.26784196496009827, 0.07008472084999084, 0.019359968602657318, 0.07130628079175949, 0.047827016562223434, 0.13490508496761322, 0.10751171410083771, 0.009118560701608658, 0.018201302736997604, 0.0054192994721233845, 0.056650836020708084, 0.03662686422467232, 0.19797997176647186, 0.06520973145961761, 0.06324682384729385, 0.3857240676879883, 0.17105045914649963, 0.27910059690475464, 0.006616401951760054, 0.007355945184826851, 0.048248738050460815, 0.020618649199604988, 0.06904046982526779, 0.059339895844459534, 0.19047334790229797, 0.14314405620098114, -1]}
{"idB": "749647_18_item1_p181_s0", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "In the Food and Drug Administration Safety and Innovation Act (FDASIA) which was signed into law in July 2012, the U.S. Congress encouraged the FDA to utilize innovative and flexible approaches to the assessment of product candidates under accelerated approval.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "In", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act", "(FDASIA)", "which", "was", "signed", "into", "law", "in", "July", "2012,", "the", "U.S.", "Congress", "encouraged", "the", "FDA", "to", "utilize", "innovative", "and", "flexible", "approaches", "to", "the", "assessment", "of", "product", "candidates", "under", "accelerated", "approval.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["In", "the", "Food", "and", "Drug", "Administration", "Safety", "and", "Innovation", "Act", "(FDASIA)", "which", "was", "signed", "into", "law", "in", "July", "2012,", "the", "U.S.", "Congress", "encouraged", "the", "FDA", "to", "utilize", "innovative", "and", "flexible", "approaches", "to", "the", "assessment", "of", "product", "candidates", "under", "accelerated", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04537750780582428, 0.03269776701927185, 0.44165706634521484, 0.38662615418434143, 0.38455069065093994, 0.3922971487045288, 0.2590027451515198, 0.2105693221092224, 0.20299874246120453, 0.29275277256965637, 0.21756473183631897, 0.0003003565361723304, 0.007769396994262934, 0.04321588575839996, 0.035121407359838486, 0.06274805217981339, 0.009580623358488083, 0.02994750253856182, 0.06080473214387894, 0.008547978475689888, 0.03724220022559166, 0.06550738215446472, 0.07827148586511612, 0.02874155528843403, 0.08594455569982529, 0.018528815358877182, 0.061686329543590546, 0.06144331768155098, 0.02515277825295925, 0.1325504034757614, 0.12633417546749115, 0.016845466569066048, 0.01537769753485918, 0.07338453829288483, 0.03761104866862297, 0.0660734549164772, 0.08769991993904114, 0.016104726120829582, 0.06393179297447205, 0.04777034372091293, -1]}
{"idB": "749647_18_item1_p250_s0", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "Our industry is highly regulated by the FDA and comparable foreign regulatory agencies.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "Our", "industry", "is", "highly", "regulated", "by", "the", "FDA", "and", "comparable", "foreign", "regulatory", "agencies.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["Our", "industry", "is", "highly", "regulated", "by", "the", "FDA", "and", "comparable", "foreign", "regulatory", "agencies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017300857231020927, 0.1803351640701294, 0.04923909902572632, 0.6155922412872314, 0.9408103823661804, 0.03382974863052368, 0.024588875472545624, 0.07874474674463272, 0.013566028326749802, 0.030448755249381065, 0.0951140820980072, 0.09053099900484085, 0.07659292966127396, -1]}
{"idB": "749647_18_item1_p256_s0", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "New gene-based products for therapeutic applications are subject to extensive regulation by the FDA and comparable agencies in other countries.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "New", "gene-based", "products", "for", "therapeutic", "applications", "are", "subject", "to", "extensive", "regulation", "by", "the", "FDA", "and", "comparable", "agencies", "in", "other", "countries.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["New", "gene-based", "products", "for", "therapeutic", "applications", "are", "subject", "to", "extensive", "regulation", "by", "the", "FDA", "and", "comparable", "agencies", "in", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.13827180862426758, 0.6382045745849609, 0.3285771608352661, 0.03308927267789841, 0.4091278314590454, 0.17744934558868408, 0.003237541299313307, 0.019693510606884956, 0.0077932351268827915, 0.12096138298511505, 0.14930154383182526, 0.004545701667666435, 0.0047737243585288525, 0.033411648124456406, 0.0054785264655947685, 0.01870965212583542, 0.04348636791110039, 0.00761357182636857, 0.02392646297812462, 0.055584199726581573, -1]}
{"idB": "749647_18_item1_p297_s0", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "Our research and development activities, pre-clinical tests and clinical trials, and ultimately the manufacturing, marketing and labeling of our products, are all subject to extensive regulation by the FDA and foreign regulatory agencies.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "Our", "research", "and", "development", "activities,", "pre-clinical", "tests", "and", "clinical", "trials,", "and", "ultimately", "the", "manufacturing,", "marketing", "and", "labeling", "of", "our", "products,", "are", "all", "subject", "to", "extensive", "regulation", "by", "the", "FDA", "and", "foreign", "regulatory", "agencies.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["Our", "research", "and", "development", "activities,", "pre-clinical", "tests", "and", "clinical", "trials,", "and", "ultimately", "the", "manufacturing,", "marketing", "and", "labeling", "of", "our", "products,", "are", "all", "subject", "to", "extensive", "regulation", "by", "the", "FDA", "and", "foreign", "regulatory", "agencies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02353869192302227, 0.20989584922790527, 0.27859821915626526, 0.23372425138950348, 0.19459527730941772, 0.2827787697315216, 0.2895716428756714, 0.0636695921421051, 0.19089877605438232, 0.30093783140182495, 0.005649473983794451, 0.011609808541834354, 0.006243495736271143, 0.06210728734731674, 0.09542098641395569, 0.045906856656074524, 0.08272649347782135, 0.014052443206310272, 0.019280793145298958, 0.05842616409063339, 0.006264607422053814, 0.006969436537474394, 0.05873708426952362, 0.034011706709861755, 0.28981098532676697, 0.31894436478614807, 0.006116676609963179, 0.007515438832342625, 0.02697927877306938, 0.006703986786305904, 0.04110134765505791, 0.03217251971364021, 0.043007999658584595, -1]}
{"idB": "749647_18_item1_p299_s0", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "We are subject to the periodic inspection of our clinical trials, facilities, procedures and operations and/or the testing of our products by the FDA to determine whether our systems and processes, or those of our vendors and suppliers, are in compliance with FDA regulations.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "We", "are", "subject", "to", "the", "periodic", "inspection", "of", "our", "clinical", "trials,", "facilities,", "procedures", "and", "operations", "and/or", "the", "testing", "of", "our", "products", "by", "the", "FDA", "to", "determine", "whether", "our", "systems", "and", "processes,", "or", "those", "of", "our", "vendors", "and", "suppliers,", "are", "in", "compliance", "with", "FDA", "regulations.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["We", "are", "subject", "to", "the", "periodic", "inspection", "of", "our", "clinical", "trials,", "facilities,", "procedures", "and", "operations", "and/or", "the", "testing", "of", "our", "products", "by", "the", "FDA", "to", "determine", "whether", "our", "systems", "and", "processes,", "or", "those", "of", "our", "vendors", "and", "suppliers,", "are", "in", "compliance", "with", "FDA", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.029642490670084953, 0.006069726776331663, 0.02983764559030533, 0.007703818846493959, 0.005533905234187841, 0.031282126903533936, 0.06399735808372498, 0.02964235283434391, 0.035555895417928696, 0.5324490666389465, 0.41344353556632996, 0.06954457610845566, 0.03325457498431206, 0.007625852711498737, 0.02124650776386261, 0.008899044245481491, 0.006542375311255455, 0.07693023234605789, 0.01513986848294735, 0.021907910704612732, 0.07923216372728348, 0.005552912596613169, 0.00757876131683588, 0.021028155460953712, 0.004034887999296188, 0.00963769294321537, 0.008554515428841114, 0.00909119937568903, 0.05023960396647453, 0.03340476006269455, 0.06218000128865242, 0.008965231478214264, 0.009071863256394863, 0.006963504943996668, 0.005904515273869038, 0.02653568610548973, 0.016833608970046043, 0.025099635124206543, 0.04186089336872101, 0.04352198913693428, 0.0827779695391655, 0.024051576852798462, 0.05601960048079491, 0.07076678425073624, -1]}
{"idB": "749647_18_item1_p302_s2", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "Labeling and promotional activities also are regulated by the FDA.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "Labeling", "and", "promotional", "activities", "also", "are", "regulated", "by", "the", "FDA.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["Labeling", "and", "promotional", "activities", "also", "are", "regulated", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.35851308703422546, 0.10299920290708542, 0.6191584467887878, 0.4783930778503418, 0.014483665116131306, 0.014591283164918423, 0.22195905447006226, 0.02273857407271862, 0.01625642366707325, 0.06963525712490082, -1]}
{"idB": "749647_18_item1_p308_s1", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "In addition, exclusive marketing rights in the U.S. may be limited if we seek approval for an indication broader than the orphan-designated indication or may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "In", "addition,", "exclusive", "marketing", "rights", "in", "the", "U.S.", "may", "be", "limited", "if", "we", "seek", "approval", "for", "an", "indication", "broader", "than", "the", "orphan-designated", "indication", "or", "may", "be", "lost", "if", "the", "FDA", "later", "determines", "that", "the", "request", "for", "designation", "was", "materially", "defective", "or", "if", "the", "manufacturer", "is", "unable", "to", "assure", "sufficient", "quantities", "of", "the", "product", "to", "meet", "the", "needs", "of", "patients", "with", "the", "rare", "disease", "or", "condition.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["In", "addition,", "exclusive", "marketing", "rights", "in", "the", "U.S.", "may", "be", "limited", "if", "we", "seek", "approval", "for", "an", "indication", "broader", "than", "the", "orphan-designated", "indication", "or", "may", "be", "lost", "if", "the", "FDA", "later", "determines", "that", "the", "request", "for", "designation", "was", "materially", "defective", "or", "if", "the", "manufacturer", "is", "unable", "to", "assure", "sufficient", "quantities", "of", "the", "product", "to", "meet", "the", "needs", "of", "patients", "with", "the", "rare", "disease", "or", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005109233781695366, 0.015556830912828445, 0.41389623284339905, 0.716835081577301, 0.539167582988739, 0.009140447713434696, 0.0069680106826126575, 0.016052300110459328, 0.011843624524772167, 0.01524309441447258, 0.0752495676279068, 0.005941379349678755, 0.015091760084033012, 0.01708490028977394, 0.02931121177971363, 0.00840174313634634, 0.005865844432264566, 0.022584814578294754, 0.009621867910027504, 0.00846756063401699, 0.006130172871053219, 0.09854410588741302, 0.028371527791023254, 0.0012074969708919525, 0.006223492324352264, 0.006726976949721575, 0.02282206527888775, 0.006212925538420677, 0.00491263996809721, 0.020915767177939415, 0.008359651081264019, 0.010042085312306881, 0.008703729137778282, 0.00520647456869483, 0.04166337475180626, 0.014901177026331425, 0.019162315875291824, 0.015359743498265743, 0.011511924676597118, 0.02050684578716755, 0.006530080456286669, 0.0056928908452391624, 0.0039258841425180435, 0.02551688812673092, 0.0128403902053833, 0.04380784556269646, 0.017818136140704155, 0.028606483712792397, 0.03723098337650299, 0.09529657661914825, 0.020768875256180763, 0.014400070533156395, 0.05351518839597702, 0.008148722350597382, 0.005176932085305452, 0.009815200231969357, 0.0179531741887331, 0.00491334917023778, 0.02632199414074421, 0.013564050197601318, 0.008991197682917118, 0.028872540220618248, 0.026448268443346024, 0.024969646707177162, 0.01828826032578945, -1]}
{"idB": "749647_18_item1_p312_s6", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "In addition, uncertainty remains regarding proposed significant reforms to the U.S. health care system.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "In", "addition,", "uncertainty", "remains", "regarding", "proposed", "significant", "reforms", "to", "the", "U.S.", "health", "care", "system.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["In", "addition,", "uncertainty", "remains", "regarding", "proposed", "significant", "reforms", "to", "the", "U.S.", "health", "care", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004050962161272764, 0.012704824097454548, 0.3067539632320404, 0.036191605031490326, 0.035763829946517944, 0.06971342861652374, 0.09830321371555328, 0.2071302980184555, 0.07842839509248734, 0.06265702098608017, 0.21830062568187714, 0.7940919399261475, 0.6508846879005432, 0.4265950322151184, -1]}
{"idB": "749647_18_item1_p323_s4", "idA": "749647_17_item1_p177_s0", "sentA": "In addition, manufacturing establishments in the U.S. and abroad are subject to periodic inspections by the FDA and must comply with current good manufacturing practices (cGMP).", "sentB": "In addition, while these clinical trials are subject to the applicable local laws, FDA acceptance of the data will be dependent upon its determination that the trials also complied with all applicable U.S. laws and regulations.", "type": 2, "words": ["<tag1>", "In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP).", "<tag2>", "In", "addition,", "while", "these", "clinical", "trials", "are", "subject", "to", "the", "applicable", "local", "laws,", "FDA", "acceptance", "of", "the", "data", "will", "be", "dependent", "upon", "its", "determination", "that", "the", "trials", "also", "complied", "with", "all", "applicable", "U.S.", "laws", "and", "regulations.", "<tag3>"], "wordsA": ["In", "addition,", "manufacturing", "establishments", "in", "the", "U.S.", "and", "abroad", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "must", "comply", "with", "current", "good", "manufacturing", "practices", "(cGMP)."], "wordsB": ["In", "addition,", "while", "these", "clinical", "trials", "are", "subject", "to", "the", "applicable", "local", "laws,", "FDA", "acceptance", "of", "the", "data", "will", "be", "dependent", "upon", "its", "determination", "that", "the", "trials", "also", "complied", "with", "all", "applicable", "U.S.", "laws", "and", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00698393490165472, 0.012832384556531906, 0.013720802031457424, 0.016185786575078964, 0.587899386882782, 0.5475711822509766, 0.01019084732979536, 0.053134310990571976, 0.01609211415052414, 0.007730301935225725, 0.07490921765565872, 0.20486098527908325, 0.25684845447540283, 0.05296751484274864, 0.09588929265737534, 0.03644842281937599, 0.026722300797700882, 0.07599515467882156, 0.012062004767358303, 0.00848436076194048, 0.030917836353182793, 0.006575580686330795, 0.0057488479651510715, 0.020616954192519188, 0.008051237091422081, 0.008284245617687702, 0.09612887352705002, 0.02925943024456501, 0.11303205043077469, 0.0309540256857872, 0.04994847625494003, 0.07999778538942337, 0.0685468539595604, 0.05077657476067543, 0.028517315164208412, 0.06680983304977417, -1]}
{"idB": "749647_18_item1_p193_s0", "idA": "749647_17_item1_p178_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "In addition to regulations in the U.S., we will be subject to a variety of regulations of other countries governing, among other things, any clinical trials and commercial sales and distribution of our product candidates.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "a", "variety", "of", "regulations", "of", "other", "countries", "governing,", "among", "other", "things,", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "a", "variety", "of", "regulations", "of", "other", "countries", "governing,", "among", "other", "things,", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04018038883805275, 0.11799702048301697, 0.04174274206161499, 0.2687980830669403, 0.05143140256404877, 0.03071315586566925, 0.3276294767856598, 0.03984023630619049, 0.030311675742268562, 0.022054843604564667, 0.09893416613340378, 0.03938433527946472, 0.05176566541194916, 0.243508979678154, 0.051393795758485794, 0.23302294313907623, 0.0175254438072443, 0.03497002273797989, 0.07925809174776077, 0.06586203724145889, 0.021837783977389336, 0.02187553234398365, 0.014160092920064926, 0.023740455508232117, 0.05442110449075699, 0.06009085103869438, 0.01682162843644619, 0.03126540780067444, 0.04770267754793167, 0.02573792263865471, 0.037062838673591614, 0.022564910352230072, 0.025621579959988594, 0.04780007153749466, 0.060307107865810394, -1]}
{"idB": "749647_18_item1_p20_s4", "idA": "749647_17_item1_p178_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "The Company expects to submit and believes that applications will be accepted in South Korea, Taiwan and Vietnam, three other significant markets for ThermoDox if it were to receive approval in Europe, China or the U.S.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "The", "Company", "expects", "to", "submit", "and", "believes", "that", "applications", "will", "be", "accepted", "in", "South", "Korea,", "Taiwan", "and", "Vietnam,", "three", "other", "significant", "markets", "for", "ThermoDox", "if", "it", "were", "to", "receive", "approval", "in", "Europe,", "China", "or", "the", "U.S.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["The", "Company", "expects", "to", "submit", "and", "believes", "that", "applications", "will", "be", "accepted", "in", "South", "Korea,", "Taiwan", "and", "Vietnam,", "three", "other", "significant", "markets", "for", "ThermoDox", "if", "it", "were", "to", "receive", "approval", "in", "Europe,", "China", "or", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012891181744635105, 0.10079975426197052, 0.12099359929561615, 0.12414668500423431, 0.22043932974338531, 0.024025768041610718, 0.1188274696469307, 0.06125887110829353, 0.24493129551410675, 0.04101726412773132, 0.03816552087664604, 0.08589165657758713, 0.031180167570710182, 0.18619917333126068, 0.3225994110107422, 0.1580318659543991, 0.13078756630420685, 0.21902160346508026, 0.006319908425211906, 0.004247764125466347, 0.02015785500407219, 0.04088262468576431, 0.02810523845255375, 0.06284726411104202, 0.00877278670668602, 0.007954051718115807, 0.015226427465677261, 0.015166725032031536, 0.021534878760576248, 0.055982284247875214, 0.008229900151491165, 0.029229899868369102, 0.03528178483247757, 0.017342526465654373, 0.01008287351578474, 0.03396570682525635, -1]}
{"idB": "749647_18_item1_p249_s2", "idA": "749647_17_item1_p178_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "Even if we receive approval, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and subject us to restrictions, withdrawal from the market, or penalties if we fail to comply with applicable regulatory requirements or if we experience unanticipated problems with our product candidates, when and if approved.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "Even", "if", "we", "receive", "approval,", "we", "will", "be", "subject", "to", "ongoing", "regulatory", "obligations", "and", "continued", "regulatory", "review,", "which", "may", "result", "in", "significant", "additional", "expense", "and", "subject", "us", "to", "restrictions,", "withdrawal", "from", "the", "market,", "or", "penalties", "if", "we", "fail", "to", "comply", "with", "applicable", "regulatory", "requirements", "or", "if", "we", "experience", "unanticipated", "problems", "with", "our", "product", "candidates,", "when", "and", "if", "approved.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["Even", "if", "we", "receive", "approval,", "we", "will", "be", "subject", "to", "ongoing", "regulatory", "obligations", "and", "continued", "regulatory", "review,", "which", "may", "result", "in", "significant", "additional", "expense", "and", "subject", "us", "to", "restrictions,", "withdrawal", "from", "the", "market,", "or", "penalties", "if", "we", "fail", "to", "comply", "with", "applicable", "regulatory", "requirements", "or", "if", "we", "experience", "unanticipated", "problems", "with", "our", "product", "candidates,", "when", "and", "if", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04792014881968498, 0.06616776436567307, 0.1276543140411377, 0.46784886717796326, 0.3514626622200012, 0.013444487936794758, 0.010585950687527657, 0.011421111412346363, 0.03990032896399498, 0.017709990963339806, 0.04460611194372177, 0.13084657490253448, 0.11262217909097672, 0.009331137873232365, 0.059331461787223816, 0.13601462543010712, 0.15590043365955353, 0.0002264814538648352, 0.005753238219767809, 0.0060206083580851555, 0.005425882991403341, 0.007668936159461737, 0.007156210020184517, 0.010435696691274643, 0.0002242072077933699, 0.009700401686131954, 0.00955349113792181, 0.011871302500367165, 0.0564587265253067, 0.2455211579799652, 0.17399396002292633, 0.1266154646873474, 0.17097988724708557, 0.0009267251589335501, 0.01665814220905304, 0.00964274536818266, 0.01978263072669506, 0.14955896139144897, 0.06456878781318665, 0.04718172922730446, 0.017834141850471497, 0.026359597221016884, 0.04433724656701088, 0.03927035257220268, 0.0006254101754166186, 0.00725057628005743, 0.017292970791459084, 0.0340709425508976, 0.09957730770111084, 0.15500189363956451, 0.0728686973452568, 0.03726904094219208, 0.12952333688735962, 0.12844079732894897, 0.05234569311141968, 0.043876584619283676, 0.0756688266992569, 0.08419490605592728, -1]}
{"idB": "749647_18_item1_p258_s3", "idA": "749647_17_item1_p178_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "It is difficult to determine how long it will take or how much it will cost to obtain regulatory approvals for our product candidates in either the U.S. or the European Union or how long it will take to commercialize our product candidates.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "It", "is", "difficult", "to", "determine", "how", "long", "it", "will", "take", "or", "how", "much", "it", "will", "cost", "to", "obtain", "regulatory", "approvals", "for", "our", "product", "candidates", "in", "either", "the", "U.S.", "or", "the", "European", "Union", "or", "how", "long", "it", "will", "take", "to", "commercialize", "our", "product", "candidates.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["It", "is", "difficult", "to", "determine", "how", "long", "it", "will", "take", "or", "how", "much", "it", "will", "cost", "to", "obtain", "regulatory", "approvals", "for", "our", "product", "candidates", "in", "either", "the", "U.S.", "or", "the", "European", "Union", "or", "how", "long", "it", "will", "take", "to", "commercialize", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01240371074527502, 0.018466180190443993, 0.13298849761486053, 0.1246659904718399, 0.2649584710597992, 0.13891169428825378, 0.16868144273757935, 0.033436376601457596, 0.06112860143184662, 0.05060368403792381, 0.027584712952375412, 0.0744420513510704, 0.056126873940229416, 0.01967708393931389, 0.0490640327334404, 0.08011454343795776, 0.03801313042640686, 0.09396553039550781, 0.23576763272285461, 0.2506544589996338, 0.02989870309829712, 0.029687201604247093, 0.09215889126062393, 0.08866764605045319, 0.012524240650236607, 0.03400423377752304, 0.012545988894999027, 0.053383130580186844, 0.03188813850283623, 0.022570930421352386, 0.051036760210990906, 0.07063367962837219, 0.01506116520613432, 0.059699464589357376, 0.044856030493974686, 0.013099406845867634, 0.020576048642396927, 0.023315226659178734, 0.053249917924404144, 0.1782020777463913, 0.031846512109041214, 0.11641637980937958, 0.1049986183643341, -1]}
{"idB": "749647_18_item1_p298_s1", "idA": "749647_17_item1_p178_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "If the results of pivotal clinical trials do not establish the safety and efficacy of our product candidates to the satisfaction of the FDA and other foreign regulatory agencies, we will not receive the approvals necessary to market such product candidates.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "If", "the", "results", "of", "pivotal", "clinical", "trials", "do", "not", "establish", "the", "safety", "and", "efficacy", "of", "our", "product", "candidates", "to", "the", "satisfaction", "of", "the", "FDA", "and", "other", "foreign", "regulatory", "agencies,", "we", "will", "not", "receive", "the", "approvals", "necessary", "to", "market", "such", "product", "candidates.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["If", "the", "results", "of", "pivotal", "clinical", "trials", "do", "not", "establish", "the", "safety", "and", "efficacy", "of", "our", "product", "candidates", "to", "the", "satisfaction", "of", "the", "FDA", "and", "other", "foreign", "regulatory", "agencies,", "we", "will", "not", "receive", "the", "approvals", "necessary", "to", "market", "such", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.046997249126434326, 0.040219441056251526, 0.1258266568183899, 0.016721339896321297, 0.1159358099102974, 0.1391744613647461, 0.16123788058757782, 0.15255944430828094, 0.20592285692691803, 0.1518068164587021, 0.05077380686998367, 0.1738767772912979, 0.12399886548519135, 0.16810427606105804, 0.03515731543302536, 0.029529094696044922, 0.07799459993839264, 0.07959902286529541, 0.003496368881314993, 0.013079878874123096, 0.022780846804380417, 0.011552092619240284, 0.012594823725521564, 0.03169994428753853, 0.007641743868589401, 0.006983909290283918, 0.028108062222599983, 0.03551136702299118, 0.04426266998052597, 0.03246436268091202, 0.05986384302377701, 0.3592921197414398, 0.3662925064563751, 0.12182234972715378, 0.3385187089443207, 0.03843151777982712, 0.02247186377644539, 0.05166492238640785, 0.02425353042781353, 0.059027623385190964, 0.055280860513448715, -1]}
{"idB": "749647_18_item1_p307_s1", "idA": "749647_17_item1_p178_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 individuals annually in the U.S., or a patient population greater than 200,000 in the U.S. where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the U.S.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "Under", "the", "Orphan", "Drug", "Act,", "the", "FDA", "may", "designate", "a", "drug", "as", "an", "orphan", "drug", "if", "it", "is", "a", "drug", "intended", "to", "treat", "a", "rare", "disease", "or", "condition,", "which", "is", "generally", "defined", "as", "a", "patient", "population", "of", "fewer", "than", "200,000", "individuals", "annually", "in", "the", "U.S.,", "or", "a", "patient", "population", "greater", "than", "200,000", "in", "the", "U.S.", "where", "there", "is", "no", "reasonable", "expectation", "that", "the", "cost", "of", "developing", "the", "drug", "will", "be", "recovered", "from", "sales", "in", "the", "U.S.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["Under", "the", "Orphan", "Drug", "Act,", "the", "FDA", "may", "designate", "a", "drug", "as", "an", "orphan", "drug", "if", "it", "is", "a", "drug", "intended", "to", "treat", "a", "rare", "disease", "or", "condition,", "which", "is", "generally", "defined", "as", "a", "patient", "population", "of", "fewer", "than", "200,000", "individuals", "annually", "in", "the", "U.S.,", "or", "a", "patient", "population", "greater", "than", "200,000", "in", "the", "U.S.", "where", "there", "is", "no", "reasonable", "expectation", "that", "the", "cost", "of", "developing", "the", "drug", "will", "be", "recovered", "from", "sales", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11610279977321625, 0.038996800780296326, 0.43252691626548767, 0.4189668893814087, 0.2938476800918579, 0.012888887897133827, 0.06100776046514511, 0.03105257637798786, 0.07174214720726013, 0.0386829636991024, 0.1452007293701172, 0.03137743100523949, 0.02658190205693245, 0.2152206003665924, 0.14645041525363922, 0.004062830004841089, 0.006358088925480843, 0.00570640480145812, 0.005632552783936262, 0.02947363816201687, 0.010524438694119453, 0.009998258203268051, 0.02125730738043785, 0.011966549791395664, 0.030443882569670677, 0.039713118225336075, 0.02864227071404457, 0.03935982659459114, 0.00020898290676996112, 0.0099760377779603, 0.007345729507505894, 0.006643660832196474, 0.0066385273821651936, 0.007106171455234289, 0.03542567789554596, 0.04537129029631615, 0.033208202570676804, 0.3933982253074646, 0.31215253472328186, 0.2727107107639313, 0.13949407637119293, 0.01094383466988802, 0.003978197928518057, 0.004673302173614502, 0.01146311592310667, 0.003290283726528287, 0.00566142750903964, 0.024580489844083786, 0.04755420982837677, 0.1787593513727188, 0.13604991137981415, 0.061466727405786514, 0.004539168439805508, 0.0047541395761072636, 0.011235864832997322, 0.013201653026044369, 0.008517389185726643, 0.009426973760128021, 0.05843256413936615, 0.0964173972606659, 0.08815475553274155, 0.020627697929739952, 0.022990062832832336, 0.12169509381055832, 0.046376392245292664, 0.07483581453561783, 0.03358908370137215, 0.09675397723913193, 0.11706759035587311, 0.11415992677211761, 0.2522871196269989, 0.12118717283010483, 0.17629961669445038, 0.016740527004003525, 0.008728563785552979, 0.027341745793819427, -1]}
{"idB": "749647_18_item1_p325_s4", "idA": "749647_17_item1_p178_s0", "sentA": "In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates.", "sentB": "To the extent that we do enter into such arrangements, we will be dependent on our marketing and distribution partners.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates.", "<tag2>", "To", "the", "extent", "that", "we", "do", "enter", "into", "such", "arrangements,", "we", "will", "be", "dependent", "on", "our", "marketing", "and", "distribution", "partners.", "<tag3>"], "wordsA": ["In", "addition", "to", "regulations", "in", "the", "U.S.,", "we", "will", "be", "subject", "to", "regulations", "of", "other", "countries", "governing", "any", "clinical", "trials", "and", "commercial", "sales", "and", "distribution", "of", "our", "product", "candidates."], "wordsB": ["To", "the", "extent", "that", "we", "do", "enter", "into", "such", "arrangements,", "we", "will", "be", "dependent", "on", "our", "marketing", "and", "distribution", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022450268268585205, 0.019647862762212753, 0.04700622335076332, 0.01792656071484089, 0.05965067818760872, 0.22104981541633606, 0.1450919210910797, 0.11739113926887512, 0.08125178515911102, 0.1727290004491806, 0.027875687927007675, 0.05040053650736809, 0.050117023289203644, 0.3133729100227356, 0.12460990995168686, 0.09559972584247589, 0.278653621673584, 0.13841435313224792, 0.34469670057296753, 0.2938630282878876, -1]}
{"idB": "749647_18_item1_p193_s1", "idA": "749647_17_item1_p178_s1", "sentA": "Whether or not we obtain FDA approval for a product, we must obtain approval by the comparable regulatory authorities of countries outside of the U.S. before we can commence clinical trials in such countries and approval of the regulators of such countries or economic areas, such as the European Union and China, before we may market products in those countries or areas.", "sentB": "Whether or not we obtain FDA approval (clinical trial or marketing) for a product, we must obtain the requisite approvals from regulatory authorities in countries outside of the U.S., such as the EU and Chine, prior to the commencement of clinical trials or marketing of the products in those countries.", "type": 2, "words": ["<tag1>", "Whether", "or", "not", "we", "obtain", "FDA", "approval", "for", "a", "product,", "we", "must", "obtain", "approval", "by", "the", "comparable", "regulatory", "authorities", "of", "countries", "outside", "of", "the", "U.S.", "before", "we", "can", "commence", "clinical", "trials", "in", "such", "countries", "and", "approval", "of", "the", "regulators", "of", "such", "countries", "or", "economic", "areas,", "such", "as", "the", "European", "Union", "and", "China,", "before", "we", "may", "market", "products", "in", "those", "countries", "or", "areas.", "<tag2>", "Whether", "or", "not", "we", "obtain", "FDA", "approval", "(clinical", "trial", "or", "marketing)", "for", "a", "product,", "we", "must", "obtain", "the", "requisite", "approvals", "from", "regulatory", "authorities", "in", "countries", "outside", "of", "the", "U.S.,", "such", "as", "the", "EU", "and", "Chine,", "prior", "to", "the", "commencement", "of", "clinical", "trials", "or", "marketing", "of", "the", "products", "in", "those", "countries.", "<tag3>"], "wordsA": ["Whether", "or", "not", "we", "obtain", "FDA", "approval", "for", "a", "product,", "we", "must", "obtain", "approval", "by", "the", "comparable", "regulatory", "authorities", "of", "countries", "outside", "of", "the", "U.S.", "before", "we", "can", "commence", "clinical", "trials", "in", "such", "countries", "and", "approval", "of", "the", "regulators", "of", "such", "countries", "or", "economic", "areas,", "such", "as", "the", "European", "Union", "and", "China,", "before", "we", "may", "market", "products", "in", "those", "countries", "or", "areas."], "wordsB": ["Whether", "or", "not", "we", "obtain", "FDA", "approval", "(clinical", "trial", "or", "marketing)", "for", "a", "product,", "we", "must", "obtain", "the", "requisite", "approvals", "from", "regulatory", "authorities", "in", "countries", "outside", "of", "the", "U.S.,", "such", "as", "the", "EU", "and", "Chine,", "prior", "to", "the", "commencement", "of", "clinical", "trials", "or", "marketing", "of", "the", "products", "in", "those", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010611641220748425, 0.009524699300527573, 0.012287914752960205, 0.02404201403260231, 0.05485842004418373, 0.09821240603923798, 0.09515582025051117, 0.026508376002311707, 0.04823289066553116, 0.03333888202905655, 0.06236133724451065, 0.00807863473892212, 0.007100057788193226, 0.030819017440080643, 0.0062581393867731094, 0.00847886223345995, 0.04139156639575958, 0.01168174110352993, 0.2563803493976593, 0.22994010150432587, 0.011691256426274776, 0.03936915844678879, 0.07772723585367203, 0.006871417630463839, 0.03328312933444977, 0.01851179637014866, 0.00896565429866314, 0.009718209505081177, 0.01615607738494873, 0.005654106382280588, 0.01312707643955946, 0.030148139223456383, 0.3223567605018616, 0.2360745370388031, 0.4477223753929138, 0.04804898798465729, 0.031937163323163986, 0.012044413015246391, 0.036779873073101044, 0.02660125307738781, 0.04939279705286026, 0.05000070482492447, 0.040821921080350876, 0.21390964090824127, 0.03556784614920616, 0.04571005329489708, 0.15153111517429352, 0.02024787664413452, 0.023423604667186737, 0.059957776218652725, -1]}
{"idB": "749647_18_item1_p249_s3", "idA": "749647_17_item1_p178_s1", "sentA": "Whether or not we obtain FDA approval for a product, we must obtain approval by the comparable regulatory authorities of countries outside of the U.S. before we can commence clinical trials in such countries and approval of the regulators of such countries or economic areas, such as the European Union and China, before we may market products in those countries or areas.", "sentB": "Finally, even if we obtain FDA approval of any of our product candidates, we may never obtain approval or commercialize such products outside of the United States, given that we may be subject to additional or different regulatory burdens in other markets.", "type": 2, "words": ["<tag1>", "Whether", "or", "not", "we", "obtain", "FDA", "approval", "for", "a", "product,", "we", "must", "obtain", "approval", "by", "the", "comparable", "regulatory", "authorities", "of", "countries", "outside", "of", "the", "U.S.", "before", "we", "can", "commence", "clinical", "trials", "in", "such", "countries", "and", "approval", "of", "the", "regulators", "of", "such", "countries", "or", "economic", "areas,", "such", "as", "the", "European", "Union", "and", "China,", "before", "we", "may", "market", "products", "in", "those", "countries", "or", "areas.", "<tag2>", "Finally,", "even", "if", "we", "obtain", "FDA", "approval", "of", "any", "of", "our", "product", "candidates,", "we", "may", "never", "obtain", "approval", "or", "commercialize", "such", "products", "outside", "of", "the", "United", "States,", "given", "that", "we", "may", "be", "subject", "to", "additional", "or", "different", "regulatory", "burdens", "in", "other", "markets.", "<tag3>"], "wordsA": ["Whether", "or", "not", "we", "obtain", "FDA", "approval", "for", "a", "product,", "we", "must", "obtain", "approval", "by", "the", "comparable", "regulatory", "authorities", "of", "countries", "outside", "of", "the", "U.S.", "before", "we", "can", "commence", "clinical", "trials", "in", "such", "countries", "and", "approval", "of", "the", "regulators", "of", "such", "countries", "or", "economic", "areas,", "such", "as", "the", "European", "Union", "and", "China,", "before", "we", "may", "market", "products", "in", "those", "countries", "or", "areas."], "wordsB": ["Finally,", "even", "if", "we", "obtain", "FDA", "approval", "of", "any", "of", "our", "product", "candidates,", "we", "may", "never", "obtain", "approval", "or", "commercialize", "such", "products", "outside", "of", "the", "United", "States,", "given", "that", "we", "may", "be", "subject", "to", "additional", "or", "different", "regulatory", "burdens", "in", "other", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02404610626399517, 0.047282133251428604, 0.0373084731400013, 0.027158955112099648, 0.0319364108145237, 0.04507825896143913, 0.06852781772613525, 0.01260407269001007, 0.0473364032804966, 0.021403498947620392, 0.03363912180066109, 0.14922966063022614, 0.11928068101406097, 0.01861499808728695, 0.0840805172920227, 0.6663099527359009, 0.2788540720939636, 0.23446017503738403, 0.13464941084384918, 0.4028148651123047, 0.17049847543239594, 0.23769068717956543, 0.07827770709991455, 0.025767609477043152, 0.021062735468149185, 0.046302713453769684, 0.06367461383342743, 0.006986657623201609, 0.00625614682212472, 0.007263221777975559, 0.007835900411009789, 0.009203472174704075, 0.015565917827188969, 0.010106602683663368, 0.017257262021303177, 0.008068128488957882, 0.023849407210946083, 0.05878637358546257, 0.0619925893843174, 0.011844785884022713, 0.0356963686645031, 0.06811071932315826, -1]}
{"idB": "749647_18_item1_p202_s0", "idA": "749647_17_item1_p180_s0", "sentA": "Under European Union regulatory systems, a company may submit marketing authorization applications either under a centralized or decentralized procedure.", "sentB": "Marketing authorization applications for designated orphan medicinal products must be submitted through the centralized procedure.", "type": 2, "words": ["<tag1>", "Under", "European", "Union", "regulatory", "systems,", "a", "company", "may", "submit", "marketing", "authorization", "applications", "either", "under", "a", "centralized", "or", "decentralized", "procedure.", "<tag2>", "Marketing", "authorization", "applications", "for", "designated", "orphan", "medicinal", "products", "must", "be", "submitted", "through", "the", "centralized", "procedure.", "<tag3>"], "wordsA": ["Under", "European", "Union", "regulatory", "systems,", "a", "company", "may", "submit", "marketing", "authorization", "applications", "either", "under", "a", "centralized", "or", "decentralized", "procedure."], "wordsB": ["Marketing", "authorization", "applications", "for", "designated", "orphan", "medicinal", "products", "must", "be", "submitted", "through", "the", "centralized", "procedure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.032433126121759415, 0.05235021188855171, 0.056825220584869385, 0.03613700345158577, 0.44266411662101746, 0.7349702715873718, 0.7510696053504944, 0.5907793641090393, 0.012046558782458305, 0.005753625184297562, 0.02161118946969509, 0.022925084456801414, 0.014277220703661442, 0.10375179350376129, 0.040088530629873276, -1]}
{"idB": "749647_18_item1_p197_s2", "idA": "749647_17_item1_p180_s1", "sentA": "The centralized procedure, which is compulsory for medicines produced by biotechnology or those medicines intended to treat AIDS, cancer, neurodegenerative disorders or diabetes and is optional for those medicines that are highly innovative, provides for the grant of a single marketing authorization that is valid for all European Union member states.", "sentB": "The centralized procedure, which is compulsory for medicines produced by biotechnology or those medicines intended to treat AIDS, cancer, neurodegenerative disorders or diabetes and is optional for those medicines that are highly innovative, provides for the grant of a single marketing authorization that is valid for all EU Member States.", "type": 2, "words": ["<tag1>", "The", "centralized", "procedure,", "which", "is", "compulsory", "for", "medicines", "produced", "by", "biotechnology", "or", "those", "medicines", "intended", "to", "treat", "AIDS,", "cancer,", "neurodegenerative", "disorders", "or", "diabetes", "and", "is", "optional", "for", "those", "medicines", "that", "are", "highly", "innovative,", "provides", "for", "the", "grant", "of", "a", "single", "marketing", "authorization", "that", "is", "valid", "for", "all", "European", "Union", "member", "states.", "<tag2>", "The", "centralized", "procedure,", "which", "is", "compulsory", "for", "medicines", "produced", "by", "biotechnology", "or", "those", "medicines", "intended", "to", "treat", "AIDS,", "cancer,", "neurodegenerative", "disorders", "or", "diabetes", "and", "is", "optional", "for", "those", "medicines", "that", "are", "highly", "innovative,", "provides", "for", "the", "grant", "of", "a", "single", "marketing", "authorization", "that", "is", "valid", "for", "all", "EU", "Member", "States.", "<tag3>"], "wordsA": ["The", "centralized", "procedure,", "which", "is", "compulsory", "for", "medicines", "produced", "by", "biotechnology", "or", "those", "medicines", "intended", "to", "treat", "AIDS,", "cancer,", "neurodegenerative", "disorders", "or", "diabetes", "and", "is", "optional", "for", "those", "medicines", "that", "are", "highly", "innovative,", "provides", "for", "the", "grant", "of", "a", "single", "marketing", "authorization", "that", "is", "valid", "for", "all", "European", "Union", "member", "states."], "wordsB": ["The", "centralized", "procedure,", "which", "is", "compulsory", "for", "medicines", "produced", "by", "biotechnology", "or", "those", "medicines", "intended", "to", "treat", "AIDS,", "cancer,", "neurodegenerative", "disorders", "or", "diabetes", "and", "is", "optional", "for", "those", "medicines", "that", "are", "highly", "innovative,", "provides", "for", "the", "grant", "of", "a", "single", "marketing", "authorization", "that", "is", "valid", "for", "all", "EU", "Member", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013515532948076725, 0.0666101798415184, 0.06922673434019089, 0.029123853892087936, 0.05034270137548447, 0.28872430324554443, 0.055040594190359116, 0.08880292624235153, 0.04528019204735756, 0.03489561751484871, 0.059669721871614456, 0.029342250898480415, 0.02312386780977249, 0.037386614829301834, 0.0324699766933918, 0.032962970435619354, 0.032039739191532135, 0.040171194821596146, 0.031624987721443176, 0.05505359545350075, 0.04655010253190994, 0.021263273432850838, 0.03941241651773453, 0.0030310379806905985, 0.02767196297645569, 0.110990509390831, 0.03270723298192024, 0.024858321994543076, 0.06349772214889526, 0.024826375767588615, 0.036082152277231216, 0.06247198209166527, 0.044900696724653244, 0.025907745584845543, 0.027913615107536316, 0.02328888699412346, 0.020603962242603302, 0.024069061502814293, 0.02385043539106846, 0.03601943328976631, 0.03761506825685501, 0.042495083063840866, 0.02217993140220642, 0.024844709783792496, 0.033831775188446045, 0.032146863639354706, 0.057479001581668854, 0.5747469663619995, 0.2713417410850525, 0.2520017623901367, -1]}
{"idB": "749647_18_item1_p198_s0", "idA": "749647_17_item1_p181_s0", "sentA": "Under this procedure, the holder of a national marketing authorization may submit an application to the remaining member states.", "sentB": "The requirements for an application dossier for a biological product contain different aspects than that of a chemical medicinal product.", "type": 2, "words": ["<tag1>", "Under", "this", "procedure,", "the", "holder", "of", "a", "national", "marketing", "authorization", "may", "submit", "an", "application", "to", "the", "remaining", "member", "states.", "<tag2>", "The", "requirements", "for", "an", "application", "dossier", "for", "a", "biological", "product", "contain", "different", "aspects", "than", "that", "of", "a", "chemical", "medicinal", "product.", "<tag3>"], "wordsA": ["Under", "this", "procedure,", "the", "holder", "of", "a", "national", "marketing", "authorization", "may", "submit", "an", "application", "to", "the", "remaining", "member", "states."], "wordsB": ["The", "requirements", "for", "an", "application", "dossier", "for", "a", "biological", "product", "contain", "different", "aspects", "than", "that", "of", "a", "chemical", "medicinal", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013721345923841, 0.19408904016017914, 0.028314733877778053, 0.023471180349588394, 0.20294281840324402, 0.2611348032951355, 0.023468350991606712, 0.018604667857289314, 0.2548663914203644, 0.2953135371208191, 0.0682511106133461, 0.38449352979660034, 0.17768274247646332, 0.12145861238241196, 0.021671608090400696, 0.014712361618876457, 0.015713071450591087, 0.10280994325876236, 0.2044743001461029, 0.1667763590812683, -1]}
{"idB": "749647_18_item1_p201_s0", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "We may seek orphan designations for our product candidates.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "We", "may", "seek", "orphan", "designations", "for", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["We", "may", "seek", "orphan", "designations", "for", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10920760035514832, 0.1824633926153183, 0.3862481117248535, 0.8325471878051758, 0.6142551898956299, 0.028343791142106056, 0.01745673455297947, 0.04152637720108032, 0.04242613911628723, -1]}
{"idB": "749647_18_item1_p250_s1", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "We must comply with extensive, strictly enforced regulatory requirements to develop, obtain, and maintain marketing approval for any of our product candidates.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "We", "must", "comply", "with", "extensive,", "strictly", "enforced", "regulatory", "requirements", "to", "develop,", "obtain,", "and", "maintain", "marketing", "approval", "for", "any", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["We", "must", "comply", "with", "extensive,", "strictly", "enforced", "regulatory", "requirements", "to", "develop,", "obtain,", "and", "maintain", "marketing", "approval", "for", "any", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08043686300516129, 0.25575965642929077, 0.3761705160140991, 0.14693190157413483, 0.18853507936000824, 0.21314555406570435, 0.22832272946834564, 0.20942538976669312, 0.2909723222255707, 0.029804741963744164, 0.03614158555865288, 0.03107469528913498, 0.023731349036097527, 0.16270188987255096, 0.06923949718475342, 0.06920230388641357, 0.008157861419022083, 0.009580175392329693, 0.005351691041141748, 0.005259986501187086, 0.015569220297038555, 0.01535585056990385, -1]}
{"idB": "749647_18_item1_p255_s1", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "Failure to demonstrate adequately the quality, safety, and efficacy of any of our product candidates would delay or prevent marketing approval of the applicable product candidate.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "Failure", "to", "demonstrate", "adequately", "the", "quality,", "safety,", "and", "efficacy", "of", "any", "of", "our", "product", "candidates", "would", "delay", "or", "prevent", "marketing", "approval", "of", "the", "applicable", "product", "candidate.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["Failure", "to", "demonstrate", "adequately", "the", "quality,", "safety,", "and", "efficacy", "of", "any", "of", "our", "product", "candidates", "would", "delay", "or", "prevent", "marketing", "approval", "of", "the", "applicable", "product", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.30942195653915405, 0.2579890191555023, 0.3421578109264374, 0.29191988706588745, 0.06203802675008774, 0.13362877070903778, 0.12187705934047699, 0.07963266223669052, 0.12348202615976334, 0.015077834017574787, 0.019088124856352806, 0.012064117938280106, 0.01679934747517109, 0.042588990181684494, 0.045221131294965744, 0.02577926591038704, 0.21472986042499542, 0.07023441046476364, 0.168014258146286, 0.113750159740448, 0.10171761363744736, 0.014177616685628891, 0.009292076341807842, 0.026089390739798546, 0.041106216609478, 0.04900012165307999, -1]}
{"idB": "749647_18_item1_p278_s0", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "If any of our pending patent applications do not issue, or are deemed invalid following issuance, we may lose valuable intellectual property protection.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "If", "any", "of", "our", "pending", "patent", "applications", "do", "not", "issue,", "or", "are", "deemed", "invalid", "following", "issuance,", "we", "may", "lose", "valuable", "intellectual", "property", "protection.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["If", "any", "of", "our", "pending", "patent", "applications", "do", "not", "issue,", "or", "are", "deemed", "invalid", "following", "issuance,", "we", "may", "lose", "valuable", "intellectual", "property", "protection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04134858399629593, 0.08291111886501312, 0.020503384992480278, 0.033617131412029266, 0.14331965148448944, 0.35553720593452454, 0.3323212265968323, 0.12518523633480072, 0.17888137698173523, 0.08539550751447678, 0.0016321976436302066, 0.057380810379981995, 0.06113654747605324, 0.19994217157363892, 0.022470971569418907, 0.024722503498196602, 0.0003641290822997689, 0.034173786640167236, 0.08742254227399826, 0.044555533677339554, 0.07065434008836746, 0.08071866631507874, 0.11180496215820312, -1]}
{"idB": "749647_18_item1_p280_s0", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "We have filed patent applications, and plan to file additional patent applications, covering various aspects of our technologies and our proprietary product candidates.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "We", "have", "filed", "patent", "applications,", "and", "plan", "to", "file", "additional", "patent", "applications,", "covering", "various", "aspects", "of", "our", "technologies", "and", "our", "proprietary", "product", "candidates.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["We", "have", "filed", "patent", "applications,", "and", "plan", "to", "file", "additional", "patent", "applications,", "covering", "various", "aspects", "of", "our", "technologies", "and", "our", "proprietary", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08720752596855164, 0.13725902140140533, 0.6373669505119324, 0.48606234788894653, 0.5245926976203918, 0.011825941503047943, 0.13512252271175385, 0.10417821258306503, 0.1764025092124939, 0.102208711206913, 0.18441714346408844, 0.17343896627426147, 0.0038242656737565994, 0.011592328548431396, 0.013162780553102493, 0.004466225393116474, 0.004281382542103529, 0.015334704890847206, 0.004507673904299736, 0.003742967965081334, 0.02763681299984455, 0.01639392599463463, 0.013644804246723652, -1]}
{"idB": "749647_18_item1_p291_s0", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "We do not independently conduct clinical trials for our drug candidates.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "We", "do", "not", "independently", "conduct", "clinical", "trials", "for", "our", "drug", "candidates.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["We", "do", "not", "independently", "conduct", "clinical", "trials", "for", "our", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06640655547380447, 0.27120327949523926, 0.40640315413475037, 0.5693144202232361, 0.6824374794960022, 0.6511072516441345, 0.7255426049232483, 0.0328204408288002, 0.021595003083348274, 0.06546149402856827, 0.06457392126321793, -1]}
{"idB": "749647_18_item1_p295_s1", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "We do not own manufacturing facilities or supply sources for such components and materials.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "We", "do", "not", "own", "manufacturing", "facilities", "or", "supply", "sources", "for", "such", "components", "and", "materials.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["We", "do", "not", "own", "manufacturing", "facilities", "or", "supply", "sources", "for", "such", "components", "and", "materials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.055084727704524994, 0.42734313011169434, 0.6321220993995667, 0.7302877306938171, 0.21331487596035004, 0.2072758972644806, 0.04294098913669586, 0.3012447655200958, 0.2655129134654999, 0.03485516086220741, 0.04258004203438759, 0.09007137268781662, 0.05227489769458771, 0.0902186706662178, -1]}
{"idB": "749647_18_item1_p297_s2", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "Additional government regulation may be established that could prevent or delay regulatory approval of our product candidates.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "Additional", "government", "regulation", "may", "be", "established", "that", "could", "prevent", "or", "delay", "regulatory", "approval", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["Additional", "government", "regulation", "may", "be", "established", "that", "could", "prevent", "or", "delay", "regulatory", "approval", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.12916119396686554, 0.238467276096344, 0.3667672872543335, 0.04993295297026634, 0.027381667867302895, 0.07664601504802704, 0.00021207716781646013, 0.024312186986207962, 0.11210928857326508, 0.0643983706831932, 0.1401273012161255, 0.10984890908002853, 0.10380076617002487, 0.017521291971206665, 0.01613209955394268, 0.052542250603437424, 0.05095826834440231, -1]}
{"idB": "749647_18_item1_p329_s8", "idA": "749647_17_item1_p183_s0", "sentA": "We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates.", "sentB": "Further, we do not carry key man insurance on any of our personnel.", "type": 2, "words": ["<tag1>", "We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates.", "<tag2>", "Further,", "we", "do", "not", "carry", "key", "man", "insurance", "on", "any", "of", "our", "personnel.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "own", "or", "operate", "manufacturing", "facilities", "for", "the", "production", "of", "preclinical,", "clinical", "or", "commercial", "quantities", "of", "any", "of", "our", "product", "candidates."], "wordsB": ["Further,", "we", "do", "not", "carry", "key", "man", "insurance", "on", "any", "of", "our", "personnel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.044116415083408356, 0.07049232721328735, 0.2790878713130951, 0.4459196925163269, 0.6738941669464111, 0.5474109053611755, 0.7266051173210144, 0.8354758024215698, 0.070528045296669, 0.0769105851650238, 0.03243780881166458, 0.02790156565606594, 0.08550626039505005, -1]}
{"idB": "749647_18_item1_p235_s0", "idA": "749647_17_item1_p183_s1", "sentA": "We currently contract with third party contract manufacturing organizations (CMOs) for our preclinical and clinical trial supplies, and we expect to continue to do so to meet the preclinical and any clinical requirements of our product candidates.", "sentB": "We have a history of significant losses from operations and expect to continue to incur significant losses for the foreseeable future.", "type": 2, "words": ["<tag1>", "We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates.", "<tag2>", "We", "have", "a", "history", "of", "significant", "losses", "from", "operations", "and", "expect", "to", "continue", "to", "incur", "significant", "losses", "for", "the", "foreseeable", "future.", "<tag3>"], "wordsA": ["We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates."], "wordsB": ["We", "have", "a", "history", "of", "significant", "losses", "from", "operations", "and", "expect", "to", "continue", "to", "incur", "significant", "losses", "for", "the", "foreseeable", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.042269397526979446, 0.02191718854010105, 0.01594851352274418, 0.10943074524402618, 0.0371052548289299, 0.3709390461444855, 0.7463124990463257, 0.0595780573785305, 0.10316679626703262, 0.006857017055153847, 0.013315953314304352, 0.009994784370064735, 0.018110452219843864, 0.013631667010486126, 0.10369434952735901, 0.19599005579948425, 0.3588496744632721, 0.010241059586405754, 0.011862099170684814, 0.024170376360416412, 0.03248368576169014, -1]}
{"idB": "749647_18_item1_p291_s1", "idA": "749647_17_item1_p183_s1", "sentA": "We currently contract with third party contract manufacturing organizations (CMOs) for our preclinical and clinical trial supplies, and we expect to continue to do so to meet the preclinical and any clinical requirements of our product candidates.", "sentB": "We rely, and expect to continue to rely, on third-party clinical investigators, clinical research organizations (CROs), clinical data management organizations and consultants to design, conduct, supervise and monitor our clinical trials.", "type": 2, "words": ["<tag1>", "We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates.", "<tag2>", "We", "rely,", "and", "expect", "to", "continue", "to", "rely,", "on", "third-party", "clinical", "investigators,", "clinical", "research", "organizations", "(CROs),", "clinical", "data", "management", "organizations", "and", "consultants", "to", "design,", "conduct,", "supervise", "and", "monitor", "our", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates."], "wordsB": ["We", "rely,", "and", "expect", "to", "continue", "to", "rely,", "on", "third-party", "clinical", "investigators,", "clinical", "research", "organizations", "(CROs),", "clinical", "data", "management", "organizations", "and", "consultants", "to", "design,", "conduct,", "supervise", "and", "monitor", "our", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02923172153532505, 0.42045485973358154, 0.006783677265048027, 0.01623864285647869, 0.012193484231829643, 0.025810202583670616, 0.02634570002555847, 0.0920303538441658, 0.03422528877854347, 0.028800787404179573, 0.12373265624046326, 0.10575300455093384, 0.103385329246521, 0.19667504727840424, 0.0928722620010376, 0.1072625145316124, 0.17384648323059082, 0.37615641951560974, 0.344279408454895, 0.14921095967292786, 0.0069691892713308334, 0.07008161395788193, 0.017682604491710663, 0.06898082792758942, 0.06998546421527863, 0.1439359039068222, 0.07372333854436874, 0.171089306473732, 0.018327875062823296, 0.06300263851881027, 0.06674302369356155, -1]}
{"idB": "749647_18_item1_p295_s0", "idA": "749647_17_item1_p183_s1", "sentA": "We currently contract with third party contract manufacturing organizations (CMOs) for our preclinical and clinical trial supplies, and we expect to continue to do so to meet the preclinical and any clinical requirements of our product candidates.", "sentB": "We rely on third party supply and manufacturing partners to supply the materials and components for, and manufacture, our research and development, preclinical and clinical trial drug supplies.", "type": 2, "words": ["<tag1>", "We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates.", "<tag2>", "We", "rely", "on", "third", "party", "supply", "and", "manufacturing", "partners", "to", "supply", "the", "materials", "and", "components", "for,", "and", "manufacture,", "our", "research", "and", "development,", "preclinical", "and", "clinical", "trial", "drug", "supplies.", "<tag3>"], "wordsA": ["We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates."], "wordsB": ["We", "rely", "on", "third", "party", "supply", "and", "manufacturing", "partners", "to", "supply", "the", "materials", "and", "components", "for,", "and", "manufacture,", "our", "research", "and", "development,", "preclinical", "and", "clinical", "trial", "drug", "supplies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0425344817340374, 0.6020660400390625, 0.14145731925964355, 0.06936703622341156, 0.13455961644649506, 0.09082727134227753, 0.0321047343313694, 0.055237896740436554, 0.14249511063098907, 0.0703960582613945, 0.2564731240272522, 0.04964899271726608, 0.13228969275951385, 0.08140593022108078, 0.13785430788993835, 0.01684452034533024, 0.010778525844216347, 0.045335881412029266, 0.013103678822517395, 0.022506989538669586, 0.02861359715461731, 0.018330484628677368, 0.008287027478218079, 0.003058504546061158, 0.007891443558037281, 0.010575946420431137, 0.033534251153469086, 0.049937210977077484, -1]}
{"idB": "749647_18_item1_p318_s2", "idA": "749647_17_item1_p183_s1", "sentA": "We currently contract with third party contract manufacturing organizations (CMOs) for our preclinical and clinical trial supplies, and we expect to continue to do so to meet the preclinical and any clinical requirements of our product candidates.", "sentB": "Our testing and clinical practice may not confirm the safety and efficacy of our product candidates or even if further testing and clinical practice produce positive results, the medical community may view these new forms of treatment as effective and desirable or our efforts to market our new products may fail.", "type": 2, "words": ["<tag1>", "We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates.", "<tag2>", "Our", "testing", "and", "clinical", "practice", "may", "not", "confirm", "the", "safety", "and", "efficacy", "of", "our", "product", "candidates", "or", "even", "if", "further", "testing", "and", "clinical", "practice", "produce", "positive", "results,", "the", "medical", "community", "may", "view", "these", "new", "forms", "of", "treatment", "as", "effective", "and", "desirable", "or", "our", "efforts", "to", "market", "our", "new", "products", "may", "fail.", "<tag3>"], "wordsA": ["We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates."], "wordsB": ["Our", "testing", "and", "clinical", "practice", "may", "not", "confirm", "the", "safety", "and", "efficacy", "of", "our", "product", "candidates", "or", "even", "if", "further", "testing", "and", "clinical", "practice", "produce", "positive", "results,", "the", "medical", "community", "may", "view", "these", "new", "forms", "of", "treatment", "as", "effective", "and", "desirable", "or", "our", "efforts", "to", "market", "our", "new", "products", "may", "fail."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027808651328086853, 0.18054556846618652, 0.018724489957094193, 0.08430736511945724, 0.08419612050056458, 0.03239927068352699, 0.14821647107601166, 0.1927674263715744, 0.06923937052488327, 0.13142865896224976, 0.09556102752685547, 0.12744660675525665, 0.032082073390483856, 0.03398336470127106, 0.11928605288267136, 0.13374382257461548, 0.0030405367724597454, 0.00927063636481762, 0.019617317244410515, 0.07350943237543106, 0.11718685925006866, 0.012902295216917992, 0.05771880969405174, 0.04411208629608154, 0.05457596853375435, 0.10097715258598328, 0.045490894466638565, 0.010348389856517315, 0.07630027085542679, 0.09876514971256256, 0.016653697937726974, 0.045202113687992096, 0.015019325539469719, 0.04592198133468628, 0.05411534011363983, 0.04948100447654724, 0.08652791380882263, 0.024711228907108307, 0.06059580296278, 0.014683103188872337, 0.03653649240732193, 0.009686934761703014, 0.01192905381321907, 0.10533010214567184, 0.03078644722700119, 0.11586574465036392, 0.014487925916910172, 0.05526164174079895, 0.11635471135377884, 0.0512729287147522, 0.18750078976154327, -1]}
{"idB": "749647_18_item1_p339_s0", "idA": "749647_17_item1_p183_s1", "sentA": "We currently contract with third party contract manufacturing organizations (CMOs) for our preclinical and clinical trial supplies, and we expect to continue to do so to meet the preclinical and any clinical requirements of our product candidates.", "sentB": "The trading price for our common stock has been, and we expect it to continue to be, volatile.", "type": 2, "words": ["<tag1>", "We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates.", "<tag2>", "The", "trading", "price", "for", "our", "common", "stock", "has", "been,", "and", "we", "expect", "it", "to", "continue", "to", "be,", "volatile.", "<tag3>"], "wordsA": ["We", "currently", "contract", "with", "third", "party", "contract", "manufacturing", "organizations", "(CMOs)", "for", "our", "preclinical", "and", "clinical", "trial", "supplies,", "and", "we", "expect", "to", "continue", "to", "do", "so", "to", "meet", "the", "preclinical", "and", "any", "clinical", "requirements", "of", "our", "product", "candidates."], "wordsB": ["The", "trading", "price", "for", "our", "common", "stock", "has", "been,", "and", "we", "expect", "it", "to", "continue", "to", "be,", "volatile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.019484814256429672, 0.5482977628707886, 0.46651870012283325, 0.06635868549346924, 0.037227582186460495, 0.2909967601299286, 0.3179909884929657, 0.06438834965229034, 0.06674472242593765, 0.0036422989796847105, 0.009743094444274902, 0.011322835460305214, 0.00577749265357852, 0.010002884082496166, 0.02448391355574131, 0.0216472577303648, 0.05693286284804344, 0.5707318782806396, -1]}
{"idB": "749647_18_item1_p331_s2", "idA": "749647_17_item1_p183_s3", "sentA": "In addition, we believe that adequate alternative sources for such supplies exist.", "sentB": "In addition, we must effectively expand, train and manage our employees.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "believe", "that", "adequate", "alternative", "sources", "for", "such", "supplies", "exist.", "<tag2>", "In", "addition,", "we", "must", "effectively", "expand,", "train", "and", "manage", "our", "employees.", "<tag3>"], "wordsA": ["In", "addition,", "we", "believe", "that", "adequate", "alternative", "sources", "for", "such", "supplies", "exist."], "wordsB": ["In", "addition,", "we", "must", "effectively", "expand,", "train", "and", "manage", "our", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006305708549916744, 0.02050500363111496, 0.06477902829647064, 0.10217220336198807, 0.26655641198158264, 0.7506268620491028, 0.7527982592582703, 0.2886461019515991, 0.6692141890525818, 0.1417282074689865, 0.27306705713272095, -1]}
{"idB": "749647_18_item1_p233_s0", "idA": "749647_17_item1_p183_s4", "sentA": "However, there is a risk that, if supplies are interrupted, it would materially harm our business.", "sentB": "We are providing the following cautionary discussion of risk factors, uncertainties and assumptions that we believe are relevant to our business.", "type": 2, "words": ["<tag1>", "However,", "there", "is", "a", "risk", "that,", "if", "supplies", "are", "interrupted,", "it", "would", "materially", "harm", "our", "business.", "<tag2>", "We", "are", "providing", "the", "following", "cautionary", "discussion", "of", "risk", "factors,", "uncertainties", "and", "assumptions", "that", "we", "believe", "are", "relevant", "to", "our", "business.", "<tag3>"], "wordsA": ["However,", "there", "is", "a", "risk", "that,", "if", "supplies", "are", "interrupted,", "it", "would", "materially", "harm", "our", "business."], "wordsB": ["We", "are", "providing", "the", "following", "cautionary", "discussion", "of", "risk", "factors,", "uncertainties", "and", "assumptions", "that", "we", "believe", "are", "relevant", "to", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.041505616158246994, 0.010683593340218067, 0.10750306397676468, 0.030291598290205002, 0.10111486166715622, 0.4691329002380371, 0.4536673128604889, 0.03501030430197716, 0.1091030016541481, 0.0766308605670929, 0.15762238204479218, 0.057397108525037766, 0.2033127397298813, 0.008674624375998974, 0.010718211531639099, 0.00883539579808712, 0.01293127704411745, 0.03192321956157684, 0.02170996181666851, 0.021020010113716125, 0.05420481041073799, -1]}
{"idB": "749647_18_item1_p311_s0", "idA": "749647_17_item1_p183_s4", "sentA": "However, there is a risk that, if supplies are interrupted, it would materially harm our business.", "sentB": "Legislative and regulatory changes affecting the healthcare industry could adversely affect our business.", "type": 2, "words": ["<tag1>", "However,", "there", "is", "a", "risk", "that,", "if", "supplies", "are", "interrupted,", "it", "would", "materially", "harm", "our", "business.", "<tag2>", "Legislative", "and", "regulatory", "changes", "affecting", "the", "healthcare", "industry", "could", "adversely", "affect", "our", "business.", "<tag3>"], "wordsA": ["However,", "there", "is", "a", "risk", "that,", "if", "supplies", "are", "interrupted,", "it", "would", "materially", "harm", "our", "business."], "wordsB": ["Legislative", "and", "regulatory", "changes", "affecting", "the", "healthcare", "industry", "could", "adversely", "affect", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.38219329714775085, 0.17728298902511597, 0.2561356723308563, 0.512780487537384, 0.08263053745031357, 0.03178555890917778, 0.1824377328157425, 0.13035954535007477, 0.03886100649833679, 0.20310662686824799, 0.314572274684906, 0.05831363797187805, 0.10918943583965302, -1]}
{"idB": "749647_18_item1_p317_s0", "idA": "749647_17_item1_p183_s4", "sentA": "However, there is a risk that, if supplies are interrupted, it would materially harm our business.", "sentB": "Our products may not achieve sufficient acceptance by the medical community to sustain our business.", "type": 2, "words": ["<tag1>", "However,", "there", "is", "a", "risk", "that,", "if", "supplies", "are", "interrupted,", "it", "would", "materially", "harm", "our", "business.", "<tag2>", "Our", "products", "may", "not", "achieve", "sufficient", "acceptance", "by", "the", "medical", "community", "to", "sustain", "our", "business.", "<tag3>"], "wordsA": ["However,", "there", "is", "a", "risk", "that,", "if", "supplies", "are", "interrupted,", "it", "would", "materially", "harm", "our", "business."], "wordsB": ["Our", "products", "may", "not", "achieve", "sufficient", "acceptance", "by", "the", "medical", "community", "to", "sustain", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05186506733298302, 0.29978492856025696, 0.14524182677268982, 0.5025650858879089, 0.4177651107311249, 0.3611862361431122, 0.5956416130065918, 0.061954811215400696, 0.04082276299595833, 0.08385690301656723, 0.10158130526542664, 0.0533650740981102, 0.28318601846694946, 0.05302226543426514, 0.12542451918125153, -1]}
{"idB": "749647_18_item1_p269_s1", "idA": "749647_17_item1_p185_s0", "sentA": "Our CMOs manufacture our product candidates under current Good Manufacturing Practice (cGMP) conditions.", "sentB": "Accordingly, our revenue sources are, and will remain, extremely limited until our product candidates are clinically tested, approved by the FDA or foreign regulatory agencies and successfully marketed.", "type": 2, "words": ["<tag1>", "Our", "CMOs", "manufacture", "our", "product", "candidates", "under", "current", "Good", "Manufacturing", "Practice", "(cGMP)", "conditions.", "<tag2>", "Accordingly,", "our", "revenue", "sources", "are,", "and", "will", "remain,", "extremely", "limited", "until", "our", "product", "candidates", "are", "clinically", "tested,", "approved", "by", "the", "FDA", "or", "foreign", "regulatory", "agencies", "and", "successfully", "marketed.", "<tag3>"], "wordsA": ["Our", "CMOs", "manufacture", "our", "product", "candidates", "under", "current", "Good", "Manufacturing", "Practice", "(cGMP)", "conditions."], "wordsB": ["Accordingly,", "our", "revenue", "sources", "are,", "and", "will", "remain,", "extremely", "limited", "until", "our", "product", "candidates", "are", "clinically", "tested,", "approved", "by", "the", "FDA", "or", "foreign", "regulatory", "agencies", "and", "successfully", "marketed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.019989868625998497, 0.024399610236287117, 0.37289413809776306, 0.36095330119132996, 0.05700589716434479, 0.008204398676753044, 0.026958348229527473, 0.11337318271398544, 0.19391559064388275, 0.39761024713516235, 0.0159946046769619, 0.0116153908893466, 0.07588841766119003, 0.08552414178848267, 0.06319090723991394, 0.10145439207553864, 0.09077990800142288, 0.06700833141803741, 0.013096010312438011, 0.012675339356064796, 0.03328917175531387, 0.016883207485079765, 0.040293607860803604, 0.05237969756126404, 0.05421225354075432, 0.01080720778554678, 0.12651264667510986, 0.14734384417533875, -1]}
{"idB": "749647_18_item1_p260_s4", "idA": "749647_17_item1_p186_s0", "sentA": "Our current focus is on the development of our existing portfolio, the completion of clinical trials and, if and where appropriate, the registration of our product candidates.", "sentB": "Any increased scrutiny could delay or increase the costs of our product development efforts or clinical trials.", "type": 2, "words": ["<tag1>", "Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates.", "<tag2>", "Any", "increased", "scrutiny", "could", "delay", "or", "increase", "the", "costs", "of", "our", "product", "development", "efforts", "or", "clinical", "trials.", "<tag3>"], "wordsA": ["Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates."], "wordsB": ["Any", "increased", "scrutiny", "could", "delay", "or", "increase", "the", "costs", "of", "our", "product", "development", "efforts", "or", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.043047934770584106, 0.1753510683774948, 0.35748887062072754, 0.04305846616625786, 0.4215678870677948, 0.111672542989254, 0.21247883141040802, 0.10157188773155212, 0.382891446352005, 0.03496905788779259, 0.0372878760099411, 0.16431327164173126, 0.12171504646539688, 0.12284334003925323, 0.041333939880132675, 0.11599504202604294, 0.11394946277141571, -1]}
{"idB": "749647_18_item1_p262_s0", "idA": "749647_17_item1_p186_s0", "sentA": "Our current focus is on the development of our existing portfolio, the completion of clinical trials and, if and where appropriate, the registration of our product candidates.", "sentB": "Serious adverse events, undesirable side effects or other unexpected properties of our product candidates may be identified during development or after approval, which could lead to the discontinuation of our clinical development programs, refusal by regulatory authorities to approve our product candidates or, if discovered following marketing approval, revocation of marketing authorizations or limitations on the use of our product candidates thereby limiting the commercial potential of such product candidate.", "type": 2, "words": ["<tag1>", "Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates.", "<tag2>", "Serious", "adverse", "events,", "undesirable", "side", "effects", "or", "other", "unexpected", "properties", "of", "our", "product", "candidates", "may", "be", "identified", "during", "development", "or", "after", "approval,", "which", "could", "lead", "to", "the", "discontinuation", "of", "our", "clinical", "development", "programs,", "refusal", "by", "regulatory", "authorities", "to", "approve", "our", "product", "candidates", "or,", "if", "discovered", "following", "marketing", "approval,", "revocation", "of", "marketing", "authorizations", "or", "limitations", "on", "the", "use", "of", "our", "product", "candidates", "thereby", "limiting", "the", "commercial", "potential", "of", "such", "product", "candidate.", "<tag3>"], "wordsA": ["Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates."], "wordsB": ["Serious", "adverse", "events,", "undesirable", "side", "effects", "or", "other", "unexpected", "properties", "of", "our", "product", "candidates", "may", "be", "identified", "during", "development", "or", "after", "approval,", "which", "could", "lead", "to", "the", "discontinuation", "of", "our", "clinical", "development", "programs,", "refusal", "by", "regulatory", "authorities", "to", "approve", "our", "product", "candidates", "or,", "if", "discovered", "following", "marketing", "approval,", "revocation", "of", "marketing", "authorizations", "or", "limitations", "on", "the", "use", "of", "our", "product", "candidates", "thereby", "limiting", "the", "commercial", "potential", "of", "such", "product", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06831075251102448, 0.17033743858337402, 0.15719152987003326, 0.12204832583665848, 0.07430221885442734, 0.05817316100001335, 0.007685105316340923, 0.00843789242208004, 0.037915293127298355, 0.032185740768909454, 0.01285423245280981, 0.00893393810838461, 0.05126545578241348, 0.063421830534935, 0.006325114518404007, 0.005016711074858904, 0.019420718774199486, 0.030170634388923645, 0.05209360271692276, 0.0056318375281989574, 0.07265595346689224, 0.04140012338757515, 0.0004386980726849288, 0.006975989788770676, 0.006062809377908707, 0.006148692686110735, 0.010329942218959332, 0.15724104642868042, 0.029328977689146996, 0.016337070614099503, 0.1188124269247055, 0.11330665647983551, 0.06484733521938324, 0.04570325091481209, 0.008847823366522789, 0.02384202741086483, 0.035406604409217834, 0.04057740420103073, 0.06913992762565613, 0.020354386419057846, 0.06980941444635391, 0.07137301564216614, 0.003842852311208844, 0.007956664077937603, 0.011031570844352245, 0.016839781776070595, 0.011431485414505005, 0.01231008768081665, 0.10343541949987411, 0.03383970260620117, 0.09278538823127747, 0.09857477247714996, 0.015314621850848198, 0.13623012602329254, 0.02719370648264885, 0.020458785817027092, 0.05750488117337227, 0.020177610218524933, 0.01255358848720789, 0.05214419960975647, 0.060786981135606766, 0.0006160520133562386, 0.10331614315509796, 0.02142157033085823, 0.11738654971122742, 0.09279640763998032, 0.02614428848028183, 0.01336666289716959, 0.058762844651937485, 0.07427624613046646, -1]}
{"idB": "749647_18_item1_p263_s0", "idA": "749647_17_item1_p186_s0", "sentA": "Our current focus is on the development of our existing portfolio, the completion of clinical trials and, if and where appropriate, the registration of our product candidates.", "sentB": "As we continue our development of our product candidates and initiate clinical trials of our additional product candidates, serious adverse events, undesirable side effects or unexpected characteristics may emerge causing us to abandon these product candidates or limit their development to more narrow uses or subpopulations in which the serious adverse events, undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective.", "type": 2, "words": ["<tag1>", "Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates.", "<tag2>", "As", "we", "continue", "our", "development", "of", "our", "product", "candidates", "and", "initiate", "clinical", "trials", "of", "our", "additional", "product", "candidates,", "serious", "adverse", "events,", "undesirable", "side", "effects", "or", "unexpected", "characteristics", "may", "emerge", "causing", "us", "to", "abandon", "these", "product", "candidates", "or", "limit", "their", "development", "to", "more", "narrow", "uses", "or", "subpopulations", "in", "which", "the", "serious", "adverse", "events,", "undesirable", "side", "effects", "or", "other", "characteristics", "are", "less", "prevalent,", "less", "severe", "or", "more", "acceptable", "from", "a", "risk-benefit", "perspective.", "<tag3>"], "wordsA": ["Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates."], "wordsB": ["As", "we", "continue", "our", "development", "of", "our", "product", "candidates", "and", "initiate", "clinical", "trials", "of", "our", "additional", "product", "candidates,", "serious", "adverse", "events,", "undesirable", "side", "effects", "or", "unexpected", "characteristics", "may", "emerge", "causing", "us", "to", "abandon", "these", "product", "candidates", "or", "limit", "their", "development", "to", "more", "narrow", "uses", "or", "subpopulations", "in", "which", "the", "serious", "adverse", "events,", "undesirable", "side", "effects", "or", "other", "characteristics", "are", "less", "prevalent,", "less", "severe", "or", "more", "acceptable", "from", "a", "risk-benefit", "perspective."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00710664875805378, 0.025288622826337814, 0.09898728877305984, 0.08349374681711197, 0.1583711951971054, 0.03879484906792641, 0.03797090798616409, 0.07671976089477539, 0.10847993940114975, 0.006454203277826309, 0.124605692923069, 0.12904538214206696, 0.15209046006202698, 0.0059279161505401134, 0.009705065749585629, 0.06213734298944473, 0.062113672494888306, 0.06687615066766739, 0.008720003068447113, 0.0064264824613928795, 0.007480415049940348, 0.005208283197134733, 0.004540403373539448, 0.0048029921017587185, 0.0024117149878293276, 0.006723122671246529, 0.008591766469180584, 0.003949100151658058, 0.008819709531962872, 0.004582778085023165, 0.015917688608169556, 0.01652134209871292, 0.48268651962280273, 0.04754490405321121, 0.19594979286193848, 0.27793219685554504, 0.00039389857556670904, 0.026133332401514053, 0.014839858748018742, 0.08456467092037201, 0.005540771875530481, 0.007304497063159943, 0.0210651196539402, 0.030567152425646782, 0.004841780290007591, 0.01574990712106228, 0.0004642247804440558, 0.004281043540686369, 0.0036336949560791254, 0.00581215089187026, 0.004347709007561207, 0.0065370406955480576, 0.010633963160216808, 0.010306705720722675, 0.008665977045893669, 0.003967852331697941, 0.005152718164026737, 0.013822260312736034, 0.01568828895688057, 0.2108098566532135, 0.07718650251626968, 0.2147504687309265, 0.11795563250780106, 0.0004591595206875354, 0.06122291460633278, 0.030029255896806717, 0.006901474669575691, 0.007880967110395432, 0.04796753078699112, 0.019252726808190346, -1]}
{"idB": "749647_18_item1_p323_s6", "idA": "749647_17_item1_p186_s0", "sentA": "Our current focus is on the development of our existing portfolio, the completion of clinical trials and, if and where appropriate, the registration of our product candidates.", "sentB": "If the FDA does not accept the data from such clinical trials, it would likely result in the need for additional trials, which would be costly and time-consuming and delay or permanently halt our development of our product candidates.", "type": 2, "words": ["<tag1>", "Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates.", "<tag2>", "If", "the", "FDA", "does", "not", "accept", "the", "data", "from", "such", "clinical", "trials,", "it", "would", "likely", "result", "in", "the", "need", "for", "additional", "trials,", "which", "would", "be", "costly", "and", "time-consuming", "and", "delay", "or", "permanently", "halt", "our", "development", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates."], "wordsB": ["If", "the", "FDA", "does", "not", "accept", "the", "data", "from", "such", "clinical", "trials,", "it", "would", "likely", "result", "in", "the", "need", "for", "additional", "trials,", "which", "would", "be", "costly", "and", "time-consuming", "and", "delay", "or", "permanently", "halt", "our", "development", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02116836979985237, 0.011286146938800812, 0.0665230080485344, 0.12949438393115997, 0.30708858370780945, 0.3323943316936493, 0.2165229320526123, 0.3733075261116028, 0.0708090141415596, 0.0715387612581253, 0.1378191113471985, 0.1412028968334198, 0.0002003291592700407, 0.008436906151473522, 0.009118525311350822, 0.007056484464555979, 0.005224366672337055, 0.01052772905677557, 0.03736429288983345, 0.023999741300940514, 0.1180998831987381, 0.1813143491744995, 0.00013625845895148814, 0.007570008747279644, 0.006118769757449627, 0.009867850691080093, 0.007306031882762909, 0.014175677672028542, 0.006085480097681284, 0.036558907479047775, 0.01062088180333376, 0.02002607099711895, 0.3983100950717926, 0.037397630512714386, 0.18242886662483215, 0.03581948205828667, 0.021579595282673836, 0.06347480416297913, 0.08497179299592972, -1]}
{"idB": "749647_18_item1_p337_s3", "idA": "749647_17_item1_p186_s0", "sentA": "Our current focus is on the development of our existing portfolio, the completion of clinical trials and, if and where appropriate, the registration of our product candidates.", "sentB": "To the extent that any disruption or privacy or security breach were to result in a loss of, or damage to, our data, or inappropriate disclosure of confidential or proprietary information, we could be subject to reputational harm, monetary fines, civil suits, civil penalties or criminal sanctions and requirements to disclose the breach, and other forms of liability and the development of our product candidates could be delayed.", "type": 2, "words": ["<tag1>", "Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates.", "<tag2>", "To", "the", "extent", "that", "any", "disruption", "or", "privacy", "or", "security", "breach", "were", "to", "result", "in", "a", "loss", "of,", "or", "damage", "to,", "our", "data,", "or", "inappropriate", "disclosure", "of", "confidential", "or", "proprietary", "information,", "we", "could", "be", "subject", "to", "reputational", "harm,", "monetary", "fines,", "civil", "suits,", "civil", "penalties", "or", "criminal", "sanctions", "and", "requirements", "to", "disclose", "the", "breach,", "and", "other", "forms", "of", "liability", "and", "the", "development", "of", "our", "product", "candidates", "could", "be", "delayed.", "<tag3>"], "wordsA": ["Our", "current", "focus", "is", "on", "the", "development", "of", "our", "existing", "portfolio,", "the", "completion", "of", "clinical", "trials", "and,", "if", "and", "where", "appropriate,", "the", "registration", "of", "our", "product", "candidates."], "wordsB": ["To", "the", "extent", "that", "any", "disruption", "or", "privacy", "or", "security", "breach", "were", "to", "result", "in", "a", "loss", "of,", "or", "damage", "to,", "our", "data,", "or", "inappropriate", "disclosure", "of", "confidential", "or", "proprietary", "information,", "we", "could", "be", "subject", "to", "reputational", "harm,", "monetary", "fines,", "civil", "suits,", "civil", "penalties", "or", "criminal", "sanctions", "and", "requirements", "to", "disclose", "the", "breach,", "and", "other", "forms", "of", "liability", "and", "the", "development", "of", "our", "product", "candidates", "could", "be", "delayed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016641316935420036, 0.03466900438070297, 0.02154138684272766, 0.013671468943357468, 0.048504091799259186, 0.06014106050133705, 0.03780674934387207, 0.06351056694984436, 0.030382957309484482, 0.05463327839970589, 0.06810105592012405, 0.010105139575898647, 0.007972502149641514, 0.00786991324275732, 0.00751062436029315, 0.00903193186968565, 0.052105020731687546, 0.043573830276727676, 0.011907996609807014, 0.04912341758608818, 0.024913480505347252, 0.03790871053934097, 0.1457156389951706, 0.004416107665747404, 0.020121579989790916, 0.03853762522339821, 0.01324018556624651, 0.03388935700058937, 0.010156764648854733, 0.02561403252184391, 0.06569691747426987, 0.009096784517168999, 0.009437644854187965, 0.016061797738075256, 0.013608022592961788, 0.011332694441080093, 0.0314648374915123, 0.021486278623342514, 0.02862779051065445, 0.07162422686815262, 0.07250647246837616, 0.06276341527700424, 0.05016491934657097, 0.040049392729997635, 0.010075998492538929, 0.02118055522441864, 0.03134891390800476, 0.00045831469469703734, 0.02285703644156456, 0.012368538416922092, 0.01757887564599514, 0.016561228781938553, 0.028505662456154823, 0.0011002508690580726, 0.00743807852268219, 0.020807014778256416, 0.0139569491147995, 0.021064914762973785, 0.008480843156576157, 0.0124624939635396, 0.14654231071472168, 0.03049003891646862, 0.02048790454864502, 0.08646062016487122, 0.10286625474691391, 0.029276421293616295, 0.0740470439195633, 0.26414188742637634, -1]}
{"idB": "749647_18_item1_p325_s0", "idA": "749647_17_item1_p186_s1", "sentA": "We currently do not have marketing, sales and distribution capabilities.", "sentB": "We currently have no sales, marketing or distribution capabilities.", "type": 2, "words": ["<tag1>", "We", "currently", "do", "not", "have", "marketing,", "sales", "and", "distribution", "capabilities.", "<tag2>", "We", "currently", "have", "no", "sales,", "marketing", "or", "distribution", "capabilities.", "<tag3>"], "wordsA": ["We", "currently", "do", "not", "have", "marketing,", "sales", "and", "distribution", "capabilities."], "wordsB": ["We", "currently", "have", "no", "sales,", "marketing", "or", "distribution", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.046088628470897675, 0.07417106628417969, 0.3841594159603119, 0.9857217073440552, 0.845639169216156, 0.04573005437850952, 0.018639307469129562, 0.028700683265924454, 0.12209372222423553, -1]}
{"idB": "749647_18_item1_p323_s3", "idA": "749647_17_item1_p186_s2", "sentA": "If we receive marketing and commercialization approval for any of our product candidates, we intend to market the product either directly or through strategic alliances and distribution agreements with third parties.", "sentB": "In general, the patient population for any clinical trials conducted outside of the United States must be representative of the population for whom we intend to label the product in the United States.", "type": 2, "words": ["<tag1>", "If", "we", "receive", "marketing", "and", "commercialization", "approval", "for", "any", "of", "our", "product", "candidates,", "we", "intend", "to", "market", "the", "product", "either", "directly", "or", "through", "strategic", "alliances", "and", "distribution", "agreements", "with", "third", "parties.", "<tag2>", "In", "general,", "the", "patient", "population", "for", "any", "clinical", "trials", "conducted", "outside", "of", "the", "United", "States", "must", "be", "representative", "of", "the", "population", "for", "whom", "we", "intend", "to", "label", "the", "product", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["If", "we", "receive", "marketing", "and", "commercialization", "approval", "for", "any", "of", "our", "product", "candidates,", "we", "intend", "to", "market", "the", "product", "either", "directly", "or", "through", "strategic", "alliances", "and", "distribution", "agreements", "with", "third", "parties."], "wordsB": ["In", "general,", "the", "patient", "population", "for", "any", "clinical", "trials", "conducted", "outside", "of", "the", "United", "States", "must", "be", "representative", "of", "the", "population", "for", "whom", "we", "intend", "to", "label", "the", "product", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07582392543554306, 0.060617845505476, 0.0374143011868, 0.5228840708732605, 0.5740731954574585, 0.032437410205602646, 0.023057589307427406, 0.1917661875486374, 0.19034776091575623, 0.0243991632014513, 0.09856577217578888, 0.04954398423433304, 0.04499753564596176, 0.060238420963287354, 0.09801113605499268, 0.04130205884575844, 0.03887604922056198, 0.1365499645471573, 0.04218349605798721, 0.02365654706954956, 0.1020895317196846, 0.015172425657510757, 0.005633285269141197, 0.009827915579080582, 0.01451965980231762, 0.014476350508630276, 0.12915492057800293, 0.029118161648511887, 0.07968908548355103, 0.013087242841720581, 0.009919957257807255, 0.01907227747142315, 0.026646941900253296, -1]}
{"idB": "749647_18_item1_p325_s1", "idA": "749647_17_item1_p186_s2", "sentA": "If we receive marketing and commercialization approval for any of our product candidates, we intend to market the product either directly or through strategic alliances and distribution agreements with third parties.", "sentB": "We intend to market our products, if and when such products are approved for commercialization by the FDA and foreign regulatory agencies, either directly or through other strategic alliances and distribution arrangements with third parties.", "type": 2, "words": ["<tag1>", "If", "we", "receive", "marketing", "and", "commercialization", "approval", "for", "any", "of", "our", "product", "candidates,", "we", "intend", "to", "market", "the", "product", "either", "directly", "or", "through", "strategic", "alliances", "and", "distribution", "agreements", "with", "third", "parties.", "<tag2>", "We", "intend", "to", "market", "our", "products,", "if", "and", "when", "such", "products", "are", "approved", "for", "commercialization", "by", "the", "FDA", "and", "foreign", "regulatory", "agencies,", "either", "directly", "or", "through", "other", "strategic", "alliances", "and", "distribution", "arrangements", "with", "third", "parties.", "<tag3>"], "wordsA": ["If", "we", "receive", "marketing", "and", "commercialization", "approval", "for", "any", "of", "our", "product", "candidates,", "we", "intend", "to", "market", "the", "product", "either", "directly", "or", "through", "strategic", "alliances", "and", "distribution", "agreements", "with", "third", "parties."], "wordsB": ["We", "intend", "to", "market", "our", "products,", "if", "and", "when", "such", "products", "are", "approved", "for", "commercialization", "by", "the", "FDA", "and", "foreign", "regulatory", "agencies,", "either", "directly", "or", "through", "other", "strategic", "alliances", "and", "distribution", "arrangements", "with", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02859722077846527, 0.08822058886289597, 0.08905968815088272, 0.5327358841896057, 0.2783779501914978, 0.3403640687465668, 0.07315423339605331, 0.07476043701171875, 0.03480114787817001, 0.06188565865159035, 0.18340660631656647, 0.09153129160404205, 0.0958562046289444, 0.02336946502327919, 0.03207112103700638, 0.009361871518194675, 0.012869840487837791, 0.03920615091919899, 0.015586163848638535, 0.03524605184793472, 0.044589389115571976, 0.06937026977539062, 0.01421702466905117, 0.019982976838946342, 0.009870419278740883, 0.006903583183884621, 0.005520759616047144, 0.018685469403862953, 0.02828020043671131, 0.006735488772392273, 0.028917495161294937, 0.03546140342950821, 0.01832045055925846, 0.041093550622463226, 0.04770423471927643, -1]}
{"idB": "749647_18_item1_p293_s2", "idA": "749647_17_item1_p186_s3", "sentA": "The ultimate implementation of our strategy for realizing the financial value of our product candidates is dependent on the results of clinical trials for our product candidates, the availability of regulatory approvals and the ability to negotiate acceptable commercial terms with third parties.", "sentB": "We also are required to register ongoing clinical trials and post the results of completed clinical trials on a government-sponsored database , ClinicalTrials.gov , within certain timeframes.", "type": 2, "words": ["<tag1>", "The", "ultimate", "implementation", "of", "our", "strategy", "for", "realizing", "the", "financial", "value", "of", "our", "product", "candidates", "is", "dependent", "on", "the", "results", "of", "clinical", "trials", "for", "our", "product", "candidates,", "the", "availability", "of", "regulatory", "approvals", "and", "the", "ability", "to", "negotiate", "acceptable", "commercial", "terms", "with", "third", "parties.", "<tag2>", "We", "also", "are", "required", "to", "register", "ongoing", "clinical", "trials", "and", "post", "the", "results", "of", "completed", "clinical", "trials", "on", "a", "government-sponsored", "database", ",", "ClinicalTrials.gov", ",", "within", "certain", "timeframes.", "<tag3>"], "wordsA": ["The", "ultimate", "implementation", "of", "our", "strategy", "for", "realizing", "the", "financial", "value", "of", "our", "product", "candidates", "is", "dependent", "on", "the", "results", "of", "clinical", "trials", "for", "our", "product", "candidates,", "the", "availability", "of", "regulatory", "approvals", "and", "the", "ability", "to", "negotiate", "acceptable", "commercial", "terms", "with", "third", "parties."], "wordsB": ["We", "also", "are", "required", "to", "register", "ongoing", "clinical", "trials", "and", "post", "the", "results", "of", "completed", "clinical", "trials", "on", "a", "government-sponsored", "database", ",", "ClinicalTrials.gov", ",", "within", "certain", "timeframes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03522835671901703, 0.009357999078929424, 0.009533691219985485, 0.19299402832984924, 0.08198027312755585, 0.29876482486724854, 0.20775072276592255, 0.2477225959300995, 0.23984389007091522, 0.007718204986304045, 0.1509794443845749, 0.020428920164704323, 0.05456213280558586, 0.009626012295484543, 0.2596796751022339, 0.1770855337381363, 0.17847119271755219, 0.014731395058333874, 0.013979155570268631, 0.0767381489276886, 0.11425693333148956, 9.339246025774628e-05, 0.13757377862930298, 7.820232713129371e-05, 0.007661530282348394, 0.025265932083129883, 0.04476932808756828, -1]}
{"idB": "749647_18_item1_p320_s0", "idA": "749647_17_item1_p186_s3", "sentA": "The ultimate implementation of our strategy for realizing the financial value of our product candidates is dependent on the results of clinical trials for our product candidates, the availability of regulatory approvals and the ability to negotiate acceptable commercial terms with third parties.", "sentB": "It is very difficult to predict the commercial potential of product candidates due to important factors such as safety and efficacy compared to other available treatments, including potential generic drug alternatives with similar efficacy profiles, changing standards of care, third party payor reimbursement standards, patient and physician preferences, the availability of competitive alternatives that may emerge either during the long drug development process or after commercial introduction, and the availability of generic versions of our successful product candidates following approval by government health authorities based on the expiration of regulatory exclusivity or our inability to prevent generic versions from coming to market by asserting our patents.", "type": 2, "words": ["<tag1>", "The", "ultimate", "implementation", "of", "our", "strategy", "for", "realizing", "the", "financial", "value", "of", "our", "product", "candidates", "is", "dependent", "on", "the", "results", "of", "clinical", "trials", "for", "our", "product", "candidates,", "the", "availability", "of", "regulatory", "approvals", "and", "the", "ability", "to", "negotiate", "acceptable", "commercial", "terms", "with", "third", "parties.", "<tag2>", "It", "is", "very", "difficult", "to", "predict", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payor", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents.", "<tag3>"], "wordsA": ["The", "ultimate", "implementation", "of", "our", "strategy", "for", "realizing", "the", "financial", "value", "of", "our", "product", "candidates", "is", "dependent", "on", "the", "results", "of", "clinical", "trials", "for", "our", "product", "candidates,", "the", "availability", "of", "regulatory", "approvals", "and", "the", "ability", "to", "negotiate", "acceptable", "commercial", "terms", "with", "third", "parties."], "wordsB": ["It", "is", "very", "difficult", "to", "predict", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payor", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005768494680523872, 0.008241458795964718, 0.019682224839925766, 0.020462047308683395, 0.026656461879611015, 0.07216916978359222, 0.00858691893517971, 0.06010934337973595, 0.016221297904849052, 0.006377071607857943, 0.02618440054357052, 0.03773636743426323, 0.0013452465645968914, 0.0036424719728529453, 0.004076891113072634, 0.005092333536595106, 0.004723168443888426, 0.005379179026931524, 0.008793734945356846, 0.009701671078801155, 0.007585600949823856, 0.005467337556183338, 0.0052203284576535225, 0.004124438390135765, 0.008814524859189987, 0.01258155982941389, 0.008352247066795826, 0.006585134658962488, 0.02072678506374359, 0.019830355420708656, 0.01636398956179619, 0.007277590222656727, 0.013230196200311184, 0.03369061276316643, 0.022252250462770462, 0.038670942187309265, 0.06431303918361664, 0.028284572064876556, 0.030573470517992973, 0.011457297950983047, 0.034016821533441544, 0.08434245735406876, 0.1395834982395172, 0.10039930045604706, 0.11649253964424133, 0.053813185542821884, 0.14663362503051758, 0.08576151728630066, 0.005312204826623201, 0.02405499666929245, 0.008430685847997665, 0.3547116219997406, 0.37851598858833313, 0.0030245406087487936, 0.006393849849700928, 0.014598725363612175, 0.008085676468908787, 0.008786685764789581, 0.007671977858990431, 0.0467536598443985, 0.05140439420938492, 0.036633580923080444, 0.04748258367180824, 0.0012217945186421275, 0.10525692999362946, 0.07298006117343903, 0.02455906756222248, 0.0072594303637743, 0.01624496653676033, 0.021706292405724525, 0.004850698634982109, 0.06914235651493073, 0.08463239669799805, 0.004223176743835211, 0.00664454884827137, 0.04761156439781189, 0.05540228635072708, 0.04369363188743591, 0.017227189615368843, 0.026709940284490585, 0.006560553330928087, 0.01911894977092743, 0.02643606811761856, 0.036311469972133636, 0.002087752567604184, 0.0036483677104115486, 0.002661831444129348, 0.006511573679745197, 0.004842853639274836, 0.014206964522600174, 0.012493540532886982, 0.0021025524474680424, 0.005186818540096283, 0.013508311472833157, 0.014350789599120617, 0.008074580691754818, 0.0442388541996479, 0.0457744374871254, 0.01623900793492794, 0.019072161987423897, 0.026042018085718155, 0.03425784781575203, 0.007321672514081001, 0.07663699239492416, 0.011119694449007511, 0.07930241525173187, -1]}
{"idB": "749647_18_item1_p192_s0", "idA": "749647_17_item1_p187_s0", "sentA": "Our business exposes us to potential product liability risks that are inherent in the testing, manufacturing and marketing of human therapeutic products.", "sentB": "From time to time, legislation is drafted, introduced and passed in Congress that could significantly change the statutory provisions governing the testing, approval, manufacturing and marketing of products regulated by the FDA.", "type": 2, "words": ["<tag1>", "Our", "business", "exposes", "us", "to", "potential", "product", "liability", "risks", "that", "are", "inherent", "in", "the", "testing,", "manufacturing", "and", "marketing", "of", "human", "therapeutic", "products.", "<tag2>", "From", "time", "to", "time,", "legislation", "is", "drafted,", "introduced", "and", "passed", "in", "Congress", "that", "could", "significantly", "change", "the", "statutory", "provisions", "governing", "the", "testing,", "approval,", "manufacturing", "and", "marketing", "of", "products", "regulated", "by", "the", "FDA.", "<tag3>"], "wordsA": ["Our", "business", "exposes", "us", "to", "potential", "product", "liability", "risks", "that", "are", "inherent", "in", "the", "testing,", "manufacturing", "and", "marketing", "of", "human", "therapeutic", "products."], "wordsB": ["From", "time", "to", "time,", "legislation", "is", "drafted,", "introduced", "and", "passed", "in", "Congress", "that", "could", "significantly", "change", "the", "statutory", "provisions", "governing", "the", "testing,", "approval,", "manufacturing", "and", "marketing", "of", "products", "regulated", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022738991305232048, 0.01692267879843712, 0.015504192560911179, 0.01855291984975338, 0.3966740667819977, 0.03162945806980133, 0.1480882167816162, 0.0704345554113388, 0.06001247093081474, 0.08902717381715775, 0.0951383039355278, 0.18347977101802826, 0.0006890590884722769, 0.02099141664803028, 0.041887737810611725, 0.0802745595574379, 0.013579709455370903, 0.16055741906166077, 0.10812879353761673, 0.01153433509171009, 0.009495027363300323, 0.024244436994194984, 0.009976259432733059, 0.01284330990165472, 0.004641687497496605, 0.012004385702311993, 0.007924779318273067, 0.04101204127073288, 0.02046363428235054, 0.01465518306940794, 0.02499377727508545, 0.05968276783823967, -1]}
{"idB": "749647_18_item1_p335_s0", "idA": "749647_17_item1_p187_s0", "sentA": "Our business exposes us to potential product liability risks that are inherent in the testing, manufacturing and marketing of human therapeutic products.", "sentB": "Our business exposes us to potential product liability risks inherent in the testing, manufacturing and marketing of human therapeutic products.", "type": 2, "words": ["<tag1>", "Our", "business", "exposes", "us", "to", "potential", "product", "liability", "risks", "that", "are", "inherent", "in", "the", "testing,", "manufacturing", "and", "marketing", "of", "human", "therapeutic", "products.", "<tag2>", "Our", "business", "exposes", "us", "to", "potential", "product", "liability", "risks", "inherent", "in", "the", "testing,", "manufacturing", "and", "marketing", "of", "human", "therapeutic", "products.", "<tag3>"], "wordsA": ["Our", "business", "exposes", "us", "to", "potential", "product", "liability", "risks", "that", "are", "inherent", "in", "the", "testing,", "manufacturing", "and", "marketing", "of", "human", "therapeutic", "products."], "wordsB": ["Our", "business", "exposes", "us", "to", "potential", "product", "liability", "risks", "inherent", "in", "the", "testing,", "manufacturing", "and", "marketing", "of", "human", "therapeutic", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11574605852365494, 0.48206615447998047, 0.518142819404602, 0.21801918745040894, 0.07026169449090958, 0.10721997171640396, 0.18391098082065582, 0.16741062700748444, 0.15149462223052979, 0.07559742033481598, 0.04728015139698982, 0.035935353487730026, 0.12908345460891724, 0.08617443591356277, 0.043332163244485855, 0.05630836263298988, 0.0409996397793293, 0.06319104880094528, 0.102699413895607, 0.09117186814546585, -1]}
{"idB": "749647_18_item1_p260_s0", "idA": "749647_17_item1_p187_s1", "sentA": "We presently have product liability insurance limited to $10 million per incident, and if we were to be subject to a claim in excess of this coverage or to a claim not covered by our insurance and the claim succeeded, we would be required to pay the claim out of our own limited resources.", "sentB": "For example, i f we were to engage an NIH-funded institution to conduct a clinical trial, we may be subject to review by the NIH Office of Biotechnology Activities Recombinant DNA Advisory Committee (the RAC).", "type": 2, "words": ["<tag1>", "We", "presently", "have", "product", "liability", "insurance", "limited", "to", "$10", "million", "per", "incident,", "and", "if", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "out", "of", "our", "own", "limited", "resources.", "<tag2>", "For", "example,", "i", "f", "we", "were", "to", "engage", "an", "NIH-funded", "institution", "to", "conduct", "a", "clinical", "trial,", "we", "may", "be", "subject", "to", "review", "by", "the", "NIH", "Office", "of", "Biotechnology", "Activities", "Recombinant", "DNA", "Advisory", "Committee", "(the", "RAC).", "<tag3>"], "wordsA": ["We", "presently", "have", "product", "liability", "insurance", "limited", "to", "$10", "million", "per", "incident,", "and", "if", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "out", "of", "our", "own", "limited", "resources."], "wordsB": ["For", "example,", "i", "f", "we", "were", "to", "engage", "an", "NIH-funded", "institution", "to", "conduct", "a", "clinical", "trial,", "we", "may", "be", "subject", "to", "review", "by", "the", "NIH", "Office", "of", "Biotechnology", "Activities", "Recombinant", "DNA", "Advisory", "Committee", "(the", "RAC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.019915390759706497, 0.02867589145898819, 0.02753639407455921, 0.04159057140350342, 0.041050683706998825, 0.037589896470308304, 0.04396838694810867, 0.26805219054222107, 0.05836263298988342, 0.20811106264591217, 0.17654986679553986, 0.02993682399392128, 0.13484224677085876, 0.09797940403223038, 0.21776527166366577, 0.3563745617866516, 0.007798092905431986, 0.024185936897993088, 0.013076801784336567, 0.05555730685591698, 0.07302647829055786, 0.20329800248146057, 0.02641211822628975, 0.023467672988772392, 0.06509456783533096, 0.08127748966217041, 0.0504445880651474, 0.08330319821834564, 0.10703790932893753, 0.2829669415950775, 0.3925119936466217, 0.16653499007225037, 0.22992876172065735, 0.03665361553430557, 0.2053723782300949, -1]}
{"idB": "749647_18_item1_p335_s1", "idA": "749647_17_item1_p187_s1", "sentA": "We presently have product liability insurance limited to $10 million per incident, and if we were to be subject to a claim in excess of this coverage or to a claim not covered by our insurance and the claim succeeded, we would be required to pay the claim out of our own limited resources.", "sentB": "We presently have product liability insurance limited to $10 million per incident and $10 million annually.", "type": 2, "words": ["<tag1>", "We", "presently", "have", "product", "liability", "insurance", "limited", "to", "$10", "million", "per", "incident,", "and", "if", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "out", "of", "our", "own", "limited", "resources.", "<tag2>", "We", "presently", "have", "product", "liability", "insurance", "limited", "to", "$10", "million", "per", "incident", "and", "$10", "million", "annually.", "<tag3>"], "wordsA": ["We", "presently", "have", "product", "liability", "insurance", "limited", "to", "$10", "million", "per", "incident,", "and", "if", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "out", "of", "our", "own", "limited", "resources."], "wordsB": ["We", "presently", "have", "product", "liability", "insurance", "limited", "to", "$10", "million", "per", "incident", "and", "$10", "million", "annually."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006854166276752949, 0.007461899891495705, 0.0034696715883910656, 0.01357340719550848, 0.023651573807001114, 0.0342123880982399, 0.05973123386502266, 0.014071074314415455, 0.9673587083816528, 0.48984208703041077, 0.04136928543448448, 0.048494450747966766, 0.0021389552857726812, 0.06853414326906204, 0.14124907553195953, 0.3558376133441925, -1]}
{"idB": "749647_18_item1_p335_s2", "idA": "749647_17_item1_p187_s1", "sentA": "We presently have product liability insurance limited to $10 million per incident, and if we were to be subject to a claim in excess of this coverage or to a claim not covered by our insurance and the claim succeeded, we would be required to pay the claim out of our own limited resources.", "sentB": "If we were to be subject to a claim in excess of this coverage or to a claim not covered by our insurance and the claim succeeded, we would be required to pay the claim with our own limited resources, which could have a severe adverse effect on our business.", "type": 2, "words": ["<tag1>", "We", "presently", "have", "product", "liability", "insurance", "limited", "to", "$10", "million", "per", "incident,", "and", "if", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "out", "of", "our", "own", "limited", "resources.", "<tag2>", "If", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "with", "our", "own", "limited", "resources,", "which", "could", "have", "a", "severe", "adverse", "effect", "on", "our", "business.", "<tag3>"], "wordsA": ["We", "presently", "have", "product", "liability", "insurance", "limited", "to", "$10", "million", "per", "incident,", "and", "if", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "out", "of", "our", "own", "limited", "resources."], "wordsB": ["If", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "with", "our", "own", "limited", "resources,", "which", "could", "have", "a", "severe", "adverse", "effect", "on", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009963301941752434, 0.01938580721616745, 0.02022547833621502, 0.013971591368317604, 0.014003606513142586, 0.06165168434381485, 0.03844496235251427, 0.022556383162736893, 0.10133323818445206, 0.031676653772592545, 0.10113000869750977, 0.017807524651288986, 0.02410641871392727, 0.057055335491895676, 0.0053682406432926655, 0.004140148870646954, 0.0045278496108949184, 0.03176838532090187, 0.1299341470003128, 0.038581013679504395, 0.008205663412809372, 0.016048971563577652, 0.050034958869218826, 0.005384881980717182, 0.005037461407482624, 0.04037860780954361, 0.13920170068740845, 0.006646103225648403, 0.005601994693279266, 0.005829798057675362, 0.01554383710026741, 0.015500613488256931, 0.055652160197496414, 0.030439071357250214, 0.15540091693401337, 0.07965856045484543, 0.18858475983142853, 0.2556707561016083, 0.21963271498680115, 0.11308259516954422, 0.00023135596711654216, 0.008243224583566189, 0.008056418970227242, 0.007001991383731365, 0.02338140271604061, 0.0371008962392807, 0.020606139674782753, 0.013418832793831825, 0.018785644322633743, 0.05763082206249237, -1]}
{"idB": "749647_18_item1_p327_s0", "idA": "749647_17_item1_p188_s0", "sentA": "Competition in the discovery and development of new methods for treating and preventing disease is intense.", "sentB": "Various methods for treating cancer currently are, and in the future, are expected to be, the subject of extensive research and development.", "type": 2, "words": ["<tag1>", "Competition", "in", "the", "discovery", "and", "development", "of", "new", "methods", "for", "treating", "and", "preventing", "disease", "is", "intense.", "<tag2>", "Various", "methods", "for", "treating", "cancer", "currently", "are,", "and", "in", "the", "future,", "are", "expected", "to", "be,", "the", "subject", "of", "extensive", "research", "and", "development.", "<tag3>"], "wordsA": ["Competition", "in", "the", "discovery", "and", "development", "of", "new", "methods", "for", "treating", "and", "preventing", "disease", "is", "intense."], "wordsB": ["Various", "methods", "for", "treating", "cancer", "currently", "are,", "and", "in", "the", "future,", "are", "expected", "to", "be,", "the", "subject", "of", "extensive", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09641768783330917, 0.09472446888685226, 0.022966865450143814, 0.2659165859222412, 0.8449833989143372, 0.006380788516253233, 0.007418811786919832, 0.005163915455341339, 0.014453204348683357, 0.009926695376634598, 0.02813052572309971, 0.004187978804111481, 0.02544504776597023, 0.01676386222243309, 0.01254551112651825, 0.005282296333462, 0.017355982214212418, 0.007001832127571106, 0.10961207747459412, 0.04192562401294708, 0.013543764129281044, 0.03260170668363571, -1]}
{"idB": "749647_18_item1_p279_s0", "idA": "749647_17_item1_p188_s1", "sentA": "We face, and will continue to face, competition from pharmaceutical and biotechnology companies, as well as academic and research institutions and government agencies both in the U.S. and abroad.", "sentB": "The patent positions of pharmaceutical and biotechnology companies, such as ours, are uncertain and involve complex legal and factual issues.", "type": 2, "words": ["<tag1>", "We", "face,", "and", "will", "continue", "to", "face,", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad.", "<tag2>", "The", "patent", "positions", "of", "pharmaceutical", "and", "biotechnology", "companies,", "such", "as", "ours,", "are", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "issues.", "<tag3>"], "wordsA": ["We", "face,", "and", "will", "continue", "to", "face,", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad."], "wordsB": ["The", "patent", "positions", "of", "pharmaceutical", "and", "biotechnology", "companies,", "such", "as", "ours,", "are", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "issues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018810423091053963, 0.529666006565094, 0.5404396653175354, 0.02693873830139637, 0.03224722668528557, 0.005469814408570528, 0.017859365791082382, 0.03126804903149605, 0.005956762004643679, 0.007276264019310474, 0.014553663320839405, 0.01990211009979248, 0.21606497466564178, 0.014245683327317238, 0.03635948523879051, 0.042767152190208435, 0.07897789776325226, 0.03054947964847088, 0.05945293977856636, 0.09651677310466766, -1]}
{"idB": "749647_18_item1_p329_s6", "idA": "749647_17_item1_p188_s1", "sentA": "We face, and will continue to face, competition from pharmaceutical and biotechnology companies, as well as academic and research institutions and government agencies both in the U.S. and abroad.", "sentB": "However, as our business and the demands on our key employees expand, we have been, and will continue to be, required to recruit additional qualified employees.", "type": 2, "words": ["<tag1>", "We", "face,", "and", "will", "continue", "to", "face,", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad.", "<tag2>", "However,", "as", "our", "business", "and", "the", "demands", "on", "our", "key", "employees", "expand,", "we", "have", "been,", "and", "will", "continue", "to", "be,", "required", "to", "recruit", "additional", "qualified", "employees.", "<tag3>"], "wordsA": ["We", "face,", "and", "will", "continue", "to", "face,", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad."], "wordsB": ["However,", "as", "our", "business", "and", "the", "demands", "on", "our", "key", "employees", "expand,", "we", "have", "been,", "and", "will", "continue", "to", "be,", "required", "to", "recruit", "additional", "qualified", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01656930148601532, 0.00882487092167139, 0.023623540997505188, 0.14433953166007996, 0.01987530291080475, 0.03585970401763916, 0.21577636897563934, 0.04375101625919342, 0.01921040005981922, 0.07281383126974106, 0.13022451102733612, 0.15096911787986755, 0.016796085983514786, 0.01214925292879343, 0.015649912878870964, 0.0059171272441744804, 0.006493589375168085, 0.01461080089211464, 0.008887125179171562, 0.012967255897819996, 0.14534811675548553, 0.09386022388935089, 0.3395380675792694, 0.18752416968345642, 0.2543475329875946, 0.3137010633945465, -1]}
{"idB": "749647_18_item1_p333_s2", "idA": "749647_17_item1_p188_s1", "sentA": "We face, and will continue to face, competition from pharmaceutical and biotechnology companies, as well as academic and research institutions and government agencies both in the U.S. and abroad.", "sentB": "Potential competitors engaged in all areas of cancer treatment research in the U.S. and other countries include, among others, major pharmaceutical, specialized technology companies, and universities and other research institutions.", "type": 2, "words": ["<tag1>", "We", "face,", "and", "will", "continue", "to", "face,", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad.", "<tag2>", "Potential", "competitors", "engaged", "in", "all", "areas", "of", "cancer", "treatment", "research", "in", "the", "U.S.", "and", "other", "countries", "include,", "among", "others,", "major", "pharmaceutical,", "specialized", "technology", "companies,", "and", "universities", "and", "other", "research", "institutions.", "<tag3>"], "wordsA": ["We", "face,", "and", "will", "continue", "to", "face,", "competition", "from", "pharmaceutical", "and", "biotechnology", "companies,", "as", "well", "as", "academic", "and", "research", "institutions", "and", "government", "agencies", "both", "in", "the", "U.S.", "and", "abroad."], "wordsB": ["Potential", "competitors", "engaged", "in", "all", "areas", "of", "cancer", "treatment", "research", "in", "the", "U.S.", "and", "other", "countries", "include,", "among", "others,", "major", "pharmaceutical,", "specialized", "technology", "companies,", "and", "universities", "and", "other", "research", "institutions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.15393124520778656, 0.2658389210700989, 0.12890028953552246, 0.04737355187535286, 0.13134042918682098, 0.07689494639635086, 0.04165849834680557, 0.2037101686000824, 0.2759714126586914, 0.20601347088813782, 0.010791636072099209, 0.01207848358899355, 0.020775271579623222, 0.007056304253637791, 0.009230046533048153, 0.03316522389650345, 0.007014066446572542, 0.007699328940361738, 0.007288915105164051, 0.01814892143011093, 0.04830101132392883, 0.032290179282426834, 0.06240417808294296, 0.08206410706043243, 0.00618144404143095, 0.027695853263139725, 0.008179357275366783, 0.010571695864200592, 0.0427059568464756, 0.04145660623908043, -1]}
{"idB": "749647_18_item1_p318_s1", "idA": "749647_17_item1_p188_s2", "sentA": "We face significant competition from organizations pursuing the same or similar technologies used by us in our drug discovery efforts and from organizations developing pharmaceuticals that are competitive with our product candidates.", "sentB": "Any of our drug candidates or similar product candidates being investigated by our competitors may prove not to be effective in trial or in practice, cause adverse events or other undesirable side effects.", "type": 2, "words": ["<tag1>", "We", "face", "significant", "competition", "from", "organizations", "pursuing", "the", "same", "or", "similar", "technologies", "used", "by", "us", "in", "our", "drug", "discovery", "efforts", "and", "from", "organizations", "developing", "pharmaceuticals", "that", "are", "competitive", "with", "our", "product", "candidates.", "<tag2>", "Any", "of", "our", "drug", "candidates", "or", "similar", "product", "candidates", "being", "investigated", "by", "our", "competitors", "may", "prove", "not", "to", "be", "effective", "in", "trial", "or", "in", "practice,", "cause", "adverse", "events", "or", "other", "undesirable", "side", "effects.", "<tag3>"], "wordsA": ["We", "face", "significant", "competition", "from", "organizations", "pursuing", "the", "same", "or", "similar", "technologies", "used", "by", "us", "in", "our", "drug", "discovery", "efforts", "and", "from", "organizations", "developing", "pharmaceuticals", "that", "are", "competitive", "with", "our", "product", "candidates."], "wordsB": ["Any", "of", "our", "drug", "candidates", "or", "similar", "product", "candidates", "being", "investigated", "by", "our", "competitors", "may", "prove", "not", "to", "be", "effective", "in", "trial", "or", "in", "practice,", "cause", "adverse", "events", "or", "other", "undesirable", "side", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06986145675182343, 0.01878337562084198, 0.02228921465575695, 0.19748175144195557, 0.1961219161748886, 0.011551286093890667, 0.04975691810250282, 0.07905347645282745, 0.09255190938711166, 0.0126703642308712, 0.11145269870758057, 0.013314218260347843, 0.01108902134001255, 0.06468942761421204, 0.018643643707036972, 0.06119716167449951, 0.31607136130332947, 0.15763087570667267, 0.16946613788604736, 0.2080419361591339, 0.05236554518342018, 0.08623151481151581, 0.011460669338703156, 0.04627154767513275, 0.08568547666072845, 0.011843088082969189, 0.037713926285505295, 0.07095085084438324, 0.010061388835310936, 0.014924685470759869, 0.15532830357551575, 0.078603096306324, 0.07796605676412582, -1]}
{"idB": "749647_18_item1_p337_s2", "idA": "749647_17_item1_p188_s2", "sentA": "We face significant competition from organizations pursuing the same or similar technologies used by us in our drug discovery efforts and from organizations developing pharmaceuticals that are competitive with our product candidates.", "sentB": "For instance, the loss of preclinical data or data from any clinical trial involving our product candidates could result in delays in our development and regulatory filing efforts and significantly increase our costs.", "type": 2, "words": ["<tag1>", "We", "face", "significant", "competition", "from", "organizations", "pursuing", "the", "same", "or", "similar", "technologies", "used", "by", "us", "in", "our", "drug", "discovery", "efforts", "and", "from", "organizations", "developing", "pharmaceuticals", "that", "are", "competitive", "with", "our", "product", "candidates.", "<tag2>", "For", "instance,", "the", "loss", "of", "preclinical", "data", "or", "data", "from", "any", "clinical", "trial", "involving", "our", "product", "candidates", "could", "result", "in", "delays", "in", "our", "development", "and", "regulatory", "filing", "efforts", "and", "significantly", "increase", "our", "costs.", "<tag3>"], "wordsA": ["We", "face", "significant", "competition", "from", "organizations", "pursuing", "the", "same", "or", "similar", "technologies", "used", "by", "us", "in", "our", "drug", "discovery", "efforts", "and", "from", "organizations", "developing", "pharmaceuticals", "that", "are", "competitive", "with", "our", "product", "candidates."], "wordsB": ["For", "instance,", "the", "loss", "of", "preclinical", "data", "or", "data", "from", "any", "clinical", "trial", "involving", "our", "product", "candidates", "could", "result", "in", "delays", "in", "our", "development", "and", "regulatory", "filing", "efforts", "and", "significantly", "increase", "our", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007612786255776882, 0.014172586612403393, 0.014533489011228085, 0.669232964515686, 0.37207168340682983, 0.6027427315711975, 0.5282125473022461, 0.13635867834091187, 0.31162208318710327, 0.018798409029841423, 0.01755143329501152, 0.08299265801906586, 0.08738894015550613, 0.032906219363212585, 0.007645088713616133, 0.028827548027038574, 0.039498236030340195, 0.004693769849836826, 0.011106996797025204, 0.014512660913169384, 0.2573496699333191, 0.02066161297261715, 0.014054115861654282, 0.06501545011997223, 0.008879818953573704, 0.06640443205833435, 0.10967250168323517, 0.0881839171051979, 0.00025012949481606483, 0.051423605531454086, 0.10327783226966858, 0.04680271074175835, 0.11473186314105988, -1]}
{"idB": "749647_18_item1_p335_s3", "idA": "749647_17_item1_p189_s0", "sentA": "Most of our competitors, either alone or together with their collaborative partners, have substantially greater financial resources and larger research and development staffs than we do.", "sentB": "Whether or not we are ultimately successful in any product liability litigation, such litigation would harm the business by diverting the attention and resources of our management, consuming substantial amounts of our financial resources and by damaging our reputation.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "competitors,", "either", "alone", "or", "together", "with", "their", "collaborative", "partners,", "have", "substantially", "greater", "financial", "resources", "and", "larger", "research", "and", "development", "staffs", "than", "we", "do.", "<tag2>", "Whether", "or", "not", "we", "are", "ultimately", "successful", "in", "any", "product", "liability", "litigation,", "such", "litigation", "would", "harm", "the", "business", "by", "diverting", "the", "attention", "and", "resources", "of", "our", "management,", "consuming", "substantial", "amounts", "of", "our", "financial", "resources", "and", "by", "damaging", "our", "reputation.", "<tag3>"], "wordsA": ["Most", "of", "our", "competitors,", "either", "alone", "or", "together", "with", "their", "collaborative", "partners,", "have", "substantially", "greater", "financial", "resources", "and", "larger", "research", "and", "development", "staffs", "than", "we", "do."], "wordsB": ["Whether", "or", "not", "we", "are", "ultimately", "successful", "in", "any", "product", "liability", "litigation,", "such", "litigation", "would", "harm", "the", "business", "by", "diverting", "the", "attention", "and", "resources", "of", "our", "management,", "consuming", "substantial", "amounts", "of", "our", "financial", "resources", "and", "by", "damaging", "our", "reputation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03676796332001686, 0.03386876359581947, 0.02048478089272976, 0.06523000448942184, 0.049058426171541214, 0.06279194355010986, 0.08982126414775848, 0.027820074930787086, 0.028056733310222626, 0.16093213856220245, 0.18271107971668243, 0.21771299839019775, 0.011267634108662605, 0.11567501723766327, 0.021107155829668045, 0.03977353125810623, 0.016225088387727737, 0.09509904682636261, 0.0005230834358371794, 0.039443641901016235, 0.0007166037685237825, 0.047904226928949356, 0.016899917274713516, 0.042420655488967896, 0.009542240761220455, 0.013664237223565578, 0.05347326397895813, 0.062140487134456635, 0.05275196582078934, 0.0341300368309021, 0.04375949501991272, 0.026955436915159225, 0.13927797973155975, 0.10633976012468338, 0.00022257734963204712, 0.008198150433599949, 0.150839701294899, 0.06510787457227707, 0.13044901192188263, -1]}
{"idB": "749647_18_item1_p333_s3", "idA": "749647_17_item1_p189_s1", "sentA": "In addition, most of these organizations, either alone or together with their collaborators, have significantly greater experience than we do in developing products, undertaking preclinical testing and clinical trials, obtaining FDA and other regulatory approvals of products, and manufacturing and marketing products.", "sentB": "Most of our current and potential competitors have substantially greater financial, technical, human and other resources, and may also have far greater experience than do we, both in pre-clinical testing and human clinical trials of new products and in obtaining FDA and other regulatory approvals.", "type": 2, "words": ["<tag1>", "In", "addition,", "most", "of", "these", "organizations,", "either", "alone", "or", "together", "with", "their", "collaborators,", "have", "significantly", "greater", "experience", "than", "we", "do", "in", "developing", "products,", "undertaking", "preclinical", "testing", "and", "clinical", "trials,", "obtaining", "FDA", "and", "other", "regulatory", "approvals", "of", "products,", "and", "manufacturing", "and", "marketing", "products.", "<tag2>", "Most", "of", "our", "current", "and", "potential", "competitors", "have", "substantially", "greater", "financial,", "technical,", "human", "and", "other", "resources,", "and", "may", "also", "have", "far", "greater", "experience", "than", "do", "we,", "both", "in", "pre-clinical", "testing", "and", "human", "clinical", "trials", "of", "new", "products", "and", "in", "obtaining", "FDA", "and", "other", "regulatory", "approvals.", "<tag3>"], "wordsA": ["In", "addition,", "most", "of", "these", "organizations,", "either", "alone", "or", "together", "with", "their", "collaborators,", "have", "significantly", "greater", "experience", "than", "we", "do", "in", "developing", "products,", "undertaking", "preclinical", "testing", "and", "clinical", "trials,", "obtaining", "FDA", "and", "other", "regulatory", "approvals", "of", "products,", "and", "manufacturing", "and", "marketing", "products."], "wordsB": ["Most", "of", "our", "current", "and", "potential", "competitors", "have", "substantially", "greater", "financial,", "technical,", "human", "and", "other", "resources,", "and", "may", "also", "have", "far", "greater", "experience", "than", "do", "we,", "both", "in", "pre-clinical", "testing", "and", "human", "clinical", "trials", "of", "new", "products", "and", "in", "obtaining", "FDA", "and", "other", "regulatory", "approvals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.028550194576382637, 0.012938656844198704, 0.025093242526054382, 0.053190551698207855, 0.016690852120518684, 0.04938263073563576, 0.1392170786857605, 0.005690600257366896, 0.016067594289779663, 0.02646714821457863, 0.05690152943134308, 0.04746261239051819, 0.0762491375207901, 0.012175199575722218, 0.09452071040868759, 0.11408168822526932, 0.006949597969651222, 0.006551428232342005, 0.0037092980928719044, 0.008236760273575783, 0.015146013349294662, 0.03710150346159935, 0.03773893043398857, 0.015039937570691109, 0.00695410743355751, 0.009972325526177883, 0.003253597067669034, 0.004129508510231972, 0.012031028978526592, 0.009258202277123928, 0.0025936230085790157, 0.00622540945187211, 0.017523016780614853, 0.02217906527221203, 0.00489436648786068, 0.07023683935403824, 0.0934716984629631, 0.006688278168439865, 0.0038900193758308887, 0.0074707623571157455, 0.008164669387042522, 0.0032722249161452055, 0.0036469188053160906, 0.009002250619232655, 0.009719256311655045, -1]}
{"idB": "749647_18_item1_p172_s0", "idA": "749647_17_item1_p18_s0", "sentA": "On December 16, 2015, we announced that we had received the clinical trial application approval from the China Food and Drug Administration (the CFDA ) to conduct the OPTIMA Study in China.", "sentB": "The Food and Drug Administration (FDA) regulates gene-based products as biological products.", "type": 2, "words": ["<tag1>", "On", "December", "16,", "2015,", "we", "announced", "that", "we", "had", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "China", "Food", "and", "Drug", "Administration", "(the", "CFDA", ")", "to", "conduct", "the", "OPTIMA", "Study", "in", "China.", "<tag2>", "The", "Food", "and", "Drug", "Administration", "(FDA)", "regulates", "gene-based", "products", "as", "biological", "products.", "<tag3>"], "wordsA": ["On", "December", "16,", "2015,", "we", "announced", "that", "we", "had", "received", "the", "clinical", "trial", "application", "approval", "from", "the", "China", "Food", "and", "Drug", "Administration", "(the", "CFDA", ")", "to", "conduct", "the", "OPTIMA", "Study", "in", "China."], "wordsB": ["The", "Food", "and", "Drug", "Administration", "(FDA)", "regulates", "gene-based", "products", "as", "biological", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010481155477464199, 0.09996550530195236, 0.035331081598997116, 0.042412541806697845, 0.11063709855079651, 0.3090466558933258, 0.4844129681587219, 0.45825156569480896, 0.5267871022224426, 0.17405833303928375, 0.5113891959190369, 0.5021962523460388, -1]}
{"idB": "749647_18_item1_p103_s1", "idA": "749647_17_item1_p18_s1", "sentA": "This clinical trial application approval will allow Celsion to enroll patients at up to 20 clinical sites in China.", "sentB": "A second Investigators Meeting was held on September 23, 2017 with physicians in China.", "type": 2, "words": ["<tag1>", "This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China.", "<tag2>", "A", "second", "Investigators", "Meeting", "was", "held", "on", "September", "23,", "2017", "with", "physicians", "in", "China.", "<tag3>"], "wordsA": ["This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China."], "wordsB": ["A", "second", "Investigators", "Meeting", "was", "held", "on", "September", "23,", "2017", "with", "physicians", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02690432406961918, 0.26163554191589355, 0.5986918807029724, 0.6819481253623962, 0.013351391069591045, 0.03227068856358528, 0.02715831995010376, 0.09281889349222183, 0.10808522254228592, 0.1576591283082962, 0.026049159467220306, 0.11430517584085464, 0.011713361367583275, 0.024264691397547722, -1]}
{"idB": "749647_18_item1_p103_s2", "idA": "749647_17_item1_p18_s1", "sentA": "This clinical trial application approval will allow Celsion to enroll patients at up to 20 clinical sites in China.", "sentB": "As of December 31, 2017, the Company had initiated approximately 65 clinical sites in 14 countries and has plans to activate up to 8 additional clinical trial sites in China and Vietnam by the middle of 2018.", "type": 2, "words": ["<tag1>", "This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China.", "<tag2>", "As", "of", "December", "31,", "2017,", "the", "Company", "had", "initiated", "approximately", "65", "clinical", "sites", "in", "14", "countries", "and", "has", "plans", "to", "activate", "up", "to", "8", "additional", "clinical", "trial", "sites", "in", "China", "and", "Vietnam", "by", "the", "middle", "of", "2018.", "<tag3>"], "wordsA": ["This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China."], "wordsB": ["As", "of", "December", "31,", "2017,", "the", "Company", "had", "initiated", "approximately", "65", "clinical", "sites", "in", "14", "countries", "and", "has", "plans", "to", "activate", "up", "to", "8", "additional", "clinical", "trial", "sites", "in", "China", "and", "Vietnam", "by", "the", "middle", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03405851870775223, 0.027235906571149826, 0.03729308396577835, 0.031794220209121704, 0.08387228846549988, 0.007338354364037514, 0.07385429739952087, 0.019472671672701836, 0.12422385811805725, 0.10623662173748016, 0.5645348429679871, 0.2881511151790619, 0.26991644501686096, 0.012561554089188576, 0.10784250497817993, 0.059156712144613266, 0.00010619853856042027, 0.01219919417053461, 0.05794007331132889, 0.027749214321374893, 0.25627851486206055, 0.031241681426763535, 0.014402403496205807, 0.36357393860816956, 0.1849735528230667, 0.10066063702106476, 0.08466952294111252, 0.13798850774765015, 0.009276722557842731, 0.040180839598178864, 0.023341866210103035, 0.0675596371293068, 0.015009023249149323, 0.010952344164252281, 0.03143051639199257, 0.05064544826745987, 0.0896296575665474, -1]}
{"idB": "749647_18_item1_p19_s1", "idA": "749647_17_item1_p18_s1", "sentA": "This clinical trial application approval will allow Celsion to enroll patients at up to 20 clinical sites in China.", "sentB": "A second Investigators Meeting was held on September 23, 2017 with physicians in China.", "type": 2, "words": ["<tag1>", "This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China.", "<tag2>", "A", "second", "Investigators", "Meeting", "was", "held", "on", "September", "23,", "2017", "with", "physicians", "in", "China.", "<tag3>"], "wordsA": ["This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China."], "wordsB": ["A", "second", "Investigators", "Meeting", "was", "held", "on", "September", "23,", "2017", "with", "physicians", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02690432406961918, 0.26163554191589355, 0.5986918807029724, 0.6819481253623962, 0.013351391069591045, 0.03227068856358528, 0.02715831995010376, 0.09281889349222183, 0.10808522254228592, 0.1576591283082962, 0.026049159467220306, 0.11430517584085464, 0.011713361367583275, 0.024264691397547722, -1]}
{"idB": "749647_18_item1_p19_s2", "idA": "749647_17_item1_p18_s1", "sentA": "This clinical trial application approval will allow Celsion to enroll patients at up to 20 clinical sites in China.", "sentB": "As of December 31, 2017, the Company had initiated approximately 65 clinical sites in 14 countries and has plans to activate up to 8 additional clinical trial sites in China and Vietnam by the middle of 2018.", "type": 2, "words": ["<tag1>", "This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China.", "<tag2>", "As", "of", "December", "31,", "2017,", "the", "Company", "had", "initiated", "approximately", "65", "clinical", "sites", "in", "14", "countries", "and", "has", "plans", "to", "activate", "up", "to", "8", "additional", "clinical", "trial", "sites", "in", "China", "and", "Vietnam", "by", "the", "middle", "of", "2018.", "<tag3>"], "wordsA": ["This", "clinical", "trial", "application", "approval", "will", "allow", "Celsion", "to", "enroll", "patients", "at", "up", "to", "20", "clinical", "sites", "in", "China."], "wordsB": ["As", "of", "December", "31,", "2017,", "the", "Company", "had", "initiated", "approximately", "65", "clinical", "sites", "in", "14", "countries", "and", "has", "plans", "to", "activate", "up", "to", "8", "additional", "clinical", "trial", "sites", "in", "China", "and", "Vietnam", "by", "the", "middle", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03405851870775223, 0.027235906571149826, 0.03729308396577835, 0.031794220209121704, 0.08387228846549988, 0.007338354364037514, 0.07385429739952087, 0.019472671672701836, 0.12422385811805725, 0.10623662173748016, 0.5645348429679871, 0.2881511151790619, 0.26991644501686096, 0.012561554089188576, 0.10784250497817993, 0.059156712144613266, 0.00010619853856042027, 0.01219919417053461, 0.05794007331132889, 0.027749214321374893, 0.25627851486206055, 0.031241681426763535, 0.014402403496205807, 0.36357393860816956, 0.1849735528230667, 0.10066063702106476, 0.08466952294111252, 0.13798850774765015, 0.009276722557842731, 0.040180839598178864, 0.023341866210103035, 0.0675596371293068, 0.015009023249149323, 0.010952344164252281, 0.03143051639199257, 0.05064544826745987, 0.0896296575665474, -1]}
{"idB": "749647_18_item1_p102_s0", "idA": "749647_17_item1_p18_s3", "sentA": "On April 26, 2016, we announced that the first patient in China had been enrolled in the OPTIMA Study.", "sentB": "On August 7, 2017, the Company announced that the independent Data Monitoring Committee (DMC) for the Company s OPTIMA Study completed a regularly scheduled review of the first 50% of patients enrolled in the trial and has unanimously recommended that the OPTIMA Study continue according to protocol to its final data readout.", "type": 2, "words": ["<tag1>", "On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "had", "been", "enrolled", "in", "the", "OPTIMA", "Study.", "<tag2>", "On", "August", "7,", "2017,", "the", "Company", "announced", "that", "the", "independent", "Data", "Monitoring", "Committee", "(DMC)", "for", "the", "Company", "s", "OPTIMA", "Study", "completed", "a", "regularly", "scheduled", "review", "of", "the", "first", "50%", "of", "patients", "enrolled", "in", "the", "trial", "and", "has", "unanimously", "recommended", "that", "the", "OPTIMA", "Study", "continue", "according", "to", "protocol", "to", "its", "final", "data", "readout.", "<tag3>"], "wordsA": ["On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "had", "been", "enrolled", "in", "the", "OPTIMA", "Study."], "wordsB": ["On", "August", "7,", "2017,", "the", "Company", "announced", "that", "the", "independent", "Data", "Monitoring", "Committee", "(DMC)", "for", "the", "Company", "s", "OPTIMA", "Study", "completed", "a", "regularly", "scheduled", "review", "of", "the", "first", "50%", "of", "patients", "enrolled", "in", "the", "trial", "and", "has", "unanimously", "recommended", "that", "the", "OPTIMA", "Study", "continue", "according", "to", "protocol", "to", "its", "final", "data", "readout."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024615272879600525, 0.5191746354103088, 0.36227279901504517, 0.6523376107215881, 0.005061674397438765, 0.07263753563165665, 0.02855597622692585, 0.009266034699976444, 0.011696304194629192, 0.31957775354385376, 0.3942791223526001, 0.2068375200033188, 0.25203433632850647, 0.1800183653831482, 0.004088964778929949, 0.004402359016239643, 0.029303235933184624, 0.0058004227466881275, 0.016056712716817856, 0.02327282913029194, 0.0421631895005703, 0.009416671469807625, 0.021789362654089928, 0.02864179015159607, 0.0548037551343441, 0.008068996481597424, 0.0067006731405854225, 0.04139767959713936, 0.07555272430181503, 0.024711210280656815, 0.0942683294415474, 0.005882222671061754, 0.0029320786707103252, 0.003513022093102336, 0.0191901046782732, 0.0001958918001037091, 0.008972877636551857, 0.04000155255198479, 0.06726017594337463, 0.01323517132550478, 0.005544548854231834, 0.02868414670228958, 0.04048115015029907, 0.07559985667467117, 0.03853042423725128, 0.013554579578340054, 0.023779327049851418, 0.00845461618155241, 0.0055855643004179, 0.029136501252651215, 0.04867051914334297, 0.038317371159791946, -1]}
{"idB": "749647_18_item1_p18_s0", "idA": "749647_17_item1_p18_s3", "sentA": "On April 26, 2016, we announced that the first patient in China had been enrolled in the OPTIMA Study.", "sentB": "On August 7, 2017, the Company announced that the independent Data Monitoring Committee (DMC) for the Company s OPTIMA Study completed a regularly scheduled review of the first 50% of patients enrolled in the trial and has unanimously recommended that the OPTIMA Study continue according to protocol to its final data readout.", "type": 2, "words": ["<tag1>", "On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "had", "been", "enrolled", "in", "the", "OPTIMA", "Study.", "<tag2>", "On", "August", "7,", "2017,", "the", "Company", "announced", "that", "the", "independent", "Data", "Monitoring", "Committee", "(DMC)", "for", "the", "Company", "s", "OPTIMA", "Study", "completed", "a", "regularly", "scheduled", "review", "of", "the", "first", "50%", "of", "patients", "enrolled", "in", "the", "trial", "and", "has", "unanimously", "recommended", "that", "the", "OPTIMA", "Study", "continue", "according", "to", "protocol", "to", "its", "final", "data", "readout.", "<tag3>"], "wordsA": ["On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "had", "been", "enrolled", "in", "the", "OPTIMA", "Study."], "wordsB": ["On", "August", "7,", "2017,", "the", "Company", "announced", "that", "the", "independent", "Data", "Monitoring", "Committee", "(DMC)", "for", "the", "Company", "s", "OPTIMA", "Study", "completed", "a", "regularly", "scheduled", "review", "of", "the", "first", "50%", "of", "patients", "enrolled", "in", "the", "trial", "and", "has", "unanimously", "recommended", "that", "the", "OPTIMA", "Study", "continue", "according", "to", "protocol", "to", "its", "final", "data", "readout."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.024615272879600525, 0.5191746354103088, 0.36227279901504517, 0.6523376107215881, 0.005061674397438765, 0.07263753563165665, 0.02855597622692585, 0.009266034699976444, 0.011696304194629192, 0.31957775354385376, 0.3942791223526001, 0.2068375200033188, 0.25203433632850647, 0.1800183653831482, 0.004088964778929949, 0.004402359016239643, 0.029303235933184624, 0.0058004227466881275, 0.016056712716817856, 0.02327282913029194, 0.0421631895005703, 0.009416671469807625, 0.021789362654089928, 0.02864179015159607, 0.0548037551343441, 0.008068996481597424, 0.0067006731405854225, 0.04139767959713936, 0.07555272430181503, 0.024711210280656815, 0.0942683294415474, 0.005882222671061754, 0.0029320786707103252, 0.003513022093102336, 0.0191901046782732, 0.0001958918001037091, 0.008972877636551857, 0.04000155255198479, 0.06726017594337463, 0.01323517132550478, 0.005544548854231834, 0.02868414670228958, 0.04048115015029907, 0.07559985667467117, 0.03853042423725128, 0.013554579578340054, 0.023779327049851418, 0.00845461618155241, 0.0055855643004179, 0.029136501252651215, 0.04867051914334297, 0.038317371159791946, -1]}
{"idB": "749647_18_item1_p191_s1", "idA": "749647_17_item1_p190_s0", "sentA": "Mergers and acquisitions in the pharmaceutical industry may result in even more resources being concentrated among our competitors.", "sentB": "Failure of an application to meet any of these criteria may result in the application not being approvable based on the foreign data alone.", "type": 2, "words": ["<tag1>", "Mergers", "and", "acquisitions", "in", "the", "pharmaceutical", "industry", "may", "result", "in", "even", "more", "resources", "being", "concentrated", "among", "our", "competitors.", "<tag2>", "Failure", "of", "an", "application", "to", "meet", "any", "of", "these", "criteria", "may", "result", "in", "the", "application", "not", "being", "approvable", "based", "on", "the", "foreign", "data", "alone.", "<tag3>"], "wordsA": ["Mergers", "and", "acquisitions", "in", "the", "pharmaceutical", "industry", "may", "result", "in", "even", "more", "resources", "being", "concentrated", "among", "our", "competitors."], "wordsB": ["Failure", "of", "an", "application", "to", "meet", "any", "of", "these", "criteria", "may", "result", "in", "the", "application", "not", "being", "approvable", "based", "on", "the", "foreign", "data", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4637420177459717, 0.26188886165618896, 0.31054577231407166, 0.6576024293899536, 0.03448837995529175, 0.030249228700995445, 0.017381729558110237, 0.008532330393791199, 0.014993577264249325, 0.04675402119755745, 0.004360214341431856, 0.00914793461561203, 0.006744018290191889, 0.006596620660275221, 0.2663196325302124, 0.5194999575614929, 0.3760203719139099, 0.3877757489681244, 0.011912666261196136, 0.006554778199642897, 0.0073563698679208755, 0.049162473529577255, 0.04215863347053528, 0.15855534374713898, -1]}
{"idB": "749647_18_item1_p201_s3", "idA": "749647_17_item1_p190_s2", "sentA": "Our ability to compete successfully with other companies in the pharmaceutical and biotechnology field also depends on the status of our collaborations and on the continuing availability of capital to us.", "sentB": "Fee reductions are also available depending on the status of the sponsor and the type of service required.", "type": 2, "words": ["<tag1>", "Our", "ability", "to", "compete", "successfully", "with", "other", "companies", "in", "the", "pharmaceutical", "and", "biotechnology", "field", "also", "depends", "on", "the", "status", "of", "our", "collaborations", "and", "on", "the", "continuing", "availability", "of", "capital", "to", "us.", "<tag2>", "Fee", "reductions", "are", "also", "available", "depending", "on", "the", "status", "of", "the", "sponsor", "and", "the", "type", "of", "service", "required.", "<tag3>"], "wordsA": ["Our", "ability", "to", "compete", "successfully", "with", "other", "companies", "in", "the", "pharmaceutical", "and", "biotechnology", "field", "also", "depends", "on", "the", "status", "of", "our", "collaborations", "and", "on", "the", "continuing", "availability", "of", "capital", "to", "us."], "wordsB": ["Fee", "reductions", "are", "also", "available", "depending", "on", "the", "status", "of", "the", "sponsor", "and", "the", "type", "of", "service", "required."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.826630175113678, 0.8284000158309937, 0.007152893580496311, 0.010746568441390991, 0.05734588950872421, 0.017906859517097473, 0.011230489239096642, 0.008879618719220161, 0.061449553817510605, 0.024705523625016212, 0.030471784994006157, 0.1345021277666092, 0.014043265022337437, 0.009448501281440258, 0.02990252524614334, 0.0578748881816864, 0.14498861134052277, 0.056472260504961014, -1]}
{"idB": "749647_18_item1_p329_s0", "idA": "749647_17_item1_p190_s2", "sentA": "Our ability to compete successfully with other companies in the pharmaceutical and biotechnology field also depends on the status of our collaborations and on the continuing availability of capital to us.", "sentB": "Our success depends significantly on the continued contributions of our executive officers, scientific and technical personnel and consultants, including those retained in the EGEN acquisition, and on our ability to attract additional personnel as we seek to implement our business strategy and develop our product candidates and businesses.", "type": 2, "words": ["<tag1>", "Our", "ability", "to", "compete", "successfully", "with", "other", "companies", "in", "the", "pharmaceutical", "and", "biotechnology", "field", "also", "depends", "on", "the", "status", "of", "our", "collaborations", "and", "on", "the", "continuing", "availability", "of", "capital", "to", "us.", "<tag2>", "Our", "success", "depends", "significantly", "on", "the", "continued", "contributions", "of", "our", "executive", "officers,", "scientific", "and", "technical", "personnel", "and", "consultants,", "including", "those", "retained", "in", "the", "EGEN", "acquisition,", "and", "on", "our", "ability", "to", "attract", "additional", "personnel", "as", "we", "seek", "to", "implement", "our", "business", "strategy", "and", "develop", "our", "product", "candidates", "and", "businesses.", "<tag3>"], "wordsA": ["Our", "ability", "to", "compete", "successfully", "with", "other", "companies", "in", "the", "pharmaceutical", "and", "biotechnology", "field", "also", "depends", "on", "the", "status", "of", "our", "collaborations", "and", "on", "the", "continuing", "availability", "of", "capital", "to", "us."], "wordsB": ["Our", "success", "depends", "significantly", "on", "the", "continued", "contributions", "of", "our", "executive", "officers,", "scientific", "and", "technical", "personnel", "and", "consultants,", "including", "those", "retained", "in", "the", "EGEN", "acquisition,", "and", "on", "our", "ability", "to", "attract", "additional", "personnel", "as", "we", "seek", "to", "implement", "our", "business", "strategy", "and", "develop", "our", "product", "candidates", "and", "businesses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0060018147341907024, 0.06446072459220886, 0.03237725794315338, 0.06501509249210358, 0.011081197299063206, 0.010361016727983952, 0.13850973546504974, 0.3178856670856476, 0.03335237875580788, 0.031150557100772858, 0.2793596088886261, 0.28195104002952576, 0.05118228495121002, 0.029042895883321762, 0.05473235994577408, 0.12284300476312637, 0.026872672140598297, 0.11064261943101883, 0.00477512227371335, 0.006655166391283274, 0.010659695602953434, 0.007320675067603588, 0.0074628605507314205, 0.03757889196276665, 0.05695418640971184, 0.005225524306297302, 0.0031625228002667427, 0.0076077161356806755, 0.035866741091012955, 0.016490254551172256, 0.2099936604499817, 0.17483685910701752, 0.3606496751308441, 0.003934009466320276, 0.010241330601274967, 0.013556652702391148, 0.010210182517766953, 0.08121619373559952, 0.021324409171938896, 0.14107729494571686, 0.10215730965137482, 0.010461105965077877, 0.06864896416664124, 0.013425096869468689, 0.06860972940921783, 0.0775487944483757, 0.026734214276075363, 0.08275309950113297, -1]}
{"idB": "749647_18_item1_p176_s0", "idA": "749647_17_item1_p191_s1", "sentA": "In addition, the Company is not aware of any other Phase III clinical trial for the treatment of HCC or primary liver cancer.", "sentB": "In addition, the FDA conducts laboratory research related to the regulatory standards on the safety, purity, potency, and effectiveness of biological products.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer.", "<tag2>", "In", "addition,", "the", "FDA", "conducts", "laboratory", "research", "related", "to", "the", "regulatory", "standards", "on", "the", "safety,", "purity,", "potency,", "and", "effectiveness", "of", "biological", "products.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer."], "wordsB": ["In", "addition,", "the", "FDA", "conducts", "laboratory", "research", "related", "to", "the", "regulatory", "standards", "on", "the", "safety,", "purity,", "potency,", "and", "effectiveness", "of", "biological", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007517313119024038, 0.03660868480801582, 0.033779729157686234, 0.38476985692977905, 0.27572283148765564, 0.4303448498249054, 0.4972377419471741, 0.05080843344330788, 0.017217019572854042, 0.010921373963356018, 0.05678345263004303, 0.06100251525640488, 0.02046339586377144, 0.009423618204891682, 0.06761763989925385, 0.06664469093084335, 0.04707169160246849, 0.01856507547199726, 0.06565829366445541, 0.0299061369150877, 0.14508581161499023, 0.10710246860980988, -1]}
{"idB": "749647_18_item1_p237_s1", "idA": "749647_17_item1_p191_s1", "sentA": "In addition, the Company is not aware of any other Phase III clinical trial for the treatment of HCC or primary liver cancer.", "sentB": "Our lead drug candidate failed to meet its primary endpoint in our earlier Phase III clinical trial.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer.", "<tag2>", "Our", "lead", "drug", "candidate", "failed", "to", "meet", "its", "primary", "endpoint", "in", "our", "earlier", "Phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer."], "wordsB": ["Our", "lead", "drug", "candidate", "failed", "to", "meet", "its", "primary", "endpoint", "in", "our", "earlier", "Phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018189847469329834, 0.13452094793319702, 0.21361075341701508, 0.14525866508483887, 0.7245062589645386, 0.536867618560791, 0.3630934953689575, 0.10132679343223572, 0.20946809649467468, 0.1695956140756607, 0.008054925128817558, 0.009023484773933887, 0.050441674888134, 0.03370215371251106, 0.023499082773923874, 0.05239931866526604, 0.05759568512439728, -1]}
{"idB": "749647_18_item1_p32_s2", "idA": "749647_17_item1_p191_s1", "sentA": "In addition, the Company is not aware of any other Phase III clinical trial for the treatment of HCC or primary liver cancer.", "sentB": "It provides a comprehensive review of ThermoDox for the treatment of primary liver cancer.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer.", "<tag2>", "It", "provides", "a", "comprehensive", "review", "of", "ThermoDox", "for", "the", "treatment", "of", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer."], "wordsB": ["It", "provides", "a", "comprehensive", "review", "of", "ThermoDox", "for", "the", "treatment", "of", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025666987523436546, 0.209542915225029, 0.10920842736959457, 0.4896032214164734, 0.5564211010932922, 0.17174264788627625, 0.8088741302490234, 0.017979692667722702, 0.016199739649891853, 0.030684180557727814, 0.009054670110344887, 0.019999023526906967, 0.016050701960921288, 0.013208332471549511, -1]}
{"idB": "749647_18_item1_p35_s1", "idA": "749647_17_item1_p191_s1", "sentA": "In addition, the Company is not aware of any other Phase III clinical trial for the treatment of HCC or primary liver cancer.", "sentB": "We may reinitiate this program following a successful trial in primary liver cancer.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer.", "<tag2>", "We", "may", "reinitiate", "this", "program", "following", "a", "successful", "trial", "in", "primary", "liver", "cancer.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "is", "not", "aware", "of", "any", "other", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "HCC", "or", "primary", "liver", "cancer."], "wordsB": ["We", "may", "reinitiate", "this", "program", "following", "a", "successful", "trial", "in", "primary", "liver", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10013571381568909, 0.13450069725513458, 0.4070263206958771, 0.11512460559606552, 0.2344595044851303, 0.2008219063282013, 0.04723237082362175, 0.21431514620780945, 0.18107469379901886, 0.025914939120411873, 0.07926786690950394, 0.05567310377955437, 0.050506167113780975, -1]}
{"idB": "749647_18_item1_p42_s2", "idA": "749647_17_item1_p192_s0", "sentA": "Studied indications for GEN-1 include ovarian cancer and glioblastoma multiforme (GBM) brain cancer.", "sentB": "The Company is continuing to evaluate the development of GEN-1 in glioblastoma multiforme brain cancer in light of other substantial competitive development programs in this indication.", "type": 2, "words": ["<tag1>", "Studied", "indications", "for", "GEN-1", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer.", "<tag2>", "The", "Company", "is", "continuing", "to", "evaluate", "the", "development", "of", "GEN-1", "in", "glioblastoma", "multiforme", "brain", "cancer", "in", "light", "of", "other", "substantial", "competitive", "development", "programs", "in", "this", "indication.", "<tag3>"], "wordsA": ["Studied", "indications", "for", "GEN-1", "include", "ovarian", "cancer", "and", "glioblastoma", "multiforme", "(GBM)", "brain", "cancer."], "wordsB": ["The", "Company", "is", "continuing", "to", "evaluate", "the", "development", "of", "GEN-1", "in", "glioblastoma", "multiforme", "brain", "cancer", "in", "light", "of", "other", "substantial", "competitive", "development", "programs", "in", "this", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007051688153296709, 0.09535159170627594, 0.018250303342938423, 0.3264625072479248, 0.1926000565290451, 0.4722796678543091, 0.09495577216148376, 0.1647939532995224, 0.0645604133605957, 0.27663978934288025, 0.021865790709853172, 0.11924131959676743, 0.02858240157365799, 0.04408420994877815, 0.061950694769620895, 0.00016506417887285352, 0.005641315132379532, 0.005293336696922779, 0.003923668991774321, 0.012362189590930939, 0.03506755828857422, 0.041417744010686874, 0.032078638672828674, 0.006651810370385647, 0.006007102783769369, 0.035312652587890625, -1]}
{"idB": "749647_18_item1_p350_s0", "idA": "749647_17_item1_p192_s2", "sentA": "Avastin is currently also being evaluated for early stage disease.", "sentB": "Our common stock is currently listed on The NASDAQ Capital Market.", "type": 2, "words": ["<tag1>", "Avastin", "is", "currently", "also", "being", "evaluated", "for", "early", "stage", "disease.", "<tag2>", "Our", "common", "stock", "is", "currently", "listed", "on", "The", "NASDAQ", "Capital", "Market.", "<tag3>"], "wordsA": ["Avastin", "is", "currently", "also", "being", "evaluated", "for", "early", "stage", "disease."], "wordsB": ["Our", "common", "stock", "is", "currently", "listed", "on", "The", "NASDAQ", "Capital", "Market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05746995285153389, 0.5055012106895447, 0.6055155396461487, 0.015400848351418972, 0.041339948773384094, 0.2814117968082428, 0.12325474619865417, 0.10451556742191315, 0.6865342855453491, 0.5005107522010803, 0.5058164596557617, -1]}
{"idB": "749647_18_item1_p276_s1", "idA": "749647_17_item1_p194_s0", "sentA": "In 1999, we entered into a license agreement with Duke University under which we received exclusive rights, subject to certain exceptions, to commercialize and use Duke s thermo-liposome technology.", "sentB": "For instance, we are party to license agreements with Duke University, under which we have exclusive rights to commercialize medical treatment products and procedures based on Duke s thermo-sensitive liposome technology.", "type": 2, "words": ["<tag1>", "In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology.", "<tag2>", "For", "instance,", "we", "are", "party", "to", "license", "agreements", "with", "Duke", "University,", "under", "which", "we", "have", "exclusive", "rights", "to", "commercialize", "medical", "treatment", "products", "and", "procedures", "based", "on", "Duke", "s", "thermo-sensitive", "liposome", "technology.", "<tag3>"], "wordsA": ["In", "1999,", "we", "entered", "into", "a", "license", "agreement", "with", "Duke", "University", "under", "which", "we", "received", "exclusive", "rights,", "subject", "to", "certain", "exceptions,", "to", "commercialize", "and", "use", "Duke", "s", "thermo-liposome", "technology."], "wordsB": ["For", "instance,", "we", "are", "party", "to", "license", "agreements", "with", "Duke", "University,", "under", "which", "we", "have", "exclusive", "rights", "to", "commercialize", "medical", "treatment", "products", "and", "procedures", "based", "on", "Duke", "s", "thermo-sensitive", "liposome", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06154981628060341, 0.11849503964185715, 0.049592841416597366, 0.05163118988275528, 0.47270509600639343, 0.12735776603221893, 0.10733957588672638, 0.10123968124389648, 0.015117702074348927, 0.027754373848438263, 0.03644435480237007, 0.011890576221048832, 0.007118778768926859, 0.020218193531036377, 0.03734034299850464, 0.0490134097635746, 0.032337017357349396, 0.013182602822780609, 0.05486314371228218, 0.5557190775871277, 0.4906812608242035, 0.3219171464443207, 0.09053277224302292, 0.19017881155014038, 0.02822098694741726, 0.018191318958997726, 0.024346986785531044, 0.014713038690388203, 0.044786237180233, 0.022927111014723778, 0.049940649420022964, -1]}
{"idB": "749647_18_item1_p244_s4", "idA": "749647_17_item1_p195_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "Such dilutive equity financings could dilute the percentage ownership of our current common stockholders and could significantly lower the market value of our common stock.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "Such", "dilutive", "equity", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["Such", "dilutive", "equity", "financings", "could", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03311016783118248, 0.4585331380367279, 0.5533849000930786, 0.5211294293403625, 0.025680094957351685, 0.2707846164703369, 0.03580784425139427, 0.24721238017082214, 0.3053332567214966, 0.02634633705019951, 0.01136716827750206, 0.06669872254133224, 0.07892642915248871, 0.0840502604842186, 0.000283090106677264, 0.011964468285441399, 0.08986788988113403, 0.37613362073898315, 0.03374478965997696, 0.08771859854459763, 0.0846138596534729, 0.0190060306340456, 0.013009121641516685, 0.05903234705328941, 0.04564641788601875, -1]}
{"idB": "749647_18_item1_p259_s0", "idA": "749647_17_item1_p195_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "Adverse events or the perception of adverse events in the field of gene therapy generally, or with respect to our product candidates specifically, may have a particularly negative impact on public perception of gene therapy and result in greater governmental regulation, including future bans or stricter standards imposed on gene-based therapy clinical trials, stricter labeling requirements and other regulatory delays in the testing or approval of our potential products.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "Adverse", "events", "or", "the", "perception", "of", "adverse", "events", "in", "the", "field", "of", "gene", "therapy", "generally,", "or", "with", "respect", "to", "our", "product", "candidates", "specifically,", "may", "have", "a", "particularly", "negative", "impact", "on", "public", "perception", "of", "gene", "therapy", "and", "result", "in", "greater", "governmental", "regulation,", "including", "future", "bans", "or", "stricter", "standards", "imposed", "on", "gene-based", "therapy", "clinical", "trials,", "stricter", "labeling", "requirements", "and", "other", "regulatory", "delays", "in", "the", "testing", "or", "approval", "of", "our", "potential", "products.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["Adverse", "events", "or", "the", "perception", "of", "adverse", "events", "in", "the", "field", "of", "gene", "therapy", "generally,", "or", "with", "respect", "to", "our", "product", "candidates", "specifically,", "may", "have", "a", "particularly", "negative", "impact", "on", "public", "perception", "of", "gene", "therapy", "and", "result", "in", "greater", "governmental", "regulation,", "including", "future", "bans", "or", "stricter", "standards", "imposed", "on", "gene-based", "therapy", "clinical", "trials,", "stricter", "labeling", "requirements", "and", "other", "regulatory", "delays", "in", "the", "testing", "or", "approval", "of", "our", "potential", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.22501182556152344, 0.2665552496910095, 0.017491502687335014, 0.00961425993591547, 0.05033808574080467, 0.01698043756186962, 0.13128985464572906, 0.10539180785417557, 0.01543259248137474, 0.014624064788222313, 0.03791661560535431, 0.03488742187619209, 0.11112480610609055, 0.10162825137376785, 0.011596049182116985, 0.0055245631374418736, 0.0050737797282636166, 0.010688861832022667, 0.010300394147634506, 0.013385504484176636, 0.0852632001042366, 0.07329820841550827, 0.01914248801767826, 0.008803840726613998, 0.015549828298389912, 0.009790160693228245, 0.02725093998014927, 0.15129496157169342, 0.040272507816553116, 0.015397774055600166, 0.05207470804452896, 0.046665940433740616, 0.024089325219392776, 0.0634709969162941, 0.05869736149907112, 0.0005654535489156842, 0.009495304897427559, 0.008031610399484634, 0.025514012202620506, 0.04496267810463905, 0.04882769659161568, 0.001592016313225031, 0.008366294205188751, 0.12937141954898834, 0.006009033415466547, 0.060396306216716766, 0.046270985156297684, 0.01412997767329216, 0.011410380713641644, 0.0876983031630516, 0.12315230071544647, 0.07033104449510574, 0.07944191247224808, 0.08518388122320175, 0.1400706171989441, 0.0875440239906311, 0.006678272038698196, 0.006275505293160677, 0.07634921371936798, 0.15094736218452454, 0.017360324040055275, 0.01213623397052288, 0.05771892890334129, 0.01379577349871397, 0.043497875332832336, 0.01653105393052101, 0.014242315664887428, 0.05165627971291542, 0.09414903074502945, -1]}
{"idB": "749647_18_item1_p276_s2", "idA": "749647_17_item1_p195_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "The Duke University license agreement contains a license fee, royalty and/or research support provisions, testing and regulatory milestones, and other performance requirements that we must meet by certain deadlines.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "The", "Duke", "University", "license", "agreement", "contains", "a", "license", "fee,", "royalty", "and/or", "research", "support", "provisions,", "testing", "and", "regulatory", "milestones,", "and", "other", "performance", "requirements", "that", "we", "must", "meet", "by", "certain", "deadlines.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["The", "Duke", "University", "license", "agreement", "contains", "a", "license", "fee,", "royalty", "and/or", "research", "support", "provisions,", "testing", "and", "regulatory", "milestones,", "and", "other", "performance", "requirements", "that", "we", "must", "meet", "by", "certain", "deadlines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01900852844119072, 0.03606833890080452, 0.03406677395105362, 0.08643417060375214, 0.12228637933731079, 0.1521499752998352, 0.07032980769872665, 0.3833056390285492, 0.46008050441741943, 0.33983737230300903, 0.08056876063346863, 0.24093212187290192, 0.3858987092971802, 0.3640742301940918, 0.009396007284522057, 0.004248928278684616, 0.005965263117104769, 0.011241422966122627, 0.005149099510163069, 0.0109172398224473, 0.05565193295478821, 0.2454281896352768, 0.012062766589224339, 0.049777332693338394, 0.0842684805393219, 0.07982560992240906, 0.025999166071414948, 0.048533886671066284, 0.07391825318336487, -1]}
{"idB": "749647_18_item1_p346_s0", "idA": "749647_17_item1_p195_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "In order to raise additional capital or pursue strategic transactions, we may in the future offer, issue or sell additional shares of our common stock or other securities convertible into or exchangeable for our common stock, including the issuance of common stock in relation to the achievement, if any, of milestones triggering our payment of earn-out consideration in connection with the EGEN acquisition.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "In", "order", "to", "raise", "additional", "capital", "or", "pursue", "strategic", "transactions,", "we", "may", "in", "the", "future", "offer,", "issue", "or", "sell", "additional", "shares", "of", "our", "common", "stock", "or", "other", "securities", "convertible", "into", "or", "exchangeable", "for", "our", "common", "stock,", "including", "the", "issuance", "of", "common", "stock", "in", "relation", "to", "the", "achievement,", "if", "any,", "of", "milestones", "triggering", "our", "payment", "of", "earn-out", "consideration", "in", "connection", "with", "the", "EGEN", "acquisition.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["In", "order", "to", "raise", "additional", "capital", "or", "pursue", "strategic", "transactions,", "we", "may", "in", "the", "future", "offer,", "issue", "or", "sell", "additional", "shares", "of", "our", "common", "stock", "or", "other", "securities", "convertible", "into", "or", "exchangeable", "for", "our", "common", "stock,", "including", "the", "issuance", "of", "common", "stock", "in", "relation", "to", "the", "achievement,", "if", "any,", "of", "milestones", "triggering", "our", "payment", "of", "earn-out", "consideration", "in", "connection", "with", "the", "EGEN", "acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016144275665283203, 0.013269354589283466, 0.011101881973445415, 0.0597832165658474, 0.05582618713378906, 0.04961971193552017, 0.009084397926926613, 0.02073279581964016, 0.04344535991549492, 0.046334363520145416, 0.035100098699331284, 0.07889434695243835, 0.018453435972332954, 0.013361570425331593, 0.02795841172337532, 0.06770850718021393, 0.08720803260803223, 0.07215289771556854, 0.46593162417411804, 0.09123105555772781, 0.10905373096466064, 0.02878861129283905, 0.02519308216869831, 0.13432997465133667, 0.08973295241594315, 0.00784385297447443, 0.007500237785279751, 0.03683173283934593, 0.01163533516228199, 0.010902512818574905, 0.010264305397868156, 0.01091329101473093, 0.009423951618373394, 0.008608081378042698, 0.023883303627371788, 0.030071131885051727, 0.0017953523201867938, 0.0038606745656579733, 0.018249819055199623, 0.008215379901230335, 0.017724083736538887, 0.019489835947752, 0.011003909632563591, 0.008379371836781502, 0.007429325953125954, 0.007733858190476894, 0.01736637018620968, 0.016413060948252678, 0.019587716087698936, 0.006608609110116959, 0.038364216685295105, 0.013622949831187725, 0.006823014467954636, 0.02305801957845688, 0.01568068563938141, 0.11361521482467651, 0.043531812727451324, 0.005606374237686396, 0.008133774623274803, 0.008704493753612041, 0.009076631627976894, 0.10960513353347778, 0.07445010542869568, -1]}
{"idB": "749647_18_item1_p358_s0", "idA": "749647_17_item1_p195_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "We have never declared or paid cash dividends on our common stock.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "We", "have", "never", "declared", "or", "paid", "cash", "dividends", "on", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["We", "have", "never", "declared", "or", "paid", "cash", "dividends", "on", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 1, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07833771407604218, 0.11316519230604172, 0.7466292977333069, 0.7843528985977173, 0.2595463991165161, 0.6872999668121338, 0.6367856860160828, 0.6868619322776794, 0.09150087088346481, 0.039276208728551865, 0.08602263778448105, 0.08683278411626816, -1]}
{"idB": "749647_18_item1_p358_s3", "idA": "749647_17_item1_p195_s0", "sentA": "In 2003, our obligations under the license agreement with Duke University with respect to the testing and regulatory milestones and other licensed technology performance deadlines were eliminated in exchange for a payment of shares of our common stock.", "sentB": "As a result, capital appreciation, if any, of our common stock will be the sole source of gain for the foreseeable future for holders of our common stock.", "type": 2, "words": ["<tag1>", "In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock.", "<tag2>", "As", "a", "result,", "capital", "appreciation,", "if", "any,", "of", "our", "common", "stock", "will", "be", "the", "sole", "source", "of", "gain", "for", "the", "foreseeable", "future", "for", "holders", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "2003,", "our", "obligations", "under", "the", "license", "agreement", "with", "Duke", "University", "with", "respect", "to", "the", "testing", "and", "regulatory", "milestones", "and", "other", "licensed", "technology", "performance", "deadlines", "were", "eliminated", "in", "exchange", "for", "a", "payment", "of", "shares", "of", "our", "common", "stock."], "wordsB": ["As", "a", "result,", "capital", "appreciation,", "if", "any,", "of", "our", "common", "stock", "will", "be", "the", "sole", "source", "of", "gain", "for", "the", "foreseeable", "future", "for", "holders", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025901200249791145, 0.023022694513201714, 0.06434134393930435, 0.5703806281089783, 0.6507376432418823, 0.04754416644573212, 0.06865471601486206, 0.043395381420850754, 0.02951781637966633, 0.1104494109749794, 0.0633402094244957, 0.04178958386182785, 0.03460881486535072, 0.025140026584267616, 0.20671990513801575, 0.1208825334906578, 0.09162180125713348, 0.250859797000885, 0.010780518874526024, 0.011058938689529896, 0.02613435871899128, 0.03491859883069992, 0.014673510566353798, 0.07563073933124542, 0.015067723579704762, 0.012907757423818111, 0.039649952203035355, 0.03730716556310654, -1]}
{"idB": "749647_18_item1_p174_s0", "idA": "749647_17_item1_p195_s1", "sentA": "The license agreement continues to be subject to agreements to pay a royalty based upon future sales.", "sentB": "After a BLA is approved, the biological product may be subject to official lot release as a condition of approval.", "type": 2, "words": ["<tag1>", "The", "license", "agreement", "continues", "to", "be", "subject", "to", "agreements", "to", "pay", "a", "royalty", "based", "upon", "future", "sales.", "<tag2>", "After", "a", "BLA", "is", "approved,", "the", "biological", "product", "may", "be", "subject", "to", "official", "lot", "release", "as", "a", "condition", "of", "approval.", "<tag3>"], "wordsA": ["The", "license", "agreement", "continues", "to", "be", "subject", "to", "agreements", "to", "pay", "a", "royalty", "based", "upon", "future", "sales."], "wordsB": ["After", "a", "BLA", "is", "approved,", "the", "biological", "product", "may", "be", "subject", "to", "official", "lot", "release", "as", "a", "condition", "of", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05459684506058693, 0.049655038863420486, 0.3396942615509033, 0.12145286798477173, 0.18287938833236694, 0.01919742114841938, 0.2788313925266266, 0.2962806522846222, 0.03692649304866791, 0.033362604677677155, 0.13050703704357147, 0.08256454765796661, 0.24584975838661194, 0.3676924407482147, 0.542651355266571, 0.010224977508187294, 0.01407934445887804, 0.03783746063709259, 0.01991390623152256, 0.10816321521997452, -1]}
{"idB": "749647_18_item1_p334_s0", "idA": "749647_17_item1_p195_s1", "sentA": "The license agreement continues to be subject to agreements to pay a royalty based upon future sales.", "sentB": "We may be subject to significant product liability claims and litigation.", "type": 2, "words": ["<tag1>", "The", "license", "agreement", "continues", "to", "be", "subject", "to", "agreements", "to", "pay", "a", "royalty", "based", "upon", "future", "sales.", "<tag2>", "We", "may", "be", "subject", "to", "significant", "product", "liability", "claims", "and", "litigation.", "<tag3>"], "wordsA": ["The", "license", "agreement", "continues", "to", "be", "subject", "to", "agreements", "to", "pay", "a", "royalty", "based", "upon", "future", "sales."], "wordsB": ["We", "may", "be", "subject", "to", "significant", "product", "liability", "claims", "and", "litigation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0537816621363163, 0.03299647569656372, 0.01343249436467886, 0.14006167650222778, 0.03655005991458893, 0.15641075372695923, 0.4907588064670563, 0.7747482061386108, 0.6160458922386169, 0.15226705372333527, 0.6208685040473938, -1]}
{"idB": "749647_18_item1_p203_s0", "idA": "749647_17_item1_p196_s0", "sentA": "In conjunction with the patent holder, we have filed international applications for a certain number of the U.S. patents.", "sentB": "The EU Data Protection Directive and Member State implementing legislation may also apply to health-related and other personal information obtained outside of the U.S.", "type": 2, "words": ["<tag1>", "In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "U.S.", "patents.", "<tag2>", "The", "EU", "Data", "Protection", "Directive", "and", "Member", "State", "implementing", "legislation", "may", "also", "apply", "to", "health-related", "and", "other", "personal", "information", "obtained", "outside", "of", "the", "U.S.", "<tag3>"], "wordsA": ["In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "U.S.", "patents."], "wordsB": ["The", "EU", "Data", "Protection", "Directive", "and", "Member", "State", "implementing", "legislation", "may", "also", "apply", "to", "health-related", "and", "other", "personal", "information", "obtained", "outside", "of", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013962640427052975, 0.2384808212518692, 0.4970356225967407, 0.39414528012275696, 0.3043728768825531, 0.01038854569196701, 0.06869471818208694, 0.08328819274902344, 0.08300236612558365, 0.1163216382265091, 0.008079096674919128, 0.008205734193325043, 0.04322085157036781, 0.036789700388908386, 0.36777400970458984, 0.06137559190392494, 0.07781088352203369, 0.26778358221054077, 0.3687502443790436, 0.057412829250097275, 0.23416832089424133, 0.17246848344802856, 0.18311132490634918, 0.3262709379196167, -1]}
{"idB": "749647_18_item1_p279_s7", "idA": "749647_17_item1_p196_s0", "sentA": "In conjunction with the patent holder, we have filed international applications for a certain number of the U.S. patents.", "sentB": "We may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office, which could result in a loss of the patent and/or substantial cost to us.", "type": 2, "words": ["<tag1>", "In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "U.S.", "patents.", "<tag2>", "We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us.", "<tag3>"], "wordsA": ["In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "U.S.", "patents."], "wordsB": ["We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030892806127667427, 0.021834328770637512, 0.035556625574827194, 0.018349867314100266, 0.18643999099731445, 0.10169874131679535, 0.5756392478942871, 0.6447140574455261, 0.06953594088554382, 0.026205044239759445, 0.020668966695666313, 0.038733214139938354, 0.08992572128772736, 0.06783907115459442, 0.21090278029441833, 0.16690883040428162, 0.00010484836820978671, 0.004591675009578466, 0.006927108857780695, 0.008353902027010918, 0.008791283704340458, 0.2769876718521118, 0.07566075772047043, 0.05031328648328781, 0.31391099095344543, 0.010441601276397705, 0.030817082151770592, 0.05978607386350632, 0.0196284968405962, 0.021414320915937424, -1]}
{"idB": "749647_18_item1_p329_s5", "idA": "749647_17_item1_p196_s0", "sentA": "In conjunction with the patent holder, we have filed international applications for a certain number of the U.S. patents.", "sentB": "Additionally, during our operating history, we have assigned many essential responsibilities to a relatively small number of individuals.", "type": 2, "words": ["<tag1>", "In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "U.S.", "patents.", "<tag2>", "Additionally,", "during", "our", "operating", "history,", "we", "have", "assigned", "many", "essential", "responsibilities", "to", "a", "relatively", "small", "number", "of", "individuals.", "<tag3>"], "wordsA": ["In", "conjunction", "with", "the", "patent", "holder,", "we", "have", "filed", "international", "applications", "for", "a", "certain", "number", "of", "the", "U.S.", "patents."], "wordsB": ["Additionally,", "during", "our", "operating", "history,", "we", "have", "assigned", "many", "essential", "responsibilities", "to", "a", "relatively", "small", "number", "of", "individuals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014978839084506035, 0.01872311532497406, 0.022768134251236916, 0.10208097100257874, 0.06978455185890198, 0.04905480146408081, 0.016829412430524826, 0.4264031648635864, 0.1641385555267334, 0.47175130248069763, 0.704962432384491, 0.018385890871286392, 0.018994519487023354, 0.0600380040705204, 0.20404064655303955, 0.161056250333786, 0.11419595032930374, 0.23630377650260925, -1]}
{"idB": "749647_18_item1_p199_s0", "idA": "749647_17_item1_p197_s0", "sentA": "Our rights under the license agreement with Duke University extend for the longer of 20 years or the end of any term for which any relevant patents are issued by the United States Patent and Trademark Office.", "sentB": "In the EU, the requirements for pricing, coverage and reimbursement of any product candidates for which we obtain regulatory approval are provided for by the national laws of EU Member States.", "type": 2, "words": ["<tag1>", "Our", "rights", "under", "the", "license", "agreement", "with", "Duke", "University", "extend", "for", "the", "longer", "of", "20", "years", "or", "the", "end", "of", "any", "term", "for", "which", "any", "relevant", "patents", "are", "issued", "by", "the", "United", "States", "Patent", "and", "Trademark", "Office.", "<tag2>", "In", "the", "EU,", "the", "requirements", "for", "pricing,", "coverage", "and", "reimbursement", "of", "any", "product", "candidates", "for", "which", "we", "obtain", "regulatory", "approval", "are", "provided", "for", "by", "the", "national", "laws", "of", "EU", "Member", "States.", "<tag3>"], "wordsA": ["Our", "rights", "under", "the", "license", "agreement", "with", "Duke", "University", "extend", "for", "the", "longer", "of", "20", "years", "or", "the", "end", "of", "any", "term", "for", "which", "any", "relevant", "patents", "are", "issued", "by", "the", "United", "States", "Patent", "and", "Trademark", "Office."], "wordsB": ["In", "the", "EU,", "the", "requirements", "for", "pricing,", "coverage", "and", "reimbursement", "of", "any", "product", "candidates", "for", "which", "we", "obtain", "regulatory", "approval", "are", "provided", "for", "by", "the", "national", "laws", "of", "EU", "Member", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.050861433148384094, 0.0403212234377861, 0.32112887501716614, 0.010992384515702724, 0.29547062516212463, 0.073866106569767, 0.24173001945018768, 0.2845270335674286, 0.06305408477783203, 0.4718554615974426, 0.062436629086732864, 0.03410974144935608, 0.26136383414268494, 0.2056700885295868, 0.00803400855511427, 0.005715586710721254, 0.009003965184092522, 0.016626974567770958, 0.06277333199977875, 0.07942883670330048, 0.0060641029849648476, 0.03704993799328804, 0.017779789865016937, 0.011315301060676575, 0.013754649087786674, 0.14264905452728271, 0.21602272987365723, 0.01900000311434269, 0.1123213842511177, 0.05978517606854439, 0.08137453347444534, -1]}
{"idB": "749647_18_item1_p218_s3", "idA": "749647_17_item1_p197_s3", "sentA": "For this technology, our license rights are worldwide, including the U.S., Canada, certain European countries, Australia, Hong Kong, and Japan.", "sentB": "For this technology, our license rights are worldwide, including the U.S., Canada, certain EU Member States, Australia, Hong Kong, and Japan.", "type": 2, "words": ["<tag1>", "For", "this", "technology,", "our", "license", "rights", "are", "worldwide,", "including", "the", "U.S.,", "Canada,", "certain", "European", "countries,", "Australia,", "Hong", "Kong,", "and", "Japan.", "<tag2>", "For", "this", "technology,", "our", "license", "rights", "are", "worldwide,", "including", "the", "U.S.,", "Canada,", "certain", "EU", "Member", "States,", "Australia,", "Hong", "Kong,", "and", "Japan.", "<tag3>"], "wordsA": ["For", "this", "technology,", "our", "license", "rights", "are", "worldwide,", "including", "the", "U.S.,", "Canada,", "certain", "European", "countries,", "Australia,", "Hong", "Kong,", "and", "Japan."], "wordsB": ["For", "this", "technology,", "our", "license", "rights", "are", "worldwide,", "including", "the", "U.S.,", "Canada,", "certain", "EU", "Member", "States,", "Australia,", "Hong", "Kong,", "and", "Japan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007272651884704828, 0.005174688063561916, 0.007689539808779955, 0.002836192725226283, 0.015058561228215694, 0.01682933233678341, 0.0096540916711092, 0.016194725409150124, 0.0055567240342497826, 0.004563407506793737, 0.01218991819769144, 0.014024210162460804, 0.029371334239840508, 0.7756574153900146, 0.7659565806388855, 0.7400859594345093, 0.01292125228792429, 0.007900695316493511, 0.00699601648375392, 0.0056304545141756535, 0.010373872704803944, -1]}
{"idB": "749647_18_item1_p197_s0", "idA": "749647_17_item1_p198_s3", "sentA": "These patents are the first in this family, which includes pending applications in the U.S., Europe and additional key commercial geographies in Asia.", "sentB": "As in the U.S., no medicinal product may be placed on the EU market unless a marketing authorization has been issued.", "type": 2, "words": ["<tag1>", "These", "patents", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia.", "<tag2>", "As", "in", "the", "U.S.,", "no", "medicinal", "product", "may", "be", "placed", "on", "the", "EU", "market", "unless", "a", "marketing", "authorization", "has", "been", "issued.", "<tag3>"], "wordsA": ["These", "patents", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia."], "wordsB": ["As", "in", "the", "U.S.,", "no", "medicinal", "product", "may", "be", "placed", "on", "the", "EU", "market", "unless", "a", "marketing", "authorization", "has", "been", "issued."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02126942202448845, 0.016043933108448982, 0.01209567952901125, 0.032944511622190475, 0.4948592483997345, 0.502165675163269, 0.5250973701477051, 0.18515050411224365, 0.13643114268779755, 0.15257740020751953, 0.1422014981508255, 0.09815312176942825, 0.2857739329338074, 0.26631054282188416, 0.04243160039186478, 0.016919830814003944, 0.05008368939161301, 0.06697531789541245, 0.04185260832309723, 0.027367882430553436, 0.030266787856817245, -1]}
{"idB": "749647_18_item1_p20_s3", "idA": "749647_17_item1_p198_s3", "sentA": "These patents are the first in this family, which includes pending applications in the U.S., Europe and additional key commercial geographies in Asia.", "sentB": "The Company fully expects to submit registrational applications in the U.S., Europe and China.", "type": 2, "words": ["<tag1>", "These", "patents", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia.", "<tag2>", "The", "Company", "fully", "expects", "to", "submit", "registrational", "applications", "in", "the", "U.S.,", "Europe", "and", "China.", "<tag3>"], "wordsA": ["These", "patents", "are", "the", "first", "in", "this", "family,", "which", "includes", "pending", "applications", "in", "the", "U.S.,", "Europe", "and", "additional", "key", "commercial", "geographies", "in", "Asia."], "wordsB": ["The", "Company", "fully", "expects", "to", "submit", "registrational", "applications", "in", "the", "U.S.,", "Europe", "and", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005760852713137865, 0.08970247209072113, 0.19535496830940247, 0.1540798842906952, 0.0905805230140686, 0.4456811547279358, 0.777622401714325, 0.539133608341217, 0.009256260469555855, 0.008548395708203316, 0.013454660773277283, 0.008848735131323338, 0.006334592588245869, 0.027454782277345657, -1]}
{"idB": "749647_18_item1_p219_s4", "idA": "749647_17_item1_p198_s4", "sentA": "This extended patent runway to 2026 allows for the evaluation of future development activities for ThermoDox and Celsion's heat-sensitive liposome technology platform.", "sentB": "This extended patent runway to 2026 allows for the evaluation of future development activities for ThermoDox and Celsion s heat-sensitive liposome technology platform.", "type": 2, "words": ["<tag1>", "This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion's", "heat-sensitive", "liposome", "technology", "platform.", "<tag2>", "This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion", "s", "heat-sensitive", "liposome", "technology", "platform.", "<tag3>"], "wordsA": ["This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion's", "heat-sensitive", "liposome", "technology", "platform."], "wordsB": ["This", "extended", "patent", "runway", "to", "2026", "allows", "for", "the", "evaluation", "of", "future", "development", "activities", "for", "ThermoDox", "and", "Celsion", "s", "heat-sensitive", "liposome", "technology", "platform."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04829166829586029, 0.3756258189678192, 0.40961992740631104, 0.3933979570865631, 0.11664561927318573, 0.1843777298927307, 0.12171674519777298, 0.0614154078066349, 0.038940656930208206, 0.187394917011261, 0.06776217371225357, 0.11360126733779907, 0.16757351160049438, 0.13378041982650757, 0.06654594838619232, 0.2536812722682953, 0.0506288968026638, 0.1984931230545044, 0.11549723893404007, 0.15165016055107117, 0.1881849467754364, 0.06301721930503845, 0.10734370350837708, -1]}
{"idB": "749647_18_item1_p32_s0", "idA": "749647_17_item1_p19_s2", "sentA": "On August 15, 2016, the Company announced updated results from its final retrospective OS analysis of the data from the HEAT Study.", "sentB": "On October 16, 2017, the Company announced the publication of the manuscript, Phase III HEAT STUDY Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions, in Clinical Cancer Research , a peer-reviewed medical journal.", "type": 2, "words": ["<tag1>", "On", "August", "15,", "2016,", "the", "Company", "announced", "updated", "results", "from", "its", "final", "retrospective", "OS", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study.", "<tag2>", "On", "October", "16,", "2017,", "the", "Company", "announced", "the", "publication", "of", "the", "manuscript,", "Phase", "III", "HEAT", "STUDY", "Adding", "Lyso-Thermosensitive", "Liposomal", "Doxorubicin", "to", "Radiofrequency", "Ablation", "in", "Patients", "with", "Unresectable", "Hepatocellular", "Carcinoma", "Lesions,", "in", "Clinical", "Cancer", "Research", ",", "a", "peer-reviewed", "medical", "journal.", "<tag3>"], "wordsA": ["On", "August", "15,", "2016,", "the", "Company", "announced", "updated", "results", "from", "its", "final", "retrospective", "OS", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study."], "wordsB": ["On", "October", "16,", "2017,", "the", "Company", "announced", "the", "publication", "of", "the", "manuscript,", "Phase", "III", "HEAT", "STUDY", "Adding", "Lyso-Thermosensitive", "Liposomal", "Doxorubicin", "to", "Radiofrequency", "Ablation", "in", "Patients", "with", "Unresectable", "Hepatocellular", "Carcinoma", "Lesions,", "in", "Clinical", "Cancer", "Research", ",", "a", "peer-reviewed", "medical", "journal."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.018750149756669998, 0.6288776397705078, 0.4704422652721405, 0.47546613216400146, 0.0022158888168632984, 0.02342895418405533, 0.03819439932703972, 0.009859539568424225, 0.12335570901632309, 0.011441185139119625, 0.008869938552379608, 0.06528595089912415, 0.02101566269993782, 0.07098710536956787, 0.04493033513426781, 0.030152639374136925, 0.0682159811258316, 0.11297763139009476, 0.05273886024951935, 0.10019052773714066, 0.009651620872318745, 0.03301183134317398, 0.02883940190076828, 0.005945323500782251, 0.03975386172533035, 0.025993216782808304, 0.19520746171474457, 0.10645291209220886, 0.06455351412296295, 0.0627264678478241, 0.004904008936136961, 0.03850873187184334, 0.031438589096069336, 0.04139664024114609, 0.00012871454237028956, 0.006507743615657091, 0.032160840928554535, 0.052303630858659744, 0.035442862659692764, -1]}
{"idB": "749647_18_item1_p32_s3", "idA": "749647_17_item1_p19_s2", "sentA": "On August 15, 2016, the Company announced updated results from its final retrospective OS analysis of the data from the HEAT Study.", "sentB": "The article details learnings from the Company s 701 patient HEAT Study and includes results from computer simulation studies and includes findings from a post hoc subgroup analysis, all of which are consistent with each other and which - when examined together - suggests a clearer understanding of a key ThermoDox heat-based mechanism of action: the longer the target tissue is heated, the greater the doxorubicin tissue concentration.", "type": 2, "words": ["<tag1>", "On", "August", "15,", "2016,", "the", "Company", "announced", "updated", "results", "from", "its", "final", "retrospective", "OS", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study.", "<tag2>", "The", "article", "details", "learnings", "from", "the", "Company", "s", "701", "patient", "HEAT", "Study", "and", "includes", "results", "from", "computer", "simulation", "studies", "and", "includes", "findings", "from", "a", "post", "hoc", "subgroup", "analysis,", "all", "of", "which", "are", "consistent", "with", "each", "other", "and", "which", "-", "when", "examined", "together", "-", "suggests", "a", "clearer", "understanding", "of", "a", "key", "ThermoDox", "heat-based", "mechanism", "of", "action:", "the", "longer", "the", "target", "tissue", "is", "heated,", "the", "greater", "the", "doxorubicin", "tissue", "concentration.", "<tag3>"], "wordsA": ["On", "August", "15,", "2016,", "the", "Company", "announced", "updated", "results", "from", "its", "final", "retrospective", "OS", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study."], "wordsB": ["The", "article", "details", "learnings", "from", "the", "Company", "s", "701", "patient", "HEAT", "Study", "and", "includes", "results", "from", "computer", "simulation", "studies", "and", "includes", "findings", "from", "a", "post", "hoc", "subgroup", "analysis,", "all", "of", "which", "are", "consistent", "with", "each", "other", "and", "which", "-", "when", "examined", "together", "-", "suggests", "a", "clearer", "understanding", "of", "a", "key", "ThermoDox", "heat-based", "mechanism", "of", "action:", "the", "longer", "the", "target", "tissue", "is", "heated,", "the", "greater", "the", "doxorubicin", "tissue", "concentration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007946567609906197, 0.1118735745549202, 0.09009350091218948, 0.2636101245880127, 0.03015509992837906, 0.009152565151453018, 0.0416194312274456, 0.027497965842485428, 0.3176281750202179, 0.2407613843679428, 0.10470974445343018, 0.08388763666152954, 0.0004138234944548458, 0.021530045196413994, 0.04325816407799721, 0.016113130375742912, 0.2311861366033554, 0.21008983254432678, 0.1197163462638855, 0.0005181938176974654, 0.00954452995210886, 0.044334474951028824, 0.0073064398020505905, 0.006946541368961334, 0.09972436726093292, 0.15919741988182068, 0.18305960297584534, 0.12232688814401627, 0.014192326925694942, 0.0075706313364207745, 0.0006386198801919818, 0.014964359812438488, 0.0741971954703331, 0.042066335678100586, 0.04670364409685135, 0.03245902433991432, 0.0003386827593203634, 0.0005125954048708081, 0.009363636374473572, 0.013204436749219894, 0.024399662390351295, 0.017850544303655624, 0.0018899425631389022, 0.015828832983970642, 0.010745386593043804, 0.03794553503394127, 0.049195464700460434, 0.007046495098620653, 0.006552585866302252, 0.01588393934071064, 0.03510158136487007, 0.0639425739645958, 0.03365902602672577, 0.021278422325849533, 0.02742506004869938, 0.05327882245182991, 0.20663022994995117, 0.041084256023168564, 0.16769056022167206, 0.23484747111797333, 0.18148356676101685, 0.25454413890838623, 0.0488082580268383, 0.24099938571453094, 0.03744770213961601, 0.20425836741924286, 0.3126004636287689, 0.20384617149829865, -1]}
{"idB": "749647_18_item1_p279_s1", "idA": "749647_17_item1_p200_s0", "sentA": "For the TheraPlas technology, we own three U.S. and international patents and related applications with claims and methods and compositions of matters that cover various aspects of TheraPlas and GEN-1 technologies, with expiration dates ranging from 2020 to 2028.", "sentB": "We own various U.S. and international patents and have pending U.S. and international patent applications that cover various aspects of our technologies.", "type": 2, "words": ["<tag1>", "For", "the", "TheraPlas", "technology,", "we", "own", "three", "U.S.", "and", "international", "patents", "and", "related", "applications", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "TheraPlas", "and", "GEN-1", "technologies,", "with", "expiration", "dates", "ranging", "from", "2020", "to", "2028.", "<tag2>", "We", "own", "various", "U.S.", "and", "international", "patents", "and", "have", "pending", "U.S.", "and", "international", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag3>"], "wordsA": ["For", "the", "TheraPlas", "technology,", "we", "own", "three", "U.S.", "and", "international", "patents", "and", "related", "applications", "with", "claims", "and", "methods", "and", "compositions", "of", "matters", "that", "cover", "various", "aspects", "of", "TheraPlas", "and", "GEN-1", "technologies,", "with", "expiration", "dates", "ranging", "from", "2020", "to", "2028."], "wordsB": ["We", "own", "various", "U.S.", "and", "international", "patents", "and", "have", "pending", "U.S.", "and", "international", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.026343204081058502, 0.02632436342537403, 0.021716061979532242, 0.013165982440114021, 0.0052768392488360405, 0.016778362914919853, 0.06707591563463211, 0.005922764539718628, 0.007011476904153824, 0.1353234499692917, 0.068386971950531, 0.008375882171094418, 0.025445133447647095, 0.13187681138515472, 0.08666626363992691, 0.007281486876308918, 0.011065083555877209, 0.009161243215203285, 0.01282478030771017, 0.005872878711670637, 0.025170616805553436, 0.06411011517047882, -1]}
{"idB": "749647_18_item1_p279_s2", "idA": "749647_17_item1_p201_s0", "sentA": "There can be no assurance that an issued patent will remain valid and enforceable in a court of law through the entire patent term.", "sentB": "There can be no assurance that patents that have issued will be held valid and enforceable in a court of law through the entire patent term.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "an", "issued", "patent", "will", "remain", "valid", "and", "enforceable", "in", "a", "court", "of", "law", "through", "the", "entire", "patent", "term.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "held", "valid", "and", "enforceable", "in", "a", "court", "of", "law", "through", "the", "entire", "patent", "term.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "an", "issued", "patent", "will", "remain", "valid", "and", "enforceable", "in", "a", "court", "of", "law", "through", "the", "entire", "patent", "term."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "held", "valid", "and", "enforceable", "in", "a", "court", "of", "law", "through", "the", "entire", "patent", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006058774422854185, 0.011605930514633656, 0.008475717157125473, 0.0887099876999855, 0.10776904970407486, 0.04922262206673622, 0.36447808146476746, 0.011787120252847672, 0.012558909133076668, 0.017835335806012154, 0.10673512518405914, 0.1761195808649063, 0.5315191745758057, 0.28366875648498535, 0.06954064220190048, 0.1240425780415535, 0.014858071692287922, 0.006724772974848747, 0.010601533576846123, 0.009872179478406906, 0.01186793576925993, 0.006396837532520294, 0.006641795393079519, 0.010167324915528297, 0.01636950671672821, 0.012801934033632278, -1]}
{"idB": "749647_18_item1_p279_s3", "idA": "749647_17_item1_p201_s1", "sentA": "Should the validity of a patent be challenged, the legal process associated with defending the patent can be costly and time consuming.", "sentB": "Even for patents that are held valid and enforceable, the legal process associated with obtaining such a judgment is time consuming and costly.", "type": 2, "words": ["<tag1>", "Should", "the", "validity", "of", "a", "patent", "be", "challenged,", "the", "legal", "process", "associated", "with", "defending", "the", "patent", "can", "be", "costly", "and", "time", "consuming.", "<tag2>", "Even", "for", "patents", "that", "are", "held", "valid", "and", "enforceable,", "the", "legal", "process", "associated", "with", "obtaining", "such", "a", "judgment", "is", "time", "consuming", "and", "costly.", "<tag3>"], "wordsA": ["Should", "the", "validity", "of", "a", "patent", "be", "challenged,", "the", "legal", "process", "associated", "with", "defending", "the", "patent", "can", "be", "costly", "and", "time", "consuming."], "wordsB": ["Even", "for", "patents", "that", "are", "held", "valid", "and", "enforceable,", "the", "legal", "process", "associated", "with", "obtaining", "such", "a", "judgment", "is", "time", "consuming", "and", "costly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08109092712402344, 0.03309341147542, 0.11984339356422424, 0.015040664933621883, 0.03223718702793121, 0.08501451462507248, 0.1102171540260315, 0.046573515981435776, 0.21585705876350403, 0.00932223442941904, 0.0566498227417469, 0.06693925708532333, 0.014232671819627285, 0.011679176241159439, 0.436476469039917, 0.11886909604072571, 0.06394690275192261, 0.32795387506484985, 0.023276450112462044, 0.02606150694191456, 0.024900374934077263, 0.007042782846838236, 0.023773619905114174, -1]}
{"idB": "749647_18_item1_p281_s0", "idA": "749647_17_item1_p201_s1", "sentA": "Should the validity of a patent be challenged, the legal process associated with defending the patent can be costly and time consuming.", "sentB": "The coverage claimed in a patent application can be significantly reduced before the patent is issued.", "type": 2, "words": ["<tag1>", "Should", "the", "validity", "of", "a", "patent", "be", "challenged,", "the", "legal", "process", "associated", "with", "defending", "the", "patent", "can", "be", "costly", "and", "time", "consuming.", "<tag2>", "The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued.", "<tag3>"], "wordsA": ["Should", "the", "validity", "of", "a", "patent", "be", "challenged,", "the", "legal", "process", "associated", "with", "defending", "the", "patent", "can", "be", "costly", "and", "time", "consuming."], "wordsB": ["The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.029403051361441612, 0.5340999364852905, 0.08301480114459991, 0.04643082991242409, 0.02913713827729225, 0.07103464007377625, 0.07137595117092133, 0.05548926815390587, 0.17678527534008026, 0.30923375487327576, 0.6251083016395569, 0.19952136278152466, 0.065394826233387, 0.2282613217830658, 0.17874573171138763, 0.21516430377960205, -1]}
{"idB": "749647_18_item1_p279_s4", "idA": "749647_17_item1_p201_s2", "sentA": "Issued patents can be subject to oppositions, interferences and other third party challenges that can result in the revocation of the patent or maintenance of the patent in amended form (and potentially in a form that renders the patent without commercially relevant or broad coverage).", "sentB": "Additionally, issued patents can be subject to opposition, interferences or other proceedings that can result in the revocation of the patent or maintenance of the patent in amended form (and potentially in a form that renders the patent without commercially relevant or broad coverage).", "type": 2, "words": ["<tag1>", "Issued", "patents", "can", "be", "subject", "to", "oppositions,", "interferences", "and", "other", "third", "party", "challenges", "that", "can", "result", "in", "the", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "or", "broad", "coverage).", "<tag2>", "Additionally,", "issued", "patents", "can", "be", "subject", "to", "opposition,", "interferences", "or", "other", "proceedings", "that", "can", "result", "in", "the", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "or", "broad", "coverage).", "<tag3>"], "wordsA": ["Issued", "patents", "can", "be", "subject", "to", "oppositions,", "interferences", "and", "other", "third", "party", "challenges", "that", "can", "result", "in", "the", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "or", "broad", "coverage)."], "wordsB": ["Additionally,", "issued", "patents", "can", "be", "subject", "to", "opposition,", "interferences", "or", "other", "proceedings", "that", "can", "result", "in", "the", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "or", "broad", "coverage)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08986243605613708, 0.09728024899959564, 0.15503965318202972, 0.023368818685412407, 0.018456798046827316, 0.04289720207452774, 0.02705472894012928, 0.12013155221939087, 0.09092359244823456, 0.014553138054907322, 0.02792282961308956, 0.18873514235019684, 0.015709111467003822, 0.017332307994365692, 0.016430197283625603, 0.025547724217176437, 0.0324973464012146, 0.5849710702896118, 0.09542464464902878, 0.07152191549539566, 0.2634444236755371, 0.021709496155381203, 0.05389411002397537, 0.02496250905096531, 0.026200763881206512, 0.1079069972038269, 0.02329435385763645, 0.045282769948244095, 0.04432348906993866, 0.007096797693520784, 0.023320654407143593, 0.01597844809293747, 0.017116984352469444, 0.02735668234527111, 0.012648324482142925, 0.024711089208722115, 0.01737416721880436, 0.09971476346254349, 0.40603017807006836, 0.050981175154447556, 0.05018669739365578, 0.01783187873661518, 0.03169574216008186, 0.05511286109685898, -1]}
{"idB": "749647_18_item1_p261_s2", "idA": "749647_17_item1_p202_s0", "sentA": "Competitors may be able to circumvent our patents.", "sentB": "This governmental oversight may be particularly strict with respect to gene-based therapies.", "type": 2, "words": ["<tag1>", "Competitors", "may", "be", "able", "to", "circumvent", "our", "patents.", "<tag2>", "This", "governmental", "oversight", "may", "be", "particularly", "strict", "with", "respect", "to", "gene-based", "therapies.", "<tag3>"], "wordsA": ["Competitors", "may", "be", "able", "to", "circumvent", "our", "patents."], "wordsB": ["This", "governmental", "oversight", "may", "be", "particularly", "strict", "with", "respect", "to", "gene-based", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.011793437413871288, 0.346257746219635, 0.35392436385154724, 0.026043832302093506, 0.016222182661294937, 0.02694876119494438, 0.07705926150083542, 0.006291186902672052, 0.03883117809891701, 0.048185110092163086, 0.5317566990852356, 0.42043501138687134, -1]}
{"idB": "749647_18_item1_p267_s0", "idA": "749647_17_item1_p202_s0", "sentA": "Competitors may be able to circumvent our patents.", "sentB": "We have devoted our resources to developing a new generation of products and will not be able to market these products until we have completed clinical trials and obtain all necessary governmental approvals.", "type": 2, "words": ["<tag1>", "Competitors", "may", "be", "able", "to", "circumvent", "our", "patents.", "<tag2>", "We", "have", "devoted", "our", "resources", "to", "developing", "a", "new", "generation", "of", "products", "and", "will", "not", "be", "able", "to", "market", "these", "products", "until", "we", "have", "completed", "clinical", "trials", "and", "obtain", "all", "necessary", "governmental", "approvals.", "<tag3>"], "wordsA": ["Competitors", "may", "be", "able", "to", "circumvent", "our", "patents."], "wordsB": ["We", "have", "devoted", "our", "resources", "to", "developing", "a", "new", "generation", "of", "products", "and", "will", "not", "be", "able", "to", "market", "these", "products", "until", "we", "have", "completed", "clinical", "trials", "and", "obtain", "all", "necessary", "governmental", "approvals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.056376323103904724, 0.020544305443763733, 0.08112142980098724, 0.07999978214502335, 0.124063640832901, 0.04309723153710365, 0.22242888808250427, 0.04159492254257202, 0.05178428068757057, 0.08693934977054596, 0.07811804115772247, 0.18649956583976746, 9.843092993833125e-05, 0.029454896226525307, 0.3538252115249634, 0.09737895429134369, 0.2602393627166748, 0.24157656729221344, 0.4115482568740845, 0.06784404814243317, 0.16316980123519897, 0.022708961740136147, 0.019491028040647507, 0.03054681234061718, 0.1009393185377121, 0.07036218047142029, 0.09076163917779922, 0.0001264327293029055, 0.04828709363937378, 0.030507799237966537, 0.04698321223258972, 0.06661055982112885, 0.11787105351686478, -1]}
{"idB": "749647_18_item1_p279_s5", "idA": "749647_17_item1_p202_s0", "sentA": "Competitors may be able to circumvent our patents.", "sentB": "Further, our competitors may be able to circumvent and otherwise design around our patents.", "type": 2, "words": ["<tag1>", "Competitors", "may", "be", "able", "to", "circumvent", "our", "patents.", "<tag2>", "Further,", "our", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents.", "<tag3>"], "wordsA": ["Competitors", "may", "be", "able", "to", "circumvent", "our", "patents."], "wordsB": ["Further,", "our", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.029196344316005707, 0.007524399086833, 0.041162747889757156, 0.010293974541127682, 0.005712165497243404, 0.011127369478344917, 0.006191819440573454, 0.031236780807375908, 0.05057220160961151, 0.5503484606742859, 0.7806780934333801, 0.36852720379829407, 0.10826098173856735, 0.32927921414375305, -1]}
{"idB": "749647_18_item1_p335_s4", "idA": "749647_17_item1_p202_s0", "sentA": "Competitors may be able to circumvent our patents.", "sentB": "Additionally, we may not be able to maintain our product liability insurance at an acceptable cost, if at all.", "type": 2, "words": ["<tag1>", "Competitors", "may", "be", "able", "to", "circumvent", "our", "patents.", "<tag2>", "Additionally,", "we", "may", "not", "be", "able", "to", "maintain", "our", "product", "liability", "insurance", "at", "an", "acceptable", "cost,", "if", "at", "all.", "<tag3>"], "wordsA": ["Competitors", "may", "be", "able", "to", "circumvent", "our", "patents."], "wordsB": ["Additionally,", "we", "may", "not", "be", "able", "to", "maintain", "our", "product", "liability", "insurance", "at", "an", "acceptable", "cost,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01729349046945572, 0.09205405414104462, 0.059713877737522125, 0.4005407392978668, 0.14468158781528473, 0.351913720369339, 0.27937066555023193, 0.5997087955474854, 0.23903866112232208, 0.5101718306541443, 0.6954193711280823, 0.7583143711090088, 0.032134756445884705, 0.024916473776102066, 0.05549521744251251, 0.05806051567196846, 0.01333641167730093, 0.011252771131694317, 0.012356305494904518, -1]}
{"idB": "749647_18_item1_p279_s6", "idA": "749647_17_item1_p203_s0", "sentA": "Development and commercialization of pharmaceutical products can be subject to substantial delays and it is possible that at the time of commercialization any patent covering the product has expired or will be in force for only a short period of time following commercialization.", "sentB": "Even if a patent is issued and enforceable, because development and commercialization of pharmaceutical products can be subject to substantial delays, patents may expire early and provide only a short period of protection, if any, following the commercialization of products encompassed by our patents.", "type": 2, "words": ["<tag1>", "Development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays", "and", "it", "is", "possible", "that", "at", "the", "time", "of", "commercialization", "any", "patent", "covering", "the", "product", "has", "expired", "or", "will", "be", "in", "force", "for", "only", "a", "short", "period", "of", "time", "following", "commercialization.", "<tag2>", "Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents.", "<tag3>"], "wordsA": ["Development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays", "and", "it", "is", "possible", "that", "at", "the", "time", "of", "commercialization", "any", "patent", "covering", "the", "product", "has", "expired", "or", "will", "be", "in", "force", "for", "only", "a", "short", "period", "of", "time", "following", "commercialization."], "wordsB": ["Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03166264295578003, 0.023463323712348938, 0.011287149041891098, 0.18537473678588867, 0.21278531849384308, 0.1634903997182846, 0.09794668853282928, 0.48207736015319824, 0.004298713989555836, 0.00410609832033515, 0.0023982226848602295, 0.0035315356217324734, 0.0022347981575876474, 0.008441347628831863, 0.007523516658693552, 0.004999225959181786, 0.004711030051112175, 0.00633935397490859, 0.0036586797796189785, 0.008638476021587849, 0.013559509068727493, 0.20332767069339752, 0.05254894122481346, 0.32950302958488464, 0.10213593393564224, 0.004879914689809084, 0.02709205448627472, 0.025166310369968414, 0.0056287674233317375, 0.01586751453578472, 0.024499570950865746, 0.01448754407465458, 0.06056709587574005, 0.011901489458978176, 0.010782752186059952, 0.008998082019388676, 0.005891149863600731, 0.025081316009163857, 0.006607769522815943, 0.07170869410037994, 0.09793016314506531, 0.051224350929260254, 0.026579823344945908, 0.14068885147571564, -1]}
{"idB": "749647_18_item1_p203_s1", "idA": "749647_17_item1_p204_s0", "sentA": "We cannot predict with any certainty if any third party U.S. or foreign patent rights, other proprietary rights, will be deemed infringed by the use of our technology.", "sentB": "The Directive will be replaced by the EU General Data Protection Regulation in May 2018.", "type": 2, "words": ["<tag1>", "We", "cannot", "predict", "with", "any", "certainty", "if", "any", "third", "party", "U.S.", "or", "foreign", "patent", "rights,", "other", "proprietary", "rights,", "will", "be", "deemed", "infringed", "by", "the", "use", "of", "our", "technology.", "<tag2>", "The", "Directive", "will", "be", "replaced", "by", "the", "EU", "General", "Data", "Protection", "Regulation", "in", "May", "2018.", "<tag3>"], "wordsA": ["We", "cannot", "predict", "with", "any", "certainty", "if", "any", "third", "party", "U.S.", "or", "foreign", "patent", "rights,", "other", "proprietary", "rights,", "will", "be", "deemed", "infringed", "by", "the", "use", "of", "our", "technology."], "wordsB": ["The", "Directive", "will", "be", "replaced", "by", "the", "EU", "General", "Data", "Protection", "Regulation", "in", "May", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.022853264585137367, 0.2906852662563324, 0.076866514980793, 0.10831623524427414, 0.3299700915813446, 0.05208761990070343, 0.05314537137746811, 0.172017902135849, 0.2210497260093689, 0.6674547791481018, 0.5998284816741943, 0.2709190547466278, 0.042839184403419495, 0.07813846319913864, 0.11413345485925674, -1]}
{"idB": "749647_18_item1_p327_s1", "idA": "749647_17_item1_p204_s0", "sentA": "We cannot predict with any certainty if any third party U.S. or foreign patent rights, other proprietary rights, will be deemed infringed by the use of our technology.", "sentB": "Many possible treatments that are being researched, if successfully developed, may not require, or may supplant, the use of our technologies.", "type": 2, "words": ["<tag1>", "We", "cannot", "predict", "with", "any", "certainty", "if", "any", "third", "party", "U.S.", "or", "foreign", "patent", "rights,", "other", "proprietary", "rights,", "will", "be", "deemed", "infringed", "by", "the", "use", "of", "our", "technology.", "<tag2>", "Many", "possible", "treatments", "that", "are", "being", "researched,", "if", "successfully", "developed,", "may", "not", "require,", "or", "may", "supplant,", "the", "use", "of", "our", "technologies.", "<tag3>"], "wordsA": ["We", "cannot", "predict", "with", "any", "certainty", "if", "any", "third", "party", "U.S.", "or", "foreign", "patent", "rights,", "other", "proprietary", "rights,", "will", "be", "deemed", "infringed", "by", "the", "use", "of", "our", "technology."], "wordsB": ["Many", "possible", "treatments", "that", "are", "being", "researched,", "if", "successfully", "developed,", "may", "not", "require,", "or", "may", "supplant,", "the", "use", "of", "our", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.14867304265499115, 0.1619422733783722, 0.3841506540775299, 0.0053304629400372505, 0.010668730363249779, 0.01651490479707718, 0.03035002201795578, 0.009489952586591244, 0.03996293619275093, 0.03994164988398552, 0.06044909730553627, 0.24991446733474731, 0.26553478837013245, 0.012134736403822899, 0.1027182787656784, 0.5192619562149048, 0.052876174449920654, 0.1698029488325119, 0.04966897517442703, 0.03788797929883003, 0.14489510655403137, -1]}
{"idB": "749647_18_item1_p293_s4", "idA": "749647_17_item1_p204_s1", "sentA": "Nor can we predict with certainty which, if any, of these rights will or may be asserted against us by third parties.", "sentB": "Our reliance on third parties that we do not control does not relieve us of these responsibilities and requirements.", "type": 2, "words": ["<tag1>", "Nor", "can", "we", "predict", "with", "certainty", "which,", "if", "any,", "of", "these", "rights", "will", "or", "may", "be", "asserted", "against", "us", "by", "third", "parties.", "<tag2>", "Our", "reliance", "on", "third", "parties", "that", "we", "do", "not", "control", "does", "not", "relieve", "us", "of", "these", "responsibilities", "and", "requirements.", "<tag3>"], "wordsA": ["Nor", "can", "we", "predict", "with", "certainty", "which,", "if", "any,", "of", "these", "rights", "will", "or", "may", "be", "asserted", "against", "us", "by", "third", "parties."], "wordsB": ["Our", "reliance", "on", "third", "parties", "that", "we", "do", "not", "control", "does", "not", "relieve", "us", "of", "these", "responsibilities", "and", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.052760668098926544, 0.4206116199493408, 0.2050519436597824, 0.1811913251876831, 0.20308376848697662, 0.013365971855819225, 0.042446233332157135, 0.19928038120269775, 0.22078226506710052, 0.2078053504228592, 0.06063959002494812, 0.0728454440832138, 0.2551710903644562, 0.0647551566362381, 0.05804523825645447, 0.0506565235555172, 0.11306758970022202, 0.05475630238652229, 0.09585077315568924, -1]}
{"idB": "749647_18_item1_p244_s5", "idA": "749647_17_item1_p204_s3", "sentA": "Furthermore, parties making such claims may be able to obtain injunctive or other equitable relief, which could effectively block our ability to develop or commercialize some or all of our products in the U.S. and abroad, and could result in the award of substantial damages.", "sentB": "In addition, a financing could result in the issuance of new securities that may have rights, preferences or privileges senior to those of our existing stockholders.", "type": 2, "words": ["<tag1>", "Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages.", "<tag2>", "In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders.", "<tag3>"], "wordsA": ["Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages."], "wordsB": ["In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.012943821959197521, 0.010516415350139141, 0.006703974213451147, 0.12504354119300842, 0.01213296502828598, 0.030496394261717796, 0.018765198066830635, 0.018363069742918015, 0.6466302275657654, 0.22267648577690125, 0.41352689266204834, 0.6012477278709412, 0.00036532938247546554, 0.006815912667661905, 0.009765367954969406, 0.031079893931746483, 0.024561787024140358, 0.012563386932015419, 0.03538348898291588, 0.027361765503883362, 0.010775699280202389, 0.006039470434188843, 0.006733709946274757, 0.008912453427910805, 0.04109816625714302, 0.09271657466888428, -1]}
{"idB": "749647_18_item1_p248_s2", "idA": "749647_17_item1_p204_s3", "sentA": "Furthermore, parties making such claims may be able to obtain injunctive or other equitable relief, which could effectively block our ability to develop or commercialize some or all of our products in the U.S. and abroad, and could result in the award of substantial damages.", "sentB": "In addition, our drug candidates may have undesirable side effects or other unexpected characteristics that could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restricted label or the delay or denial of regulatory approval by regulatory authorities.", "type": 2, "words": ["<tag1>", "Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages.", "<tag2>", "In", "addition,", "our", "drug", "candidates", "may", "have", "undesirable", "side", "effects", "or", "other", "unexpected", "characteristics", "that", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities.", "<tag3>"], "wordsA": ["Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages."], "wordsB": ["In", "addition,", "our", "drug", "candidates", "may", "have", "undesirable", "side", "effects", "or", "other", "unexpected", "characteristics", "that", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01348599512130022, 0.011877691373229027, 0.05668415129184723, 0.3863041400909424, 0.36929941177368164, 0.01672997511923313, 0.051667049527168274, 0.2828286290168762, 0.15226121246814728, 0.11707275360822678, 0.006198122166097164, 0.010336157865822315, 0.06893619894981384, 0.06643379479646683, 0.000483302166685462, 0.005337637849152088, 0.010996365919709206, 0.02546779252588749, 0.007192889228463173, 0.038273394107818604, 0.05525224283337593, 0.011014524847269058, 0.05075345188379288, 0.05401897430419922, 0.021201111376285553, 0.16163897514343262, 0.08082219958305359, 0.13072261214256287, 0.0002436490321997553, 0.005203354638069868, 0.006245282478630543, 0.006699022836983204, 0.008457662537693977, 0.014889282174408436, 0.15625131130218506, 0.03882989287376404, 0.005179486703127623, 0.009461792185902596, 0.07466446608304977, 0.02243770658969879, 0.23932014405727386, 0.11856111884117126, 0.17288078367710114, 0.18404127657413483, 0.010902795940637589, 0.040231719613075256, 0.04159560799598694, -1]}
{"idB": "749647_18_item1_p283_s1", "idA": "749647_17_item1_p204_s3", "sentA": "Furthermore, parties making such claims may be able to obtain injunctive or other equitable relief, which could effectively block our ability to develop or commercialize some or all of our products in the U.S. and abroad, and could result in the award of substantial damages.", "sentB": "In those instances where we seek an intellectual property license from another, we may not be able to obtain the license on a commercially reasonable basis, if at all, thereby raising concerns on our ability to freely commercialize our technologies or products.", "type": 2, "words": ["<tag1>", "Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages.", "<tag2>", "In", "those", "instances", "where", "we", "seek", "an", "intellectual", "property", "license", "from", "another,", "we", "may", "not", "be", "able", "to", "obtain", "the", "license", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all,", "thereby", "raising", "concerns", "on", "our", "ability", "to", "freely", "commercialize", "our", "technologies", "or", "products.", "<tag3>"], "wordsA": ["Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages."], "wordsB": ["In", "those", "instances", "where", "we", "seek", "an", "intellectual", "property", "license", "from", "another,", "we", "may", "not", "be", "able", "to", "obtain", "the", "license", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all,", "thereby", "raising", "concerns", "on", "our", "ability", "to", "freely", "commercialize", "our", "technologies", "or", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004903546068817377, 0.00691528944298625, 0.022760964930057526, 0.005442959722131491, 0.04939901828765869, 0.22904552519321442, 0.11639535427093506, 0.23687836527824402, 0.2612505257129669, 0.4447629451751709, 0.040093742311000824, 0.09261590242385864, 0.015920301899313927, 0.06955672800540924, 0.5467521548271179, 0.17162150144577026, 0.33978888392448425, 0.24020841717720032, 0.3443872332572937, 0.09157069772481918, 0.24542443454265594, 0.06605125218629837, 0.04704379290342331, 0.16099585592746735, 0.11949867010116577, 0.08316518366336823, 0.012644448317587376, 0.01853836514055729, 0.019046291708946228, 0.008158436045050621, 0.008993379771709442, 0.026965267956256866, 0.012677961029112339, 0.016967054456472397, 0.041966646909713745, 0.0395437628030777, 0.22739066183567047, 0.12321051955223083, 0.013059164397418499, 0.025994867086410522, 0.014461072161793709, 0.02854222059249878, -1]}
{"idB": "749647_18_item1_p336_s0", "idA": "749647_17_item1_p204_s3", "sentA": "Furthermore, parties making such claims may be able to obtain injunctive or other equitable relief, which could effectively block our ability to develop or commercialize some or all of our products in the U.S. and abroad, and could result in the award of substantial damages.", "sentB": "Our internal computer systems, or those of our CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our product development programs.", "type": 2, "words": ["<tag1>", "Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages.", "<tag2>", "Our", "internal", "computer", "systems,", "or", "those", "of", "our", "CROs", "or", "other", "contractors", "or", "consultants,", "may", "fail", "or", "suffer", "security", "breaches,", "which", "could", "result", "in", "a", "material", "disruption", "of", "our", "product", "development", "programs.", "<tag3>"], "wordsA": ["Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages."], "wordsB": ["Our", "internal", "computer", "systems,", "or", "those", "of", "our", "CROs", "or", "other", "contractors", "or", "consultants,", "may", "fail", "or", "suffer", "security", "breaches,", "which", "could", "result", "in", "a", "material", "disruption", "of", "our", "product", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05814331769943237, 0.31977659463882446, 0.60917729139328, 0.5603545308113098, 0.010401754640042782, 0.00932300090789795, 0.006019694730639458, 0.007028595544397831, 0.035255976021289825, 0.011283104307949543, 0.010503399185836315, 0.040053557604551315, 0.024179479107260704, 0.04555913060903549, 0.024709340184926987, 0.30936792492866516, 0.02027713507413864, 0.13619588315486908, 0.12462574243545532, 0.1184321939945221, 0.000346871733199805, 0.011138476431369781, 0.008090059272944927, 0.009704695083200932, 0.008105303160846233, 0.03512214869260788, 0.18214982748031616, 0.016813261434435844, 0.01354200579226017, 0.07553083449602127, 0.06870725750923157, 0.059101201593875885, -1]}
{"idB": "749647_18_item1_p356_s5", "idA": "749647_17_item1_p204_s3", "sentA": "Furthermore, parties making such claims may be able to obtain injunctive or other equitable relief, which could effectively block our ability to develop or commercialize some or all of our products in the U.S. and abroad, and could result in the award of substantial damages.", "sentB": "Future changes in our stock ownership, some of which are outside of our control, could result in an ownership change under Section 382 of the Code, which would significantly limit our ability to utilize NOLs to offset future taxable income.", "type": 2, "words": ["<tag1>", "Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages.", "<tag2>", "Future", "changes", "in", "our", "stock", "ownership,", "some", "of", "which", "are", "outside", "of", "our", "control,", "could", "result", "in", "an", "ownership", "change", "under", "Section", "382", "of", "the", "Code,", "which", "would", "significantly", "limit", "our", "ability", "to", "utilize", "NOLs", "to", "offset", "future", "taxable", "income.", "<tag3>"], "wordsA": ["Furthermore,", "parties", "making", "such", "claims", "may", "be", "able", "to", "obtain", "injunctive", "or", "other", "equitable", "relief,", "which", "could", "effectively", "block", "our", "ability", "to", "develop", "or", "commercialize", "some", "or", "all", "of", "our", "products", "in", "the", "U.S.", "and", "abroad,", "and", "could", "result", "in", "the", "award", "of", "substantial", "damages."], "wordsB": ["Future", "changes", "in", "our", "stock", "ownership,", "some", "of", "which", "are", "outside", "of", "our", "control,", "could", "result", "in", "an", "ownership", "change", "under", "Section", "382", "of", "the", "Code,", "which", "would", "significantly", "limit", "our", "ability", "to", "utilize", "NOLs", "to", "offset", "future", "taxable", "income."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10780051350593567, 0.2732967436313629, 0.11862526088953018, 0.11623115837574005, 0.5257202982902527, 0.46717211604118347, 0.011965027078986168, 0.005105909425765276, 0.004229825455695391, 0.02519264817237854, 0.24450890719890594, 0.20108555257320404, 0.19670388102531433, 0.24954719841480255, 0.006365153938531876, 0.006613306235522032, 0.00508869206532836, 0.005452301353216171, 0.1498144119977951, 0.1625557839870453, 0.01426069624722004, 0.04464532434940338, 0.09419109672307968, 0.009156318381428719, 0.010619986802339554, 0.021123871207237244, 0.0003196384641341865, 0.007235538214445114, 0.012233459390699863, 0.11008960753679276, 0.03901563212275505, 0.09677296131849289, 0.06617080420255661, 0.13656564056873322, 0.19909995794296265, 0.007792325224727392, 0.0392063744366169, 0.023356543853878975, 0.03178326040506363, 0.05086908116936684, -1]}
{"idB": "749647_18_item1_p203_s2", "idA": "749647_17_item1_p205_s0", "sentA": "In the event of a claim of infringement, we or our partners may be required to obtain one or more licenses from a third party.", "sentB": "The Regulation will increase our responsibility and liability in relation to personal data that we process, and we may be required to put in place additional mechanisms to ensure compliance with the new EU data protection rules.", "type": 2, "words": ["<tag1>", "In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party.", "<tag2>", "The", "Regulation", "will", "increase", "our", "responsibility", "and", "liability", "in", "relation", "to", "personal", "data", "that", "we", "process,", "and", "we", "may", "be", "required", "to", "put", "in", "place", "additional", "mechanisms", "to", "ensure", "compliance", "with", "the", "new", "EU", "data", "protection", "rules.", "<tag3>"], "wordsA": ["In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party."], "wordsB": ["The", "Regulation", "will", "increase", "our", "responsibility", "and", "liability", "in", "relation", "to", "personal", "data", "that", "we", "process,", "and", "we", "may", "be", "required", "to", "put", "in", "place", "additional", "mechanisms", "to", "ensure", "compliance", "with", "the", "new", "EU", "data", "protection", "rules."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008903940208256245, 0.10048619657754898, 0.02627239190042019, 0.06188296526670456, 0.07587029784917831, 0.26737067103385925, 0.17080926895141602, 0.3581303656101227, 0.027851304039359093, 0.09090758860111237, 0.08165011554956436, 0.35941094160079956, 0.550317108631134, 0.008331538178026676, 0.015600811690092087, 0.03278234601020813, 0.0009687500423751771, 0.020092185586690903, 0.010532008484005928, 0.007177718449383974, 0.03796019405126572, 0.014408945105969906, 0.06432212889194489, 0.12819547951221466, 0.1010366827249527, 0.0715661346912384, 0.21367007493972778, 0.0036017680540680885, 0.00805771816521883, 0.015610736794769764, 0.005697689019143581, 0.006699396762996912, 0.012903249822556973, 0.020959455519914627, 0.10129889845848083, 0.05132786184549332, 0.03520115837454796, -1]}
{"idB": "749647_18_item1_p277_s1", "idA": "749647_17_item1_p205_s0", "sentA": "In the event of a claim of infringement, we or our partners may be required to obtain one or more licenses from a third party.", "sentB": "We may be required to alter any of our potential products or processes or enter into a license and pay licensing fees to a third party or cease certain activities.", "type": 2, "words": ["<tag1>", "In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party.", "<tag2>", "We", "may", "be", "required", "to", "alter", "any", "of", "our", "potential", "products", "or", "processes", "or", "enter", "into", "a", "license", "and", "pay", "licensing", "fees", "to", "a", "third", "party", "or", "cease", "certain", "activities.", "<tag3>"], "wordsA": ["In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party."], "wordsB": ["We", "may", "be", "required", "to", "alter", "any", "of", "our", "potential", "products", "or", "processes", "or", "enter", "into", "a", "license", "and", "pay", "licensing", "fees", "to", "a", "third", "party", "or", "cease", "certain", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.035621121525764465, 0.013466033153235912, 0.008862186223268509, 0.05041767284274101, 0.06819690763950348, 0.7010351419448853, 0.24754208326339722, 0.11770770698785782, 0.17016279697418213, 0.2510024309158325, 0.31059738993644714, 0.12586559355258942, 0.2059931755065918, 0.016860967501997948, 0.12653854489326477, 0.14195789396762848, 0.12957707047462463, 0.1928824931383133, 0.009299186989665031, 0.10175234824419022, 0.11018762737512589, 0.12289828062057495, 0.01078195869922638, 0.011119198054075241, 0.028494596481323242, 0.03963395580649376, 0.012246747501194477, 0.1407041698694229, 0.060884978622198105, 0.08200646936893463, -1]}
{"idB": "749647_18_item1_p288_s0", "idA": "749647_17_item1_p205_s0", "sentA": "In the event of a claim of infringement, we or our partners may be required to obtain one or more licenses from a third party.", "sentB": "There may be third party patents that relate to our products and technology.", "type": 2, "words": ["<tag1>", "In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party.", "<tag2>", "There", "may", "be", "third", "party", "patents", "that", "relate", "to", "our", "products", "and", "technology.", "<tag3>"], "wordsA": ["In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party."], "wordsB": ["There", "may", "be", "third", "party", "patents", "that", "relate", "to", "our", "products", "and", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005301655735820532, 0.016608063131570816, 0.00988435372710228, 0.23351338505744934, 0.40742751955986023, 0.8714328408241272, 0.015436665154993534, 0.06748197227716446, 0.03883368521928787, 0.02777671255171299, 0.07237403094768524, 0.05155712366104126, 0.07106111198663712, -1]}
{"idB": "749647_18_item1_p288_s2", "idA": "749647_17_item1_p205_s0", "sentA": "In the event of a claim of infringement, we or our partners may be required to obtain one or more licenses from a third party.", "sentB": "Although we currently are not involved in any material litigation involving patents, a third party patent holder may assert a claim of patent infringement against us in the future.", "type": 2, "words": ["<tag1>", "In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party.", "<tag2>", "Although", "we", "currently", "are", "not", "involved", "in", "any", "material", "litigation", "involving", "patents,", "a", "third", "party", "patent", "holder", "may", "assert", "a", "claim", "of", "patent", "infringement", "against", "us", "in", "the", "future.", "<tag3>"], "wordsA": ["In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party."], "wordsB": ["Although", "we", "currently", "are", "not", "involved", "in", "any", "material", "litigation", "involving", "patents,", "a", "third", "party", "patent", "holder", "may", "assert", "a", "claim", "of", "patent", "infringement", "against", "us", "in", "the", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.033690884709358215, 0.05691181495785713, 0.06983695179224014, 0.09772948175668716, 0.7493107914924622, 0.5262402296066284, 0.19711507856845856, 0.1397365778684616, 0.23455092310905457, 0.32047975063323975, 0.10793451964855194, 0.1296142190694809, 0.014527781866490841, 0.05623462423682213, 0.08424654603004456, 0.11829454451799393, 0.10097260028123856, 0.03012971021234989, 0.11825787276029587, 0.06097828224301338, 0.09015954285860062, 0.04453464224934578, 0.2925020158290863, 0.24342310428619385, 0.04789990559220314, 0.05394716188311577, 0.04877231642603874, 0.035759542137384415, 0.07408074289560318, -1]}
{"idB": "749647_18_item1_p288_s4", "idA": "749647_17_item1_p205_s0", "sentA": "In the event of a claim of infringement, we or our partners may be required to obtain one or more licenses from a third party.", "sentB": "If a claim of infringement is asserted against us and is successful, and therefore we are found to infringe, we could be required to pay damages for infringement, including treble damages if it is determined that we knew or became aware of such a patent and we failed to exercise due care in determining whether or not we infringed the patent.", "type": 2, "words": ["<tag1>", "In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party.", "<tag2>", "If", "a", "claim", "of", "infringement", "is", "asserted", "against", "us", "and", "is", "successful,", "and", "therefore", "we", "are", "found", "to", "infringe,", "we", "could", "be", "required", "to", "pay", "damages", "for", "infringement,", "including", "treble", "damages", "if", "it", "is", "determined", "that", "we", "knew", "or", "became", "aware", "of", "such", "a", "patent", "and", "we", "failed", "to", "exercise", "due", "care", "in", "determining", "whether", "or", "not", "we", "infringed", "the", "patent.", "<tag3>"], "wordsA": ["In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party."], "wordsB": ["If", "a", "claim", "of", "infringement", "is", "asserted", "against", "us", "and", "is", "successful,", "and", "therefore", "we", "are", "found", "to", "infringe,", "we", "could", "be", "required", "to", "pay", "damages", "for", "infringement,", "including", "treble", "damages", "if", "it", "is", "determined", "that", "we", "knew", "or", "became", "aware", "of", "such", "a", "patent", "and", "we", "failed", "to", "exercise", "due", "care", "in", "determining", "whether", "or", "not", "we", "infringed", "the", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.031192246824502945, 0.010968409478664398, 0.12310197949409485, 0.01133490540087223, 0.03386753797531128, 0.031020402908325195, 0.0860605239868164, 0.1259421706199646, 0.17273467779159546, 0.0011246856302022934, 0.0579075813293457, 0.07078889012336731, 0.0008592738886363804, 0.00667135464027524, 0.027660740539431572, 0.020136529579758644, 0.03229423984885216, 0.041641995310783386, 0.13498981297016144, 0.02001294679939747, 0.01866796799004078, 0.022396184504032135, 0.045037489384412766, 0.03614504262804985, 0.22549358010292053, 0.19110657274723053, 0.02501559816300869, 0.027367258444428444, 0.00955277495086193, 0.09570764005184174, 0.1475924849510193, 0.012882095761597157, 0.018577083945274353, 0.01647421531379223, 0.023648902773857117, 0.014972887001931667, 0.048115089535713196, 0.13082849979400635, 0.07200166583061218, 0.07339433580636978, 0.09412841498851776, 0.08583730459213257, 0.036778874695301056, 0.033996403217315674, 0.12473952770233154, 0.00043370918137952685, 0.01909797079861164, 0.10859540104866028, 0.044388651847839355, 0.033743735402822495, 0.037286460399627686, 0.0505116805434227, 0.01194514986127615, 0.02971123345196247, 0.032651137560606, 0.02194005437195301, 0.039383865892887115, 0.043552979826927185, 0.25296953320503235, 0.08512763679027557, 0.228123277425766, -1]}
{"idB": "749647_18_item1_p293_s5", "idA": "749647_17_item1_p205_s0", "sentA": "In the event of a claim of infringement, we or our partners may be required to obtain one or more licenses from a third party.", "sentB": "If we or a third party we rely on fails to meet these requirements, we may not be able to obtain, or may be delayed in obtaining, marketing authorizations for our drug candidates and will not be able to, or may be delayed in our efforts to, successfully commercialize our drug candidates.", "type": 2, "words": ["<tag1>", "In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party.", "<tag2>", "If", "we", "or", "a", "third", "party", "we", "rely", "on", "fails", "to", "meet", "these", "requirements,", "we", "may", "not", "be", "able", "to", "obtain,", "or", "may", "be", "delayed", "in", "obtaining,", "marketing", "authorizations", "for", "our", "drug", "candidates", "and", "will", "not", "be", "able", "to,", "or", "may", "be", "delayed", "in", "our", "efforts", "to,", "successfully", "commercialize", "our", "drug", "candidates.", "<tag3>"], "wordsA": ["In", "the", "event", "of", "a", "claim", "of", "infringement,", "we", "or", "our", "partners", "may", "be", "required", "to", "obtain", "one", "or", "more", "licenses", "from", "a", "third", "party."], "wordsB": ["If", "we", "or", "a", "third", "party", "we", "rely", "on", "fails", "to", "meet", "these", "requirements,", "we", "may", "not", "be", "able", "to", "obtain,", "or", "may", "be", "delayed", "in", "obtaining,", "marketing", "authorizations", "for", "our", "drug", "candidates", "and", "will", "not", "be", "able", "to,", "or", "may", "be", "delayed", "in", "our", "efforts", "to,", "successfully", "commercialize", "our", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.016557935625314713, 0.030265361070632935, 0.01561643835157156, 0.007844984531402588, 0.048353273421525955, 0.07122524827718735, 0.007940390147268772, 0.020567389205098152, 0.009145795367658138, 0.26025909185409546, 0.2120099663734436, 0.2179846167564392, 0.10671541839838028, 0.18975594639778137, 0.015855375677347183, 0.02959330379962921, 0.096249520778656, 0.03719240799546242, 0.12504208087921143, 0.11453327536582947, 0.15400592982769012, 0.006392722949385643, 0.013704758137464523, 0.02149650827050209, 0.07685807347297668, 0.016409926116466522, 0.052787814289331436, 0.12156332284212112, 0.23489633202552795, 0.015866044908761978, 0.013969773426651955, 0.05747028812766075, 0.07242214679718018, 0.006912624463438988, 0.016085002571344376, 0.06475237756967545, 0.026102479547262192, 0.04405653104186058, 0.061292536556720734, 0.006253058556467295, 0.010153979063034058, 0.017528614029288292, 0.07850828766822815, 0.009009177796542645, 0.015124548226594925, 0.04342353716492653, 0.029302585870027542, 0.07108103483915329, 0.16631080210208893, 0.0179302878677845, 0.0704609677195549, 0.08608754724264145, -1]}
{"idB": "749647_18_item1_p277_s2", "idA": "749647_17_item1_p205_s1", "sentA": "There can be no assurance that we can obtain a license on a reasonable basis should we deem it necessary to obtain rights to an alternative technology that meets our needs.", "sentB": "There can be no assurance that we can obtain a license to any technology that we determine we need on reasonable terms, if at all, or that we could develop or otherwise obtain alternate technology.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "on", "a", "reasonable", "basis", "should", "we", "deem", "it", "necessary", "to", "obtain", "rights", "to", "an", "alternative", "technology", "that", "meets", "our", "needs.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "to", "any", "technology", "that", "we", "determine", "we", "need", "on", "reasonable", "terms,", "if", "at", "all,", "or", "that", "we", "could", "develop", "or", "otherwise", "obtain", "alternate", "technology.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "on", "a", "reasonable", "basis", "should", "we", "deem", "it", "necessary", "to", "obtain", "rights", "to", "an", "alternative", "technology", "that", "meets", "our", "needs."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "to", "any", "technology", "that", "we", "determine", "we", "need", "on", "reasonable", "terms,", "if", "at", "all,", "or", "that", "we", "could", "develop", "or", "otherwise", "obtain", "alternate", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006227817386388779, 0.00920418556779623, 0.0086197629570961, 0.022977733984589577, 0.05082482844591141, 0.009077823720872402, 0.030614566057920456, 0.04496714472770691, 0.03839024156332016, 0.01781604252755642, 0.06911823153495789, 0.016848649829626083, 0.08037792891263962, 0.08536620438098907, 0.015217163600027561, 0.02625143714249134, 0.04129282012581825, 0.031070835888385773, 0.05233466997742653, 0.0314977653324604, 0.19483067095279694, 0.11110354959964752, 0.14986173808574677, 0.12217562645673752, 0.17107205092906952, 0.013227078132331371, 0.014442226849496365, 0.027803562581539154, 0.09374896436929703, 0.1911003440618515, 0.0717526450753212, 0.16715340316295624, 0.13714373111724854, 0.055328093469142914, 0.05160192772746086, -1]}
{"idB": "749647_18_item1_p234_s5", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "New factors emerge from time to time and it is not possible to predict the impact of all of these factors on our business, financial condition or results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "New", "factors", "emerge", "from", "time", "to", "time", "and", "it", "is", "not", "possible", "to", "predict", "the", "impact", "of", "all", "of", "these", "factors", "on", "our", "business,", "financial", "condition", "or", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["New", "factors", "emerge", "from", "time", "to", "time", "and", "it", "is", "not", "possible", "to", "predict", "the", "impact", "of", "all", "of", "these", "factors", "on", "our", "business,", "financial", "condition", "or", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.18441341817378998, 0.278976708650589, 0.10041696578264236, 0.017809776589274406, 0.025324789807200432, 0.013178849592804909, 0.02330935001373291, 0.008387025445699692, 0.0066992733627557755, 0.016739804297685623, 0.13763809204101562, 0.07712660729885101, 0.1516966074705124, 0.27148810029029846, 0.07149116694927216, 0.19559688866138458, 0.049872592091560364, 0.0448744036257267, 0.037574995309114456, 0.06455682218074799, 0.08718860894441605, 0.021685734391212463, 0.009957756847143173, 0.01851293444633484, 0.006138932891190052, 0.005415546242147684, 0.003148087067529559, 0.005340625997632742, 0.003062332049012184, 0.008398478850722313, -1]}
{"idB": "749647_18_item1_p236_s6", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "If we or our collaborators are unable to develop and commercialize one or more of our product candidates or if sales revenue from any product candidate that receives approval is insufficient, we will not achieve profitability, which could have a material adverse effect on our business, financial condition, results of operations and prospects.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "we", "or", "our", "collaborators", "are", "unable", "to", "develop", "and", "commercialize", "one", "or", "more", "of", "our", "product", "candidates", "or", "if", "sales", "revenue", "from", "any", "product", "candidate", "that", "receives", "approval", "is", "insufficient,", "we", "will", "not", "achieve", "profitability,", "which", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition,", "results", "of", "operations", "and", "prospects.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "we", "or", "our", "collaborators", "are", "unable", "to", "develop", "and", "commercialize", "one", "or", "more", "of", "our", "product", "candidates", "or", "if", "sales", "revenue", "from", "any", "product", "candidate", "that", "receives", "approval", "is", "insufficient,", "we", "will", "not", "achieve", "profitability,", "which", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition,", "results", "of", "operations", "and", "prospects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.019336050376296043, 0.049742452800273895, 0.010370309464633465, 0.011173435486853123, 0.06540223956108093, 0.058445997536182404, 0.528196394443512, 0.3671344816684723, 0.5171583294868469, 0.24389594793319702, 0.5559404492378235, 0.03455269709229469, 0.01276283897459507, 0.02932972088456154, 0.03373350948095322, 0.019214827567338943, 0.13300712406635284, 0.21363946795463562, 0.00020260353630874306, 0.005873215384781361, 0.036209285259246826, 0.054648082703351974, 0.007165604270994663, 0.00789035577327013, 0.03579378500580788, 0.03772731125354767, 0.00017608172493055463, 0.012608027085661888, 0.01098240539431572, 0.019692378118634224, 0.06285452842712402, 0.009412922896444798, 0.01320637483149767, 0.14612960815429688, 0.0878855362534523, 0.09531385451555252, 0.00027936004335060716, 0.005151058547198772, 0.003731782315298915, 0.0025337645784020424, 0.005513695999979973, 0.0027674485463649035, 0.002652362920343876, 0.001862245611846447, 0.002242286456748843, 0.0039183394983410835, 0.002338662277907133, 0.002187195932492614, 0.0023015933111310005, 0.001577865332365036, 0.002312099328264594, 0.0020767496898770332, 0.0030297241173684597, -1]}
{"idB": "749647_18_item1_p240_s6", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "The failure of one or more of our drug candidates or development programs could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "or", "development", "programs", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "or", "development", "programs", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.005471305921673775, 0.1624893695116043, 0.10669419169425964, 0.24662384390830994, 0.07312621921300888, 0.21209022402763367, 0.19841089844703674, 0.11076335608959198, 0.7465737462043762, 0.7937601208686829, 0.0651606023311615, 0.34402748942375183, 0.5745022892951965, 0.005983457434922457, 0.0037119369953870773, 0.00266684265807271, 0.004199289716780186, 0.002843765541911125, 0.0028413489926606417, 0.0017108104657381773, 0.0018198539037257433, 0.0029564262367784977, 0.0023544151335954666, 0.0023345849476754665, 0.0017608602065593004, 0.0021392167545855045, 0.0018947492353618145, 0.0032533586490899324, -1]}
{"idB": "749647_18_item1_p246_s0", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "If we do not obtain or maintain FDA and foreign regulatory approvals for our drug candidates on a timely basis, or at all, or if the terms of any approval impose significant restrictions or limitations on use, we will be unable to sell those products and our business, results of operations and financial condition will be negatively affected.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "we", "do", "not", "obtain", "or", "maintain", "FDA", "and", "foreign", "regulatory", "approvals", "for", "our", "drug", "candidates", "on", "a", "timely", "basis,", "or", "at", "all,", "or", "if", "the", "terms", "of", "any", "approval", "impose", "significant", "restrictions", "or", "limitations", "on", "use,", "we", "will", "be", "unable", "to", "sell", "those", "products", "and", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "will", "be", "negatively", "affected.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "we", "do", "not", "obtain", "or", "maintain", "FDA", "and", "foreign", "regulatory", "approvals", "for", "our", "drug", "candidates", "on", "a", "timely", "basis,", "or", "at", "all,", "or", "if", "the", "terms", "of", "any", "approval", "impose", "significant", "restrictions", "or", "limitations", "on", "use,", "we", "will", "be", "unable", "to", "sell", "those", "products", "and", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "will", "be", "negatively", "affected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03566532954573631, 0.06040315330028534, 0.3321150839328766, 0.473132848739624, 0.2740359902381897, 0.1583808809518814, 0.3066706657409668, 0.09637301415205002, 0.012318765744566917, 0.02020571380853653, 0.028344651684165, 0.503075361251831, 0.015790175646543503, 0.011816767044365406, 0.03428245335817337, 0.04128050059080124, 0.024287043139338493, 0.02266664057970047, 0.06827732920646667, 0.031322989612817764, 0.0001013347864500247, 0.01127829123288393, 0.01620730385184288, 0.00015364630962722003, 0.007448951248079538, 0.00809055007994175, 0.013090851716697216, 0.005183065310120583, 0.00915679894387722, 0.013159001246094704, 0.012282220646739006, 0.015148709528148174, 0.01466395054012537, 0.01169678010046482, 0.02158573642373085, 0.019309598952531815, 0.020071465522050858, 0.018586672842502594, 0.01871970295906067, 0.05159296467900276, 0.4958018958568573, 0.3680351674556732, 0.37850701808929443, 0.024506723508238792, 0.06459608674049377, 0.006974893156439066, 0.005655299872159958, 0.024540042504668236, 0.004831730388104916, 0.001947467913851142, 0.0038259681314229965, 0.0017794854938983917, 0.003273450769484043, 0.0034855701960623264, 0.015815705060958862, 0.03289534151554108, 0.45541462302207947, 0.2853991985321045, -1]}
{"idB": "749647_18_item1_p249_s1", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "The failure to obtain timely regulatory approval of product candidates, the imposition of marketing limitations, or a product withdrawal would negatively impact our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "The", "failure", "to", "obtain", "timely", "regulatory", "approval", "of", "product", "candidates,", "the", "imposition", "of", "marketing", "limitations,", "or", "a", "product", "withdrawal", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["The", "failure", "to", "obtain", "timely", "regulatory", "approval", "of", "product", "candidates,", "the", "imposition", "of", "marketing", "limitations,", "or", "a", "product", "withdrawal", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00452885078266263, 0.06345155090093613, 0.028847860172390938, 0.1476655900478363, 0.5441311001777649, 0.6067596673965454, 0.8166289925575256, 0.07573902606964111, 0.13085447251796722, 0.1665484607219696, 0.004688760731369257, 0.088776595890522, 0.02372654341161251, 0.10535240173339844, 0.1543368548154831, 0.007141902577131987, 0.02294347807765007, 0.2707785964012146, 0.40814727544784546, 0.008251677267253399, 0.16167517006397247, 0.10477566719055176, 0.004381055012345314, 0.01378824282437563, 0.0029217463452368975, 0.001345104887150228, 0.0025025701615959406, 0.001465284381993115, 0.001966045703738928, 0.002306134207174182, -1]}
{"idB": "749647_18_item1_p271_s3", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Accordingly, although there can be no assurance that we will undertake or successfully complete any transactions of the nature described above, any transactions that we do complete may be subject to the foregoing or other risks and have a material adverse effect on our business, results of operations, financial condition and prospects.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Accordingly,", "although", "there", "can", "be", "no", "assurance", "that", "we", "will", "undertake", "or", "successfully", "complete", "any", "transactions", "of", "the", "nature", "described", "above,", "any", "transactions", "that", "we", "do", "complete", "may", "be", "subject", "to", "the", "foregoing", "or", "other", "risks", "and", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations,", "financial", "condition", "and", "prospects.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Accordingly,", "although", "there", "can", "be", "no", "assurance", "that", "we", "will", "undertake", "or", "successfully", "complete", "any", "transactions", "of", "the", "nature", "described", "above,", "any", "transactions", "that", "we", "do", "complete", "may", "be", "subject", "to", "the", "foregoing", "or", "other", "risks", "and", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations,", "financial", "condition", "and", "prospects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.029545878991484642, 0.015944113954901695, 0.009024671278893948, 0.016755500808358192, 0.010874226689338684, 0.0363277941942215, 0.06452514976263046, 0.07567566633224487, 0.16909919679164886, 0.300453782081604, 0.40790003538131714, 0.16353575885295868, 0.34932056069374084, 0.4371877908706665, 0.18724046647548676, 0.4147040843963623, 0.015162409283220768, 0.011910947039723396, 0.015888934955000877, 0.005542059428989887, 0.008168570697307587, 0.03686053678393364, 0.3506563603878021, 0.008386487141251564, 0.03485456109046936, 0.10755197703838348, 0.058165043592453, 0.00977140199393034, 0.006375602446496487, 0.007304558530449867, 0.006393128540366888, 0.006400329992175102, 0.008241611532866955, 0.00480641471222043, 0.004892634693533182, 0.01222897693514824, 0.006578145083039999, 0.005805068649351597, 0.00471377233043313, 0.005979448091238737, 0.004509114194661379, 0.0032630714122205973, 0.0028431301470845938, 0.004262521397322416, 0.006259040907025337, 0.00264068809337914, 0.002289974596351385, 0.0028184258844703436, 0.0027263034135103226, 0.0027817501686513424, 0.002703698817640543, 0.003608384868130088, -1]}
{"idB": "749647_18_item1_p274_s1", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "We cannot assure you that we will be successful in overcoming problems encountered in connection with any transactions, and our inability to do so could significantly harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "We", "cannot", "assure", "you", "that", "we", "will", "be", "successful", "in", "overcoming", "problems", "encountered", "in", "connection", "with", "any", "transactions,", "and", "our", "inability", "to", "do", "so", "could", "significantly", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["We", "cannot", "assure", "you", "that", "we", "will", "be", "successful", "in", "overcoming", "problems", "encountered", "in", "connection", "with", "any", "transactions,", "and", "our", "inability", "to", "do", "so", "could", "significantly", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04625583440065384, 0.1282430738210678, 0.09534214437007904, 0.06268563121557236, 0.06128009781241417, 0.09865890443325043, 0.11241001635789871, 0.1334458738565445, 0.20353583991527557, 0.025223422795534134, 0.0956587940454483, 0.05425618961453438, 0.01222369633615017, 0.01438222173601389, 0.013439908623695374, 0.01467891689389944, 0.029586168006062508, 0.07828621566295624, 0.007734055630862713, 0.021467972546815872, 0.5129281878471375, 0.37772107124328613, 0.3556041419506073, 0.3169802725315094, 0.02170601487159729, 0.0840219110250473, 0.26560425758361816, 0.020046116784214973, 0.06291784346103668, 0.0043457807041704655, 0.002551587065681815, 0.003781144507229328, 0.002372521674260497, 0.002703976584598422, 0.003318364266306162, -1]}
{"idB": "749647_18_item1_p274_s2", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "These transactions could dilute a stockholder s investment in us and cause us to incur debt, contingent liabilities and amortization/impairment charges related to intangible assets, all of which could materially and adversely affect our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "These", "transactions", "could", "dilute", "a", "stockholder", "s", "investment", "in", "us", "and", "cause", "us", "to", "incur", "debt,", "contingent", "liabilities", "and", "amortization/impairment", "charges", "related", "to", "intangible", "assets,", "all", "of", "which", "could", "materially", "and", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["These", "transactions", "could", "dilute", "a", "stockholder", "s", "investment", "in", "us", "and", "cause", "us", "to", "incur", "debt,", "contingent", "liabilities", "and", "amortization/impairment", "charges", "related", "to", "intangible", "assets,", "all", "of", "which", "could", "materially", "and", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017202254384756088, 0.23956739902496338, 0.0288247037678957, 0.3119870722293854, 0.04833665490150452, 0.3602038621902466, 0.23371492326259613, 0.39399051666259766, 0.16787704825401306, 0.05900880694389343, 0.006355350837111473, 0.020808152854442596, 0.03399647772312164, 0.02014518529176712, 0.09552861750125885, 0.15832829475402832, 0.05848343297839165, 0.05264968425035477, 0.006634478457272053, 0.04669946804642677, 0.09137456119060516, 0.0052351574413478374, 0.006179089657962322, 0.024219393730163574, 0.04069630429148674, 0.0008099449332803488, 0.0006841592839919031, 0.0003604180528782308, 0.0053843301720917225, 0.012502274475991726, 0.0035845490638166666, 0.012200768105685711, 0.02800283581018448, 0.005670631304383278, 0.01625138148665428, 0.0026041672099381685, 0.0021148337982594967, 0.002701779827475548, 0.002103246981278062, 0.0027018894907087088, 0.0031151226721704006, -1]}
{"idB": "749647_18_item1_p276_s4", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Any such loss of rights and access to technology could have a material adverse effect on our business.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Any", "such", "loss", "of", "rights", "and", "access", "to", "technology", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Any", "such", "loss", "of", "rights", "and", "access", "to", "technology", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.032213322818279266, 0.05536062642931938, 0.6455547213554382, 0.5478348135948181, 0.6210691928863525, 0.14203281700611115, 0.38094693422317505, 0.2729641795158386, 0.3089199364185333, 0.004553471691906452, 0.004245719872415066, 0.0029453267343342304, 0.007059953175485134, 0.006822455674409866, 0.007307878695428371, 0.007406522054225206, 0.009250105358660221, 0.026135437190532684, -1]}
{"idB": "749647_18_item1_p277_s3", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "If a license is not available on commercially reasonable terms or at all, our business, results of operations, and financial condition could be significantly harmed and we may be prevented from developing and commercializing the product.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "our", "business,", "results", "of", "operations,", "and", "financial", "condition", "could", "be", "significantly", "harmed", "and", "we", "may", "be", "prevented", "from", "developing", "and", "commercializing", "the", "product.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "our", "business,", "results", "of", "operations,", "and", "financial", "condition", "could", "be", "significantly", "harmed", "and", "we", "may", "be", "prevented", "from", "developing", "and", "commercializing", "the", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.035181961953639984, 0.042293138802051544, 0.18372344970703125, 0.24999360740184784, 0.7059668898582458, 0.4430890381336212, 0.2750888466835022, 0.21469873189926147, 0.32247281074523926, 0.34269195795059204, 0.017041362822055817, 0.03619800880551338, 0.05780103802680969, 0.006990413181483746, 0.05046810582280159, 0.006396564655005932, 0.00294267269782722, 0.0049878391437232494, 0.002007425529882312, 0.005169999785721302, 0.004173374269157648, 0.014478940516710281, 0.022333916276693344, 0.04216621443629265, 0.06915212422609329, 0.005221547093242407, 0.015190161764621735, 0.01396877970546484, 0.032912321388721466, 0.25214701890945435, 0.21299047768115997, 0.22410187125205994, 0.22033527493476868, 0.2679961919784546, 0.0501742847263813, 0.07069853693246841, -1]}
{"idB": "749647_18_item1_p293_s6", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "This could have a material adverse effect on our business, financial condition, results of operations and prospects.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "This", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition,", "results", "of", "operations", "and", "prospects.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["This", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition,", "results", "of", "operations", "and", "prospects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.020297221839427948, 0.038104161620140076, 0.027336452156305313, 0.007362497039139271, 0.0366222970187664, 0.013584052212536335, 0.016284380108118057, 0.009562415070831776, 0.007713057566434145, 0.010318058542907238, 0.006044499110430479, 0.005497878883033991, 0.004967366345226765, 0.0029669813811779022, 0.006828733254224062, 0.005783566273748875, 0.12232767045497894, -1]}
{"idB": "749647_18_item1_p301_s0", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Although we have internal compliance programs, if these programs do not meet regulatory agency standards or if our compliance is deemed deficient in any significant way, it could have a material adverse effect on the Company.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Although", "we", "have", "internal", "compliance", "programs,", "if", "these", "programs", "do", "not", "meet", "regulatory", "agency", "standards", "or", "if", "our", "compliance", "is", "deemed", "deficient", "in", "any", "significant", "way,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "the", "Company.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Although", "we", "have", "internal", "compliance", "programs,", "if", "these", "programs", "do", "not", "meet", "regulatory", "agency", "standards", "or", "if", "our", "compliance", "is", "deemed", "deficient", "in", "any", "significant", "way,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "the", "Company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03151950240135193, 0.05259036272764206, 0.07760168612003326, 0.32873469591140747, 0.6368358731269836, 0.3207283616065979, 0.009504799731075764, 0.009422803297638893, 0.13181442022323608, 0.11443519592285156, 0.17442230880260468, 0.12250316888093948, 0.06911482661962509, 0.06274870038032532, 0.10750382393598557, 0.00013288269110489637, 0.01050026249140501, 0.027425624430179596, 0.2575069069862366, 0.07422344386577606, 0.09017116576433182, 0.2532695531845093, 0.019617129117250443, 0.0379030741751194, 0.02549075148999691, 0.02534414827823639, 0.005907130427658558, 0.014307787641882896, 0.015752142295241356, 0.005731415003538132, 0.01269335113465786, 0.012064346112310886, 0.014521284028887749, 0.03337351232767105, 0.03637494519352913, 0.16219525039196014, -1]}
{"idB": "749647_18_item1_p303_s1", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "There can be no assurance that one or more states will not impose regulations or requirements that have a material adverse effect on our ability to sell our products.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "one", "or", "more", "states", "will", "not", "impose", "regulations", "or", "requirements", "that", "have", "a", "material", "adverse", "effect", "on", "our", "ability", "to", "sell", "our", "products.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "one", "or", "more", "states", "will", "not", "impose", "regulations", "or", "requirements", "that", "have", "a", "material", "adverse", "effect", "on", "our", "ability", "to", "sell", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007767464499920607, 0.01988532766699791, 0.008887478150427341, 0.22073037922382355, 0.34944412112236023, 0.07744143158197403, 0.0498463399708271, 0.011242360807955265, 0.036020923405885696, 0.1433476358652115, 0.12913697957992554, 0.38398128747940063, 0.3409198522567749, 0.39889490604400635, 0.11039088666439056, 0.3386659324169159, 0.013601656071841717, 0.020644374191761017, 0.008460277691483498, 0.018084244802594185, 0.014559696428477764, 0.012776077724993229, 0.019367605447769165, 0.03464476764202118, 0.15622921288013458, 0.13598817586898804, 0.22766683995723724, 0.07347183674573898, 0.18322856724262238, -1]}
{"idB": "749647_18_item1_p304_s1", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "There can be no assurance that one or more countries or agencies will not impose regulations or requirements that could have a material adverse effect on our ability to sell our products.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "one", "or", "more", "countries", "or", "agencies", "will", "not", "impose", "regulations", "or", "requirements", "that", "could", "have", "a", "material", "adverse", "effect", "on", "our", "ability", "to", "sell", "our", "products.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "one", "or", "more", "countries", "or", "agencies", "will", "not", "impose", "regulations", "or", "requirements", "that", "could", "have", "a", "material", "adverse", "effect", "on", "our", "ability", "to", "sell", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.007965241558849812, 0.017687179148197174, 0.00905919261276722, 0.20695357024669647, 0.3187517821788788, 0.07089496403932571, 0.04963536933064461, 0.010781433433294296, 0.03244728222489357, 0.08217933773994446, 0.02478921413421631, 0.10420846939086914, 0.08646197617053986, 0.351867139339447, 0.3346334397792816, 0.37845832109451294, 0.09636371582746506, 0.27578723430633545, 0.007545740809291601, 0.018476752564311028, 0.010631815530359745, 0.005276916548609734, 0.01019886415451765, 0.010454859584569931, 0.009919188916683197, 0.01344178058207035, 0.02540276199579239, 0.13505293428897858, 0.1424257755279541, 0.22265224158763885, 0.0591239295899868, 0.1614290177822113, -1]}
{"idB": "749647_18_item1_p312_s0", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Political, economic and regulatory influences are subjecting the healthcare industry to potential fundamental changes that could substantially affect our results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Political,", "economic", "and", "regulatory", "influences", "are", "subjecting", "the", "healthcare", "industry", "to", "potential", "fundamental", "changes", "that", "could", "substantially", "affect", "our", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Political,", "economic", "and", "regulatory", "influences", "are", "subjecting", "the", "healthcare", "industry", "to", "potential", "fundamental", "changes", "that", "could", "substantially", "affect", "our", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.16541747748851776, 0.07694996148347855, 0.014154902659356594, 0.12626713514328003, 0.28897982835769653, 0.007772651966661215, 0.15601520240306854, 0.024177802726626396, 0.20563139021396637, 0.1745922714471817, 0.06321270018815994, 0.052676957100629807, 0.15359559655189514, 0.265566349029541, 0.0002925987937487662, 0.01300804316997528, 0.046598587185144424, 0.10865916311740875, 0.01528140064328909, 0.037481892853975296, 0.007099889684468508, 0.022768616676330566, -1]}
{"idB": "749647_18_item1_p312_s5", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "We cannot predict the effect healthcare reforms may have on our business and we can offer no assurances that any of these reforms will not have a material adverse effect on our business.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "We", "cannot", "predict", "the", "effect", "healthcare", "reforms", "may", "have", "on", "our", "business", "and", "we", "can", "offer", "no", "assurances", "that", "any", "of", "these", "reforms", "will", "not", "have", "a", "material", "adverse", "effect", "on", "our", "business.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["We", "cannot", "predict", "the", "effect", "healthcare", "reforms", "may", "have", "on", "our", "business", "and", "we", "can", "offer", "no", "assurances", "that", "any", "of", "these", "reforms", "will", "not", "have", "a", "material", "adverse", "effect", "on", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03605686500668526, 0.2517280578613281, 0.367756187915802, 0.11104827374219894, 0.0911654457449913, 0.2542504370212555, 0.30153903365135193, 0.0589531771838665, 0.05196147784590721, 0.03266826644539833, 0.030680185183882713, 0.0775618925690651, 0.007053571753203869, 0.022524667903780937, 0.03539291396737099, 0.07788543403148651, 0.17118358612060547, 0.12180966138839722, 0.06326685845851898, 0.09566792845726013, 0.04064560681581497, 0.04306264966726303, 0.18160542845726013, 0.24132993817329407, 0.679882824420929, 0.2679506838321686, 0.14402389526367188, 0.19908764958381653, 0.10332586616277695, 0.10672009736299515, 0.04476914182305336, 0.03773628920316696, 0.07580602914094925, -1]}
{"idB": "749647_18_item1_p318_s4", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Any of these factors could have an adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Any", "of", "these", "factors", "could", "have", "an", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Any", "of", "these", "factors", "could", "have", "an", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6332259178161621, 0.3794978857040405, 0.214487686753273, 0.5868561267852783, 0.03504424914717674, 0.018969809636473656, 0.011568805202841759, 0.020345399156212807, 0.013225117698311806, 0.008744842372834682, 0.006561429239809513, 0.010321293026208878, 0.005566453095525503, 0.004998308606445789, 0.0026789566036313772, 0.004868905525654554, 0.0031552480068057775, 0.007550882175564766, -1]}
{"idB": "749647_18_item1_p319_s1", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "If the market size for a new drug is significantly smaller than we anticipate, it could significantly and negatively impact our revenue, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.036523524671792984, 0.019307462498545647, 0.4378209412097931, 0.43676817417144775, 0.06632515788078308, 0.02816706895828247, 0.131286159157753, 0.1625041961669922, 0.11402223259210587, 0.13349370658397675, 0.3726710379123688, 0.029046492651104927, 0.03214352950453758, 0.03518988937139511, 0.00022115412866696715, 0.02467416785657406, 0.06909205764532089, 0.02065696381032467, 0.19612862169742584, 0.16750502586364746, 0.05161406099796295, 0.2766892910003662, 0.004195026587694883, 0.002645200816914439, 0.003684018272906542, 0.0022281319834291935, 0.002865934744477272, 0.003351061837747693, -1]}
{"idB": "749647_18_item1_p320_s1", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "If due to one or more of these risks the market potential for a drug candidate is lower than we anticipated, it could significantly and negatively impact the revenue potential for such drug candidate and would adversely affect our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "due", "to", "one", "or", "more", "of", "these", "risks", "the", "market", "potential", "for", "a", "drug", "candidate", "is", "lower", "than", "we", "anticipated,", "it", "could", "significantly", "and", "negatively", "impact", "the", "revenue", "potential", "for", "such", "drug", "candidate", "and", "would", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "due", "to", "one", "or", "more", "of", "these", "risks", "the", "market", "potential", "for", "a", "drug", "candidate", "is", "lower", "than", "we", "anticipated,", "it", "could", "significantly", "and", "negatively", "impact", "the", "revenue", "potential", "for", "such", "drug", "candidate", "and", "would", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02540004998445511, 0.023113230243325233, 0.0169838834553957, 0.02620965987443924, 0.012364950962364674, 0.021717282012104988, 0.010723026469349861, 0.014287123456597328, 0.029528096318244934, 0.01303232740610838, 0.30184704065322876, 0.3357263207435608, 0.08098598569631577, 0.032112013548612595, 0.1811390072107315, 0.16406624019145966, 0.11432899534702301, 0.3376213014125824, 0.04882510378956795, 0.02508578635752201, 0.04835890233516693, 0.00042410421883687377, 0.019121501594781876, 0.03539973869919777, 0.012562037445604801, 0.08347476273775101, 0.08697833120822906, 0.02051333710551262, 0.1308612823486328, 0.06076066941022873, 0.010759009048342705, 0.009238396771252155, 0.03340670466423035, 0.024480951949954033, 0.00036850973265245557, 0.012366742826998234, 0.028454402461647987, 0.12399707734584808, 0.01222081296145916, 0.043956611305475235, 0.0075692348182201385, 0.006751196458935738, 0.0023763799108564854, 0.003995612729340792, 0.002472204389050603, 0.0052864993922412395, -1]}
{"idB": "749647_18_item1_p329_s3", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "We cannot guarantee that we will retain key employees to the same extent that we and EGEN retained each of our own employees in the past, which could have a negative impact on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "We", "cannot", "guarantee", "that", "we", "will", "retain", "key", "employees", "to", "the", "same", "extent", "that", "we", "and", "EGEN", "retained", "each", "of", "our", "own", "employees", "in", "the", "past,", "which", "could", "have", "a", "negative", "impact", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["We", "cannot", "guarantee", "that", "we", "will", "retain", "key", "employees", "to", "the", "same", "extent", "that", "we", "and", "EGEN", "retained", "each", "of", "our", "own", "employees", "in", "the", "past,", "which", "could", "have", "a", "negative", "impact", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.045617613941431046, 0.13826444745063782, 0.2180086374282837, 0.09193477034568787, 0.11651968210935593, 0.14398133754730225, 0.3487834930419922, 0.34770873188972473, 0.474778950214386, 0.012274437583982944, 0.00014038824883755296, 0.013812768273055553, 0.050153326243162155, 0.006039513740688562, 0.015939051285386086, 0.008957024663686752, 0.03820808604359627, 0.16476687788963318, 0.13200588524341583, 0.06156623363494873, 0.07276897132396698, 0.18529601395130157, 0.1682102084159851, 0.007021716330200434, 0.005917667876929045, 0.016409026458859444, 0.0001563787809573114, 0.006271165329962969, 0.00410453462973237, 0.004355807788670063, 0.18836915493011475, 0.014303773641586304, 0.004464344587177038, 0.0031105061061680317, 0.0057915556244552135, 0.002284852322191, 0.0019699246622622013, 0.0022571447771042585, 0.0019323251908645034, 0.0024222396314144135, 0.0026265261694788933, -1]}
{"idB": "749647_18_item1_p331_s4", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "There can be no assurance that we will be able to manage our growth and a failure to do so could have a material adverse effect on our business.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "we", "will", "be", "able", "to", "manage", "our", "growth", "and", "a", "failure", "to", "do", "so", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "we", "will", "be", "able", "to", "manage", "our", "growth", "and", "a", "failure", "to", "do", "so", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.009221835061907768, 0.03551500290632248, 0.0164885763078928, 0.2638135254383087, 0.33409827947616577, 0.08671140670776367, 0.13964056968688965, 0.16177862882614136, 0.18505461513996124, 0.31117668747901917, 0.21470332145690918, 0.39775753021240234, 0.25391072034835815, 0.3500394821166992, 0.007107504177838564, 0.012271755374968052, 0.2237180918455124, 0.09253515303134918, 0.1928274780511856, 0.17390944063663483, 0.028899958357214928, 0.009551181457936764, 0.004317581653594971, 0.011256755329668522, 0.006395619362592697, 0.005840838886797428, 0.004166611935943365, 0.0072593060322105885, 0.027753697708249092, -1]}
{"idB": "749647_18_item1_p342_s1", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Such loss of investor confidence may result in extreme price and volume fluctuations in our common stock that are unrelated or disproportionate to the operating performance of our business, financial condition or results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Such", "loss", "of", "investor", "confidence", "may", "result", "in", "extreme", "price", "and", "volume", "fluctuations", "in", "our", "common", "stock", "that", "are", "unrelated", "or", "disproportionate", "to", "the", "operating", "performance", "of", "our", "business,", "financial", "condition", "or", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Such", "loss", "of", "investor", "confidence", "may", "result", "in", "extreme", "price", "and", "volume", "fluctuations", "in", "our", "common", "stock", "that", "are", "unrelated", "or", "disproportionate", "to", "the", "operating", "performance", "of", "our", "business,", "financial", "condition", "or", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017396772280335426, 0.44375181198120117, 0.22923089563846588, 0.26171937584877014, 0.4798907935619354, 0.007332639303058386, 0.011786693707108498, 0.009398120455443859, 0.04971383139491081, 0.049935195595026016, 0.07292785495519638, 0.099848672747612, 0.12421795725822449, 0.049067363142967224, 0.030074592679739, 0.13499899208545685, 0.1462254524230957, 0.0001316708221565932, 0.01712973043322563, 0.12973935902118683, 0.011293619871139526, 0.16133376955986023, 0.025865888223052025, 0.0066337743774056435, 0.03371116891503334, 0.024125466123223305, 0.002787221223115921, 0.0029742291662842035, 0.010628722608089447, 0.002857118146494031, 0.0030362599063664675, 0.0017208429053425789, 0.0024976874701678753, 0.0019288623007014394, 0.003833368420600891, -1]}
{"idB": "749647_18_item1_p342_s3", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Such litigation, even if unsuccessful, could be costly to defend and divert management s attention and resources, which could further materially harm our financial condition and results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Such", "litigation,", "even", "if", "unsuccessful,", "could", "be", "costly", "to", "defend", "and", "divert", "management", "s", "attention", "and", "resources,", "which", "could", "further", "materially", "harm", "our", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Such", "litigation,", "even", "if", "unsuccessful,", "could", "be", "costly", "to", "defend", "and", "divert", "management", "s", "attention", "and", "resources,", "which", "could", "further", "materially", "harm", "our", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.040197376161813736, 0.5282894372940063, 0.009370783343911171, 0.023427067324519157, 0.08354046195745468, 0.016572384163737297, 0.01312279049307108, 0.028385741636157036, 0.007771714590489864, 0.03890179097652435, 0.006094104144722223, 0.04695195332169533, 0.0518493577837944, 0.03263164684176445, 0.04396265000104904, 0.01197836548089981, 0.0595378577709198, 0.00025220285169780254, 0.008359856903553009, 0.008696626871824265, 0.035833366215229034, 0.1227094754576683, 0.004785081371665001, 0.02617759071290493, 0.010579913854598999, 0.002696472452953458, 0.004046682268381119, 0.0024479026906192303, 0.0062259165570139885, -1]}
{"idB": "749647_18_item1_p349_s1", "idA": "749647_17_item1_p205_s2", "sentA": "The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "This could result in the lack of a market for our common stock, cause a decrease in the value of an investment in us, and adversely affect our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "This", "could", "result", "in", "the", "lack", "of", "a", "market", "for", "our", "common", "stock,", "cause", "a", "decrease", "in", "the", "value", "of", "an", "investment", "in", "us,", "and", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "to", "obtain", "a", "license", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["This", "could", "result", "in", "the", "lack", "of", "a", "market", "for", "our", "common", "stock,", "cause", "a", "decrease", "in", "the", "value", "of", "an", "investment", "in", "us,", "and", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00451932055875659, 0.010491002351045609, 0.029421653598546982, 0.023224888369441032, 0.0257845651358366, 0.735913097858429, 0.5722554326057434, 0.6176729798316956, 0.8307386040687561, 0.3424719572067261, 0.175144761800766, 0.31057003140449524, 0.41793179512023926, 0.0235788282006979, 0.02653014287352562, 0.1801670789718628, 0.08914611488580704, 0.016044188290834427, 0.07738402485847473, 0.03218832239508629, 0.03641002997756004, 0.0964575931429863, 0.026059472933411598, 0.021298013627529144, 8.771209832048044e-05, 0.011410229839384556, 0.01616019383072853, 0.0035682804882526398, 0.00844511203467846, 0.0022362724412232637, 0.002290372271090746, 0.0013585672713816166, 0.0017531259218230844, 0.0014823870733380318, 0.0027149906381964684, -1]}
{"idB": "749647_18_item1_p285_s0", "idA": "749647_17_item1_p206_s0", "sentA": "In addition to the rights available to us under completed or pending license agreements, we rely on our proprietary know-how and experience in the development and use of heat for medical therapies, which we seek to protect, in part, through proprietary information agreements with employees, consultants and others.", "sentB": "We rely on trade secrets and confidential information that we seek to protect, in part, by confidentiality agreements with our corporate partners, collaborators, employees and consultants.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "rights", "available", "to", "us", "under", "completed", "or", "pending", "license", "agreements,", "we", "rely", "on", "our", "proprietary", "know-how", "and", "experience", "in", "the", "development", "and", "use", "of", "heat", "for", "medical", "therapies,", "which", "we", "seek", "to", "protect,", "in", "part,", "through", "proprietary", "information", "agreements", "with", "employees,", "consultants", "and", "others.", "<tag2>", "We", "rely", "on", "trade", "secrets", "and", "confidential", "information", "that", "we", "seek", "to", "protect,", "in", "part,", "by", "confidentiality", "agreements", "with", "our", "corporate", "partners,", "collaborators,", "employees", "and", "consultants.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "rights", "available", "to", "us", "under", "completed", "or", "pending", "license", "agreements,", "we", "rely", "on", "our", "proprietary", "know-how", "and", "experience", "in", "the", "development", "and", "use", "of", "heat", "for", "medical", "therapies,", "which", "we", "seek", "to", "protect,", "in", "part,", "through", "proprietary", "information", "agreements", "with", "employees,", "consultants", "and", "others."], "wordsB": ["We", "rely", "on", "trade", "secrets", "and", "confidential", "information", "that", "we", "seek", "to", "protect,", "in", "part,", "by", "confidentiality", "agreements", "with", "our", "corporate", "partners,", "collaborators,", "employees", "and", "consultants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010159371420741081, 0.04245526343584061, 0.02492658607661724, 0.6378573179244995, 0.7929096221923828, 0.0778183788061142, 0.7217476963996887, 0.4914019703865051, 0.0034335958771407604, 0.0028742083813995123, 0.003832554677501321, 0.0024570112582296133, 0.0104904780164361, 0.0024886818137019873, 0.004389911890029907, 0.003835607087239623, 0.3133891224861145, 0.11466323584318161, 0.002750857500359416, 0.0037108403630554676, 0.048523467034101486, 0.014540914446115494, 0.0108953220769763, 0.006268301047384739, 0.002154779154807329, 0.006884902250021696, -1]}
{"idB": "749647_18_item1_p285_s1", "idA": "749647_17_item1_p206_s1", "sentA": "There can be no assurance that these proprietary information agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "sentB": "We cannot assure you that these agreements are adequate to protect our trade secrets and confidential information or will not be breached or, if breached, we will have adequate remedies.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "these", "proprietary", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag2>", "We", "cannot", "assure", "you", "that", "these", "agreements", "are", "adequate", "to", "protect", "our", "trade", "secrets", "and", "confidential", "information", "or", "will", "not", "be", "breached", "or,", "if", "breached,", "we", "will", "have", "adequate", "remedies.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "these", "proprietary", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "wordsB": ["We", "cannot", "assure", "you", "that", "these", "agreements", "are", "adequate", "to", "protect", "our", "trade", "secrets", "and", "confidential", "information", "or", "will", "not", "be", "breached", "or,", "if", "breached,", "we", "will", "have", "adequate", "remedies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.033413369208574295, 0.2426844984292984, 0.10840380936861038, 0.04642335698008537, 0.019776130095124245, 0.018168356269598007, 0.06996104121208191, 0.02763168141245842, 0.0542476512491703, 0.025396496057510376, 0.1559547632932663, 0.07130537927150726, 0.2966058850288391, 0.30860963463783264, 0.021498557180166245, 0.2704915404319763, 0.30743837356567383, 0.010668916627764702, 0.03738807141780853, 0.14144138991832733, 0.08308832347393036, 0.08522979170084, 0.005747243296355009, 0.03328800946474075, 0.07599176466464996, 0.012268501333892345, 0.01985934004187584, 0.030991800129413605, 0.06257671117782593, 0.03230990096926689, -1]}
{"idB": "749647_18_item1_p295_s2", "idA": "749647_17_item1_p206_s1", "sentA": "There can be no assurance that these proprietary information agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "sentB": "There can be no assurance that our supply of research and development, preclinical and clinical development drugs and other materials will not be limited, interrupted, restricted in certain geographic regions or of satisfactory quality or continue to be available at acceptable prices.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "these", "proprietary", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "our", "supply", "of", "research", "and", "development,", "preclinical", "and", "clinical", "development", "drugs", "and", "other", "materials", "will", "not", "be", "limited,", "interrupted,", "restricted", "in", "certain", "geographic", "regions", "or", "of", "satisfactory", "quality", "or", "continue", "to", "be", "available", "at", "acceptable", "prices.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "these", "proprietary", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "our", "supply", "of", "research", "and", "development,", "preclinical", "and", "clinical", "development", "drugs", "and", "other", "materials", "will", "not", "be", "limited,", "interrupted,", "restricted", "in", "certain", "geographic", "regions", "or", "of", "satisfactory", "quality", "or", "continue", "to", "be", "available", "at", "acceptable", "prices."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002982762176543474, 0.003927568439394236, 0.003432496218010783, 0.00941821001470089, 0.032172225415706635, 0.016512636095285416, 0.03495589643716812, 0.24281719326972961, 0.14391028881072998, 0.248715341091156, 0.12088873237371445, 0.21581047773361206, 0.045793063938617706, 0.01553924847394228, 0.03744938597083092, 0.07772191613912582, 0.07841799408197403, 0.008252800442278385, 0.013042304664850235, 0.0472363643348217, 0.07268638163805008, 0.16319182515144348, 0.12824471294879913, 0.25847917795181274, 0.2555467486381531, 0.25903499126434326, 0.0058523849584162235, 0.011016941629350185, 0.02018081769347191, 0.019243299961090088, 0.010381435044109821, 0.023323724046349525, 0.07091082632541656, 0.045601919293403625, 0.016889076679944992, 0.1964281052350998, 0.11990512162446976, 0.1234147846698761, 0.14042484760284424, 0.059459786862134933, 0.20052672922611237, 0.18676747381687164, -1]}
{"idB": "749647_18_item1_p350_s3", "idA": "749647_17_item1_p206_s1", "sentA": "There can be no assurance that these proprietary information agreements will not be breached, that we will have adequate remedies for any breach, or that these agreements, even if fully enforced, will be adequate to prevent third-party use of the Company s proprietary technology.", "sentB": "There is no assurance that we will continue to meet the minimum closing price requirement and other listing requirements.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "these", "proprietary", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology.", "<tag2>", "There", "is", "no", "assurance", "that", "we", "will", "continue", "to", "meet", "the", "minimum", "closing", "price", "requirement", "and", "other", "listing", "requirements.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "these", "proprietary", "information", "agreements", "will", "not", "be", "breached,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "these", "agreements,", "even", "if", "fully", "enforced,", "will", "be", "adequate", "to", "prevent", "third-party", "use", "of", "the", "Company", "s", "proprietary", "technology."], "wordsB": ["There", "is", "no", "assurance", "that", "we", "will", "continue", "to", "meet", "the", "minimum", "closing", "price", "requirement", "and", "other", "listing", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00292198802344501, 0.002438145922496915, 0.0304632019251585, 0.04940228536725044, 0.0186909269541502, 0.06523371487855911, 0.12126171588897705, 0.4473806619644165, 0.3735593259334564, 0.572826623916626, 0.15513283014297485, 0.44327086210250854, 0.6310040950775146, 0.5361030697822571, 0.4987201392650604, 0.03920644894242287, 0.04622849076986313, 0.16230961680412292, 0.22687578201293945, -1]}
{"idB": "749647_18_item1_p265_s2", "idA": "749647_17_item1_p207_s0", "sentA": "Please refer to Item 1A, Risk Factors, including, but not limited to, We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "sentB": "Any of these occurrences could prevent us from achieving or maintaining market acceptance and may harm our business, financial condition and prospects significantly.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Any", "of", "these", "occurrences", "could", "prevent", "us", "from", "achieving", "or", "maintaining", "market", "acceptance", "and", "may", "harm", "our", "business,", "financial", "condition", "and", "prospects", "significantly.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Any", "of", "these", "occurrences", "could", "prevent", "us", "from", "achieving", "or", "maintaining", "market", "acceptance", "and", "may", "harm", "our", "business,", "financial", "condition", "and", "prospects", "significantly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07281362265348434, 0.025853214785456657, 0.026524648070335388, 0.09674699604511261, 0.040396325290203094, 0.29848983883857727, 0.07441053539514542, 0.27041125297546387, 0.27664914727211, 0.13812372088432312, 0.41082119941711426, 0.2080179899930954, 0.22796979546546936, 0.005920670460909605, 0.032557979226112366, 0.1258193403482437, 0.029427839443087578, 0.08182438462972641, 0.05309584364295006, 0.045474402606487274, 0.01537349447607994, 0.05980045720934868, 0.08404248207807541, -1]}
{"idB": "749647_18_item1_p284_s0", "idA": "749647_17_item1_p207_s0", "sentA": "Please refer to Item 1A, Risk Factors, including, but not limited to, We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "sentB": "We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.20028109848499298, 0.15179385244846344, 0.05746830254793167, 0.15561017394065857, 0.15365023910999298, 0.11272264271974564, 0.02840971201658249, 0.02970276214182377, 0.07433511316776276, 0.08231062442064285, 0.09594497084617615, 0.026230191811919212, 0.05294015631079674, 0.06684661656618118, 0.05453735589981079, 0.018032360821962357, 0.025372639298439026, 0.15431423485279083, 0.03588993474841118, 0.0321279801428318, 0.10159589350223541, 0.017606467008590698, 0.051661960780620575, 0.02872318960726261, 0.066561758518219, 0.027977213263511658, 0.02547961287200451, 0.035249676555395126, 0.021785173565149307, 0.024728402495384216, 0.03792225196957588, -1]}
{"idB": "749647_18_item1_p285_s3", "idA": "749647_17_item1_p207_s0", "sentA": "Please refer to Item 1A, Risk Factors, including, but not limited to, We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "sentB": "Any loss of trade secret protection or other unpatented proprietary rights could harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Any", "loss", "of", "trade", "secret", "protection", "or", "other", "unpatented", "proprietary", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Any", "loss", "of", "trade", "secret", "protection", "or", "other", "unpatented", "proprietary", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05689467489719391, 0.8009273409843445, 0.08955736458301544, 0.1806328147649765, 0.12414722889661789, 0.0864974707365036, 0.009829595685005188, 0.008835379034280777, 0.024345342069864273, 0.06394053995609283, 0.07657933980226517, 0.023305486887693405, 0.07751835882663727, 0.0422961451113224, 0.11441844701766968, 0.013566730543971062, 0.010892393067479134, 0.016120607033371925, 0.009230496361851692, 0.011396468617022038, 0.014998987317085266, -1]}
{"idB": "749647_18_item1_p277_s0", "idA": "749647_17_item1_p207_s1", "sentA": "Similarly, we cannot guarantee that technology rights licensed to us by others will not be successfully challenged or circumvented by third parties, or that the rights granted will provide us with adequate protection.", "sentB": "Further, we cannot guarantee that any patent or other technology rights licensed to us by others will not be challenged or circumvented successfully by third parties, or that the rights granted will provide adequate protection.", "type": 2, "words": ["<tag1>", "Similarly,", "we", "cannot", "guarantee", "that", "technology", "rights", "licensed", "to", "us", "by", "others", "will", "not", "be", "successfully", "challenged", "or", "circumvented", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "us", "with", "adequate", "protection.", "<tag2>", "Further,", "we", "cannot", "guarantee", "that", "any", "patent", "or", "other", "technology", "rights", "licensed", "to", "us", "by", "others", "will", "not", "be", "challenged", "or", "circumvented", "successfully", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "adequate", "protection.", "<tag3>"], "wordsA": ["Similarly,", "we", "cannot", "guarantee", "that", "technology", "rights", "licensed", "to", "us", "by", "others", "will", "not", "be", "successfully", "challenged", "or", "circumvented", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "us", "with", "adequate", "protection."], "wordsB": ["Further,", "we", "cannot", "guarantee", "that", "any", "patent", "or", "other", "technology", "rights", "licensed", "to", "us", "by", "others", "will", "not", "be", "challenged", "or", "circumvented", "successfully", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "adequate", "protection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05058717727661133, 0.024053184315562248, 0.06459291279315948, 0.06462205201387405, 0.011111844331026077, 0.11817643791437149, 0.4648900330066681, 0.05034232139587402, 0.02321275882422924, 0.05508877709507942, 0.07868191599845886, 0.021871143952012062, 0.017408447340130806, 0.018129561096429825, 0.011632039211690426, 0.018957987427711487, 0.019176142290234566, 0.22367751598358154, 0.025880001485347748, 0.05786997079849243, 0.012985498644411564, 0.02297224849462509, 0.024080118164420128, 0.01171017624437809, 0.018230218440294266, 0.020892448723316193, 0.00929606705904007, 0.006521649193018675, 0.007719586603343487, 0.06385393440723419, 0.030095180496573448, 0.01246224157512188, 0.011215467005968094, 0.027321739122271538, 0.030065540224313736, -1]}
{"idB": "749647_18_item1_p275_s0", "idA": "749647_17_item1_p207_s2", "sentA": "Please refer to Item 1A, Risk Factors, including, but not limited to, Our business depends on licensing agreements with third parties to permit us to use patented technologies.", "sentB": "Our business depends on license agreements with third parties to permit us to use patented technologies.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "Our", "business", "depends", "on", "licensing", "agreements", "with", "third", "parties", "to", "permit", "us", "to", "use", "patented", "technologies.", "<tag2>", "Our", "business", "depends", "on", "license", "agreements", "with", "third", "parties", "to", "permit", "us", "to", "use", "patented", "technologies.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Item", "1A,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "Our", "business", "depends", "on", "licensing", "agreements", "with", "third", "parties", "to", "permit", "us", "to", "use", "patented", "technologies."], "wordsB": ["Our", "business", "depends", "on", "license", "agreements", "with", "third", "parties", "to", "permit", "us", "to", "use", "patented", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013498511165380478, 0.49730968475341797, 0.29290711879730225, 0.0677451491355896, 0.5935413837432861, 0.454479455947876, 0.03264085203409195, 0.11858624964952469, 0.10031531006097794, 0.006944252643734217, 0.022531770169734955, 0.022054487839341164, 0.014376138336956501, 0.018134986981749535, 0.026514610275626183, 0.02450687810778618, -1]}
{"idB": "749647_18_item1_p252_s1", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "Any of our present and future clinical trials may be delayed, halted, not authorized, or approval of any of our products may be delayed or may not be obtained due to any of the following:", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "Any", "of", "our", "present", "and", "future", "clinical", "trials", "may", "be", "delayed,", "halted,", "not", "authorized,", "or", "approval", "of", "any", "of", "our", "products", "may", "be", "delayed", "or", "may", "not", "be", "obtained", "due", "to", "any", "of", "the", "following:", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["Any", "of", "our", "present", "and", "future", "clinical", "trials", "may", "be", "delayed,", "halted,", "not", "authorized,", "or", "approval", "of", "any", "of", "our", "products", "may", "be", "delayed", "or", "may", "not", "be", "obtained", "due", "to", "any", "of", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04600371792912483, 0.020200995728373528, 0.05613212287425995, 0.0903870016336441, 0.04806843400001526, 0.11415796726942062, 0.2694869637489319, 0.3280509412288666, 0.028150755912065506, 0.05376962944865227, 0.18399474024772644, 0.20762845873832703, 0.13979081809520721, 0.15482094883918762, 0.007237531710416079, 0.17789091169834137, 0.029774416238069534, 0.020199650898575783, 0.014133232645690441, 0.032801464200019836, 0.06536911427974701, 0.01594638079404831, 0.02269594371318817, 0.1198178082704544, 0.0025502366479486227, 0.028746671974658966, 0.11030755937099457, 0.05447032302618027, 0.06537315994501114, 0.01603245735168457, 0.018120206892490387, 0.021985352039337158, 0.02000635303556919, 0.018129104748368263, 0.02853960357606411, -1]}
{"idB": "749647_18_item1_p270_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "We may not successfully engage in future strategic transactions, which could adversely affect our ability to develop and commercialize product candidates, impact our cash position, increase our expense and present significant distractions to our management.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "We", "may", "not", "successfully", "engage", "in", "future", "strategic", "transactions,", "which", "could", "adversely", "affect", "our", "ability", "to", "develop", "and", "commercialize", "product", "candidates,", "impact", "our", "cash", "position,", "increase", "our", "expense", "and", "present", "significant", "distractions", "to", "our", "management.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["We", "may", "not", "successfully", "engage", "in", "future", "strategic", "transactions,", "which", "could", "adversely", "affect", "our", "ability", "to", "develop", "and", "commercialize", "product", "candidates,", "impact", "our", "cash", "position,", "increase", "our", "expense", "and", "present", "significant", "distractions", "to", "our", "management."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04072894901037216, 0.048117440193891525, 0.16289402544498444, 0.08693060278892517, 0.21230265498161316, 0.07843050360679626, 0.07159070670604706, 0.21259553730487823, 0.27686750888824463, 0.0003800115082412958, 0.0074181947857141495, 0.02175557054579258, 0.07090219110250473, 0.013722938485443592, 0.03289555385708809, 0.017010686919093132, 0.042930543422698975, 0.03109920769929886, 0.11966691166162491, 0.05554545298218727, 0.0999838188290596, 0.06891072541475296, 0.013990944251418114, 0.09317771345376968, 0.09471660107374191, 0.03959428146481514, 0.02027609758079052, 0.05895620211958885, 0.006435803137719631, 0.05661911517381668, 0.06813036650419235, 0.15671153366565704, 0.020750360563397408, 0.017744775861501694, 0.04785533621907234, -1]}
{"idB": "749647_18_item1_p276_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "Our success will depend, in a substantial part, on our ability to maintain our rights under license agreements granting us rights to use patented technologies.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "Our", "success", "will", "depend,", "in", "a", "substantial", "part,", "on", "our", "ability", "to", "maintain", "our", "rights", "under", "license", "agreements", "granting", "us", "rights", "to", "use", "patented", "technologies.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["Our", "success", "will", "depend,", "in", "a", "substantial", "part,", "on", "our", "ability", "to", "maintain", "our", "rights", "under", "license", "agreements", "granting", "us", "rights", "to", "use", "patented", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.038172319531440735, 0.1501970887184143, 0.04094729572534561, 0.10730528831481934, 0.03412870690226555, 0.014321312308311462, 0.05381370335817337, 0.034672245383262634, 0.04751712083816528, 0.04512545093894005, 0.16212014853954315, 0.1245991438627243, 0.4410150647163391, 0.14656174182891846, 0.23120298981666565, 0.030022380873560905, 0.2113686501979828, 0.10860747843980789, 0.08034221082925797, 0.03689782693982124, 0.08854969590902328, 0.02705671638250351, 0.04349585995078087, 0.051422663033008575, 0.06054474785923958, -1]}
{"idB": "749647_18_item1_p281_s1", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "The scope of our claim coverage can be critical to our ability to enter into licensing transactions with third parties and our right to receive royalties from our collaboration partnerships.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "The", "scope", "of", "our", "claim", "coverage", "can", "be", "critical", "to", "our", "ability", "to", "enter", "into", "licensing", "transactions", "with", "third", "parties", "and", "our", "right", "to", "receive", "royalties", "from", "our", "collaboration", "partnerships.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["The", "scope", "of", "our", "claim", "coverage", "can", "be", "critical", "to", "our", "ability", "to", "enter", "into", "licensing", "transactions", "with", "third", "parties", "and", "our", "right", "to", "receive", "royalties", "from", "our", "collaboration", "partnerships."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021662233397364616, 0.1946258395910263, 0.03331935033202171, 0.033129800111055374, 0.1413855254650116, 0.1188734918832779, 0.027131982147693634, 0.028122318908572197, 0.1815568208694458, 0.024124471470713615, 0.04529837891459465, 0.08576902747154236, 0.0852830559015274, 0.28633469343185425, 0.33147427439689636, 0.43512916564941406, 0.4761655330657959, 0.06811675429344177, 0.1227232813835144, 0.12167587131261826, 0.00017820316134020686, 0.029684871435165405, 0.07881982624530792, 0.017261315137147903, 0.19772160053253174, 0.1804801970720291, 0.019871922209858894, 0.01716442033648491, 0.0662786066532135, 0.050901804119348526, -1]}
{"idB": "749647_18_item1_p286_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "Our products may infringe patent rights of others, which may require costly litigation and, if we are not successful, could cause us to pay substantial damages or limit our ability to commercialize our products.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "Our", "products", "may", "infringe", "patent", "rights", "of", "others,", "which", "may", "require", "costly", "litigation", "and,", "if", "we", "are", "not", "successful,", "could", "cause", "us", "to", "pay", "substantial", "damages", "or", "limit", "our", "ability", "to", "commercialize", "our", "products.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["Our", "products", "may", "infringe", "patent", "rights", "of", "others,", "which", "may", "require", "costly", "litigation", "and,", "if", "we", "are", "not", "successful,", "could", "cause", "us", "to", "pay", "substantial", "damages", "or", "limit", "our", "ability", "to", "commercialize", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.049087587743997574, 0.18723398447036743, 0.05856410041451454, 0.4631046652793884, 0.4552137553691864, 0.5997734069824219, 0.031516265124082565, 0.06662402302026749, 0.00010195248614763841, 0.006089724600315094, 0.007386878598481417, 0.01655733212828636, 0.03802049905061722, 0.00011432378232711926, 0.00870489701628685, 0.014082496985793114, 0.012433008290827274, 0.02921903319656849, 0.01989571750164032, 0.008950668387115002, 0.011793247424066067, 0.014225160703063011, 0.010805646888911724, 0.05423770472407341, 0.060740817338228226, 0.07140485942363739, 0.007292438764125109, 0.1398943066596985, 0.027506841346621513, 0.107989601790905, 0.1038108691573143, 0.2702319324016571, 0.03704165294766426, 0.11738566309213638, -1]}
{"idB": "749647_18_item1_p289_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "We can also be prevented from selling or commercializing any of our products that use the infringing technology in the future, unless we obtain a license from such third party.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "We", "can", "also", "be", "prevented", "from", "selling", "or", "commercializing", "any", "of", "our", "products", "that", "use", "the", "infringing", "technology", "in", "the", "future,", "unless", "we", "obtain", "a", "license", "from", "such", "third", "party.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["We", "can", "also", "be", "prevented", "from", "selling", "or", "commercializing", "any", "of", "our", "products", "that", "use", "the", "infringing", "technology", "in", "the", "future,", "unless", "we", "obtain", "a", "license", "from", "such", "third", "party."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05373850464820862, 0.029401274397969246, 0.0394299291074276, 0.037141427397727966, 0.4199751317501068, 0.3520728349685669, 0.5123493671417236, 0.21386978030204773, 0.46384912729263306, 0.14294373989105225, 0.09248336404561996, 0.09280272573232651, 0.19764012098312378, 0.005181570537388325, 0.027479123324155807, 0.008476141840219498, 0.0427265465259552, 0.03645255044102669, 0.01605234295129776, 0.012326187454164028, 0.018511516973376274, 0.011077780276536942, 0.023967472836375237, 0.053778309375047684, 0.04255472496151924, 0.09833163022994995, 0.01628763973712921, 0.01248258538544178, 0.06811798363924026, 0.08309029787778854, -1]}
{"idB": "749647_18_item1_p289_s2", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "Any modification to include a non-infringing technology may not be possible or if possible may be difficult or time-consuming to develop, and require revalidation, which could delay our ability to commercialize our products.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "Any", "modification", "to", "include", "a", "non-infringing", "technology", "may", "not", "be", "possible", "or", "if", "possible", "may", "be", "difficult", "or", "time-consuming", "to", "develop,", "and", "require", "revalidation,", "which", "could", "delay", "our", "ability", "to", "commercialize", "our", "products.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["Any", "modification", "to", "include", "a", "non-infringing", "technology", "may", "not", "be", "possible", "or", "if", "possible", "may", "be", "difficult", "or", "time-consuming", "to", "develop,", "and", "require", "revalidation,", "which", "could", "delay", "our", "ability", "to", "commercialize", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05830134451389313, 0.24843759834766388, 0.006828694138675928, 0.018915319815278053, 0.012425564229488373, 0.39043334126472473, 0.14588573575019836, 0.010137648321688175, 0.020409857854247093, 0.01216911617666483, 0.018188051879405975, 0.0003164553490933031, 0.007479763124138117, 0.011308817192912102, 0.0062150838784873486, 0.009298408403992653, 0.020299812778830528, 0.009682507254183292, 0.06381035596132278, 0.02191852778196335, 0.04364269599318504, 0.00024132757971528918, 0.03456282243132591, 0.09734440594911575, 0.0002019662642851472, 0.007508334703743458, 0.222320094704628, 0.026647070422768593, 0.07757126539945602, 0.0900881364941597, 0.12030383199453354, 0.04399168863892555, 0.09009969234466553, -1]}
{"idB": "749647_18_item1_p296_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "Our business is subject to numerous and evolving state, federal and foreign regulations and we may not be able to secure the government approvals needed to develop and market our products.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "Our", "business", "is", "subject", "to", "numerous", "and", "evolving", "state,", "federal", "and", "foreign", "regulations", "and", "we", "may", "not", "be", "able", "to", "secure", "the", "government", "approvals", "needed", "to", "develop", "and", "market", "our", "products.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["Our", "business", "is", "subject", "to", "numerous", "and", "evolving", "state,", "federal", "and", "foreign", "regulations", "and", "we", "may", "not", "be", "able", "to", "secure", "the", "government", "approvals", "needed", "to", "develop", "and", "market", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02070837840437889, 0.16316339373588562, 0.02815961465239525, 0.11278782039880753, 0.03819584473967552, 0.077854223549366, 0.009427442215383053, 0.12756703794002533, 0.09984258562326431, 0.04725513607263565, 0.010809965431690216, 0.05102745443582535, 0.2511120140552521, 0.00394715741276741, 0.040311798453330994, 0.052215270698070526, 0.27247413992881775, 0.13720068335533142, 0.17528371512889862, 0.16523060202598572, 0.30153948068618774, 0.06209409609436989, 0.24545204639434814, 0.4034472703933716, 0.04053640365600586, 0.018027253448963165, 0.019065577536821365, 0.005956809502094984, 0.02274373546242714, 0.011568225920200348, 0.033353980630636215, -1]}
{"idB": "749647_18_item1_p313_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "The success of our products may be harmed if the government, private health insurers and other third-party payers do not provide sufficient coverage or reimbursement.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "The", "success", "of", "our", "products", "may", "be", "harmed", "if", "the", "government,", "private", "health", "insurers", "and", "other", "third-party", "payers", "do", "not", "provide", "sufficient", "coverage", "or", "reimbursement.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["The", "success", "of", "our", "products", "may", "be", "harmed", "if", "the", "government,", "private", "health", "insurers", "and", "other", "third-party", "payers", "do", "not", "provide", "sufficient", "coverage", "or", "reimbursement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015321138314902782, 0.21300943195819855, 0.04358328506350517, 0.05290084332227707, 0.12376198917627335, 0.04493580013513565, 0.05319784954190254, 0.18671195209026337, 0.011700424365699291, 0.011464960873126984, 0.08056219667196274, 0.11964871734380722, 0.17408765852451324, 0.14238543808460236, 0.012837857939302921, 0.019664492458105087, 0.08688758313655853, 0.07539001107215881, 0.2559359073638916, 0.4103762209415436, 0.3708406686782837, 0.3337831199169159, 0.45075541734695435, 0.15397007763385773, 0.4598439335823059, -1]}
{"idB": "749647_18_item1_p318_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "The commercial success of our products will depend upon their acceptance by the medical community and third-party payors as clinically useful, cost effective and safe.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "The", "commercial", "success", "of", "our", "products", "will", "depend", "upon", "their", "acceptance", "by", "the", "medical", "community", "and", "third-party", "payors", "as", "clinically", "useful,", "cost", "effective", "and", "safe.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["The", "commercial", "success", "of", "our", "products", "will", "depend", "upon", "their", "acceptance", "by", "the", "medical", "community", "and", "third-party", "payors", "as", "clinically", "useful,", "cost", "effective", "and", "safe."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.019967976957559586, 0.24610376358032227, 0.22980690002441406, 0.036265138536691666, 0.05888747423887253, 0.1621776521205902, 0.0356881320476532, 0.14578324556350708, 0.08240144699811935, 0.05660291761159897, 0.2360318899154663, 0.04858175292611122, 0.029881922528147697, 0.15023398399353027, 0.11553097516298294, 0.014356476254761219, 0.09024083614349365, 0.16269633173942566, 0.02851390279829502, 0.08615719527006149, 0.10061924159526825, 0.14634692668914795, 0.09363831579685211, 0.001367685734294355, 0.14149968326091766, -1]}
{"idB": "749647_18_item1_p325_s2", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "If we decide to market our products directly, we will need to commit significant financial and managerial resources to develop a marketing and sales force with technical expertise and with supporting distribution, administration and compliance capabilities.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "If", "we", "decide", "to", "market", "our", "products", "directly,", "we", "will", "need", "to", "commit", "significant", "financial", "and", "managerial", "resources", "to", "develop", "a", "marketing", "and", "sales", "force", "with", "technical", "expertise", "and", "with", "supporting", "distribution,", "administration", "and", "compliance", "capabilities.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["If", "we", "decide", "to", "market", "our", "products", "directly,", "we", "will", "need", "to", "commit", "significant", "financial", "and", "managerial", "resources", "to", "develop", "a", "marketing", "and", "sales", "force", "with", "technical", "expertise", "and", "with", "supporting", "distribution,", "administration", "and", "compliance", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.036802057176828384, 0.05650167539715767, 0.18878789246082306, 0.14424727857112885, 0.19840864837169647, 0.07028716802597046, 0.11583266407251358, 0.25711801648139954, 0.015546785667538643, 0.019138909876346588, 0.02753877453505993, 0.01470554806292057, 0.12388679385185242, 0.09960024803876877, 0.16120018064975739, 0.03085385076701641, 0.1121392548084259, 0.1189020574092865, 0.008720587939023972, 0.014797658659517765, 0.009160637855529785, 0.04022247716784477, 0.015265335328876972, 0.0588485486805439, 0.03667285293340683, 0.000305559195112437, 0.010191607289016247, 0.020420348271727562, 0.0003130596305709332, 0.0060866656713187695, 0.014319077134132385, 0.018808521330356598, 0.027022285386919975, 0.009248916991055012, 0.04205349087715149, 0.023691793903708458, -1]}
{"idB": "749647_18_item1_p332_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "We face intense competition and the failure to compete effectively could adversely affect our ability to develop and market our products.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "We", "face", "intense", "competition", "and", "the", "failure", "to", "compete", "effectively", "could", "adversely", "affect", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["We", "face", "intense", "competition", "and", "the", "failure", "to", "compete", "effectively", "could", "adversely", "affect", "our", "ability", "to", "develop", "and", "market", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.035368651151657104, 0.13889575004577637, 0.33143696188926697, 0.2658803164958954, 0.0018743068212643266, 0.009933028370141983, 0.488710880279541, 0.38037219643592834, 0.432828426361084, 0.22836463153362274, 0.007113657891750336, 0.054707061499357224, 0.1256146878004074, 0.027011657133698463, 0.05128521844744682, 0.015197203494608402, 0.00885257963091135, 0.0035316513385623693, 0.00971550215035677, 0.0055088503286242485, 0.013250201009213924, -1]}
{"idB": "749647_18_item1_p333_s5", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "Furthermore, if we are permitted to commence commercial sales of any of our products, we will also be competing, with respect to manufacturing efficiency and marketing, with companies having substantially greater resources and experience in these areas.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "Furthermore,", "if", "we", "are", "permitted", "to", "commence", "commercial", "sales", "of", "any", "of", "our", "products,", "we", "will", "also", "be", "competing,", "with", "respect", "to", "manufacturing", "efficiency", "and", "marketing,", "with", "companies", "having", "substantially", "greater", "resources", "and", "experience", "in", "these", "areas.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["Furthermore,", "if", "we", "are", "permitted", "to", "commence", "commercial", "sales", "of", "any", "of", "our", "products,", "we", "will", "also", "be", "competing,", "with", "respect", "to", "manufacturing", "efficiency", "and", "marketing,", "with", "companies", "having", "substantially", "greater", "resources", "and", "experience", "in", "these", "areas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023160435259342194, 0.04199777543544769, 0.05451233312487602, 0.05405201390385628, 0.3104202151298523, 0.16552624106407166, 0.2571377158164978, 0.4861292243003845, 0.5561282634735107, 0.07417243719100952, 0.05580917000770569, 0.04978569597005844, 0.05242134630680084, 0.08531125634908676, 0.012490976601839066, 0.017841367051005363, 0.015560511499643326, 0.01918957754969597, 0.22389400005340576, 0.0004033194563817233, 0.004589622840285301, 0.008349564857780933, 0.023047300055623055, 0.026815323159098625, 0.012880118563771248, 0.027073534205555916, 0.006170249544084072, 0.028491508215665817, 0.007277562282979488, 0.021068422123789787, 0.04503040015697479, 0.056956540793180466, 0.010813307017087936, 0.050786688923835754, 0.010173364542424679, 0.011456693522632122, 0.02101503685116768, -1]}
{"idB": "749647_18_item1_p344_s0", "idA": "749647_17_item1_p207_s3", "sentA": "The loss of any of our rights under these agreements could impair our ability to develop and market our products.", "sentB": "Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities.", "type": 2, "words": ["<tag1>", "The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products.", "<tag2>", "Sales", "of", "a", "substantial", "number", "of", "shares", "of", "our", "common", "stock", "in", "the", "public", "market,", "or", "the", "perception", "that", "these", "sales", "might", "occur,", "could", "depress", "the", "market", "price", "of", "our", "common", "stock", "and", "could", "impair", "our", "ability", "to", "raise", "capital", "through", "the", "sale", "of", "additional", "equity", "securities.", "<tag3>"], "wordsA": ["The", "loss", "of", "any", "of", "our", "rights", "under", "these", "agreements", "could", "impair", "our", "ability", "to", "develop", "and", "market", "our", "products."], "wordsB": ["Sales", "of", "a", "substantial", "number", "of", "shares", "of", "our", "common", "stock", "in", "the", "public", "market,", "or", "the", "perception", "that", "these", "sales", "might", "occur,", "could", "depress", "the", "market", "price", "of", "our", "common", "stock", "and", "could", "impair", "our", "ability", "to", "raise", "capital", "through", "the", "sale", "of", "additional", "equity", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.42093876004219055, 0.14440682530403137, 0.08365724235773087, 0.20898182690143585, 0.22995077073574066, 0.20424816012382507, 0.28443917632102966, 0.07775776833295822, 0.03696964308619499, 0.13625280559062958, 0.158940389752388, 0.019333165138959885, 0.013478530570864677, 0.051534224301576614, 0.09333062171936035, 0.005445533432066441, 0.004957133904099464, 0.022151857614517212, 0.007817690260708332, 0.0182984359562397, 0.05360087379813194, 0.02445646934211254, 0.02585354633629322, 0.010723516345024109, 0.19214527308940887, 0.05437305197119713, 0.23557542264461517, 0.19897136092185974, 0.04644480347633362, 0.023280786350369453, 0.10701173543930054, 0.08235785365104675, 0.0002808148565236479, 0.007130308076739311, 0.0617087259888649, 0.028174445033073425, 0.082406185567379, 0.05952072516083717, 0.1457299143075943, 0.13190774619579315, 0.008965426124632359, 0.007613925263285637, 0.043316081166267395, 0.02436567097902298, 0.04609517380595207, 0.12387628108263016, 0.13498596847057343, -1]}
{"idB": "749647_18_item1_p229_s0", "idA": "749647_17_item1_p208_s0", "sentA": "As of March 23, 2017, we employed 19 full-time employees.", "sentB": "As of March 26, 2018, we employed 21 full-time employees.", "type": 2, "words": ["<tag1>", "As", "of", "March", "23,", "2017,", "we", "employed", "19", "full-time", "employees.", "<tag2>", "As", "of", "March", "26,", "2018,", "we", "employed", "21", "full-time", "employees.", "<tag3>"], "wordsA": ["As", "of", "March", "23,", "2017,", "we", "employed", "19", "full-time", "employees."], "wordsB": ["As", "of", "March", "26,", "2018,", "we", "employed", "21", "full-time", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.008638409897685051, 0.007187619339674711, 0.08575865626335144, 0.5653745532035828, 0.6503286957740784, 0.0042809294536709785, 0.029871640726923943, 0.8432924747467041, 0.1478261947631836, 0.11247914284467697, -1]}
{"idB": "749647_18_item1_p122_s0", "idA": "749647_17_item1_p20_s0", "sentA": "Additional findings from this most recent analysis specific to the Chinese patient cohort of 223 patients are summarized below:", "sentB": "Key translational research findings from all evaluable patients are consistent with the earlier reports from partial analysis of the data and are summarized below:", "type": 2, "words": ["<tag1>", "Additional", "findings", "from", "this", "most", "recent", "analysis", "specific", "to", "the", "Chinese", "patient", "cohort", "of", "223", "patients", "are", "summarized", "below:", "<tag2>", "Key", "translational", "research", "findings", "from", "all", "evaluable", "patients", "are", "consistent", "with", "the", "earlier", "reports", "from", "partial", "analysis", "of", "the", "data", "and", "are", "summarized", "below:", "<tag3>"], "wordsA": ["Additional", "findings", "from", "this", "most", "recent", "analysis", "specific", "to", "the", "Chinese", "patient", "cohort", "of", "223", "patients", "are", "summarized", "below:"], "wordsB": ["Key", "translational", "research", "findings", "from", "all", "evaluable", "patients", "are", "consistent", "with", "the", "earlier", "reports", "from", "partial", "analysis", "of", "the", "data", "and", "are", "summarized", "below:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.049813054502010345, 0.21690241992473602, 0.17450721561908722, 0.12249555438756943, 0.030688825994729996, 0.3699512183666229, 0.470589816570282, 0.34754735231399536, 0.00012516863353084773, 0.0315730981528759, 0.008559411391615868, 0.005364549811929464, 0.052957482635974884, 0.054323870688676834, 0.005717155989259481, 0.27349796891212463, 0.12416939437389374, 0.006472151726484299, 0.0059962584637105465, 0.0433940552175045, 5.379873255151324e-05, 0.003870070679113269, 0.008523874916136265, 0.015409816056489944, -1]}
{"idB": "749647_18_item1_p48_s0", "idA": "749647_17_item1_p20_s0", "sentA": "Additional findings from this most recent analysis specific to the Chinese patient cohort of 223 patients are summarized below:", "sentB": "Key translational research findings from all evaluable patients are consistent with the earlier reports from partial analysis of the data and are summarized below:", "type": 2, "words": ["<tag1>", "Additional", "findings", "from", "this", "most", "recent", "analysis", "specific", "to", "the", "Chinese", "patient", "cohort", "of", "223", "patients", "are", "summarized", "below:", "<tag2>", "Key", "translational", "research", "findings", "from", "all", "evaluable", "patients", "are", "consistent", "with", "the", "earlier", "reports", "from", "partial", "analysis", "of", "the", "data", "and", "are", "summarized", "below:", "<tag3>"], "wordsA": ["Additional", "findings", "from", "this", "most", "recent", "analysis", "specific", "to", "the", "Chinese", "patient", "cohort", "of", "223", "patients", "are", "summarized", "below:"], "wordsB": ["Key", "translational", "research", "findings", "from", "all", "evaluable", "patients", "are", "consistent", "with", "the", "earlier", "reports", "from", "partial", "analysis", "of", "the", "data", "and", "are", "summarized", "below:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.049813054502010345, 0.21690241992473602, 0.17450721561908722, 0.12249555438756943, 0.030688825994729996, 0.3699512183666229, 0.470589816570282, 0.34754735231399536, 0.00012516863353084773, 0.0315730981528759, 0.008559411391615868, 0.005364549811929464, 0.052957482635974884, 0.054323870688676834, 0.005717155989259481, 0.27349796891212463, 0.12416939437389374, 0.006472151726484299, 0.0059962584637105465, 0.0433940552175045, 5.379873255151324e-05, 0.003870070679113269, 0.008523874916136265, 0.015409816056489944, -1]}
{"idB": "749647_18_item1_p360_s3", "idA": "749647_17_item1_p210_s2", "sentA": "We intend to disclose on our internet website any amendments to or waivers from our code of business conduct and ethics as well as any amendments to its corporate governance principles or the charters of various committees of the Board of Directors.", "sentB": "In addition, our Board of Directors may discourage such transactions by increasing the amount of time necessary to obtain majority representation on our Board of Directors.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "disclose", "on", "our", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "our", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors.", "<tag2>", "In", "addition,", "our", "Board", "of", "Directors", "may", "discourage", "such", "transactions", "by", "increasing", "the", "amount", "of", "time", "necessary", "to", "obtain", "majority", "representation", "on", "our", "Board", "of", "Directors.", "<tag3>"], "wordsA": ["We", "intend", "to", "disclose", "on", "our", "internet", "website", "any", "amendments", "to", "or", "waivers", "from", "our", "code", "of", "business", "conduct", "and", "ethics", "as", "well", "as", "any", "amendments", "to", "its", "corporate", "governance", "principles", "or", "the", "charters", "of", "various", "committees", "of", "the", "Board", "of", "Directors."], "wordsB": ["In", "addition,", "our", "Board", "of", "Directors", "may", "discourage", "such", "transactions", "by", "increasing", "the", "amount", "of", "time", "necessary", "to", "obtain", "majority", "representation", "on", "our", "Board", "of", "Directors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.023686036467552185, 0.02998429536819458, 0.0290971752256155, 0.12912040948867798, 0.05726637318730354, 0.10472952574491501, 0.07057687640190125, 0.707542896270752, 0.3222600519657135, 0.5110584497451782, 0.008318586274981499, 0.009872842580080032, 0.0018117616418749094, 0.00984083954244852, 0.007884389720857143, 0.014473974704742432, 0.008120282553136349, 0.0075179170817136765, 0.01736234314739704, 0.07274163514375687, 0.07647807151079178, 0.030444085597991943, 0.02313162572681904, 0.05049142986536026, 0.031199732795357704, 0.05370268225669861, -1]}
{"idB": "749647_18_item1_p340_s1", "idA": "749647_17_item1_p210_s3", "sentA": "Copies of these documents may be obtained, free of charge, from our website.", "sentB": "Some of these factors are beyond our control.", "type": 2, "words": ["<tag1>", "Copies", "of", "these", "documents", "may", "be", "obtained,", "free", "of", "charge,", "from", "our", "website.", "<tag2>", "Some", "of", "these", "factors", "are", "beyond", "our", "control.", "<tag3>"], "wordsA": ["Copies", "of", "these", "documents", "may", "be", "obtained,", "free", "of", "charge,", "from", "our", "website."], "wordsB": ["Some", "of", "these", "factors", "are", "beyond", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1128351092338562, 0.031218303367495537, 0.05858819931745529, 0.20087359845638275, 0.16668403148651123, 0.8441674113273621, 0.6928218603134155, 0.8773000240325928, -1]}
{"idB": "749647_18_item1_p282_s1", "idA": "749647_17_item1_p210_s4", "sentA": "In addition, copies of these documents will be made available free of charge upon written request.", "sentB": "In addition, there is no guarantee that we will be the first to file a patent application directed to an invention.", "type": 2, "words": ["<tag1>", "In", "addition,", "copies", "of", "these", "documents", "will", "be", "made", "available", "free", "of", "charge", "upon", "written", "request.", "<tag2>", "In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention.", "<tag3>"], "wordsA": ["In", "addition,", "copies", "of", "these", "documents", "will", "be", "made", "available", "free", "of", "charge", "upon", "written", "request."], "wordsB": ["In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006710143759846687, 0.027138469740748405, 0.01965305581688881, 0.021201085299253464, 0.3617572784423828, 0.5356431603431702, 0.11165066808462143, 0.11850334703922272, 0.22449658811092377, 0.13211435079574585, 0.11407256126403809, 0.34277310967445374, 0.2938474118709564, 0.3683706521987915, 0.16669967770576477, 0.3006685674190521, 0.4368464946746826, 0.0489620715379715, 0.029371945187449455, 0.03222605586051941, 0.07369869202375412, -1]}
{"idB": "749647_18_item1_p42_s1", "idA": "749647_17_item1_p210_s9", "sentA": "The information available on or through our website is not a part of this Annual Report on Form 10-K and should not be relied upon.", "sentB": "As of the date of this Annual Report on Form 10-K, the Company does not anticipate that the ovarian cancer earnout payment will be made before the fourth quarter of 2019.", "type": 2, "words": ["<tag1>", "The", "information", "available", "on", "or", "through", "our", "website", "is", "not", "a", "part", "of", "this", "Annual", "Report", "on", "Form", "10-K", "and", "should", "not", "be", "relied", "upon.", "<tag2>", "As", "of", "the", "date", "of", "this", "Annual", "Report", "on", "Form", "10-K,", "the", "Company", "does", "not", "anticipate", "that", "the", "ovarian", "cancer", "earnout", "payment", "will", "be", "made", "before", "the", "fourth", "quarter", "of", "2019.", "<tag3>"], "wordsA": ["The", "information", "available", "on", "or", "through", "our", "website", "is", "not", "a", "part", "of", "this", "Annual", "Report", "on", "Form", "10-K", "and", "should", "not", "be", "relied", "upon."], "wordsB": ["As", "of", "the", "date", "of", "this", "Annual", "Report", "on", "Form", "10-K,", "the", "Company", "does", "not", "anticipate", "that", "the", "ovarian", "cancer", "earnout", "payment", "will", "be", "made", "before", "the", "fourth", "quarter", "of", "2019."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.049944426864385605, 0.021617351099848747, 0.010118341073393822, 0.019623780623078346, 0.008273604325950146, 0.009166057221591473, 0.02904200181365013, 0.03351563960313797, 0.006389731075614691, 0.017070509493350983, 0.010307075455784798, 0.012451102957129478, 0.10613700747489929, 0.25827932357788086, 0.301592618227005, 0.2832934856414795, 0.07632093876600266, 0.032942913472652435, 0.16241230070590973, 0.16799291968345642, 0.21310624480247498, 0.20892000198364258, 0.09815341979265213, 0.08592662960290909, 0.09931690245866776, 0.11555037647485733, 0.025122186169028282, 0.0826050415635109, 0.10098296403884888, 0.10102825611829758, 0.12505482137203217, -1]}
{"idB": "749647_18_item1_p344_s2", "idA": "749647_17_item1_p211_s1", "sentA": "In addition, the Company sold Series AA Warrants (the Series AA Warrants ) to purchase up to 16,489,402 shares of common stock and Pre-Funded Series BB Warrants (the Pre-Funded Series BB Warrants ) to purchase up to 2,600,000 shares of common stock.", "sentB": "In addition, all of the shares of common stock issuable upon exercise of warrants will be freely tradable without restriction or further registration upon issuance.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "sold", "Series", "AA", "Warrants", "(the", "Series", "AA", "Warrants", ")", "to", "purchase", "up", "to", "16,489,402", "shares", "of", "common", "stock", "and", "Pre-Funded", "Series", "BB", "Warrants", "(the", "Pre-Funded", "Series", "BB", "Warrants", ")", "to", "purchase", "up", "to", "2,600,000", "shares", "of", "common", "stock.", "<tag2>", "In", "addition,", "all", "of", "the", "shares", "of", "common", "stock", "issuable", "upon", "exercise", "of", "warrants", "will", "be", "freely", "tradable", "without", "restriction", "or", "further", "registration", "upon", "issuance.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "sold", "Series", "AA", "Warrants", "(the", "Series", "AA", "Warrants", ")", "to", "purchase", "up", "to", "16,489,402", "shares", "of", "common", "stock", "and", "Pre-Funded", "Series", "BB", "Warrants", "(the", "Pre-Funded", "Series", "BB", "Warrants", ")", "to", "purchase", "up", "to", "2,600,000", "shares", "of", "common", "stock."], "wordsB": ["In", "addition,", "all", "of", "the", "shares", "of", "common", "stock", "issuable", "upon", "exercise", "of", "warrants", "will", "be", "freely", "tradable", "without", "restriction", "or", "further", "registration", "upon", "issuance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006224984768778086, 0.024254996329545975, 0.1979515105485916, 0.08961653709411621, 0.0866960808634758, 0.43723711371421814, 0.0289175882935524, 0.055643562227487564, 0.04526960849761963, 0.45546087622642517, 0.019892755895853043, 0.038275450468063354, 0.018623214215040207, 0.05035272240638733, 0.0895637646317482, 0.16596943140029907, 0.6369898915290833, 0.7595673203468323, 0.10506568104028702, 0.1342039406299591, 0.037292513996362686, 0.06622453033924103, 0.14358477294445038, 0.04109906405210495, 0.06612392514944077, -1]}
{"idB": "749647_18_item1_p348_s0", "idA": "749647_17_item1_p211_s1", "sentA": "In addition, the Company sold Series AA Warrants (the Series AA Warrants ) to purchase up to 16,489,402 shares of common stock and Pre-Funded Series BB Warrants (the Pre-Funded Series BB Warrants ) to purchase up to 2,600,000 shares of common stock.", "sentB": "As of March 26, 2018, we have a significant number of securities convertible into, or allowing the purchase of, our common stock, including 3,058,42 shares of common stock issuable upon exercise of warrants outstanding, 589,741 options to purchase shares of our common stock and restricted stock awards outstanding, and 110,152 shares of common stock reserved for future issuance under our stock incentive plan.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "Company", "sold", "Series", "AA", "Warrants", "(the", "Series", "AA", "Warrants", ")", "to", "purchase", "up", "to", "16,489,402", "shares", "of", "common", "stock", "and", "Pre-Funded", "Series", "BB", "Warrants", "(the", "Pre-Funded", "Series", "BB", "Warrants", ")", "to", "purchase", "up", "to", "2,600,000", "shares", "of", "common", "stock.", "<tag2>", "As", "of", "March", "26,", "2018,", "we", "have", "a", "significant", "number", "of", "securities", "convertible", "into,", "or", "allowing", "the", "purchase", "of,", "our", "common", "stock,", "including", "3,058,42", "shares", "of", "common", "stock", "issuable", "upon", "exercise", "of", "warrants", "outstanding,", "589,741", "options", "to", "purchase", "shares", "of", "our", "common", "stock", "and", "restricted", "stock", "awards", "outstanding,", "and", "110,152", "shares", "of", "common", "stock", "reserved", "for", "future", "issuance", "under", "our", "stock", "incentive", "plan.", "<tag3>"], "wordsA": ["In", "addition,", "the", "Company", "sold", "Series", "AA", "Warrants", "(the", "Series", "AA", "Warrants", ")", "to", "purchase", "up", "to", "16,489,402", "shares", "of", "common", "stock", "and", "Pre-Funded", "Series", "BB", "Warrants", "(the", "Pre-Funded", "Series", "BB", "Warrants", ")", "to", "purchase", "up", "to", "2,600,000", "shares", "of", "common", "stock."], "wordsB": ["As", "of", "March", "26,", "2018,", "we", "have", "a", "significant", "number", "of", "securities", "convertible", "into,", "or", "allowing", "the", "purchase", "of,", "our", "common", "stock,", "including", "3,058,42", "shares", "of", "common", "stock", "issuable", "upon", "exercise", "of", "warrants", "outstanding,", "589,741", "options", "to", "purchase", "shares", "of", "our", "common", "stock", "and", "restricted", "stock", "awards", "outstanding,", "and", "110,152", "shares", "of", "common", "stock", "reserved", "for", "future", "issuance", "under", "our", "stock", "incentive", "plan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.025144174695014954, 0.036233291029930115, 0.04457562044262886, 0.03022056259214878, 0.0717952772974968, 0.02512117475271225, 0.02980843000113964, 0.013276780024170876, 0.0325448252260685, 0.04815644025802612, 0.042621396481990814, 0.056660912930965424, 0.08561602234840393, 0.016656681895256042, 0.007466980256140232, 0.01281894650310278, 0.010802650824189186, 0.017216624692082405, 0.008438211865723133, 0.007290699053555727, 0.01683502085506916, 0.01348965521901846, 0.00519702909514308, 0.3050829768180847, 0.27802056074142456, 0.006241909693926573, 0.02334659919142723, 0.021964658051729202, 0.040497440844774246, 0.003301086835563183, 0.00911251362413168, 0.005080895032733679, 0.025134988129138947, 0.035784266889095306, 0.4227129817008972, 0.1369766741991043, 0.0033568560611456633, 0.027082491666078568, 0.033101510256528854, 0.004684089682996273, 0.004829831887036562, 0.033619627356529236, 0.036854032427072525, 0.0037434338591992855, 0.24856673181056976, 0.25565221905708313, 0.09097137302160263, 0.018420515581965446, 0.0067909350618720055, 0.46456092596054077, 0.2573789656162262, 0.014437832869589329, 0.049214523285627365, 0.06731836497783661, 0.012693310156464577, 0.004992195870727301, 0.016704155132174492, 0.02029200829565525, 0.006612635683268309, 0.005384130869060755, 0.04581507295370102, 0.043589167296886444, 0.0294042881578207, -1]}
{"idB": "749647_18_item1_p348_s2", "idA": "749647_17_item1_p211_s4", "sentA": "The Company received approximately $5.0 million in gross proceeds (excluding the proceeds, if any, from the exercise of the warrants) in the February 14, 2017 Public Offering.", "sentB": "We have sold $12.8 million in gross proceeds under the Sales Agreement as of March 26, 2018.", "type": 2, "words": ["<tag1>", "The", "Company", "received", "approximately", "$5.0", "million", "in", "gross", "proceeds", "(excluding", "the", "proceeds,", "if", "any,", "from", "the", "exercise", "of", "the", "warrants)", "in", "the", "February", "14,", "2017", "Public", "Offering.", "<tag2>", "We", "have", "sold", "$12.8", "million", "in", "gross", "proceeds", "under", "the", "Sales", "Agreement", "as", "of", "March", "26,", "2018.", "<tag3>"], "wordsA": ["The", "Company", "received", "approximately", "$5.0", "million", "in", "gross", "proceeds", "(excluding", "the", "proceeds,", "if", "any,", "from", "the", "exercise", "of", "the", "warrants)", "in", "the", "February", "14,", "2017", "Public", "Offering."], "wordsB": ["We", "have", "sold", "$12.8", "million", "in", "gross", "proceeds", "under", "the", "Sales", "Agreement", "as", "of", "March", "26,", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08862363547086716, 0.035904619842767715, 0.37999752163887024, 0.8351841568946838, 0.3000433146953583, 0.023858459666371346, 0.04562840983271599, 0.06165480986237526, 0.04379580542445183, 0.020213831216096878, 0.15417973697185516, 0.17258977890014648, 0.04967523366212845, 0.0424906350672245, 0.26464375853538513, 0.28367429971694946, 0.4768385589122772, -1]}
{"idB": "749647_18_item1_p100_s0", "idA": "749647_17_item1_p24_s1", "sentA": "The NIH analysis, which sought to evaluate the correlation between RFA burn time per tumor volume (min/ml) and clinical outcome, concluded that increased burn time per tumor volume significantly improved overall survival in patients treated with RFA plus ThermoDox compared to patients treated with RFA alone.", "sentB": "For all patients with single lesions treated with RFA plus ThermoDox :", "type": 2, "words": ["<tag1>", "The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone.", "<tag2>", "For", "all", "patients", "with", "single", "lesions", "treated", "with", "RFA", "plus", "ThermoDox", ":", "<tag3>"], "wordsA": ["The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone."], "wordsB": ["For", "all", "patients", "with", "single", "lesions", "treated", "with", "RFA", "plus", "ThermoDox", ":"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06436604261398315, 0.26983946561813354, 0.24268825352191925, 0.0919497013092041, 0.8297961950302124, 0.6828271746635437, 0.024101587012410164, 0.0070983837358653545, 0.042849842458963394, 0.013759017921984196, 0.025362273678183556, 8.524751319782808e-05, -1]}
{"idB": "749647_18_item1_p101_s0", "idA": "749647_17_item1_p24_s1", "sentA": "The NIH analysis, which sought to evaluate the correlation between RFA burn time per tumor volume (min/ml) and clinical outcome, concluded that increased burn time per tumor volume significantly improved overall survival in patients treated with RFA plus ThermoDox compared to patients treated with RFA alone.", "sentB": "Burn time per tumor volume did not have a significant effect on overall survival in single lesion patients treated with RFA only.", "type": 2, "words": ["<tag1>", "The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone.", "<tag2>", "Burn", "time", "per", "tumor", "volume", "did", "not", "have", "a", "significant", "effect", "on", "overall", "survival", "in", "single", "lesion", "patients", "treated", "with", "RFA", "only.", "<tag3>"], "wordsA": ["The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone."], "wordsB": ["Burn", "time", "per", "tumor", "volume", "did", "not", "have", "a", "significant", "effect", "on", "overall", "survival", "in", "single", "lesion", "patients", "treated", "with", "RFA", "only."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.18822301924228668, 0.1397382616996765, 0.011097826063632965, 0.02683897316455841, 0.030447643250226974, 0.3017956614494324, 0.643589973449707, 0.31315430998802185, 0.2045084536075592, 0.3578004240989685, 0.26187339425086975, 0.09652864933013916, 0.15207931399345398, 0.12464381009340286, 0.02339654229581356, 0.544034481048584, 0.5041274428367615, 0.20493224263191223, 0.0326261892914772, 0.01578153856098652, 0.052132997661828995, 0.2949528992176056, -1]}
{"idB": "749647_18_item1_p27_s0", "idA": "749647_17_item1_p24_s1", "sentA": "The NIH analysis, which sought to evaluate the correlation between RFA burn time per tumor volume (min/ml) and clinical outcome, concluded that increased burn time per tumor volume significantly improved overall survival in patients treated with RFA plus ThermoDox compared to patients treated with RFA alone.", "sentB": "For all patients with single lesions treated with RFA plus ThermoDox :", "type": 2, "words": ["<tag1>", "The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone.", "<tag2>", "For", "all", "patients", "with", "single", "lesions", "treated", "with", "RFA", "plus", "ThermoDox", ":", "<tag3>"], "wordsA": ["The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone."], "wordsB": ["For", "all", "patients", "with", "single", "lesions", "treated", "with", "RFA", "plus", "ThermoDox", ":"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06436604261398315, 0.26983946561813354, 0.24268825352191925, 0.0919497013092041, 0.8297961950302124, 0.6828271746635437, 0.024101587012410164, 0.0070983837358653545, 0.042849842458963394, 0.013759017921984196, 0.025362273678183556, 8.524751319782808e-05, -1]}
{"idB": "749647_18_item1_p28_s0", "idA": "749647_17_item1_p24_s1", "sentA": "The NIH analysis, which sought to evaluate the correlation between RFA burn time per tumor volume (min/ml) and clinical outcome, concluded that increased burn time per tumor volume significantly improved overall survival in patients treated with RFA plus ThermoDox compared to patients treated with RFA alone.", "sentB": "Burn time per tumor volume did not have a significant effect on overall survival in single lesion patients treated with RFA only.", "type": 2, "words": ["<tag1>", "The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone.", "<tag2>", "Burn", "time", "per", "tumor", "volume", "did", "not", "have", "a", "significant", "effect", "on", "overall", "survival", "in", "single", "lesion", "patients", "treated", "with", "RFA", "only.", "<tag3>"], "wordsA": ["The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone."], "wordsB": ["Burn", "time", "per", "tumor", "volume", "did", "not", "have", "a", "significant", "effect", "on", "overall", "survival", "in", "single", "lesion", "patients", "treated", "with", "RFA", "only."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.18822301924228668, 0.1397382616996765, 0.011097826063632965, 0.02683897316455841, 0.030447643250226974, 0.3017956614494324, 0.643589973449707, 0.31315430998802185, 0.2045084536075592, 0.3578004240989685, 0.26187339425086975, 0.09652864933013916, 0.15207931399345398, 0.12464381009340286, 0.02339654229581356, 0.544034481048584, 0.5041274428367615, 0.20493224263191223, 0.0326261892914772, 0.01578153856098652, 0.052132997661828995, 0.2949528992176056, -1]}
{"idB": "749647_18_item1_p238_s0", "idA": "749647_17_item1_p25_s0", "sentA": "On January 31, 2013, the Company announced that the HEAT Study, ThermoDox in combination with RFA, did not meet the primary endpoint, PFS, of a Phase III clinical trial enrolling 701 patients with primary liver cancer.", "sentB": "On January 31, 2013, we announced that our lead product ThermoDox in combination with radiofrequency ablation (RFA) failed to meet the primary endpoint of the Phase III clinical trial for primary liver cancer, known as the HEAT study.", "type": 2, "words": ["<tag1>", "On", "January", "31,", "2013,", "the", "Company", "announced", "that", "the", "HEAT", "Study,", "ThermoDox", "in", "combination", "with", "RFA,", "did", "not", "meet", "the", "primary", "endpoint,", "PFS,", "of", "a", "Phase", "III", "clinical", "trial", "enrolling", "701", "patients", "with", "primary", "liver", "cancer.", "<tag2>", "On", "January", "31,", "2013,", "we", "announced", "that", "our", "lead", "product", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "(RFA)", "failed", "to", "meet", "the", "primary", "endpoint", "of", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer,", "known", "as", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "the", "Company", "announced", "that", "the", "HEAT", "Study,", "ThermoDox", "in", "combination", "with", "RFA,", "did", "not", "meet", "the", "primary", "endpoint,", "PFS,", "of", "a", "Phase", "III", "clinical", "trial", "enrolling", "701", "patients", "with", "primary", "liver", "cancer."], "wordsB": ["On", "January", "31,", "2013,", "we", "announced", "that", "our", "lead", "product", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "(RFA)", "failed", "to", "meet", "the", "primary", "endpoint", "of", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer,", "known", "as", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003278888063505292, 0.0040760338306427, 0.00433992687612772, 0.006111023016273975, 0.011813371442258358, 0.04238197207450867, 0.05412983149290085, 0.01919923536479473, 0.1162649616599083, 0.09351752698421478, 0.026091663166880608, 0.005413838196545839, 0.017158010974526405, 0.013138503767549992, 0.4552963078022003, 0.6188565492630005, 0.019295502454042435, 0.860406219959259, 0.7309237718582153, 0.23346565663814545, 0.06005476787686348, 0.06692731380462646, 0.09849821776151657, 0.003553572576493025, 0.008431320078670979, 0.011324361898005009, 0.009293864481151104, 0.0202201958745718, 0.046909961849451065, 0.0071601299569010735, 0.018901746720075607, 0.01606062985956669, 0.020366452634334564, 0.0049097416922450066, 0.002781789982691407, 0.00506029836833477, 0.01995811052620411, 0.019712423905730247, -1]}
{"idB": "749647_18_item1_p29_s1", "idA": "749647_17_item1_p25_s1", "sentA": "This determination was made after conferring with the HEAT Study independent Data Monitoring Committee, that the HEAT Study did not meet the goal of demonstrating a clinically meaningful improvement in progression free survival.", "sentB": "This determination was made after conferring with the HEAT Study independent DMC, that the HEAT Study did not meet the goal of demonstrating a clinically meaningful improvement in progression free survival.", "type": 2, "words": ["<tag1>", "This", "determination", "was", "made", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival.", "<tag2>", "This", "determination", "was", "made", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "DMC,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival.", "<tag3>"], "wordsA": ["This", "determination", "was", "made", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "Data", "Monitoring", "Committee,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival."], "wordsB": ["This", "determination", "was", "made", "after", "conferring", "with", "the", "HEAT", "Study", "independent", "DMC,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "a", "clinically", "meaningful", "improvement", "in", "progression", "free", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0020865043625235558, 0.013369481079280376, 0.0026622633449733257, 0.00407597329467535, 0.0031607195269316435, 0.006787083577364683, 0.0026042351964861155, 0.002300502033904195, 0.017334191128611565, 0.02839547209441662, 0.07755014300346375, 0.9595947265625, 0.003131509991362691, 0.002566239098086953, 0.02206314355134964, 0.022503608837723732, 0.20482957363128662, 0.2429317981004715, 0.027072124183177948, 0.0046050893142819405, 0.007181950379163027, 0.0031118975020945072, 0.008242596872150898, 0.0037684484850615263, 0.006189768668264151, 0.004979329649358988, 0.008426561020314693, 0.002790182363241911, 0.0041588833555579185, 0.004462800454348326, 0.005761150270700455, -1]}
{"idB": "749647_18_item1_p234_s0", "idA": "749647_17_item1_p2_s1", "sentA": "Although we believe that our expectations are based on reasonable assumptions within the bounds of our knowledge of our industry, business and operations, we cannot guarantee that actual results will not differ materially from our expectations.", "sentB": "These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected or historical results and our forward-looking statements.", "type": 2, "words": ["<tag1>", "Although", "we", "believe", "that", "our", "expectations", "are", "based", "on", "reasonable", "assumptions", "within", "the", "bounds", "of", "our", "knowledge", "of", "our", "industry,", "business", "and", "operations,", "we", "cannot", "guarantee", "that", "actual", "results", "will", "not", "differ", "materially", "from", "our", "expectations.", "<tag2>", "These", "are", "factors", "that,", "individually", "or", "in", "the", "aggregate,", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "or", "historical", "results", "and", "our", "forward-looking", "statements.", "<tag3>"], "wordsA": ["Although", "we", "believe", "that", "our", "expectations", "are", "based", "on", "reasonable", "assumptions", "within", "the", "bounds", "of", "our", "knowledge", "of", "our", "industry,", "business", "and", "operations,", "we", "cannot", "guarantee", "that", "actual", "results", "will", "not", "differ", "materially", "from", "our", "expectations."], "wordsB": ["These", "are", "factors", "that,", "individually", "or", "in", "the", "aggregate,", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "or", "historical", "results", "and", "our", "forward-looking", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07308237254619598, 0.05725697800517082, 0.26186084747314453, 0.015656769275665283, 0.33689960837364197, 0.21407674252986908, 0.1300213485956192, 0.09616079926490784, 0.17917966842651367, 0.022392582148313522, 0.019215505570173264, 0.08020252734422684, 0.1165923997759819, 0.01964041031897068, 0.07933004945516586, 0.09546346217393875, 0.096162810921669, 0.13457174599170685, 0.07096541672945023, 0.04873200133442879, 0.1237042099237442, 0.026263395324349403, 0.15328240394592285, 0.13169100880622864, 0.009472142904996872, 0.011519870720803738, 0.26327526569366455, 0.2508988082408905, -1]}
{"idB": "749647_18_item1_p338_s0", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "The market price of our common stock has been, and may continue to be volatile and fluctuate significantly, which could result in substantial losses for investors and subject us to securities class action litigation.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "The", "market", "price", "of", "our", "common", "stock", "has", "been,", "and", "may", "continue", "to", "be", "volatile", "and", "fluctuate", "significantly,", "which", "could", "result", "in", "substantial", "losses", "for", "investors", "and", "subject", "us", "to", "securities", "class", "action", "litigation.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["The", "market", "price", "of", "our", "common", "stock", "has", "been,", "and", "may", "continue", "to", "be", "volatile", "and", "fluctuate", "significantly,", "which", "could", "result", "in", "substantial", "losses", "for", "investors", "and", "subject", "us", "to", "securities", "class", "action", "litigation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017742007970809937, 0.39225175976753235, 0.4698619842529297, 0.061121683567762375, 0.037875305861234665, 0.1694982945919037, 0.13895800709724426, 0.08372881263494492, 0.0897240936756134, 0.007296554744243622, 0.01910599321126938, 0.03667303919792175, 0.022061262279748917, 0.04331880062818527, 0.19789385795593262, 0.012661498039960861, 0.2853049635887146, 0.10806050151586533, 0.00023350559058599174, 0.0076402644626796246, 0.00887450110167265, 0.00884847529232502, 0.036464400589466095, 0.08915280550718307, 0.010950484313070774, 0.053723547607660294, 0.0002064313302980736, 0.02801005356013775, 0.02734014205634594, 0.02017107792198658, 0.053273800760507584, 0.07041222602128983, 0.10350555181503296, 0.16445426642894745, -1]}
{"idB": "749647_18_item1_p340_s2", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "Broad market fluctuations may lower the market price of our common stock and affect the volume of trading in our stock, regardless of our financial condition, results of operations, business or prospect.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "Broad", "market", "fluctuations", "may", "lower", "the", "market", "price", "of", "our", "common", "stock", "and", "affect", "the", "volume", "of", "trading", "in", "our", "stock,", "regardless", "of", "our", "financial", "condition,", "results", "of", "operations,", "business", "or", "prospect.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["Broad", "market", "fluctuations", "may", "lower", "the", "market", "price", "of", "our", "common", "stock", "and", "affect", "the", "volume", "of", "trading", "in", "our", "stock,", "regardless", "of", "our", "financial", "condition,", "results", "of", "operations,", "business", "or", "prospect."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4473336637020111, 0.6153414845466614, 0.5716629028320312, 0.037227943539619446, 0.27506324648857117, 0.05490225553512573, 0.30075764656066895, 0.287335604429245, 0.027030518278479576, 0.018963761627674103, 0.09271039068698883, 0.0849105641245842, 0.009648549370467663, 0.08631868660449982, 0.016114361584186554, 0.08559668809175491, 0.05818312242627144, 0.11797893047332764, 0.0516895093023777, 0.03533003106713295, 0.07781513780355453, 0.015816913917660713, 0.010705776512622833, 0.00838189572095871, 0.016496364027261734, 0.01909521594643593, 0.020870482549071312, 0.007388777565211058, 0.019162733107805252, 0.01782149262726307, 0.0209407489746809, 0.020259065553545952, -1]}
{"idB": "749647_18_item1_p340_s4", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "Among the factors that may cause the market price of our common stock to fluctuate are the risks described in this Risk Factors section and other factors, including:", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "Among", "the", "factors", "that", "may", "cause", "the", "market", "price", "of", "our", "common", "stock", "to", "fluctuate", "are", "the", "risks", "described", "in", "this", "Risk", "Factors", "section", "and", "other", "factors,", "including:", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["Among", "the", "factors", "that", "may", "cause", "the", "market", "price", "of", "our", "common", "stock", "to", "fluctuate", "are", "the", "risks", "described", "in", "this", "Risk", "Factors", "section", "and", "other", "factors,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08103122562170029, 0.02424968034029007, 0.10653752833604813, 0.01063099317252636, 0.015098289586603642, 0.03848261386156082, 0.055711857974529266, 0.37593546509742737, 0.4069806635379791, 0.04636376351118088, 0.04366474598646164, 0.1493866890668869, 0.11830409616231918, 0.18904699385166168, 0.4676491320133209, 0.0007414956344291568, 0.03627690672874451, 0.20607824623584747, 0.012721533887088299, 0.009757274761795998, 0.009656107053160667, 0.04590009152889252, 0.0631127879023552, 0.038543593138456345, 0.018398620188236237, 0.016627425327897072, 0.041600778698921204, 0.20480979979038239, -1]}
{"idB": "749647_18_item1_p341_s0", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "the trading volume of our common stock.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "the", "trading", "volume", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["the", "trading", "volume", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06443223357200623, 0.9213440418243408, 0.8120415806770325, 0.09217233955860138, 0.06890898942947388, 0.21012087166309357, 0.200553759932518, -1]}
{"idB": "749647_18_item1_p342_s2", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "These broad market and industry factors may materially harm the market price of our common stock and expose us to securities class action litigation.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "These", "broad", "market", "and", "industry", "factors", "may", "materially", "harm", "the", "market", "price", "of", "our", "common", "stock", "and", "expose", "us", "to", "securities", "class", "action", "litigation.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["These", "broad", "market", "and", "industry", "factors", "may", "materially", "harm", "the", "market", "price", "of", "our", "common", "stock", "and", "expose", "us", "to", "securities", "class", "action", "litigation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.043763916939496994, 0.3109340965747833, 0.32076945900917053, 0.028691932559013367, 0.14147357642650604, 0.17333468794822693, 0.028961019590497017, 0.058952584862709045, 0.19582603871822357, 0.05284983664751053, 0.19403192400932312, 0.1687723994255066, 0.031768541783094406, 0.025929514318704605, 0.09108105301856995, 0.08632441610097885, 0.0002944715670309961, 0.07300804555416107, 0.038616422563791275, 0.03915862366557121, 0.0816701203584671, 0.1035517230629921, 0.1681603342294693, 0.2518136501312256, -1]}
{"idB": "749647_18_item1_p343_s0", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "Future sales of our common stock in the public market could cause our stock price to fall.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "Future", "sales", "of", "our", "common", "stock", "in", "the", "public", "market", "could", "cause", "our", "stock", "price", "to", "fall.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["Future", "sales", "of", "our", "common", "stock", "in", "the", "public", "market", "could", "cause", "our", "stock", "price", "to", "fall."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.25639608502388, 0.525355339050293, 0.12162768840789795, 0.07545044273138046, 0.1871805042028427, 0.18584288656711578, 0.04861105978488922, 0.038880933076143265, 0.1244652271270752, 0.14005306363105774, 0.03913065046072006, 0.1247067078948021, 0.04589700326323509, 0.37467145919799805, 0.377753883600235, 0.32310646772384644, 0.7390996813774109, -1]}
{"idB": "749647_18_item1_p349_s0", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "We may be unable to maintain compliance with The NASDAQ Marketplace Rules which could cause our common stock to be delisted from The NASDAQ Capital Market.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "We", "may", "be", "unable", "to", "maintain", "compliance", "with", "The", "NASDAQ", "Marketplace", "Rules", "which", "could", "cause", "our", "common", "stock", "to", "be", "delisted", "from", "The", "NASDAQ", "Capital", "Market.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["We", "may", "be", "unable", "to", "maintain", "compliance", "with", "The", "NASDAQ", "Marketplace", "Rules", "which", "could", "cause", "our", "common", "stock", "to", "be", "delisted", "from", "The", "NASDAQ", "Capital", "Market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0705111101269722, 0.05141386017203331, 0.03243080899119377, 0.23850509524345398, 0.12924207746982574, 0.3024590015411377, 0.4680558145046234, 0.12535835802555084, 0.0593486949801445, 0.12697356939315796, 0.17875216901302338, 0.17683859169483185, 0.0003384245210327208, 0.013407563790678978, 0.027889808639883995, 0.028382111340761185, 0.15964224934577942, 0.17437130212783813, 0.07848436385393143, 0.08841588348150253, 0.375357985496521, 0.11806419491767883, 0.05243925377726555, 0.071861632168293, 0.07171321660280228, 0.14061222970485687, -1]}
{"idB": "749647_18_item1_p350_s2", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "As of March 26, 2018, the closing sale price per share of our common stock was $2.53, the total market value of our publicly held shares of our common stock (excluding shares held by our executive officers, directors and 10% or more stockholders) was approximately $44.7 million and the total market value of our listed securities was approximately $44.9 million.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "As", "of", "March", "26,", "2018,", "the", "closing", "sale", "price", "per", "share", "of", "our", "common", "stock", "was", "$2.53,", "the", "total", "market", "value", "of", "our", "publicly", "held", "shares", "of", "our", "common", "stock", "(excluding", "shares", "held", "by", "our", "executive", "officers,", "directors", "and", "10%", "or", "more", "stockholders)", "was", "approximately", "$44.7", "million", "and", "the", "total", "market", "value", "of", "our", "listed", "securities", "was", "approximately", "$44.9", "million.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["As", "of", "March", "26,", "2018,", "the", "closing", "sale", "price", "per", "share", "of", "our", "common", "stock", "was", "$2.53,", "the", "total", "market", "value", "of", "our", "publicly", "held", "shares", "of", "our", "common", "stock", "(excluding", "shares", "held", "by", "our", "executive", "officers,", "directors", "and", "10%", "or", "more", "stockholders)", "was", "approximately", "$44.7", "million", "and", "the", "total", "market", "value", "of", "our", "listed", "securities", "was", "approximately", "$44.9", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05596818029880524, 0.06775646656751633, 0.16401909291744232, 0.14917916059494019, 0.1374332308769226, 0.006876430474221706, 0.12043192237615585, 0.13796818256378174, 0.15667027235031128, 0.10748273134231567, 0.08936245739459991, 0.011759874410927296, 0.013303153216838837, 0.04033873602747917, 0.03292326256632805, 0.018928974866867065, 0.3132827877998352, 0.006144672632217407, 0.10477403551340103, 0.12446816265583038, 0.10881689935922623, 0.009335154667496681, 0.015856316313147545, 0.2008489966392517, 0.4094840884208679, 0.302857369184494, 0.013135474175214767, 0.010193579830229282, 0.053536150604486465, 0.04000609368085861, 0.11072427779436111, 0.07591663300991058, 0.025145739316940308, 0.008781672455370426, 0.010624239221215248, 0.03604349493980408, 0.03615473210811615, 0.030945051461458206, 0.005451693665236235, 0.02552567422389984, 0.01892014965415001, 0.023532884195446968, 0.05322691798210144, 0.007078093476593494, 0.02560795098543167, 0.13384436070919037, 0.08385135233402252, 0.0005456265062093735, 0.0047387839294970036, 0.09620552510023117, 0.13599365949630737, 0.14540202915668488, 0.00658067874610424, 0.010052629746496677, 0.07214954495429993, 0.07229901850223541, 0.008528747595846653, 0.02199762500822544, 0.21377034485340118, 0.08533443510532379, -1]}
{"idB": "749647_18_item1_p37_s2", "idA": "749647_17_item1_p33_s1", "sentA": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 2,712,188 shares of our common stock to EGEN.", "sentB": "At the closing, we paid approximately $3.0 million in cash after the expense adjustment and issued 193,728 shares of our common stock to EGEN.", "type": 2, "words": ["<tag1>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag2>", "At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "193,728", "shares", "of", "our", "common", "stock", "to", "EGEN.", "<tag3>"], "wordsA": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "2,712,188", "shares", "of", "our", "common", "stock", "to", "EGEN."], "wordsB": ["At", "the", "closing,", "we", "paid", "approximately", "$3.0", "million", "in", "cash", "after", "the", "expense", "adjustment", "and", "issued", "193,728", "shares", "of", "our", "common", "stock", "to", "EGEN."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0021643065847456455, 0.0020595958922058344, 0.006180500611662865, 0.004195518791675568, 0.008825128898024559, 0.006335510406643152, 0.00469954265281558, 0.004297584295272827, 0.0025998048949986696, 0.004338120575994253, 0.003070309991016984, 0.0022748627234250307, 0.004700886085629463, 0.004819794557988644, 0.0027821706607937813, 0.029682237654924393, 0.8670475482940674, 0.4966655373573303, 0.0038611586205661297, 0.0028091324493288994, 0.007422837428748608, 0.0075538624078035355, 0.0028595859184861183, 0.005062829237431288, -1]}
{"idB": "749647_18_item1_p232_s0", "idA": "749647_17_item1_p34_s0", "sentA": "The shares of common stock were issued in a private transaction exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(2) thereof.", "sentB": "On February 6, 2018, we filed a prospectus supplement to the base prospectus that forms a part of the registration statement on Form S-3 (File No. 333-206789), filed on September 4, 2015 and declared effective by the SEC on September 25, 2015, pursuant to which we may offer and sell up to $10,000,000 of shares of common stock from time to time under the ATM Agreement.", "type": 2, "words": ["<tag1>", "The", "shares", "of", "common", "stock", "were", "issued", "in", "a", "private", "transaction", "exempt", "from", "registration", "under", "the", "Securities", "Act", "of", "1933,", "as", "amended,", "pursuant", "to", "Section", "4(2)", "thereof.", "<tag2>", "On", "February", "6,", "2018,", "we", "filed", "a", "prospectus", "supplement", "to", "the", "base", "prospectus", "that", "forms", "a", "part", "of", "the", "registration", "statement", "on", "Form", "S-3", "(File", "No.", "333-206789),", "filed", "on", "September", "4,", "2015", "and", "declared", "effective", "by", "the", "SEC", "on", "September", "25,", "2015,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell", "up", "to", "$10,000,000", "of", "shares", "of", "common", "stock", "from", "time", "to", "time", "under", "the", "ATM", "Agreement.", "<tag3>"], "wordsA": ["The", "shares", "of", "common", "stock", "were", "issued", "in", "a", "private", "transaction", "exempt", "from", "registration", "under", "the", "Securities", "Act", "of", "1933,", "as", "amended,", "pursuant", "to", "Section", "4(2)", "thereof."], "wordsB": ["On", "February", "6,", "2018,", "we", "filed", "a", "prospectus", "supplement", "to", "the", "base", "prospectus", "that", "forms", "a", "part", "of", "the", "registration", "statement", "on", "Form", "S-3", "(File", "No.", "333-206789),", "filed", "on", "September", "4,", "2015", "and", "declared", "effective", "by", "the", "SEC", "on", "September", "25,", "2015,", "pursuant", "to", "which", "we", "may", "offer", "and", "sell", "up", "to", "$10,000,000", "of", "shares", "of", "common", "stock", "from", "time", "to", "time", "under", "the", "ATM", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.027705086395144463, 0.14496946334838867, 0.12161178141832352, 0.23887978494167328, 0.06454017013311386, 0.2003462016582489, 0.06829482316970825, 0.2115163654088974, 0.09447456151247025, 0.0203635785728693, 0.01718047633767128, 0.08560618758201599, 0.12450100481510162, 0.0009106242214329541, 0.014380760490894318, 0.00783964991569519, 0.012546384707093239, 0.010711363516747952, 0.011911800131201744, 0.06406417489051819, 0.04001988098025322, 0.010018260218203068, 0.07689809054136276, 0.08132582157850266, 0.045835066586732864, 0.06395383179187775, 0.11406812071800232, 0.007910015061497688, 0.011871951632201672, 0.02201121114194393, 0.012199596501886845, 0.030247656628489494, 0.0003478861472103745, 0.020919926464557648, 0.01973739080131054, 0.023469846695661545, 0.02858448214828968, 0.025784287601709366, 0.01705641858279705, 0.026006095111370087, 0.012523184530436993, 0.03278494253754616, 0.007326990831643343, 0.011068656109273434, 0.011090883053839207, 0.012878058478236198, 0.017760589718818665, 0.04696356877684593, 0.037617266178131104, 0.06339927762746811, 0.05530161038041115, 0.03038000874221325, 0.1286313384771347, 0.03573057800531387, 0.058797769248485565, 0.01591166853904724, 0.03368156775832176, 0.0365997813642025, 0.009631076827645302, 0.014658226631581783, 0.011481545865535736, 0.023821938782930374, 0.03812612220644951, 0.023980993777513504, 0.21553723514080048, 0.2413429617881775, -1]}
{"idB": "749647_18_item1_p232_s1", "idA": "749647_17_item1_p34_s0", "sentA": "The shares of common stock were issued in a private transaction exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(2) thereof.", "sentB": "In January 2018 and thus far in 2018, we have sold 457,070 shares of common stock for net proceeds of $1.3 million under the ATM.", "type": 2, "words": ["<tag1>", "The", "shares", "of", "common", "stock", "were", "issued", "in", "a", "private", "transaction", "exempt", "from", "registration", "under", "the", "Securities", "Act", "of", "1933,", "as", "amended,", "pursuant", "to", "Section", "4(2)", "thereof.", "<tag2>", "In", "January", "2018", "and", "thus", "far", "in", "2018,", "we", "have", "sold", "457,070", "shares", "of", "common", "stock", "for", "net", "proceeds", "of", "$1.3", "million", "under", "the", "ATM.", "<tag3>"], "wordsA": ["The", "shares", "of", "common", "stock", "were", "issued", "in", "a", "private", "transaction", "exempt", "from", "registration", "under", "the", "Securities", "Act", "of", "1933,", "as", "amended,", "pursuant", "to", "Section", "4(2)", "thereof."], "wordsB": ["In", "January", "2018", "and", "thus", "far", "in", "2018,", "we", "have", "sold", "457,070", "shares", "of", "common", "stock", "for", "net", "proceeds", "of", "$1.3", "million", "under", "the", "ATM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.037908125668764114, 0.09792862832546234, 0.17092813551425934, 0.013550199568271637, 0.0537501722574234, 0.03220285102725029, 0.04106985405087471, 0.08226657658815384, 0.05985076725482941, 0.03483204171061516, 0.45863354206085205, 0.39097556471824646, 0.2340594381093979, 0.03936001658439636, 0.060571443289518356, 0.07020735740661621, 0.005645939148962498, 0.036168232560157776, 0.0584152527153492, 0.013535287231206894, 0.03831619396805763, 0.04328911378979683, 0.07328286021947861, 0.0506742037832737, 0.11848196387290955, -1]}
{"idB": "749647_18_item1_p329_s2", "idA": "749647_17_item1_p34_s1", "sentA": "In addition, 670,070 shares of common stock were held back by us at the closing and are issuable to EGEN pending certain potential adjustments for expenses or in relation to EGEN s indemnification obligations under the Asset Purchase Agreement.", "sentB": "Key employees may depart if we fail to successfully manage this additional business location or in relation to any uncertainties or difficulties of integration with Celsion.", "type": 2, "words": ["<tag1>", "In", "addition,", "670,070", "shares", "of", "common", "stock", "were", "held", "back", "by", "us", "at", "the", "closing", "and", "are", "issuable", "to", "EGEN", "pending", "certain", "potential", "adjustments", "for", "expenses", "or", "in", "relation", "to", "EGEN", "s", "indemnification", "obligations", "under", "the", "Asset", "Purchase", "Agreement.", "<tag2>", "Key", "employees", "may", "depart", "if", "we", "fail", "to", "successfully", "manage", "this", "additional", "business", "location", "or", "in", "relation", "to", "any", "uncertainties", "or", "difficulties", "of", "integration", "with", "Celsion.", "<tag3>"], "wordsA": ["In", "addition,", "670,070", "shares", "of", "common", "stock", "were", "held", "back", "by", "us", "at", "the", "closing", "and", "are", "issuable", "to", "EGEN", "pending", "certain", "potential", "adjustments", "for", "expenses", "or", "in", "relation", "to", "EGEN", "s", "indemnification", "obligations", "under", "the", "Asset", "Purchase", "Agreement."], "wordsB": ["Key", "employees", "may", "depart", "if", "we", "fail", "to", "successfully", "manage", "this", "additional", "business", "location", "or", "in", "relation", "to", "any", "uncertainties", "or", "difficulties", "of", "integration", "with", "Celsion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.16201511025428772, 0.24114438891410828, 0.04337526485323906, 0.28583526611328125, 0.01910395547747612, 0.052311573177576065, 0.11285155266523361, 0.025848278775811195, 0.045300520956516266, 0.08458973467350006, 0.009523943066596985, 0.03820004686713219, 0.10337651520967484, 0.05445246770977974, 0.0001882888755062595, 0.008921858854591846, 0.00821126252412796, 0.00501770107075572, 0.007175539620220661, 0.03416317328810692, 0.009029840119183064, 0.03829272836446762, 0.008939564228057861, 0.04189686477184296, 0.022749347612261772, 0.07459952682256699, -1]}
{"idB": "749647_18_item1_p38_s1", "idA": "749647_17_item1_p34_s1", "sentA": "In addition, 670,070 shares of common stock were held back by us at the closing and are issuable to EGEN pending certain potential adjustments for expenses or in relation to EGEN s indemnification obligations under the Asset Purchase Agreement.", "sentB": "In addition, 47,862 shares of common stock were held back by us at the closing and were issued to EGEN pending satisfactory resolution of any post-closing adjustments for expenses or in relation to EGEN s indemnification obligations under the Asset Purchase Agreement.", "type": 2, "words": ["<tag1>", "In", "addition,", "670,070", "shares", "of", "common", "stock", "were", "held", "back", "by", "us", "at", "the", "closing", "and", "are", "issuable", "to", "EGEN", "pending", "certain", "potential", "adjustments", "for", "expenses", "or", "in", "relation", "to", "EGEN", "s", "indemnification", "obligations", "under", "the", "Asset", "Purchase", "Agreement.", "<tag2>", "In", "addition,", "47,862", "shares", "of", "common", "stock", "were", "held", "back", "by", "us", "at", "the", "closing", "and", "were", "issued", "to", "EGEN", "pending", "satisfactory", "resolution", "of", "any", "post-closing", "adjustments", "for", "expenses", "or", "in", "relation", "to", "EGEN", "s", "indemnification", "obligations", "under", "the", "Asset", "Purchase", "Agreement.", "<tag3>"], "wordsA": ["In", "addition,", "670,070", "shares", "of", "common", "stock", "were", "held", "back", "by", "us", "at", "the", "closing", "and", "are", "issuable", "to", "EGEN", "pending", "certain", "potential", "adjustments", "for", "expenses", "or", "in", "relation", "to", "EGEN", "s", "indemnification", "obligations", "under", "the", "Asset", "Purchase", "Agreement."], "wordsB": ["In", "addition,", "47,862", "shares", "of", "common", "stock", "were", "held", "back", "by", "us", "at", "the", "closing", "and", "were", "issued", "to", "EGEN", "pending", "satisfactory", "resolution", "of", "any", "post-closing", "adjustments", "for", "expenses", "or", "in", "relation", "to", "EGEN", "s", "indemnification", "obligations", "under", "the", "Asset", "Purchase", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0028582215309143066, 0.006641546729952097, 0.9128972291946411, 0.49150288105010986, 0.003995229490101337, 0.008166260085999966, 0.017298588529229164, 0.0019544013775885105, 0.0032141662668436766, 0.002598067279905081, 0.0016913925064727664, 0.0030347462743520737, 0.001784613123163581, 0.0018204639200121164, 0.003667944110929966, 0.00013146482524462044, 0.002160505624487996, 0.02917943149805069, 0.006871026940643787, 0.009101824834942818, 0.0034443687181919813, 0.01234594639390707, 0.009502088651061058, 0.0023815720342099667, 0.003197072073817253, 0.008874382823705673, 0.007861298508942127, 0.002027494367212057, 0.003184506669640541, 0.00028607327840290964, 0.0016510180430486798, 0.001998775638639927, 0.0017028512666001916, 0.002890955423936248, 0.002086508320644498, 0.004561759531497955, 0.0035142775159329176, 0.001987570896744728, 0.0018105676863342524, 0.003176409751176834, 0.002918663900345564, 0.0034048573579639196, -1]}
{"idB": "749647_18_item1_p40_s0", "idA": "749647_17_item1_p35_s0", "sentA": "The earnout payments of up to $30.4 million will become payable, in cash, shares of our common stock or a combination thereof, at our option, upon achievement of three major milestone events as follows:", "sentB": "There being no immediate opportunity to out-license TheraSilence, earnout payments have been adjusted and now up to $24.4 million will become payable, in cash, shares of our common stock or a combination thereof, at our option, upon achievement of two major milestone events as follows :", "type": 2, "words": ["<tag1>", "The", "earnout", "payments", "of", "up", "to", "$30.4", "million", "will", "become", "payable,", "in", "cash,", "shares", "of", "our", "common", "stock", "or", "a", "combination", "thereof,", "at", "our", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:", "<tag2>", "There", "being", "no", "immediate", "opportunity", "to", "out-license", "TheraSilence,", "earnout", "payments", "have", "been", "adjusted", "and", "now", "up", "to", "$24.4", "million", "will", "become", "payable,", "in", "cash,", "shares", "of", "our", "common", "stock", "or", "a", "combination", "thereof,", "at", "our", "option,", "upon", "achievement", "of", "two", "major", "milestone", "events", "as", "follows", ":", "<tag3>"], "wordsA": ["The", "earnout", "payments", "of", "up", "to", "$30.4", "million", "will", "become", "payable,", "in", "cash,", "shares", "of", "our", "common", "stock", "or", "a", "combination", "thereof,", "at", "our", "option,", "upon", "achievement", "of", "three", "major", "milestone", "events", "as", "follows:"], "wordsB": ["There", "being", "no", "immediate", "opportunity", "to", "out-license", "TheraSilence,", "earnout", "payments", "have", "been", "adjusted", "and", "now", "up", "to", "$24.4", "million", "will", "become", "payable,", "in", "cash,", "shares", "of", "our", "common", "stock", "or", "a", "combination", "thereof,", "at", "our", "option,", "upon", "achievement", "of", "two", "major", "milestone", "events", "as", "follows", ":"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004227630794048309, 0.018023958429694176, 0.3380850851535797, 0.4717319905757904, 0.41911157965660095, 0.0966353639960289, 0.18286800384521484, 0.0847923755645752, 0.006772797089070082, 0.013387192040681839, 0.005123831331729889, 0.00556228356435895, 0.006529743783175945, 0.002665306208655238, 0.002210246166214347, 0.0062415520660579205, 0.00494831707328558, 0.8815692067146301, 0.06446665525436401, 0.001581698888912797, 0.002061792416498065, 0.002805271651595831, 0.0023291227407753468, 0.0028047547675669193, 0.0029617079999297857, 0.0016910004196688533, 0.0024449212942272425, 0.0027279851492494345, 0.0028268354944884777, 0.0025884273927658796, 0.0027495771646499634, 0.003263738239184022, 0.00346187362447381, 0.0018499152502045035, 0.002120446413755417, 0.003143641399219632, 0.001414455589838326, 0.010552848689258099, 0.0033403150737285614, 0.6604686379432678, 0.06659746170043945, 0.05081721395254135, 0.026103343814611435, 0.0026638894341886044, 0.005105722229927778, 0.0076169418171048164, -1]}
{"idB": "749647_18_item1_p329_s4", "idA": "749647_17_item1_p36_s0", "sentA": "up to $6.0 million will become payable upon achieving certain specified milestones relating to the TheraSilence technology acquired from EGEN in the acquisition.", "sentB": "Our integration of EGEN and ability to operate in the fields we acquired from EGEN may be more difficult if we lose key employees.", "type": 2, "words": ["<tag1>", "up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology", "acquired", "from", "EGEN", "in", "the", "acquisition.", "<tag2>", "Our", "integration", "of", "EGEN", "and", "ability", "to", "operate", "in", "the", "fields", "we", "acquired", "from", "EGEN", "may", "be", "more", "difficult", "if", "we", "lose", "key", "employees.", "<tag3>"], "wordsA": ["up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology", "acquired", "from", "EGEN", "in", "the", "acquisition."], "wordsB": ["Our", "integration", "of", "EGEN", "and", "ability", "to", "operate", "in", "the", "fields", "we", "acquired", "from", "EGEN", "may", "be", "more", "difficult", "if", "we", "lose", "key", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.044126126915216446, 0.2578170895576477, 0.16545207798480988, 0.4558287560939789, 0.030752459540963173, 0.1727231740951538, 0.20441433787345886, 0.3493269979953766, 0.05231213942170143, 0.03881731256842613, 0.11290133744478226, 0.011778169311583042, 0.01684386469423771, 0.014384923502802849, 0.02294846437871456, 0.022922327741980553, 0.02542511187493801, 0.03924363851547241, 0.04381347820162773, 0.016660025343298912, 0.025885870680212975, 0.1326957643032074, 0.1166410818696022, 0.15203934907913208, -1]}
{"idB": "749647_18_item1_p41_s0", "idA": "749647_17_item1_p36_s0", "sentA": "up to $6.0 million will become payable upon achieving certain specified milestones relating to the TheraSilence technology acquired from EGEN in the acquisition.", "sentB": "$12.0 million will become payable upon achieving certain specified development milestones relating to a GEN-1 glioblastoma multiforme brain cancer study to be conducted by us or our subsidiary .", "type": 2, "words": ["<tag1>", "up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology", "acquired", "from", "EGEN", "in", "the", "acquisition.", "<tag2>", "$12.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "development", "milestones", "relating", "to", "a", "GEN-1", "glioblastoma", "multiforme", "brain", "cancer", "study", "to", "be", "conducted", "by", "us", "or", "our", "subsidiary", ".", "<tag3>"], "wordsA": ["up", "to", "$6.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "milestones", "relating", "to", "the", "TheraSilence", "technology", "acquired", "from", "EGEN", "in", "the", "acquisition."], "wordsB": ["$12.0", "million", "will", "become", "payable", "upon", "achieving", "certain", "specified", "development", "milestones", "relating", "to", "a", "GEN-1", "glioblastoma", "multiforme", "brain", "cancer", "study", "to", "be", "conducted", "by", "us", "or", "our", "subsidiary", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.9795801043510437, 0.3297008275985718, 0.0017712732078507543, 0.0018742819083854556, 0.003395726438611746, 0.001547117717564106, 0.002680623671039939, 0.0017279223538935184, 0.0039632790721952915, 0.008876186795532703, 0.010001306422054768, 0.024651629850268364, 0.026081610471010208, 0.031797852367162704, 0.24247364699840546, 0.5189837217330933, 0.35850319266319275, 0.33013612031936646, 0.506589949131012, 0.42146438360214233, 4.297644773032516e-05, 0.0021955149713903666, 0.015374217182397842, 0.0035479881335049868, 0.011821969412267208, 0.008100190199911594, 0.005379924550652504, 0.021610403433442116, 3.0268416594481096e-05, -1]}
{"idB": "749647_18_item1_p8_s3", "idA": "749647_17_item1_p37_s1", "sentA": "In the acquisition, we purchased GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian and brain cancers, and two platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies, including TheraPlas and TheraSilence .", "sentB": "We have two platform technologies providing the basis for the future development of a range of therapeutics for difficult-to-treat forms of cancer including: Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat and TheraPlas, a novel nucleic acid-based treatment for local transfection of therapeutic plasmids.", "type": 2, "words": ["<tag1>", "In", "the", "acquisition,", "we", "purchased", "GEN-1,", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "two", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", ".", "<tag2>", "We", "have", "two", "platform", "technologies", "providing", "the", "basis", "for", "the", "future", "development", "of", "a", "range", "of", "therapeutics", "for", "difficult-to-treat", "forms", "of", "cancer", "including:", "Lysolipid", "Thermally", "Sensitive", "Liposomes,", "a", "heat", "sensitive", "liposomal", "based", "dosage", "form", "that", "targets", "disease", "with", "known", "therapeutics", "in", "the", "presence", "of", "mild", "heat", "and", "TheraPlas,", "a", "novel", "nucleic", "acid-based", "treatment", "for", "local", "transfection", "of", "therapeutic", "plasmids.", "<tag3>"], "wordsA": ["In", "the", "acquisition,", "we", "purchased", "GEN-1,", "a", "DNA-based", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers,", "and", "two", "platform", "technologies", "for", "the", "development", "of", "treatments", "for", "those", "suffering", "with", "difficult-to-treat", "forms", "of", "cancer,", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies,", "including", "TheraPlas", "and", "TheraSilence", "."], "wordsB": ["We", "have", "two", "platform", "technologies", "providing", "the", "basis", "for", "the", "future", "development", "of", "a", "range", "of", "therapeutics", "for", "difficult-to-treat", "forms", "of", "cancer", "including:", "Lysolipid", "Thermally", "Sensitive", "Liposomes,", "a", "heat", "sensitive", "liposomal", "based", "dosage", "form", "that", "targets", "disease", "with", "known", "therapeutics", "in", "the", "presence", "of", "mild", "heat", "and", "TheraPlas,", "a", "novel", "nucleic", "acid-based", "treatment", "for", "local", "transfection", "of", "therapeutic", "plasmids."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00640606414526701, 0.0037397402338683605, 0.008048739284276962, 0.011470921337604523, 0.019447289407253265, 0.019268956035375595, 0.023828018456697464, 0.041471656411886215, 0.00804163608700037, 0.007988923229277134, 0.01806737668812275, 0.037098951637744904, 0.010607241652905941, 0.006729025859385729, 0.014864843338727951, 0.01017671637237072, 0.0904165729880333, 0.0044533745385706425, 0.007234455086290836, 0.013752379454672337, 0.006505265831947327, 0.0349775068461895, 0.02719178795814514, 0.48412784934043884, 0.3256756067276001, 0.33914750814437866, 0.36621958017349243, 0.004877257160842419, 0.2502198815345764, 0.2763120234012604, 0.23602360486984253, 0.1718682497739792, 0.10412972420454025, 0.13345105946063995, 0.0001345014461548999, 0.022826513275504112, 0.04412122070789337, 0.004947718232870102, 0.013114333152770996, 0.05242849886417389, 0.004455271176993847, 0.0004842045600526035, 0.013318052515387535, 0.005156936123967171, 0.05495237186551094, 0.0527179017663002, 0.003541469806805253, 0.03268451243638992, 0.0021377636585384607, 0.015495868399739265, 0.04704684391617775, 0.017531292513012886, 0.060453228652477264, 0.008163291960954666, 0.23973777890205383, 0.43560701608657837, 0.010046714916825294, 0.190492644906044, 0.27860745787620544, -1]}
{"idB": "749647_18_item1_p8_s2", "idA": "749647_17_item1_p38_s0", "sentA": "GEN-1 is a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers by intraperitoneally administering an Interleukin-12 ( IL-12 ) plasmid formulated with our proprietary TheraPlas delivery system.", "sentB": "Second in our pipeline is GEN-1, a DNA-mediated immunotherapy for the localized treatment of ovarian and brain cancers.", "type": 2, "words": ["<tag1>", "GEN-1", "is", "a", "DNA-based", "immunotherapeutic", "product", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers", "by", "intraperitoneally", "administering", "an", "Interleukin-12", "(", "IL-12", ")", "plasmid", "formulated", "with", "our", "proprietary", "TheraPlas", "delivery", "system.", "<tag2>", "Second", "in", "our", "pipeline", "is", "GEN-1,", "a", "DNA-mediated", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers.", "<tag3>"], "wordsA": ["GEN-1", "is", "a", "DNA-based", "immunotherapeutic", "product", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers", "by", "intraperitoneally", "administering", "an", "Interleukin-12", "(", "IL-12", ")", "plasmid", "formulated", "with", "our", "proprietary", "TheraPlas", "delivery", "system."], "wordsB": ["Second", "in", "our", "pipeline", "is", "GEN-1,", "a", "DNA-mediated", "immunotherapy", "for", "the", "localized", "treatment", "of", "ovarian", "and", "brain", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09864820539951324, 0.0301078949123621, 0.02617364004254341, 0.05460456758737564, 0.006364149507135153, 0.037049125880002975, 0.006404036656022072, 0.8612675070762634, 0.35797324776649475, 0.0018008704064413905, 0.0018891304498538375, 0.00434048380702734, 0.0056292032822966576, 0.0018774619093164802, 0.004337371326982975, 0.002438844181597233, 0.004209419712424278, 0.004926038905978203, -1]}
{"idB": "749647_18_item1_p119_s0", "idA": "749647_17_item1_p39_s0", "sentA": "In February 2015, we announced that the FDA accepted, without objection, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study ).", "sentB": "In February 2015, we announced that the FDA accepted, without objection, the Phase I b dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study ).", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ").", "<tag2>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "b", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ").", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ")."], "wordsB": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "b", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017689066007733345, 0.038383666425943375, 0.03217994421720505, 0.023792359977960587, 0.022914424538612366, 0.017544182017445564, 0.014431660994887352, 0.10763155668973923, 0.10013598948717117, 0.07192090898752213, 0.0841992050409317, 0.014591872692108154, 0.09317468851804733, 0.046077560633420944, 0.8176993727684021, 0.07624547928571701, 0.01994246430695057, 0.01882816106081009, 0.012848873622715473, 0.040519583970308304, 0.01774832233786583, 0.024865778163075447, 0.022172478958964348, 0.016803370788693428, 0.021795719861984253, 0.020595649257302284, 0.02137267403304577, 0.013406231999397278, 0.03332863375544548, 0.026007918640971184, 0.019675448536872864, 0.010615432634949684, 0.02042543701827526, 0.01727459579706192, 0.00038454256718978286, -1]}
{"idB": "749647_18_item1_p243_s2", "idA": "749647_17_item1_p39_s0", "sentA": "In February 2015, we announced that the FDA accepted, without objection, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study ).", "sentB": "We completed a Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer in the third quarter of 2017 and plan to expand our clinical development program for GEN-1 in ovarian cancer in 2018.", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ").", "<tag2>", "We", "completed", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "in", "the", "third", "quarter", "of", "2017", "and", "plan", "to", "expand", "our", "clinical", "development", "program", "for", "GEN-1", "in", "ovarian", "cancer", "in", "2018.", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ")."], "wordsB": ["We", "completed", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "in", "the", "third", "quarter", "of", "2017", "and", "plan", "to", "expand", "our", "clinical", "development", "program", "for", "GEN-1", "in", "ovarian", "cancer", "in", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06016261503100395, 0.5387961268424988, 0.030853858217597008, 0.02761840634047985, 0.014152253046631813, 0.02363697811961174, 0.019527746364474297, 0.032227788120508194, 0.005261680576950312, 0.017647018656134605, 0.004647374618798494, 0.006212770007550716, 0.0034264044370502234, 0.0039702183566987514, 0.008268442936241627, 0.004627611022442579, 0.007691467646509409, 0.0027638317551463842, 0.006514038424938917, 0.0064004454761743546, 0.011067721992731094, 0.027531174942851067, 0.01589464768767357, 0.054296646267175674, 0.1329611837863922, 0.13334353268146515, 0.5079159140586853, 0.00895417109131813, 0.07340134680271149, 0.04467672109603882, 0.12128724157810211, 0.04490818828344345, 0.13114991784095764, 0.08612702041864395, 0.08980126678943634, 0.010805230587720871, 0.024813465774059296, 0.0035144812427461147, 0.00802051741629839, 0.019395405426621437, 0.04746365174651146, 0.4991677701473236, -1]}
{"idB": "749647_18_item1_p268_s1", "idA": "749647_17_item1_p39_s0", "sentA": "In February 2015, we announced that the FDA accepted, without objection, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study ).", "sentB": "We conducted a Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer starting in the second half of 2015 and completing enrollment in 2017.", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ").", "<tag2>", "We", "conducted", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "starting", "in", "the", "second", "half", "of", "2015", "and", "completing", "enrollment", "in", "2017.", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ")."], "wordsB": ["We", "conducted", "a", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "starting", "in", "the", "second", "half", "of", "2015", "and", "completing", "enrollment", "in", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.06092837452888489, 0.14787812530994415, 0.02890002727508545, 0.022649262100458145, 0.018084436655044556, 0.01889311894774437, 0.01686074584722519, 0.03359990939497948, 0.01037515513598919, 0.024496980011463165, 0.007881996221840382, 0.01179549377411604, 0.007318835239857435, 0.007948341779410839, 0.016658414155244827, 0.007834592834115028, 0.012786365114152431, 0.0045906007289886475, 0.01336504053324461, 0.011823958717286587, 0.015608238987624645, 0.07345915585756302, 0.041417572647333145, 0.0414394810795784, 0.20555542409420013, 0.1845097690820694, 0.16030296683311462, 0.1330704241991043, 0.008602499961853027, 0.29039081931114197, 0.3762034773826599, 0.16858062148094177, 0.6250623464584351, -1]}
{"idB": "749647_18_item1_p45_s0", "idA": "749647_17_item1_p39_s0", "sentA": "In February 2015, we announced that the FDA accepted, without objection, the Phase I dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study ).", "sentB": "In February 2015, we announced that the FDA accepted, without objection, the Phase Ib dose-escalation clinical trial of GEN-1 in combination with the standard of care in neo-adjuvant ovarian cancer (the OVATION Study ).", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ").", "<tag2>", "In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "Ib", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ").", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ")."], "wordsB": ["In", "February", "2015,", "we", "announced", "that", "the", "FDA", "accepted,", "without", "objection,", "the", "Phase", "Ib", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "combination", "with", "the", "standard", "of", "care", "in", "neo-adjuvant", "ovarian", "cancer", "(the", "OVATION", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0027712120208889246, 0.005075512453913689, 0.005323643796145916, 0.003869467880576849, 0.004107242915779352, 0.003260507248342037, 0.0026530090253800154, 0.010450114496052265, 0.012379871681332588, 0.009844914078712463, 0.009784577414393425, 0.0028043247293680906, 0.04026181623339653, 0.9667471647262573, 0.011625709012150764, 0.003576521063223481, 0.003742804052308202, 0.002538787666708231, 0.004963841754943132, 0.0027238514740020037, 0.004107925109565258, 0.0035313714761286974, 0.0028600632213056087, 0.004080022685229778, 0.003790128743276, 0.0037911192048341036, 0.002607648493722081, 0.005723996087908745, 0.004318356513977051, 0.0029863915406167507, 0.00223457720130682, 0.0042302655056118965, 0.0037546607200056314, 0.0001603016717126593, -1]}
{"idB": "749647_18_item1_p132_s3", "idA": "749647_17_item1_p39_s1", "sentA": "On September 30, 2015, we announced enrollment of the first patient in the OVATION Study.", "sentB": "Summarized below are the latest PFS results for all patients treated per protocol in the OVATION Study:", "type": 2, "words": ["<tag1>", "On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "the", "OVATION", "Study.", "<tag2>", "Summarized", "below", "are", "the", "latest", "PFS", "results", "for", "all", "patients", "treated", "per", "protocol", "in", "the", "OVATION", "Study:", "<tag3>"], "wordsA": ["On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "the", "OVATION", "Study."], "wordsB": ["Summarized", "below", "are", "the", "latest", "PFS", "results", "for", "all", "patients", "treated", "per", "protocol", "in", "the", "OVATION", "Study:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11593325436115265, 0.1244899332523346, 0.03407594561576843, 0.06099460646510124, 0.21327799558639526, 0.22583797574043274, 0.33528196811676025, 0.08097463101148605, 0.39319944381713867, 0.28214991092681885, 0.13448908925056458, 0.026368021965026855, 0.055850423872470856, 0.009881203062832355, 0.008605782873928547, 0.016849402338266373, 0.12355396896600723, -1]}
{"idB": "749647_18_item1_p58_s3", "idA": "749647_17_item1_p39_s1", "sentA": "On September 30, 2015, we announced enrollment of the first patient in the OVATION Study.", "sentB": "Summarized below are the latest PFS results for all patients treated per protocol in the OVATION Study:", "type": 2, "words": ["<tag1>", "On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "the", "OVATION", "Study.", "<tag2>", "Summarized", "below", "are", "the", "latest", "PFS", "results", "for", "all", "patients", "treated", "per", "protocol", "in", "the", "OVATION", "Study:", "<tag3>"], "wordsA": ["On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "the", "OVATION", "Study."], "wordsB": ["Summarized", "below", "are", "the", "latest", "PFS", "results", "for", "all", "patients", "treated", "per", "protocol", "in", "the", "OVATION", "Study:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11593325436115265, 0.1244899332523346, 0.03407594561576843, 0.06099460646510124, 0.21327799558639526, 0.22583797574043274, 0.33528196811676025, 0.08097463101148605, 0.39319944381713867, 0.28214991092681885, 0.13448908925056458, 0.026368021965026855, 0.055850423872470856, 0.009881203062832355, 0.008605782873928547, 0.016849402338266373, 0.12355396896600723, -1]}
{"idB": "749647_18_item1_p119_s2", "idA": "749647_17_item1_p39_s2", "sentA": "The OVATION Study will seek to identify a safe, tolerable and potentially therapeutically active dose of GEN-1 by recruiting and maximizing an immune response and is designed to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study combining GEN-1 with Avastin and Doxil .", "sentB": "The OVATION Study is designed (i) to identify a safe, tolerable and potentially therapeutically active dose of GEN-1 by recruiting and maximizing an immune response and (ii) to enroll three to six patients per dose level to evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study.", "type": 2, "words": ["<tag1>", "The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag2>", "The", "OVATION", "Study", "is", "designed", "(i)", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "(ii)", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "to", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study.", "<tag3>"], "wordsA": ["The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "wordsB": ["The", "OVATION", "Study", "is", "designed", "(i)", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "(ii)", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "to", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0069122579880058765, 0.020635239779949188, 0.028131326660513878, 0.013630538247525692, 0.0333159863948822, 0.2776280343532562, 0.01005148608237505, 0.011154407635331154, 0.009011128917336464, 0.016512542963027954, 0.017268629744648933, 0.011748973280191422, 0.009510907344520092, 0.01144151296466589, 0.01302959956228733, 0.01087187323719263, 0.008369768969714642, 0.02455155737698078, 0.006892730947583914, 0.011488595046103, 0.008838971145451069, 0.010132860392332077, 0.007713553961366415, 0.011820146813988686, 0.011633656919002533, 0.008846995420753956, 0.0471525564789772, 0.00744718499481678, 0.015035148710012436, 0.03549824655056, 0.010837866924703121, 0.05983911454677582, 0.09692879021167755, 0.008534221909940243, 0.010618623346090317, 0.007931703701615334, 0.008732021786272526, 0.007189320866018534, 0.010283724404871464, 0.008922990411520004, 0.007758971769362688, 0.007107194978743792, 0.008800213225185871, 0.01194914523512125, 0.010436386801302433, 0.008396695367991924, 0.03839460015296936, 0.03930213674902916, 0.0052582621574401855, 0.005979598965495825, 0.010395219549536705, 0.010217229835689068, 0.010172081179916859, 0.00793895497918129, -1]}
{"idB": "749647_18_item1_p45_s2", "idA": "749647_17_item1_p39_s2", "sentA": "The OVATION Study will seek to identify a safe, tolerable and potentially therapeutically active dose of GEN-1 by recruiting and maximizing an immune response and is designed to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study combining GEN-1 with Avastin and Doxil .", "sentB": "The OVATION Study is designed (i) to identify a safe, tolerable and potentially therapeutically active dose of GEN-1 by recruiting and maximizing an immune response and (ii) to enroll three to six patients per dose level to evaluate safety and efficacy and attempt to define an optimal dose for a follow-on Phase I/II study.", "type": 2, "words": ["<tag1>", "The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", ".", "<tag2>", "The", "OVATION", "Study", "is", "designed", "(i)", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "(ii)", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "to", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study.", "<tag3>"], "wordsA": ["The", "OVATION", "Study", "will", "seek", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study", "combining", "GEN-1", "with", "Avastin", "and", "Doxil", "."], "wordsB": ["The", "OVATION", "Study", "is", "designed", "(i)", "to", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "by", "recruiting", "and", "maximizing", "an", "immune", "response", "and", "(ii)", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "to", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "for", "a", "follow-on", "Phase", "I/II", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0069122579880058765, 0.020635239779949188, 0.028131326660513878, 0.013630538247525692, 0.0333159863948822, 0.2776280343532562, 0.01005148608237505, 0.011154407635331154, 0.009011128917336464, 0.016512542963027954, 0.017268629744648933, 0.011748973280191422, 0.009510907344520092, 0.01144151296466589, 0.01302959956228733, 0.01087187323719263, 0.008369768969714642, 0.02455155737698078, 0.006892730947583914, 0.011488595046103, 0.008838971145451069, 0.010132860392332077, 0.007713553961366415, 0.011820146813988686, 0.011633656919002533, 0.008846995420753956, 0.0471525564789772, 0.00744718499481678, 0.015035148710012436, 0.03549824655056, 0.010837866924703121, 0.05983911454677582, 0.09692879021167755, 0.008534221909940243, 0.010618623346090317, 0.007931703701615334, 0.008732021786272526, 0.007189320866018534, 0.010283724404871464, 0.008922990411520004, 0.007758971769362688, 0.007107194978743792, 0.008800213225185871, 0.01194914523512125, 0.010436386801302433, 0.008396695367991924, 0.03839460015296936, 0.03930213674902916, 0.0052582621574401855, 0.005979598965495825, 0.010395219549536705, 0.010217229835689068, 0.010172081179916859, 0.00793895497918129, -1]}
{"idB": "749647_18_item1_p121_s0", "idA": "749647_17_item1_p41_s0", "sentA": "We have initiated the OVATION Study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "sentB": "We initiated the OVATION Study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "type": 2, "words": ["<tag1>", "We", "have", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag2>", "We", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag3>"], "wordsA": ["We", "have", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "wordsB": ["We", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4619244337081909, 0.4096516966819763, 0.07306758314371109, 0.27364200353622437, 0.31240904331207275, 0.0842592865228653, 0.41326388716697693, 0.19434691965579987, 0.32067376375198364, 0.06682846695184708, 0.054110679775476456, 0.19422022998332977, 0.14602693915367126, 0.23062533140182495, 0.09755487740039825, 0.17502932250499725, 0.19224773347377777, 0.17686480283737183, 0.14277277886867523, 0.1879255175590515, 0.12711097300052643, 0.17283909022808075, 0.0765349492430687, 0.12218311429023743, 0.12330205738544464, 0.043808966875076294, 0.04110089689493179, 0.22684341669082642, 0.17903776466846466, 0.0946081206202507, 0.20185697078704834, -1]}
{"idB": "749647_18_item1_p47_s0", "idA": "749647_17_item1_p41_s0", "sentA": "We have initiated the OVATION Study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "sentB": "We initiated the OVATION Study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "type": 2, "words": ["<tag1>", "We", "have", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag2>", "We", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag3>"], "wordsA": ["We", "have", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "wordsB": ["We", "initiated", "the", "OVATION", "Study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.4619244337081909, 0.4096516966819763, 0.07306758314371109, 0.27364200353622437, 0.31240904331207275, 0.0842592865228653, 0.41326388716697693, 0.19434691965579987, 0.32067376375198364, 0.06682846695184708, 0.054110679775476456, 0.19422022998332977, 0.14602693915367126, 0.23062533140182495, 0.09755487740039825, 0.17502932250499725, 0.19224773347377777, 0.17686480283737183, 0.14277277886867523, 0.1879255175590515, 0.12711097300052643, 0.17283909022808075, 0.0765349492430687, 0.12218311429023743, 0.12330205738544464, 0.043808966875076294, 0.04110089689493179, 0.22684341669082642, 0.17903776466846466, 0.0946081206202507, 0.20185697078704834, -1]}
{"idB": "749647_18_item1_p121_s1", "idA": "749647_17_item1_p41_s1", "sentA": "During 2016 and 2017, we announced data from the first four cohorts of patients in the OVATION Study, respectively.", "sentB": "During 2016 and 2017, we announced data from the first fourteen patients in the OVATION Study who completed treatment.", "type": 2, "words": ["<tag1>", "During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively.", "<tag2>", "During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "fourteen", "patients", "in", "the", "OVATION", "Study", "who", "completed", "treatment.", "<tag3>"], "wordsA": ["During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively."], "wordsB": ["During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "fourteen", "patients", "in", "the", "OVATION", "Study", "who", "completed", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00352828879840672, 0.003978203982114792, 0.0036270960699766874, 0.0029278132133185863, 0.002711656503379345, 0.00611468218266964, 0.016078906133770943, 0.00921451486647129, 0.00883569661527872, 0.10056772828102112, 0.9093132019042969, 0.407257080078125, 0.003432070603594184, 0.0023360003251582384, 0.009093880653381348, 0.026386193931102753, 0.014707150869071484, 0.31362929940223694, 0.11006125807762146, -1]}
{"idB": "749647_18_item1_p129_s1", "idA": "749647_17_item1_p41_s1", "sentA": "During 2016 and 2017, we announced data from the first four cohorts of patients in the OVATION Study, respectively.", "sentB": "Seven out of eight (87%) patients in the highest two dose cohorts experienced a R0 surgical resection.", "type": 2, "words": ["<tag1>", "During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively.", "<tag2>", "Seven", "out", "of", "eight", "(87%)", "patients", "in", "the", "highest", "two", "dose", "cohorts", "experienced", "a", "R0", "surgical", "resection.", "<tag3>"], "wordsA": ["During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively."], "wordsB": ["Seven", "out", "of", "eight", "(87%)", "patients", "in", "the", "highest", "two", "dose", "cohorts", "experienced", "a", "R0", "surgical", "resection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6149021983146667, 0.22489747405052185, 0.13223065435886383, 0.4662930369377136, 0.20560024678707123, 0.18850162625312805, 0.00955885834991932, 0.010021842084825039, 0.11635766923427582, 0.29180917143821716, 0.19004927575588226, 0.10002067685127258, 0.08926662057638168, 0.032544299960136414, 0.24663867056369781, 0.11978904157876968, 0.1632699817419052, -1]}
{"idB": "749647_18_item1_p47_s1", "idA": "749647_17_item1_p41_s1", "sentA": "During 2016 and 2017, we announced data from the first four cohorts of patients in the OVATION Study, respectively.", "sentB": "During 2016 and 2017, we announced data from the first fourteen patients in the OVATION Study who completed treatment.", "type": 2, "words": ["<tag1>", "During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively.", "<tag2>", "During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "fourteen", "patients", "in", "the", "OVATION", "Study", "who", "completed", "treatment.", "<tag3>"], "wordsA": ["During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively."], "wordsB": ["During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "fourteen", "patients", "in", "the", "OVATION", "Study", "who", "completed", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00352828879840672, 0.003978203982114792, 0.0036270960699766874, 0.0029278132133185863, 0.002711656503379345, 0.00611468218266964, 0.016078906133770943, 0.00921451486647129, 0.00883569661527872, 0.10056772828102112, 0.9093132019042969, 0.407257080078125, 0.003432070603594184, 0.0023360003251582384, 0.009093880653381348, 0.026386193931102753, 0.014707150869071484, 0.31362929940223694, 0.11006125807762146, -1]}
{"idB": "749647_18_item1_p55_s1", "idA": "749647_17_item1_p41_s1", "sentA": "During 2016 and 2017, we announced data from the first four cohorts of patients in the OVATION Study, respectively.", "sentB": "Seven out of eight (87%) patients in the highest two dose cohorts experienced a R0 surgical resection.", "type": 2, "words": ["<tag1>", "During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively.", "<tag2>", "Seven", "out", "of", "eight", "(87%)", "patients", "in", "the", "highest", "two", "dose", "cohorts", "experienced", "a", "R0", "surgical", "resection.", "<tag3>"], "wordsA": ["During", "2016", "and", "2017,", "we", "announced", "data", "from", "the", "first", "four", "cohorts", "of", "patients", "in", "the", "OVATION", "Study,", "respectively."], "wordsB": ["Seven", "out", "of", "eight", "(87%)", "patients", "in", "the", "highest", "two", "dose", "cohorts", "experienced", "a", "R0", "surgical", "resection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6149021983146667, 0.22489747405052185, 0.13223065435886383, 0.4662930369377136, 0.20560024678707123, 0.18850162625312805, 0.00955885834991932, 0.010021842084825039, 0.11635766923427582, 0.29180917143821716, 0.19004927575588226, 0.10002067685127258, 0.08926662057638168, 0.032544299960136414, 0.24663867056369781, 0.11978904157876968, 0.1632699817419052, -1]}
{"idB": "749647_18_item1_p183_s2", "idA": "749647_17_item1_p41_s5", "sentA": "The results of the OVATION Study to date are as follows:", "sentB": "Sponsors are also obligated to disclose the results of their clinical trials within one year of completion, although disclosure of the results of these trials can be delayed in certain circumstances for up to two additional years.", "type": 2, "words": ["<tag1>", "The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:", "<tag2>", "Sponsors", "are", "also", "obligated", "to", "disclose", "the", "results", "of", "their", "clinical", "trials", "within", "one", "year", "of", "completion,", "although", "disclosure", "of", "the", "results", "of", "these", "trials", "can", "be", "delayed", "in", "certain", "circumstances", "for", "up", "to", "two", "additional", "years.", "<tag3>"], "wordsA": ["The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:"], "wordsB": ["Sponsors", "are", "also", "obligated", "to", "disclose", "the", "results", "of", "their", "clinical", "trials", "within", "one", "year", "of", "completion,", "although", "disclosure", "of", "the", "results", "of", "these", "trials", "can", "be", "delayed", "in", "certain", "circumstances", "for", "up", "to", "two", "additional", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.23135851323604584, 0.020146269351243973, 0.03374628722667694, 0.10608187317848206, 0.06960754096508026, 0.3308553397655487, 0.06365042924880981, 0.10159149020910263, 0.020749978721141815, 0.03422148898243904, 0.336809903383255, 0.3429098427295685, 0.08253581076860428, 0.11532966047525406, 0.08587593585252762, 0.06788469851016998, 0.06640036404132843, 7.17707589501515e-05, 0.17182306945323944, 0.02707931399345398, 0.018080448731780052, 0.05645817518234253, 0.009013180620968342, 0.012116612866520882, 0.13513724505901337, 0.018160587176680565, 0.015255597420036793, 0.05314593389630318, 0.009868936613202095, 0.018823502585291862, 0.02818462811410427, 0.02829747274518013, 0.018522541970014572, 0.0199033934623003, 0.05409843102097511, 0.03500724583864212, 0.05920868366956711, -1]}
{"idB": "749647_18_item1_p128_s1", "idA": "749647_17_item1_p42_s1", "sentA": "This translates to a 100% disease control rate ( DCR ) and 75% objective response rate ( ORR ).", "sentB": "This translates to a 100% disease control rate ( DCR ) and an 86% objective response rate ( ORR ).", "type": 2, "words": ["<tag1>", "This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ").", "<tag2>", "This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "an", "86%", "objective", "response", "rate", "(", "ORR", ").", "<tag3>"], "wordsA": ["This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ")."], "wordsB": ["This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "an", "86%", "objective", "response", "rate", "(", "ORR", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0017153837252408266, 0.004236508626490831, 0.002201591618359089, 0.001981736859306693, 0.010990673676133156, 0.004802606999874115, 0.004354945383965969, 0.004024133086204529, 0.002752511529251933, 0.008141379803419113, 6.026379924151115e-05, 0.0030870845075696707, 0.0041808197274804115, 0.9885653853416443, 0.028891701251268387, 0.013933739624917507, 0.011187659576535225, 0.0025929517578333616, 0.013120628893375397, 6.26807232038118e-05, -1]}
{"idB": "749647_18_item1_p54_s1", "idA": "749647_17_item1_p42_s1", "sentA": "This translates to a 100% disease control rate ( DCR ) and 75% objective response rate ( ORR ).", "sentB": "This translates to a 100% disease control rate ( DCR ) and an 86% objective response rate ( ORR ).", "type": 2, "words": ["<tag1>", "This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ").", "<tag2>", "This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "an", "86%", "objective", "response", "rate", "(", "ORR", ").", "<tag3>"], "wordsA": ["This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ")."], "wordsB": ["This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "an", "86%", "objective", "response", "rate", "(", "ORR", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0017153837252408266, 0.004236508626490831, 0.002201591618359089, 0.001981736859306693, 0.010990673676133156, 0.004802606999874115, 0.004354945383965969, 0.004024133086204529, 0.002752511529251933, 0.008141379803419113, 6.026379924151115e-05, 0.0030870845075696707, 0.0041808197274804115, 0.9885653853416443, 0.028891701251268387, 0.013933739624917507, 0.011187659576535225, 0.0025929517578333616, 0.013120628893375397, 6.26807232038118e-05, -1]}
{"idB": "749647_18_item1_p129_s2", "idA": "749647_17_item1_p44_s1", "sentA": "These data compare favorably to historical data, which indicate that cPRs are typically seen in less than 7% of patients receiving neoadjuvant chemotherapy followed by surgical resection.", "sentB": "All five patients treated at the highest dose cohort experienced a R0 surgical resection.", "type": 2, "words": ["<tag1>", "These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection.", "<tag2>", "All", "five", "patients", "treated", "at", "the", "highest", "dose", "cohort", "experienced", "a", "R0", "surgical", "resection.", "<tag3>"], "wordsA": ["These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection."], "wordsB": ["All", "five", "patients", "treated", "at", "the", "highest", "dose", "cohort", "experienced", "a", "R0", "surgical", "resection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1587160974740982, 0.36822643876075745, 0.2564582824707031, 0.09163910150527954, 0.02258923090994358, 0.013607022352516651, 0.20575609803199768, 0.23642292618751526, 0.0634976178407669, 0.13357293605804443, 0.03679194301366806, 0.5598666667938232, 0.11168086528778076, 0.2617892622947693, -1]}
{"idB": "749647_18_item1_p132_s2", "idA": "749647_17_item1_p44_s1", "sentA": "These data compare favorably to historical data, which indicate that cPRs are typically seen in less than 7% of patients receiving neoadjuvant chemotherapy followed by surgical resection.", "sentB": "This compares favorably to the historical median progression-free survival of 12 months for newly diagnosed patients with Stage III and IV ovarian cancer that undergo neoadjuvant chemotherapy followed by interval debulking surgery.", "type": 2, "words": ["<tag1>", "These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection.", "<tag2>", "This", "compares", "favorably", "to", "the", "historical", "median", "progression-free", "survival", "of", "12", "months", "for", "newly", "diagnosed", "patients", "with", "Stage", "III", "and", "IV", "ovarian", "cancer", "that", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "interval", "debulking", "surgery.", "<tag3>"], "wordsA": ["These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection."], "wordsB": ["This", "compares", "favorably", "to", "the", "historical", "median", "progression-free", "survival", "of", "12", "months", "for", "newly", "diagnosed", "patients", "with", "Stage", "III", "and", "IV", "ovarian", "cancer", "that", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "interval", "debulking", "surgery."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003150561824440956, 0.02219345048069954, 0.0139482906088233, 0.00406488124281168, 0.005190059542655945, 0.05634189397096634, 0.2554529905319214, 0.6099261045455933, 0.3128308653831482, 0.0633082389831543, 0.34436050057411194, 0.15156544744968414, 0.007553729694336653, 0.03020809218287468, 0.03145423159003258, 0.07876551896333694, 0.013766228221356869, 0.029253758490085602, 0.11291250586509705, 0.09548711776733398, 0.11061545461416245, 0.13386312127113342, 0.08437993377447128, 0.0004923444939777255, 0.027067482471466064, 0.013338018208742142, 0.04612027481198311, 0.012413457036018372, 0.018385568633675575, 0.5333554148674011, 0.7769343256950378, 0.3816605508327484, -1]}
{"idB": "749647_18_item1_p55_s2", "idA": "749647_17_item1_p44_s1", "sentA": "These data compare favorably to historical data, which indicate that cPRs are typically seen in less than 7% of patients receiving neoadjuvant chemotherapy followed by surgical resection.", "sentB": "All five patients treated at the highest dose cohort experienced a R0 surgical resection.", "type": 2, "words": ["<tag1>", "These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection.", "<tag2>", "All", "five", "patients", "treated", "at", "the", "highest", "dose", "cohort", "experienced", "a", "R0", "surgical", "resection.", "<tag3>"], "wordsA": ["These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection."], "wordsB": ["All", "five", "patients", "treated", "at", "the", "highest", "dose", "cohort", "experienced", "a", "R0", "surgical", "resection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.1587160974740982, 0.36822643876075745, 0.2564582824707031, 0.09163910150527954, 0.02258923090994358, 0.013607022352516651, 0.20575609803199768, 0.23642292618751526, 0.0634976178407669, 0.13357293605804443, 0.03679194301366806, 0.5598666667938232, 0.11168086528778076, 0.2617892622947693, -1]}
{"idB": "749647_18_item1_p58_s2", "idA": "749647_17_item1_p44_s1", "sentA": "These data compare favorably to historical data, which indicate that cPRs are typically seen in less than 7% of patients receiving neoadjuvant chemotherapy followed by surgical resection.", "sentB": "This compares favorably to the historical median progression-free survival of 12 months for newly diagnosed patients with Stage III and IV ovarian cancer that undergo neoadjuvant chemotherapy followed by interval debulking surgery.", "type": 2, "words": ["<tag1>", "These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection.", "<tag2>", "This", "compares", "favorably", "to", "the", "historical", "median", "progression-free", "survival", "of", "12", "months", "for", "newly", "diagnosed", "patients", "with", "Stage", "III", "and", "IV", "ovarian", "cancer", "that", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "interval", "debulking", "surgery.", "<tag3>"], "wordsA": ["These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection."], "wordsB": ["This", "compares", "favorably", "to", "the", "historical", "median", "progression-free", "survival", "of", "12", "months", "for", "newly", "diagnosed", "patients", "with", "Stage", "III", "and", "IV", "ovarian", "cancer", "that", "undergo", "neoadjuvant", "chemotherapy", "followed", "by", "interval", "debulking", "surgery."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003150561824440956, 0.02219345048069954, 0.0139482906088233, 0.00406488124281168, 0.005190059542655945, 0.05634189397096634, 0.2554529905319214, 0.6099261045455933, 0.3128308653831482, 0.0633082389831543, 0.34436050057411194, 0.15156544744968414, 0.007553729694336653, 0.03020809218287468, 0.03145423159003258, 0.07876551896333694, 0.013766228221356869, 0.029253758490085602, 0.11291250586509705, 0.09548711776733398, 0.11061545461416245, 0.13386312127113342, 0.08437993377447128, 0.0004923444939777255, 0.027067482471466064, 0.013338018208742142, 0.04612027481198311, 0.012413457036018372, 0.018385568633675575, 0.5333554148674011, 0.7769343256950378, 0.3816605508327484, -1]}
{"idB": "749647_18_item1_p124_s0", "idA": "749647_17_item1_p48_s1", "sentA": "Top line data demonstrates intriguing immunological changes in the tumor that are consistent with the activation of the immune system.", "sentB": "Consistent with the previous partial reports, the effects observed in the IHC analysis were pronounced decreases in the density of immunosuppressive T-cell signals (Foxp3, PD-1, PDL-1, IDO-1) and increases in CD8+ cells in the tumor microenvironment.", "type": 2, "words": ["<tag1>", "Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system.", "<tag2>", "Consistent", "with", "the", "previous", "partial", "reports,", "the", "effects", "observed", "in", "the", "IHC", "analysis", "were", "pronounced", "decreases", "in", "the", "density", "of", "immunosuppressive", "T-cell", "signals", "(Foxp3,", "PD-1,", "PDL-1,", "IDO-1)", "and", "increases", "in", "CD8+", "cells", "in", "the", "tumor", "microenvironment.", "<tag3>"], "wordsA": ["Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system."], "wordsB": ["Consistent", "with", "the", "previous", "partial", "reports,", "the", "effects", "observed", "in", "the", "IHC", "analysis", "were", "pronounced", "decreases", "in", "the", "density", "of", "immunosuppressive", "T-cell", "signals", "(Foxp3,", "PD-1,", "PDL-1,", "IDO-1)", "and", "increases", "in", "CD8+", "cells", "in", "the", "tumor", "microenvironment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01572093740105629, 0.0037666447460651398, 0.0034477384760975838, 0.00874236412346363, 0.10531814396381378, 0.09198195487260818, 0.004256154876202345, 0.09565948694944382, 0.00806200597435236, 0.0055521330796182156, 0.0050810412503778934, 0.0904373899102211, 0.03944744914770126, 0.006687799468636513, 0.09888538718223572, 0.3711547553539276, 0.11170180141925812, 0.052190300077199936, 0.2619594931602478, 0.12887601554393768, 0.23445424437522888, 0.4950220584869385, 0.3075660169124603, 0.29304853081703186, 0.19451405107975006, 0.17811383306980133, 0.26767420768737793, 0.009341824799776077, 0.2153281718492508, 0.14088797569274902, 0.5734586119651794, 0.48436424136161804, 0.019174573943018913, 0.015615799464285374, 0.08540691435337067, 0.0858001634478569, -1]}
{"idB": "749647_18_item1_p50_s0", "idA": "749647_17_item1_p48_s1", "sentA": "Top line data demonstrates intriguing immunological changes in the tumor that are consistent with the activation of the immune system.", "sentB": "Consistent with the previous partial reports, the effects observed in the IHC analysis were pronounced decreases in the density of immunosuppressive T-cell signals (Foxp3, PD-1, PDL-1, IDO-1) and increases in CD8+ cells in the tumor microenvironment.", "type": 2, "words": ["<tag1>", "Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system.", "<tag2>", "Consistent", "with", "the", "previous", "partial", "reports,", "the", "effects", "observed", "in", "the", "IHC", "analysis", "were", "pronounced", "decreases", "in", "the", "density", "of", "immunosuppressive", "T-cell", "signals", "(Foxp3,", "PD-1,", "PDL-1,", "IDO-1)", "and", "increases", "in", "CD8+", "cells", "in", "the", "tumor", "microenvironment.", "<tag3>"], "wordsA": ["Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system."], "wordsB": ["Consistent", "with", "the", "previous", "partial", "reports,", "the", "effects", "observed", "in", "the", "IHC", "analysis", "were", "pronounced", "decreases", "in", "the", "density", "of", "immunosuppressive", "T-cell", "signals", "(Foxp3,", "PD-1,", "PDL-1,", "IDO-1)", "and", "increases", "in", "CD8+", "cells", "in", "the", "tumor", "microenvironment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01572093740105629, 0.0037666447460651398, 0.0034477384760975838, 0.00874236412346363, 0.10531814396381378, 0.09198195487260818, 0.004256154876202345, 0.09565948694944382, 0.00806200597435236, 0.0055521330796182156, 0.0050810412503778934, 0.0904373899102211, 0.03944744914770126, 0.006687799468636513, 0.09888538718223572, 0.3711547553539276, 0.11170180141925812, 0.052190300077199936, 0.2619594931602478, 0.12887601554393768, 0.23445424437522888, 0.4950220584869385, 0.3075660169124603, 0.29304853081703186, 0.19451405107975006, 0.17811383306980133, 0.26767420768737793, 0.009341824799776077, 0.2153281718492508, 0.14088797569274902, 0.5734586119651794, 0.48436424136161804, 0.019174573943018913, 0.015615799464285374, 0.08540691435337067, 0.0858001634478569, -1]}
{"idB": "749647_18_item1_p125_s0", "idA": "749647_17_item1_p49_s2", "sentA": "The ratio of CD8+/FoxP3+ cells was increased in all four evaluable patients.", "sentB": "The ratio of CD8+ cells to immunosuppressive cells was increased in approximately 75% of patients suggesting an overall shift in the tumor microenvironment from immunosuppressive to pro-immune stimulatory following treatment with GEN-1.", "type": 2, "words": ["<tag1>", "The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients.", "<tag2>", "The", "ratio", "of", "CD8+", "cells", "to", "immunosuppressive", "cells", "was", "increased", "in", "approximately", "75%", "of", "patients", "suggesting", "an", "overall", "shift", "in", "the", "tumor", "microenvironment", "from", "immunosuppressive", "to", "pro-immune", "stimulatory", "following", "treatment", "with", "GEN-1.", "<tag3>"], "wordsA": ["The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients."], "wordsB": ["The", "ratio", "of", "CD8+", "cells", "to", "immunosuppressive", "cells", "was", "increased", "in", "approximately", "75%", "of", "patients", "suggesting", "an", "overall", "shift", "in", "the", "tumor", "microenvironment", "from", "immunosuppressive", "to", "pro-immune", "stimulatory", "following", "treatment", "with", "GEN-1."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003785934066399932, 0.05019724369049072, 0.012483949773013592, 0.0903138592839241, 0.07518157362937927, 0.029903482645750046, 0.4288610517978668, 0.3136713206768036, 0.006928745191544294, 0.03564552590250969, 0.01921393908560276, 0.21535399556159973, 0.6390377879142761, 0.09365276247262955, 0.16455209255218506, 0.0042105005122721195, 0.004490089602768421, 0.04709493741393089, 0.036402784287929535, 0.012099552899599075, 0.00948264915496111, 0.04763474687933922, 0.055834051221609116, 0.039785608649253845, 0.09387709945440292, 0.05340617150068283, 0.21612250804901123, 0.05041610077023506, 0.008345721289515495, 0.028271431103348732, 0.02775743417441845, 0.11164546757936478, -1]}
{"idB": "749647_18_item1_p132_s0", "idA": "749647_17_item1_p49_s2", "sentA": "The ratio of CD8+/FoxP3+ cells was increased in all four evaluable patients.", "sentB": "Of the 13 patients who received GEN-1 treatment in all four dose escalating cohorts, only five patients cancers have progressed as of March 15, 2018.", "type": 2, "words": ["<tag1>", "The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients.", "<tag2>", "Of", "the", "13", "patients", "who", "received", "GEN-1", "treatment", "in", "all", "four", "dose", "escalating", "cohorts,", "only", "five", "patients", "cancers", "have", "progressed", "as", "of", "March", "15,", "2018.", "<tag3>"], "wordsA": ["The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients."], "wordsB": ["Of", "the", "13", "patients", "who", "received", "GEN-1", "treatment", "in", "all", "four", "dose", "escalating", "cohorts,", "only", "five", "patients", "cancers", "have", "progressed", "as", "of", "March", "15,", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01832040771842003, 0.009471959434449673, 0.3114163279533386, 0.1882680505514145, 0.004983572289347649, 0.03659068048000336, 0.23662443459033966, 0.1414863020181656, 0.004379237536340952, 0.00542479706928134, 0.018738606944680214, 0.09198912233114243, 0.12318061292171478, 0.04159627854824066, 0.04357938840985298, 0.4483844041824341, 0.2258792519569397, 0.15088345110416412, 0.06816025823354721, 0.11007639020681381, 0.015169018879532814, 0.01616469770669937, 0.02601361647248268, 0.015233450569212437, 0.04444685950875282, -1]}
{"idB": "749647_18_item1_p51_s0", "idA": "749647_17_item1_p49_s2", "sentA": "The ratio of CD8+/FoxP3+ cells was increased in all four evaluable patients.", "sentB": "The ratio of CD8+ cells to immunosuppressive cells was increased in approximately 75% of patients suggesting an overall shift in the tumor microenvironment from immunosuppressive to pro-immune stimulatory following treatment with GEN-1.", "type": 2, "words": ["<tag1>", "The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients.", "<tag2>", "The", "ratio", "of", "CD8+", "cells", "to", "immunosuppressive", "cells", "was", "increased", "in", "approximately", "75%", "of", "patients", "suggesting", "an", "overall", "shift", "in", "the", "tumor", "microenvironment", "from", "immunosuppressive", "to", "pro-immune", "stimulatory", "following", "treatment", "with", "GEN-1.", "<tag3>"], "wordsA": ["The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients."], "wordsB": ["The", "ratio", "of", "CD8+", "cells", "to", "immunosuppressive", "cells", "was", "increased", "in", "approximately", "75%", "of", "patients", "suggesting", "an", "overall", "shift", "in", "the", "tumor", "microenvironment", "from", "immunosuppressive", "to", "pro-immune", "stimulatory", "following", "treatment", "with", "GEN-1."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.003785934066399932, 0.05019724369049072, 0.012483949773013592, 0.0903138592839241, 0.07518157362937927, 0.029903482645750046, 0.4288610517978668, 0.3136713206768036, 0.006928745191544294, 0.03564552590250969, 0.01921393908560276, 0.21535399556159973, 0.6390377879142761, 0.09365276247262955, 0.16455209255218506, 0.0042105005122721195, 0.004490089602768421, 0.04709493741393089, 0.036402784287929535, 0.012099552899599075, 0.00948264915496111, 0.04763474687933922, 0.055834051221609116, 0.039785608649253845, 0.09387709945440292, 0.05340617150068283, 0.21612250804901123, 0.05041610077023506, 0.008345721289515495, 0.028271431103348732, 0.02775743417441845, 0.11164546757936478, -1]}
{"idB": "749647_18_item1_p58_s0", "idA": "749647_17_item1_p49_s2", "sentA": "The ratio of CD8+/FoxP3+ cells was increased in all four evaluable patients.", "sentB": "Of the 13 patients who received GEN-1 treatment in all four dose escalating cohorts, only five patients cancers have progressed as of March 15, 2018.", "type": 2, "words": ["<tag1>", "The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients.", "<tag2>", "Of", "the", "13", "patients", "who", "received", "GEN-1", "treatment", "in", "all", "four", "dose", "escalating", "cohorts,", "only", "five", "patients", "cancers", "have", "progressed", "as", "of", "March", "15,", "2018.", "<tag3>"], "wordsA": ["The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients."], "wordsB": ["Of", "the", "13", "patients", "who", "received", "GEN-1", "treatment", "in", "all", "four", "dose", "escalating", "cohorts,", "only", "five", "patients", "cancers", "have", "progressed", "as", "of", "March", "15,", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01832040771842003, 0.009471959434449673, 0.3114163279533386, 0.1882680505514145, 0.004983572289347649, 0.03659068048000336, 0.23662443459033966, 0.1414863020181656, 0.004379237536340952, 0.00542479706928134, 0.018738606944680214, 0.09198912233114243, 0.12318061292171478, 0.04159627854824066, 0.04357938840985298, 0.4483844041824341, 0.2258792519569397, 0.15088345110416412, 0.06816025823354721, 0.11007639020681381, 0.015169018879532814, 0.01616469770669937, 0.02601361647248268, 0.015233450569212437, 0.04444685950875282, -1]}
{"idB": "749647_18_item1_p234_s3", "idA": "749647_17_item1_p4_s0", "sentA": "The discussion of risks and uncertainties set forth in this Annual Report on Form 10-K is not necessarily a complete or exhaustive list of all risks facing the Company at any particular point in time.", "sentB": "Consequently, you should not consider the following to be a complete discussion of all potential risks or uncertainties that may impact our business.", "type": 2, "words": ["<tag1>", "The", "discussion", "of", "risks", "and", "uncertainties", "set", "forth", "in", "this", "Annual", "Report", "on", "Form", "10-K", "is", "not", "necessarily", "a", "complete", "or", "exhaustive", "list", "of", "all", "risks", "facing", "the", "Company", "at", "any", "particular", "point", "in", "time.", "<tag2>", "Consequently,", "you", "should", "not", "consider", "the", "following", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "impact", "our", "business.", "<tag3>"], "wordsA": ["The", "discussion", "of", "risks", "and", "uncertainties", "set", "forth", "in", "this", "Annual", "Report", "on", "Form", "10-K", "is", "not", "necessarily", "a", "complete", "or", "exhaustive", "list", "of", "all", "risks", "facing", "the", "Company", "at", "any", "particular", "point", "in", "time."], "wordsB": ["Consequently,", "you", "should", "not", "consider", "the", "following", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "impact", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.07042476534843445, 0.12666712701320648, 0.20299911499023438, 0.5814926624298096, 0.42911985516548157, 0.09788525104522705, 0.2118554413318634, 0.24077676236629486, 0.13849219679832458, 0.09211818873882294, 0.3351080119609833, 0.1969367414712906, 0.02416113018989563, 0.04226039722561836, 0.04769527167081833, 0.04926551133394241, 0.016248639672994614, 0.031221376731991768, 0.010664558969438076, 0.02658846788108349, 0.08511640876531601, 0.056685615330934525, 0.13238516449928284, -1]}
{"idB": "749647_18_item1_p67_s1", "idA": "749647_17_item1_p59_s1", "sentA": "To support our research and development, we raised gross proceeds of approximately $127.2 million in equity financings and warrant and option exercises in the years 2010 through 2015.", "sentB": "To support our research and development, we raised gross proceeds of approximately $132 million in equity financings and warrant and option exercises in the years 2011 through 2016.", "type": 2, "words": ["<tag1>", "To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$127.2", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2010", "through", "2015.", "<tag2>", "To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$132", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2011", "through", "2016.", "<tag3>"], "wordsA": ["To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$127.2", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2010", "through", "2015."], "wordsB": ["To", "support", "our", "research", "and", "development,", "we", "raised", "gross", "proceeds", "of", "approximately", "$132", "million", "in", "equity", "financings", "and", "warrant", "and", "option", "exercises", "in", "the", "years", "2011", "through", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0019053067080676556, 0.00395623967051506, 0.00251469062641263, 0.004309610929340124, 0.0028178603388369083, 0.0031645200215280056, 0.002732406137511134, 0.0052450899966061115, 0.004520300775766373, 0.007199954241514206, 0.003301238641142845, 0.010110502131283283, 0.9334302544593811, 0.1966649889945984, 0.0022308032494038343, 0.003929581493139267, 0.006208634935319424, 0.0016661841655150056, 0.002422141609713435, 0.001999234315007925, 0.0028108961414545774, 0.0035497420467436314, 0.00210925517603755, 0.001984039321541786, 0.026578523218631744, 0.8462294340133667, 0.30397748947143555, 0.6722924709320068, -1]}
{"idB": "749647_18_item1_p67_s2", "idA": "749647_17_item1_p59_s2", "sentA": "During 2016, we raised gross proceeds of $7.8 million through two registered direct equity financings with several institutional investors.", "sentB": "During 2017, we raised gross proceeds of approximately $39 million through an underwritten public equity offering, a registered direct equity offering, an equity offering made on a reasonable best efforts basis, warrant exercises and equity sales though an at the market equity facility (ATM Facility).", "type": 2, "words": ["<tag1>", "During", "2016,", "we", "raised", "gross", "proceeds", "of", "$7.8", "million", "through", "two", "registered", "direct", "equity", "financings", "with", "several", "institutional", "investors.", "<tag2>", "During", "2017,", "we", "raised", "gross", "proceeds", "of", "approximately", "$39", "million", "through", "an", "underwritten", "public", "equity", "offering,", "a", "registered", "direct", "equity", "offering,", "an", "equity", "offering", "made", "on", "a", "reasonable", "best", "efforts", "basis,", "warrant", "exercises", "and", "equity", "sales", "though", "an", "at", "the", "market", "equity", "facility", "(ATM", "Facility).", "<tag3>"], "wordsA": ["During", "2016,", "we", "raised", "gross", "proceeds", "of", "$7.8", "million", "through", "two", "registered", "direct", "equity", "financings", "with", "several", "institutional", "investors."], "wordsB": ["During", "2017,", "we", "raised", "gross", "proceeds", "of", "approximately", "$39", "million", "through", "an", "underwritten", "public", "equity", "offering,", "a", "registered", "direct", "equity", "offering,", "an", "equity", "offering", "made", "on", "a", "reasonable", "best", "efforts", "basis,", "warrant", "exercises", "and", "equity", "sales", "though", "an", "at", "the", "market", "equity", "facility", "(ATM", "Facility)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.041059061884880066, 0.6948801875114441, 0.0040697394870221615, 0.0064149596728384495, 0.00569947762414813, 0.008187631145119667, 0.003300686599686742, 0.021758874878287315, 0.859038233757019, 0.11360335350036621, 0.005468730349093676, 0.013590815477073193, 0.22898657619953156, 0.1264619529247284, 0.22758778929710388, 0.2829172611236572, 0.0032627517357468605, 0.012605621479451656, 0.01391169149428606, 0.013269997201859951, 0.06605757027864456, 0.0005053267232142389, 0.0335027314722538, 0.04055918753147125, 0.0051437378861010075, 0.00017507172015029937, 0.0002667211228981614, 0.008898703381419182, 0.009339874610304832, 0.02035919390618801, 0.012890598736703396, 0.061369769275188446, 0.10797125846147537, 0.011828326620161533, 0.12244530767202377, 0.20852063596248627, 0.009852279908955097, 0.006751483306288719, 0.011589612811803818, 0.006881782319396734, 0.021033605560660362, 0.032007306814193726, 0.034937892109155655, 0.03130726143717766, 0.03895339369773865, -1]}
{"idB": "749647_18_item1_p236_s0", "idA": "749647_17_item1_p59_s3", "sentA": "We had cash, cash equivalents, short-term investments and interest receivable totaling $4.3 million at December 31, 2016.", "sentB": "Since our inception, our expenses have substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit of $ 262 million at December 31, 2017.", "type": 2, "words": ["<tag1>", "We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$4.3", "million", "at", "December", "31,", "2016.", "<tag2>", "Since", "our", "inception,", "our", "expenses", "have", "substantially", "exceeded", "our", "revenue,", "resulting", "in", "continuing", "losses", "and", "an", "accumulated", "deficit", "of", "$", "262", "million", "at", "December", "31,", "2017.", "<tag3>"], "wordsA": ["We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$4.3", "million", "at", "December", "31,", "2016."], "wordsB": ["Since", "our", "inception,", "our", "expenses", "have", "substantially", "exceeded", "our", "revenue,", "resulting", "in", "continuing", "losses", "and", "an", "accumulated", "deficit", "of", "$", "262", "million", "at", "December", "31,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.031323228031396866, 0.02168869599699974, 0.03944796696305275, 0.010574688203632832, 0.28668197989463806, 0.08621089160442352, 0.21401415765285492, 0.547930896282196, 0.10487204045057297, 0.31176528334617615, 0.006368942558765411, 0.006153770722448826, 0.040253642946481705, 0.20001563429832458, 0.006392281036823988, 0.006615715567022562, 0.05167794227600098, 0.22056537866592407, 0.008931887336075306, 0.09190123528242111, 0.5513603687286377, 0.23284482955932617, 0.0033688212279230356, 0.007094305008649826, 0.007740282919257879, 0.14504379034042358, -1]}
{"idB": "749647_18_item1_p67_s3", "idA": "749647_17_item1_p59_s3", "sentA": "We had cash, cash equivalents, short-term investments and interest receivable totaling $4.3 million at December 31, 2016.", "sentB": "We had cash, cash equivalents and short-term investments of $24.2 million and $13.5 million available for future sales under our ATM Facility at December 31, 2017.", "type": 2, "words": ["<tag1>", "We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$4.3", "million", "at", "December", "31,", "2016.", "<tag2>", "We", "had", "cash,", "cash", "equivalents", "and", "short-term", "investments", "of", "$24.2", "million", "and", "$13.5", "million", "available", "for", "future", "sales", "under", "our", "ATM", "Facility", "at", "December", "31,", "2017.", "<tag3>"], "wordsA": ["We", "had", "cash,", "cash", "equivalents,", "short-term", "investments", "and", "interest", "receivable", "totaling", "$4.3", "million", "at", "December", "31,", "2016."], "wordsB": ["We", "had", "cash,", "cash", "equivalents", "and", "short-term", "investments", "of", "$24.2", "million", "and", "$13.5", "million", "available", "for", "future", "sales", "under", "our", "ATM", "Facility", "at", "December", "31,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.004360365215688944, 0.003251166781410575, 0.007035133894532919, 0.004763525445014238, 0.004292624536901712, 0.0020784838125109673, 0.0054163858294487, 0.03082985430955887, 0.011600241996347904, 0.9013196229934692, 0.2881518602371216, 0.027134619653224945, 0.7980858087539673, 0.5268242359161377, 0.028955750167369843, 0.01511575747281313, 0.0738414078950882, 0.11568523198366165, 0.020627044141292572, 0.018021970987319946, 0.031032387167215347, 0.03720884025096893, 0.005022927187383175, 0.007322782184928656, 0.007189014460891485, 0.22431793808937073, -1]}
{"idB": "749647_18_item1_p234_s4", "idA": "749647_17_item1_p5_s0", "sentA": "We operate in a highly competitive, highly regulated and rapidly changing environment and our business is in a state of evolution.", "sentB": "Moreover, we operate in a competitive and rapidly changing environment.", "type": 2, "words": ["<tag1>", "We", "operate", "in", "a", "highly", "competitive,", "highly", "regulated", "and", "rapidly", "changing", "environment", "and", "our", "business", "is", "in", "a", "state", "of", "evolution.", "<tag2>", "Moreover,", "we", "operate", "in", "a", "competitive", "and", "rapidly", "changing", "environment.", "<tag3>"], "wordsA": ["We", "operate", "in", "a", "highly", "competitive,", "highly", "regulated", "and", "rapidly", "changing", "environment", "and", "our", "business", "is", "in", "a", "state", "of", "evolution."], "wordsB": ["Moreover,", "we", "operate", "in", "a", "competitive", "and", "rapidly", "changing", "environment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0360351987183094, 0.03808542340993881, 0.06068333610892296, 0.011551374569535255, 0.009930931963026524, 0.8085867166519165, 0.009878563694655895, 0.08502715826034546, 0.24918101727962494, 0.11981946974992752, -1]}
{"idB": "749647_18_item1_p234_s2", "idA": "749647_17_item1_p5_s2", "sentA": "It is not possible for management to predict all such risk factors or changes therein, or to assess either the impact of all such risk factors on our business or the extent to which any individual risk factor, combination of factors, or new or altered factors, may cause results to differ materially from those contained in any forward-looking statement.", "sentB": "You should understand that it is not possible to predict or identify all such factors.", "type": 2, "words": ["<tag1>", "It", "is", "not", "possible", "for", "management", "to", "predict", "all", "such", "risk", "factors", "or", "changes", "therein,", "or", "to", "assess", "either", "the", "impact", "of", "all", "such", "risk", "factors", "on", "our", "business", "or", "the", "extent", "to", "which", "any", "individual", "risk", "factor,", "combination", "of", "factors,", "or", "new", "or", "altered", "factors,", "may", "cause", "results", "to", "differ", "materially", "from", "those", "contained", "in", "any", "forward-looking", "statement.", "<tag2>", "You", "should", "understand", "that", "it", "is", "not", "possible", "to", "predict", "or", "identify", "all", "such", "factors.", "<tag3>"], "wordsA": ["It", "is", "not", "possible", "for", "management", "to", "predict", "all", "such", "risk", "factors", "or", "changes", "therein,", "or", "to", "assess", "either", "the", "impact", "of", "all", "such", "risk", "factors", "on", "our", "business", "or", "the", "extent", "to", "which", "any", "individual", "risk", "factor,", "combination", "of", "factors,", "or", "new", "or", "altered", "factors,", "may", "cause", "results", "to", "differ", "materially", "from", "those", "contained", "in", "any", "forward-looking", "statement."], "wordsB": ["You", "should", "understand", "that", "it", "is", "not", "possible", "to", "predict", "or", "identify", "all", "such", "factors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11534551531076431, 0.10750517249107361, 0.21153923869132996, 0.05038246512413025, 0.03412933647632599, 0.07110294699668884, 0.7806898951530457, 0.4580734372138977, 0.26072052121162415, 0.46662020683288574, 0.3226730227470398, 0.7204188704490662, 0.22545573115348816, 0.24783122539520264, 0.3362964987754822, -1]}
{"idB": "749647_18_item1_p68_s0", "idA": "749647_17_item1_p60_s0", "sentA": "In June 2012, Celsion and Zhejiand Hisun Pharmaceutical Co. Ltd ( Hisun ) signed a long-term commercial supply agreement for the production of ThermoDox .", "sentB": "In June 2012, Celsion and Zh eijang Hisun Pharmaceutical Co. Ltd ( Hisun ) signed a long-term commercial supply agreement for the production of ThermoDox .", "type": 2, "words": ["<tag1>", "In", "June", "2012,", "Celsion", "and", "Zhejiand", "Hisun", "Pharmaceutical", "Co.", "Ltd", "(", "Hisun", ")", "signed", "a", "long-term", "commercial", "supply", "agreement", "for", "the", "production", "of", "ThermoDox", ".", "<tag2>", "In", "June", "2012,", "Celsion", "and", "Zh", "eijang", "Hisun", "Pharmaceutical", "Co.", "Ltd", "(", "Hisun", ")", "signed", "a", "long-term", "commercial", "supply", "agreement", "for", "the", "production", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["In", "June", "2012,", "Celsion", "and", "Zhejiand", "Hisun", "Pharmaceutical", "Co.", "Ltd", "(", "Hisun", ")", "signed", "a", "long-term", "commercial", "supply", "agreement", "for", "the", "production", "of", "ThermoDox", "."], "wordsB": ["In", "June", "2012,", "Celsion", "and", "Zh", "eijang", "Hisun", "Pharmaceutical", "Co.", "Ltd", "(", "Hisun", ")", "signed", "a", "long-term", "commercial", "supply", "agreement", "for", "the", "production", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.002971081994473934, 0.0043188403360545635, 0.005810465198010206, 0.008308695629239082, 0.004977033939212561, 0.528503954410553, 0.9337130784988403, 0.0636972114443779, 0.02604260854423046, 0.013002878054976463, 0.007135690655559301, 0.0038948894944041967, 0.013718660920858383, 0.0001125497292377986, 0.005287389736622572, 0.0026326754596084356, 0.00417642155662179, 0.004474833142012358, 0.005310144275426865, 0.005955883301794529, 0.002581937937065959, 0.0025391995441168547, 0.0038864549715071917, 0.0027484882157295942, 0.006404100451618433, 9.775539365364239e-05, -1]}
{"idB": "749647_18_item1_p194_s0", "idA": "749647_17_item1_p60_s3", "sentA": "During 2015, Hisun successfully completed the manufacture of three registration batches for ThermoDox and has obtained regulatory approvals to supply ThermoDox to participating clinical trial sites in all of the countries of South East Asia, Europe and North America, as well as to the European Union countries allowing for early access to ThermoDox .", "sentB": "In the EU, before starting a clinical trial, a valid request for authorization must be submitted by the sponsor to the competent authority of the EU Member State(s) in which the sponsor plans to conduct the clinical trial, as well as to an independent national Ethics Committee.", "type": 2, "words": ["<tag1>", "During", "2015,", "Hisun", "successfully", "completed", "the", "manufacture", "of", "three", "registration", "batches", "for", "ThermoDox", "and", "has", "obtained", "regulatory", "approvals", "to", "supply", "ThermoDox", "to", "participating", "clinical", "trial", "sites", "in", "all", "of", "the", "countries", "of", "South", "East", "Asia,", "Europe", "and", "North", "America,", "as", "well", "as", "to", "the", "European", "Union", "countries", "allowing", "for", "early", "access", "to", "ThermoDox", ".", "<tag2>", "In", "the", "EU,", "before", "starting", "a", "clinical", "trial,", "a", "valid", "request", "for", "authorization", "must", "be", "submitted", "by", "the", "sponsor", "to", "the", "competent", "authority", "of", "the", "EU", "Member", "State(s)", "in", "which", "the", "sponsor", "plans", "to", "conduct", "the", "clinical", "trial,", "as", "well", "as", "to", "an", "independent", "national", "Ethics", "Committee.", "<tag3>"], "wordsA": ["During", "2015,", "Hisun", "successfully", "completed", "the", "manufacture", "of", "three", "registration", "batches", "for", "ThermoDox", "and", "has", "obtained", "regulatory", "approvals", "to", "supply", "ThermoDox", "to", "participating", "clinical", "trial", "sites", "in", "all", "of", "the", "countries", "of", "South", "East", "Asia,", "Europe", "and", "North", "America,", "as", "well", "as", "to", "the", "European", "Union", "countries", "allowing", "for", "early", "access", "to", "ThermoDox", "."], "wordsB": ["In", "the", "EU,", "before", "starting", "a", "clinical", "trial,", "a", "valid", "request", "for", "authorization", "must", "be", "submitted", "by", "the", "sponsor", "to", "the", "competent", "authority", "of", "the", "EU", "Member", "State(s)", "in", "which", "the", "sponsor", "plans", "to", "conduct", "the", "clinical", "trial,", "as", "well", "as", "to", "an", "independent", "national", "Ethics", "Committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02648964338004589, 0.020745065063238144, 0.1360754817724228, 0.1358490288257599, 0.2579526901245117, 0.1372068077325821, 0.1750487983226776, 0.2195304036140442, 0.015643810853362083, 0.257813960313797, 0.4008941948413849, 0.1559392362833023, 0.24012044072151184, 0.05372045561671257, 0.035447973757982254, 0.09126679599285126, 0.026329390704631805, 0.02361813373863697, 0.08454354107379913, 0.017602765932679176, 0.015714207664132118, 0.04920937493443489, 0.07687810808420181, 0.014288902282714844, 0.01143905334174633, 0.046908095479011536, 0.04213636741042137, 0.0641518086194992, 0.008214594796299934, 0.006992684211581945, 0.00736107537522912, 0.0541093610227108, 0.07883655279874802, 0.05124522000551224, 0.07467412948608398, 0.027703067287802696, 0.07106069475412369, 0.08144298940896988, 0.0007752476958557963, 0.006865731440484524, 0.008351503871381283, 0.018771225586533546, 0.017059383913874626, 0.12769143283367157, 0.1909688264131546, 0.3442574143409729, 0.2907172441482544, -1]}
{"idB": "749647_18_item1_p297_s1", "idA": "749647_17_item1_p64_s0", "sentA": "Hisun will collaborate with Celsion around the regulatory approval activities for GEN-1 with the CFDA.", "sentB": "Pre-clinical testing and clinical trial requirements and the regulatory approval process typically take years and require the expenditure of substantial resources.", "type": 2, "words": ["<tag1>", "Hisun", "will", "collaborate", "with", "Celsion", "around", "the", "regulatory", "approval", "activities", "for", "GEN-1", "with", "the", "CFDA.", "<tag2>", "Pre-clinical", "testing", "and", "clinical", "trial", "requirements", "and", "the", "regulatory", "approval", "process", "typically", "take", "years", "and", "require", "the", "expenditure", "of", "substantial", "resources.", "<tag3>"], "wordsA": ["Hisun", "will", "collaborate", "with", "Celsion", "around", "the", "regulatory", "approval", "activities", "for", "GEN-1", "with", "the", "CFDA."], "wordsB": ["Pre-clinical", "testing", "and", "clinical", "trial", "requirements", "and", "the", "regulatory", "approval", "process", "typically", "take", "years", "and", "require", "the", "expenditure", "of", "substantial", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.5903694033622742, 0.3901827335357666, 0.020510029047727585, 0.2073560506105423, 0.16629621386528015, 0.08218921720981598, 0.005334378220140934, 0.006705581210553646, 0.03185584768652916, 0.035488128662109375, 0.023286109790205956, 0.012785601429641247, 0.016709065064787865, 0.042591243982315063, 7.641641423106194e-05, 0.023612918332219124, 0.00037985050585120916, 0.05679231137037277, 0.01846739463508129, 0.044688932597637177, 0.06464017927646637, -1]}
{"idB": "749647_18_item1_p73_s0", "idA": "749647_17_item1_p65_s0", "sentA": "As a result of the risks and uncertainties discussed in this Annual Report on Form 10-K, among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product.", "sentB": "Because of the risks and uncertainties discussed in this Annual Report on Form 10-K, among others, we are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product.", "<tag2>", "Because", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product."], "wordsB": ["Because", "of", "the", "risks", "and", "uncertainties", "discussed", "in", "this", "Annual", "Report", "on", "Form", "10-K,", "among", "others,", "we", "are", "unable", "to", "estimate", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects", "or", "when,", "if", "ever,", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "a", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.341687947511673, 0.07701302319765091, 0.03153063729405403, 0.04696979746222496, 0.02245636284351349, 0.03837285190820694, 0.012692340649664402, 0.01086683850735426, 0.009973245672881603, 0.01619016006588936, 0.014415866695344448, 0.011245005764067173, 0.01669781096279621, 0.022892378270626068, 0.017858954146504402, 0.012381031177937984, 0.03398943692445755, 0.14804194867610931, 0.9212696552276611, 0.5864620804786682, 0.3875860273838043, 0.030700432136654854, 0.06949937343597412, 0.018124490976333618, 0.03881828486919403, 0.030155442655086517, 0.0101346829906106, 0.009535645134747028, 0.016780273988842964, 0.015072189271450043, 0.015836790204048157, 0.014833969064056873, 0.015066414140164852, 0.01463053934276104, 0.020253214985132217, 0.023081397637724876, 0.012107559479773045, 0.019047029316425323, 0.028959153220057487, 0.02462594024837017, 0.019918201491236687, 0.015161107294261456, 0.06812167912721634, 0.033940304070711136, 0.05697779729962349, 0.009725057519972324, 0.013487156480550766, 0.025125084444880486, 0.013095696456730366, 0.016745779663324356, 0.012977690435945988, 0.01115275640040636, 0.025886720046401024, -1]}
{"idB": "749647_18_item1_p324_s1", "idA": "749647_17_item1_p65_s3", "sentA": "We do not know whether we will be able to access additional capital when needed or on terms favorable to us or our stockholders.", "sentB": "If we are unable to create sales, marketing and distribution capabilities or enter into alliances with others possessing such capabilities to perform these functions, we will not be able to commercialize our products successfully.", "type": 2, "words": ["<tag1>", "We", "do", "not", "know", "whether", "we", "will", "be", "able", "to", "access", "additional", "capital", "when", "needed", "or", "on", "terms", "favorable", "to", "us", "or", "our", "stockholders.", "<tag2>", "If", "we", "are", "unable", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "enter", "into", "alliances", "with", "others", "possessing", "such", "capabilities", "to", "perform", "these", "functions,", "we", "will", "not", "be", "able", "to", "commercialize", "our", "products", "successfully.", "<tag3>"], "wordsA": ["We", "do", "not", "know", "whether", "we", "will", "be", "able", "to", "access", "additional", "capital", "when", "needed", "or", "on", "terms", "favorable", "to", "us", "or", "our", "stockholders."], "wordsB": ["If", "we", "are", "unable", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "enter", "into", "alliances", "with", "others", "possessing", "such", "capabilities", "to", "perform", "these", "functions,", "we", "will", "not", "be", "able", "to", "commercialize", "our", "products", "successfully."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.03492259234189987, 0.04987545311450958, 0.02583153173327446, 0.2610165774822235, 0.10913931578397751, 0.2126903384923935, 0.34744811058044434, 0.22769242525100708, 0.10163506120443344, 0.26366135478019714, 0.3900749981403351, 0.006826217286288738, 0.0679658055305481, 0.06043344363570213, 0.12150547653436661, 0.015362975187599659, 0.023229116573929787, 0.01716824248433113, 0.01238927897065878, 0.02211526781320572, 0.006773024797439575, 0.009719972498714924, 0.007046228740364313, 0.01555864978581667, 0.01893104426562786, 0.026820413768291473, 0.1813560426235199, 0.04269593581557274, 0.10375216603279114, 0.07525128871202469, 0.3004581034183502, 0.08313597738742828, 0.13104720413684845, 0.15912872552871704, -1]}
{"idB": "749647_18_item1_p306_s1", "idA": "749647_17_item1_p65_s4", "sentA": "Our inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.", "sentB": "As part of our business strategy, we may seek Orphan Drug Designation for other product candidates, but we may be unsuccessful.", "type": 2, "words": ["<tag1>", "Our", "inability", "to", "raise", "additional", "capital,", "or", "to", "do", "so", "on", "terms", "reasonably", "acceptable", "to", "us,", "would", "jeopardize", "the", "future", "success", "of", "our", "business.", "<tag2>", "As", "part", "of", "our", "business", "strategy,", "we", "may", "seek", "Orphan", "Drug", "Designation", "for", "other", "product", "candidates,", "but", "we", "may", "be", "unsuccessful.", "<tag3>"], "wordsA": ["Our", "inability", "to", "raise", "additional", "capital,", "or", "to", "do", "so", "on", "terms", "reasonably", "acceptable", "to", "us,", "would", "jeopardize", "the", "future", "success", "of", "our", "business."], "wordsB": ["As", "part", "of", "our", "business", "strategy,", "we", "may", "seek", "Orphan", "Drug", "Designation", "for", "other", "product", "candidates,", "but", "we", "may", "be", "unsuccessful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.006731661967933178, 0.0076154605485498905, 0.006564538460224867, 0.007563362363725901, 0.0728289932012558, 0.042349785566329956, 0.0261392742395401, 0.059070371091365814, 0.38840073347091675, 0.4599491059780121, 0.4875393509864807, 0.5328400731086731, 0.016776932403445244, 0.017775878310203552, 0.043578751385211945, 0.07266128063201904, 0.00355142867192626, 0.01314969826489687, 0.03607015311717987, 0.044388409703969955, 0.22629472613334656, -1]}
{"idB": "749647_18_item1_p192_s1", "idA": "749647_17_item1_p66_s0", "sentA": "As a clinical stage biopharmaceutical company, our business and our ability to execute our strategy to achieve our corporate goals are subject to numerous risks and uncertainties.", "sentB": "In addition to new legislation, FDA regulations and policies are often revised or interpreted by the agency in ways that may significantly affect our business and our products.", "type": 2, "words": ["<tag1>", "As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties.", "<tag2>", "In", "addition", "to", "new", "legislation,", "FDA", "regulations", "and", "policies", "are", "often", "revised", "or", "interpreted", "by", "the", "agency", "in", "ways", "that", "may", "significantly", "affect", "our", "business", "and", "our", "products.", "<tag3>"], "wordsA": ["As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties."], "wordsB": ["In", "addition", "to", "new", "legislation,", "FDA", "regulations", "and", "policies", "are", "often", "revised", "or", "interpreted", "by", "the", "agency", "in", "ways", "that", "may", "significantly", "affect", "our", "business", "and", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.014028258621692657, 0.01361207477748394, 0.010230335406959057, 0.06418131291866302, 0.2920142412185669, 0.2857087552547455, 0.24876832962036133, 0.03494109958410263, 0.18957708775997162, 0.015969114378094673, 0.02777675911784172, 0.1510825902223587, 0.03225088119506836, 0.10099375993013382, 0.016890129074454308, 0.014983300119638443, 0.10070471465587616, 0.000312214920995757, 0.015134737826883793, 0.00037510888068936765, 0.011640018783509731, 0.01971844956278801, 0.1518240123987198, 0.020426567643880844, 0.11310109496116638, 0.02315237559378147, 0.0242123082280159, 0.0869581550359726, -1]}
{"idB": "749647_18_item1_p297_s3", "idA": "749647_17_item1_p66_s0", "sentA": "As a clinical stage biopharmaceutical company, our business and our ability to execute our strategy to achieve our corporate goals are subject to numerous risks and uncertainties.", "sentB": "Delays or rejections in obtaining regulatory approvals would adversely affect our ability to commercialize any product candidates and our ability to generate product revenue or royalties.", "type": 2, "words": ["<tag1>", "As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties.", "<tag2>", "Delays", "or", "rejections", "in", "obtaining", "regulatory", "approvals", "would", "adversely", "affect", "our", "ability", "to", "commercialize", "any", "product", "candidates", "and", "our", "ability", "to", "generate", "product", "revenue", "or", "royalties.", "<tag3>"], "wordsA": ["As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties."], "wordsB": ["Delays", "or", "rejections", "in", "obtaining", "regulatory", "approvals", "would", "adversely", "affect", "our", "ability", "to", "commercialize", "any", "product", "candidates", "and", "our", "ability", "to", "generate", "product", "revenue", "or", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.22772341966629028, 0.14857932925224304, 0.4868311285972595, 0.018402425572276115, 0.11218950152397156, 0.24527767300605774, 0.24123619496822357, 0.007513990625739098, 0.024476580321788788, 0.05580049753189087, 0.017888419330120087, 0.05529283732175827, 0.033868208527565, 0.17951804399490356, 0.025536607950925827, 0.13727927207946777, 0.1177423745393753, 0.001330584054812789, 0.009093132801353931, 0.010340881533920765, 0.004768813494592905, 0.03882194682955742, 0.042401272803545, 0.05493008717894554, 0.03495268523693085, 0.10011617839336395, -1]}
{"idB": "749647_18_item1_p354_s0", "idA": "749647_17_item1_p66_s0", "sentA": "As a clinical stage biopharmaceutical company, our business and our ability to execute our strategy to achieve our corporate goals are subject to numerous risks and uncertainties.", "sentB": "Our ability to use net operating losses to offset future taxable income are subject to certain limitations.", "type": 2, "words": ["<tag1>", "As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties.", "<tag2>", "Our", "ability", "to", "use", "net", "operating", "losses", "to", "offset", "future", "taxable", "income", "are", "subject", "to", "certain", "limitations.", "<tag3>"], "wordsA": ["As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties."], "wordsB": ["Our", "ability", "to", "use", "net", "operating", "losses", "to", "offset", "future", "taxable", "income", "are", "subject", "to", "certain", "limitations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.021238574758172035, 0.07330832630395889, 0.02580595389008522, 0.10348624736070633, 0.4590250849723816, 0.696884274482727, 0.7861586213111877, 0.008467181585729122, 0.053898897022008896, 0.02753048948943615, 0.0833641067147255, 0.13651050627231598, 0.00014963636931497604, 0.02788762003183365, 0.009317012503743172, 0.08114366978406906, 0.19755145907402039, -1]}
{"idB": "749647_18_item1_p74_s1", "idA": "749647_17_item1_p66_s1", "sentA": "Material risks and uncertainties relating to our business and our industry are described in \" Part I, Item 1A. Risk Factors \" in this Annual Report on Form 10-K.", "sentB": "Material risks and uncertainties relating to our business and our industry are described in Part I, Item 1A. Risk Factors in this Annual Report on Form 10-K.", "type": 2, "words": ["<tag1>", "Material", "risks", "and", "uncertainties", "relating", "to", "our", "business", "and", "our", "industry", "are", "described", "in", "\"", "Part", "I,", "Item", "1A.", "Risk", "Factors", "\"", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag2>", "Material", "risks", "and", "uncertainties", "relating", "to", "our", "business", "and", "our", "industry", "are", "described", "in", "Part", "I,", "Item", "1A.", "Risk", "Factors", "in", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag3>"], "wordsA": ["Material", "risks", "and", "uncertainties", "relating", "to", "our", "business", "and", "our", "industry", "are", "described", "in", "\"", "Part", "I,", "Item", "1A.", "Risk", "Factors", "\"", "in", "this", "Annual", "Report", "on", "Form", "10-K."], "wordsB": ["Material", "risks", "and", "uncertainties", "relating", "to", "our", "business", "and", "our", "industry", "are", "described", "in", "Part", "I,", "Item", "1A.", "Risk", "Factors", "in", "this", "Annual", "Report", "on", "Form", "10-K."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.21084176003932953, 0.1884901076555252, 0.059791449457407, 0.2190549671649933, 0.12414976954460144, 0.0694860890507698, 0.13003675639629364, 0.15580280125141144, 0.062353670597076416, 0.05922970175743103, 0.12669514119625092, 0.03116723522543907, 0.07790346443653107, 0.05542520061135292, 0.17704913020133972, 0.3863997757434845, 0.16761058568954468, 0.48305022716522217, 0.20789340138435364, 0.25109580159187317, 0.02287929691374302, 0.023961171507835388, 0.05418827012181282, 0.07430686056613922, 0.03359594568610191, 0.14084215462207794, 0.45884382724761963, -1]}
{"idB": "749647_18_item1_p258_s1", "idA": "749647_17_item1_p6_s0", "sentA": "Except as required by law, we assume no obligation to revise or update any forward-looking statement that may be made from time to time by us or on our behalf for any reason, even if new information becomes available in the future.", "sentB": "Regulatory requirements governing gene and cell therapy products have changed frequently and may continue to change in the future.", "type": 2, "words": ["<tag1>", "Except", "as", "required", "by", "law,", "we", "assume", "no", "obligation", "to", "revise", "or", "update", "any", "forward-looking", "statement", "that", "may", "be", "made", "from", "time", "to", "time", "by", "us", "or", "on", "our", "behalf", "for", "any", "reason,", "even", "if", "new", "information", "becomes", "available", "in", "the", "future.", "<tag2>", "Regulatory", "requirements", "governing", "gene", "and", "cell", "therapy", "products", "have", "changed", "frequently", "and", "may", "continue", "to", "change", "in", "the", "future.", "<tag3>"], "wordsA": ["Except", "as", "required", "by", "law,", "we", "assume", "no", "obligation", "to", "revise", "or", "update", "any", "forward-looking", "statement", "that", "may", "be", "made", "from", "time", "to", "time", "by", "us", "or", "on", "our", "behalf", "for", "any", "reason,", "even", "if", "new", "information", "becomes", "available", "in", "the", "future."], "wordsB": ["Regulatory", "requirements", "governing", "gene", "and", "cell", "therapy", "products", "have", "changed", "frequently", "and", "may", "continue", "to", "change", "in", "the", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.41223520040512085, 0.38417285680770874, 0.11022178828716278, 0.2679412364959717, 0.20580530166625977, 0.3261072635650635, 0.2778669595718384, 0.14160265028476715, 0.0376238077878952, 0.13836908340454102, 0.06451855599880219, 0.00796689186245203, 0.008754718117415905, 0.03508942946791649, 0.05091509595513344, 0.12976746261119843, 0.017030559480190277, 0.01211814396083355, 0.03532519191503525, -1]}
{"idB": "749647_18_item1_p358_s1", "idA": "749647_17_item1_p6_s0", "sentA": "Except as required by law, we assume no obligation to revise or update any forward-looking statement that may be made from time to time by us or on our behalf for any reason, even if new information becomes available in the future.", "sentB": "We do not anticipate paying any cash dividends on our common stock in the foreseeable future.", "type": 2, "words": ["<tag1>", "Except", "as", "required", "by", "law,", "we", "assume", "no", "obligation", "to", "revise", "or", "update", "any", "forward-looking", "statement", "that", "may", "be", "made", "from", "time", "to", "time", "by", "us", "or", "on", "our", "behalf", "for", "any", "reason,", "even", "if", "new", "information", "becomes", "available", "in", "the", "future.", "<tag2>", "We", "do", "not", "anticipate", "paying", "any", "cash", "dividends", "on", "our", "common", "stock", "in", "the", "foreseeable", "future.", "<tag3>"], "wordsA": ["Except", "as", "required", "by", "law,", "we", "assume", "no", "obligation", "to", "revise", "or", "update", "any", "forward-looking", "statement", "that", "may", "be", "made", "from", "time", "to", "time", "by", "us", "or", "on", "our", "behalf", "for", "any", "reason,", "even", "if", "new", "information", "becomes", "available", "in", "the", "future."], "wordsB": ["We", "do", "not", "anticipate", "paying", "any", "cash", "dividends", "on", "our", "common", "stock", "in", "the", "foreseeable", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 1, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08401580899953842, 0.325110524892807, 0.5779600143432617, 0.6838952898979187, 0.5356607437133789, 0.2864299416542053, 0.45970094203948975, 0.505427896976471, 0.1039053350687027, 0.06056995689868927, 0.19072285294532776, 0.24683216214179993, 0.02446359023451805, 0.02059163711965084, 0.04569175839424133, 0.06373760104179382, -1]}
{"idB": "749647_18_item1_p78_s0", "idA": "749647_17_item1_p70_s0", "sentA": "We are using several available focused-heat technologies, such as radio frequency ablation (RFA), microwave energy and high intensity focused ultrasound (HIFU), to activate the release of drugs from our novel heat sensitive liposomes.", "sentB": "We are using several available focused-heat technologies, such as RFA, microwave energy and high intensity focused ultrasound (HIFU), to activate the release of drugs from our novel heat sensitive liposomes.", "type": 2, "words": ["<tag1>", "We", "are", "using", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(RFA),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat", "sensitive", "liposomes.", "<tag2>", "We", "are", "using", "several", "available", "focused-heat", "technologies,", "such", "as", "RFA,", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat", "sensitive", "liposomes.", "<tag3>"], "wordsA": ["We", "are", "using", "several", "available", "focused-heat", "technologies,", "such", "as", "radio", "frequency", "ablation", "(RFA),", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat", "sensitive", "liposomes."], "wordsB": ["We", "are", "using", "several", "available", "focused-heat", "technologies,", "such", "as", "RFA,", "microwave", "energy", "and", "high", "intensity", "focused", "ultrasound", "(HIFU),", "to", "activate", "the", "release", "of", "drugs", "from", "our", "novel", "heat", "sensitive", "liposomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.08028899878263474, 0.027714405208826065, 0.08384762704372406, 0.10055813938379288, 0.13107623159885406, 0.20324555039405823, 0.07812879979610443, 0.03395708650350571, 0.02897069603204727, 0.2094520628452301, 0.10109614580869675, 0.1046505942940712, 0.016522148624062538, 0.2939503490924835, 0.6026673316955566, 0.07954908907413483, 0.05445931851863861, 0.17382006347179413, 0.02770145609974861, 0.05302682891488075, 0.020275747403502464, 0.12601272761821747, 0.042995717376470566, 0.18583469092845917, 0.02952664904296398, 0.023954804986715317, 0.0518670454621315, 0.06592138111591339, 0.06326956301927567, 0.06466108560562134, -1]}
{"idB": "749647_18_item1_p32_s1", "idA": "749647_17_item1_p71_s0", "sentA": "Primary liver cancer (hepatocellular carcinoma or HCC) is one of the most common and deadliest forms of cancer worldwide.", "sentB": "The article reports on one of the largest controlled studies in hepatocellular carcinoma.", "type": 2, "words": ["<tag1>", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag2>", "The", "article", "reports", "on", "one", "of", "the", "largest", "controlled", "studies", "in", "hepatocellular", "carcinoma.", "<tag3>"], "wordsA": ["Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "wordsB": ["The", "article", "reports", "on", "one", "of", "the", "largest", "controlled", "studies", "in", "hepatocellular", "carcinoma."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.01619836501777172, 0.09061215072870255, 0.05164020135998726, 0.03263389691710472, 0.0364726297557354, 0.03272907808423042, 0.03764215111732483, 0.2154400795698166, 0.6368840932846069, 0.6459901332855225, 0.1387036144733429, 0.23278692364692688, 0.1417793333530426, -1]}
{"idB": "749647_18_item1_p79_s0", "idA": "749647_17_item1_p71_s0", "sentA": "Primary liver cancer (hepatocellular carcinoma or HCC) is one of the most common and deadliest forms of cancer worldwide.", "sentB": "HCC is one of the most common and deadliest forms of cancer worldwide.", "type": 2, "words": ["<tag1>", "Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag2>", "HCC", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide.", "<tag3>"], "wordsA": ["Primary", "liver", "cancer", "(hepatocellular", "carcinoma", "or", "HCC)", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "wordsB": ["HCC", "is", "one", "of", "the", "most", "common", "and", "deadliest", "forms", "of", "cancer", "worldwide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.9899988770484924, 0.024639660492539406, 0.008437233045697212, 0.006076413206756115, 0.0057202656753361225, 0.006374878343194723, 0.01646680012345314, 0.0027357046492397785, 0.032457441091537476, 0.061296939849853516, 0.018257079645991325, 0.06716672331094742, 0.009738564491271973, -1]}
{"idB": "749647_18_item1_p86_s1", "idA": "749647_17_item1_p78_s1", "sentA": "The study was carried out at the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) and Queen Mary Hospital in Hong Kong.", "sentB": "The study was carried out at the National Cancer Institute (NCI), which is part of the NIH and Queen Mary Hospital in Hong Kong.", "type": 2, "words": ["<tag1>", "The", "study", "was", "carried", "out", "at", "the", "National", "Cancer", "Institute", "(NCI),", "which", "is", "part", "of", "the", "National", "Institutes", "of", "Health", "(NIH)", "and", "Queen", "Mary", "Hospital", "in", "Hong", "Kong.", "<tag2>", "The", "study", "was", "carried", "out", "at", "the", "National", "Cancer", "Institute", "(NCI),", "which", "is", "part", "of", "the", "NIH", "and", "Queen", "Mary", "Hospital", "in", "Hong", "Kong.", "<tag3>"], "wordsA": ["The", "study", "was", "carried", "out", "at", "the", "National", "Cancer", "Institute", "(NCI),", "which", "is", "part", "of", "the", "National", "Institutes", "of", "Health", "(NIH)", "and", "Queen", "Mary", "Hospital", "in", "Hong", "Kong."], "wordsB": ["The", "study", "was", "carried", "out", "at", "the", "National", "Cancer", "Institute", "(NCI),", "which", "is", "part", "of", "the", "NIH", "and", "Queen", "Mary", "Hospital", "in", "Hong", "Kong."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.031048651784658432, 0.42769426107406616, 0.07982363551855087, 0.23582234978675842, 0.17530976235866547, 0.11504308879375458, 0.05388150364160538, 0.27102258801460266, 0.44594043493270874, 0.3458137810230255, 0.4060305953025818, 0.0014295874862000346, 0.05102890729904175, 0.13869981467723846, 0.07064517587423325, 0.04474466294050217, 0.4784742593765259, 0.14748570322990417, 0.22415517270565033, 0.2569669187068939, 0.36068639159202576, 0.07220111042261124, 0.11989358812570572, 0.1722428798675537, -1]}
{"idB": "749647_18_item1_p7_s0", "idA": "749647_17_item1_p7_s0", "sentA": "The Celsion Corporation ( Celsion or the Company ) brand and product names, including but not limited to Celsion , and ThermoDox contained in this document are trademarks, registered trademarks or service marks of Celsion Corporation or its subsidiary in the United States (U.S.) and certain other countries.", "sentB": "The Celsion brand and product names, including but not limited to Celsion , and ThermoDox contained in this document are trademarks, registered trademarks or service marks of Celsion Corporation or its subsidiary in the United States (U.S.) and certain other countries.", "type": 2, "words": ["<tag1>", "The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "and", "ThermoDox", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries.", "<tag2>", "The", "Celsion", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "and", "ThermoDox", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries.", "<tag3>"], "wordsA": ["The", "Celsion", "Corporation", "(", "Celsion", "or", "the", "Company", ")", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "and", "ThermoDox", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries."], "wordsB": ["The", "Celsion", "brand", "and", "product", "names,", "including", "but", "not", "limited", "to", "Celsion", ",", "and", "ThermoDox", "contained", "in", "this", "document", "are", "trademarks,", "registered", "trademarks", "or", "service", "marks", "of", "Celsion", "Corporation", "or", "its", "subsidiary", "in", "the", "United", "States", "(U.S.)", "and", "certain", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02859954535961151, 0.44785892963409424, 0.22338256239891052, 0.06742583215236664, 0.11015808582305908, 0.13580770790576935, 0.11025997996330261, 0.10058337450027466, 0.31896522641181946, 0.42480459809303284, 0.135624498128891, 0.2174629420042038, 0.00027964598848484457, 0.033768512308597565, 0.21331168711185455, 0.06887111812829971, 0.049049261957407, 0.051148999482393265, 0.10657857358455658, 0.050702497363090515, 0.3270252048969269, 0.12934410572052002, 0.1940940022468567, 0.03971153125166893, 0.09453307837247849, 0.10204999148845673, 0.03804798796772957, 0.11398246139287949, 0.11853716522455215, 0.06806222349405289, 0.0840192511677742, 0.13196304440498352, 0.04982353746891022, 0.04582700505852699, 0.10012851655483246, 0.09815489500761032, 0.13335198163986206, 0.03314796835184097, 0.04797149449586868, 0.04131285846233368, 0.09183669090270996, -1]}
{"idB": "749647_18_item1_p186_s5", "idA": "749647_17_item1_p80_s1", "sentA": "The Special Protocol Assessment (SPA) agreed to with the FDA specified PFS as the HEAT Study s primary endpoint.", "sentB": "Complexities associated with the larger, and often more complex, structures of biological products, as well as the process by which such products are manufactured, pose significant hurdles to implementation, which is still being evaluated by the FDA.", "type": 2, "words": ["<tag1>", "The", "Special", "Protocol", "Assessment", "(SPA)", "agreed", "to", "with", "the", "FDA", "specified", "PFS", "as", "the", "HEAT", "Study", "s", "primary", "endpoint.", "<tag2>", "Complexities", "associated", "with", "the", "larger,", "and", "often", "more", "complex,", "structures", "of", "biological", "products,", "as", "well", "as", "the", "process", "by", "which", "such", "products", "are", "manufactured,", "pose", "significant", "hurdles", "to", "implementation,", "which", "is", "still", "being", "evaluated", "by", "the", "FDA.", "<tag3>"], "wordsA": ["The", "Special", "Protocol", "Assessment", "(SPA)", "agreed", "to", "with", "the", "FDA", "specified", "PFS", "as", "the", "HEAT", "Study", "s", "primary", "endpoint."], "wordsB": ["Complexities", "associated", "with", "the", "larger,", "and", "often", "more", "complex,", "structures", "of", "biological", "products,", "as", "well", "as", "the", "process", "by", "which", "such", "products", "are", "manufactured,", "pose", "significant", "hurdles", "to", "implementation,", "which", "is", "still", "being", "evaluated", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.171900674700737, 0.014158821664750576, 0.010937425307929516, 0.009111548773944378, 0.03629128262400627, 0.0020571514032781124, 0.006165598519146442, 0.021581338718533516, 0.0641019269824028, 0.07223005592823029, 0.014499396085739136, 0.22544066607952118, 0.17051805555820465, 0.011860555969178677, 0.006544803269207478, 0.007034900598227978, 0.0059973387978971004, 0.027551962062716484, 0.007793696131557226, 0.004243216942995787, 0.016040567308664322, 0.0711284652352333, 0.020974332466721535, 0.032347626984119415, 0.020808491855859756, 0.02578197792172432, 0.07454267889261246, 0.0308049488812685, 0.052541181445121765, 0.00905943289399147, 0.006167048122733831, 0.005500731989741325, 0.008015857078135014, 0.03577062115073204, 0.010262714698910713, 0.008871225640177727, 0.06454379111528397, -1]}
{"idB": "749647_18_item1_p240_s0", "idA": "749647_17_item1_p80_s3", "sentA": "Following review by the iDMC, on January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the HEAT Study s primary endpoint of PFS.", "sentB": "Preclinical testing and clinical trials are long, expensive and highly uncertain processes and failure can unexpectedly occur at any stage of clinical development, as evidenced by the failure of ThermoDox to meet its primary endpoint in the HEAT study.", "type": 2, "words": ["<tag1>", "Following", "review", "by", "the", "iDMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "HEAT", "Study", "s", "primary", "endpoint", "of", "PFS.", "<tag2>", "Preclinical", "testing", "and", "clinical", "trials", "are", "long,", "expensive", "and", "highly", "uncertain", "processes", "and", "failure", "can", "unexpectedly", "occur", "at", "any", "stage", "of", "clinical", "development,", "as", "evidenced", "by", "the", "failure", "of", "ThermoDox", "to", "meet", "its", "primary", "endpoint", "in", "the", "HEAT", "study.", "<tag3>"], "wordsA": ["Following", "review", "by", "the", "iDMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "HEAT", "Study", "s", "primary", "endpoint", "of", "PFS."], "wordsB": ["Preclinical", "testing", "and", "clinical", "trials", "are", "long,", "expensive", "and", "highly", "uncertain", "processes", "and", "failure", "can", "unexpectedly", "occur", "at", "any", "stage", "of", "clinical", "development,", "as", "evidenced", "by", "the", "failure", "of", "ThermoDox", "to", "meet", "its", "primary", "endpoint", "in", "the", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.2827947735786438, 0.2825658619403839, 0.00970753189176321, 0.11648233234882355, 0.12678706645965576, 0.010536461137235165, 0.029112230986356735, 0.03616780787706375, 0.000298575236229226, 0.027777409180998802, 0.08473795652389526, 0.04244908317923546, 0.006024444010108709, 0.12368506193161011, 0.008405848406255245, 0.018678074702620506, 0.029473958536982536, 0.009889730252325535, 0.029678354039788246, 0.02516908384859562, 0.015167123638093472, 0.02997175045311451, 0.03100503608584404, 0.000158516617375426, 0.010948200710117817, 0.0057544466108083725, 0.009242705069482327, 0.4408646523952484, 0.05381795018911362, 0.14233528077602386, 0.1557808816432953, 0.10847967118024826, 0.03318341076374054, 0.07433580607175827, 0.07293228060007095, 0.00892593339085579, 0.006942969746887684, 0.038594115525484085, 0.03442518040537834, -1]}
{"idB": "749647_18_item1_p339_s1", "idA": "749647_17_item1_p80_s4", "sentA": "Specifically, we determined, after conferring with the iDMC, that the HEAT Study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT Study.", "sentB": "Our January 31, 2013 announcement that the HEAT Study failed to meet its primary endpoint has resulted in significant volatility and a steep decline in the price of our common stock, a level of decline that could result in securities litigation.", "type": 2, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "iDMC,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "Study.", "<tag2>", "Our", "January", "31,", "2013", "announcement", "that", "the", "HEAT", "Study", "failed", "to", "meet", "its", "primary", "endpoint", "has", "resulted", "in", "significant", "volatility", "and", "a", "steep", "decline", "in", "the", "price", "of", "our", "common", "stock,", "a", "level", "of", "decline", "that", "could", "result", "in", "securities", "litigation.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "iDMC,", "that", "the", "HEAT", "Study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "Study."], "wordsB": ["Our", "January", "31,", "2013", "announcement", "that", "the", "HEAT", "Study", "failed", "to", "meet", "its", "primary", "endpoint", "has", "resulted", "in", "significant", "volatility", "and", "a", "steep", "decline", "in", "the", "price", "of", "our", "common", "stock,", "a", "level", "of", "decline", "that", "could", "result", "in", "securities", "litigation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.017073480412364006, 0.03230610489845276, 0.04224105924367905, 0.1003938838839531, 0.11701896786689758, 0.03003229759633541, 0.013387405313551426, 0.07516561448574066, 0.15051302313804626, 0.5833899974822998, 0.45375359058380127, 0.2861803472042084, 0.08508460968732834, 0.15052807331085205, 0.16905219852924347, 0.008396025747060776, 0.03741718828678131, 0.02869502082467079, 0.14224660396575928, 0.35798346996307373, 0.015696575865149498, 0.025251027196645737, 0.19998380541801453, 0.36305686831474304, 0.07994088530540466, 0.059546757489442825, 0.15094217658042908, 0.08360937237739563, 0.05072404816746712, 0.16439658403396606, 0.1791362464427948, 0.0001992925681406632, 0.034424230456352234, 0.00031475949799641967, 0.17287248373031616, 0.0001808191736927256, 0.006131983827799559, 0.009798060171306133, 0.013109483756124973, 0.07856243848800659, 0.13675490021705627, -1]}
{"idB": "749647_18_item1_p267_s2", "idA": "749647_17_item1_p82_s0", "sentA": "As provided for in the SPA, we continued to follow patients enrolled in the HEAT Study to the secondary endpoint of Overall Survival (OS).", "sentB": "Following our announcement on January 31, 2013 that the HEAT Study failed to meet its primary endpoint of progression free survival, we continued to follow the patients enrolled in the HEAT Study to the secondary endpoint, overall survival.", "type": 2, "words": ["<tag1>", "As", "provided", "for", "in", "the", "SPA,", "we", "continued", "to", "follow", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "Overall", "Survival", "(OS).", "<tag2>", "Following", "our", "announcement", "on", "January", "31,", "2013", "that", "the", "HEAT", "Study", "failed", "to", "meet", "its", "primary", "endpoint", "of", "progression", "free", "survival,", "we", "continued", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag3>"], "wordsA": ["As", "provided", "for", "in", "the", "SPA,", "we", "continued", "to", "follow", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint", "of", "Overall", "Survival", "(OS)."], "wordsB": ["Following", "our", "announcement", "on", "January", "31,", "2013", "that", "the", "HEAT", "Study", "failed", "to", "meet", "its", "primary", "endpoint", "of", "progression", "free", "survival,", "we", "continued", "to", "follow", "the", "patients", "enrolled", "in", "the", "HEAT", "Study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02404247410595417, 0.022783178836107254, 0.06058722361922264, 0.023988325148820877, 0.1153435930609703, 0.14571599662303925, 0.13455180823802948, 0.018499232828617096, 0.005790358874946833, 0.050161540508270264, 0.16143152117729187, 0.6327945590019226, 0.3713681101799011, 0.20062533020973206, 0.03199663758277893, 0.07163884490728378, 0.12005534023046494, 0.047678399831056595, 0.5445788502693176, 0.7097877860069275, 0.6435901522636414, 0.008031959645450115, 0.011720096692442894, 0.004394991789013147, 0.01743602193892002, 0.004690211731940508, 0.03290652483701706, 0.006642280146479607, 0.002671611960977316, 0.0027923390734940767, 0.009232362732291222, 0.012557591311633587, 0.0022524346131831408, 0.002913960488513112, 0.00779353454709053, 0.005730876699090004, 0.009663058444857597, 0.036080360412597656, -1]}
{"idB": "749647_18_item1_p238_s1", "idA": "749647_17_item1_p84_s1", "sentA": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, clearance for the OPTIMA Study, our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with standardized RFA in primary liver cancer.", "sentB": "We have not completed our final analysis of the data and do not know the extent to which, if any, the failure of ThermoDox to meet its primary endpoint in the Phase III trial could impact our other ongoing studies of ThermoDox including a pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with RFA in primary liver cancer, known as the OPTIMA study, which we launched in the first half of 2014.", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer.", "<tag2>", "We", "have", "not", "completed", "our", "final", "analysis", "of", "the", "data", "and", "do", "not", "know", "the", "extent", "to", "which,", "if", "any,", "the", "failure", "of", "ThermoDox", "to", "meet", "its", "primary", "endpoint", "in", "the", "Phase", "III", "trial", "could", "impact", "our", "other", "ongoing", "studies", "of", "ThermoDox", "including", "a", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "known", "as", "the", "OPTIMA", "study,", "which", "we", "launched", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer."], "wordsB": ["We", "have", "not", "completed", "our", "final", "analysis", "of", "the", "data", "and", "do", "not", "know", "the", "extent", "to", "which,", "if", "any,", "the", "failure", "of", "ThermoDox", "to", "meet", "its", "primary", "endpoint", "in", "the", "Phase", "III", "trial", "could", "impact", "our", "other", "ongoing", "studies", "of", "ThermoDox", "including", "a", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "known", "as", "the", "OPTIMA", "study,", "which", "we", "launched", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04694690182805061, 0.0703117698431015, 0.20309250056743622, 0.3226035535335541, 0.07170213758945465, 0.20244301855564117, 0.257795125246048, 0.055879537016153336, 0.0311043169349432, 0.06544577330350876, 0.01080677006393671, 0.0987228974699974, 0.11540337651968002, 0.08640314638614655, 0.029546506702899933, 0.040167003870010376, 0.025854019448161125, 0.019123537465929985, 0.024078337475657463, 0.02997857891023159, 0.024919888004660606, 0.15651369094848633, 0.08184100687503815, 0.11048810184001923, 0.049301572144031525, 0.04975208267569542, 0.022889800369739532, 0.045413896441459656, 0.030012689530849457, 0.007518062833696604, 0.007360866293311119, 0.009802372194826603, 0.008095785975456238, 0.01815224066376686, 0.0694788247346878, 0.10436760634183884, 0.01642872579395771, 0.013035831041634083, 0.05890769511461258, 0.0662541463971138, 0.023021290078759193, 0.01776896044611931, 0.0034019965678453445, 0.004343763459473848, 0.012401986867189407, 0.017144178971648216, 0.013972380198538303, 0.009624957107007504, 0.008447619155049324, 0.016315147280693054, 0.008029426448047161, 0.022575058043003082, 0.005581449717283249, 0.007513382472097874, 0.007339842151850462, 0.02146066538989544, 0.0044963243417441845, 0.046716317534446716, 0.035787805914878845, 0.01874220184981823, 0.004066980443894863, 0.0040831537917256355, 0.004965618252754211, 0.016588464379310608, 0.025641346350312233, 0.005546801723539829, 0.015321237966418266, 0.10859018564224243, 0.008433197624981403, 0.009688261896371841, 0.06535448879003525, 0.06006241589784622, 0.052754539996385574, 0.053519923239946365, -1]}
{"idB": "749647_18_item1_p267_s3", "idA": "749647_17_item1_p84_s1", "sentA": "On February 24, 2014, we announced that the FDA, after its customary 30 day review period, accepted without comment, subject to compliance with regulatory standards, clearance for the OPTIMA Study, our pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with standardized RFA in primary liver cancer.", "sentB": "Based on the overall survival data from the post-hoc analysis of results from the HEAT Study, we launched a pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox in combination with RFA in primary liver cancer, known as the OPTIMA Study, in the first half of 2014.", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer.", "<tag2>", "Based", "on", "the", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study,", "we", "launched", "a", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "known", "as", "the", "OPTIMA", "Study,", "in", "the", "first", "half", "of", "2014.", "<tag3>"], "wordsA": ["On", "February", "24,", "2014,", "we", "announced", "that", "the", "FDA,", "after", "its", "customary", "30", "day", "review", "period,", "accepted", "without", "comment,", "subject", "to", "compliance", "with", "regulatory", "standards,", "clearance", "for", "the", "OPTIMA", "Study,", "our", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "standardized", "RFA", "in", "primary", "liver", "cancer."], "wordsB": ["Based", "on", "the", "overall", "survival", "data", "from", "the", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study,", "we", "launched", "a", "pivotal,", "double-blind,", "placebo-controlled", "Phase", "III", "trial", "of", "ThermoDox", "in", "combination", "with", "RFA", "in", "primary", "liver", "cancer,", "known", "as", "the", "OPTIMA", "Study,", "in", "the", "first", "half", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05413675308227539, 0.039104193449020386, 0.018532227724790573, 0.42867526412010193, 0.4777291715145111, 0.28463658690452576, 0.01692861132323742, 0.01373424381017685, 0.20148715376853943, 0.22809021174907684, 0.018527911975979805, 0.06146702170372009, 0.025125140324234962, 0.014543312601745129, 0.15084131062030792, 0.37551450729370117, 0.018770061433315277, 0.11778193712234497, 0.017574207857251167, 0.013870121911168098, 0.010057788342237473, 0.008637028746306896, 0.010928326286375523, 0.01005974505096674, 0.05400507152080536, 0.007756123319268227, 0.01429580245167017, 0.004374105483293533, 0.007762460503727198, 0.006694268435239792, 0.01227357517927885, 0.0036245430819690228, 0.012147176079452038, 0.015556537546217442, 0.013461016118526459, 0.0032822294160723686, 0.003808707231655717, 0.004454017151147127, 0.015737324953079224, 0.02383403480052948, 0.008559281937777996, 0.008931410498917103, 0.05863264948129654, 0.058563005179166794, 0.06250281631946564, 0.05034574493765831, -1]}
{"idB": "749647_18_item1_p93_s0", "idA": "749647_17_item1_p85_s0", "sentA": "HCC incidence globally is approximately 800,000 new cases per year.", "sentB": "HCC incidence globally is approximately 850,000 new cases per year.", "type": 2, "words": ["<tag1>", "HCC", "incidence", "globally", "is", "approximately", "800,000", "new", "cases", "per", "year.", "<tag2>", "HCC", "incidence", "globally", "is", "approximately", "850,000", "new", "cases", "per", "year.", "<tag3>"], "wordsA": ["HCC", "incidence", "globally", "is", "approximately", "800,000", "new", "cases", "per", "year."], "wordsB": ["HCC", "incidence", "globally", "is", "approximately", "850,000", "new", "cases", "per", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04331369325518608, 0.022361481562256813, 0.012140374630689621, 0.007171331904828548, 0.025379275903105736, 0.9703715443611145, 0.08663685619831085, 0.07769731432199478, 0.007948680780827999, 0.013028997927904129, -1]}
{"idB": "749647_18_item1_p95_s0", "idA": "749647_17_item1_p87_s0", "sentA": "Designed with extensive input from globally recognized HCC researchers and clinicians and after formal written consultation with the FDA, the OPTIMA Study was launched in the first half of 2014.", "sentB": "Designed with extensive input from globally recognized HCC researchers and clinicians and after formal written consultation with the FDA, the OPTIMA Study was launched in the 2014.", "type": 2, "words": ["<tag1>", "Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014.", "<tag2>", "Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "2014.", "<tag3>"], "wordsA": ["Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "first", "half", "of", "2014."], "wordsB": ["Designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "written", "consultation", "with", "the", "FDA,", "the", "OPTIMA", "Study", "was", "launched", "in", "the", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.05247798189520836, 0.04914047569036484, 0.28792688250541687, 0.33609911799430847, 0.055702850222587585, 0.17358997464179993, 0.1364322006702423, 0.4570131003856659, 0.1849004477262497, 0.03155157342553139, 0.09512142837047577, 0.013826245442032814, 0.2741321623325348, 0.2038854956626892, 0.1387866735458374, 0.09861084073781967, 0.038535598665475845, 0.0251100305467844, 0.15650931000709534, 0.01614304818212986, 0.1076744869351387, 0.21062538027763367, 0.022064004093408585, 0.07364547252655029, 0.03482185676693916, 0.037564270198345184, 0.2535848617553711, -1]}
{"idB": "749647_18_item1_p8_s0", "idA": "749647_17_item1_p8_s0", "sentA": "Celsion is a fully-integrated , development stage oncology drug company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA based therapies.", "sentB": "Celsion is a fully-integrated development stage oncology drug company focused on advancing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA based therapies.", "type": 2, "words": ["<tag1>", "Celsion", "is", "a", "fully-integrated", ",", "development", "stage", "oncology", "drug", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA", "based", "therapies.", "<tag2>", "Celsion", "is", "a", "fully-integrated", "development", "stage", "oncology", "drug", "company", "focused", "on", "advancing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA", "based", "therapies.", "<tag3>"], "wordsA": ["Celsion", "is", "a", "fully-integrated", ",", "development", "stage", "oncology", "drug", "company", "focused", "on", "developing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA", "based", "therapies."], "wordsB": ["Celsion", "is", "a", "fully-integrated", "development", "stage", "oncology", "drug", "company", "focused", "on", "advancing", "a", "portfolio", "of", "innovative", "cancer", "treatments,", "including", "directed", "chemotherapies,", "DNA-mediated", "immunotherapy", "and", "RNA", "based", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.22645263373851776, 0.016800953075289726, 0.01815086230635643, 0.12660425901412964, 0.047029681503772736, 0.03788255527615547, 0.05197964608669281, 0.035687606781721115, 0.0456567220389843, 0.021834490820765495, 0.0210760198533535, 0.6561649441719055, 0.14558544754981995, 0.22704562544822693, 0.05072775110602379, 0.12461821734905243, 0.13091860711574554, 0.15118694305419922, 0.0235372856259346, 0.05265723168849945, 0.0732019767165184, 0.07460523396730423, 0.04631051793694496, 0.014488838613033295, 0.059135448187589645, 0.018401918932795525, 0.030316650867462158, -1]}
{"idB": "749647_18_item1_p8_s1", "idA": "749647_17_item1_p8_s1", "sentA": "Our lead product candidate is ThermoDox , a proprietary dosage form of doxorubicin based on a heat-activated liposomal platform technology, currently in a Phase III clinical trial for the treatment of non-resectable hepatocellular carcinoma ( HCC ), also known as primary liver cancer, and a Phase II clinical trial for recurrent chest wall breast cancer.", "sentB": "Our lead product candidate is ThermoDox , a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in a Phase III clinical trial for the treatment of primary liver cancer (the OPTIMA Study ), and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer (the DIGNITY Study ).", "type": 2, "words": ["<tag1>", "Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "dosage", "form", "of", "doxorubicin", "based", "on", "a", "heat-activated", "liposomal", "platform", "technology,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "non-resectable", "hepatocellular", "carcinoma", "(", "HCC", "),", "also", "known", "as", "primary", "liver", "cancer,", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer.", "<tag2>", "Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", "),", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ").", "<tag3>"], "wordsA": ["Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "dosage", "form", "of", "doxorubicin", "based", "on", "a", "heat-activated", "liposomal", "platform", "technology,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "non-resectable", "hepatocellular", "carcinoma", "(", "HCC", "),", "also", "known", "as", "primary", "liver", "cancer,", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer."], "wordsB": ["Our", "lead", "product", "candidate", "is", "ThermoDox", ",", "a", "proprietary", "heat-activated", "liposomal", "encapsulation", "of", "doxorubicin,", "currently", "in", "a", "Phase", "III", "clinical", "trial", "for", "the", "treatment", "of", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", "),", "and", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0026525321882218122, 0.010667779482901096, 0.010346450842916965, 0.020631369203329086, 0.003806916531175375, 0.016155533492565155, 0.0001697839907137677, 0.002968056360259652, 0.015882272273302078, 0.017430173233151436, 0.0396588109433651, 0.4393463134765625, 0.0683143362402916, 0.1101175993680954, 0.003391149453818798, 0.0026080331299453974, 0.0021808126475661993, 0.006679715123027563, 0.005580115597695112, 0.006223498377948999, 0.010530893690884113, 0.0024873127695173025, 0.0029630681965500116, 0.02921226993203163, 0.009182789362967014, 0.1121966689825058, 0.10398150980472565, 0.041153959929943085, 0.026136046275496483, 0.6371584534645081, 0.545712947845459, 0.0001086471529561095, 0.0035291635431349277, 0.002030477626249194, 0.009244338609278202, 0.007735425140708685, 0.010783814825117588, 0.01863105408847332, 0.002788312267512083, 0.002560126595199108, 0.017243940383195877, 0.003891449887305498, 0.015782581642270088, 0.012897025793790817, 0.012650981545448303, 0.014711737632751465, 0.018286846578121185, 0.01824101060628891, 0.6310060620307922, 0.6031829118728638, 9.89462569123134e-05, -1]}
{"idB": "749647_18_item1_p134_s0", "idA": "749647_17_item1_p8_s2", "sentA": "Our pipeline also includes GEN-1, a DNA-based immunotherapy currently in a Phase I clinical trial for the localized treatment of ovarian cancer and pre-clinical development for brain cancer.", "sentB": "On November 13, 2017, the Company filed its Phase I/II clinical trial protocol with the U.S. Food and Drug Administration for GEN-1 for the localized treatment of ovarian cancer.", "type": 2, "words": ["<tag1>", "Our", "pipeline", "also", "includes", "GEN-1,", "a", "DNA-based", "immunotherapy", "currently", "in", "a", "Phase", "I", "clinical", "trial", "for", "the", "localized", "treatment", "of", "ovarian", "cancer", "and", "pre-clinical", "development", "for", "brain", "cancer.", "<tag2>", "On", "November", "13,", "2017,", "the", "Company", "filed", "its", "Phase", "I/II", "clinical", "trial", "protocol", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "for", "GEN-1", "for", "the", "localized", "treatment", "of", "ovarian", "cancer.", "<tag3>"], "wordsA": ["Our", "pipeline", "also", "includes", "GEN-1,", "a", "DNA-based", "immunotherapy", "currently", "in", "a", "Phase", "I", "clinical", "trial", "for", "the", "localized", "treatment", "of", "ovarian", "cancer", "and", "pre-clinical", "development", "for", "brain", "cancer."], "wordsB": ["On", "November", "13,", "2017,", "the", "Company", "filed", "its", "Phase", "I/II", "clinical", "trial", "protocol", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "for", "GEN-1", "for", "the", "localized", "treatment", "of", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02727801539003849, 0.10951080918312073, 0.05261800065636635, 0.1628706008195877, 0.008474787697196007, 0.12349795550107956, 0.40729397535324097, 0.05964360013604164, 0.06216978281736374, 0.0679236575961113, 0.14271746575832367, 0.10295762121677399, 0.14470632374286652, 0.08127856254577637, 0.045076556503772736, 0.07009050250053406, 0.16809041798114777, 0.09202844649553299, 0.11982160061597824, 0.1627027690410614, 0.02761228382587433, 0.03593086078763008, 0.006610549986362457, 0.006129810120910406, 0.017368484288454056, 0.01764305680990219, 0.005075310356914997, 0.01205736305564642, 0.025541454553604126, -1]}
{"idB": "749647_18_item1_p268_s0", "idA": "749647_17_item1_p8_s2", "sentA": "Our pipeline also includes GEN-1, a DNA-based immunotherapy currently in a Phase I clinical trial for the localized treatment of ovarian cancer and pre-clinical development for brain cancer.", "sentB": "GEN-1 is currently in an early stage of clinical development for the treatment of ovarian cancer.", "type": 2, "words": ["<tag1>", "Our", "pipeline", "also", "includes", "GEN-1,", "a", "DNA-based", "immunotherapy", "currently", "in", "a", "Phase", "I", "clinical", "trial", "for", "the", "localized", "treatment", "of", "ovarian", "cancer", "and", "pre-clinical", "development", "for", "brain", "cancer.", "<tag2>", "GEN-1", "is", "currently", "in", "an", "early", "stage", "of", "clinical", "development", "for", "the", "treatment", "of", "ovarian", "cancer.", "<tag3>"], "wordsA": ["Our", "pipeline", "also", "includes", "GEN-1,", "a", "DNA-based", "immunotherapy", "currently", "in", "a", "Phase", "I", "clinical", "trial", "for", "the", "localized", "treatment", "of", "ovarian", "cancer", "and", "pre-clinical", "development", "for", "brain", "cancer."], "wordsB": ["GEN-1", "is", "currently", "in", "an", "early", "stage", "of", "clinical", "development", "for", "the", "treatment", "of", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.10450886934995651, 0.014871855266392231, 0.019299903884530067, 0.06190286949276924, 0.02926824428141117, 0.9366580247879028, 0.6116193532943726, 0.2043933868408203, 0.31907781958580017, 0.27543720602989197, 0.008235699497163296, 0.00907837226986885, 0.03167077153921127, 0.008763710968196392, 0.01863096095621586, 0.032852210104465485, -1]}
{"idB": "749647_18_item1_p60_s0", "idA": "749647_17_item1_p8_s2", "sentA": "Our pipeline also includes GEN-1, a DNA-based immunotherapy currently in a Phase I clinical trial for the localized treatment of ovarian cancer and pre-clinical development for brain cancer.", "sentB": "On November 13, 2017, the Company filed its Phase I/II clinical trial protocol with the U.S. Food and Drug Administration for GEN-1 for the localized treatment of ovarian cancer.", "type": 2, "words": ["<tag1>", "Our", "pipeline", "also", "includes", "GEN-1,", "a", "DNA-based", "immunotherapy", "currently", "in", "a", "Phase", "I", "clinical", "trial", "for", "the", "localized", "treatment", "of", "ovarian", "cancer", "and", "pre-clinical", "development", "for", "brain", "cancer.", "<tag2>", "On", "November", "13,", "2017,", "the", "Company", "filed", "its", "Phase", "I/II", "clinical", "trial", "protocol", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "for", "GEN-1", "for", "the", "localized", "treatment", "of", "ovarian", "cancer.", "<tag3>"], "wordsA": ["Our", "pipeline", "also", "includes", "GEN-1,", "a", "DNA-based", "immunotherapy", "currently", "in", "a", "Phase", "I", "clinical", "trial", "for", "the", "localized", "treatment", "of", "ovarian", "cancer", "and", "pre-clinical", "development", "for", "brain", "cancer."], "wordsB": ["On", "November", "13,", "2017,", "the", "Company", "filed", "its", "Phase", "I/II", "clinical", "trial", "protocol", "with", "the", "U.S.", "Food", "and", "Drug", "Administration", "for", "GEN-1", "for", "the", "localized", "treatment", "of", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.02727801539003849, 0.10951080918312073, 0.05261800065636635, 0.1628706008195877, 0.008474787697196007, 0.12349795550107956, 0.40729397535324097, 0.05964360013604164, 0.06216978281736374, 0.0679236575961113, 0.14271746575832367, 0.10295762121677399, 0.14470632374286652, 0.08127856254577637, 0.045076556503772736, 0.07009050250053406, 0.16809041798114777, 0.09202844649553299, 0.11982160061597824, 0.1627027690410614, 0.02761228382587433, 0.03593086078763008, 0.006610549986362457, 0.006129810120910406, 0.017368484288454056, 0.01764305680990219, 0.005075310356914997, 0.01205736305564642, 0.025541454553604126, -1]}
{"idB": "749647_18_item1_p44_s0", "idA": "749647_17_item1_p8_s3", "sentA": "GEN-1 is based on a platform technology for the development of treatments using novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.", "sentB": "We believe the rationale for local therapy with GEN-1 is based on the following.", "type": 2, "words": ["<tag1>", "GEN-1", "is", "based", "on", "a", "platform", "technology", "for", "the", "development", "of", "treatments", "using", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies.", "<tag2>", "We", "believe", "the", "rationale", "for", "local", "therapy", "with", "GEN-1", "is", "based", "on", "the", "following.", "<tag3>"], "wordsA": ["GEN-1", "is", "based", "on", "a", "platform", "technology", "for", "the", "development", "of", "treatments", "using", "novel", "nucleic", "acid-based", "immunotherapies", "and", "other", "anti-cancer", "DNA", "or", "RNA", "therapies."], "wordsB": ["We", "believe", "the", "rationale", "for", "local", "therapy", "with", "GEN-1", "is", "based", "on", "the", "following."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.09991597384214401, 0.10821062326431274, 0.034902915358543396, 0.2305913269519806, 0.04341256618499756, 0.3555681109428406, 0.5112908482551575, 0.01651473343372345, 0.03805188089609146, 0.027951223775744438, 0.11774445325136185, 0.09660716354846954, 0.10513775050640106, 0.4703141450881958, -1]}
{"idB": "749647_18_item1_p98_s2", "idA": "749647_17_item1_p90_s2", "sentA": "With the addition of these Chinese clinical sites, the Company expects to complete enrollment in the OPTIMA Study during the first half of 2018.", "sentB": "With the addition of these Chinese clinical sites, the Company expects to complete enrollment in the OPTIMA Study by the end of the third quarter of 2018.", "type": 2, "words": ["<tag1>", "With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "half", "of", "2018.", "<tag2>", "With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "by", "the", "end", "of", "the", "third", "quarter", "of", "2018.", "<tag3>"], "wordsA": ["With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "during", "the", "first", "half", "of", "2018."], "wordsB": ["With", "the", "addition", "of", "these", "Chinese", "clinical", "sites,", "the", "Company", "expects", "to", "complete", "enrollment", "in", "the", "OPTIMA", "Study", "by", "the", "end", "of", "the", "third", "quarter", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.0030002850107848644, 0.003321442985907197, 0.005135039333254099, 0.003079186426475644, 0.0032443844247609377, 0.005344254430383444, 0.005123709328472614, 0.006117545999586582, 0.002143861260265112, 0.007890916429460049, 0.006988487206399441, 0.003911509644240141, 0.012356887571513653, 0.01251691859215498, 0.003267860971391201, 0.002846722723916173, 0.005549262277781963, 0.009857063181698322, 0.14652767777442932, 0.07046496868133545, 0.6831852793693542, 0.2711387574672699, 0.16205203533172607, 0.8531038165092468, 0.7447934746742249, 0.463856965303421, 0.12781426310539246, -1]}
{"idB": "749647_18_item1_p20_s2", "idA": "749647_17_item1_p90_s3", "sentA": "On April 26, 2016, we announced that the first patient in China has been enrolled in the OPTIMA Study.", "sentB": "Subject to a successful trial, the OPTIMA Study has been designed to support registration in all key primary liver cancer markets.", "type": 2, "words": ["<tag1>", "On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "has", "been", "enrolled", "in", "the", "OPTIMA", "Study.", "<tag2>", "Subject", "to", "a", "successful", "trial,", "the", "OPTIMA", "Study", "has", "been", "designed", "to", "support", "registration", "in", "all", "key", "primary", "liver", "cancer", "markets.", "<tag3>"], "wordsA": ["On", "April", "26,", "2016,", "we", "announced", "that", "the", "first", "patient", "in", "China", "has", "been", "enrolled", "in", "the", "OPTIMA", "Study."], "wordsB": ["Subject", "to", "a", "successful", "trial,", "the", "OPTIMA", "Study", "has", "been", "designed", "to", "support", "registration", "in", "all", "key", "primary", "liver", "cancer", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.15336823463439941, 0.02807655744254589, 0.027202730998396873, 0.14577552676200867, 0.1972247064113617, 0.011068831197917461, 0.060687366873025894, 0.0906945988535881, 0.02060525305569172, 0.020210955291986465, 0.06315884739160538, 0.03265009820461273, 0.31671327352523804, 0.5262554883956909, 0.04771324619650841, 0.08322295546531677, 0.05994042009115219, 0.11063026636838913, 0.11507387459278107, 0.1430039256811142, 0.16572216153144836, -1]}
{"idB": "749647_18_item1_p104_s2", "idA": "749647_17_item1_p92_s2", "sentA": "As we evaluate strategic alternatives, we will need to consider a number of factors, including investment in, or acquisition of, complementary businesses, technologies or products, possible capital raising transactions, partnering opportunities and working capital requirements.", "sentB": "As we evaluate strategic alternatives, we will need to consider many factors, including investment in, or acquisition of, complementary businesses, technologies or products, possible capital raising transactions, partnering opportunities and working capital requirements.", "type": 2, "words": ["<tag1>", "As", "we", "evaluate", "strategic", "alternatives,", "we", "will", "need", "to", "consider", "a", "number", "of", "factors,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products,", "possible", "capital", "raising", "transactions,", "partnering", "opportunities", "and", "working", "capital", "requirements.", "<tag2>", "As", "we", "evaluate", "strategic", "alternatives,", "we", "will", "need", "to", "consider", "many", "factors,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products,", "possible", "capital", "raising", "transactions,", "partnering", "opportunities", "and", "working", "capital", "requirements.", "<tag3>"], "wordsA": ["As", "we", "evaluate", "strategic", "alternatives,", "we", "will", "need", "to", "consider", "a", "number", "of", "factors,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products,", "possible", "capital", "raising", "transactions,", "partnering", "opportunities", "and", "working", "capital", "requirements."], "wordsB": ["As", "we", "evaluate", "strategic", "alternatives,", "we", "will", "need", "to", "consider", "many", "factors,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products,", "possible", "capital", "raising", "transactions,", "partnering", "opportunities", "and", "working", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.020984191447496414, 0.05076169595122337, 0.0639936700463295, 0.05463613569736481, 0.057684581726789474, 0.03109821490943432, 0.027205288410186768, 0.03128376975655556, 0.028351055458188057, 0.06256070733070374, 0.6928830742835999, 0.1839551329612732, 0.03747932240366936, 0.06729104369878769, 0.04027346521615982, 0.02612237073481083, 0.05564732104539871, 0.036544352769851685, 0.04805287718772888, 0.051843736320734024, 0.04827887564897537, 0.02939467690885067, 0.044549889862537384, 0.03719001263380051, 0.051990706473588943, 0.05818777531385422, 0.04201744496822357, 0.036397311836481094, 0.04918419197201729, 0.027988173067569733, 0.042579423636198044, 0.04425092041492462, 0.03705061227083206, -1]}
{"idB": "749647_18_item1_p20_s0", "idA": "749647_17_item1_p94_s0", "sentA": "Breast cancer is the most common malignancy in women in both the U.S. and the world.", "sentB": "ThermoDox has received U.S. FDA Fast Track Designation and has been granted orphan drug designation for primary liver cancer in both the U.S. and the EU.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world.", "<tag2>", "ThermoDox", "has", "received", "U.S.", "FDA", "Fast", "Track", "Designation", "and", "has", "been", "granted", "orphan", "drug", "designation", "for", "primary", "liver", "cancer", "in", "both", "the", "U.S.", "and", "the", "EU.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world."], "wordsB": ["ThermoDox", "has", "received", "U.S.", "FDA", "Fast", "Track", "Designation", "and", "has", "been", "granted", "orphan", "drug", "designation", "for", "primary", "liver", "cancer", "in", "both", "the", "U.S.", "and", "the", "EU."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.5957674980163574, 0.02147808112204075, 0.036264561116695404, 0.022598404437303543, 0.024998867884278297, 0.039001986384391785, 0.043850526213645935, 0.0759478211402893, 8.762240031501278e-05, 0.005857397802174091, 0.009639168158173561, 0.06262994557619095, 0.29645398259162903, 0.32858389616012573, 0.1397673785686493, 0.015195255167782307, 0.08913982659578323, 0.5240369439125061, 0.40085914731025696, 0.0033124194014817476, 0.003684035502374172, 0.003539343597367406, 0.007259759586304426, 0.005623742006719112, 0.006673592142760754, 0.040616653859615326, -1]}
{"idB": "749647_18_item1_p20_s1", "idA": "749647_17_item1_p94_s0", "sentA": "Breast cancer is the most common malignancy in women in both the U.S. and the world.", "sentB": "Additionally, the U.S. FDA has provided ThermoDox with a 505(b)(2) registration pathway.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world.", "<tag2>", "Additionally,", "the", "U.S.", "FDA", "has", "provided", "ThermoDox", "with", "a", "505(b)(2)", "registration", "pathway.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world."], "wordsB": ["Additionally,", "the", "U.S.", "FDA", "has", "provided", "ThermoDox", "with", "a", "505(b)(2)", "registration", "pathway."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.015737369656562805, 0.01635959930717945, 0.05418379604816437, 0.154682919383049, 0.03226635605096817, 0.1306714415550232, 0.648554265499115, 0.03911786526441574, 0.038394950330257416, 0.19660663604736328, 0.28671178221702576, 0.22435227036476135, -1]}
{"idB": "749647_18_item1_p306_s0", "idA": "749647_17_item1_p94_s0", "sentA": "Breast cancer is the most common malignancy in women in both the U.S. and the world.", "sentB": "ThermoDox has been granted orphan drug designation for primary liver cancer in both the U.S. and Europe.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world.", "<tag2>", "ThermoDox", "has", "been", "granted", "orphan", "drug", "designation", "for", "primary", "liver", "cancer", "in", "both", "the", "U.S.", "and", "Europe.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world."], "wordsB": ["ThermoDox", "has", "been", "granted", "orphan", "drug", "designation", "for", "primary", "liver", "cancer", "in", "both", "the", "U.S.", "and", "Europe."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.6870569586753845, 0.033558592200279236, 0.029940256848931313, 0.09541020542383194, 0.3264641761779785, 0.33115431666374207, 0.13403131067752838, 0.019290786236524582, 0.11444444954395294, 0.4528035819530487, 0.37415656447410583, 0.004832389764487743, 0.005839094053953886, 0.005062214098870754, 0.010898703709244728, 0.006352108437567949, 0.0169245395809412, -1]}
{"idB": "749647_18_item1_p307_s0", "idA": "749647_17_item1_p94_s0", "sentA": "Breast cancer is the most common malignancy in women in both the U.S. and the world.", "sentB": "Regulatory authorities in some jurisdictions, including the U.S. and Europe, may designate drugs for relatively small patient populations as orphan drugs.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world.", "<tag2>", "Regulatory", "authorities", "in", "some", "jurisdictions,", "including", "the", "U.S.", "and", "Europe,", "may", "designate", "drugs", "for", "relatively", "small", "patient", "populations", "as", "orphan", "drugs.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world."], "wordsB": ["Regulatory", "authorities", "in", "some", "jurisdictions,", "including", "the", "U.S.", "and", "Europe,", "may", "designate", "drugs", "for", "relatively", "small", "patient", "populations", "as", "orphan", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.23433217406272888, 0.17542247474193573, 0.007716496009379625, 0.018034551292657852, 0.029363900423049927, 0.003098150249570608, 0.0030602964106947184, 0.006561973597854376, 0.005610623862594366, 0.009353579953312874, 0.016336066648364067, 0.1563754677772522, 0.5405265688896179, 0.010194552130997181, 0.021041011437773705, 0.10165145993232727, 0.13069498538970947, 0.07454561442136765, 0.061896342784166336, 0.5895518064498901, 0.527098536491394, -1]}
{"idB": "749647_18_item1_p323_s2", "idA": "749647_17_item1_p94_s0", "sentA": "Breast cancer is the most common malignancy in women in both the U.S. and the world.", "sentB": "The trial population must also adequately represent the U.S. population, and the data must be applicable to the U.S. population and U.S. medical practice in ways that the FDA deems clinically meaningful.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world.", "<tag2>", "The", "trial", "population", "must", "also", "adequately", "represent", "the", "U.S.", "population,", "and", "the", "data", "must", "be", "applicable", "to", "the", "U.S.", "population", "and", "U.S.", "medical", "practice", "in", "ways", "that", "the", "FDA", "deems", "clinically", "meaningful.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world."], "wordsB": ["The", "trial", "population", "must", "also", "adequately", "represent", "the", "U.S.", "population,", "and", "the", "data", "must", "be", "applicable", "to", "the", "U.S.", "population", "and", "U.S.", "medical", "practice", "in", "ways", "that", "the", "FDA", "deems", "clinically", "meaningful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.013856870122253895, 0.37211301922798157, 0.4391132593154907, 0.027077799662947655, 0.01204978208988905, 0.09252621978521347, 0.22104738652706146, 0.06508195400238037, 0.119660384953022, 0.18838465213775635, 9.140669862972572e-05, 0.005475990939885378, 0.11690793186426163, 0.019479813054203987, 0.018647508695721626, 0.09056343883275986, 0.019517509266734123, 0.013054359704256058, 0.04247358441352844, 0.05592302605509758, 0.010816811583936214, 0.036466084420681, 0.0660826712846756, 0.06231654807925224, 0.00011428246216382831, 0.010274472646415234, 0.005490836221724749, 0.006142658181488514, 0.03072326071560383, 0.031396687030792236, 0.034032076597213745, 0.027444791048765182, -1]}
{"idB": "749647_18_item1_p355_s2", "idA": "749647_17_item1_p94_s0", "sentA": "Breast cancer is the most common malignancy in women in both the U.S. and the world.", "sentB": "The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018.", "type": 2, "words": ["<tag1>", "Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world.", "<tag2>", "The", "Tax", "Reform", "Act", "permanently", "reduces", "the", "U.S.", "corporate", "income", "tax", "rate", "from", "a", "maximum", "of", "35%", "to", "a", "flat", "21%", "rate,", "effective", "January", "1,", "2018.", "<tag3>"], "wordsA": ["Breast", "cancer", "is", "the", "most", "common", "malignancy", "in", "women", "in", "both", "the", "U.S.", "and", "the", "world."], "wordsB": ["The", "Tax", "Reform", "Act", "permanently", "reduces", "the", "U.S.", "corporate", "income", "tax", "rate", "from", "a", "maximum", "of", "35%", "to", "a", "flat", "21%", "rate,", "effective", "January", "1,", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.030882690101861954, 0.5251259207725525, 0.29402801394462585, 0.23341043293476105, 0.042356979101896286, 0.14995381236076355, 0.049090150743722916, 0.12686945497989655, 0.5534471273422241, 0.7285600304603577, 0.5805842280387878, 0.34280896186828613, 0.03686319291591644, 0.01798178069293499, 0.04042401537299156, 0.05819978937506676, 0.22731240093708038, 0.017268290743231773, 0.014408051036298275, 0.11499916017055511, 0.1733996421098709, 0.1014430895447731, 0.01818416640162468, 0.014245315454900265, 0.015530681237578392, 0.051682353019714355, -1]}
{"idB": "749647_18_item1_p239_s1", "idA": "749647_17_item1_p9_s0", "sentA": "ThermoDox is being evaluated in a Phase III clinical trial, in combination with a standardized radiofrequency ablation ( RFA ), for primary liver cancer (the OPTIMA Study ) and a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study ).", "sentB": "ThermoDox is also being evaluated in a Phase II clinical trial for recurrent chest wall breast cancer and other preclinical studies.", "type": 2, "words": ["<tag1>", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ").", "<tag2>", "ThermoDox", "is", "also", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "other", "preclinical", "studies.", "<tag3>"], "wordsA": ["ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ")."], "wordsB": ["ThermoDox", "is", "also", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "other", "preclinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.00783469621092081, 0.0021068991627544165, 0.0035315826535224915, 0.0060926866717636585, 0.017359543591737747, 0.003055508015677333, 0.0021736130584031343, 0.008737512864172459, 0.006682916544377804, 0.010195769369602203, 0.015270921401679516, 0.00369967520236969, 0.015862464904785156, 0.014858797192573547, 0.00912400335073471, 0.019032128155231476, 0.02184196002781391, 0.016713030636310577, 0.02451740764081478, 0.9504402279853821, 0.47035762667655945, -1]}
{"idB": "749647_18_item1_p243_s1", "idA": "749647_17_item1_p9_s0", "sentA": "ThermoDox is being evaluated in a Phase III clinical trial, in combination with a standardized radiofrequency ablation ( RFA ), for primary liver cancer (the OPTIMA Study ) and a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study ).", "sentB": "For example, ThermoDox is being evaluated in a Phase III clinical trial in combination with RFA for the treatment of primary liver cancer and other preclinical studies.", "type": 2, "words": ["<tag1>", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ").", "<tag2>", "For", "example,", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "liver", "cancer", "and", "other", "preclinical", "studies.", "<tag3>"], "wordsA": ["ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ")."], "wordsB": ["For", "example,", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "in", "combination", "with", "RFA", "for", "the", "treatment", "of", "primary", "liver", "cancer", "and", "other", "preclinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.04090363159775734, 0.0177178755402565, 0.01132900733500719, 0.0023829422425478697, 0.00703450758010149, 0.01791025511920452, 0.0031044287607073784, 0.0024987973738461733, 0.006884243339300156, 0.005642079748213291, 0.0073262834921479225, 0.007994351908564568, 0.0033064470626413822, 0.005869966931641102, 0.004251562058925629, 0.011259578168392181, 0.003103327937424183, 0.003454846329987049, 0.02210736647248268, 0.004859625827521086, 0.018199484795331955, 0.026121078059077263, 0.01659790240228176, 0.013657060451805592, 0.026869071647524834, 0.9266922473907471, 0.5307453870773315, -1]}
{"idB": "749647_18_item1_p267_s4", "idA": "749647_17_item1_p9_s0", "sentA": "ThermoDox is being evaluated in a Phase III clinical trial, in combination with a standardized radiofrequency ablation ( RFA ), for primary liver cancer (the OPTIMA Study ) and a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study ).", "sentB": "ThermoDox is currently also being evaluated in a Phase II clinical trial for the treatment of recurrent chest wall breast cancer, known as the DIGNITY Study, and other preclinical studies.", "type": 2, "words": ["<tag1>", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ").", "<tag2>", "ThermoDox", "is", "currently", "also", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer,", "known", "as", "the", "DIGNITY", "Study,", "and", "other", "preclinical", "studies.", "<tag3>"], "wordsA": ["ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ")."], "wordsB": ["ThermoDox", "is", "currently", "also", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "the", "treatment", "of", "recurrent", "chest", "wall", "breast", "cancer,", "known", "as", "the", "DIGNITY", "Study,", "and", "other", "preclinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.010122228413820267, 0.003490834031254053, 0.006235855165868998, 0.005988243501633406, 0.011998388916254044, 0.02395063079893589, 0.003901710733771324, 0.002950236899778247, 0.009623649530112743, 0.007200759369879961, 0.011227057315409184, 0.016515439376235008, 0.004797452129423618, 0.006388362962752581, 0.03509650006890297, 0.01392342522740364, 0.06064674258232117, 0.03643240034580231, 0.025490187108516693, 0.03282730281352997, 0.021343786269426346, 0.004605276510119438, 0.004732680041342974, 0.004648769274353981, 0.07041266560554504, 0.07840675860643387, 0.012484083883464336, 0.021729154512286186, 0.904963493347168, 0.4946329891681671, -1]}
{"idB": "749647_18_item1_p9_s0", "idA": "749647_17_item1_p9_s0", "sentA": "ThermoDox is being evaluated in a Phase III clinical trial, in combination with a standardized radiofrequency ablation ( RFA ), for primary liver cancer (the OPTIMA Study ) and a Phase II clinical trial for recurrent chest wall breast cancer (the DIGNITY Study ).", "sentB": "ThermoDox , in combination with a standardized radiofrequency ablation ( RFA ), is being evaluated in a Phase III clinical trial for primary liver cancer (the OPTIMA Study ).", "type": 2, "words": ["<tag1>", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ").", "<tag2>", "ThermoDox", ",", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ").", "<tag3>"], "wordsA": ["ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial,", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")", "and", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "(the", "DIGNITY", "Study", ")."], "wordsB": ["ThermoDox", ",", "in", "combination", "with", "a", "standardized", "radiofrequency", "ablation", "(", "RFA", "),", "is", "being", "evaluated", "in", "a", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "OPTIMA", "Study", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 0.11131753027439117, 0.0003806693712249398, 0.017071636393666267, 0.03904141113162041, 0.01410446036607027, 0.00777947623282671, 0.034738510847091675, 0.040007855743169785, 0.02142510376870632, 0.014706128276884556, 0.11670611053705215, 0.00013432660489343107, 0.006037017796188593, 0.011951555497944355, 0.03181798756122589, 0.008108892478048801, 0.006750313565135002, 0.0179449450224638, 0.029265960678458214, 0.01539192721247673, 0.03174024447798729, 0.008946245536208153, 0.40642306208610535, 0.3429241478443146, 0.09322679042816162, 0.009091105312108994, 0.023780731484293938, 0.029827572405338287, 0.00012948407675139606, -1]}
